0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,ad8678de-ee78-d061-ea5f-d2a6b949b0e5, minocycline hydrochloride tablets are indicated in the treatment of the following infections due to susceptible strains of the designated microorganisms rocky mountain spotted fever  typhus fever and the typhus group  q fever  rickettsialpox and tick fevers caused by rickettsiae,1
1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,ad8678de-ee78-d061-ea5f-d2a6b949b0e5,respiratory tract infections caused by mycoplasma pneumoniae,1
2,2,2,2,2,2,2,2,2,2,2,2,2,2,2,2,2,2,2,2,ad8678de-ee78-d061-ea5f-d2a6b949b0e5,lymphogranuloma venereum caused by chlamydia trachomatis,1
3,3,3,3,3,3,3,3,3,3,3,3,3,3,3,3,3,3,3,3,ad8678de-ee78-d061-ea5f-d2a6b949b0e5,psittacosis ( ornithosis ) due to chlamydia psittaci,1
4,4,4,4,4,4,4,4,4,4,4,4,4,4,4,4,4,4,4,4,ad8678de-ee78-d061-ea5f-d2a6b949b0e5,trachoma caused by chlamydia trachomatis  although the infectious agent is not always eliminated  as judged by immunofluorescence,1
5,5,5,5,5,5,5,5,5,5,5,5,5,5,5,5,5,5,5,5,ad8678de-ee78-d061-ea5f-d2a6b949b0e5,inclusion conjunctivitis caused by chlamydia trachomatis,1
6,6,6,6,6,6,6,6,6,6,6,6,6,6,6,6,6,6,6,6,ad8678de-ee78-d061-ea5f-d2a6b949b0e5,nongonococcal urethritis  endocervical  or rectal infections in adults caused by ureaplasma urealyticum or chlamydia trachomatis,1
7,7,7,7,7,7,7,7,7,7,7,7,7,7,7,7,7,7,7,7,ad8678de-ee78-d061-ea5f-d2a6b949b0e5,relapsing fever due to borrelia recurrentis,1
8,8,8,8,8,8,8,8,8,8,8,8,8,8,8,8,8,8,8,8,ad8678de-ee78-d061-ea5f-d2a6b949b0e5,chancroid caused by haemophilus ducreyi plague due to yersinia pestis,1
9,9,9,9,9,9,9,9,9,9,9,9,9,9,9,9,9,9,9,9,ad8678de-ee78-d061-ea5f-d2a6b949b0e5,tularemia due to francisella tularensis,1
10,10,10,10,10,10,10,10,10,10,10,10,10,10,10,10,10,10,10,10,ad8678de-ee78-d061-ea5f-d2a6b949b0e5,cholera caused by vibrio cholerae,1
11,11,11,11,11,11,11,11,11,11,11,11,11,11,11,11,11,11,11,11,ad8678de-ee78-d061-ea5f-d2a6b949b0e5,campylobacter fetus infections caused by campylobacter fetus,1
12,12,12,12,12,12,12,12,12,12,12,12,12,12,12,12,12,12,12,12,ad8678de-ee78-d061-ea5f-d2a6b949b0e5,brucellosis due to brucella species ( in conjunction with streptomycin ),1
13,13,13,13,13,13,13,13,13,13,13,13,13,13,13,13,13,13,13,13,ad8678de-ee78-d061-ea5f-d2a6b949b0e5,bartonellosis due to bartonella bacilliformis,1
14,14,14,14,14,14,14,14,14,14,14,14,14,14,14,14,14,14,14,14,ad8678de-ee78-d061-ea5f-d2a6b949b0e5,granuloma inguinale caused by calymmatobacterium granulomatis,1
15,15,15,15,15,15,15,15,15,15,15,15,15,15,15,15,15,15,15,15,ad8678de-ee78-d061-ea5f-d2a6b949b0e5,minocycline is indicated for treatment of infections caused by the following gram negative microorganisms when bacteriologic testing indicates appropriate susceptibility to the drug escherichia coli,1
16,16,16,16,16,16,16,16,16,16,16,16,16,16,16,16,16,16,16,16,ad8678de-ee78-d061-ea5f-d2a6b949b0e5,respiratory tract infections caused by haemophilus influenzae,1
17,17,17,17,17,17,17,17,17,17,17,17,17,17,17,17,17,17,17,17,2c272405-837d-007f-e054-00144ff88e88, use as prescribed,0
18,18,18,18,18,18,18,18,18,18,18,18,18,18,18,18,18,18,18,18,16a441d8-610e-de3f-c352-9c0fab0b9d3c, libido formulated for symptoms associated with libido imbalance  hormonal changes and erectile dysfunction,1
19,19,19,19,19,19,19,19,19,19,19,19,19,19,19,19,19,19,19,19,7f2a7a7b-d750-623a-74e0-f96b8d41cbb8, hyperactivity mental focus formulated for symptoms associated with adult attention deficit and hyperactivity disorders  for emotional balance and mental focus,1
20,20,20,20,20,20,20,20,20,20,20,20,20,20,20,20,20,20,20,20,a9b53259-8388-76fa-6e83-2b8ca1f5358b, incontinence formulated for symptoms associated with various types of incontinence such as stress incontinence  urge incontinence and overflow incontinence,1
21,21,21,21,21,21,21,21,21,21,21,21,21,21,21,21,21,21,21,21,3402f015-7456-4142-bb9b-bcbd6a29c067, uses for temporary relief of confusion about sexual identity  sexual guilt or depression  denial of sexuality,1
22,22,22,22,22,22,22,22,22,22,22,22,22,22,22,22,22,22,22,22,7adf3df7-3f05-20de-5cb9-9b66a7bbe5fa,product name indications section prostate formulated for symptoms associated with erectile dysfunction  benign prostatic hypertrophy  prostatitis  dysuria and other prostate related conditions,1
23,23,23,23,23,23,23,23,23,23,23,23,23,23,23,23,23,23,23,23,c4874f89-3040-48df-a6c4-e0a4af5365f6,indications for temporary relief of hunger sensations  overeating  obesity  overweight  adipose storage  excessive appetite  cravings for sweets starches  abdominal fat,1
24,24,24,24,24,24,24,24,24,24,24,24,24,24,24,24,24,24,24,24,8d7842e2-c508-4e15-a4f8-595ac9e58163,indications for temporary relief of acute stress due to emotional strain  anxiety  sleeplessness  apprehension or fear,1
25,25,25,25,25,25,25,25,25,25,25,25,25,25,25,25,25,25,25,25,c6f22638-e6da-81fb-bfa6-d1668183fec0, oral care gingivitis formulated for symptoms associated with periodontal conditions such as mouth ulcerations  gingivitis  halitosis  teeth pain and gum sensitivity,1
26,26,26,26,26,26,26,26,26,26,26,26,26,26,26,26,26,26,26,26,c3760d58-05f0-973d-f5e8-6f672eb82e73, injury rescue formulated for symptoms associated with injury  trauma or surgery such as pain  shock  emotional upset  bruising and inflammation,1
27,27,27,27,27,27,27,27,27,27,27,27,27,27,27,27,27,27,27,27,51034a86-2b78-419a-5bbc-338211e903c1, fear phobia formulated for symptoms associated with fears and phobias such as agoraphobia  acrophobia  aviophobia  claustrophobia and stage fright,1
28,28,28,28,28,28,28,28,28,28,28,28,28,28,28,28,28,28,28,28,5465a1ad-e29f-21a7-1f51-fb3bdb481f20, warts moles skin tags formulated for various types of skin conditions such as warts ( including genital )  moles  keloids  molluscum and skin tags,1
29,29,29,29,29,29,29,29,29,29,29,29,29,29,29,29,29,29,29,29,24754d27-186c-424f-9066-91225e6bd562,uses temporarily relieves nausea  vomiting  pain  soreness restless sleep after surgical procedures,1
30,30,30,30,30,30,30,30,30,30,30,30,30,30,30,30,30,30,30,30,10be3e95-da2f-4340-8c12-2e676472a94d,uses temporarily relieves pain and soreness due to injury,1
31,31,31,31,31,31,31,31,31,31,31,31,31,31,31,31,31,31,31,31,24877f94-a1de-4b3a-9f1c-409269ea192c, uses a natural aid for negativity toward sexual matters  misdirected or harmful erotic thoughts  guilt over sexual issues  effects of sexual abuse,1
32,32,32,32,32,32,32,32,32,32,32,32,32,32,32,32,32,32,32,32,fe431ed4-ea6f-4e99-b4bc-ec25ae7b8553,1  kybella is a cytolytic drug indicated for improvement in the appearance of moderate to severe convexity or fullness associated with submental fat in adults,1
33,33,33,33,33,33,33,33,33,33,33,33,33,33,33,33,33,33,33,33,fe431ed4-ea6f-4e99-b4bc-ec25ae7b8553,( 1 1 ) limitation of use the safe and effective use of kybella for the treatment of subcutaneous fat outside the submental region has not been established and is not recommended,2
34,34,34,34,34,34,34,34,34,34,34,34,34,34,34,34,34,34,34,34,fe431ed4-ea6f-4e99-b4bc-ec25ae7b8553,( 1 2 ) 1 1 fullness associated with submental fat kybella ( deoxycholic acid ) injection is indicated for improvement in the appearance of moderate to severe convexity or fullness associated with submental fat in adults,1
35,35,35,35,35,35,35,35,35,35,35,35,35,35,35,35,35,35,35,35,fe431ed4-ea6f-4e99-b4bc-ec25ae7b8553,1 2 limitation of use the safe and effective use of kybella for the treatment of subcutaneous fat outside the submental region has not been established and is not recommended,0
36,36,36,36,36,36,36,36,36,36,36,36,36,36,36,36,36,36,36,36,2d3ef049-e9c0-3e60-e054-00144ff88e88, for temporary relief of symptms of excess body fat and the inability to metabolize body fat,1
37,37,37,37,37,37,37,37,37,37,37,37,37,37,37,37,37,37,37,37,419e4aa7-987b-8d29-3520-7117038ef287,product name indications section heavy metal amalga detox formulated for symptoms of heavy metal and amalgam exposure such as fatigue  headaches  compromised immunity and sluggish elimination,1
38,38,38,38,38,38,38,38,38,38,38,38,38,38,38,38,38,38,38,38,5a47186d-964b-42e2-bc55-c18cd6fbc08f, allergenic extract is used for diagnostic testing and for the treatment ( immunotherapy ) of patients whose histories indicate that upon natural exposure to the allergen  they experience allergic symptoms,1
39,39,39,39,39,39,39,39,39,39,39,39,39,39,39,39,39,39,39,39,5a47186d-964b-42e2-bc55-c18cd6fbc08f,confirmation is determined by skin testing,0
40,40,40,40,40,40,40,40,40,40,40,40,40,40,40,40,40,40,40,40,5a47186d-964b-42e2-bc55-c18cd6fbc08f,diagnostic use of allergenic extracts usually begins with direct skin testing,4
41,41,41,41,41,41,41,41,41,41,41,41,41,41,41,41,41,41,41,41,5a47186d-964b-42e2-bc55-c18cd6fbc08f,this product is not intended for treatment of patients who do not manifest immediate hypersensitivity reactions to the allergenic extract following skin testing,2
42,42,42,42,42,42,42,42,42,42,42,42,42,42,42,42,42,42,42,42,2bae60bf-dda8-4710-9459-714552084fdd,indications to speed muscle recovery time and assist the body in replacing spent electrolytes after exertion,1
43,43,43,43,43,43,43,43,43,43,43,43,43,43,43,43,43,43,43,43,2bae60bf-dda8-4710-9459-714552084fdd,these statements are based upon traditional homeopathic practice,
44,44,44,44,44,44,44,44,44,44,44,44,44,44,44,44,44,44,44,44,2bae60bf-dda8-4710-9459-714552084fdd,they have not been reviewed by the food and drug administration,0
45,45,45,45,45,45,45,45,45,45,45,45,45,45,45,45,45,45,45,45,fd3b2868-746d-48a2-acaa-17b926bc7c6e,homeopathic indications for temporary relief of symptoms related to heavy metal toxicity caused by toxic dental materials in the mouth,1
46,46,46,46,46,46,46,46,46,46,46,46,46,46,46,46,46,46,46,46,fd3b2868-746d-48a2-acaa-17b926bc7c6e,these include muscle cramps  ulcerations  inflammation  mental confusion and joint pain,1
47,47,47,47,47,47,47,49,49,49,49,49,49,49,49,49,49,49,49,49,b7347635-bc34-c047-6e90-ef7a0fe52d36, connective tissue formulated for symptoms associated with lupus  rheumatoid arthritis  fibromyalgia  neuralgia  scleroderma and other immune related conditions,1
48,48,48,48,48,48,48,50,50,50,50,50,50,50,50,50,50,50,50,50,d11432b4-74a0-7de5-dde2-973896201931, formulated for symptoms associated with respiratory  gastro intestinal  integumentary or vascular systems,1
49,49,49,49,49,49,49,52,52,52,52,52,52,52,52,52,52,52,52,52,2e8f5361-5b20-f3aa-743d-4fe0cd562959, formulated for symptoms associated with a compromised immune system such as hypersensitivity  debility  glandular swellings  infections and inflammation,1
50,50,50,50,50,50,50,53,53,53,53,53,53,53,53,53,53,53,53,53,e4c9240d-46fe-6586-bedc-f74d070ec2d4,product name indications section hemorrhoids formulated for associated symptoms such as enlarged or bleeding hemorrhoidal veins  itching  inflammation  burning pain and pressure,1
51,51,51,51,51,51,51,54,54,54,54,54,54,54,54,54,54,54,54,54,40192502-5a80-4375-abd6-ed7327442845,swollen glands  sinus congestion  head congestion  mucous secretions  skin eruptions,1
52,52,52,52,52,52,52,55,55,55,55,55,55,55,55,55,55,55,55,55,e7c5d1e7-8f0b-bb84-9e95-d41af27bdf52, ear care formulated for symptoms associated with meniere 's disease  mastoiditis  otitis  otorrhea and other related ear conditions,1
53,53,53,53,53,53,53,56,56,56,56,56,56,56,56,56,56,56,56,56,7ab56d67-f1b5-4366-b626-b94c696a01b7,uses a natural aid for discouragement  disappointment  humiliation  bitterness  intolerance of criticism  rejection and contradiction,1
54,54,54,54,54,54,54,57,57,57,57,57,57,57,57,57,57,57,57,57,6053bb74-b6cf-67ee-e053-2991aa0a993c, depression mood distress formulated for associated symptoms such as grief  despondency  difficult concentration  irritability  oversensitivity and prolonged sadness,1
55,55,55,55,55,55,55,58,58,58,58,58,58,58,58,58,58,58,58,58,a89820d0-26e1-d70e-9131-4a02423f9109, tinnitus formulated for associated symptoms such as ringing  buzzing  echoing  pressure  pain  throbbing and sensitivity to noise,1
56,56,56,56,56,56,56,63,63,63,63,63,63,63,63,63,63,63,63,63,6dc279cc-9861-4fa8-8083-ca3b3c57b513,1  terbinafine tablets  usp are indicated for the treatment of onychomycosis of the toenail or fingernail due to dermatophytes ( tinea unguium ),1
57,57,57,57,57,57,57,64,64,64,64,64,64,64,64,64,64,64,64,64,6dc279cc-9861-4fa8-8083-ca3b3c57b513,prior to initiating treatment  appropriate nail specimens for laboratory testing potassium hydroxide ( koh ) preparation  fungal culture  or nail biopsy should be obtained to confirm the diagnosis of onychomycosis,4
58,58,58,58,58,58,58,65,65,65,65,65,65,65,65,65,65,65,65,65,6dc279cc-9861-4fa8-8083-ca3b3c57b513,terbinafine tablets are an allylamine antifungal indicated for the treatment of onychomycosis of the toenail or fingernail due to dermatophytes ( tinea unguium ),1
59,59,59,59,59,59,59,66,66,66,66,66,66,66,66,66,66,66,66,66,26081998-16db-41f6-b366-3fd7007b99de, allergenic extracts are indicated for use in diagnostic testing and as part of a treatment regime for allergic disease  as established by allergy history and skin test reactivity,1
60,60,60,60,60,60,60,67,67,67,67,67,67,67,67,67,67,67,67,67,26081998-16db-41f6-b366-3fd7007b99de,allergenic extracts are indicated for the treatment of allergen specific allergic disease for use as hyposensitization or immunotherapy when avoidance of specific allergens can not be attained,1
61,61,61,61,61,61,61,68,68,68,68,68,68,68,68,68,68,68,68,68,26081998-16db-41f6-b366-3fd7007b99de,the use of allergenic extracts for therapeutic purpose has been established by well controlled clinical studies,0
62,62,62,62,62,62,62,69,69,69,69,69,69,69,69,69,69,69,69,69,26081998-16db-41f6-b366-3fd7007b99de,allergenic extracts may be used as adjunctive therapy along with pharmacotherapy which includes antihistamines  corticosteroids  and cromoglycate  and avoidance measures,1
63,63,63,63,63,63,63,70,70,70,70,70,70,70,70,70,70,70,70,70,26081998-16db-41f6-b366-3fd7007b99de,allergenic extracts for therapeutic use should be given using only the allergen selection to which the patient is allergic  has a history of exposure and are likely to be exposed to again,4
64,64,64,64,64,64,64,71,71,71,71,71,71,71,71,71,71,71,71,71,2b881e46-28c6-41e3-9ef0-bbd425abda2d, uses for absent mindedness  confusion  forgetfulness  slow perception or comprehension,1
65,65,65,65,65,65,65,72,72,72,72,72,72,72,72,72,72,72,72,72,b34eb42a-fca0-2b42-1429-886121bd5178, insect bites formulated for symptoms associated with bites and stings such as pain  burning  itching and swelling,1
66,66,66,66,66,66,66,73,73,73,73,73,73,73,73,73,73,73,73,73,60c69d77-3cac-d1e7-5307-9423b79044b1, tobacco withdrawal formulated for symptoms associated with tobacco use such as anxiety  cravings  irritability  tremors  stress  dyspnea  cough  excess mucus and headaches,1
67,67,67,67,67,67,67,74,74,74,74,74,74,74,74,74,74,74,74,74,2970ff61-3c7a-c55d-ee8e-628a7bdd2fa5, vaginitis feminine care formulated for symptoms associated with vaginitis and leucorrhea such as itching  burning  dryness  swelling  snoreness and discharge,1
68,68,68,68,68,68,68,75,75,75,75,75,75,75,75,75,75,75,75,75,e8b76200-c0aa-491b-aad7-e22d2f68496f,1  prohance is a gadolinium based paramagnetic mri contrast agent indicated for intravenous use to visualize lesions with abnormal vascularity in the brain ( intracranial lesions )  spine and associated tissues in adults and pediatric patients over 2 years of age ( 1 1 ) lesions in the head and neck in adults ( 1 2 ) 1 1 mri of the central nervous system ( cns ) prohance is indicated for use in magnetic resonance imaging ( mri ) in adults and pediatric patients over 2 years of age to visualize lesions with abnormal vascularity in the brain ( intracranial lesions )  spine and associated tissues,1
69,69,69,69,69,69,69,76,76,76,76,76,76,76,76,76,76,76,76,76,e8b76200-c0aa-491b-aad7-e22d2f68496f,1 2 mri of extracranial extraspinal tissues prohance is indicated for use in mri in adults to visualize lesions in the head and neck,1
70,70,70,70,70,70,70,86,86,86,86,86,86,86,86,86,86,86,86,86,1b022d6f-3049-140c-e054-00144ff8d46c, appetite control formulated for symptoms associated with compromised glucose metabolism such as overeating  cravings  fatigue and emotional discomfort,1
71,71,71,71,71,71,71,87,87,87,87,87,87,87,87,87,87,87,87,87,9dc40eda-2420-0a9b-cabe-172f38653fcb,product name indications section insomnia formulated for associated symptoms such as the inability to fall asleep as well as return to sleep after waking  frequent waking and restlessness,1
72,72,72,72,72,72,72,88,88,88,88,88,88,88,88,88,88,88,88,88,f80a8b31-394c-7efc-d4b0-f44ffe3cd138, insomnia formulated for associated symptoms such as the inability to fall asleep as well as return to sleep after waking  frequent waking and restlessness,1
73,73,73,73,73,73,73,89,89,89,89,89,89,89,89,89,89,89,89,89,216b6e1f-e0a8-40db-9d19-6e3f16ae0172,indications targets symptoms of hunger cravings  overeating  obesity  overweight  adipose storage  excessive appetite  cravings for sweets and starches  abdominal fat,1
74,74,74,74,74,74,74,90,90,90,90,90,90,90,90,90,90,90,90,90,3e3a703b-7fe3-7b9e-478e-f18638f65240, female fibroids formulated for symptoms associated with non malignant uterine or ovarian fibroids  ovarian or vaginal cysts and uterine polyps,1
75,75,75,75,75,75,75,91,91,91,91,91,91,91,91,91,91,91,91,91,d3f2d68b-9b8f-1529-93c9-8335198ea5a9, restless leg formulated for symptoms associated with restless leg syndrome  parkinson 's  neuroleptic induced akathisia and other related conditions,1
76,76,76,76,76,76,76,92,92,92,92,92,92,92,92,92,92,92,92,92,481bd51c-afc6-4b33-abce-6f94ef6b1483,indication and usage placenta compositum injection solution is indicated for stimulation of metabolic functions of the peripheral circulation of the blood as well as for a revitalizing and stimulating effect on the liver and peripheral vascular system,1
77,77,77,77,77,77,77,93,93,93,93,93,93,93,93,93,93,93,93,93,481bd51c-afc6-4b33-abce-6f94ef6b1483,placenta compositum injection solution is classified as a homeopathic combination drug,0
78,78,78,78,78,78,78,94,94,94,94,94,94,94,94,94,94,94,94,94,481bd51c-afc6-4b33-abce-6f94ef6b1483,botanical ingredients aesculus hippocastanum ( horse chestnut ) melilotus officinalis ( yellow sweet clover ) secale cornutum ( rye ergot ) solanum nigrum ( black nightshade ) strophanthus hispidus ( strophanthus ) tabacum ( tobacco ) mineral ingredients baryta carbonica ( barium carbonate ) cuprum sulphuricum ( copper sulfate ) natrum pyruvicum ( sodium pyruvate ) plumbum iodatum ( lead iodide ) sarcolacticum acidum ( l lactic acid ) animal derived ingredients arteria suis ( porcine artery ) embryo suis ( porcine embryo ) funiculus umbilicalis suis ( porcine umbilical cord ) placenta suis ( porcine placenta ) vena suis ( porcine vein ) vipera berus ( common viper ),0
79,79,79,79,79,79,79,95,95,95,95,95,95,95,95,95,95,95,95,95,230fa998-20ef-46ef-8252-7ac87b58040b,fem repair non preg for the temporary relief of headaches  nausea  swelling  night sweats and irritability with abnormal menstrual flow and function,1
80,80,80,80,80,80,80,96,96,96,96,96,96,96,96,96,96,96,96,96,af25d44a-3ef1-43e5-ec41-121dcb484c5a, headache migraine formulated for associated symptoms such as throbbing pain  pressure  congestion  dizziness  nausea and light sensitivity,1
81,81,81,81,81,81,81,97,97,97,97,97,97,97,97,97,97,97,97,97,2c516866-b1c3-4910-b665-6c20ca21e9af,indications for the temporary relief of symptoms associated with chronic skin disorders such as warts  itching  and eczema symptoms of liver damage such as nausea  vomiting  and right upper quadrant pain and symptoms of depression such as feeling sad  difficulty in concentrating  and inability to focus,1
82,82,82,82,82,82,82,98,98,98,98,98,98,98,98,98,98,98,98,98,064db435-6737-75ab-b84a-7590d5dbf99d, menstrual pms formulated for associated symptoms such as irregularity  cramping  bloating  headache  cravings  emotional upsets and mood swings,1
83,83,83,83,83,83,83,99,99,99,99,99,99,99,99,99,99,99,99,99,a6598a5b-5714-aae6-80ca-e9284fcb3c66, menorrhagia formulated for associated symptoms such as uterine fibroids  uterine polyps  endometriosis and other uterine and ovarian conditions,1
84,84,84,84,84,84,84,100,100,100,100,100,100,100,100,100,100,100,100,100,cce9998b-1d26-04ae-ebd5-302be37b538a, endometriosis formulated for associated symptoms such as menorrhagia  dysmenorrhea  dyspareunia and infertility,1
85,85,85,85,85,85,85,101,101,101,101,101,101,101,101,101,101,101,101,101,a54dd642-8884-415a-a082-cd9fb544e400,indications se natal 19 chewable tablets are indicated for use in improving the nutritional status of women throughout pregnancy and in the postnatal period for both lactating and non lactating mothers,1
86,86,86,86,86,86,86,102,102,102,102,102,102,102,102,102,102,102,102,102,a54dd642-8884-415a-a082-cd9fb544e400,se natal 19 chewable tablets are also useful in improving the nutritional status of women prior to conception,u
87,87,87,87,87,87,87,103,103,103,103,103,103,103,103,103,103,103,103,103,9b79c950-4312-4a53-9e36-fb8e00b053df,indications prenate elite is a multivitamin multimineral fatty acid dietary supplement indicated for use in improving the nutritional status of women throughout pregnancy and in the postnatal period for both lactating and nonlactating mothers,1
88,88,88,88,88,88,88,104,104,104,104,104,104,104,104,104,104,104,104,104,40fa2c3a-f41f-434c-91de-5150a18d3e4b,usage vitafol ultra provides vitamin  mineral  and dha supplementation prior to conception  throughout pregnancy  and during the postnatal period for the lactating and non lactating mother  including individuals with known allergies to fish,u
89,89,89,89,89,89,89,105,105,105,105,105,105,105,105,105,105,105,105,105,40fa2c3a-f41f-434c-91de-5150a18d3e4b,vitafol ultra does not contain fish  fish oils  fish proteins or fish byproducts,0
90,90,90,90,90,90,90,106,106,106,106,106,106,106,106,106,106,106,106,106,adc77b02-a00f-430b-ae61-f89387b6fe3b,usage select ob chewable caplets provide vitamin and mineral supplementation prior to conception  throughout pregnancy  and during the postnatal period for the lactating and non lactating mother,u
91,91,91,91,91,91,91,107,107,107,107,107,107,107,107,107,107,107,107,107,cb5c567a-8733-4004-832e-de8132b8da9e, select ob dha is indicated to provide vitamin  mineral  and omega 3 fatty acid supplementation prior to conception  throughout pregnancy  and during the postnatal period for the lactating and non lactating mother  including individuals with known allergies to fish,1
92,92,92,92,92,92,92,108,108,108,108,108,108,108,108,108,108,108,108,108,cb5c567a-8733-4004-832e-de8132b8da9e,select ob dha does not contain fish  fish oils  fish proteins or fish byproducts,0
93,93,93,93,93,93,93,109,109,109,109,109,109,109,109,109,109,109,109,109,bf9624d8-b2ef-45a4-9ad6-a3b8701e76b7, active fe is indicated for the prevention and treatment of iron deficiency anemia and or nutritional megaloblastic anemias this statement has not been evaluated by the food and drug administration,1
94,94,94,94,94,94,94,110,110,110,110,110,110,110,110,110,110,110,110,110,bf9624d8-b2ef-45a4-9ad6-a3b8701e76b7,this product is not intended to diagnose  treat  cure  or prevent disease,0
95,95,95,95,95,95,95,111,111,111,111,111,111,111,111,111,111,111,111,111,9532f8de-115c-4f37-9148-2e6899800f65,indications this product is a gluten free prescription regimen of prenatal multi vitamin  multi mineral and omega 3 fatty acid supplements indicated for use in improving the nutritional status of women throughout pregnancy and in the post natal period for both lactating and non lactating mothers,1
96,96,96,96,96,96,96,112,112,112,112,112,112,112,112,112,112,112,112,112,9532f8de-115c-4f37-9148-2e6899800f65,this product is also useful in improving the nutritional status prior to conception,u
97,97,97,97,97,97,97,113,113,113,113,113,113,113,113,113,113,113,113,113,0b2d95e4-5846-47dd-bddf-53a7db0dadbe,indications pr natal 430 ec is a prescription regimen of prenatal multi vitamin  multi mineral  and omega 3 fatty acid supplements indicated for use in improving the nutritional status of women throughout pregnancy and in the post natal period for both lactating and non lactating mothers,1
98,98,98,98,98,98,98,114,114,114,114,114,114,114,114,114,114,114,114,114,0b2d95e4-5846-47dd-bddf-53a7db0dadbe,pr natal 430 ec is also useful in improving nutritional status prior to conception,u
99,99,99,99,99,99,99,115,115,115,115,115,115,115,115,115,115,115,115,115,1af224e5-440b-4376-bcb6-625563a4bf29,indications to provide vitamin and mineral supplementation throughout pregnancy and during the postnatal period for both the lactating and non lactating mother,1
100,100,100,100,100,100,100,116,116,116,116,116,116,116,116,116,116,116,116,116,1af224e5-440b-4376-bcb6-625563a4bf29,it is also useful for improving nutritional status prior to conception,u
101,101,101,101,101,101,101,119,119,119,119,119,119,119,119,119,119,119,119,119,8283f298-0c56-444a-88e4-d508ff86e026, to provide vitamin and mineral supplementation throughout pregnancy and during the postnatal period for both the lactating and non lactating mother,u
102,102,102,102,102,102,102,121,121,121,121,121,121,121,121,121,121,121,121,121,aab1f6c4-4fdb-49df-9610-31c5d1e9a5a5,indications prenatal 19 tablets are indicated for use in improving the nutritional status of women throughout pregnancy and in the postnatal period for both lactating and non lactating mothers,1
103,103,103,103,103,103,103,122,122,122,122,122,122,122,122,122,122,122,122,122,aab1f6c4-4fdb-49df-9610-31c5d1e9a5a5,prenatal 19 tablets are also useful in improving the nutritional status of women prior to conception,u
104,104,104,104,104,104,104,123,123,123,123,123,123,123,123,123,123,123,123,123,198442c8-730a-4635-a496-91e4767714a3,indications prenatal 19 chewable tablets are indicated for use in improving the nutritional status of women throughout pregnancy and in postnatal period for both lactating and non lactating mothers,1
105,105,105,105,105,105,105,124,124,124,124,124,124,124,124,124,124,124,124,124,198442c8-730a-4635-a496-91e4767714a3,prenatal 19 chewable tablets are also useful in improving the nutritional status of women prior to conception,u
106,106,106,106,106,106,106,125,125,125,125,125,125,125,125,125,125,125,125,125,635104e6-6a53-4684-ac9a-7ac31b33083d,indications se natal 19 tablets are indicated for use in improving the nutritional status of women throughout pregnancy and in the postnatal period for both lactating and non lactating mothers,1
107,107,107,107,107,107,107,126,126,126,126,126,126,126,126,126,126,126,126,126,635104e6-6a53-4684-ac9a-7ac31b33083d,se natal 19 tablets are also useful in improving the nutritional status of women prior to conception,u
108,108,108,108,108,108,108,127,127,127,127,127,127,127,127,127,127,127,127,127,f7445e81-8ae7-47fb-81c0-6b14837edbe4,indications this product is a gluten free prescription regimen of prenatal multi vitamin  multi mineral and omega fatty acid supplements indicated for use in improving the nutritional status of women throughout pregnancy and in the post natal period for both lactating and non lactating mothers,1
109,109,109,109,109,109,109,129,129,129,129,129,129,129,129,129,129,129,129,129,043f8497-8bb3-4604-84eb-d463ef25f724, natachew is a prescription pre post natal multivitamin  multimineral indicated for use in improving the nutritional status of women throughout pregnancy  as well as in the post natal period for both lactating and non lactating mothers,1
110,110,110,110,110,110,110,130,130,130,130,130,130,130,130,130,130,130,130,130,043f8497-8bb3-4604-84eb-d463ef25f724,this product is also useful in improving the nutritional status of women prior to conception,u
111,111,111,111,111,111,111,131,131,131,131,131,131,131,131,131,131,131,131,131,8ddbb72f-bf98-4e6f-ac3e-4ebc3fc46cbf, escavite d multi vitamin with iron and fluoride chewable tablets is a prescription drug product for the dietary management of the metabolic processes of caries prophylaxis  and provides supplementation of the diet with twelve essential vitamins  magnesium  zinc  copper and iron,u
112,112,112,112,112,112,112,132,132,132,132,132,132,132,132,132,132,132,132,132,8ddbb72f-bf98-4e6f-ac3e-4ebc3fc46cbf,escavite d multi vitamin with iron and fluoride chewable tablets provide 0 25 mg of fluoride in a chewable tablet form for children 4 6 years of age where the drinking water contains 0 3 through 0 6 ppm of fluoride,1
113,113,113,113,113,113,113,133,133,133,133,133,133,133,133,133,133,133,133,133,8ddbb72f-bf98-4e6f-ac3e-4ebc3fc46cbf,escavite d multi vitamin with iron and fluoride chewable tablets supply significant amounts of vitamins a  c  d  e  thiamine  riboflavin  niacin  vitamin b6  folate  vitamin b12  biotin  pantothenic acid  to supplement the diet  and to help assure that nutritional deficiencies of these vitamins will not develop,u
114,114,114,114,114,114,114,134,134,134,134,134,134,134,134,134,134,134,134,134,8ddbb72f-bf98-4e6f-ac3e-4ebc3fc46cbf,thus  in a single easy to use preparation  children obtain twelve essential vitamins and the important minerals  magnesium  zinc  copper  iron and fluoride,0
115,115,115,115,115,115,115,135,135,135,135,135,135,135,135,135,135,135,135,135,8ddbb72f-bf98-4e6f-ac3e-4ebc3fc46cbf,the american academy of pediatrics recommends that children up to the age of 16  in areas where drinking water contains less than optimal levels of fluoride  receive daily fluoride supplementation,0
116,116,116,116,116,116,116,136,136,136,136,136,136,136,136,136,136,136,136,136,8ddbb72f-bf98-4e6f-ac3e-4ebc3fc46cbf,children using escavite d multi vitamin with iron and fluoride chewable tablets regularly should receive semiannual dental examinations,0
117,117,117,117,117,117,117,137,137,137,137,137,137,137,137,137,137,137,137,137,8ddbb72f-bf98-4e6f-ac3e-4ebc3fc46cbf,the regular brushing of teeth and attention to good oral hygiene practices are also essential,0
118,118,118,118,118,118,118,138,138,138,138,138,138,138,138,138,138,138,138,138,5c1eb2c1-1046-4a4a-939b-5c1043c6ccdd,indications to provide vitamin and mineral supplementation throughout pregnancy and during the postnatal period for both the lactating and nonlactating mother,u
119,119,119,119,119,119,119,140,140,140,140,140,140,140,140,140,140,140,140,140,bfdfc2c8-3f3e-42a4-8d5b-fd2c73ff7938, select ob is indicated to provide vitamin  mineral supplementation prior to conception  throughout pregnancy  and during the postnatal period for the lactating and non lactating mother,1
120,120,120,120,120,120,120,141,141,141,141,141,141,141,141,141,141,141,141,141,2e7c1e97-b8b2-44c0-aeac-18f9142a522b, albuterol tablets are indicated for the relief of bronchospasm in adults and children 6 years of age and older with reversible obstructive airway disease,1
121,121,121,121,121,121,121,142,142,142,142,142,142,142,142,142,142,142,142,142,9832312e-0310-4ab6-8501-afa976fc7eb2,1  combivent respimat is indicated for use in patients with chronic obstructive pulmonary disease ( copd ) on a regular aerosol bronchodilator who continue to have evidence of bronchospasm and who require a second bronchodilator,1
122,122,122,122,122,122,122,143,143,143,143,143,143,143,143,143,143,143,143,143,9832312e-0310-4ab6-8501-afa976fc7eb2,combivent respimat inhalation spray is a combination of an anticholinergic and beta2 adrenergic agonist indicated for patients with chronic obstructive pulmonary disease ( copd ) on a regular aerosol bronchodilator who continue to have evidence of bronchospasm and who require a second bronchodilator ( 1 ),1
123,123,123,123,123,123,123,144,144,144,144,144,144,144,144,144,144,144,144,144,2105d1c1-54ef-4d1a-a63c-b1619e8b50db,indications as an electrolyte replenisher in magnesium deficiencies,1
124,124,124,124,124,124,124,145,145,145,145,145,145,145,145,145,145,145,145,145,8469d6fb-d6ef-476f-8cc3-0905192de0a8,1  clinimix e is indicated as a source of calories  protein  and electrolytes for patients requiring parenteral nutrition when oral or enteral nutrition is not possible  insufficient  or contraindicated,1
125,125,125,125,125,125,125,146,146,146,146,146,146,146,146,146,146,146,146,146,8469d6fb-d6ef-476f-8cc3-0905192de0a8,clinimix e may be used to treat negative nitrogen balance in patients,1
126,126,126,126,126,126,126,147,147,147,147,147,147,147,147,147,147,147,147,147,8469d6fb-d6ef-476f-8cc3-0905192de0a8,clinimix e is indicated as a source of calories  protein  and electrolytes for patients requiring parenteral nutrition when oral or enteral nutrition is not possible  insufficient  or contraindicated,1
127,127,127,127,127,127,127,149,149,149,149,149,149,149,149,149,149,149,149,149,cebc5f95-5904-4641-b4c9-24ff2f76ae4b,cold extremities  fatigue  pulsating headache  swollen veins,1
128,128,128,128,128,128,128,150,150,150,150,150,150,150,150,150,150,150,150,150,ba3821bd-edbc-a470-67f0-bc0b8dcded6a,product name indications section constipation formulated for symptoms associated with acute or chronic constipation due to conditions such as poor diet  pregnancy  inactivity and rectal weakness,1
129,129,129,129,129,129,129,151,151,151,151,151,151,151,151,151,151,151,151,151,28488c7b-cf6a-4a03-916f-cc66b3afdc57, for use as an extraocular and intraocular irrigating solution during ocular surgical procedure involving perfusion of the eye with an expected maximum duration of less than 60 minutes,1
130,130,130,130,130,130,130,152,152,152,152,152,152,152,152,152,152,152,152,152,d5b85158-b0d6-4855-9d07-8d1b3ad9ab71,1  extraneal ( icodextrin ) is indicated for a single daily exchange for the long ( 8 to 16 hour ) dwell during continuous ambulatory peritoneal dialysis ( capd ) or automated peritoneal dialysis ( apd ) for the management of end stage renal disease,1
131,131,131,131,131,131,131,153,153,153,153,153,153,153,153,153,153,153,153,153,d5b85158-b0d6-4855-9d07-8d1b3ad9ab71,extraneal is also indicated to improve ( compared to 4 25 dextrose ) long dwell ultrafiltration and clearance of creatinine and urea nitrogen in patients with high average or greater transport characteristics  as defined using the peritoneal equilibration test ( pet ) see clinical pharmacology ( 12 )  clinical studies ( 14 ),1
132,132,132,132,132,132,132,154,154,154,154,154,154,154,154,154,154,154,154,154,d5b85158-b0d6-4855-9d07-8d1b3ad9ab71,extraneal is indicated for a single daily exchange for the long ( 8 to 16 hour ) dwell during continuous ambulatory peritoneal dialysis ( capd ) or automated peritoneal dialysis ( apd ) for the management of end stage renal disease,1
133,133,133,133,133,133,133,155,155,155,155,155,155,155,155,155,155,155,155,155,d5b85158-b0d6-4855-9d07-8d1b3ad9ab71,( 1 ) to improve ( compared to 4 25 dextrose ) long dwell ultrafiltration and clearance of creatinine and urea nitrogen in patients with high average or greater transport characteristics  as defined using the peritoneal equilibration test ( pet ),1
134,134,134,134,134,134,134,156,156,156,156,156,156,156,156,156,156,156,156,156,7f675fee-8940-4ece-bb0c-75ac79d8708c,1  prismasol and phoxillum solutions are indicated in pediatric and adult patients for use as a replacement solution in continuous renal replacement therapy ( crrt ) to replace plasma volume removed by ultrafiltration and to correct electrolyte and acid base imbalances,1
135,135,135,135,135,135,135,157,157,157,157,157,157,157,157,157,157,157,157,157,7f675fee-8940-4ece-bb0c-75ac79d8708c,they may also be used in case of drug poisoning when crrt is used to remove dialyzable substances,1
136,136,136,136,136,136,136,158,158,158,158,158,158,158,158,158,158,158,158,158,7f675fee-8940-4ece-bb0c-75ac79d8708c,prismasol and phoxillum solutions are indicated as a replacement solution in continuous renal replacement therapy ( crrt ) and in case of drug poisoning when crrt is used to remove dialyzable substances ( 1 ),1
137,137,137,137,137,137,137,159,159,159,159,159,159,159,159,159,159,159,159,159,0e382487-a6ee-4d29-90f8-4467d6cbdff3,1 indication and usage prismasol solution is indicated in adults and children for use as a replacement solution in continuous renal replacement therapy ( crrt ) to replace plasma volume removed by ultrafiltration and to correct electrolytes and acid base imbalances,1
138,138,138,138,138,138,138,160,160,160,160,160,160,160,160,160,160,160,160,160,0e382487-a6ee-4d29-90f8-4467d6cbdff3,prismasol solution may also be used in case of drug poisoning when crrt is used to remove filterable substances,1
139,139,139,139,139,139,139,161,161,161,161,161,161,161,161,161,161,161,161,161,0e382487-a6ee-4d29-90f8-4467d6cbdff3,prismasol solution is indicated as a replacement solution in continuous renal replacement therapy ( crrt ) in case of drug poisoning when crrt is used,1
140,140,140,140,140,140,140,162,162,162,162,162,162,162,162,162,162,162,162,162,150437b6-320e-4c69-a434-2a26a1f0b2e4, this solution is indicated for use in adults as a source of electrolytes and water for hydration  and as an alkalinizing agent,1
141,141,141,141,141,141,141,164,164,164,164,164,164,164,164,164,164,164,164,164,3c12918e-d32f-4400-9af5-dfe90324d5e1, this solution is indicated for use in adults as a source of electrolytes  calories and water for hydration  and as an alkalinizing agent,1
142,142,142,142,142,142,142,165,165,165,165,165,165,165,165,165,165,165,165,165,81d75979-e503-486b-ae76-5f11252e694d, plasma lyte 148 and 5 dextrose injection ( multiple electrolytes and dextrose injection  type 1  usp ) is indicated as a source of water  electrolytes  and calories  or as an alkalinizing agent,1
143,143,143,143,143,143,143,166,166,166,166,166,166,166,166,166,166,166,166,166,1f32c7ce-8ec1-43d1-8e24-e7d486194938, plasma lyte r injection ( multiple electrolytes injection  type 2  usp ) is indicated as a source of water and electrolytes or as an alkalinizing agent,1
144,144,144,144,144,144,144,167,167,167,167,167,167,167,167,167,167,167,167,167,6ec9e61c-2c26-402f-8604-f446b2e34058, plasma lyte a injection ph 7 4 ( multiple electrolytes injection  type 1  usp ) is indicated as a source of water and electrolytes or as an alkalinizing agent,1
145,145,145,145,145,145,145,168,168,168,168,168,168,168,168,168,168,168,168,168,6ec9e61c-2c26-402f-8604-f446b2e34058,plasma lyte a injection ph 7 4 ( multiple electrolytes injection  type 1  usp ) is compatible with blood or blood components,0
146,146,146,146,146,146,146,169,169,169,169,169,169,169,169,169,169,169,169,169,6ec9e61c-2c26-402f-8604-f446b2e34058,it may be administered prior to or following the infusion of blood through the same administration set ( i e  as a priming solution )  added to or infused concurrently with blood components  or used as a diluent in the transfusion of packed erythrocytes,4
147,147,147,147,147,147,147,170,170,170,170,170,170,170,170,170,170,170,170,170,6ec9e61c-2c26-402f-8604-f446b2e34058,plasma lyte a injection and 0 9 sodium chloride injection  usp are equally compatible with blood or blood components,0
148,148,148,148,148,148,148,171,171,171,171,171,171,171,171,171,171,171,171,171,beb5b6e0-46ed-443d-aad9-eebe389b7672, hyperlyte cr is indicated for use as a supplement to parenteral nutritional solutions containing amino acids  dextrose and or other calorie sources delivered by central venous or peripheral infusion  to facilitate amino acid utilization and maintain electrolyte balance in adults,1
149,149,149,149,149,149,149,172,172,172,172,172,172,172,172,172,172,172,172,172,beb5b6e0-46ed-443d-aad9-eebe389b7672,hyperlyte cr ( multi electrolyte concentrate ) is also indicated as a source of replacement electrolytes for the depleted adult patient during parenteral therapy,1
150,150,150,150,150,150,150,173,173,173,173,173,173,173,173,173,173,173,173,173,b283a454-0c20-4fbf-92d3-dae1f3cd3cad, 5 dextrose and electrolyte no,u
151,151,151,151,151,151,151,174,174,174,174,174,174,174,174,174,174,174,174,174,b283a454-0c20-4fbf-92d3-dae1f3cd3cad,48 injection ( multiple electrolytes and dextrose injection  type 1  usp ) is indicated as a source of water  electrolytes  and calories or as an alkalinizing agent,1
152,152,152,152,152,152,152,175,175,175,175,175,175,175,175,175,175,175,175,175,f69655c5-cf32-6461-e00e-3a5c4a761344, bss plus is indicated for use as an intraocular irrigating solution during intraocular surgical procedures involving perfusion of the eye,1
153,153,153,153,153,153,153,176,176,176,176,176,176,176,176,176,176,176,176,176,25c4d41f-bdcc-479e-a49f-96d7a2d46fc1,1  prismasol and phoxillum solutions are indicated in pediatric and adult patients for use as a replacement solution in continuous renal replacement therapy ( crrt ) to replace plasma volume removed by ultrafiltration and to correct electrolyte and acid base imbalances they may also be used in case of drug poisoning when crrt is used to remove dialyzable substances,1
154,154,154,154,154,154,154,178,178,178,178,178,178,178,178,178,178,178,178,178,50265baf-0232-45cf-7388-31c0bbfbc2a3, normosol r and 5 dextrose injection is indicated for replacement of acute extracellular fluid volume losses in surgery  trauma  burns or shock,1
155,155,155,155,155,155,155,179,179,179,179,179,179,179,179,179,179,179,179,179,50265baf-0232-45cf-7388-31c0bbfbc2a3,normosol r and 5 dextrose also can be used as an adjunct to restore a decrease in circulatory volume in patients with moderate blood loss,1
156,156,156,156,156,156,156,180,180,180,180,180,180,180,180,180,180,180,180,180,50265baf-0232-45cf-7388-31c0bbfbc2a3,the solution is not intended to supplant transfusion of whole blood or packed red cells in the presence of uncontrolled hemorrhage or severe reductions of red cell volume,2
157,157,157,157,157,157,157,181,181,181,181,181,181,181,181,181,181,181,181,181,1fd50ce5-2799-4c26-81da-02cf0578dd9e, baxter cardioplegic solution when suitably buffered in combination with ischemia and hypothermia is used to induce cardiac arrest during open heart surgery,1
158,158,158,158,158,158,158,182,182,182,182,182,182,182,182,182,182,182,182,182,c00817bc-7b62-4abe-0280-e7930eda3f94, tpn electrolytes ( multiple electrolyte additive ) is indicated for use as a supplement to nutritional solutions containing concentrated dextrose and amino acids delivered by central venous infusion  to help maintain electrolyte homeostasis in adult patients,1
159,159,159,159,159,159,159,183,183,183,183,183,183,183,183,183,183,183,183,183,b2dde4a1-398b-11e2-81c1-0800200c9a66, delflex peritoneal dialysis solutions are indicated in the treatment of chronic renal failure patients being maintained on peritoneal dialysis when nondialytic medical therapy is judged to be inadequate,1
160,160,160,160,160,160,160,185,185,185,185,185,185,185,185,185,185,185,185,185,207aab2b-4be1-4629-ffb5-5481e2ad534f, ionosol mb and 5 dextrose injection is indicated for intravenous administration to infants for treatment of dehydration  acidosis  diarrhea  and burns  but only after administration of an initial priming solution 15 ml of 5 dextrose and 0 45 sodium chloride injection kg of body weight,1
161,161,161,161,161,161,161,186,186,186,186,186,186,186,186,186,186,186,186,186,207aab2b-4be1-4629-ffb5-5481e2ad534f,in adults  ionosol mb and 5 dextrose injection is indicated postoperatively for intravenous fluid and electrolyte maintenance therapy  with a small amount of carbohydrate calories for reducing catabolism of endogenous protein reserves,1
162,162,162,162,162,162,162,187,187,187,187,187,187,187,187,187,187,187,187,187,87afd103-6e64-444f-971d-0e732e9ae995, ganciclovir for injection is indicated for the treatment of cmv retinitis in immunocompromised patients  including patients with acquired immunodeficiency syndrome ( aids ),1
163,163,163,163,163,163,163,188,188,188,188,188,188,188,188,188,188,188,188,188,87afd103-6e64-444f-971d-0e732e9ae995,ganciclovir for injection is also indicated for the prevention of cmv disease in transplant recipients at risk for cmv disease ( see clinical trials ),1
164,164,164,164,164,164,164,189,189,189,189,189,189,189,189,189,189,189,189,189,87afd103-6e64-444f-971d-0e732e9ae995,safety and efficacy of ganciclovir for injection has not been established for congenital or neonatal cmv disease nor for the treatment of established cmv disease other than retinitis nor for use in non immunocompromised individuals,2
165,165,165,165,165,165,165,190,190,190,190,190,190,190,190,190,190,190,190,190,6e0228a8-e3d3-4ae9-8873-d7aa3e0dcfee, carefully consider the potential benefits and risks of tolmetin sodium tablets  usp and other treatment options before deciding to use tolmetin sodium tablets,4
166,166,166,166,166,166,166,191,191,191,191,191,191,191,191,191,191,191,191,191,6e0228a8-e3d3-4ae9-8873-d7aa3e0dcfee,use the lowest effective dose for the shortest duration consistent with individual patient treatment goals ( see warnings ),4
167,167,167,167,167,167,167,192,192,192,192,192,192,192,192,192,192,192,192,192,6e0228a8-e3d3-4ae9-8873-d7aa3e0dcfee,tolmetin sodium tablets are indicated for the relief of signs and symptoms of rheumatoid arthritis and osteoarthritis,1
168,168,168,168,168,168,168,193,193,193,193,193,193,193,193,193,193,193,193,193,6e0228a8-e3d3-4ae9-8873-d7aa3e0dcfee,tolmetin sodium tablets are indicated in the treatment of acute flares and the long term management of the chronic disease,1
169,169,169,169,169,169,169,194,194,194,194,194,194,194,194,194,194,194,194,194,6e0228a8-e3d3-4ae9-8873-d7aa3e0dcfee,tolmetin sodium tablets are also indicated for treatment of juvenile rheumatoid arthritis,1
170,170,170,170,170,170,170,195,195,195,195,195,195,195,195,195,195,195,195,195,6e0228a8-e3d3-4ae9-8873-d7aa3e0dcfee,the safety and effectiveness of tolmetin sodium tablets have not been established in pediatric patients under 2 years of age ( see precautions pediatric use and dosage and administration ),2
171,171,171,171,171,171,171,196,196,196,196,196,196,196,196,196,196,196,196,196,c40b3f4e-2d71-41a1-a1fc-f64f38724879,1  karbinal er extended release oral suspension is an h1 receptor antagonist indicated for the symptomatic treatment of seasonal and perennial allergic rhinitis vasomotor rhinitis allergic conjunctivitis due to inhalant allergens and foods mild  uncomplicated allergic skin manifestations of urticaria and angioedema dermatographism as therapy for anaphylactic reactions adjunctive to epinephrine and other standard measures after the acute manifestations have been controlled amelioration of the severity of allergic reactions to blood or plasma karbinal er ( carbinoxamine maleate ) extended release oral suspension is an h1 receptor antagonist indicated for the symptomatic treatment of seasonal and perennial allergic rhinitis ( 1 ) vasomotor rhinitis ( 1 ) allergic conjunctivitis due to inhalant allergens and foods ( 1 ) mild  uncomplicated allergic skin manifestations of urticaria and angioedema ( 1 ) dermatographism ( 1 ) as therapy for anaphylactic reactions adjunctive to epinephrine and other standard measures after the acute manifestations have been controlled ( 1 ) amelioration of the severity of allergic reactions to blood or plasma ( 1 ),1
172,172,172,172,172,172,172,202,202,202,202,202,202,202,202,202,202,202,202,202,c1114779-3e11-47ab-8889-f534406f4041, immunotherapy using allergenic extracts is indicated for use in patients with severe allergy symptoms ( hay fever  rhinitis  etc ),1
173,173,173,173,173,173,173,203,203,203,203,203,203,203,203,203,203,203,203,203,c1114779-3e11-47ab-8889-f534406f4041,to pollens  molds  insects  animal danders and various other allergens,u
174,174,174,174,174,174,174,204,204,204,204,204,204,204,204,204,204,204,204,204,c1114779-3e11-47ab-8889-f534406f4041,immunotherapy is intended for patients whose symptoms are not satisfactorily controlled by avoidance of the offending allergen or by the use of symptomatic medications,1
175,175,175,175,175,175,175,205,205,205,205,205,205,205,205,205,205,205,205,205,c1114779-3e11-47ab-8889-f534406f4041,treatment uses only those specific allergens that the patient is sensitive to based on diagnostic tests and medical history,4
176,176,176,176,176,176,176,206,206,206,206,206,206,206,206,206,206,206,206,206,c1114779-3e11-47ab-8889-f534406f4041,it is not intended for treatment of patients who do not manifest immediate hypersensitivity reactions to the allergenic extract following skin testing,2
177,177,177,177,177,177,177,211,211,211,211,211,211,211,211,211,211,211,211,211,32167dd7-5d37-457b-9b00-cd735de6b060,1  tinidazole tablets is a nitroimidazole antimicrobial indicated for trichomoniasis ( 1 1 ) giardiasis in patients age 3 and older ( 1 2 ) amebiasis in patients age 3 and older ( 1 3 ) bacterial vaginosis in non pregnant  adult women ( 1 4  8 1 ) 1 1 trichomoniasis tinidazole is indicated for the treatment of trichomoniasis caused by trichomonas vaginalis,1
178,178,178,178,178,178,178,212,212,212,212,212,212,212,212,212,212,212,212,212,32167dd7-5d37-457b-9b00-cd735de6b060,the organism should be identified by appropriate diagnostic procedures,
179,179,179,179,179,179,179,213,213,213,213,213,213,213,213,213,213,213,213,213,32167dd7-5d37-457b-9b00-cd735de6b060,because trichomoniasis is a sexually transmitted disease with potentially serious sequelae  partners of infected patients should be treated simultaneously in order to prevent re infection see clinical studies ( 14 1 ),4
180,180,180,180,180,180,180,214,214,214,214,214,214,214,214,214,214,214,214,214,32167dd7-5d37-457b-9b00-cd735de6b060,1 2 giardiasis tinidazole is indicated for the treatment of giardiasis caused by giardia duodenalis ( also termed g lamblia ) in both adults and pediatric patients older than three years of age see clinical studies ( 14 2 ),1
181,181,181,181,181,181,181,215,215,215,215,215,215,215,215,215,215,215,215,215,32167dd7-5d37-457b-9b00-cd735de6b060,1 3 amebiasis tinidazole is indicated for the treatment of intestinal amebiasis and amebic liver abscess caused by entamoeba histolytica in both adults and pediatric patients older than three years of age,1
182,182,182,182,182,182,182,216,216,216,216,216,216,216,216,216,216,216,216,216,32167dd7-5d37-457b-9b00-cd735de6b060,it is not indicated in the treatment of asymptomatic cyst passage see clinical studies ( 14 3  14 4 ),2
183,183,183,183,183,183,183,217,217,217,217,217,217,217,217,217,217,217,217,217,32167dd7-5d37-457b-9b00-cd735de6b060,1 4 bacterial vaginosis tinidazole is indicated for the treatment of bacterial vaginosis ( formerly referred to as haemophilus vaginitis  gardnerella vaginitis  nonspecific vaginitis  or anaerobic vaginosis ) in non pregnant women,1
184,184,184,184,184,184,184,218,218,218,218,218,218,218,218,218,218,218,218,218,ac09d19a-e321-4556-8a5c-66bd27cb6533,1  xiidra ( lifitegrast ophthalmic solution ) 5 is indicated for the treatment of the signs and symptoms of dry eye disease ( ded ),1
185,185,185,185,185,185,185,219,219,219,219,219,219,219,219,219,219,219,219,219,ac09d19a-e321-4556-8a5c-66bd27cb6533,xiidra ( lifitegrast ophthalmic solution ) 5 is a lymphocyte function associated antigen 1 ( lfa 1 ) antagonist indicated for the treatment of the signs and symptoms of dry eye disease ( ded ),1
186,186,186,186,186,186,186,220,220,220,220,220,220,220,220,220,220,220,220,220,e3c2e3e7-bc83-465d-b615-3ad56580b3a7, floxuridine for injection  usp is effective in the palliative management of gastrointestinal adenocarcinoma metastatic to the liver  when given by continuous regional intra arterial infusion in carefully selected patients who are considered incurable by surgery or other means,1
187,187,187,187,187,187,187,221,221,221,221,221,221,221,221,221,221,221,221,221,e3c2e3e7-bc83-465d-b615-3ad56580b3a7,patients with known disease extending beyond an area capable of infusion via a single artery should  except in unusual circumstances  be considered for systemic therapy with other chemotherapeutic agents,4
188,188,188,188,188,188,188,222,222,222,222,222,222,222,222,222,222,222,222,222,643ad951-a10c-88a7-277c-d756e4b47966,product name indications section arthritic joint care formulated for symptoms associated with arthritis  uric acid build up  fibromyalgia  gout  rheumatism and other inflammatory conditions,1
189,189,189,189,189,189,189,223,223,223,223,223,223,223,223,223,223,223,223,223,eb57106f-320a-4abc-bffc-987dfb87909b,indication and usage spascupreel injection solution is a homeopathic drug product indicated for the relief of spasms of the smooth musculature of the gastrointestinal and the urogenital tract as well as general muscle spasms,1
190,190,190,190,190,190,190,224,224,224,224,224,224,224,224,224,224,224,224,224,4de8df82-23db-421b-8531-c755854b3e5e,indication and usage fda has classified the following indications as possibly effective for use as adjunctive therapy in the treatment of irritable bowel syndrome ( irritable colon  spastic colon  mucous colitis ) and acute enterocolitis,1
191,191,191,191,191,191,191,225,225,225,225,225,225,225,225,225,225,225,225,225,4de8df82-23db-421b-8531-c755854b3e5e,may also be useful as adjunctive therapy in the treatment of duodenal ulcer,1
192,192,192,192,192,192,192,226,226,226,226,226,226,226,226,226,226,226,226,226,4de8df82-23db-421b-8531-c755854b3e5e,it has not been shown conclusively whether anticholinergic antispasmodic drugs aid in the healing of a duodenal ulcer  decrease the rate of recurrences or prevent complications,0
193,193,193,193,193,193,193,227,227,227,227,227,227,227,227,227,227,227,227,227,bdeb47eb-e538-498d-ae98-14d5db29eab0, enlon plus ( edrophonium chloride  usp and atropine sulfate  usp ) injection is recommended as a reversal agent or antagonist of nondepolarizing neuromuscular blocking agents,1
194,194,194,194,194,194,194,228,228,228,228,228,228,228,228,228,228,228,228,228,bdeb47eb-e538-498d-ae98-14d5db29eab0,it is not effective against depolarizing neuromuscular blocking agents,2
195,195,195,195,195,195,195,229,229,229,229,229,229,229,229,229,229,229,229,229,bdeb47eb-e538-498d-ae98-14d5db29eab0,it is also useful if used adjunctively in the treatment of respiratory depression caused by curare overdosage,1
196,196,196,196,196,196,196,230,230,230,230,230,230,230,230,230,230,230,230,230,bdeb47eb-e538-498d-ae98-14d5db29eab0,the appropriateness of the specific fixed ratio of edrophonium and atropine contained in enlon plus has not been evaluated in myasthenia gravis,0
197,197,197,197,197,197,197,231,231,231,231,231,231,231,231,231,231,231,231,231,bdeb47eb-e538-498d-ae98-14d5db29eab0,therefore  enlon plus is not recommended for use in the differential diagnosis of this condition,2
198,198,198,198,198,198,198,232,232,232,232,232,232,232,232,232,232,232,232,232,4cd3f029-a5e3-5812-e054-00144ff8d46c, motofen is indicated as adjunctive therapy in the management of acute nonspecific diarrhea and acute exacerbations of chronic functional diarrhea,1
199,199,199,199,199,199,199,233,233,233,233,233,233,233,233,233,233,233,233,233,542b6ceb-7ad4-4d0d-b604-79bd1f567d79, diphenoxylate hydrochloride and atropine sulfate tablets are effective as adjunctive therapy in the management of diarrhea,1
200,200,200,200,200,200,200,234,234,234,234,234,234,234,234,234,234,234,234,234,21e8e8e6-3f85-4fdd-8452-c9d14d2ef69a, cytarabine in combination with other approved anticancer drugs is indicated for remission induction in acute non lymphocytic leukemia of adults and children,1
201,201,201,201,201,201,201,235,235,235,235,235,235,235,235,235,235,235,235,235,21e8e8e6-3f85-4fdd-8452-c9d14d2ef69a,it has also been found useful in the treatment of acute lymphocytic leukemia and the blast phase of chronic myelocytic leukemia,1
202,202,202,202,202,202,202,236,236,236,236,236,236,236,236,236,236,236,236,236,21e8e8e6-3f85-4fdd-8452-c9d14d2ef69a,intrathecal administration of cytarabine injection ( preservative free only ) is indicated for the prophylaxis and treatment of meningeal leukemia,1
203,203,203,203,203,203,203,237,237,237,237,237,237,237,237,237,237,237,237,237,7ea701ce-e7d3-4349-a9c2-642a501d45c8,1  vyxeos is indicated for the treatment of adults with newly diagnosed therapy related acute myeloid leukemia ( t aml ) or aml with myelodysplasia related changes ( aml mrc ),1
204,204,204,204,204,204,204,238,238,238,238,238,238,238,238,238,238,238,238,238,7ea701ce-e7d3-4349-a9c2-642a501d45c8,vyxeos is a liposomal combination of daunorubicin  an anthracycline topoisomerase inhibitor  and cytarabine  a nucleoside metabolic inhibitor  that is indicated for the treatment of adults with newly diagnosed therapy related acute myeloid leukemia ( t aml ) or aml with myelodysplasia related changes ( aml mrc ),1
205,205,205,205,205,205,205,239,239,239,239,239,239,239,239,239,239,239,239,239,ff41e901-5a6f-4ad5-be8a-a68eae787e5e,1  mometasone furoate nasal spray is a corticosteroid indicated for 1,u
206,206,206,206,206,206,206,240,240,240,240,240,240,240,240,240,240,240,240,240,ff41e901-5a6f-4ad5-be8a-a68eae787e5e,treatment of nasal symptoms of allergic rhinitis in patients 2 years of age ( 1 1 ) 2,1
207,207,207,207,207,207,207,241,241,241,241,241,241,241,241,241,241,241,241,241,ff41e901-5a6f-4ad5-be8a-a68eae787e5e,treatment of nasal congestion associated with seasonal allergic rhinitis in patients 2 years of age ( 1 2 ) 3,1
208,208,208,208,208,208,208,242,242,242,242,242,242,242,242,242,242,242,242,242,ff41e901-5a6f-4ad5-be8a-a68eae787e5e,prophylaxis of seasonal allergic rhinitis in patients 12 years of age ( 1 3 ) 4,1
209,209,209,209,209,209,209,243,243,243,243,243,243,243,243,243,243,243,243,243,ff41e901-5a6f-4ad5-be8a-a68eae787e5e,treatment of nasal polyps in patients 18 years of age ( 1 4 ) 1 1 treatment of allergic rhinitis mometasone furoate nasal spray 50 mcg is indicated for the treatment of the nasal symptoms of seasonal allergic and perennial allergic rhinitis  in adults and pediatric patients 2 years of age and older,1
210,210,210,210,210,210,210,244,244,244,244,244,244,244,244,244,244,244,244,244,ff41e901-5a6f-4ad5-be8a-a68eae787e5e,1 2 treatment of nasal congestion associated with seasonal allergic rhinitis mometasone furoate nasal spray 50 mcg is indicated for the relief of nasal congestion associated with seasonal allergic rhinitis  in adults and pediatric patients 2 years of age and older,1
211,211,211,211,211,211,211,245,245,245,245,245,245,245,245,245,245,245,245,245,ff41e901-5a6f-4ad5-be8a-a68eae787e5e,1 3 prophylaxis of seasonal allergic rhinitis mometasone furoate nasal spray 50 mcg is indicated for the prophylaxis of the nasal symptoms of seasonal allergic rhinitis in adult and adolescent patients 12 years and older,1
212,212,212,212,212,212,212,246,246,246,246,246,246,246,246,246,246,246,246,246,ff41e901-5a6f-4ad5-be8a-a68eae787e5e,1 4 treatment of nasal polyps mometasone furoate nasal spray 50 mcg is indicated for the treatment of nasal polyps in patients 18 years of age and older,1
213,213,213,213,213,213,213,247,247,247,247,247,247,247,247,247,247,247,247,247,116464ce-cfd8-4b9f-8b5a-3a114b6ff2b1,1  dulera is a combination product containing a corticosteroid and a long acting beta2 adrenergic agonist ( laba ) indicated for treatment of asthma in patients 12 years of age and older,1
214,214,214,214,214,214,214,248,248,248,248,248,248,248,248,248,248,248,248,248,116464ce-cfd8-4b9f-8b5a-3a114b6ff2b1,( 1 1 ) important limitation of use not indicated for the relief of acute bronchospasm,2
215,215,215,215,215,215,215,249,249,249,249,249,249,249,249,249,249,249,249,249,116464ce-cfd8-4b9f-8b5a-3a114b6ff2b1,( 1 1 ) 1 1 treatment of asthma dulera is indicated for the twice daily treatment of asthma in patients 12 years of age and older,1
216,216,216,216,216,216,216,250,250,250,250,250,250,250,250,250,250,250,250,250,116464ce-cfd8-4b9f-8b5a-3a114b6ff2b1,dulera should be used for patients not adequately controlled on a long term asthma control medication such as an inhaled corticosteroid ( ics ) or whose disease warrants initiation of treatment with both an ics and long acting beta2 adrenergic agonist ( laba ),1
217,217,217,217,217,217,217,251,251,251,251,251,251,251,251,251,251,251,251,251,116464ce-cfd8-4b9f-8b5a-3a114b6ff2b1,important limitation of use dulera is not indicated for the relief of acute bronchospasm,2
218,218,218,218,218,218,218,252,252,252,252,252,252,252,252,252,252,252,252,252,80f3b79c-a399-45b3-b755-8535457719af,1  irinotecan hydrochloride injection  usp is a topoisomerase inhibitor indicated for first line therapy in combination with 5 fluorouracil and leucovorin for patients with metastatic carcinoma of the colon or rectum,1
219,219,219,219,219,219,219,253,253,253,253,253,253,253,253,253,253,253,253,253,80f3b79c-a399-45b3-b755-8535457719af,( 1 ) patients with metastatic carcinoma of the colon or rectum whose disease has recurred or progressed following initial fluorouracil based therapy,1
220,220,220,220,220,220,220,254,254,254,254,254,254,254,254,254,254,254,254,254,80f3b79c-a399-45b3-b755-8535457719af,( 1 ) irinotecan hydrochloride injection  usp is indicated as a component of first line therapy in combination with 5 fluorouracil ( 5 fu ) and leucovorin ( lv ) for patients with metastatic carcinoma of the colon or rectum,1
221,221,221,221,221,221,221,255,255,255,255,255,255,255,255,255,255,255,255,255,80f3b79c-a399-45b3-b755-8535457719af,irinotecan hydrochloride injection  usp is indicated for patients with metastatic carcinoma of the colon or rectum whose disease has recurred or progressed following initial fluorouracil based therapy,1
222,222,222,222,222,222,222,256,256,256,256,256,256,256,256,256,256,256,256,256,cdfbe0cd-eb15-45a1-ac17-531bcda21aec,1  ocaliva is indicated for the treatment of primary biliary cholangitis ( pbc ) in combination with ursodeoxycholic acid ( udca ) in adults with an inadequate response to udca  or as monotherapy in adults unable to tolerate udca,1
223,223,223,223,223,223,223,257,257,257,257,257,257,257,257,257,257,257,257,257,cdfbe0cd-eb15-45a1-ac17-531bcda21aec,this indication is approved under accelerated approval based on a reduction in alkaline phosphatase ( alp ) see clinical studies ( 14 ),u
224,224,224,224,224,224,224,258,258,258,258,258,258,258,258,258,258,258,258,258,cdfbe0cd-eb15-45a1-ac17-531bcda21aec,an improvement in survival or disease related symptoms has not been established,0
225,225,225,225,225,225,225,259,259,259,259,259,259,259,259,259,259,259,259,259,cdfbe0cd-eb15-45a1-ac17-531bcda21aec,continued approval for this indication may be contingent upon verification and description of clinical benefit in confirmatory trials,0
226,226,226,226,226,226,226,260,260,260,260,260,260,260,260,260,260,260,260,260,cdfbe0cd-eb15-45a1-ac17-531bcda21aec,ocaliva  a farnesoid x receptor ( fxr ) agonist  is indicated for the treatment of primary biliary cholangitis ( pbc ) in combination with ursodeoxycholic acid ( udca ) in adults with an inadequate response to udca  or as monotherapy in adults unable to tolerate udca,1
227,227,227,227,227,227,227,261,261,261,261,261,261,261,261,261,261,261,261,261,cdfbe0cd-eb15-45a1-ac17-531bcda21aec,this indication is approved under accelerated approval based on a reduction in alkaline phosphatase ( alp ),0
228,228,228,228,228,228,228,264,264,264,264,264,264,264,264,264,264,264,264,264,79a31029-c221-4a4c-8dd9-bf78cbf2a16a, lidocaine and prilocaine cream usp  2 5 2 5 ( a eutectic mixture of lidocaine 2 5 and prilocaine 2 5 ) is indicated as a topical anesthetic for use on normal intact skin for local analgesia,1
229,229,229,229,229,229,229,265,265,265,265,265,265,265,265,265,265,265,265,265,79a31029-c221-4a4c-8dd9-bf78cbf2a16a,genital mucous membranes for superficial minor surgery and as pretreatment for infiltration anesthesia,1
230,230,230,230,230,230,230,266,266,266,266,266,266,266,266,266,266,266,266,266,79a31029-c221-4a4c-8dd9-bf78cbf2a16a,lidocaine and prilocaine cream is not recommended in any clinical situation in which penetration or migration beyond the tympanic membrane into the middle ear is possible because of the ototoxic effects observed in animal studies ( see warnings ),2
231,231,231,231,231,231,231,267,267,267,267,267,267,267,267,267,267,267,267,267,"Active Ingredient UNII(s)
046O35D44R; 98PI200987; F446C597KA    19c622bd-f8c7-4667-9470-60925e1b2d70
046O35D44R; 98PI200987; F446C597KA    19c622bd-f8c7-4667-9470-60925e1b2d70
Name: SET ID dtype: object",active ingredient unii ( s ) 046o35d44r 98pi200987 f446c597ka active ingredient unii ( s ) 046o35d44r 98pi2009 046o35d44r 98pi200987 f446c597ka active ingredient unii ( s ) 046o35d44r 98pi2009 name content xml  dtype object,0
232,232,232,232,232,232,232,269,269,269,269,269,269,269,269,269,269,269,269,269,"Active Ingredient UNII(s)
046O35D44R; 98PI200987; V13007Z41A    b668ee73-12c6-4013-9d52-5fd8b90c113c
046O35D44R; 98PI200987; V13007Z41A    b668ee73-12c6-4013-9d52-5fd8b90c113c
Name: SET ID dtype: object",active ingredient unii ( s ) 046o35d44r 98pi200987 v13007z41a active ingredient unii ( s ) 046o35d44r 98pi2009 046o35d44r 98pi200987 v13007z41a active ingredient unii ( s ) 046o35d44r 98pi2009 name content xml  dtype object,0
233,233,233,233,233,233,233,271,271,271,271,271,271,271,271,271,271,271,271,271,8268b70f-3f10-48dd-bb24-baaeb27a1325, for the production of mydriasis,
234,234,234,234,234,234,234,272,272,272,272,272,272,272,272,272,272,272,272,272,545ae063-21bf-4dc8-9ad0-0c113b1b0dea, for relief of coughs and upper respiratory symptoms  including nasal congestion  associated with allergy or the common cold,1
235,235,235,235,235,235,235,273,273,273,273,273,273,273,273,273,273,273,273,273,5c3c2c1b-ab52-410b-8c94-c125c6adb4d2, promethazine hcl  phenylephrine hcl and codeine phosphate syrup is indicated for the temporary relief of coughs and upper respiratory symptoms  including nasal congestion  associated with allergy or the common cold,1
236,236,236,236,236,236,236,274,274,274,274,274,274,274,274,274,274,274,274,274,cf4ef7c0-2f4a-4b0f-9060-ad0b909d1ed4, promethazine hydrochloride and phenylephrine hydrochloride oral solution  usp is indicated for the temporary relief of upper respiratory symptoms  including nasal congestion  associated with allergy or the common cold,1
237,237,237,237,237,237,237,275,275,275,275,275,275,275,275,275,275,275,275,275,0722734e-5a30-47af-99a3-2512848b45cd,indication and usage irospan 24 6 is indicated for the treatment of all anemias that are responsive to oral iron therapy,1
238,238,238,238,238,238,238,276,276,276,276,276,276,276,276,276,276,276,276,276,0722734e-5a30-47af-99a3-2512848b45cd,these include hypochromic anemia associated with pregnancy  chronic and or acute blood loss  metabolic disease  post surgical convalescence  and dietary needs,1
239,239,239,239,239,239,239,277,277,277,277,277,277,277,277,277,277,277,277,277,e4e9ecb0-13b2-4de9-9ef0-5c05da2734bb, procalamine is indicated for peripheral administration in adults to preserve body protein and improve nitrogen balance in well nourished  mildly catabolic patients who require short term parenteral nutrition,1
240,240,240,240,240,240,240,278,278,278,278,278,278,278,278,278,278,278,278,278,1d88fbe0-eb97-4964-8a78-88940064f8f0, trophamine is indicated for the nutritional support of infants ( including those of low birth weight ) and young pediatric patients requiring tpn via either central or peripheral infusion routes,1
241,241,241,241,241,241,241,279,279,279,279,279,279,279,279,279,279,279,279,279,1d88fbe0-eb97-4964-8a78-88940064f8f0,parenteral nutrition with trophamine is indicated to prevent nitrogen and weight loss or treat negative nitrogen balance in infants and young pediatric patients where ( 1 ) the alimentary tract  by the oral  gastrostomy  or jejunostomy route  cannot or should not be used  or adequate protein intake is not feasible by these routes ( 2 ) gastrointestinal absorption of protein is impaired or ( 3 ) protein requirements are substantially increased as with extensive burns,1
242,242,242,242,242,242,242,280,280,280,280,280,280,280,280,280,280,280,280,280,1d88fbe0-eb97-4964-8a78-88940064f8f0,dosage  route of administration  and concomitant infusion of non protein calories are dependent on various factors  such as nutritional and metabolic status of the patient  anticipated duration of parenteral nutritional support  and vein tolerance,4
243,243,243,243,243,243,243,281,281,281,281,281,281,281,281,281,281,281,281,281,1d88fbe0-eb97-4964-8a78-88940064f8f0,see warnings  precautions  pediatric use  and dosage and administration,0
244,244,244,244,244,244,244,282,282,282,282,282,282,282,282,282,282,282,282,282,1d88fbe0-eb97-4964-8a78-88940064f8f0,central venous nutrition central venous infusion should be considered when amino acid solutions are to be admixed with hypertonic dextrose to promote protein synthesis in hypercatabolic or severely depleted infants  or those requiring long term parenteral nutrition,1
245,245,245,245,245,245,245,283,283,283,283,283,283,283,283,283,283,283,283,283,1d88fbe0-eb97-4964-8a78-88940064f8f0,peripheral parenteral nutrition for moderately catabolic or depleted patients in whom the central venous route is not indicated  diluted amino acid solutions mixed with 5 10 dextrose solutions may be infused by peripheral vein  supplemented  if desired  with fat emulsion,u
246,246,246,246,246,246,246,284,284,284,284,284,284,284,284,284,284,284,284,284,1d88fbe0-eb97-4964-8a78-88940064f8f0,in pediatric patients  the final solution should not exceed twice normal serum osmolarity ( 718 mosmol l ),4
247,247,247,247,247,247,247,285,285,285,285,285,285,285,285,285,285,285,285,285,e649dc50-a3ce-4151-f698-788b6d5c83d0, aminosyn pf 10  sulfite free  ( an amino acid injection pediatric formula ) is indicated for the nutritional support of infants ( including those of low birth weight ) and young children requiring tpn via either central or peripheral infusion routes,1
248,248,248,248,248,248,248,286,286,286,286,286,286,286,286,286,286,286,286,286,e649dc50-a3ce-4151-f698-788b6d5c83d0,parenteral nutrition with aminosyn pf 10 is indicated to prevent nitrogen and weight loss or treat negative nitrogen balance in infants and young children where ( 1 ) the alimentary tract by the oral gastrostomy  or jejunostomy route  cannot or should not be used or adequate protein intake is not feasible by these routes ( 2 ) gastrointestinal absorption of protein is impaired or ( 3 ) protein requirements are substantially increased as with extensive burns,1
249,249,249,249,249,249,249,287,287,287,287,287,287,287,287,287,287,287,287,287,e649dc50-a3ce-4151-f698-788b6d5c83d0,dosage  route of administration  and concomitant infusion of non protein calories are dependent on various factors  such as nutritional and metabolic status of the patient  anticipated duration of parenteral nutrition support  and vein tolerance,4
250,250,250,250,250,250,250,288,288,288,288,288,288,288,288,288,288,288,288,288,e649dc50-a3ce-4151-f698-788b6d5c83d0,see dosage and administration for additional information,0
251,251,251,251,251,251,251,289,289,289,289,289,289,289,289,289,289,289,289,289,e649dc50-a3ce-4151-f698-788b6d5c83d0,central venous infusion central venous infusion should be considered when amino acid solutions are to be admixed with hypertonic dextrose to promote protein synthesis in hypercatabolic or severely depleted infants or those requiring long term parenteral nutrition,1
252,252,252,252,252,252,252,290,290,290,290,290,290,290,290,290,290,290,290,290,e649dc50-a3ce-4151-f698-788b6d5c83d0,peripheral parenteral nutrition for moderately catabolic or depleted patients in whom the central venous route is not indicated  diluted amino acid solutions mixed with 5 to 10 dextrose solutions may be infused by peripheral vein  supplemented  if desired  with fat emulsion,u
253,253,253,253,253,253,253,291,291,291,291,291,291,291,291,291,291,291,291,291,9afdcc3e-0d06-47f4-86ca-40da48b2b02b, 6 and 10 premasol sulfite free ( amino acid ) injections are indicated for the nutritional support of infants ( including those of low birth weight ) and young children requiring tpn via either central or peripheral infusion routes,1
254,254,254,254,254,254,254,292,292,292,292,292,292,292,292,292,292,292,292,292,9afdcc3e-0d06-47f4-86ca-40da48b2b02b,parenteral nutrition with premasol sulfite free ( amino acid ) injections is indicated to prevent nitrogen and weight loss or treat negative nitrogen balance in infants and young children where ( 1 ) the alimentary tract  by the oral  gastrostomy  or jejunostomy route  cannot or should not be used  or adequate protein intake is not feasible by these routes ( 2 ) gastrointestinal absorption of protein is impaired or ( 3 ) protein requirements are substantially increased as with extensive burns,1
255,255,255,255,255,255,255,297,297,297,297,297,297,297,297,297,297,297,297,297,c2eb5522-8572-45f4-869d-42f9fd251bb6,1  perikabiven is indicated as a source of calories  protein  electrolytes and essential fatty acids for adult patients requiring parenteral nutrition when oral or enteral nutrition is not possible  insufficient  or contraindicated,1
256,256,256,256,256,256,256,298,298,298,298,298,298,298,298,298,298,298,298,298,c2eb5522-8572-45f4-869d-42f9fd251bb6,perikabiven may be used to prevent essential fatty acid deficiency or treat negative nitrogen balance in adult patients,1
257,257,257,257,257,257,257,299,299,299,299,299,299,299,299,299,299,299,299,299,c2eb5522-8572-45f4-869d-42f9fd251bb6,limitations of use perikabiven is not recommended for use in pediatric patients under the age of 2 years  including preterm infants because the fixed content of the formulation does not meet the nutritional requirements of this age group see warnings and precautions ( 5 1 ) and use in specific populations ( 8 4 ),0
258,258,258,258,258,258,258,300,300,300,300,300,300,300,300,300,300,300,300,300,c2eb5522-8572-45f4-869d-42f9fd251bb6,perikabiven is indicated as a source of calories  protein  electrolytes and essential fatty acids for adult patients requiring parenteral nutrition when oral or enteral nutrition is not possible  insufficient  or contraindicated,1
259,259,259,259,259,259,259,302,302,302,302,302,302,302,302,302,302,302,302,302,c2eb5522-8572-45f4-869d-42f9fd251bb6,( 1 ) limitations of use not recommended for use in pediatric patients 2 years including preterm infants because the fixed content of the formulation does not meet nutritional requirements in this age group,2
260,260,260,260,260,260,260,303,303,303,303,303,303,303,303,303,303,303,303,303,9cf0a954-36f4-4db5-efbe-6b05d0845d74, aminosyn ii  sulfite free  ( an amino acid injection ) infused with dextrose by peripheral vein infusion is indicated as a source of nitrogen in the nutritional support of patients with adequate stores of body fat  in whom  for short periods of time  oral nutrition cannot be tolerated  is undesirable  or inadequate,1
261,261,261,261,261,261,261,304,304,304,304,304,304,304,304,304,304,304,304,304,9cf0a954-36f4-4db5-efbe-6b05d0845d74,supplemental electrolytes  in accordance with the prescription of the attending physician  must be added to aminosyn ii solutions without electrolytes,4
262,262,262,262,262,262,262,305,305,305,305,305,305,305,305,305,305,305,305,305,9cf0a954-36f4-4db5-efbe-6b05d0845d74,aminosyn ii can be administered peripherally with dilute ( 5 to 10 ) dextrose solution and i v,4
263,263,263,263,263,263,263,306,306,306,306,306,306,306,306,306,306,306,306,306,9cf0a954-36f4-4db5-efbe-6b05d0845d74,fat emulsion as a source of nutritional support,
264,264,264,264,264,264,264,307,307,307,307,307,307,307,307,307,307,307,307,307,9cf0a954-36f4-4db5-efbe-6b05d0845d74,this form of nutritional support can help to preserve protein and reduce catabolism in stress conditions where oral intake is inadequate,1
265,265,265,265,265,265,265,308,308,308,308,308,308,308,308,308,308,308,308,308,9cf0a954-36f4-4db5-efbe-6b05d0845d74,aminosyn ii is also indicated for central vein infusion to prevent or reverse negative nitrogen balance in patients where the alimentary tract  by the oral  gastrostomy or jejunostomy route cannot or should not be used and gastrointestinal absorption of protein is impaired,1
266,266,266,266,266,266,266,309,309,309,309,309,309,309,309,309,309,309,309,309,dccff103-8695-400c-a15d-cc2fd078760a,1  clinimix is indicated as a source of calories and protein for patients requiring parenteral nutrition when oral or enteral nutrition is not possible  insufficient  or contraindicated,1
267,267,267,267,267,267,267,310,310,310,310,310,310,310,310,310,310,310,310,310,dccff103-8695-400c-a15d-cc2fd078760a,clinimix may be used to treat negative nitrogen balance in patients,1
268,268,268,268,268,268,268,311,311,311,311,311,311,311,311,311,311,311,311,311,dccff103-8695-400c-a15d-cc2fd078760a,clinimix is indicated as a source of calories and protein for patients requiring parenteral nutrition when oral or enteral nutrition is not possible  insufficient  or contraindicated,1
269,269,269,269,269,269,269,313,313,313,313,313,313,313,313,313,313,313,313,313,8543b5be-0f43-4891-9e56-d7c39fe839b5,1  travasol is indicated as a source of amino acids for patients requiring parenteral nutrition ( pn ) when oral or enteral nutrition is not possible  insufficient  or contraindicated,1
270,270,270,270,270,270,270,314,314,314,314,314,314,314,314,314,314,314,314,314,8543b5be-0f43-4891-9e56-d7c39fe839b5,travasol may be used to treat negative nitrogen balance in patients,1
271,271,271,271,271,271,271,315,315,315,315,315,315,315,315,315,315,315,315,315,8543b5be-0f43-4891-9e56-d7c39fe839b5,travasol is indicated as a source of amino acids for patients requiring parenteral nutrition ( pn ) when oral or enteral nutrition is not possible  insufficient  or contraindicated,1
272,272,272,272,272,272,272,317,317,317,317,317,317,317,317,317,317,317,317,317,2ec547bc-355c-42d4-a197-72e652c212de, hepatamine is indicated for the treatment of hepatic encephalopathy in patients with cirrhosis or hepatitis,1
273,273,273,273,273,273,273,318,318,318,318,318,318,318,318,318,318,318,318,318,2ec547bc-355c-42d4-a197-72e652c212de,hepatamine provides nutritional support for patients with these diseases of the liver who require parenteral nutrition and are intolerant of general purpose amino acid injections  which are contraindicated in patients with hepatic coma,1
274,274,274,274,274,274,274,319,319,319,319,319,319,319,319,319,319,319,319,319,6ea7ec73-403e-4303-8862-6380e2f1fda6, parenteral nutrition with 6 9 freamine hbc ( amino acid injection ) is indicated to prevent nitrogen loss or treat negative nitrogen balance in adults where ( 1 ) the alimentary tract  by the oral  gastrostomy  or jejunostomy route  cannot or should not be used  or adequate protein intake is not feasible by these routes ( 2 ) gastrointestinal absorption of protein is impaired or ( 3 ) nitrogen homeostasis is substantially impaired as with severe trauma or sepsis,1
275,275,275,275,275,275,275,321,321,321,321,321,321,321,321,321,321,321,321,321,6ea7ec73-403e-4303-8862-6380e2f1fda6,see dosage and administration,0
276,276,276,276,276,276,276,322,322,322,322,322,322,322,322,322,322,322,322,322,6ea7ec73-403e-4303-8862-6380e2f1fda6,central venous nutrition central venous infusion should be considered when amino acid solutions are to be admixed with hypertonic dextrose to promote protein synthesis in hypercatabolic or severely depleted patients  or those requiring long term parenteral nutrition,1
277,277,277,277,277,277,277,323,323,323,323,323,323,323,323,323,323,323,323,323,6ea7ec73-403e-4303-8862-6380e2f1fda6,peripheral parenteral nutrition for moderately catabolic or depleted patients in whom the central venous route is not indicated  diluted amino acid solutions with minimal caloric supplementation may be infused by peripheral vein  supplemented  if desired  with fat emulsion,u
278,278,278,278,278,278,278,325,325,325,325,325,325,325,325,325,325,325,325,325,b924dbf2-5400-4036-941e-487d2ddbb5c4, 5 4 nephramine ( essential amino acid injection ) is indicated for adult and pediatric use  in conjunction with other measures  to provide nutritional support for uremic patients  particularly when oral nutrition is infeasible or impractical,1
279,279,279,279,279,279,279,326,326,326,326,326,326,326,326,326,326,326,326,326,b924dbf2-5400-4036-941e-487d2ddbb5c4,see warnings  precautions  pediatric use  special precautions in pediatric patients  and dosage and administration,0
280,280,280,280,280,280,280,327,327,327,327,327,327,327,327,327,327,327,327,327,70c21d52-b73a-4d44-a08a-15b852d9307c,indications for temporary relief of symptoms related to the thyroid system,1
281,281,281,281,281,281,281,328,328,328,328,328,328,328,328,328,328,328,328,328,ba1d17c3-cb34-4425-a407-ba7209d8bdee,homeopathic indications for temporary reduction of the symptoms of sleeplessness such as tiredness  fatigue  and lack of energy,1
282,282,282,282,282,282,282,329,329,329,329,329,329,329,329,329,329,329,329,329,ba1d17c3-cb34-4425-a407-ba7209d8bdee,these statements are based upon homeopathic principles,0
283,283,283,283,283,283,283,331,331,331,331,331,331,331,331,331,331,331,331,331,268fa997-b43c-4dab-af9c-6e58310fbeec,indications for temporary eduction of the symptoms of insomnia,1
284,284,284,284,284,284,284,332,332,332,332,332,332,332,332,332,332,332,332,332,4c9bbe4f-44ae-4f99-8371-a607d81cc8cd,indications for temporary relief of depression,1
285,285,285,285,285,285,285,333,333,333,333,333,333,333,333,333,333,333,333,333,17ffc094-8ca7-45d2-80d8-fd043bc9a221,1  vosevi is indicated for the treatment of adult patients with chronic hepatitis c virus ( hcv ) infection without cirrhosis or with compensated cirrhosis ( child pugh a ) who have see dosage and administration ( 2 2 ) and clinical studies ( 14 ) genotype 1  2  3  4  5  or 6 infection and have previously been treated with an hcv regimen containing an ns5a inhibitor,1
286,286,286,286,286,286,286,334,334,334,334,334,334,334,334,334,334,334,334,334,17ffc094-8ca7-45d2-80d8-fd043bc9a221,genotype 1a or 3 infection and have previously been treated with an hcv regimen containing sofosbuvir without an ns5a inhibitor,0
287,287,287,287,287,287,287,335,335,335,335,335,335,335,335,335,335,335,335,335,17ffc094-8ca7-45d2-80d8-fd043bc9a221,additional benefit of vosevi over sofosbuvir velpatasvir was not shown in adults with genotype 1b  2  4  5  or 6 infection previously treated with sofosbuvir without an ns5a inhibitor,2
288,288,288,288,288,288,288,336,336,336,336,336,336,336,336,336,336,336,336,336,17ffc094-8ca7-45d2-80d8-fd043bc9a221,vosevi is a fixed dose combination of sofosbuvir  a hepatitis c virus ( hcv ) nucleotide analog ns5b polymerase inhibitor  velpatasvir  an hcv ns5a inhibitor  and voxilaprevir  an hcv ns3 4a protease inhibitor  and is indicated for the treatment of adult patients with chronic hcv infection without cirrhosis or with compensated cirrhosis ( child pugh a ) who have ( 1  2 2  14 ) genotype 1  2  3  4  5  or 6 infection and have previously been treated with an hcv regimen containing an ns5a inhibitor,1
289,289,289,289,289,289,289,339,339,339,339,339,339,339,339,339,339,339,339,339,777dbfab-f83e-4738-ae1e-78619a9f82a7, to reduce the development of drug resistant bacteria and maintain the effectiveness of neomycin sulfate tablets usp and other antibacterial drugs  neomycin sulfate tablets usp should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria,2
290,290,290,290,290,290,290,340,340,340,340,340,340,340,340,340,340,340,340,340,777dbfab-f83e-4738-ae1e-78619a9f82a7,when culture and susceptibility information are available  they should be considered in selecting or modifying antibacterial therapy,4
291,291,291,291,291,291,291,341,341,341,341,341,341,341,341,341,341,341,341,341,777dbfab-f83e-4738-ae1e-78619a9f82a7,in the absence of such data  local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy,4
292,292,292,292,292,292,292,342,342,342,342,342,342,342,342,342,342,342,342,342,777dbfab-f83e-4738-ae1e-78619a9f82a7,suppression of intestinal bacteria neomycin sulfate tablets are indicated as adjunctive therapy as part of a regimen for the suppression of the normal bacterial flora of the bowel  eg  preoperative preparation of the bowel,1
293,293,293,293,293,293,293,343,343,343,343,343,343,343,343,343,343,343,343,343,777dbfab-f83e-4738-ae1e-78619a9f82a7,it is given concomitantly with erythromycin enteric coated base ( see dosage and administration ),4
294,294,294,294,294,294,294,344,344,344,344,344,344,344,344,344,344,344,344,344,777dbfab-f83e-4738-ae1e-78619a9f82a7,hepatic coma ( portal systemic encephalopathy ) neomycin sulfate has been shown to be effective adjunctive therapy in hepatic coma by reduction of the ammonia forming bacteria in the intestinal tract,1
295,295,295,295,295,295,295,345,345,345,345,345,345,345,345,345,345,345,345,345,777dbfab-f83e-4738-ae1e-78619a9f82a7,the subsequent reduction in blood ammonia has resulted in neurologic improvement,0
296,296,296,296,296,296,296,346,346,346,346,346,346,346,346,346,346,346,346,346,1141956e-8a4c-4f80-95d1-f15bdb57fdf6, neo synalar cream is indicated for the treatment of corticosteroid responsive dermatoses with secondary infection,1
297,297,297,297,297,297,297,347,347,347,347,347,347,347,347,347,347,347,347,347,1141956e-8a4c-4f80-95d1-f15bdb57fdf6,it has not been demonstrated that this steroid antibiotic combination provides greater benefit than the steroid component alone after 7 days of treatment ( see warnings section ),2
298,298,298,298,298,298,298,348,348,348,348,348,348,348,348,348,348,348,348,348,a2f47d77-efd3-4c84-a364-08fb6d9978eb, neomycin and polymyxin b sulfates solution for irrigation is indicated for short term use ( up to 10 days ) as a continuous irrigant or rinse in the urinary bladder of abacteriuric patients to help prevent bacteriuria and gram negative rod septicemia associated with the use of indwelling catheters,1
299,299,299,299,299,299,299,349,349,349,349,349,349,349,349,349,349,349,349,349,a2f47d77-efd3-4c84-a364-08fb6d9978eb,since organisms gain entrance to the bladder by way of  through  and around the catheter  significant bacteriuria is induced by bacterial multiplication in the bladder urine  in the mucoid film often present between catheter and urethra  and in other sites,0
300,300,300,300,300,300,300,350,350,350,350,350,350,350,350,350,350,350,350,350,a2f47d77-efd3-4c84-a364-08fb6d9978eb,urinary tract infection may result from the repeated presence in the urine of large numbers of pathogenic bacteria,0
301,301,301,301,301,301,301,351,351,351,351,351,351,351,351,351,351,351,351,351,a2f47d77-efd3-4c84-a364-08fb6d9978eb,the use of closed systems with indwelling catheters has been shown to reduce the risk of infection,u
302,302,302,302,302,302,302,352,352,352,352,352,352,352,352,352,352,352,352,352,a2f47d77-efd3-4c84-a364-08fb6d9978eb,a three way closed catheter system with constant neomycin polymyxin b bladder rinse is indicated to prevent the development of infection while using indwelling catheters,1
303,303,303,303,303,303,303,353,353,353,353,353,353,353,353,353,353,353,353,353,a2f47d77-efd3-4c84-a364-08fb6d9978eb,if uropathogens are isolated  they should be identified and tested for susceptibility so that appropriate antimicrobial therapy for systemic use can be initiated,2
304,304,304,304,304,304,304,354,354,354,354,354,354,354,354,354,354,354,354,354,e86a5293-312d-4425-bf95-35e4d7149aed, for the treatment of corticosteroid responsive dermatoses with secondary infection,1
305,305,305,305,305,305,305,355,355,355,355,355,355,355,355,355,355,355,355,355,e86a5293-312d-4425-bf95-35e4d7149aed,it has not been demonstrated that this steroid antibiotic combination provides greater benefit than the steroid component alone after 7 days of treatment ( see warnings ),0
306,306,306,306,306,306,306,356,356,356,356,356,356,356,356,356,356,356,356,356,e76c3a5a-d417-473b-ab9a-165d9d9963c6, neomycin and polymyxin b sulfates and bacitracin zinc with hydrocortisone acetate ophthalmic ointment is indicated for steroid responsive inflammatory ocular conditions for which a corticosteroid is indicated and where bacterial infection or a risk of bacterial infection exists,1
307,307,307,307,307,307,307,357,357,357,357,357,357,357,357,357,357,357,357,357,e76c3a5a-d417-473b-ab9a-165d9d9963c6,ocular corticosteroids are indicated in inflammatory conditions of the palpebral and bulbar conjunctiva  cornea  and anterior segment of the globe where the inherent risk of corticosteroid use in certain infective conjunctivitides is accepted to obtain a diminution in edema and inflammation,1
308,308,308,308,308,308,308,358,358,358,358,358,358,358,358,358,358,358,358,358,e76c3a5a-d417-473b-ab9a-165d9d9963c6,they are also indicated in chronic anterior uveitis and corneal injury from chemical  radiation  or thermal burns  or penetration of foreign bodies,1
309,309,309,309,309,309,309,359,359,359,359,359,359,359,359,359,359,359,359,359,e76c3a5a-d417-473b-ab9a-165d9d9963c6,the use of a combination drug with an anti infective component is indicated where the risk of infection is high or where there is an expectation that potentially dangerous numbers of bacteria will be present in the eye ( see clinical pharmacology microbiology ),1
310,310,310,310,310,310,310,360,360,360,360,360,360,360,360,360,360,360,360,360,e76c3a5a-d417-473b-ab9a-165d9d9963c6,the particular anti infective drugs in this product are active against the following common bacterial eye pathogens staphylococcus aureus  streptococci  including streptococcus pneumoniae  escherichia coli  haemophilus influenzae  klebsiella enterobacter species  neisseria species  and pseudomonas aeruginosa,1
311,311,311,311,311,311,311,361,361,361,361,361,361,361,361,361,361,361,361,361,e76c3a5a-d417-473b-ab9a-165d9d9963c6,the product does not provide adequate coverage against serratia marcescens,2
312,312,312,312,312,312,312,362,362,362,362,362,362,362,362,362,362,362,362,362,9691178e-5323-40ce-a8b3-f79e88f02797, neomycin and polymyxin b sulfates and gramicidin ophthalmic solution  usp is indicated for the topical treatment of superficial infections of the external eye and its adnexa caused by susceptible bacteria,1
313,313,313,313,313,313,313,363,363,363,363,363,363,363,363,363,363,363,363,363,9691178e-5323-40ce-a8b3-f79e88f02797,such infections encompass conjunctivitis  keratitis and keratoconjunctivitis  blepharitis and blepharoconjunctivitis,1
314,314,314,314,314,314,314,364,364,364,364,364,364,364,364,364,364,364,364,364,681d27fa-de41-43c3-abed-0b70ea286012, for steroid responsive inflammatory ocular conditions for which a corticosteroid is indicated and where bacterial infection or risk of bacterial ocular infection exists,1
315,315,315,315,315,315,315,365,365,365,365,365,365,365,365,365,365,365,365,365,681d27fa-de41-43c3-abed-0b70ea286012,ocular steroids are indicated in inflammatory conditions of the palpebral and bulbar conjunctiva  cornea  and anterior segment of the globe where the inherent risk of steroid use in certain infective conjunctivitises is accepted to obtain a diminution in edema and inflammation,0
316,316,316,316,316,316,316,366,366,366,366,366,366,366,366,366,366,366,366,366,681d27fa-de41-43c3-abed-0b70ea286012,they are also indicated in chronic anterior uveitis and corneal injury from chemical  radiation or thermal burns or penetration of foreign bodies,1
317,317,317,317,317,317,317,367,367,367,367,367,367,367,367,367,367,367,367,367,681d27fa-de41-43c3-abed-0b70ea286012,the use of a combination drug with an anti infective component is indicated where the risk of infection is high or where there is an expectation that potentially dangerous numbers of bacteria will be present in the eye,1
318,318,318,318,318,318,318,368,368,368,368,368,368,368,368,368,368,368,368,368,681d27fa-de41-43c3-abed-0b70ea286012,the particular anti infective drugs in this product is active against the following common bacterial eye pathogens staphylococcus aureus  escherichia coli  haemophilus influenzae  klebsiella enterobacter species  niesseria species  and pseudomonas aeruginosa,1
319,319,319,319,319,319,319,369,369,369,369,369,369,369,369,369,369,369,369,369,681d27fa-de41-43c3-abed-0b70ea286012,this product does not provide adequate coverage against serratia marcescens and streptococci  including streptococcus pneumoniae,2
320,320,320,320,320,320,320,370,370,370,370,370,370,370,370,370,370,370,370,370,cf18b051-b656-4f46-8b69-a1df6f5d8d29, neo polycin ophthalmic ointment is indicated for the topical treatment of superficial infections of the external eye and its adnexa caused by susceptible bacteria,1
321,321,321,321,321,321,321,371,371,371,371,371,371,371,371,371,371,371,371,371,cf18b051-b656-4f46-8b69-a1df6f5d8d29,such infections encompass conjunctivitis  keratitis  and keratoconjunctivitis  blepharitis and blepharoconjunctivitis,1
322,322,322,322,322,322,322,372,372,372,372,372,372,372,372,372,372,372,372,372,"Active Ingredient UNII(s)
057Y626693; 19371312D4; 89Y4M234ES; V13007Z41A    906c715a-c47c-47f7-9ba0-4e990fb82e89
057Y626693; 19371312D4; 89Y4M234ES; V13007Z41A    906c715a-c47c-47f7-9ba0-4e990fb82e89
Name: SET ID dtype: object",active ingredient unii ( s ) 057y626693 19371312d4 89y4m234es v13007z41a active ingredient unii ( s ) 057y626693 19371312 057y626693 19371312d4 89y4m234es v13007z41a active ingredient unii ( s ) 057y626693 19371312 name content xml  dtype object,0
323,323,323,323,323,323,323,375,375,375,375,375,375,375,375,375,375,375,375,375,097a7a8d-04d4-4736-c8b7-0796117457bf,it has not been demonstrated that this steroid antibiotic combination provides greater benefit than the steroid component alone after 7 days of treatment,2
324,324,324,324,324,324,324,376,376,376,376,376,376,376,376,376,376,376,376,376,cef55cbb-2566-4f54-826a-70f0a7ebb88f,indlcatlons and usage for the treatment of superficial bacterial infections of the external auditory canal caused by organisms susceptible to the action of the antibiotics  and for the treatment of infections of mastoidectomy and fenestration cavities caused by organisms susceptible to the antibiotics,1
325,325,325,325,325,325,325,377,377,377,377,377,377,377,377,377,377,377,377,377,256f4083-5b34-4643-a75a-dd1a59a5d964, coly mycin s otic is indicated for the treatment of superficial bacterial infections of the external auditory canal  caused by organisms susceptible to the action of the antibiotics and for the treatment of infections of mastoidectomy and fenestration cavities  caused by organisms susceptible to the antibiotics,1
326,326,326,326,326,326,326,378,378,378,378,378,378,378,378,378,378,378,378,378,87d6e9dc-fe3b-4593-ac9a-d7493d1959c7, this parenteral preparation is indicated only for diluting or dissolving drugs for intravenous  intramuscular or subcutaneous injection  according to instructions of the manufacturer of the drug to be administered,1
327,327,327,327,327,327,327,379,379,379,379,379,379,379,379,379,379,379,379,379,56733651-d331-4e69-a6a3-303756ccc53c,1  epoprostenol sodium for injection is indicated for the treatment of pulmonary arterial hypertension ( pah ) ( who group i ) to improve exercise capacity,1
328,328,328,328,328,328,328,380,380,380,380,380,380,380,380,380,380,380,380,380,56733651-d331-4e69-a6a3-303756ccc53c,trials establishing effectiveness included predominantly ( 97 ) patients with new york heart association ( nyha ) functional class iii iv symptoms and etiologies of idiopathic or heritable pah ( 49 ) or pah associated with connective tissue diseases ( 51 ),0
329,329,329,329,329,329,329,381,381,381,381,381,381,381,381,381,381,381,381,381,56733651-d331-4e69-a6a3-303756ccc53c,epoprostenol sodium for injection is a prostacyclin vasodilator indicated for the treatment of pulmonary arterial hypertension ( pah ) ( who group i ) to improve exercise capacity,1
330,330,330,330,330,330,330,382,382,382,382,382,382,382,382,382,382,382,382,382,56733651-d331-4e69-a6a3-303756ccc53c,studies establishing effectiveness included predominantly ( 97 ) patients with nyha functional class iii iv symptoms and etiologies of idiopathic or heritable pah ( 49 ) or pah associated with connective tissue diseases ( 51 ),0
331,331,331,331,331,331,331,383,383,383,383,383,383,383,383,383,383,383,383,383,06c018a4-293e-42b5-b77a-bb121501cb16,1  icg for injection set  a tricarbocyanine dye  is indicated for use with the karl storz icg imaging system to provide real time endoscopic visible and near infrared fluorescence imaging,1
332,332,332,332,332,332,332,384,384,384,384,384,384,384,384,384,384,384,384,384,06c018a4-293e-42b5-b77a-bb121501cb16,indocyanine green for injection  usp used in conjunction with the karl storz icg imaging system enables surgeons to perform minimally invasive surgery using standard endoscopic visible light as well as icg for injection set  a tricarbocyanine dye  is indicated for use with the karl storz icg imaging system to provide real time endoscopic visible and near infrared fluorescence imaging,1
333,333,333,333,333,333,333,385,385,385,385,385,385,385,385,385,385,385,385,385,06c018a4-293e-42b5-b77a-bb121501cb16,icg for injection set used in conjunction with the karl storz icg imaging system enables surgeons to perform minimally invasive surgery using standard endoscopic visible light as well as visual assessment of vessels  blood flow and related tissue perfusion,u
334,334,334,334,334,334,334,386,386,386,386,386,386,386,386,386,386,386,386,386,06c018a4-293e-42b5-b77a-bb121501cb16,( 1 1 ) visual assessment of at least one of the major extra hepatic bile ducts ( cystic duct  common bile duct and common hepatic duct )  using near infrared imaging,1
335,335,335,335,335,335,335,387,387,387,387,387,387,387,387,387,387,387,387,387,06c018a4-293e-42b5-b77a-bb121501cb16,fluorescence imaging of biliary ducts with the karl storz icg imaging system is intended for use with standard of care white light and  when indicated  intraoperative cholangiography,1
336,336,336,336,336,336,336,388,388,388,388,388,388,388,388,388,388,388,388,388,06c018a4-293e-42b5-b77a-bb121501cb16,the device is not intended for standalone use for biliary duct visualization,2
337,337,337,337,337,337,337,389,389,389,389,389,389,389,389,389,389,389,389,389,06c018a4-293e-42b5-b77a-bb121501cb16,( 1 2 ) 1 1 visual assessment of vessels  blood flow and related tissue perfusion 1 2 visual assessment of at least one of the major extra hepatic bile ducts ( cystic duct  common bile duct and common hepatic duct )  using near infrared imaging,
338,338,338,338,338,338,338,390,390,390,390,390,390,390,390,390,390,390,390,390,06c018a4-293e-42b5-b77a-bb121501cb16,visual assessment of at least one of the major extra hepatic bile ducts ( cystic duct  common bile duct and common hepatic duct )  using near infrared imaging,
339,339,339,339,339,339,339,393,393,393,393,393,393,393,393,393,393,393,393,393,6c80bb38-e8db-4138-9f0d-dbbf9c673185, remodulin is a prostacyclin vasodilator indicated for treatment of pulmonary arterial hypertension ( pah ) ( who group 1 ) to diminish symptoms associated with exercise,1
340,340,340,340,340,340,340,394,394,394,394,394,394,394,394,394,394,394,394,394,6c80bb38-e8db-4138-9f0d-dbbf9c673185,studies establishing effectiveness included patients with nyha functional class ii iv symptoms and etiologies of idiopathic or heritable pah ( 58 )  pah associated with congenital systemic to pulmonary shunts ( 23 )  or pah associated with connective tissue diseases ( 19 ) ( 1 1 ) patients who require transition from flolan  to reduce the rate of clinical deterioration,0
341,341,341,341,341,341,341,395,395,395,395,395,395,395,395,395,395,395,395,395,6c80bb38-e8db-4138-9f0d-dbbf9c673185,the risks and benefits of each drug should be carefully considered prior to transition,0
342,342,342,342,342,342,342,396,396,396,396,396,396,396,396,396,396,396,396,396,6c80bb38-e8db-4138-9f0d-dbbf9c673185,( 1 2 ) 1 1 pulmonary arterial hypertension remodulin is indicated for the treatment of pulmonary arterial hypertension ( pah ) ( who group 1 ) to diminish symptoms associated with exercise,1
343,343,343,343,343,343,343,397,397,397,397,397,397,397,397,397,397,397,397,397,6c80bb38-e8db-4138-9f0d-dbbf9c673185,studies establishing effectiveness included patients with nyha functional class ii iv symptoms and etiologies of idiopathic or heritable pah ( 58 )  pah associated with congenital systemic to pulmonary shunts ( 23 )  or pah associated with connective tissue diseases ( 19 ) see clinical studies ( 14 1 ),u
344,344,344,344,344,344,344,398,398,398,398,398,398,398,398,398,398,398,398,398,6c80bb38-e8db-4138-9f0d-dbbf9c673185,it may be administered as a continuous subcutaneous infusion or continuous intravenous ( iv ) infusion however  because of the risks associated with chronic indwelling central venous catheters  including serious blood stream infections ( bsis )  reserve continuous intravenous infusion for patients who are intolerant of the subcutaneous route  or in whom these risks are considered warranted see warnings and precautions 5 1,4
345,345,345,345,345,345,345,399,399,399,399,399,399,399,399,399,399,399,399,399,6c80bb38-e8db-4138-9f0d-dbbf9c673185,1 2 pulmonary arterial hypertension in patients requiring transition from flolan in patients with pulmonary arterial hypertension requiring transition from flolan ( epoprostenol sodium )  remodulin is indicated to diminish the rate of clinical deterioration,1
346,346,346,346,346,346,346,400,400,400,400,400,400,400,400,400,400,400,400,400,6c80bb38-e8db-4138-9f0d-dbbf9c673185,consider the risks and benefits of each drug prior to transition,0
347,347,347,347,347,347,347,401,401,401,401,401,401,401,401,401,401,401,401,401,f950988c-0bcc-4d07-bdc2-2426959a85a4,1  locoid lipocream is indicated for relief of the inflammatory and pruritic manifestations of corticosteroid responsive dermatoses in adults,1
348,348,348,348,348,348,348,402,402,402,402,402,402,402,402,402,402,402,402,402,f950988c-0bcc-4d07-bdc2-2426959a85a4,the topical treatment of mild to moderate atopic dermatitis in pediatric patients 3 months to 18 years of age,1
349,349,349,349,349,349,349,403,403,403,403,403,403,403,403,403,403,403,403,403,f950988c-0bcc-4d07-bdc2-2426959a85a4,locoid lipocream is a corticosteroid indicated for relief of the inflammatory and pruritic manifestations of corticosteroid responsive dermatoses in adults,1
350,350,350,350,350,350,350,404,404,404,404,404,404,404,404,404,404,404,404,404,f950988c-0bcc-4d07-bdc2-2426959a85a4,( 1 ) the treatment of mild to moderate atopic dermatitis in patients 3 months to 18 years of age,1
351,351,351,351,351,351,351,405,405,405,405,405,405,405,405,405,405,405,405,405,e26adce8-a53d-4d04-ab66-6de34d1e8bc4, when the natural exposure to elevated aeroallergens produces symptoms as described under clinical pharmacology  specific diagnosis and therapeutic procedures are indicated,1
352,352,352,352,352,352,352,406,406,406,406,406,406,406,406,406,406,406,406,406,e26adce8-a53d-4d04-ab66-6de34d1e8bc4,clearly  important clues to the cause of a person 's allergic condition can be gleaned from a thorough history and careful physical examination,0
353,353,353,353,353,353,353,407,407,407,407,407,407,407,407,407,407,407,407,407,e26adce8-a53d-4d04-ab66-6de34d1e8bc4,diagnostic tests in vitro or in vivo serve only to confirm the physician 's suspicions or to improve investigative skills,0
354,354,354,354,354,354,354,408,408,408,408,408,408,408,408,408,408,408,408,408,e26adce8-a53d-4d04-ab66-6de34d1e8bc4,specific diagnosis is especially indicated when the patient 's symptoms are not controlled by medication,1
355,355,355,355,355,355,355,409,409,409,409,409,409,409,409,409,409,409,409,409,e26adce8-a53d-4d04-ab66-6de34d1e8bc4,when immunotherapy is contemplated demonstration of sensitivity to a specific allergenic extract is necessary,4
356,356,356,356,356,356,356,410,410,410,410,410,410,410,410,410,410,410,410,410,e26adce8-a53d-4d04-ab66-6de34d1e8bc4,an orderly approach to the use of diagnostic tests usually begins with direct skin testing,0
357,357,357,357,357,357,357,411,411,411,411,411,411,411,411,411,411,411,411,411,e26adce8-a53d-4d04-ab66-6de34d1e8bc4,5  6  11 this product is not intended for treatment of patients who do not manifest immediate hypersensitivity reactions to the allergenic extract following skin testing,2
358,358,358,358,358,358,358,524,524,524,524,524,524,524,524,524,524,524,524,524,bec9e89a-a6a5-0a83-926e-1311dff6f14f, formulated for associated symptoms such as nasal catarrh  post nasal drip  sneezing  glandular swellings and pharyngitis,1
359,359,359,359,359,359,359,543,543,543,543,543,543,543,543,543,543,543,543,543,9838a8a2-dd5a-4eb2-beee-2fb45d35f6de,1  pliaglis is indicated for use on intact skin in adults to provide topical local analgesia for superficial dermatological procedures such as dermal filler injection  pulsed dye laser therapy  facial laser resurfacing  and laser assisted tattoo removal,1
360,360,360,360,360,360,360,544,544,544,544,544,544,544,544,544,544,544,544,544,9838a8a2-dd5a-4eb2-beee-2fb45d35f6de,pliaglis is a combination of lidocaine  an amide local anesthetic  and tetracaine  an ester local anesthetic  indicated for use on intact skin in adults to provide topical local analgesia for superficial dermatological procedures such as dermal filler injection  pulsed dye laser therapy  facial laser resurfacing  and laser assisted tattoo removal,1
361,361,361,361,361,361,361,545,545,545,545,545,545,545,545,545,545,545,545,545,27c2c560-8532-a8e4-6e6f-c478ffbeba4b,product name indications section cold cough formulated for coughs associated with tonsilitis  allergies  sinusitis  bronchitis  croup  colds and other respiratory conditions,1
362,362,362,362,362,362,362,546,546,546,546,546,546,546,546,546,546,546,546,546,4fa493ff-9ea2-4e17-9e16-994c11207440,uses temporarily relieves sensitive  bleeding gums and gingivitis,1
363,363,363,363,363,363,363,547,547,547,547,547,547,547,547,547,547,547,547,547,4fa493ff-9ea2-4e17-9e16-994c11207440,this statement has not been evaluated by the fda,0
364,364,364,364,364,364,364,548,548,548,548,548,548,548,548,548,548,548,548,548,4fa493ff-9ea2-4e17-9e16-994c11207440,it is based on documented homeopathic materia medica,0
365,365,365,365,365,365,365,549,549,549,549,549,549,549,549,549,549,549,549,549,c09655ea-7af5-4443-a769-86e416214f59,1  vibativ is a lipoglycopeptide antibacterial drug indicated for the treatment of the following infections in adult patients caused by designated susceptible bacteria complicated skin and skin structure infections ( csssi ) ( 1 1 ) hospital acquired and ventilator associated bacterial pneumonia ( habp vabp ) caused by susceptible isolates of staphylococcus aureus,1
366,366,366,366,366,366,366,550,550,550,550,550,550,550,550,550,550,550,550,550,c09655ea-7af5-4443-a769-86e416214f59,vibativ should be reserved for use when alternative treatments are not suitable,4
367,367,367,367,367,367,367,551,551,551,551,551,551,551,551,551,551,551,551,551,c09655ea-7af5-4443-a769-86e416214f59,( 1 2 ) to reduce the development of drug resistant bacteria and maintain the effectiveness of vibativ and other antibacterial drugs vibativ should only be used to treat or prevent infections that are proven or strongly suspected to be caused by bacteria,4
368,368,368,368,368,368,368,552,552,552,552,552,552,552,552,552,552,552,552,552,c09655ea-7af5-4443-a769-86e416214f59,1 1 complicated skin and skin structure infections vibativ is indicated for the treatment of adult patients with complicated skin and skin structure infections ( csssi ) caused by susceptible isolates of the following gram positive microorganisms staphylococcus aureus ( including methicillin susceptible and resistant isolates )  streptococcus pyogenes  streptococcus agalactiae  streptococcus anginosus group ( includes s anginosus  s intermedius  and s constellatus )  or enterococcus faecalis ( vancomycin susceptible isolates only ),1
369,369,369,369,369,369,369,553,553,553,553,553,553,553,553,553,553,553,553,553,c09655ea-7af5-4443-a769-86e416214f59,1 2 habp vabp vibativ is indicated for the treatment of adult patients with hospital acquired and ventilator associated bacterial pneumonia ( habp vabp )  caused by susceptible isolates of staphylococcus aureus ( both methicillin susceptible and resistant isolates ),1
370,370,370,370,370,370,370,555,555,555,555,555,555,555,555,555,555,555,555,555,c09655ea-7af5-4443-a769-86e416214f59,1 3 usage combination therapy may be clinically indicated if the documented or presumed pathogens include gram negative organisms,1
371,371,371,371,371,371,371,556,556,556,556,556,556,556,556,556,556,556,556,556,c09655ea-7af5-4443-a769-86e416214f59,appropriate specimens for bacteriological examination should be obtained in order to isolate and identify the causative pathogens and to determine their susceptibility to telavancin,0
372,372,372,372,372,372,372,557,557,557,557,557,557,557,557,557,557,557,557,557,c09655ea-7af5-4443-a769-86e416214f59,vibativ may be initiated as empiric therapy before results of these tests are known,u
373,373,373,373,373,373,373,558,558,558,558,558,558,558,558,558,558,558,558,558,b6d11c45-b502-478e-bb28-2ff596ea259c, gonal f rff redi ject is a prefilled gonadotropin containing auto injection device indicated for induction of ovulation and pregnancy in oligo anovulatory women in whom the cause of infertility is functional and not due to primary ovarian failure ( 1 1 ) development of multiple follicles in ovulatory women as part of an assisted reproductive technology ( art ) cycle ( 1 2 ) 1 1 induction of ovulation and pregnancy in oligo anovulatory women in whom the cause of infertility is functional and not due to primary ovarian failure prior to initiation of treatment with gonal f rff redi ject perform a complete gynecologic and endocrinologic evaluation exclude primary ovarian failure exclude the possibility of pregnancy demonstrate tubal patency evaluate the fertility status of the male partner 1 2 development of multiple follicles in ovulatory women as part of an assisted reproductive technology ( art ) cycle prior to initiation of treatment with gonal f rff redi ject perform a complete gynecologic and endocrinologic evaluation  and diagnose the cause of infertility exclude the possibility of pregnancy evaluate the fertility status of the male partner,1
374,374,374,374,374,374,374,559,559,559,559,559,559,559,559,559,559,559,559,559,22c8db95-c3db-1770-8086-31356fbabe35,1  menopur ( menotropins for injection ) is a gonadotropin indicated for development of multiple follicles and pregnancy in ovulatory women as part of an assisted reproductive technology ( art ) cycle ( 1 ) prior to initiation of treatment with menopur ( menotropins for injection ) perform a complete gynecologic and endocrinologic evaluation  and diagnose the cause of infertility exclude the possibility of pregnancy evaluate the fertility status of the male partner exclude a diagnosis of primary ovarian failure,1
375,375,375,375,375,375,375,560,560,560,560,560,560,560,560,560,560,560,560,560,64ffb680-ea8c-42fc-9649-9e8c0eb77ddb,1  imlygic is a genetically modified oncolytic viral therapy indicated for the local treatment of unresectable cutaneous  subcutaneous  and nodal lesions in patients with melanoma recurrent after initial surgery,1
376,376,376,376,376,376,376,561,561,561,561,561,561,561,561,561,561,561,561,561,64ffb680-ea8c-42fc-9649-9e8c0eb77ddb,limitations of use imlygic has not been shown to improve overall survival or have an effect on visceral metastases,2
377,377,377,377,377,377,377,562,562,562,562,562,562,562,562,562,562,562,562,562,64ffb680-ea8c-42fc-9649-9e8c0eb77ddb,imlygic is a genetically modified oncolytic viral therapy indicated for the local treatment of unresectable cutaneous  subcutaneous  and nodal lesions in patients with melanoma recurrent after initial surgery,1
378,378,378,378,378,378,378,580,580,580,580,580,580,580,580,580,580,580,580,580,e5b72731-1acb-45b7-9c13-290ad12d3951,1  belsomra ( suvorexant ) is indicated for the treatment of insomnia characterized by difficulties with sleep onset and or sleep maintenance,1
379,379,379,379,379,379,379,581,581,581,581,581,581,581,581,581,581,581,581,581,e5b72731-1acb-45b7-9c13-290ad12d3951,belsomra is an orexin receptor antagonist indicated for the treatment of insomnia  characterized by difficulties with sleep onset and or sleep maintenance ( 1 ),1
380,380,380,380,380,380,380,582,582,582,582,582,582,582,582,582,582,582,582,582,1e6dc9ae-1c4c-42d9-87aa-c315ecc51b56,1  tremfya is indicated for the treatment of adults with moderate to severe plaque psoriasis who are candidates for systemic therapy or phototherapy,1
381,381,381,381,381,381,381,583,583,583,583,583,583,583,583,583,583,583,583,583,1e6dc9ae-1c4c-42d9-87aa-c315ecc51b56,tremfya is an interleukin 23 blocker indicated for the treatment of adult patients with moderate to severe plaque psoriasis who are candidates for systemic therapy or phototherapy,1
382,382,382,382,382,382,382,584,584,584,584,584,584,584,584,584,584,584,584,584,3f91cd92-eb6d-4bda-9cad-2e11e0b0fbe2,essential hypertension ( use with guna male fem ) 1 2,1
383,383,383,383,383,383,383,585,585,585,585,585,585,585,585,585,585,585,585,585,3f91cd92-eb6d-4bda-9cad-2e11e0b0fbe2,fluid retention ( use with guna pms ) 1 3,1
384,384,384,384,384,384,384,586,586,586,586,586,586,586,586,586,586,586,586,586,3f91cd92-eb6d-4bda-9cad-2e11e0b0fbe2,temporary weight gain ( use with guna matrix and guna lympho ) 1 4,1
385,385,385,385,385,385,385,587,587,587,587,587,587,587,587,587,587,587,587,587,3f91cd92-eb6d-4bda-9cad-2e11e0b0fbe2,lymphedema ( use with guna lympho ) 1 5,1
386,386,386,386,386,386,386,588,588,588,588,588,588,588,588,588,588,588,588,588,3f91cd92-eb6d-4bda-9cad-2e11e0b0fbe2,tissue swelling administration may vary according to individual needs,0
387,387,387,387,387,387,387,589,589,589,589,589,589,589,589,589,589,589,589,589,3f91cd92-eb6d-4bda-9cad-2e11e0b0fbe2,guna diur may be used together with other homeopathic medications,4
388,388,388,388,388,388,388,590,590,590,590,590,590,590,590,590,590,590,590,590,75df146d-f7a1-424e-b308-46389150ecd6,1  trelstar is indicated for the palliative treatment of advanced prostate cancer see clinical studies ( 14 ),1
389,389,389,389,389,389,389,591,591,591,591,591,591,591,591,591,591,591,591,591,75df146d-f7a1-424e-b308-46389150ecd6,trelstar is a gonadotropin releasing hormone ( gnrh ) agonist indicated for the palliative treatment of advanced prostate cancer,1
390,390,390,390,390,390,390,592,592,592,592,592,592,592,592,592,592,592,592,592,0ae10bc4-6b65-402f-9db5-2d7753054922,1  elitek is indicated for the initial management of plasma uric acid levels in pediatric and adult patients with leukemia  lymphoma  and solid tumor malignancies who are receiving anti cancer therapy expected to result in tumor lysis and subsequent elevation of plasma uric acid,1
391,391,391,391,391,391,391,593,593,593,593,593,593,593,593,593,593,593,593,593,0ae10bc4-6b65-402f-9db5-2d7753054922,limitation of use elitek is indicated only for a single course of treatment see warnings and precautions ( 5 1 ),1
392,392,392,392,392,392,392,594,594,594,594,594,594,594,594,594,594,594,594,594,0ae10bc4-6b65-402f-9db5-2d7753054922,elitek is a recombinant urate oxidase indicated for initial management of plasma uric acid levels in pediatric and adult patients with leukemia  lymphoma  and solid tumor malignancies who are receiving anti cancer therapy expected to result in tumor lysis and subsequent elevation of plasma uric acid ( 1 ),1
393,393,393,393,393,393,393,595,595,595,595,595,595,595,595,595,595,595,595,595,0ae10bc4-6b65-402f-9db5-2d7753054922,limitation of use elitek is indicated only for a single course of treatment ( 1 ),4
394,394,394,394,394,394,394,596,596,596,596,596,596,596,596,596,596,596,596,596,549e0b36-7085-0f5d-e054-00144ff88e88,1 indications usage clopidogrel is a p2y 12 platelet inhibitor indicated for acute coronary syndrome for patients with non st segment elevation acs unstable angina ( ua ) non st elevation myocardial infarction ( nstemi )  clopidogrel has been shown to reduce the rate of myocardial infarction ( mi ) and stroke,1
395,395,395,395,395,395,395,597,597,597,597,597,597,597,597,597,597,597,597,597,549e0b36-7085-0f5d-e054-00144ff88e88,( 1 1 ) for patients with st elevation myocardial infarction ( stemi )  clopidogrel has been shown to reduce the rate of mi and stroke,1
396,396,396,396,396,396,396,598,598,598,598,598,598,598,598,598,598,598,598,598,549e0b36-7085-0f5d-e054-00144ff88e88,( 1 1 ) recent mi  recent stroke  or established peripheral arterial disease,1
397,397,397,397,397,397,397,599,599,599,599,599,599,599,599,599,599,599,599,599,549e0b36-7085-0f5d-e054-00144ff88e88,clopidogrel has been shown to reduce the rate of mi and stroke,1
398,398,398,398,398,398,398,600,600,600,600,600,600,600,600,600,600,600,600,600,549e0b36-7085-0f5d-e054-00144ff88e88,( 1 2 ) 1 1 acute coronary syndrome ( acs ) clopidogrel is indicated to reduce the rate of myocardial infarction and stroke ( mi ) in patients with non st segment elevation acs unstable angina ( ua ) non st elevation myocardial infarction ( nstemi )  including patients who are to be managed medically and those who are to be managed with coronary revascularization,1
399,399,399,399,399,399,399,601,601,601,601,601,601,601,601,601,601,601,601,601,549e0b36-7085-0f5d-e054-00144ff88e88,clopidogrel should be administered in conjunction with aspirin,4
400,400,400,400,400,400,400,602,602,602,602,602,602,602,602,602,602,602,602,602,549e0b36-7085-0f5d-e054-00144ff88e88,clopidogrel is indicated to reduce the rate of myocardial infarction and stroke in patients with acute st elevation myocardial infarction ( stemi ) who are to be managed medically,1
401,401,401,401,401,401,401,604,604,604,604,604,604,604,604,604,604,604,604,604,549e0b36-7085-0f5d-e054-00144ff88e88,1 2 recent mi  recent stroke  or established peripheral arterial disease in patients with established peripheral arterial disease or with a history of recent myocardial infarction ( mi ) or recent stroke clopidogrel is indicated to reduce the rate of mi and stroke,1
402,402,402,402,402,402,402,605,605,605,605,605,605,605,605,605,605,605,605,605,126c5279-0ac1-4ed8-8c0f-b9084e3d7bb2,1  clopidogrel bisulfate is a p2y12 platelet inhibitor indicated for acute coronary syndrome for patients with non st segment elevation acs unstable angina ( ua ) non st elevation myocardial infarction ( nstemi )  clopidogrel bisulfate has been shown to reduce the rate of myocardial infarction ( mi ) and stroke,1
403,403,403,403,403,403,403,606,606,606,606,606,606,606,606,606,606,606,606,606,126c5279-0ac1-4ed8-8c0f-b9084e3d7bb2,( 1 1 ) for patients with st elevation myocardial infarction ( stemi )  clopidogrel bisulfate has been shown to reduce the rate of mi and stroke,1
404,404,404,404,404,404,404,608,608,608,608,608,608,608,608,608,608,608,608,608,126c5279-0ac1-4ed8-8c0f-b9084e3d7bb2,clopidogrel bisulfate has been shown to reduce the rate of mi and stroke,1
405,405,405,405,405,405,405,609,609,609,609,609,609,609,609,609,609,609,609,609,126c5279-0ac1-4ed8-8c0f-b9084e3d7bb2,( 1 2 ) 1 1 acute coronary syndrome ( acs ) clopidogrel tablets are indicated to reduce the rate of myocardial infarction and stroke ( mi ) in patients with non st segment elevation acs unstable angina ( ua ) non st elevation myocardial infarction ( nstemi )  including patients who are to be managed medically and those who are to be managed with coronary revascularization,1
406,406,406,406,406,406,406,611,611,611,611,611,611,611,611,611,611,611,611,611,126c5279-0ac1-4ed8-8c0f-b9084e3d7bb2,clopidogrel tablets are indicated to reduce the rate of myocardial infarction and stroke in patients with acute st elevation myocardial infarction ( stemi ) who are to be managed medically,1
407,407,407,407,407,407,407,612,612,612,612,612,612,612,612,612,612,612,612,612,126c5279-0ac1-4ed8-8c0f-b9084e3d7bb2,clopidogrel bisulfate should be administered in conjunction with aspirin,4
408,408,408,408,408,408,408,613,613,613,613,613,613,613,613,613,613,613,613,613,126c5279-0ac1-4ed8-8c0f-b9084e3d7bb2,1 2 recent mi  recent stroke  or established peripheral arterial disease in patients with established peripheral arterial disease or with a history of recent myocardial infarction ( mi ) or recent stroke clopidogrel bisulfate is indicated to reduce the rate of mi and stroke,1
409,409,409,409,409,409,409,621,621,621,621,621,621,621,621,621,621,621,621,621,ef9e7711-f478-4e35-bf4e-6021c8457e3b,1  zurampic is indicated in combination with a xanthine oxidase inhibitor for the treatment of hyperuricemia associated with gout in patients who have not achieved target serum uric acid levels with a xanthine oxidase inhibitor alone see clinical studies ( 14 ),1
410,410,410,410,410,410,410,622,622,622,622,622,622,622,622,622,622,622,622,622,ef9e7711-f478-4e35-bf4e-6021c8457e3b,zurampic is a urat1 inhibitor indicated in combination with a xanthine oxidase inhibitor for the treatment of hyperuricemia associated with gout in patients who have not achieved target serum uric acid levels with a xanthine oxidase inhibitor alone,1
411,411,411,411,411,411,411,623,623,623,623,623,623,623,623,623,623,623,623,623,ef9e7711-f478-4e35-bf4e-6021c8457e3b,( 1 ) limitations of use zurampic is not recommended for the treatment of asymptomatic hyperuricemia,2
412,412,412,412,412,412,412,624,624,624,624,624,624,624,624,624,624,624,624,624,ef9e7711-f478-4e35-bf4e-6021c8457e3b,( 1 1 ) zurampic should not be used as monotherapy,2
413,413,413,413,413,413,413,625,625,625,625,625,625,625,625,625,625,625,625,625,ef9e7711-f478-4e35-bf4e-6021c8457e3b,( 1 1  5 1 ) 1 1 limitations of use zurampic is not recommended for the treatment of asymptomatic hyperuricemia,2
414,414,414,414,414,414,414,626,626,626,626,626,626,626,626,626,626,626,626,626,ef9e7711-f478-4e35-bf4e-6021c8457e3b,zurampic should not be used as monotherapy see warnings and precautions ( 5 1 ),2
415,415,415,415,415,415,415,627,627,627,627,627,627,627,627,627,627,627,627,627,d4bd0c41-90ce-4255-8ff3-a4d47a5b25f8,1  duzallo  a combination of lesinurad  a uric acid transporter 1 ( urat1 ) inhibitor  and allopurinol  a xanthine oxidase inhibitor  is indicated for the treatment of hyperuricemia associated with gout in patients who have not achieved target serum uric acid levels with a medically appropriate daily dose of allopurinol alone see clinical studies ( 14 ),1
416,416,416,416,416,416,416,628,628,628,628,628,628,628,628,628,628,628,628,628,d4bd0c41-90ce-4255-8ff3-a4d47a5b25f8,duzallo  a combination of lesinurad  a urat1 inhibitor  and allopurinol  a xanthine oxidase inhibitor  is indicated for the treatment of hyperuricemia associated with gout in patients who have not achieved target serum uric acid levels with a medically appropriate daily dose of allopurinol alone,1
417,417,417,417,417,417,417,629,629,629,629,629,629,629,629,629,629,629,629,629,d4bd0c41-90ce-4255-8ff3-a4d47a5b25f8,( 1 ) limitations of use duzallo is not recommended for the treatment of asymptomatic hyperuricemia,2
418,418,418,418,418,418,418,630,630,630,630,630,630,630,630,630,630,630,630,630,d4bd0c41-90ce-4255-8ff3-a4d47a5b25f8,( 1 1 ) 1 1 limitations of use duzallo is not recommended for the treatment of asymptomatic hyperuricemia,2
419,419,419,419,419,419,419,631,631,631,631,631,631,631,631,631,631,631,631,631,90550274-6605-44de-8c25-c5591080270f,1  asclera ( polidocanol ) is indicated to sclerose uncomplicated spider veins ( varicose veins 1 mm in diameter ) and uncomplicated reticular veins ( varicose veins 1 to 3 mm in diameter ) in the lower extremity,1
420,420,420,420,420,420,420,632,632,632,632,632,632,632,632,632,632,632,632,632,90550274-6605-44de-8c25-c5591080270f,asclera has not been studied in varicose veins more than 3 mm in diameter,0
421,421,421,421,421,421,421,633,633,633,633,633,633,633,633,633,633,633,633,633,90550274-6605-44de-8c25-c5591080270f,asclera ( polidocanol ) is a sclerosing agent indicated to treat uncomplicated spider veins ( varicose veins 1 mm in diameter ) and uncomplicated reticular veins ( varicose veins 1 to 3 mm in diameter ) in the lower extremity,1
422,422,422,422,422,422,422,634,634,634,634,634,634,634,634,634,634,634,634,634,90550274-6605-44de-8c25-c5591080270f,it has not been studied in larger varicose veins 3 mm in diameter,0
423,423,423,423,423,423,423,635,635,635,635,635,635,635,635,635,635,635,635,635,544e9f79-2984-4bbe-8cc2-c664c64b2996,indications indications juniperus virginiana allergies allium cepa head cold thuja lobbi dry  hacking cough galphimia glauca sneezing frax amer fever sores on lips quercus robur diarrhea ulmus fulva constipation,1
424,424,424,424,424,424,424,636,636,636,636,636,636,636,636,636,636,636,636,636,7617f4a4-8812-44c4-8386-bc991f4d3a77, armour thyroid tablets are indicated as replacement or supplemental therapy in patients with hypothyroidism of any etiology  except transient hypothyroidism during the recovery phase of subacute thyroiditis,1
425,425,425,425,425,425,425,637,637,637,637,637,637,637,637,637,637,637,637,637,7617f4a4-8812-44c4-8386-bc991f4d3a77,this category includes cretinism  myxedema  and ordinary hypothyroidism in patients of any age ( children  adults  the elderly )  or state ( including pregnancy ) primary hypothyroidism resulting from functional deficiency  primary atrophy  partial or total absence of thyroid gland  or the effects of surgery  radiation  or drugs  with or without the presence of goiter and secondary ( pituitary )  or tertiary ( hypothalamic ) hypothyroidism ( see warnings ),1
426,426,426,426,426,426,426,638,638,638,638,638,638,638,638,638,638,638,638,638,7617f4a4-8812-44c4-8386-bc991f4d3a77,as pituitary tsh suppressants  in the treatment or prevention of various types of euthyroid goiters  including thyroid nodules  subacute or chronic iymphocytic thyroiditis ( hashimoto 's )  multinodular goiter  and in the management of thyroid cancer,1
427,427,427,427,427,427,427,639,639,639,639,639,639,639,639,639,639,639,639,639,bf23808e-e14c-b813-6a49-ee7ec367811b, formulated for associated symptoms of spring and early summer pollens such as nasal catarrh  post nasal drip  sneezing  glandular swellings and pharyngitis,1
428,428,428,428,428,428,428,640,640,640,640,640,640,640,640,640,640,640,640,640,8080de86-492c-4fd0-9b52-f4262bae0b29,indication and usage lymphomyosot x injection solution is a homeopathic drug product indicated for the improvement of lymphatic drainage  the non specific immune defense  and conditions such as benign hypertrophy of lymphnodes  chronic tonsillitis  tonsillar hypertrophy and lymphatic edema,1
429,429,429,429,429,429,429,641,641,641,641,641,641,641,641,641,641,641,641,641,108ab0a7-9eee-236a-f36f-e9a248bd3a81, exhaustion chronic fatigue formulated for symptoms associated with severe fatigue  epstein barr  chronic fatigue syndrome  adrenal exhaustion and other related conditions,1
430,430,430,430,430,430,430,642,642,642,642,642,642,642,642,642,642,642,642,642,606610ab-eb1f-78d6-e053-2a91aa0ad14d, formulated for symptoms associated with valley fever  gulf war syndrome  environmental sensitivity and other related conditions,1
431,431,431,431,431,431,431,643,643,643,643,643,643,643,643,643,643,643,643,643,60a4e737-d056-a417-e053-2a91aa0a3455, thyroid care formulated for symptoms associated with grave 's disease  hyperthyroidism  hashimoto 's disease  hypothyroidism and other related conditions,1
432,432,432,432,432,432,432,644,644,644,644,644,644,644,644,644,644,644,644,644,8455132c-ae0a-8144-f17e-a7f9b9824a31, hypoglycemia formulated for symptoms associated with blood sugar imbalance such as anxiety  trembling  palpitations  fatigue  irritability  headache and cravings,1
433,433,433,433,433,433,433,645,645,645,645,645,645,645,645,645,645,645,645,645,5e8b68b3-fb9b-beea-0c59-54a6d19dff1c, candida yeast formulated for symptoms associated with vaginal yeast infections  oral thrush  esophogeal candidiasis  and other yeast or fungal overgrowth conditions,1
434,434,434,434,434,434,434,646,646,646,646,646,646,646,646,646,646,646,646,646,6bf08861-e6bb-4fb5-77f3-be4dbd145b49,product name indications section candida yeast formulated for symptoms associated with vaginal yeast infections  oral thrush  esophogeal candidiasis  and other yeast or fungal overgrowth conditions,1
435,435,435,435,435,435,435,647,647,647,647,647,647,647,647,647,647,647,647,647,1aef3339-f552-3c25-e054-00144ff8d46c, energy complex formulated for symptoms associated with low energy  mild stress and weakness,1
436,436,436,436,436,436,436,648,648,648,648,648,648,648,648,648,648,648,648,648,d612a284-b301-40a9-a94d-222697637a44,uses helps restore mental alertness,1
437,437,437,437,437,437,437,649,649,649,649,649,649,649,649,649,649,649,649,649,ab4b547a-5af6-4449-94e9-d478dfdce1c5, uses for symptoms of adhd  hyperactive mind  difficulty concentrating or sleeping  forgetfulness  difficulty reading and writing,1
438,438,438,438,438,438,438,650,650,650,650,650,650,650,650,650,650,650,650,650,81b38b65-c69b-49e0-b1db-6757c7a379f0,increased or decreased thirst  dryness  headaches  low energy  mental sluggishness,1
439,439,439,439,439,439,439,651,651,651,651,651,651,651,651,651,651,651,651,651,69eaabac-dca6-481c-b10e-bf8759a657f7,uses temporarily relieves endocrine system imbalance ( glands hormones ),1
440,440,440,440,440,440,440,654,654,654,654,654,654,654,654,654,654,654,654,654,6a9cbc29-9f15-4b24-8d86-206b82887f3d,1  intelence registered trademark of tibotec pharmaceuticals  in combination with other antiretroviral agents  is indicated for the treatment of human immunodeficiency virus type 1 ( hiv 1 ) infection in antiretroviral treatment experienced patients ages 6 years and older  who have evidence of viral replication and hiv 1 strains resistant to a non nucleoside reverse transcriptase inhibitor ( nnrti ) and other antiretroviral agents,1
441,441,441,441,441,441,441,655,655,655,655,655,655,655,655,655,655,655,655,655,6a9cbc29-9f15-4b24-8d86-206b82887f3d,the indication for adult use is based on week 48 analyses from 2 randomized  double blind  placebo controlled trials of intelence,0
442,442,442,442,442,442,442,656,656,656,656,656,656,656,656,656,656,656,656,656,6a9cbc29-9f15-4b24-8d86-206b82887f3d,both studies were conducted in clinically advanced  3 class antiretroviral ( nnrti  n t rti  pi ) treatment experienced adults,0
443,443,443,443,443,443,443,657,657,657,657,657,657,657,657,657,657,657,657,657,6a9cbc29-9f15-4b24-8d86-206b82887f3d,the indication for pediatric use is based on 24 week analyses of a single arm  phase 2 trial in antiretroviral treatment experienced pediatric subjects 6 years to less than 18 years of age see use in specific populations ( 8 4 ),0
444,444,444,444,444,444,444,658,658,658,658,658,658,658,658,658,658,658,658,658,6a9cbc29-9f15-4b24-8d86-206b82887f3d,in treatment experienced adult and pediatric patients  the following points should be considered when initiating therapy with intelence treatment history and resistance testing should guide the use of intelence due to concerns for potential cross resistance see microbiology ( 12 4 ) and clinical studies ( 14 ),0
445,445,445,445,445,445,445,659,659,659,659,659,659,659,659,659,659,659,659,659,6a9cbc29-9f15-4b24-8d86-206b82887f3d,in patients who have experienced virologic failure on an nnrti containing regimen  do not use intelence in combination with only n t rtis see clinical studies ( 14 ),2
446,446,446,446,446,446,446,660,660,660,660,660,660,660,660,660,660,660,660,660,6a9cbc29-9f15-4b24-8d86-206b82887f3d,the use of other active antiretroviral agents with intelence is associated with an increased likelihood of treatment response,4
447,447,447,447,447,447,447,661,661,661,661,661,661,661,661,661,661,661,661,661,6a9cbc29-9f15-4b24-8d86-206b82887f3d,the safety and efficacy of intelence have not been established in pediatric patients less than 6 years of age or in treatment na ve adult or pediatric patients,2
448,448,448,448,448,448,448,662,662,662,662,662,662,662,662,662,662,662,662,662,6a9cbc29-9f15-4b24-8d86-206b82887f3d,intelence is a human immunodeficiency virus type 1 ( hiv 1 ) non nucleoside reverse transcriptase inhibitor ( nnrti ) indicated for treatment of hiv 1 infection in treatment experienced patients 6 years of age and older with viral strains resistant to an nnrti and other antiretroviral agents,1
449,449,449,449,449,449,449,663,663,663,663,663,663,663,663,663,663,663,663,663,6a9cbc29-9f15-4b24-8d86-206b82887f3d,( 1 ) in patients who have experienced virologic failure on an nnrti containing regimen  do not use intelence in combination with only n t rtis,1
450,450,450,450,450,450,450,664,664,664,664,664,664,664,664,664,664,664,664,664,6a9cbc29-9f15-4b24-8d86-206b82887f3d,( 1 ) treatment history and resistance testing should guide the use of intelence,0
451,451,451,451,451,451,451,665,665,665,665,665,665,665,665,665,665,665,665,665,a35fa709-5eb5-4429-b38f-f1e0019bf0ee,1  tri luma cream is a combination of fluocinolone acetonide ( a corticosteroid )  hydroquinone ( a melanin synthesis inhibitor )  and tretinoin ( a retinoid ) that is indicated for the short term treatment of moderate to severe melasma of the face  in the presence of measures for sun avoidance  including the use of sunscreens,1
452,452,452,452,452,452,452,666,666,666,666,666,666,666,666,666,666,666,666,666,a35fa709-5eb5-4429-b38f-f1e0019bf0ee,1 1 indication tri luma cream is a combination of fluocinolone acetonide ( a corticosteroid )  hydroquinone ( a melanin synthesis inhibitor )  and tretinoin ( a retinoid ) that is indicated for the short term treatment of moderate to severe melasma of the face  in the presence of measures for sun avoidance  including the use of sunscreens,1
453,453,453,453,453,453,453,667,667,667,667,667,667,667,667,667,667,667,667,667,a35fa709-5eb5-4429-b38f-f1e0019bf0ee,1 2 limitations of use tri luma cream is not indicated for the maintenance treatment of melasma,2
454,454,454,454,454,454,454,668,668,668,668,668,668,668,668,668,668,668,668,668,a35fa709-5eb5-4429-b38f-f1e0019bf0ee,after achieving control with tri luma cream  some patients may be managed with other treatments instead of triple therapy with tri luma cream,0
455,455,455,455,455,455,455,669,669,669,669,669,669,669,669,669,669,669,669,669,a35fa709-5eb5-4429-b38f-f1e0019bf0ee,melasma usually recurs upon discontinuation of tri luma cream,0
456,456,456,456,456,456,456,670,670,670,670,670,670,670,670,670,670,670,670,670,a35fa709-5eb5-4429-b38f-f1e0019bf0ee,the safety and efficacy of tri luma cream in patients of fitzpatrick skin types v and vi have not been studied,0
457,457,457,457,457,457,457,671,671,671,671,671,671,671,671,671,671,671,671,671,a35fa709-5eb5-4429-b38f-f1e0019bf0ee,excessive bleaching resulting in undesirable cosmetic effect in patients with darker skin cannot be excluded,0
458,458,458,458,458,458,458,672,672,672,672,672,672,672,672,672,672,672,672,672,a35fa709-5eb5-4429-b38f-f1e0019bf0ee,the safety and efficacy of tri luma cream in the treatment of hyperpigmentation conditions other than melasma of the face have not been studied,0
459,459,459,459,459,459,459,673,673,673,673,673,673,673,673,673,673,673,673,673,a35fa709-5eb5-4429-b38f-f1e0019bf0ee,because pregnant and lactating women were excluded from  and women of childbearing potential had to use birth control measures in the clinical trials  the safety and efficacy of tri luma cream in pregnant women and nursing mothers have not been established see use in specific populations ( 8 1  8 3 ),0
460,460,460,460,460,460,460,674,674,674,674,674,674,674,674,674,674,674,674,674,1a7e4806-3138-4b7a-b798-a99e163ee846,1  otovel is indicated for the treatment of acute otitis media with tympanostomy tubes ( aomt ) in pediatric patients ( aged 6 months and older ) due to staphylococcus aureus  streptococcus pneumoniae  haemophilus influenzae  moraxella catarrhalis  and pseudomonas aeruginosa,1
461,461,461,461,461,461,461,675,675,675,675,675,675,675,675,675,675,675,675,675,1a7e4806-3138-4b7a-b798-a99e163ee846,otovel is a combination of ciprofloxacin  a fluoroquinolone antibacterial  and fluocinolone acetonide  a corticosteroid  indicated for the treatment of acute otitis media with tympanostomy tubes ( aomt ) in pediatric patients ( aged 6 months and older ) due to staphylococcus aureus  streptococcus pneumoniae  haemophilus influenzae  moraxella catarrhalis  and pseudomonas aeruginosa ( 1 ),1
462,462,462,462,462,462,462,676,676,676,676,676,676,676,676,676,676,676,676,676,"Active Ingredient UNII(s)
0CD5FD6S2M; 8W8T17847W    136cb37e-e939-40b5-9725-194b14a9b090
0CD5FD6S2M; 8W8T17847W    136cb37e-e939-40b5-9725-194b14a9b090
Name: SET ID dtype: object",active ingredient unii ( s ) 0cd5fd6s2m 8w8t17847w active ingredient unii ( s ) 0cd5fd6s2m 8w8t1784 0cd5fd6s2m 8w8t17847w active ingredient unii ( s ) 0cd5fd6s2m 8w8t1784 name content xml  dtype object,0
463,463,463,463,463,463,463,678,678,678,678,678,678,678,678,678,678,678,678,678,46fc3acf-1e6d-4830-ae9a-abd9c1132fca, dialyvite supreme d is a prescription folic acid supplement with additional nutrients indicated for use in improving the nutritional status of renal dialysis patients,1
464,464,464,464,464,464,464,679,679,679,679,679,679,679,679,679,679,679,679,679,0bf5d3b9-5931-4180-9517-19977b58fe9a, dialyvite 3000 is a prescription folic acid supplement with additional nutrients indicated for use in improving the nutritional status of renal dialysis patients,1
465,465,465,465,465,465,465,680,680,680,680,680,680,680,680,680,680,680,680,680,bee9a137-160f-47e8-a551-ca461ae4f51e,indications bal in oil ( dimercaprol injection usp ) is indicated in the treatment of arsenic  gold and mercury poisoning,1
466,466,466,466,466,466,466,681,681,681,681,681,681,681,681,681,681,681,681,681,bee9a137-160f-47e8-a551-ca461ae4f51e,it is indicated in acute lead poisoning when used concomitantly with edetate calcium disodium injection usp,1
467,467,467,467,467,467,467,682,682,682,682,682,682,682,682,682,682,682,682,682,bee9a137-160f-47e8-a551-ca461ae4f51e,dimercaprol injection usp is effective for use in acute poisoning by mercury salts if therapy is begun within one or two hours following ingestion,1
468,468,468,468,468,468,468,683,683,683,683,683,683,683,683,683,683,683,683,683,bee9a137-160f-47e8-a551-ca461ae4f51e,it is not very effective for chronic mercury poisoning,0
469,469,469,469,469,469,469,684,684,684,684,684,684,684,684,684,684,684,684,684,bee9a137-160f-47e8-a551-ca461ae4f51e,dimercaprol injection usp is of questionable value in poisoning caused by other heavy metals such as antimony and bismuth,0
470,470,470,470,470,470,470,685,685,685,685,685,685,685,685,685,685,685,685,685,bee9a137-160f-47e8-a551-ca461ae4f51e,it should not be used in iron  cadmium  or selenium poisoning because the resulting dimercaprol metal complexes are more toxic than the metal alone  especially to the kidneys,2
471,471,471,471,471,471,471,686,686,686,686,686,686,686,686,686,686,686,686,686,7a31fc4c-579f-45cc-9559-39cfad9a57b3, protamine sulfate injection  usp is indicated in the treatment of heparin overdosage,1
472,472,472,472,472,472,472,687,687,687,687,687,687,687,687,687,687,687,687,687,bfccb051-7d05-4457-9823-9b460ee12232, citalopram hydrobromide tablets are indicated for the treatment of depression,1
473,473,473,473,473,473,473,688,688,688,688,688,688,688,688,688,688,688,688,688,bfccb051-7d05-4457-9823-9b460ee12232,the efficacy of citalopram hydrobromide tablets in the treatment of depression was established in 4 to 6 week  controlled trials of outpatients whose diagnosis corresponded most closely to the dsm iii and dsm iii r category of major depressive disorder ( see clinical pharmacology ),u
474,474,474,474,474,474,474,689,689,689,689,689,689,689,689,689,689,689,689,689,bfccb051-7d05-4457-9823-9b460ee12232,a major depressive episode ( dsm lv ) implies a prominent and relatively persistent ( nearly every day for at least 2 weeks ) depressed or dysphoric mood that usually interferes with daily functioning  and includes at least five of the following nine symptoms depressed mood  loss of interest in usual activities  significant change in weight and or appetite  insomnia or hypersomnia  psychomotor agitation or retardation  increased fatigue  feelings of guilt or worthlessness  slowed thinking or impaired concentration  a suicide attempt or suicidal ideation,0
475,475,475,475,475,475,475,690,690,690,690,690,690,690,690,690,690,690,690,690,bfccb051-7d05-4457-9823-9b460ee12232,the antidepressant action of citalopram hydrobromide tablets in hospitalized depressed patients has not been adequately studied,0
476,476,476,476,476,476,476,691,691,691,691,691,691,691,691,691,691,691,691,691,bfccb051-7d05-4457-9823-9b460ee12232,the efficacy of citalopram hydrobromide tablets in maintaining an antidepressant response for up to 24 weeks following 6 to 8 weeks of acute treatment was demonstrated in two placebo controlled trials ( see clinical pharmacology ),u
477,477,477,477,477,477,477,692,692,692,692,692,692,692,692,692,692,692,692,692,bfccb051-7d05-4457-9823-9b460ee12232,nevertheless  the physician who elects to use citalopram hydrobromide tablets for extended periods should periodically reevaluate the long term usefulness of the drug for the individual patient,4
478,478,478,478,478,478,478,693,693,693,693,693,693,693,693,693,693,693,693,693,ae0b15aa-d679-4ec8-95b2-b8c422927188,1  diclofenac sodium and misoprostol delayed release tablets are indicated for treatment of the signs and symptoms of osteoarthritis or rheumatoid arthritis in patients at high risk of developing nsaid induced gastric and duodenal ulcers and their complications,1
479,479,479,479,479,479,479,694,694,694,694,694,694,694,694,694,694,694,694,694,ae0b15aa-d679-4ec8-95b2-b8c422927188,for a list of factors that may increase the risk of nsaid induced gastric and duodenal ulcers and their complications see warnings and precautions ( 5 2 ),0
480,480,480,480,480,480,480,695,695,695,695,695,695,695,695,695,695,695,695,695,ae0b15aa-d679-4ec8-95b2-b8c422927188,diclofenac sodium and misoprostol delayed release tablets are a combination non steroidal anti inflammatory and prostaglandin e1 analog drug indicated for the treatment of signs and symptoms of osteoarthritis ( oa ) or rheumatoid arthritis ( ra ) in patients at high risk of developing nsaid induced gastric and duodenal ulcers and their complications ( 1 ),1
481,481,481,481,481,481,481,696,696,696,696,696,696,696,696,696,696,696,696,696,5856840b-9012-4613-8de4-3ad0f4ed110e,1  1 1 hevert gelsemium comp,1
482,482,482,482,482,482,482,697,697,697,697,697,697,697,697,697,697,697,697,697,5856840b-9012-4613-8de4-3ad0f4ed110e,is a homeopathic drug indicated for the improvement of painful nerve conditions  such as postherpetic neuralgia  trigeminal neuralgia  or sciatic nerve pain,1
483,483,483,483,483,483,483,698,698,698,698,698,698,698,698,698,698,698,698,698,0863075b-3e85-a539-ae7a-1631e1f6efd9, gastritis ulcer formulated for symptoms associated with gastritis and duodenal  esophageal or stomach ulcers,1
484,484,484,484,484,484,484,699,699,699,699,699,699,699,699,699,699,699,699,699,d799b97e-8adc-97a5-b4a0-1e29f198c50c, gas indigestion formulated for symptoms associated with dyspepsia such as bloating  nausea  eructations and pain or burning sensation in the upper abdomen,1
485,485,485,485,485,485,485,700,700,700,700,700,700,700,700,700,700,700,700,700,4a9e0337-9cb2-0a38-4e3c-4fe7170129da, digestive care formulated for digestive health and for symptoms associated with ibs  gerd  'leaky gut' syndrome  dyspepsia and other gi conditions,1
486,486,486,486,486,486,486,701,701,701,701,701,701,701,701,701,701,701,701,701,13a9bbba-db21-4cba-991c-5d8afaf2ed74, renacidin is indicated for dissolution of bladder calculi of the struvite or apatite variety by local intermittent irrigation through a urethral catheter or cystostomy tube as an alternative or adjunct to surgical procedures,1
487,487,487,487,487,487,487,702,702,702,702,702,702,702,702,702,702,702,702,702,13a9bbba-db21-4cba-991c-5d8afaf2ed74,renacidin is also indicated for use as an intermittent irrigating solution to prevent encrustations of indwelling urethral catheters and cystostomy tubes,1
488,488,488,488,488,488,488,703,703,703,703,703,703,703,703,703,703,703,703,703,7cfe22f2-b8c8-421b-6aa0-bf73bea73a4b, normosol m and 5 dextrose injection ( multiple electrolytes and 5 dextrose injection type 1  usp ) is indicated for parenteral maintenance of routine daily fluid and electrolyte requirements with minimal carbohydrate calories from dextrose,1
489,489,489,489,489,489,489,704,704,704,704,704,704,704,704,704,704,704,704,704,7cfe22f2-b8c8-421b-6aa0-bf73bea73a4b,magnesium in the formula may help to prevent iatrogenic magnesium deficiency in patients receiving prolonged parenteral therapy,u
490,490,490,490,490,490,490,705,705,705,705,705,705,705,705,705,705,705,705,705,7971c019-b58e-44ee-abea-1b74d97b9407, phenazopyridine hcl is indicated for the symptomatic relief of pain  burning  urgency  frequency  and other discomforts arising from irritation of the lower urinary tract mucosa caused by infection  trauma  surgery  endoscopic procedures  or the passage of sounds or catheters,1
491,491,491,491,491,491,491,706,706,706,706,706,706,706,706,706,706,706,706,706,7971c019-b58e-44ee-abea-1b74d97b9407,the use of phenazopyridine hcl for relief of symptoms should not delay definitive diagnosis and treatment of causative conditions,0
492,492,492,492,492,492,492,707,707,707,707,707,707,707,707,707,707,707,707,707,7971c019-b58e-44ee-abea-1b74d97b9407,because it provides only symptomatic relief  prompt appropriate treatment of the cause of pain must be instituted and phenazopyridine hcl should be discontinued when symptoms are controlled,0
493,493,493,493,493,493,493,708,708,708,708,708,708,708,708,708,708,708,708,708,7971c019-b58e-44ee-abea-1b74d97b9407,the analgesic action may reduce or eliminate the need for systemic analgesics or narcotics,0
494,494,494,494,494,494,494,709,709,709,709,709,709,709,709,709,709,709,709,709,7971c019-b58e-44ee-abea-1b74d97b9407,it is  however  compatible with antibacterial therapy and can help to relieve pain and discomfort during the interval before antibacterial therapy controls the infection,u
495,495,495,495,495,495,495,710,710,710,710,710,710,710,710,710,710,710,710,710,7971c019-b58e-44ee-abea-1b74d97b9407,treatment of a urinary tract infection with phenazopyridine hcl should not exceed two days because there is a lack of evidence that the combined administration of phenazopyridine hcl and an antibacterial provides greater benefit than administration of the antibacterial alone after two days,4
496,496,496,496,496,496,496,711,711,711,711,711,711,711,711,711,711,711,711,711,7971c019-b58e-44ee-abea-1b74d97b9407,( see dosage and administration section ),0
497,497,497,497,497,497,497,712,712,712,712,712,712,712,712,712,712,712,712,712,c8a590a7-628b-45c5-ac2c-24214a69eaa6, levocarnitine is indicated in the treatment of primary systemic carnitine deficiency,1
498,498,498,498,498,498,498,713,713,713,713,713,713,713,713,713,713,713,713,713,c8a590a7-628b-45c5-ac2c-24214a69eaa6,in the reported cases  the clinical presentation consisted of recurrent episodes of reye like encephalopathy  hypoketotic hypoglycemia  and or cardiomyopathy,0
499,499,499,499,499,499,499,714,714,714,714,714,714,714,714,714,714,714,714,714,c8a590a7-628b-45c5-ac2c-24214a69eaa6,associated symptoms included hypotonia  muscle weakness and failure to thrive,0
500,500,500,500,500,500,500,715,715,715,715,715,715,715,715,715,715,715,715,715,c8a590a7-628b-45c5-ac2c-24214a69eaa6,a diagnosis of primary carnitine deficiency requires that serum  red cell and or tissue carnitine levels be low and that the patient does not have a primary defect in fatty acid or organic acid oxidation ( see clinical pharmacology ),0
501,501,501,501,501,501,501,716,716,716,716,716,716,716,716,716,716,716,716,716,c8a590a7-628b-45c5-ac2c-24214a69eaa6,in some patients  particularly those presenting with cardiomyopathy  carnitine supplementation rapidly alleviated signs and symptoms,u
502,502,502,502,502,502,502,717,717,717,717,717,717,717,717,717,717,717,717,717,c8a590a7-628b-45c5-ac2c-24214a69eaa6,treatment should include  in addition to carnitine  supportive and other therapy as indicated by the condition of the patient,4
503,503,503,503,503,503,503,718,718,718,718,718,718,718,718,718,718,718,718,718,c8a590a7-628b-45c5-ac2c-24214a69eaa6,levocarnitine is also indicated for acute and chronic treatment of patients with an inborn error of metabolism which results in a secondary carnitine deficiency,1
504,504,504,504,504,504,504,719,719,719,719,719,719,719,719,719,719,719,719,719,64a6ee88-c6b1-4e13-8208-b6772ef65a74, celontin is indicated for the control of absence ( petit mal ) seizures that are refractory to other drugs,1
505,505,505,505,505,505,505,720,720,720,720,720,720,720,720,720,720,720,720,720,769e0a3b-826d-4faf-9129-5eeb7ebe0b67, chenodiol is indicated for patients with radiolucent stones in well opacifying gallbladders  in whom selective surgery would be undertaken except for the presence of increased surgical risk due to systemic disease or age,1
506,506,506,506,506,506,506,721,721,721,721,721,721,721,721,721,721,721,721,721,769e0a3b-826d-4faf-9129-5eeb7ebe0b67,the likelihood of successful dissolution is far greater if the stones are floatable or small,0
507,507,507,507,507,507,507,722,722,722,722,722,722,722,722,722,722,722,722,722,769e0a3b-826d-4faf-9129-5eeb7ebe0b67,for patients with nonfloatable stones  dissolution is less likely and added weight should be given to the risk that more emergent surgery might result form a delay due to unsuccessful treatment,0
508,508,508,508,508,508,508,723,723,723,723,723,723,723,723,723,723,723,723,723,769e0a3b-826d-4faf-9129-5eeb7ebe0b67,safety of use beyond 24 months is not established,0
509,509,509,509,509,509,509,724,724,724,724,724,724,724,724,724,724,724,724,724,769e0a3b-826d-4faf-9129-5eeb7ebe0b67,chenodiol will not dissolve calcified ( radiopaque ) or radiolucent bile pigment stones,0
510,510,510,510,510,510,510,725,725,725,725,725,725,725,725,725,725,725,725,725,bc4d6887-e543-416e-9865-c0af4060af9c, to reduce the development of drug resistant bacteria and maintain the effectiveness of cefotetan for injection usp and dextrose injection usp and other antibacterial drugs  cefotetan for injection usp and dextrose injection usp should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria,1
511,511,511,511,511,511,511,726,726,726,726,726,726,726,726,726,726,726,726,726,bc4d6887-e543-416e-9865-c0af4060af9c,when culture and susceptibility information are available  they should be considered in selecting or modifying antimicrobial therapy,4
512,512,512,512,512,512,512,728,728,728,728,728,728,728,728,728,728,728,728,728,bc4d6887-e543-416e-9865-c0af4060af9c,treatment cefotetan for injection usp and dextrose injection usp is indicated for the therapeutic treatment of the following infections when caused by susceptible strains of the designated organisms urinary tract infections caused by e coli  klebsiella spp ( including k pneumoniae )  proteus mirabilis and proteus spp ( which may include the organisms now called proteus vulgaris  providencia rettgeri  and morganella morganii ),1
513,513,513,513,513,513,513,729,729,729,729,729,729,729,729,729,729,729,729,729,bc4d6887-e543-416e-9865-c0af4060af9c,lower respiratory tract infections caused by streptococcus pneumoniae  staphylococcus aureus ( penicillinase and nonpenicillinase producing strains )  haemophilus influenzae ( including ampicillin resistant strains )  klebsiella species ( including k pneumoniae )  e coli  proteus mirabilis  and serratia marcescens efficacy for this organism in this organ system was studied in fewer than ten infections,1
514,514,514,514,514,514,514,730,730,730,730,730,730,730,730,730,730,730,730,730,bc4d6887-e543-416e-9865-c0af4060af9c,skin and skin structure infections due to staphylococcus aureus ( penicillinase and nonpenicillinase producing strains )  staphylococcus epidermidis  streptococcus pyogenes  streptococcus species ( excluding enterococci )  escherichia coli  klebsiella pneumoniae  peptococcus niger  peptostreptococcus species,1
515,515,515,515,515,515,515,731,731,731,731,731,731,731,731,731,731,731,731,731,bc4d6887-e543-416e-9865-c0af4060af9c,gynecologic infections caused by staphylococcus aureus ( including penicillinase and nonpenicillinase producing strains )  staphylococcus epidermidis  s,1
516,516,516,516,516,516,516,732,732,732,732,732,732,732,732,732,732,732,732,732,40dd5602-53da-45ac-bb4b-15789aba40f9,1  qsymia is indicated as an adjunct to a reduced calorie diet and increased physical activity for chronic weight management in adult patients with an initial body mass index ( bmi ) of 30 kg m 2 or greater ( obese )  or 27 kg m 2 or greater ( overweight ) in the presence of at least one weight related comorbidity such as hypertension  type 2 diabetes mellitus  or dyslipidemia qsymia is a combination of phentermine  a sympathomimetic amine anorectic  and topiramate extended release  an antiepileptic drug  indicated as an adjunct to a reduced calorie diet and increased physical activity for chronic weight management in adults with an initial body mass index ( bmi ) of 30 kg m 2 or greater ( obese ) ( 1 ) or 27 kg m 2 or greater ( overweight ) in the presence of at least one weight related comorbidity such as hypertension  type 2 diabetes mellitus  or dyslipidemia ( 1 ) limitations of use the effect of qsymia on cardiovascular morbidity and mortality has not been established ( 1 ),1
517,517,517,517,517,517,517,733,733,733,733,733,733,733,733,733,733,733,733,733,40dd5602-53da-45ac-bb4b-15789aba40f9,the safety and effectiveness of qsymia in combination with other products intended for weight loss  including prescription and over the counter drugs  and herbal preparations  have not been established ( 1 ),0
518,518,518,518,518,518,518,734,734,734,734,734,734,734,734,734,734,734,734,734,40dd5602-53da-45ac-bb4b-15789aba40f9,limitations of use the effect of qsymia on cardiovascular morbidity and mortality has not been established,0
519,519,519,519,519,519,519,735,735,735,735,735,735,735,735,735,735,735,735,735,40dd5602-53da-45ac-bb4b-15789aba40f9,the safety and effectiveness of qsymia in combination with other products intended for weight loss  including prescription and over the counter drugs and herbal preparations have not been established,0
520,520,520,520,520,520,520,736,736,736,736,736,736,736,736,736,736,736,736,736,e670f465-1d21-f729-cf8e-b58707dd4f41, breast care fibrocystic formulated for symptoms associated with fibrocystic breasts  mastitis  post partum and breast feeding disorders and other related breast conditions,1
521,521,521,521,521,521,521,737,737,737,737,737,737,737,737,737,737,737,737,737,b41a7148-10e9-d127-b6eb-ea0ffbab18cb, eczema skin care formulated for symptoms associated with seborrhea  eczema  psoriasis  cellulitis  dermatitis  lichen planus and other skin related conditions,1
522,522,522,522,522,522,522,738,738,738,738,738,738,738,738,738,738,738,738,738,5f79a7a8-6a81-a7fb-9640-8dfb80152b5c,product name indications section eczema skin care formulated for symptoms associated with seborrhea  eczema  psoriasis  cellulitis  dermatitis  lichen planus and other skin related conditions,1
523,523,523,523,523,523,523,739,739,739,739,739,739,739,739,739,739,739,739,739,7debaeec-50fc-a03b-dbab-83a6770f9aa7, herpes sores formulated for associated symptoms of herpes simplex and herpes zoster such as itching  tingling  crusting and painful skin eruptions or ulcerations,1
524,524,524,524,524,524,524,740,740,740,740,740,740,740,740,740,740,740,740,740,fe5db88c-8b7e-b090-096b-668f6fee44ba, urticaria rashes formulated for symptoms associated with hives and other allergic skin responses such as burning  itching  redness  swelling and discomfort,1
525,525,525,525,525,525,525,741,741,741,741,741,741,741,741,741,741,741,741,741,3b8042e1-4f9e-6d5d-1897-cf8ab900b439, poison ivy formulated for symptoms associated with poison ivy  oak and sumac such as itching  burning  pain  swelling and blistering,1
526,526,526,526,526,526,526,742,742,742,742,742,742,742,742,742,742,742,742,742,6c08b50e-cc9f-4c49-d7ae-f0fddcb10199, theophylline is indicated for the treatment of the symptoms and reversible airflow obstruction associated with chronic asthma and other chronic lung diseases  e g  emphysema and chronic bronchitis,1
527,527,527,527,527,527,527,743,743,743,743,743,743,743,743,743,743,743,743,743,c3bb34c1-89b2-48c3-9ad2-16b4b2bce5f9, theophylline in 5 dextrose injection usp is indicated as an adjunct to inhaled beta 2 selective agonists and systemically administered corticosteroids for the treatment of acute exacerbations of the symptoms and reversible airflow obstruction associated with asthma and other chronic lung diseases  e g  emphysema and chronic bronchitis,1
528,528,528,528,528,528,528,744,744,744,744,744,744,744,744,744,744,744,744,744,"Active Ingredient UNII(s)
0I55128JYK; N91BDP6H0X    39d936d1-29a7-48b6-9327-94f2028012e7
0I55128JYK; N91BDP6H0X    39d936d1-29a7-48b6-9327-94f2028012e7
Name: SET ID dtype: object",active ingredient unii ( s ) 0i55128jyk n91bdp6h0x active ingredient unii ( s ) 0i55128jyk n91bdp6h 0i55128jyk n91bdp6h0x active ingredient unii ( s ) 0i55128jyk n91bdp6h name content xml  dtype object,0
529,529,529,529,529,529,529,746,746,746,746,746,746,746,746,746,746,746,746,746,938eb1ae-9fa3-40c8-bc62-bc6db26f6b45, indomethacin for injection is indicated to close a hemodynamically significant patent ductus arteriosus in premature infants weighing between 500 and 1750 g when after 48 hours usual medical management ( e g  fluid restriction  diuretics  digitalis  respiratory support  etc ),1
530,530,530,530,530,530,530,747,747,747,747,747,747,747,747,747,747,747,747,747,938eb1ae-9fa3-40c8-bc62-bc6db26f6b45,clear cut clinical evidence of a hemodynamically significant patent ductus arteriosus should be present  such as respiratory distress  a continuous murmur  a hyperactive precordium  cardiomegaly and pulmonary plethora on chest x ray,u
531,531,531,531,531,531,531,748,748,748,748,748,748,748,748,748,748,748,748,748,85b8f9c6-aa53-4aa1-85d6-19f823d0d252,1  olmesartan medoxomil  amlodipine and hydrochlorothiazide tablets are a combination of an angiotensin 2 receptor blocker  a dihydropyridine calcium channel blocker  and a thiazide diuretic indicated for the treatment of hypertension  to lower blood pressure,1
532,532,532,532,532,532,532,749,749,749,749,749,749,749,749,749,749,749,749,749,85b8f9c6-aa53-4aa1-85d6-19f823d0d252,lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events  primarily strokes and myocardial infarctions ( 1 ),0
533,533,533,533,533,533,533,750,750,750,750,750,750,750,750,750,750,750,750,750,85b8f9c6-aa53-4aa1-85d6-19f823d0d252,limitations of use olmesartan medoxomil  amlodipine and hydrochlorothiazide tablets is not indicated for initial therapy,0
534,534,534,534,534,534,534,751,751,751,751,751,751,751,751,751,751,751,751,751,85b8f9c6-aa53-4aa1-85d6-19f823d0d252,olmesartan medoxomil  amlodipine and hydrochlorothiazide tablets are indicated for the treatment of hypertension  alone or with other antihypertensive agents  to lower blood pressure,1
535,535,535,535,535,535,535,752,752,752,752,752,752,752,752,752,752,752,752,752,85b8f9c6-aa53-4aa1-85d6-19f823d0d252,lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events  primarily strokes and myocardial infarctions,0
536,536,536,536,536,536,536,753,753,753,753,753,753,753,753,753,753,753,753,753,85b8f9c6-aa53-4aa1-85d6-19f823d0d252,these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including the class to which this drug principally belongs,0
537,537,537,537,537,537,537,754,754,754,754,754,754,754,754,754,754,754,754,754,85b8f9c6-aa53-4aa1-85d6-19f823d0d252,there are no controlled trials demonstrating risk reduction with olmesartan medoxomil  amlodipine and hydrochlorothiazide tablets,0
538,538,538,538,538,538,538,755,755,755,755,755,755,755,755,755,755,755,755,755,85b8f9c6-aa53-4aa1-85d6-19f823d0d252,control of high blood pressure should be part of comprehensive cardiovascular risk management  including  as appropriate  lipid control  diabetes management  antithrombotic therapy  smoking cessation  exercise  and limited sodium intake,0
539,539,539,539,539,539,539,756,756,756,756,756,756,756,756,756,756,756,756,756,85b8f9c6-aa53-4aa1-85d6-19f823d0d252,many patients will require more than one drug to achieve blood pressure goals,0
540,540,540,540,540,540,540,757,757,757,757,757,757,757,757,757,757,757,757,757,85b8f9c6-aa53-4aa1-85d6-19f823d0d252,for specific advice on goals and management  see published guidelines  such as those of the national high blood pressure education program 's joint national committee on prevention  detection  evaluation  and treatment of high blood pressure ( jnc ),0
541,541,541,541,541,541,541,758,758,758,758,758,758,758,758,758,758,758,758,758,85b8f9c6-aa53-4aa1-85d6-19f823d0d252,numerous antihypertensive drugs  from a variety of pharmacologic classes and with different mechanisms of action  have been shown in randomized controlled trials to reduce cardiovascular morbidity and mortality  and it can be concluded that it is blood pressure reduction  and not some other pharmacologic property of the drugs  that is largely responsible for those benefits,0
542,542,542,542,542,542,542,759,759,759,759,759,759,759,759,759,759,759,759,759,85b8f9c6-aa53-4aa1-85d6-19f823d0d252,the largest and most consistent cardiovascular outcome benefit has been a reduction in the risk of stroke  but reductions in myocardial infarction and cardiovascular mortality also have been seen regularly,0
543,543,543,543,543,543,543,760,760,760,760,760,760,760,760,760,760,760,760,760,85b8f9c6-aa53-4aa1-85d6-19f823d0d252,elevated systolic or diastolic pressure causes increased cardiovascular risk  and the absolute risk increase per mmhg is greater at higher blood pressures  so that even modest reductions of severe hypertension can provide substantial benefit,0
544,544,544,544,544,544,544,761,761,761,761,761,761,761,761,761,761,761,761,761,85b8f9c6-aa53-4aa1-85d6-19f823d0d252,relative risk reduction from blood pressure reduction is similar across populations with varying absolute risk  so the absolute benefit is greater in patients who are at higher risk independent of their hypertension ( for example  patients with diabetes or hyperlipidemia )  and such patients would be expected to benefit from more aggressive treatment to a lower blood pressure goal,0
545,545,545,545,545,545,545,762,762,762,762,762,762,762,762,762,762,762,762,762,85b8f9c6-aa53-4aa1-85d6-19f823d0d252,some antihypertensive drugs have smaller blood pressure effect,0
546,546,546,546,546,546,546,763,763,763,763,763,763,763,763,763,763,763,763,763,d7fa3c79-9f26-415b-8039-eb2acabcf66b, spironolactone  an ingredient of spironolactone and hydrochlorothiazide  has been shown to be a tumorigen in chronic toxicity studies in rats ( see precautions section ),1
547,547,547,547,547,547,547,764,764,764,764,764,764,764,764,764,764,764,764,764,d7fa3c79-9f26-415b-8039-eb2acabcf66b,spironolactone and hydrochlorothiazide should be used only in those conditions described below,0
548,548,548,548,548,548,548,765,765,765,765,765,765,765,765,765,765,765,765,765,d7fa3c79-9f26-415b-8039-eb2acabcf66b,unnecessary use of this drug should be avoided,0
549,549,549,549,549,549,549,766,766,766,766,766,766,766,766,766,766,766,766,766,d7fa3c79-9f26-415b-8039-eb2acabcf66b,spironolactone and hydrochlorothiazide is indicated for edematous conditions for patients with congestive heart failure for the management of edema and sodium retention when the patient is only partially responsive to  or is intolerant of  other therapeutic measures the treatment of diuretic induced hypokalemia in patients with congestive heart failure when other measures are considered inappropriate the treatment of patients with congestive heart failure taking digitalis when other therapies are considered inadequate or inappropriate,1
550,550,550,550,550,550,550,767,767,767,767,767,767,767,767,767,767,767,767,767,d7fa3c79-9f26-415b-8039-eb2acabcf66b,cirrhosis of the liver accompanied by edema and or ascites aldosterone levels may be exceptionally high in this condition,u
551,551,551,551,551,551,551,768,768,768,768,768,768,768,768,768,768,768,768,768,d7fa3c79-9f26-415b-8039-eb2acabcf66b,spironolactone and hydrochlorothiazide tablets are indicated for maintenance therapy together with bed rest and the restriction of fluid and sodium,1
552,552,552,552,552,552,552,769,769,769,769,769,769,769,769,769,769,769,769,769,d7fa3c79-9f26-415b-8039-eb2acabcf66b,the nephrotic syndrome for nephrotic patients when treatment of the underlying disease  restriction of fluid and sodium intake  and the use of other diuretics do not provide an adequate response,1
553,553,553,553,553,553,553,770,770,770,770,770,770,770,770,770,770,770,770,770,d7fa3c79-9f26-415b-8039-eb2acabcf66b,essential hypertension for patients with essential hypertension in whom other measures are considered inadequate or inappropriate in hypertensive patients for the treatment of a diuretic induced hypo,u
554,554,554,554,554,554,554,771,771,771,771,771,771,771,771,771,771,771,771,771,ba72b914-1252-4370-9b4b-0105186ffb42, quinapril hydrochloride and hydrochlorothiazide tablets are indicated for the treatment of hypertension,1
555,555,555,555,555,555,555,772,772,772,772,772,772,772,772,772,772,772,772,772,ba72b914-1252-4370-9b4b-0105186ffb42,this fixed combination is not indicated for the initial therapy of hypertension ( see dosage and administration ),2
556,556,556,556,556,556,556,773,773,773,773,773,773,773,773,773,773,773,773,773,ba72b914-1252-4370-9b4b-0105186ffb42,in using quinapril hydrochloride and hydrochlorothiazide  consideration should be given to the fact that another angiotensin converting enzyme inhibitor  captopril  has caused agranulocytosis  particularly in patients with renal impairment or collagen vascular disease,0
557,557,557,557,557,557,557,774,774,774,774,774,774,774,774,774,774,774,774,774,ba72b914-1252-4370-9b4b-0105186ffb42,available data are insufficient to show that quinapril does not have a similar risk ( see warnings neutropenia agranulocytosis ),0
558,558,558,558,558,558,558,775,775,775,775,775,775,775,775,775,775,775,775,775,ba72b914-1252-4370-9b4b-0105186ffb42,angioedema in black patients black patients receiving ace inhibitor monotherapy have been reported to have a higher incidence of angioedema compared to non blacks,3
559,559,559,559,559,559,559,776,776,776,776,776,776,776,776,776,776,776,776,776,ba72b914-1252-4370-9b4b-0105186ffb42,it should also be noted that in controlled clinical trials  ace inhibitors have an effect on blood pressure that is less in black patients than in non blacks,3
560,560,560,560,560,560,560,777,777,777,777,777,777,777,777,777,777,777,777,777,5bf74178-66b8-44d4-a87d-1fd760b94ad3, hypertension ( see box warning ),0
561,561,561,561,561,561,561,778,778,778,778,778,778,778,778,778,778,778,778,778,268d12e8-1cfc-4086-b613-8fd94f2d7c4e,1  olmesartan medoxomil  amlodipine and hydrochlorothiazide tablets is indicated for the treatment of hypertension  to lower blood pressure,1
562,562,562,562,562,562,562,784,784,784,784,784,784,784,784,784,784,784,784,784,268d12e8-1cfc-4086-b613-8fd94f2d7c4e,for specific advice on goals and management  see published guidelines  such as those of the national high blood pressure education program s joint national committee on prevention  detection  evaluation  and treatment of high blood pressure ( jnc ),0
563,563,563,563,563,563,563,789,789,789,789,789,789,789,789,789,789,789,789,789,268d12e8-1cfc-4086-b613-8fd94f2d7c4e,some antihypertensive drugs have smaller blood pressure effects ( as monotherapy ) in black patients  and many antihypertensive drugs have additional approved indications and effects ( e g  on angina  heart failure  or diabetic kidney disease ),u
564,564,564,564,564,564,564,790,790,790,790,790,790,790,790,790,790,790,790,790,268d12e8-1cfc-4086-b613-8fd94f2d7c4e,these considerations may guide selection of therapy,0
565,565,565,565,565,565,565,791,791,791,791,791,791,791,791,791,791,791,791,791,268d12e8-1cfc-4086-b613-8fd94f2d7c4e,this fixed combination drug is not indicated for the initial therapy of hypertension see dosage and administration ( 2 ),2
566,566,566,566,566,566,566,792,792,792,792,792,792,792,792,792,792,792,792,792,268d12e8-1cfc-4086-b613-8fd94f2d7c4e,olmesartan medoxomil  amlodipine and hydrochlorothiazide tablets is a combination of an angiotensin 2 receptor blocker  a dihydropyridine calcium channel blocker  and a thiazide diuretic indicated for the treatment of hypertension  to lower blood pressure,1
567,567,567,567,567,567,567,794,794,794,794,794,794,794,794,794,794,794,794,794,268d12e8-1cfc-4086-b613-8fd94f2d7c4e,olmesartan medoxomil  amlodipine,1
568,568,568,568,568,568,568,795,795,795,795,795,795,795,795,795,795,795,795,795,f6a79b4e-d7b3-4849-a552-7a37017e0a7a,diovan hct ( valsartan and hydrochlorothiazide  usp ) is indicated for the treatment of hypertension,1
569,569,569,569,569,569,569,796,796,796,796,796,796,796,796,796,796,796,796,796,f6a79b4e-d7b3-4849-a552-7a37017e0a7a,diovan hct may be used in patients whose blood pressure is not adequately controlled on monotherapy,u
570,570,570,570,570,570,570,797,797,797,797,797,797,797,797,797,797,797,797,797,f6a79b4e-d7b3-4849-a552-7a37017e0a7a,diovan hct may be used as initial therapy in patients who are likely to need multiple drugs to achieve blood pressure goals,u
571,571,571,571,571,571,571,798,798,798,798,798,798,798,798,798,798,798,798,798,f6a79b4e-d7b3-4849-a552-7a37017e0a7a,the choice of diovan hct as initial therapy for hypertension should be based on an assessment of potential benefits and risks,0
572,572,572,572,572,572,572,799,799,799,799,799,799,799,799,799,799,799,799,799,f6a79b4e-d7b3-4849-a552-7a37017e0a7a,patients with stage 2 hypertension are at a relatively high risk for cardiovascular events ( such as strokes  heart attacks  and heart failure )  kidney failure  and vision problems  so prompt treatment is clinically relevant,0
573,573,573,573,573,573,573,800,800,800,800,800,800,800,800,800,800,800,800,800,f6a79b4e-d7b3-4849-a552-7a37017e0a7a,the decision to use a combination as initial therapy should be individualized and should be shaped by considerations such as baseline blood pressure  the target goal and the incremental likelihood of achieving goal with a combination compared to monotherapy,0
574,574,574,574,574,574,574,801,801,801,801,801,801,801,801,801,801,801,801,801,f6a79b4e-d7b3-4849-a552-7a37017e0a7a,individual blood pressure goals may vary based upon the patient s risk,0
575,575,575,575,575,575,575,802,802,802,802,802,802,802,802,802,802,802,802,802,f6a79b4e-d7b3-4849-a552-7a37017e0a7a,data from the high dose multifactorial trial see clinical studies ( 14 1 ) provides estimates of the probability of reaching a target blood pressure with diovan hct compared to valsartan or hydrochlorothiazide monotherapy,0
576,576,576,576,576,576,576,803,803,803,803,803,803,803,803,803,803,803,803,803,f6a79b4e-d7b3-4849-a552-7a37017e0a7a,the figures below provide estimates of the likelihood of achieving systolic or diastolic blood pressure control with diovan hct 320 25 mg  based upon baseline systolic or diastolic blood pressure,0
577,577,577,577,577,577,577,804,804,804,804,804,804,804,804,804,804,804,804,804,f6a79b4e-d7b3-4849-a552-7a37017e0a7a,the curve of each treatment group was estimated by logistic regression modeling,0
578,578,578,578,578,578,578,805,805,805,805,805,805,805,805,805,805,805,805,805,f6a79b4e-d7b3-4849-a552-7a37017e0a7a,the estimated likelihood at the right tail of each curve is less reliable due to small numbers of subjects with high baseline blood pressures,0
579,579,579,579,579,579,579,806,806,806,806,806,806,806,806,806,806,806,806,806,f6a79b4e-d7b3-4849-a552-7a37017e0a7a,for example  a patient with a baseline blood pressure of 160 100 mmhg has about a 41 likelihood of achieving a goal of less than 140 mmhg ( systolic ) and 60 likelihood of achieving less than 90 mmhg ( diastolic ) on valsartan alone and the likelihood of achieving these goals on hctz alone is about 50 ( systolic ) or 57 ( diastolic ),0
580,580,580,580,580,580,580,807,807,807,807,807,807,807,807,807,807,807,807,807,f6a79b4e-d7b3-4849-a552-7a37017e0a7a,the likelihood of achieving these goals on diovan hct rises to about 84 ( systolic ) or 80 ( diastolic ),0
581,581,581,581,581,581,581,808,808,808,808,808,808,808,808,808,808,808,808,808,f6a79b4e-d7b3-4849-a552-7a37017e0a7a,the likelihood of achieving these goals on placebo is about 23 ( systolic ) or 36 ( diastolic ),0
582,582,582,582,582,582,582,809,809,809,809,809,809,809,809,809,809,809,809,809,b53261bc-fe16-4e48-8bd1-e964ee575e4b,1  amlodipine valsartan hydrochlorothiazide is indicated for the treatment of hypertension  to lower blood pressure,1
583,583,583,583,583,583,583,811,811,811,811,811,811,811,811,811,811,811,811,811,b53261bc-fe16-4e48-8bd1-e964ee575e4b,these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes  including amlodipine  hydrochlorothiazide  and the arb class to which valsartan principally belongs,0
584,584,584,584,584,584,584,812,812,812,812,812,812,812,812,812,812,812,812,812,b53261bc-fe16-4e48-8bd1-e964ee575e4b,there are no controlled trials demonstrating risk reduction with amlodipine valsartan hydrochlorothiazide,0
585,585,585,585,585,585,585,819,819,819,819,819,819,819,819,819,819,819,819,819,b53261bc-fe16-4e48-8bd1-e964ee575e4b,relative risk reduction from blood pressure reduction is similar across populations with varying absolute risk  so the absolute benefit is greater in patients who are at higher risk independent of their hypertension ( e g  patients with diabetes or hyperlipidemia )  and such patients would be expected to benefit from more aggressive treatment to a lower blood pressure goal,0
586,586,586,586,586,586,586,823,823,823,823,823,823,823,823,823,823,823,823,823,b53261bc-fe16-4e48-8bd1-e964ee575e4b,amlodipine valsartan hydrochlorothiazide is a combination tablet of amlodipine  a dihydropyridine calcium channel blocker ( dhp ccb )  valsartan  an angiotensin ii receptor blocker ( arb )  and hydrochlorothiazide  a thiazide diuretic,0
587,587,587,587,587,587,587,824,824,824,824,824,824,824,824,824,824,824,824,824,b53261bc-fe16-4e48-8bd1-e964ee575e4b,amlodipine valsartan hydrochlorothiazide is indicated for the treatment of hypertension to lower blood pressure,1
588,588,588,588,588,588,588,825,825,825,825,825,825,825,825,825,825,825,825,825,b53261bc-fe16-4e48-8bd1-e964ee575e4b,lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events  primarily strokes  and myocardial infarctions ( linkhtml href link 2e816089 275e 46,0
589,589,589,589,589,589,589,826,826,826,826,826,826,826,826,826,826,826,826,826,bdd0658e-38fb-4726-9720-09c502138ab0, hypertension ( see boxed warning ),0
590,590,590,590,590,590,590,827,827,827,827,827,827,827,827,827,827,827,827,827,b1dfcac3-ef66-4d3e-9d58-37d3f516eb31, teveten hct is indicated for the treatment of hypertension,1
591,591,591,591,591,591,591,828,828,828,828,828,828,828,828,828,828,828,828,828,b1dfcac3-ef66-4d3e-9d58-37d3f516eb31,it may be used alone or in combination with other antihypertensives such as calcium channel blockers,0
592,592,592,592,592,592,592,829,829,829,829,829,829,829,829,829,829,829,829,829,b1dfcac3-ef66-4d3e-9d58-37d3f516eb31,this fixed dose combination is not indicated for initial therapy ( see dosage and administration ),2
593,593,593,593,593,593,593,830,830,830,830,830,830,830,830,830,830,830,830,830,f0266d1a-2af2-415b-9433-69b5a690f9bb, captopril and hydrochlorothiazide tablets are indicated for the treatment of hypertension,1
594,594,594,594,594,594,594,831,831,831,831,831,831,831,831,831,831,831,831,831,f0266d1a-2af2-415b-9433-69b5a690f9bb,the blood pressure lowering effects of captopril and thiazides are approximately additive,0
595,595,595,595,595,595,595,832,832,832,832,832,832,832,832,832,832,832,832,832,f0266d1a-2af2-415b-9433-69b5a690f9bb,this fixed combination drug may be used as initial therapy or substituted for previously titrated doses of the individual components,0
596,596,596,596,596,596,596,833,833,833,833,833,833,833,833,833,833,833,833,833,f0266d1a-2af2-415b-9433-69b5a690f9bb,when captopril and hydrochlorothiazide are given together it may not be necessary to administer captopril in divided doses to attain blood pressure control at trough ( before the next dose ),4
597,597,597,597,597,597,597,834,834,834,834,834,834,834,834,834,834,834,834,834,f0266d1a-2af2-415b-9433-69b5a690f9bb,also  with such a combination  a daily dose of 15 mg of hydrochlorothiazide may be adequate,4
598,598,598,598,598,598,598,835,835,835,835,835,835,835,835,835,835,835,835,835,f0266d1a-2af2-415b-9433-69b5a690f9bb,treatment may  therefore  be initiated with captopril and hydrochlorothiazide tablets 25 mg 15 mg once daily,4
599,599,599,599,599,599,599,836,836,836,836,836,836,836,836,836,836,836,836,836,f0266d1a-2af2-415b-9433-69b5a690f9bb,subsequent titration should be with additional doses of the components ( captopril  hydrochlorothiazide ) as single agents or as captopril and hydrochlorothiazide tablets 50 mg 15 mg  25 mg 25 mg  or 50 mg 25 mg ( see dosage and administration ),4
600,600,600,600,600,600,600,837,837,837,837,837,837,837,837,837,837,837,837,837,f0266d1a-2af2-415b-9433-69b5a690f9bb,in using captopril and hydrochlorothiazide  consideration should be given to the risk of neutropenia agranulocytosis ( see warnings ),3
601,601,601,601,601,601,601,838,838,838,838,838,838,838,838,838,838,838,838,838,f0266d1a-2af2-415b-9433-69b5a690f9bb,captopril and hydrochlorothiazide may be used for patients with normal renal function  in whom the risk is relatively low,u
602,602,602,602,602,602,602,839,839,839,839,839,839,839,839,839,839,839,839,839,f0266d1a-2af2-415b-9433-69b5a690f9bb,in patients with impaired renal function  particularly those with collagen vascular disease  captopril and hydrochlorothiazide should be reserved for hypertensives who have either developed unacceptable side effects on other drugs  or have failed to respond satisfactorily to other drug combinations,u
603,603,603,603,603,603,603,840,840,840,840,840,840,840,840,840,840,840,840,840,f0266d1a-2af2-415b-9433-69b5a690f9bb,ace inhibitors ( for which adequate data are available ) cause a higher rate of angioedema in black than in non black patients ( see warnings captopril head and neck angioedema and intestinal angioedema ),3
604,604,604,604,604,604,604,841,841,841,841,841,841,841,841,841,841,841,841,841,8df0ca6a-58cf-41fc-b890-5c7fa5a3792c,1  tekturna hct is indicated for the treatment of hypertension  to lower blood pressure,1
605,605,605,605,605,605,605,843,843,843,843,843,843,843,843,843,843,843,843,843,8df0ca6a-58cf-41fc-b890-5c7fa5a3792c,these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including hydrochlorothiazide ( hctz ),0
606,606,606,606,606,606,606,844,844,844,844,844,844,844,844,844,844,844,844,844,8df0ca6a-58cf-41fc-b890-5c7fa5a3792c,there are no controlled trials demonstrating risk reduction with tekturna hct,0
607,607,607,607,607,607,607,846,846,846,846,846,846,846,846,846,846,846,846,846,8df0ca6a-58cf-41fc-b890-5c7fa5a3792c,many patients will require more than 1 drug to achieve blood pressure goals,0
608,608,608,608,608,608,608,849,849,849,849,849,849,849,849,849,849,849,849,849,8df0ca6a-58cf-41fc-b890-5c7fa5a3792c,the largest and most consistent cardiovascular outcome benefit has been a reduction in the risk of stroke  but reductions in myocardial infarction and cardiovascular mortality have also been seen regularly,0
609,609,609,609,609,609,609,854,854,854,854,854,854,854,854,854,854,854,854,854,8df0ca6a-58cf-41fc-b890-5c7fa5a3792c,tekturna hct is a combination of aliskiren  a renin inhibitor  and hydrochlorothiazide ( hctz )  a thiazide diuretic  indicated for the treatment of hypertension  to lower blood pressure in patients not adequately controlled with monotherapy,1
610,610,610,610,610,610,610,855,855,855,855,855,855,855,855,855,855,855,855,855,8df0ca6a-58cf-41fc-b890-5c7fa5a3792c,( 1 ) as initial therapy in patients likely to need multiple drugs to achieve their blood pressure goals,0
611,611,611,611,611,611,611,856,856,856,856,856,856,856,856,856,856,856,856,856,8df0ca6a-58cf-41fc-b890-5c7fa5a3792c,( 1 ) lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events  primarily strokes and myocardial infarction,0
612,612,612,612,612,612,612,857,857,857,857,857,857,857,857,857,857,857,857,857,8df0ca6a-58cf-41fc-b890-5c7fa5a3792c,code code 42229 5 codesystem 2 16 840 1 113883 6 1 displayname spl uncl,0
613,613,613,613,613,613,613,858,858,858,858,858,858,858,858,858,858,858,858,858,90656b7e-c3b6-46f9-9428-421b7d61d0cc, propranolol hydrochloride and hydrochlorothiazide tablets  usp are indicated in the management of hypertension,1
614,614,614,614,614,614,614,859,859,859,859,859,859,859,859,859,859,859,859,859,90656b7e-c3b6-46f9-9428-421b7d61d0cc,this fixed combination is not indicated for initial therapy of hypertension,2
615,615,615,615,615,615,615,860,860,860,860,860,860,860,860,860,860,860,860,860,90656b7e-c3b6-46f9-9428-421b7d61d0cc,hypertension requires therapy titrated to the individual patient,0
616,616,616,616,616,616,616,861,861,861,861,861,861,861,861,861,861,861,861,861,90656b7e-c3b6-46f9-9428-421b7d61d0cc,if the fixed combination represents the dosage so determined  its use may be more convenient in patient management,0
617,617,617,617,617,617,617,862,862,862,862,862,862,862,862,862,862,862,862,862,8b2c581a-f955-4a8e-bf85-e768e903fd10, amiloride hydrochloride and hydrochlorothiazide tablets are indicated in those patients with hypertension or with congestive heart failure who develop hypokalemia when thiazides or other kaliuretic diuretics are used alone  or in whom maintenance of normal serum potassium levels is considered to be clinically important  e g  digitalized patients  or patients with significant cardiac arrhythmias,1
618,618,618,618,618,618,618,863,863,863,863,863,863,863,863,863,863,863,863,863,8b2c581a-f955-4a8e-bf85-e768e903fd10,the use of potassium conserving agents is often unnecessary in patients receiving diuretics for uncomplicated essential hypertension when such patients have a normal diet,u
619,619,619,619,619,619,619,864,864,864,864,864,864,864,864,864,864,864,864,864,8b2c581a-f955-4a8e-bf85-e768e903fd10,amiloride hydrochloride and hydrochlorothiazide tablets may be used alone or as an adjunct to other antihypertensive drugs  such as methyldopa or beta blockers,4
620,620,620,620,620,620,620,865,865,865,865,865,865,865,865,865,865,865,865,865,8b2c581a-f955-4a8e-bf85-e768e903fd10,since amiloride hydrochloride and hydrochlorothiazide enhances the action of these agents  dosage adjustments may be necessary to avoid an excessive fall in blood pressure and other unwanted side effects,4
621,621,621,621,621,621,621,866,866,866,866,866,866,866,866,866,866,866,866,866,8b2c581a-f955-4a8e-bf85-e768e903fd10,the fixed combination drug is not indicated for the initial therapy of edema or hypertension except in individuals in whom the development of hypokalemia cannot be risked,u
622,622,622,622,622,622,622,867,867,867,867,867,867,867,867,867,867,867,867,867,dfa547a8-cb88-47e8-b0a7-ec6cd3950358, fosinopril sodium and hydrochlorothiazide tablets are indicated for the treatment of hypertension,1
623,623,623,623,623,623,623,868,868,868,868,868,868,868,868,868,868,868,868,868,dfa547a8-cb88-47e8-b0a7-ec6cd3950358,these fixed dose combinations are not indicated for initial therapy,2
624,624,624,624,624,624,624,869,869,869,869,869,869,869,869,869,869,869,869,869,dfa547a8-cb88-47e8-b0a7-ec6cd3950358,( see dosage and administration ) in using fosinopril sodium and hydrochlorothiazide tablets  consideration should be given to the fact that another angiotensin converting enzyme inhibitor  captopril  has caused agranulocytosis  particularly in patients with renal impairment or collagen vascular disease,3
625,625,625,625,625,625,625,870,870,870,870,870,870,870,870,870,870,870,870,870,dfa547a8-cb88-47e8-b0a7-ec6cd3950358,available data are insufficient to show that fosinopril does not have a similar risk ( see warnings neutropenia agranulocytosis ),3
626,626,626,626,626,626,626,871,871,871,871,871,871,871,871,871,871,871,871,871,dfa547a8-cb88-47e8-b0a7-ec6cd3950358,ace inhibitors ( for which adequate data are available ) cause a higher rate of angioedema in black than in non black patients ( see warnings head and neck angioedema and intestinal angioedema ),3
627,627,627,627,627,627,627,872,872,872,872,872,872,872,872,872,872,872,872,872,e71002c8-3463-4950-b984-c4eee356a5f2, moexipril hydrochloride and hydrochlorothiazide tablets are indicated for treatment of patients with hypertension,1
628,628,628,628,628,628,628,874,874,874,874,874,874,874,874,874,874,874,874,874,e71002c8-3463-4950-b984-c4eee356a5f2,in using moexipril hydrochloride and hydrochlorothiazide tablets  consideration should be given to the fact that another ace inhibitor  captopril  has caused agranulocytosis  particularly in patients with renal impairment or collagen vascular disease,0
629,629,629,629,629,629,629,875,875,875,875,875,875,875,875,875,875,875,875,875,e71002c8-3463-4950-b984-c4eee356a5f2,available data are insufficient to show that moexipril hydrochloride and hydrochlorothiazide tablets do not have a similar risk ( see warnings  neutropenia agranulocytosis ),0
630,630,630,630,630,630,630,876,876,876,876,876,876,876,876,876,876,876,876,876,e71002c8-3463-4950-b984-c4eee356a5f2,in addition  ace inhibitors  for which adequate data are available  cause a higher rate of angioedema in black than in nonblack patients ( see warnings  angioedema ),3
631,631,631,631,631,631,631,877,877,877,877,877,877,877,877,877,877,877,877,877,69ffe86d-7993-482d-b1bb-04287bdd6aa9,1  dutoprol is a combination tablet of metoprolol succinate  a beta adrenoceptor blocking agent and hydrochlorothiazide  a diuretic,0
632,632,632,632,632,632,632,878,878,878,878,878,878,878,878,878,878,878,878,878,69ffe86d-7993-482d-b1bb-04287bdd6aa9,dutoprol is indicated for the treatment of hypertension  to lower blood pressure,1
633,633,633,633,633,633,633,879,879,879,879,879,879,879,879,879,879,879,879,879,69ffe86d-7993-482d-b1bb-04287bdd6aa9,lowering blood pressure lowers the risk of fatal and non fatal cardiovascular ( cv ) events  primarily strokes and myocardial infarction,0
634,634,634,634,634,634,634,880,880,880,880,880,880,880,880,880,880,880,880,880,69ffe86d-7993-482d-b1bb-04287bdd6aa9,these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including metoprolol and hydrochlorothiazide,0
635,635,635,635,635,635,635,890,890,890,890,890,890,890,890,890,890,890,890,890,69ffe86d-7993-482d-b1bb-04287bdd6aa9,dutoprol may be administered with other antihypertensive agents,4
636,636,636,636,636,636,636,891,891,891,891,891,891,891,891,891,891,891,891,891,69ffe86d-7993-482d-b1bb-04287bdd6aa9,dutoprol is the combination tablet of metoprolol succinate  a beta adrenoceptor blocker and hydrochlorothiazide ( hctz )  a thiazide diuretic  indicated for the treatment of hypertension  to lower blood pressure,1
637,637,637,637,637,637,637,893,893,893,893,893,893,893,893,893,893,893,893,893,8208a3ba-5036-4dbf-b199-2447b36165ad, bisoprolol fumarate and hydrochlorothiazide tablets are indicated in the management of hypertension,1
638,638,638,638,638,638,638,894,894,894,894,894,894,894,894,894,894,894,894,894,2b77f66f-6891-4977-be8f-7955473d2f92, metoprolol tartrate and hydrochlorothiazide tablets are indicated for the management of hypertension,1
639,639,639,639,639,639,639,895,895,895,895,895,895,895,895,895,895,895,895,895,2b77f66f-6891-4977-be8f-7955473d2f92,this fixed combination drug is not indicated for initial therapy of hypertension,0
640,640,640,640,640,640,640,896,896,896,896,896,896,896,896,896,896,896,896,896,2b77f66f-6891-4977-be8f-7955473d2f92,if the fixed combination represents the dose titrated to the individual patient s needs  therapy with the fixed combination may be more convenient than with the separate components,0
641,641,641,641,641,641,641,897,897,897,897,897,897,897,897,897,897,897,897,897,80442e7b-4846-486f-926e-a7b51cbf7250, this fixed combination drug is not indicated for the initial therapy of edema or hypertension except in individuals in whom the development of hypokalemia cannot be risked,u
642,642,642,642,642,642,642,898,898,898,898,898,898,898,898,898,898,898,898,898,80442e7b-4846-486f-926e-a7b51cbf7250,dyazide is indicated for the treatment of hypertension or edema in patients who develop hypokalemia on hydrochlorothiazide alone,1
643,643,643,643,643,643,643,899,899,899,899,899,899,899,899,899,899,899,899,899,80442e7b-4846-486f-926e-a7b51cbf7250,dyazide is also indicated for those patients who require a thiazide diuretic and in whom the development of hypokalemia cannot be risked,1
644,644,644,644,644,644,644,900,900,900,900,900,900,900,900,900,900,900,900,900,80442e7b-4846-486f-926e-a7b51cbf7250,dyazide may be used alone or as an adjunct to other antihypertensive drugs  such as beta blockers,4
645,645,645,645,645,645,645,901,901,901,901,901,901,901,901,901,901,901,901,901,80442e7b-4846-486f-926e-a7b51cbf7250,since dyazide may enhance the action of these agents  dosage adjustments may be necessary,4
646,646,646,646,646,646,646,902,902,902,902,902,902,902,902,902,902,902,902,902,80442e7b-4846-486f-926e-a7b51cbf7250,usage in pregnancy the routine use of diuretics in an otherwise healthy woman is inappropriate and exposes mother and fetus to unnecessary hazard,2
647,647,647,647,647,647,647,903,903,903,903,903,903,903,903,903,903,903,903,903,80442e7b-4846-486f-926e-a7b51cbf7250,diuretics do not prevent development of toxemia of pregnancy  and there is no satisfactory evidence that they are useful in the treatment of developed toxemia,0
648,648,648,648,648,648,648,904,904,904,904,904,904,904,904,904,904,904,904,904,80442e7b-4846-486f-926e-a7b51cbf7250,edema during pregnancy may arise from pathological causes or from the physiologic and mechanical consequences of pregnancy,0
649,649,649,649,649,649,649,905,905,905,905,905,905,905,905,905,905,905,905,905,80442e7b-4846-486f-926e-a7b51cbf7250,diuretics are indicated in pregnancy when edema is due to pathologic causes  just as they are in the absence of pregnancy,1
650,650,650,650,650,650,650,906,906,906,906,906,906,906,906,906,906,906,906,906,80442e7b-4846-486f-926e-a7b51cbf7250,dependent edema in pregnancy resulting from restriction of venous return by the expanded uterus is properly treated through elevation of the lower extremities and use of support hose use of diuretics to lower intravascular volume in this case is illogical and unnecessary,2
651,651,651,651,651,651,651,907,907,907,907,907,907,907,907,907,907,907,907,907,80442e7b-4846-486f-926e-a7b51cbf7250,there is hypervolemia during normal pregnancy which is harmful to neither the fetus nor the mother ( in the absence of cardiovascular disease )  but which is associated with edema  including generalized edema in the majority of pregnant women,0
652,652,652,652,652,652,652,908,908,908,908,908,908,908,908,908,908,908,908,908,80442e7b-4846-486f-926e-a7b51cbf7250,if this edema produces discomfort  increased recumbency will often provide relief,0
653,653,653,653,653,653,653,909,909,909,909,909,909,909,909,909,909,909,909,909,80442e7b-4846-486f-926e-a7b51cbf7250,in rare instances this edema may cause extreme discomfort which is not relieved by rest,0
654,654,654,654,654,654,654,910,910,910,910,910,910,910,910,910,910,910,910,910,80442e7b-4846-486f-926e-a7b51cbf7250,in these cases  a short course of diuretics may provide relief and may be appropriate,1
655,655,655,655,655,655,655,911,911,911,911,911,911,911,911,911,911,911,911,911,b7ab5257-dbf8-4eec-8dcb-5703a267d0a6, zinc sulfate injection  usp is indicated for use as a supplement to intravenous solutions given for tpn,1
656,656,656,656,656,656,656,912,912,912,912,912,912,912,912,912,912,912,912,912,b7ab5257-dbf8-4eec-8dcb-5703a267d0a6,administration helps to maintain plasma levels and to prevent depletion of endogenous stores,u
657,657,657,657,657,657,657,913,913,913,913,913,913,913,913,913,913,913,913,913,f7f1c99e-1a67-4b34-b1f4-0ac38b9d8006,indications acunol is indicated for the treatment of mild to moderate acne vulgaris  acne rosacea  peri oral dermatitis  and folliculitis,1
658,658,658,658,658,658,658,914,914,914,914,914,914,914,914,914,914,914,914,914,f7f1c99e-1a67-4b34-b1f4-0ac38b9d8006,it has been found to work well with a variety of combination therapies,4
659,659,659,659,659,659,659,915,915,915,915,915,915,915,915,915,915,915,915,915,b59e6dba-c8e3-e7de-6e77-ab5ad363bcd3, law of similars use according to standard homeopathic indications,0
660,660,660,660,660,660,660,916,916,916,916,916,916,916,916,916,916,916,916,916,46ed6b7c-274a-46c4-aca0-1b7ca943e1b7,indications for temporary relief of aches and pains of joints and muscles as a consequence of lyme disease infection,1
661,661,661,661,661,661,661,919,919,919,919,919,919,919,919,919,919,919,919,919,3ad48650-75e3-4c74-9302-01b0088f164e,1  nevanac ( nepafenac ophthalmic suspension )  0 1 is indicated for the treatment of pain and inflammation associated with cataract surgery,1
662,662,662,662,662,662,662,920,920,920,920,920,920,920,920,920,920,920,920,920,3ad48650-75e3-4c74-9302-01b0088f164e,nevanac ( nepafenac ophthalmic suspension )  0 1 is a nonsteroidal  anti inflammatory prodrug indicated for the treatment of pain and inflammation associated with cataract surgery ( 1 ),1
663,663,663,663,663,663,663,921,921,921,921,921,921,921,921,921,921,921,921,921,c5e39c9d-6e4f-b4da-c157-a126fb36898e,product name indications section bronchitis asthma formulated for symptoms associated with bronchitis  pneumonia  asthma  croup and other respiratory system conditions,1
664,664,664,664,664,664,664,922,922,922,922,922,922,922,922,922,922,922,922,922,576dfd47-97da-25a3-e053-2a91aa0ad9d8, phentermine hydrochloride  usp 15 mg and 30 mg is indicated as a short term ( a few weeks ) adjunct in a regimen of weight reduction based on exercise  behavioral modification and caloric restriction in the management of exogenous obesity for patients with an initial body mass index greater than or equal to 30 kg m2  or greater than or equal to 27 kg m2 in the presence of other risk factors ( e g  controlled hypertension  diabetes  hyperlipidemia ),1
665,665,665,665,665,665,665,923,923,923,923,923,923,923,923,923,923,923,923,923,576dfd47-97da-25a3-e053-2a91aa0ad9d8,below is a chart of body mass index ( bmi ) based on various heights and weights,0
666,666,666,666,666,666,666,924,924,924,924,924,924,924,924,924,924,924,924,924,576dfd47-97da-25a3-e053-2a91aa0ad9d8,bmi is calculated by taking the patient s weight  in kilograms ( kg )  divided by the patient s height  in meters ( m )  squared,0
667,667,667,667,667,667,667,925,925,925,925,925,925,925,925,925,925,925,925,925,576dfd47-97da-25a3-e053-2a91aa0ad9d8,metric conversions are as follows pounds 2 2 kg inches x 0 0254 meters,0
668,668,668,668,668,668,668,926,926,926,926,926,926,926,926,926,926,926,926,926,576dfd47-97da-25a3-e053-2a91aa0ad9d8,view image at permanent link listed below,0
669,669,669,669,669,669,669,927,927,927,927,927,927,927,927,927,927,927,927,927,576dfd47-97da-25a3-e053-2a91aa0ad9d8,the limited usefulness of agents of this class  including phentermine hydrochloride  see clinical pharmacology ( 12 1  12 2 ) should be measured against possible risk factors inherent in their use such as those described below,0
670,670,670,670,670,670,670,928,928,928,928,928,928,928,928,928,928,928,928,928,576dfd47-97da-25a3-e053-2a91aa0ad9d8,please review the manufacturer 's complete drug information available from the fda at www fda gov permanent link https dailymed nlm nih gov dailymed druginfo cfm ? setid b963f7bb fa65 4e28 81c9 282fbe70a6a6,0
671,671,671,671,671,671,671,929,929,929,929,929,929,929,929,929,929,929,929,929,39cf31cc-8f3d-4919-a93a-f997ad6850dc,1  carvedilol tablets are an alpha beta adrenergic blocking agent indicated for the treatment of mild to severe chronic heart failure ( 1 1 ) left ventricular dysfunction following myocardial infarction in clinically stable patients ( 1 2 ) hypertension ( 1 3 ) 1 1 heart failure carvedilol tablets are indicated for the treatment of mild to severe chronic heart failure of ischemic or cardiomyopathic origin  usually in addition to diuretics  ace inhibitors  and digitalis  to increase survival and  also  to reduce the risk of hospitalization see drug interactions ( 7 4 ) and clinical studies ( 14 1 ),1
672,672,672,672,672,672,672,930,930,930,930,930,930,930,930,930,930,930,930,930,39cf31cc-8f3d-4919-a93a-f997ad6850dc,1 2 left ventricular dysfunction following myocardial infarction carvedilol tablets are indicated to reduce cardiovascular mortality in clinically stable patients who have survived the acute phase of a myocardial infarction and have a left ventricular ejection fraction of less than or equal to 40 ( with or without symptomatic heart failure ) see clinical studies ( 14 2 ),1
673,673,673,673,673,673,673,931,931,931,931,931,931,931,931,931,931,931,931,931,39cf31cc-8f3d-4919-a93a-f997ad6850dc,1 3 hypertension carvedilol tablets are indicated for the management of essential hypertension see clinical studies ( 14 3  14 4 ),1
674,674,674,674,674,674,674,932,932,932,932,932,932,932,932,932,932,932,932,932,39cf31cc-8f3d-4919-a93a-f997ad6850dc,it can be used alone or in combination with other antihypertensive agents  especially thiazide type diuretics see drug interactions ( 7 2 ),4
675,675,675,675,675,675,675,933,933,933,933,933,933,933,933,933,933,933,933,933,"Active Ingredient UNII(s)
0K47UL67F2; 94ZLA3W45F    4400de87-e9c4-4a0e-9275-1715a12ab46d
0K47UL67F2; 94ZLA3W45F    4400de87-e9c4-4a0e-9275-1715a12ab46d
0K47UL67F2; 94ZLA3W45F    4400de87-e9c4-4a0e-9275-1715a12ab46d
Name: SET ID dtype: object",active ingredient unii ( s ) 0k47ul67f2 94zla3w45f active ingredient unii ( s ) 0k47ul67f2 94zla3w4 0k47ul67f2 94zla3w45f active ingredient unii ( s ) 0k47ul67f2 94zla3w4 0k47ul67f2 94zla3w45f active ingredient unii ( s ) 0k47ul67f2 94zla3w4 name content xml  dtype object,0
676,676,676,676,676,676,676,936,936,936,936,936,936,936,936,936,936,936,936,936,2f4c571b-a27e-40ef-b0cd-e6e44ac9a15e, h pylori eradication to reduce the risk of duodenal ulcer recurrence the components in prevpac ( prevacid  amoxicillin  and clarithromycin ) are indicated for the treatment of patients with h pylori infection and duodenal ulcer disease ( active or one year history of a duodenal ulcer ) to eradicate h pylori,1
677,677,677,677,677,677,677,937,937,937,937,937,937,937,937,937,937,937,937,937,2f4c571b-a27e-40ef-b0cd-e6e44ac9a15e,eradication of h pylori has been shown to reduce the risk of duodenal ulcer recurrence ( see clinical studies and dosage and administration ),0
678,678,678,678,678,678,678,938,938,938,938,938,938,938,938,938,938,938,938,938,2f4c571b-a27e-40ef-b0cd-e6e44ac9a15e,to reduce the development of drug resistant bacteria and maintain the effectiveness of prevpac and other antibacterial drugs  prevpac should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria,4
679,679,679,679,679,679,679,941,941,941,941,941,941,941,941,941,941,941,941,941,4964f278-12c9-4a3c-9f40-f47972a6f5b1,indications prophylactic treatment preceding a dental appointment intended to enhance the body 's ability to reduce trauma and related discomfort,1
680,680,680,680,680,680,680,942,942,942,942,942,942,942,942,942,942,942,942,942,db024677-5c14-4900-9d04-58791330e9ba, uses a natural aid for stress induced states nervous tension  minor anxiety  fearfulness  over sensitivity,1
681,681,681,681,681,681,681,943,943,943,943,943,943,943,943,943,943,943,943,943,207e9cf2-e8ec-43d7-9c11-46283c9cdb37, terconazole vaginal suppositories  80 mg are indicated for the local treatment of vulvovaginal candidiasis ( moniliasis ),1
682,682,682,682,682,682,682,944,944,944,944,944,944,944,944,944,944,944,944,944,207e9cf2-e8ec-43d7-9c11-46283c9cdb37,as this product is effective only for vulvovaginitis caused by the genus candida  the diagnosis should be confirmed by koh smears and or cultures,4
683,683,683,683,683,683,683,945,945,945,945,945,945,945,945,945,945,945,945,945,9ed38b29-ff21-49dc-a22e-4e014d167fc2, for temporary relief of allergies due to molds,1
684,684,684,684,684,684,684,948,948,948,948,948,948,948,948,948,948,948,948,948,4c557ec4-c4cf-11df-851a-0800200c9a66,1  dymista containing an h1 receptor antagonist and a corticosteroid  and is indicated for the relief of symptoms of seasonal allergic rhinitis in patients 6 years of age and older who require treatment with both azelastine hydrochloride and fluticasone propionate for symptomatic relief,1
685,685,685,685,685,685,685,949,949,949,949,949,949,949,949,949,949,949,949,949,4c557ec4-c4cf-11df-851a-0800200c9a66,( 1 1 ) 1 1 seasonal allergic rhinitis dymista nasal spray is indicated for the relief of symptoms of seasonal allergic rhinitis in patients 6 years of age and older who require treatment with both azelastine hydrochloride and fluticasone propionate for symptomatic relief,1
686,686,686,686,686,686,686,950,950,950,950,950,950,950,950,950,950,950,950,950,cdc2594d-78af-8bc5-cf5f-9eb2a78563b2, formulated for associated symptoms of late summer and fall pollens such as nasal catarrh  post nasal drip  sneezing  glandular swelling and pharyngitis,1
687,687,687,687,687,687,687,951,951,951,951,951,951,951,951,951,951,951,951,951,e83b2dd3-a9a0-40bc-ade4-6cd4db433b06,indications enlyte is indicated in the treatment of pernicious anemia  and the prevention of vitamin b9 deficiency,1
688,688,688,688,688,688,688,952,952,952,952,952,952,952,952,952,952,952,952,952,6f14fa40-97ab-4ec5-b66b-793d6d1abac9,indications enbrace hr is indicated in the treatment of pernicious anemias of pregnancy  and prophylactic folate supplementation,1
689,689,689,689,689,689,689,964,964,964,964,964,964,964,964,964,964,964,964,964,10549cba-9c15-4d2e-a68c-5afbc178591d, sulfadiazine tablets usp are indicated in the following conditions chancroid trachoma inclusion conjunctivitis nocardiosis urinary tract infections ( primarily pyelonephritis  pyelitis and cystitis ) in the absence of obstructive uropathy or foreign bodies  when these infections are caused by susceptible strains of the following organisms escherichia coli  klebsiella species  enterobacter species  staphylococcus aureus  proteus mirabilis and p vulgaris,1
690,690,690,690,690,690,690,965,965,965,965,965,965,965,965,965,965,965,965,965,10549cba-9c15-4d2e-a68c-5afbc178591d,sulfadiazine should be used for urinary tract infections only after use of more soluble sulfonamides has been unsuccessful,1
691,691,691,691,691,691,691,966,966,966,966,966,966,966,966,966,966,966,966,966,10549cba-9c15-4d2e-a68c-5afbc178591d,toxoplasmosis encephalitis in patients with and without acquired immunodeficiency syndrome  as adjunctive therapy with pyrimethamine,1
692,692,692,692,692,692,692,967,967,967,967,967,967,967,967,967,967,967,967,967,10549cba-9c15-4d2e-a68c-5afbc178591d,malaria due to chloroquine resistant strains of plasmodium falciparum  when used as adjunctive therapy,1
693,693,693,693,693,693,693,968,968,968,968,968,968,968,968,968,968,968,968,968,10549cba-9c15-4d2e-a68c-5afbc178591d,prophylaxis of meningococcal meningitis when sulfonamide sensitive group a strains are known to prevail in family groups or larger closed populations ( the prophylactic usefulness of sulfonamides when group b or c infections are prevalent is not proved and may be harmful in closed population groups ),1
694,694,694,694,694,694,694,969,969,969,969,969,969,969,969,969,969,969,969,969,10549cba-9c15-4d2e-a68c-5afbc178591d,meningococcal meningitis  when the organism has been demonstrated to be susceptible,1
695,695,695,695,695,695,695,970,970,970,970,970,970,970,970,970,970,970,970,970,10549cba-9c15-4d2e-a68c-5afbc178591d,acute otitis media due to haemophilus influenzae  when used concomitantly with adequate doses of penicillin,1
696,696,696,696,696,696,696,971,971,971,971,971,971,971,971,971,971,971,971,971,10549cba-9c15-4d2e-a68c-5afbc178591d,prophylaxis against recurrences of rheumatic fever  as an alternative to penicillin,1
697,697,697,697,697,697,697,972,972,972,972,972,972,972,972,972,972,972,972,972,10549cba-9c15-4d2e-a68c-5afbc178591d,h influenzae meningitis  as adjunctive therapy with parental streptomycin,1
698,698,698,698,698,698,698,973,973,973,973,973,973,973,973,973,973,973,973,973,10549cba-9c15-4d2e-a68c-5afbc178591d,important notes in vitro sulfonamide susceptibility tests are not always reliable,0
699,699,699,699,699,699,699,974,974,974,974,974,974,974,974,974,974,974,974,974,10549cba-9c15-4d2e-a68c-5afbc178591d,the test must be carefully coordinated with bacteriologic and clinical response,0
700,700,700,700,700,700,700,975,975,975,975,975,975,975,975,975,975,975,975,975,10549cba-9c15-4d2e-a68c-5afbc178591d,when the patient is already taking sulfonamides  follow up cultures should have aminobenzoic acid added to the culture media,4
701,701,701,701,701,701,701,976,976,976,976,976,976,976,976,976,976,976,976,976,10549cba-9c15-4d2e-a68c-5afbc178591d,currently  the increasing frequency of resistant organisms limits the usefulness of antibacterial agents  including the sulfonamides  especially in the treatment of recurrent and complicated urinary tract infections,0
702,702,702,702,702,702,702,977,977,977,977,977,977,977,977,977,977,977,977,977,10549cba-9c15-4d2e-a68c-5afbc178591d,wide variation in blood levels may result with identical doses,0
703,703,703,703,703,703,703,978,978,978,978,978,978,978,978,978,978,978,978,978,10549cba-9c15-4d2e-a68c-5afbc178591d,blood levels should be measured in patients receiving sulfonamides for serious infections,4
704,704,704,704,704,704,704,979,979,979,979,979,979,979,979,979,979,979,979,979,10549cba-9c15-4d2e-a68c-5afbc178591d,free sulfonamide blood levels of 5 mg to 15 mg per 100 ml may be considered therapeutically effective for most infections and blood levels of 12 mg to 15 mg per 100 ml may be considered optimal for serious infections,4
705,705,705,705,705,705,705,980,980,980,980,980,980,980,980,980,980,980,980,980,10549cba-9c15-4d2e-a68c-5afbc178591d,twenty mg per 100 ml should be the maximum total sulfonamide level  since adverse reactions occur more frequently above this level,4
706,706,706,706,706,706,706,981,981,981,981,981,981,981,981,981,981,981,981,981,db7ac73a-e508-6b09-5bfc-5cfd0abb5e3e, edema formulated for symptoms associated with generalized or peripheral edema due to injury or various health conditions,1
707,707,707,707,707,707,707,982,982,982,982,982,982,982,982,982,982,982,982,982,60406a32-9fd1-a4bb-e053-2a91aa0afd42, cardiac care formulated for symptoms associated with arteriosclerosis  tachycardia  arrhythmias  palpitations and other related conditions,1
708,708,708,708,708,708,708,983,983,983,983,983,983,983,983,983,983,983,983,983,b1619473-c1b2-6e35-07c2-cc7ab77a18d7,product name indications section hypertension formulated for symptoms including headache  elevated b p readings  tinnitus  anxiety  depression  sweating  pallor and nausea,1
709,709,709,709,709,709,709,984,984,984,984,984,984,984,984,984,984,984,984,984,8b81500f-f062-2c86-abd2-abcf72b49345,product name indications section varicose veins phlebitis formulated for symptoms associated with varicose veins  phlebitis  ecchymosis  spider veins and other vascular related conditions,1
710,710,710,710,710,710,710,985,985,985,985,985,985,985,985,985,985,985,985,985,da9b26bb-d2d7-4113-a0f9-c6c2280f4875, trovan is indicated for the treatment of patients initiating therapy in in patient health care facilities ( i e  hospitals and long term nursing care facilities ) with serious  life or limb threatening infections caused by susceptible strains of the designated microorganisms in the conditions listed below,1
711,711,711,711,711,711,711,986,986,986,986,986,986,986,986,986,986,986,986,986,da9b26bb-d2d7-4113-a0f9-c6c2280f4875,( see dosage and administration ),0
712,712,712,712,712,712,712,987,987,987,987,987,987,987,987,987,987,987,987,987,da9b26bb-d2d7-4113-a0f9-c6c2280f4875,nosocomial pneumonia caused by escherichia coli  pseudomonas aeruginosa  haemophilus influenzae  or staphylococcus aureus,1
713,713,713,713,713,713,713,988,988,988,988,988,988,988,988,988,988,988,988,988,da9b26bb-d2d7-4113-a0f9-c6c2280f4875,as with other antimicrobials  where pseudomonas aeruginosa is a documented or presumptive pathogen  combination therapy with either an aminoglycoside or aztreonam may be clinically indicated,1
714,714,714,714,714,714,714,989,989,989,989,989,989,989,989,989,989,989,989,989,da9b26bb-d2d7-4113-a0f9-c6c2280f4875,community acquired pneumonia caused by streptococcus pneumoniae  haemophilus influenzae  klebsiella pneumoniae  staphylococcus aureus  mycoplasma pneumoniae  moraxella catarrhalis  legionella pneumophila  or chlamydia pneumoniae,1
715,715,715,715,715,715,715,990,990,990,990,990,990,990,990,990,990,990,990,990,da9b26bb-d2d7-4113-a0f9-c6c2280f4875,complicated intra abdominal infections  including post surgical infections caused by escherichia coli  bacteroides fragilis  viridans group streptococci  pseudomonas aeruginosa  klebsiella pneumoniae  peptostreptococcus species  or prevotella species,1
716,716,716,716,716,716,716,991,991,991,991,991,991,991,991,991,991,991,991,991,da9b26bb-d2d7-4113-a0f9-c6c2280f4875,gynecologic and pelvic infections including endomyometritis  parametritis  septic abortion and post partum infections caused by escherichia coli  bacteroides fragilis  viridans group streptococci  enterococcus faecalis  streptococcus agalactiae  peptostreptococcus species  prevotella species  or gardnerella vaginalis,1
717,717,717,717,717,717,717,992,992,992,992,992,992,992,992,992,992,992,992,992,da9b26bb-d2d7-4113-a0f9-c6c2280f4875,complicated skin and skin structure infections  including diabetic foot infections  caused by staphylococcus aureus  streptococcus agalactiae  pseudomonas aeruginosa  enterococcus faecalis  escherichia coli  or proteus mirabilis,1
718,718,718,718,718,718,718,993,993,993,993,993,993,993,993,993,993,993,993,993,da9b26bb-d2d7-4113-a0f9-c6c2280f4875,note trovan has not been studied in the treatment of osteomyelitis,0
719,719,719,719,719,719,719,994,994,994,994,994,994,994,994,994,994,994,994,994,c9a1d0a8-581f-4f91-a2b8-f419192d0ebf,1  daliresp is indicated as a treatment to reduce the risk of copd exacerbations in patients with severe copd associated with chronic bronchitis and a history of exacerbations,1
720,720,720,720,720,720,720,995,995,995,995,995,995,995,995,995,995,995,995,995,c9a1d0a8-581f-4f91-a2b8-f419192d0ebf,daliresp is a selective phosphodiesterase 4 inhibitor indicated as a treatment to reduce the risk of copd exacerbations in patients with severe copd associated with chronic bronchitis and a history of exacerbations,1
721,721,721,721,721,721,721,996,996,996,996,996,996,996,996,996,996,996,996,996,c9a1d0a8-581f-4f91-a2b8-f419192d0ebf,( 1  14 ) limitations of use daliresp is not a bronchodilator and is not indicated for the relief of acute bronchospasm,2
722,722,722,722,722,722,722,997,997,997,997,997,997,997,997,997,997,997,997,997,c9a1d0a8-581f-4f91-a2b8-f419192d0ebf,( 1  14 ) daliresp 250 mcg is a starting dose  for the first 4 weeks of treatment only and is not the effective ( therapeutic ) dose,4
723,723,723,723,723,723,723,998,998,998,998,998,998,998,998,998,998,998,998,998,c9a1d0a8-581f-4f91-a2b8-f419192d0ebf,( 2  14 ) limitations of use daliresp is not a bronchodilator and is not indicated for the relief of acute bronchospasm,2
724,724,724,724,724,724,724,999,999,999,999,999,999,999,999,999,999,999,999,999,c9a1d0a8-581f-4f91-a2b8-f419192d0ebf,daliresp 250 mcg is a starting dose  for the first 4 weeks of treatment only and is not the effective ( therapeutic ) dose,4
725,725,725,725,725,725,725,1000,1000,1000,1000,1000,1000,1000,1000,1000,1000,1000,1000,1000,ad20e6ff-98bc-47e6-aa00-7fb441edd2b0,1  coagadex  coagulation factor x ( human )  is a plasma derived human blood coagulation factor indicated in adults and children ( aged 12 years and above ) with hereditary factor x deficiency for on demand treatment and control of bleeding episodes perioperative management of bleeding in patients with mild hereditary factor x deficiency coagadex  coagulation factor x ( human )  is a plasma derived human blood coagulation factor indicated in adults and children ( aged 12 years and above ) with hereditary factor x deficiency for on demand treatment and control of bleeding episodes ( 1 ) perioperative management of bleeding in patients with mild hereditary factor x deficiency ( 1 ) limitation of use perioperative management of bleeding in major surgery in patients with moderate and severe hereditary factor x deficiency has not been studied,1
726,726,726,726,726,726,726,1001,1001,1001,1001,1001,1001,1001,1001,1001,1001,1001,1001,1001,ad20e6ff-98bc-47e6-aa00-7fb441edd2b0,limitation of use perioperative management of bleeding in major surgery in patients with moderate and severe hereditary factor x deficiency has not been studied,2
727,727,727,727,727,727,727,1002,1002,1002,1002,1002,1002,1002,1002,1002,1002,1002,1002,1002,5b42e05f-33dd-49a0-ae24-a316f07a4b8d,1  belviq xr ( lorcaserin hydrochloride ) extended release tablet is indicated as an adjunct to a reduced calorie diet and increased physical activity for chronic weight management in adult patients with an initial body mass index ( bmi ) of 30 kg m2 or greater ( obese )  or 27 kg m2 or greater ( overweight ) in the presence of at least one weight related comorbid condition ( e g  hypertension  dyslipidemia  type 2 diabetes ) s ee dosage and administration ( 2 ) limitations of use the safety and efficacy of coadministration of belviq xr with other products intended for weight loss including prescription drugs ( e g  phentermine )  over the counter drugs  and herbal preparations have not been established,1
728,728,728,728,728,728,728,1003,1003,1003,1003,1003,1003,1003,1003,1003,1003,1003,1003,1003,5b42e05f-33dd-49a0-ae24-a316f07a4b8d,the effect of belviq xr on cardiovascular morbidity and mortality has not been established,0
729,729,729,729,729,729,729,1004,1004,1004,1004,1004,1004,1004,1004,1004,1004,1004,1004,1004,5b42e05f-33dd-49a0-ae24-a316f07a4b8d,belviq xr is a serotonin 2c receptor agonist indicated as an adjunct to a reduced calorie diet and increased physical activity for chronic weight management in adults with an initial body mass index ( bmi ) of 30 kg m2 or greater ( obese ) ( 1 ) or 27 kg m2 or greater ( overweight ) in the presence of at least one weight related comorbid condition  ( e g  hypertension  dyslipidemia  type 2 diabetes ) ( 1 ) limitations of use the safety and efficacy of coadministration with other products for weight loss have not been established ( 1 ) the effect of belviq xr on cardiovascular morbidity and mortality has not been established ( 1 ),1
730,730,730,730,730,730,730,1005,1005,1005,1005,1005,1005,1005,1005,1005,1005,1005,1005,1005,add96910-9404-48aa-bb3c-945e321a11ab,indication and usage strovite forte provides nutritional supplementation to support optimum vitamin and mineral levels,u
731,731,731,731,731,731,731,1006,1006,1006,1006,1006,1006,1006,1006,1006,1006,1006,1006,1006,b9b71fa4-89c7-4f5b-8174-950649434ba5, strovite one is indicated to provide nutritional supplementation to support optimum vitamin and mineral levels,1
732,732,732,732,732,732,732,1007,1007,1007,1007,1007,1007,1007,1007,1007,1007,1007,1007,1007,fa3cbd5d-677c-4b19-9032-d9182cb69a83,1  elelyso is indicated for the treatment of patients with a confirmed diagnosis of type 1 gaucher disease,1
733,733,733,733,733,733,733,1008,1008,1008,1008,1008,1008,1008,1008,1008,1008,1008,1008,1008,fa3cbd5d-677c-4b19-9032-d9182cb69a83,elelyso is a hydrolytic lysosomal glucocerebroside specific enzyme indicated for the treatment of patients with a confirmed diagnosis of type 1 gaucher disease ( 1 ),1
734,734,734,734,734,734,734,1009,1009,1009,1009,1009,1009,1009,1009,1009,1009,1009,1009,1009,d5a783f4-12ef-4326-8faa-40018e45ba3b,1  endari is indicated to reduce the acute complications of sickle cell disease in adult and pediatric patients 5 years of age and older,1
735,735,735,735,735,735,735,1010,1010,1010,1010,1010,1010,1010,1010,1010,1010,1010,1010,1010,d5a783f4-12ef-4326-8faa-40018e45ba3b,endari is an amino acid indicated to reduce the acute complications of sickle cell disease in adult and pediatric patients 5 years of age and older,1
736,736,736,736,736,736,736,1011,1011,1011,1011,1011,1011,1011,1011,1011,1011,1011,1011,1011,6868666b-c25e-40d1-9d1f-306bbe9390c1,1  invokamet ( canagliflozin and metformin hydrochloride ) is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both canagliflozin and metformin is appropriate,1
737,737,737,737,737,737,737,1012,1012,1012,1012,1012,1012,1012,1012,1012,1012,1012,1012,1012,6868666b-c25e-40d1-9d1f-306bbe9390c1,invokamet is a sodium glucose co transporter 2 ( sglt2 ) inhibitor and biguanide combination product indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both canagliflozin and metformin is appropriate ( 1 ) limitation of use not for treatment of type 1 diabetes or diabetic ketoacidosis ( 1 ) limitations of use invokamet is not recommended in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis,1
738,738,738,738,738,738,738,1014,1014,1014,1014,1014,1014,1014,1014,1014,1014,1014,1014,1014,9797c01d-6b52-4d22-a541-61a55b8d8611,homeopathic indications for temporary relief of symptoms related to hormonal dysfunction including irregular  excessive or absent menstruation  vaginal discharge  pain and fever,1
739,739,739,739,739,739,739,1015,1015,1015,1015,1015,1015,1015,1015,1015,1015,1015,1015,1015,9797c01d-6b52-4d22-a541-61a55b8d8611,these statements are based upon traditional homeopathic principles,0
740,740,740,740,740,740,740,1017,1017,1017,1017,1017,1017,1017,1017,1017,1017,1017,1017,1017,3244852e-61f3-4676-80ed-3f76b6941dc1,indications may temporarily relieve the ill effects not the therapeutic effects of oral or injected vaccines,1
741,741,741,741,741,741,741,1018,1018,1018,1018,1018,1018,1018,1018,1018,1018,1018,1018,1018,3244852e-61f3-4676-80ed-3f76b6941dc1,children and adults may expect temporary relief from symptoms such as minor fever pain redness swelling weakness lack of energy these statements are based upon traditional homeopathic practice,u
742,742,742,742,742,742,742,1020,1020,1020,1020,1020,1020,1020,1020,1020,1020,1020,1020,1020,07a983fd-9619-43ea-9b42-d183ff5daf72,indications temporarily supports the body to rebalance human growth hormone ( hgh ) output,1
743,743,743,743,743,743,743,1021,1021,1021,1021,1021,1021,1021,1021,1021,1021,1021,1021,1021,07a983fd-9619-43ea-9b42-d183ff5daf72,symptoms of imbalanced hgh may include poor muscle fat balance  dry wrinkled looking skin  low energy  sleeplessness  weak immune system,u
744,744,744,744,744,744,744,1022,1022,1022,1022,1022,1022,1022,1022,1022,1022,1022,1022,1022,8e4a234c-785f-4be0-9a11-50bd82e2311e, treatment of arthrosis osteoarthritis  and or rheumatic joint diseases zeel injection solution is a homeopathic drug product indicated for the treatment of arthrosis osteoarthritis  and or rheumatic joint diseases and for the relief of symptoms such as pain and joint stiffness,1
745,745,745,745,745,745,745,1023,1023,1023,1023,1023,1023,1023,1023,1023,1023,1023,1023,1023,8e4a234c-785f-4be0-9a11-50bd82e2311e,co administration therapy with traumeel injection solution for the treatment of inflammatory and degenerative conditions of the musculoskeletal system,u
746,746,746,746,746,746,746,1024,1024,1024,1024,1024,1024,1024,1024,1024,1024,1024,1024,1024,8e4a234c-785f-4be0-9a11-50bd82e2311e,zeel injection solution is a homeopathic drug product indicated  in combination with traumeel injection solution  for the treatment of inflammatory and degenerative conditions of the musculoskeletal system  such as arthrosis osteoarthritis and or rheumatic joint diseases  and for the relief of symptoms including pain  swelling  and joint stiffness,1
747,747,747,747,747,747,747,1025,1025,1025,1025,1025,1025,1025,1025,1025,1025,1025,1025,1025,f003f554-81a8-459a-9ad9-e4ea473131c1,migrating pains  skin eruptions  fatigue  swollen glands,1
748,748,748,748,748,748,748,1026,1026,1026,1026,1026,1026,1026,1026,1026,1026,1026,1026,1026,d6cea949-5b05-4c8e-b37f-40e33659510c, miglitol tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus,1
749,749,749,749,749,749,749,1027,1027,1027,1027,1027,1027,1027,1027,1027,1027,1027,1027,1027,e9afbbef-5be5-4141-be45-30e1d6e7fa89, cyclobenzaprine hcl tablets usp are indicated as an adjunct to rest and physical therapy for relief of muscle spasm associated with acute  painful musculoskeletal conditions,1
750,750,750,750,750,750,750,1028,1028,1028,1028,1028,1028,1028,1028,1028,1028,1028,1028,1028,e9afbbef-5be5-4141-be45-30e1d6e7fa89,improvement is manifested by relief of muscle spasm and its associated signs and symptoms  namely  pain  tenderness  limitation of motion  and restriction in activities of daily living,0
751,751,751,751,751,751,751,1029,1029,1029,1029,1029,1029,1029,1029,1029,1029,1029,1029,1029,e9afbbef-5be5-4141-be45-30e1d6e7fa89,cyclobenzaprine hcl should be used only for short periods ( up to two or three weeks ) because adequate evidence of effectiveness for more prolonged use is not available and because muscle spasm associated with acute  painful musculoskeletal conditions is generally of short duration and specific therapy for longer periods is seldom warranted,4
752,752,752,752,752,752,752,1030,1030,1030,1030,1030,1030,1030,1030,1030,1030,1030,1030,1030,e9afbbef-5be5-4141-be45-30e1d6e7fa89,cyclobenzaprine hcl has not been found effective in the treatment of spasticity associated with cerebral or spinal cord disease  or in children with cerebral palsy,0
753,753,753,753,753,753,753,1031,1031,1031,1031,1031,1031,1031,1031,1031,1031,1031,1031,1031,"Active Ingredient UNII(s)
0VE05JYS2P; 2ACZ6IPC6I    6f49de96-1090-46bc-b7bf-0dc70f7d9530
0VE05JYS2P; 2ACZ6IPC6I    6f49de96-1090-46bc-b7bf-0dc70f7d9530
Name: SET ID dtype: object",active ingredient unii ( s ) 0ve05jys2p 2acz6ipc6i active ingredient unii ( s ) 0ve05jys2p 2acz6ipc 0ve05jys2p 2acz6ipc6i active ingredient unii ( s ) 0ve05jys2p 2acz6ipc name content xml  dtype object,0
754,754,754,754,754,754,754,1033,1033,1033,1033,1033,1033,1033,1033,1033,1033,1033,1033,1033,ca38d5da-07f9-4b37-b69f-bc501a197914,equipment required supplies needed to compound this kit equipment item quantity cyclobenzaprine hcl ( included ) 3 grams magnesium oxide heavy powder ( included ) 60 grams lactose monohydrate spray dried powder ( included ) 60 grams riboflavin powder ( included ) 0 15 grams red 1 capsules ( required not included ) 300 capsules,0
755,755,755,755,755,755,755,1034,1034,1034,1034,1034,1034,1034,1034,1034,1034,1034,1034,1034,900ec4c1-e5e3-e940-5b02-cf2589955e20,indications usage for procedures requiring a disclosing agent in combination with a topical ophthalmic anesthetic agent such as tonometry  gonioscopy  removal of corneal foreign bodies and other short corneal or conjunctival procedures,1
756,756,756,756,756,756,756,1035,1035,1035,1035,1035,1035,1035,1035,1035,1035,1035,1035,1035,e8983096-65e6-41f2-8b6f-bbf0a7227307, provocholine is indicated for the diagnosis of bronchial airway hyperreactivity in subjects who do not have clinically apparent asthma,1
757,757,757,757,757,757,757,1036,1036,1036,1036,1036,1036,1036,1036,1036,1036,1036,1036,1036,4dd69142-d320-40d9-ad27-680b2fe7fd42, betoptic pilo ophthalmic suspension is indicated for the reduction of elevated intraocular pressure in patients with primary open angle glaucoma and ocular hypertension who are insufficiently responsive to betoptic s ( failed to achieve target iop determined after multiple measurements over time ),1
758,758,758,758,758,758,758,1037,1037,1037,1037,1037,1037,1037,1037,1037,1037,1037,1037,1037,4dd69142-d320-40d9-ad27-680b2fe7fd42,it is not known whether betoptic pilo is equivalent in iop lowering efficacy to the administration of betoptic s 0 25 and pilocarpine 1 75 dosed separately,0
759,759,759,759,759,759,759,1038,1038,1038,1038,1038,1038,1038,1038,1038,1038,1038,1038,1038,4dd69142-d320-40d9-ad27-680b2fe7fd42,it is not known whether betoptic pilo is equivalent to other beta blockers given in combination with pilocarpine,0
760,760,760,760,760,760,760,1039,1039,1039,1039,1039,1039,1039,1039,1039,1039,1039,1039,1039,e18dcccf-bcf2-45d4-b1fe-45729c926854, carefully consider the potential benefits and risks of fenoprofen calcium and other treatment options before deciding to use fenoprofen calcium,4
761,761,761,761,761,761,761,1041,1041,1041,1041,1041,1041,1041,1041,1041,1041,1041,1041,1041,e18dcccf-bcf2-45d4-b1fe-45729c926854,fenoprofen calcium is indicated for relief of mild to moderate pain in adults,1
762,762,762,762,762,762,762,1042,1042,1042,1042,1042,1042,1042,1042,1042,1042,1042,1042,1042,e18dcccf-bcf2-45d4-b1fe-45729c926854,for relief of the signs and symptoms of rheumatoid arthritis,1
763,763,763,763,763,763,763,1043,1043,1043,1043,1043,1043,1043,1043,1043,1043,1043,1043,1043,e18dcccf-bcf2-45d4-b1fe-45729c926854,for relief of the signs and symptoms of osteoarthritis,1
764,764,764,764,764,764,764,1053,1053,1053,1053,1053,1053,1053,1053,1053,1053,1053,1053,1053,952f4c80-50b1-4308-9ee6-311ffefb13df,1  visudyne ( verteporfin for injection ) therapy is indicated for the treatment of patients with predominantly classic subfoveal choroidal neovascularization due to age related macular degeneration  pathologic myopia or presumed ocular histoplasmosis,1
765,765,765,765,765,765,765,1054,1054,1054,1054,1054,1054,1054,1054,1054,1054,1054,1054,1054,952f4c80-50b1-4308-9ee6-311ffefb13df,there is insufficient evidence to indicate visudyne for the treatment of predominantly occult subfoveal choroidal neovascularization,2
766,766,766,766,766,766,766,1055,1055,1055,1055,1055,1055,1055,1055,1055,1055,1055,1055,1055,952f4c80-50b1-4308-9ee6-311ffefb13df,visudyne ( verteporfin for injection ) therapy is indicated for the treatment of patients with predominantly classic subfoveal choroidal neovascularization due to age related macular degeneration  pathologic myopia or presumed ocular histoplasmosis,1
767,767,767,767,767,767,767,1061,1061,1061,1061,1061,1061,1061,1061,1061,1061,1061,1061,1061,675cb354-9d13-482e-8ac2-22f709c58b4f, myobloc is indicated for the treatment of adults with cervical dystonia to reduce the severity of abnormal head position and neck pain associated with cervical dystonia,1
768,768,768,768,768,768,768,1062,1062,1062,1062,1062,1062,1062,1062,1062,1062,1062,1062,1062,ecccdf03-0686-4a0d-b0ee-62583e201f6c,indications for temporary relief of symptoms due to painful chronically enlarged lymph glands exhaustion and emaciation  chronic intermittent fever with chills,1
769,769,769,769,769,769,769,1063,1063,1063,1063,1063,1063,1063,1063,1063,1063,1063,1063,1063,f63d818c-a21f-4415-8dad-d55b5d91ada0,indications for temporary relief of symptoms of acute or chronic lymphatic congestion general immune support and lymphatic drainage,1
770,770,770,770,770,770,770,1066,1066,1066,1066,1066,1066,1066,1066,1066,1066,1066,1066,1066,1fb00fd5-4b97-49ab-9370-78eff75601d1,indications may temporarily relieve symptoms associated with lymphatic congestion  tendency to catch colds  fluid retention and fatigue,1
771,771,771,771,771,771,771,1067,1067,1067,1067,1067,1067,1067,1067,1067,1067,1067,1067,1067,b54d9b6e-e6f7-38d5-310d-b90fccb1206c, throat care formulated for symptoms associated with tonsilitis  laryngitis  pharyngitis  bacterial viral infections and other related throat conditions,1
772,772,772,772,772,772,772,1068,1068,1068,1068,1068,1068,1068,1068,1068,1068,1068,1068,1068,aae9d9a6-6dcf-1588-cbbc-6b676a255d82, cell salts formulated for mineral balance utilizing all 12 tissue salts,1
773,773,773,773,773,773,773,1069,1069,1069,1069,1069,1069,1069,1069,1069,1069,1069,1069,1069,33b2570c-cf5c-358e-1bda-16d6e5cc2ecb,product name indications section cell salts formulated for mineral balance utilizing all 12 tissue salts,u
774,774,774,774,774,774,774,1070,1070,1070,1070,1070,1070,1070,1070,1070,1070,1070,1070,1070,bd9f13a9-0f13-4809-ad70-8f3cc2bd19bd,1  colprep kit is indicated for cleansing of the colon as a preparation for colonoscopy in adults,1
775,775,775,775,775,775,775,1071,1071,1071,1071,1071,1071,1071,1071,1071,1071,1071,1071,1071,bd9f13a9-0f13-4809-ad70-8f3cc2bd19bd,colprep kit is an osmotic laxative indicated for cleansing of the colon as a preparation for colonoscopy in adults,1
776,776,776,776,776,776,776,1072,1072,1072,1072,1072,1072,1072,1072,1072,1072,1072,1072,1072,8b9820bb-d592-46bf-b1db-f91947bf49aa,indication and usage lymphomyosot injection solution is classified as a homeopathic combination drug,0
777,777,777,777,777,777,777,1073,1073,1073,1073,1073,1073,1073,1073,1073,1073,1073,1073,1073,8b9820bb-d592-46bf-b1db-f91947bf49aa,botanical ingredients equisetum hyemale ( horsetail )  fumaria officinalis ( common fumitory )  gentiana lutea ( yellow gentian )  geranium robertianum ( herb robert )  juglans regia ( walnut )  myosotis arvensis ( forget me not )  nasturtium aquaticum ( watercress )  pinus sylvestris ( scotch pine )  sarsaparilla ( wild liquorice )  scrophularia nodosa ( figwort )  teucrium scorodonia ( wood germander )  veronica officinalis ( common speedwell ),0
778,778,778,778,778,778,778,1074,1074,1074,1074,1074,1074,1074,1074,1074,1074,1074,1074,1074,8b9820bb-d592-46bf-b1db-f91947bf49aa,mineral ingredients calcarea phosphorica ( tribasic calcium phosphate )  ferrum iodatum ( ferrous iodide )  natrum sulphuricum ( disodium sulfate ),0
779,779,779,779,779,779,779,1075,1075,1075,1075,1075,1075,1075,1075,1075,1075,1075,1075,1075,8b9820bb-d592-46bf-b1db-f91947bf49aa,animal derived ingredients aranea diadema ( papal cross spider )  levothyroxine ( l thyroxine ),0
780,780,780,780,780,780,780,1076,1076,1076,1076,1076,1076,1076,1076,1076,1076,1076,1076,1076,8b9820bb-d592-46bf-b1db-f91947bf49aa,lymphomyosot injection solution is indicated for the temporary relief of swelling due to poor circulation  minor injury and environmental toxins,1
781,781,781,781,781,781,781,1077,1077,1077,1077,1077,1077,1077,1077,1077,1077,1077,1077,1077,ef9102c1-fcc9-40bc-b991-185de7452f56,sinus congestion  sinus pain  hay fever,1
782,782,782,782,782,782,782,1078,1078,1078,1078,1078,1078,1078,1078,1078,1078,1078,1078,1078,ad34d2e1-1e98-11e4-8c21-0800200c9a66, colyte with flavor packs is indicated for bowel cleansing prior to colonoscopy or barium enema x ray examination,1
783,783,783,783,783,783,783,1079,1079,1079,1079,1079,1079,1079,1079,1079,1079,1079,1079,1079,8ff46193-2a3b-4de0-9572-775dda8cd8b2,1  moviprep is an osmotic laxative indicated for cleansing of the colon as a preparation for colonoscopy in adults 18 years of age or older,1
784,784,784,784,784,784,784,1080,1080,1080,1080,1080,1080,1080,1080,1080,1080,1080,1080,1080,8ff46193-2a3b-4de0-9572-775dda8cd8b2,moviprep is an osmotic laxative indicated for cleansing of the colon as a preparation for colonoscopy in adults 18 years or older,1
785,785,785,785,785,785,785,1081,1081,1081,1081,1081,1081,1081,1081,1081,1081,1081,1081,1081,15e469a5-8309-0c25-e054-00144ff88e88,these highlights do not include all the information needed to use fludeoxyglucose f18 injection,0
786,786,786,786,786,786,786,1082,1082,1082,1082,1082,1082,1082,1082,1082,1082,1082,1082,1082,15e469a5-8309-0c25-e054-00144ff88e88,see full prescribing information for fludeoxyglucose f18 injection,0
787,787,787,787,787,787,787,1083,1083,1083,1083,1083,1083,1083,1083,1083,1083,1083,1083,1083,15e469a5-8309-0c25-e054-00144ff88e88,initial u s approval 1994 1  fludeoxyglucose f18 injection is indicated for positron emission tomography ( pet ) imaging in the following settings 1 1 oncology for assessment of abnormal glucose metabolism to assist in the evaluation of malignancy in patients with known or suspected abnormalities found by other testing modalities  or in patients with an existing diagnosis of cancer,1
788,788,788,788,788,788,788,1084,1084,1084,1084,1084,1084,1084,1084,1084,1084,1084,1084,1084,15e469a5-8309-0c25-e054-00144ff88e88,1 2 cardiology for the identification of left ventricular myocardium with residual glucose metabolism and reversible loss of systolic function in patients with coronary artery disease and left ventricular dysfunction  when used together with myocardial perfusion imaging,1
789,789,789,789,789,789,789,1085,1085,1085,1085,1085,1085,1085,1085,1085,1085,1085,1085,1085,15e469a5-8309-0c25-e054-00144ff88e88,1 3 neurology for the identification of regions of abnormal glucose metabolism associated with foci of epileptic seizures,1
790,790,790,790,790,790,790,1086,1086,1086,1086,1086,1086,1086,1086,1086,1086,1086,1086,1086,15e469a5-8309-0c25-e054-00144ff88e88, fludeoxyglucose f18 injection is indicated for positron emission tomography ( pet ) imaging in the following settings ( 1 ) oncology for assessment of abnormal glucose metabolism to assist in the evaluation of malignancy in patients with known or suspected abnormalities found by other testing modalities  or in patients with an existing diagnosis of cancer,1
791,791,791,791,791,791,791,1087,1087,1087,1087,1087,1087,1087,1087,1087,1087,1087,1087,1087,15e469a5-8309-0c25-e054-00144ff88e88,cardiology for the identification of left ventricular myocardium with residual glucose metabolism and reversible loss of systolic function in patients with coronary artery disease and left ventricular dysfunction  when used together with myocardial perfusion imaging,1
792,792,792,792,792,792,792,1088,1088,1088,1088,1088,1088,1088,1088,1088,1088,1088,1088,1088,15e469a5-8309-0c25-e054-00144ff88e88,neurology for the identification of regions of abnormal glucose metabolism associated with foci of epileptic seizures ( 1 ),1
793,793,793,793,793,793,793,1089,1089,1089,1089,1089,1089,1089,1089,1089,1089,1089,1089,1089,60d1aea0-f106-4b20-8ef4-7a80e37f8a50, for treatment of acute otitis media in children that is caused by susceptible strains of haemophilus influenzae,1
794,794,794,794,794,794,794,1090,1090,1090,1090,1090,1090,1090,1090,1090,1090,1090,1090,1090,3803df6e-b765-4917-ab0e-4d91a23be47f,1  uloric is a xanthine oxidase ( xo ) inhibitor indicated for the chronic management of hyperuricemia in patients with gout,1
795,795,795,795,795,795,795,1091,1091,1091,1091,1091,1091,1091,1091,1091,1091,1091,1091,1091,3803df6e-b765-4917-ab0e-4d91a23be47f,uloric is not recommended for the treatment of asymptomatic hyperuricemia,0
796,796,796,796,796,796,796,1092,1092,1092,1092,1092,1092,1092,1092,1092,1092,1092,1092,1092,3803df6e-b765-4917-ab0e-4d91a23be47f,uloric is a xanthine oxidase ( xo ) inhibitor indicated for the chronic management of hyperuricemia in patients with gout,1
797,797,797,797,797,797,797,1093,1093,1093,1093,1093,1093,1093,1093,1093,1093,1093,1093,1093,3803df6e-b765-4917-ab0e-4d91a23be47f,( 1 ) uloric is not recommended for the treatment of asymptomatic hyperuricemia,2
798,798,798,798,798,798,798,1094,1094,1094,1094,1094,1094,1094,1094,1094,1094,1094,1094,1094,26b07e91-91bc-58ec-bd16-5a83f4a689d9, parasites formulated for associated symptoms such as bloating  fatigue  itching  nausea  teeth grinding  increased appetite and intestinal dysfunction,1
799,799,799,799,799,799,799,1095,1095,1095,1095,1095,1095,1095,1095,1095,1095,1095,1095,1095,52661b65-ecab-4dc1-9dfd-2fefd9ce24eb,uses temporarily relieves symptoms caused by parasites and worms such as bloating  itching and intestinal dysfunction,1
800,800,800,800,800,800,800,1098,1098,1098,1098,1098,1098,1098,1098,1098,1098,1098,1098,1098,aae667c5-381f-4f92-93df-2ed6158d07b0,1  forteo is recombinant human parathyroid hormone analog ( 1 34 )  rhpth ( 1 34 ) indicated for treatment of postmenopausal women with osteoporosis at high risk for fracture ( 1 1 ) increase of bone mass in men with primary or hypogonadal osteoporosis at high risk for fracture ( 1 2 ) treatment of men and women with osteoporosis associated with sustained systemic glucocorticoid therapy at high risk for fracture ( 1 3 ) 1 1 treatment of postmenopausal women with osteoporosis at high risk for fracture forteo is indicated for the treatment of postmenopausal women with osteoporosis at high risk for fracture  defined as a history of osteoporotic fracture  multiple risk factors for fracture  or patients who have failed or are intolerant to other available osteoporosis therapy,1
801,801,801,801,801,801,801,1099,1099,1099,1099,1099,1099,1099,1099,1099,1099,1099,1099,1099,aae667c5-381f-4f92-93df-2ed6158d07b0,in postmenopausal women with osteoporosis  forteo reduces the risk of vertebral and nonvertebral fractures see clinical studies ( 14 1 ),u
802,802,802,802,802,802,802,1100,1100,1100,1100,1100,1100,1100,1100,1100,1100,1100,1100,1100,aae667c5-381f-4f92-93df-2ed6158d07b0,1 2 increase of bone mass in men with primary or hypogonadal osteoporosis at high risk for fracture forteo is indicated to increase bone mass in men with primary or hypogonadal osteoporosis at high risk for fracture  defined as a history of osteoporotic fracture  multiple risk factors for fracture  or patients who have failed or are intolerant to other available osteoporosis therapy see clinical studies ( 14 2 ),1
803,803,803,803,803,803,803,1101,1101,1101,1101,1101,1101,1101,1101,1101,1101,1101,1101,1101,aae667c5-381f-4f92-93df-2ed6158d07b0,1 3 treatment of men and women with glucocorticoid induced osteoporosis at high risk for fracture forteo is indicated for the treatment of men and women with osteoporosis associated with sustained systemic glucocorticoid therapy ( daily dosage equivalent to 5 mg or greater of prednisone ) at high risk for fracture  defined as a history of osteoporotic fracture  multiple risk factors for fracture  or patients who have failed or are intolerant to other available osteoporosis therapy see clinical studies ( 14 3 ),1
804,804,804,804,804,804,804,1102,1102,1102,1102,1102,1102,1102,1102,1102,1102,1102,1102,1102,78fe1c29-e22a-4615-a2f9-a61cd4eb38a3,1 indications usage gavilyte h and bisacodyl delayed release tablet  usp is indicated for cleansing of the colon as a preparation for colonoscopy in adults,1
805,805,805,805,805,805,805,1103,1103,1103,1103,1103,1103,1103,1103,1103,1103,1103,1103,1103,78fe1c29-e22a-4615-a2f9-a61cd4eb38a3,gavilyte h and bisacodyl delayed release tablet  usp is a combination of peg 3350  an osmotic laxative and bisacodyl  a stimulant laxative  indicated for cleansing of the colon as a preparation for colonoscopy in adults ( 1 ),1
806,806,806,806,806,806,806,1104,1104,1104,1104,1104,1104,1104,1104,1104,1104,1104,1104,1104,"Active Ingredient UNII(s)
10X0709Y6I; 4T6H12BN9U; G2M7P15E5P; RHO26O1T9V; W1792A2RVD    0c2fb345-d45e-4d17-897a-3d7d2c2296cb
10X0709Y6I; 4T6H12BN9U; G2M7P15E5P; RHO26O1T9V; W1792A2RVD    0c2fb345-d45e-4d17-897a-3d7d2c2296cb
10X0709Y6I; 4T6H12BN9U; G2M7P15E5P; RHO26O1T9V; W1792A2RVD    0c2fb345-d45e-4d17-897a-3d7d2c2296cb
10X0709Y6I; 4T6H12BN9U; G2M7P15E5P; RHO26O1T9V; W1792A2RVD    0c2fb345-d45e-4d17-897a-3d7d2c2296cb
10X0709Y6I; 4T6H12BN9U; G2M7P15E5P; RHO26O1T9V; W1792A2RVD    0c2fb345-d45e-4d17-897a-3d7d2c2296cb
Name: SET ID dtype: object",active ingredient unii ( s ) 10x0709y6i 4t6h12bn9u g2m7p15e5p rho26o1t9v w1792a2rvd active ingredient unii ( s ) 10x0709y6i 4t6h12bn 10x0709y6i 4t6h12bn9u g2m7p15e5p rho26o1t9v w1792a2rvd active ingredient unii ( s ) 10x0709y6i 4t6h12bn 10x0709y6i 4t6h12bn9u g2m7p15e5p rho26o1t9v w1792a2rvd active ingredient unii ( s ) 10x0709y6i 4t6h12bn 10x0709y6i 4t6h12bn9u g2m7p15e5p rho26o1t9v w1792a2rvd active ingredient unii ( s ) 10x0709y6i 4t6h12bn 10x0709y6i 4t6h12bn9u g2m7p15e5p rho26o1t9v w1792a2rvd active ingredient unii ( s ) 10x0709y6i 4t6h12bn name content xml  dtype object,0
807,807,807,807,807,807,807,1109,1109,1109,1109,1109,1109,1109,1109,1109,1109,1109,1109,1109,ec5b909e-3406-4154-90aa-19b996e632a8,1  naratriptan tablets are indicated for the acute treatment of migraine with or without aura in adults,1
808,808,808,808,808,808,808,1110,1110,1110,1110,1110,1110,1110,1110,1110,1110,1110,1110,1110,ec5b909e-3406-4154-90aa-19b996e632a8,limitations of use use only if a clear diagnosis of migraine has been established,4
809,809,809,809,809,809,809,1111,1111,1111,1111,1111,1111,1111,1111,1111,1111,1111,1111,1111,ec5b909e-3406-4154-90aa-19b996e632a8,if a patient has no response to the first migraine attack treated with naratriptan tablets  reconsider the diagnosis of migraine before naratriptan tablets are administered to treat any subsequent attacks,0
810,810,810,810,810,810,810,1112,1112,1112,1112,1112,1112,1112,1112,1112,1112,1112,1112,1112,ec5b909e-3406-4154-90aa-19b996e632a8,naratriptan tablets are not indicated for the prevention of migraine attacks,2
811,811,811,811,811,811,811,1113,1113,1113,1113,1113,1113,1113,1113,1113,1113,1113,1113,1113,ec5b909e-3406-4154-90aa-19b996e632a8,safety and effectiveness of naratriptan tablets have not been established for cluster headache,0
812,812,812,812,812,812,812,1114,1114,1114,1114,1114,1114,1114,1114,1114,1114,1114,1114,1114,ec5b909e-3406-4154-90aa-19b996e632a8,naratriptan tablets are a serotonin ( 5 ht1b 1d ) receptor agonist ( triptan ) indicated for the acute treatment of migraine with or without aura in adults,1
813,813,813,813,813,813,813,1115,1115,1115,1115,1115,1115,1115,1115,1115,1115,1115,1115,1115,ec5b909e-3406-4154-90aa-19b996e632a8,( 1 ) limitations of use use only if a clear diagnosis of migraine has been established,4
814,814,814,814,814,814,814,1116,1116,1116,1116,1116,1116,1116,1116,1116,1116,1116,1116,1116,ec5b909e-3406-4154-90aa-19b996e632a8,( 1 ) not indicated for the prophylactic therapy of migraine attacks,2
815,815,815,815,815,815,815,1117,1117,1117,1117,1117,1117,1117,1117,1117,1117,1117,1117,1117,ec5b909e-3406-4154-90aa-19b996e632a8,( 1 ) not indicated for the treatment of cluster headache,2
816,816,816,816,816,816,816,1118,1118,1118,1118,1118,1118,1118,1118,1118,1118,1118,1118,1118,3af5077a-54ee-41de-8750-dce3eea327e6, vitafol plus is indicated to provide vitamin  mineral and omega 3 fatty acid supplementation prior to conception  throughout pregnancy  and during the postnatal period for the lactating and non lactating mother  including individuals with known allergies to fish,1
817,817,817,817,817,817,817,1119,1119,1119,1119,1119,1119,1119,1119,1119,1119,1119,1119,1119,3af5077a-54ee-41de-8750-dce3eea327e6,vitafol plus does not contain fish  fish oils  fish proteins or fish byproducts,0
818,818,818,818,818,818,818,1120,1120,1120,1120,1120,1120,1120,1120,1120,1120,1120,1120,1120,9b2819ac-eb41-4a95-a53f-972498c66102, thyreoidea compositum injection solution is indicated for stimulation of the defense system in thyroid dysfunction  connective tissue dysfunction and glandular dysfunction,1
819,819,819,819,819,819,819,1121,1121,1121,1121,1121,1121,1121,1121,1121,1121,1121,1121,1121,943d5364-3966-09ba-9566-c00029529063, sciatica back care formulated for associated symptoms such as inflammation  sharp or throbbing pain  paresthesia and discomfort,1
820,820,820,820,820,820,820,1122,1122,1122,1122,1122,1122,1122,1122,1122,1122,1122,1122,1122,931030b4-47e0-db78-37d5-445d88613ca1, fungal infection formulated for symptoms associated with tinea versicolor  tinea corporis  tinea cruris  tinea pedis  onychomycosis and other fungal infections,1
821,821,821,821,821,821,821,1123,1123,1123,1123,1123,1123,1123,1123,1123,1123,1123,1123,1123,d56c6bce-8481-4cf8-a9f3-aef712cfc4a8,1  1 1 hevert lymphaden comp,0
822,822,822,822,822,822,822,1124,1124,1124,1124,1124,1124,1124,1124,1124,1124,1124,1124,1124,d56c6bce-8481-4cf8-a9f3-aef712cfc4a8,is a homeopathic drug indicated for the improvement of conditions such as swelling of the lymph nodes  and lymphatic edema,1
823,823,823,823,823,823,823,1125,1125,1125,1125,1125,1125,1125,1125,1125,1125,1125,1125,1125,4eaea38a-c0ab-460b-b5b8-62b2061ab519, use for symptomatic relief of yeast or fungal overgrowth in men  women  and children yeast infection  fatigue  congestion  headache  indigestion  poor bowel function  achy joints  poor memory  sensitive emotions  changing moods  and mold sensitivity,1
824,824,824,824,824,824,824,1126,1126,1126,1126,1126,1126,1126,1126,1126,1126,1126,1126,1126,751a0887-483c-9cd6-86a6-fb81626f0d0a, muscle tendon formulated for symptoms associated with tendinitis  carpal tunnel  myasthenia  myalgia  myotonia and other muscle or tendon disorders,1
825,825,825,825,825,825,825,1127,1127,1127,1127,1127,1127,1127,1127,1127,1127,1127,1127,1127,a70a620a-5c41-45df-adc9-6207534cfa4a,indications for temporary relief of minor aches and pains in muscles and joints  fever with dryness of mucous membranes and dry cough  chilliness  and headaches,1
826,826,826,826,826,826,826,1130,1130,1130,1130,1130,1130,1130,1130,1130,1130,1130,1130,1130,0ae45d25-0611-4726-9900-42daf068a7f7,indications for temporary relief of minor symptoms of muscle aches  pains from overexertion  and injury,1
827,827,827,827,827,827,827,1131,1131,1131,1131,1131,1131,1131,1131,1131,1131,1131,1131,1131,3d54ea1d-5527-4255-9ba2-113857b48647, for the temporary relief of minor symptoms of back and neck discomfort,1
828,828,828,828,828,828,828,1132,1132,1132,1132,1132,1132,1132,1132,1132,1132,1132,1132,1132,5819bdf7-300e-45b8-8f3a-447b53656293,1  codeine sulfate tablets are indicated for the management of mild to moderate pain  where treatment with an opioid is appropriate and for which alternative treatments are inadequate,1
829,829,829,829,829,829,829,1133,1133,1133,1133,1133,1133,1133,1133,1133,1133,1133,1133,1133,5819bdf7-300e-45b8-8f3a-447b53656293,limitations of use because of the risks of addiction  abuse  and misuse with opioids  even at recommended doses s ee warnings and precautions ( 5 1 )  reserve codeine sulfate tablets for use in patients for whom alternative treatment options e g  non opioid analgesics or opioid combination products have not been tolerated  or are not expected to be tolerated  have not provided adequate analgesia  or are not expected to provide adequate analgesia,2
830,830,830,830,830,830,830,1134,1134,1134,1134,1134,1134,1134,1134,1134,1134,1134,1134,1134,5819bdf7-300e-45b8-8f3a-447b53656293,codeine sulfate tablets are an opioid agonist  indicated for the management of mild to moderate pain  where treatment with an opioid is appropriate and for which alternative treatments are inadequate,1
831,831,831,831,831,831,831,1135,1135,1135,1135,1135,1135,1135,1135,1135,1135,1135,1135,1135,5819bdf7-300e-45b8-8f3a-447b53656293,( 1 ) limitations of use ( 1 ) because of the risks of addiction  abuse  and misuse with opioids  even at recommended doses  reserve codeine sulfate tablets for use in patients for whom alternative treatment options e g  non opioid analgesics or opioid combination products have not been tolerated  or are not expected to be tolerated  have not provided adequate analgesia  or are not expected to provide adequate analgesia,2
832,832,832,832,832,832,832,1136,1136,1136,1136,1136,1136,1136,1136,1136,1136,1136,1136,1136,9781f06d-485e-41f0-84aa-ee177f0ad137,1  alfentanil injection is indicated as an analgesic adjunct given in incremental doses in the maintenance of anesthesia with barbiturate nitrous oxide oxygen,1
833,833,833,833,833,833,833,1137,1137,1137,1137,1137,1137,1137,1137,1137,1137,1137,1137,1137,9781f06d-485e-41f0-84aa-ee177f0ad137,as an analgesic administered by continuous infusion with nitrous oxide oxygen in the maintenance of general anesthesia,1
834,834,834,834,834,834,834,1138,1138,1138,1138,1138,1138,1138,1138,1138,1138,1138,1138,1138,9781f06d-485e-41f0-84aa-ee177f0ad137,as a primary anesthetic agent for the induction of anesthesia in patients undergoing general surgery in which endotracheal intubation and mechanical ventilation are required,1
835,835,835,835,835,835,835,1139,1139,1139,1139,1139,1139,1139,1139,1139,1139,1139,1139,1139,9781f06d-485e-41f0-84aa-ee177f0ad137,as the analgesic component for monitored anesthesia care ( mac ),1
836,836,836,836,836,836,836,1140,1140,1140,1140,1140,1140,1140,1140,1140,1140,1140,1140,1140,9781f06d-485e-41f0-84aa-ee177f0ad137,alfentanil injection is an opioid agonist indicated as an analgesic adjunct given in incremental doses in the maintenance of anesthesia with barbiturate nitrous oxide oxygen,1
837,837,837,837,837,837,837,1143,1143,1143,1143,1143,1143,1143,1143,1143,1143,1143,1143,1143,9781f06d-485e-41f0-84aa-ee177f0ad137,as the analgesic component for monitored anesthesia care ( mac ) ( 1 ),1
838,838,838,838,838,838,838,1144,1144,1144,1144,1144,1144,1144,1144,1144,1144,1144,1144,1144,420b3f66-87f0-47d8-947c-541e84eb594a, livostin 0 05 ( levocabastine hydrochloride ophthalmic suspension ) is indicated for the temporary relief of the signs and symptoms of seasonal allergic conjunctivitis,1
839,839,839,839,839,839,839,1145,1145,1145,1145,1145,1145,1145,1145,1145,1145,1145,1145,1145,0c60979b-489d-4e7b-8893-468ae00c44bb,1  potiga is indicated as adjunctive treatment of partial onset seizures in patients aged 18 years and older who have responded inadequately to several alternative treatments and for whom the benefits outweigh the risk of retinal abnormalities and potential decline in visual acuity see warnings and precautions ( 5 1 ),1
840,840,840,840,840,840,840,1146,1146,1146,1146,1146,1146,1146,1146,1146,1146,1146,1146,1146,0c60979b-489d-4e7b-8893-468ae00c44bb,potiga is a potassium channel opener indicated as adjunctive treatment of partial onset seizures in patients aged 18 years and older who have responded inadequately to several alternative treatments and for whom the benefits outweigh the risk of retinal abnormalities and potential decline in visual acuity,1
841,841,841,841,841,841,841,1147,1147,1147,1147,1147,1147,1147,1147,1147,1147,1147,1147,1147,97187865-4bf2-48de-b6de-6a950faae2d5,homeopathic indications for temporary relief of symptoms relating to systemic drainage and cellular detox such as fatigue  low energy  headaches and body aches,1
842,842,842,842,842,842,842,1150,1150,1150,1150,1150,1150,1150,1150,1150,1150,1150,1150,1150,23527b8b-9b28-4e6d-9751-33b143975ac7,1  fragmin is a low molecular weight heparin ( lmwh ) indicated for prophylaxis of ischemic complications of unstable angina and non q wave myocardial infarction ( 1 1 ) prophylaxis of deep vein thrombosis ( dvt ) in abdominal surgery  hip replacement surgery or medical patients with severely restricted mobility during acute illness ( 1 2 ) extended treatment of symptomatic venous thromboembolism ( vte ) to reduce the recurrence in patients with cancer,1
843,843,843,843,843,843,843,1151,1151,1151,1151,1151,1151,1151,1151,1151,1151,1151,1151,1151,23527b8b-9b28-4e6d-9751-33b143975ac7,in these patients  the fragmin therapy begins with the initial vte treatment and continues for six months ( 1 3 ) limitations of use fragmin is not indicated for the acute treatment of vte,2
844,844,844,844,844,844,844,1152,1152,1152,1152,1152,1152,1152,1152,1152,1152,1152,1152,1152,23527b8b-9b28-4e6d-9751-33b143975ac7,1 1 prophylaxis of ischemic complications in unstable angina and non q wave myocardial infarction fragmin injection is indicated for the prophylaxis of ischemic complications in unstable angina and non q wave myocardial infarction  when concurrently administered with aspirin therapy see clinical studies ( 14 1 ),1
845,845,845,845,845,845,845,1153,1153,1153,1153,1153,1153,1153,1153,1153,1153,1153,1153,1153,23527b8b-9b28-4e6d-9751-33b143975ac7,1 2 prophylaxis of deep vein thrombosis fragmin is also indicated for the prophylaxis of deep vein thrombosis ( dvt )  which may lead to pulmonary embolism ( pe ) in patients undergoing hip replacement surgery see clinical studies ( 14 2 ) in patients undergoing abdominal surgery who are at risk for thromboembolic complications see clinical studies ( 14 3 ) in medical patients who are at risk for thromboembolic complications due to severely restricted mobility during acute illness see clinical studies ( 14 4 ),1
846,846,846,846,846,846,846,1154,1154,1154,1154,1154,1154,1154,1154,1154,1154,1154,1154,1154,23527b8b-9b28-4e6d-9751-33b143975ac7,1 3 extended treatment of symptomatic venous thromboembolism in patients with cancer fragmin is also indicated for the extended treatment of symptomatic venous thromboembolism ( vte ) ( proximal dvt and or pe )  to reduce the recurrence of vte in patients with cancer,1
847,847,847,847,847,847,847,1155,1155,1155,1155,1155,1155,1155,1155,1155,1155,1155,1155,1155,23527b8b-9b28-4e6d-9751-33b143975ac7,in these patients  the fragmin ther,0
848,848,848,848,848,848,848,1157,1157,1157,1157,1157,1157,1157,1157,1157,1157,1157,1157,1157,60b94d5f-b111-e1ea-e053-2a91aa0aad6c, vaccination illness formulated for vaccinations and viral related symptoms such as headache  site pain  irritability and other reactions,1
849,849,849,849,849,849,849,1158,1158,1158,1158,1158,1158,1158,1158,1158,1158,1158,1158,1158,1fc2ebaa-baf6-89a2-6941-cc98df4dad6e, influenza formulated for symptoms associated with colds and flu such as aches  discomfort  fatigue  respiratory dysfunction and digestive upset,1
850,850,850,850,850,850,850,1159,1159,1159,1159,1159,1159,1159,1159,1159,1159,1159,1159,1159,80686b7e-f6f4-4154-b5c0-c846425e2d91,1  empliciti is indicated in combination with lenalidomide and dexamethasone for the treatment of patients with multiple myeloma who have received one to three prior therapies,1
851,851,851,851,851,851,851,1160,1160,1160,1160,1160,1160,1160,1160,1160,1160,1160,1160,1160,80686b7e-f6f4-4154-b5c0-c846425e2d91,empliciti is a slamf7 directed immunostimulatory antibody indicated in combination with lenalidomide and dexamethasone for the treatment of patients with multiple myeloma who have received one to three prior therapies,1
852,852,852,852,852,852,852,1161,1161,1161,1161,1161,1161,1161,1161,1161,1161,1161,1161,1161,2ceb0136-7075-4175-a49d-c8c228aa0a7a, primidone  used alone or concomitantly with other anticonvulsants  is indicated in the control of grand mal  psychomotor  and focal epileptic seizures,1
853,853,853,853,853,853,853,1162,1162,1162,1162,1162,1162,1162,1162,1162,1162,1162,1162,1162,2ceb0136-7075-4175-a49d-c8c228aa0a7a,it may control grand mal seizures refractory to other anticonvulsant therapy,u
854,854,854,854,854,854,854,1163,1163,1163,1163,1163,1163,1163,1163,1163,1163,1163,1163,1163,"Active Ingredient UNII(s)
13T4O6VMAM; 2ACZ6IPC6I    403af9f8-63bf-41a2-bf3b-20e5b92c389a
13T4O6VMAM; 2ACZ6IPC6I    403af9f8-63bf-41a2-bf3b-20e5b92c389a
Name: SET ID dtype: object",active ingredient unii ( s ) 13t4o6vmam 2acz6ipc6i active ingredient unii ( s ) 13t4o6vmam 2acz6ipc 13t4o6vmam 2acz6ipc6i active ingredient unii ( s ) 13t4o6vmam 2acz6ipc name content xml  dtype object,0
855,855,855,855,855,855,855,1165,1165,1165,1165,1165,1165,1165,1165,1165,1165,1165,1165,1165,a762e164-b390-4e8c-bd46-bf6c31eeb486,1  pylera is a combination metronidazole  a nitroimidazole antimicrobial  tetracycline  a tetracycline class antimicrobial and bismuth subcitrate potassium  indicated for use  in combination with omeprazole  for the treatment of patients with helicobacter pylori infection and duodenal ulcer disease ( active or history of within the past 5 years ) to eradicate h pylori,1
856,856,856,856,856,856,856,1166,1166,1166,1166,1166,1166,1166,1166,1166,1166,1166,1166,1166,a762e164-b390-4e8c-bd46-bf6c31eeb486,( 1 1 ) to reduce the development of drug resistant bacteria and maintain the effectiveness of pylera and other antibacterial drugs  pylera should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria,1
857,857,857,857,857,857,857,1167,1167,1167,1167,1167,1167,1167,1167,1167,1167,1167,1167,1167,a762e164-b390-4e8c-bd46-bf6c31eeb486,( 1 2 ) 1 1 eradication of helicobacter pylori in patients with active duodenal ulcer or history of duodenal ulcer disease pylera in combination with omeprazole are indicated for the treatment of patients with helicobacter pylori infection and duodenal ulcer disease ( active or history of within the past 5 years ) to eradicate h pylori,1
858,858,858,858,858,858,858,1168,1168,1168,1168,1168,1168,1168,1168,1168,1168,1168,1168,1168,a762e164-b390-4e8c-bd46-bf6c31eeb486,the eradication of helicobacter pylori has been shown to reduce the risk of duodenal ulcer recurrence,0
859,859,859,859,859,859,859,1169,1169,1169,1169,1169,1169,1169,1169,1169,1169,1169,1169,1169,a762e164-b390-4e8c-bd46-bf6c31eeb486,1 2 usage to reduce the development of drug resistant bacteria and maintain the effectiveness of pylera and other antibacterial drugs  pylera should be used to treat only indicated infections that are proven or strongly suspected to be caused by susceptible bacteria,1
860,860,860,860,860,860,860,1172,1172,1172,1172,1172,1172,1172,1172,1172,1172,1172,1172,1172,45add8a4-a7ef-4055-b57d-310040dae7ad,homeopathic indications for temporary relief of symptoms related to jet lag  general body aches  nervousness  muscle cramps  sleep dysfunction  and fatigue,1
861,861,861,861,861,861,861,1175,1175,1175,1175,1175,1175,1175,1175,1175,1175,1175,1175,1175,fe7cd92a-f066-4c4a-80c8-e3f929ad4181, calcipotriene ointment  0 005  is indicated for the treatment of plaque psoriasis in adults,1
862,862,862,862,862,862,862,1176,1176,1176,1176,1176,1176,1176,1176,1176,1176,1176,1176,1176,fe7cd92a-f066-4c4a-80c8-e3f929ad4181,the safety and effectiveness of topical calcipotriene in dermatoses other than psoriasis have not been established,0
863,863,863,863,863,863,863,1177,1177,1177,1177,1177,1177,1177,1177,1177,1177,1177,1177,1177,6c2ed55a-c7f2-42be-a194-bd498707ce3f,1 indications usage calcipotriene and betamethasone dipropionate ointment is indicated for the topical treatment of plaque psoriasis in patients 18 years of age and older,1
864,864,864,864,864,864,864,1178,1178,1178,1178,1178,1178,1178,1178,1178,1178,1178,1178,1178,6c2ed55a-c7f2-42be-a194-bd498707ce3f,pediatric use information for patients ages 12 years and above is approved for leo pharma a s s taclonex ( calcipotriene and betamethasone dipropionate ) ointment,0
865,865,865,865,865,865,865,1179,1179,1179,1179,1179,1179,1179,1179,1179,1179,1179,1179,1179,6c2ed55a-c7f2-42be-a194-bd498707ce3f,however  due to leo pharma a s s marketing exclusivity rights  this drug product is not labeled with that information,0
866,866,866,866,866,866,866,1180,1180,1180,1180,1180,1180,1180,1180,1180,1180,1180,1180,1180,6c2ed55a-c7f2-42be-a194-bd498707ce3f,calcipotriene and betamethasone dipropionate ointment is a vitamin d analogue and corticosteroid combination product indicated for the topical treatment of plaque psoriasis in patients 18 years of age and older ( 1 ),1
867,867,867,867,867,867,867,1181,1181,1181,1181,1181,1181,1181,1181,1181,1181,1181,1181,1181,8b6c4230-397e-427d-b444-2b2ede5126d1, penicillin v potassium tablets are indicated in the treatment of mild to moderately severe infections due to penicillin g sensitive microorganisms,1
868,868,868,868,868,868,868,1182,1182,1182,1182,1182,1182,1182,1182,1182,1182,1182,1182,1182,8b6c4230-397e-427d-b444-2b2ede5126d1,therapy should be guided by bacteriological studies ( including sensitivity tests ) and by clinical response,0
869,869,869,869,869,869,869,1183,1183,1183,1183,1183,1183,1183,1183,1183,1183,1183,1183,1183,8b6c4230-397e-427d-b444-2b2ede5126d1,note severe pneumonia  empyema  bacteremia  pericarditis  meningitis  and arthritis should not be treated with penicillin v during the acute stage,2
870,870,870,870,870,870,870,1184,1184,1184,1184,1184,1184,1184,1184,1184,1184,1184,1184,1184,8b6c4230-397e-427d-b444-2b2ede5126d1,indicated surgical procedures should be performed,u
871,871,871,871,871,871,871,1185,1185,1185,1185,1185,1185,1185,1185,1185,1185,1185,1185,1185,8b6c4230-397e-427d-b444-2b2ede5126d1,the following infections will usually respond to adequate dosage of penicillin v streptococcal infections ( without bacteremia ) mild to moderate infections of the upper respiratory tract  scarlet fever  and mild erysipelas,1
872,872,872,872,872,872,872,1186,1186,1186,1186,1186,1186,1186,1186,1186,1186,1186,1186,1186,8b6c4230-397e-427d-b444-2b2ede5126d1,note streptococci in groups a  c  g  h  l  and m are very sensitive to penicillin,u
873,873,873,873,873,873,873,1187,1187,1187,1187,1187,1187,1187,1187,1187,1187,1187,1187,1187,8b6c4230-397e-427d-b444-2b2ede5126d1,other groups  including group d ( enterococcus )  are resistant,0
874,874,874,874,874,874,874,1188,1188,1188,1188,1188,1188,1188,1188,1188,1188,1188,1188,1188,8b6c4230-397e-427d-b444-2b2ede5126d1,pneumococcal infections mild to moderately severe infections of the respiratory tract,1
875,875,875,875,875,875,875,1189,1189,1189,1189,1189,1189,1189,1189,1189,1189,1189,1189,1189,8b6c4230-397e-427d-b444-2b2ede5126d1,staphylococcal infections penicillin g sensitive mild infections of the skin and soft tissues,u
876,876,876,876,876,876,876,1190,1190,1190,1190,1190,1190,1190,1190,1190,1190,1190,1190,1190,8b6c4230-397e-427d-b444-2b2ede5126d1,note reports indicate an increasing number of strains of staphylococci resistant to penicillin g  emphasizing the need for culture and sensitivity studies in treating suspected staphylococcal infections,0
877,877,877,877,877,877,877,1191,1191,1191,1191,1191,1191,1191,1191,1191,1191,1191,1191,1191,8b6c4230-397e-427d-b444-2b2ede5126d1,fusospirochetosis ( vincent s gingivitis and pharyngitis ) mild to moderately severe infections of the oropharynx usually respond to therapy with oral penicillin,u
878,878,878,878,878,878,878,1192,1192,1192,1192,1192,1192,1192,1192,1192,1192,1192,1192,1192,8b6c4230-397e-427d-b444-2b2ede5126d1,note necessary dental care should be accomplished in infections involving the gum tissue,0
879,879,879,879,879,879,879,1193,1193,1193,1193,1193,1193,1193,1193,1193,1193,1193,1193,1193,8b6c4230-397e-427d-b444-2b2ede5126d1,medical conditions in which oral penicillin therapy is indicated as prophylaxis for the prevention of recurrence following rheumatic fever and or chorea prophylaxis with oral penicillin on a continuing basis has proven effective in preventing recurrence of these conditions,1
880,880,880,880,880,880,880,1194,1194,1194,1194,1194,1194,1194,1194,1194,1194,1194,1194,1194,8b6c4230-397e-427d-b444-2b2ede5126d1,although no controlled clinical efficacy studies have been conducted  penicillin v has been suggested by the american heart association and the american dental association for use as an oral regim,u
881,881,881,881,881,881,881,1195,1195,1195,1195,1195,1195,1195,1195,1195,1195,1195,1195,1195,abffdafd-f922-44ab-8e98-972a72ca1004, studies have shown that skin tests with cat extract are useful in the diagnosis of cat allergy,u
882,882,882,882,882,882,882,1196,1196,1196,1196,1196,1196,1196,1196,1196,1196,1196,1196,1196,abffdafd-f922-44ab-8e98-972a72ca1004,as a rule  persons with cat allergy have positive skin reactions when tested with cat extract  and non allergic individuals rarely react7  8  9,0
883,883,883,883,883,883,883,1197,1197,1197,1197,1197,1197,1197,1197,1197,1197,1197,1197,1197,abffdafd-f922-44ab-8e98-972a72ca1004,however  the relationship between a positive skin test and the appearance of clinical symptoms after exposure to a cat is not absolute  i e  some skin test positive persons do not experience allergic symptoms after exposure10,0
884,884,884,884,884,884,884,1198,1198,1198,1198,1198,1198,1198,1198,1198,1198,1198,1198,1198,abffdafd-f922-44ab-8e98-972a72ca1004,failure to experience symptoms may be dose related  since it is known that cats vary significantly in the amount of fel d1 they produce11,0
885,885,885,885,885,885,885,1199,1199,1199,1199,1199,1199,1199,1199,1199,1199,1199,1199,1199,abffdafd-f922-44ab-8e98-972a72ca1004,the efficacy of cat extract immunotherapy in the treatment of bronchial asthma has been shown in two studies12  13,u
886,886,886,886,886,886,886,1200,1200,1200,1200,1200,1200,1200,1200,1200,1200,1200,1200,1200,abffdafd-f922-44ab-8e98-972a72ca1004,a reduction in bronchial sensitivity was observed in five patients with cat allergy  whereas no reduction was observed in placebo treated  cat allergic patients,0
887,887,887,887,887,887,887,1201,1201,1201,1201,1201,1201,1201,1201,1201,1201,1201,1201,1201,ec59746f-dcf3-4152-8325-a1d50e264e27,indications for temporary relief of allergies due to animals,1
888,888,888,888,888,888,888,1211,1211,1211,1211,1211,1211,1211,1211,1211,1211,1211,1211,1211,f96cfd69-da34-41ee-90a9-610a4655cd1c,1  eylea is indicated for the treatment of eylea is a vascular endothelial growth factor ( vegf ) inhibitor indicated for the treatment of patients with neovascular ( wet ) age related macular degeneration ( amd ) ( 1 1 ) macular edema following retinal vein occlusion ( rvo ) ( 1 2 ) diabetic macular edema ( dme ) ( 1 3 ) diabetic retinopathy ( dr ) in patients with dme ( 1 4 ) 1 1 neovascular ( wet ) age related macular degeneration ( amd ) 1 2 macular edema following retinal vein occlusion ( rvo ) 1 3 diabetic macular edema ( dme ) 1 4 diabetic retinopathy ( dr ) in patients with dme,1
889,889,889,889,889,889,889,1212,1212,1212,1212,1212,1212,1212,1212,1212,1212,1212,1212,1212,4678375a-492e-4481-9f0c-253a60852de2,usage helps prevent sunburn apply liberally at least 20 minutes prior to sun exposure reapply as needed for children under the age of 6 months please contact physician before use,u
890,890,890,890,890,890,890,1213,1213,1213,1213,1213,1213,1213,1213,1213,1213,1213,1213,1213,6cfd790a-5342-4ed8-acc6-a871f32ef2bb, for relief of symptoms related to food additives  herbicides and insecticides including muscle weakness  skin irritation  poor muscle coordination  headache  cough  diarrhea  dizziness  fatigue  fever  liver problems  pneumonia  stomach pain and vomitting,1
891,891,891,891,891,891,891,1214,1214,1214,1214,1214,1214,1214,1214,1214,1214,1214,1214,1214,"Active Ingredient UNII(s)
15FIX9V2JP; 4X49Y0596W; 4Y5P7MUD51; 5688UTC01R; G63QQF2NOX    588b4ad4-2fb8-4230-9611-0f6ff2f8bf2d
15FIX9V2JP; 4X49Y0596W; 4Y5P7MUD51; 5688UTC01R; G63QQF2NOX    588b4ad4-2fb8-4230-9611-0f6ff2f8bf2d
Name: SET ID dtype: object",active ingredient unii ( s ) 15fix9v2jp 4x49y0596w 4y5p7mud51 5688utc01r g63qqf2nox active ingredient unii ( s ) 15fix9v2jp 4x49y059 15fix9v2jp 4x49y0596w 4y5p7mud51 5688utc01r g63qqf2nox active ingredient unii ( s ) 15fix9v2jp 4x49y059 name content xml  dtype object,0
892,892,892,892,892,892,892,1216,1216,1216,1216,1216,1216,1216,1216,1216,1216,1216,1216,1216,3783829a-5bbf-4692-82b1-e04c0cb718de,discontinue use of signs of irritation occur caution for external use only,0
893,893,893,893,893,893,893,1217,1217,1217,1217,1217,1217,1217,1217,1217,1217,1217,1217,1217,3783829a-5bbf-4692-82b1-e04c0cb718de,no such information water aqua  cyclomethicone  c12 15 alkyl benzoate  alumina  aluminum stearate  polyhydroxystearic acid  stearic acid  disteardimonium hectorite  propylene carbonate  isododecane  diisostearyl polyglyceryl 3 diisostearate  trimethylsiloxysilicate  cyclopentasiloxane  glyceryl stearate  peg 10 dimethicone  talc  dimethicone  triethanolamine  synthetic wax  phenoxyethanol  methylparaben  ethylparaben  propylparaben  butylparaben  propylene glycol  diazolidinyl urea  iodopropynyl butylcarbamate  silica silylate  stearoyl inulin  panthenol  sodium chloride  tocopheryl acetate  trisodium edta  triethoxycaprylysilane  may contain titanium dioxide ci77891  iron oxides ci77491 77492 77499,0
894,894,894,894,894,894,894,1218,1218,1218,1218,1218,1218,1218,1218,1218,1218,1218,1218,1218,decfb4bd-c7aa-46eb-ac08-eee56ef4390f,uses helps prevent sunburn if used as directed wiht other sun protection measures ( see directions )  decreases the risk of skin cancer and early skin aging caused by the sun,u
895,895,895,895,895,895,895,1219,1219,1219,1219,1219,1219,1219,1219,1219,1219,1219,1219,1219,3f9bd7a0-3aa1-484d-a72a-e75d4f81f7e7,if used as directed with other sun protection measures ( see directions )  decreases the risk of skin cancer and early skin aging caused by the sun,0
896,896,896,896,896,896,896,1220,1220,1220,1220,1220,1220,1220,1220,1220,1220,1220,1220,1220,a910443d-dd0c-4556-900c-540c0103a904, docetaxel injection is a microtubule inhibitor indicated for breast cancer ( bc ) single agent for locally advanced or metastatic bc after chemotherapy failure and with doxorubicin and cyclophosphamide as adjuvant treatment of operable node positive bc ( 1 1 ) non small cell lung cancer ( nsclc ) single agent for locally advanced or metastatic nsclc after platinum therapy failure and with cisplatin for unresectable  locally advanced or metastatic untreated nsclc ( 1 2 ) hormone refractory prostate cancer ( hrpc ) with prednisone in androgen independent ( hormone refractory ) metastatic prostate cancer ( 1 3 ) gastric adenocarcinoma ( gc ) with cisplatin and fluorouracil for untreated  advanced gc  including the gastroesophageal junction ( 1 4 ) squamous cell carcinoma of the head and neck cancer ( scchn ) with cisplatin and fluorouracil for induction treatment of locally advanced scchn ( 1 5 ) 1 1,1
897,897,897,897,897,897,897,1221,1221,1221,1221,1221,1221,1221,1221,1221,1221,1221,1221,1221,a910443d-dd0c-4556-900c-540c0103a904,breast cancer docetaxel injection is indicated for the treatment of patients with locally advanced or metastatic breast cancer after failure of prior chemotherapy,1
898,898,898,898,898,898,898,1222,1222,1222,1222,1222,1222,1222,1222,1222,1222,1222,1222,1222,a910443d-dd0c-4556-900c-540c0103a904,docetaxel injection in combination with doxorubicin and cyclophosphamide is indicated for the adjuvant treatment of patients with operable node positive breast cancer,1
899,899,899,899,899,899,899,1223,1223,1223,1223,1223,1223,1223,1223,1223,1223,1223,1223,1223,a910443d-dd0c-4556-900c-540c0103a904,non small cell lung cancer docetaxel injection as a single agent is indicated for the treatment of patients with locally advanced or metastatic non small cell lung cancer after failure of prior platinum based chemotherapy,1
900,900,900,900,900,900,900,1224,1224,1224,1224,1224,1224,1224,1224,1224,1224,1224,1224,1224,a910443d-dd0c-4556-900c-540c0103a904,docetaxel injection in combination with cisplatin is indicated for the treatment of patients with unresectable  locally advanced or metastatic non small cell lung cancer who have not previously received chemotherapy for this condition,1
901,901,901,901,901,901,901,1225,1225,1225,1225,1225,1225,1225,1225,1225,1225,1225,1225,1225,a910443d-dd0c-4556-900c-540c0103a904,prostate cancer docetaxel injection in combination with prednisone is indicated for the treatment of patients with androgen independent,1
902,902,902,902,902,902,902,1226,1226,1226,1226,1226,1226,1226,1226,1226,1226,1226,1226,1226,0fd36cb9-c4f6-4167-93c9-8530865db3f9,1  aranesp is an erythropoiesis stimulating agent ( esa ) indicated for the treatment of anemia due to chronic kidney disease ( ckd ) in patients on dialysis and patients not on dialysis ( 1 1 ),1
903,903,903,903,903,903,903,1227,1227,1227,1227,1227,1227,1227,1227,1227,1227,1227,1227,1227,0fd36cb9-c4f6-4167-93c9-8530865db3f9,the effects of concomitant myelosuppressive chemotherapy  and upon initiation  there is a minimum of two additional months of planned chemotherapy ( 1 2 ),0
904,904,904,904,904,904,904,1228,1228,1228,1228,1228,1228,1228,1228,1228,1228,1228,1228,1228,0fd36cb9-c4f6-4167-93c9-8530865db3f9,limitations of use aranesp has not been shown to improve quality of life  fatigue  or patient well being ( 1 3 ),2
905,905,905,905,905,905,905,1229,1229,1229,1229,1229,1229,1229,1229,1229,1229,1229,1229,1229,0fd36cb9-c4f6-4167-93c9-8530865db3f9,aranesp is not indicated for use in patients with cancer receiving hormonal agents  biologic products  or radiotherapy  unless also receiving concomitant myelosuppressive chemotherapy ( 1 3 ),2
906,906,906,906,906,906,906,1230,1230,1230,1230,1230,1230,1230,1230,1230,1230,1230,1230,1230,0fd36cb9-c4f6-4167-93c9-8530865db3f9,in patients with cancer receiving myelosuppressive chemotherapy when the anticipated outcome is cure ( 1 3 ),0
907,907,907,907,907,907,907,1231,1231,1231,1231,1231,1231,1231,1231,1231,1231,1231,1231,1231,0fd36cb9-c4f6-4167-93c9-8530865db3f9,in patients with cancer receiving myelosuppressive chemotherapy in whom the anemia can be managed by transfusion ( 1 3 ),0
908,908,908,908,908,908,908,1232,1232,1232,1232,1232,1232,1232,1232,1232,1232,1232,1232,1232,0fd36cb9-c4f6-4167-93c9-8530865db3f9,as a substitute for rbc transfusions in patients who require immediate correction of anemia ( 1 3 ),0
909,909,909,909,909,909,909,1233,1233,1233,1233,1233,1233,1233,1233,1233,1233,1233,1233,1233,0fd36cb9-c4f6-4167-93c9-8530865db3f9,1 1 anemia due to chronic kidney disease aranesp is indicated for the treatment of anemia due to chronic kidney disease ( ckd )  including patients on dialysis and patients not on dialysis,1
910,910,910,910,910,910,910,1234,1234,1234,1234,1234,1234,1234,1234,1234,1234,1234,1234,1234,0fd36cb9-c4f6-4167-93c9-8530865db3f9,1 2 anemia due to chemotherapy in patients with cancer aranesp is indicated for the treatment of anemia in patients with non myeloid malignancies where anemia is due to the effect of concomitant myelosuppressive chemotherapy  and upon initiation  there is a minimum of two additional months of planned chemotherapy,1
911,911,911,911,911,911,911,1235,1235,1235,1235,1235,1235,1235,1235,1235,1235,1235,1235,1235,0fd36cb9-c4f6-4167-93c9-8530865db3f9,1 3 limitations of use aranesp has not been shown to improve quality of life  fatigue  or patient well being,2
912,912,912,912,912,912,912,1246,1246,1246,1246,1246,1246,1246,1246,1246,1246,1246,1246,1246,de96dc6e-e6d1-4383-9ce1-4d06bac08e00,indications podocon 25 ( 25 podophyllin in benzoin tincture ) is indicated for the removal of soft genital ( venereal ) warts ( condylomata acuminata ) ( 4 ),1
913,913,913,913,913,913,913,1247,1247,1247,1247,1247,1247,1247,1247,1247,1247,1247,1247,1247,3423d014-4c35-441a-8528-2a7bc050f809, sodium polystyrene sulfonate for suspension is indicated for the treatment of hyperkalemia,1
914,914,914,914,914,914,914,1248,1248,1248,1248,1248,1248,1248,1248,1248,1248,1248,1248,1248,c08f73ff-4f15-449c-9507-c422367f106b, allergenic extract is indicated for diagnostic testing and treatment ( immunotherapy ) of patients whose histories indicate allergic symptoms upon natural exposure to grass allergens,1
915,915,915,915,915,915,915,1250,1250,1250,1250,1250,1250,1250,1250,1250,1250,1250,1250,1250,c08f73ff-4f15-449c-9507-c422367f106b,10  000 bau ml extracts are intended for percutaneous testing,0
916,916,916,916,916,916,916,1251,1251,1251,1251,1251,1251,1251,1251,1251,1251,1251,1251,1251,c08f73ff-4f15-449c-9507-c422367f106b,if negative  100  000 bau ml products can be used for percutaneous test,0
917,917,917,917,917,917,917,1252,1252,1252,1252,1252,1252,1252,1252,1252,1252,1252,1252,1252,c08f73ff-4f15-449c-9507-c422367f106b,dilutions made from 10  000 bau ml products are indicated for immunotherapy of previously untreated patients,1
918,918,918,918,918,918,918,1253,1253,1253,1253,1253,1253,1253,1253,1253,1253,1253,1253,1253,c08f73ff-4f15-449c-9507-c422367f106b,if 10  000 bau ml product is tolerated and symptoms persist  dilutions made from 100  000 bau ml can be administered,0
919,919,919,919,919,919,919,1254,1254,1254,1254,1254,1254,1254,1254,1254,1254,1254,1254,1254,c08f73ff-4f15-449c-9507-c422367f106b,standardized grass pollen extracts labeled in bioequivalent allergy units ( bau ml ) are not interchangeable with grass pollen extracts labeled in allergy units ( au ml ) or with non standardized grass pollen extracts,0
920,920,920,920,920,920,920,1255,1255,1255,1255,1255,1255,1255,1255,1255,1255,1255,1255,1255,c5390880-3440-46f1-8fef-f1ff0bde6edb, standardized grass pollen extracts are used for the diagnosis and treatment of allergic disease to grass pollen,1
921,921,921,921,921,921,921,1256,1256,1256,1256,1256,1256,1256,1256,1256,1256,1256,1256,1256,c5390880-3440-46f1-8fef-f1ff0bde6edb,the standardized ( bioequivalent allergy unit ) extract in these vials is designed primarily for the physician equipped to prepare dilutions and mixtures as required,0
922,922,922,922,922,922,922,1257,1257,1257,1257,1257,1257,1257,1257,1257,1257,1257,1257,1257,c5390880-3440-46f1-8fef-f1ff0bde6edb,standardized grass pollen extracts l a beled in bau ml are not interchangeable with grass pollen extracts labeled in au ml or with non standardized ( weight volume ) grass pollen extracts,0
923,923,923,923,923,923,923,1258,1258,1258,1258,1258,1258,1258,1258,1258,1258,1258,1258,1258,c5390880-3440-46f1-8fef-f1ff0bde6edb,patients being switched from other types of extracts to allergy laboratories should have their dose adjusted,0
924,924,924,924,924,924,924,1259,1259,1259,1259,1259,1259,1259,1259,1259,1259,1259,1259,1259,c5390880-3440-46f1-8fef-f1ff0bde6edb,diagnosis of allergic disease to these grasses is made through a combined medical history sufficiently complete to identify allergic symptoms to grass pollen and identification of grass allergy by diagnostic skin testing,0
925,925,925,925,925,925,925,1260,1260,1260,1260,1260,1260,1260,1260,1260,1260,1260,1260,1260,c5390880-3440-46f1-8fef-f1ff0bde6edb,it is recommended that diagnostic skin testing ( scratch or puncture ) be performed with 10  000 bau ml grass pollen extracts before testing with 100  000 bau ml grass pollen extracts,0
926,926,926,926,926,926,926,1261,1261,1261,1261,1261,1261,1261,1261,1261,1261,1261,1261,1261,c5390880-3440-46f1-8fef-f1ff0bde6edb,10  000 bau ml and 100  000 bau ml grass pollen extracts for immunotherapy are available for previously treated patients to facilitate dose selection for safe switching from non standardized to standardized extracts,0
927,927,927,927,927,927,927,1262,1262,1262,1262,1262,1262,1262,1262,1262,1262,1262,1262,1262,c5390880-3440-46f1-8fef-f1ff0bde6edb,patients being treated with grass pollen extracts for the first time can be initially immunized with dilutions prepared from the 10  000 bau ml extract ( see dosage and administration ),0
928,928,928,928,928,928,928,1263,1263,1263,1263,1263,1263,1263,1263,1263,1263,1263,1263,1263,c5390880-3440-46f1-8fef-f1ff0bde6edb,100  000 bau ml grass pollen extract can be administered if the patient tolerates the 10  000 bau ml extract,0
929,929,929,929,929,929,929,1264,1264,1264,1264,1264,1264,1264,1264,1264,1264,1264,1264,1264,c5390880-3440-46f1-8fef-f1ff0bde6edb,grass pollen immunotherapy is intended for patients whose grass allergic symptoms cannot be satisfactorily controlled by avoidance of the offending allergen or by the use of symptomatic medications,u
930,930,930,930,930,930,930,1272,1272,1272,1272,1272,1272,1272,1272,1272,1272,1272,1272,1272,000dc81d-ab91-450c-8eae-8eb74e72296f,1  entresto is a combination of sacubitril  a neprilysin inhibitor  and valsartan  an angiotensin ii receptor blocker  indicated to reduce the risk of cardiovascular death and hospitalization for heart failure in patients with chronic heart failure ( nyha class ii iv ) and reduced ejection fraction,1
931,931,931,931,931,931,931,1273,1273,1273,1273,1273,1273,1273,1273,1273,1273,1273,1273,1273,000dc81d-ab91-450c-8eae-8eb74e72296f,( 1 1 ) entresto is usually administered in conjunction with other heart failure therapies  in place of an ace inhibitor or other arb,0
932,932,932,932,932,932,932,1274,1274,1274,1274,1274,1274,1274,1274,1274,1274,1274,1274,1274,000dc81d-ab91-450c-8eae-8eb74e72296f,( 1 1 ) 1 1 heart failure entresto is indicated to reduce the risk of cardiovascular death and hospitalization for heart failure in patients with chronic heart failure ( nyha class ii iv ) and reduced ejection fraction,1
933,933,933,933,933,933,933,1275,1275,1275,1275,1275,1275,1275,1275,1275,1275,1275,1275,1275,000dc81d-ab91-450c-8eae-8eb74e72296f,entresto is usually administered in conjunction with other heart failure therapies  in place of an ace inhibitor or other arb,0
934,934,934,934,934,934,934,1276,1276,1276,1276,1276,1276,1276,1276,1276,1276,1276,1276,1276,07fe2b47-34ac-4a20-be67-3c788c77b207, penicillin g procaine is indicated in the treatment of moderately severe infections in both adults and pediatric patients due to penicillin g susceptible microorganisms that are susceptible to the low and persistent serum levels common to this particular dosage form in the indications listed below,1
935,935,935,935,935,935,935,1277,1277,1277,1277,1277,1277,1277,1277,1277,1277,1277,1277,1277,07fe2b47-34ac-4a20-be67-3c788c77b207,therapy should be guided by bacteriological studies ( including susceptibility tests ) and by clinical response,0
936,936,936,936,936,936,936,1278,1278,1278,1278,1278,1278,1278,1278,1278,1278,1278,1278,1278,07fe2b47-34ac-4a20-be67-3c788c77b207,note when high  sustained serum levels are required  aqueous penicillin g  either im or iv  should be used,u
937,937,937,937,937,937,937,1279,1279,1279,1279,1279,1279,1279,1279,1279,1279,1279,1279,1279,07fe2b47-34ac-4a20-be67-3c788c77b207,the following infections will usually respond to adequate dosages of intramuscular penicillin g procaine moderately severe to severe infections of the upper respiratory tract  skin and soft tissue infections  scarlet fever  and erysipelas due to susceptible streptococci ( group a without bacteremia ),0
938,938,938,938,938,938,938,1280,1280,1280,1280,1280,1280,1280,1280,1280,1280,1280,1280,1280,07fe2b47-34ac-4a20-be67-3c788c77b207,note streptococci in groups a  c  g  h  l  and m are very sensitive to penicillin g other groups  including group d ( enterococcus )  are resistant,0
939,939,939,939,939,939,939,1281,1281,1281,1281,1281,1281,1281,1281,1281,1281,1281,1281,1281,07fe2b47-34ac-4a20-be67-3c788c77b207,aqueous penicillin is recommended for streptococcal infections with bacteremia,u
940,940,940,940,940,940,940,1282,1282,1282,1282,1282,1282,1282,1282,1282,1282,1282,1282,1282,07fe2b47-34ac-4a20-be67-3c788c77b207,moderately severe infections of the respiratory tract due to susceptible pneumococci,1
941,941,941,941,941,941,941,1283,1283,1283,1283,1283,1283,1283,1283,1283,1283,1283,1283,1283,07fe2b47-34ac-4a20-be67-3c788c77b207,note severe pneumonia  empyema  bacteremia  pericarditis  meningitis  peritonitis  and arthritis of pneumococcal etiology are better treated with aqueous penicillin g during the acute stage,u
942,942,942,942,942,942,942,1284,1284,1284,1284,1284,1284,1284,1284,1284,1284,1284,1284,1284,07fe2b47-34ac-4a20-be67-3c788c77b207,moderately severe infections of the skin and soft tissues due to susceptible staphylococci ( penicillin g susceptible ),1
943,943,943,943,943,943,943,1287,1287,1287,1287,1287,1287,1287,1287,1287,1287,1287,1287,1287,07fe2b47-34ac-4a20-be67-3c788c77b207,fusospirochetosis ( vincent 's gingivitis and pharyngitis ),1
944,944,944,944,944,944,944,1288,1288,1288,1288,1288,1288,1288,1288,1288,1288,1288,1288,1288,07fe2b47-34ac-4a20-be67-3c788c77b207,moderately severe infections of the oropharynx due to susceptible fusiform bacilli and spirochetes,1
945,945,945,945,945,945,945,1290,1290,1290,1290,1290,1290,1290,1290,1290,1290,1290,1290,1290,07fe2b47-34ac-4a20-be67-3c788c77b207,syphilis ( all stages ) due to susceptible treponema pallidum,1
946,946,946,946,946,946,946,1291,1291,1291,1291,1291,1291,1291,1291,1291,1291,1291,1291,1291,07fe2b47-34ac-4a20-be67-3c788c77b207,note this drug should not be used in the treatment of beta lactamase producing organisms which include most strains of neisseria gonorrhea,2
947,947,947,947,947,947,947,1292,1292,1292,1292,1292,1292,1292,1292,1292,1292,1292,1292,1292,07fe2b47-34ac-4a20-be67-3c788c77b207,yaws  bejel  pinta due to susceptible organisms,1
948,948,948,948,948,948,948,1293,1293,1293,1293,1293,1293,1293,1293,1293,1293,1293,1293,1293,07fe2b47-34ac-4a20-be67-3c788c77b207,penicillin g procaine is an adjunct to antitoxin for prevention of the carrier stage of diphtheria due to susceptible c diphtheriae,1
949,949,949,949,949,949,949,1294,1294,1294,1294,1294,1294,1294,1294,1294,1294,1294,1294,1294,07fe2b47-34ac-4a20-be67-3c788c77b207,anthrax due to bacillus anthracis  including inhalational anthrax ( post exposure ) to reduce the incidence or progression of the disease following exposure to aerosolized bacillus anthracis,1
950,950,950,950,950,950,950,1295,1295,1295,1295,1295,1295,1295,1295,1295,1295,1295,1295,1295,07fe2b47-34ac-4a20-be67-3c788c77b207,rat bite fever due to susceptible streptobacillus moniliformis and spirillum minus organisms,1
951,951,951,951,951,951,951,1296,1296,1296,1296,1296,1296,1296,1296,1296,1296,1296,1296,1296,07fe2b47-34ac-4a20-be67-3c788c77b207,erysipeloid due to susceptible erysipelothrix rhusiopathiae,1
952,952,952,952,952,952,952,1297,1297,1297,1297,1297,1297,1297,1297,1297,1297,1297,1297,1297,07fe2b47-34ac-4a20-be67-3c788c77b207,subacute bacterial endocarditis  only in extremely sensitive infections  due to susceptible group,u
953,953,953,953,953,953,953,1298,1298,1298,1298,1298,1298,1298,1298,1298,1298,1298,1298,1298,ba7b9199-4710-4189-a85d-77ed75befe4d, to reduce the development of drug resistant bacteria and maintain the effectiveness of bicillin c r 900 300 and other antibacterial drugs  bicillin c r 900 300 should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria,1
954,954,954,954,954,954,954,1301,1301,1301,1301,1301,1301,1301,1301,1301,1301,1301,1301,1301,ba7b9199-4710-4189-a85d-77ed75befe4d,bicillin c r 900 300 is indicated in the treatment of infections as described below that are susceptible to serum levels characteristic of this particular dosage form,1
955,955,955,955,955,955,955,1302,1302,1302,1302,1302,1302,1302,1302,1302,1302,1302,1302,1302,ba7b9199-4710-4189-a85d-77ed75befe4d,therapy should be guided by bacteriological studies ( including susceptibility testing ) and by clinical response,0
956,956,956,956,956,956,956,1303,1303,1303,1303,1303,1303,1303,1303,1303,1303,1303,1303,1303,ba7b9199-4710-4189-a85d-77ed75befe4d,bicillin c r 900 300 is indicated in the treatment of the following in pediatric patients moderately severe to severe infections of the upper respiratory tract  scarlet fever  erysipelas  and skin and soft tissue infections due to susceptible streptococci,1
957,957,957,957,957,957,957,1304,1304,1304,1304,1304,1304,1304,1304,1304,1304,1304,1304,1304,ba7b9199-4710-4189-a85d-77ed75befe4d,note streptococci in groups a  c  g  h  l  and m are very susceptible to penicillin g other groups  including group d ( enterococci )  are resistant,0
958,958,958,958,958,958,958,1305,1305,1305,1305,1305,1305,1305,1305,1305,1305,1305,1305,1305,ba7b9199-4710-4189-a85d-77ed75befe4d,penicillin g sodium or potassium is recommended for streptococcal infections with bacteremia,1
959,959,959,959,959,959,959,1306,1306,1306,1306,1306,1306,1306,1306,1306,1306,1306,1306,1306,ba7b9199-4710-4189-a85d-77ed75befe4d,moderately severe pneumonia and otitis media due to susceptible streptococcus pneumoniae,1
960,960,960,960,960,960,960,1307,1307,1307,1307,1307,1307,1307,1307,1307,1307,1307,1307,1307,ba7b9199-4710-4189-a85d-77ed75befe4d,note severe pneumonia  empyema  bacteremia  pericarditis  meningitis  peritonitis  and arthritis of pneumococcal etiology are better treated with penicillin g sodium or potassium during the acute stage,u
961,961,961,961,961,961,961,1308,1308,1308,1308,1308,1308,1308,1308,1308,1308,1308,1308,1308,ba7b9199-4710-4189-a85d-77ed75befe4d,when high  sustained serum levels are required  penicillin g sodium or potassium  either im or iv  should be used,u
962,962,962,962,962,962,962,1309,1309,1309,1309,1309,1309,1309,1309,1309,1309,1309,1309,1309,ba7b9199-4710-4189-a85d-77ed75befe4d,this drug should not be used in the treatment of venereal diseases  including syphilis  gonorrhea  yaws  bejel  and pinta,2
963,963,963,963,963,963,963,1310,1310,1310,1310,1310,1310,1310,1310,1310,1310,1310,1310,1310,56aa1dc9-278f-4028-9771-526b381d7e35,indications primacare is a multivitamin multimineral fatty acid dietary supplement indicated for use in improving the nutritional status of omen throughout pregnancy and in the postnatal period for both lactating and nonlactating mothers,1
964,964,964,964,964,964,964,1311,1311,1311,1311,1311,1311,1311,1311,1311,1311,1311,1311,1311,9b71b219-91ae-46b2-8fb5-d3d118d73873,indication and usage nestabs one is a prescription prenatal multi vitamin mineral supplement with dha that can be taken throughout pregnancy and during the postnatal period for both lactating and non lactating mothers,u
965,965,965,965,965,965,965,1312,1312,1312,1312,1312,1312,1312,1312,1312,1312,1312,1312,1312,9b71b219-91ae-46b2-8fb5-d3d118d73873,nestabs one may also be useful in improving the nutritional status of women prior to conception,u
966,966,966,966,966,966,966,1313,1313,1313,1313,1313,1313,1313,1313,1313,1313,1313,1313,1313,9b71b219-91ae-46b2-8fb5-d3d118d73873,the usual dose is one softgel daily  or as directed by a physician,4
967,967,967,967,967,967,967,1314,1314,1314,1314,1314,1314,1314,1314,1314,1314,1314,1314,1314,967ed3ff-d99b-41e8-b768-dfb586d3d9a6, leukeran ( chlorambucil ) is indicated in the treatment of chronic lymphatic ( lymphocytic ) leukemia  malignant lymphomas including lymphosarcoma  giant follicular lymphoma  and hodgkin s disease,1
968,968,968,968,968,968,968,1315,1315,1315,1315,1315,1315,1315,1315,1315,1315,1315,1315,1315,967ed3ff-d99b-41e8-b768-dfb586d3d9a6,it is not curative in any of these disorders but may produce clinically useful palliation,0
969,969,969,969,969,969,969,1316,1316,1316,1316,1316,1316,1316,1316,1316,1316,1316,1316,1316,e76d62c6-7b27-441c-9de6-1fee2611a464,uses temporarily relieves sensitive scalp,1
970,970,970,970,970,970,970,1317,1317,1317,1317,1317,1317,1317,1317,1317,1317,1317,1317,1317,e76d62c6-7b27-441c-9de6-1fee2611a464,promotes hair restoration and improves circulation to hair follicles this statement has not been evaluated by the fda,0
971,971,971,971,971,971,971,1319,1319,1319,1319,1319,1319,1319,1319,1319,1319,1319,1319,1319,066570e8-4877-4412-8eb0-cf3dbf704b85, uses for temporary  symptomatic relief of rage  physically violent tendencies  violent temper  uncontrollable anger,1
972,972,972,972,972,972,972,1320,1320,1320,1320,1320,1320,1320,1320,1320,1320,1320,1320,1320,257f8cfb-a40c-4539-8f7f-d61966b071b0, indications traumeel ointment is an analgesic antiflammatory homeopathic drug product indicated for the treatment of injuries  inflammatory and degenerative conditions of the musculoskeletal system and for the relief of associated symptoms such as pain,1
973,973,973,973,973,973,973,1321,1321,1321,1321,1321,1321,1321,1321,1321,1321,1321,1321,1321,4e954f6b-ba49-4281-fa23-9f89fd5e5e0e, panic ease formulated for symptoms associated with emotional conditions such as panic attacks  mania  shock  hysteria  delirium and extreme fear or anxiety,1
974,974,974,974,974,974,974,1322,1322,1322,1322,1322,1322,1322,1322,1322,1322,1322,1322,1322,9f70e311-9d2c-1748-c8ce-b42174b6716d,product name indications section cataracts formulated for symptoms associated with cataracts such as blurred vision  photophobia  diplopia and opacities,1
975,975,975,975,975,975,975,1323,1323,1323,1323,1323,1323,1323,1323,1323,1323,1323,1323,1323,bcca68ac-9c2c-4ee4-9a0a-69c8fbcc1578, traumeel tablets are an analgesic anti inflammatory homeopathic drug product indicated for the treatment of injuries  inflammatory and degenerative conditions of the musculoskeletal system and for the relief of associated symptoms such as pain,1
976,976,976,976,976,976,976,1324,1324,1324,1324,1324,1324,1324,1324,1324,1324,1324,1324,1324,abc4b132-4d35-46a4-9a8e-9bd4c7a0f4b0, speedgel rx is indicated for the relief of pain and inflammation from arthritis or injuries such as sprains  strains  dislocations  repetitive overuse injuries  traumatic edema  post surgical edema  general swelling of joints and soft tissues of the hand  wrist  elbow  shoulder  neck  back  knee  ankle  foot and toe and general aches and pains,1
977,977,977,977,977,977,977,1325,1325,1325,1325,1325,1325,1325,1325,1325,1325,1325,1325,1325,2d001581-f547-42a5-bc34-0738c2854f04, the drug is indicated for the relief of symptoms  including pain and inflammation associated with arthritis or trauma ( such as sprains  strains  dislocations  repetitive overuse injuries  traumatic  edema  post surgical edema  hematoma  general swelling of joints and soft tissues ) to areas such as hand  wrist elbow  shoulder  neck  back  knees  ankles  feet and toes,1
978,978,978,978,978,978,978,1326,1326,1326,1326,1326,1326,1326,1326,1326,1326,1326,1326,1326,26f69dcf-5fc1-4fa3-9d81-af491dae85de,uses temporarily relieves minor pain and discomfort due to varicose veins  improving blood vessels tone and relieving inflammation,1
979,979,979,979,979,979,979,1327,1327,1327,1327,1327,1327,1327,1327,1327,1327,1327,1327,1327,26f69dcf-5fc1-4fa3-9d81-af491dae85de,also effective in the hemorrhoidal plexus,u
980,980,980,980,980,980,980,1330,1330,1330,1330,1330,1330,1330,1330,1330,1330,1330,1330,1330,6720fab5-6ef0-e922-0c2c-2fe5280838ab,indications ahealon is indicated for the acute and chronic treatment of pain and or inflammation  as well as a general healing aid  an infection deterrent  an agent to help reduce scar tissue and a source of moisturization ( dry cracked burned skin )  that include all burn injuries  radiation dermatitis  surgical incisions  rashes  pruritic conditions  arthritis joint pain  lower back pain  wounds  pressure sores  tumors  neuropathic discomfort and any generally painful and or inflamed area,1
981,981,981,981,981,981,981,1331,1331,1331,1331,1331,1331,1331,1331,1331,1331,1331,1331,1331,6720fab5-6ef0-e922-0c2c-2fe5280838ab,pain remediation can secondarily benefit sleep quality and duration pain reduction can also relieve chronic stress induced cortisol production and thus contribute to less patient stress and anxiety and the reversal of chronic non healing wounds,0
982,982,982,982,982,982,982,1332,1332,1332,1332,1332,1332,1332,1332,1332,1332,1332,1332,1332,6720fab5-6ef0-e922-0c2c-2fe5280838ab,expedited use on pain trauma patients may quickly control pain such as to reduce the possibility of shock,4
983,983,983,983,983,983,983,1333,1333,1333,1333,1333,1333,1333,1333,1333,1333,1333,1333,1333,14aaadca-7d86-47e8-8483-6e05d456949d, clemastine fumarate tablets  usp  2 68 mg are indicated for the relief of symptoms associated with allergic rhinitis such as sneezing  rhinorrhea  pruritus  and lacrimation,1
984,984,984,984,984,984,984,1334,1334,1334,1334,1334,1334,1334,1334,1334,1334,1334,1334,1334,14aaadca-7d86-47e8-8483-6e05d456949d,clemastine fumarate tablets  usp  2 68 mg are also indicated for the relief of mild  uncomplicated allergic skin manifestations of urticaria and angioedema,1
985,985,985,985,985,985,985,1335,1335,1335,1335,1335,1335,1335,1335,1335,1335,1335,1335,1335,14aaadca-7d86-47e8-8483-6e05d456949d,it should be noted that clemastine fumarate is indicated for the dermatologic indications at the 2 68 mg dosage level only,1
986,986,986,986,986,986,986,1336,1336,1336,1336,1336,1336,1336,1336,1336,1336,1336,1336,1336,a974c557-e88f-451b-a1bd-d2c656be226e, acute infections caused by susceptible strains of pseudomonas aeruginosa,1
987,987,987,987,987,987,987,1337,1337,1337,1337,1337,1337,1337,1337,1337,1337,1337,1337,1337,a974c557-e88f-451b-a1bd-d2c656be226e,polymyxin b sulfate is a drug of choice in the treatment of infections of the urinary tract  meninges  and bloodstream caused by susceptible strains of ps,1
988,988,988,988,988,988,988,1338,1338,1338,1338,1338,1338,1338,1338,1338,1338,1338,1338,1338,a974c557-e88f-451b-a1bd-d2c656be226e,it may also be used topically and subconjunctivally in the treatment of infections of the eye caused by susceptible strains of ps,1
989,989,989,989,989,989,989,1339,1339,1339,1339,1339,1339,1339,1339,1339,1339,1339,1339,1339,a974c557-e88f-451b-a1bd-d2c656be226e,it may be indicated in serious infections caused by susceptible strains of the following organisms  when less potentially toxic drugs are ineffective or contraindicated h influenzae  specifically meningeal infections,1
990,990,990,990,990,990,990,1340,1340,1340,1340,1340,1340,1340,1340,1340,1340,1340,1340,1340,a974c557-e88f-451b-a1bd-d2c656be226e,escherichia coli  specifically urinary tract infections,1
991,991,991,991,991,991,991,1341,1341,1341,1341,1341,1341,1341,1341,1341,1341,1341,1341,1341,a974c557-e88f-451b-a1bd-d2c656be226e,aerobacter aerogenes  specifically bacteremia,1
992,992,992,992,992,992,992,1342,1342,1342,1342,1342,1342,1342,1342,1342,1342,1342,1342,1342,a974c557-e88f-451b-a1bd-d2c656be226e,klebsiella pneumoniae  specifically bacteremia,1
993,993,993,993,993,993,993,1343,1343,1343,1343,1343,1343,1343,1343,1343,1343,1343,1343,1343,a974c557-e88f-451b-a1bd-d2c656be226e,note in meningeal infections  polymyxin b sulfate should be administered only by the intrathecal route,4
994,994,994,994,994,994,994,1344,1344,1344,1344,1344,1344,1344,1344,1344,1344,1344,1344,1344,a974c557-e88f-451b-a1bd-d2c656be226e,to reduce the development of drug resistant bacteria and maintain the effectiveness of polymyxin b and other antibacterial drugs  polymyxin b should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria,4
995,995,995,995,995,995,995,1347,1347,1347,1347,1347,1347,1347,1347,1347,1347,1347,1347,1347,1df13524-99f3-416c-94f8-4f6e16eb1c7e, for the treatment of superficial ocular infections involving the conjunctiva and or cornea caused by organisms susceptible to bacitracin zinc and polymyxin b sulfate,1
996,996,996,996,996,996,996,1348,1348,1348,1348,1348,1348,1348,1348,1348,1348,1348,1348,1348,60f5cfcf-cdb2-0e45-e053-2991aa0ae85a, polymyxin b sulfate and trimethoprim ophthalmic solution is indicated in the treatment of surface ocular bacterial infections  including acute bacterial conjunctivitis  and blepharoconjunctivitis  caused by susceptible strains of the following microorganisms staphylococcus aureus  staphylococcus epidermidis  streptococcus pneumoniae  streptococcus viridans  haemophilus influenzae and pseudomonas aeruginosa,1
997,997,997,997,997,997,997,1349,1349,1349,1349,1349,1349,1349,1349,1349,1349,1349,1349,1349,60f5cfcf-cdb2-0e45-e053-2991aa0ae85a,efficacy for this organism in this organ system was studied in fewer than 10 infections,0
998,998,998,998,998,998,998,1350,1350,1350,1350,1350,1350,1350,1350,1350,1350,1350,1350,1350,cbc5b3c3-4d2c-4fa0-adbb-8ddf42e881c5,1  perindopril erbumine is indicated for the treatment of patients with essential hypertension,1
999,999,999,999,999,999,999,1351,1351,1351,1351,1351,1351,1351,1351,1351,1351,1351,1351,1351,cbc5b3c3-4d2c-4fa0-adbb-8ddf42e881c5,( 1 1 ) perindopril erbumine is indicated for treatment of patients with stable coronary artery disease to reduce the risk of cardiovascular mortality or nonfatal myocardial infarction,1
1000,1000,1000,1000,1000,1000,1000,1352,1352,1352,1352,1352,1352,1352,1352,1352,1352,1352,1352,1352,cbc5b3c3-4d2c-4fa0-adbb-8ddf42e881c5,( 1 2 ) 1 1 hypertension perindopril erbumine is indicated for the treatment of patients with essential hypertension,1
1001,1001,1001,1001,1001,1001,1001,1353,1353,1353,1353,1353,1353,1353,1353,1353,1353,1353,1353,1353,cbc5b3c3-4d2c-4fa0-adbb-8ddf42e881c5,perindopril erbumine may be used alone or given with other classes of antihypertensives  especially thiazide diuretics,4
1002,1002,1002,1002,1002,1002,1002,1354,1354,1354,1354,1354,1354,1354,1354,1354,1354,1354,1354,1354,cbc5b3c3-4d2c-4fa0-adbb-8ddf42e881c5,1 2 stable coronary artery disease perindopril erbumine is indicated for treatment of patients with stable coronary artery disease to reduce the risk of cardiovascular mortality or nonfatal myocardial infarction,1
1003,1003,1003,1003,1003,1003,1003,1355,1355,1355,1355,1355,1355,1355,1355,1355,1355,1355,1355,1355,cbc5b3c3-4d2c-4fa0-adbb-8ddf42e881c5,perindopril erbumine can be used with conventional treatment for management of coronary artery disease  such as antiplatelet  antihypertensive or lipid lowering therapy,4
1004,1004,1004,1004,1004,1004,1004,1356,1356,1356,1356,1356,1356,1356,1356,1356,1356,1356,1356,1356,adc0815e-6ab2-3f6d-43f2-b7c0b8e9a931, inflammation fever formulated for symptoms associated with abscesses  ulcerations  cellulitis  sepsis  fever and other inflammatory and infectious processes,1
1005,1005,1005,1005,1005,1005,1005,1357,1357,1357,1357,1357,1357,1357,1357,1357,1357,1357,1357,1357,dfd9ada9-529f-4970-b058-04b220ab227e, uses for fast relief of symptoms fever  sweats  chills  aches  nausea  lethargy  irritability  oversensitivity  restlessness,1
1006,1006,1006,1006,1006,1006,1006,1358,1358,1358,1358,1358,1358,1358,1358,1358,1358,1358,1358,1358,dfd9ada9-529f-4970-b058-04b220ab227e,if fever lasts for more than three days  is accompanied by a rash or persistent headache  or if new symptoms occur  consult a doctor,0
1007,1007,1007,1007,1007,1007,1007,1364,1364,1364,1364,1364,1364,1364,1364,1364,1364,1364,1364,1364,aaeffe62-b538-43ca-a3b9-47e28b765d89, intradermal skin tests with trichophyton extract are indicated for use in persons who are suspected of having type i hypersensitivity ( i e,1
1008,1008,1008,1008,1008,1008,1008,1365,1365,1365,1365,1365,1365,1365,1365,1365,1365,1365,1365,1365,feb95882-69f1-4f30-91aa-505f45f3ab3f, quflora fe pediatric liquid drops is a prescription dietary supplement providing essential vitamins  iron and fluoride,1
1009,1009,1009,1009,1009,1009,1009,1366,1366,1366,1366,1366,1366,1366,1366,1366,1366,1366,1366,1366,5fc73ffc-5d0e-4d94-b4e5-8043d58fb59b, mynephron capsule is indicated in the wasting syndrome of chronic renal failure  uremia and impaired metabolic functions of the kidney  and to maintain levels when the dietary intake of vitamins is inadequate or excretion ( loss ) is excessive,1
1010,1010,1010,1010,1010,1010,1010,1367,1367,1367,1367,1367,1367,1367,1367,1367,1367,1367,1367,1367,5fc73ffc-5d0e-4d94-b4e5-8043d58fb59b,mynephron is also highly effective as a stress vitamin,u
1011,1011,1011,1011,1011,1011,1011,1368,1368,1368,1368,1368,1368,1368,1368,1368,1368,1368,1368,1368,bedb16ed-9d87-4514-83c6-92dc037c0ea0,indications for temporary relief of pressure in the eyes  and pain in and around the eyes,1
1012,1012,1012,1012,1012,1012,1012,1369,1369,1369,1369,1369,1369,1369,1369,1369,1369,1369,1369,1369,08fcf6d6-4335-43ea-acc0-8f72d7b53517,uses temporary relief of temperature fluctuations  mood swings  restless sleep  irritability,1
1013,1013,1013,1013,1013,1013,1013,1370,1370,1370,1370,1370,1370,1370,1370,1370,1370,1370,1370,1370,6507a9e2-c6d2-dc2a-cb0b-f6dfcf46e19a, prime of life formulated for symptoms associated with cognitive impairment  muscular atrophy  arthritis  impotence and other aging related  degenerative conditions,1
1014,1014,1014,1014,1014,1014,1014,1371,1371,1371,1371,1371,1371,1371,1371,1371,1371,1371,1371,1371,a6826aa3-fabb-4ff1-a7a3-cd4c34e3a330,1  cleviprex is indicated for the reduction of blood pressure when oral therapy is not feasible or not desirable,1
1015,1015,1015,1015,1015,1015,1015,1372,1372,1372,1372,1372,1372,1372,1372,1372,1372,1372,1372,1372,a6826aa3-fabb-4ff1-a7a3-cd4c34e3a330,cleviprex is a dihydropyridine calcium channel blocker indicated for the reduction of blood pressure when oral therapy is not feasible or not desirable,1
1016,1016,1016,1016,1016,1016,1016,1373,1373,1373,1373,1373,1373,1373,1373,1373,1373,1373,1373,1373,6935e846-d5a1-49e5-89a2-f8ebe4d5590d,1  fuzeon in combination with other antiretroviral agents is indicated for the treatment of hiv 1 infection in treatment experienced patients with evidence of hiv 1 replication despite ongoing antiretroviral therapy,1
1017,1017,1017,1017,1017,1017,1017,1374,1374,1374,1374,1374,1374,1374,1374,1374,1374,1374,1374,1374,6935e846-d5a1-49e5-89a2-f8ebe4d5590d,this indication is based on results from two controlled studies of 48 weeks duration,0
1018,1018,1018,1018,1018,1018,1018,1375,1375,1375,1375,1375,1375,1375,1375,1375,1375,1375,1375,1375,6935e846-d5a1-49e5-89a2-f8ebe4d5590d,subjects enrolled were treatment experienced adults many had advanced disease,0
1019,1019,1019,1019,1019,1019,1019,1376,1376,1376,1376,1376,1376,1376,1376,1376,1376,1376,1376,1376,6935e846-d5a1-49e5-89a2-f8ebe4d5590d,there are no studies of fuzeon in antiretroviral naive subjects,0
1020,1020,1020,1020,1020,1020,1020,1377,1377,1377,1377,1377,1377,1377,1377,1377,1377,1377,1377,1377,6935e846-d5a1-49e5-89a2-f8ebe4d5590d,fuzeon is an hiv 1 fusion inhibitor indicated for use in combination with other antiretroviral agents for the treatment of hiv 1 infection in treatment experienced patients with hiv 1 replication despite ongoing antiretroviral therapy,1
1021,1021,1021,1021,1021,1021,1021,1378,1378,1378,1378,1378,1378,1378,1378,1378,1378,1378,1378,1378,0d213a24-ebbf-41df-8f32-de44a572829e, diethylpropion hydrochloride extended release tablets  75 mg are indicated in the management of exogenous obesity as a short term adjunct ( a few weeks ) in a regimen of weight reduction based on caloric restriction in patients with an initial body mass index ( bmi ) of 30 kg m 2 or higher and who have not responded to appropriate weight reducing regimen ( diet and or exercise ) alone,1
1022,1022,1022,1022,1022,1022,1022,1379,1379,1379,1379,1379,1379,1379,1379,1379,1379,1379,1379,1379,0d213a24-ebbf-41df-8f32-de44a572829e,below is a chart of bmi based on various heights and weights,0
1023,1023,1023,1023,1023,1023,1023,1381,1381,1381,1381,1381,1381,1381,1381,1381,1381,1381,1381,1381,0d213a24-ebbf-41df-8f32-de44a572829e,metric conversions are as follows pounds divided by 2 2 kg inches x 0 0254 meters,0
1024,1024,1024,1024,1024,1024,1024,1382,1382,1382,1382,1382,1382,1382,1382,1382,1382,1382,1382,1382,0d213a24-ebbf-41df-8f32-de44a572829e,body mass index ( bmi )  kg m 2 weight ( pounds ) height ( feet  inches ) 5 0 5 3 5 6 5 9 6 0 6 3 140 27 25 23 td align center stylecode botrule toprule lrule,0
1025,1025,1025,1025,1025,1025,1025,1383,1383,1383,1383,1383,1383,1383,1383,1383,1383,1383,1383,1383,f234f419-42da-4a6d-82c6-92106cd77c67,1  doxycycline hyclate tablet is a tetracycline class drug indicated for rickettsial infections ( 1 1 ) sexually transmitted infections ( 1 2 ) respiratory tract infections ( 1 3 ) specific bacterial infections ( 1 4 ) ophthalmic infections ( 1 5 ) anthrax  including inhalational anthrax ( post exposure ) ( 1 6 ) alternative treatment for selected infections when penicillin is contraindicated ( 1 7 ) adjunctive therapy for acute intestinal amebiasis and severe acne ( 1 8 ) prophylaxis of malaria ( 1 9 ) to reduce the development of drug resistant bacteria and maintain the effectiveness of doxycycline hyclate tablets and other antibacterial drugs  doxycycline hyclate tablets should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria,1
1026,1026,1026,1026,1026,1026,1026,1384,1384,1384,1384,1384,1384,1384,1384,1384,1384,1384,1384,1384,f234f419-42da-4a6d-82c6-92106cd77c67,( 1 10 ) 1 1 rickettsial infections doxycycline hyclate tablets are indicated for treatment of rocky mountain spotted fever  typhus fever and the typhus group  q fever  rickettsial pox  and tick fevers caused by rickettsiae,1
1027,1027,1027,1027,1027,1027,1027,1385,1385,1385,1385,1385,1385,1385,1385,1385,1385,1385,1385,1385,f234f419-42da-4a6d-82c6-92106cd77c67,1 2 sexually transmitted infections doxycycline hyclate tablets are indicated for treatment of the following sexually transmitted infections uncomplicated urethral  endocervical or rectal infections caused by chlamydia trachomatis,1
1028,1028,1028,1028,1028,1028,1028,1386,1386,1386,1386,1386,1386,1386,1386,1386,1386,1386,1386,1386,f234f419-42da-4a6d-82c6-92106cd77c67,nongonococcal urethritis caused by ureaplasma urealyticum,1
1029,1029,1029,1029,1029,1029,1029,1388,1388,1388,1388,1388,1388,1388,1388,1388,1388,1388,1388,1388,f234f419-42da-4a6d-82c6-92106cd77c67,granuloma inguinale caused by klebsiella granulomatis,1
1030,1030,1030,1030,1030,1030,1030,1389,1389,1389,1389,1389,1389,1389,1389,1389,1389,1389,1389,1389,f234f419-42da-4a6d-82c6-92106cd77c67,uncomplicated gonorrhea caused by neisseria gonorrhoeae,1
1031,1031,1031,1031,1031,1031,1031,1390,1390,1390,1390,1390,1390,1390,1390,1390,1390,1390,1390,1390,f234f419-42da-4a6d-82c6-92106cd77c67,chancroid caused by haemophilus ducreyi,1
1032,1032,1032,1032,1032,1032,1032,1391,1391,1391,1391,1391,1391,1391,1391,1391,1391,1391,1391,1391,f234f419-42da-4a6d-82c6-92106cd77c67,1 3 respiratory tract infections doxycycline hyclate tablets are indicated for treatment of the following respiratory tract infections list listtype unordered id id191 st,1
1033,1033,1033,1033,1033,1033,1033,1392,1392,1392,1392,1392,1392,1392,1392,1392,1392,1392,1392,1392,d6f98d3c-5a20-4cbf-9a9c-abef10b9e465, to reduce the development of drug resistant bacteria and maintain effectiveness of vibramycin and other antibacterial drugs  vibramycin should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria,1
1034,1034,1034,1034,1034,1034,1034,1395,1395,1395,1395,1395,1395,1395,1395,1395,1395,1395,1395,1395,d6f98d3c-5a20-4cbf-9a9c-abef10b9e465,treatment doxycycline is indicated for the treatment of the following infections rocky mountain spotted fever  typhus fever and the typhus group  q fever  rickettsialpox  and tick fevers caused by rickettsiae,1
1035,1035,1035,1035,1035,1035,1035,1398,1398,1398,1398,1398,1398,1398,1398,1398,1398,1398,1398,1398,d6f98d3c-5a20-4cbf-9a9c-abef10b9e465,psittacosis ( ornithosis ) caused by chlamydophila psittaci,1
1036,1036,1036,1036,1036,1036,1036,1401,1401,1401,1401,1401,1401,1401,1401,1401,1401,1401,1401,1401,d6f98d3c-5a20-4cbf-9a9c-abef10b9e465,uncomplicated urethral  endocervical  or rectal infections in adults caused by chlamydia trachomatis,1
1037,1037,1037,1037,1037,1037,1037,1404,1404,1404,1404,1404,1404,1404,1404,1404,1404,1404,1404,1404,d6f98d3c-5a20-4cbf-9a9c-abef10b9e465,doxycycline is also indicated for the treatment of infections caused by the following gram negative microorganisms chancroid caused by haemophilus ducreyi,1
1038,1038,1038,1038,1038,1038,1038,1411,1411,1411,1411,1411,1411,1411,1411,1411,1411,1411,1411,1411,d6f98d3c-5a20-4cbf-9a9c-abef10b9e465,because many strains of the following groups of microorganisms have been shown to be resistant to doxycycline  culture and susceptibility testing are recommended,4
1039,1039,1039,1039,1039,1039,1039,1412,1412,1412,1412,1412,1412,1412,1412,1412,1412,1412,1412,1412,d6f98d3c-5a20-4cbf-9a9c-abef10b9e465,doxycycline is indicated for treatment of infections caused by the following gram negative bacteria  when bacteriologic testing indicates appropriate susceptibility to the drug paragraph,1
1040,1040,1040,1040,1040,1040,1040,1413,1413,1413,1413,1413,1413,1413,1413,1413,1413,1413,1413,1413,fd2c7d21-7b07-4ab3-8983-816ab3223771,1  regranex gel contains becaplermin  a human platelet derived growth factor that is indicated for the treatment of lower extremity diabetic neuropathic ulcers that extend into the subcutaneous tissue or beyond and have an adequate blood supply,1
1041,1041,1041,1041,1041,1041,1041,1414,1414,1414,1414,1414,1414,1414,1414,1414,1414,1414,1414,1414,fd2c7d21-7b07-4ab3-8983-816ab3223771,regranex gel is indicated as an adjunct to  and not a substitute for  good ulcer care practices,1
1042,1042,1042,1042,1042,1042,1042,1415,1415,1415,1415,1415,1415,1415,1415,1415,1415,1415,1415,1415,fd2c7d21-7b07-4ab3-8983-816ab3223771,( 1 1 ) limitations of use the efficacy of regranex gel has not been established for the treatment of pressure ulcers and venous stasis ulcers,2
1043,1043,1043,1043,1043,1043,1043,1416,1416,1416,1416,1416,1416,1416,1416,1416,1416,1416,1416,1416,fd2c7d21-7b07-4ab3-8983-816ab3223771,( 1 2 ) the effects of regranex gel on exposed joints  tendons  ligaments  and bone have not been established in humans,0
1044,1044,1044,1044,1044,1044,1044,1417,1417,1417,1417,1417,1417,1417,1417,1417,1417,1417,1417,1417,fd2c7d21-7b07-4ab3-8983-816ab3223771,( 1 2 ) regranex gel is a non sterile  low bioburden preserved product,0
1045,1045,1045,1045,1045,1045,1045,1418,1418,1418,1418,1418,1418,1418,1418,1418,1418,1418,1418,1418,fd2c7d21-7b07-4ab3-8983-816ab3223771,therefore  it should not be used in wounds that close by primary intention,2
1046,1046,1046,1046,1046,1046,1046,1419,1419,1419,1419,1419,1419,1419,1419,1419,1419,1419,1419,1419,fd2c7d21-7b07-4ab3-8983-816ab3223771,( 1 2 ) 1 1 indication regranex ( becaplermin ) gel is indicated for the treatment of lower extremity diabetic neuropathic ulcers that extend into the subcutaneous tissue or beyond and have an adequate blood supply  when used as an adjunct to  and not a substitute for  good ulcer care practices including initial sharp debridement  pressure relief and infection control,1
1047,1047,1047,1047,1047,1047,1047,1420,1420,1420,1420,1420,1420,1420,1420,1420,1420,1420,1420,1420,fd2c7d21-7b07-4ab3-8983-816ab3223771,1 2 limitations of use the efficacy of regranex gel has not been established for the treatment of pressure ulcers and venous stasis ulcers see clinical studies ( 14 ) and has not been evaluated for the treatment of diabetic neuropathic ulcers that do not extend through the dermis into subcutaneous tissue ( stage i or ii  iaet staging classification ) or ischemic diabetic ulcers,2
1048,1048,1048,1048,1048,1048,1048,1421,1421,1421,1421,1421,1421,1421,1421,1421,1421,1421,1421,1421,fd2c7d21-7b07-4ab3-8983-816ab3223771,the effects of becaplermin on exposed joints  tendons  ligaments  and bone have not been established in humans,0
1049,1049,1049,1049,1049,1049,1049,1422,1422,1422,1422,1422,1422,1422,1422,1422,1422,1422,1422,1422,fd2c7d21-7b07-4ab3-8983-816ab3223771,see nonclinical toxicology ( 13 2 ) regranex gel is a non sterile  low bioburden preserved product,0
1050,1050,1050,1050,1050,1050,1050,1424,1424,1424,1424,1424,1424,1424,1424,1424,1424,1424,1424,1424,1283a8ff-00f4-11af-4357-ae102066fe65,uses relieves occasional constipation ( irregularity ) generally produces a bowel movement in 6 12 hours,1
1051,1051,1051,1051,1051,1051,1051,1425,1425,1425,1425,1425,1425,1425,1425,1425,1425,1425,1425,1425,3c5101a0-0c7e-4078-8dc3-a57beb9a0e92,1  gadavist is a gadolinium based contrast agent indicated for use with magnetic resonance imaging ( mri ) to detect and visualize areas with disrupted blood brain barrier and or abnormal vascularity of the central nervous system in adult and pediatric patients ( including term neonates ) ( 1 1 ) to assess the presence and extent of malignant breast disease ( 1 2 ) to evaluate known or suspected supra aortic or renal artery disease in adult and pediatric patients ( including term neonates ) ( 1 3 ) 1 1 magnetic resonance imaging ( mri ) of the central nervous system ( cns ) gadavist is indicated for use with magnetic resonance imaging ( mri ) in adult and pediatric patients ( including term neonates ) to detect and visualize areas with disrupted blood brain barrier and or abnormal vascularity of the central nervous system,1
1052,1052,1052,1052,1052,1052,1052,1426,1426,1426,1426,1426,1426,1426,1426,1426,1426,1426,1426,1426,3c5101a0-0c7e-4078-8dc3-a57beb9a0e92,1 2 mri of the breast gadavist is indicated for use with mri to assess the presence and extent of malignant breast disease,1
1053,1053,1053,1053,1053,1053,1053,1427,1427,1427,1427,1427,1427,1427,1427,1427,1427,1427,1427,1427,3c5101a0-0c7e-4078-8dc3-a57beb9a0e92,1 3 magnetic resonance angiography ( mra ) gadavist is indicated for use in magnetic resonance angiography ( mra ) in adult and pediatric patients ( including term neonates ) to evaluate known or suspected supra aortic or renal artery disease,1
1054,1054,1054,1054,1054,1054,1054,1428,1428,1428,1428,1428,1428,1428,1428,1428,1428,1428,1428,1428,9f999b75-8a66-40bf-9352-478850b41225, technetium tc 99m labeled red blood cells are used for blood pool imaging  including cardiac first pass and gated equilibrium imaging and for detection of sites of gastrointestinal bleeding,1
1055,1055,1055,1055,1055,1055,1055,1429,1429,1429,1429,1429,1429,1429,1429,1429,1429,1429,1429,1429,304b63f4-a32e-4700-805d-5bc9f27e7d6a, technetium tc 99m pyrophosphate injection is a skeletal imaging agent used to demonstrate areas of altered osteogenesis  and a cardiac imaging agent used as an adjunct in the diagnosis of acute myocardial infarction,1
1056,1056,1056,1056,1056,1056,1056,1430,1430,1430,1430,1430,1430,1430,1430,1430,1430,1430,1430,1430,304b63f4-a32e-4700-805d-5bc9f27e7d6a,as an adjunct in the diagnosis of confirmed myocardial infarction ( ecg and serum enzymes positive )  the incidence of false negative images has been found to be 6,1
1057,1057,1057,1057,1057,1057,1057,1431,1431,1431,1431,1431,1431,1431,1431,1431,1431,1431,1431,1431,304b63f4-a32e-4700-805d-5bc9f27e7d6a,false negative images can also occur if made too early in the evolutionary phase of the infarct or too late in the resolution phase,0
1058,1058,1058,1058,1058,1058,1058,1432,1432,1432,1432,1432,1432,1432,1432,1432,1432,1432,1432,1432,304b63f4-a32e-4700-805d-5bc9f27e7d6a,in a limited study involving 22 patients in whom the ecg was positive and serum enzymes questionable or negative  but in whom the final diagnosis of acute myocardial infarction was made  the incidence of false negative images was 23,0
1059,1059,1059,1059,1059,1059,1059,1433,1433,1433,1433,1433,1433,1433,1433,1433,1433,1433,1433,1433,304b63f4-a32e-4700-805d-5bc9f27e7d6a,the incidence of false positive images has been found to be 7 to 9,0
1060,1060,1060,1060,1060,1060,1060,1434,1434,1434,1434,1434,1434,1434,1434,1434,1434,1434,1434,1434,304b63f4-a32e-4700-805d-5bc9f27e7d6a,false positive images have been reported following coronary by pass graft surgery  in unstable angina pectoris  old myocardial infarcts and in cardiac contusions,0
1061,1061,1061,1061,1061,1061,1061,1435,1435,1435,1435,1435,1435,1435,1435,1435,1435,1435,1435,1435,304b63f4-a32e-4700-805d-5bc9f27e7d6a,technescan pyp is a blood pool imaging agent which may be used for gated blood pool imaging and for the detection of sites of gastrointestinal bleeding,1
1062,1062,1062,1062,1062,1062,1062,1436,1436,1436,1436,1436,1436,1436,1436,1436,1436,1436,1436,1436,304b63f4-a32e-4700-805d-5bc9f27e7d6a,when administered intravenously 15 to 30 minutes prior to intravenous administration of sodium pertechnetate tc 99m for in vivo red blood cell labeling  approximately 75 of the injected activity remains in the blood pool,0
1063,1063,1063,1063,1063,1063,1063,1437,1437,1437,1437,1437,1437,1437,1437,1437,1437,1437,1437,1437,304b63f4-a32e-4700-805d-5bc9f27e7d6a,the modified in vivo in vitro red blood cell labeling method may also be used for blood pool imaging,u
1064,1064,1064,1064,1064,1064,1064,1438,1438,1438,1438,1438,1438,1438,1438,1438,1438,1438,1438,1438,4650d12c-b9c8-4525-b07f-a2d773eca155,1  aubagio is indicated for the treatment of patients with relapsing forms of multiple sclerosis,1
1065,1065,1065,1065,1065,1065,1065,1439,1439,1439,1439,1439,1439,1439,1439,1439,1439,1439,1439,1439,4650d12c-b9c8-4525-b07f-a2d773eca155,aubagio is a pyrimidine synthesis inhibitor indicated for the treatment of patients with relapsing forms of multiple sclerosis ( 1 ),1
1066,1066,1066,1066,1066,1066,1066,1440,1440,1440,1440,1440,1440,1440,1440,1440,1440,1440,1440,1440,ca1d3449-ea29-49a4-8863-365ec95f1553, sski ( potassium iodide oral solution  usp ) is for use as an expectorant in the symptomatic treatment of chronic pulmonary diseases where tenacious mucus complicates the problem  including bronchial asthma  bronchitis and pulmonary emphysema,1
1067,1067,1067,1067,1067,1067,1067,1441,1441,1441,1441,1441,1441,1441,1441,1441,1441,1441,1441,1441,92ccf7d4-4527-49f0-b890-1a11b5a10086,indications tristart dha is an orally administered multivitamin multimineral fatty acid dietary supplement indicated to improve the nutritional status of women throughout pregnancy and in the postnatal period for both lactating and nonlactating mothers,1
1068,1068,1068,1068,1068,1068,1068,1442,1442,1442,1442,1442,1442,1442,1442,1442,1442,1442,1442,1442,92ccf7d4-4527-49f0-b890-1a11b5a10086,tristart dha can also be beneficial in improving the nutritional status of women prior to conception this statement has not been evaluated by the food and drug administration,u
1069,1069,1069,1069,1069,1069,1069,1444,1444,1444,1444,1444,1444,1444,1444,1444,1444,1444,1444,1444,fe0a737e-4f28-40d8-b4a7-090edf86a823,indications prenate pixie is a multivitamin multimineral fatty acid dietary supplement indicated for use in improving the nutritional status of women throughout pregnancy and in the postnatal period for both lactating and nonlactating mothers,1
1070,1070,1070,1070,1070,1070,1070,1445,1445,1445,1445,1445,1445,1445,1445,1445,1445,1445,1445,1445,c755a5b6-f304-404a-90d9-09ecee83024c, preferaob dha is a prescription multivitamin multimineral ( preferaob ) and omega 3 fatty acid ( life 'sdha ) nutritional supplement indicated for use in improving the nutritional status of women throughout pregnancy and in the postnatal period for both lactating and non lactating mothers,1
1071,1071,1071,1071,1071,1071,1071,1446,1446,1446,1446,1446,1446,1446,1446,1446,1446,1446,1446,1446,c755a5b6-f304-404a-90d9-09ecee83024c,preferaob dha is also beneficial in improving the nutritional status of women prior to conception,u
1072,1072,1072,1072,1072,1072,1072,1447,1447,1447,1447,1447,1447,1447,1447,1447,1447,1447,1447,1447,db9fede8-b6d5-40a9-84cb-f928553f8e6c, preferaob one is a prescription multivitamin multimineral nutritional supplement with omega 3 fatty acid ( life 'sdha ) indicated for use in improving the nutritional status of women throughout pregnancy and in the postnatal period for both lactating and non lactating mothers,1
1073,1073,1073,1073,1073,1073,1073,1448,1448,1448,1448,1448,1448,1448,1448,1448,1448,1448,1448,1448,db9fede8-b6d5-40a9-84cb-f928553f8e6c,preferaob one is also beneficial in improving the nutritional status of women prior to conception,u
1074,1074,1074,1074,1074,1074,1074,1449,1449,1449,1449,1449,1449,1449,1449,1449,1449,1449,1449,1449,9f4ce551-7a80-4ddb-a014-95c44b54a420,indications pnv select is a multivitamin multimineral nutritional supplement indicated for use in the dietary management of patients with nutritional deficiencies or are in need of nutritional supplementation,1
1075,1075,1075,1075,1075,1075,1075,1450,1450,1450,1450,1450,1450,1450,1450,1450,1450,1450,1450,1450,61945c85-3c9a-4b57-a8e1-79dd0469a042, nestabs is indicated for use in improving the nutritional status of women throughout pregnancy and in the postnatal period for both lactating and nonlactating mothers,1
1076,1076,1076,1076,1076,1076,1076,1451,1451,1451,1451,1451,1451,1451,1451,1451,1451,1451,1451,1451,61945c85-3c9a-4b57-a8e1-79dd0469a042,nestabs is also beneficial in improving the nutritional status of women prior to conception,u
1077,1077,1077,1077,1077,1077,1077,1452,1452,1452,1452,1452,1452,1452,1452,1452,1452,1452,1452,1452,34d3382c-8ccd-4d1c-805d-223b4ca05d04, pre tabs dha is indicated to provide vitamin mineral and omega 3 fatty acid supplementation to women throughout pregnancy  during the postnatal for both lactating and nonlactating mothers,1
1078,1078,1078,1078,1078,1078,1078,1453,1453,1453,1453,1453,1453,1453,1453,1453,1453,1453,1453,1453,34d3382c-8ccd-4d1c-805d-223b4ca05d04,pre tabs dha is also beneficial in improving the nutritional status of women prior to conception,u
1079,1079,1079,1079,1079,1079,1079,1454,1454,1454,1454,1454,1454,1454,1454,1454,1454,1454,1454,1454,2dd25bf2-f1a7-4bc4-bdf2-12d9065ea0cf, nestabs dha is indicated to provide vitamin mineral and omega 3 fatty acid supplementation to women throughout pregnancy  during the postnatal for both lactating and nonlactating mothers,1
1080,1080,1080,1080,1080,1080,1080,1455,1455,1455,1455,1455,1455,1455,1455,1455,1455,1455,1455,1455,2dd25bf2-f1a7-4bc4-bdf2-12d9065ea0cf,nestabs dha is also beneficial in improving the nutritional status of women prior to conception,u
1081,1081,1081,1081,1081,1081,1081,1456,1456,1456,1456,1456,1456,1456,1456,1456,1456,1456,1456,1456,864fdaeb-a030-4ebd-93f1-a51d4e8eaa94,indications inatal ultra is a multivitamin multimineral nutritional supplement indicated for use in improving the nutritional status of women throughout pregnancy and in the postnatal period for both lactating and nonlactating mothers,1
1082,1082,1082,1082,1082,1082,1082,1457,1457,1457,1457,1457,1457,1457,1457,1457,1457,1457,1457,1457,864fdaeb-a030-4ebd-93f1-a51d4e8eaa94,ultra natalcare can also be beneficial in improving the nutritional status of women prior to conception,u
1083,1083,1083,1083,1083,1083,1083,1458,1458,1458,1458,1458,1458,1458,1458,1458,1458,1458,1458,1458,93bbb992-f6b1-44a2-9de8-46208f3abdf5, pnv ob dha is a multivitamin mineral prescription drug indicated for use in improving the nutritional status of women prior to conception  throughout pregnancy  and in the postnatal period for both lactating and nonlactating mothers,1
1084,1084,1084,1084,1084,1084,1084,1459,1459,1459,1459,1459,1459,1459,1459,1459,1459,1459,1459,1459,e8b17c58-8670-405a-8189-5e6f2acff6f6, prenatal dha is indicated to provide vitamin mineral and dha omega 3 fatty acid supplement to women throughout pregnancy  during the postnatal period for both lactating and non lactating mothers  and throughout the childbearing years,1
1085,1085,1085,1085,1085,1085,1085,1460,1460,1460,1460,1460,1460,1460,1460,1460,1460,1460,1460,1460,e8b17c58-8670-405a-8189-5e6f2acff6f6,prenatal dha may be beneficial in improving the nutritional status of women prior to conception,u
1086,1086,1086,1086,1086,1086,1086,1461,1461,1461,1461,1461,1461,1461,1461,1461,1461,1461,1461,1461,8ab766c2-d554-4141-92b2-fbe038e80c9f,indications prenate mini is a multivitamin multimineral fatty acid dietary supplement indicated for use in improving the nutritional status of women throughout pregnancy and in the postnatal period for both lactating and nonlactating mothers,1
1087,1087,1087,1087,1087,1087,1087,1462,1462,1462,1462,1462,1462,1462,1462,1462,1462,1462,1462,1462,e5acfb2a-0959-4542-9b4c-790be194d581,indications prenate essential is a multivitamin multimineral fatty acid dietary supplement indicated for use in improving the nutritional status of women throughout pregnancy and in the postnatal period for both lactating and nonlactating mothers,1
1088,1088,1088,1088,1088,1088,1088,1463,1463,1463,1463,1463,1463,1463,1463,1463,1463,1463,1463,1463,cf10de09-6ed5-4a66-84fa-2da4f668bbe6,indications prenate enhance is a multivitamin multimineral fatty acid dietary supplement indicated for use in improving the nutritional status of women throughout pregnancy and in the postnatal period for both lactating and nonlactating mothers,1
1089,1089,1089,1089,1089,1089,1089,1464,1464,1464,1464,1464,1464,1464,1464,1464,1464,1464,1464,1464,cf10de09-6ed5-4a66-84fa-2da4f668bbe6,prenate enhance can also be beneficial in improving the nutritional status of women prior to conception,u
1090,1090,1090,1090,1090,1090,1090,1465,1465,1465,1465,1465,1465,1465,1465,1465,1465,1465,1465,1465,735c5531-137f-4cee-8c68-ae121045a8ff,indications pnv omega is a multivitamin multimineral dietary supplement indicated for use in the dietary management of patients with nutritional deficiencies or are in need of nutritionalsupplementation,1
1091,1091,1091,1091,1091,1091,1091,1466,1466,1466,1466,1466,1466,1466,1466,1466,1466,1466,1466,1466,4c86031c-e555-6bef-2351-0f04a99f43d8, acne cystic acne formulated for symptoms associated with acne and other skin conditions such as boils  pimples  pustules and sebaceous cysts,1
1092,1092,1092,1092,1092,1092,1092,1467,1467,1467,1467,1467,1467,1467,1467,1467,1467,1467,1467,1467,da51a41f-8744-ea38-69b7-51282c6d454b, sinusitis formulated for symptoms of acute or chronic sinusitis associated with allergies and bacterial or fungal infections,1
1093,1093,1093,1093,1093,1093,1093,1468,1468,1468,1468,1468,1468,1468,1468,1468,1468,1468,1468,1468,81e639d7-352e-4eaa-87d9-582da68b9728,indications citranatal 90 dha is a multivitamin mineral prescription drug indicated for use in improving the nutritional status of women prior to conception  throughout pregnancy  and in the postnatal period for both lactating and nonlactating mothers,1
1094,1094,1094,1094,1094,1094,1094,1469,1469,1469,1469,1469,1469,1469,1469,1469,1469,1469,1469,1469,e5027852-b374-10e4-7acd-42f9ada83f81,indications citranatal dha is a multi vitamin mineral prescription drug indicated for use in improving the nutritional status of women prior to conception  throughout pregnancy  and in the postnatal period for both lactating and nonlactating mothers,1
1095,1095,1095,1095,1095,1095,1095,1470,1470,1470,1470,1470,1470,1470,1470,1470,1470,1470,1470,1470,e5027852-b374-10e4-7acd-42f9ada83f81,contraindications this product is contraindicated in patients with a known hypersensitivity to any of the ingredients,1
1096,1096,1096,1096,1096,1096,1096,1471,1471,1471,1471,1471,1471,1471,1471,1471,1471,1471,1471,1471,8ee7be74-6442-5692-edab-5d8626a510dd,indications citranatal rx is a multivitamin multimineral prescription drug indicated for use in improving the nutritional status of women prior to conception  throughout pregnancy  and in the postnatal period for both lactating and nonlactating mothers,1
1097,1097,1097,1097,1097,1097,1097,1473,1473,1473,1473,1473,1473,1473,1473,1473,1473,1473,1473,1473,c02cc80c-adb1-5582-6f60-d819a1e41748,indications citranatal rx is a multi vitamin mineral prescription drug indicated for use in improving the nutritional status of women prior to conception  throughout pregnancy  and in the postnatal period for both lactating and nonlactating mothers,1
1098,1098,1098,1098,1098,1098,1098,1475,1475,1475,1475,1475,1475,1475,1475,1475,1475,1475,1475,1475,f3aca2b2-8df2-4995-91fd-c81c3286a0f8,uses temporarily relieves fatigue due to overwork and or overexertion,1
1099,1099,1099,1099,1099,1099,1099,1476,1476,1476,1476,1476,1476,1476,1476,1476,1476,1476,1476,1476,f3aca2b2-8df2-4995-91fd-c81c3286a0f8,convalescence  especially after debilitating illness  surgical procedures or pregnancy,1
1100,1100,1100,1100,1100,1100,1100,1477,1477,1477,1477,1477,1477,1477,1477,1477,1477,1477,1477,1477,f3aca2b2-8df2-4995-91fd-c81c3286a0f8,loss of appetite  loss of weight,1
1101,1101,1101,1101,1101,1101,1101,1478,1478,1478,1478,1478,1478,1478,1478,1478,1478,1478,1478,1478,f3aca2b2-8df2-4995-91fd-c81c3286a0f8,supports appetite and growth in children  stabilizes the nervous systems and helps restore mental alertness,u
1102,1102,1102,1102,1102,1102,1102,1479,1479,1479,1479,1479,1479,1479,1479,1479,1479,1479,1479,1479,f3aca2b2-8df2-4995-91fd-c81c3286a0f8,claims based on traditional homeopathic practice  not accepted medical evidence,0
1103,1103,1103,1103,1103,1103,1103,1480,1480,1480,1480,1480,1480,1480,1480,1480,1480,1480,1480,1480,"Active Ingredient UNII(s)
1C4QK22F9J; 30Q7KI53AK; 3QJ8WS6V8H; 9679TC07X4; EC2CNF7XFP    6d061538-7a4e-4af2-a4a6-a9b010c092f6
1C4QK22F9J; 30Q7KI53AK; 3QJ8WS6V8H; 9679TC07X4; EC2CNF7XFP    6d061538-7a4e-4af2-a4a6-a9b010c092f6
1C4QK22F9J; 30Q7KI53AK; 3QJ8WS6V8H; 9679TC07X4; EC2CNF7XFP    6d061538-7a4e-4af2-a4a6-a9b010c092f6
Name: SET ID dtype: object",active ingredient unii ( s ) 1c4qk22f9j 30q7ki53ak 3qj8ws6v8h 9679tc07x4 ec2cnf7xfp active ingredient unii ( s ) 1c4qk22f9j 30q7ki53 1c4qk22f9j 30q7ki53ak 3qj8ws6v8h 9679tc07x4 ec2cnf7xfp active ingredient unii ( s ) 1c4qk22f9j 30q7ki53 1c4qk22f9j 30q7ki53ak 3qj8ws6v8h 9679tc07x4 ec2cnf7xfp active ingredient unii ( s ) 1c4qk22f9j 30q7ki53 name content xml  dtype object,0
1104,1104,1104,1104,1104,1104,1104,1483,1483,1483,1483,1483,1483,1483,1483,1483,1483,1483,1483,1483,cf5b0102-4f76-4f9e-907a-bf9425890aea,use source of iodne indictaions this product has several uses where iodine is indicated,0
1105,1105,1105,1105,1105,1105,1105,1484,1484,1484,1484,1484,1484,1484,1484,1484,1484,1484,1484,1484,cf5b0102-4f76-4f9e-907a-bf9425890aea,this product may be used in the treatment of hyperthyroidism in the immediate preoperative period in preparation for thyroidectomy,u
1106,1106,1106,1106,1106,1106,1106,1485,1485,1485,1485,1485,1485,1485,1485,1485,1485,1485,1485,1485,cf5b0102-4f76-4f9e-907a-bf9425890aea,it may be used alone  but more frequently is used after the hyperthyroidism is controlled by an antithyroid drug,u
1107,1107,1107,1107,1107,1107,1107,1486,1486,1486,1486,1486,1486,1486,1486,1486,1486,1486,1486,1486,cf5b0102-4f76-4f9e-907a-bf9425890aea,it is given during the 10 days immediately prior to the operation,4
1108,1108,1108,1108,1108,1108,1108,1487,1487,1487,1487,1487,1487,1487,1487,1487,1487,1487,1487,1487,cf5b0102-4f76-4f9e-907a-bf9425890aea,optimal control of hyperthyroidism is achieved if antithyroid drugs are first given alone,4
1109,1109,1109,1109,1109,1109,1109,1488,1488,1488,1488,1488,1488,1488,1488,1488,1488,1488,1488,1488,cf5b0102-4f76-4f9e-907a-bf9425890aea,this product is also used in thyrotoxicosis crisis in conjunction with supportive measures to control fever and adequate fluid intake,4
1110,1110,1110,1110,1110,1110,1110,1489,1489,1489,1489,1489,1489,1489,1489,1489,1489,1489,1489,1489,4ff223f7-e076-4e81-8151-5c06724fabd9,1  infuvite pediatric is a combination of vitamins indicated for the prevention of vitamin deficiency in pediatric patients up to 11 years of age receiving parenteral nutrition,1
1111,1111,1111,1111,1111,1111,1111,1490,1490,1490,1490,1490,1490,1490,1490,1490,1490,1490,1490,1490,4ff223f7-e076-4e81-8151-5c06724fabd9,the physician should not await the development of clinical signs of vitamin deficiency before initiating vitamin therapy,4
1112,1112,1112,1112,1112,1112,1112,1491,1491,1491,1491,1491,1491,1491,1491,1491,1491,1491,1491,1491,4ff223f7-e076-4e81-8151-5c06724fabd9,infuvite pediatric is a combination of vitamins indicated for the prevention of vitamin deficiency in pediatric patients up to 11 years of age receiving parenteral nutrition ( 1 ),1
1113,1113,1113,1113,1113,1113,1113,1492,1492,1492,1492,1492,1492,1492,1492,1492,1492,1492,1492,1492,d5609742-e456-4409-bca9-706b0ea90d35, supplementation of the diet with vitamins a  c and d multi vitamin drops with fluoride and iron 0 25 mg also provides fluoride for caries prophylaxis,1
1114,1114,1114,1114,1114,1114,1114,1493,1493,1493,1493,1493,1493,1493,1493,1493,1493,1493,1493,1493,d5609742-e456-4409-bca9-706b0ea90d35,the american academy of pediatrics recommends that children up to age 16  in areas where drinking water contains less than optimal levels of fluoride  receive daily fluoride supplementation,u
1115,1115,1115,1115,1115,1115,1115,1494,1494,1494,1494,1494,1494,1494,1494,1494,1494,1494,1494,1494,d5609742-e456-4409-bca9-706b0ea90d35,the american academy of pediatrics recommend that infants and young children 6 months to 3 years of age  in areas where the drinking water contains less than 0 3 ppm of fluoride  and children 3 6 years of age  in areas where the drinking water contains 0 3 through 0 6 ppm of fluoride  receive 0 25 mg of supplemental fluoride daily which is provided in a dose of 1 ml of multi vitamin drops with fluoride 0 25 mg ( see dosage and administration ),u
1116,1116,1116,1116,1116,1116,1116,1495,1495,1495,1495,1495,1495,1495,1495,1495,1495,1495,1495,1495,d5609742-e456-4409-bca9-706b0ea90d35,multi vitamin drops with fluoride and iron 0 25 mg supply significant amounts of vitamins a  c and d to supplement the diet  and to help assure that nutritional deficiencies of these vitamins will not develop,0
1117,1117,1117,1117,1117,1117,1117,1496,1496,1496,1496,1496,1496,1496,1496,1496,1496,1496,1496,1496,d5609742-e456-4409-bca9-706b0ea90d35,thus  in a single easy to use preparation  children obtain essential vitamins and fluoride,0
1118,1118,1118,1118,1118,1118,1118,1497,1497,1497,1497,1497,1497,1497,1497,1497,1497,1497,1497,1497,d1ca3779-21b0-4ebc-95d7-a92b0d6fbe7a, supplementation of the diet with eight essential vitamins and iron,1
1119,1119,1119,1119,1119,1119,1119,1498,1498,1498,1498,1498,1498,1498,1498,1498,1498,1498,1498,1498,d1ca3779-21b0-4ebc-95d7-a92b0d6fbe7a,supplementation of the diet with fluoride for caries prophylaxis,1
1120,1120,1120,1120,1120,1120,1120,1499,1499,1499,1499,1499,1499,1499,1499,1499,1499,1499,1499,1499,d1ca3779-21b0-4ebc-95d7-a92b0d6fbe7a,multi vit with fluoride 0 25 mg and iron drops provide fluoride in drop form for infants and young children from 6 months to 3 years of age in areas where the drinking water contains less than 0 3 ppm of fluoride and for children ages 3 to 6 years in areas where the drinking water contains 0 3 through 0 6 ppm of fluoride 2  3 each 1 ml supplies sodium fluoride ( 0 25 mg fluoride ) plus eight essential vitamins and iron,0
1121,1121,1121,1121,1121,1121,1121,1500,1500,1500,1500,1500,1500,1500,1500,1500,1500,1500,1500,1500,d1ca3779-21b0-4ebc-95d7-a92b0d6fbe7a,multi vit with fluoride 0 25 mg and iron drops supply significant amounts of vitamins a  c  d  e  thiamin  riboflavin  niacin  vitamin b6 and iron to supplement the diet  and to help assure that deficiencies of these nutrients will not develop,u
1122,1122,1122,1122,1122,1122,1122,1501,1501,1501,1501,1501,1501,1501,1501,1501,1501,1501,1501,1501,d1ca3779-21b0-4ebc-95d7-a92b0d6fbe7a,thus  in a single easy to use preparation  infants and children obtain eight essential vitamins and iron  plus fluoride,0
1123,1123,1123,1123,1123,1123,1123,1502,1502,1502,1502,1502,1502,1502,1502,1502,1502,1502,1502,1502,cdeca352-ca84-4876-b218-e5b71851566d, supplementation of the diet with eight essential vitamins and iron  plus fluoride,1
1124,1124,1124,1124,1124,1124,1124,1505,1505,1505,1505,1505,1505,1505,1505,1505,1505,1505,1505,1505,cdeca352-ca84-4876-b218-e5b71851566d,multi vitamin  iron and fluoride supplemental drops 0 25 provide fluoride in drop form for children ages 2 3 years where the drinking water contains less than 0 3 ppm of fluoride and for children over 3 years  in areas where the drinking water contains 0 3 through 0 7 ppm of fluoride,0
1125,1125,1125,1125,1125,1125,1125,1506,1506,1506,1506,1506,1506,1506,1506,1506,1506,1506,1506,1506,cdeca352-ca84-4876-b218-e5b71851566d,each 1 0 ml provides sodium fluoride ( 0 25 mg fluoride ) plus eight essential vitamins and iron,0
1126,1126,1126,1126,1126,1126,1126,1507,1507,1507,1507,1507,1507,1507,1507,1507,1507,1507,1507,1507,cdeca352-ca84-4876-b218-e5b71851566d,the american academy of pediatrics and the american dental association currently recommend that infants and children under 2 years of age  in areas where drinking water contains less than 0 3 ppm of fluoride  and children 2 3  years of age  in areas where the drinking water contains 0 3 through 0 7 ppm of fluoride  receive 0 25 mg of supplemental fluoride daily which is provided in a full dose ( 1ml ) of multi vitamin  iron and fluoride supplemental drops 0 25 mg multi vitamin  iron and fluoride supplemental drops 0 25 mg provide significant amounts of vitamins a  d  e  c thiamine  riboflavin  niacin  pyridoxine  and iron to supplement the diet  and to help assure that nutritional deficiencies of these vitamins will not develop,0
1127,1127,1127,1127,1127,1127,1127,1508,1508,1508,1508,1508,1508,1508,1508,1508,1508,1508,1508,1508,cdeca352-ca84-4876-b218-e5b71851566d,thus  in a single easy to use preparation  children obtain eight essential vitamins and iron  plus fluoride,0
1128,1128,1128,1128,1128,1128,1128,1509,1509,1509,1509,1509,1509,1509,1509,1509,1509,1509,1509,1509,33fd4fe4-24f6-4a55-a4d7-fe414465eeb2, supplementation of the diet with nine essential vitamins,1
1129,1129,1129,1129,1129,1129,1129,1512,1512,1512,1512,1512,1512,1512,1512,1512,1512,1512,1512,1512,33fd4fe4-24f6-4a55-a4d7-fe414465eeb2,multivitamin and fluoride supplemental drops 0 25 mg provide fluoride in drop form for infants and young children 6 months to 3 years of age  in areas where the drinking water contains less than 0 3 ppm of fluoride and for children ages 3 6 years  in areas where the drinking water contains 0 3 through 0 6 ppm of fluoride,0
1130,1130,1130,1130,1130,1130,1130,1513,1513,1513,1513,1513,1513,1513,1513,1513,1513,1513,1513,1513,33fd4fe4-24f6-4a55-a4d7-fe414465eeb2,each 1 0 ml supplies sodium fluoride ( 0 25 mg fluoride ) plus nine essential vitamins,0
1131,1131,1131,1131,1131,1131,1131,1514,1514,1514,1514,1514,1514,1514,1514,1514,1514,1514,1514,1514,33fd4fe4-24f6-4a55-a4d7-fe414465eeb2,the american academy of pediatrics recommended that infants and young children 6 months to 3 years of age  in areas where drinking water contains less than 0 3 ppm of fluoride  and children 3 6  years of age  in areas where the drinking water contains 0 3 through 0 6 ppm of fluoride  receive 0 25 mg of supplemental fluoride daily which is provided in a full dose ( 1ml ) of multi vitamin and fluoride supplemental drops 0 25 mg a half dose ( 0 5ml ) of multi vitamin and fluoride supplemental drops 0 5 mg could also provide a daily fluoride intake of 0 25mg however  the dosage reduces vitamin supplementation by half,0
1132,1132,1132,1132,1132,1132,1132,1515,1515,1515,1515,1515,1515,1515,1515,1515,1515,1515,1515,1515,33fd4fe4-24f6-4a55-a4d7-fe414465eeb2,multi vitamin and fluoride supplemental drops 0 25 mg and multi vitamin and fluoride supplemental drops 0 5 mg drops supply significant amounts of vitamins a  c  d  e  thiamine  riboflavin  niacin  pyridoxine  and cyanocobalamin to supplement the diet  and to help assure that nutritional deficiencies of these vitamins will not develop,u
1133,1133,1133,1133,1133,1133,1133,1516,1516,1516,1516,1516,1516,1516,1516,1516,1516,1516,1516,1516,33fd4fe4-24f6-4a55-a4d7-fe414465eeb2,thus  in a single easy to use preparation  infants and children obtain nine essential vitamins and fluoride,0
1134,1134,1134,1134,1134,1134,1134,1517,1517,1517,1517,1517,1517,1517,1517,1517,1517,1517,1517,1517,33fd4fe4-24f6-4a55-a4d7-fe414465eeb2,a comprehensive 5 1 2 year series of studies of the effectiveness of multivitamin  iron  and fluoride drops in caries protection has been published,0
1135,1135,1135,1135,1135,1135,1135,1518,1518,1518,1518,1518,1518,1518,1518,1518,1518,1518,1518,1518,33fd4fe4-24f6-4a55-a4d7-fe414465eeb2,children in this continuing study lived in an area where the water supply contained only 0 05 ppm fluoride,0
1136,1136,1136,1136,1136,1136,1136,1519,1519,1519,1519,1519,1519,1519,1519,1519,1519,1519,1519,1519,33fd4fe4-24f6-4a55-a4d7-fe414465eeb2,the subjects were divided into 2 groups  one which used only the non fluoride vitamin product  and the other  multi vitamins fluoride products,0
1137,1137,1137,1137,1137,1137,1137,1521,1521,1521,1521,1521,1521,1521,1521,1521,1521,1521,1521,1521,33fd4fe4-24f6-4a55-a4d7-fe414465eeb2,the subjects were divided into 2 groups  one which used only non fluoridated vitamin product and the other  multi vitamins fluoride products,0
1138,1138,1138,1138,1138,1138,1138,1522,1522,1522,1522,1522,1522,1522,1522,1522,1522,1522,1522,1522,33fd4fe4-24f6-4a55-a4d7-fe414465eeb2,the three year interim report showed 63 fewer carious surfaces in primary teeth and 43 fewer carious surfaces in permanent teeth of the children taking multi vitamin fluoride products,0
1139,1139,1139,1139,1139,1139,1139,1523,1523,1523,1523,1523,1523,1523,1523,1523,1523,1523,1523,1523,33fd4fe4-24f6-4a55-a4d7-fe414465eeb2,after four years  the studies continued to support the effectiveness of multi vitamin fluoride products  showing a reduction in carious surfaces of 68 in primary teeth and 46 in permanent teeth,0
1140,1140,1140,1140,1140,1140,1140,1524,1524,1524,1524,1524,1524,1524,1524,1524,1524,1524,1524,1524,33fd4fe4-24f6-4a55-a4d7-fe414465eeb2,results at the end of the 51 2 years further confirmed the previous findings and indicated that significant reductions in dental caries are apparent with the continued use of multi vitamin fluoride products,0
1141,1141,1141,1141,1141,1141,1141,1525,1525,1525,1525,1525,1525,1525,1525,1525,1525,1525,1525,1525,880df628-5bba-4dc4-b557-1fcc822adba8, supplementation of the diet with vitamins a  c and d multi vitamin drops with fluoride 0 25 mg also provides fluoride for caries prophylaxis,0
1142,1142,1142,1142,1142,1142,1142,1528,1528,1528,1528,1528,1528,1528,1528,1528,1528,1528,1528,1528,880df628-5bba-4dc4-b557-1fcc822adba8,multi vitamin drops with fluoride 0 25 mg supply significant amounts of vitamins a  c and d to supplement the diet  and to help assure that nutritional deficiencies of these vitamins will not develop,0
1143,1143,1143,1143,1143,1143,1143,1532,1532,1532,1532,1532,1532,1532,1532,1532,1532,1532,1532,1532,e57d5887-ec11-4a8a-958e-473f39be52de,multi vit with fluoride 0 25 mg drops were developed to provide fluoride in drop form for infants and young children from 6 months to 3 years of age in areas where the drinking water contains less than 0 3 ppm of fluoride and for children ages 3 to 6 years in areas where the drinking water contains 0 3 through 0 6 ppm of fluoride 2  3 each 1 ml supplies sodium fluoride ( 0 25 mg fluoride ) plus nine essential vitamins,0
1144,1144,1144,1144,1144,1144,1144,1533,1533,1533,1533,1533,1533,1533,1533,1533,1533,1533,1533,1533,e57d5887-ec11-4a8a-958e-473f39be52de,multi vit with fluoride 0 25 mg drops supply significant amounts of vitamins a  c  d  e  thiamin  riboflavin  niacin  vitamin b6 and vitamin b12 to supplement the diet  and to help assure that nutritional deficiencies of these vitamins will not develop,0
1145,1145,1145,1145,1145,1145,1145,1534,1534,1534,1534,1534,1534,1534,1534,1534,1534,1534,1534,1534,e57d5887-ec11-4a8a-958e-473f39be52de,thus  in a single easy to use preparation  infants and children obtain nine essential vitamins plus fluoride,0
1146,1146,1146,1146,1146,1146,1146,1535,1535,1535,1535,1535,1535,1535,1535,1535,1535,1535,1535,1535,d8df6fd7-7e75-4e23-a620-4eccb8078d16, supplementation of the diet with nine essential vitamins and iron  and supplementation of the diet with fluoride for caries prophylaxis,1
1147,1147,1147,1147,1147,1147,1147,1536,1536,1536,1536,1536,1536,1536,1536,1536,1536,1536,1536,1536,d8df6fd7-7e75-4e23-a620-4eccb8078d16,the american academy of pediatrics recommends that children up to age 16  in areas where drinking water contains less than optimal levels of fluoride  receive daily fluoride supplementation 2 escavite lq multi vitamin with iron and fluoride 0 25 mg provides fluoride in drop form for infants and young children from 6 months to 3 years of age in areas where the drinking water contains less than 0 3 ppm of fluoride and for children ages 3 6 years in areas where the drinking water contains 0 3 through 0 6 ppm of fluoride 2  3 each 1 0 ml supplies sodium fluoride ( 0 25 mg fluoride per 1 ml ) plus nine essential vitamins and iron,0
1148,1148,1148,1148,1148,1148,1148,1537,1537,1537,1537,1537,1537,1537,1537,1537,1537,1537,1537,1537,d8df6fd7-7e75-4e23-a620-4eccb8078d16,escavite lq multi vitamin with iron and fluoride 0 25 mg supplies significant amounts of vitamins a  c  d  e  thiamin  riboflavin  niacin  vitamin b6  vitamin b12  and iron to supplement the diet  and to help assure the deficiencies of these nutrients will not develop,u
1149,1149,1149,1149,1149,1149,1149,1538,1538,1538,1538,1538,1538,1538,1538,1538,1538,1538,1538,1538,d8df6fd7-7e75-4e23-a620-4eccb8078d16,thus  in a single easy to use preparation  infants and children obtain nine essential vitamins and iron  plus fluoride,0
1150,1150,1150,1150,1150,1150,1150,1539,1539,1539,1539,1539,1539,1539,1539,1539,1539,1539,1539,1539,f3c4d2dd-be31-461f-ad1d-d8f124957bf7, supplementation of the diet with vitamins a  d  c  and iron,1
1151,1151,1151,1151,1151,1151,1151,1540,1540,1540,1540,1540,1540,1540,1540,1540,1540,1540,1540,1540,f3c4d2dd-be31-461f-ad1d-d8f124957bf7,supplementation of the diet with fluoride for caries prophylaxsis,1
1152,1152,1152,1152,1152,1152,1152,1541,1541,1541,1541,1541,1541,1541,1541,1541,1541,1541,1541,1541,f3c4d2dd-be31-461f-ad1d-d8f124957bf7,tri vit with fluoride 0 25 mg and iron ( vitamins a  d  c  iron and fluoride ) drops provide fluoride in drop form for infants and young children from 6 months to 3 years of age in areas where the drinking water contains less than 0 3 ppm of fluoride and for children ages 3 to 6 years in areas where the drinking water contains 0 3 through 0 6 ppm of fluoride 2  3,0
1153,1153,1153,1153,1153,1153,1153,1542,1542,1542,1542,1542,1542,1542,1542,1542,1542,1542,1542,1542,914e18c9-5692-4c58-b115-389f9547ebc3, supplementation of the diet with vitamins a  d  and c tri vit with fluoride 0 5 mg drops also provide fluoride for caries prophylaxis,1
1154,1154,1154,1154,1154,1154,1154,1543,1543,1543,1543,1543,1543,1543,1543,1543,1543,1543,1543,1543,914e18c9-5692-4c58-b115-389f9547ebc3,tri vit with fluoride 0 5 mg ( vitamins a  d  c and fluoride ) drops provide fluoride in drop form for children ages 3 to 6 years in areas where the drinking water contains less than 0 3 ppm of fluoride and for children 6 years of age and older in areas where the drinking water contains 0 3 through 0 6 ppm of fluoride 2 each 1 ml supplies sodium fluoride ( 0 5 mg fluoride ) plus three basic vitamins,u
1155,1155,1155,1155,1155,1155,1155,1544,1544,1544,1544,1544,1544,1544,1544,1544,1544,1544,1544,1544,914e18c9-5692-4c58-b115-389f9547ebc3,tri vit with fluoride 0 5 mg drops supply significant amounts of vitamins a  d  and c to supplement the diet  and to help assure that nutritional deficiencies of these vitamins will not develop,0
1156,1156,1156,1156,1156,1156,1156,1545,1545,1545,1545,1545,1545,1545,1545,1545,1545,1545,1545,1545,914e18c9-5692-4c58-b115-389f9547ebc3,thus  in a single easy to use preparation  infants and children obtain three essential vitamins plus fluoride,0
1157,1157,1157,1157,1157,1157,1157,1546,1546,1546,1546,1546,1546,1546,1546,1546,1546,1546,1546,1546,914e18c9-5692-4c58-b115-389f9547ebc3,a comprehensive 5 1 2 year series of studies of the effectiveness of vitamin fluoride products in caries protection has been published 3 6 children in this continuing study lived in an area where the water supply contained only 0 05 ppm fluoride,0
1158,1158,1158,1158,1158,1158,1158,1547,1547,1547,1547,1547,1547,1547,1547,1547,1547,1547,1547,1547,914e18c9-5692-4c58-b115-389f9547ebc3,the subjects were divided into two groups  one which used only non fluoridated vitamin products and other vitamin fluoride products,0
1159,1159,1159,1159,1159,1159,1159,1548,1548,1548,1548,1548,1548,1548,1548,1548,1548,1548,1548,1548,914e18c9-5692-4c58-b115-389f9547ebc3,the three year interim report showed 63 fewer carious surfaces in primary teeth and 43 fewer carious surfaces in permanent teeth of the children taking vitamin fluoride products 3 after four years the studies continued to support the effectiveness of vitamin fluoride products  showing a reduction in carious surfaces of 68 in primary teeth and 46 in permanent teeth 4 results at the end of 5 1 2 years further confirmed the previous findings and indicated that significant reductions in dental caries are apparent with the continued use of vitamin fluoride products 5,0
1160,1160,1160,1160,1160,1160,1160,1549,1549,1549,1549,1549,1549,1549,1549,1549,1549,1549,1549,1549,b8e08798-d8bb-4616-996b-a2c07a5d730a, quflora pediatric chewable tablets with 0 5 mg fluoride is a prescription dietary fluoride supplement providing twelve essential vitamins and minerals,u
1161,1161,1161,1161,1161,1161,1161,1550,1550,1550,1550,1550,1550,1550,1550,1550,1550,1550,1550,1550,539225d3-7457-4bbe-a79a-4c10dba44e81, quflora 0 5 mg ml f pediatric drops is a prescription dietary supplement providing essential vitamins  minerals and fluoride,0
1162,1162,1162,1162,1162,1162,1162,1551,1551,1551,1551,1551,1551,1551,1551,1551,1551,1551,1551,1551,0674df74-3e12-4484-9ffd-3c73f982a727,indications inatal advance is a multivitamin multimineral nutritional supplement indicated for use in improving the nutritional status of women throughout pregnancy and in the postnatal period for both lactating and nonlactating mothers,1
1163,1163,1163,1163,1163,1163,1163,1552,1552,1552,1552,1552,1552,1552,1552,1552,1552,1552,1552,1552,0674df74-3e12-4484-9ffd-3c73f982a727,inatal advanced can also be beneficial in improving the nutritional status of women prior to conception,u
1164,1164,1164,1164,1164,1164,1164,1553,1553,1553,1553,1553,1553,1553,1553,1553,1553,1553,1553,1553,8a61e46d-d4fa-46be-8935-da6af40559d1, supplementation of the diet with ten essential vitamins,1
1165,1165,1165,1165,1165,1165,1165,1555,1555,1555,1555,1555,1555,1555,1555,1555,1555,1555,1555,1555,8a61e46d-d4fa-46be-8935-da6af40559d1,multi vitamin with fluoride chewable tablets 1 0 mg provide fluoride in tablet form for children 6 16 years of age in areas where the water fluoride level is less than 0 3 ppm,0
1166,1166,1166,1166,1166,1166,1166,1556,1556,1556,1556,1556,1556,1556,1556,1556,1556,1556,1556,1556,8a61e46d-d4fa-46be-8935-da6af40559d1,multi vitamin with fluoride chewable tablets 0 5 mg provide fluoride in tablet form for children 4 6 years of age in areas where the water fluoride level is less than 0 3 ppm  and for children 6 years of age and above where the drinking water contains 0 3 through 0 6 ppm if fluoride,0
1167,1167,1167,1167,1167,1167,1167,1557,1557,1557,1557,1557,1557,1557,1557,1557,1557,1557,1557,1557,8a61e46d-d4fa-46be-8935-da6af40559d1,multi vitamin with fluoride chewable tablets 0 25 mg provide fluoride in tablet form for children 4 6 years of age where the drinking water contains 0 3 through 0 6 ppm of fluoride,0
1168,1168,1168,1168,1168,1168,1168,1558,1558,1558,1558,1558,1558,1558,1558,1558,1558,1558,1558,1558,8a61e46d-d4fa-46be-8935-da6af40559d1,multi vitamin with fluoride chewable tablets supply significant amounts of vitamins a  c  d  e  thiamine  riboflavin  niacin  vitamin b6  vitamin b 12  and folate to supplement the diet  and to help assure that nutritional deficiencies of these vitamins will not develop,u
1169,1169,1169,1169,1169,1169,1169,1559,1559,1559,1559,1559,1559,1559,1559,1559,1559,1559,1559,1559,8a61e46d-d4fa-46be-8935-da6af40559d1,thus  in a single easy to use preparation  children obtain ten essential vitamins and the important mineral  fluoride,0
1170,1170,1170,1170,1170,1170,1170,1561,1561,1561,1561,1561,1561,1561,1561,1561,1561,1561,1561,1561,8a61e46d-d4fa-46be-8935-da6af40559d1,children using multi vitamin with fluoride chewable tablets should regularly receive semi annual dental examinations,0
1171,1171,1171,1171,1171,1171,1171,1562,1562,1562,1562,1562,1562,1562,1562,1562,1562,1562,1562,1562,8a61e46d-d4fa-46be-8935-da6af40559d1,teeth brushing and good oral hygiene practices are essential as well,0
1172,1172,1172,1172,1172,1172,1172,1563,1563,1563,1563,1563,1563,1563,1563,1563,1563,1563,1563,1563,40480393-700d-4afd-8309-704ac8689e85,indications citranatal assure is a multivitamin mineral prescription drug indicated for use in improving the nutritional status of women prior to conception  throughout pregnancy  and in the postnatal period for both lactating and nonlactating mothers,1
1173,1173,1173,1173,1173,1173,1173,1566,1566,1566,1566,1566,1566,1566,1566,1566,1566,1566,1566,1566,4cb0eca0-aa84-4bcd-bebf-2ef41ca70e10,multivitamin with 0 25 mg fluoride chewable tablets provide 0 25 mg fluoride in tablet form for children 4 6 years of age in areas where the drinking water contains 0 3 through 0 6 ppm of fluoride,0
1174,1174,1174,1174,1174,1174,1174,1567,1567,1567,1567,1567,1567,1567,1567,1567,1567,1567,1567,1567,4cb0eca0-aa84-4bcd-bebf-2ef41ca70e10,multivitamin with 0 25 mg fluoride chewable tablets supply significant amounts of vitamins a  c  d  e  thiamine  riboflavin  niacin  vitamin b6  vitamin b12  and folate to supplement the diet  and to help assure that nutritional deficiencies of these vitamins will not develop,u
1175,1175,1175,1175,1175,1175,1175,1569,1569,1569,1569,1569,1569,1569,1569,1569,1569,1569,1569,1569,4cb0eca0-aa84-4bcd-bebf-2ef41ca70e10,the american academy of pediatrics recommends that children up to age 16  in areas where drinking water contains less than optimal levels of fluoride  receive daily fluoride supplements,0
1176,1176,1176,1176,1176,1176,1176,1570,1570,1570,1570,1570,1570,1570,1570,1570,1570,1570,1570,1570,4cb0eca0-aa84-4bcd-bebf-2ef41ca70e10,children using multivitamin with 0 25 mg fluoride chewable tablets regularly should receive semiannual dental examinations,4
1177,1177,1177,1177,1177,1177,1177,1572,1572,1572,1572,1572,1572,1572,1572,1572,1572,1572,1572,1572,4cb0eca0-aa84-4bcd-bebf-2ef41ca70e10,multivitamin with fluoride chewable tablets is a prescription product for the clinical dietary management of the metabolic processes of caries prophylaxis and provides supplementation of the diet with ten essential vitamins,1
1178,1178,1178,1178,1178,1178,1178,1573,1573,1573,1573,1573,1573,1573,1573,1573,1573,1573,1573,1573,d358a991-e17a-47ff-beeb-8ef0aea56944,indication to provide vitamin and mineral supplementation throughout pregnancy and during the postnatal period for both the lactating and non lactating mother,1
1179,1179,1179,1179,1179,1179,1179,1575,1575,1575,1575,1575,1575,1575,1575,1575,1575,1575,1575,1575,854b90e1-fe4d-46a1-aaa1-6ab701d8bb3d,indications natafort is a multivitamin mineral prescription drug indicated for use in improving the nutritional status of women prior to conception  throughout pregnancy  and in the postnatal period for both lactating and nonlactating mothers,1
1180,1180,1180,1180,1180,1180,1180,1576,1576,1576,1576,1576,1576,1576,1576,1576,1576,1576,1576,1576,9f28c5db-b7c4-4c85-bada-a7d0e0df1cb1, tricare prenatal tablets are indicated to provide vitamin and mineral supplementation throughout pregnancy and during the postnatal period for both the lactating and non lactating mother,1
1181,1181,1181,1181,1181,1181,1181,1588,1588,1588,1588,1588,1588,1588,1588,1588,1588,1588,1588,1588,3b24458b-6d48-4cc6-8233-81f173277cb8,indications for vitamin and mineral supplementation,u
1182,1182,1182,1182,1182,1182,1182,1589,1589,1589,1589,1589,1589,1589,1589,1589,1589,1589,1589,1589,33f32537-b148-48f3-a732-1f7c2f092f00,suggest use as a dietary supplement  adults take one ( 1 ) capsule daily preferably with a meal or as recommended by a physician,4
1183,1183,1183,1183,1183,1183,1183,1590,1590,1590,1590,1590,1590,1590,1590,1590,1590,1590,1590,1590,c78bb534-9297-4442-9cda-76eec6a8872d,indications to provide vitamin and mineral supplementation prior to and through pregnancy and during the postnatal period  for both lactating and non lactating mothers,1
1184,1184,1184,1184,1184,1184,1184,1593,1593,1593,1593,1593,1593,1593,1593,1593,1593,1593,1593,1593,f74db588-313c-4eec-8c9d-9ff9455c9fa6,directions before  during and after pregnancy  one tablet daily or as directed by a physician,4
1185,1185,1185,1185,1185,1185,1185,1594,1594,1594,1594,1594,1594,1594,1594,1594,1594,1594,1594,1594,4cf69ae7-0c43-4752-b58c-a2052e39b3fa, supplementation of the diet with vitamins a  c and d multi vitamin fluoride drops 0 25 mg also provide fluoride for caries prophylaxis,1
1186,1186,1186,1186,1186,1186,1186,1596,1596,1596,1596,1596,1596,1596,1596,1596,1596,1596,1596,1596,4cf69ae7-0c43-4752-b58c-a2052e39b3fa,the american academy of pediatrics recommend that infants and young children 6 months to 3 years of age  in areas where drinking water contains less than 0 3 ppm of fluoride  and children 3 6 years of age  in areas where the drinking water contains 0 3 through 0 6 ppm of fluoride  receive 0 25 mg of supplemental fluoride daily which is provided in a dose of 1 ml of multi vitamin fluoride 0 25 mg drops,0
1187,1187,1187,1187,1187,1187,1187,1598,1598,1598,1598,1598,1598,1598,1598,1598,1598,1598,1598,1598,4cf69ae7-0c43-4752-b58c-a2052e39b3fa,multi vitamin fluoride 0 25 mg drops supply significant amounts of vitamins a  c and d to supplement the diet  and to help assure that nutritional deficiencies of these vitamins will not develop,u
1188,1188,1188,1188,1188,1188,1188,1600,1600,1600,1600,1600,1600,1600,1600,1600,1600,1600,1600,1600,c0ec7e75-03b9-4b5b-ca8b-58cb0f65b5d9,1  fosamax plus d is a combination of a bisphosphonate and vitamin d indicated for treatment of osteoporosis in postmenopausal women ( 1 1 ) treatment to increase bone mass in men with osteoporosis ( 1 2 ) limitations of use fosamax plus d alone should not be used to treat vitamin d deficiency,1
1189,1189,1189,1189,1189,1189,1189,1601,1601,1601,1601,1601,1601,1601,1601,1601,1601,1601,1601,1601,c0ec7e75-03b9-4b5b-ca8b-58cb0f65b5d9,( 1 3 ) optimal duration of use has not been determined,0
1190,1190,1190,1190,1190,1190,1190,1602,1602,1602,1602,1602,1602,1602,1602,1602,1602,1602,1602,1602,c0ec7e75-03b9-4b5b-ca8b-58cb0f65b5d9,for patients at low risk for fracture  consider drug discontinuation after 3 to 5 years of use,u
1191,1191,1191,1191,1191,1191,1191,1603,1603,1603,1603,1603,1603,1603,1603,1603,1603,1603,1603,1603,c0ec7e75-03b9-4b5b-ca8b-58cb0f65b5d9,( 1 3 ) 1 1 treatment of osteoporosis in postmenopausal women fosamax plus d is indicated for the treatment of osteoporosis in postmenopausal women,1
1192,1192,1192,1192,1192,1192,1192,1604,1604,1604,1604,1604,1604,1604,1604,1604,1604,1604,1604,1604,c0ec7e75-03b9-4b5b-ca8b-58cb0f65b5d9,in postmenopausal women  fosamax plus d increases bone mass and reduces the incidence of fractures  including those of the hip and spine ( vertebral compression fractures ),u
1193,1193,1193,1193,1193,1193,1193,1605,1605,1605,1605,1605,1605,1605,1605,1605,1605,1605,1605,1605,c0ec7e75-03b9-4b5b-ca8b-58cb0f65b5d9,1 2 treatment to increase bone mass in men with osteoporosis fosamax plus d is indicated for treatment to increase bone mass in men with osteoporosis see clinical studies ( 14 2 ),1
1194,1194,1194,1194,1194,1194,1194,1606,1606,1606,1606,1606,1606,1606,1606,1606,1606,1606,1606,1606,c0ec7e75-03b9-4b5b-ca8b-58cb0f65b5d9,1 3 important limitations of use fosamax plus d alone should not be used to treat vitamin d deficiency,2
1195,1195,1195,1195,1195,1195,1195,1607,1607,1607,1607,1607,1607,1607,1607,1607,1607,1607,1607,1607,c0ec7e75-03b9-4b5b-ca8b-58cb0f65b5d9,the optimal duration of use has not been determined,0
1196,1196,1196,1196,1196,1196,1196,1608,1608,1608,1608,1608,1608,1608,1608,1608,1608,1608,1608,1608,c0ec7e75-03b9-4b5b-ca8b-58cb0f65b5d9,the safety and effectiveness of fosamax plus d for the treatment of osteoporosis are based on clinical data of four years duration,0
1197,1197,1197,1197,1197,1197,1197,1609,1609,1609,1609,1609,1609,1609,1609,1609,1609,1609,1609,1609,c0ec7e75-03b9-4b5b-ca8b-58cb0f65b5d9,all patients on bisphosphonate therapy should have the need for continued therapy re evaluated on a periodic basis,0
1198,1198,1198,1198,1198,1198,1198,1610,1610,1610,1610,1610,1610,1610,1610,1610,1610,1610,1610,1610,c0ec7e75-03b9-4b5b-ca8b-58cb0f65b5d9,patients at low risk for fracture should be considered for drug discontinuation after 3 to 5 years of use,4
1199,1199,1199,1199,1199,1199,1199,1611,1611,1611,1611,1611,1611,1611,1611,1611,1611,1611,1611,1611,c0ec7e75-03b9-4b5b-ca8b-58cb0f65b5d9,patients who discontinue therapy should have their risk for fracture re,0
1200,1200,1200,1200,1200,1200,1200,1612,1612,1612,1612,1612,1612,1612,1612,1612,1612,1612,1612,1612,1076ba9a-0168-492f-ba9b-99fa02186092,indications prenate restore is a multivitamin multimineral fatty acid dietary supplement indicated for use in improving the nutritional status of women during the postnatal period for both lactating and non lactating mothers,1
1201,1201,1201,1201,1201,1201,1201,1613,1613,1613,1613,1613,1613,1613,1613,1613,1613,1613,1613,1613,917f02ce-51b9-4819-81e0-522842f6732a,indications prenate chewable is a multivitamin multimineral dietary supplement indicated for use in improving the nutritional status of women throughout pregnancy and in the postnatal period for both lactating and nonlactating mothers,1
1202,1202,1202,1202,1202,1202,1202,1614,1614,1614,1614,1614,1614,1614,1614,1614,1614,1614,1614,1614,917f02ce-51b9-4819-81e0-522842f6732a,prenate chewable can also be beneficial in improving the nutritional status of women prior to conception,u
1203,1203,1203,1203,1203,1203,1203,1615,1615,1615,1615,1615,1615,1615,1615,1615,1615,1615,1615,1615,8f2eca71-9a82-4a19-9206-36a04b865fe1,indications prenate dha is a multivitamin multimineral fatty acid dietary supplement indicated for use in improving the nutritional status of women throughout pregnancy and in the postnatal period for both lactating and nonlactating mothers,1
1204,1204,1204,1204,1204,1204,1204,1616,1616,1616,1616,1616,1616,1616,1616,1616,1616,1616,1616,1616,7725d8ee-62ab-4d1d-96bc-c87ef70d35c8,indications citranatal harmony is a multivitamin mineral prescription drug indicated for use in improving the nutritional status of women prior to conception  throughout pregnancy  and in the postnatal period for both lactating and nonlactating mothers,1
1205,1205,1205,1205,1205,1205,1205,1617,1617,1617,1617,1617,1617,1617,1617,1617,1617,1617,1617,1617,1459ccd1-2372-450f-ac17-382ca9a5b175,indications prenaissance plus is a multivitamin mineral prescription drug indicated for use in improving the nutritional status of women prior to conception  throughout pregnancy  and in the postnatal period for both lactating and nonlactating mothers,1
1206,1206,1206,1206,1206,1206,1206,1618,1618,1618,1618,1618,1618,1618,1618,1618,1618,1618,1618,1618,b7846220-4137-4f1f-aea8-cd47e992a845,indications citranatal b calm is a multivitamin mineral prescription drug indicated for use in improving the nutritional status of women prior to conception  throughout pregnancy  and in the postnatal period for both lactating and nonlactating mothers,1
1207,1207,1207,1207,1207,1207,1207,1619,1619,1619,1619,1619,1619,1619,1619,1619,1619,1619,1619,1619,b7846220-4137-4f1f-aea8-cd47e992a845,citranatal b calm may be used in conjunction with a physician prescribed regimen to help minimize pregnancy related nausea and vomiting,u
1208,1208,1208,1208,1208,1208,1208,1620,1620,1620,1620,1620,1620,1620,1620,1620,1620,1620,1620,1620,8c1b2367-cec5-4a18-82a0-e132b4aece3a, c nate dha is a prescription multivitamin multimineral indicated for use in improving the nutritional status of women prior to conception  throughout pregnancy and in the postnatal period for both lactating and nonlactating mothers,1
1209,1209,1209,1209,1209,1209,1209,1621,1621,1621,1621,1621,1621,1621,1621,1621,1621,1621,1621,1621,d77846ab-bce6-4646-8c09-ddfcf09898a3,indication animi 3 with vitamin d capsules are indicated for improving nutritional status in conditions requiring essential fatty acids  vitamin b12  vitamin b6  vitamin d3 and folic acid supplementation,1
1210,1210,1210,1210,1210,1210,1210,1622,1622,1622,1622,1622,1622,1622,1622,1622,1622,1622,1622,1622,ad02306c-e1a3-441d-825e-d79047c61022, viva ct prenatal chewable is indicated for the distinct nutritional requirements of individuals in need of prenatal postnatal dietary supplementation as determined by a licensed medical practitioner,1
1211,1211,1211,1211,1211,1211,1211,1623,1623,1623,1623,1623,1623,1623,1623,1623,1623,1623,1623,1623,ad02306c-e1a3-441d-825e-d79047c61022,this product can be used fordietary management prior to conception,u
1212,1212,1212,1212,1212,1212,1212,1624,1624,1624,1624,1624,1624,1624,1624,1624,1624,1624,1624,1624,ad02306c-e1a3-441d-825e-d79047c61022,viva ct prenatal chewable should be administered under the supervision of a licensed medical practitioner,4
1213,1213,1213,1213,1213,1213,1213,1625,1625,1625,1625,1625,1625,1625,1625,1625,1625,1625,1625,1625,d4c2b6ae-0a15-435d-bc6c-7443b1306d18,usage vitafol nano provides vitamin and mineral supplementation prior to conception  throughout pregnancy  and during the postnatal period for the lactating and non lactating mother,u
1214,1214,1214,1214,1214,1214,1214,1628,1628,1628,1628,1628,1628,1628,1628,1628,1628,1628,1628,1628,7240d5fb-cb2d-4278-988f-c8e6bba6560d,indications prenaissance capsules are a multivitamin multimineral nutritional supplement with dha indicated for use in the dietary management of patients with nutritional deficiencies or are in need of nutritional supplementation,1
1215,1215,1215,1215,1215,1215,1215,1629,1629,1629,1629,1629,1629,1629,1629,1629,1629,1629,1629,1629,54eeeeda-9314-4b7c-9efc-0bedfffb91b6,how to use fill dropper to appropriate line and dispense with a single squeeze of the dropper bulb,0
1216,1216,1216,1216,1216,1216,1216,1630,1630,1630,1630,1630,1630,1630,1630,1630,1630,1630,1630,1630,54eeeeda-9314-4b7c-9efc-0bedfffb91b6,it is normal for a small amount to remain in the tip of the dropper,0
1217,1217,1217,1217,1217,1217,1217,1631,1631,1631,1631,1631,1631,1631,1631,1631,1631,1631,1631,1631,54eeeeda-9314-4b7c-9efc-0bedfffb91b6,do not accept if tamper evident box seal is broken or missing,
1218,1218,1218,1218,1218,1218,1218,1632,1632,1632,1632,1632,1632,1632,1632,1632,1632,1632,1632,1632,54eeeeda-9314-4b7c-9efc-0bedfffb91b6,the manufacturer of this product requires that it be dispensed only under the order of a physician or licensed medical practitioner,4
1219,1219,1219,1219,1219,1219,1219,1633,1633,1633,1633,1633,1633,1633,1633,1633,1633,1633,1633,1633,7bc8730c-38cf-4bae-b8f2-da92751a551c, ciferex is indicated for dietary management of patients with unique nutritional needs requiring increased folate levels  vitamin d deficiency or are in need of vitamin d supplementation and other nutritional supplementation,1
1220,1220,1220,1220,1220,1220,1220,1635,1635,1635,1635,1635,1635,1635,1635,1635,1635,1635,1635,1635,67c74737-6c8b-9aeb-e053-2a91aa0adf09,citranatal medley is a multi vitamin mineral prescription drug indicated for use in improving the nutritional status of women prior to conception  throughout pregnancy  and in the postnatal period for both lactating and nonlactating mothers,1
1221,1221,1221,1221,1221,1221,1221,1636,1636,1636,1636,1636,1636,1636,1636,1636,1636,1636,1636,1636,9f89cb91-bd3b-4103-a8a1-c1c1512fe514, calcium folic acid plus d chewable wafers are indicated  in addition to diet  to help satisfy the distinctive nutritional requirements of individuals under the supervision of a physician for the treatment of calcium deficiency  skeletal weakness and osteoporosis,1
1222,1222,1222,1222,1222,1222,1222,1637,1637,1637,1637,1637,1637,1637,1637,1637,1637,1637,1637,1637,9f89cb91-bd3b-4103-a8a1-c1c1512fe514,calcium folic acid plus d chewable wafers supplementation may be beneficial to individuals who have an insufficient dietary intake of the nutrients contained therein,u
1223,1223,1223,1223,1223,1223,1223,1638,1638,1638,1638,1638,1638,1638,1638,1638,1638,1638,1638,1638,9f89cb91-bd3b-4103-a8a1-c1c1512fe514,calcium and vitamin d supplementation may be useful in both preventing and treating osteoporosis,0
1224,1224,1224,1224,1224,1224,1224,1639,1639,1639,1639,1639,1639,1639,1639,1639,1639,1639,1639,1639,9f89cb91-bd3b-4103-a8a1-c1c1512fe514,vitamin d supplementation may be beneficial to those who are institutionalized and or have reduced exposure to sunlight,u
1225,1225,1225,1225,1225,1225,1225,1640,1640,1640,1640,1640,1640,1640,1640,1640,1640,1640,1640,1640,9f89cb91-bd3b-4103-a8a1-c1c1512fe514,folic acid  vitamin b 6  and vitamin b 12  may help reduce the risk of cardiovascular disease by lowering blood levels of homocysteine,u
1226,1226,1226,1226,1226,1226,1226,1641,1641,1641,1641,1641,1641,1641,1641,1641,1641,1641,1641,1641,9f89cb91-bd3b-4103-a8a1-c1c1512fe514,if dietary intake of calcium is inadequate  patients currently taking bisphosphonates for treatment of osteoporosis should be instructed to take calcium and vitamin d daily ( calcium folic acid plus d chewable wafers ),1
1227,1227,1227,1227,1227,1227,1227,1642,1642,1642,1642,1642,1642,1642,1642,1642,1642,1642,1642,1642,038fe2e7-dc16-485c-b5fb-746db7231347,indications pnv dha is a multivitamin multimineral nutritional supplement indicated for use in the dietary management of patients with nutritional deficiencies or are in need of nutritional supplementation,1
1228,1228,1228,1228,1228,1228,1228,1643,1643,1643,1643,1643,1643,1643,1643,1643,1643,1643,1643,1643,576e8bbb-1625-493c-85da-43caf2f02e3c,indications pnv dha docusate is a multivitamin mineral prescription dietary supplement indicated for use in improving the nutritional status of women prior to conception  throughout pregnancy  and in the postnatal period for both lactating and nonlactating mothers,1
1229,1229,1229,1229,1229,1229,1229,1644,1644,1644,1644,1644,1644,1644,1644,1644,1644,1644,1644,1644,f76d4389-dd27-ca13-dc55-e41dcfa2f72b, dizziness vertigo formulated for symptoms associated with vertigo such as dizziness  disequilibrium  presyncope  nausea and sensations of motion  spinning or floating,1
1230,1230,1230,1230,1230,1230,1230,1645,1645,1645,1645,1645,1645,1645,1645,1645,1645,1645,1645,1645,b1c00853-695a-4859-6c8b-22374a98f46d,indications vitamin a injection is effective for the treatment of vitamin a deficiency,u
1231,1231,1231,1231,1231,1231,1231,1646,1646,1646,1646,1646,1646,1646,1646,1646,1646,1646,1646,1646,b1c00853-695a-4859-6c8b-22374a98f46d,the parenteral administration is indicated when the oral administration is not feasible as in anorexia  nausea  vomiting  pre and postoperative conditions  or it is not available as in the malabsorption syndrome with accompanying steatorrhea,1
1232,1232,1232,1232,1232,1232,1232,1647,1647,1647,1647,1647,1647,1647,1647,1647,1647,1647,1647,1647,b1c00853-695a-4859-6c8b-22374a98f46d,pediatric use vitamin a treatment for deficiency states has been recognized as an especially effective and important therapy in the pediatric population,1
1233,1233,1233,1233,1233,1233,1233,1648,1648,1648,1648,1648,1648,1648,1648,1648,1648,1648,1648,1648,b1c00853-695a-4859-6c8b-22374a98f46d,vitamin a supplementation for deficiency states in this population has been addressed by the committee on clinical practice issues of the american society for clinical nutrition  by the american society for parenteral and enteral nutrition  and by the world health organization,
1234,1234,1234,1234,1234,1234,1234,1649,1649,1649,1649,1649,1649,1649,1649,1649,1649,1649,1649,1649,2e11cbfd-47c8-4d0f-ac7d-0beca0ea58aa, ertaczo ( sertaconazole nitrate ) cream  2  is indicated for the topical treatment of interdigital tinea pedis in immunocompetent patients 12 years of age and older  caused by trichophyton rubrum  trichophyton mentagrophytes  and epidermophyton floccosum ( see clinical studies section ),1
1235,1235,1235,1235,1235,1235,1235,1650,1650,1650,1650,1650,1650,1650,1650,1650,1650,1650,1650,1650,6a711666-9e80-4728-b745-e7dc86f57510,1  trospium chloride tablets are a muscarinic antagonist indicated for the treatment of overactive bladder ( oab ) with symptoms of urge urinary incontinence  urgency  and urinary frequency,1
1236,1236,1236,1236,1236,1236,1236,1651,1651,1651,1651,1651,1651,1651,1651,1651,1651,1651,1651,1651,6a711666-9e80-4728-b745-e7dc86f57510,trospium chloride tablets are a muscarinic antagonist indicated for the treatment of overactive bladder ( oab ) with symptoms of urge urinary incontinence  urgency  and urinary frequency,1
1237,1237,1237,1237,1237,1237,1237,1652,1652,1652,1652,1652,1652,1652,1652,1652,1652,1652,1652,1652,bf002984-d6c9-46df-aecb-a07733f763c1,1  veltassa is indicated for the treatment of hyperkalemia,1
1238,1238,1238,1238,1238,1238,1238,1653,1653,1653,1653,1653,1653,1653,1653,1653,1653,1653,1653,1653,bf002984-d6c9-46df-aecb-a07733f763c1,limitation of use veltassa should not be used as an emergency treatment for life threatening hyperkalemia because of its delayed onset of action see clinical pharmacology ( 12 2 ),2
1239,1239,1239,1239,1239,1239,1239,1654,1654,1654,1654,1654,1654,1654,1654,1654,1654,1654,1654,1654,bf002984-d6c9-46df-aecb-a07733f763c1,veltassa is a potassium binder indicated for the treatment of hyperkalemia,1
1240,1240,1240,1240,1240,1240,1240,1655,1655,1655,1655,1655,1655,1655,1655,1655,1655,1655,1655,1655,bf002984-d6c9-46df-aecb-a07733f763c1,( 1 ) limitation of use veltassa should not be used as an emergency treatment for life threatening hyperkalemia because of its delayed onset of action,2
1241,1241,1241,1241,1241,1241,1241,1656,1656,1656,1656,1656,1656,1656,1656,1656,1656,1656,1656,1656,4b0a80fc-51d6-4a70-8ebb-6a403ab91f4f, labetalol hydrochloride tablets  usp are indicated in the management of hypertension,1
1242,1242,1242,1242,1242,1242,1242,1657,1657,1657,1657,1657,1657,1657,1657,1657,1657,1657,1657,1657,4b0a80fc-51d6-4a70-8ebb-6a403ab91f4f,labetalol hydrochloride tablets  usp may be used alone or in combination with other antihypertensive agents  especially thiazide and loop diuretics,4
1243,1243,1243,1243,1243,1243,1243,1658,1658,1658,1658,1658,1658,1658,1658,1658,1658,1658,1658,1658,c2c45e02-5d9a-4a54-f291-e5b54671b08b,1  voluven ( 6 hydroxyethyl starch 130 0 4 in 0 9 sodium chloride injection ) is indicated for the treatment and prophylaxis of hypovolemia in adults and children,1
1244,1244,1244,1244,1244,1244,1244,1659,1659,1659,1659,1659,1659,1659,1659,1659,1659,1659,1659,1659,c2c45e02-5d9a-4a54-f291-e5b54671b08b,it is not a substitute for red blood cells or coagulation factors in plasma,0
1245,1245,1245,1245,1245,1245,1245,1660,1660,1660,1660,1660,1660,1660,1660,1660,1660,1660,1660,1660,c2c45e02-5d9a-4a54-f291-e5b54671b08b,voluven is a plasma volume substitute indicated for the treatment and prophylaxis of hypovolemia in adults and children,1
1246,1246,1246,1246,1246,1246,1246,1661,1661,1661,1661,1661,1661,1661,1661,1661,1661,1661,1661,1661,be7729c9-f7cf-483b-bafe-0d42d6b62f06,1  6 hydroxyethyl starch 130 0 4 in 0 9 sodium chloride injection is indicated for the treatment and prophylaxis of hypovolemia in adults and children,1
1247,1247,1247,1247,1247,1247,1247,1663,1663,1663,1663,1663,1663,1663,1663,1663,1663,1663,1663,1663,be7729c9-f7cf-483b-bafe-0d42d6b62f06,6 hydroxyethyl starch 130 0 4 in 0 9 sodium chloride injection is a plasma volume substitute indicated for the treatment and prophylaxis of hypovolemia in adults and children,1
1248,1248,1248,1248,1248,1248,1248,1664,1664,1664,1664,1664,1664,1664,1664,1664,1664,1664,1664,1664,1b49df80-be4f-47e0-a0b7-123f3e69395b,1  prevymis is indicated for prophylaxis of cytomegalovirus ( cmv ) infection and disease in adult cmv seropositive recipients r of an allogeneic hematopoietic stem cell transplant ( hsct ),1
1249,1249,1249,1249,1249,1249,1249,1665,1665,1665,1665,1665,1665,1665,1665,1665,1665,1665,1665,1665,1b49df80-be4f-47e0-a0b7-123f3e69395b,prevymis is a cmv dna terminase complex inhibitor indicated for prophylaxis of cytomegalovirus ( cmv ) infection and disease in adult cmv seropositive recipients r of an allogeneic hematopoietic stem cell transplant ( hsct ),1
1250,1250,1250,1250,1250,1250,1250,1666,1666,1666,1666,1666,1666,1666,1666,1666,1666,1666,1666,1666,e4be1c0e-0fe6-45a0-9229-5cde98434b84,1  glucagon for injection is indicated for use as a diagnostic aid during radiologic examinations to temporarily inhibit movement of the gastrointestinal tract,1
1251,1251,1251,1251,1251,1251,1251,1667,1667,1667,1667,1667,1667,1667,1667,1667,1667,1667,1667,1667,e4be1c0e-0fe6-45a0-9229-5cde98434b84,limitations of use glucagon for injection is not indicated for the emergency treatment of hypoglycemia because it is not packaged with a syringe and diluent necessary for rapid preparation and administration during an emergency outside of a healthcare facility,2
1252,1252,1252,1252,1252,1252,1252,1668,1668,1668,1668,1668,1668,1668,1668,1668,1668,1668,1668,1668,e4be1c0e-0fe6-45a0-9229-5cde98434b84,glucagon for injection is a gastrointestinal motility inhibitor indicated for use as a diagnostic aid during radiologic examinations to temporarily inhibit movement of the gastrointestinal ( gi ) tract ( 1 ) limitations of use glucagon for injection is not indicated for the emergency treatment of hypoglycemia ( 1 ),1
1253,1253,1253,1253,1253,1253,1253,1669,1669,1669,1669,1669,1669,1669,1669,1669,1669,1669,1669,1669,06ab03b5-07ed-4087-9f04-7a4ea2743169,indications drying agent for pre and post surgical removal of warts  or for non surgical laser treatment of warts where dryness is required,1
1254,1254,1254,1254,1254,1254,1254,1670,1670,1670,1670,1670,1670,1670,1670,1670,1670,1670,1670,1670,06ab03b5-07ed-4087-9f04-7a4ea2743169,safeguards against offensive odor and dries excessive moisture of feet,u
1255,1255,1255,1255,1255,1255,1255,1671,1671,1671,1671,1671,1671,1671,1671,1671,1671,1671,1671,1671,06ab03b5-07ed-4087-9f04-7a4ea2743169,not to be used in patients known to be sensitive to any of the ingredients in this product,2
1256,1256,1256,1256,1256,1256,1256,1672,1672,1672,1672,1672,1672,1672,1672,1672,1672,1672,1672,1672,90c0086a-b62c-4cdd-a6af-2efed69cfd4d, orap ( pimozide ) is indicated for the suppression of motor and phonic tics in patients with tourette s disorder who have failed to respond satisfactorily to standard treatment,1
1257,1257,1257,1257,1257,1257,1257,1673,1673,1673,1673,1673,1673,1673,1673,1673,1673,1673,1673,1673,90c0086a-b62c-4cdd-a6af-2efed69cfd4d,orap is not intended as a treatment of first choice nor is it intended for the treatment of tics that are merely annoying or cosmetically troublesome,2
1258,1258,1258,1258,1258,1258,1258,1674,1674,1674,1674,1674,1674,1674,1674,1674,1674,1674,1674,1674,90c0086a-b62c-4cdd-a6af-2efed69cfd4d,orap should be reserved for use in tourette s disorder patients whose development and or daily life function is severely compromised by the presence of motor and phonic tics,1
1259,1259,1259,1259,1259,1259,1259,1675,1675,1675,1675,1675,1675,1675,1675,1675,1675,1675,1675,1675,90c0086a-b62c-4cdd-a6af-2efed69cfd4d,evidence supporting approval of pimozide for use in tourette s disorder was obtained in two controlled clinical investigations which enrolled patients between the ages of 8 and 53 years,0
1260,1260,1260,1260,1260,1260,1260,1676,1676,1676,1676,1676,1676,1676,1676,1676,1676,1676,1676,1676,90c0086a-b62c-4cdd-a6af-2efed69cfd4d,most subjects in the two trials were 12 or older,0
1261,1261,1261,1261,1261,1261,1261,1677,1677,1677,1677,1677,1677,1677,1677,1677,1677,1677,1677,1677,a0da0dba-a56d-486b-a45b-e8a7cdfbeac6, halcion is indicated for the short term treatment of insomnia ( generally 7 10 days ),1
1262,1262,1262,1262,1262,1262,1262,1678,1678,1678,1678,1678,1678,1678,1678,1678,1678,1678,1678,1678,a0da0dba-a56d-486b-a45b-e8a7cdfbeac6,use for more than 2 3 weeks requires complete reevaluation of the patient ( see warnings ),4
1263,1263,1263,1263,1263,1263,1263,1679,1679,1679,1679,1679,1679,1679,1679,1679,1679,1679,1679,1679,a0da0dba-a56d-486b-a45b-e8a7cdfbeac6,prescriptions for halcion should be written for short term use ( 7 10 days ) and it should not be prescribed in quantities exceeding a 1 month supply,4
1264,1264,1264,1264,1264,1264,1264,1680,1680,1680,1680,1680,1680,1680,1680,1680,1680,1680,1680,1680,24f32b90-2a3a-49a8-bdbf-0e8385a96a3a,1  amlodipine and olmesartan medoxomil tablets are a combination of a dihydropyridine calcium channel blocker and angiotensin ii receptor blocker combination product indicated for the treatment of hypertension  alone or with other antihypertensive agents  to lower blood pressure,1
1265,1265,1265,1265,1265,1265,1265,1682,1682,1682,1682,1682,1682,1682,1682,1682,1682,1682,1682,1682,24f32b90-2a3a-49a8-bdbf-0e8385a96a3a,amlodipine and olmesartan medoxomil tablets may also be used as initial therapy in patients likely to need multiple antihypertensive agents to achieve their blood pressure goals ( 1 ),u
1266,1266,1266,1266,1266,1266,1266,1683,1683,1683,1683,1683,1683,1683,1683,1683,1683,1683,1683,1683,24f32b90-2a3a-49a8-bdbf-0e8385a96a3a,amlodipine and olmesartan medoxomil tablets are indicated for the treatment of hypertension  alone or with other antihypertensive agents  to lower blood pressure,1
1267,1267,1267,1267,1267,1267,1267,1686,1686,1686,1686,1686,1686,1686,1686,1686,1686,1686,1686,1686,24f32b90-2a3a-49a8-bdbf-0e8385a96a3a,there are no controlled trials demonstrating risk reduction with amlodipine and olmesartan medoxomil tablets,0
1268,1268,1268,1268,1268,1268,1268,1694,1694,1694,1694,1694,1694,1694,1694,1694,1694,1694,1694,1694,24f32b90-2a3a-49a8-bdbf-0e8385a96a3a,some antihypertensive drugs have smaller blood pressure effects ( as monotherapy ) in black patients  and many antihypertens,0
1269,1269,1269,1269,1269,1269,1269,1695,1695,1695,1695,1695,1695,1695,1695,1695,1695,1695,1695,1695,d16a48c5-6b71-40a0-bcda-204f043fe832, important notice oxytocin injection  usp ( synthetic ) is indicated for the medical rather than the elective induction of labor,1
1270,1270,1270,1270,1270,1270,1270,1696,1696,1696,1696,1696,1696,1696,1696,1696,1696,1696,1696,1696,d16a48c5-6b71-40a0-bcda-204f043fe832,available data and information are inadequate to define the benefits to risks considerations in the use of the drug product for elective induction,0
1271,1271,1271,1271,1271,1271,1271,1697,1697,1697,1697,1697,1697,1697,1697,1697,1697,1697,1697,1697,d16a48c5-6b71-40a0-bcda-204f043fe832,elective induction of labor is defined as the initiation of labor for convenience in an individual with a term pregnancy who is free of medical indications,0
1272,1272,1272,1272,1272,1272,1272,1698,1698,1698,1698,1698,1698,1698,1698,1698,1698,1698,1698,1698,d16a48c5-6b71-40a0-bcda-204f043fe832,antepartum oxytocin injection  usp ( synthetic ) is indicated for the initiation or improvement of uterine contractions  where this is desirable and considered suitable  in order to achieve early vaginal delivery for fetal or maternal reasons,1
1273,1273,1273,1273,1273,1273,1273,1699,1699,1699,1699,1699,1699,1699,1699,1699,1699,1699,1699,1699,d16a48c5-6b71-40a0-bcda-204f043fe832,it is indicated for ( 1 ) induction of labor in patients with a medical indication for the initiation of labor  such as rh problems  maternal diabetes  pre eclampsia at or near term  when delivery is in the best interest of mother and fetus or when membranes are prematurely ruptured and delivery is indicated ( 2 ) stimulation or reinforcement of labor  as in selected cases of uterine inertia ( 3 ) adjunctive therapy in the management of incomplete or inevitable abortion,1
1274,1274,1274,1274,1274,1274,1274,1700,1700,1700,1700,1700,1700,1700,1700,1700,1700,1700,1700,1700,d16a48c5-6b71-40a0-bcda-204f043fe832,in the first trimester  curettage is generally considered primary therapy,u
1275,1275,1275,1275,1275,1275,1275,1701,1701,1701,1701,1701,1701,1701,1701,1701,1701,1701,1701,1701,d16a48c5-6b71-40a0-bcda-204f043fe832,in second trimester abortion  oxytocin infusion will often be successful in emptying the uterus,u
1276,1276,1276,1276,1276,1276,1276,1702,1702,1702,1702,1702,1702,1702,1702,1702,1702,1702,1702,1702,d16a48c5-6b71-40a0-bcda-204f043fe832,other means of therapy  however  may be required in such cases,0
1277,1277,1277,1277,1277,1277,1277,1703,1703,1703,1703,1703,1703,1703,1703,1703,1703,1703,1703,1703,d16a48c5-6b71-40a0-bcda-204f043fe832,postpartum oxytocin injection  usp ( synthetic ) is indicated to produce uterine contractions during the third stage of labor and to control postpartum bleeding or hemorrhage,1
1278,1278,1278,1278,1278,1278,1278,1704,1704,1704,1704,1704,1704,1704,1704,1704,1704,1704,1704,1704,02b8c11b-99e8-4039-b6fa-a9c38d2f48fa,1  cinacalcet hydrochloride is a calcium sensing receptor agonist indicated for secondary hyperparathyroidism ( hpt ) in adult patients with chronic kidney disease ( ckd ) on dialysis,1
1279,1279,1279,1279,1279,1279,1279,1705,1705,1705,1705,1705,1705,1705,1705,1705,1705,1705,1705,1705,02b8c11b-99e8-4039-b6fa-a9c38d2f48fa,( 1 1 ) limitations of use cinacalcet hydrochloride tablets are not indicated for use in patients with ckd who are not on dialysis,2
1280,1280,1280,1280,1280,1280,1280,1706,1706,1706,1706,1706,1706,1706,1706,1706,1706,1706,1706,1706,02b8c11b-99e8-4039-b6fa-a9c38d2f48fa,hypercalcemia in adult patients with parathyroid carcinoma ( pc ),u
1281,1281,1281,1281,1281,1281,1281,1707,1707,1707,1707,1707,1707,1707,1707,1707,1707,1707,1707,1707,02b8c11b-99e8-4039-b6fa-a9c38d2f48fa,( 1 2 ) severe hypercalcemia in adult patients with primary hpt who are unable to undergo parathyroidectomy,u
1282,1282,1282,1282,1282,1282,1282,1708,1708,1708,1708,1708,1708,1708,1708,1708,1708,1708,1708,1708,02b8c11b-99e8-4039-b6fa-a9c38d2f48fa,( 1 3 ) 1 1 secondary hyperparathyroidism cinacalcet hydrochloride tablets are indicated for the treatment of secondary hyperparathyroidism ( hpt ) in adult patients with chronic kidney disease ( ckd ) on dialysis see clinical studies ( 14 1 ),1
1283,1283,1283,1283,1283,1283,1283,1709,1709,1709,1709,1709,1709,1709,1709,1709,1709,1709,1709,1709,02b8c11b-99e8-4039-b6fa-a9c38d2f48fa,limitations of use cinacalcet hydrochloride tablets are not indicated for use in patients with ckd who are not on dialysis because of an increased risk of hypocalcemia see warnings and precautions ( 5 1 ),2
1284,1284,1284,1284,1284,1284,1284,1710,1710,1710,1710,1710,1710,1710,1710,1710,1710,1710,1710,1710,02b8c11b-99e8-4039-b6fa-a9c38d2f48fa,1 2 parathyroid carcinoma cinacalcet tablets are indicated for the treatment of hypercalcemia in adult patients with parathyroid carcinoma see clinical studies ( 14 2 ),1
1285,1285,1285,1285,1285,1285,1285,1711,1711,1711,1711,1711,1711,1711,1711,1711,1711,1711,1711,1711,02b8c11b-99e8-4039-b6fa-a9c38d2f48fa,1 3 primary hyperparathyroidism cinacalcet hydrochloride tablets are indicated for the treatment of severe hypercalcemia in adult patients with primary hpt who are unable to undergo parathyroidectomy see clinical studies ( 14 3 ),1
1286,1286,1286,1286,1286,1286,1286,1712,1712,1712,1712,1712,1712,1712,1712,1712,1712,1712,1712,1712,5ce78048-0e5c-45b5-82bf-9f61307611cd, adapalene topical solution  0 1 is indicated for the topical treatment of acne vulgaris,1
1287,1287,1287,1287,1287,1287,1287,1713,1713,1713,1713,1713,1713,1713,1713,1713,1713,1713,1713,1713,e50e3ef9-3a9b-4172-a908-71c973a7fb5c,1  adapalene and benzoyl peroxide gel  0 1 2 5 is indicated for the topical treatment of acne vulgaris in patients 9 years of age and older,1
1288,1288,1288,1288,1288,1288,1288,1714,1714,1714,1714,1714,1714,1714,1714,1714,1714,1714,1714,1714,e50e3ef9-3a9b-4172-a908-71c973a7fb5c,adapalene and benzoyl peroxide gel  0 1 2 5 is a combination of adapalene  a retinoid  and benzoyl peroxide  and is indicated for the topical treatment of acne vulgaris in patients 9 years of age and older,1
1289,1289,1289,1289,1289,1289,1289,1715,1715,1715,1715,1715,1715,1715,1715,1715,1715,1715,1715,1715,e85bfe8a-b2c2-4083-acfd-11b32d6d8436, uses for symptoms associated with acute viral inflammation including fever  aches  chills  swollen glands  fatigue  headaches  colds and flu,1
1290,1290,1290,1290,1290,1290,1290,1716,1716,1716,1716,1716,1716,1716,1716,1716,1716,1716,1716,1716,b8c56424-81b5-4d61-b07c-216381b11042,directions for oral use only,0
1291,1291,1291,1291,1291,1291,1291,1717,1717,1717,1717,1717,1717,1717,1717,1717,1717,1717,1717,1717,4c218d3a-a508-4abc-9ed8-a6e8e191d1b4,1  cinvanti  in combination with other antiemetic agents  is indicated in adults for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of highly emetogenic cancer chemotherapy ( hec ) including high dose cisplatin,1
1292,1292,1292,1292,1292,1292,1292,1718,1718,1718,1718,1718,1718,1718,1718,1718,1718,1718,1718,1718,4c218d3a-a508-4abc-9ed8-a6e8e191d1b4,nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy ( mec ),1
1293,1293,1293,1293,1293,1293,1293,1719,1719,1719,1719,1719,1719,1719,1719,1719,1719,1719,1719,1719,4c218d3a-a508-4abc-9ed8-a6e8e191d1b4,limitations of use cinvanti has not been studied for the treatment of established nausea and vomiting,2
1294,1294,1294,1294,1294,1294,1294,1720,1720,1720,1720,1720,1720,1720,1720,1720,1720,1720,1720,1720,4c218d3a-a508-4abc-9ed8-a6e8e191d1b4,cinvanti is a substance p neurokinin 1 ( nk 1 ) receptor antagonist  indicated in adults  in combination with other antiemetic agents  for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of highly emetogenic cancer chemotherapy ( hec ) including high dose cisplatin,1
1295,1295,1295,1295,1295,1295,1295,1721,1721,1721,1721,1721,1721,1721,1721,1721,1721,1721,1721,1721,4c218d3a-a508-4abc-9ed8-a6e8e191d1b4,( 1 ) nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy ( mec ),1
1296,1296,1296,1296,1296,1296,1296,1722,1722,1722,1722,1722,1722,1722,1722,1722,1722,1722,1722,1722,4c218d3a-a508-4abc-9ed8-a6e8e191d1b4,( 1 ) limitations of use cinvanti has not been studied for treatment of established nausea and vomiting,2
1297,1297,1297,1297,1297,1297,1297,1723,1723,1723,1723,1723,1723,1723,1723,1723,1723,1723,1723,1723,bb0868ce-607d-4d68-a488-f9bf2be33a70,uses a natural aid for emotional and physical effects of guilt  remorse  heavy conscience  tormenting thoughts,1
1298,1298,1298,1298,1298,1298,1298,1724,1724,1724,1724,1724,1724,1724,1724,1724,1724,1724,1724,1724,a9799afd-12fc-1408-0962-a183c8de5f77, nervousness anxiety formulated for symptoms associated with generalized anxiety disorder  post traumatic stress disorder  panic attacks and other related conditions,1
1299,1299,1299,1299,1299,1299,1299,1725,1725,1725,1725,1725,1725,1725,1725,1725,1725,1725,1725,1725,d8b13f26-ed02-4c88-b661-b028d2273b6f,1  1 1 hevert calmvalera comp,u
1300,1300,1300,1300,1300,1300,1300,1726,1726,1726,1726,1726,1726,1726,1726,1726,1726,1726,1726,1726,d8b13f26-ed02-4c88-b661-b028d2273b6f,is a homeopathic drug indicated for the treatment of nervous disorders  such as restlessness and sleep disorders  mild depressive states  and mental exhaustion,1
1301,1301,1301,1301,1301,1301,1301,1727,1727,1727,1727,1727,1727,1727,1727,1727,1727,1727,1727,1727,c81ca29c-fae6-d796-d003-51fe7001b635, menopause formulated for symptoms associated with menopause such as hot flashes  decreased libido  insomnia  mood swings  discomfort and fatigue,1
1302,1302,1302,1302,1302,1302,1302,1728,1728,1728,1728,1728,1728,1728,1728,1728,1728,1728,1728,1728,5fbdf681-32dc-702c-0afd-8844056f5564, neuro care formulated for symptoms associated with neuralgia  paralysis  neuropathy  parkinson 's disease  nerve trauma and other nervous system disorders,1
1303,1303,1303,1303,1303,1303,1303,1729,1729,1729,1729,1729,1729,1729,1729,1729,1729,1729,1729,1729,6aeb78ea-1d73-4d27-bedc-9a19f3bcccb2, metaxalone is indicated as an adjunct to rest  physical therapy  and other measures for the relief of discomforts associated with acute  painful musculoskeletal conditions,1
1304,1304,1304,1304,1304,1304,1304,1730,1730,1730,1730,1730,1730,1730,1730,1730,1730,1730,1730,1730,6aeb78ea-1d73-4d27-bedc-9a19f3bcccb2,the mode of action of this drug has not been clearly identified  but may be related to its sedative properties,0
1305,1305,1305,1305,1305,1305,1305,1731,1731,1731,1731,1731,1731,1731,1731,1731,1731,1731,1731,1731,6aeb78ea-1d73-4d27-bedc-9a19f3bcccb2,metaxalone does not directly relax tense skeletal muscles in man,0
1306,1306,1306,1306,1306,1306,1306,1732,1732,1732,1732,1732,1732,1732,1732,1732,1732,1732,1732,1732,7b6bed8d-94f2-d18d-ed19-388275337aa0, diabetes formulated for symptoms associated with pancreatic dysfunction such as excessive thirst or hunger  polyuria  neuralgia and slow healing wounds,1
1307,1307,1307,1307,1307,1307,1307,1733,1733,1733,1733,1733,1733,1733,1733,1733,1733,1733,1733,1733,8ee00126-a4a7-4e67-983f-3d4a049b55a1,indications may temporarily relieve these symptoms associated with hormonal imbalance  which may accompany menopause mood swings  hot flashes  irritability  vaginal dryness  lack of sexual vitality,1
1308,1308,1308,1308,1308,1308,1308,1735,1735,1735,1735,1735,1735,1735,1735,1735,1735,1735,1735,1735,8ee00126-a4a7-4e67-983f-3d4a049b55a1,they have not been reviewed by the u s food and drug administration,0
1309,1309,1309,1309,1309,1309,1309,1736,1736,1736,1736,1736,1736,1736,1736,1736,1736,1736,1736,1736,a7378cfe-9619-4f2e-872b-ef90fb07ce9e,indications hair loss  brittle  dry  falling out  premature greying  tangled in bunches,1
1310,1310,1310,1310,1310,1310,1310,1737,1737,1737,1737,1737,1737,1737,1737,1737,1737,1737,1737,1737,fc222eb3-b680-42a4-929f-dd7ed529a269, uses for symptoms of impaired growth  weak muscular strength  loss of appetite  poor mineral absorption  nervousness  lack of focus  mental weakness  loss of confidence,1
1311,1311,1311,1311,1311,1311,1311,1738,1738,1738,1738,1738,1738,1738,1738,1738,1738,1738,1738,1738,5c31cacd-c3e1-4241-beca-29f1b28a6fd1,indication and usage psorinoheel oral vials is a homeopathic drug product indicated for the stimulation of the defense mechanism in chronic skin disorders  hepatic damage  and chronic illness,1
1312,1312,1312,1312,1312,1312,1312,1739,1739,1739,1739,1739,1739,1739,1739,1739,1739,1739,1739,1739,7589f8f3-e82a-43b0-868a-cbb991e2183f, this formulation is indicated as daily multivitamin maintenance dosage for infants and children up to 11 years of age receiving parenteral nutrition,1
1313,1313,1313,1313,1313,1313,1313,1740,1740,1740,1740,1740,1740,1740,1740,1740,1740,1740,1740,1740,7589f8f3-e82a-43b0-868a-cbb991e2183f,it is also indicated in other situations where administration by the intravenous route is required,u
1314,1314,1314,1314,1314,1314,1314,1741,1741,1741,1741,1741,1741,1741,1741,1741,1741,1741,1741,1741,7589f8f3-e82a-43b0-868a-cbb991e2183f,such situations include surgery  extensive burns  fractures and other trauma  severe infectious diseases  and comatose states  which may provoke a stress situation with profound alterations in the body 's metabolic demands and consequent tissue depletion of nutrients,1
1315,1315,1315,1315,1315,1315,1315,1743,1743,1743,1743,1743,1743,1743,1743,1743,1743,1743,1743,1743,7589f8f3-e82a-43b0-868a-cbb991e2183f,pediatric ( reconstituted and administered in intravenous fluids under proper dilution ) contributes intake of these necessary vitamins toward maintaining the body 's normal resistance and repair processes,
1316,1316,1316,1316,1316,1316,1316,1744,1744,1744,1744,1744,1744,1744,1744,1744,1744,1744,1744,1744,7589f8f3-e82a-43b0-868a-cbb991e2183f,patients with multiple vitamin deficiencies or with markedly increased requirements may be given multiples of the daily dosage for two or more days as indicated by the clinical status,u
1317,1317,1317,1317,1317,1317,1317,1745,1745,1745,1745,1745,1745,1745,1745,1745,1745,1745,1745,1745,7589f8f3-e82a-43b0-868a-cbb991e2183f,blood vitamin concentrations should be monitored to ensure maintenance of adequate levels  particularly in patients receiving parenteral multivitamins as their sole source of vitamins for long periods of time,4
1318,1318,1318,1318,1318,1318,1318,1746,1746,1746,1746,1746,1746,1746,1746,1746,1746,1746,1746,1746,282ccec8-9bcd-4571-9b91-bbb96ef2620d, in disorders requiring parenteral administration of vitamins  i e,u
1319,1319,1319,1319,1319,1319,1319,1747,1747,1747,1747,1747,1747,1747,1747,1747,1747,1747,1747,1747,282ccec8-9bcd-4571-9b91-bbb96ef2620d,pre and post operative treatment  when requirements are increased as in fever  severe burns  increased metabolism  pregnancy  gastrointestinal disorders interfering with intake or absorption of vitamins  prolonged or wasting diseases  alcoholism and where other deficiencies exist,u
1320,1320,1320,1320,1320,1320,1320,1748,1748,1748,1748,1748,1748,1748,1748,1748,1748,1748,1748,1748,a3173c26-0e19-47af-a01c-3fc06b2700d1,1  zioptan ( tafluprost ophthalmic solution ) 0 0015 is indicated for reducing elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension,1
1321,1321,1321,1321,1321,1321,1321,1749,1749,1749,1749,1749,1749,1749,1749,1749,1749,1749,1749,1749,a3173c26-0e19-47af-a01c-3fc06b2700d1,zioptan ( tafluprost ophthalmic solution ) 0 0015 is a prostaglandin analog indicated for reducing elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension,1
1322,1322,1322,1322,1322,1322,1322,1750,1750,1750,1750,1750,1750,1750,1750,1750,1750,1750,1750,1750,806653d1-bf35-4924-b999-ad5d21821cc1,1  juluca is indicated as a complete regimen for the treatment of human immunodeficiency virus type 1 ( hiv 1 ) infection in adults to replace the current antiretroviral regimen in those who are virologically suppressed ( hiv 1 rna less than 50 copies per ml ) on a stable antiretroviral regimen for at least 6 months with no history of treatment failure and no known substitutions associated with resistance to the individual components of juluca,1
1323,1323,1323,1323,1323,1323,1323,1751,1751,1751,1751,1751,1751,1751,1751,1751,1751,1751,1751,1751,806653d1-bf35-4924-b999-ad5d21821cc1,juluca  a two drug combination of dolutegravir  a human immunodeficiency virus type 1 ( hiv 1 ) integrase strand transfer inhibitor ( insti )  and rilpivirine  a hiv 1 non nucleoside reverse transcriptase inhibitor ( nnrti )  is indicated as a complete regimen for the treatment of hiv 1 infection in adults to replace the current antiretroviral regimen in those who are virologically suppressed ( hiv 1 rna less than 50 copies per ml ) on a stable antiretroviral regimen for at least 6 months with no history of treatment failure and no known substitutions associated with resistance to the individual components of juluca,1
1324,1324,1324,1324,1324,1324,1324,1752,1752,1752,1752,1752,1752,1752,1752,1752,1752,1752,1752,1752,2403de1f-db30-4931-96f0-6ab98d4f41a2,1  triumeq is indicated for the treatment of human immunodeficiency virus type 1 ( hiv 1 ) infection in adults and in pediatric patients weighing at least 40 kg,1
1325,1325,1325,1325,1325,1325,1325,1753,1753,1753,1753,1753,1753,1753,1753,1753,1753,1753,1753,1753,2403de1f-db30-4931-96f0-6ab98d4f41a2,limitations of use triumeq alone is not recommended in patients with resistance associated integrase substitutions or clinically suspected integrase strand transfer inhibitor resistance because the dose of dolutegravir in triumeq is insufficient in these subpopulations,2
1326,1326,1326,1326,1326,1326,1326,1754,1754,1754,1754,1754,1754,1754,1754,1754,1754,1754,1754,1754,2403de1f-db30-4931-96f0-6ab98d4f41a2,see full prescribing information for tivicay ( dolutegravir ),0
1327,1327,1327,1327,1327,1327,1327,1755,1755,1755,1755,1755,1755,1755,1755,1755,1755,1755,1755,1755,2403de1f-db30-4931-96f0-6ab98d4f41a2,triumeq  a combination of dolutegravir ( integrase strand transfer inhibitor insti )  abacavir  and lamivudine ( both nucleoside analogue reverse transcriptase inhibitors ) is indicated for the treatment of hiv 1 infection in adults and in pediatric patients weighing at least 40 kg,1
1328,1328,1328,1328,1328,1328,1328,1756,1756,1756,1756,1756,1756,1756,1756,1756,1756,1756,1756,1756,2403de1f-db30-4931-96f0-6ab98d4f41a2,( 1 ) limitations of use triumeq alone is not recommended in patients with resistance associated integrase substitutions or clinically suspected integrase strand transfer inhibitor resistance because the dose of dolutegravir in triumeq is insufficient in these subpopulations,2
1329,1329,1329,1329,1329,1329,1329,1757,1757,1757,1757,1757,1757,1757,1757,1757,1757,1757,1757,1757,2403de1f-db30-4931-96f0-6ab98d4f41a2,see the dolutegravir prescribing information,0
1330,1330,1330,1330,1330,1330,1330,1758,1758,1758,1758,1758,1758,1758,1758,1758,1758,1758,1758,1758,1a2ad203-63fe-42ac-88c6-23dd28385005, for use with automated plasmapheresis equipment only,u
1331,1331,1331,1331,1331,1331,1331,1759,1759,1759,1759,1759,1759,1759,1759,1759,1759,1759,1759,1759,1a2ad203-63fe-42ac-88c6-23dd28385005,use according to equipment manufacturer s instructions,0
1332,1332,1332,1332,1332,1332,1332,1760,1760,1760,1760,1760,1760,1760,1760,1760,1760,1760,1760,1760,1a2ad203-63fe-42ac-88c6-23dd28385005,this unit should be used for plasmapheresis only,u
1333,1333,1333,1333,1333,1333,1333,1761,1761,1761,1761,1761,1761,1761,1761,1761,1761,1761,1761,1761,6c5cf2fb-8f57-496e-b756-dfbfba07b516, for collection of blood and preparation of red blood cells  plasma and platelets,1
1334,1334,1334,1334,1334,1334,1334,1763,1763,1763,1763,1763,1763,1763,1763,1763,1763,1763,1763,1763,145f874d-bba2-42b7-a7f5-63c43bce506e,platelets are not intended to be produced when using doubles,0
1335,1335,1335,1335,1335,1335,1335,1764,1764,1764,1764,1764,1764,1764,1764,1764,1764,1764,1764,1764,"Active Ingredient UNII(s)
1Q73Q2JULR; 2968PHW8QP; 593YOG76RN; LX22YL083G    836cb352-d1ea-455c-ba6f-ea9aa0c973fe
1Q73Q2JULR; 2968PHW8QP; 593YOG76RN; LX22YL083G    836cb352-d1ea-455c-ba6f-ea9aa0c973fe
Name: SET ID dtype: object",active ingredient unii ( s ) 1q73q2julr 2968phw8qp 593yog76rn lx22yl083g active ingredient unii ( s ) 1q73q2julr 2968phw8 1q73q2julr 2968phw8qp 593yog76rn lx22yl083g active ingredient unii ( s ) 1q73q2julr 2968phw8 name content xml  dtype object,0
1336,1336,1336,1336,1336,1336,1336,1766,1766,1766,1766,1766,1766,1766,1766,1766,1766,1766,1766,1766,75a008b2-9666-4bfa-ab18-6d09b43b2215, msc127d for collection of up to 250 ml of umbilical cord blood,1
1337,1337,1337,1337,1337,1337,1337,1767,1767,1767,1767,1767,1767,1767,1767,1767,1767,1767,1767,1767,2ecb42a2-82f1-456b-8f1e-02c2d0a7b5ad,indications and advantages tricitrates sf oral solution is an effective alkalinizing agent useful in those conditions where long term maintenance of an alkaline urine is desirable  such as in patients with uric acid and cystine calculi of the urinary tract,1
1338,1338,1338,1338,1338,1338,1338,1768,1768,1768,1768,1768,1768,1768,1768,1768,1768,1768,1768,1768,2ecb42a2-82f1-456b-8f1e-02c2d0a7b5ad,in addition  it is a valuable adjuvant when administered with uricosuric agents in gout therapy  since urates tend to crystallize out of an acid urine,u
1339,1339,1339,1339,1339,1339,1339,1769,1769,1769,1769,1769,1769,1769,1769,1769,1769,1769,1769,1769,2ecb42a2-82f1-456b-8f1e-02c2d0a7b5ad,it is also effective in correcting the acidosis of certain renal tubular disorders,1
1340,1340,1340,1340,1340,1340,1340,1770,1770,1770,1770,1770,1770,1770,1770,1770,1770,1770,1770,1770,2ecb42a2-82f1-456b-8f1e-02c2d0a7b5ad,this product is highly concentrated  and when administered after meals and before bedtime  allows one to maintain an alkaline urine ph around the clock  usually without the necessity of a 2 a m dose,u
1341,1341,1341,1341,1341,1341,1341,1771,1771,1771,1771,1771,1771,1771,1771,1771,1771,1771,1771,1771,2ecb42a2-82f1-456b-8f1e-02c2d0a7b5ad,this product alkalinizes the urine without producing a systemic alkalosis in recommended dosage,u
1342,1342,1342,1342,1342,1342,1342,1772,1772,1772,1772,1772,1772,1772,1772,1772,1772,1772,1772,1772,2ecb42a2-82f1-456b-8f1e-02c2d0a7b5ad,it is highly palatable  pleasant tasting  and tolerable  even when administered for long periods,0
1343,1343,1343,1343,1343,1343,1343,1773,1773,1773,1773,1773,1773,1773,1773,1773,1773,1773,1773,1773,2ecb42a2-82f1-456b-8f1e-02c2d0a7b5ad,potassium citrate and sodium citrate do not neutralize the gastric juice or disturb digestion,0
1344,1344,1344,1344,1344,1344,1344,1774,1774,1774,1774,1774,1774,1774,1774,1774,1774,1774,1774,1774,66240374-3ad4-4832-9f33-5462d22d1a97, sodium citrate and citric acid oral solution usp is an effective alkalinizing agent,u
1345,1345,1345,1345,1345,1345,1345,1775,1775,1775,1775,1775,1775,1775,1775,1775,1775,1775,1775,1775,66240374-3ad4-4832-9f33-5462d22d1a97,it is useful in those conditions where long term maintenance of an alkaline urine is desirable  and is of value in the alleviation of chronic metabolic acidosis  such as results from chronic renal insufficiency or the syndrome of renal tubular acidosis  especially when the administration of potassium salts is undesirable or contraindicated,1
1346,1346,1346,1346,1346,1346,1346,1776,1776,1776,1776,1776,1776,1776,1776,1776,1776,1776,1776,1776,66240374-3ad4-4832-9f33-5462d22d1a97,this product is also useful for buffering and neutralizing gastric hydrochloric acid quickly and effectively,u
1347,1347,1347,1347,1347,1347,1347,1777,1777,1777,1777,1777,1777,1777,1777,1777,1777,1777,1777,1777,66240374-3ad4-4832-9f33-5462d22d1a97,sodium citrate and citric acid oral solution usp is concentrated  and when administered after meals and before bedtime  allows one to maintain an alkaline urinary ph around the clock  usually without the necessity of a 2 a m dose,u
1348,1348,1348,1348,1348,1348,1348,1778,1778,1778,1778,1778,1778,1778,1778,1778,1778,1778,1778,1778,66240374-3ad4-4832-9f33-5462d22d1a97,this product alkalinizes the urine without producing a systemic alkalosis in the recommended dosage,u
1349,1349,1349,1349,1349,1349,1349,1779,1779,1779,1779,1779,1779,1779,1779,1779,1779,1779,1779,1779,66240374-3ad4-4832-9f33-5462d22d1a97,this product is highly palatable  pleasant tasting  and tolerable  even when administered for long periods,0
1350,1350,1350,1350,1350,1350,1350,1780,1780,1780,1780,1780,1780,1780,1780,1780,1780,1780,1780,1780,91ecdef2-95ff-42dd-a31c-c8a09cab3ad9, cathflo activase ( alteplase ) is indicated for the restoration of function to central venous access devices as assessed by the ability to withdraw blood,1
1351,1351,1351,1351,1351,1351,1351,1781,1781,1781,1781,1781,1781,1781,1781,1781,1781,1781,1781,1781,d776d5d1-cb5b-80f9-e00c-75d4c3ae4d20, trandolapril verapamil hydrochloride er tablets are indicated for the treatment of hypertension,1
1352,1352,1352,1352,1352,1352,1352,1782,1782,1782,1782,1782,1782,1782,1782,1782,1782,1782,1782,1782,d776d5d1-cb5b-80f9-e00c-75d4c3ae4d20,this fixed combination drug is not indicated for the initial therapy of hypertension ( see dosage and administration ),2
1353,1353,1353,1353,1353,1353,1353,1783,1783,1783,1783,1783,1783,1783,1783,1783,1783,1783,1783,1783,d776d5d1-cb5b-80f9-e00c-75d4c3ae4d20,in using trandolapril verapamil hydrochloride er tablets  consideration should be given to the fact that an angiotensin converting enzyme inhibitor  captopril  has caused agranulocytosis  particularly in patients with renal impairment or collagen vascular disease  and that available data are insufficient to show that trandolapril does not have similar risk ( see warnings neutropenia agranulocytosis ),0
1354,1354,1354,1354,1354,1354,1354,1784,1784,1784,1784,1784,1784,1784,1784,1784,1784,1784,1784,1784,b3aea089-3961-43ea-8335-8128e9bae13b, exelderm ( sulconazole nitrate  usp ) solution  1 0 is a broad spectrum antifungal agent indicated for the treatment of tinea cruris and tinea corporis caused by trichophyton rubrum  trichophyton mentagrophytes  epidermophyton floccosum  and microsporum canis and for the treatment of tinea versicolor,1
1355,1355,1355,1355,1355,1355,1355,1785,1785,1785,1785,1785,1785,1785,1785,1785,1785,1785,1785,1785,b3aea089-3961-43ea-8335-8128e9bae13b,effectiveness has not been proven in tinea pedis ( athlete s foot ),0
1356,1356,1356,1356,1356,1356,1356,1786,1786,1786,1786,1786,1786,1786,1786,1786,1786,1786,1786,1786,b3aea089-3961-43ea-8335-8128e9bae13b,symptomatic relief usually occurs within a few days after starting exelderm solution and clinical improvement usually occurs within one week,0
1357,1357,1357,1357,1357,1357,1357,1787,1787,1787,1787,1787,1787,1787,1787,1787,1787,1787,1787,1787,17b0b6e9-1805-6488-e054-00144ff88e88,uses relieves pain due to kidney stones,1
1358,1358,1358,1358,1358,1358,1358,1788,1788,1788,1788,1788,1788,1788,1788,1788,1788,1788,1788,1788,1944fe7b-8d1f-bde9-c67c-486dae25ba63,product name indications section drainer formulated for liver  kidney and colon functions and for symptoms associated with toxic conditions,u
1359,1359,1359,1359,1359,1359,1359,1789,1789,1789,1789,1789,1789,1789,1789,1789,1789,1789,1789,1789,17a286f7-c58a-52dd-e054-00144ff8d46c, detox complex formulated for liver  kidney and colon functions and for symptoms associated with toxic conditions,u
1360,1360,1360,1360,1360,1360,1360,1790,1790,1790,1790,1790,1790,1790,1790,1790,1790,1790,1790,1790,0859a460-4685-08f8-5ce2-8a34cdb67457, lymphatic drainer formulated for lymphatic health and for symptoms such as swollen glands  nodes and sluggish elimination,1
1361,1361,1361,1361,1361,1361,1361,1791,1791,1791,1791,1791,1791,1791,1791,1791,1791,1791,1791,1791,a9cdad4c-c953-35cf-972b-174b1f598758, bladder kidney formulated for symptoms associated with urinary tract infections  renal lithiasis and other kidney or bladder dysfunction,u
1362,1362,1362,1362,1362,1362,1362,1792,1792,1792,1792,1792,1792,1792,1792,1792,1792,1792,1792,1792,967b6a9e-c193-4fcd-8f95-cb39fa90f706,indications may temporarily relieve symptoms associated with pregnancy such as morning sickness  emotional fluctuations  backaches  bladder problems and hemorrhoids,1
1363,1363,1363,1363,1363,1363,1363,1795,1795,1795,1795,1795,1795,1795,1795,1795,1795,1795,1795,1795,884edcf8-ffd8-4f75-ac78-c0c04abc6c72,homeopathic indications for temporary relief of symptoms related to rheumatism including joint pain  fever  inflammation and pain of leg ( s ),1
1364,1364,1364,1364,1364,1364,1364,1798,1798,1798,1798,1798,1798,1798,1798,1798,1798,1798,1798,1798,13c5de6d-d266-4d83-99c4-072ef104e7ff, panretin gel is indicated for topical treatment of cutaneous lesions in patients with aids related kaposi s sarcoma,1
1365,1365,1365,1365,1365,1365,1365,1799,1799,1799,1799,1799,1799,1799,1799,1799,1799,1799,1799,1799,13c5de6d-d266-4d83-99c4-072ef104e7ff,panretin gel is not indicated when systemic anti ks therapy is required ( e g  more than 10 new ks lesions in the prior month  symptomatic lymphedema  symptomatic pulmonary ks  or symptomatic visceral involvement ),2
1366,1366,1366,1366,1366,1366,1366,1800,1800,1800,1800,1800,1800,1800,1800,1800,1800,1800,1800,1800,13c5de6d-d266-4d83-99c4-072ef104e7ff,there is no experience to date using panretin gel with systemic anti ks treatment,0
1367,1367,1367,1367,1367,1367,1367,1801,1801,1801,1801,1801,1801,1801,1801,1801,1801,1801,1801,1801,423c489c-085b-4320-b892-7868ebd6dc6b,1  qtern ( dapagliflozin and saxagliptin ) is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus ( t2dm ) who have inadequate control with dapagliflozin or who are already treated with dapagliflozin and saxagliptin see clinical studies ( 14 ),1
1368,1368,1368,1368,1368,1368,1368,1802,1802,1802,1802,1802,1802,1802,1802,1802,1802,1802,1802,1802,423c489c-085b-4320-b892-7868ebd6dc6b,limitations of use qtern is not indicated for the treatment of type 1 diabetes mellitus or diabetic ketoacidosis,2
1369,1369,1369,1369,1369,1369,1369,1803,1803,1803,1803,1803,1803,1803,1803,1803,1803,1803,1803,1803,423c489c-085b-4320-b892-7868ebd6dc6b,qtern should only be used in patients who tolerate 10 mg dapagliflozin,4
1370,1370,1370,1370,1370,1370,1370,1804,1804,1804,1804,1804,1804,1804,1804,1804,1804,1804,1804,1804,423c489c-085b-4320-b892-7868ebd6dc6b,qtern is a sodium glucose cotransporter 2 ( sglt 2 ) inhibitor and a dipeptidyl peptidase 4 ( dpp 4 ) inhibitor combination product indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus ( t2dm ) who have inadequate control with dapagliflozin or who are already treated with dapagliflozin and saxagliptin,1
1371,1371,1371,1371,1371,1371,1371,1805,1805,1805,1805,1805,1805,1805,1805,1805,1805,1805,1805,1805,423c489c-085b-4320-b892-7868ebd6dc6b,( 1  14 ) limitations of use is not indicated for the treatment of type 1 diabetes mellitus or diabetic ketoacidosis,2
1372,1372,1372,1372,1372,1372,1372,1806,1806,1806,1806,1806,1806,1806,1806,1806,1806,1806,1806,1806,423c489c-085b-4320-b892-7868ebd6dc6b,( 1 ) should only be used in patients who tolerate 10 mg dapagliflozin,u
1373,1373,1373,1373,1373,1373,1373,1807,1807,1807,1807,1807,1807,1807,1807,1807,1807,1807,1807,1807,c5d68b96-14bd-4605-b6d2-2bf8b0c5ca8a,1  evomela is an alkylating drug indicated for use as a high dose conditioning treatment prior to hematopoietic progenitor ( stem ) cell transplantation in patients with multiple myeloma,1
1374,1374,1374,1374,1374,1374,1374,1808,1808,1808,1808,1808,1808,1808,1808,1808,1808,1808,1808,1808,c5d68b96-14bd-4605-b6d2-2bf8b0c5ca8a,( 1 1 ) the palliative treatment of patients with multiple myeloma for whom oral therapy is not appropriate,1
1375,1375,1375,1375,1375,1375,1375,1809,1809,1809,1809,1809,1809,1809,1809,1809,1809,1809,1809,1809,c5d68b96-14bd-4605-b6d2-2bf8b0c5ca8a,( 1 2 ) 1 1 multiple myeloma conditioning treatment evomela is indicated for use as a high dose conditioning treatment prior to hematopoietic progenitor ( stem ) cell transplantation in patients with multiple myeloma,1
1376,1376,1376,1376,1376,1376,1376,1810,1810,1810,1810,1810,1810,1810,1810,1810,1810,1810,1810,1810,c5d68b96-14bd-4605-b6d2-2bf8b0c5ca8a,1 2 multiple myeloma palliative treatment evomela is indicated for the palliative treatment of patients with multiple myeloma for whom oral therapy is not appropriate,1
1377,1377,1377,1377,1377,1377,1377,1811,1811,1811,1811,1811,1811,1811,1811,1811,1811,1811,1811,1811,23a9d8f1-fe3b-45ca-8750-21248a441e52, rifabutin capsules usp are indicated for the prevention of disseminated mycobacterium avium complex ( mac ) disease in patients with advanced hiv infection,1
1378,1378,1378,1378,1378,1378,1378,1812,1812,1812,1812,1812,1812,1812,1812,1812,1812,1812,1812,1812,21470688-4e81-4ea5-ac38-f72e10552e7e,1  omidria is added to an ocular irrigating solution used during cataract surgery or intraocular lens replacement and is indicated for maintaining pupil size by preventing intraoperative miosis and reducing postoperative ocular pain,1
1379,1379,1379,1379,1379,1379,1379,1813,1813,1813,1813,1813,1813,1813,1813,1813,1813,1813,1813,1813,21470688-4e81-4ea5-ac38-f72e10552e7e,omidria is an alpha 1 adrenergic receptor agonist and nonselective cyclooxygenase inhibitor indicated for maintaining pupil size by preventing intraoperative miosis ( 1 ) reducing postoperative pain ( 1 ) omidria is added to an ocular irrigating solution used during cataract surgery or intraocular lens replacement,1
1380,1380,1380,1380,1380,1380,1380,1814,1814,1814,1814,1814,1814,1814,1814,1814,1814,1814,1814,1814,b8fc91d7-f4ce-4507-b01d-62d42a4429d4,indications usage uri control is a homeopathic drug indicated for the treatment of urinary tract infection  albuminuria  hematuria  incontinence,1
1381,1381,1381,1381,1381,1381,1381,1815,1815,1815,1815,1815,1815,1815,1815,1815,1815,1815,1815,1815,0dfd0279-ff17-4ea9-89be-9803c71bab44,1  imbruvica is a kinase inhibitor indicated for the treatment of adult patients with mantle cell lymphoma ( mcl ) who have received at least one prior therapy ( 1 1 ),1
1382,1382,1382,1382,1382,1382,1382,1816,1816,1816,1816,1816,1816,1816,1816,1816,1816,1816,1816,1816,0dfd0279-ff17-4ea9-89be-9803c71bab44,accelerated approval was granted for this indication based on overall response rate,0
1383,1383,1383,1383,1383,1383,1383,1817,1817,1817,1817,1817,1817,1817,1817,1817,1817,1817,1817,1817,0dfd0279-ff17-4ea9-89be-9803c71bab44,continued approval for this indication may be contingent upon verification and description of clinical benefit in a confirmatory trial,0
1384,1384,1384,1384,1384,1384,1384,1818,1818,1818,1818,1818,1818,1818,1818,1818,1818,1818,1818,1818,0dfd0279-ff17-4ea9-89be-9803c71bab44,chronic lymphocytic leukemia ( cll ) small lymphocytic lymphoma ( sll ) ( 1 2 ),1
1385,1385,1385,1385,1385,1385,1385,1819,1819,1819,1819,1819,1819,1819,1819,1819,1819,1819,1819,1819,0dfd0279-ff17-4ea9-89be-9803c71bab44,chronic lymphocytic leukemia ( cll ) small lymphocytic lymphoma ( sll ) with 17p deletion ( 1 3 ),u
1386,1386,1386,1386,1386,1386,1386,1820,1820,1820,1820,1820,1820,1820,1820,1820,1820,1820,1820,1820,0dfd0279-ff17-4ea9-89be-9803c71bab44,waldenstr m 's macroglobulinemia ( wm ) ( 1 4 ),1
1387,1387,1387,1387,1387,1387,1387,1821,1821,1821,1821,1821,1821,1821,1821,1821,1821,1821,1821,1821,0dfd0279-ff17-4ea9-89be-9803c71bab44,marginal zone lymphoma ( mzl ) who require systemic therapy and have received at least one prior anti cd20 based therapy ( 1 5 ),1
1388,1388,1388,1388,1388,1388,1388,1824,1824,1824,1824,1824,1824,1824,1824,1824,1824,1824,1824,1824,0dfd0279-ff17-4ea9-89be-9803c71bab44,chronic graft versus host disease ( cgvhd ) after failure of one or more lines of systemic therapy ( 1 6 ),1
1389,1389,1389,1389,1389,1389,1389,1825,1825,1825,1825,1825,1825,1825,1825,1825,1825,1825,1825,1825,0dfd0279-ff17-4ea9-89be-9803c71bab44,1 1 mantle cell lymphoma imbruvica is indicated for the treatment of adult patients with mantle cell lymphoma ( mcl ) who have received at least one prior therapy,1
1390,1390,1390,1390,1390,1390,1390,1827,1827,1827,1827,1827,1827,1827,1827,1827,1827,1827,1827,1827,0dfd0279-ff17-4ea9-89be-9803c71bab44,continued approval for this indication may be contingent upon verification and description of clinical benefit in a confirmatory trial see clinical studies ( 14 1 ),0
1391,1391,1391,1391,1391,1391,1391,1828,1828,1828,1828,1828,1828,1828,1828,1828,1828,1828,1828,1828,0dfd0279-ff17-4ea9-89be-9803c71bab44,1 2 chronic lymphocytic leukemia small lymphocytic lymphoma imbruvica is indicated for the treatment of adult patients with chronic lymphocytic leukemia ( cll ) small lymphocytic lymphoma ( sll ),1
1392,1392,1392,1392,1392,1392,1392,1829,1829,1829,1829,1829,1829,1829,1829,1829,1829,1829,1829,1829,0dfd0279-ff17-4ea9-89be-9803c71bab44,1 3 chronic lymphocytic leukemia small lymphocytic lymphoma with 17p deletion imbruvica is indicated for the treatment of adult patients with chronic lymphocytic leukemia ( cll ) small lymphocytic lymphoma ( sll ) with 17p deletion,1
1393,1393,1393,1393,1393,1393,1393,1830,1830,1830,1830,1830,1830,1830,1830,1830,1830,1830,1830,1830,4a8ae85c-66a0-48be-4099-b3c72c838176, fludarabine phosphate for injection  usp is indicated for the treatment of adult patients with b cell chronic lymphocytic leukemia ( cll ) who have not responded to or whose disease has progressed during treatment with at least one standard alkylating agent containing regimen,1
1394,1394,1394,1394,1394,1394,1394,1831,1831,1831,1831,1831,1831,1831,1831,1831,1831,1831,1831,1831,4a8ae85c-66a0-48be-4099-b3c72c838176,the safety and effectiveness of fludarabine phosphate  usp in previously untreated or non refractory patients with cll have not been established,0
1395,1395,1395,1395,1395,1395,1395,1832,1832,1832,1832,1832,1832,1832,1832,1832,1832,1832,1832,1832,509b83b6-cde6-393b-8560-557793b6a529,1  balsalazide disodium capsules  usp are indicated for the treatment of mildly to moderately active ulcerative colitis in adults,1
1396,1396,1396,1396,1396,1396,1396,1833,1833,1833,1833,1833,1833,1833,1833,1833,1833,1833,1833,1833,509b83b6-cde6-393b-8560-557793b6a529,safety and effectiveness of balsalazide beyond 12 weeks in adults have not been established,0
1397,1397,1397,1397,1397,1397,1397,1834,1834,1834,1834,1834,1834,1834,1834,1834,1834,1834,1834,1834,509b83b6-cde6-393b-8560-557793b6a529,balsalazide is a locally acting aminosalicylate indicated for the treatment of mildly to moderately active ulcerative colitis in adults ( 1 ) safety and effectiveness of balsalazide beyond 12 weeks in adults have not been established,1
1398,1398,1398,1398,1398,1398,1398,1839,1839,1839,1839,1839,1839,1839,1839,1839,1839,1839,1839,1839,b60e8dd0-1d48-4dc9-87fd-e14675255e8c,1  humulin r u 500 is a concentrated human insulin indicated to improve glycemic control in adult and pediatric patients with diabetes mellitus requiring more than 200 units of insulin per day,1
1399,1399,1399,1399,1399,1399,1399,1840,1840,1840,1840,1840,1840,1840,1840,1840,1840,1840,1840,1840,b60e8dd0-1d48-4dc9-87fd-e14675255e8c,humulin r u 500 is a concentrated human insulin indicated to improve glycemic control in adults and children with diabetes mellitus requiring more than 200 units of insulin per day,1
1400,1400,1400,1400,1400,1400,1400,1841,1841,1841,1841,1841,1841,1841,1841,1841,1841,1841,1841,1841,b60e8dd0-1d48-4dc9-87fd-e14675255e8c,( 1 ) limitation of use the safety and efficacy of humulin r u 500 used in combination with other insulins has not been determined,0
1401,1401,1401,1401,1401,1401,1401,1842,1842,1842,1842,1842,1842,1842,1842,1842,1842,1842,1842,1842,b60e8dd0-1d48-4dc9-87fd-e14675255e8c,the safety and efficacy of humulin r u 500 delivered by continuous subcutaneous infusion has not been determined,0
1402,1402,1402,1402,1402,1402,1402,1843,1843,1843,1843,1843,1843,1843,1843,1843,1843,1843,1843,1843,b60e8dd0-1d48-4dc9-87fd-e14675255e8c,( 1 1 ) 1 1 limitation of use the safety and efficacy of humulin r u 500 used in combination with other insulins has not been determined,0
1403,1403,1403,1403,1403,1403,1403,1845,1845,1845,1845,1845,1845,1845,1845,1845,1845,1845,1845,1845,20542ed4-eece-437c-a88f-ccd666afce03,recommended use homepathic medicine,0
1404,1404,1404,1404,1404,1404,1404,1846,1846,1846,1846,1846,1846,1846,1846,1846,1846,1846,1846,1846,a3b4b25d-0ddb-4531-badb-f1ba3168ac07, desipramine hcl tablets  usp are indicated for the treatment of depression,1
1405,1405,1405,1405,1405,1405,1405,1847,1847,1847,1847,1847,1847,1847,1847,1847,1847,1847,1847,1847,0ab0c9f8-3eee-4e0f-9f3f-c1e16aaffe25,1  kalydeco is a cystic fibrosis transmembrane conductance regulator ( cftr ) potentiator indicated for the treatment of cystic fibrosis ( cf ) in patients age 2 years and older who have one mutation in the cftr gene that is responsive to ivacaftor potentiation based on clinical and or in vitro assay data see clinical pharmacology ( 12 1 ) and clinical studies ( 14 ),1
1406,1406,1406,1406,1406,1406,1406,1848,1848,1848,1848,1848,1848,1848,1848,1848,1848,1848,1848,1848,0ab0c9f8-3eee-4e0f-9f3f-c1e16aaffe25,if the patient 's genotype is unknown  an fda cleared cf mutation test should be used to detect the presence of a cftr mutation followed by verification with bi directional sequencing when recommended by the mutation test instructions for use,u
1407,1407,1407,1407,1407,1407,1407,1849,1849,1849,1849,1849,1849,1849,1849,1849,1849,1849,1849,1849,0ab0c9f8-3eee-4e0f-9f3f-c1e16aaffe25,kalydeco is a cystic fibrosis transmembrane conductance regulator ( cftr ) potentiator indicated for the treatment of cystic fibrosis ( cf ) in patients age 2 years and older who have one mutation in the cftr gene that is responsive to ivacaftor based on clinical and or in vitro assay data,1
1408,1408,1408,1408,1408,1408,1408,1850,1850,1850,1850,1850,1850,1850,1850,1850,1850,1850,1850,1850,0ab0c9f8-3eee-4e0f-9f3f-c1e16aaffe25,( 12 1  14 ) if the patient 's genotype is unknown  an fda cleared cf mutation test should be used to detect the presence of a cftr mutation followed by verification with bi directional sequencing when recommended by the mutation test instructions for use,u
1409,1409,1409,1409,1409,1409,1409,1851,1851,1851,1851,1851,1851,1851,1851,1851,1851,1851,1851,1851,302ae804-37db-44fd-ac2f-3dbdeda9aa4b,1  symdeko is indicated for the treatment of patients with cystic fibrosis ( cf ) aged 12 years and older who are homozygous for the f508del mutation or who have at least one mutation in the cystic fibrosis transmembrane conductance regulator ( cftr ) gene that is responsive to tezacaftor ivacaftor based on in vitro data and or clinical evidence see clinical pharmacology ( 12 1 ) and clinical studies ( 14 ),1
1410,1410,1410,1410,1410,1410,1410,1853,1853,1853,1853,1853,1853,1853,1853,1853,1853,1853,1853,1853,302ae804-37db-44fd-ac2f-3dbdeda9aa4b,symdeko is a combination of tezacaftor and ivacaftor  indicated for the treatment of patients with cystic fibrosis ( cf ) aged 12 years and older who are homozygous for the f508del mutation or who have at least one mutation in the cystic fibrosis transmembrane conductance regulator ( cftr ) gene that is responsive to tezacaftor ivacaftor based on in vitro data and or clinical evidence,1
1411,1411,1411,1411,1411,1411,1411,1855,1855,1855,1855,1855,1855,1855,1855,1855,1855,1855,1855,1855,3fc1c40e-cfac-47a1-9e1a-61ead3570600,1  orkambi is a combination of lumacaftor and ivacaftor indicated for the treatment of cystic fibrosis ( cf ) in patients age 6 years and older who are homozygous for the f508del mutation in the cftr gene,1
1412,1412,1412,1412,1412,1412,1412,1856,1856,1856,1856,1856,1856,1856,1856,1856,1856,1856,1856,1856,3fc1c40e-cfac-47a1-9e1a-61ead3570600,if the patient 's genotype is unknown  an fda cleared cf mutation test should be used to detect the presence of the f508del mutation on both alleles of the cftr gene,u
1413,1413,1413,1413,1413,1413,1413,1857,1857,1857,1857,1857,1857,1857,1857,1857,1857,1857,1857,1857,3fc1c40e-cfac-47a1-9e1a-61ead3570600,orkambi is a combination of lumacaftor and ivacaftor  a cystic fibrosis transmembrane conductance regulator ( cftr ) potentiator  indicated for the treatment of cystic fibrosis ( cf ) in patients age 6 years and older who are homozygous for the f508del mutation in the cftr gene,1
1414,1414,1414,1414,1414,1414,1414,1859,1859,1859,1859,1859,1859,1859,1859,1859,1859,1859,1859,1859,3fc1c40e-cfac-47a1-9e1a-61ead3570600,( 1 ) limitations of use the efficacy and safety of orkambi have not been established in patients with cf other than those homozygous for the f508del mutation,2
1415,1415,1415,1415,1415,1415,1415,1861,1861,1861,1861,1861,1861,1861,1861,1861,1861,1861,1861,1861,0d6eb64c-d3c0-4eb2-84cf-3dcacfed5769,indications usage triamcinolone acetonide cream usp is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid responsive dermatoses,1
1416,1416,1416,1416,1416,1416,1416,1862,1862,1862,1862,1862,1862,1862,1862,1862,1862,1862,1862,1862,f35ec9aa-2be6-40c9-9112-b9e3b80f8fa8, buspirone hydrochloride tablets are indicated for the management of anxiety disorders or the short term relief of the symptoms of anxiety,1
1417,1417,1417,1417,1417,1417,1417,1863,1863,1863,1863,1863,1863,1863,1863,1863,1863,1863,1863,1863,f35ec9aa-2be6-40c9-9112-b9e3b80f8fa8,anxiety or tension associated with the stress of everyday life usually does not require treatment with an anxiolytic,0
1418,1418,1418,1418,1418,1418,1418,1864,1864,1864,1864,1864,1864,1864,1864,1864,1864,1864,1864,1864,f35ec9aa-2be6-40c9-9112-b9e3b80f8fa8,the efficacy of buspirone has been demonstrated in controlled clinical trials of outpatients whose diagnosis roughly corresponds to generalized anxiety disorder ( gad ),u
1419,1419,1419,1419,1419,1419,1419,1865,1865,1865,1865,1865,1865,1865,1865,1865,1865,1865,1865,1865,f35ec9aa-2be6-40c9-9112-b9e3b80f8fa8,many of the patients enrolled in these studies also had coexisting depressive symptoms and buspirone relieved anxiety in the presence of these coexisting depressive symptoms,0
1420,1420,1420,1420,1420,1420,1420,1866,1866,1866,1866,1866,1866,1866,1866,1866,1866,1866,1866,1866,f35ec9aa-2be6-40c9-9112-b9e3b80f8fa8,the patients evaluated in these studies had experienced symptoms for periods of 1 month to over 1 year prior to the study  with an average symptom duration of 6 months,0
1421,1421,1421,1421,1421,1421,1421,1867,1867,1867,1867,1867,1867,1867,1867,1867,1867,1867,1867,1867,f35ec9aa-2be6-40c9-9112-b9e3b80f8fa8,generalized anxiety disorder ( 300 02 ) is described in the american psychiatric association s diagnostic and statistical manual  lll1 as follows generalized  persistent anxiety ( of at least 1 month continual duration )  manifested by symptoms from three of the four following categories motor tension shakiness  jitteriness  jumpiness  trembling  tension  muscle aches  fatigability  inability to relax  eyelid twitch  furrowed brow  strained face  fidgeting  restlessness  easy startle,0
1422,1422,1422,1422,1422,1422,1422,1868,1868,1868,1868,1868,1868,1868,1868,1868,1868,1868,1868,1868,f35ec9aa-2be6-40c9-9112-b9e3b80f8fa8,autonomic hyperactivity sweating  heart pounding or racing  cold  clammy hands  dry mouth  dizziness  lightheadedness  paresthesias ( tingling in hands or feet )  upset stomach  hot or cold spells  frequent urination  diarrhea  discomfort in the pit of the stomach  lump in the throat  flushing  pallor  high resting pulse  and respiration rate,u
1423,1423,1423,1423,1423,1423,1423,1869,1869,1869,1869,1869,1869,1869,1869,1869,1869,1869,1869,1869,f35ec9aa-2be6-40c9-9112-b9e3b80f8fa8,apprehensive expectation anxiety  worry  fear  rumination  and anticipation of misfortune to self or others,u
1424,1424,1424,1424,1424,1424,1424,1870,1870,1870,1870,1870,1870,1870,1870,1870,1870,1870,1870,1870,f35ec9aa-2be6-40c9-9112-b9e3b80f8fa8,vigilance and scanning hyperattentiveness resulting in distractibility  difficulty in concentrating  insomnia  feeling on edge  irritability  impatience,u
1425,1425,1425,1425,1425,1425,1425,1871,1871,1871,1871,1871,1871,1871,1871,1871,1871,1871,1871,1871,f35ec9aa-2be6-40c9-9112-b9e3b80f8fa8,the above symptoms would not be due to another mental disorder  such as a depressive disorder or schizophrenia,0
1426,1426,1426,1426,1426,1426,1426,1872,1872,1872,1872,1872,1872,1872,1872,1872,1872,1872,1872,1872,f35ec9aa-2be6-40c9-9112-b9e3b80f8fa8,however  mild depressive symptoms are common in gad,0
1427,1427,1427,1427,1427,1427,1427,1873,1873,1873,1873,1873,1873,1873,1873,1873,1873,1873,1873,1873,f35ec9aa-2be6-40c9-9112-b9e3b80f8fa8,the effectiveness of buspirone in long term use  that is  for more than 3 to 4 weeks  has not been demonstrated in controlled trials,0
1428,1428,1428,1428,1428,1428,1428,1874,1874,1874,1874,1874,1874,1874,1874,1874,1874,1874,1874,1874,f35ec9aa-2be6-40c9-9112-b9e3b80f8fa8,there is no body of evidence available that systematically addresses the appropriate duration of treatment for gad,0
1429,1429,1429,1429,1429,1429,1429,1875,1875,1875,1875,1875,1875,1875,1875,1875,1875,1875,1875,1875,f35ec9aa-2be6-40c9-9112-b9e3b80f8fa8,however  in a study of long term use  264 patients were treated with buspirone for 1 year without ill effect,0
1430,1430,1430,1430,1430,1430,1430,1876,1876,1876,1876,1876,1876,1876,1876,1876,1876,1876,1876,1876,f35ec9aa-2be6-40c9-9112-b9e3b80f8fa8,therefore  the physician who elects to use buspirone for extended periods should periodically reassess the usefulness of the drug for the individual patient,0
1431,1431,1431,1431,1431,1431,1431,1877,1877,1877,1877,1877,1877,1877,1877,1877,1877,1877,1877,1877,38eea320-7e0c-485a-bc30-98c3c45e2763,1  zelboraf is a kinase inhibitor indicated for the treatment of patients with unresectable or metastatic melanoma with braf v600e mutation as detected by an fda approved test,1
1432,1432,1432,1432,1432,1432,1432,1878,1878,1878,1878,1878,1878,1878,1878,1878,1878,1878,1878,1878,38eea320-7e0c-485a-bc30-98c3c45e2763,( 1 1  2 1 ) zelboraf is indicated for the treatment of patients with erdheim chester disease with braf v600 mutation,1
1433,1433,1433,1433,1433,1433,1433,1879,1879,1879,1879,1879,1879,1879,1879,1879,1879,1879,1879,1879,38eea320-7e0c-485a-bc30-98c3c45e2763,( 1 2  2 1 ) limitation of use zelboraf is not indicated for treatment of patients with wild type braf melanoma ( 2 1  5 2 ) 1 1 unresectable or metastatic melanoma zelboraf is indicated for the treatment of patients with unresectable or metastatic melanoma with braf v600e mutation as detected by an fda approved test,2
1434,1434,1434,1434,1434,1434,1434,1880,1880,1880,1880,1880,1880,1880,1880,1880,1880,1880,1880,1880,38eea320-7e0c-485a-bc30-98c3c45e2763,limitation of use zelboraf is not indicated for treatment of patients with wild type braf melanoma see warnings and precautions ( 5 2 ),2
1435,1435,1435,1435,1435,1435,1435,1881,1881,1881,1881,1881,1881,1881,1881,1881,1881,1881,1881,1881,38eea320-7e0c-485a-bc30-98c3c45e2763,1 2 erdheim chester disease zelboraf is indicated for the treatment of patients with erdheim chester disease ( ecd ) with braf v600 mutation,1
1436,1436,1436,1436,1436,1436,1436,1882,1882,1882,1882,1882,1882,1882,1882,1882,1882,1882,1882,1882,2c312c31-3198-4775-91ab-294e0b4b9e7f,1  daytrana ( methylphenidate transdermal system ) is indicated for the treatment of attention deficit hyperactivity disorder ( adhd ),1
1437,1437,1437,1437,1437,1437,1437,1883,1883,1883,1883,1883,1883,1883,1883,1883,1883,1883,1883,1883,2c312c31-3198-4775-91ab-294e0b4b9e7f,the efficacy of daytrana in patients diagnosed with adhd was established in two 7 week controlled clinical trials in children ( ages 6 12 ) and one 7 week  controlled clinical trial in adolescents ( ages 13 17 ),0
1438,1438,1438,1438,1438,1438,1438,1884,1884,1884,1884,1884,1884,1884,1884,1884,1884,1884,1884,1884,2c312c31-3198-4775-91ab-294e0b4b9e7f,a diagnosis of adhd ( dsm iv tr ) implies the presence of hyperactive impulsive or inattentive symptoms that caused impairment and were present before age 7 years,0
1439,1439,1439,1439,1439,1439,1439,1885,1885,1885,1885,1885,1885,1885,1885,1885,1885,1885,1885,1885,2c312c31-3198-4775-91ab-294e0b4b9e7f,the symptoms must cause clinically significant impairment  e g  in social  academic  or occupational functioning  and be present in two or more settings  e g  school ( or work ) and at home,0
1440,1440,1440,1440,1440,1440,1440,1886,1886,1886,1886,1886,1886,1886,1886,1886,1886,1886,1886,1886,2c312c31-3198-4775-91ab-294e0b4b9e7f,the symptoms must not be better accounted for by another mental disorder,0
1441,1441,1441,1441,1441,1441,1441,1887,1887,1887,1887,1887,1887,1887,1887,1887,1887,1887,1887,1887,2c312c31-3198-4775-91ab-294e0b4b9e7f,for the inattentive type  at least six of the following symptoms must have persisted for at least 6 months lack of attention to details careless mistakes lack of sustained attention poor listener failure to follow through on tasks poor organization avoids tasks requiring sustained mental effort loses things easily distracted forgetful,u
1442,1442,1442,1442,1442,1442,1442,1888,1888,1888,1888,1888,1888,1888,1888,1888,1888,1888,1888,1888,2c312c31-3198-4775-91ab-294e0b4b9e7f,for the hyperactive impulsive type  at least six of the following symptoms must have persisted for at least 6 months fidgeting squirming leaving seat inappropriate running climbing difficulty with quiet activities on the go excessive talking blurting answers ca n't wait turn intrusive,u
1443,1443,1443,1443,1443,1443,1443,1889,1889,1889,1889,1889,1889,1889,1889,1889,1889,1889,1889,1889,2c312c31-3198-4775-91ab-294e0b4b9e7f,the combined type requires both inattentive and hyperactive impulsive criteria to be met,u
1444,1444,1444,1444,1444,1444,1444,1890,1890,1890,1890,1890,1890,1890,1890,1890,1890,1890,1890,1890,2c312c31-3198-4775-91ab-294e0b4b9e7f,daytrana is a cns stimulant indicated for the treatment of attention deficit hyperactivity disorder ( adhd ),1
1445,1445,1445,1445,1445,1445,1445,1891,1891,1891,1891,1891,1891,1891,1891,1891,1891,1891,1891,1891,2c312c31-3198-4775-91ab-294e0b4b9e7f,( 1 ) children ( ages 6 12 ) the efficacy of daytrana in adhd was established in two 7 week controlled trials in children ( 1 ) adolescents ( ages 13 17 ) the efficacy of daytrana in adhd was established in one 7 week  controlled study in adolescents ( 1 ) 1 1 special diagnostic considerations the specific etiology of this syndrome is unknown  and there is no single diagnostic test,0
1446,1446,1446,1446,1446,1446,1446,1892,1892,1892,1892,1892,1892,1892,1892,1892,1892,1892,1892,1892,2c312c31-3198-4775-91ab-294e0b4b9e7f,adequate diagnosis requires the use not only of medical but of special psychological  educational  and social resources,0
1447,1447,1447,1447,1447,1447,1447,1893,1893,1893,1893,1893,1893,1893,1893,1893,1893,1893,1893,1893,2c312c31-3198-4775-91ab-294e0b4b9e7f,learning may or may not be impaired,0
1448,1448,1448,1448,1448,1448,1448,1894,1894,1894,1894,1894,1894,1894,1894,1894,1894,1894,1894,1894,2c312c31-3198-4775-91ab-294e0b4b9e7f,the diagnosis must be based upon a complete history and evaluation of the patient and not solely on the presence of the required number of dsm iv tr characteristics,0
1449,1449,1449,1449,1449,1449,1449,1895,1895,1895,1895,1895,1895,1895,1895,1895,1895,1895,1895,1895,2c312c31-3198-4775-91ab-294e0b4b9e7f,1 2 need for comprehensive treatment program daytrana,0
1450,1450,1450,1450,1450,1450,1450,1896,1896,1896,1896,1896,1896,1896,1896,1896,1896,1896,1896,1896,ac6918ff-9dc3-40d9-8619-54b26e4bdfc8, hcg has not been demonstrated to be effective adjunctive therapy in the treatment of obesity,2
1451,1451,1451,1451,1451,1451,1451,1897,1897,1897,1897,1897,1897,1897,1897,1897,1897,1897,1897,1897,ac6918ff-9dc3-40d9-8619-54b26e4bdfc8,there is no substantial evidence that it increases weight loss beyond that resulting from caloric restriction  that it causes a more attractive or normal distribution of fat  or that it decreases the hunger and discomfort associated with calorie restricted diets,0
1452,1452,1452,1452,1452,1452,1452,1898,1898,1898,1898,1898,1898,1898,1898,1898,1898,1898,1898,1898,ac6918ff-9dc3-40d9-8619-54b26e4bdfc8,prepubertal cryptorchidism not due to anatomic obstruction,1
1453,1453,1453,1453,1453,1453,1453,1899,1899,1899,1899,1899,1899,1899,1899,1899,1899,1899,1899,1899,ac6918ff-9dc3-40d9-8619-54b26e4bdfc8,in general  hcg is thought to induce testicular descent in situations when descent would have occurred at puberty,u
1454,1454,1454,1454,1454,1454,1454,1900,1900,1900,1900,1900,1900,1900,1900,1900,1900,1900,1900,1900,ac6918ff-9dc3-40d9-8619-54b26e4bdfc8,hcg thus may help to predict whether or not orchiopexy will be needed in the future,0
1455,1455,1455,1455,1455,1455,1455,1901,1901,1901,1901,1901,1901,1901,1901,1901,1901,1901,1901,1901,ac6918ff-9dc3-40d9-8619-54b26e4bdfc8,although  in some cases  descent following hcg administration is permanent  in most cases the response is temporary,0
1456,1456,1456,1456,1456,1456,1456,1902,1902,1902,1902,1902,1902,1902,1902,1902,1902,1902,1902,1902,ac6918ff-9dc3-40d9-8619-54b26e4bdfc8,therapy is usually instituted between the ages of 4 and 9,0
1457,1457,1457,1457,1457,1457,1457,1903,1903,1903,1903,1903,1903,1903,1903,1903,1903,1903,1903,1903,ac6918ff-9dc3-40d9-8619-54b26e4bdfc8,selected cases of hypogonadotropic hypogonadism ( hypogonadism secondary to a pituitary deficiency ) in males,1
1458,1458,1458,1458,1458,1458,1458,1904,1904,1904,1904,1904,1904,1904,1904,1904,1904,1904,1904,1904,ac6918ff-9dc3-40d9-8619-54b26e4bdfc8,induction of ovulation and pregnancy in the anovulatory  infertile woman in whom the cause of anovulation is secondary and not due to primary ovarian failure  and who has been appropriately pretreated with human menotropins,1
1459,1459,1459,1459,1459,1459,1459,1905,1905,1905,1905,1905,1905,1905,1905,1905,1905,1905,1905,1905,f82cfe92-1a24-11e3-8ffd-0800200c9a66, photrexa viscous and photrexa are indicated for use in corneal collagen cross linking in combination with the kxl system for the treatment of photrexa viscous and photrexa are photoenhancers indicated for use with the kxl system in corneal collagen cross linking for the treatment of progressive keratoconus ( 1 1 ) and corneal ectasia following refractive surgery ( 1 2 ),1
1460,1460,1460,1460,1460,1460,1460,1906,1906,1906,1906,1906,1906,1906,1906,1906,1906,1906,1906,1906,f82cfe92-1a24-11e3-8ffd-0800200c9a66,1 1 progressive keratoconus 1 2 corneal ectasia following refractive surgery,1
1461,1461,1461,1461,1461,1461,1461,1907,1907,1907,1907,1907,1907,1907,1907,1907,1907,1907,1907,1907,d344f475-1bf2-4aaf-aae3-0cd0be4995d1, for the treatment of vulvovaginitis caused by candida albicans,1
1462,1462,1462,1462,1462,1462,1462,1908,1908,1908,1908,1908,1908,1908,1908,1908,1908,1908,1908,1908,03880372-2c68-45c6-a53a-f420c49541d6,1  edurant  in combination with other antiretroviral agents  is indicated for the treatment of human immunodeficiency virus type 1 ( hiv 1 ) infection in antiretroviral treatment na ve patients 12 years of age and older and weighing at least 35 kg with plasma hiv 1 rna less than or equal to 100  000 copies ml at the start of therapy,1
1463,1463,1463,1463,1463,1463,1463,1909,1909,1909,1909,1909,1909,1909,1909,1909,1909,1909,1909,1909,03880372-2c68-45c6-a53a-f420c49541d6,edurant is a human immunodeficiency virus type 1 ( hiv 1 ) specific  non nucleoside reverse transcriptase inhibitor ( nnrti ) indicated in combination with other antiretroviral agents for the treatment of hiv 1 infection in treatment na ve patients 12 years of age and older and weighing at least 35 kg with hiv 1 rna less than or equal to 100  000 copies ml ( 1 ),1
1464,1464,1464,1464,1464,1464,1464,1910,1910,1910,1910,1910,1910,1910,1910,1910,1910,1910,1910,1910,03880372-2c68-45c6-a53a-f420c49541d6,limitations of use more edurant treated subjects with hiv 1 rna greater than 100  000 copies ml at the start of therapy experienced virologic failure ( hiv 1 rna 50 copies ml ) compared to edurant treated subjects with hiv 1 rna less than or equal to 100  000 copies ml,0
1465,1465,1465,1465,1465,1465,1465,1911,1911,1911,1911,1911,1911,1911,1911,1911,1911,1911,1911,1911,03880372-2c68-45c6-a53a-f420c49541d6,( 1  14 ) limitations of use more edurant treated subjects with hiv 1 rna greater than 100  000 copies ml at the start of therapy experienced virologic failure ( hiv 1 rna 50 copies ml ) compared to edurant treated subjects with hiv 1 rna less than or equal to 100  000 copies ml see clinical studies ( 14 1 ),0
1466,1466,1466,1466,1466,1466,1466,1912,1912,1912,1912,1912,1912,1912,1912,1912,1912,1912,1912,1912,ea3b9ec8-e04a-412c-8b3f-e5cbc7e641d5,1  odefsey is indicated as a complete regimen for the treatment of hiv 1 infection in patients 12 years of age and older as initial therapy in those with no antiretroviral treatment history with hiv 1 rna less than or equal to 100  000 copies per ml or to replace a stable antiretroviral regimen in those who are virologically suppressed ( hiv 1 rna less than 50 copies per ml ) for at least six months with no history of treatment failure and no known substitutions associated with resistance to the individual components of odefsey see microbiology ( 12 4 ) and clinical studies ( 14 ),1
1467,1467,1467,1467,1467,1467,1467,1913,1913,1913,1913,1913,1913,1913,1913,1913,1913,1913,1913,1913,ea3b9ec8-e04a-412c-8b3f-e5cbc7e641d5,odefsey is a three drug combination of emtricitabine ( ftc ) and tenofovir alafenamide ( taf )  both hiv nucleoside analog reverse transcriptase inhibitors ( nrtis )  and rilpivirine ( rpv )  a non nucleoside reverse transcriptase inhibitor ( nnrti )  and is indicated as a complete regimen for the treatment of hiv 1 infection in patients 12 years of age and older as initial therapy in those with no antiretroviral treatment history with hiv 1 rna less than or equal to 100  000 copies per ml or to replace a stable antiretroviral regimen in those who are virologically suppressed ( hiv 1 rna less than 50 copies per ml ) for at least six months with no history of treatment failure and no known substitutions associated with resistance to the individual components of odefsey,1
1468,1468,1468,1468,1468,1468,1468,1914,1914,1914,1914,1914,1914,1914,1914,1914,1914,1914,1914,1914,9176bf31-c889-47bd-861c-f2d3fc37ab8d,1  complera  a combination of two nucleoside analog hiv 1 reverse transcriptase inhibitors ( nrtis ) ( emtricitabine and tenofovir disoproxil fumarate ) and one non nucleoside reverse transcriptase inhibitor ( nnrti ) ( rilpivirine )  is indicated for use as a complete regimen for the treatment of hiv 1 infection in patients 12 years of age and older with no antiretroviral treatment history and with hiv 1 rna less than or equal to 100  000 copies ml at the start of therapy  and in certain virologically suppressed ( hiv 1 rna 50 copies ml ) patients on a stable antiretroviral regimen at start of therapy in order to replace their current antiretroviral treatment regimen ( see below ),1
1469,1469,1469,1469,1469,1469,1469,1915,1915,1915,1915,1915,1915,1915,1915,1915,1915,1915,1915,1915,9176bf31-c889-47bd-861c-f2d3fc37ab8d,the following points should be considered when initiating therapy with complera in patients with no antiretroviral treatment history more rilpivirine treated subjects with hiv 1 rna greater than 100  000 copies ml at the start of therapy experienced virologic failure ( hiv 1 rna 50 copies ml ) compared to rilpivirine treated subjects with hiv 1 rna less than or equal to 100  000 copies ml see clinical studies ( 14 ),0
1470,1470,1470,1470,1470,1470,1470,1916,1916,1916,1916,1916,1916,1916,1916,1916,1916,1916,1916,1916,9176bf31-c889-47bd-861c-f2d3fc37ab8d,regardless of hiv 1 rna level at the start of therapy  more rilpivirine treated subjects with cd4 cell count less than 200 cells mm3 experienced virologic failure compared to rilpivirine treated subjects with cd4 cell count greater than or equal to 200 cells mm3 see clinical studies ( 14 ),0
1471,1471,1471,1471,1471,1471,1471,1917,1917,1917,1917,1917,1917,1917,1917,1917,1917,1917,1917,1917,9176bf31-c889-47bd-861c-f2d3fc37ab8d,the observed virologic failure rate in rilpivirine treated subjects conferred a higher rate of overall treatment resistance and cross resistance to the nnrti class compared to efavirenz see microbiology ( 12 4 ),0
1472,1472,1472,1472,1472,1472,1472,1918,1918,1918,1918,1918,1918,1918,1918,1918,1918,1918,1918,1918,9176bf31-c889-47bd-861c-f2d3fc37ab8d,more subjects treated with rilpivirine developed tenofovir and lamivudine emtricitabine associated resistance compared to efavirenz see microbiology ( 12 4 ),0
1473,1473,1473,1473,1473,1473,1473,1919,1919,1919,1919,1919,1919,1919,1919,1919,1919,1919,1919,1919,9176bf31-c889-47bd-861c-f2d3fc37ab8d,the efficacy of complera was established in patients who were virologically suppressed ( hiv 1 rna 50 copies ml ) on stable ritonavir boosted protease inhibitor ( pi ) containing regimen,u
1474,1474,1474,1474,1474,1474,1474,1920,1920,1920,1920,1920,1920,1920,1920,1920,1920,1920,1920,1920,9176bf31-c889-47bd-861c-f2d3fc37ab8d,the following points should be met when considering replacing the current regimen with complera in virologically suppressed patients see clinical studies ( 14 ) patients should have no history of virologic failure,u
1475,1475,1475,1475,1475,1475,1475,1921,1921,1921,1921,1921,1921,1921,1921,1921,1921,1921,1921,1921,9176bf31-c889-47bd-861c-f2d3fc37ab8d,patients should have been stably suppressed ( hiv 1 rna 50 copies ml ) for at least 6 months prior to switching therapy,u
1476,1476,1476,1476,1476,1476,1476,1922,1922,1922,1922,1922,1922,1922,1922,1922,1922,1922,1922,1922,9176bf31-c889-47bd-861c-f2d3fc37ab8d,patients should currently be on their first or second antiretroviral regimen prior to switching therapy,u
1477,1477,1477,1477,1477,1477,1477,1923,1923,1923,1923,1923,1923,1923,1923,1923,1923,1923,1923,1923,9176bf31-c889-47bd-861c-f2d3fc37ab8d,patients should have no current or past history of resistance to any of the three components of complera,u
1478,1478,1478,1478,1478,1478,1478,1924,1924,1924,1924,1924,1924,1924,1924,1924,1924,1924,1924,1924,9176bf31-c889-47bd-861c-f2d3fc37ab8d,additional monitoring of hiv 1 rna and regimen tolerability is recommended after replacing therapy to assess for potential virologic failure or rebound,4
1479,1479,1479,1479,1479,1479,1479,1925,1925,1925,1925,1925,1925,1925,1925,1925,1925,1925,1925,1925,9176bf31-c889-47bd-861c-f2d3fc37ab8d,complera  a combination of two nucleoside analog hiv 1 reverse,0
1480,1480,1480,1480,1480,1480,1480,1926,1926,1926,1926,1926,1926,1926,1926,1926,1926,1926,1926,1926,d607e3c2-62f5-4f4c-bbb3-423ac9478420,1  ziprasidone is an atypical antipsychotic,1
1481,1481,1481,1481,1481,1481,1481,1927,1927,1927,1927,1927,1927,1927,1927,1927,1927,1927,1927,1927,d607e3c2-62f5-4f4c-bbb3-423ac9478420,in choosing among treatments  prescribers should be aware of the capacity of ziprasidone to prolong the qt interval and may consider the use of other drugs first ( 5 2 ) ziprasidone hydrochloride capsules are indicated as an oral formulation for the treatment of schizophrenia,1
1482,1482,1482,1482,1482,1482,1482,1928,1928,1928,1928,1928,1928,1928,1928,1928,1928,1928,1928,1928,d607e3c2-62f5-4f4c-bbb3-423ac9478420,( 1 1 ) adults efficacy was established in four 4 to 6 week trials and one maintenance trial in adult patients with schizophrenia,0
1483,1483,1483,1483,1483,1483,1483,1929,1929,1929,1929,1929,1929,1929,1929,1929,1929,1929,1929,1929,d607e3c2-62f5-4f4c-bbb3-423ac9478420,( 14 1 ) ziprasidone hydrochloride capsules are indicated for the treatment of schizophrenia,1
1484,1484,1484,1484,1484,1484,1484,1930,1930,1930,1930,1930,1930,1930,1930,1930,1930,1930,1930,1930,d607e3c2-62f5-4f4c-bbb3-423ac9478420,when deciding among the alternative treatments available for the condition needing treatment  the prescriber should consider the finding of ziprasidone 's greater capacity to prolong the qt qtc interval compared to several other antipsychotic drugs see warnings and precautions ( 5 2 ),0
1485,1485,1485,1485,1485,1485,1485,1931,1931,1931,1931,1931,1931,1931,1931,1931,1931,1931,1931,1931,d607e3c2-62f5-4f4c-bbb3-423ac9478420,prolongation of the qtc interval is associated in some other drugs with the ability to cause torsade de pointes type arrhythmia  a potentially fatal polymorphic ventricular tachycardia  and sudden death,0
1486,1486,1486,1486,1486,1486,1486,1932,1932,1932,1932,1932,1932,1932,1932,1932,1932,1932,1932,1932,d607e3c2-62f5-4f4c-bbb3-423ac9478420,in many cases this would lead to the conclusion that other drugs should be tried first,0
1487,1487,1487,1487,1487,1487,1487,1933,1933,1933,1933,1933,1933,1933,1933,1933,1933,1933,1933,1933,d607e3c2-62f5-4f4c-bbb3-423ac9478420,whether ziprasidone will cause torsade de pointes or increase the rate of sudden death is not yet known see warnings and precautions ( 5 2 ) 1 1 schizophrenia ziprasidone hydrochloride capsules are indicated for the treatment of schizophrenia,1
1488,1488,1488,1488,1488,1488,1488,1934,1934,1934,1934,1934,1934,1934,1934,1934,1934,1934,1934,1934,d607e3c2-62f5-4f4c-bbb3-423ac9478420,the efficacy of oral ziprasidone was established in four short term ( 4 and 6 week ) controlled trials of adult schizophrenic inpatients and in one maintenance trial of stable adult schizophrenic inpatients see clinical studies ( 14 1 ),u
1489,1489,1489,1489,1489,1489,1489,1935,1935,1935,1935,1935,1935,1935,1935,1935,1935,1935,1935,1935,8326928a-2cb6-4f7f-9712-03a425a14c37,1  geodon is indicated for the treatment of schizophrenia  as monotherapy for the acute treatment of bipolar manic or mixed episodes  and as an adjunct to lithium or valproate for the maintenance treatment of bipolar disorder,1
1490,1490,1490,1490,1490,1490,1490,1936,1936,1936,1936,1936,1936,1936,1936,1936,1936,1936,1936,1936,8326928a-2cb6-4f7f-9712-03a425a14c37,geodon intramuscular is indicated for acute agitation in schizophrenic patients,1
1491,1491,1491,1491,1491,1491,1491,1940,1940,1940,1940,1940,1940,1940,1940,1940,1940,1940,1940,1940,8326928a-2cb6-4f7f-9712-03a425a14c37,whether ziprasidone will cause torsade de pointes or increase the rate of sudden death is not yet known see warnings and precautions ( 5 2 ) geodon is an atypical antipsychotic,0
1492,1492,1492,1492,1492,1492,1492,1941,1941,1941,1941,1941,1941,1941,1941,1941,1941,1941,1941,1941,8326928a-2cb6-4f7f-9712-03a425a14c37,in choosing among treatments  prescribers should be aware of the capacity of geodon to prolong the qt interval and may consider the use of other drugs first ( 5 2 ) geodon is indicated as an oral formulation for the treatment of schizophrenia,1
1493,1493,1493,1493,1493,1493,1493,1942,1942,1942,1942,1942,1942,1942,1942,1942,1942,1942,1942,1942,8326928a-2cb6-4f7f-9712-03a425a14c37,( 1 1 ) adults efficacy was established in four 4 6 week trials and one maintenance trial in adult patients with schizophrenia,u
1494,1494,1494,1494,1494,1494,1494,1943,1943,1943,1943,1943,1943,1943,1943,1943,1943,1943,1943,1943,8326928a-2cb6-4f7f-9712-03a425a14c37,( 14 1 ) acute treatment as monotherapy of manic or mixed episodes associated with bipolar i disorder,1
1495,1495,1495,1495,1495,1495,1495,1944,1944,1944,1944,1944,1944,1944,1944,1944,1944,1944,1944,1944,8326928a-2cb6-4f7f-9712-03a425a14c37,( 1 2 ) adults efficacy was established in two 3 week trials in adult patients with manic or mixed episodes,0
1496,1496,1496,1496,1496,1496,1496,1945,1945,1945,1945,1945,1945,1945,1945,1945,1945,1945,1945,1945,8326928a-2cb6-4f7f-9712-03a425a14c37,( 14 2 ) maintenance treatment of bipolar i disorder as an adjunct to lithium or valproate,1
1497,1497,1497,1497,1497,1497,1497,1946,1946,1946,1946,1946,1946,1946,1946,1946,1946,1946,1946,1946,8326928a-2cb6-4f7f-9712-03a425a14c37,( 1 2 ) adults efficacy was established in one maintenance trial in adult patients,0
1498,1498,1498,1498,1498,1498,1498,1947,1947,1947,1947,1947,1947,1947,1947,1947,1947,1947,1947,1947,8326928a-2cb6-4f7f-9712-03a425a14c37,( 14 2 ) geodon as an intramuscular injection is indicated for the acute treatment of agitation in schizophrenic patients,1
1499,1499,1499,1499,1499,1499,1499,1948,1948,1948,1948,1948,1948,1948,1948,1948,1948,1948,1948,1948,8326928a-2cb6-4f7f-9712-03a425a14c37,( 1 3 ) adults efficacy was established in two short term trials in agitated patients with schizophrenia,0
1500,1500,1500,1500,1500,1500,1500,1949,1949,1949,1949,1949,1949,1949,1949,1949,1949,1949,1949,1949,8326928a-2cb6-4f7f-9712-03a425a14c37,( 1 3 ) 1 1 schizophrenia geodon is indicated for the treatment of schizophrenia,1
1501,1501,1501,1501,1501,1501,1501,1950,1950,1950,1950,1950,1950,1950,1950,1950,1950,1950,1950,1950,8326928a-2cb6-4f7f-9712-03a425a14c37,the efficacy of oral ziprasidone was established in four short term ( 4 and 6 week ) controlled trials of ad,0
1502,1502,1502,1502,1502,1502,1502,1951,1951,1951,1951,1951,1951,1951,1951,1951,1951,1951,1951,1951,"Active Ingredient UNII(s)
21925K482H; 2ACZ6IPC6I    99265e39-af23-43eb-a552-305f0a218fdf
21925K482H; 2ACZ6IPC6I    99265e39-af23-43eb-a552-305f0a218fdf
21925K482H; 2ACZ6IPC6I    99265e39-af23-43eb-a552-305f0a218fdf
Name: SET ID dtype: object",active ingredient unii ( s ) 21925k482h 2acz6ipc6i active ingredient unii ( s ) 21925k482h 2acz6ipc 21925k482h 2acz6ipc6i active ingredient unii ( s ) 21925k482h 2acz6ipc 21925k482h 2acz6ipc6i active ingredient unii ( s ) 21925k482h 2acz6ipc name content xml  dtype object,0
1503,1503,1503,1503,1503,1503,1503,1954,1954,1954,1954,1954,1954,1954,1954,1954,1954,1954,1954,1954,4d9f0f73-c6a5-405d-b0eb-fa14ab030682, carisoprodol and aspirin tablets are indicated for the relief of discomfort associated with acute  painful musculoskeletal conditions in adults,1
1504,1504,1504,1504,1504,1504,1504,1955,1955,1955,1955,1955,1955,1955,1955,1955,1955,1955,1955,1955,4d9f0f73-c6a5-405d-b0eb-fa14ab030682,carisoprodol and aspirin tablets should only be used for short periods ( up to two or three weeks ) because adequate evidence of effectiveness for more prolonged use has not been established and because acute  painful musculoskeletal conditions are generally of short duration ( see dosage and administration ),4
1505,1505,1505,1505,1505,1505,1505,1956,1956,1956,1956,1956,1956,1956,1956,1956,1956,1956,1956,1956,5d0b1256-1981-4519-94f4-a4a2f98bd8a3,1  actimmune is indicated for reducing the frequency and severity of serious infections associated with chronic granulomatous disease ( cgd ),1
1506,1506,1506,1506,1506,1506,1506,1957,1957,1957,1957,1957,1957,1957,1957,1957,1957,1957,1957,1957,5d0b1256-1981-4519-94f4-a4a2f98bd8a3,actimmune is indicated for delaying time to disease progression in patients with severe  malignant osteopetrosis ( smo ),1
1507,1507,1507,1507,1507,1507,1507,1958,1958,1958,1958,1958,1958,1958,1958,1958,1958,1958,1958,1958,5d0b1256-1981-4519-94f4-a4a2f98bd8a3,actimmune is an interferon gamma indicated for reducing the frequency and severity of serious infections associated with chronic granulomatous disease ( cgd ) ( 1 ) delaying time to disease progression in patients with severe  malignant osteopetrosis ( smo ) ( 1 ),1
1508,1508,1508,1508,1508,1508,1508,1959,1959,1959,1959,1959,1959,1959,1959,1959,1959,1959,1959,1959,3b433650-0dca-4714-bb72-341036d3972e,1 indications usage epirubicin hydrochloride injection is indicated as a component of adjuvant therapy in patients with evidence of axillary node tumor involvement following resection of primary breast cancer see clinical studies ( 14 1 ),1
1509,1509,1509,1509,1509,1509,1509,1960,1960,1960,1960,1960,1960,1960,1960,1960,1960,1960,1960,1960,3b433650-0dca-4714-bb72-341036d3972e,epirubicin hydrochloride injection is an anthracycline topoisomerase ii inhibitor indicated as a component of adjuvant therapy in patients with evidence of axillary node tumor involvement following resection of primary breast cancer ( 1 ),1
1510,1510,1510,1510,1510,1510,1510,1961,1961,1961,1961,1961,1961,1961,1961,1961,1961,1961,1961,1961,db37a292-5685-4f10-92fc-57631e1a25f9,1  methadone hydrochloride tablets usp are indicated for the management of moderate to severe pain when a continuous  around the clock opioid analgesic is needed for an extended period of time,1
1511,1511,1511,1511,1511,1511,1511,1962,1962,1962,1962,1962,1962,1962,1962,1962,1962,1962,1962,1962,db37a292-5685-4f10-92fc-57631e1a25f9,detoxification treatment of opioid addiction ( heroin or other morphine like drugs ),1
1512,1512,1512,1512,1512,1512,1512,1963,1963,1963,1963,1963,1963,1963,1963,1963,1963,1963,1963,1963,db37a292-5685-4f10-92fc-57631e1a25f9,maintenance treatment of opioid addiction ( heroin or other morphine like drugs )  in conjunction with appropriate social and medical services,1
1513,1513,1513,1513,1513,1513,1513,1964,1964,1964,1964,1964,1964,1964,1964,1964,1964,1964,1964,1964,db37a292-5685-4f10-92fc-57631e1a25f9,limitations of use methadone hydrochloride tablets usp are not for use as an as needed ( prn ) analgesic for pain that is mild or not expected to persist for an extended period of time for acute pain for postoperative pain conditions for distribution and use of methadone products for the treatment of opioid addiction code of federal regulations  title 42  sec 8 methadone products when used for the treatment of opioid addiction in detoxification or maintenance programs  shall be dispensed only by opioid treatment programs ( and agencies  practitioners or institutions by formal agreement with the program sponsor ) certified by the substance abuse and mental health services administration and approved by the designated state authority,2
1514,1514,1514,1514,1514,1514,1514,1965,1965,1965,1965,1965,1965,1965,1965,1965,1965,1965,1965,1965,db37a292-5685-4f10-92fc-57631e1a25f9,certified treatment programs shall dispense and use methadone in oral form only and according to the treatment requirements stipulated in the federal opioid treatment standards ( 42 cfr 8 12 ),0
1515,1515,1515,1515,1515,1515,1515,1966,1966,1966,1966,1966,1966,1966,1966,1966,1966,1966,1966,1966,db37a292-5685-4f10-92fc-57631e1a25f9,see below for important regulatory exceptions to the general requirement for certification to provide opioid agonist treatment,0
1516,1516,1516,1516,1516,1516,1516,1967,1967,1967,1967,1967,1967,1967,1967,1967,1967,1967,1967,1967,db37a292-5685-4f10-92fc-57631e1a25f9,failure to abide by the requirements in these regulations may result in criminal prosecution  seizure of the drug supply  revocation of the program approval  and injunction precluding operation of the program,0
1517,1517,1517,1517,1517,1517,1517,1968,1968,1968,1968,1968,1968,1968,1968,1968,1968,1968,1968,1968,db37a292-5685-4f10-92fc-57631e1a25f9,regulatory exceptions to the general requirement for certification to provide opioid agonist treatment during inpatient care  when the patient was admitted for any condition other than concurrent opioid addiction ( pursuant to 21cfr 1306 07 ( c ) )  to facilitate the treatment of the primary admitting diagnosis ),0
1518,1518,1518,1518,1518,1518,1518,1969,1969,1969,1969,1969,1969,1969,1969,1969,1969,1969,1969,1969,db37a292-5685-4f10-92fc-57631e1a25f9,during an emergency period of no longer than 3 days while definitive care for the addiction is being sought in an appropriately licensed facility ( pursuant to 21cfr 1306 07 ( b ) ),0
1519,1519,1519,1519,1519,1519,1519,1970,1970,1970,1970,1970,1970,1970,1970,1970,1970,1970,1970,1970,db37a292-5685-4f10-92fc-57631e1a25f9,methadone hydrochloride tablets usp are an opioid agonist indicated for the management of moderate to severe pain when a continuous  around the clock opioid analgesic is needed for an extended period of time  de,1
1520,1520,1520,1520,1520,1520,1520,1971,1971,1971,1971,1971,1971,1971,1971,1971,1971,1971,1971,1971,09b3fdc2-38de-4a37-ac9b-d7eabb6db0f9, phospha 250 tm neutral increases urinary phosphate and pyrophosphate,u
1521,1521,1521,1521,1521,1521,1521,1972,1972,1972,1972,1972,1972,1972,1972,1972,1972,1972,1972,1972,09b3fdc2-38de-4a37-ac9b-d7eabb6db0f9,as a phosphorus supplement  each tablet supplies 25 of the u s,0
1522,1522,1522,1522,1522,1522,1522,1973,1973,1973,1973,1973,1973,1973,1973,1973,1973,1973,1973,1973,09b3fdc2-38de-4a37-ac9b-d7eabb6db0f9,recommended daily allowance ( u s rda ) of phosphorus for adults and children over 4 years of age,0
1523,1523,1523,1523,1523,1523,1523,1974,1974,1974,1974,1974,1974,1974,1974,1974,1974,1974,1974,1974,88015023-2955-4797-baa4-fa104e80cb62, monobasic sodium phosphate and dibasic sodium phosphate tablets are indicated for cleansing of the colon as a preparation for colonoscopy in adults 18 years of age or older,1
1524,1524,1524,1524,1524,1524,1524,1975,1975,1975,1975,1975,1975,1975,1975,1975,1975,1975,1975,1975,c1b6e536-df5f-4f76-8e3c-6dc2f1e9975e,amyl nitrite is indicated for the rapid relief of angina pectoris,1
1525,1525,1525,1525,1525,1525,1525,1976,1976,1976,1976,1976,1976,1976,1976,1976,1976,1976,1976,1976,c1b6e536-df5f-4f76-8e3c-6dc2f1e9975e,its effect appears within 30 seconds and lasts for approximately 3 to 5 minutes,0
1526,1526,1526,1526,1526,1526,1526,1977,1977,1977,1977,1977,1977,1977,1977,1977,1977,1977,1977,1977,83d7a440-e904-4e36-afb5-cb02b1c919f7,1  monotherapy faslodex is indicated for the treatment of hormone receptor ( hr ) positive  human epidermal growth factor receptor 2 ( her2 ) negative advanced breast cancer in postmenopausal women not previously treated with endocrine therapy  or hr positive advanced breast cancer in postmenopausal women with disease progression following endocrine therapy,1
1527,1527,1527,1527,1527,1527,1527,1978,1978,1978,1978,1978,1978,1978,1978,1978,1978,1978,1978,1978,83d7a440-e904-4e36-afb5-cb02b1c919f7,combination therapy faslodex is indicated for the treatment of hr positive  her2 negative advanced or metastatic breast cancer in combination with palbociclib or abemaciclib in women with disease progression after endocrine therapy,1
1528,1528,1528,1528,1528,1528,1528,1979,1979,1979,1979,1979,1979,1979,1979,1979,1979,1979,1979,1979,83d7a440-e904-4e36-afb5-cb02b1c919f7,faslodex is an estrogen receptor antagonist indicated for the treatment of hormone receptor ( hr ) positive  human epidermal growth factor receptor 2 ( her2 ) negative advanced breast cancer in postmenopausal women not previously treated with endocrine therapy,1
1529,1529,1529,1529,1529,1529,1529,1980,1980,1980,1980,1980,1980,1980,1980,1980,1980,1980,1980,1980,83d7a440-e904-4e36-afb5-cb02b1c919f7,( 1 ) treatment of hr positive advanced breast cancer in postmenopausal women with disease progression following endocrine therapy,1
1530,1530,1530,1530,1530,1530,1530,1981,1981,1981,1981,1981,1981,1981,1981,1981,1981,1981,1981,1981,83d7a440-e904-4e36-afb5-cb02b1c919f7,( 1 ) treatment of hr positive  her2 negative advanced or metastatic breast cancer in combination with palbociclib or abemaciclib in women with disease progression after endocrine therapy,1
1531,1531,1531,1531,1531,1531,1531,1982,1982,1982,1982,1982,1982,1982,1982,1982,1982,1982,1982,1982,8e47618e-af46-4d82-94e8-1507c042252d,1  akynzeo is indicated for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of cancer chemotherapy  including  but not limited to  highly emetogenic chemotherapy,1
1532,1532,1532,1532,1532,1532,1532,1983,1983,1983,1983,1983,1983,1983,1983,1983,1983,1983,1983,1983,8e47618e-af46-4d82-94e8-1507c042252d,akynzeo is an oral fixed combination of palonosetron and netupitant palonosetron prevents nausea and vomiting during the acute phase and netupitant prevents nausea and vomiting during both the acute and delayed phase after cancer chemotherapy,1
1533,1533,1533,1533,1533,1533,1533,1984,1984,1984,1984,1984,1984,1984,1984,1984,1984,1984,1984,1984,8e47618e-af46-4d82-94e8-1507c042252d,akynzeo is a fixed combination of netupitant  a substance p neurokinin 1 ( nk1 ) receptor antagonist  and palonosetron  a serotonin 3 ( 5 ht3 ) receptor antagonist indicated for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of cancer chemotherapy  including  but not limited to  highly emetogenic chemotherapy,1
1534,1534,1534,1534,1534,1534,1534,1985,1985,1985,1985,1985,1985,1985,1985,1985,1985,1985,1985,1985,8e47618e-af46-4d82-94e8-1507c042252d,oral palonosetron prevents nausea and vomiting during the acute phase and netupitant prevents nausea and vomiting during both the acute and delayed phase after cancer chemotherapy,1
1535,1535,1535,1535,1535,1535,1535,1986,1986,1986,1986,1986,1986,1986,1986,1986,1986,1986,1986,1986,9e5e2ce4-7a57-4c61-a826-64c8d11d038e, papaverine is recommended in various conditions accompanied by spasm of smooth muscle  such as vascular spasm associated with acute myocardial infarction ( coronary occlusion )  angina pectoris  peripheral and pulmonary embolism  peripheral vascular disease in which there is a vasospastic element  or certain cerebral angiospastic states and visceral spasm  as in ureteral  biliary  or gastrointestinal colic,1
1536,1536,1536,1536,1536,1536,1536,1987,1987,1987,1987,1987,1987,1987,1987,1987,1987,1987,1987,1987,87c9a8ba-85a3-4efd-9c3d-9a887fb9369b,1  to reduce the development of drug resistant bacteria and maintain the effectiveness of amoxicillin and clavulanate potassium powder for oral suspension  usp ( amoxicillin clavulanate potassium ) and other antibacterial drugs  amoxicillin and clavulanate potassium powder for oral suspension  usp should be used only to treat infections that are proven or strongly suspected to be caused by susceptible bacteria,1
1537,1537,1537,1537,1537,1537,1537,1990,1990,1990,1990,1990,1990,1990,1990,1990,1990,1990,1990,1990,87c9a8ba-85a3-4efd-9c3d-9a887fb9369b,amoxicillin and clavulanate potassium powder for oral suspension  usp is a combination penicillin class antibacterial and beta lactamase inhibitor indicated in the treatment of infections due to susceptible isolates of the designated bacteria in the conditions listed below amoxicillin and clavulanate potassium powder for oral suspension  usp is a combination penicillin class antibacterial and beta lactamase inhibitor indicated for treatment of the following lower respiratory tract infections ( 1 1 ) acute bacterial otitis media ( 1 2 ) sinusitis ( 1 3 ) skin and skin structure infections ( 1 4 ) urinary tract infections ( 1 5 ) 1 1 lower respiratory tract infections caused by beta lactamase producing isolates of haemophilus influenzae and moraxella catarrhalis,1
1538,1538,1538,1538,1538,1538,1538,1991,1991,1991,1991,1991,1991,1991,1991,1991,1991,1991,1991,1991,87c9a8ba-85a3-4efd-9c3d-9a887fb9369b,1 2 acute bacterial otitis media caused by beta lactamase producing isolates of h influenzae and m catarrhalis,1
1539,1539,1539,1539,1539,1539,1539,1992,1992,1992,1992,1992,1992,1992,1992,1992,1992,1992,1992,1992,fa2a3546-29df-4f74-bd14-95fa0753e9b0, neuralgo rheum injection solution is a homeopathic drug product indicated for the treatment of nerve pain  soft tissue rheumatism and symptoms of disc protrusion,1
1540,1540,1540,1540,1540,1540,1540,1993,1993,1993,1993,1993,1993,1993,1993,1993,1993,1993,1993,1993,"Active Ingredient UNII(s)
23H32AOH17; BGI20Z6M57    05f405bb-6933-44a1-ab48-05faf19fbb4d
23H32AOH17; BGI20Z6M57    05f405bb-6933-44a1-ab48-05faf19fbb4d
Name: SET ID dtype: object",active ingredient unii ( s ) 23h32aoh17 bgi20z6m57 active ingredient unii ( s ) 23h32aoh17 bgi20z6m 23h32aoh17 bgi20z6m57 active ingredient unii ( s ) 23h32aoh17 bgi20z6m name content xml  dtype object,0
1541,1541,1541,1541,1541,1541,1541,1995,1995,1995,1995,1995,1995,1995,1995,1995,1995,1995,1995,1995,ca02f7a4-ae4f-43c1-a06a-259fe4fcf9cf,1  vpriv is indicated for long term enzyme replacement therapy ( ert ) for patients with type 1 gaucher disease,1
1542,1542,1542,1542,1542,1542,1542,1996,1996,1996,1996,1996,1996,1996,1996,1996,1996,1996,1996,1996,ca02f7a4-ae4f-43c1-a06a-259fe4fcf9cf,vpriv is a hydrolytic lysosomal glucocerebroside specific enzyme indicated for long term enzyme replacement therapy ( ert ) for patients with type 1 gaucher disease ( 1 ),1
1543,1543,1543,1543,1543,1543,1543,1997,1997,1997,1997,1997,1997,1997,1997,1997,1997,1997,1997,1997,28f698df-b584-4455-2e94-6efc41313960, to reduce the development of drug resistant bacteria and maintain the effectiveness of synercid and other antibacterial drugs  synercid should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria,1
1544,1544,1544,1544,1544,1544,1544,2000,2000,2000,2000,2000,2000,2000,2000,2000,2000,2000,2000,2000,28f698df-b584-4455-2e94-6efc41313960,synercid is indicated in adults for the treatment of the following infections when caused by susceptible strains of the designated microorganisms,1
1545,1545,1545,1545,1545,1545,1545,2001,2001,2001,2001,2001,2001,2001,2001,2001,2001,2001,2001,2001,28f698df-b584-4455-2e94-6efc41313960,complicated skin and skin structure infections caused by staphylococcus aureus ( methicillin susceptible ) or streptococcus pyogenes,1
1546,1546,1546,1546,1546,1546,1546,2002,2002,2002,2002,2002,2002,2002,2002,2002,2002,2002,2002,2002,8fc6228a-faf3-4ba7-80e1-ff56ae934383, iobenguane is indicated as a radioactive isotope diagnosing for adrenomedullary disorders and neuroendocrine tumors,1
1547,1547,1547,1547,1547,1547,1547,2003,2003,2003,2003,2003,2003,2003,2003,2003,2003,2003,2003,2003,8fc6228a-faf3-4ba7-80e1-ff56ae934383,tumors  adrenal medulla ( diagnosis ) i 123 mibg is used for diagnostic imaging of the adrenal medulla  for the evaluation and localization of intra and extra adrenal pheochromocytomas  paragangliomas  and neuroblastomas  as well as for localization of metastatic lesions from these tumors,1
1548,1548,1548,1548,1548,1548,1548,2004,2004,2004,2004,2004,2004,2004,2004,2004,2004,2004,2004,2004,8fc6228a-faf3-4ba7-80e1-ff56ae934383,i 123 mibg can also be used for confirmation of diagnosis of pheochromocytoma when catecholamine determination tests are unclear,1
1549,1549,1549,1549,1549,1549,1549,2005,2005,2005,2005,2005,2005,2005,2005,2005,2005,2005,2005,2005,8fc6228a-faf3-4ba7-80e1-ff56ae934383,tumors  carcinoid ( diagnosis ) i 123 mibg scintigraphy is used as screening procedures for suspected carcinoid tumors  especially those of intestinal origin,1
1550,1550,1550,1550,1550,1550,1550,2006,2006,2006,2006,2006,2006,2006,2006,2006,2006,2006,2006,2006,8fc6228a-faf3-4ba7-80e1-ff56ae934383,hyperplasia  adrenal medulla ( diagnosis ) i 123 mibg is used in the evaluation of the adrenal medulla for disorders such as medullary hyperplasia in patients at risk of developing medullary disease ( e g  multiple endocrine neoplasia men type 2  men type 3 ),1
1551,1551,1551,1551,1551,1551,1551,2007,2007,2007,2007,2007,2007,2007,2007,2007,2007,2007,2007,2007,8fc6228a-faf3-4ba7-80e1-ff56ae934383,carcinoma  thyroid ( diagnosis ) i 123 mibg is used for diagnostic imaging of medullary thyroid carcinoma,1
1552,1552,1552,1552,1552,1552,1552,2008,2008,2008,2008,2008,2008,2008,2008,2008,2008,2008,2008,2008,8fc6228a-faf3-4ba7-80e1-ff56ae934383,distribution after intravenous administration  there is rapid uptake of mibg mainly in the liver  and in lesser amounts in the lungs  heart  and salivary glands,0
1553,1553,1553,1553,1553,1553,1553,2009,2009,2009,2009,2009,2009,2009,2009,2009,2009,2009,2009,2009,8fc6228a-faf3-4ba7-80e1-ff56ae934383,a limited number of patients may show activity in normal adrenals  lung  skeletal  muscle  and blocked thyroid glands,0
1554,1554,1554,1554,1554,1554,1554,2010,2010,2010,2010,2010,2010,2010,2010,2010,2010,2010,2010,2010,8fc6228a-faf3-4ba7-80e1-ff56ae934383,although the uptake in normal adrenal glands is very low  hyperplastic adrenals and tumors such as pheochromocytoma  neuroblastoma  and other tumors with neurosecretory granules have a relatively higher uptake,0
1555,1555,1555,1555,1555,1555,1555,2011,2011,2011,2011,2011,2011,2011,2011,2011,2011,2011,2011,2011,8fc6228a-faf3-4ba7-80e1-ff56ae934383,significant clearance of i 123 mibg from the liver and the spleen occurs within 72 hours,0
1556,1556,1556,1556,1556,1556,1556,2012,2012,2012,2012,2012,2012,2012,2012,2012,2012,2012,2012,2012,8fc6228a-faf3-4ba7-80e1-ff56ae934383,i 123 mibg in adrenal medullary tumors initial images may be obtained 2 to 3 hours after injection,0
1557,1557,1557,1557,1557,1557,1557,2013,2013,2013,2013,2013,2013,2013,2013,2013,2013,2013,2013,2013,8fc6228a-faf3-4ba7-80e1-ff56ae934383,images may also be obtained at 18 to 24 hours  and as late as 48 hours post injection,0
1558,1558,1558,1558,1558,1558,1558,2014,2014,2014,2014,2014,2014,2014,2014,2014,2014,2014,2014,2014,8fc6228a-faf3-4ba7-80e1-ff56ae934383,most pheochromocytomas are visualized at 24 hours,0
1559,1559,1559,1559,1559,1559,1559,2015,2015,2015,2015,2015,2015,2015,2015,2015,2015,2015,2015,2015,8fc6228a-faf3-4ba7-80e1-ff56ae934383,however  due to the short half life of i 123 mibg  images may not be possible at times when background ( e g  liver ) activity is low and imaging would be optimal,2
1560,1560,1560,1560,1560,1560,1560,2016,2016,2016,2016,2016,2016,2016,2016,2016,2016,2016,2016,2016,8fc6228a-faf3-4ba7-80e1-ff56ae934383,small amounts of radioactivity used in diagnosis radiation received is low and considered safe,0
1561,1561,1561,1561,1561,1561,1561,2017,2017,2017,2017,2017,2017,2017,2017,2017,2017,2017,2017,2017,8fc6228a-faf3-4ba7-80e1-ff56ae934383,elimination renal about 40 to 50 of the injected activity is eliminated within 24 hours and about 70 to 90 within 4 days ( mainly as unchanged drug with small amounts of i 123 m iodohippuric acid i 123 miha  i 123 iodide  and i 123 m iodobenzoic acid i 123 miba ),0
1562,1562,1562,1562,1562,1562,1562,2018,2018,2018,2018,2018,2018,2018,2018,2018,2018,2018,2018,2018,cbd3396e-6b85-41bf-82d2-940beba86686, intralipid 20 pharmacy bulk package is indicated for use in a pharmacy admixture program for the preparation of three inone or total nutrition admixtures ( tnas ) to provide a source of calories and essential fatty acids for patients requiring parenteral nutrition for extended periods of time ( usually for more than 5 days ) and a source of essential fatty acids for prevention of efad,1
1563,1563,1563,1563,1563,1563,1563,2019,2019,2019,2019,2019,2019,2019,2019,2019,2019,2019,2019,2019,ae98eb03-c0e7-49d1-b024-77968e3d9d6e,1  clinolipid is indicated in adults for providing a source of calories and essential fatty acids for parenteral nutrition when oral or enteral nutrition is not possible  insufficient  or contraindicated,1
1564,1564,1564,1564,1564,1564,1564,2020,2020,2020,2020,2020,2020,2020,2020,2020,2020,2020,2020,2020,ae98eb03-c0e7-49d1-b024-77968e3d9d6e,limitations of use clinolipid is not indicated for use in pediatric patients because there is insufficient data to demonstrate that clinolipid provides sufficient amounts of essential fatty acids in this population,2
1565,1565,1565,1565,1565,1565,1565,2021,2021,2021,2021,2021,2021,2021,2021,2021,2021,2021,2021,2021,ae98eb03-c0e7-49d1-b024-77968e3d9d6e,see use in specific populations ( 8 4 ) the omega 3 omega 6 fatty acid ratio in clinolipid has not been shown to improve clinical outcomes compared to other intravenous lipid emulsions,0
1566,1566,1566,1566,1566,1566,1566,2022,2022,2022,2022,2022,2022,2022,2022,2022,2022,2022,2022,2022,ae98eb03-c0e7-49d1-b024-77968e3d9d6e,see clinical studies ( 14 ) clinolipid is indicated in adults for parenteral nutrition providing a source of calories and essential fatty acids when oral or enteral nutrition is not possible  insufficient  or contraindicated,1
1567,1567,1567,1567,1567,1567,1567,2023,2023,2023,2023,2023,2023,2023,2023,2023,2023,2023,2023,2023,ae98eb03-c0e7-49d1-b024-77968e3d9d6e,( 1 ) limitations of use clinolipid is not indicated for use in pediatric patients because there is insufficient data to demonstrate that clinolipid provides sufficient amounts of essential fatty acids in this population ( 1  8 4 ) the omega 3 omega 6 fatty acid ratio in clinolipid has not been shown to improve clinical outcomes compared to other intravenous lipid emulsions ( 1 ),2
1568,1568,1568,1568,1568,1568,1568,2024,2024,2024,2024,2024,2024,2024,2024,2024,2024,2024,2024,2024,e0e9d917-ff6f-488e-a6a8-0ad59dd17d80,1  smoflipid is indicated in adults as a source of calories and essential fatty acids for parenteral nutrition when oral or enteral nutrition is not possible  insufficient  or contraindicated,1
1569,1569,1569,1569,1569,1569,1569,2025,2025,2025,2025,2025,2025,2025,2025,2025,2025,2025,2025,2025,e0e9d917-ff6f-488e-a6a8-0ad59dd17d80,limitations of use the omega 6 omega 3 fatty acid ratio and medium chain triglycerides in smoflipid have not been shown to improve clinical outcomes compared to other intravenous lipid emulsions see clinical studies ( 14 ),2
1570,1570,1570,1570,1570,1570,1570,2026,2026,2026,2026,2026,2026,2026,2026,2026,2026,2026,2026,2026,e0e9d917-ff6f-488e-a6a8-0ad59dd17d80,smoflipid is indicated in adults as a source of calories and essential fatty acids for parenteral nutrition when oral or enteral nutrition is not possible  insufficient  or contraindicated,1
1571,1571,1571,1571,1571,1571,1571,2027,2027,2027,2027,2027,2027,2027,2027,2027,2027,2027,2027,2027,e0e9d917-ff6f-488e-a6a8-0ad59dd17d80,( 1 ) limitations of use the omega 6 omega 3 fatty acid ratio and medium chain triglycerides in smoflipid have not been shown to improve clinical outcomes compared to other intravenous lipid emulsions,2
1572,1572,1572,1572,1572,1572,1572,2028,2028,2028,2028,2028,2028,2028,2028,2028,2028,2028,2028,2028,e2f854cb-7f91-4269-ba67-97065ac8b4a0,1  kaletra is indicated in combination with other antiretroviral agents for the treatment of hiv 1 infection in adults and pediatric patients 14 days and older,1
1573,1573,1573,1573,1573,1573,1573,2029,2029,2029,2029,2029,2029,2029,2029,2029,2029,2029,2029,2029,e2f854cb-7f91-4269-ba67-97065ac8b4a0,limitations of use genotypic or phenotypic testing and or treatment history should guide the use of kaletra,2
1574,1574,1574,1574,1574,1574,1574,2030,2030,2030,2030,2030,2030,2030,2030,2030,2030,2030,2030,2030,e2f854cb-7f91-4269-ba67-97065ac8b4a0,the number of baseline lopinavir resistance associated substitutions affects the virologic response to kaletra see microbiology ( 12 4 ),0
1575,1575,1575,1575,1575,1575,1575,2031,2031,2031,2031,2031,2031,2031,2031,2031,2031,2031,2031,2031,e2f854cb-7f91-4269-ba67-97065ac8b4a0,kaletra is an hiv 1 protease inhibitor indicated in combination with other antiretroviral agents for the treatment of hiv 1 infection in adults and pediatric patients ( 14 days and older ),1
1576,1576,1576,1576,1576,1576,1576,2032,2032,2032,2032,2032,2032,2032,2032,2032,2032,2032,2032,2032,9f6bb5bf-0846-4a3d-9aee-97e6d50cc41a, maintains the system under the stress of malignancy regardless of location,u
1577,1577,1577,1577,1577,1577,1577,2033,2033,2033,2033,2033,2033,2033,2033,2033,2033,2033,2033,2033,9f6bb5bf-0846-4a3d-9aee-97e6d50cc41a,modulate cancerous action  tumors  targets tissues that tend to be more susceptible to cancer  neuralgias  and dropsy of extremities  and rheumatic pains,u
1578,1578,1578,1578,1578,1578,1578,2034,2034,2034,2034,2034,2034,2034,2034,2034,2034,2034,2034,2034,9f6bb5bf-0846-4a3d-9aee-97e6d50cc41a,based on the homeopathic materia medicas,0
1579,1579,1579,1579,1579,1579,1579,2035,2035,2035,2035,2035,2035,2035,2035,2035,2035,2035,2035,2035,f77e0d17-44de-4ac0-84a4-dcb3cb83cd33, indication maintains the system under the stress of malignancy regardless of location,u
1580,1580,1580,1580,1580,1580,1580,2036,2036,2036,2036,2036,2036,2036,2036,2036,2036,2036,2036,2036,f77e0d17-44de-4ac0-84a4-dcb3cb83cd33,targets tissues that tend to be more susceptible to cancer  neuralgias and dropsy of extremities  yellowed skin  headache  physical weakness and rheumatic pains based on the homeopathic materia medicas,u
1581,1581,1581,1581,1581,1581,1581,2037,2037,2037,2037,2037,2037,2037,2037,2037,2037,2037,2037,2037,a26390e8-eb86-4623-8cdd-45b24b14df74, permax is indicated as adjunctive treatment to levodopa carbidopa in the management of the signs and symptoms of parkinson 's disease,1
1582,1582,1582,1582,1582,1582,1582,2038,2038,2038,2038,2038,2038,2038,2038,2038,2038,2038,2038,2038,a26390e8-eb86-4623-8cdd-45b24b14df74,evidence to support the efficacy of pergolide as an antiparkinsonian adjunct was obtained in a multicenter study enrolling 376 patients with mild to moderate parkinson 's disease who were intolerant to l dopa carbidopa as manifested by moderate to severe dyskinesia and or on off phenomena,0
1583,1583,1583,1583,1583,1583,1583,2039,2039,2039,2039,2039,2039,2039,2039,2039,2039,2039,2039,2039,a26390e8-eb86-4623-8cdd-45b24b14df74,on average  the patients evaluated had been on l dopa carbidopa for 3 9 years ( range  2 days to 16 8 years ),0
1584,1584,1584,1584,1584,1584,1584,2040,2040,2040,2040,2040,2040,2040,2040,2040,2040,2040,2040,2040,a26390e8-eb86-4623-8cdd-45b24b14df74,the administration of pergolide permitted a 5 to 30 reduction in the daily dose of l dopa,0
1585,1585,1585,1585,1585,1585,1585,2041,2041,2041,2041,2041,2041,2041,2041,2041,2041,2041,2041,2041,a26390e8-eb86-4623-8cdd-45b24b14df74,on average  these patients treated with pergolide maintained an equivalent or better clinical status than they exhibited at baseline,0
1586,1586,1586,1586,1586,1586,1586,2042,2042,2042,2042,2042,2042,2042,2042,2042,2042,2042,2042,2042,06eeaab8-a00d-4b41-b46b-40163f09ecb8,1  vinorelbine injection  usp is indicated in combination with cisplatin for first line treatment of patients with locally advanced or metastatic non small cell lung cancer ( nsclc ) as a single agent  for the treatment of patients with metastatic nsclc vinorelbine injection  usp  is a vinca alkaloid indicated in combination with cisplatin for first line treatment of patients with locally advanced or metastatic non small cell lung cancer ( nsclc ) ( 1 ) as a single agent for first line treatment of patients with metastatic nsclc ( 1 ),1
1587,1587,1587,1587,1587,1587,1587,2048,2048,2048,2048,2048,2048,2048,2048,2048,2048,2048,2048,2048,ed23b6bc-32c7-4c50-a53d-313ae78e5623, treatment cefotaxime for injection  usp is indicated for the treatment of patients with serious infections caused by susceptible strains of the designated microorganisms in the diseases listed below,1
1588,1588,1588,1588,1588,1588,1588,2049,2049,2049,2049,2049,2049,2049,2049,2049,2049,2049,2049,2049,ed23b6bc-32c7-4c50-a53d-313ae78e5623,( 1 ) lower respiratory tract infections  including pneumonia  caused by streptococcus pneumoniae ( formerly diplococcus pneumoniae )  streptococcus pyogenes ( group a streptococci ) and other streptococci ( excluding enterococci  e g  enterococcus faecalis )  staphylococcus aureus ( penicillinase and non penicillinase producing )  escherichia coli  klebsiella species  haemophilus influenzae ( including ampicillin resistant strains )  haemophilus parainfluenzae  proteus mirabilis  serratia marcescens  enterobacter species  indole positive proteus and pseudomonas species ( including p aeruginosa ),1
1589,1589,1589,1589,1589,1589,1589,2050,2050,2050,2050,2050,2050,2050,2050,2050,2050,2050,2050,2050,ed23b6bc-32c7-4c50-a53d-313ae78e5623,urinary tract infections caused by enterococcus species  staphylococcus epidermidis  staphylococcus aureus  ( penicillinase and non penicillinase producing )  citrobacter species  enterobacter species  escherichia coli  klebsiella species  proteus mirabilis  proteus vulgaris  providencia stuartii  morganella morganii  providencia rettgeri  serratia marcescens and pseudomonas species ( including p aeruginosa ),1
1590,1590,1590,1590,1590,1590,1590,2051,2051,2051,2051,2051,2051,2051,2051,2051,2051,2051,2051,2051,ed23b6bc-32c7-4c50-a53d-313ae78e5623,also  uncomplicated gonorrhea ( cervical urethral and rectal ) caused by neisseria gonorrhoeae  including penicillinase producing strains,1
1591,1591,1591,1591,1591,1591,1591,2052,2052,2052,2052,2052,2052,2052,2052,2052,2052,2052,2052,2052,ed23b6bc-32c7-4c50-a53d-313ae78e5623,( 3 ) gynecologic infections  including pelvic inflammatory disease  endometritis and pelvic cellulitis caused by staphylococcus epidermidis  streptococcus species  enterococcus species  enterobacter species  klebsiella,1
1592,1592,1592,1592,1592,1592,1592,2053,2053,2053,2053,2053,2053,2053,2053,2053,2053,2053,2053,2053,5e7045f7-b771-d8af-ce30-be95b2597c10,1  varibar nectar is indicated for use in modified barium swallow examinations to evaluate the oral and pharyngeal function and morphology in adult and pediatric patients,1
1593,1593,1593,1593,1593,1593,1593,2054,2054,2054,2054,2054,2054,2054,2054,2054,2054,2054,2054,2054,5e7045f7-b771-d8af-ce30-be95b2597c10,varibar nectar is a radiographic contrast agent indicated for use in modified barium swallow examinations to evaluate the oral and pharyngeal function and morphology in adult and pediatric patients,1
1594,1594,1594,1594,1594,1594,1594,2055,2055,2055,2055,2055,2055,2055,2055,2055,2055,2055,2055,2055,74435a8a-28a9-4080-93d0-d9d5f10b325e, edetate calcium disodium is indicated for the reduction of blood levels and depot stores of lead in lead poisoning ( acute and chronic ) and lead encephalopathy  in both pediatric populations and adults,1
1595,1595,1595,1595,1595,1595,1595,2056,2056,2056,2056,2056,2056,2056,2056,2056,2056,2056,2056,2056,74435a8a-28a9-4080-93d0-d9d5f10b325e,chelation therapy should not replace effective measures to eliminate or reduce further exposure to lead,0
1596,1596,1596,1596,1596,1596,1596,2057,2057,2057,2057,2057,2057,2057,2057,2057,2057,2057,2057,2057,be27854a-a805-4300-9729-accd1b7f226f,indications based on a review of this drug by the national academy of sciences national research council and or other information  fda has classified the indications as follows lacking substantial evidence of effectiveness as a fixed combination urobiotic 250 is indicated in the therapy of a number of genitourinary infections caused by susceptible organisms,u
1597,1597,1597,1597,1597,1597,1597,2058,2058,2058,2058,2058,2058,2058,2058,2058,2058,2058,2058,2058,be27854a-a805-4300-9729-accd1b7f226f,these infections include the following pyelonephritis  pyelitis  ureteritis  cystitis  prostatitis  and urethritis,1
1598,1598,1598,1598,1598,1598,1598,2059,2059,2059,2059,2059,2059,2059,2059,2059,2059,2059,2059,2059,be27854a-a805-4300-9729-accd1b7f226f,since both terramycin and sulfamethizole provide effective levels in blood  tissue  and urine  urobiotic 250 provides a multiple antimicrobial approach at the site of infection,0
1599,1599,1599,1599,1599,1599,1599,2060,2060,2060,2060,2060,2060,2060,2060,2060,2060,2060,2060,2060,be27854a-a805-4300-9729-accd1b7f226f,both antibacterial components are active against the most common urinary pathogens  including escherichia coli  pseudomonas aeruginosa  aerobacter aerogenes  streptococcus faecalis  streptococcus hemolyticus  and micrococcus pyogenes,u
1600,1600,1600,1600,1600,1600,1600,2061,2061,2061,2061,2061,2061,2061,2061,2061,2061,2061,2061,2061,be27854a-a805-4300-9729-accd1b7f226f,urobiotic 250 is particularly useful in the treatment of infections caused by bacteria more sensitive to the combination than to either component alone,u
1601,1601,1601,1601,1601,1601,1601,2062,2062,2062,2062,2062,2062,2062,2062,2062,2062,2062,2062,2062,be27854a-a805-4300-9729-accd1b7f226f,the combination is also of value in those cases with mixed infections  and in those instances where the causative organism is unknown pending laboratory isolation,u
1602,1602,1602,1602,1602,1602,1602,2063,2063,2063,2063,2063,2063,2063,2063,2063,2063,2063,2063,2063,be27854a-a805-4300-9729-accd1b7f226f,final classification of the less than effective indications requires further investigation,0
1603,1603,1603,1603,1603,1603,1603,2064,2064,2064,2064,2064,2064,2064,2064,2064,2064,2064,2064,2064,be27854a-a805-4300-9729-accd1b7f226f,clinical studies to substantiate the efficacy of urobiotic 250 are ongoing,0
1604,1604,1604,1604,1604,1604,1604,2065,2065,2065,2065,2065,2065,2065,2065,2065,2065,2065,2065,2065,be27854a-a805-4300-9729-accd1b7f226f,completion of these ongoing studies will provide data for final classification of these indications,0
1605,1605,1605,1605,1605,1605,1605,2066,2066,2066,2066,2066,2066,2066,2066,2066,2066,2066,2066,2066,34beae32-51e4-4bdc-8ca5-1d8d79f193b2,indications bacmin is indicated for prophylactic or therapeutic nutritional supplementation in physiologically stressful conditions,1
1606,1606,1606,1606,1606,1606,1606,2067,2067,2067,2067,2067,2067,2067,2067,2067,2067,2067,2067,2067,34beae32-51e4-4bdc-8ca5-1d8d79f193b2,these include conditions causing depletion  reduced absorption or bioavailability of essential vitamins and minerals inadequate intake due to highly restricted or unbalanced diets such as those frequently associated with anorexic conditions and other states of severe malnutrition,1
1607,1607,1607,1607,1607,1607,1607,2068,2068,2068,2068,2068,2068,2068,2068,2068,2068,2068,2068,2068,34beae32-51e4-4bdc-8ca5-1d8d79f193b2,gastrointestinal disorders  chronic alcoholism  chronic or acute infections ( especially those involving febrile illness )  prolonged or wasting disease  congestive heart failure  hyperthyroidism  poorly controlled diabetes or other physiologic stress,1
1608,1608,1608,1608,1608,1608,1608,2069,2069,2069,2069,2069,2069,2069,2069,2069,2069,2069,2069,2069,34beae32-51e4-4bdc-8ca5-1d8d79f193b2,also  patients on estrogenic oral contraceptives or other estrogen therapy  anti bacterials which affect intestinal microflora  or other interfering drugs,1
1609,1609,1609,1609,1609,1609,1609,2070,2070,2070,2070,2070,2070,2070,2070,2070,2070,2070,2070,2070,34beae32-51e4-4bdc-8ca5-1d8d79f193b2,certain conditions resulting from severe b vitamin or ascorbic acid deficiency recovery from surgery or trauma involving severe burns  fractures or other extensive tissue damage,1
1610,1610,1610,1610,1610,1610,1610,2071,2071,2071,2071,2071,2071,2071,2071,2071,2071,2071,2071,2071,34beae32-51e4-4bdc-8ca5-1d8d79f193b2,also  pregnant women and those with heavy menstrual bleeding,1
1611,1611,1611,1611,1611,1611,1611,2072,2072,2072,2072,2072,2072,2072,2072,2072,2072,2072,2072,2072,06508e37-5ae6-4a17-bf60-b3828c6082a7, dialyvite with zinc is a prescription folic acid supplement with zinc and additional nutrients indicated for use in improving the nutritional status of renal dialysis patients,1
1612,1612,1612,1612,1612,1612,1612,2073,2073,2073,2073,2073,2073,2073,2073,2073,2073,2073,2073,2073,24d0f7d8-1409-452b-8fec-ce471e89f85e, dialyvite is a prescription folic acid supplement with additional nutrients indicated for use in improving the nutritional status of renal dialysis patients,1
1613,1613,1613,1613,1613,1613,1613,2074,2074,2074,2074,2074,2074,2074,2074,2074,2074,2074,2074,2074,ef0391c1-bbd8-400d-a8ab-add565df2d6c, in the wasting syndrome in chronic renal failure uremia impaired metabolic functions of the kidney and to maintain levels when dietary intake of vitamins is inadequate or excretion or loss in excessive,1
1614,1614,1614,1614,1614,1614,1614,2075,2075,2075,2075,2075,2075,2075,2075,2075,2075,2075,2075,2075,ef0391c1-bbd8-400d-a8ab-add565df2d6c,also  highly effective as a stress vitamin,u
1615,1615,1615,1615,1615,1615,1615,2076,2076,2076,2076,2076,2076,2076,2076,2076,2076,2076,2076,2076,e7a81dfd-7591-442f-b839-4fb2fc79af98, renal caps is indicated in the wasting syndrome of chronic renal failure uremia and impaired metabolic functions of the kidney,1
1616,1616,1616,1616,1616,1616,1616,2077,2077,2077,2077,2077,2077,2077,2077,2077,2077,2077,2077,2077,e7a81dfd-7591-442f-b839-4fb2fc79af98,renal caps ia also highly effective as a stress vitamin,u
1617,1617,1617,1617,1617,1617,1617,2078,2078,2078,2078,2078,2078,2078,2078,2078,2078,2078,2078,2078,e3381145-ab3b-4f5a-8c45-9eadd53943a4,indications purefe ob plus is a prenatal vitamin mineral preparation designed to supply nutritional supplementation for women throughout pregnancy and during the postnatal period to lactating and non lactating mothers,
1618,1618,1618,1618,1618,1618,1618,2079,2079,2079,2079,2079,2079,2079,2079,2079,2079,2079,2079,2079,e3381145-ab3b-4f5a-8c45-9eadd53943a4,purefe ob plus may also be used to improve the nutritional status of women before conception,u
1619,1619,1619,1619,1619,1619,1619,2080,2080,2080,2080,2080,2080,2080,2080,2080,2080,2080,2080,2080,71f63741-cad4-43b5-bb3e-c63a188d10a2,indications purevit dualfe plus is indicated for the treatment of iron deficiency anemia and folate deficiency as in extended convalescence  menorrhagia  pregnancy  puberty  excessive blood loss and advanced age,1
1620,1620,1620,1620,1620,1620,1620,2081,2081,2081,2081,2081,2081,2081,2081,2081,2081,2081,2081,2081,71f63741-cad4-43b5-bb3e-c63a188d10a2,also for treatment of condition in which iron deficiency and vitamin c deficiency occur together  along with a deficient intake or increased need for b complex vitamins in chronic and acute illness  as well as cases of metabolic stress  and in convalescence,u
1621,1621,1621,1621,1621,1621,1621,2082,2082,2082,2082,2082,2082,2082,2082,2082,2082,2082,2082,2082,4d4d823b-ff2f-4746-9bd7-44def2b81347,indications for the treatment of anemia due to lack of iron and low folate as in menorrhagia  pregnancy  puberty  excessive blood loss  and advanced age,1
1622,1622,1622,1622,1622,1622,1622,2083,2083,2083,2083,2083,2083,2083,2083,2083,2083,2083,2083,2083,4d4d823b-ff2f-4746-9bd7-44def2b81347,also for treatment of conditions where iron and vitamin c deficiency occur together  along with a poor intake or increased need for b complex vitamins in chronic and acute illness  as well as cases of metabolic stress  and in periods of extended recovery,1
1623,1623,1623,1623,1623,1623,1623,2084,2084,2084,2084,2084,2084,2084,2084,2084,2084,2084,2084,2084,578a7991-b26a-4544-9836-d5018eaeff37,purefe plus is indicated for the treatment of iron deficiency anemia  and folate deficiency as in extended convalescence  menorrhagia  pregnancy  puberty  excessive blood loss  and advanced age,1
1624,1624,1624,1624,1624,1624,1624,2085,2085,2085,2085,2085,2085,2085,2085,2085,2085,2085,2085,2085,578a7991-b26a-4544-9836-d5018eaeff37,also for the treatment of conditions in which iron deficiency and vitamin c deficiency occur together  along with a deficient intake or increased need for b complex vitamins in chronic and acute illness  as well as cases of metabolic stress and in convalescence,1
1625,1625,1625,1625,1625,1625,1625,2086,2086,2086,2086,2086,2086,2086,2086,2086,2086,2086,2086,2086,eb368bb6-80e3-4df9-8a85-91df0a2ada6a,1  erivedge capsule is indicated for the treatment of adults with metastatic basal cell carcinoma  or with locally advanced basal cell carcinoma that has recurred following surgery or who are not candidates for surgery  and who are not candidates for radiation,1
1626,1626,1626,1626,1626,1626,1626,2087,2087,2087,2087,2087,2087,2087,2087,2087,2087,2087,2087,2087,eb368bb6-80e3-4df9-8a85-91df0a2ada6a,erivedge ( vismodegib ) capsule is a hedgehog pathway inhibitor indicated for the treatment of adults with metastatic basal cell carcinoma  or with locally advanced basal cell carcinoma that has recurred following surgery or who are not candidates for surgery  and who are not candidates for radiation,1
1627,1627,1627,1627,1627,1627,1627,2088,2088,2088,2088,2088,2088,2088,2088,2088,2088,2088,2088,2088,0013824b-6aee-4da4-affd-35bc6bf19d91, cefizox ( ceftizoxime for injection  usp ) is indicated in the treatment of infections due to susceptible strains of the microorganisms listed below,1
1628,1628,1628,1628,1628,1628,1628,2089,2089,2089,2089,2089,2089,2089,2089,2089,2089,2089,2089,2089,0013824b-6aee-4da4-affd-35bc6bf19d91,lower respiratory tract infections caused by klebsiella spp,1
1629,1629,1629,1629,1629,1629,1629,2090,2090,2090,2090,2090,2090,2090,2090,2090,2090,2090,2090,2090,0013824b-6aee-4da4-affd-35bc6bf19d91,proteus mirabilis escherichia coli haemophilus influenzae including ampicillin resistant strains staphylococcus aureus ( penicillinase and nonpenicillinase producing ) serratia spp,1
1630,1630,1630,1630,1630,1630,1630,2091,2091,2091,2091,2091,2091,2091,2091,2091,2091,2091,2091,2091,0013824b-6aee-4da4-affd-35bc6bf19d91,including s pneumoniae  but excluding enterococci,1
1631,1631,1631,1631,1631,1631,1631,2092,2092,2092,2092,2092,2092,2092,2092,2092,2092,2092,2092,2092,0013824b-6aee-4da4-affd-35bc6bf19d91,urinary tract infections caused by staphylococcus aureus ( penicillinase and nonpenicillinase producing ) escherichia coli pseudomonas spp,1
1632,1632,1632,1632,1632,1632,1632,2093,2093,2093,2093,2093,2093,2093,2093,2093,2093,2093,2093,2093,0013824b-6aee-4da4-affd-35bc6bf19d91,including p aeruginosa proteus mirabilis p vulgaris providencia rettgeri ( formerly proteus rettgeri ) and morganella morganii ( formerly proteus morganii ) klebsiella spp,1
1633,1633,1633,1633,1633,1633,1633,2094,2094,2094,2094,2094,2094,2094,2094,2094,2094,2094,2094,2094,0013824b-6aee-4da4-affd-35bc6bf19d91,including s marcescens and enterobacter spp,1
1634,1634,1634,1634,1634,1634,1634,2095,2095,2095,2095,2095,2095,2095,2095,2095,2095,2095,2095,2095,0013824b-6aee-4da4-affd-35bc6bf19d91,gonorrhea including uncomplicated cervical and urethral gonorrhea caused by neisseria gonorrhoeae,1
1635,1635,1635,1635,1635,1635,1635,2096,2096,2096,2096,2096,2096,2096,2096,2096,2096,2096,2096,2096,0013824b-6aee-4da4-affd-35bc6bf19d91,pelvic inflammatory disease caused by neisseria gonorrhoeae  escherichia coli or streptococcus agalactiae,1
1636,1636,1636,1636,1636,1636,1636,2097,2097,2097,2097,2097,2097,2097,2097,2097,2097,2097,2097,2097,0013824b-6aee-4da4-affd-35bc6bf19d91,note ceftizoxime  like other cephalosporins  has no activity against chlamydia trachomatis,2
1637,1637,1637,1637,1637,1637,1637,2098,2098,2098,2098,2098,2098,2098,2098,2098,2098,2098,2098,2098,0013824b-6aee-4da4-affd-35bc6bf19d91,therefore  when cephalosporins are used in the treatment of patients with pelvic inflammatory disease and c trachomatis is one of the suspected pathogens  appropriate anti chlamydial coverage should be added,4
1638,1638,1638,1638,1638,1638,1638,2099,2099,2099,2099,2099,2099,2099,2099,2099,2099,2099,2099,2099,0013824b-6aee-4da4-affd-35bc6bf19d91,intra abdominal infections caused by escherichia coli staphylococcus epidermidis streptococcus spp,1
1639,1639,1639,1639,1639,1639,1639,2100,2100,2100,2100,2100,2100,2100,2100,2100,2100,2100,2100,2100,0013824b-6aee-4da4-affd-35bc6bf19d91,( excluding enterococci ) enterobacter spp,1
1640,1640,1640,1640,1640,1640,1640,2101,2101,2101,2101,2101,2101,2101,2101,2101,2101,2101,2101,2101,0013824b-6aee-4da4-affd-35bc6bf19d91,including b fragilis and anaerobic cocci  including peptococcus spp,1
1641,1641,1641,1641,1641,1641,1641,2102,2102,2102,2102,2102,2102,2102,2102,2102,2102,2102,2102,2102,0013824b-6aee-4da4-affd-35bc6bf19d91,septicemia caused by streptococcus spp,1
1642,1642,1642,1642,1642,1642,1642,2103,2103,2103,2103,2103,2103,2103,2103,2103,2103,2103,2103,2103,0013824b-6aee-4da4-affd-35bc6bf19d91,including s pneumoniae ( but excluding enterococci ) staphylococcus aureus ( penicillinase and nonpenicillinase producing ) escherichia,1
1643,1643,1643,1643,1643,1643,1643,2104,2104,2104,2104,2104,2104,2104,2104,2104,2104,2104,2104,2104,bd2051f7-b887-46f6-8d4a-b099fcd08629,indications concept dhatm is a prescription prenatal vitamin mineral preparation containing omega 3 fatty acid supplements designed to supply nutritional supplementation for women throughout pregnancy and during the postnatal period to lactating and non lactating mothers,u
1644,1644,1644,1644,1644,1644,1644,2105,2105,2105,2105,2105,2105,2105,2105,2105,2105,2105,2105,2105,bd2051f7-b887-46f6-8d4a-b099fcd08629,concept dhatm may also be used to improve the nutritional status of women before conception,u
1645,1645,1645,1645,1645,1645,1645,2106,2106,2106,2106,2106,2106,2106,2106,2106,2106,2106,2106,2106,37992a25-68bd-4050-b936-596ddedc25a3,indications concept obtm is a prenatal supplement designed to improve the nutritional status for women throughout pregnancy and during the postnatal period to lactating and non lactating mothers,u
1646,1646,1646,1646,1646,1646,1646,2107,2107,2107,2107,2107,2107,2107,2107,2107,2107,2107,2107,2107,37992a25-68bd-4050-b936-596ddedc25a3,concept obtm may also be used to improve the nutritional status of women before conception,u
1647,1647,1647,1647,1647,1647,1647,2108,2108,2108,2108,2108,2108,2108,2108,2108,2108,2108,2108,2108,"Active Ingredient UNII(s)
2679MF687A; 68Y4CF58BV; 789U1901C5; 81G40H8B0T; 8K0I04919X; 935E97BOY8; 9679TC07X4; 9VU1KI44GP; E1UOL152H7; F05Q2T2JA0; H4N855PNZ1; I38ZP9992A; J41CSQ7QDS; P6YC3EG204; PQ6CK8PD0R; TLM2976OFR; ZAD9OKH9JC    f02b9e2f-426a-45e8-b98f-a6f382f9a28e
2679MF687A; 68Y4CF58BV; 789U1901C5; 81G40H8B0T; 8K0I04919X; 935E97BOY8; 9679TC07X4; 9VU1KI44GP; E1UOL152H7; F05Q2T2JA0; H4N855PNZ1; I38ZP9992A; J41CSQ7QDS; P6YC3EG204; PQ6CK8PD0R; TLM2976OFR; ZAD9OKH9JC    f02b9e2f-426a-45e8-b98f-a6f382f9a28e
Name: SET ID dtype: object",active ingredient unii ( s ) 2679mf687a 68y4cf58bv 789u1901c5 81g40h8b0t 8k0i04919x 935e97boy8 9679tc07x4 9vu1ki44gp e1uol152h7 f05q2t2ja0 h4n855pnz1 i38zp9992a j41csq7qds p6yc3eg204 pq6ck8pd0r tlm2976ofr zad9okh9jc active ingredient unii ( s ) 2679mf687a 68y4cf58 2679mf687a 68y4cf58bv 789u1901c5 81g40h8b0t 8k0i04919x 935e97boy8 9679tc07x4 9vu1ki44gp e1uol152h7 f05q2t2ja0 h4n855pnz1 i38zp9992a j41csq7qds p6yc3eg204 pq6ck8pd0r tlm2976ofr zad9okh9jc active ingredient unii ( s ) 2679mf687a 68y4cf58 name content xml  dtype object,0
1648,1648,1648,1648,1648,1648,1648,2110,2110,2110,2110,2110,2110,2110,2110,2110,2110,2110,2110,2110,22828f24-600d-4aa6-9b3a-cf8c991f9a97, vitafol ob is indicated to provide vitamin  mineral  supplementation prior to conception  throughout pregnancy  and during the postnatal period for the lactating and non lactating mother,1
1649,1649,1649,1649,1649,1649,1649,2111,2111,2111,2111,2111,2111,2111,2111,2111,2111,2111,2111,2111,a0e273e2-0876-4830-a903-282085be7f32, vitafol ob dha is indicated to provide vitamin  mineral and omega 3 fatty acid supplementation prior to conception  throughout pregnancy  and during the postnatal period for the lactating and non lactating mother including individuals with known allergies to fish,1
1650,1650,1650,1650,1650,1650,1650,2112,2112,2112,2112,2112,2112,2112,2112,2112,2112,2112,2112,2112,a0e273e2-0876-4830-a903-282085be7f32,vitafol ob dha does not contain fish  fish oils  fish proteins or fish byproducts,0
1651,1651,1651,1651,1651,1651,1651,2113,2113,2113,2113,2113,2113,2113,2113,2113,2113,2113,2113,2113,d4713072-1864-40ce-b003-a171fb2bc127, vitafol is indicated to provide vitamin  mineral supplementation to support optimum vitamin levels,1
1652,1652,1652,1652,1652,1652,1652,2114,2114,2114,2114,2114,2114,2114,2114,2114,2114,2114,2114,2114,025fee85-53a8-4161-a806-44fd95d0ca74,indications integra ftm is indicated for the treatment of iron deficiency anemia  and folate deficiency anemia,1
1653,1653,1653,1653,1653,1653,1653,2115,2115,2115,2115,2115,2115,2115,2115,2115,2115,2115,2115,2115,025fee85-53a8-4161-a806-44fd95d0ca74,integra ftm is indicated in pregnancy for the prevention and treatment of iron deficiency and to supply a maintenance dosage of folic acid,1
1654,1654,1654,1654,1654,1654,1654,2116,2116,2116,2116,2116,2116,2116,2116,2116,2116,2116,2116,2116,dbdee4c0-86fa-4857-b536-79bf9ebb911a, therapy with lipid altering agents should be only one component of multiple risk factor intervention in individuals at significantly increased risk for atherosclerotic vascular disease due to hypercholesterolemia,4
1655,1655,1655,1655,1655,1655,1655,2117,2117,2117,2117,2117,2117,2117,2117,2117,2117,2117,2117,2117,dbdee4c0-86fa-4857-b536-79bf9ebb911a,drug therapy is indicated as an adjunct to diet when the response to a diet restricted in saturated fat and cholesterol and other nonpharmacologic measures alone has been inadequate ( see also table 8 and the ncep treatment guidelines1 ),1
1656,1656,1656,1656,1656,1656,1656,2118,2118,2118,2118,2118,2118,2118,2118,2118,2118,2118,2118,2118,dbdee4c0-86fa-4857-b536-79bf9ebb911a,advicor advicor ( niacin extended release and lovastatin ) is indicated for use when treatment with both niaspan and lovastatin is appropriate,1
1657,1657,1657,1657,1657,1657,1657,2119,2119,2119,2119,2119,2119,2119,2119,2119,2119,2119,2119,2119,dbdee4c0-86fa-4857-b536-79bf9ebb911a,as described in the labeling for niaspan and lovastatin below  the components of advicor are both indicated for the treatment of hypercholesterolemia,1
1658,1658,1658,1658,1658,1658,1658,2120,2120,2120,2120,2120,2120,2120,2120,2120,2120,2120,2120,2120,dbdee4c0-86fa-4857-b536-79bf9ebb911a,patients receiving treatment with advicor should be on a standard cholesterol lowering diet and should continue on this diet during treatment,4
1659,1659,1659,1659,1659,1659,1659,2121,2121,2121,2121,2121,2121,2121,2121,2121,2121,2121,2121,2121,dbdee4c0-86fa-4857-b536-79bf9ebb911a,niaspan ( niacin extended release ) hypercholesterolemia niaspan is indicated as an adjunct to diet for reduction of elevated tc  ldl c  apo b and tg levels  and to increase hdl c in patients with primary hypercholesterolemia ( heterozygous familial and nonfamilial ) and mixed dyslipidemia ( table 7 )  when the response to an appropriate diet has been inadequate,1
1660,1660,1660,1660,1660,1660,1660,2122,2122,2122,2122,2122,2122,2122,2122,2122,2122,2122,2122,2122,dbdee4c0-86fa-4857-b536-79bf9ebb911a,secondary prevention of cardiovascular events in patients with a history of myocardial infarction and hypercholesterolemia  niacin is indicated to reduce the risk of recurrent nonfatal myocardial infarction,1
1661,1661,1661,1661,1661,1661,1661,2123,2123,2123,2123,2123,2123,2123,2123,2123,2123,2123,2123,2123,dbdee4c0-86fa-4857-b536-79bf9ebb911a,hypertriglyceridemia niacin is also indicated as adjunctive therapy for treatment of adult patients with very high serum triglyceride levels ( table 7 ) who present a risk of pancreatitis and who do not respond adequately to a determined dietary effort to control them,1
1662,1662,1662,1662,1662,1662,1662,2124,2124,2124,2124,2124,2124,2124,2124,2124,2124,2124,2124,2124,dbdee4c0-86fa-4857-b536-79bf9ebb911a,such patients typically have serum tg levels over 2000 mg dl and have elevations of vldl c as well as fasting chylomicrons ( table 7 ),0
1663,1663,1663,1663,1663,1663,1663,2125,2125,2125,2125,2125,2125,2125,2125,2125,2125,2125,2125,2125,dd749fb9-e279-4958-9534-ad75a5b6754b,1  therapy with lipid altering agents should be only one component of multiple risk factor intervention in individuals at significantly increased risk for atherosclerotic vascular disease due to hypercholesterolemia,4
1664,1664,1664,1664,1664,1664,1664,2126,2126,2126,2126,2126,2126,2126,2126,2126,2126,2126,2126,2126,dd749fb9-e279-4958-9534-ad75a5b6754b,drug therapy is indicated as an adjunct to diet when the response to a diet restricted in saturated fat and cholesterol and other nonpharmacologic measures alone has been inadequate,1
1665,1665,1665,1665,1665,1665,1665,2127,2127,2127,2127,2127,2127,2127,2127,2127,2127,2127,2127,2127,dd749fb9-e279-4958-9534-ad75a5b6754b,simcor is a combination of simvastatin  an hmg co a reductase inhibitor  and niacin extended release ( niaspan )  nicotinic acid,0
1666,1666,1666,1666,1666,1666,1666,2128,2128,2128,2128,2128,2128,2128,2128,2128,2128,2128,2128,2128,dd749fb9-e279-4958-9534-ad75a5b6754b,simcor is indicated to reduce elevated total c  ldl c  apo b  non hdl c  tg  or to increase hdl c in patients with primary hypercholesterolemia and mixed dyslipidemia when treatment with simvastatin monotherapy or niacin extended release monotherapy is considered inadequate,1
1667,1667,1667,1667,1667,1667,1667,2129,2129,2129,2129,2129,2129,2129,2129,2129,2129,2129,2129,2129,dd749fb9-e279-4958-9534-ad75a5b6754b,( 1 1 ) reduce tg in patients with hypertriglyceridemia when treatment with simvastatin monotherapy or niacin extended release monotherapy is considered inadequate,1
1668,1668,1668,1668,1668,1668,1668,2130,2130,2130,2130,2130,2130,2130,2130,2130,2130,2130,2130,2130,dd749fb9-e279-4958-9534-ad75a5b6754b,( 1 1 ) limitations of use no incremental benefit of simcor on cardiovascular morbidity and mortality over and above that demonstrated for simvastatin monotherapy and niacin monotherapy has been established,2
1669,1669,1669,1669,1669,1669,1669,2131,2131,2131,2131,2131,2131,2131,2131,2131,2131,2131,2131,2131,dd749fb9-e279-4958-9534-ad75a5b6754b,( 1 1 ) 1 1 patients with hypercholesterolemia requiring modifications of lipid profiles simcor simcor is indicated to reduce total c  ldl c  apo b  non hdl c  tg  or to increase hdl c in patients with primary hypercholesterolemia and mixed dyslipidemia when treatment with simvastatin monotherapy or niacin extended release monotherapy is considered inadequate,1
1670,1670,1670,1670,1670,1670,1670,2132,2132,2132,2132,2132,2132,2132,2132,2132,2132,2132,2132,2132,dd749fb9-e279-4958-9534-ad75a5b6754b,simcor is indicated to reduce tg in patients with hypertriglyceridemia when treatment with simvastatin monotherapy or niacin extended release monotherapy is considered inadequate,1
1671,1671,1671,1671,1671,1671,1671,2133,2133,2133,2133,2133,2133,2133,2133,2133,2133,2133,2133,2133,dd749fb9-e279-4958-9534-ad75a5b6754b,limitations of use no incremental benefit of simcor on cardiovascular morbidity and mortality over and above that demonstrated for simvastatin monotherapy and niacin monotherapy has been established,2
1672,1672,1672,1672,1672,1672,1672,2134,2134,2134,2134,2134,2134,2134,2134,2134,2134,2134,2134,2134,513a41d0-37d4-4355-8a6d-a2c643bce6fa, nardil has been found to be effective in depressed patients clinically characterized as atypical  nonendogenous  or neurotic,1
1673,1673,1673,1673,1673,1673,1673,2135,2135,2135,2135,2135,2135,2135,2135,2135,2135,2135,2135,2135,513a41d0-37d4-4355-8a6d-a2c643bce6fa,these patients often have mixed anxiety and depression and phobic or hypochondriacal features,0
1674,1674,1674,1674,1674,1674,1674,2136,2136,2136,2136,2136,2136,2136,2136,2136,2136,2136,2136,2136,513a41d0-37d4-4355-8a6d-a2c643bce6fa,there is less conclusive evidence of its usefulness with severely depressed patients with endogenous features,u
1675,1675,1675,1675,1675,1675,1675,2137,2137,2137,2137,2137,2137,2137,2137,2137,2137,2137,2137,2137,513a41d0-37d4-4355-8a6d-a2c643bce6fa,nardil should rarely be the first antidepressant drug used,4
1676,1676,1676,1676,1676,1676,1676,2138,2138,2138,2138,2138,2138,2138,2138,2138,2138,2138,2138,2138,513a41d0-37d4-4355-8a6d-a2c643bce6fa,rather  it is more suitable for use with patients who have failed to respond to the drugs more commonly used for these conditions,4
1677,1677,1677,1677,1677,1677,1677,2139,2139,2139,2139,2139,2139,2139,2139,2139,2139,2139,2139,2139,4f31df66-7dc2-1f04-e054-00144ff88e88, trimipramine maleate capsules are indicated for the relief of symptoms of depression,1
1678,1678,1678,1678,1678,1678,1678,2140,2140,2140,2140,2140,2140,2140,2140,2140,2140,2140,2140,2140,4f31df66-7dc2-1f04-e054-00144ff88e88,endogenous depression is more likely to be alleviated than other depressive states,u
1679,1679,1679,1679,1679,1679,1679,2141,2141,2141,2141,2141,2141,2141,2141,2141,2141,2141,2141,2141,4f31df66-7dc2-1f04-e054-00144ff88e88,in studies with neurotic outpatients  the drug appeared to be equivalent to amitriptyline in the less depressed patients but somewhat less effective than amitriptyline in the more severely depressed patients,0
1680,1680,1680,1680,1680,1680,1680,2142,2142,2142,2142,2142,2142,2142,2142,2142,2142,2142,2142,2142,4f31df66-7dc2-1f04-e054-00144ff88e88,in hospitalized depressed patients  trimipramine and imipramine were equally effective in relieving depression,u
1681,1681,1681,1681,1681,1681,1681,2143,2143,2143,2143,2143,2143,2143,2143,2143,2143,2143,2143,2143,70bb951d-fa42-5062-5d94-07292c6e7e73, intestinal bacteria formulated for symptoms of bacterial imbalance of the gastro intestinal tract such as diarrhea  dyspepsia  fever  cramping  nausea and vomiting,u
1682,1682,1682,1682,1682,1682,1682,2144,2144,2144,2144,2144,2144,2144,2144,2144,2144,2144,2144,2144,3b716e57-8def-6bde-e3c7-74d755933205, bacterial infection formulated for symptoms related to bacterial infections such as fever  chills  fatigue  swollen glands  pain  weakness and loss of appetite,u
1683,1683,1683,1683,1683,1683,1683,2145,2145,2145,2145,2145,2145,2145,2145,2145,2145,2145,2145,2145,920158ec-fee7-5e2b-0bcd-e56d3d0effde, glaucoma formulated for associated symptoms such as increased intraocular pressure  swelling of eyes  atrophy of optic nerve and narrow field of vision,u
1684,1684,1684,1684,1684,1684,1684,2146,2146,2146,2146,2146,2146,2146,2146,2146,2146,2146,2146,2146,29855045-5cc6-49c4-99a6-5906f3d41175, uses for symptomatic relief of mucous congestion  headaches  gas and bloating  itchiness  mild swelling  sensitivity to smell  difficulty thinking  mood swings  irritability,u
1685,1685,1685,1685,1685,1685,1685,2147,2147,2147,2147,2147,2147,2147,2147,2147,2147,2147,2147,2147,5a783af4-c84e-44a6-b073-52fa1309b381, a natural aid in the treatment of chronic cough  chest pain  mucus congestion  bleeding of the lungs  shortness of breath  difficult respiration  hoarseness  hay fever  asthma  recurring pneumonia  mental or physical fatigue  during times of chronic disease or malignancy,u
1686,1686,1686,1686,1686,1686,1686,2149,2149,2149,2149,2149,2149,2149,2149,2149,2149,2149,2149,2149,66a756f2-ac77-451c-a19a-08896d73b15c, chlordiazepoxide and amitriptyline hydrochloride tablets are indicated for the treatment of patients with moderate to severe depression associated with moderate to severe anxiety,1
1687,1687,1687,1687,1687,1687,1687,2150,2150,2150,2150,2150,2150,2150,2150,2150,2150,2150,2150,2150,66a756f2-ac77-451c-a19a-08896d73b15c,the therapeutic response to chlordiazepoxide and amitriptyline hydrochloride tablets occur earlier and with fewer treatment failures than when either amitriptyline or chlordiazepoxide is used alone,0
1688,1688,1688,1688,1688,1688,1688,2151,2151,2151,2151,2151,2151,2151,2151,2151,2151,2151,2151,2151,66a756f2-ac77-451c-a19a-08896d73b15c,symptoms likely to respond in the first week of treatment include insomnia  feelings of guilt or worthlessness  agitation  psychic and somatic anxiety  suicidal ideation and anorexia,0
1689,1689,1689,1689,1689,1689,1689,2152,2152,2152,2152,2152,2152,2152,2152,2152,2152,2152,2152,2152,e2937445-c015-c9a5-52f8-a2959da97290, perphenazine and amitriptyline hydrochloride tablets are recommended for treatment of ( 1 ) patients with moderate to severe anxiety and or agitation and depressed mood  ( 2 ) patients with depression in whom anxiety and or agitation are severe  and ( 3 ) patients with depression and anxiety in association with chronic physical disease,1
1690,1690,1690,1690,1690,1690,1690,2153,2153,2153,2153,2153,2153,2153,2153,2153,2153,2153,2153,2153,e2937445-c015-c9a5-52f8-a2959da97290,in many of these patients  anxiety masks the depressive state so that  although therapy with a tranquilizer appears to be indicated  the administration of a tranquilizer alone will not be adequate,4
1691,1691,1691,1691,1691,1691,1691,2154,2154,2154,2154,2154,2154,2154,2154,2154,2154,2154,2154,2154,e2937445-c015-c9a5-52f8-a2959da97290,schizophrenic patients who have associated depressive symptoms should be considered for therapy with perphenazine and amitriptyline hydrochloride tablets,u
1692,1692,1692,1692,1692,1692,1692,2155,2155,2155,2155,2155,2155,2155,2155,2155,2155,2155,2155,2155,"Active Ingredient UNII(s)
26LUD4JO9K; N91BDP6H0X    f72a1419-0df4-4aaa-84cf-606a17cac493
26LUD4JO9K; N91BDP6H0X    f72a1419-0df4-4aaa-84cf-606a17cac493
Name: SET ID dtype: object",active ingredient unii ( s ) 26lud4jo9k n91bdp6h0x active ingredient unii ( s ) 26lud4jo9k n91bdp6h 26lud4jo9k n91bdp6h0x active ingredient unii ( s ) 26lud4jo9k n91bdp6h name content xml  dtype object,0
1693,1693,1693,1693,1693,1693,1693,2157,2157,2157,2157,2157,2157,2157,2157,2157,2157,2157,2157,2157,06cae35d-4312-47dd-a600-3ef043398710,indications temporarily supports the body to rebalance estrogen output,1
1694,1694,1694,1694,1694,1694,1694,2158,2158,2158,2158,2158,2158,2158,2158,2158,2158,2158,2158,2158,06cae35d-4312-47dd-a600-3ef043398710,symptoms may include mood swings  hot flashes  irritability  lack of energy,u
1695,1695,1695,1695,1695,1695,1695,2159,2159,2159,2159,2159,2159,2159,2159,2159,2159,2159,2159,2159,a572ec9e-fc3e-433b-aa57-12dd90b4c28d, uses for symptomatic relief of headaches  vertigo  aversion to light  forgetfulness and confusion  brain fatigue  mental weakness  anxiety and fear  weight loss due to impaired nutrition,1
1696,1696,1696,1696,1696,1696,1696,2160,2160,2160,2160,2160,2160,2160,2160,2160,2160,2160,2160,2160,51ff7db5-aaf9-4c3c-86e6-958ebf16b60f, nefazodone hydrochloride tablets are indicated for the treatment of depression,1
1697,1697,1697,1697,1697,1697,1697,2161,2161,2161,2161,2161,2161,2161,2161,2161,2161,2161,2161,2161,51ff7db5-aaf9-4c3c-86e6-958ebf16b60f,when deciding among the alternative treatments available for this condition  the prescriber should consider the risk of hepatic failure associated with nefazodone hydrochloride treatment ( see warnings ),4
1698,1698,1698,1698,1698,1698,1698,2162,2162,2162,2162,2162,2162,2162,2162,2162,2162,2162,2162,2162,51ff7db5-aaf9-4c3c-86e6-958ebf16b60f,in many cases  this would lead to the conclusion that other drugs should be tried first,0
1699,1699,1699,1699,1699,1699,1699,2163,2163,2163,2163,2163,2163,2163,2163,2163,2163,2163,2163,2163,51ff7db5-aaf9-4c3c-86e6-958ebf16b60f,the efficacy of nefazodone in the treatment of depression was established in 6 to 8 week controlled trials of outpatients and in a 6 week controlled trial of depressed inpatients whose diagnoses corresponded most closely to the dsm iii or dsm iiir category of major depressive disorder ( see clinical pharmacology ),0
1700,1700,1700,1700,1700,1700,1700,2164,2164,2164,2164,2164,2164,2164,2164,2164,2164,2164,2164,2164,51ff7db5-aaf9-4c3c-86e6-958ebf16b60f,a major depressive episode implies a prominent and relatively persistent depressed or dysphoric mood that usually interferes with daily functioning ( nearly every day for at least 2 weeks ),0
1701,1701,1701,1701,1701,1701,1701,2165,2165,2165,2165,2165,2165,2165,2165,2165,2165,2165,2165,2165,51ff7db5-aaf9-4c3c-86e6-958ebf16b60f,it must include either depressed mood or loss of interest or pleasure and at least five of the following nine symptoms depressed mood  loss of interest in usual activities  significant change in weight and or appetite  insomnia or hypersomnia  psychomotor agitation or retardation  increased fatigue  feelings of guilt or worthlessness  slowed thinking or impaired concentration  a suicide attempt or suicidal ideation,0
1702,1702,1702,1702,1702,1702,1702,2166,2166,2166,2166,2166,2166,2166,2166,2166,2166,2166,2166,2166,51ff7db5-aaf9-4c3c-86e6-958ebf16b60f,the efficacy of nefazodone in reducing relapse in patients with major depression who were judged to have had a satisfactory clinical response to 16 weeks of open label nefazodone treatment for an acute depressive episode has been demonstrated in a randomized placebo controlled trial ( see clinical pharmacology ),u
1703,1703,1703,1703,1703,1703,1703,2167,2167,2167,2167,2167,2167,2167,2167,2167,2167,2167,2167,2167,51ff7db5-aaf9-4c3c-86e6-958ebf16b60f,although remitted patients were followed for as long as 36 weeks in the study cited ( i e  52 weeks total )  the physician who elects to use nefazodone for extended periods should periodically reevaluate the long term usefulness of the drug for the individual patient,0
1704,1704,1704,1704,1704,1704,1704,2168,2168,2168,2168,2168,2168,2168,2168,2168,2168,2168,2168,2168,5b025376-4ecd-8422-6a4e-2f759bd06240, macular degeneration formulated for symptoms of atrophic and neovascular forms of macular degeneration as well as symptoms associated with the macula and retina,1
1705,1705,1705,1705,1705,1705,1705,2169,2169,2169,2169,2169,2169,2169,2169,2169,2169,2169,2169,2169,542a0691-7c57-6110-1390-9d347fc204c5, eye floaters formulated for associated symptoms such as dark or grey specks and strings or cobwebs of material floating within the field of vision,1
1706,1706,1706,1706,1706,1706,1706,2170,2170,2170,2170,2170,2170,2170,2170,2170,2170,2170,2170,2170,28a58cbe-95cf-48de-a8ad-030135fcbf6c, for the treatment of the following symptoms associated with malignancy and cancerous states,0
1707,1707,1707,1707,1707,1707,1707,2171,2171,2171,2171,2171,2171,2171,2171,2171,2171,2171,2171,2171,28a58cbe-95cf-48de-a8ad-030135fcbf6c,for tissues that tend to be more susceptible to cancer,0
1708,1708,1708,1708,1708,1708,1708,2172,2172,2172,2172,2172,2172,2172,2172,2172,2172,2172,2172,2172,28a58cbe-95cf-48de-a8ad-030135fcbf6c,debility  nervous exhaustion and weakness of body and mind,1
1709,1709,1709,1709,1709,1709,1709,2173,2173,2173,2173,2173,2173,2173,2173,2173,2173,2173,2173,2173,28a58cbe-95cf-48de-a8ad-030135fcbf6c,anxiety  fear  discouragement  apathy  loss of will power and depression,1
1710,1710,1710,1710,1710,1710,1710,2174,2174,2174,2174,2174,2174,2174,2174,2174,2174,2174,2174,2174,28a58cbe-95cf-48de-a8ad-030135fcbf6c,profound acting remedy for every organ and tissue of the body including liver  lymph  digestion  musculoskeletal  respiratory  nervous system and circulatory system based on the homeopathic materia medicas,u
1711,1711,1711,1711,1711,1711,1711,2175,2175,2175,2175,2175,2175,2175,2175,2175,2175,2175,2175,2175,f5bbbf87-f059-4bbd-aea9-27d31462654f, cefadroxil capsules usp are indicated for the treatment of patients with infection caused by susceptible strains of the designated organisms in the following diseases urinary tract infections caused by e coli  p mirabilis  and klebsiella species,1
1712,1712,1712,1712,1712,1712,1712,2176,2176,2176,2176,2176,2176,2176,2176,2176,2176,2176,2176,2176,f5bbbf87-f059-4bbd-aea9-27d31462654f,skin and skin structure infections caused by staphylococci and or streptococci,1
1713,1713,1713,1713,1713,1713,1713,2177,2177,2177,2177,2177,2177,2177,2177,2177,2177,2177,2177,2177,f5bbbf87-f059-4bbd-aea9-27d31462654f,pharyngitis and or tonsillitis caused by streptococcus pyogenes ( group a beta hemolytic streptococci ),1
1714,1714,1714,1714,1714,1714,1714,2178,2178,2178,2178,2178,2178,2178,2178,2178,2178,2178,2178,2178,f5bbbf87-f059-4bbd-aea9-27d31462654f,note only penicillin by the intramuscular route of administration has been shown to be effective in the prophylaxis of rheumatic fever,u
1715,1715,1715,1715,1715,1715,1715,2179,2179,2179,2179,2179,2179,2179,2179,2179,2179,2179,2179,2179,f5bbbf87-f059-4bbd-aea9-27d31462654f,cefadroxil monohydrate is generally effective in the eradication of streptococci from the oropharynx,1
1716,1716,1716,1716,1716,1716,1716,2180,2180,2180,2180,2180,2180,2180,2180,2180,2180,2180,2180,2180,f5bbbf87-f059-4bbd-aea9-27d31462654f,however  data establishing the efficacy of cefadroxil monohydrate for the prophylaxis of subsequent rheumatic fever are not available,0
1717,1717,1717,1717,1717,1717,1717,2181,2181,2181,2181,2181,2181,2181,2181,2181,2181,2181,2181,2181,f5bbbf87-f059-4bbd-aea9-27d31462654f,note culture and susceptibility tests should be initiated prior to and during therapy,0
1718,1718,1718,1718,1718,1718,1718,2182,2182,2182,2182,2182,2182,2182,2182,2182,2182,2182,2182,2182,f5bbbf87-f059-4bbd-aea9-27d31462654f,renal function studies should be performed when indicated,u
1719,1719,1719,1719,1719,1719,1719,2183,2183,2183,2183,2183,2183,2183,2183,2183,2183,2183,2183,2183,f5bbbf87-f059-4bbd-aea9-27d31462654f,to reduce the development of drug resistant bacteria and maintain the effectiveness of cefadroxil capsules and other antibacterial drugs  cefadroxil capsules should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria,0
1720,1720,1720,1720,1720,1720,1720,2186,2186,2186,2186,2186,2186,2186,2186,2186,2186,2186,2186,2186,ab0efc75-0598-4f4e-91ad-6195bb2661fe, dantrolene sodium for injection is indicated  along with appropriate supportive measures  for the management of the fulminant hypermetabolism of skeletal muscle characteristic of malignant hyperthermia crises in patients of all ages,1
1721,1721,1721,1721,1721,1721,1721,2187,2187,2187,2187,2187,2187,2187,2187,2187,2187,2187,2187,2187,ab0efc75-0598-4f4e-91ad-6195bb2661fe,dantrolene sodium for injection should be administered by continuous rapid intravenous push as soon as the malignant hyperthermia reaction is recognized ( i e  tachycardia  tachypnea  central venous desaturation  hypercarbia  metabolic acidosis  skeletal muscle rigidity  increased utilization of anesthesia circuit carbon dioxide absorber  cyanosis and mottling of the skin  and  in many cases  fever ),4
1722,1722,1722,1722,1722,1722,1722,2188,2188,2188,2188,2188,2188,2188,2188,2188,2188,2188,2188,2188,ab0efc75-0598-4f4e-91ad-6195bb2661fe,dantrolene sodium for injection is also indicated preoperatively  and sometimes postoperatively  to prevent or attenuate the development of clinical and laboratory signs of malignant hyperthermia in individuals judged to be malignant hyperthermia susceptible,1
1723,1723,1723,1723,1723,1723,1723,2189,2189,2189,2189,2189,2189,2189,2189,2189,2189,2189,2189,2189,a39b46a2-f7e1-444f-b992-6f81b5e306ef, utira c tablets are indicated for the treatment of symptoms of irritative voiding,1
1724,1724,1724,1724,1724,1724,1724,2190,2190,2190,2190,2190,2190,2190,2190,2190,2190,2190,2190,2190,a39b46a2-f7e1-444f-b992-6f81b5e306ef,indicated for the relief of local symptoms  such as inflammation  hypermotility  and pain  which accompany lower urinary tract infections,1
1725,1725,1725,1725,1725,1725,1725,2191,2191,2191,2191,2191,2191,2191,2191,2191,2191,2191,2191,2191,a39b46a2-f7e1-444f-b992-6f81b5e306ef,indicated for the relief of urinary tract symptoms caused by diagnostic procedures,1
1726,1726,1726,1726,1726,1726,1726,2192,2192,2192,2192,2192,2192,2192,2192,2192,2192,2192,2192,2192,1d80a11c-6f86-403b-85d4-32ec1924dbe9, urelle is indicated for the treatment of symptoms of irritative voiding,1
1727,1727,1727,1727,1727,1727,1727,2195,2195,2195,2195,2195,2195,2195,2195,2195,2195,2195,2195,2195,02f19c91-9d39-4843-b6a4-25d81280b067, vilevev mb is indicated for the treatment of symptoms of irritative voiding,1
1728,1728,1728,1728,1728,1728,1728,2196,2196,2196,2196,2196,2196,2196,2196,2196,2196,2196,2196,2196,02f19c91-9d39-4843-b6a4-25d81280b067,indicated for the relief of local symptoms  such as inflammation  hypermotility  and pain  which accompany lower urinary tract infections and antispasmodic,1
1729,1729,1729,1729,1729,1729,1729,2198,2198,2198,2198,2198,2198,2198,2198,2198,2198,2198,2198,2198,2c1f0f4c-e57b-4df5-9a58-41d39c3d8893, hyophen tablets are indicated for the treatment of symptoms of irritative voiding,1
1730,1730,1730,1730,1730,1730,1730,2201,2201,2201,2201,2201,2201,2201,2201,2201,2201,2201,2201,2201,8baba4ea-2855-42fa-9bd9-5a7548d4cec3,1  imfinzi is a programmed death ligand 1 ( pd l1 ) blocking antibody indicated for the treatment of patients with locally advanced or metastatic urothelial carcinoma who ohave disease progression during or following platinum containing chemotherapy,1
1731,1731,1731,1731,1731,1731,1731,2202,2202,2202,2202,2202,2202,2202,2202,2202,2202,2202,2202,2202,8baba4ea-2855-42fa-9bd9-5a7548d4cec3,( 1 1 ) ohave disease progression within 12 months of neoadjuvant or adjuvant treatment with platinum containing chemotherapy,1
1732,1732,1732,1732,1732,1732,1732,2203,2203,2203,2203,2203,2203,2203,2203,2203,2203,2203,2203,2203,8baba4ea-2855-42fa-9bd9-5a7548d4cec3,( 1 1 ) this indication is approved under accelerated approval based on tumor response rate and duration of response,0
1733,1733,1733,1733,1733,1733,1733,2205,2205,2205,2205,2205,2205,2205,2205,2205,2205,2205,2205,2205,8baba4ea-2855-42fa-9bd9-5a7548d4cec3,( 1 1 ) unresectable  stage iii non small cell lung cancer ( nsclc ) whose disease has not progressed following concurrent platinum based chemotherapy and radiation therapy,1
1734,1734,1734,1734,1734,1734,1734,2206,2206,2206,2206,2206,2206,2206,2206,2206,2206,2206,2206,2206,8baba4ea-2855-42fa-9bd9-5a7548d4cec3,( 1 2 ) 1 1 urothelial carcinoma imfinzi is indicated for the treatment of patients with locally advanced or metastatic urothelial carcinoma who have disease progression during or following platinum containing chemotherapy,1
1735,1735,1735,1735,1735,1735,1735,2207,2207,2207,2207,2207,2207,2207,2207,2207,2207,2207,2207,2207,8baba4ea-2855-42fa-9bd9-5a7548d4cec3,have disease progression within 12 months of neoadjuvant or adjuvant treatment with platinum containing chemotherapy,0
1736,1736,1736,1736,1736,1736,1736,2208,2208,2208,2208,2208,2208,2208,2208,2208,2208,2208,2208,2208,8baba4ea-2855-42fa-9bd9-5a7548d4cec3,this indication is approved under accelerated approval based on tumor response rate and duration of response,0
1737,1737,1737,1737,1737,1737,1737,2209,2209,2209,2209,2209,2209,2209,2209,2209,2209,2209,2209,2209,8baba4ea-2855-42fa-9bd9-5a7548d4cec3,continued approval for this indication may be contingent upon verification and description of clinical benefit in confirmatory trials see clinical studies ( 14 1 ),0
1738,1738,1738,1738,1738,1738,1738,2210,2210,2210,2210,2210,2210,2210,2210,2210,2210,2210,2210,2210,8baba4ea-2855-42fa-9bd9-5a7548d4cec3,1 2 non small cell lung cancer imfinzi is indicated for the treatment of patients with unresectable stage iii non small cell lung cancer ( nsclc ) whose disease has not progressed following concurrent platinum based chemotherapy and radiation therapy,1
1739,1739,1739,1739,1739,1739,1739,2211,2211,2211,2211,2211,2211,2211,2211,2211,2211,2211,2211,2211,caf64301-262c-45ca-acd1-a9d6696c584e, bextra tablets are indicated for relief of the signs and symptoms of osteoarthritis and adult rheumatoid arthritis,1
1740,1740,1740,1740,1740,1740,1740,2212,2212,2212,2212,2212,2212,2212,2212,2212,2212,2212,2212,2212,caf64301-262c-45ca-acd1-a9d6696c584e,for the treatment of primary dysmenorrhea,1
1741,1741,1741,1741,1741,1741,1741,2218,2218,2218,2218,2218,2218,2218,2218,2218,2218,2218,2218,2218,cd358c23-b653-49f8-8062-9cd5ee4dbead,indications for use the haemonetics 250ml anticoagulant citrate phosphate double dextrose ( cp2d ) and 250ml additive solution formula 3 ( as 3 ) nutrient solution are intended to be used only with automated apheresis devices for collecting human blood and blood components,1
1742,1742,1742,1742,1742,1742,1742,2219,2219,2219,2219,2219,2219,2219,2219,2219,2219,2219,2219,2219,cd358c23-b653-49f8-8062-9cd5ee4dbead,the anticoagulant solution is metered by the apheresis machine into the collected whole blood,4
1743,1743,1743,1743,1743,1743,1743,2220,2220,2220,2220,2220,2220,2220,2220,2220,2220,2220,2220,2220,cd358c23-b653-49f8-8062-9cd5ee4dbead,it is not to be infused directly into the donor,4
1744,1744,1744,1744,1744,1744,1744,2221,2221,2221,2221,2221,2221,2221,2221,2221,2221,2221,2221,2221,cd358c23-b653-49f8-8062-9cd5ee4dbead,after the anticoagulant is used  the bag in which it was contained is discarded,4
1745,1745,1745,1745,1745,1745,1745,2222,2222,2222,2222,2222,2222,2222,2222,2222,2222,2222,2222,2222,cd358c23-b653-49f8-8062-9cd5ee4dbead,when collecting plasma in the rbcp protocol  the plasma is collected into an empty plasma collection bag,4
1746,1746,1746,1746,1746,1746,1746,2223,2223,2223,2223,2223,2223,2223,2223,2223,2223,2223,2223,2223,cd358c23-b653-49f8-8062-9cd5ee4dbead,one hundred milliliters ( 100ml ) of as 3 is transferred into one rbc collection bag when using the rbcp protocol or 2 separate bags when using the 2rbc protocol,4
1747,1747,1747,1747,1747,1747,1747,2224,2224,2224,2224,2224,2224,2224,2224,2224,2224,2224,2224,2224,cd358c23-b653-49f8-8062-9cd5ee4dbead,as 3 solution provides nutrients to keep the red blood cells viable for 42 days when refrigerated,4
1748,1748,1748,1748,1748,1748,1748,2225,2225,2225,2225,2225,2225,2225,2225,2225,2225,2225,2225,2225,cd358c23-b653-49f8-8062-9cd5ee4dbead,cp2d is also indicated for the collection of ffp and pf24 plasma  collected and stored plasma collected using the 822  822 2p and 822f 2p disposable sets may be frozen within 8 hours ( ffp ) or within 24 hours which includes 8 hours room temperature storage and 16 hours refrigeration storage ( pf24 ),1
1749,1749,1749,1749,1749,1749,1749,2226,2226,2226,2226,2226,2226,2226,2226,2226,2226,2226,2226,2226,cd358c23-b653-49f8-8062-9cd5ee4dbead,the 300ml as 3 is used in conjunction with automated red blood cell washing devices,4
1750,1750,1750,1750,1750,1750,1750,2227,2227,2227,2227,2227,2227,2227,2227,2227,2227,2227,2227,2227,cd358c23-b653-49f8-8062-9cd5ee4dbead,as 3 serves as the nutrient solution for storage of the red blood cell product after deglycerolization,4
1751,1751,1751,1751,1751,1751,1751,2228,2228,2228,2228,2228,2228,2228,2228,2228,2228,2228,2228,2228,cd358c23-b653-49f8-8062-9cd5ee4dbead,the red blood cells are washed using the model 215 system,4
1752,1752,1752,1752,1752,1752,1752,2229,2229,2229,2229,2229,2229,2229,2229,2229,2229,2229,2229,2229,cd358c23-b653-49f8-8062-9cd5ee4dbead,as 3 is used for priming the disposable and for the last wash of the red blood cells,4
1753,1753,1753,1753,1753,1753,1753,2230,2230,2230,2230,2230,2230,2230,2230,2230,2230,2230,2230,2230,cd358c23-b653-49f8-8062-9cd5ee4dbead,the washed cells are then re suspended in 100ml of the as 3 before transfer into a product collection bag or storage bag,4
1754,1754,1754,1754,1754,1754,1754,2231,2231,2231,2231,2231,2231,2231,2231,2231,2231,2231,2231,2231,cd358c23-b653-49f8-8062-9cd5ee4dbead,additive solution formula 3 ( as 3 ) provides nutrients to keep the washed red blood cells viable for up to 14 days after washing when refrigerated,4
1755,1755,1755,1755,1755,1755,1755,2232,2232,2232,2232,2232,2232,2232,2232,2232,2232,2232,2232,2232,cd358c23-b653-49f8-8062-9cd5ee4dbead,neither the cp2d nor the as 3 container is used for the storage of blood or blood components,0
1756,1756,1756,1756,1756,1756,1756,2248,2248,2248,2248,2248,2248,2248,2248,2248,2248,2248,2248,2248,bc26abed-8e6e-475d-8ab3-abf7d0377003,indications oracit is indicated for the treatment of metabolic acidosis,1
1757,1757,1757,1757,1757,1757,1757,2249,2249,2249,2249,2249,2249,2249,2249,2249,2249,2249,2249,2249,bc26abed-8e6e-475d-8ab3-abf7d0377003,this solution is also useful in conditions where long term maintenance of alkaline urine is needed ( e g,u
1758,1758,1758,1758,1758,1758,1758,2250,2250,2250,2250,2250,2250,2250,2250,2250,2250,2250,2250,2250,bc26abed-8e6e-475d-8ab3-abf7d0377003,uric acid and cystine calculi of the urinary tract ),u
1759,1759,1759,1759,1759,1759,1759,2251,2251,2251,2251,2251,2251,2251,2251,2251,2251,2251,2251,2251,bc26abed-8e6e-475d-8ab3-abf7d0377003,oracit is also effective in treatment for acidosis of certain renal tubular disorders,1
1760,1760,1760,1760,1760,1760,1760,2252,2252,2252,2252,2252,2252,2252,2252,2252,2252,2252,2252,2252,395aec48-198a-4aed-8e38-7accfb3232f9,1  anticoagulant citrate dextrose solution usp ( acd ) solution a is an anticoagulant for blood collection for use only with apheresis devices,1
1761,1761,1761,1761,1761,1761,1761,2253,2253,2253,2253,2253,2253,2253,2253,2253,2253,2253,2253,2253,395aec48-198a-4aed-8e38-7accfb3232f9,see dosage and administration ( 2 ),0
1762,1762,1762,1762,1762,1762,1762,2254,2254,2254,2254,2254,2254,2254,2254,2254,2254,2254,2254,2254,395aec48-198a-4aed-8e38-7accfb3232f9,anticoagulant citrate dextrose solution usp ( acd ) solution a is an anticoagulant for blood collection for use only with apheresis devices,1
1763,1763,1763,1763,1763,1763,1763,2255,2255,2255,2255,2255,2255,2255,2255,2255,2255,2255,2255,2255,490c77d7-47f8-439f-aa37-953692f4c23a, cytra k crystals is an effective alkalinizing agent useful in those conditions where long term maintenance of an alkaline urine is desirable  such as in patients with uric acid and cystine calculi of the urinary tract  especially when the administration of sodium salts is undesirable or contraindicated,1
1764,1764,1764,1764,1764,1764,1764,2257,2257,2257,2257,2257,2257,2257,2257,2257,2257,2257,2257,2257,490c77d7-47f8-439f-aa37-953692f4c23a,it is also effective in correcting the acidosis of certain renal tubular disorders where the administration of potassium citrate may be preferable,1
1765,1765,1765,1765,1765,1765,1765,2258,2258,2258,2258,2258,2258,2258,2258,2258,2258,2258,2258,2258,490c77d7-47f8-439f-aa37-953692f4c23a,cytra k crystals is highly concentrated  and when administered after meals and before bedtime  allows one to maintain an alkaline urinary ph around the clock  usually without the necessity of a 2 a m dose,u
1766,1766,1766,1766,1766,1766,1766,2259,2259,2259,2259,2259,2259,2259,2259,2259,2259,2259,2259,2259,490c77d7-47f8-439f-aa37-953692f4c23a,cytra k crystals alkalinizes the urine without producing a systemic alkalosis in recommended dosage,u
1767,1767,1767,1767,1767,1767,1767,2261,2261,2261,2261,2261,2261,2261,2261,2261,2261,2261,2261,2261,490c77d7-47f8-439f-aa37-953692f4c23a,potassium citrate does not neutralize the gastric juice or disturb digestion,0
1768,1768,1768,1768,1768,1768,1768,2262,2262,2262,2262,2262,2262,2262,2262,2262,2262,2262,2262,2262,8baab7a7-5d20-46ad-9c4a-762992ef6b51,intended use the exalenz breathid breath test system is intended for use in the qualitative detection of urease associated with helicobacter pylori ( h pylori ) in the human stomach and as an aid in the initial diagnosis and post treatment monitoring of h pylori infection in adult patients,1
1769,1769,1769,1769,1769,1769,1769,2263,2263,2263,2263,2263,2263,2263,2263,2263,2263,2263,2263,2263,8baab7a7-5d20-46ad-9c4a-762992ef6b51,this test should be used after at least four weeks of h pylori eradication therapy,0
1770,1770,1770,1770,1770,1770,1770,2264,2264,2264,2264,2264,2264,2264,2264,2264,2264,2264,2264,2264,8baab7a7-5d20-46ad-9c4a-762992ef6b51,for these purposes  the system utilizes molecular correlation spectrometry ( mcs ) for the measurement of the ratio of 13co2 to 12co2 in breath samples,0
1771,1771,1771,1771,1771,1771,1771,2265,2265,2265,2265,2265,2265,2265,2265,2265,2265,2265,2265,2265,8baab7a7-5d20-46ad-9c4a-762992ef6b51,the exalenz breathid system is used to detect and monitor h pylori infection by measuring changes in the 13co2 to 12co2 ratio in a patient s breath following the ingestion of 13c urea the exalenz breathid breath test system consists of the idkit hp kits containing 13c urea tablet  75 mg for oral solution and 4 3 g citrica powder ( 4g citric acid ) for oral solution the breathid device and the idcheck system quality control accessory the device is for use by trained healthcare professionals and the test kit is to be administered under a physician s supervision,1
1772,1772,1772,1772,1772,1772,1772,2266,2266,2266,2266,2266,2266,2266,2266,2266,2266,2266,2266,2266,1ac6098e-abfc-4ad3-8f60-74e7c3aecd0d, demeclocycline hcl tablets  usp are indicated in the treatment of infections caused by susceptible strains of the designated microorganisms in the conditions below rocky mountain spotted fever  typhus fever and the typhus group  q fever  rickettsialpox and tick fevers caused by rickettsiae respiratory tract infections caused by mycoplasma pneumoniae lymphogranuloma venereum due to chlamydia trachomatis psittacosis ( ornithosis ) due to chlamydia psittaci trachoma due to chlamydia trachomatis  although the infectious agent is not always eliminated as judged by immunofluorescence inclusion conjunctivitis caused by chlamydia trachomatis nongonococcal urethritis in adults caused by ureaplasma urealyticum or chlamydia trachomatis relapsing fever due to borrelia recurrentis chancroid caused by haemophilus ducreyi plague due to yersinia pestis tularemia due to francisella tularensis cholera caused by vibrio cholerae campylobacter fetus infections cause by campylobacter fetus brucellosis due to brucella species ( in conjunction with streptomycin ) bartonellosis due to bartonella bacilliformis granuloma inguinale caused by calymmatobacterium granulomatis demeclocycline hcl tablets  usp are indicated for treatment of infections by the following gram negative microorganisms  when bacteriologic testing indicates appropriate susceptibility to the drug escherichia coli enterobacter aerogenes shigella species acinetobacter species respiratory tract infections caused by haemophilus influenzae respiratory tract and urinary tract infections caused by klebsiella species demeclocycline hcl tablets  usp are indicat,1
1773,1773,1773,1773,1773,1773,1773,2267,2267,2267,2267,2267,2267,2267,2267,2267,2267,2267,2267,2267,493fa2ab-4eb0-4434-9739-3079b2f0e272, administration of sodium iodide i 123 capsules is indicated as a diagnostic procedure to be used in evaluating thyroid function and or morphology,1
1774,1774,1774,1774,1774,1774,1774,2268,2268,2268,2268,2268,2268,2268,2268,2268,2268,2268,2268,2268,39ad8799-00a4-4fc8-9852-c0536350c474,1  anthim is a monoclonal antibody directed against the protective antigen of bacillus anthracis,u
1775,1775,1775,1775,1775,1775,1775,2269,2269,2269,2269,2269,2269,2269,2269,2269,2269,2269,2269,2269,39ad8799-00a4-4fc8-9852-c0536350c474,it is indicated in adult and pediatric patients for treatment of inhalational anthrax due to b anthracis in combination with appropriate antibacterial drugs and  for prophylaxis of inhalational anthrax when alternative therapies are not available or are not appropriate,1
1776,1776,1776,1776,1776,1776,1776,2270,2270,2270,2270,2270,2270,2270,2270,2270,2270,2270,2270,2270,39ad8799-00a4-4fc8-9852-c0536350c474,( 1 1 ) limitations of use anthim should only be used for prophylaxis when its benefit for prevention of inhalational anthrax outweighs the risk of hypersensitivity and anaphylaxis,4
1777,1777,1777,1777,1777,1777,1777,2271,2271,2271,2271,2271,2271,2271,2271,2271,2271,2271,2271,2271,39ad8799-00a4-4fc8-9852-c0536350c474,( 1 2  5 1 ) the effectiveness of anthim is based solely on efficacy studies in animal models of inhalational anthrax,0
1778,1778,1778,1778,1778,1778,1778,2272,2272,2272,2272,2272,2272,2272,2272,2272,2272,2272,2272,2272,39ad8799-00a4-4fc8-9852-c0536350c474,( 1 2  14 ) there have been no studies of the safety or pharmacokinetics ( pk ) of anthim in the pediatric population,0
1779,1779,1779,1779,1779,1779,1779,2273,2273,2273,2273,2273,2273,2273,2273,2273,2273,2273,2273,2273,39ad8799-00a4-4fc8-9852-c0536350c474,dosing in pediatric patients was derived using a population pk approach,0
1780,1780,1780,1780,1780,1780,1780,2274,2274,2274,2274,2274,2274,2274,2274,2274,2274,2274,2274,2274,39ad8799-00a4-4fc8-9852-c0536350c474,( 1 2  8 4 ) anthim does not have direct antibacterial activity,0
1781,1781,1781,1781,1781,1781,1781,2275,2275,2275,2275,2275,2275,2275,2275,2275,2275,2275,2275,2275,39ad8799-00a4-4fc8-9852-c0536350c474,anthim should be used in combination with appropriate antibacterial drugs,1
1782,1782,1782,1782,1782,1782,1782,2276,2276,2276,2276,2276,2276,2276,2276,2276,2276,2276,2276,2276,39ad8799-00a4-4fc8-9852-c0536350c474,( 1 2 ) anthim is not expected to cross the blood brain barrier and does not prevent or treat meningitis,0
1783,1783,1783,1783,1783,1783,1783,2277,2277,2277,2277,2277,2277,2277,2277,2277,2277,2277,2277,2277,39ad8799-00a4-4fc8-9852-c0536350c474,( 1 2 ) 1 1 inhalational anthrax anthim is indicated in adult and pediatric patients for the treatment of inhalational anthrax due to bacillus anthracis in combination with appropriate antibacterial drugs,1
1784,1784,1784,1784,1784,1784,1784,2278,2278,2278,2278,2278,2278,2278,2278,2278,2278,2278,2278,2278,39ad8799-00a4-4fc8-9852-c0536350c474,anthim is indicated for prophylaxis of inhalational anthrax due to b anthracis when alternative therapies are not available or not appropriate see  ( 1 2 ),1
1785,1785,1785,1785,1785,1785,1785,2279,2279,2279,2279,2279,2279,2279,2279,2279,2279,2279,2279,2279,39ad8799-00a4-4fc8-9852-c0536350c474,1 2 limitations of use anthim should only be used for prophylaxis when its benefit for prevention of inhalational anthrax outweighs the risk of hypersensitivity and anaphylaxis see warnings and precautions ( 5 1 ),2
1786,1786,1786,1786,1786,1786,1786,2280,2280,2280,2280,2280,2280,2280,2280,2280,2280,2280,2280,2280,39ad8799-00a4-4fc8-9852-c0536350c474,the effectiveness of anthim is based solely on efficacy studies in animal models of inhalational anthrax,0
1787,1787,1787,1787,1787,1787,1787,2281,2281,2281,2281,2281,2281,2281,2281,2281,2281,2281,2281,2281,39ad8799-00a4-4fc8-9852-c0536350c474,it is not ethical or feasible to conduct controlled clinical trials with intentional exposure of humans to an,0
1788,1788,1788,1788,1788,1788,1788,2282,2282,2282,2282,2282,2282,2282,2282,2282,2282,2282,2282,2282,"Active Ingredient UNII(s)
2ACZ6IPC6I; 362O9ITL9D; GSL05Y1MN6    a2ca6210-578d-496c-9a0e-6eb716f87ae6
2ACZ6IPC6I; 362O9ITL9D; GSL05Y1MN6    a2ca6210-578d-496c-9a0e-6eb716f87ae6
Name: SET ID dtype: object",active ingredient unii ( s ) 2acz6ipc6i 362o9itl9d gsl05y1mn6 active ingredient unii ( s ) 2acz6ipc6i 362o9itl 2acz6ipc6i 362o9itl9d gsl05y1mn6 active ingredient unii ( s ) 2acz6ipc6i 362o9itl name content xml  dtype object,0
1789,1789,1789,1789,1789,1789,1789,2284,2284,2284,2284,2284,2284,2284,2284,2284,2284,2284,2284,2284,"Active Ingredient UNII(s)
2ACZ6IPC6I; 362O9ITL9D; NO70W886KK    09c9f50f-e78a-463f-b6da-49bf64b4ed40
2ACZ6IPC6I; 362O9ITL9D; NO70W886KK    09c9f50f-e78a-463f-b6da-49bf64b4ed40
Name: SET ID dtype: object",active ingredient unii ( s ) 2acz6ipc6i 362o9itl9d no70w886kk active ingredient unii ( s ) 2acz6ipc6i 362o9itl 2acz6ipc6i 362o9itl9d no70w886kk active ingredient unii ( s ) 2acz6ipc6i 362o9itl name content xml  dtype object,0
1790,1790,1790,1790,1790,1790,1790,2286,2286,2286,2286,2286,2286,2286,2286,2286,2286,2286,2286,2286,"Active Ingredient UNII(s)
2ACZ6IPC6I; 57Y76R9ATQ    701b69d8-cce8-42de-a770-96020c1a870a
2ACZ6IPC6I; 57Y76R9ATQ    701b69d8-cce8-42de-a770-96020c1a870a
Name: SET ID dtype: object",active ingredient unii ( s ) 2acz6ipc6i 57y76r9atq active ingredient unii ( s ) 2acz6ipc6i 57y76r9a 2acz6ipc6i 57y76r9atq active ingredient unii ( s ) 2acz6ipc6i 57y76r9a name content xml  dtype object,0
1791,1791,1791,1791,1791,1791,1791,2288,2288,2288,2288,2288,2288,2288,2288,2288,2288,2288,2288,2288,"Active Ingredient UNII(s)
2ACZ6IPC6I; 6CW7F3G59X    5d86f813-e784-4490-a842-bcb78eb0d9a4
2ACZ6IPC6I; 6CW7F3G59X    5d86f813-e784-4490-a842-bcb78eb0d9a4
Name: SET ID dtype: object",active ingredient unii ( s ) 2acz6ipc6i 6cw7f3g59x active ingredient unii ( s ) 2acz6ipc6i 6cw7f3g5 2acz6ipc6i 6cw7f3g59x active ingredient unii ( s ) 2acz6ipc6i 6cw7f3g5 name content xml  dtype object,0
1792,1792,1792,1792,1792,1792,1792,2290,2290,2290,2290,2290,2290,2290,2290,2290,2290,2290,2290,2290,b4a17a69-e764-456c-8aa9-d31221c86a6b, tramadol hydrochloride tablets are indicated for the management of moderate to moderately severe pain in adults,1
1793,1793,1793,1793,1793,1793,1793,2291,2291,2291,2291,2291,2291,2291,2291,2291,2291,2291,2291,2291,"Active Ingredient UNII(s)
2ACZ6IPC6I; WK2XYI10QM    b720c99f-feaa-4453-ba4a-c3377501f7b8
2ACZ6IPC6I; WK2XYI10QM    b720c99f-feaa-4453-ba4a-c3377501f7b8
Name: SET ID dtype: object",active ingredient unii ( s ) 2acz6ipc6i wk2xyi10qm active ingredient unii ( s ) 2acz6ipc6i wk2xyi10 2acz6ipc6i wk2xyi10qm active ingredient unii ( s ) 2acz6ipc6i wk2xyi10 name content xml  dtype object,0
1794,1794,1794,1794,1794,1794,1794,2293,2293,2293,2293,2293,2293,2293,2293,2293,2293,2293,2293,2293,611b0ea2-6378-4c8f-953d-87f6b35b0634, lithium carbonate extended release tablet is indicated in the treatment of manic episodes of bipolar disorder,1
1795,1795,1795,1795,1795,1795,1795,2294,2294,2294,2294,2294,2294,2294,2294,2294,2294,2294,2294,2294,611b0ea2-6378-4c8f-953d-87f6b35b0634,bipolar disorder  manic ( dsm iv ) is equivalent to manic depressive illness  manic  in the older dsm ii terminology,u
1796,1796,1796,1796,1796,1796,1796,2295,2295,2295,2295,2295,2295,2295,2295,2295,2295,2295,2295,2295,611b0ea2-6378-4c8f-953d-87f6b35b0634,lithium carbonate extended release tablet is also indicated as a maintenance treatment for individuals with a diagnosis of bipolar disorder,1
1797,1797,1797,1797,1797,1797,1797,2296,2296,2296,2296,2296,2296,2296,2296,2296,2296,2296,2296,2296,611b0ea2-6378-4c8f-953d-87f6b35b0634,maintenance therapy reduces the frequency of manic episodes and diminishes the intensity of those episodes which may occur,u
1798,1798,1798,1798,1798,1798,1798,2297,2297,2297,2297,2297,2297,2297,2297,2297,2297,2297,2297,2297,611b0ea2-6378-4c8f-953d-87f6b35b0634,typical symptoms of mania include pressure of speech  motor hyperactivity  reduced need for sleep  flight of ideas  grandiosity  elation  poor judgment  aggressiveness  and possibly hostility,u
1799,1799,1799,1799,1799,1799,1799,2298,2298,2298,2298,2298,2298,2298,2298,2298,2298,2298,2298,2298,611b0ea2-6378-4c8f-953d-87f6b35b0634,when given to a patient experiencing a manic episode  lithium may produce a normalization of symptomatology within 1 to 3 weeks,1
1800,1800,1800,1800,1800,1800,1800,2299,2299,2299,2299,2299,2299,2299,2299,2299,2299,2299,2299,2299,7dc9c6d2-6d9a-49e4-a8ab-437b0ed5f84e,1  lithium is a mood stabilizing agent indicated for the treatment of manic episodes and as maintenance treatment for bipolar i disorder,1
1801,1801,1801,1801,1801,1801,1801,2300,2300,2300,2300,2300,2300,2300,2300,2300,2300,2300,2300,2300,7dc9c6d2-6d9a-49e4-a8ab-437b0ed5f84e,lithium is a mood stabilizing agent indicated for the treatment of manic episodes and as maintenance treatment for bipolar i disorder,1
1802,1802,1802,1802,1802,1802,1802,2301,2301,2301,2301,2301,2301,2301,2301,2301,2301,2301,2301,2301,89bcf553-669a-40b0-a9d7-67a5c1d2f591,1  portrazza is an epidermal growth factor receptor ( egfr ) antagonist indicated  in combination with gemcitabine and cisplatin  for first line treatment of patients with metastatic squamous non small cell lung cancer,1
1803,1803,1803,1803,1803,1803,1803,2302,2302,2302,2302,2302,2302,2302,2302,2302,2302,2302,2302,2302,89bcf553-669a-40b0-a9d7-67a5c1d2f591,( 1 1 ) limitation of use portrazza is not indicated for treatment of non squamous non small cell lung cancer,2
1804,1804,1804,1804,1804,1804,1804,2303,2303,2303,2303,2303,2303,2303,2303,2303,2303,2303,2303,2303,89bcf553-669a-40b0-a9d7-67a5c1d2f591,( 1 2  5 6  14 2 ) 1 1 squamous non small cell lung cancer ( nsclc ) portrazza is indicated  in combination with gemcitabine and cisplatin  for first line treatment of patients with metastatic squamous non small cell lung cancer,1
1805,1805,1805,1805,1805,1805,1805,2304,2304,2304,2304,2304,2304,2304,2304,2304,2304,2304,2304,2304,89bcf553-669a-40b0-a9d7-67a5c1d2f591,1 2 limitation of use portrazza is not indicated for treatment of non squamous non small cell lung cancer see warnings and precautions ( 5 6 ) and clinical studies ( 14 2 ),2
1806,1806,1806,1806,1806,1806,1806,2305,2305,2305,2305,2305,2305,2305,2305,2305,2305,2305,2305,2305,dc8cbc3d-026c-0db5-42e8-8e93d374dd23,1  ferriprox ( deferiprone ) is indicated for the treatment of patients with transfusional iron overload due to thalassemia syndromes when current chelation therapy is inadequate,1
1807,1807,1807,1807,1807,1807,1807,2306,2306,2306,2306,2306,2306,2306,2306,2306,2306,2306,2306,2306,dc8cbc3d-026c-0db5-42e8-8e93d374dd23,approval is based on a reduction in serum ferritin levels,u
1808,1808,1808,1808,1808,1808,1808,2307,2307,2307,2307,2307,2307,2307,2307,2307,2307,2307,2307,2307,dc8cbc3d-026c-0db5-42e8-8e93d374dd23,there are no controlled trials demonstrating a direct treatment benefit  such as improvement in disease related symptoms  functioning  or increased survival see clinical studies ( 14 ),0
1809,1809,1809,1809,1809,1809,1809,2308,2308,2308,2308,2308,2308,2308,2308,2308,2308,2308,2308,2308,dc8cbc3d-026c-0db5-42e8-8e93d374dd23,limitation of use safety and effectiveness have not been established for the treatment of transfusional iron overload in patients with other chronic anemias,2
1810,1810,1810,1810,1810,1810,1810,2309,2309,2309,2309,2309,2309,2309,2309,2309,2309,2309,2309,2309,dc8cbc3d-026c-0db5-42e8-8e93d374dd23,ferriprox ( deferiprone ) is an iron chelator indicated for the treatment of patients with transfusional iron overload due to thalassemia syndromes when current chelation therapy is inadequate,1
1811,1811,1811,1811,1811,1811,1811,2310,2310,2310,2310,2310,2310,2310,2310,2310,2310,2310,2310,2310,dc8cbc3d-026c-0db5-42e8-8e93d374dd23,( 1 ) approval is based on a reduction in serum ferritin levels,0
1812,1812,1812,1812,1812,1812,1812,2311,2311,2311,2311,2311,2311,2311,2311,2311,2311,2311,2311,2311,dc8cbc3d-026c-0db5-42e8-8e93d374dd23,there are no controlled trials demonstrating a direct treatment benefit  such as improvement in disease related symptoms  functioning  or increased survival,0
1813,1813,1813,1813,1813,1813,1813,2312,2312,2312,2312,2312,2312,2312,2312,2312,2312,2312,2312,2312,dc8cbc3d-026c-0db5-42e8-8e93d374dd23,( 1 ) limitation of use safety and effectiveness have not been established for the treatment of transfusional iron overload in patients with other chronic anemias,2
1814,1814,1814,1814,1814,1814,1814,2313,2313,2313,2313,2313,2313,2313,2313,2313,2313,2313,2313,2313,e96f30a0-6662-11de-8f80-0002a5d5c51b,1  valstar is an anthracycline topoisomerase inhibitor indicated for intravesical therapy of bcg refractory carcinoma in situ ( cis ) of the urinary bladder in patients for whom immediate cystectomy would be associated with unacceptable morbidity or mortality,1
1815,1815,1815,1815,1815,1815,1815,2314,2314,2314,2314,2314,2314,2314,2314,2314,2314,2314,2314,2314,e96f30a0-6662-11de-8f80-0002a5d5c51b,valstar is an anthracycline topoisomerase inhibitor indicated for intravesical therapy of bcg refractory carcinoma in situ ( cis ) of the urinary bladder in patients for whom immediate cystectomy would be associated with unacceptable morbidity or mortality,1
1816,1816,1816,1816,1816,1816,1816,2315,2315,2315,2315,2315,2315,2315,2315,2315,2315,2315,2315,2315,0b8b3809-ab3d-47c9-8e9d-15d1a3b15395, uses for symptomatic relief of anxiety  compulsive behaviors  obsessive thoughts  peculiar mental impulses,1
1817,1817,1817,1817,1817,1817,1817,2316,2316,2316,2316,2316,2316,2316,2316,2316,2316,2316,2316,2316,d20c4ed9-4c45-4dd6-918e-253dfb391996, for temporary relief of weakness  weariness  thirst  pms  and bone pain,1
1818,1818,1818,1818,1818,1818,1818,2319,2319,2319,2319,2319,2319,2319,2319,2319,2319,2319,2319,2319,e91c4a69-2ad5-4e21-a279-9e1302b1a3d3,1  alosetron hydrochloride tablets are indicated only for women with severe diarrhea predominant irritable bowel syndrome ( ibs ) who have chronic ibs symptoms ( generally lasting 6 months or longer )  had anatomic or biochemical abnormalities of the gastrointestinal tract excluded  and not responded adequately to conventional therapy,1
1819,1819,1819,1819,1819,1819,1819,2320,2320,2320,2320,2320,2320,2320,2320,2320,2320,2320,2320,2320,e91c4a69-2ad5-4e21-a279-9e1302b1a3d3,diarrhea predominant ibs is severe if it includes diarrhea and one or more of the following frequent and severe abdominal pain discomfort  frequent bowel urgency or fecal incontinence  disability or restriction of daily activities due to ibs,
1820,1820,1820,1820,1820,1820,1820,2321,2321,2321,2321,2321,2321,2321,2321,2321,2321,2321,2321,2321,e91c4a69-2ad5-4e21-a279-9e1302b1a3d3,because of infrequent but serious gastrointestinal adverse reactions associated with alosetron hydrochloride tablets  the indication is restricted to those patients for whom the benefit to risk balance is most favorable,3
1821,1821,1821,1821,1821,1821,1821,2322,2322,2322,2322,2322,2322,2322,2322,2322,2322,2322,2322,2322,e91c4a69-2ad5-4e21-a279-9e1302b1a3d3,clinical studies have not been performed to adequately confirm the benefits of alosetron hydrochloride tablets in men,0
1822,1822,1822,1822,1822,1822,1822,2323,2323,2323,2323,2323,2323,2323,2323,2323,2323,2323,2323,2323,e91c4a69-2ad5-4e21-a279-9e1302b1a3d3,alosetron hydrochloride tablets are a selective serotonin 5 ht3 antagonist indicated only for women with severe diarrhea predominant irritable bowel syndrome ( ibs ) who have chronic ibs symptoms ( generally lasting 6 months or longer )  had anatomic or biochemical abnormalities of the gastrointestinal tract excluded  and not responded adequately to conventional therapy,1
1823,1823,1823,1823,1823,1823,1823,2324,2324,2324,2324,2324,2324,2324,2324,2324,2324,2324,2324,2324,e91c4a69-2ad5-4e21-a279-9e1302b1a3d3,( 1 ) severe ibs includes diarrhea and 1 or more of the following frequent and severe abdominal pain discomfort  frequent bowel urgency or fecal incontinence  disability or restriction of daily activities due to ibs,0
1824,1824,1824,1824,1824,1824,1824,2325,2325,2325,2325,2325,2325,2325,2325,2325,2325,2325,2325,2325,17c2c1b4-bef5-6e61-e054-00144ff8d46c,uses reduces water retention in the body,1
1825,1825,1825,1825,1825,1825,1825,2326,2326,2326,2326,2326,2326,2326,2326,2326,2326,2326,2326,2326,a734b368-6008-441c-ab44-5634e46be9a4,1  zolmitriptan orally disintegrating tabletsare indicated for the acute treatment of migraine with or without aura in adults,1
1826,1826,1826,1826,1826,1826,1826,2327,2327,2327,2327,2327,2327,2327,2327,2327,2327,2327,2327,2327,a734b368-6008-441c-ab44-5634e46be9a4,limitations of use only use zolmitriptan orally disintegrating tablets if a clear diagnosis of migraine has been established,2
1827,1827,1827,1827,1827,1827,1827,2328,2328,2328,2328,2328,2328,2328,2328,2328,2328,2328,2328,2328,a734b368-6008-441c-ab44-5634e46be9a4,if a patient has no response to zolmitriptan orally disintegrating tablets treatment for the first migraine attack  reconsider the diagnosis of migraine before zolmitriptan orally disintegrating tablets are administered to treat any subsequent attacks,0
1828,1828,1828,1828,1828,1828,1828,2329,2329,2329,2329,2329,2329,2329,2329,2329,2329,2329,2329,2329,a734b368-6008-441c-ab44-5634e46be9a4,zolmitriptan orally disintegrating tablets are not indicated for the prevention of migraine attacks,2
1829,1829,1829,1829,1829,1829,1829,2330,2330,2330,2330,2330,2330,2330,2330,2330,2330,2330,2330,2330,a734b368-6008-441c-ab44-5634e46be9a4,safety and effectiveness of zolmitriptan orally disintegrating tablets have not been established for cluster headache,0
1830,1830,1830,1830,1830,1830,1830,2331,2331,2331,2331,2331,2331,2331,2331,2331,2331,2331,2331,2331,a734b368-6008-441c-ab44-5634e46be9a4,zolmitriptan orally disintegrating tablets are a serotonin ( 5 ht ) 1b 1d receptor agonist ( triptan ) indicated for the acute treatment of migraine with or without aura in adults ( 1 ) limitations of use use only after a clear diagnosis of migraine has been established ( 1 ) not indicated for the prophylactic therapy of migraine ( 1 ) not indicated for the treatment of cluster headache ( 1 ),1
1831,1831,1831,1831,1831,1831,1831,2332,2332,2332,2332,2332,2332,2332,2332,2332,2332,2332,2332,2332,26dde4a4-9bb1-4adc-a5f2-fb44e42e5c15, tc99m sulfur colloid is used in lymphoscintigraphy studies in breast cancer patients  for liver  spleen and bone marrow imaging and gastric transit studies and gastroesophageal reflux,1
1832,1832,1832,1832,1832,1832,1832,2333,2333,2333,2333,2333,2333,2333,2333,2333,2333,2333,2333,2333,acaef5a6-b740-40e3-8ffe-74a75c74745c,1  voraxaze ( glucarpidase ) is a carboxypeptidase enzyme indicated for the treatment of toxic plasma methotrexate concentrations ( 1 micromole per liter ) in patients with delayed methotrexate clearance due to impaired renal function,1
1833,1833,1833,1833,1833,1833,1833,2334,2334,2334,2334,2334,2334,2334,2334,2334,2334,2334,2334,2334,acaef5a6-b740-40e3-8ffe-74a75c74745c,( 1 1 ) limitation of use voraxaze is not indicated for use in patients who exhibit the expected clearance of methotrexate ( plasma methotrexate concentrations within 2 standard deviations of the mean methotrexate excretion curve specific for the dose of methotrexate administered ) or those with normal or mildly impaired renal function because of the potential risk of subtherapeutic exposure to methotrexate,2
1834,1834,1834,1834,1834,1834,1834,2335,2335,2335,2335,2335,2335,2335,2335,2335,2335,2335,2335,2335,acaef5a6-b740-40e3-8ffe-74a75c74745c,( 1 2 ) 1 1 indication voraxaze ( glucarpidase ) is indicated for the treatment of toxic plasma methotrexate concentrations ( 1 micromole per liter ) in patients with delayed methotrexate clearance due to impaired renal function,1
1835,1835,1835,1835,1835,1835,1835,2336,2336,2336,2336,2336,2336,2336,2336,2336,2336,2336,2336,2336,acaef5a6-b740-40e3-8ffe-74a75c74745c,1 2 limitation of use voraxaze is not indicated for use in patients who exhibit the expected clearance of methotrexate ( plasma methotrexate concentrations within 2 standard deviations of the mean methotrexate excretion curve specific for the dose of methotrexate administered ) or those with normal or mildly impaired renal function because of the potential risk of subtherapeutic exposure to methotrexate,2
1836,1836,1836,1836,1836,1836,1836,2337,2337,2337,2337,2337,2337,2337,2337,2337,2337,2337,2337,2337,2d301358-6291-4ec1-bd87-37b4ad9bd850,1  rexulti is indicated for adjunctive treatment of major depressive disorder ( mdd ) see clinical studies ( 14 1 ),1
1837,1837,1837,1837,1837,1837,1837,2338,2338,2338,2338,2338,2338,2338,2338,2338,2338,2338,2338,2338,2d301358-6291-4ec1-bd87-37b4ad9bd850,treatment of schizophrenia see clinical studies ( 14 2 ),u
1838,1838,1838,1838,1838,1838,1838,2339,2339,2339,2339,2339,2339,2339,2339,2339,2339,2339,2339,2339,2d301358-6291-4ec1-bd87-37b4ad9bd850,rexulti is an atypical antipsychotic indicated for use as an adjunctive therapy to antidepressants for the treatment of major depressive disorder ( mdd ) ( 1  14 1 ) treatment of schizophrenia ( 1  14 2 ),1
1839,1839,1839,1839,1839,1839,1839,2340,2340,2340,2340,2340,2340,2340,2340,2340,2340,2340,2340,2340,e82416ba-23b9-4d40-a41d-baba8e11751b,1  arcapta neohaler is a long acting beta2 adrenergic agonist indicated for the long term  once daily maintenance bronchodilator treatment of airflow obstruction in patients with chronic obstructive pulmonary disease ( copd )  including chronic bronchitis and or emphysema,1
1840,1840,1840,1840,1840,1840,1840,2341,2341,2341,2341,2341,2341,2341,2341,2341,2341,2341,2341,2341,e82416ba-23b9-4d40-a41d-baba8e11751b,( 1 1 ) important limitations arcapta neohaler is not indicated to treat acute deteriorations of chronic obstructive pulmonary disease,2
1841,1841,1841,1841,1841,1841,1841,2342,2342,2342,2342,2342,2342,2342,2342,2342,2342,2342,2342,2342,e82416ba-23b9-4d40-a41d-baba8e11751b,( 1 2 ) arcapta neohaler is not indicated for asthma,2
1842,1842,1842,1842,1842,1842,1842,2343,2343,2343,2343,2343,2343,2343,2343,2343,2343,2343,2343,2343,e82416ba-23b9-4d40-a41d-baba8e11751b,( 1 2 ) 1 1 maintenance treatment of copd arcapta neohaler is a long acting beta2 agonist indicated for long term  once daily maintenance bronchodilator treatment of airflow obstruction in patients with chronic obstructive pulmonary disease ( copd )  including chronic bronchitis and or emphysema,1
1843,1843,1843,1843,1843,1843,1843,2344,2344,2344,2344,2344,2344,2344,2344,2344,2344,2344,2344,2344,e82416ba-23b9-4d40-a41d-baba8e11751b,1 2 important limitations of use arcapta neohaler is not indicated to treat acute deteriorations of chronic obstructive pulmonary disease see warnings and precautions ( 5 2 ),2
1844,1844,1844,1844,1844,1844,1844,2345,2345,2345,2345,2345,2345,2345,2345,2345,2345,2345,2345,2345,e82416ba-23b9-4d40-a41d-baba8e11751b,arcapta neohaler is not indicated to treat asthma,2
1845,1845,1845,1845,1845,1845,1845,2346,2346,2346,2346,2346,2346,2346,2346,2346,2346,2346,2346,2346,e82416ba-23b9-4d40-a41d-baba8e11751b,the safety and effectiveness of arcapta neohaler in asthma have not been established,0
1846,1846,1846,1846,1846,1846,1846,2347,2347,2347,2347,2347,2347,2347,2347,2347,2347,2347,2347,2347,7782a48e-38bb-404a-94ef-051278d8bfef,1  utibrontm neohaler is a combination of indacaterol and glycopyrrolate indicated for the long term  maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease ( copd )  including chronic bronchitis and or emphysema,1
1847,1847,1847,1847,1847,1847,1847,2348,2348,2348,2348,2348,2348,2348,2348,2348,2348,2348,2348,2348,7782a48e-38bb-404a-94ef-051278d8bfef,important limitations of use utibron neohaler is not indicated for the relief of acute bronchospasm or for the treatment of asthma see warnings and precautions ( 5 1  5 2 ),2
1848,1848,1848,1848,1848,1848,1848,2349,2349,2349,2349,2349,2349,2349,2349,2349,2349,2349,2349,2349,7782a48e-38bb-404a-94ef-051278d8bfef,utibron neohaler is a combination of indacaterol  a long acting beta2 adrenergic agonist ( laba )  and glycopyrrolate  an anticholinergic  indicated for the long term  maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease ( copd ),1
1849,1849,1849,1849,1849,1849,1849,2350,2350,2350,2350,2350,2350,2350,2350,2350,2350,2350,2350,2350,7782a48e-38bb-404a-94ef-051278d8bfef,( 1 ) limitations of use not indicated for the relief of acute bronchospasm or for the treatment of asthma,2
1850,1850,1850,1850,1850,1850,1850,2351,2351,2351,2351,2351,2351,2351,2351,2351,2351,2351,2351,2351,b891bd9f-fdb8-4862-89c5-ecdd700398a3,1  emsam ( selegiline transdermal system ) is a monoamine oxidase inhibitor ( maoi ) indicated for the treatment of adults with major depressive disorder ( mdd ) see clinical studies ( 14 ),1
1851,1851,1851,1851,1851,1851,1851,2352,2352,2352,2352,2352,2352,2352,2352,2352,2352,2352,2352,2352,b891bd9f-fdb8-4862-89c5-ecdd700398a3,emsam ( selegiline transdermal system ) is a monoamine oxidase inhibitor ( maoi ) indicated for the treatment of major depressive disorder ( mdd ) ( 1 ),1
1852,1852,1852,1852,1852,1852,1852,2353,2353,2353,2353,2353,2353,2353,2353,2353,2353,2353,2353,2353,429a2f62-9fe6-4299-b314-92a9d22b1381, rifater is indicated in the initial phase of the short course treatment of pulmonary tuberculosis,1
1853,1853,1853,1853,1853,1853,1853,2354,2354,2354,2354,2354,2354,2354,2354,2354,2354,2354,2354,2354,429a2f62-9fe6-4299-b314-92a9d22b1381,during this phase  which should last 2 months  rifater should be administered on a daily  continuous basis ( see dosage and administration ),4
1854,1854,1854,1854,1854,1854,1854,2355,2355,2355,2355,2355,2355,2355,2355,2355,2355,2355,2355,2355,429a2f62-9fe6-4299-b314-92a9d22b1381,following the initial phase and treatment with rifater  treatment should be continued with rifampin and isoniazid ( e g  rifamate ) for at least 4 months,4
1855,1855,1855,1855,1855,1855,1855,2356,2356,2356,2356,2356,2356,2356,2356,2356,2356,2356,2356,2356,429a2f62-9fe6-4299-b314-92a9d22b1381,treatment should be continued for a longer period of time if the patient is still sputum or culture positive  if resistant organisms are present  or if the patient is hiv positive,4
1856,1856,1856,1856,1856,1856,1856,2357,2357,2357,2357,2357,2357,2357,2357,2357,2357,2357,2357,2357,429a2f62-9fe6-4299-b314-92a9d22b1381,in the treatment of tuberculosis  the small number of resistant cells present within large populations of susceptible cells can rapidly become the predominant type,0
1857,1857,1857,1857,1857,1857,1857,2358,2358,2358,2358,2358,2358,2358,2358,2358,2358,2358,2358,2358,429a2f62-9fe6-4299-b314-92a9d22b1381,since resistance can emerge rapidly  susceptibility tests should be performed in the event of persistent positive cultures during the course of treatment,4
1858,1858,1858,1858,1858,1858,1858,2359,2359,2359,2359,2359,2359,2359,2359,2359,2359,2359,2359,2359,429a2f62-9fe6-4299-b314-92a9d22b1381,bacteriologic smears or cultures should be obtained before the start of therapy to confirm the susceptibility of the organism to rifampin  isoniazid  and pyrazinamide and they should be repeated throughout therapy to monitor response to the treatment,4
1859,1859,1859,1859,1859,1859,1859,2360,2360,2360,2360,2360,2360,2360,2360,2360,2360,2360,2360,2360,429a2f62-9fe6-4299-b314-92a9d22b1381,if test results show resistance to any of the components of rifater and the patient is not responding to therapy  the drug regimen should be modified,0
1860,1860,1860,1860,1860,1860,1860,2361,2361,2361,2361,2361,2361,2361,2361,2361,2361,2361,2361,2361,9c069ce5-ea67-4f42-afe4-30b01b4ce24d, butorphanol tartrate nasal spray is indicated for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate,1
1861,1861,1861,1861,1861,1861,1861,2362,2362,2362,2362,2362,2362,2362,2362,2362,2362,2362,2362,2362,9c069ce5-ea67-4f42-afe4-30b01b4ce24d,limitations of use because of the risks of addiction  abuse  and misuse  with opioids  even at recommended doses ( see warnings )  reserve butorphanol tartrate nasal spray for use in patients for whom alternative treatment options ( e g  non opioid analgesics ) have not been tolerated  or are not expected to be tolerated,2
1862,1862,1862,1862,1862,1862,1862,2363,2363,2363,2363,2363,2363,2363,2363,2363,2363,2363,2363,2363,9c069ce5-ea67-4f42-afe4-30b01b4ce24d,have not provided adequate analgesia  or are not expected to provide adequate analgesia,u
1863,1863,1863,1863,1863,1863,1863,2364,2364,2364,2364,2364,2364,2364,2364,2364,2364,2364,2364,2364,ffe0d471-a9fd-4348-b9a1-8989a2e50233, carefully consider the potential benefits and risks of etodolac capsules and tablets  usp  and other treatment options before deciding to use etodolac capsules and tablets  usp,4
1864,1864,1864,1864,1864,1864,1864,2366,2366,2366,2366,2366,2366,2366,2366,2366,2366,2366,2366,2366,ffe0d471-a9fd-4348-b9a1-8989a2e50233,etodolac capsules and tablets  usp are indicated for acute and long term use in the management of signs and symptoms of the following osteoarthritis rheumatoid arthritis for the management of acute pain,1
1865,1865,1865,1865,1865,1865,1865,2367,2367,2367,2367,2367,2367,2367,2367,2367,2367,2367,2367,2367,"Active Ingredient UNII(s)
2M36281008; L7T10EIP3A; LAV5U5022Y; S07O44R1ZM    678f5379-b080-392c-e053-2991aa0a0abf
2M36281008; L7T10EIP3A; LAV5U5022Y; S07O44R1ZM    678f5379-b080-392c-e053-2991aa0a0abf
Name: SET ID dtype: object",active ingredient unii ( s ) 2m36281008 l7t10eip3a lav5u5022y s07o44r1zm active ingredient unii ( s ) 2m36281008 l7t10eip 2m36281008 l7t10eip3a lav5u5022y s07o44r1zm active ingredient unii ( s ) 2m36281008 l7t10eip name content xml  dtype object,0
1866,1866,1866,1866,1866,1866,1866,2369,2369,2369,2369,2369,2369,2369,2369,2369,2369,2369,2369,2369,bb582d64-0f51-11df-8a39-0800200c9a66, cesamet capsules are indicated for the treatment of the nausea and vomiting associated with cancer chemotherapy in patients who have failed to respond adequately to conventional antiemetic treatments,1
1867,1867,1867,1867,1867,1867,1867,2370,2370,2370,2370,2370,2370,2370,2370,2370,2370,2370,2370,2370,bb582d64-0f51-11df-8a39-0800200c9a66,this restriction is required because a substantial proportion of any group of patients treated with cesamet can be expected to experience disturbing psychotomimetic reactions not observed with other antiemetic agents,2
1868,1868,1868,1868,1868,1868,1868,2371,2371,2371,2371,2371,2371,2371,2371,2371,2371,2371,2371,2371,bb582d64-0f51-11df-8a39-0800200c9a66,because of its potential to alter the mental state  cesamet is intended for use under circumstances that permit close supervision of the patient by a responsible individual particularly during initial use of cesamet and during dose adjustments,1
1869,1869,1869,1869,1869,1869,1869,2372,2372,2372,2372,2372,2372,2372,2372,2372,2372,2372,2372,2372,bb582d64-0f51-11df-8a39-0800200c9a66,cesamet contains nabilone  which is controlled in schedule ii of the controlled substances act,0
1870,1870,1870,1870,1870,1870,1870,2373,2373,2373,2373,2373,2373,2373,2373,2373,2373,2373,2373,2373,bb582d64-0f51-11df-8a39-0800200c9a66,schedule ii substances have a high potential for abuse,0
1871,1871,1871,1871,1871,1871,1871,2374,2374,2374,2374,2374,2374,2374,2374,2374,2374,2374,2374,2374,bb582d64-0f51-11df-8a39-0800200c9a66,prescriptions for cesamet should be limited to the amount necessary for a single cycle of chemotherapy ( i e  a few days ),4
1872,1872,1872,1872,1872,1872,1872,2375,2375,2375,2375,2375,2375,2375,2375,2375,2375,2375,2375,2375,bb582d64-0f51-11df-8a39-0800200c9a66,cesamet capsules are not intended to be used on as needed basis or as a first antiemetic product prescribed for a patient,2
1873,1873,1873,1873,1873,1873,1873,2376,2376,2376,2376,2376,2376,2376,2376,2376,2376,2376,2376,2376,bb582d64-0f51-11df-8a39-0800200c9a66,as with all controlled drugs  prescribers should monitor patients receiving nabilone for signs of excessive use  abuse and misuse,4
1874,1874,1874,1874,1874,1874,1874,2377,2377,2377,2377,2377,2377,2377,2377,2377,2377,2377,2377,2377,bb582d64-0f51-11df-8a39-0800200c9a66,patients who may be at increased risk for substance abuse include those with a personal or family history of substance abuse ( including drug or alcohol abuse ) or mental illness,0
1875,1875,1875,1875,1875,1875,1875,2378,2378,2378,2378,2378,2378,2378,2378,2378,2378,2378,2378,2378,6c64b058-a8c1-4b04-8630-82ae46577a66,olive rectal spray a homeopathic remedy for the relief of anal and rectal irritations including external and internal itching  soreness  hemmorhoid  swelling  buring pain and abnormal dischare  that can be mixed with mucus and blood,1
1876,1876,1876,1876,1876,1876,1876,2379,2379,2379,2379,2379,2379,2379,2379,2379,2379,2379,2379,2379,7f6a2191-adfb-48b9-9bfa-0d9920479f0d,1  xolair is an anti ige antibody indicated for moderate to severe persistent asthma in patients 6 years of age and older with a positive skin test or in vitro reactivity to a perennial aeroallergen and symptoms that are inadequately controlled with inhaled corticosteroids ( 1 1 ) chronic idiopathic urticaria in adults and adolescents 12 years of age and older who remain symptomatic despite h1 antihistamine treatment ( 1 2 ) limitations of use not indicated for other allergic conditions or other forms of urticaria,1
1877,1877,1877,1877,1877,1877,1877,2380,2380,2380,2380,2380,2380,2380,2380,2380,2380,2380,2380,2380,7f6a2191-adfb-48b9-9bfa-0d9920479f0d,( 1 1  1 2  ) not indicated for acute bronchospasm or status asthmaticus,2
1878,1878,1878,1878,1878,1878,1878,2381,2381,2381,2381,2381,2381,2381,2381,2381,2381,2381,2381,2381,7f6a2191-adfb-48b9-9bfa-0d9920479f0d,( 1 1  5 3 ) 1 1 asthma xolair is indicated for patients 6 years of age and older with moderate to severe persistent asthma who have a positive skin test or in vitro reactivity to a perennial aeroallergen and whose symptoms are inadequately controlled with inhaled corticosteroids,1
1879,1879,1879,1879,1879,1879,1879,2382,2382,2382,2382,2382,2382,2382,2382,2382,2382,2382,2382,2382,7f6a2191-adfb-48b9-9bfa-0d9920479f0d,xolair has been shown to decrease the incidence of asthma exacerbations in these patients,u
1880,1880,1880,1880,1880,1880,1880,2383,2383,2383,2383,2383,2383,2383,2383,2383,2383,2383,2383,2383,7f6a2191-adfb-48b9-9bfa-0d9920479f0d,limitations of use xolair is not indicated for the relief of acute bronchospasm or status asthmaticus,2
1881,1881,1881,1881,1881,1881,1881,2384,2384,2384,2384,2384,2384,2384,2384,2384,2384,2384,2384,2384,7f6a2191-adfb-48b9-9bfa-0d9920479f0d,xolair is not indicated for treatment of other allergic conditions,2
1882,1882,1882,1882,1882,1882,1882,2385,2385,2385,2385,2385,2385,2385,2385,2385,2385,2385,2385,2385,7f6a2191-adfb-48b9-9bfa-0d9920479f0d,1 2 chronic idiopathic urticaria ( ciu ) xolair is indicated for the treatment of adults and adolescents 12 years of age and older with chronic idiopathic urticaria who remain symptomatic despite h1 antihistamine treatment,1
1883,1883,1883,1883,1883,1883,1883,2386,2386,2386,2386,2386,2386,2386,2386,2386,2386,2386,2386,2386,7f6a2191-adfb-48b9-9bfa-0d9920479f0d,limitation of use xolair is not indicated for treatment of other forms of urticaria,2
1884,1884,1884,1884,1884,1884,1884,2387,2387,2387,2387,2387,2387,2387,2387,2387,2387,2387,2387,2387,98572928-c809-48f6-9597-6105e2e6ed61,indication and usage for the temporary relief of arthritic pain relief of muscular aches pains  including symptomatic relief of lower back pains,1
1885,1885,1885,1885,1885,1885,1885,2388,2388,2388,2388,2388,2388,2388,2388,2388,2388,2388,2388,2388,98572928-c809-48f6-9597-6105e2e6ed61,may also assist with increased joint mobility reduce inflammation and swelling associated with arthritis and gout,1
1886,1886,1886,1886,1886,1886,1886,2398,2398,2398,2398,2398,2398,2398,2398,2398,2398,2398,2398,2398,68178694-31d0-4398-8a01-8ce8ea89574c, seasonal allergic rhinitis fexofenadine hydrochloride tablets are indicated for the relief of symptoms associated with seasonal allergic rhinitis in adults and children 6 years of age and older,1
1887,1887,1887,1887,1887,1887,1887,2399,2399,2399,2399,2399,2399,2399,2399,2399,2399,2399,2399,2399,68178694-31d0-4398-8a01-8ce8ea89574c,symptoms treated effectively were sneezing  rhinorrhea  itchy nose palate throat  itchy watery red eyes,1
1888,1888,1888,1888,1888,1888,1888,2400,2400,2400,2400,2400,2400,2400,2400,2400,2400,2400,2400,2400,68178694-31d0-4398-8a01-8ce8ea89574c,chronic idiopathic urticaria fexofenadine hydrochloride tablets are indicated for treatment of uncomplicated skin manifestations of chronic idiopathic urticaria in adults and children 6 years of age and older,1
1889,1889,1889,1889,1889,1889,1889,2401,2401,2401,2401,2401,2401,2401,2401,2401,2401,2401,2401,2401,68178694-31d0-4398-8a01-8ce8ea89574c,it significantly reduces pruritus and the number of wheals,u
1890,1890,1890,1890,1890,1890,1890,2402,2402,2402,2402,2402,2402,2402,2402,2402,2402,2402,2402,2402,8c563f3e-3d21-00ca-b75e-0d052837c1bd, fexofenadine hcl 180 mg and pseudoephedrine hcl 240 mg extended release tablets ( 24 hour formulation ) are indicated for the relief of symptoms associated with seasonal allergic rhinitis in adults and children 12 years of age and older,1
1891,1891,1891,1891,1891,1891,1891,2403,2403,2403,2403,2403,2403,2403,2403,2403,2403,2403,2403,2403,8c563f3e-3d21-00ca-b75e-0d052837c1bd,symptoms treated effectively include sneezing  rhinorrhea  itchy nose palate and or throat  itchy watery red eyes  and nasal congestion,1
1892,1892,1892,1892,1892,1892,1892,2404,2404,2404,2404,2404,2404,2404,2404,2404,2404,2404,2404,2404,8c563f3e-3d21-00ca-b75e-0d052837c1bd,fexofenadine hcl 180 mg and pseudoephedrine hcl 240 mg extended release tablets ( 24 hour formulation ) should be administered when both the antihistaminic properties of fexofenadine hydrochloride and the nasal decongestant properties of pseudoephedrine hydrochloride are desired ( see clinical pharmacology ),1
1893,1893,1893,1893,1893,1893,1893,2405,2405,2405,2405,2405,2405,2405,2405,2405,2405,2405,2405,2405,939b5d1f-9fb2-4499-80ef-0607aa6b114e,1  avastin is a vascular endothelial growth factor directed antibody indicated for the treatment of metastatic colorectal cancer  in combination with intravenous 5 fluorouracil based chemotherapy for first or second line treatment,1
1894,1894,1894,1894,1894,1894,1894,2406,2406,2406,2406,2406,2406,2406,2406,2406,2406,2406,2406,2406,939b5d1f-9fb2-4499-80ef-0607aa6b114e,( 1 1 ) metastatic colorectal cancer  in combination with fluoropyrimidine irinotecan or fluoropyrimidine oxaliplatin based chemotherapy for second line treatment in patients who have progressed on a first line avastin containing regimen,1
1895,1895,1895,1895,1895,1895,1895,2407,2407,2407,2407,2407,2407,2407,2407,2407,2407,2407,2407,2407,939b5d1f-9fb2-4499-80ef-0607aa6b114e,( 1 1 ) limitation of use avastin is not indicated for adjuvant treatment of colon cancer,2
1896,1896,1896,1896,1896,1896,1896,2408,2408,2408,2408,2408,2408,2408,2408,2408,2408,2408,2408,2408,939b5d1f-9fb2-4499-80ef-0607aa6b114e,( 1 1 ) unresectable  locally advanced  recurrent or metastatic non squamous non small cell lung cancer  in combination with carboplatin and paclitaxel for first line treatment,1
1897,1897,1897,1897,1897,1897,1897,2409,2409,2409,2409,2409,2409,2409,2409,2409,2409,2409,2409,2409,939b5d1f-9fb2-4499-80ef-0607aa6b114e,( 1 2 ) recurrent glioblastoma in adults,1
1898,1898,1898,1898,1898,1898,1898,2410,2410,2410,2410,2410,2410,2410,2410,2410,2410,2410,2410,2410,939b5d1f-9fb2-4499-80ef-0607aa6b114e,( 1 3 ) metastatic renal cell carcinoma in combination with interferon alfa,1
1899,1899,1899,1899,1899,1899,1899,2411,2411,2411,2411,2411,2411,2411,2411,2411,2411,2411,2411,2411,939b5d1f-9fb2-4499-80ef-0607aa6b114e,( 1 4 ) persistent  recurrent  or metastatic cervical cancer  in combination with paclitaxel and cisplatin  or paclitaxel and topotecan,1
1900,1900,1900,1900,1900,1900,1900,2412,2412,2412,2412,2412,2412,2412,2412,2412,2412,2412,2412,2412,939b5d1f-9fb2-4499-80ef-0607aa6b114e,( 1 5 ) recurrent epithelial ovarian  fallopian tube  or primary peritoneal cancer that is platinum resistant in combination with paclitaxel  pegylated liposomal doxorubicin  or topotecan platinum sensitive in combination with carboplatin and paclitaxel or carboplatin and gemcitabine followed by avastin as a single agent ( 1 6 ) 1 1 metastatic colorectal cancer ( mcrc ) avastin  in combination with intravenous 5 fluorouracil based chemotherapy  is indicated for the first or second line treatment of patients with metastatic colorectal cancer,1
1901,1901,1901,1901,1901,1901,1901,2413,2413,2413,2413,2413,2413,2413,2413,2413,2413,2413,2413,2413,939b5d1f-9fb2-4499-80ef-0607aa6b114e,avastin  in combination with fluoropyrimidine irinotecan or fluoropyrimidine oxaliplatin based chemotherapy  is indicated for the second line treatment of patients with metastatic colorectal cancer who have progressed on a first line avastin containing regimen,1
1902,1902,1902,1902,1902,1902,1902,2414,2414,2414,2414,2414,2414,2414,2414,2414,2414,2414,2414,2414,939b5d1f-9fb2-4499-80ef-0607aa6b114e,limitation of use avastin is not indicated for adjuvant treatment of colon cancer see clinical studies ( 14 2 ),2
1903,1903,1903,1903,1903,1903,1903,2415,2415,2415,2415,2415,2415,2415,2415,2415,2415,2415,2415,2415,08313a24-e7ce-457a-bb3f-161bc45517ee,1  luxturna ( voretigene neparvovec rzyl ) is an adeno associated virus vector based gene therapy indicated for the treatment of patients with confirmed biallelic rpe65 mutation associated retinal dystrophy,1
1904,1904,1904,1904,1904,1904,1904,2416,2416,2416,2416,2416,2416,2416,2416,2416,2416,2416,2416,2416,08313a24-e7ce-457a-bb3f-161bc45517ee,patients must have viable retinal cells as determined by the treating physician ( s ),4
1905,1905,1905,1905,1905,1905,1905,2417,2417,2417,2417,2417,2417,2417,2417,2417,2417,2417,2417,2417,08313a24-e7ce-457a-bb3f-161bc45517ee,luxturna is an adeno associated virus vector based gene therapy indicated for the treatment of patients with confirmed biallelic rpe65 mutation associated retinal dystrophy,1
1906,1906,1906,1906,1906,1906,1906,2419,2419,2419,2419,2419,2419,2419,2419,2419,2419,2419,2419,2419,d9370dfc-283b-4a91-8e5e-18c35d2a78e6,1  lamivudine and zidovudine tablets  a combination of 2 nucleoside analogues  are indicated in combination with other antiretrovirals for the treatment of human immunodeficiency virus type 1 ( hiv 1 ) infection,1
1907,1907,1907,1907,1907,1907,1907,2420,2420,2420,2420,2420,2420,2420,2420,2420,2420,2420,2420,2420,d9370dfc-283b-4a91-8e5e-18c35d2a78e6,lamivudine and zidovudine tablets  a combination of 2 nucleoside analogue reverse transcriptase inhibitors  are indicated in combination with other antiretroviral agents for the treatment of hiv 1 infection,1
1908,1908,1908,1908,1908,1908,1908,2421,2421,2421,2421,2421,2421,2421,2421,2421,2421,2421,2421,2421,f5f7c0d9-a247-4308-8269-32accc490ea6,1  abacavir  lamivudine and zidovudine tablet  a combination of abacavir  lamivudine  and zidovudine  each nucleoside analogue hiv 1 reverse transcriptase inhibitors  is indicated in combination with other antiretroviral agents for the treatment of hiv 1 infection,1
1909,1909,1909,1909,1909,1909,1909,2422,2422,2422,2422,2422,2422,2422,2422,2422,2422,2422,2422,2422,f5f7c0d9-a247-4308-8269-32accc490ea6,( 1 ) abacavir  lamivudine and zidovudine tablet is indicated in combination with other antiretrovirals or alone for the treatment of human immunodeficiency virus type 1 ( hiv 1 ) infection,1
1910,1910,1910,1910,1910,1910,1910,2423,2423,2423,2423,2423,2423,2423,2423,2423,2423,2423,2423,2423,f5f7c0d9-a247-4308-8269-32accc490ea6,limitations of use limited data exist on the use of abacavir  lamivudine and zidovudine tablets alone in patients with higher baseline viral load levels ( greater than 100  000 copies per ml ) see clinical studies ( 14 ),2
1911,1911,1911,1911,1911,1911,1911,2424,2424,2424,2424,2424,2424,2424,2424,2424,2424,2424,2424,2424,8b7f7043-5bfb-47a5-80cb-4f3f65358dff, cefpodoxime proxetil is indicated for the treatment of patients with mild to moderate infections caused by susceptible strains of the designated microorganisms in the conditions listed below,1
1912,1912,1912,1912,1912,1912,1912,2425,2425,2425,2425,2425,2425,2425,2425,2425,2425,2425,2425,2425,8b7f7043-5bfb-47a5-80cb-4f3f65358dff,recommended dosages  durations of therapy  and applicable patient populations vary among these infections,0
1913,1913,1913,1913,1913,1913,1913,2426,2426,2426,2426,2426,2426,2426,2426,2426,2426,2426,2426,2426,8b7f7043-5bfb-47a5-80cb-4f3f65358dff,please see dosage and administration for specific recommendations,0
1914,1914,1914,1914,1914,1914,1914,2427,2427,2427,2427,2427,2427,2427,2427,2427,2427,2427,2427,2427,8b7f7043-5bfb-47a5-80cb-4f3f65358dff,acute otitis media caused by streptococcus pneumoniae ( excluding penicillin resistant strains )  streptococcus pyogenes  haemophilus influenzae ( including beta lactamase producing strains )  or moraxella ( branhamella ) catarrhalis ( including beta lactamase producing strains ),1
1915,1915,1915,1915,1915,1915,1915,2428,2428,2428,2428,2428,2428,2428,2428,2428,2428,2428,2428,2428,8b7f7043-5bfb-47a5-80cb-4f3f65358dff,pharyngitis and or tonsillitis caused by streptococcus pyogenes,1
1916,1916,1916,1916,1916,1916,1916,2430,2430,2430,2430,2430,2430,2430,2430,2430,2430,2430,2430,2430,8b7f7043-5bfb-47a5-80cb-4f3f65358dff,cefpodoxime proxetil is generally effective in the eradication of streptococci from the oropharynx,1
1917,1917,1917,1917,1917,1917,1917,2431,2431,2431,2431,2431,2431,2431,2431,2431,2431,2431,2431,2431,8b7f7043-5bfb-47a5-80cb-4f3f65358dff,however  data establishing the efficacy of cefpodoxime proxetil for the prophylaxis of subsequent rheumatic fever are not available,0
1918,1918,1918,1918,1918,1918,1918,2432,2432,2432,2432,2432,2432,2432,2432,2432,2432,2432,2432,2432,8b7f7043-5bfb-47a5-80cb-4f3f65358dff,community acquired pneumonia caused by s pneumoniae or h influenzae ( including beta lactamase producing strains ),1
1919,1919,1919,1919,1919,1919,1919,2433,2433,2433,2433,2433,2433,2433,2433,2433,2433,2433,2433,2433,8b7f7043-5bfb-47a5-80cb-4f3f65358dff,acute bacterial exacerbation of chronic bronchitis caused by s pneumoniae  h influenzae ( non beta lactamase producing strains only )  or m catarrhalis,1
1920,1920,1920,1920,1920,1920,1920,2434,2434,2434,2434,2434,2434,2434,2434,2434,2434,2434,2434,2434,8b7f7043-5bfb-47a5-80cb-4f3f65358dff,data are insufficient at this time to establish efficacy in patients with acute bacterial exacerbations of chronic bronchitis caused by beta lactamase producing strains of h influenzae,0
1921,1921,1921,1921,1921,1921,1921,2435,2435,2435,2435,2435,2435,2435,2435,2435,2435,2435,2435,2435,8b7f7043-5bfb-47a5-80cb-4f3f65358dff,acute  uncomplicated urethral and cervical gonorrhea caused by neisseria gonorrhoeae ( including penicillinase producing strains ),1
1922,1922,1922,1922,1922,1922,1922,2436,2436,2436,2436,2436,2436,2436,2436,2436,2436,2436,2436,2436,8b7f7043-5bfb-47a5-80cb-4f3f65358dff,acute  uncomplicated ano rectal infections in women due to neisseria gonorrhoeae ( including penicillinase producing strains ),1
1923,1923,1923,1923,1923,1923,1923,2437,2437,2437,2437,2437,2437,2437,2437,2437,2437,2437,2437,2437,8b7f7043-5bfb-47a5-80cb-4f3f65358dff,note the efficacy of cefpodoxime in treating male patients with rectal infections caused by n gonorrhoeae has not been established,0
1924,1924,1924,1924,1924,1924,1924,2438,2438,2438,2438,2438,2438,2438,2438,2438,2438,2438,2438,2438,8b7f7043-5bfb-47a5-80cb-4f3f65358dff,data do not support the use of cefpodoxime proxetil in the treatment of pharyngeal infections due to n gonorrhoeae in men or women,2
1925,1925,1925,1925,1925,1925,1925,2439,2439,2439,2439,2439,2439,2439,2439,2439,2439,2439,2439,2439,5a0ba417-8a4a-4d7f-b85a-1839ee8bd3f1,1  vistogard is indicated for the emergency treatment of adult and pediatric patients following a fluorouracil or capecitabine overdose regardless of the presence of symptoms  or who exhibit early onset  severe or life threatening toxicity affecting the cardiac or central nervous system  and or early onset  unusually severe adverse reactions ( e g  gastrointestinal toxicity and or neutropenia ) within 96 hours following the end of fluorouracil or capecitabine administration,1
1926,1926,1926,1926,1926,1926,1926,2440,2440,2440,2440,2440,2440,2440,2440,2440,2440,2440,2440,2440,5a0ba417-8a4a-4d7f-b85a-1839ee8bd3f1,vistogard is a pyrimidine analog indicated for the emergency treatment of adult and pediatric patients following a fluorouracil or capecitabine overdose regardless of the presence of symptoms  or who exhibit early onset  severe or life threatening toxicity affecting the cardiac or central nervous system  and or early onset  unusually severe adverse reactions ( e g  gastrointestinal toxicity and or neutropenia ) within 96 hours following the end of fluorouracil or capecitabine administration,1
1927,1927,1927,1927,1927,1927,1927,2441,2441,2441,2441,2441,2441,2441,2441,2441,2441,2441,2441,2441,5a0ba417-8a4a-4d7f-b85a-1839ee8bd3f1,( 1 ) limitations of use vistogard is not recommended for the non emergent treatment of adverse reactions associated with fluorouracil or capecitabine because it may diminish the efficacy of these drugs,2
1928,1928,1928,1928,1928,1928,1928,2442,2442,2442,2442,2442,2442,2442,2442,2442,2442,2442,2442,2442,5a0ba417-8a4a-4d7f-b85a-1839ee8bd3f1,( 1 ) the safety and efficacy of vistogard initiated more than 96 hours following the end of fluorouracil or capecitabine administration have not been established,0
1929,1929,1929,1929,1929,1929,1929,2444,2444,2444,2444,2444,2444,2444,2444,2444,2444,2444,2444,2444,5a0ba417-8a4a-4d7f-b85a-1839ee8bd3f1,the safety and efficacy of vistogard initiated more than 96 hours following the end of fluorouracil or capecitabine administration have not been established,0
1930,1930,1930,1930,1930,1930,1930,2445,2445,2445,2445,2445,2445,2445,2445,2445,2445,2445,2445,2445,7bf99777-0401-9095-8645-16c6e907fcc0,1  mavyret is indicated for the treatment of adult patients with chronic hepatitis c virus ( hcv ) genotype 1  2  3  4  5 or 6 infection without cirrhosis or with compensated cirrhosis ( child pugh a ),1
1931,1931,1931,1931,1931,1931,1931,2446,2446,2446,2446,2446,2446,2446,2446,2446,2446,2446,2446,2446,7bf99777-0401-9095-8645-16c6e907fcc0,mavyret is also indicated for the treatment of adult patients with hcv genotype 1 infection  who previously have been treated with a regimen containing an hcv ns5a inhibitor or an ns3 4a protease inhibitor ( pi )  but not both see dosage and administration ( 2 2 ) and clinical studies ( 14 ),1
1932,1932,1932,1932,1932,1932,1932,2447,2447,2447,2447,2447,2447,2447,2447,2447,2447,2447,2447,2447,7bf99777-0401-9095-8645-16c6e907fcc0,mavyret is a fixed dose combination of glecaprevir  a hepatitis c virus ( hcv ) ns3 4a protease inhibitor  and pibrentasvir  an hcv ns5a inhibitor  and is indicated for the treatment of patients with chronic hcv genotype ( gt ) 1  2  3  4  5 or 6 infection without cirrhosis and with compensated cirrhosis ( child pugh a ),1
1933,1933,1933,1933,1933,1933,1933,2448,2448,2448,2448,2448,2448,2448,2448,2448,2448,2448,2448,2448,7bf99777-0401-9095-8645-16c6e907fcc0,mavyret is also indicated for the treatment of adult patients with hcv genotype 1 infection  who previously have been treated with a regimen containing an hcv ns5a inhibitor or an ns3 4a protease inhibitor  but not both,1
1934,1934,1934,1934,1934,1934,1934,2449,2449,2449,2449,2449,2449,2449,2449,2449,2449,2449,2449,2449,057289f4-2e18-4c1e-bed4-6c1858e2ef16,1  lexiscan ( regadenoson ) injection is a pharmacologic stress agent indicated for radionuclide myocardial perfusion imaging ( mpi ) in patients unable to undergo adequate exercise stress,1
1935,1935,1935,1935,1935,1935,1935,2450,2450,2450,2450,2450,2450,2450,2450,2450,2450,2450,2450,2450,057289f4-2e18-4c1e-bed4-6c1858e2ef16,lexiscan is a pharmacologic stress agent indicated for radionuclide myocardial perfusion imaging ( mpi ) in patients unable to undergo adequate exercise stress ( 1 ),1
1936,1936,1936,1936,1936,1936,1936,2451,2451,2451,2451,2451,2451,2451,2451,2451,2451,2451,2451,2451,c9b74876-e665-442b-87ad-b7333bc9a67a, tice bcg is indicated for the treatment and prophylaxis of carcinoma in situ ( cis ) of the urinary bladder  and for the prophylaxis of primary or recurrent stage ta and or t1 papillary tumors following transurethral resection ( tur ),1
1937,1937,1937,1937,1937,1937,1937,2452,2452,2452,2452,2452,2452,2452,2452,2452,2452,2452,2452,2452,c9b74876-e665-442b-87ad-b7333bc9a67a,tice bcg is not recommended for stage tag1 papillary tumors  unless they are judged to be at high risk of tumor recurrence,u
1938,1938,1938,1938,1938,1938,1938,2453,2453,2453,2453,2453,2453,2453,2453,2453,2453,2453,2453,2453,c9b74876-e665-442b-87ad-b7333bc9a67a,tice bcg is not indicated for papillary tumors of stages higher than t1,2
1939,1939,1939,1939,1939,1939,1939,2454,2454,2454,2454,2454,2454,2454,2454,2454,2454,2454,2454,2454,e3b94a78-0d41-4618-aca5-b1770f945559, perennial and seasonal allergic rhinitis vasomotor rhinitis allergic conjunctivitis due to inhalant allergens and foods mild  uncomplicated allergic skin manifestations of urticaria and angioedema amelioration of allergic reactions to blood or plasma cold urticaria dermatographism as therapy for anaphylactic reactions adjunctive to epinephrine and other standard measures after the acute manifestations have been controlled,1
1940,1940,1940,1940,1940,1940,1940,2455,2455,2455,2455,2455,2455,2455,2455,2455,2455,2455,2455,2455,5d4f90d4-e535-4681-a863-3d774a2064e6,1  anastrozole tablets are an aromatase inhibitor indicated for adjuvant treatment of postmenopausal women with hormone receptor positive early breast cancer ( 1 1 ) first line treatment of postmenopausal women with hormone receptor positive or hormone receptor unknown locally advanced or metastatic breast cancer ( 1 2 ) treatment of advanced breast cancer in postmenopausal women with disease progression following tamoxifen therapy,1
1941,1941,1941,1941,1941,1941,1941,2456,2456,2456,2456,2456,2456,2456,2456,2456,2456,2456,2456,2456,5d4f90d4-e535-4681-a863-3d774a2064e6,patients with er negative disease and patients who did not respond to previous tamoxifen therapy rarely responded to anastrozole tablets ( 1 3 ) 1 1 adjuvant treatment anastrozole tablets are indicated for adjuvant treatment of postmenopausal women with hormone receptor positive early breast cancer,1
1942,1942,1942,1942,1942,1942,1942,2457,2457,2457,2457,2457,2457,2457,2457,2457,2457,2457,2457,2457,5d4f90d4-e535-4681-a863-3d774a2064e6,1 2 first line treatment anastrozole tablets are indicated for the first line treatment of postmenopausal women with hormone receptor positive or hormone receptor unknown locally advanced or metastatic breast cancer,1
1943,1943,1943,1943,1943,1943,1943,2458,2458,2458,2458,2458,2458,2458,2458,2458,2458,2458,2458,2458,5d4f90d4-e535-4681-a863-3d774a2064e6,1 3 second line treatment anastrozole tablets are indicated for the treatment of advanced breast cancer in postmenopausal women with disease progression following tamoxifen therapy,1
1944,1944,1944,1944,1944,1944,1944,2459,2459,2459,2459,2459,2459,2459,2459,2459,2459,2459,2459,2459,5d4f90d4-e535-4681-a863-3d774a2064e6,patients with er negative disease and patients who did not respond to previous tamoxifen therapy rarely responded to anastrozole tablets,u
1945,1945,1945,1945,1945,1945,1945,2460,2460,2460,2460,2460,2460,2460,2460,2460,2460,2460,2460,2460,b861fdd9-e134-436e-8c0c-a60dd0006dd3,1  lantus is indicated to improve glycemic control in adults and children with type 1 diabetes mellitus and in adults with type 2 diabetes mellitus,1
1946,1946,1946,1946,1946,1946,1946,2461,2461,2461,2461,2461,2461,2461,2461,2461,2461,2461,2461,2461,b861fdd9-e134-436e-8c0c-a60dd0006dd3,important limitations of use lantus is not recommended for the treatment of diabetic ketoacidosis,2
1947,1947,1947,1947,1947,1947,1947,2462,2462,2462,2462,2462,2462,2462,2462,2462,2462,2462,2462,2462,b861fdd9-e134-436e-8c0c-a60dd0006dd3,intravenous short acting insulin is the preferred treatment for this condition,u
1948,1948,1948,1948,1948,1948,1948,2463,2463,2463,2463,2463,2463,2463,2463,2463,2463,2463,2463,2463,b861fdd9-e134-436e-8c0c-a60dd0006dd3,lantus is a long acting human insulin analog indicated to improve glycemic control in adults and children with type 1 diabetes mellitus and in adults with type 2 diabetes mellitus,1
1949,1949,1949,1949,1949,1949,1949,2464,2464,2464,2464,2464,2464,2464,2464,2464,2464,2464,2464,2464,b861fdd9-e134-436e-8c0c-a60dd0006dd3,( 1 ) important limitations of use not recommended for treating diabetic ketoacidosis,2
1950,1950,1950,1950,1950,1950,1950,2465,2465,2465,2465,2465,2465,2465,2465,2465,2465,2465,2465,2465,b861fdd9-e134-436e-8c0c-a60dd0006dd3,use intravenous  short acting insulin instead,0
1951,1951,1951,1951,1951,1951,1951,2466,2466,2466,2466,2466,2466,2466,2466,2466,2466,2466,2466,2466,4bba538b-cf7c-4310-ae8f-cb711ed21bcc,1  soliqua 100 33 is a combination of insulin glargine and lixisenatide and is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus inadequately controlled on basal insulin ( less than 60 units daily ) or lixisenatide,1
1952,1952,1952,1952,1952,1952,1952,2467,2467,2467,2467,2467,2467,2467,2467,2467,2467,2467,2467,2467,4bba538b-cf7c-4310-ae8f-cb711ed21bcc,limitations of use soliqua 100 33 has not been studied in patients with a history of pancreatitis see warnings and precautions ( 5 2 ),0
1953,1953,1953,1953,1953,1953,1953,2468,2468,2468,2468,2468,2468,2468,2468,2468,2468,2468,2468,2468,4bba538b-cf7c-4310-ae8f-cb711ed21bcc,consider other antidiabetic therapies in patients with a history of pancreatitis,0
1954,1954,1954,1954,1954,1954,1954,2469,2469,2469,2469,2469,2469,2469,2469,2469,2469,2469,2469,2469,4bba538b-cf7c-4310-ae8f-cb711ed21bcc,soliqua 100 33 is not recommended for use in combination with any other product containing lixisenatide or another glp 1 receptor agonist see warnings and precautions ( 5 5 ),2
1955,1955,1955,1955,1955,1955,1955,2470,2470,2470,2470,2470,2470,2470,2470,2470,2470,2470,2470,2470,4bba538b-cf7c-4310-ae8f-cb711ed21bcc,soliqua 100 33 is not indicated for use in patients with type 1 diabetes mellitus or for the treatment of diabetic ketoacidosis,2
1956,1956,1956,1956,1956,1956,1956,2471,2471,2471,2471,2471,2471,2471,2471,2471,2471,2471,2471,2471,4bba538b-cf7c-4310-ae8f-cb711ed21bcc,soliqua 100 33 has not been studied in patients with gastroparesis and is not recommended in patients with gastroparesis,2
1957,1957,1957,1957,1957,1957,1957,2472,2472,2472,2472,2472,2472,2472,2472,2472,2472,2472,2472,2472,4bba538b-cf7c-4310-ae8f-cb711ed21bcc,soliqua 100 33 has not been studied in combination with prandial insulin,0
1958,1958,1958,1958,1958,1958,1958,2473,2473,2473,2473,2473,2473,2473,2473,2473,2473,2473,2473,2473,4bba538b-cf7c-4310-ae8f-cb711ed21bcc,soliqua 100 33 is a combination of a long acting human insulin analog with a glucagon like peptide 1 ( glp 1 ) receptor agonist indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus inadequately controlled on basal insulin ( less than 60 units daily ) or lixisenatide,1
1959,1959,1959,1959,1959,1959,1959,2474,2474,2474,2474,2474,2474,2474,2474,2474,2474,2474,2474,2474,4bba538b-cf7c-4310-ae8f-cb711ed21bcc,( 1 ) limitations of use ( 1 ) has not been studied in patients with a history of pancreatitis,0
1960,1960,1960,1960,1960,1960,1960,2476,2476,2476,2476,2476,2476,2476,2476,2476,2476,2476,2476,2476,4bba538b-cf7c-4310-ae8f-cb711ed21bcc,not recommended for use in combination with any other product containing lixisenatide or another glp 1 receptor agonist,2
1961,1961,1961,1961,1961,1961,1961,2477,2477,2477,2477,2477,2477,2477,2477,2477,2477,2477,2477,2477,4bba538b-cf7c-4310-ae8f-cb711ed21bcc,not for treatment of type 1 diabetes mellitus or diabetic ketoacidosis,2
1962,1962,1962,1962,1962,1962,1962,2478,2478,2478,2478,2478,2478,2478,2478,2478,2478,2478,2478,2478,4bba538b-cf7c-4310-ae8f-cb711ed21bcc,not recommended for use in patients with gastroparesis,2
1963,1963,1963,1963,1963,1963,1963,2479,2479,2479,2479,2479,2479,2479,2479,2479,2479,2479,2479,2479,4bba538b-cf7c-4310-ae8f-cb711ed21bcc,has not been studied in combination with prandial insulin,0
1964,1964,1964,1964,1964,1964,1964,2480,2480,2480,2480,2480,2480,2480,2480,2480,2480,2480,2480,2480,b03a3917-9a65-45c2-bbbb-871da858ef34,1  nexplanon is indicated for use by women to prevent pregnancy,1
1965,1965,1965,1965,1965,1965,1965,2481,2481,2481,2481,2481,2481,2481,2481,2481,2481,2481,2481,2481,b03a3917-9a65-45c2-bbbb-871da858ef34,nexplanon is a progestin indicated for use by women to prevent pregnancy,1
1966,1966,1966,1966,1966,1966,1966,2482,2482,2482,2482,2482,2482,2482,2482,2482,2482,2482,2482,2482,1347d58b-c505-45e7-aa9d-9800b9cf40c5,1  for vaginal use only nuvaring is indicated for use by females of reproductive age to prevent pregnancy,1
1967,1967,1967,1967,1967,1967,1967,2483,2483,2483,2483,2483,2483,2483,2483,2483,2483,2483,2483,2483,1347d58b-c505-45e7-aa9d-9800b9cf40c5,nuvaring is an estrogen progestin combination hormonal contraceptive ( chc ) indicated for use by women to prevent pregnancy,1
1968,1968,1968,1968,1968,1968,1968,2484,2484,2484,2484,2484,2484,2484,2484,2484,2484,2484,2484,2484,ae50721d-ee15-4ee7-9fe7-afd98c56461b, sporanox ( itraconazole ) oral solution is indicated for the treatment of oropharyngeal and esophageal candidiasis,1
1969,1969,1969,1969,1969,1969,1969,2485,2485,2485,2485,2485,2485,2485,2485,2485,2485,2485,2485,2485,ae50721d-ee15-4ee7-9fe7-afd98c56461b,( see clinical pharmacology special populations  warnings  and adverse reactions post marketing experience for more information ),0
1970,1970,1970,1970,1970,1970,1970,2486,2486,2486,2486,2486,2486,2486,2486,2486,2486,2486,2486,2486,6006df06-0448-462d-b81e-7add50a6d71b,1  guanfacine extended release tablets are indicated for the treatment of attention deficit hyperactivity disorder ( adhd ) as monotherapy and as adjunctive therapy to stimulant medications see clinical studies ( 14 ),1
1971,1971,1971,1971,1971,1971,1971,2487,2487,2487,2487,2487,2487,2487,2487,2487,2487,2487,2487,2487,6006df06-0448-462d-b81e-7add50a6d71b,guanfacine extended release tablets are central alpha2a adrenergic receptor agonist indicated for the treatment of attention deficit hyperactivity disorder ( adhd ) as monotherapyand as adjunctive therapy to stimulant medications ( 1  14 ),1
1972,1972,1972,1972,1972,1972,1972,2488,2488,2488,2488,2488,2488,2488,2488,2488,2488,2488,2488,2488,fab28f67-9dfa-4bf7-8758-c0c4b6aef56a, bupivacaine hydrochloride is indicated for the production of local or regional anesthesia or analgesia for surgery  dental and oral surgery procedures  diagnostic and therapeutic procedures  and for obstetrical procedures,1
1973,1973,1973,1973,1973,1973,1973,2489,2489,2489,2489,2489,2489,2489,2489,2489,2489,2489,2489,2489,fab28f67-9dfa-4bf7-8758-c0c4b6aef56a,only the 0 25 and 0 5 concentrations are indicated for obstetrical anesthesia,1
1974,1974,1974,1974,1974,1974,1974,2490,2490,2490,2490,2490,2490,2490,2490,2490,2490,2490,2490,2490,fab28f67-9dfa-4bf7-8758-c0c4b6aef56a,experience with nonobstetrical surgical procedures in pregnant patients is not sufficient to recommend use of 0 75 concentration of bupivacaine hydrochloride in these patients,0
1975,1975,1975,1975,1975,1975,1975,2491,2491,2491,2491,2491,2491,2491,2491,2491,2491,2491,2491,2491,fab28f67-9dfa-4bf7-8758-c0c4b6aef56a,bupivacaine hydrochloride is not recommended for intravenous regional anesthesia ( bier block ),2
1976,1976,1976,1976,1976,1976,1976,2492,2492,2492,2492,2492,2492,2492,2492,2492,2492,2492,2492,2492,fab28f67-9dfa-4bf7-8758-c0c4b6aef56a,the routes of administration and indicated bupivacaine hydrochloride concentrations are ( see dosage and administration for additional information ),0
1977,1977,1977,1977,1977,1977,1977,2493,2493,2493,2493,2493,2493,2493,2493,2493,2493,2493,2493,2493,fab28f67-9dfa-4bf7-8758-c0c4b6aef56a,standard textbooks should be consulted to determine the accepted procedures and techniques for the administration of bupivacaine hydrochloride,4
1978,1978,1978,1978,1978,1978,1978,2494,2494,2494,2494,2494,2494,2494,2494,2494,2494,2494,2494,2494,"Active Ingredient UNII(s)
30Q7KI53AK; 85H0HZU99M; EC2CNF7XFP; ND2M416302    5dba6f5e-19c9-4a30-a5c5-74e6dc906704
30Q7KI53AK; 85H0HZU99M; EC2CNF7XFP; ND2M416302    5dba6f5e-19c9-4a30-a5c5-74e6dc906704
30Q7KI53AK; 85H0HZU99M; EC2CNF7XFP; ND2M416302    5dba6f5e-19c9-4a30-a5c5-74e6dc906704
Name: SET ID dtype: object",active ingredient unii ( s ) 30q7ki53ak 85h0hzu99m ec2cnf7xfp nd2m416302 active ingredient unii ( s ) 30q7ki53ak 85h0hzu9 30q7ki53ak 85h0hzu99m ec2cnf7xfp nd2m416302 active ingredient unii ( s ) 30q7ki53ak 85h0hzu9 30q7ki53ak 85h0hzu99m ec2cnf7xfp nd2m416302 active ingredient unii ( s ) 30q7ki53ak 85h0hzu9 name content xml  dtype object,0
1979,1979,1979,1979,1979,1979,1979,2497,2497,2497,2497,2497,2497,2497,2497,2497,2497,2497,2497,2497,e213c4f8-1fab-46fb-bcc7-1f68b3bd1696,indications usage xylocaine ( lidocaine hcl ) injections are indicated for production of local or regional anesthesia by infiltration techniques such as percutaneous injection and intravenous regional anesthesia by peripheral nerve block techniques such as brachial plexus and intercostal and by central neural techniques such as lumbar and caudal epidural blocks  when the accepted procedures for these techniques as described in standard textbooks are observed,1
1980,1980,1980,1980,1980,1980,1980,2498,2498,2498,2498,2498,2498,2498,2498,2498,2498,2498,2498,2498,b374a5f1-ef37-402d-b011-ca8d20689f02, prilocaine hydrochloride 4 with epinephrine 1 200  000 injection is indicated for the production of local anesthesia in dentistry by nerve block or infiltration techniques,1
1981,1981,1981,1981,1981,1981,1981,2499,2499,2499,2499,2499,2499,2499,2499,2499,2499,2499,2499,2499,b374a5f1-ef37-402d-b011-ca8d20689f02,only accepted procedures for these techniques as described in standard textbooks are recommended,0
1982,1982,1982,1982,1982,1982,1982,2500,2500,2500,2500,2500,2500,2500,2500,2500,2500,2500,2500,2500,d9402ac2-fedd-4fb0-90a3-2c466a786526,1  articaine hcl and epinephrine  an amide local anesthetic containing a vasoconstrictor  is indicated for local  infiltrative  or conductive anesthesia in both simple and complex dental procedures,1
1983,1983,1983,1983,1983,1983,1983,2501,2501,2501,2501,2501,2501,2501,2501,2501,2501,2501,2501,2501,d9402ac2-fedd-4fb0-90a3-2c466a786526,articaine hcl and epinephrine  an amide local anesthetic containing a vasoconstrictor  is indicated for local  infiltrative  or conductive anesthesia in both simple and complex dental procedures,1
1984,1984,1984,1984,1984,1984,1984,2502,2502,2502,2502,2502,2502,2502,2502,2502,2502,2502,2502,2502,2eb798cf-f480-408d-8feb-73f4f943e884,1  granisetron hydrochloride injection  usp is a serotonin 3 ( 5 ht3 ) receptor antagonist indicated for the prevention of nausea and or vomiting associated with initial and repeat courses of emetogenic cancer therapy  including high dose cisplatin,1
1985,1985,1985,1985,1985,1985,1985,2503,2503,2503,2503,2503,2503,2503,2503,2503,2503,2503,2503,2503,2eb798cf-f480-408d-8feb-73f4f943e884,granisetron hydrochloride injection  usp is a serotonin 3 ( 5 ht3 ) receptor antagonist indicated for prevention of nausea and or vomiting associated with initial and repeat courses of emetogenic cancer therapy  including high dose cisplatin,1
1986,1986,1986,1986,1986,1986,1986,2504,2504,2504,2504,2504,2504,2504,2504,2504,2504,2504,2504,2504,762b51be-1893-4cd1-9511-e645fc420d3a,1  inomax is indicated to improve oxygenation and reduce the need for extracorporeal membrane oxygenation in term and near term ( 34 weeks gestation ) neonates with hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension in conjunction with ventilatory support and other appropriate agents,1
1987,1987,1987,1987,1987,1987,1987,2505,2505,2505,2505,2505,2505,2505,2505,2505,2505,2505,2505,2505,762b51be-1893-4cd1-9511-e645fc420d3a,inomax is a vasodilator indicated to improve oxygenation and reduce the need for extracorporeal membrane oxygenation in term and near term ( 34 weeks gestation ) neonates with hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension in conjunction with ventilatory support and other appropriate agents,1
1988,1988,1988,1988,1988,1988,1988,2506,2506,2506,2506,2506,2506,2506,2506,2506,2506,2506,2506,2506,2c07ce91-cc83-45e3-bd2b-f923a9c8286c, glofil 125 ( sodium iothalamate i 125 injection ) is indicated for evaluation of glomerular filtration in the diagnosis or monitoring of patients with renal disease,1
1989,1989,1989,1989,1989,1989,1989,2507,2507,2507,2507,2507,2507,2507,2507,2507,2507,2507,2507,2507,8f7f73b8-586a-4df0-935f-fecd4696c16c,1  cresemba is an azole antifungal indicated for use in the treatment of invasive aspergillosis ( 1 1 ),1
1990,1990,1990,1990,1990,1990,1990,2508,2508,2508,2508,2508,2508,2508,2508,2508,2508,2508,2508,2508,8f7f73b8-586a-4df0-935f-fecd4696c16c,1 1 invasive aspergillosis cresemba is an azole antifungal indicated for patients 18 years of age and older for the treatment of invasive aspergillosis,1
1991,1991,1991,1991,1991,1991,1991,2509,2509,2509,2509,2509,2509,2509,2509,2509,2509,2509,2509,2509,8f7f73b8-586a-4df0-935f-fecd4696c16c,see clinical studies ( 14 1 ) and clinical pharmacology ( 12 4 ),0
1992,1992,1992,1992,1992,1992,1992,2510,2510,2510,2510,2510,2510,2510,2510,2510,2510,2510,2510,2510,8f7f73b8-586a-4df0-935f-fecd4696c16c,1 2 invasive mucormycosis cresemba is an azole antifungal indicated for patients 18 years of age and older for the treatment of invasive mucormycosis,1
1993,1993,1993,1993,1993,1993,1993,2511,2511,2511,2511,2511,2511,2511,2511,2511,2511,2511,2511,2511,8f7f73b8-586a-4df0-935f-fecd4696c16c,see clinical studies ( 14 2 ) and clinical pharmacology ( 12 4 ),0
1994,1994,1994,1994,1994,1994,1994,2512,2512,2512,2512,2512,2512,2512,2512,2512,2512,2512,2512,2512,8f7f73b8-586a-4df0-935f-fecd4696c16c,1 3 usage specimens for fungal culture and other relevant laboratory studies ( including histopathology ) to isolate and identify causative organism ( s ) should be obtained prior to initiating antifungal therapy,4
1995,1995,1995,1995,1995,1995,1995,2513,2513,2513,2513,2513,2513,2513,2513,2513,2513,2513,2513,2513,8f7f73b8-586a-4df0-935f-fecd4696c16c,therapy may be instituted before the results of the cultures and other laboratory studies are known,0
1996,1996,1996,1996,1996,1996,1996,2514,2514,2514,2514,2514,2514,2514,2514,2514,2514,2514,2514,2514,8f7f73b8-586a-4df0-935f-fecd4696c16c,however  once these results become available  antifungal therapy should be adjusted accordingly,0
1997,1997,1997,1997,1997,1997,1997,2515,2515,2515,2515,2515,2515,2515,2515,2515,2515,2515,2515,2515,a7c1400a-d230-45db-afff-d5f70b091ee9, biferarx is a prescription iron supplement indicated for use in improving the nutritional status of iron deficiency,1
1998,1998,1998,1998,1998,1998,1998,2516,2516,2516,2516,2516,2516,2516,2516,2516,2516,2516,2516,2516,d0006282-ecfa-49bc-b725-95994ef95109, hemetab is a prescription iron supplement indicated for use in improving the nutritional status of iron deficiency,1
1999,1999,1999,1999,1999,1999,1999,2517,2517,2517,2517,2517,2517,2517,2517,2517,2517,2517,2517,2517,f570b9c4-6846-4de2-abfa-4d0a4ae4e394,1  opdivo is a programmed death receptor 1 ( pd 1 ) blocking antibody indicated for the treatment of patients with braf v600 wild type unresectable or metastatic melanoma  as a single agent,1
2000,2000,2000,2000,2000,2000,2000,2518,2518,2518,2518,2518,2518,2518,2518,2518,2518,2518,2518,2518,f570b9c4-6846-4de2-abfa-4d0a4ae4e394,( 1 1 ) patients with braf v600 mutation positive unresectable or metastatic melanoma  as a single agent a ( 1 1 ) patients with unresectable or metastatic melanoma  in combination with ipilimumab a ( 1 1 ) patients with melanoma with lymph node involvement or metastatic disease who have undergone complete resection  in the adjuvant setting,1
2001,2001,2001,2001,2001,2001,2001,2519,2519,2519,2519,2519,2519,2519,2519,2519,2519,2519,2519,2519,f570b9c4-6846-4de2-abfa-4d0a4ae4e394,( 1 2 ) patients with metastatic non small cell lung cancer and progression on or after platinum based chemotherapy,1
2002,2002,2002,2002,2002,2002,2002,2520,2520,2520,2520,2520,2520,2520,2520,2520,2520,2520,2520,2520,f570b9c4-6846-4de2-abfa-4d0a4ae4e394,patients with egfr or alk genomic tumor aberrations should have disease progression on fda approved therapy for these aberrations prior to receiving opdivo,u
2003,2003,2003,2003,2003,2003,2003,2521,2521,2521,2521,2521,2521,2521,2521,2521,2521,2521,2521,2521,f570b9c4-6846-4de2-abfa-4d0a4ae4e394,( 1 3 ) patients with advanced renal cell carcinoma who have received prior anti angiogenic therapy,1
2004,2004,2004,2004,2004,2004,2004,2522,2522,2522,2522,2522,2522,2522,2522,2522,2522,2522,2522,2522,f570b9c4-6846-4de2-abfa-4d0a4ae4e394,( 1 4 ) adult patients with classical hodgkin lymphoma that has relapsed or progressed afterb ( 1 5 ) autologous hematopoietic stem cell transplantation ( hsct ) and brentuximab vedotin  or 3 or more lines of systemic therapy that includes autologous hsct,1
2005,2005,2005,2005,2005,2005,2005,2523,2523,2523,2523,2523,2523,2523,2523,2523,2523,2523,2523,2523,f570b9c4-6846-4de2-abfa-4d0a4ae4e394,patients with recurrent or metastatic squamous cell carcinoma of the head and neck with disease progression on or after a platinum based therapy,1
2006,2006,2006,2006,2006,2006,2006,2524,2524,2524,2524,2524,2524,2524,2524,2524,2524,2524,2524,2524,f570b9c4-6846-4de2-abfa-4d0a4ae4e394,( 1 6 ) patients with locally advanced or metastatic urothelial carcinoma whob have disease progression during or following platinum containing chemotherapy have disease progression within 12 months of neoadjuvant or adjuvant treatment with platinum containing chemotherapy,1
2007,2007,2007,2007,2007,2007,2007,2525,2525,2525,2525,2525,2525,2525,2525,2525,2525,2525,2525,2525,f570b9c4-6846-4de2-abfa-4d0a4ae4e394,( 1 7 ) adult and pediatric ( 12 years and older ) patients with microsatellite instability high ( msi h ) or mismatch repair deficient ( dmmr ) metastatic colorectal cancer that has progressed following treatment with a fluoropyrimidine  oxalip,1
2008,2008,2008,2008,2008,2008,2008,2526,2526,2526,2526,2526,2526,2526,2526,2526,2526,2526,2526,2526,ed6657ca-ab68-477a-9968-e12dc928b540,1  firazyr ( icatibant ) is indicated for the treatment of acute attacks of hereditary angioedema ( hae ) in adults 18 years of age and older,1
2009,2009,2009,2009,2009,2009,2009,2527,2527,2527,2527,2527,2527,2527,2527,2527,2527,2527,2527,2527,ed6657ca-ab68-477a-9968-e12dc928b540,firazyr is a bradykinin b2 receptor antagonist indicated for treatment of acute attacks of hereditary angioedema ( hae ) in adults 18 years of age and older,1
2010,2010,2010,2010,2010,2010,2010,2528,2528,2528,2528,2528,2528,2528,2528,2528,2528,2528,2528,2528,af318d5d-cc39-4a63-a590-b87c50f2694f, griseofulvin oral suspension usp  is indicated for the treatment of dermatophyte infections of the skin not adequately treated by topical therapy  hair and nails  namely tinea corporis tinea pedis tinea cruris tinea barbae tinea capitis tinea unguium when caused by one or more of the following species of fungi epidermophyton floccosum microsporum audouinii microsporum canis microsporum gypseum trichophyton crateriform trichophyton gallinae trichophyton interdigitalis trichophyton megnini trichophyton mentagrophytes trichophyton rubrum trichophyton schoenleini trichophyton sulphureum trichophyton tonsurans trichophyton verrucosum note prior to therapy  a dermatophyte should be identified as responsible for the infection,1
2011,2011,2011,2011,2011,2011,2011,2529,2529,2529,2529,2529,2529,2529,2529,2529,2529,2529,2529,2529,af318d5d-cc39-4a63-a590-b87c50f2694f,prior to initiating treatment  appropriate specimens for laboratory testing ( koh preparation  fungal culture  or nail biopsy ) should be obtained to confirm the diagnosis,4
2012,2012,2012,2012,2012,2012,2012,2530,2530,2530,2530,2530,2530,2530,2530,2530,2530,2530,2530,2530,af318d5d-cc39-4a63-a590-b87c50f2694f,griseofulvin is not effective in the following bacterial infections candidiasis ( moniliasis ) histoplasmosis actinomycosis sporotrichosis chromoblastomycosis coccidioidomycosis north american blastomycosis cryptococcosis ( torulosis ) tinea versicolor nocardiosis the use of this drug is not justified in minor or trivial dermatophyte infections which will respond to topical agents alone,2
2013,2013,2013,2013,2013,2013,2013,2531,2531,2531,2531,2531,2531,2531,2531,2531,2531,2531,2531,2531,e77d3400-56ad-11e3-949a-0800200c9a66,1  savaysa is a factor xa inhibitor indicated to reduce the risk of stroke and systemic embolism ( se ) in patients with nonvalvular atrial fibrillation ( nvaf ) ( 1 1 ) limitation of use for nvaf savaysa should not be used in patients with creatinine clearance ( crcl ) 95 ml min because of increased risk of ischemic stroke compared to warfarin at the highest dose studied ( 60 mg ) ( 1 1 ) savaysa is indicated for the treatment of deep vein thrombosis ( dvt ) and pulmonary embolism ( pe ) following 5 to 10 days of initial therapy with a parenteral anticoagulant ( 1 2 ) 1 1 reduction in the risk of stroke and systemic embolism in nonvalvular atrial fibrillation savaysa is indicated to reduce the risk of stroke and systemic embolism ( se ) in patients with nonvalvular atrial fibrillation ( nvaf ),1
2014,2014,2014,2014,2014,2014,2014,2532,2532,2532,2532,2532,2532,2532,2532,2532,2532,2532,2532,2532,e77d3400-56ad-11e3-949a-0800200c9a66,limitation of use for nvaf savaysa should not be used in patients with crcl 95 ml min because of an increased risk of ischemic stroke compared to warfarin see dosage and administration ( 2 1 )  warnings and precautions ( 5 1 )  clinical studies ( 14 1 ),2
2015,2015,2015,2015,2015,2015,2015,2533,2533,2533,2533,2533,2533,2533,2533,2533,2533,2533,2533,2533,e77d3400-56ad-11e3-949a-0800200c9a66,1 2 treatment of deep vein thrombosis and pulmonary embolism savaysa is indicated for the treatment of deep vein thrombosis ( dvt ) and pulmonary embolism ( pe ) following 5 to 10 days of initial therapy with a parenteral anticoagulant,1
2016,2016,2016,2016,2016,2016,2016,2534,2534,2534,2534,2534,2534,2534,2534,2534,2534,2534,2534,2534,598b5aa9-8cdc-4183-93ed-3b8558d9adec, hypertension quinapril tablets usp are indicated for the treatment of hypertension  to lower blood pressure,1
2017,2017,2017,2017,2017,2017,2017,2537,2537,2537,2537,2537,2537,2537,2537,2537,2537,2537,2537,2537,598b5aa9-8cdc-4183-93ed-3b8558d9adec,there are no controlled trials demonstrating risk reduction with quinapril tablets usp,0
2018,2018,2018,2018,2018,2018,2018,2545,2545,2545,2545,2545,2545,2545,2545,2545,2545,2545,2545,2545,598b5aa9-8cdc-4183-93ed-3b8558d9adec,some antihypertensive drugs have smaller blood pressure effects ( as monotherapy ) in black patients  and many antihypertensive drugs have additional approved indications and effects ( e g  on angina  heart failure or diabetic kidney disease ),u
2019,2019,2019,2019,2019,2019,2019,2547,2547,2547,2547,2547,2547,2547,2547,2547,2547,2547,2547,2547,598b5aa9-8cdc-4183-93ed-3b8558d9adec,quinapril tablets usp may be used alone or in combination with thiazide diuretics,4
2020,2020,2020,2020,2020,2020,2020,2548,2548,2548,2548,2548,2548,2548,2548,2548,2548,2548,2548,2548,598b5aa9-8cdc-4183-93ed-3b8558d9adec,heart failure quinapril tablets usp is indicated in the management of heart failure as adjunctive therapy when added to conventional therapy including,1
2021,2021,2021,2021,2021,2021,2021,2553,2553,2553,2553,2553,2553,2553,2553,2553,2553,2553,2553,2553,8d409411-aa9f-4f3a-a52c-fbcb0c3ec053, epilepsy tegretol is indicated for use as an anticonvulsant drug,1
2022,2022,2022,2022,2022,2022,2022,2554,2554,2554,2554,2554,2554,2554,2554,2554,2554,2554,2554,2554,8d409411-aa9f-4f3a-a52c-fbcb0c3ec053,evidence supporting efficacy of tegretol as an anticonvulsant was derived from active drug controlled studies that enrolled patients with the following seizure types partial seizures with complex symptomatology ( psychomotor  temporal lobe ),u
2023,2023,2023,2023,2023,2023,2023,2555,2555,2555,2555,2555,2555,2555,2555,2555,2555,2555,2555,2555,8d409411-aa9f-4f3a-a52c-fbcb0c3ec053,patients with these seizures appear to show greater improvement than those with other types,u
2024,2024,2024,2024,2024,2024,2024,2556,2556,2556,2556,2556,2556,2556,2556,2556,2556,2556,2556,2556,8d409411-aa9f-4f3a-a52c-fbcb0c3ec053,generalized tonic clonic seizures ( grand mal ),u
2025,2025,2025,2025,2025,2025,2025,2557,2557,2557,2557,2557,2557,2557,2557,2557,2557,2557,2557,2557,8d409411-aa9f-4f3a-a52c-fbcb0c3ec053,mixed seizure patterns which include the above  or other partial or generalized seizures,1
2026,2026,2026,2026,2026,2026,2026,2558,2558,2558,2558,2558,2558,2558,2558,2558,2558,2558,2558,2558,8d409411-aa9f-4f3a-a52c-fbcb0c3ec053,absence seizures ( petit mal ) do not appear to be controlled by tegretol ( see precautions  general ),1
2027,2027,2027,2027,2027,2027,2027,2559,2559,2559,2559,2559,2559,2559,2559,2559,2559,2559,2559,2559,8d409411-aa9f-4f3a-a52c-fbcb0c3ec053,trigeminal neuralgia tegretol is indicated in the treatment of the pain associated with true trigeminal neuralgia,1
2028,2028,2028,2028,2028,2028,2028,2560,2560,2560,2560,2560,2560,2560,2560,2560,2560,2560,2560,2560,8d409411-aa9f-4f3a-a52c-fbcb0c3ec053,beneficial results have also been reported in glossopharyngeal neuralgia,u
2029,2029,2029,2029,2029,2029,2029,2561,2561,2561,2561,2561,2561,2561,2561,2561,2561,2561,2561,2561,8d409411-aa9f-4f3a-a52c-fbcb0c3ec053,this drug is not a simple analgesic and should not be used for the relief of trivial aches or pains,2
2030,2030,2030,2030,2030,2030,2030,2562,2562,2562,2562,2562,2562,2562,2562,2562,2562,2562,2562,2562,a96c405f-bd70-4bb4-719e-ac6a79dcc213, erythrocin lactobionate iv ( erythromycin lactobionate for injection  usp ) is indicated in the treatment of infections caused by susceptible strains of the designated organisms in the diseases listed below when oral administration is not possible or when the severity of the infection requires immediate high serum levels of erythromycin,1
2031,2031,2031,2031,2031,2031,2031,2563,2563,2563,2563,2563,2563,2563,2563,2563,2563,2563,2563,2563,a96c405f-bd70-4bb4-719e-ac6a79dcc213,intravenous therapy should be replaced by oral administration at the appropriate time,4
2032,2032,2032,2032,2032,2032,2032,2564,2564,2564,2564,2564,2564,2564,2564,2564,2564,2564,2564,2564,a96c405f-bd70-4bb4-719e-ac6a79dcc213,upper respiratory tract infections of mild to moderate degree caused by streptococcus pyogenes ( group a beta hemolytic streptococci ) streptococcus pneumoniae ( diplococcus pneumoniae ) haemophilus influenzae ( when used concomitantly with adequate doses of sulfonamides  since many strains of h influenzae are not susceptible to the erythromycin concentrations ordinarily achieved ),u
2033,2033,2033,2033,2033,2033,2033,2565,2565,2565,2565,2565,2565,2565,2565,2565,2565,2565,2565,2565,a96c405f-bd70-4bb4-719e-ac6a79dcc213,( see appropriate sulfonamide labeling for prescribing information ),0
2034,2034,2034,2034,2034,2034,2034,2566,2566,2566,2566,2566,2566,2566,2566,2566,2566,2566,2566,2566,a96c405f-bd70-4bb4-719e-ac6a79dcc213,lower respiratory tract infections of mild to moderate severity caused by streptococcus pyogenes ( group a beta hemolytic streptococci ) streptococcus pneumoniae ( diplococcus pneumoniae ),1
2035,2035,2035,2035,2035,2035,2035,2567,2567,2567,2567,2567,2567,2567,2567,2567,2567,2567,2567,2567,a96c405f-bd70-4bb4-719e-ac6a79dcc213,respiratory tract infections due to mycoplasma pneumoniae,1
2036,2036,2036,2036,2036,2036,2036,2568,2568,2568,2568,2568,2568,2568,2568,2568,2568,2568,2568,2568,a96c405f-bd70-4bb4-719e-ac6a79dcc213,skin and skin structure infections of mild to moderate severity caused by streptococcus pyogenes and staphylococcus aureus ( resistant staphylococci may emerge during treatment ),1
2037,2037,2037,2037,2037,2037,2037,2569,2569,2569,2569,2569,2569,2569,2569,2569,2569,2569,2569,2569,a96c405f-bd70-4bb4-719e-ac6a79dcc213,diphtheria as an adjunct to antitoxin infections due to corynebacterium diphtheriae to prevent establishment of carriers and to eradicate the organism in carriers,1
2038,2038,2038,2038,2038,2038,2038,2570,2570,2570,2570,2570,2570,2570,2570,2570,2570,2570,2570,2570,a96c405f-bd70-4bb4-719e-ac6a79dcc213,erythrasma in the treatment of infections due to corynebacterium minutissimum,1
2039,2039,2039,2039,2039,2039,2039,2571,2571,2571,2571,2571,2571,2571,2571,2571,2571,2571,2571,2571,a96c405f-bd70-4bb4-719e-ac6a79dcc213,acute pelvic inflammatory disease caused by neisseria gonorrhoeae erythrocin lactobionate iv ( erythromycin lactobionate for injection  usp ) followed by erythromycin stearate or erythromycin base orally  as an alternative drug in treatment of acute pelvic inflammatory disease caused by n gonorrhoeae in female patients with a history of sensitivity to penicillin,1
2040,2040,2040,2040,2040,2040,2040,2572,2572,2572,2572,2572,2572,2572,2572,2572,2572,2572,2572,2572,814301f9-c990-46a5-b481-2879a521a16f,1  prezista  co administered with ritonavir ( prezista ritonavir )  in combination with other antiretroviral agents  is indicated for the treatment of human immunodeficiency virus ( hiv 1 ) infection in adult and pediatric patients 3 years of age and older see use in specific populations ( 8 4 ) and clinical studies ( 14 ),1
2041,2041,2041,2041,2041,2041,2041,2573,2573,2573,2573,2573,2573,2573,2573,2573,2573,2573,2573,2573,814301f9-c990-46a5-b481-2879a521a16f,prezista is a human immunodeficiency virus ( hiv 1 ) protease inhibitor indicated for the treatment of hiv 1 infection in adult and pediatric patients 3 years of age and older,1
2042,2042,2042,2042,2042,2042,2042,2574,2574,2574,2574,2574,2574,2574,2574,2574,2574,2574,2574,2574,814301f9-c990-46a5-b481-2879a521a16f,prezista must be co administered with ritonavir ( prezista ritonavir ) and with other antiretroviral agents,4
2043,2043,2043,2043,2043,2043,2043,2575,2575,2575,2575,2575,2575,2575,2575,2575,2575,2575,2575,2575,9c38fdb6-d0ba-4f16-a0e3-85d9ec334d9f,1  prezcobix is indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency virus ( hiv 1 ) infection in treatment na ve and treatment experienced adults with no darunavir resistance associated substitutions ( v11i  v32i  l33f  i47v  i50v  i54l  i54m  t74p  l76v  i84v  l89v ),1
2044,2044,2044,2044,2044,2044,2044,2576,2576,2576,2576,2576,2576,2576,2576,2576,2576,2576,2576,2576,9c38fdb6-d0ba-4f16-a0e3-85d9ec334d9f,prezcobix is a two drug combination of darunavir  a human immunodeficiency virus ( hiv 1 ) protease inhibitor and cobicistat  a cyp3a inhibitor and is indicated for the treatment of hiv 1 infection in adult patients,1
2045,2045,2045,2045,2045,2045,2045,2577,2577,2577,2577,2577,2577,2577,2577,2577,2577,2577,2577,2577,c27a87e0-9953-4425-acec-16f7ed8ede64,1  varizig varicella zoster immune globulin ( human ) is indicated for post exposure prophylaxis of varicella in high risk individuals,1
2046,2046,2046,2046,2046,2046,2046,2578,2578,2578,2578,2578,2578,2578,2578,2578,2578,2578,2578,2578,c27a87e0-9953-4425-acec-16f7ed8ede64,high risk groups include immunocompromised children and adults  newborns of mothers with varicella shortly before or after delivery  premature infants  neonates and infants less than one year of age  adults without evidence of immunity  pregnant women,0
2047,2047,2047,2047,2047,2047,2047,2579,2579,2579,2579,2579,2579,2579,2579,2579,2579,2579,2579,2579,c27a87e0-9953-4425-acec-16f7ed8ede64,varizig administration is intended to reduce the severity of varicella,1
2048,2048,2048,2048,2048,2048,2048,2580,2580,2580,2580,2580,2580,2580,2580,2580,2580,2580,2580,2580,c27a87e0-9953-4425-acec-16f7ed8ede64,administer varizig as soon as possible following varicella zoster virus ( vzv ) exposure  ideally within 96 hours for greatest effectiveness,4
2049,2049,2049,2049,2049,2049,2049,2581,2581,2581,2581,2581,2581,2581,2581,2581,2581,2581,2581,2581,c27a87e0-9953-4425-acec-16f7ed8ede64,there is no convincing evidence that varizig reduces the incidence of chickenpox infection after exposure to vzv,0
2050,2050,2050,2050,2050,2050,2050,2582,2582,2582,2582,2582,2582,2582,2582,2582,2582,2582,2582,2582,c27a87e0-9953-4425-acec-16f7ed8ede64,there is no convincing evidence that established infections with vzv can be modified by varizig administration,0
2051,2051,2051,2051,2051,2051,2051,2583,2583,2583,2583,2583,2583,2583,2583,2583,2583,2583,2583,2583,c27a87e0-9953-4425-acec-16f7ed8ede64,there is no indication for the prophylactic use of varizig in immunodeficient children or adults when there is a past history of varicella  unless the patient is undergoing bone marrow transplantation,u
2052,2052,2052,2052,2052,2052,2052,2584,2584,2584,2584,2584,2584,2584,2584,2584,2584,2584,2584,2584,c27a87e0-9953-4425-acec-16f7ed8ede64,varizig is a varicella zoster immune globulin ( human ) indicated for post exposure prophylaxis in high risk individuals ( 1 ),1
2053,2053,2053,2053,2053,2053,2053,2585,2585,2585,2585,2585,2585,2585,2585,2585,2585,2585,2585,2585,c27a87e0-9953-4425-acec-16f7ed8ede64,high risk groups include immunocompromised children and adults  newborns of mothers with varicella shortly before or after delivery  premature infants  infants less than one year of age  adults without evidence of immunity  pregnant women,0
2054,2054,2054,2054,2054,2054,2054,2587,2587,2587,2587,2587,2587,2587,2587,2587,2587,2587,2587,2587,4b4674d8-4d1e-4728-8465-d42ada33fa5c,1 indication and usage dalvance is indicated for acute bacterial skin and skin structure infections ( absssi ) caused by designated susceptible strains of gram positive microorganisms,1
2055,2055,2055,2055,2055,2055,2055,2588,2588,2588,2588,2588,2588,2588,2588,2588,2588,2588,2588,2588,4b4674d8-4d1e-4728-8465-d42ada33fa5c,( 1 1 ) to reduce the development of drug resistant bacteria and maintain the effectiveness of dalvance and other antibacterial drugs  dalvance should be used only to treat infections that are proven or strongly suspected to be caused by susceptible bacteria,4
2056,2056,2056,2056,2056,2056,2056,2589,2589,2589,2589,2589,2589,2589,2589,2589,2589,2589,2589,2589,4b4674d8-4d1e-4728-8465-d42ada33fa5c,( 1 2 ) 1 1 acute bacterial skin and skin structure infections dalvance ( dalbavancin ) for injection is indicated for the treatment of adult patients with acute bacterial skin and skin structure infections ( absssi )  caused by susceptible isolates of the following gram positive microorganisms staphylococcus aureus ( including methicillin susceptible and methicillin resistant strains )  streptococcus pyogenes  streptococcus agalactiae  streptococcus dysgalactiae  streptococcus anginosus group ( including s anginosus  s intermedius  s constellatus ) and enterococcus faecalis ( vancomycin susceptible strains ),1
2057,2057,2057,2057,2057,2057,2057,2590,2590,2590,2590,2590,2590,2590,2590,2590,2590,2590,2590,2590,4b4674d8-4d1e-4728-8465-d42ada33fa5c,1 2 usage to reduce the development of drug resistant bacteria and maintain the effectiveness of dalvance and other antibacterial agents  dalvance should be used only to treat infections that are proven or strongly suspected to be caused by susceptible bacteria,4
2058,2058,2058,2058,2058,2058,2058,2593,2593,2593,2593,2593,2593,2593,2593,2593,2593,2593,2593,2593,eeaaaf38-fb86-4d9f-a19d-0f61daac2fd7,1  votrient is indicated for the treatment of patients with advanced renal cell carcinoma ( rcc ),1
2059,2059,2059,2059,2059,2059,2059,2594,2594,2594,2594,2594,2594,2594,2594,2594,2594,2594,2594,2594,eeaaaf38-fb86-4d9f-a19d-0f61daac2fd7,votrient is indicated for the treatment of patients with advanced soft tissue sarcoma ( sts ) who have received prior chemotherapy,1
2060,2060,2060,2060,2060,2060,2060,2595,2595,2595,2595,2595,2595,2595,2595,2595,2595,2595,2595,2595,eeaaaf38-fb86-4d9f-a19d-0f61daac2fd7,limitation s of use the efficacy of votrient for the treatment of patients with adipocytic sts or gastrointestinal stromal tumors has not been demonstrated,2
2061,2061,2061,2061,2061,2061,2061,2596,2596,2596,2596,2596,2596,2596,2596,2596,2596,2596,2596,2596,eeaaaf38-fb86-4d9f-a19d-0f61daac2fd7,votrient is a kinase inhibitor indicated for the treatment of patients with advanced renal cell carcinoma,1
2062,2062,2062,2062,2062,2062,2062,2597,2597,2597,2597,2597,2597,2597,2597,2597,2597,2597,2597,2597,eeaaaf38-fb86-4d9f-a19d-0f61daac2fd7,( 1 ) advanced soft tissue sarcoma who have received prior chemotherapy,1
2063,2063,2063,2063,2063,2063,2063,2598,2598,2598,2598,2598,2598,2598,2598,2598,2598,2598,2598,2598,eeaaaf38-fb86-4d9f-a19d-0f61daac2fd7,( 1 ) limitation s of use the efficacy of votrient for the treatment of patients with adipocytic soft tissue sarcoma or gastrointestinal stromal tumors has not been demonstrated,2
2064,2064,2064,2064,2064,2064,2064,2603,2603,2603,2603,2603,2603,2603,2603,2603,2603,2603,2603,2603,172e582c-7e76-38ac-e054-00144ff88e88,uses scar management temporarily protects minor cuts  scrapes and burns temporary relief of pain associated with minor cuts  scrapes and minor skin irritations,1
2065,2065,2065,2065,2065,2065,2065,2605,2605,2605,2605,2605,2605,2605,2605,2605,2605,2605,2605,2605,073201aa-556d-4a70-918e-84e9616fd88d,1  creon ( pancrelipase ) is indicated for the treatment of exocrine pancreatic insufficiency due to cystic fibrosis  chronic pancreatitis  pancreatectomy  or other conditions,1
2066,2066,2066,2066,2066,2066,2066,2606,2606,2606,2606,2606,2606,2606,2606,2606,2606,2606,2606,2606,073201aa-556d-4a70-918e-84e9616fd88d,creon is a combination of porcine derived lipases  proteases  and amylases indicated for the treatment of exocrine pancreatic insufficiency due to cystic fibrosis  chronic pancreatitis  pancreatectomy  or other conditions,1
2067,2067,2067,2067,2067,2067,2067,2607,2607,2607,2607,2607,2607,2607,2607,2607,2607,2607,2607,2607,053b9158-2a5b-48b9-bf47-5fa78a35ec33,1  cinqair is indicated for the add on maintenance treatment of patients with severe asthma aged 18 years and older with an eosinophilic phenotype see clinical studies ( 14 ),1
2068,2068,2068,2068,2068,2068,2068,2608,2608,2608,2608,2608,2608,2608,2608,2608,2608,2608,2608,2608,053b9158-2a5b-48b9-bf47-5fa78a35ec33,limitation of use cinqair is not indicated for treatment of other eosinophilic conditions,2
2069,2069,2069,2069,2069,2069,2069,2609,2609,2609,2609,2609,2609,2609,2609,2609,2609,2609,2609,2609,053b9158-2a5b-48b9-bf47-5fa78a35ec33,cinqair is not indicated for the relief of acute bronchospasm or status asthmaticus see warnings and precautions ( 5 2 ),2
2070,2070,2070,2070,2070,2070,2070,2610,2610,2610,2610,2610,2610,2610,2610,2610,2610,2610,2610,2610,053b9158-2a5b-48b9-bf47-5fa78a35ec33,cinqair is an interleukin 5 antagonist monoclonal antibody ( igg4 kappa ) indicated for add on maintenance treatment of patients with severe asthma aged 18 years and older  and with an eosinophilic phenotype ( 1 ),1
2071,2071,2071,2071,2071,2071,2071,2611,2611,2611,2611,2611,2611,2611,2611,2611,2611,2611,2611,2611,053b9158-2a5b-48b9-bf47-5fa78a35ec33,limitations of use cinqair is not indicated for treatment of other eosinophilic conditions ( 1 ) relief of acute bronchospasm or status asthmaticus ( 1 ),2
2072,2072,2072,2072,2072,2072,2072,2612,2612,2612,2612,2612,2612,2612,2612,2612,2612,2612,2612,2612,56ffd662-60a6-4b43-a7ea-f778714dfbbd, benazepril hydrochloride tablets are indicated for the treatment of hypertension,1
2073,2073,2073,2073,2073,2073,2073,2613,2613,2613,2613,2613,2613,2613,2613,2613,2613,2613,2613,2613,56ffd662-60a6-4b43-a7ea-f778714dfbbd,they may be used alone or in combination with thiazide diuretics,4
2074,2074,2074,2074,2074,2074,2074,2614,2614,2614,2614,2614,2614,2614,2614,2614,2614,2614,2614,2614,56ffd662-60a6-4b43-a7ea-f778714dfbbd,in using benazepril hydrochloride tablets  consideration should be given to the fact that another angiotensin converting enzyme inhibitor  captopril  has caused agranulocytosis  particularly in patients with renal impairment or collagen vascular disease,4
2075,2075,2075,2075,2075,2075,2075,2615,2615,2615,2615,2615,2615,2615,2615,2615,2615,2615,2615,2615,56ffd662-60a6-4b43-a7ea-f778714dfbbd,available data are insufficient to show that benazepril hydrochloride does not have a similar risk ( see warnings ),0
2076,2076,2076,2076,2076,2076,2076,2616,2616,2616,2616,2616,2616,2616,2616,2616,2616,2616,2616,2616,56ffd662-60a6-4b43-a7ea-f778714dfbbd,black patients receiving ace inhibitors have been reported to have a higher incidence of angioedema compared to nonblacks,3
2077,2077,2077,2077,2077,2077,2077,2617,2617,2617,2617,2617,2617,2617,2617,2617,2617,2617,2617,2617,56ffd662-60a6-4b43-a7ea-f778714dfbbd,it should also be noted that in controlled clinical trials ace inhibitors have an effect on blood pressure that is less in black patients than in nonblacks,0
2078,2078,2078,2078,2078,2078,2078,2618,2618,2618,2618,2618,2618,2618,2618,2618,2618,2618,2618,2618,c5177abd-9465-40d8-861d-3904496d82b7,1  ofirmev ( acetaminophen ) injection is indicated for the management of mild to moderate pain in adult and pediatric patients 2 years and older the management of moderate to severe pain with adjunctive opioid analgesics in adult and pediatric patients 2 years and older the reduction of fever in adult and pediatric patients,1
2079,2079,2079,2079,2079,2079,2079,2619,2619,2619,2619,2619,2619,2619,2619,2619,2619,2619,2619,2619,c5177abd-9465-40d8-861d-3904496d82b7,ofirmev ( acetaminophen ) injection is indicated for the management of mild to moderate pain in adult and pediatric patients 2 years and older ( 1 ) management of moderate to severe pain with adjunctive opioid analgesics in adult and pediatric patients 2 years and older ( 1 ) reduction of fever in adult and pediatric patients ( 1 ),1
2080,2080,2080,2080,2080,2080,2080,2620,2620,2620,2620,2620,2620,2620,2620,2620,2620,2620,2620,2620,09e1e32d-1874-40d7-8829-52b3a489d9fd, this product is indicated for the relief of mild to moderate pain  either when pain is present alone or when it is accompanied by fever,1
2081,2081,2081,2081,2081,2081,2081,2621,2621,2621,2621,2621,2621,2621,2621,2621,2621,2621,2621,2621,d74db417-d2de-495b-bb75-46a83745603d,indications butalbital  acetaminophen  caffeine  and codeine phosphate capsules are indicated for the relief of the symptom complex of tension ( or muscle contraction ) headache,1
2082,2082,2082,2082,2082,2082,2082,2622,2622,2622,2622,2622,2622,2622,2622,2622,2622,2622,2622,2622,d74db417-d2de-495b-bb75-46a83745603d,evidence supporting the efficacy and safety of butalbital  acetaminophen  caffeine  and codeine phosphate capsules in the treatment of multiple recurrent headaches is unavailable,0
2083,2083,2083,2083,2083,2083,2083,2623,2623,2623,2623,2623,2623,2623,2623,2623,2623,2623,2623,2623,d74db417-d2de-495b-bb75-46a83745603d,caution in this regard is required because codeine and butalbital are habit forming and potentially abusable,4
2084,2084,2084,2084,2084,2084,2084,2624,2624,2624,2624,2624,2624,2624,2624,2624,2624,2624,2624,2624,8e99c982-50ca-49d7-b80a-b60aa18401cb, butalbital  acetaminophen and caffeine tablets are indicated for the relief of the symptom complex of tension ( or muscle contraction ) headache,1
2085,2085,2085,2085,2085,2085,2085,2625,2625,2625,2625,2625,2625,2625,2625,2625,2625,2625,2625,2625,8e99c982-50ca-49d7-b80a-b60aa18401cb,evidence supporting the efficacy and safety of this combination product in the treatment of multiple recurrent headaches is unavailable,0
2086,2086,2086,2086,2086,2086,2086,2626,2626,2626,2626,2626,2626,2626,2626,2626,2626,2626,2626,2626,8e99c982-50ca-49d7-b80a-b60aa18401cb,caution in this regard is required because butalbital is habit forming and potentially abusable,4
2087,2087,2087,2087,2087,2087,2087,2627,2627,2627,2627,2627,2627,2627,2627,2627,2627,2627,2627,2627,4b04b21b-ee68-4c59-91ad-57c3d84e2b09, for the temporary relief of minor aches and pains associated with headaches  backache  muscular aches  the menstrual and premenstrual periods  colds  the flu  toothaches  as well as for minor pain from arthritis  and to reduce fever,1
2088,2088,2088,2088,2088,2088,2088,2628,2628,2628,2628,2628,2628,2628,2628,2628,2628,2628,2628,2628,7d7495c0-f254-4cf5-acbb-a1fe476977ef, tramadol hydrochloride and acetaminophen tablets  usp are indicated for the short term ( five days or less ) management of acute pain,1
2089,2089,2089,2089,2089,2089,2089,2629,2629,2629,2629,2629,2629,2629,2629,2629,2629,2629,2629,2629,62a055f3-a58b-446d-9476-af6d36956eaf, pentazocine hydrochloride and acetaminophen tablets are indicated for the relief of mild to moderate pain,1
2090,2090,2090,2090,2090,2090,2090,2630,2630,2630,2630,2630,2630,2630,2630,2630,2630,2630,2630,2630,67369a20-8ff0-53d0-e053-2991aa0a58f2,oxycodone and acetaminophen tablets is indicated for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate,1
2091,2091,2091,2091,2091,2091,2091,2631,2631,2631,2631,2631,2631,2631,2631,2631,2631,2631,2631,2631,67369a20-8ff0-53d0-e053-2991aa0a58f2,limitations of use because of the risks of addiction  abuse  and misuse  with opioids  even at recommended doses see warnings  reserve oxycodone and acetaminophen tablets for use in patients for whom alternative treatment options e g  non opioid analgesics have not been tolerated  or are not expected to be tolerated  have not provided adequate analgesia  or are not expected to provide adequate analgesia,2
2092,2092,2092,2092,2092,2092,2092,2632,2632,2632,2632,2632,2632,2632,2632,2632,2632,2632,2632,2632,a1a85756-9773-4fbf-ab52-f29eb2a92413, propoxyphene hydrochloride and acetaminophen tablets are indicated for the relief of mild to moderate pain  either when pain is present alone or when it is accompanied by fever,1
2093,2093,2093,2093,2093,2093,2093,2633,2633,2633,2633,2633,2633,2633,2633,2633,2633,2633,2633,2633,f9cf218c-af5e-4249-aa3b-a8555ed02278, oxycodone and acetaminophen tablets are indicated for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate,1
2094,2094,2094,2094,2094,2094,2094,2635,2635,2635,2635,2635,2635,2635,2635,2635,2635,2635,2635,2635,a3c98d44-c77e-42ef-a52c-f46cacca7763, acetaminophen and codeine phosphate tablets are indicated for the management of mild to moderate pain  where treatment with an opioid is appropriate and for which alternative treatments are inadequate,1
2095,2095,2095,2095,2095,2095,2095,2636,2636,2636,2636,2636,2636,2636,2636,2636,2636,2636,2636,2636,a3c98d44-c77e-42ef-a52c-f46cacca7763,limitations of use because of the risks of addiction  abuse  and misuse  with opioids  even at recommended doses ( see warnings )  reserve acetaminophen and codeine phosphate tablets for use in patients for whom alternative treatment options ( e g  non opioid analgesics ),2
2096,2096,2096,2096,2096,2096,2096,2637,2637,2637,2637,2637,2637,2637,2637,2637,2637,2637,2637,2637,a3c98d44-c77e-42ef-a52c-f46cacca7763,have not provided adequate analgesia  or are not expected to provide adequate analgesia  have not been tolerated  or are not expected to be tolerated,0
2097,2097,2097,2097,2097,2097,2097,2638,2638,2638,2638,2638,2638,2638,2638,2638,2638,2638,2638,2638,eb338895-ea3d-4950-8819-a28b7a314ebd, allzital ( butalbital and acetaminophen ) tablets are indicated for the relief of the symptom complex of tension ( or muscle contraction ) headache,1
2098,2098,2098,2098,2098,2098,2098,2641,2641,2641,2641,2641,2641,2641,2641,2641,2641,2641,2641,2641,d77e13db-d1b1-4dbf-9de8-80827018cf43, carefully consider the potential benefits and risks of ponstel and other treatment options before deciding to use ponstel,0
2099,2099,2099,2099,2099,2099,2099,2642,2642,2642,2642,2642,2642,2642,2642,2642,2642,2642,2642,2642,d77e13db-d1b1-4dbf-9de8-80827018cf43,use the lowest effective dose for the shortest duration consistent with individual patient treatment goals ( see warnings gastrointestinal bleeding  ulceration  and perforation ),4
2100,2100,2100,2100,2100,2100,2100,2643,2643,2643,2643,2643,2643,2643,2643,2643,2643,2643,2643,2643,d77e13db-d1b1-4dbf-9de8-80827018cf43,ponstel is indicated for relief of mild to moderate pain in patients 14 years of age  when therapy will not exceed one week ( 7 days ),1
2101,2101,2101,2101,2101,2101,2101,2644,2644,2644,2644,2644,2644,2644,2644,2644,2644,2644,2644,2644,d77e13db-d1b1-4dbf-9de8-80827018cf43,for treatment of primary dysmenorrhea,1
2102,2102,2102,2102,2102,2102,2102,2645,2645,2645,2645,2645,2645,2645,2645,2645,2645,2645,2645,2645,abd6ecf0-dc8e-41de-89f2-1e36ed9d6535,indications renese is indicated as adjunctive therapy in edema associated with congestive heart failure  hepatic cirrhosis  and corticosteroid and estrogen therapy,1
2103,2103,2103,2103,2103,2103,2103,2646,2646,2646,2646,2646,2646,2646,2646,2646,2646,2646,2646,2646,abd6ecf0-dc8e-41de-89f2-1e36ed9d6535,renese has also been found useful in edema due to various forms of renal dysfunction as nephrotic syndrome acute glomerulonephritis and chronic renal failure,1
2104,2104,2104,2104,2104,2104,2104,2647,2647,2647,2647,2647,2647,2647,2647,2647,2647,2647,2647,2647,abd6ecf0-dc8e-41de-89f2-1e36ed9d6535,renese is indicated in the management of hypertension either as the sole therapeutic agent or to enhance the effectiveness of other antihypertensive drugs in the more severe forms of hypertension,1
2105,2105,2105,2105,2105,2105,2105,2651,2651,2651,2651,2651,2651,2651,2651,2651,2651,2651,2651,2651,abd6ecf0-dc8e-41de-89f2-1e36ed9d6535,thiazides are indicated in pregnancy when edema is due to pathologic causes  just as they are in the absence of pregnancy ( however  see warnings  below ),1
2106,2106,2106,2106,2106,2106,2106,2652,2652,2652,2652,2652,2652,2652,2652,2652,2652,2652,2652,2652,abd6ecf0-dc8e-41de-89f2-1e36ed9d6535,dependent edema in pregnancy  resulting from restriction of venous return by the expanded uterus  is properly treated through elevation of the lower extremities and use of support hose use of diuretics to lower intravascular volume in this case is illogical and unnecessary,u
2107,2107,2107,2107,2107,2107,2107,2653,2653,2653,2653,2653,2653,2653,2653,2653,2653,2653,2653,2653,abd6ecf0-dc8e-41de-89f2-1e36ed9d6535,there is hypervolemia during normal pregnancy which is harmful to neither the fetus nor the mother ( in the absence of cardiovascular disease )  but which is associated with edema  including generalized edema  in the majority of pregnant women,u
2108,2108,2108,2108,2108,2108,2108,2655,2655,2655,2655,2655,2655,2655,2655,2655,2655,2655,2655,2655,abd6ecf0-dc8e-41de-89f2-1e36ed9d6535,in rare instances  this edema may cause extreme discomfort which is not relieved by rest,0
2109,2109,2109,2109,2109,2109,2109,2661,2661,2661,2661,2661,2661,2661,2661,2661,2661,2661,2661,2661,b503fa5e-5726-426d-867c-e8fe59ed3ead,thiazides are indicated in pregnancy when edema is due to pathologic causes  just as they are in the absence of pregnancy ( however  see precautions pregnancy section ),1
2110,2110,2110,2110,2110,2110,2110,2663,2663,2663,2663,2663,2663,2663,2663,2663,2663,2663,2663,2663,b503fa5e-5726-426d-867c-e8fe59ed3ead,there is hypervolemia during normal pregnancy which is harmful to neither the fetus nor the mother ( in the absence of cardiovascular disease )  but which is associated with edema including generalized edema  in the majority of pregnant women,0
2111,2111,2111,2111,2111,2111,2111,2667,2667,2667,2667,2667,2667,2667,2667,2667,2667,2667,2667,2667,17367e1c-a4ad-451b-92c4-95565312e51a, minizide is indicated in the treatment of hypertension,1
2112,2112,2112,2112,2112,2112,2112,2668,2668,2668,2668,2668,2668,2668,2668,2668,2668,2668,2668,2668,14eaa94a-cc8a-4e1e-8cfb-5c976c96c606,1  buprenorphine and naloxone sublingual tablets are indicated for the maintenance treatment of opioid dependence,1
2113,2113,2113,2113,2113,2113,2113,2669,2669,2669,2669,2669,2669,2669,2669,2669,2669,2669,2669,2669,14eaa94a-cc8a-4e1e-8cfb-5c976c96c606,buprenorphine and naloxone sublingual tablets should be used as part of a complete treatment plan that includes counseling and psychosocial support,4
2114,2114,2114,2114,2114,2114,2114,2670,2670,2670,2670,2670,2670,2670,2670,2670,2670,2670,2670,2670,14eaa94a-cc8a-4e1e-8cfb-5c976c96c606,buprenorphine and naloxone sublingual tablet contains buprenorphine  a partial opioid agonist  and naloxone  an opioid antagonist  and is indicated for the maintenance treatment of opioid dependence,1
2115,2115,2115,2115,2115,2115,2115,2671,2671,2671,2671,2671,2671,2671,2671,2671,2671,2671,2671,2671,14eaa94a-cc8a-4e1e-8cfb-5c976c96c606,( 1 ) buprenorphine and naloxone sublingual tablet should be used as part of a complete treatment plan that includes counseling and psychosocial support,4
2116,2116,2116,2116,2116,2116,2116,2672,2672,2672,2672,2672,2672,2672,2672,2672,2672,2672,2672,2672,b2e04490-ce9f-493c-ab25-2f53f97969cc, golytely for oral solution is indicated for bowel cleansing prior to colonoscopy and barium enema x ray examination,1
2117,2117,2117,2117,2117,2117,2117,2673,2673,2673,2673,2673,2673,2673,2673,2673,2673,2673,2673,2673,a1e3b4bf-22e9-430a-a768-4d86ae886c9e, estazolam tablets  usp are indicated for the short term management of insomnia characterized by difficulty in falling asleep  frequent nocturnal awakenings  and or early morning awakenings,1
2118,2118,2118,2118,2118,2118,2118,2674,2674,2674,2674,2674,2674,2674,2674,2674,2674,2674,2674,2674,a1e3b4bf-22e9-430a-a768-4d86ae886c9e,both outpatient studies and a sleep laboratory study have shown that estazolam administered at bedtime improved sleep induction and sleep maintenance ( see clinical pharmacology ),u
2119,2119,2119,2119,2119,2119,2119,2675,2675,2675,2675,2675,2675,2675,2675,2675,2675,2675,2675,2675,a1e3b4bf-22e9-430a-a768-4d86ae886c9e,because insomnia is often transient and intermittent  the prolonged administration of estazolam is generally neither necessary nor recommended,u
2120,2120,2120,2120,2120,2120,2120,2676,2676,2676,2676,2676,2676,2676,2676,2676,2676,2676,2676,2676,a1e3b4bf-22e9-430a-a768-4d86ae886c9e,since insomnia may be a symptom of several other disorders  the possibility that the complaint may be related to a condition for which there is a more specific treatment should be considered,4
2121,2121,2121,2121,2121,2121,2121,2677,2677,2677,2677,2677,2677,2677,2677,2677,2677,2677,2677,2677,a1e3b4bf-22e9-430a-a768-4d86ae886c9e,there is evidence to support the ability of estazolam to enhance the duration and quality of sleep for intervals up to 12 weeks ( see clinical pharmacology ),u
2122,2122,2122,2122,2122,2122,2122,2678,2678,2678,2678,2678,2678,2678,2678,2678,2678,2678,2678,2678,7d271f3b-e4f9-4d80-8dcf-28d49123f80e,1  ilaris is an interleukin 1 blocker indicated for the treatment of periodic fever syndromes cryopyrin associated periodi c syndromes ( caps )  in adults and children 4 years of age and older including familial cold autoinflammatory syndrome ( fcas ) ( 1 1 ) muckle wells syndrome ( mws ) ( 1 1 ) tumor necrosis factor receptor associated periodic syndrome ( traps ) in adult and pediatric patients,1
2123,2123,2123,2123,2123,2123,2123,2679,2679,2679,2679,2679,2679,2679,2679,2679,2679,2679,2679,2679,7d271f3b-e4f9-4d80-8dcf-28d49123f80e,( 1 1 ) hyperimmunoglobulin d syndrome ( hids ) mevalonate kinase deficiency ( mkd ) in adult and pediatric patients,1
2124,2124,2124,2124,2124,2124,2124,2680,2680,2680,2680,2680,2680,2680,2680,2680,2680,2680,2680,2680,7d271f3b-e4f9-4d80-8dcf-28d49123f80e,( 1 1 ) familial mediterranean fever ( fmf ) in adult and pediatric patients,1
2125,2125,2125,2125,2125,2125,2125,2681,2681,2681,2681,2681,2681,2681,2681,2681,2681,2681,2681,2681,7d271f3b-e4f9-4d80-8dcf-28d49123f80e,( 1 1 ) active systemic juvenile idiopathic arthritis ( sjia ) in patients aged 2 years and older ( 1 2 ) 1 1 periodic fever syndromes ilaris ( canakinumab ) is an interleukin 1 ( il 1 ) blocker indicated for the treatment of the following autoinflammatory periodic fever syndromes cryopyrin associated periodic syndromes ( caps ) ilaris is indicated for the treatment of cryopyrin associated periodic syndromes ( caps )  in adults and children 4 years of age and older including familial cold autoinflammatory syndrome ( fcas ) muckle wells syndrome ( mws ) tumor necrosis factor receptor ( tnf ) associated periodic syndrome ( traps ) ilaris is indicated for the treatment of tumor necrosis factor ( tnf ) receptor associated periodic syndrome ( t,1
2126,2126,2126,2126,2126,2126,2126,2682,2682,2682,2682,2682,2682,2682,2682,2682,2682,2682,2682,2682,3819daf3-e935-2c53-c527-e1d57922f394,1  addyi ( flibanserin ) tablets are indicated for the treatment of premenopausal women with acquired  generalized hypoactive sexual desire disorder ( hsdd )  as characterized by low sexual desire that causes marked distress or interpersonal difficulty and is not due to a co existing medical or psychiatric condition  problems within the relationship  or the effects of a medication or other drug substance,1
2127,2127,2127,2127,2127,2127,2127,2683,2683,2683,2683,2683,2683,2683,2683,2683,2683,2683,2683,2683,3819daf3-e935-2c53-c527-e1d57922f394,acquired hsdd refers to hsdd that develops in a patient who previously had no problems with sexual desire,0
2128,2128,2128,2128,2128,2128,2128,2684,2684,2684,2684,2684,2684,2684,2684,2684,2684,2684,2684,2684,3819daf3-e935-2c53-c527-e1d57922f394,generalized hsdd refers to hsdd that occurs regardless of the type of stimulation  situation or partner,0
2129,2129,2129,2129,2129,2129,2129,2685,2685,2685,2685,2685,2685,2685,2685,2685,2685,2685,2685,2685,3819daf3-e935-2c53-c527-e1d57922f394,limitations of use addyi is not indicated for the treatment of hsdd in postmenopausal women or in men,2
2130,2130,2130,2130,2130,2130,2130,2686,2686,2686,2686,2686,2686,2686,2686,2686,2686,2686,2686,2686,3819daf3-e935-2c53-c527-e1d57922f394,addyi is not indicated to enhance sexual performance,2
2131,2131,2131,2131,2131,2131,2131,2687,2687,2687,2687,2687,2687,2687,2687,2687,2687,2687,2687,2687,3819daf3-e935-2c53-c527-e1d57922f394,addyi is indicated for the treatment of premenopausal women with acquired  generalized hypoactive sexual desire disorder ( hsdd ) as characterized by low sexual desire that causes marked distress or interpersonal difficulty and is not due to a co existing medical or psychiatric condition  problems within the relationship  or the effects of a medication or other drug substance,1
2132,2132,2132,2132,2132,2132,2132,2688,2688,2688,2688,2688,2688,2688,2688,2688,2688,2688,2688,2688,3819daf3-e935-2c53-c527-e1d57922f394,( 1 ) limitations of use addyi is not indicated for the treatment of hsdd in postmenopausal women or in men,2
2133,2133,2133,2133,2133,2133,2133,2689,2689,2689,2689,2689,2689,2689,2689,2689,2689,2689,2689,2689,3819daf3-e935-2c53-c527-e1d57922f394,( 1 ) addyi is not indicated to enhance sexual performance,2
2134,2134,2134,2134,2134,2134,2134,2690,2690,2690,2690,2690,2690,2690,2690,2690,2690,2690,2690,2690,b78d1919-9dee-44fa-90f9-e0a26d32481d,1  eligard is indicated for the palliative treatment of advanced prostate cancer,1
2135,2135,2135,2135,2135,2135,2135,2691,2691,2691,2691,2691,2691,2691,2691,2691,2691,2691,2691,2691,b78d1919-9dee-44fa-90f9-e0a26d32481d,eligard is a gonadatropin releasing hormone ( gnrh ) agonist indicated for the palliative treatment of advanced prostate cancer ( 1 ),1
2136,2136,2136,2136,2136,2136,2136,2692,2692,2692,2692,2692,2692,2692,2692,2692,2692,2692,2692,2692,f6709069-6a58-625b-d090-53a2c5cc6f3b,1  lupaneta pack ( leuprolide acetate for depot suspension and norethindrone acetate tablets ) is indicated for initial management of the painful symptoms of endometriosis and for management of recurrence of symptoms,1
2137,2137,2137,2137,2137,2137,2137,2693,2693,2693,2693,2693,2693,2693,2693,2693,2693,2693,2693,2693,f6709069-6a58-625b-d090-53a2c5cc6f3b,limitation of use duration of use is limited due to concerns about adverse impact on bone mineral density see warnings and precautions ( 5 1 ),2
2138,2138,2138,2138,2138,2138,2138,2694,2694,2694,2694,2694,2694,2694,2694,2694,2694,2694,2694,2694,f6709069-6a58-625b-d090-53a2c5cc6f3b,the initial treatment course of lupaneta pack is limited to six months,4
2139,2139,2139,2139,2139,2139,2139,2695,2695,2695,2695,2695,2695,2695,2695,2695,2695,2695,2695,2695,f6709069-6a58-625b-d090-53a2c5cc6f3b,a single retreatment course of not more than six months may be administered after the initial course of treatment if symptoms recur,4
2140,2140,2140,2140,2140,2140,2140,2696,2696,2696,2696,2696,2696,2696,2696,2696,2696,2696,2696,2696,f6709069-6a58-625b-d090-53a2c5cc6f3b,use of lupaneta pack for longer than a total of 12 months is not recommended,4
2141,2141,2141,2141,2141,2141,2141,2697,2697,2697,2697,2697,2697,2697,2697,2697,2697,2697,2697,2697,f6709069-6a58-625b-d090-53a2c5cc6f3b,lupaneta pack contains leuprolide acetate  a gonadotropin releasing hormone ( gnrh ) agonist and norethindrone acetate  a progestin  indicated for initial management of the painful symptoms of endometriosis ( 1 ) management of recurrence of symptoms ( 1 ) limitations of use initial treatment course is limited to 6 months and use is not recommended longer than a total of 12 months due to concerns about adverse impact on bone mineral density,1
2142,2142,2142,2142,2142,2142,2142,2704,2704,2704,2704,2704,2704,2704,2704,2704,2704,2704,2704,2704,a3b01473-30c7-4945-bd60-2484221aaaad, leuprolide acetate injection is indicated in the palliative treatment of advanced prostatic cancer,1
2143,2143,2143,2143,2143,2143,2143,2705,2705,2705,2705,2705,2705,2705,2705,2705,2705,2705,2705,2705,82c5998f-2253-4880-9be5-feaba553d5d1, viadur is indicated in the palliative treatment of advanced prostate cancer,1
2144,2144,2144,2144,2144,2144,2144,2706,2706,2706,2706,2706,2706,2706,2706,2706,2706,2706,2706,2706,1a61a75c-19fe-462e-e054-00144ff8d46c,indication veritgo  diarrhea  pain  or other indications,1
2145,2145,2145,2145,2145,2145,2145,2707,2707,2707,2707,2707,2707,2707,2707,2707,2707,2707,2707,2707,8301e76b-134a-43d2-a7dc-c600ccf2695c, belladonna and opium suppositories are used for relief of moderate to severe pain associated with ureteral spasm not responsive to non narcotic analgesics and to space intervals between injections of opiates,1
2146,2146,2146,2146,2146,2146,2146,2708,2708,2708,2708,2708,2708,2708,2708,2708,2708,2708,2708,2708,0ea37235-35fd-410d-b8c4-40ba15fe1294,1  rebinyn  coagulation factor ix ( recombinant )  glycopegylated  is a recombinant dna derived coagulation factor ix concentrate indicated for use in adults and children with hemophilia b for on demand treatment and control of bleeding episodes perioperative management of bleeding limitations of use rebinyn is not indicated for routine prophylaxis in the treatment of patients with hemophilia b rebinyn is not indicated for immune tolerance induction in patients with hemophilia b rebinyn  coagulation factor ix ( recombinant )  glycopegylated  is a recombinant dna derived coagulation factor ix concentrate indicated for use in adults and children with hemophilia b for on demand treatment and control of bleeding episodes perioperative management of bleeding limitations of use rebinyn is not indicated for routine prophylaxis in the treatment of patients with hemophilia b rebinyn is not indicated for immune tolerance induction in patients with hemophilia b ( 1 ),1
2147,2147,2147,2147,2147,2147,2147,2709,2709,2709,2709,2709,2709,2709,2709,2709,2709,2709,2709,2709,4c6e76bc-c964-4955-e0a3-511d3386a9cc, ultane is indicated for induction and maintenance of general anesthesia in adult and pediatric patients for inpatient and outpatient surgery,1
2148,2148,2148,2148,2148,2148,2148,2710,2710,2710,2710,2710,2710,2710,2710,2710,2710,2710,2710,2710,4c6e76bc-c964-4955-e0a3-511d3386a9cc,ultane should be administered only by persons trained in the administration of general anesthesia,4
2149,2149,2149,2149,2149,2149,2149,2711,2711,2711,2711,2711,2711,2711,2711,2711,2711,2711,2711,2711,4c6e76bc-c964-4955-e0a3-511d3386a9cc,facilities for maintenance of a patent airway  artificial ventilation  oxygen enrichment  and circulatory resuscitation must be immediately available,4
2150,2150,2150,2150,2150,2150,2150,2712,2712,2712,2712,2712,2712,2712,2712,2712,2712,2712,2712,2712,4c6e76bc-c964-4955-e0a3-511d3386a9cc,since level of anesthesia may be altered rapidly  only vaporizers producing predictable concentrations of sevoflurane should be used,4
2151,2151,2151,2151,2151,2151,2151,2713,2713,2713,2713,2713,2713,2713,2713,2713,2713,2713,2713,2713,c6c48eee-240b-4425-8691-35462523652e,indication darvon n is indicated for the relief of mild to moderate pain,1
2152,2152,2152,2152,2152,2152,2152,2714,2714,2714,2714,2714,2714,2714,2714,2714,2714,2714,2714,2714,389a502e-a7d5-43dd-b6bf-f022ff23f3b9,1  axumin is indicated for positron emission tomography ( pet ) in men with suspected prostate cancer recurrence based on elevated blood prostate specific antigen ( psa ) levels following prior treatment,1
2153,2153,2153,2153,2153,2153,2153,2715,2715,2715,2715,2715,2715,2715,2715,2715,2715,2715,2715,2715,389a502e-a7d5-43dd-b6bf-f022ff23f3b9,axumin is a radioactive diagnostic agent indicated for positron emission tomography ( pet ) imaging in men with suspected prostate cancer recurrence based on elevated blood prostate specific antigen ( psa ) levels following prior treatment ( 1 ),1
2154,2154,2154,2154,2154,2154,2154,2716,2716,2716,2716,2716,2716,2716,2716,2716,2716,2716,2716,2716,2741d8fd-51c2-46be-880b-99f2b20a6137, protopam chloride is indicated as an antidote 1 in the treatment of poisoning due to those pesticides and chemicals ( e g  nerve agents ) of the organophosphate class which have anticholinesterase activity and 2 in the control of overdosage by anticholinesterase drugs used in the treatment of myasthenia gravis,1
2155,2155,2155,2155,2155,2155,2155,2717,2717,2717,2717,2717,2717,2717,2717,2717,2717,2717,2717,2717,2741d8fd-51c2-46be-880b-99f2b20a6137,the principal indications for the use of protopam chloride are muscle weakness and respiratory depression,1
2156,2156,2156,2156,2156,2156,2156,2718,2718,2718,2718,2718,2718,2718,2718,2718,2718,2718,2718,2718,2741d8fd-51c2-46be-880b-99f2b20a6137,in severe poisoning  respiratory depression may be due to muscle weakness,u
2157,2157,2157,2157,2157,2157,2157,2719,2719,2719,2719,2719,2719,2719,2719,2719,2719,2719,2719,2719,241f42a0-1a33-40e8-8221-201767d999e5,1  duodote is indicated for the treatment of poisoning by organophosphorus nerve agents as well as organophosphorus insecticides in adults and pediatric patients weighing more than 41 kg ( 90 pounds ),1
2158,2158,2158,2158,2158,2158,2158,2720,2720,2720,2720,2720,2720,2720,2720,2720,2720,2720,2720,2720,241f42a0-1a33-40e8-8221-201767d999e5,duodote  a combination of atropine  a cholinergic muscarinic antagonist  and pralidoxime chloride  a cholinesterase reactivator  is indicated for the treatment of poisoning by organophosphorus nerve agents as well as organophosphorus insecticides in adults and pediatric patients weighing more than 41 kg ( 90 pounds ),1
2159,2159,2159,2159,2159,2159,2159,2721,2721,2721,2721,2721,2721,2721,2721,2721,2721,2721,2721,2721,674e0e6d-46ed-4868-9196-04019d667716, nipent is indicated as single agent treatment for both untreated and alpha interferon refractory hairy cell leukemia patients with active disease as defined by clinically significant anemia  neutropenia  thrombocytopenia  or disease related symptoms,1
2160,2160,2160,2160,2160,2160,2160,2722,2722,2722,2722,2722,2722,2722,2722,2722,2722,2722,2722,2722,f664b3fd-374c-4f04-abea-1a266dfea0e2,issued 6 03 teruflex blood bag system with diversion blood sampling arm cpd optisol solution read these instructions carefully before use,0
2161,2161,2161,2161,2161,2161,2161,2723,2723,2723,2723,2723,2723,2723,2723,2723,2723,2723,2723,2723,f664b3fd-374c-4f04-abea-1a266dfea0e2,the diversion blood sampling arm is intended to divert and collect blood for obtaining donor test samples,0
2162,2162,2162,2162,2162,2162,2162,2724,2724,2724,2724,2724,2724,2724,2724,2724,2724,2724,2724,2724,f664b3fd-374c-4f04-abea-1a266dfea0e2,sterile and non pyrogenic fluid path,0
2163,2163,2163,2163,2163,2163,2163,2725,2725,2725,2725,2725,2725,2725,2725,2725,2725,2725,2725,2725,f664b3fd-374c-4f04-abea-1a266dfea0e2,intended for the collection  processing and preservation of human blood and components,0
2164,2164,2164,2164,2164,2164,2164,2726,2726,2726,2726,2726,2726,2726,2726,2726,2726,2726,2726,2726,f664b3fd-374c-4f04-abea-1a266dfea0e2,precautions do not use unless the solutions are clear,0
2165,2165,2165,2165,2165,2165,2165,2727,2727,2727,2727,2727,2727,2727,2727,2727,2727,2727,2727,2727,f664b3fd-374c-4f04-abea-1a266dfea0e2,avoid excessive heat and direct sunlight,
2166,2166,2166,2166,2166,2166,2166,2728,2728,2728,2728,2728,2728,2728,2728,2728,2728,2728,2728,2728,f664b3fd-374c-4f04-abea-1a266dfea0e2,recommended storage conditions room temperature ( 15 30 c 59 86 f ),0
2167,2167,2167,2167,2167,2167,2167,2729,2729,2729,2729,2729,2729,2729,2729,2729,2729,2729,2729,2729,f664b3fd-374c-4f04-abea-1a266dfea0e2,the blood bag configuration is specified on the blister pack label,0
2168,2168,2168,2168,2168,2168,2168,2730,2730,2730,2730,2730,2730,2730,2730,2730,2730,2730,2730,2730,f664b3fd-374c-4f04-abea-1a266dfea0e2,caution do not use a dielectric tube sealer to seal the tubing while the needle is connected to the donor 's body unless it is approved for such a purpose,0
2169,2169,2169,2169,2169,2169,2169,2731,2731,2731,2731,2731,2731,2731,2731,2731,2731,2731,2731,2731,f664b3fd-374c-4f04-abea-1a266dfea0e2,instructions for blood collection use aseptic technique materials needed venoject ll tube holder ( code p 1316r ) or equivalent venoject ll multi sample luer adapter ( code mn 2000t ) or equivalent evacuated blood collection tubes ( glass or plastic ) 1,0
2170,2170,2170,2170,2170,2170,2170,2732,2732,2732,2732,2732,2732,2732,2732,2732,2732,2732,2732,2732,f664b3fd-374c-4f04-abea-1a266dfea0e2,prepare the blood bag following your institution 's standard operating procedures,0
2171,2171,2171,2171,2171,2171,2171,2733,2733,2733,2733,2733,2733,2733,2733,2733,2733,2733,2733,2733,f664b3fd-374c-4f04-abea-1a266dfea0e2,if applicable  make a loose knot in the donor tubing below the y and cliktip ( inline closure device ) unless alternate methods are used to seal the tubing at the end of collection,0
2172,2172,2172,2172,2172,2172,2172,2734,2734,2734,2734,2734,2734,2734,2734,2734,2734,2734,2734,2734,f664b3fd-374c-4f04-abea-1a266dfea0e2,temporarily clamp the donor tubing between the phlebotomy needle and the y,0
2173,2173,2173,2173,2173,2173,2173,2735,2735,2735,2735,2735,2735,2735,2735,2735,2735,2735,2735,2735,f664b3fd-374c-4f04-abea-1a266dfea0e2,close the white clamp below the diversion pouch,0
2174,2174,2174,2174,2174,2174,2174,2736,2736,2736,2736,2736,2736,2736,2736,2736,2736,2736,2736,2736,f664b3fd-374c-4f04-abea-1a266dfea0e2,tube holder luer adapter assembly a ) connect the venoject ii multi sample luer adapter to the venoject ii tube holder ( or equivalent ) ( fig 1 ),4
2175,2175,2175,2175,2175,2175,2175,2737,2737,2737,2737,2737,2737,2737,2737,2737,2737,2737,2737,2737,f664b3fd-374c-4f04-abea-1a266dfea0e2,1 here b ) twist and snap to remove the blue port cap at the end of the diversion blood sampling arm ( fig,4
2176,2176,2176,2176,2176,2176,2176,2738,2738,2738,2738,2738,2738,2738,2738,2738,2738,2738,2738,2738,f664b3fd-374c-4f04-abea-1a266dfea0e2,c ) connect the multi sample luer adapter to the female luer port,4
2177,2177,2177,2177,2177,2177,2177,2739,2739,2739,2739,2739,2739,2739,2739,2739,2739,2739,2739,2739,f664b3fd-374c-4f04-abea-1a266dfea0e2,2b ) note alternatively  steps a  b and c ( above ) may be performed at any time during bag preparation or after the blood is collected into the diversion pouch,4
2178,2178,2178,2178,2178,2178,2178,2740,2740,2740,2740,2740,2740,2740,2740,2740,2740,2740,2740,2740,f664b3fd-374c-4f04-abea-1a266dfea0e2,suspend the collection bag as far as possible below the donor 's arm,4
2179,2179,2179,2179,2179,2179,2179,2741,2741,2741,2741,2741,2741,2741,2741,2741,2741,2741,2741,2741,f664b3fd-374c-4f04-abea-1a266dfea0e2,apply blood pressure cuff or tourniquet to donor 's arm,4
2180,2180,2180,2180,2180,2180,2180,2742,2742,2742,2742,2742,2742,2742,2742,2742,2742,2742,2742,2742,f664b3fd-374c-4f04-abea-1a266dfea0e2,if blood pressure cuff is used  inflate to approximately 60 mmhg,4
2181,2181,2181,2181,2181,2181,2181,2743,2743,2743,2743,2743,2743,2743,2743,2743,2743,2743,2743,2743,f664b3fd-374c-4f04-abea-1a266dfea0e2,remove the needle cover and perform phlebotomy,4
2182,2182,2182,2182,2182,2182,2182,2744,2744,2744,2744,2744,2744,2744,2744,2744,2744,2744,2744,2744,f664b3fd-374c-4f04-abea-1a266dfea0e2,remove the temporary clamp on the donor tubing to permit blood flow into the diversion blood sampling arm pouch,4
2183,2183,2183,2183,2183,2183,2183,2745,2745,2745,2745,2745,2745,2745,2745,2745,2745,2745,2745,2745,f664b3fd-374c-4f04-abea-1a266dfea0e2,caution do not touch the needle after removing the needle protector,4
2184,2184,2184,2184,2184,2184,2184,2746,2746,2746,2746,2746,2746,2746,2746,2746,2746,2746,2746,2746,f664b3fd-374c-4f04-abea-1a266dfea0e2,assure that the white clamp below the pouch is closed prior to initiating phlebotomy,4
2185,2185,2185,2185,2185,2185,2185,2747,2747,2747,2747,2747,2747,2747,2747,2747,2747,2747,2747,2747,f664b3fd-374c-4f04-abea-1a266dfea0e2,if using a needle safety device  follow the manufacturer 's instructions to secure the device in place,4
2186,2186,2186,2186,2186,2186,2186,2748,2748,2748,2748,2748,2748,2748,2748,2748,2748,2748,2748,2748,f664b3fd-374c-4f04-abea-1a266dfea0e2,appropriately secure donor tubing to donor 's arm,4
2187,2187,2187,2187,2187,2187,2187,2749,2749,2749,2749,2749,2749,2749,2749,2749,2749,2749,2749,2749,f664b3fd-374c-4f04-abea-1a266dfea0e2,position the diversion pouch with the notches up and the tube holder luer adapter assembly ( or port cap ) down,4
2188,2188,2188,2188,2188,2188,2188,2750,2750,2750,2750,2750,2750,2750,2750,2750,2750,2750,2750,2750,f664b3fd-374c-4f04-abea-1a266dfea0e2,when the level of blood in the pouch is approximately in line with the notches  the diversion pouch is full,4
2189,2189,2189,2189,2189,2189,2189,2751,2751,2751,2751,2751,2751,2751,2751,2751,2751,2751,2751,2751,d820e42d-ad2b-4e11-907b-a94d698ca285, urogesic blue is indicated for the treatment of symptoms of irritative voiding,1
2190,2190,2190,2190,2190,2190,2190,2752,2752,2752,2752,2752,2752,2752,2752,2752,2752,2752,2752,2752,d820e42d-ad2b-4e11-907b-a94d698ca285,indicated for the relief of local symptoms  such as hypermotility which accompany lower urinary tract infections and as antispasmodic,1
2191,2191,2191,2191,2191,2191,2191,2754,2754,2754,2754,2754,2754,2754,2754,2754,2754,2754,2754,2754,6850fd73-f915-49e3-ad16-6e11899246a1,1  1 1 hevert hepar comp,1
2192,2192,2192,2192,2192,2192,2192,2755,2755,2755,2755,2755,2755,2755,2755,2755,2755,2755,2755,2755,6850fd73-f915-49e3-ad16-6e11899246a1,is a homeopathic drug indicated for the treatment of liver and biliary system disorders,1
2193,2193,2193,2193,2193,2193,2193,2756,2756,2756,2756,2756,2756,2756,2756,2756,2756,2756,2756,2756,42f2d62a-c7f2-4706-87bc-64f3e72d63a9,1  isosulfan blue injection 1 upon subcutaneous administration  delineates the lymphatic vessels draining the region of injection,1
2194,2194,2194,2194,2194,2194,2194,2757,2757,2757,2757,2757,2757,2757,2757,2757,2757,2757,2757,2757,42f2d62a-c7f2-4706-87bc-64f3e72d63a9,it is an adjunct to lymphography in primary and secondary lymphedema of the extremities chyluria  chylous ascites or chylothorax lymph node involvement by primary or secondary neoplasm lymph node response to therapeutic modalities ( 1 1 ),1
2195,2195,2195,2195,2195,2195,2195,2758,2758,2758,2758,2758,2758,2758,2758,2758,2758,2758,2758,2758,42f2d62a-c7f2-4706-87bc-64f3e72d63a9,1 1 lymphatic vessel delineation isosulfan blue injection 1 upon subcutaneous administration  delineates lymphatic vessels draining the region of injection,u
2196,2196,2196,2196,2196,2196,2196,2759,2759,2759,2759,2759,2759,2759,2759,2759,2759,2759,2759,2759,42f2d62a-c7f2-4706-87bc-64f3e72d63a9,it is an adjunct to lymphography in primary and secondary lymphedema of the extremities chyluria  chylous ascites or chylothorax lymph node involvement by primary or secondary neoplasm and lymph node response to therapeutic modalities,1
2197,2197,2197,2197,2197,2197,2197,2760,2760,2760,2760,2760,2760,2760,2760,2760,2760,2760,2760,2760,6236b0bc-82e9-4447-9a78-f57d94770269,1  lemtrada is indicated for the treatment of patients with relapsing forms of multiple sclerosis ( ms ),1
2198,2198,2198,2198,2198,2198,2198,2761,2761,2761,2761,2761,2761,2761,2761,2761,2761,2761,2761,2761,6236b0bc-82e9-4447-9a78-f57d94770269,because of its safety profile  the use of lemtrada should generally be reserved for patients who have had an inadequate response to two or more drugs indicated for the treatment of ms lemtrada is a cd52 directed cytolytic monoclonal antibody indicated for the treatment of patients with relapsing forms of multiple sclerosis ( ms ),4
2199,2199,2199,2199,2199,2199,2199,2762,2762,2762,2762,2762,2762,2762,2762,2762,2762,2762,2762,2762,6236b0bc-82e9-4447-9a78-f57d94770269,because of its safety profile  the use of lemtrada should generally be reserved for patients who have had an inadequate response to two or more drugs indicated for the treatment of ms ( 1 ),4
2200,2200,2200,2200,2200,2200,2200,2763,2763,2763,2763,2763,2763,2763,2763,2763,2763,2763,2763,2763,63e9aeed-31a5-4f22-b3eb-987d38b966f6,1  prepopik ( sodium picosulfate  magnesium oxide and anhydrous citric acid ) for oral solution is indicated for cleansing of the colon as a preparation for colonoscopy in adults,1
2201,2201,2201,2201,2201,2201,2201,2764,2764,2764,2764,2764,2764,2764,2764,2764,2764,2764,2764,2764,63e9aeed-31a5-4f22-b3eb-987d38b966f6,prepopik is a combination of sodium picosulfate  a stimulant laxative  and magnesium oxide and anhydrous citric acid which form magnesium citrate  an osmotic laxative  indicated for cleansing of the colon as a preparation for colonoscopy in adults ( 1 ),1
2202,2202,2202,2202,2202,2202,2202,2765,2765,2765,2765,2765,2765,2765,2765,2765,2765,2765,2765,2765,fdfe5d72-6b80-435a-afa4-c5d74dd852ce,1  neulasta is a leukocyte growth factor indicated to decrease the incidence of infection  as manifested by febrile neutropenia  in patients with non myeloid malignancies receiving myelosuppressive anti cancer drugs associated with a clinically significant incidence of febrile neutropenia,1
2203,2203,2203,2203,2203,2203,2203,2766,2766,2766,2766,2766,2766,2766,2766,2766,2766,2766,2766,2766,fdfe5d72-6b80-435a-afa4-c5d74dd852ce,( 1 1 ) increase survival in patients acutely exposed to myelosuppressive doses of radiation ( hematopoietic subsyndrome of acute radiation syndrome ),1
2204,2204,2204,2204,2204,2204,2204,2767,2767,2767,2767,2767,2767,2767,2767,2767,2767,2767,2767,2767,fdfe5d72-6b80-435a-afa4-c5d74dd852ce,( 1 2 ) limitations of use neulasta is not indicated for the mobilization of peripheral blood progenitor cells for hematopoietic stem cell transplantation,2
2205,2205,2205,2205,2205,2205,2205,2768,2768,2768,2768,2768,2768,2768,2768,2768,2768,2768,2768,2768,fdfe5d72-6b80-435a-afa4-c5d74dd852ce,1 1 patients with cancer receiving myelosuppressive chemotherapy neulasta is indicated to decrease the incidence of infection  as manifested by febrile neutropenia  in patients with non myeloid malignancies receiving myelosuppressive anti cancer drugs associated with a clinically significant incidence of febrile neutropenia see clinical studies ( 14 1 ),1
2206,2206,2206,2206,2206,2206,2206,2769,2769,2769,2769,2769,2769,2769,2769,2769,2769,2769,2769,2769,fdfe5d72-6b80-435a-afa4-c5d74dd852ce,limitations of use neulasta is not indicated for the mobilization of peripheral blood progenitor cells for hematopoietic stem cell transplantation,2
2207,2207,2207,2207,2207,2207,2207,2770,2770,2770,2770,2770,2770,2770,2770,2770,2770,2770,2770,2770,fdfe5d72-6b80-435a-afa4-c5d74dd852ce,1 2 patients with hematopoietic subsyndrome of acute radiation syndrome neulasta is indicated to increase survival in patients acutely exposed to myelosuppressive doses of radiation see dosage and administration ( 2 2 ) and clinical studies ( 14 2 ),1
2208,2208,2208,2208,2208,2208,2208,2771,2771,2771,2771,2771,2771,2771,2771,2771,2771,2771,2771,2771,e0141598-0bb2-4cf0-c9b8-6867b34bbb17, menest is indicated in the treatment of moderate to severe vasomotor symptoms associated with the menopause,1
2209,2209,2209,2209,2209,2209,2209,2772,2772,2772,2772,2772,2772,2772,2772,2772,2772,2772,2772,2772,e0141598-0bb2-4cf0-c9b8-6867b34bbb17,treatment of moderate to severe symptoms of vulvar and vaginal atrophy associated with the menopause,1
2210,2210,2210,2210,2210,2210,2210,2773,2773,2773,2773,2773,2773,2773,2773,2773,2773,2773,2773,2773,e0141598-0bb2-4cf0-c9b8-6867b34bbb17,when prescribing solely for the treatment of symptoms of vulvar and vaginal atrophy  topical vaginal products should be considered,0
2211,2211,2211,2211,2211,2211,2211,2774,2774,2774,2774,2774,2774,2774,2774,2774,2774,2774,2774,2774,e0141598-0bb2-4cf0-c9b8-6867b34bbb17,breast cancer ( for palliation only ) in appropriately selected women and men with metastatic disease,1
2212,2212,2212,2212,2212,2212,2212,2775,2775,2775,2775,2775,2775,2775,2775,2775,2775,2775,2775,2775,e0141598-0bb2-4cf0-c9b8-6867b34bbb17,prostatic carcinoma palliative therapy of advanced disease,1
2213,2213,2213,2213,2213,2213,2213,2776,2776,2776,2776,2776,2776,2776,2776,2776,2776,2776,2776,2776,d42eeda8-d810-4481-a403-6a3520b9e69a, esterified estrogens and methyltestosterone full and half strength tablets are indicated in the treatment of moderate to severe vasomotor symptoms associated with the menopause in those patients not improved by estrogens alone,1
2214,2214,2214,2214,2214,2214,2214,2777,2777,2777,2777,2777,2777,2777,2777,2777,2777,2777,2777,2777,d42eeda8-d810-4481-a403-6a3520b9e69a,( there is no evidence that estrogens are effective for nervous symptoms or depression without associated vasomotor symptoms  and they should not be used to treat such conditions ),0
2215,2215,2215,2215,2215,2215,2215,2778,2778,2778,2778,2778,2778,2778,2778,2778,2778,2778,2778,2778,d42eeda8-d810-4481-a403-6a3520b9e69a,esterified estrogens and methyltestosterone full and half strength tablets have not been shown to be effective for any purpose during pregnancy and its use may cause severe harm to the fetus,0
2216,2216,2216,2216,2216,2216,2216,2779,2779,2779,2779,2779,2779,2779,2779,2779,2779,2779,2779,2779,8a44f966-7f5a-4245-88b6-581f71f7b038, technetium tc99m exametazime scintigraphy ( with or without methylene blue stabilization ) may be useful as an adjunct in the detection of altered regional cerebral perfusion in stroke,1
2217,2217,2217,2217,2217,2217,2217,2780,2780,2780,2780,2780,2780,2780,2780,2780,2780,2780,2780,2780,8a44f966-7f5a-4245-88b6-581f71f7b038,tc99m exametazime without methylene blue stabilization is indicated for leukocyte labeled scintigraphy as an adjunct in the localization of intra abdominal infection and inflammatory bowel disease,1
2218,2218,2218,2218,2218,2218,2218,2781,2781,2781,2781,2781,2781,2781,2781,2781,2781,2781,2781,2781,18512df8-a453-4e7d-a782-cc6b55655a08,uses a natural aid for shyness  timidity and passivity  lack of self confidence  feeling of inferiority and inadequacy  susceptibility to peer pressure,1
2219,2219,2219,2219,2219,2219,2219,2782,2782,2782,2782,2782,2782,2782,2782,2782,2782,2782,2782,2782,5e81b4a7-b971-45e1-9c31-29cea8c87ce7,1  tagrisso is indicated for the treatment of patients with metastatic epidermal growth factor receptor ( egfr ) t790m mutation positive non small cell lung cancer ( nsclc )  as detected by an fda approved test  whose disease has progressed on or after egfr tyrosine kinase inhibitor ( tki ) therapy,1
2220,2220,2220,2220,2220,2220,2220,2783,2783,2783,2783,2783,2783,2783,2783,2783,2783,2783,2783,2783,5e81b4a7-b971-45e1-9c31-29cea8c87ce7,tagrisso is a kinase inhibitor indicated for the treatment of patients with metastatic epidermal growth factor receptor ( egfr ) t790m mutation positive non small cell lung cancer ( nsclc )  as detected by an fda approved test  whose disease has progressed on or after egfr tki therapy,1
2221,2221,2221,2221,2221,2221,2221,2784,2784,2784,2784,2784,2784,2784,2784,2784,2784,2784,2784,2784,79d73ae4-beaf-4a99-b0f3-d66438c122bd,1  pramipexole dihydrochloride extended release tablets are indicated for the treatment of parkinson 's disease,1
2222,2222,2222,2222,2222,2222,2222,2785,2785,2785,2785,2785,2785,2785,2785,2785,2785,2785,2785,2785,79d73ae4-beaf-4a99-b0f3-d66438c122bd,pramipexole dihydrochloride extended release tablets are a non ergot dopamine agonist indicated for the treatment of parkinson s disease ( pd ) ( 1 ),1
2223,2223,2223,2223,2223,2223,2223,2786,2786,2786,2786,2786,2786,2786,2786,2786,2786,2786,2786,2786,fa7e4294-0f59-492d-bd4f-d06a6c2d522c, doxercalciferol injection is indicated for the treatment of secondary hyperparathyroidism in patients with chronic kidney disease on dialysis,1
2224,2224,2224,2224,2224,2224,2224,2787,2787,2787,2787,2787,2787,2787,2787,2787,2787,2787,2787,2787,"Active Ingredient UNII(s)
3F7BHA64Z0    16a8622b-b349-4b10-b45a-f1f1551b2b06
3F7BHA64Z0    16a8622b-b349-4b10-b45a-f1f1551b2b06
Name: SET ID dtype: object",active ingredient unii ( s ) 3f7bha64z0 active ingredient unii ( s ) 3f7bha64z0 active in 3f7bha64z0 active ingredient unii ( s ) 3f7bha64z0 active in name content xml  dtype object,0
2225,2225,2225,2225,2225,2225,2225,2789,2789,2789,2789,2789,2789,2789,2789,2789,2789,2789,2789,2789,b2c6b352-f837-4903-8e4c-fb0a2b20bb60, caffeine and sodium benzoate injection has been used in conjunction with supportive measure to treat respiratory depression associated with overdosage with cns depressant drugs ( e g  narcotic analgesics  alcohol ),u
2226,2226,2226,2226,2226,2226,2226,2790,2790,2790,2790,2790,2790,2790,2790,2790,2790,2790,2790,2790,b2c6b352-f837-4903-8e4c-fb0a2b20bb60,however  because of questionable benefit and transient action  most authorities believe caffeine and other analeptics should not be used in these conditions and recommend other supportive therapy,0
2227,2227,2227,2227,2227,2227,2227,2791,2791,2791,2791,2791,2791,2791,2791,2791,2791,2791,2791,2791,ca3fe6e9-21ad-4fba-a602-e1c364cf3981, ascomp with codeine is indicated for the relief of the symptom complex of tension ( or muscle contraction ) headache,1
2228,2228,2228,2228,2228,2228,2228,2792,2792,2792,2792,2792,2792,2792,2792,2792,2792,2792,2792,2792,ca3fe6e9-21ad-4fba-a602-e1c364cf3981,evidence supporting the efficacy of ascomp with codeine is derived from 2 multi clinic trials that compared patients with tension headache randomly assigned to 4 parallel treatments butalbital  aspirin  caffeine  and codeine phosphate capsules  usp  and placebo,0
2229,2229,2229,2229,2229,2229,2229,2793,2793,2793,2793,2793,2793,2793,2793,2793,2793,2793,2793,2793,ca3fe6e9-21ad-4fba-a602-e1c364cf3981,response was assessed over the course of the first 4 hours of each of 2 distinct headaches  separated by at least 24 hours,0
2230,2230,2230,2230,2230,2230,2230,2794,2794,2794,2794,2794,2794,2794,2794,2794,2794,2794,2794,2794,ca3fe6e9-21ad-4fba-a602-e1c364cf3981,butalbital  aspirin  caffeine  and codeine phosphate capsules  usp proved statistically significantly superior to each of its components ( butalbital  aspirin  and caffeine capsules  usp and codeine ) and to placebo on measures of pain relief,0
2231,2231,2231,2231,2231,2231,2231,2795,2795,2795,2795,2795,2795,2795,2795,2795,2795,2795,2795,2795,ca3fe6e9-21ad-4fba-a602-e1c364cf3981,evidence supporting the efficacy and safety of ascomp with codeine in the treatment of multiple recurrent headaches is unavailable,0
2232,2232,2232,2232,2232,2232,2232,2797,2797,2797,2797,2797,2797,2797,2797,2797,2797,2797,2797,2797,ce47777f-8cf7-4f53-b48f-165b83516896,indications butalbital  aspirin  and caffeine tablets  usp are indicated for the relief of the symptom complex of tension ( or muscle contraction ) headache,1
2233,2233,2233,2233,2233,2233,2233,2798,2798,2798,2798,2798,2798,2798,2798,2798,2798,2798,2798,2798,ce47777f-8cf7-4f53-b48f-165b83516896,evidence supporting the efficacy and safety of butalbital  aspirin  and caffeine in the treatment of multiple recurrent headaches is unavailable,0
2234,2234,2234,2234,2234,2234,2234,2800,2800,2800,2800,2800,2800,2800,2800,2800,2800,2800,2800,2800,4ae331e0-009a-477e-8408-6118dc620634, ergotamine tartrate and caffeine indicated as therapy to abort or prevent vascular headache  e g  migraine  migraine variants or so called histaminic cephalalgia,1
2235,2235,2235,2235,2235,2235,2235,2806,2806,2806,2806,2806,2806,2806,2806,2806,2806,2806,2806,2806,43ba3de1-ab2e-06f6-e054-00144ff8d46c, ridaura ( auranofin ) is indicated in the management of adults with active classical or definite rheumatoid arthritis ( ara criteria ) who have had an insufficient therapeutic response to  or are intolerant of  an adequate trial of full doses of one or more nonsteroidal anti inflammatory drugs,1
2236,2236,2236,2236,2236,2236,2236,2807,2807,2807,2807,2807,2807,2807,2807,2807,2807,2807,2807,2807,43ba3de1-ab2e-06f6-e054-00144ff8d46c,ridaura should be added to a comprehensive baseline program  including non drug therapies,0
2237,2237,2237,2237,2237,2237,2237,2808,2808,2808,2808,2808,2808,2808,2808,2808,2808,2808,2808,2808,43ba3de1-ab2e-06f6-e054-00144ff8d46c,unlike anti inflammatory drugs  ridaura does not produce an immediate response,0
2238,2238,2238,2238,2238,2238,2238,2809,2809,2809,2809,2809,2809,2809,2809,2809,2809,2809,2809,2809,43ba3de1-ab2e-06f6-e054-00144ff8d46c,therapeutic effects may be seen after three to four months of treatment  although improvement has not been seen in some patients before six months,0
2239,2239,2239,2239,2239,2239,2239,2810,2810,2810,2810,2810,2810,2810,2810,2810,2810,2810,2810,2810,43ba3de1-ab2e-06f6-e054-00144ff8d46c,when cartilage and bone damage has already occurred  gold cannot reverse structural damage to joints caused by previous disease,0
2240,2240,2240,2240,2240,2240,2240,2811,2811,2811,2811,2811,2811,2811,2811,2811,2811,2811,2811,2811,43ba3de1-ab2e-06f6-e054-00144ff8d46c,the greatest potential benefit occurs in patients with active synovitis  particularly in its early stage,0
2241,2241,2241,2241,2241,2241,2241,2812,2812,2812,2812,2812,2812,2812,2812,2812,2812,2812,2812,2812,43ba3de1-ab2e-06f6-e054-00144ff8d46c,in controlled clinical trials comparing ridaura with injectable gold  ridaura was associated with fewer dropouts due to adverse reactions  while injectable gold was associated with fewer dropouts for inadequate or poor therapeutic effect,u
2242,2242,2242,2242,2242,2242,2242,2813,2813,2813,2813,2813,2813,2813,2813,2813,2813,2813,2813,2813,43ba3de1-ab2e-06f6-e054-00144ff8d46c,physicians should consider these findings when deciding on the use of ridaura in patients who are candidates for chrysotherapy,0
2243,2243,2243,2243,2243,2243,2243,2814,2814,2814,2814,2814,2814,2814,2814,2814,2814,2814,2814,2814,45d03177-5d52-492c-b2e0-01afc7c8d2e0,1  macugen ( pegaptanib sodium injection ) is indicated for the treatment of neovascular ( wet ) age related macular degeneration,1
2244,2244,2244,2244,2244,2244,2244,2815,2815,2815,2815,2815,2815,2815,2815,2815,2815,2815,2815,2815,45d03177-5d52-492c-b2e0-01afc7c8d2e0,macugen is indicated for the treatment of neovascular ( wet ) age related macular degeneration ( 1 ),1
2245,2245,2245,2245,2245,2245,2245,2816,2816,2816,2816,2816,2816,2816,2816,2816,2816,2816,2816,2816,0a0f8897-2099-4038-9b96-ed9c4f084018, major depressive disorder paroxetine tablets  usp are indicated for the treatment of major depressive disorder,1
2246,2246,2246,2246,2246,2246,2246,2817,2817,2817,2817,2817,2817,2817,2817,2817,2817,2817,2817,2817,0a0f8897-2099-4038-9b96-ed9c4f084018,the efficacy of paroxetine tablets  usp in the treatment of a major depressive episode was established in 6 week controlled trials of outpatients whose diagnoses corresponded most closely to the dsm iii category of major depressive disorder ( see clinical pharmacology clinical trials ),u
2247,2247,2247,2247,2247,2247,2247,2818,2818,2818,2818,2818,2818,2818,2818,2818,2818,2818,2818,2818,0a0f8897-2099-4038-9b96-ed9c4f084018,a major depressive episode implies a prominent and relatively persistent depressed or dysphoric mood that usually interferes with daily functioning ( nearly every day for at least 2 weeks ) it should include at least 4 of the following 8 symptoms change in appetite  change in sleep  psychomotor agitation or retardation  loss of interest in usual activities or decrease in sexual drive  increased fatigue  feelings of guilt or worthlessness  slowed thinking or impaired concentration  and a suicide attempt or suicidal ideation,0
2248,2248,2248,2248,2248,2248,2248,2819,2819,2819,2819,2819,2819,2819,2819,2819,2819,2819,2819,2819,0a0f8897-2099-4038-9b96-ed9c4f084018,the effects of paroxetine tablets  usp in hospitalized depressed patients have not been adequately studied,0
2249,2249,2249,2249,2249,2249,2249,2820,2820,2820,2820,2820,2820,2820,2820,2820,2820,2820,2820,2820,0a0f8897-2099-4038-9b96-ed9c4f084018,the efficacy of paroxetine tablets  usp in maintaining a response in major depressive disorder for up to 1 year was demonstrated in a placebo controlled trial ( see clinical pharmacology clinical trials ),0
2250,2250,2250,2250,2250,2250,2250,2821,2821,2821,2821,2821,2821,2821,2821,2821,2821,2821,2821,2821,0a0f8897-2099-4038-9b96-ed9c4f084018,nevertheless  the physician who elects to use paroxetine tablets  usp for extended periods should periodically re evaluate the long term usefulness of the drug for the individual patient,0
2251,2251,2251,2251,2251,2251,2251,2822,2822,2822,2822,2822,2822,2822,2822,2822,2822,2822,2822,2822,0a0f8897-2099-4038-9b96-ed9c4f084018,obsessive compulsive disorder paroxetine tablets  usp are indicated for the treatment of obsessions and compulsions in patients with obsessive compulsive disorder ( ocd ) as defined in the dsm iv,1
2252,2252,2252,2252,2252,2252,2252,2823,2823,2823,2823,2823,2823,2823,2823,2823,2823,2823,2823,2823,0a0f8897-2099-4038-9b96-ed9c4f084018,the obsessions or compulsions cause marked distress  are time consuming  or significantly interfere with social or occupational functioning,0
2253,2253,2253,2253,2253,2253,2253,2824,2824,2824,2824,2824,2824,2824,2824,2824,2824,2824,2824,2824,0a0f8897-2099-4038-9b96-ed9c4f084018,the efficacy of paroxetine tablets  usp were established in two 12 week trials with obsessive compulsive outpatients whose diagnoses corresponded most closely to the dsm iiir category of obsessive compulsive disorder ( see clinical pharmacology clinical trials ),0
2254,2254,2254,2254,2254,2254,2254,2825,2825,2825,2825,2825,2825,2825,2825,2825,2825,2825,2825,2825,0a0f8897-2099-4038-9b96-ed9c4f084018,obsessive compulsive disorder is characterized by recurrent and persistent ideas  thoughts  impulses  or images ( obsessions ) that are ego dystonic and or repetitive  purposeful  and intentional behaviors ( compulsions ) that are recognized by the person as excessive or unreasonable,0
2255,2255,2255,2255,2255,2255,2255,2826,2826,2826,2826,2826,2826,2826,2826,2826,2826,2826,2826,2826,0a0f8897-2099-4038-9b96-ed9c4f084018,long term maintenance of efficacy was demonstrated in a 6 month relapse prevention trial,0
2256,2256,2256,2256,2256,2256,2256,2827,2827,2827,2827,2827,2827,2827,2827,2827,2827,2827,2827,2827,0a0f8897-2099-4038-9b96-ed9c4f084018,in this trial  patients assigned to paroxetine showed a lower relapse rate compared to patients on placebo ( see clinical pharmacology clinical trials ),0
2257,2257,2257,2257,2257,2257,2257,2828,2828,2828,2828,2828,2828,2828,2828,2828,2828,2828,2828,2828,0a0f8897-2099-4038-9b96-ed9c4f084018,nevertheless  the physician who elects to use paroxetine tablets  usp for extended periods should periodically re evaluate the long term usefulness of the drug,0
2258,2258,2258,2258,2258,2258,2258,2829,2829,2829,2829,2829,2829,2829,2829,2829,2829,2829,2829,2829,79b0eb99-95f8-4db4-ba30-503f32538ab8, major depressive disorder paroxetine tablets  usp are indicated for the treatment of major depressive disorder,1
2259,2259,2259,2259,2259,2259,2259,2830,2830,2830,2830,2830,2830,2830,2830,2830,2830,2830,2830,2830,79b0eb99-95f8-4db4-ba30-503f32538ab8,the efficacy of paroxetine in the treatment of a major depressive episode was established in 6 week controlled trials of outpatients whose diagnoses corresponded most closely to the dsm iii category of major depressive disorder ( see clinical pharmacology  clinical trials ),0
2260,2260,2260,2260,2260,2260,2260,2832,2832,2832,2832,2832,2832,2832,2832,2832,2832,2832,2832,2832,79b0eb99-95f8-4db4-ba30-503f32538ab8,the effects of paroxetine in hospitalized depressed patients have not been adequately studied,0
2261,2261,2261,2261,2261,2261,2261,2833,2833,2833,2833,2833,2833,2833,2833,2833,2833,2833,2833,2833,79b0eb99-95f8-4db4-ba30-503f32538ab8,the efficacy of paroxetine in maintaining a response in major depressive disorder for up to 1 year was demonstrated in a placebo controlled trial ( see clinical pharmacology  clinical trials ),0
2262,2262,2262,2262,2262,2262,2262,2834,2834,2834,2834,2834,2834,2834,2834,2834,2834,2834,2834,2834,79b0eb99-95f8-4db4-ba30-503f32538ab8,nevertheless  the physician who elects to use paroxetine for extended periods should periodically re evaluate the long term usefulness of the drug for the individual patient,0
2263,2263,2263,2263,2263,2263,2263,2837,2837,2837,2837,2837,2837,2837,2837,2837,2837,2837,2837,2837,79b0eb99-95f8-4db4-ba30-503f32538ab8,the efficacy of paroxetine was established in two 12 week trials with obsessive compulsive outpatients whose diagnoses corresponded most closely to the dsm iiir category of obsessive compulsive disorder ( see clinical pharmacology  clinical trials ),0
2264,2264,2264,2264,2264,2264,2264,2840,2840,2840,2840,2840,2840,2840,2840,2840,2840,2840,2840,2840,79b0eb99-95f8-4db4-ba30-503f32538ab8,in this trial  patients assigned to paroxetine showed a lower relapse rate compared to patients on placebo ( see clinical pharmacology  clinical trials ),0
2265,2265,2265,2265,2265,2265,2265,2841,2841,2841,2841,2841,2841,2841,2841,2841,2841,2841,2841,2841,79b0eb99-95f8-4db4-ba30-503f32538ab8,nevertheless  the physician who elects to use parox,0
2266,2266,2266,2266,2266,2266,2266,2842,2842,2842,2842,2842,2842,2842,2842,2842,2842,2842,2842,2842,6f9f3d95-0e12-4cd4-bc5d-ee479ebd7337, thallous chloride ti 201 injection may be useful in myocardial perfusion imaging using either planar or spect ( single photon computed tomography ) techniques for the diagnosis and localization of myocardial infarction,1
2267,2267,2267,2267,2267,2267,2267,2843,2843,2843,2843,2843,2843,2843,2843,2843,2843,2843,2843,2843,6f9f3d95-0e12-4cd4-bc5d-ee479ebd7337,it may also have prognostic value regarding survival  when used in the clinically stable patient following the onset of symptoms of an acute myocardial infarction  to assess the site and size of the perfusion defect,u
2268,2268,2268,2268,2268,2268,2268,2844,2844,2844,2844,2844,2844,2844,2844,2844,2844,2844,2844,2844,6f9f3d95-0e12-4cd4-bc5d-ee479ebd7337,thallous chloride ti 201 injection may also be useful in conjunction with exercise stress testing as an adjunct in the diagnosis of ischemic heart disease ( atherosclerotic coronary artery disease ),u
2269,2269,2269,2269,2269,2269,2269,2845,2845,2845,2845,2845,2845,2845,2845,2845,2845,2845,2845,2845,6f9f3d95-0e12-4cd4-bc5d-ee479ebd7337,it is usually not possible to differentiate recent from old myocardial infarction  or to differentiate between recent myocardial infarction and ischemia,0
2270,2270,2270,2270,2270,2270,2270,2846,2846,2846,2846,2846,2846,2846,2846,2846,2846,2846,2846,2846,6f9f3d95-0e12-4cd4-bc5d-ee479ebd7337,thallous chloride ti 201 injection is indicated also for the localization of sites of parathyroid hyperactivity in patients with elevated serum calcium and parathyroid hormone levels,1
2271,2271,2271,2271,2271,2271,2271,2847,2847,2847,2847,2847,2847,2847,2847,2847,2847,2847,2847,2847,6f9f3d95-0e12-4cd4-bc5d-ee479ebd7337,it may also be useful in pre operative screening to localize extrathyroidal and mediastinal sites of parathyroid hyperactivity and for postsurgical reexamination,1
2272,2272,2272,2272,2272,2272,2272,2848,2848,2848,2848,2848,2848,2848,2848,2848,2848,2848,2848,2848,6f9f3d95-0e12-4cd4-bc5d-ee479ebd7337,thallous chloride tl 201 injection has not been adequately demonstrated to be effective for the localization of normal parathyroid glands,0
2273,2273,2273,2273,2273,2273,2273,2849,2849,2849,2849,2849,2849,2849,2849,2849,2849,2849,2849,2849,a75437f6-65a6-44af-8a2b-47401bff7dc2, neoplastic diseases methotrexate is indicated in the treatment of gestational choriocarcinoma  chorio adenoma destruens and hydatidiform mole,1
2274,2274,2274,2274,2274,2274,2274,2850,2850,2850,2850,2850,2850,2850,2850,2850,2850,2850,2850,2850,a75437f6-65a6-44af-8a2b-47401bff7dc2,methotrexate is used in maintenance therapy in combination with other chemotherapeutic agents,0
2275,2275,2275,2275,2275,2275,2275,2851,2851,2851,2851,2851,2851,2851,2851,2851,2851,2851,2851,2851,a75437f6-65a6-44af-8a2b-47401bff7dc2,methotrexate is used alone or in combination with other anticancer agents in the treatment of breast cancer  epidermoid cancers of the head and neck  advanced mycosis fungoides ( cutaneous t cell lymphoma )  and lung cancer  particularly squamous cell and small cell types,0
2276,2276,2276,2276,2276,2276,2276,2852,2852,2852,2852,2852,2852,2852,2852,2852,2852,2852,2852,2852,a75437f6-65a6-44af-8a2b-47401bff7dc2,methotrexate is also used in combination with other chemotherapeutic agents in the treatment of advanced stage non hodgkin s lymphomas,4
2277,2277,2277,2277,2277,2277,2277,2853,2853,2853,2853,2853,2853,2853,2853,2853,2853,2853,2853,2853,a75437f6-65a6-44af-8a2b-47401bff7dc2,psoriasis methotrexate is indicated in the symptomatic control of severe  recalcitrant  disabling psoriasis that is not adequately responsive to other forms of therapy  but only when the diagnosis has been established  as by biopsy and or after dermatologic consultation,1
2278,2278,2278,2278,2278,2278,2278,2854,2854,2854,2854,2854,2854,2854,2854,2854,2854,2854,2854,2854,a75437f6-65a6-44af-8a2b-47401bff7dc2,it is important to ensure that a psoriasis flare is not due to an undiagnosed concomitant disease affecting immune responses,0
2279,2279,2279,2279,2279,2279,2279,2855,2855,2855,2855,2855,2855,2855,2855,2855,2855,2855,2855,2855,a75437f6-65a6-44af-8a2b-47401bff7dc2,rheumatoid arthritis including polyarticular course juvenile rheumatoid arthritis methotrexate is indicated in the management of selected adults with severe  active  rheumatoid arthritis ( acr criteria )  or children with active polyarticular course juvenile rheumatoid arthritis  who have had an insufficient therapeutic response to  or are intolerant of  an adequate trial of first line therapy including full dose non steroidal anti inflammatory agents ( nsaids ),1
2280,2280,2280,2280,2280,2280,2280,2856,2856,2856,2856,2856,2856,2856,2856,2856,2856,2856,2856,2856,a75437f6-65a6-44af-8a2b-47401bff7dc2,aspirin  nsaids  and or low dose steroids may be continued  although the possibility of increased toxicity with concomitant use of nsaids including salicylates has not been fully explored,0
2281,2281,2281,2281,2281,2281,2281,2857,2857,2857,2857,2857,2857,2857,2857,2857,2857,2857,2857,2857,a75437f6-65a6-44af-8a2b-47401bff7dc2,( see precautions  drug interactions ),0
2282,2282,2282,2282,2282,2282,2282,2858,2858,2858,2858,2858,2858,2858,2858,2858,2858,2858,2858,2858,a75437f6-65a6-44af-8a2b-47401bff7dc2,steroids may be reduced gradually in patients who respond to methotrexate,4
2283,2283,2283,2283,2283,2283,2283,2859,2859,2859,2859,2859,2859,2859,2859,2859,2859,2859,2859,2859,a75437f6-65a6-44af-8a2b-47401bff7dc2,combined use of methotrexate with gold  penicillamine  hydroxychloroquine  sulfasalazine  or cytotoxic agents  has not been studied and may increase the incidence of adverse effects,0
2284,2284,2284,2284,2284,2284,2284,2860,2860,2860,2860,2860,2860,2860,2860,2860,2860,2860,2860,2860,a75437f6-65a6-44af-8a2b-47401bff7dc2,rest and physiotherapy as indicated should be continued,4
2285,2285,2285,2285,2285,2285,2285,2861,2861,2861,2861,2861,2861,2861,2861,2861,2861,2861,2861,2861,98c85037-a907-4a3a-8864-c3a5298b4759,1  myoview 30 ml is a kit for the preparation of technetium tc99m tetrofosmin for injection,u
2286,2286,2286,2286,2286,2286,2286,2862,2862,2862,2862,2862,2862,2862,2862,2862,2862,2862,2862,2862,98c85037-a907-4a3a-8864-c3a5298b4759,technetium tc99m tetrofosmin injection is a radioactive diagnostic agent indicated for the following myocardial perfusion imaging under rest and or exercise or pharmacologic stress conditions to delineate regions of reversible myocardial ischemia or infarcted myocardium in patients with known or suspected coronary artery disease ( 1 1 ) assessment of left ventricular function ( left ventricular ejection fraction and wall motion ) in patients with known or suspected heart disease ( 1 2 ) 1 1 myocardial perfusion imaging myocardial perfusion imaging under rest and or exercise or pharmacologic stress conditions to delineate regions of reversible myocardial ischemia or infarcted myocardium in patients with known or suspected coronary artery disease,1
2287,2287,2287,2287,2287,2287,2287,2863,2863,2863,2863,2863,2863,2863,2863,2863,2863,2863,2863,2863,98c85037-a907-4a3a-8864-c3a5298b4759,1 2 ventricular function imaging myoview is indicated for assessment of left ventricular function ( left ventricular ejection fraction and wall motion ) in patients with known or suspected heart disease,1
2288,2288,2288,2288,2288,2288,2288,2864,2864,2864,2864,2864,2864,2864,2864,2864,2864,2864,2864,2864,8755b020-d439-4ba2-a60b-6c57a15ece55, low ogestrel ( norgestrel and ethinyl estradiol tablets usp  0 3 mg 0 03 mg ) is indicated for the prevention of pregnancy in women who elect to use this product as a method of contraception,1
2289,2289,2289,2289,2289,2289,2289,2865,2865,2865,2865,2865,2865,2865,2865,2865,2865,2865,2865,2865,8755b020-d439-4ba2-a60b-6c57a15ece55,oral contraceptives are highly effective,0
2290,2290,2290,2290,2290,2290,2290,2866,2866,2866,2866,2866,2866,2866,2866,2866,2866,2866,2866,2866,8755b020-d439-4ba2-a60b-6c57a15ece55,table i lists the typical accidental pregnancy rates for users of combination oral contraceptives and other methods of contraception 1 the efficacy of these contraceptive methods  except sterilization  depends upon the reliability with which they are used,0
2291,2291,2291,2291,2291,2291,2291,2867,2867,2867,2867,2867,2867,2867,2867,2867,2867,2867,2867,2867,8755b020-d439-4ba2-a60b-6c57a15ece55,correct and consistent use of methods can result in lower failure rates,0
2292,2292,2292,2292,2292,2292,2292,2868,2868,2868,2868,2868,2868,2868,2868,2868,2868,2868,2868,2868,8755b020-d439-4ba2-a60b-6c57a15ece55,table i percentage of women experiencing an unintended pregnancy during the first year of a contraceptive method method perfect use average use na not available adapted from hatcher ra et al  contraceptive technology 17th revised edition,0
2293,2293,2293,2293,2293,2293,2293,2869,2869,2869,2869,2869,2869,2869,2869,2869,2869,2869,2869,2869,8755b020-d439-4ba2-a60b-6c57a15ece55,ny  ny ardent medi  inc  1998 levonorgestrel implants 0 05 0 05 male sterilization 0 10 0 15 female sterilization 0 50 0 50 depo provera ( injectable progestogen ) 0 30 0 30 oral contraceptives 5 combined 0 10 na progestin only 0 50 na iud progesterone 1 50 2 00 copper t 380a 0 60 0 80 condom ( male ) without spermicide 3 14 ( female ) without spermicide 5 21,0
2294,2294,2294,2294,2294,2294,2294,2870,2870,2870,2870,2870,2870,2870,2870,2870,2870,2870,2870,2870,c5fdde91-1989-4dd2-9129-4f3323ea2962, tysabri is an integrin receptor antagonist indicated for treatment of multiple sclerosis ( ms ) tysabri is indicated as monotherapy for the treatment of patients with relapsing forms of multiple sclerosis,1
2295,2295,2295,2295,2295,2295,2295,2871,2871,2871,2871,2871,2871,2871,2871,2871,2871,2871,2871,2871,c5fdde91-1989-4dd2-9129-4f3323ea2962,tysabri increases the risk of pml,0
2296,2296,2296,2296,2296,2296,2296,2872,2872,2872,2872,2872,2872,2872,2872,2872,2872,2872,2872,2872,c5fdde91-1989-4dd2-9129-4f3323ea2962,when initiating and continuing treatment with tysabri  physicians should consider whether the expected benefit of tysabri is sufficient to offset this risk,0
2297,2297,2297,2297,2297,2297,2297,2873,2873,2873,2873,2873,2873,2873,2873,2873,2873,2873,2873,2873,c5fdde91-1989-4dd2-9129-4f3323ea2962,see important information regarding the risk of pml with tysabri,0
2298,2298,2298,2298,2298,2298,2298,2874,2874,2874,2874,2874,2874,2874,2874,2874,2874,2874,2874,2874,c5fdde91-1989-4dd2-9129-4f3323ea2962,( 1 1  5 1 ) crohn 's disease ( cd ) tysabri is indicated for inducing and maintaining clinical response and remission in adult patients with moderately to severely active crohn 's disease with evidence of inflammation who have had an inadequate response to  or are unable to tolerate  conventional cd therapies and inhibitors of tnf,1
2299,2299,2299,2299,2299,2299,2299,2875,2875,2875,2875,2875,2875,2875,2875,2875,2875,2875,2875,2875,c5fdde91-1989-4dd2-9129-4f3323ea2962,( 1 2 ) important limitations in cd  tysabri should not be used in combination with immunosuppressants or inhibitors of tnf,2
2300,2300,2300,2300,2300,2300,2300,2876,2876,2876,2876,2876,2876,2876,2876,2876,2876,2876,2876,2876,c5fdde91-1989-4dd2-9129-4f3323ea2962,multiple sclerosis ( ms ) tysabri is indicated as monotherapy for the treatment of patients with relapsing forms of multiple sclerosis,1
2301,2301,2301,2301,2301,2301,2301,2879,2879,2879,2879,2879,2879,2879,2879,2879,2879,2879,2879,2879,c5fdde91-1989-4dd2-9129-4f3323ea2962,see important information regarding the risk of pml with tysabri see warnings and precautions ( 5 1 ),3
2302,2302,2302,2302,2302,2302,2302,2880,2880,2880,2880,2880,2880,2880,2880,2880,2880,2880,2880,2880,c5fdde91-1989-4dd2-9129-4f3323ea2962,crohn 's disease ( cd ) tysabri is indicated for inducing and maintaining clinical response and remission in adult patients with moderately to severely active crohn 's disease with evidence of inflammation who have had an inadequate response to  or are unable to tolerate  conventional cd therapies and inhibitors of tnf,1
2303,2303,2303,2303,2303,2303,2303,2881,2881,2881,2881,2881,2881,2881,2881,2881,2881,2881,2881,2881,c5fdde91-1989-4dd2-9129-4f3323ea2962,tysabri should not be used in combination with immunosuppressants ( e g  6 mercaptopurine  azathioprine  cyclosporine  or methotrexate ) or inhibitors of tnf see warnings and precautions ( 5 1 ),2
2304,2304,2304,2304,2304,2304,2304,2882,2882,2882,2882,2882,2882,2882,2882,2882,2882,2882,2882,2882,e094cb1d-80fe-4277-b8f4-9817918f8c76, tc99m bicisate is indicated as an adjunct to conventional ct or mri imaging in the localization of stroke in patients in whom stroke has already been diagnosed,1
2305,2305,2305,2305,2305,2305,2305,2883,2883,2883,2883,2883,2883,2883,2883,2883,2883,2883,2883,2883,496fa924-cdf7-4158-bc3b-38aaf675a170, dehydrated alcohol injection is indicated for therapeutic neurolysis of nerves or ganglia for the relief of intractable chronic pain in such conditions as inoperable cancer and trigeminal neuralgia ( ticdouloureux )  in patients for whom neurosurgical procedures are contraindicated,1
2306,2306,2306,2306,2306,2306,2306,2884,2884,2884,2884,2884,2884,2884,2884,2884,2884,2884,2884,2884,496fa924-cdf7-4158-bc3b-38aaf675a170,relief of trigeminal neuralgia usually is only temporary,0
2307,2307,2307,2307,2307,2307,2307,2885,2885,2885,2885,2885,2885,2885,2885,2885,2885,2885,2885,2885,496fa924-cdf7-4158-bc3b-38aaf675a170,other conditions for which injection of alcohol has been reported include glossopharyngeal neuralgia  angina pectoris and severe claudication due to peripheral vascular insufficiency,1
2308,2308,2308,2308,2308,2308,2308,2886,2886,2886,2886,2886,2886,2886,2886,2886,2886,2886,2886,2886,496fa924-cdf7-4158-bc3b-38aaf675a170,alcohol concentrations of 40 to 50 ( prepared by appropriate dilution of dehydrated alcohol ) have been used for epidural or individual motor nerve injections to control certain manifestations of cerebral palsy and spastic paraplegia,1
2309,2309,2309,2309,2309,2309,2309,2887,2887,2887,2887,2887,2887,2887,2887,2887,2887,2887,2887,2887,496fa924-cdf7-4158-bc3b-38aaf675a170,similar concentrations also have been injected for celiac plexus block to relieve pain of inoperable upper abdominal cancer  and have been injected intra and subcutaneously for relief of intractable pruritus ani,1
2310,2310,2310,2310,2310,2310,2310,2888,2888,2888,2888,2888,2888,2888,2888,2888,2888,2888,2888,2888,66b69c1e-b25c-44d3-b5ff-1c1de9a516fa,1  gattex ( teduglutide rdna origin ) for injection is indicated for the treatment of adult patients with short bowel syndrome ( sbs ) who are dependent on parenteral support see clinical pharmacology ( 12 2 ),1
2311,2311,2311,2311,2311,2311,2311,2889,2889,2889,2889,2889,2889,2889,2889,2889,2889,2889,2889,2889,66b69c1e-b25c-44d3-b5ff-1c1de9a516fa,gattex ( teduglutide rdna origin ) for injection is a glucagon like peptide 2 ( glp 2 ) analog indicated for the treatment of adult patients with short bowel syndrome ( sbs ) who are dependent on parenteral support,1
2312,2312,2312,2312,2312,2312,2312,2890,2890,2890,2890,2890,2890,2890,2890,2890,2890,2890,2890,2890,447e7ff3-f8f5-4939-bb1f-77951f1dd7b7,1  rabeprazole sodium delayed release tablets is a proton pump inhibitor ( ppi ) indicated in adults for healing of erosive or ulcerative gastroesophageal reflux disease ( gerd ) ( 1 1 ),1
2313,2313,2313,2313,2313,2313,2313,2891,2891,2891,2891,2891,2891,2891,2891,2891,2891,2891,2891,2891,447e7ff3-f8f5-4939-bb1f-77951f1dd7b7,maintenance of healing of erosive or ulcerative gerd ( 1 2 ),1
2314,2314,2314,2314,2314,2314,2314,2892,2892,2892,2892,2892,2892,2892,2892,2892,2892,2892,2892,2892,447e7ff3-f8f5-4939-bb1f-77951f1dd7b7,treatment of symptomatic gerd ( 1 3 ),1
2315,2315,2315,2315,2315,2315,2315,2893,2893,2893,2893,2893,2893,2893,2893,2893,2893,2893,2893,2893,447e7ff3-f8f5-4939-bb1f-77951f1dd7b7,healing of duodenal ulcers ( 1 4 ),1
2316,2316,2316,2316,2316,2316,2316,2894,2894,2894,2894,2894,2894,2894,2894,2894,2894,2894,2894,2894,447e7ff3-f8f5-4939-bb1f-77951f1dd7b7,helicobacter pylori eradication to reduce risk of duodenal ulcer recurrence ( 1 5 ),1
2317,2317,2317,2317,2317,2317,2317,2895,2895,2895,2895,2895,2895,2895,2895,2895,2895,2895,2895,2895,447e7ff3-f8f5-4939-bb1f-77951f1dd7b7,treatment of pathological hypersecretory conditions  including zollinger ellison syndrome ( 1 6 ),1
2318,2318,2318,2318,2318,2318,2318,2896,2896,2896,2896,2896,2896,2896,2896,2896,2896,2896,2896,2896,447e7ff3-f8f5-4939-bb1f-77951f1dd7b7,in adolescent patients 12 years of age and older for short term treatment of symptomatic gerd ( 1 7 ),1
2319,2319,2319,2319,2319,2319,2319,2897,2897,2897,2897,2897,2897,2897,2897,2897,2897,2897,2897,2897,447e7ff3-f8f5-4939-bb1f-77951f1dd7b7,1 1 healing of erosive or ulcerative gerd in adults rabeprazole sodium delayed release tablets are indicated for short term ( 4 to 8 weeks ) treatment in the healing and symptomatic relief of erosive or ulcerative gastroesophageal reflux disease ( gerd ),1
2320,2320,2320,2320,2320,2320,2320,2898,2898,2898,2898,2898,2898,2898,2898,2898,2898,2898,2898,2898,447e7ff3-f8f5-4939-bb1f-77951f1dd7b7,for those patients who have not healed after 8 weeks of treatment  an additional 8 week course of rabeprazole sodiummay be considered,0
2321,2321,2321,2321,2321,2321,2321,2899,2899,2899,2899,2899,2899,2899,2899,2899,2899,2899,2899,2899,447e7ff3-f8f5-4939-bb1f-77951f1dd7b7,1 2 maintenance of healing of erosive or ulcerative gerd in adults rabeprazole sodium delayed release tablets are indicated for maintaining healing and reduction in relapse rates of heartburn symptoms in patients with erosive or ulcerative gastroesophageal reflux disease ( gerd maintenance ),1
2322,2322,2322,2322,2322,2322,2322,2900,2900,2900,2900,2900,2900,2900,2900,2900,2900,2900,2900,2900,447e7ff3-f8f5-4939-bb1f-77951f1dd7b7,controlled studies do not extend beyond 12 months,0
2323,2323,2323,2323,2323,2323,2323,2901,2901,2901,2901,2901,2901,2901,2901,2901,2901,2901,2901,2901,447e7ff3-f8f5-4939-bb1f-77951f1dd7b7,1 3 treatment of symptomatic gerd in adults paragrap,u
2324,2324,2324,2324,2324,2324,2324,2902,2902,2902,2902,2902,2902,2902,2902,2902,2902,2902,2902,2902,a636d3c7-af25-4148-8b4e-6f44deba700b,1  sildenafil tablets are indicated for the treatment of pulmonary arterial hypertension ( who group i ) in adults to improve exercise ability and delay clinical worsening,1
2325,2325,2325,2325,2325,2325,2325,2903,2903,2903,2903,2903,2903,2903,2903,2903,2903,2903,2903,2903,a636d3c7-af25-4148-8b4e-6f44deba700b,the delay in clinical worsening was demonstrated when sildenafil tablets were added to background epoprostenol therapy see clinical studies ( 14 ),u
2326,2326,2326,2326,2326,2326,2326,2904,2904,2904,2904,2904,2904,2904,2904,2904,2904,2904,2904,2904,a636d3c7-af25-4148-8b4e-6f44deba700b,studies establishing effectiveness were short term ( 12 to 16 weeks )  and included predominately patients with new york heart association ( nyha ) functional class ii iii symptoms and idiopathic etiology ( 71 ) or associated with connective tissue disease ( ctd ) ( 25 ),u
2327,2327,2327,2327,2327,2327,2327,2905,2905,2905,2905,2905,2905,2905,2905,2905,2905,2905,2905,2905,a636d3c7-af25-4148-8b4e-6f44deba700b,limitation of use the efficacy of sildenafil tablets in the treatment of pulmonary arterial hypertension ( pah ) has not been adequately evaluated in patients taking bosentan,2
2328,2328,2328,2328,2328,2328,2328,2906,2906,2906,2906,2906,2906,2906,2906,2906,2906,2906,2906,2906,a636d3c7-af25-4148-8b4e-6f44deba700b,sildenafil tablets are a phosphodiesterase 5 ( pde 5 ) inhibitor indicated for the treatment of pulmonary arterial hypertension ( pah ) ( who group i ) in adults to improve exercise ability and delay clinical worsening,1
2329,2329,2329,2329,2329,2329,2329,2907,2907,2907,2907,2907,2907,2907,2907,2907,2907,2907,2907,2907,a636d3c7-af25-4148-8b4e-6f44deba700b,studies establishing effectiveness were short term ( 12 to 16 weeks )  and included predominately patients with nyha functional class ii iii symptoms,0
2330,2330,2330,2330,2330,2330,2330,2908,2908,2908,2908,2908,2908,2908,2908,2908,2908,2908,2908,2908,a636d3c7-af25-4148-8b4e-6f44deba700b,etiologies were idiopathic ( 71 ) or associated with connective tissue disease ( 25 ),0
2331,2331,2331,2331,2331,2331,2331,2909,2909,2909,2909,2909,2909,2909,2909,2909,2909,2909,2909,2909,a636d3c7-af25-4148-8b4e-6f44deba700b,( 1 ) limitation of use the efficacy of sildenafil tablets has not been adequately evaluated in patients taking bosentan concurrently,2
2332,2332,2332,2332,2332,2332,2332,2912,2912,2912,2912,2912,2912,2912,2912,2912,2912,2912,2912,2912,b4a580e1-5eef-4400-b4de-0a478d668df3,pravastatin sodium tablets are an hmg coa reductase inhibitor ( statin ) indicated as an adjunctive therapy to diet to reduce the risk of mi  revascularization  and cardiovascular mortality in hypercholesterolemic patients without clinically evident chd,1
2333,2333,2333,2333,2333,2333,2333,2913,2913,2913,2913,2913,2913,2913,2913,2913,2913,2913,2913,2913,b4a580e1-5eef-4400-b4de-0a478d668df3,( 1 1 ) reduce elevated total c  ldl c  apob  and tg levels and to increase hdl c in patients with primary hypercholesterolemia and mixed dyslipidemia,u
2334,2334,2334,2334,2334,2334,2334,2914,2914,2914,2914,2914,2914,2914,2914,2914,2914,2914,2914,2914,b4a580e1-5eef-4400-b4de-0a478d668df3,( 1 2 ) reduce elevated serum tg levels in patients with hypertriglyceridemia,u
2335,2335,2335,2335,2335,2335,2335,2915,2915,2915,2915,2915,2915,2915,2915,2915,2915,2915,2915,2915,b4a580e1-5eef-4400-b4de-0a478d668df3,( 1 2 ) treat patients with primary dysbetalipoproteinemia who are not responding to diet,1
2336,2336,2336,2336,2336,2336,2336,2916,2916,2916,2916,2916,2916,2916,2916,2916,2916,2916,2916,2916,b4a580e1-5eef-4400-b4de-0a478d668df3,( 1 2 ) treat children and adolescent patients ages 8 years and older with heterozygous familial hypercholesterolemia after failing an adequate trial of diet therapy,1
2337,2337,2337,2337,2337,2337,2337,2917,2917,2917,2917,2917,2917,2917,2917,2917,2917,2917,2917,2917,b4a580e1-5eef-4400-b4de-0a478d668df3,( 1 2 ) limitations of use pravastatin sodium tablets have not been studied in fredrickson types i and v dyslipidemias,0
2338,2338,2338,2338,2338,2338,2338,2918,2918,2918,2918,2918,2918,2918,2918,2918,2918,2918,2918,2918,b4a580e1-5eef-4400-b4de-0a478d668df3,( 1 3 ) 1 1 prevention of cardiovascular disease in hypercholesterolemic patients without clinically evident coronary heart disease ( chd )  pravastatin sodium tablets are indicated to reduce the risk of myocardial infarction ( mi ),1
2339,2339,2339,2339,2339,2339,2339,2919,2919,2919,2919,2919,2919,2919,2919,2919,2919,2919,2919,2919,b4a580e1-5eef-4400-b4de-0a478d668df3,reduce the risk of undergoing myocardial revascularization procedures,u
2340,2340,2340,2340,2340,2340,2340,2920,2920,2920,2920,2920,2920,2920,2920,2920,2920,2920,2920,2920,b4a580e1-5eef-4400-b4de-0a478d668df3,reduce the risk of cardiovascular mortality with no increase in death from non cardiovascular causes,u
2341,2341,2341,2341,2341,2341,2341,2921,2921,2921,2921,2921,2921,2921,2921,2921,2921,2921,2921,2921,b4a580e1-5eef-4400-b4de-0a478d668df3,1 2 hyperlipidemia pravastatin sodium tablets are indicated as an adjunct to diet to reduce elevated total cholesterol ( total c )  low density lipoprotein cholesterol ( ldl c )  apolipoprotein b ( apob ),1
2342,2342,2342,2342,2342,2342,2342,2922,2922,2922,2922,2922,2922,2922,2922,2922,2922,2922,2922,2922,ef7804d7-c691-495b-8aaf-5bc54fd5d9f6,1  datscan is a radiopharmaceutical indicated for striatal dopamine transporter visualization using single photon emission computed tomography ( spect ) brain imaging to assist in the evaluation of adult patients with suspected parkinsonian syndromes ( ps ),1
2343,2343,2343,2343,2343,2343,2343,2923,2923,2923,2923,2923,2923,2923,2923,2923,2923,2923,2923,2923,ef7804d7-c691-495b-8aaf-5bc54fd5d9f6,in these patients  datscan may be used to help differentiate essential tremor from tremor due to ps ( idiopathic parkinson 's disease  multiple system atrophy and progressive supranuclear palsy ),u
2344,2344,2344,2344,2344,2344,2344,2924,2924,2924,2924,2924,2924,2924,2924,2924,2924,2924,2924,2924,ef7804d7-c691-495b-8aaf-5bc54fd5d9f6,datscan is an adjunct to other diagnostic evaluations,u
2345,2345,2345,2345,2345,2345,2345,2925,2925,2925,2925,2925,2925,2925,2925,2925,2925,2925,2925,2925,ef7804d7-c691-495b-8aaf-5bc54fd5d9f6,datscan ( ioflupane i 123 injection ) is a radiopharmaceutical indicated for striatal dopamine transporter visualization using single photon emission computed tomography ( spect ) brain imaging to assist in the evaluation of adult patients with suspected parkinsonian syndromes ( ps ),1
2346,2346,2346,2346,2346,2346,2346,2928,2928,2928,2928,2928,2928,2928,2928,2928,2928,2928,2928,2928,9d688237-1727-46ca-ba3c-efd830b12421,1 indications usage donepezil hydrochloride tablets are indicated for the treatment of dementia of the alzheimer 's type,1
2347,2347,2347,2347,2347,2347,2347,2929,2929,2929,2929,2929,2929,2929,2929,2929,2929,2929,2929,2929,9d688237-1727-46ca-ba3c-efd830b12421,efficacy has been demonstrated in patients with mild  moderate  and severe alzheimer 's disease,0
2348,2348,2348,2348,2348,2348,2348,2930,2930,2930,2930,2930,2930,2930,2930,2930,2930,2930,2930,2930,9d688237-1727-46ca-ba3c-efd830b12421,donepezil hydrochloride is an acetylcholinesterase inhibitor indicated for the treatment of dementia of the alzheimer 's type,1
2349,2349,2349,2349,2349,2349,2349,2931,2931,2931,2931,2931,2931,2931,2931,2931,2931,2931,2931,2931,9d688237-1727-46ca-ba3c-efd830b12421,efficacy has been demonstrated in patients with mild  moderate  and severe alzheimer 's disease ( 1 ),0
2350,2350,2350,2350,2350,2350,2350,2932,2932,2932,2932,2932,2932,2932,2932,2932,2932,2932,2932,2932,2335950c-be3b-4248-ad04-e9763aee47d2,1  memantine and donepezil hydrochlorides extended release capsules are indicated for the treatment of moderate to severe dementia of the alzheimer s type in patients stabilized on 10 mg of donepezil hydrochloride once daily,1
2351,2351,2351,2351,2351,2351,2351,2933,2933,2933,2933,2933,2933,2933,2933,2933,2933,2933,2933,2933,2335950c-be3b-4248-ad04-e9763aee47d2,memantine and donepezil hydrochloridesextended release capsules are a combination of memantine hydrochloride  an nmda receptor antagonist  and donepezil hydrochloride  an acetylcholinesterase inhibitor  indicated for the treatment of moderate to severe dementia of the alzheimer s type in patients stabilized on 10 mg of donepezil hydrochloride once daily,1
2352,2352,2352,2352,2352,2352,2352,2934,2934,2934,2934,2934,2934,2934,2934,2934,2934,2934,2934,2934,8ad3145e-00e7-4412-b9a5-06f00f264f30, mannitol intravenous ( mannitol injection  usp ) is indicated for the following purposes in adults and pediatric patients,1
2353,2353,2353,2353,2353,2353,2353,2935,2935,2935,2935,2935,2935,2935,2935,2935,2935,2935,2935,2935,8ad3145e-00e7-4412-b9a5-06f00f264f30,therapeutic use promotion of diuresis in the prevention or treatment of the oliguric phase of acute renal failure before irreversible renal failure becomes established,1
2354,2354,2354,2354,2354,2354,2354,2936,2936,2936,2936,2936,2936,2936,2936,2936,2936,2936,2936,2936,8ad3145e-00e7-4412-b9a5-06f00f264f30,reduction of intracranial pressure and brain mass,u
2355,2355,2355,2355,2355,2355,2355,2937,2937,2937,2937,2937,2937,2937,2937,2937,2937,2937,2937,2937,8ad3145e-00e7-4412-b9a5-06f00f264f30,reduction of high intraocular pressure when the pressure cannot be lowered by other means,u
2356,2356,2356,2356,2356,2356,2356,2938,2938,2938,2938,2938,2938,2938,2938,2938,2938,2938,2938,2938,8ad3145e-00e7-4412-b9a5-06f00f264f30,promotion of urinary excretion of toxic materials,0
2357,2357,2357,2357,2357,2357,2357,2939,2939,2939,2939,2939,2939,2939,2939,2939,2939,2939,2939,2939,8ad3145e-00e7-4412-b9a5-06f00f264f30,diagnostic use measurement of glomerular filtration rate,1
2358,2358,2358,2358,2358,2358,2358,2940,2940,2940,2940,2940,2940,2940,2940,2940,2940,2940,2940,2940,672d4453-9dd5-4577-a38f-c15b7f33e9fb, sorbitol mannitol irrigation is indicated for use as a urologic irrigating fluid during transurethral prostatic resection and other transurethral surgical procedures,1
2359,2359,2359,2359,2359,2359,2359,2941,2941,2941,2941,2941,2941,2941,2941,2941,2941,2941,2941,2941,"Active Ingredient UNII(s)
3POA0Q644U; L7T10EIP3A; S07O44R1ZM    1a4e1221-85ee-3579-e054-00144ff88e88
3POA0Q644U; L7T10EIP3A; S07O44R1ZM    1a4e1221-85ee-3579-e054-00144ff88e88
Name: SET ID dtype: object",active ingredient unii ( s ) 3poa0q644u l7t10eip3a s07o44r1zm active ingredient unii ( s ) 3poa0q644u l7t10eip 3poa0q644u l7t10eip3a s07o44r1zm active ingredient unii ( s ) 3poa0q644u l7t10eip name content xml  dtype object,0
2360,2360,2360,2360,2360,2360,2360,2943,2943,2943,2943,2943,2943,2943,2943,2943,2943,2943,2943,2943,f63abe56-46d9-4e32-afb1-f4e22370717d,1  magnetic resonance imaging ( mri ) of the central nervous system ( cns ) in adults and pediatric patients ( including term neonates )  to visualize lesions with abnormal blood brain barrier or abnormal vascularity of the brain  spine  and associated tissues ( 1 1 ) magnetic resonance angiography ( mra ) to evaluate adults with known or suspected renal or aorto ilio femoral occlusive vascular disease,1
2361,2361,2361,2361,2361,2361,2361,2944,2944,2944,2944,2944,2944,2944,2944,2944,2944,2944,2944,2944,f63abe56-46d9-4e32-afb1-f4e22370717d,( 1 2 ) 1 1 mri of the central nervous system ( cns ) multihance is indicated for intravenous use in magnetic resonance imaging ( mri ) of the central nervous system ( cns ) in adults and pediatric patients ( including term neonates )  to visualize lesions with abnormal blood brain barrier or abnormal vascularity of the brain  spine  and associated tissues,1
2362,2362,2362,2362,2362,2362,2362,2945,2945,2945,2945,2945,2945,2945,2945,2945,2945,2945,2945,2945,f63abe56-46d9-4e32-afb1-f4e22370717d,1 2 mra of renal and aorto ilio femoral vessels multihance is indicated for use in magnetic resonance angiography ( mra ) to evaluate adults with known or suspected renal or aorto ilio femoral occlusive vascular disease,1
2363,2363,2363,2363,2363,2363,2363,2946,2946,2946,2946,2946,2946,2946,2946,2946,2946,2946,2946,2946,dd55392c-80a9-47d4-9079-408e30065aa1,used as a styptic in its undiluted form,u
2364,2364,2364,2364,2364,2364,2364,2947,2947,2947,2947,2947,2947,2947,2947,2947,2947,2947,2947,2947,d3e5fbbf-4a1f-4aa2-8e80-9729f6cf04ee, innohep is indicated for the treatment of acute symptomatic deep vein thrombosis with or without pulmonary embolism when administered in conjunction with warfarin sodium,1
2365,2365,2365,2365,2365,2365,2365,2948,2948,2948,2948,2948,2948,2948,2948,2948,2948,2948,2948,2948,d3e5fbbf-4a1f-4aa2-8e80-9729f6cf04ee,the safety and effectiveness of innohep were established in hospitalized patients,0
2366,2366,2366,2366,2366,2366,2366,2949,2949,2949,2949,2949,2949,2949,2949,2949,2949,2949,2949,2949,65450ac0-7ced-7be4-e053-2991aa0a8c10,1  cystadane ( betaine anhydrous for oral solution ) is indicated for the treatment of homocystinuria to decrease elevated homocysteine blood levels,1
2367,2367,2367,2367,2367,2367,2367,2950,2950,2950,2950,2950,2950,2950,2950,2950,2950,2950,2950,2950,65450ac0-7ced-7be4-e053-2991aa0a8c10,included within the category of homocystinuria are cystathionine beta synthase ( cbs ) deficiency 5  10 methylenetetrahydrofolate reductase ( mthfr ) deficiency cobalamin cofactor metabolism ( cbl ) defect cystadane is a methylating agent indicated for the treatment of homocystinuria to decrease elevated homocysteine blood levels,1
2368,2368,2368,2368,2368,2368,2368,2951,2951,2951,2951,2951,2951,2951,2951,2951,2951,2951,2951,2951,65450ac0-7ced-7be4-e053-2991aa0a8c10,included within the category of homocystinuria are ( 1 ) cystathionine beta synthase ( cbs ) deficiency 5  10 methylenetetrahydrofolate reductase ( mthfr ) deficiency cobalamin cofactor metabolism ( cbl ) defect,0
2369,2369,2369,2369,2369,2369,2369,2952,2952,2952,2952,2952,2952,2952,2952,2952,2952,2952,2952,2952,040dacaf-4ccf-425a-9b40-586176b7631d, for diagnostic use only,0
2370,2370,2370,2370,2370,2370,2370,2953,2953,2953,2953,2953,2953,2953,2953,2953,2953,2953,2953,2953,040dacaf-4ccf-425a-9b40-586176b7631d,this product has not been shown by adequate data to be safe and effective for therapeutic use according to federal register notice dated november 16  1994  vol,0
2371,2371,2371,2371,2371,2371,2371,2954,2954,2954,2954,2954,2954,2954,2954,2954,2954,2954,2954,2954,040dacaf-4ccf-425a-9b40-586176b7631d,the following allergenic extracts are for diagnostic use only coffee ( coffea arabic )  cottonseed ( gossypium spp,0
2372,2372,2372,2372,2372,2372,2372,2955,2955,2955,2955,2955,2955,2955,2955,2955,2955,2955,2955,2955,040dacaf-4ccf-425a-9b40-586176b7631d,)  flaxseed ( linum usitatissimum )  leafhopper ( cicadellidae )  miller moth ( night flying lepidoptera )  cricket ( gryllidae ) and moth ( frenatae ),0
2373,2373,2373,2373,2373,2373,2373,2956,2956,2956,2956,2956,2956,2956,2956,2956,2956,2956,2956,2956,040dacaf-4ccf-425a-9b40-586176b7631d,these extracts are intended for diagnostic testing of patients whose histories indicate that upon natural exposure to the allergen  they experience allergic symptoms,0
2374,2374,2374,2374,2374,2374,2374,2958,2958,2958,2958,2958,2958,2958,2958,2958,2958,2958,2958,2958,3ac8133e-e5ac-42f1-9ce6-80eee07b83bb,indications indicated for the relief of symptoms associated with post extraction alveolar osteitis ( dry socket syndrome ),1
2375,2375,2375,2375,2375,2375,2375,2959,2959,2959,2959,2959,2959,2959,2959,2959,2959,2959,2959,2959,25f2815d-978c-4043-88bd-fa5e556f8bc7, tussionex pennkinetic extended release suspension is indicated for relief of cough and upper respiratory symptoms associated with allergy or a cold in adults and children 6 years of age and older,1
2376,2376,2376,2376,2376,2376,2376,2960,2960,2960,2960,2960,2960,2960,2960,2960,2960,2960,2960,2960,dfe327e8-f6ab-41e5-bdef-d520118cd83a,1  tradjenta is a dipeptidyl peptidase 4 ( dpp 4 ) inhibitor indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus ( 1 1 ) important limitations of use should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis ( 1 2 ) has not been studied in patients with a history of pancreatitis ( 1 2 ) 1 1 monotherapy and combination therapy tradjenta is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus see clinical studies ( 14 1 ),1
2377,2377,2377,2377,2377,2377,2377,2961,2961,2961,2961,2961,2961,2961,2961,2961,2961,2961,2961,2961,dfe327e8-f6ab-41e5-bdef-d520118cd83a,1 2 important limitations of use tradjenta should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis  as it would not be effective in these settings,2
2378,2378,2378,2378,2378,2378,2378,2962,2962,2962,2962,2962,2962,2962,2962,2962,2962,2962,2962,2962,dfe327e8-f6ab-41e5-bdef-d520118cd83a,tradjenta has not been studied in patients with a history of pancreatitis,0
2379,2379,2379,2379,2379,2379,2379,2963,2963,2963,2963,2963,2963,2963,2963,2963,2963,2963,2963,2963,dfe327e8-f6ab-41e5-bdef-d520118cd83a,it is unknown whether patients with a history of pancreatitis are at an increased risk for the development of pancreatitis while using tradjenta see warnings and precautions ( 5 1 ),0
2380,2380,2380,2380,2380,2380,2380,2964,2964,2964,2964,2964,2964,2964,2964,2964,2964,2964,2964,2964,9822b5fa-6024-445a-a36d-a26106c69845,1  jentadueto is a dipeptidyl peptidase 4 ( dpp 4 ) inhibitor and biguanide combination product indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both linagliptin and metformin is appropriate ( 1 1 ) important limitations of use not for treatment of type 1 diabetes or diabetic ketoacidosis ( 1 2 ) has not been studied in patients with a history of pancreatitis ( 1 2 ) 1 1 indication jentadueto tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both linagliptin and metformin is appropriate see dosage and administration ( 2 1 ) and clinical studies ( 14 1 ),1
2381,2381,2381,2381,2381,2381,2381,2965,2965,2965,2965,2965,2965,2965,2965,2965,2965,2965,2965,2965,9822b5fa-6024-445a-a36d-a26106c69845,1 2 important limitations of use jentadueto should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis  as it would not be effective in these settings,2
2382,2382,2382,2382,2382,2382,2382,2966,2966,2966,2966,2966,2966,2966,2966,2966,2966,2966,2966,2966,9822b5fa-6024-445a-a36d-a26106c69845,jentadueto has not been studied in patients with a history of pancreatitis,0
2383,2383,2383,2383,2383,2383,2383,2967,2967,2967,2967,2967,2967,2967,2967,2967,2967,2967,2967,2967,9822b5fa-6024-445a-a36d-a26106c69845,it is unknown whether patients with a history of pancreatitis are at an increased risk for the development of pancreatitis while using jentadueto see warnings and precautions ( 5 2 ),0
2384,2384,2384,2384,2384,2384,2384,2968,2968,2968,2968,2968,2968,2968,2968,2968,2968,2968,2968,2968,1206103f-52e5-44dd-a29e-8ec2ebd826d4,1  geodon intramuscular is indicated for acute agitation in schizophrenic patients,1
2385,2385,2385,2385,2385,2385,2385,2972,2972,2972,2972,2972,2972,2972,2972,2972,2972,2972,2972,2972,1206103f-52e5-44dd-a29e-8ec2ebd826d4,whether ziprasidone will cause torsade de pointes or increase the rate of sudden death is not yet known see warnings and precautions ( 5 2 ),0
2386,2386,2386,2386,2386,2386,2386,2973,2973,2973,2973,2973,2973,2973,2973,2973,2973,2973,2973,2973,1206103f-52e5-44dd-a29e-8ec2ebd826d4,geodon is an atypical antipsychotic,0
2387,2387,2387,2387,2387,2387,2387,2974,2974,2974,2974,2974,2974,2974,2974,2974,2974,2974,2974,2974,1206103f-52e5-44dd-a29e-8ec2ebd826d4,in choosing among treatments  prescribers should be aware of the capacity of geodon to prolong the qt interval and may consider the use of other drugs first ( 5 2 ) geodon as an intramuscular injection is indicated for the acute treatment of agitation in schizophrenic patients,1
2388,2388,2388,2388,2388,2388,2388,2975,2975,2975,2975,2975,2975,2975,2975,2975,2975,2975,2975,2975,1206103f-52e5-44dd-a29e-8ec2ebd826d4,( 1 1 ) adults efficacy was established in two short term trials in agitated patients with schizophrenia,0
2389,2389,2389,2389,2389,2389,2389,2976,2976,2976,2976,2976,2976,2976,2976,2976,2976,2976,2976,2976,1206103f-52e5-44dd-a29e-8ec2ebd826d4,( 1 1 ) 1 1 acute treatment of agitation in schizophrenia geodon intramuscular is indicated for the treatment of acute agitation in schizophrenic patients for whom treatment with ziprasidone is appropriate and who need intramuscular antipsychotic medication for rapid control of agitation,1
2390,2390,2390,2390,2390,2390,2390,2977,2977,2977,2977,2977,2977,2977,2977,2977,2977,2977,2977,2977,1206103f-52e5-44dd-a29e-8ec2ebd826d4,the efficacy of intramuscular ziprasidone for acute agitation in schizophrenia was established in single day controlled trials of agitated schizophrenic inpatients see clinical trials ( 14 1 ),0
2391,2391,2391,2391,2391,2391,2391,2978,2978,2978,2978,2978,2978,2978,2978,2978,2978,2978,2978,2978,1206103f-52e5-44dd-a29e-8ec2ebd826d4,psychomotor agitation is defined in dsm iv as excessive motor activity associated with a feeling of inner tension,0
2392,2392,2392,2392,2392,2392,2392,2979,2979,2979,2979,2979,2979,2979,2979,2979,2979,2979,2979,2979,1206103f-52e5-44dd-a29e-8ec2ebd826d4,schizophrenic patients experiencing agitation often manifest behaviors that interfere with their diagnosis and care  e g  threatening behaviors  escalating or urgently distressing behavior  or self exhausting behavior  leading clinicians to the use of intramuscular antipsychotic medications to achieve immediate control of the agitation,0
2393,2393,2393,2393,2393,2393,2393,2980,2980,2980,2980,2980,2980,2980,2980,2980,2980,2980,2980,2980,1206103f-52e5-44dd-a29e-8ec2ebd826d4,since there is no experience regarding the safety of administering ziprasidone intramuscular to schizophrenic patients already taking oral ziprasidone  the practice of co administration is not recommended,2
2394,2394,2394,2394,2394,2394,2394,2981,2981,2981,2981,2981,2981,2981,2981,2981,2981,2981,2981,2981,1206103f-52e5-44dd-a29e-8ec2ebd826d4,ziprasidone intramuscular is intended for intramuscular use only and should not be administered intravenously,2
2395,2395,2395,2395,2395,2395,2395,2982,2982,2982,2982,2982,2982,2982,2982,2982,2982,2982,2982,2982,7bff901e-0496-4818-813a-108b762b83a8, for steroid responsive inflammatory ocular conditions for which a corticosteroid is indicated and where bacterial infection or a risk of bacterial ocular infection exists,1
2396,2396,2396,2396,2396,2396,2396,2983,2983,2983,2983,2983,2983,2983,2983,2983,2983,2983,2983,2983,7bff901e-0496-4818-813a-108b762b83a8,ocular steroids are indicated in inflammatory conditions of the palpebral and bulbar conjunctiva  cornea  and anterior segment of the globe where the inherent risk of steroid use in certain infective conjunctivitides is accepted to obtain a diminution in edema and inflammation,1
2397,2397,2397,2397,2397,2397,2397,2984,2984,2984,2984,2984,2984,2984,2984,2984,2984,2984,2984,2984,7bff901e-0496-4818-813a-108b762b83a8,they are also indicated in chronic anterior uveitis and corneal injury from chemical radiation  thermal burns  or penetration of foreign bodies,1
2398,2398,2398,2398,2398,2398,2398,2986,2986,2986,2986,2986,2986,2986,2986,2986,2986,2986,2986,2986,7bff901e-0496-4818-813a-108b762b83a8,the particular anti infective drug in this product is active against the following common bacterial eye pathogens staphylococcus aureus streptococci  including streptococcus pneumoniae escherichia coli neisseria species the product does not provide adequate coverage against haemophilus influenzae klebsiella enterobacter species pseudomonas aeruginosa serratia marcescens,u
2399,2399,2399,2399,2399,2399,2399,2987,2987,2987,2987,2987,2987,2987,2987,2987,2987,2987,2987,2987,3d7278ee-2c8e-4df1-9372-d43403122945,indications based on a review of a related drug by the national research council and subsequent fda classification for that drug  the indications are as follows possibly effective contact or atopic dermatitis impetiginized eczema nummular eczema endogenous chronic infectious dermatitis stasis dermatitis pyoderma nuchal eczema and chronic eczematoid otitis externa acne urticata localized or disseminated neurodermatitis lichen simplex chronicus anogenital pruritus ( vulvae  scroti  ani ) folliculitis bacterial dermatoses mycotic dermatoses such as tinea ( capitis  cruris  corporis  pedis ) monliasis intertrigo,1
2400,2400,2400,2400,2400,2400,2400,2991,2991,2991,2991,2991,2991,2991,2991,2991,2991,2991,2991,2991,3f2abee4-2841-4725-8c11-aafb35ba6bee, based on a review of a related drug by the national research council and subsequent fda classification for that drug  the indications are as follows possibly effective contact or atopic dermatitis impetiginized eczema nummular eczema endogenous chronic infectious dermatitis stasis dermatitis pyoderma nuchal eczema and chronic eczematoid otitis externa acne urticata localized or disseminated neurodermatitis lichen simplex chronicus anogenital pruritus ( vulvae  scroti  ani ) folliculitis bacterial dermatoses mycotic dermatoses such as tinea ( capitis  cruris  corporis  pedis ) monliasis intertrigo,1
2401,2401,2401,2401,2401,2401,2401,2993,2993,2993,2993,2993,2993,2993,2993,2993,2993,2993,2993,2993,9e899b72-a16e-4b55-93b5-ab5baec37d50, topical corticosteroids are indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid responsive dermatoses,1
2402,2402,2402,2402,2402,2402,2402,2994,2994,2994,2994,2994,2994,2994,2994,2994,2994,2994,2994,2994,3a24be46-df26-477e-b909-04dd14d0a014,indications product is used for the anti inflammatory and anesthetic relief of itching  pain  soreness and discomfort due to hemorrhoids  anal fissures  pruritus ani and similar conditions of the anal area,1
2403,2403,2403,2403,2403,2403,2403,2995,2995,2995,2995,2995,2995,2995,2995,2995,2995,2995,2995,2995,e56882fa-4a30-43b1-bb6b-f7d4a4101c4e,indication cystografin dilute is indicated for retrograde cystourethrography,1
2404,2404,2404,2404,2404,2404,2404,2996,2996,2996,2996,2996,2996,2996,2996,2996,2996,2996,2996,2996,b348b1cf-6250-4ab6-b2bf-3bff86628c53, md gastroview ( diatrizoate meglumine and diatrizoate sodium solution ) is indicated for radiographic examination of segments of the gastrointestinal tract ( esophagus  stomach  proximal small intestine  and colon ),1
2405,2405,2405,2405,2405,2405,2405,2997,2997,2997,2997,2997,2997,2997,2997,2997,2997,2997,2997,2997,b348b1cf-6250-4ab6-b2bf-3bff86628c53,the preparation is particularly indicated when a more viscous agent such as barium sulfate  which is not water soluble  is not feasible or is potentially dangerous,u
2406,2406,2406,2406,2406,2406,2406,2998,2998,2998,2998,2998,2998,2998,2998,2998,2998,2998,2998,2998,b348b1cf-6250-4ab6-b2bf-3bff86628c53,md gastroview may also be used as an adjunct to contrast enhancement in computed tomography of the torso ( body imaging ) the preparation is indicated  in conjunction with intravenous admin istration of a radiopaque contrast agent  when unenhanced imaging may not provide sufficient definition in distinguishing normal loops of bowel from adjacent organs or areas of suspected pathology,1
2407,2407,2407,2407,2407,2407,2407,2999,2999,2999,2999,2999,2999,2999,2999,2999,2999,2999,2999,2999,32fd1726-ed81-4441-9594-3aecf2db1dbf, sulfasalazine tablets are indicated a ) in the treatment of mild to moderate ulcerative colitis  and as adjunctive therapy in severe ulcerative colitis and b ) for the prolongation of the remission period between acute attacks of ulcerative colitis,1
2408,2408,2408,2408,2408,2408,2408,3000,3000,3000,3000,3000,3000,3000,3000,3000,3000,3000,3000,3000,903fbd33-e5d9-41fb-9414-7bd6f42a8593, guanidine is indicated for the reduction of the symptoms of muscle weakness and easy fatigability associated with the myasthenic syndrome of eaton lambert,1
2409,2409,2409,2409,2409,2409,2409,3001,3001,3001,3001,3001,3001,3001,3001,3001,3001,3001,3001,3001,903fbd33-e5d9-41fb-9414-7bd6f42a8593,it is not indicated for treating myasthenia gravis,2
2410,2410,2410,2410,2410,2410,2410,3002,3002,3002,3002,3002,3002,3002,3002,3002,3002,3002,3002,3002,903fbd33-e5d9-41fb-9414-7bd6f42a8593,the eaton lambert syndrome is ordinarily differentiated from myasthenia gravis by the usual association of the syndrome with small cell carcinoma of the lung  but myography may be necessary to make the diagnosis,0
2411,2411,2411,2411,2411,2411,2411,3008,3008,3008,3008,3008,3008,3008,3008,3008,3008,3008,3008,3008,2dbd0671-c565-40c5-bf0f-e324db26799c,1  anoro ellipta is a combination anticholinergic long acting beta2 adrenergic agonist ( anticholinergic laba ) indicated for the long term  once daily  maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease ( copd )  including chronic bronchitis and or emphysema,1
2412,2412,2412,2412,2412,2412,2412,3009,3009,3009,3009,3009,3009,3009,3009,3009,3009,3009,3009,3009,2dbd0671-c565-40c5-bf0f-e324db26799c,important limitations of use anoro ellipta is not indicated for the relief of acute bronchospasm or for the treatment of asthma,2
2413,2413,2413,2413,2413,2413,2413,3010,3010,3010,3010,3010,3010,3010,3010,3010,3010,3010,3010,3010,2dbd0671-c565-40c5-bf0f-e324db26799c,anoro ellipta is a combination of umeclidinium  an anticholinergic  and vilanterol  a long acting beta2 adrenergic agonist ( laba )  indicated for the long term  once daily  maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease ( copd ),1
2414,2414,2414,2414,2414,2414,2414,3011,3011,3011,3011,3011,3011,3011,3011,3011,3011,3011,3011,3011,2dbd0671-c565-40c5-bf0f-e324db26799c,( 1 ) important limitations not indicated for relief of acute bronchospasm or for the treatment of asthma,2
2415,2415,2415,2415,2415,2415,2415,3012,3012,3012,3012,3012,3012,3012,3012,3012,3012,3012,3012,3012,b5a81d5a-4648-4c7a-951d-33c014a63c7e,1  trelegy ellipta is a combination inhaled corticosteroid anticholinergic long acting beta2 adrenergic agonist indicated for the long term  once daily  maintenance treatment of patients with chronic obstructive pulmonary disease ( copd )  including chronic bronchitis and or emphysema  who are on a fixed dose combination of fluticasone furoate and vilanterol for airflow obstruction and reducing exacerbations in whom additional treatment of airflow obstruction is desired or for patients who are already receiving umeclidinium and a fixed dose combination of fluticasone furoate and vilanterol,1
2416,2416,2416,2416,2416,2416,2416,3013,3013,3013,3013,3013,3013,3013,3013,3013,3013,3013,3013,3013,b5a81d5a-4648-4c7a-951d-33c014a63c7e,important limitations of use trelegy ellipta is not indicated for the relief of acute bronchospasm or for the treatment of asthma,2
2417,2417,2417,2417,2417,2417,2417,3014,3014,3014,3014,3014,3014,3014,3014,3014,3014,3014,3014,3014,b5a81d5a-4648-4c7a-951d-33c014a63c7e,trelegy ellipta is a combination of fluticasone furoate  an inhaled corticosteroid ( ics ) umeclidinium  an anticholinergic and vilanterol  a long acting beta2 adrenergic agonist ( laba )  indicated for the long term  once daily  maintenance treatment of patients with chronic obstructive pulmonary disease ( copd )  including chronic bronchitis and or emphysema  who are on a fixed dose combination of fluticasone furoate and vilanterol for airflow obstruction and reducing exacerbations in whom additional treatment of airflow obstruction is desired or for patients who are already receiving umeclidinium and a fixed dose combination of fluticasone furoate and vilanterol,1
2418,2418,2418,2418,2418,2418,2418,3015,3015,3015,3015,3015,3015,3015,3015,3015,3015,3015,3015,3015,b5a81d5a-4648-4c7a-951d-33c014a63c7e,( 1 ) important limitations of use not indicated for relief of acute bronchospasm or the treatment of asthma,2
2419,2419,2419,2419,2419,2419,2419,3016,3016,3016,3016,3016,3016,3016,3016,3016,3016,3016,3016,3016,5c7dd3c6-8a9a-4b0b-ad02-d560a191ab80, atracurium besylate injection  usp is indicated  as an adjunct to general anesthesia  to facilitate endotracheal intubation and to provide skeletal muscle relaxation during surgery or mechanical ventilation,1
2420,2420,2420,2420,2420,2420,2420,3017,3017,3017,3017,3017,3017,3017,3017,3017,3017,3017,3017,3017,6189fb21-9432-45f8-8481-0bfaf3ccde95,1  sublocade is indicated for the treatment of moderate to severe opioid use disorder in patients who have initiated treatment with a transmucosal buprenorphine containing product  followed by dose adjustment for a minimum of 7 days,1
2421,2421,2421,2421,2421,2421,2421,3018,3018,3018,3018,3018,3018,3018,3018,3018,3018,3018,3018,3018,6189fb21-9432-45f8-8481-0bfaf3ccde95,sublocade should be used as part of a complete treatment plan that includes counseling and psychosocial support,4
2422,2422,2422,2422,2422,2422,2422,3019,3019,3019,3019,3019,3019,3019,3019,3019,3019,3019,3019,3019,6189fb21-9432-45f8-8481-0bfaf3ccde95,sublocade contains buprenorphine  a partial opioid agonist  and is indicated for the treatment of moderate to severe opioid use disorder in patients who have initiated treatment with a transmucosal buprenorphine containing product  followed by dose adjustment for a minimum of 7 days,1
2423,2423,2423,2423,2423,2423,2423,3020,3020,3020,3020,3020,3020,3020,3020,3020,3020,3020,3020,3020,6189fb21-9432-45f8-8481-0bfaf3ccde95,( 1 ) sublocade should be used as part of a complete treatment program that includes counseling and psychosocial support,4
2424,2424,2424,2424,2424,2424,2424,3041,3041,3041,3041,3041,3041,3041,3041,3041,3041,3041,3041,3041,bc3c31fd-5e88-4ab9-866d-ba2162e5200e, for temporary relief of feelings of being stuck,1
2425,2425,2425,2425,2425,2425,2425,3042,3042,3042,3042,3042,3042,3042,3042,3042,3042,3042,3042,3042,8848de76-8d74-4620-bcc7-a86a596e5dd9,1  dilantin is indicated for the treatment of tonic clonic ( grand mal ) and psychomotor ( temporal lobe ) seizures and prevention and treatment of seizures occurring during or following neurosurgery,1
2426,2426,2426,2426,2426,2426,2426,3043,3043,3043,3043,3043,3043,3043,3043,3043,3043,3043,3043,3043,8848de76-8d74-4620-bcc7-a86a596e5dd9,dilantin is indicated for the treatment of tonic clonic ( grand mal ) and psychomotor ( temporal lobe ) seizures and prevention and treatment of seizures occurring during or following neurosurgery,1
2427,2427,2427,2427,2427,2427,2427,3044,3044,3044,3044,3044,3044,3044,3044,3044,3044,3044,3044,3044,a6d46c03-bb1d-417b-b8e5-3bffe352fe29,1  rubraca is a poly ( adp ribose ) polymerase ( parp ) inhibitor indicated for the maintenance treatment of adult patients with recurrent epithelial ovarian  fallopian tube  or primary peritoneal cancer who are in a complete or partial response to platinum based chemotherapy,1
2428,2428,2428,2428,2428,2428,2428,3045,3045,3045,3045,3045,3045,3045,3045,3045,3045,3045,3045,3045,a6d46c03-bb1d-417b-b8e5-3bffe352fe29,( 1 1 ) for the treatment of adult patients with deleterious brca mutation ( germline and or somatic ) associated epithelial ovarian  fallopian tube  or primary peritoneal cancer who have been treated with two or more chemotherapies,1
2429,2429,2429,2429,2429,2429,2429,3046,3046,3046,3046,3046,3046,3046,3046,3046,3046,3046,3046,3046,a6d46c03-bb1d-417b-b8e5-3bffe352fe29,select patients for therapy based on an fda approved companion diagnostic for rubraca,u
2430,2430,2430,2430,2430,2430,2430,3047,3047,3047,3047,3047,3047,3047,3047,3047,3047,3047,3047,3047,a6d46c03-bb1d-417b-b8e5-3bffe352fe29,( 1 2  2 3 ) 1 1 maintenance treatment of recurrent ovarian cancer rubraca is indicated for the maintenance treatment of adult patients with recurrent epithelial ovarian  fallopian tube  or primary peritoneal cancer who are in a complete or partial response to platinum based chemotherapy see dosage and administration ( 2 1 ),1
2431,2431,2431,2431,2431,2431,2431,3048,3048,3048,3048,3048,3048,3048,3048,3048,3048,3048,3048,3048,a6d46c03-bb1d-417b-b8e5-3bffe352fe29,1 2 treatment of brca mutated ovarian cancer after 2 or more chemotherapies rubraca is indicated for the treatment of adult patients with deleterious brca mutation ( germline and or somatic ) associated epithelial ovarian  fallopian tube  or primary peritoneal cancer who have been treated with two or more chemotherapies,1
2432,2432,2432,2432,2432,2432,2432,3049,3049,3049,3049,3049,3049,3049,3049,3049,3049,3049,3049,3049,a6d46c03-bb1d-417b-b8e5-3bffe352fe29,select patients for therapy based on an fda approved companion diagnostic for rubraca see dosage and administration ( 2 1 ),0
2433,2433,2433,2433,2433,2433,2433,3050,3050,3050,3050,3050,3050,3050,3050,3050,3050,3050,3050,3050,fd638e5e-8032-e7ca-0179-95e96ab5d387,1  gilotrif is a kinase inhibitor indicated for first line treatment of patients with metastatic non small cell lung cancer ( nsclc ) whose tumors have non resistant epidermal growth factor receptor ( egfr ) mutations as detected by an fda approved test ( 1 1 ) limitation of use safety and efficacy of gilotrif were not established in patients whose tumors have resistant egfr mutations ( 1 1 ) treatment of patients with metastatic  squamous nsclc progressing after platinum based chemotherapy ( 1 2 ) 1 1 egfr mutation positive  metastatic non small cell lung cancer gilotrif is indicated for the first line treatment of patients with metastatic non small cell lung cancer ( nsclc ) whose tumors have non resistant epidermal growth factor receptor ( egfr ) mutations as detected by an fda approved test see clinical pharmacology ( 12 1 ) and clinical studies ( 14 1 ),1
2434,2434,2434,2434,2434,2434,2434,3051,3051,3051,3051,3051,3051,3051,3051,3051,3051,3051,3051,3051,fd638e5e-8032-e7ca-0179-95e96ab5d387,limitation of use the safety and efficacy of gilotrif have not been established in patients whose tumors have resistant egfr mutations see clinical studies ( 14 1 ),2
2435,2435,2435,2435,2435,2435,2435,3052,3052,3052,3052,3052,3052,3052,3052,3052,3052,3052,3052,3052,fd638e5e-8032-e7ca-0179-95e96ab5d387,1 2 previously treated  metastatic squamous nsclc gilotrif is indicated for the treatment of patients with metastatic squamous nsclc progressing after platinum based chemotherapy see clinical studies ( 14 2 ),1
2436,2436,2436,2436,2436,2436,2436,3053,3053,3053,3053,3053,3053,3053,3053,3053,3053,3053,3053,3053,595f437d-2729-40bb-9c62-c8ece1f82780,1  dupixent is indicated for the treatment of adult patients with moderate to severe atopic dermatitis whose disease is not adequately controlled with topical prescription therapies or when those therapies are not advisable,1
2437,2437,2437,2437,2437,2437,2437,3054,3054,3054,3054,3054,3054,3054,3054,3054,3054,3054,3054,3054,595f437d-2729-40bb-9c62-c8ece1f82780,dupixent can be used with or without topical corticosteroids,4
2438,2438,2438,2438,2438,2438,2438,3055,3055,3055,3055,3055,3055,3055,3055,3055,3055,3055,3055,3055,595f437d-2729-40bb-9c62-c8ece1f82780,dupixent is an interleukin 4 receptor alpha antagonist indicated for the treatment of adult patients with moderate to severe atopic dermatitis whose disease is not adequately controlled with topical prescription therapies or when those therapies are not advisable,1
2439,2439,2439,2439,2439,2439,2439,3057,3057,3057,3057,3057,3057,3057,3057,3057,3057,3057,3057,3057,eb28dcd2-c457-4137-9eec-00062e5a601b, rescriptor tablets are indicated for the treatment of hiv 1 infection in combination with at least 2 other active antiretroviral agents when therapy is warranted,1
2440,2440,2440,2440,2440,2440,2440,3058,3058,3058,3058,3058,3058,3058,3058,3058,3058,3058,3058,3058,eb28dcd2-c457-4137-9eec-00062e5a601b,the following should be considered before initiating therapy with rescriptor in treatment naive patients,0
2441,2441,2441,2441,2441,2441,2441,3059,3059,3059,3059,3059,3059,3059,3059,3059,3059,3059,3059,3059,eb28dcd2-c457-4137-9eec-00062e5a601b,there are insufficient data directly comparing antiretroviral regimens containing rescriptor with currently preferred 3 drug regimens for initial treatment of hiv,0
2442,2442,2442,2442,2442,2442,2442,3060,3060,3060,3060,3060,3060,3060,3060,3060,3060,3060,3060,3060,eb28dcd2-c457-4137-9eec-00062e5a601b,in studies comparing regimens consisting of 2 nucleoside reverse transcriptase inhibitors ( nrtis ) ( currently considered suboptimal ) to rescriptor plus 2 nrtis  the proportion of patients receiving the regimen containing rescriptor who achieved and sustained an hiv 1 rna level 400 copies ml over 1 year of therapy was relatively low ( see description of clinical studies ),0
2443,2443,2443,2443,2443,2443,2443,3061,3061,3061,3061,3061,3061,3061,3061,3061,3061,3061,3061,3061,eb28dcd2-c457-4137-9eec-00062e5a601b,resistant virus emerges rapidly when rescriptor is administered as monotherapy,0
2444,2444,2444,2444,2444,2444,2444,3062,3062,3062,3062,3062,3062,3062,3062,3062,3062,3062,3062,3062,eb28dcd2-c457-4137-9eec-00062e5a601b,therefore  rescriptor should always be administered in combination with other antiretroviral agents,4
2445,2445,2445,2445,2445,2445,2445,3063,3063,3063,3063,3063,3063,3063,3063,3063,3063,3063,3063,3063,d6a33ea7-ecd1-4f81-a984-f210a3989618, amethia tablets are indicated for use by women to prevent pregnancy,1
2446,2446,2446,2446,2446,2446,2446,3064,3064,3064,3064,3064,3064,3064,3064,3064,3064,3064,3064,3064,d6a33ea7-ecd1-4f81-a984-f210a3989618,amethia tablets are an estrogen progestin coc indicated for use by women to prevent pregnancy,1
2447,2447,2447,2447,2447,2447,2447,3065,3065,3065,3065,3065,3065,3065,3065,3065,3065,3065,3065,3065,efde9da5-2a96-4d0d-903c-20862790a9db, levonorgestrel and ethinyl estradiol tablets is indicated for the prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception,1
2448,2448,2448,2448,2448,2448,2448,3067,3067,3067,3067,3067,3067,3067,3067,3067,3067,3067,3067,3067,efde9da5-2a96-4d0d-903c-20862790a9db,table ii lists the typical accidental pregnancy rates for users of combination oral contraceptives and other methods of contraception,0
2449,2449,2449,2449,2449,2449,2449,3068,3068,3068,3068,3068,3068,3068,3068,3068,3068,3068,3068,3068,efde9da5-2a96-4d0d-903c-20862790a9db,the efficacy of these contraceptive methods  except sterilization  the iud  and levonorgestrel implants  depends upon the reliability with which they are used,0
2450,2450,2450,2450,2450,2450,2450,3070,3070,3070,3070,3070,3070,3070,3070,3070,3070,3070,3070,3070,efde9da5-2a96-4d0d-903c-20862790a9db,table ii percentage of women experiencing an unintended pregnancy during the first year of typical use and the first year of perfect use of contraception and the percentage continuing use at the end of the first year,0
2451,2451,2451,2451,2451,2451,2451,3071,3071,3071,3071,3071,3071,3071,3071,3071,3071,3071,3071,3071,efde9da5-2a96-4d0d-903c-20862790a9db,source trussell j  contraceptive efficacy,0
2452,2452,2452,2452,2452,2452,2452,3072,3072,3072,3072,3072,3072,3072,3072,3072,3072,3072,3072,3072,efde9da5-2a96-4d0d-903c-20862790a9db,in hatcher ra  trussell j  stewart f  cates w  stewart gk  kowal d  guest f  contraceptive technology seventeenth revised edition,0
2453,2453,2453,2453,2453,2453,2453,3073,3073,3073,3073,3073,3073,3073,3073,3073,3073,3073,3073,3073,efde9da5-2a96-4d0d-903c-20862790a9db,new york ny irvington publishers  1998,0
2454,2454,2454,2454,2454,2454,2454,3074,3074,3074,3074,3074,3074,3074,3074,3074,3074,3074,3074,3074,efde9da5-2a96-4d0d-903c-20862790a9db,of women experiencing an unintended pregnancy within the first year of use of women continuing use at one yearamong couples attempting to avoid pregnancy  the percentage who continue to use a method for one year,0
2455,2455,2455,2455,2455,2455,2455,3075,3075,3075,3075,3075,3075,3075,3075,3075,3075,3075,3075,3075,efde9da5-2a96-4d0d-903c-20862790a9db,method ( 1 ) typical useamong typical couples who initiate use of a method ( not necessarily for the first time )  the percentage who experience an unintended pregnancy during the first year if they do not stop use for any other reason,0
2456,2456,2456,2456,2456,2456,2456,3076,3076,3076,3076,3076,3076,3076,3076,3076,3076,3076,3076,3076,efde9da5-2a96-4d0d-903c-20862790a9db,( 2 ) perfect useamong couples who initiate use of a method ( not necessarily for the first time ) and who use it perfectly ( both consistently and correctly )  the percentage who experience an unintended pregnancy during the first year if they do not stop use for any other reason,0
2457,2457,2457,2457,2457,2457,2457,3077,3077,3077,3077,3077,3077,3077,3077,3077,3077,3077,3077,3077,efde9da5-2a96-4d0d-903c-20862790a9db,( 3 ) ( 4 ) chancethe percentages of women becoming pregnant in columns ( 2 ) and ( 3 ) are based on data from populations where contraception is not used and from women who cease using contraception in order to become pregnant,0
2458,2458,2458,2458,2458,2458,2458,3078,3078,3078,3078,3078,3078,3078,3078,3078,3078,3078,3078,3078,efde9da5-2a96-4d0d-903c-20862790a9db,among such populations  about 89 become pregnant within one year,0
2459,2459,2459,2459,2459,2459,2459,3079,3079,3079,3079,3079,3079,3079,3079,3079,3079,3079,3079,3079,efde9da5-2a96-4d0d-903c-20862790a9db,this estimate was lowered slightly ( to 85 ) to represent the percentage who would become pregnant within one year among women now relying on reversible methods of contraception if they abandoned contraception altogether,0
2460,2460,2460,2460,2460,2460,2460,3080,3080,3080,3080,3080,3080,3080,3080,3080,3080,3080,3080,3080,efde9da5-2a96-4d0d-903c-20862790a9db,85 85 spermicidesfoams  creams  gels  vaginal suppositories and vaginal film,0
2461,2461,2461,2461,2461,2461,2461,3081,3081,3081,3081,3081,3081,3081,3081,3081,3081,3081,3081,3081,efde9da5-2a96-4d0d-903c-20862790a9db,26 td align center valign t,0
2462,2462,2462,2462,2462,2462,2462,3082,3082,3082,3082,3082,3082,3082,3082,3082,3082,3082,3082,3082,64494a20-4f1c-443d-be3e-cadddf839b00, caziant ( desogestrel and ethinyl estradiol tablets usp ) is indicated for the prevention of pregnancy in women who elect to use this product as a method of contraception,1
2463,2463,2463,2463,2463,2463,2463,3084,3084,3084,3084,3084,3084,3084,3084,3084,3084,3084,3084,3084,64494a20-4f1c-443d-be3e-cadddf839b00,table 2 lists the typical unintended pregnancy rates for users of combination oral contraceptives and other methods of contraception,0
2464,2464,2464,2464,2464,2464,2464,3085,3085,3085,3085,3085,3085,3085,3085,3085,3085,3085,3085,3085,64494a20-4f1c-443d-be3e-cadddf839b00,the efficacy of these contraceptive methods  except sterilization  the iud  and implants depends upon the reliability with which they are used,0
2465,2465,2465,2465,2465,2465,2465,3086,3086,3086,3086,3086,3086,3086,3086,3086,3086,3086,3086,3086,64494a20-4f1c-443d-be3e-cadddf839b00,correct and consistent use of these methods can result in lower failure rates,0
2466,2466,2466,2466,2466,2466,2466,3087,3087,3087,3087,3087,3087,3087,3087,3087,3087,3087,3087,3087,64494a20-4f1c-443d-be3e-cadddf839b00,table 2 percentage of women experiencing an unintended pregnancy during the first year of typical use and the first year of perfect use of contraception and the percentage continuing use at the end of the first year  united states,0
2467,2467,2467,2467,2467,2467,2467,3088,3088,3088,3088,3088,3088,3088,3088,3088,3088,3088,3088,3088,64494a20-4f1c-443d-be3e-cadddf839b00,of women experiencing an unintended pregnancy within the first year of use of women continuing use at one year among couples attempting to avoid pregnancy  the percentage who continue to use a method for one year method typical use among typical couples who initiate use of a method ( not necessarily for the first time )  the percentage who experience an accidental pregnancy during the first year if they do not stop use for any other reason perfect use among couples who initiate use of a method ( not necessarily for the first time ) and who use it perfectly ( both consistently and correctly )  the percentage who experience an accidental pregnancy during the first year if they do not stop use for any other reason ( 1 ) ( 2 ) td align center stylecode rrule lrule,0
2468,2468,2468,2468,2468,2468,2468,3089,3089,3089,3089,3089,3089,3089,3089,3089,3089,3089,3089,3089,ddbb5d60-cacf-4672-935d-86d668287992, blisovi fe 1 20 is indicated for the prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception,1
2469,2469,2469,2469,2469,2469,2469,3091,3091,3091,3091,3091,3091,3091,3091,3091,3091,3091,3091,3091,ddbb5d60-cacf-4672-935d-86d668287992,table i lists the typical accidental pregnancy rates for users of combination oral contraceptives and other methods of contraception,0
2470,2470,2470,2470,2470,2470,2470,3092,3092,3092,3092,3092,3092,3092,3092,3092,3092,3092,3092,3092,ddbb5d60-cacf-4672-935d-86d668287992,the efficacy of these contraceptive methods  except sterilization  depends upon the reliability with which they are used,0
2471,2471,2471,2471,2471,2471,2471,3094,3094,3094,3094,3094,3094,3094,3094,3094,3094,3094,3094,3094,ddbb5d60-cacf-4672-935d-86d668287992,table i lowest expected and typical failure rates during the first year of continuous use of a method adapted from ra hatcher et al  reference 7,0
2472,2472,2472,2472,2472,2472,2472,3095,3095,3095,3095,3095,3095,3095,3095,3095,3095,3095,3095,3095,ddbb5d60-cacf-4672-935d-86d668287992,of women experiencing an unintended pregnancy in the first year of continuous use method lowest expectedthe authors best guess of the percentage of women expected to experience an accidental pregnancy among couples who initiate a method ( not necessarily for the first time ) and who use it consistently and correctly during the first year if they do not stop for any other reason,0
2473,2473,2473,2473,2473,2473,2473,3096,3096,3096,3096,3096,3096,3096,3096,3096,3096,3096,3096,3096,ddbb5d60-cacf-4672-935d-86d668287992,typicalthis term represents typical couples who initiate use of a method ( not necessarily for the first time )  who experience an accidental pregnancy during the first year if they do not stop use for any other reason,0
2474,2474,2474,2474,2474,2474,2474,3097,3097,3097,3097,3097,3097,3097,3097,3097,3097,3097,3097,3097,ddbb5d60-cacf-4672-935d-86d668287992,( no contraception ) ( 85 ) td align cent,0
2475,2475,2475,2475,2475,2475,2475,3098,3098,3098,3098,3098,3098,3098,3098,3098,3098,3098,3098,3098,384e7a40-dcbd-4908-bf5e-65abc9932973,1  ortho cyclen and ortho tri cyclen are estrogen progestin cocs  indicated for use by women to prevent pregnancy,1
2476,2476,2476,2476,2476,2476,2476,3099,3099,3099,3099,3099,3099,3099,3099,3099,3099,3099,3099,3099,384e7a40-dcbd-4908-bf5e-65abc9932973,( 1 1 ) ortho tri cyclen is also indicated for the treatment of moderate acne vulgaris in females at least 15 years of age  who have no known contraindications to oral contraceptive therapy and have achieved menarche,1
2477,2477,2477,2477,2477,2477,2477,3100,3100,3100,3100,3100,3100,3100,3100,3100,3100,3100,3100,3100,384e7a40-dcbd-4908-bf5e-65abc9932973,ortho tri cyclen should be used for the treatment of acne only if the patient desires an oral contraceptive for birth control,u
2478,2478,2478,2478,2478,2478,2478,3101,3101,3101,3101,3101,3101,3101,3101,3101,3101,3101,3101,3101,384e7a40-dcbd-4908-bf5e-65abc9932973,( 1 2 ) 1 1 oral contraceptive ortho cyclen and ortho tri cyclen tablets are indicated for use by females of reproductive potential to prevent pregnancy see clinical studies ( 14 ),1
2479,2479,2479,2479,2479,2479,2479,3102,3102,3102,3102,3102,3102,3102,3102,3102,3102,3102,3102,3102,384e7a40-dcbd-4908-bf5e-65abc9932973,1 2 acne ortho tri cyclen is indicated for the treatment of moderate acne vulgaris in females at least 15 years of age  who have no known contraindications to oral contraceptive therapy and have achieved menarche,1
2480,2480,2480,2480,2480,2480,2480,3103,3103,3103,3103,3103,3103,3103,3103,3103,3103,3103,3103,3103,384e7a40-dcbd-4908-bf5e-65abc9932973,ortho tri cyclen should be used for the treatment of acne only if the patient desires an oral contraceptive for birth control see clinical studies ( 14 ),u
2481,2481,2481,2481,2481,2481,2481,3104,3104,3104,3104,3104,3104,3104,3104,3104,3104,3104,3104,3104,aa17c22d-32a8-4f48-b7b6-9b8eeeb5a81a,1  nikki ( drospirenone and ethinyl estradiol tablets usp )  3 mg 0 02 mg is an estrogen progestin coc  indicated for use by women to prevent pregnancy,1
2482,2482,2482,2482,2482,2482,2482,3105,3105,3105,3105,3105,3105,3105,3105,3105,3105,3105,3105,3105,aa17c22d-32a8-4f48-b7b6-9b8eeeb5a81a,( 1 1 ) treat moderate acne for women at least 14 years old only if the patient desires an oral contraceptive for birth control,u
2483,2483,2483,2483,2483,2483,2483,3106,3106,3106,3106,3106,3106,3106,3106,3106,3106,3106,3106,3106,aa17c22d-32a8-4f48-b7b6-9b8eeeb5a81a,( 1 3 ) 1 1 oral contraceptive nikki ( drospirenone and ethinyl estradiol tablets usp )  3 mg 0 02 mg is indicated for use by women to prevent pregnancy,1
2484,2484,2484,2484,2484,2484,2484,3107,3107,3107,3107,3107,3107,3107,3107,3107,3107,3107,3107,3107,aa17c22d-32a8-4f48-b7b6-9b8eeeb5a81a,1 3 acne nikki ( drospirenone and ethinyl estradiol tablets usp )  3 mg 0 02 mg is indicated for the treatment of moderate acne vulgaris in women at least 14 years of age  who have no known contraindications to oral contraceptive therapy and have achieved menarche,1
2485,2485,2485,2485,2485,2485,2485,3108,3108,3108,3108,3108,3108,3108,3108,3108,3108,3108,3108,3108,aa17c22d-32a8-4f48-b7b6-9b8eeeb5a81a,nikki ( drospirenone and ethinyl estradiol tablets usp )  3 mg 0 02 mg should be used for the treatment of acne only if the patient desires an oral contraceptive for birth control,u
2486,2486,2486,2486,2486,2486,2486,3109,3109,3109,3109,3109,3109,3109,3109,3109,3109,3109,3109,3109,adcf17ef-e60b-48a4-9478-3998dab2bbbd,1  xulane is indicated for the prevention of pregnancy in women who elect to use a transdermal patch as a method of contraception,1
2487,2487,2487,2487,2487,2487,2487,3110,3110,3110,3110,3110,3110,3110,3110,3110,3110,3110,3110,3110,adcf17ef-e60b-48a4-9478-3998dab2bbbd,limitation of use xulane may be less effective in preventing pregnancy in women who weigh 198 lbs ( 90 kg ) or more,2
2488,2488,2488,2488,2488,2488,2488,3111,3111,3111,3111,3111,3111,3111,3111,3111,3111,3111,3111,3111,adcf17ef-e60b-48a4-9478-3998dab2bbbd,xulane is an estrogen progestin combination hormonal contraceptive ( chc )  indicated for the prevention of pregnancy in women who elect to use a transdermal patch,1
2489,2489,2489,2489,2489,2489,2489,3112,3112,3112,3112,3112,3112,3112,3112,3112,3112,3112,3112,3112,adcf17ef-e60b-48a4-9478-3998dab2bbbd,( 1 ) limitation of use xulane may be less effective in preventing pregnancy in women at or above 198 lbs ( 90 kg ),2
2490,2490,2490,2490,2490,2490,2490,3113,3113,3113,3113,3113,3113,3113,3113,3113,3113,3113,3113,3113,87a07384-d45c-418f-b050-90565dc8cc23,1  generess fe is indicated for use by women to prevent pregnancy,1
2491,2491,2491,2491,2491,2491,2491,3114,3114,3114,3114,3114,3114,3114,3114,3114,3114,3114,3114,3114,87a07384-d45c-418f-b050-90565dc8cc23,the efficacy of generess fe in women with a body mass index ( bmi ) of 35 kg m2 has not been evaluated,0
2492,2492,2492,2492,2492,2492,2492,3115,3115,3115,3115,3115,3115,3115,3115,3115,3115,3115,3115,3115,87a07384-d45c-418f-b050-90565dc8cc23,generess fe is an estrogen progestin coc indicated for use by women to prevent pregnancy,1
2493,2493,2493,2493,2493,2493,2493,3116,3116,3116,3116,3116,3116,3116,3116,3116,3116,3116,3116,3116,87a07384-d45c-418f-b050-90565dc8cc23,( 1 ) the efficacy in women with a body mass index ( bmi ) of 35 kg m2 has not been evaluated,0
2494,2494,2494,2494,2494,2494,2494,3117,3117,3117,3117,3117,3117,3117,3117,3117,3117,3117,3117,3117,48f7778e-42d5-425d-bae7-5987a089bf46, necon 7 7 7 tablets are indicated for the prevention of pregnancy in women who elect to use this product as a method of contraception,1
2495,2495,2495,2495,2495,2495,2495,3119,3119,3119,3119,3119,3119,3119,3119,3119,3119,3119,3119,3119,48f7778e-42d5-425d-bae7-5987a089bf46,table 1 lists the typical accidental pregnancy rates for users of combined oral contraceptives and other methods of contraception,0
2496,2496,2496,2496,2496,2496,2496,3120,3120,3120,3120,3120,3120,3120,3120,3120,3120,3120,3120,3120,48f7778e-42d5-425d-bae7-5987a089bf46,the efficacy of these contraceptive methods  except sterilization  the iud  and the norplant system depends upon the reliability with which they are used,0
2497,2497,2497,2497,2497,2497,2497,3122,3122,3122,3122,3122,3122,3122,3122,3122,3122,3122,3122,3122,48f7778e-42d5-425d-bae7-5987a089bf46,table 1 percentage of women experiencing an unintended pregnancy during the first year of typical use and the first year of perfect use of contraception and the percentage continuing use at the end of the first year,0
2498,2498,2498,2498,2498,2498,2498,3124,3124,3124,3124,3124,3124,3124,3124,3124,3124,3124,3124,3124,48f7778e-42d5-425d-bae7-5987a089bf46,method ( 1 ) typical useamong typical couples who initiate use of a method ( not necessarily for the first time )  the percentage who experience an accidental pregnancy during the first year if they do not stop use for any other reason,0
2499,2499,2499,2499,2499,2499,2499,3125,3125,3125,3125,3125,3125,3125,3125,3125,3125,3125,3125,3125,48f7778e-42d5-425d-bae7-5987a089bf46,( 2 ) perfect useamong couples who initiate use of a method ( not necessarily for the first time ) and who use it perfectly ( both consistently and correctly )  the percentage who experience an accidental pregnancy during the first year if they do not stop use for any other reason,0
2500,2500,2500,2500,2500,2500,2500,3126,3126,3126,3126,3126,3126,3126,3126,3126,3126,3126,3126,3126,48f7778e-42d5-425d-bae7-5987a089bf46,( 3 ) ( 4 ) adapted from hatcher et al  1998  ref,0
2501,2501,2501,2501,2501,2501,2501,3127,3127,3127,3127,3127,3127,3127,3127,3127,3127,3127,3127,3127,48f7778e-42d5-425d-bae7-5987a089bf46,emergency contraceptive pills treatment initiated within 72 hours after unprotected intercourse reduces the risk of pregnancy by at least 75 the treatment schedule is one dose within 72 hours after unprotected intercourse  and a second dose 12 hours after the first dose,0
2502,2502,2502,2502,2502,2502,2502,3128,3128,3128,3128,3128,3128,3128,3128,3128,3128,3128,3128,3128,48f7778e-42d5-425d-bae7-5987a089bf46,the food and drug administration has declared the following brands of oral contraceptives to be safe and effective for emergency contraception ovral ( 1 dose is 2 white pills )  alesse ( 1 dose is 5 pink pills )  nordette or levlen ( 1 dose is 2 light orange pills )  lo ovral ( 1 dose is 4 white pills )  triphasil or tri levlen ( 1 dose is 4 yellow pills ),0
2503,2503,2503,2503,2503,2503,2503,3129,3129,3129,3129,3129,3129,3129,3129,3129,3129,3129,3129,3129,48f7778e-42d5-425d-bae7-5987a089bf46,lactational amenorrhea method lam is a highly effective  temporary method of contraception however  to maintain effective protection against pregnancy  another method of contraception must be used as soon as menstruation resumes  the frequency or duration of breastfeeds is reduced  bottle feeds are introduced  or the baby reaches six months of age,0
2504,2504,2504,2504,2504,2504,2504,3131,3131,3131,3131,3131,3131,3131,3131,3131,3131,3131,3131,3131,b6761f84-53ac-4745-a8c8-1e5427d7e179,1  prilosec is a proton pump inhibitor ( ppi ) indicated for the treatment of active duodenal ulcer in adults ( 1 1 ) eradication of helicobacter pylori to reduce the risk of duodenal ulcer recurrence in adults ( 1 2 ) treatment of active benign gastric ulcer in adults ( 1 3 ) treatment of symptomatic gastroesophageal reflux disease ( gerd ) in patients 1 year of age and older ( 1 4 ) treatment of erosive esophagitis ( ee ) due to acid mediated gerd in patients 1 month of age and older ( 1 5 ) maintenance of healing of ee due to acid mediated gerd in patients 1 year of age and older ( 1 6 ) pathologic hypersecretory conditions in adults ( 1 7 ) 1 1 treatment of active duodenal ulcer prilosec is indicated for short term treatment of active duodenal ulcer in adults,1
2505,2505,2505,2505,2505,2505,2505,3132,3132,3132,3132,3132,3132,3132,3132,3132,3132,3132,3132,3132,b6761f84-53ac-4745-a8c8-1e5427d7e179,most patients heal within four weeks,0
2506,2506,2506,2506,2506,2506,2506,3133,3133,3133,3133,3133,3133,3133,3133,3133,3133,3133,3133,3133,b6761f84-53ac-4745-a8c8-1e5427d7e179,some patients may require an additional four weeks of therapy,0
2507,2507,2507,2507,2507,2507,2507,3134,3134,3134,3134,3134,3134,3134,3134,3134,3134,3134,3134,3134,b6761f84-53ac-4745-a8c8-1e5427d7e179,1 2 helicobacter pylori eradication to reduce the risk of duodenal ulcer recurrence eradication of h pylori has been shown to reduce the risk of duodenal ulcer recurrence,4
2508,2508,2508,2508,2508,2508,2508,3135,3135,3135,3135,3135,3135,3135,3135,3135,3135,3135,3135,3135,b6761f84-53ac-4745-a8c8-1e5427d7e179,triple therapy prilosec in combination with clarithromycin and amoxicillin  is indicated for treatment of patients with h pylori infection and duodenal ulcer disease ( active or up to 1 year history ) to eradicate h pylori in adults,1
2509,2509,2509,2509,2509,2509,2509,3136,3136,3136,3136,3136,3136,3136,3136,3136,3136,3136,3136,3136,b6761f84-53ac-4745-a8c8-1e5427d7e179,dual therapy prilosec in combination with clarithromycin is indicated for treatment of patients with h pylori infection and duodenal ulcer disease to eradicate content stylecode i,1
2510,2510,2510,2510,2510,2510,2510,3137,3137,3137,3137,3137,3137,3137,3137,3137,3137,3137,3137,3137,9ae58f3c-dbf9-4c10-9b79-233b10e0e9f1, allopurinol sodium for injection is indicated for the management of patients with leukemia  lymphoma  and solid tumor malignancies who are receiving cancer therapy which causes elevations of serum and urinary uric acid levels and who cannot tolerate oral therapy,1
2511,2511,2511,2511,2511,2511,2511,3138,3138,3138,3138,3138,3138,3138,3138,3138,3138,3138,3138,3138,85975cf0-1286-4af9-ac7f-94bb2483bf09, for adjunctive treatment of edema due to congestive heart failure drug induced edema centrencephalic epilepsies ( petit mal  unlocalized seizures ) chronic simple ( open angle ) glaucoma  secondary glaucoma  and preoperatively in acute angle closure glaucoma where delay of surgery is desired in order to lower intraocular pressure,1
2512,2512,2512,2512,2512,2512,2512,3139,3139,3139,3139,3139,3139,3139,3139,3139,3139,3139,3139,3139,da1c9f37-779e-4682-816f-93d0faa4cfc9,1  ofev is indicated for the treatment of idiopathic pulmonary fibrosis ( ipf ),1
2513,2513,2513,2513,2513,2513,2513,3140,3140,3140,3140,3140,3140,3140,3140,3140,3140,3140,3140,3140,da1c9f37-779e-4682-816f-93d0faa4cfc9,ofev is a kinase inhibitor indicated for the treatment of idiopathic pulmonary fibrosis ( ipf ),1
2514,2514,2514,2514,2514,2514,2514,3141,3141,3141,3141,3141,3141,3141,3141,3141,3141,3141,3141,3141,"Active Ingredient UNII(s)
42HK56048U; 786Z46389E    63f7ac0f-51d7-4e9e-bc54-aee51183bbaa
42HK56048U; 786Z46389E    63f7ac0f-51d7-4e9e-bc54-aee51183bbaa
Name: SET ID dtype: object",active ingredient unii ( s ) 42hk56048u 786z46389e active ingredient unii ( s ) 42hk56048u 786z4638 42hk56048u 786z46389e active ingredient unii ( s ) 42hk56048u 786z4638 name content xml  dtype object,0
2515,2515,2515,2515,2515,2515,2515,3143,3143,3143,3143,3143,3143,3143,3143,3143,3143,3143,3143,3143,"Active Ingredient UNII(s)
42HK56048U; ZG7E5POY8O    f0c3cafa-8985-4dac-9be1-a92454a4ef6e
42HK56048U; ZG7E5POY8O    f0c3cafa-8985-4dac-9be1-a92454a4ef6e
Name: SET ID dtype: object",active ingredient unii ( s ) 42hk56048u zg7e5poy8o active ingredient unii ( s ) 42hk56048u zg7e5poy 42hk56048u zg7e5poy8o active ingredient unii ( s ) 42hk56048u zg7e5poy name content xml  dtype object,0
2516,2516,2516,2516,2516,2516,2516,3145,3145,3145,3145,3145,3145,3145,3145,3145,3145,3145,3145,3145,98a010d5-4905-4abf-a9d2-c85a07daa23b, emadine ( emedastine difumarate ophthalmic solution ) 0 05 is indicated for the temporary relief of the signs and symptoms of allergic conjunctivitis,1
2517,2517,2517,2517,2517,2517,2517,3146,3146,3146,3146,3146,3146,3146,3146,3146,3146,3146,3146,3146,cf973160-d467-4192-a432-04c8c2140369,indications a proportion of individuals over sixty who manifest signs and symptoms of an idiopathic decline in mental capacity ( i e  cognitive and interpersonal skills  mood  self care  apparent motivation ) can experience some symptomatic relief upon treatment with ergoloid mesylates preparations,1
2518,2518,2518,2518,2518,2518,2518,3147,3147,3147,3147,3147,3147,3147,3147,3147,3147,3147,3147,3147,cf973160-d467-4192-a432-04c8c2140369,the identity of the specific trait ( s ) or condition ( s )  if any  which would usefully predict a response to ergoloid mesylates therapy is not known,0
2519,2519,2519,2519,2519,2519,2519,3148,3148,3148,3148,3148,3148,3148,3148,3148,3148,3148,3148,3148,cf973160-d467-4192-a432-04c8c2140369,it appears  however  that those individuals who do respond come from groups of patients who would be considered clinically to suffer from some ill defined process related to aging or to have some underlying dementing condition ( i e  primary progressive dementia  alzheimer 's dementia  senile onset  multi infarct dementia ),0
2520,2520,2520,2520,2520,2520,2520,3149,3149,3149,3149,3149,3149,3149,3149,3149,3149,3149,3149,3149,cf973160-d467-4192-a432-04c8c2140369,before prescribing ergoloid mesylates  the physician should exclude the possibility that the patient 's signs and symptoms arise from a potentially reversible and treatable condition,0
2521,2521,2521,2521,2521,2521,2521,3150,3150,3150,3150,3150,3150,3150,3150,3150,3150,3150,3150,3150,cf973160-d467-4192-a432-04c8c2140369,particular care should be taken to exclude delirium and dementiform illness secondary to systemic disease  primary neurological disease  or primary disturbance of mood,0
2522,2522,2522,2522,2522,2522,2522,3151,3151,3151,3151,3151,3151,3151,3151,3151,3151,3151,3151,3151,cf973160-d467-4192-a432-04c8c2140369,ergoloid mesylates preparations are not indicated in the treatment of acute or chronic psychosis  regardless of etiology ( see contraindications ),2
2523,2523,2523,2523,2523,2523,2523,3152,3152,3152,3152,3152,3152,3152,3152,3152,3152,3152,3152,3152,cf973160-d467-4192-a432-04c8c2140369,the decision to use ergoloid mesylates in the treatment of an individual with a symptomatic decline in mental capacity of unknown etiology should be continually reviewed since the presenting clinical picture may subsequently evolve sufficiently to allow a specific diagnosis and a specific alternative treatment,0
2524,2524,2524,2524,2524,2524,2524,3153,3153,3153,3153,3153,3153,3153,3153,3153,3153,3153,3153,3153,cf973160-d467-4192-a432-04c8c2140369,in addition  continued clinical evaluation is required to determine whether any initial benefit conferred by ergoloid mesylates therapy persists with time,0
2525,2525,2525,2525,2525,2525,2525,3154,3154,3154,3154,3154,3154,3154,3154,3154,3154,3154,3154,3154,cf973160-d467-4192-a432-04c8c2140369,the efficacy of ergoloid mesylates was evaluated using a special rating scale known as the scag ( sandoz clinical assessment geriatric ),0
2526,2526,2526,2526,2526,2526,2526,3155,3155,3155,3155,3155,3155,3155,3155,3155,3155,3155,3155,3155,cf973160-d467-4192-a432-04c8c2140369,the specific items on this scale on which modest but statistically significant changes were observed at the end of twelve weeks include mental alertness  confusion  recent memory  orientation  emotional lability  self care  depression  anxiety fears  cooperation  sociability  appetite  dizziness  fatigue  bothersome ( ness )  and an overall impression of clinical status,0
2527,2527,2527,2527,2527,2527,2527,3156,3156,3156,3156,3156,3156,3156,3156,3156,3156,3156,3156,3156,30c7a341-d9fe-40f7-a10d-818df572f5df,for intramuscular administration when oral therapy is not feasible and the strength  dosage form  and route of administration of the drug reasonably lend the preparation to the treatment of the condition  the intramuscular use of depo medrol sterile aqueous suspension is indicated as follows allergic states control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in asthma  atopic dermatitis  contact dermatitis  drug hypersensitivity reactions  seasonal or perennial allergic rhinitis  serum sickness  transfusion reactions,1
2528,2528,2528,2528,2528,2528,2528,3157,3157,3157,3157,3157,3157,3157,3157,3157,3157,3157,3157,3157,30c7a341-d9fe-40f7-a10d-818df572f5df,dermatologic diseases bullous dermatitis herpetiformis  exfoliative dermatitis  mycosis fungoides  pemphigus  severe erythema multiforme ( stevens johnson syndrome ),1
2529,2529,2529,2529,2529,2529,2529,3158,3158,3158,3158,3158,3158,3158,3158,3158,3158,3158,3158,3158,30c7a341-d9fe-40f7-a10d-818df572f5df,endocrine disorders primary or secondary adrenocortical insufficiency ( hydrocortisone or cortisone is the drug of choice synthetic analogs may be used in conjunction with mineralocorticoids where applicable in infancy  mineralocorticoid supplementation is of particular importance )  congenital adrenal hyperplasia  hypercalcemia associated with cancer  nonsupportive thyroiditis,1
2530,2530,2530,2530,2530,2530,2530,3159,3159,3159,3159,3159,3159,3159,3159,3159,3159,3159,3159,3159,30c7a341-d9fe-40f7-a10d-818df572f5df,gastrointestinal diseases to tide the patient over a critical period of the disease in regional enteritis ( systemic therapy ) and ulcerative colitis,1
2531,2531,2531,2531,2531,2531,2531,3160,3160,3160,3160,3160,3160,3160,3160,3160,3160,3160,3160,3160,30c7a341-d9fe-40f7-a10d-818df572f5df,hematologic disorders acquired ( autoimmune ) hemolytic anemia  congenital ( erythroid ) hypoplastic anemia ( diamond blackfan anemia )  pure red cell aplasia  select cases of secondary thrombocytopenia,1
2532,2532,2532,2532,2532,2532,2532,3161,3161,3161,3161,3161,3161,3161,3161,3161,3161,3161,3161,3161,30c7a341-d9fe-40f7-a10d-818df572f5df,miscellaneous trichinosis with neurologic or myocardial involvement  tuberculous meningitis with subarachnoid block or impending block when used concurrently with appropriate antituberculous chemotherapy,1
2533,2533,2533,2533,2533,2533,2533,3162,3162,3162,3162,3162,3162,3162,3162,3162,3162,3162,3162,3162,30c7a341-d9fe-40f7-a10d-818df572f5df,neoplastic diseases for palliative management of leukemias and lymphomas,1
2534,2534,2534,2534,2534,2534,2534,3163,3163,3163,3163,3163,3163,3163,3163,3163,3163,3163,3163,3163,30c7a341-d9fe-40f7-a10d-818df572f5df,nervous system acute exacerbations of multiple sclerosis cerebral edema associated with primary or metastatic brain tumor or craniotomy,1
2535,2535,2535,2535,2535,2535,2535,3164,3164,3164,3164,3164,3164,3164,3164,3164,3164,3164,3164,3164,30c7a341-d9fe-40f7-a10d-818df572f5df,ophthalmic diseases sympathetic opthalmia  temporal arteritis  uveitis  ocular inflammatory conditions unresponsive to topical corticosteroids,1
2536,2536,2536,2536,2536,2536,2536,3165,3165,3165,3165,3165,3165,3165,3165,3165,3165,3165,3165,3165,30c7a341-d9fe-40f7-a10d-818df572f5df,renal diseases to induce diuresis or remission of proteinuria in idiopathic nephrotic syndrome  or that due to lupus erythematosus,1
2537,2537,2537,2537,2537,2537,2537,3166,3166,3166,3166,3166,3166,3166,3166,3166,3166,3166,3166,3166,30c7a341-d9fe-40f7-a10d-818df572f5df,respiratory diseases berylliosis  fulminating or disseminated pulmonary tuberculosis when used concurrently with appropriate antituberculous chemotherapy  idiopathic eosinophilic pneumonias  symptomatic sarcoidosis,1
2538,2538,2538,2538,2538,2538,2538,3167,3167,3167,3167,3167,3167,3167,3167,3167,3167,3167,3167,3167,"Active Ingredient UNII(s)
43502P7F0P; 451W47IQ8X; 7TQO7W3VT8; 85H0HZU99M; EC2CNF7XFP; ND2M416302    cf098818-583d-4676-b765-a1fe00689a8c
43502P7F0P; 451W47IQ8X; 7TQO7W3VT8; 85H0HZU99M; EC2CNF7XFP; ND2M416302    cf098818-583d-4676-b765-a1fe00689a8c
43502P7F0P; 451W47IQ8X; 7TQO7W3VT8; 85H0HZU99M; EC2CNF7XFP; ND2M416302    cf098818-583d-4676-b765-a1fe00689a8c
43502P7F0P; 451W47IQ8X; 7TQO7W3VT8; 85H0HZU99M; EC2CNF7XFP; ND2M416302    cf098818-583d-4676-b765-a1fe00689a8c
43502P7F0P; 451W47IQ8X; 7TQO7W3VT8; 85H0HZU99M; EC2CNF7XFP; ND2M416302    cf098818-583d-4676-b765-a1fe00689a8c
43502P7F0P; 451W47IQ8X; 7TQO7W3VT8; 85H0HZU99M; EC2CNF7XFP; ND2M416302    cf098818-583d-4676-b765-a1fe00689a8c
43502P7F0P; 451W47IQ8X; 7TQO7W3VT8; 85H0HZU99M; EC2CNF7XFP; ND2M416302    cf098818-583d-4676-b765-a1fe00689a8c
Name: SET ID dtype: object",active ingredient unii ( s ) 43502p7f0p 451w47iq8x 7tqo7w3vt8 85h0hzu99m ec2cnf7xfp nd2m416302 active ingredient unii ( s ) 43502p7f0p 451w47iq 43502p7f0p 451w47iq8x 7tqo7w3vt8 85h0hzu99m ec2cnf7xfp nd2m416302 active ingredient unii ( s ) 43502p7f0p 451w47iq 43502p7f0p 451w47iq8x 7tqo7w3vt8 85h0hzu99m ec2cnf7xfp nd2m416302 active ingredient unii ( s ) 43502p7f0p 451w47iq 43502p7f0p 451w47iq8x 7tqo7w3vt8 85h0hzu99m ec2cnf7xfp nd2m416302 active ingredient unii ( s ) 43502p7f0p 451w47iq 43502p7f0p 451w47iq8x 7tqo7w3vt8 85h0hzu99m ec2cnf7xfp nd2m416302 active ingredient unii ( s ) 43502p7f0p 451w47iq 43502p7f0p 451w47iq8x 7tqo7w3vt8 85h0hzu99m ec2cnf7xfp nd2m416302 active ingredient unii ( s ) 43502p7f0p 451w47iq 43502p7f0p 451w47iq8x 7tqo7w3vt8 85h0hzu99m ec2cnf7xfp nd2m416302 active ingredient unii ( s ) 43502p7f0p 451w47iq name content xml  dtype object,0
2539,2539,2539,2539,2539,2539,2539,3174,3174,3174,3174,3174,3174,3174,3174,3174,3174,3174,3174,3174,"Active Ingredient UNII(s)
43502P7F0P; 7TQO7W3VT8; 85H0HZU99M    dec92845-e713-42a3-83a7-3a48920b7eed
43502P7F0P; 7TQO7W3VT8; 85H0HZU99M    dec92845-e713-42a3-83a7-3a48920b7eed
43502P7F0P; 7TQO7W3VT8; 85H0HZU99M    dec92845-e713-42a3-83a7-3a48920b7eed
Name: SET ID dtype: object",active ingredient unii ( s ) 43502p7f0p 7tqo7w3vt8 85h0hzu99m active ingredient unii ( s ) 43502p7f0p 7tqo7w3v 43502p7f0p 7tqo7w3vt8 85h0hzu99m active ingredient unii ( s ) 43502p7f0p 7tqo7w3v 43502p7f0p 7tqo7w3vt8 85h0hzu99m active ingredient unii ( s ) 43502p7f0p 7tqo7w3v name content xml  dtype object,0
2540,2540,2540,2540,2540,2540,2540,3177,3177,3177,3177,3177,3177,3177,3177,3177,3177,3177,3177,3177,"Active Ingredient UNII(s)
43502P7F0P; 7TQO7W3VT8; 85H0HZU99M; ND2M416302; V13007Z41A    cdd72141-10b6-48c6-85be-5b1294c8539c
43502P7F0P; 7TQO7W3VT8; 85H0HZU99M; ND2M416302; V13007Z41A    cdd72141-10b6-48c6-85be-5b1294c8539c
43502P7F0P; 7TQO7W3VT8; 85H0HZU99M; ND2M416302; V13007Z41A    cdd72141-10b6-48c6-85be-5b1294c8539c
43502P7F0P; 7TQO7W3VT8; 85H0HZU99M; ND2M416302; V13007Z41A    cdd72141-10b6-48c6-85be-5b1294c8539c
43502P7F0P; 7TQO7W3VT8; 85H0HZU99M; ND2M416302; V13007Z41A    cdd72141-10b6-48c6-85be-5b1294c8539c
Name: SET ID dtype: object",active ingredient unii ( s ) 43502p7f0p 7tqo7w3vt8 85h0hzu99m nd2m416302 v13007z41a active ingredient unii ( s ) 43502p7f0p 7tqo7w3v 43502p7f0p 7tqo7w3vt8 85h0hzu99m nd2m416302 v13007z41a active ingredient unii ( s ) 43502p7f0p 7tqo7w3v 43502p7f0p 7tqo7w3vt8 85h0hzu99m nd2m416302 v13007z41a active ingredient unii ( s ) 43502p7f0p 7tqo7w3v 43502p7f0p 7tqo7w3vt8 85h0hzu99m nd2m416302 v13007z41a active ingredient unii ( s ) 43502p7f0p 7tqo7w3v 43502p7f0p 7tqo7w3vt8 85h0hzu99m nd2m416302 v13007z41a active ingredient unii ( s ) 43502p7f0p 7tqo7w3v name content xml  dtype object,0
2541,2541,2541,2541,2541,2541,2541,3182,3182,3182,3182,3182,3182,3182,3182,3182,3182,3182,3182,3182,"Active Ingredient UNII(s)
43502P7F0P; 7TQO7W3VT8; V13007Z41A    28247e4a-0a18-0365-e054-00144ff88e88
43502P7F0P; 7TQO7W3VT8; V13007Z41A    28247e4a-0a18-0365-e054-00144ff88e88
43502P7F0P; 7TQO7W3VT8; V13007Z41A    28247e4a-0a18-0365-e054-00144ff88e88
Name: SET ID dtype: object",active ingredient unii ( s ) 43502p7f0p 7tqo7w3vt8 v13007z41a active ingredient unii ( s ) 43502p7f0p 7tqo7w3v 43502p7f0p 7tqo7w3vt8 v13007z41a active ingredient unii ( s ) 43502p7f0p 7tqo7w3v 43502p7f0p 7tqo7w3vt8 v13007z41a active ingredient unii ( s ) 43502p7f0p 7tqo7w3v name content xml  dtype object,0
2542,2542,2542,2542,2542,2542,2542,3185,3185,3185,3185,3185,3185,3185,3185,3185,3185,3185,3185,3185,"Active Ingredient UNII(s)
43502P7F0P; 85H0HZU99M; ND2M416302    1b19692c-dd90-4017-a905-9050375d4dcf
43502P7F0P; 85H0HZU99M; ND2M416302    1b19692c-dd90-4017-a905-9050375d4dcf
43502P7F0P; 85H0HZU99M; ND2M416302    1b19692c-dd90-4017-a905-9050375d4dcf
43502P7F0P; 85H0HZU99M; ND2M416302    1b19692c-dd90-4017-a905-9050375d4dcf
43502P7F0P; 85H0HZU99M; ND2M416302    1b19692c-dd90-4017-a905-9050375d4dcf
Name: SET ID dtype: object",active ingredient unii ( s ) 43502p7f0p 85h0hzu99m nd2m416302 active ingredient unii ( s ) 43502p7f0p 85h0hzu9 43502p7f0p 85h0hzu99m nd2m416302 active ingredient unii ( s ) 43502p7f0p 85h0hzu9 43502p7f0p 85h0hzu99m nd2m416302 active ingredient unii ( s ) 43502p7f0p 85h0hzu9 43502p7f0p 85h0hzu99m nd2m416302 active ingredient unii ( s ) 43502p7f0p 85h0hzu9 43502p7f0p 85h0hzu99m nd2m416302 active ingredient unii ( s ) 43502p7f0p 85h0hzu9 name content xml  dtype object,0
2543,2543,2543,2543,2543,2543,2543,3190,3190,3190,3190,3190,3190,3190,3190,3190,3190,3190,3190,3190,2b7014af-0cc9-4199-90f2-ec07ac02f8cf, benzphetamine hydrochloride tablets are indicated in the management of exogenous obesity as a short term ( a few weeks ) adjunct in a regimen of weight reduction based on caloric restriction in patients with an initial body mass index ( bmi ) of 30 kg m2 or higher who have not responded to appropriate weight reducing regimen ( diet and or exercise ) alone,1
2544,2544,2544,2544,2544,2544,2544,3192,3192,3192,3192,3192,3192,3192,3192,3192,3192,3192,3192,3192,2b7014af-0cc9-4199-90f2-ec07ac02f8cf,bmi is calculated by taking the patient 's weight  in kilograms ( kg )  divided by the patient 's height  in meters ( m )  squared,0
2545,2545,2545,2545,2545,2545,2545,3193,3193,3193,3193,3193,3193,3193,3193,3193,3193,3193,3193,3193,2b7014af-0cc9-4199-90f2-ec07ac02f8cf,metric conversions are as follows pounds 2 2 kg inches 0 0254 meters,0
2546,2546,2546,2546,2546,2546,2546,3194,3194,3194,3194,3194,3194,3194,3194,3194,3194,3194,3194,3194,2b7014af-0cc9-4199-90f2-ec07ac02f8cf,the limited usefulness of agents of this class ( see clinical pharmacology ) should be weighed against possible risks inherent in their use such as those described below,0
2547,2547,2547,2547,2547,2547,2547,3195,3195,3195,3195,3195,3195,3195,3195,3195,3195,3195,3195,3195,2b7014af-0cc9-4199-90f2-ec07ac02f8cf,body mass index ( bmi )  kg m 2 weight ( pounds ) height ( feet  inches ) 5'0 5'3 5'6 5'9 6'0 6'3 140 27 25 23 21 19 18 150 29 27 24 td align c,0
2548,2548,2548,2548,2548,2548,2548,3196,3196,3196,3196,3196,3196,3196,3196,3196,3196,3196,3196,3196,30789790-8317-49f9-b97b-8c5ba17b53d2, hairy cell leukemia intron a is indicated for the treatment of patients 18 years of age or older with hairy cell leukemia,1
2549,2549,2549,2549,2549,2549,2549,3197,3197,3197,3197,3197,3197,3197,3197,3197,3197,3197,3197,3197,30789790-8317-49f9-b97b-8c5ba17b53d2,malignant melanoma intron a is indicated as adjuvant to surgical treatment in patients 18 years of age or older with malignant melanoma who are free of disease but at high risk for systemic recurrence  within 56 days of surgery,1
2550,2550,2550,2550,2550,2550,2550,3198,3198,3198,3198,3198,3198,3198,3198,3198,3198,3198,3198,3198,30789790-8317-49f9-b97b-8c5ba17b53d2,follicular lymphoma intron a is indicated for the initial treatment of clinically aggressive ( see clinical pharmacology ) follicular non hodgkin 's lymphoma in conjunction with anthracycline containing combination chemotherapy in patients 18 years of age or older,1
2551,2551,2551,2551,2551,2551,2551,3199,3199,3199,3199,3199,3199,3199,3199,3199,3199,3199,3199,3199,30789790-8317-49f9-b97b-8c5ba17b53d2,efficacy of intron a therapy in patients with low grade  low tumor burden follicular non hodgkin 's lymphoma has not been demonstrated,0
2552,2552,2552,2552,2552,2552,2552,3200,3200,3200,3200,3200,3200,3200,3200,3200,3200,3200,3200,3200,30789790-8317-49f9-b97b-8c5ba17b53d2,condylomata acuminata intron a is indicated for intralesional treatment of selected patients 18 years of age or older with condylomata acuminata involving external surfaces of the genital and perianal areas ( see dosage and administration ),1
2553,2553,2553,2553,2553,2553,2553,3201,3201,3201,3201,3201,3201,3201,3201,3201,3201,3201,3201,3201,30789790-8317-49f9-b97b-8c5ba17b53d2,the use of this product in adolescents has not been studied,0
2554,2554,2554,2554,2554,2554,2554,3202,3202,3202,3202,3202,3202,3202,3202,3202,3202,3202,3202,3202,30789790-8317-49f9-b97b-8c5ba17b53d2,aids related kaposi 's sarcoma intron a is indicated for the treatment of selected patients 18 years of age or older with aids related kaposi 's sarcoma,1
2555,2555,2555,2555,2555,2555,2555,3203,3203,3203,3203,3203,3203,3203,3203,3203,3203,3203,3203,3203,30789790-8317-49f9-b97b-8c5ba17b53d2,the likelihood of response to intron a therapy is greater in patients who are without systemic symptoms  who have limited lymphadenopathy and who have a relatively intact immune system as indicated by total cd4 count,u
2556,2556,2556,2556,2556,2556,2556,3204,3204,3204,3204,3204,3204,3204,3204,3204,3204,3204,3204,3204,30789790-8317-49f9-b97b-8c5ba17b53d2,chronic hepatitis c intron a is indicated for the treatment,u
2557,2557,2557,2557,2557,2557,2557,3205,3205,3205,3205,3205,3205,3205,3205,3205,3205,3205,3205,3205,442d9e67-1c2c-73f8-e054-00144ff8d46c,isentress is indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency virus ( hiv 1 ) infection in patients 4 weeks of age and older,1
2558,2558,2558,2558,2558,2558,2558,3206,3206,3206,3206,3206,3206,3206,3206,3206,3206,3206,3206,3206,442d9e67-1c2c-73f8-e054-00144ff8d46c,the use of other active agents with isentress is associated with a greater likelihood of treatment response see clinical studies ( 14 ),0
2559,2559,2559,2559,2559,2559,2559,3207,3207,3207,3207,3207,3207,3207,3207,3207,3207,3207,3207,3207,"Active Ingredient UNII(s)
4419T9MX03    3fa9bff0-676b-45d9-9d77-a6363c63395f
4419T9MX03    3fa9bff0-676b-45d9-9d77-a6363c63395f
4419T9MX03    3fa9bff0-676b-45d9-9d77-a6363c63395f
4419T9MX03    3fa9bff0-676b-45d9-9d77-a6363c63395f
4419T9MX03    3fa9bff0-676b-45d9-9d77-a6363c63395f
Name: SET ID dtype: object",active ingredient unii ( s ) 4419t9mx03 active ingredient unii ( s ) 4419t9mx03 active in 4419t9mx03 active ingredient unii ( s ) 4419t9mx03 active in 4419t9mx03 active ingredient unii ( s ) 4419t9mx03 active in 4419t9mx03 active ingredient unii ( s ) 4419t9mx03 active in 4419t9mx03 active ingredient unii ( s ) 4419t9mx03 active in name content xml  dtype object,0
2560,2560,2560,2560,2560,2560,2560,3212,3212,3212,3212,3212,3212,3212,3212,3212,3212,3212,3212,3212,c6c7c39e-e510-4f4a-bf7a-926f0e075d3a, protriptyline hydrochloride tablets are indicated for the treatment of symptoms of mental depression in patients who are under close medical supervision,1
2561,2561,2561,2561,2561,2561,2561,3213,3213,3213,3213,3213,3213,3213,3213,3213,3213,3213,3213,3213,c6c7c39e-e510-4f4a-bf7a-926f0e075d3a,its activating properties make it particularly suitable for withdrawn and anergic patients,u
2562,2562,2562,2562,2562,2562,2562,3214,3214,3214,3214,3214,3214,3214,3214,3214,3214,3214,3214,3214,ed1b74a8-2a9b-4315-b051-673c7941cb13,1  levetiracetam injection is indicated for adjunctive therapy  as an alternative when oral administration is temporarily not feasible  in the treatment of partial onset seizures in patients 1 month of age and older with epilepsy,1
2563,2563,2563,2563,2563,2563,2563,3215,3215,3215,3215,3215,3215,3215,3215,3215,3215,3215,3215,3215,ed1b74a8-2a9b-4315-b051-673c7941cb13,( 1 1 ) myoclonic seizures in patients 12 years of age and older with juvenile myoclonic epilepsy,1
2564,2564,2564,2564,2564,2564,2564,3216,3216,3216,3216,3216,3216,3216,3216,3216,3216,3216,3216,3216,ed1b74a8-2a9b-4315-b051-673c7941cb13,( 1 2 ) primary generalized tonic clonic seizures in patients 6 years of age and older with idiopathic generalized epilepsy,1
2565,2565,2565,2565,2565,2565,2565,3217,3217,3217,3217,3217,3217,3217,3217,3217,3217,3217,3217,3217,ed1b74a8-2a9b-4315-b051-673c7941cb13,( 1 3 ) 1 1 partial onset seizures levetiracetam injection is indicated as adjunctive therapy in the treatment of partial onset seizures in adults and children 1 month of age and older with epilepsy,1
2566,2566,2566,2566,2566,2566,2566,3218,3218,3218,3218,3218,3218,3218,3218,3218,3218,3218,3218,3218,ed1b74a8-2a9b-4315-b051-673c7941cb13,levetiracetam injection is for intravenous use only as an alternative for patients when oral administration is temporarily not feasible,1
2567,2567,2567,2567,2567,2567,2567,3219,3219,3219,3219,3219,3219,3219,3219,3219,3219,3219,3219,3219,ed1b74a8-2a9b-4315-b051-673c7941cb13,1 2 myoclonic seizures in patients with juvenile myoclonic epilepsy levetiracetam injection is indicated as adjunctive therapy in the treatment of myoclonic seizures in adults and adolescents 12 years of age and older with juvenile myoclonic epilepsy,1
2568,2568,2568,2568,2568,2568,2568,3221,3221,3221,3221,3221,3221,3221,3221,3221,3221,3221,3221,3221,ed1b74a8-2a9b-4315-b051-673c7941cb13,1 3 primary generalized tonic clonic seizures levetiracetam injection is indicated as adjunctive therapy in the treatment of primary generalized tonic clonic seizures in adults and children 6 years of age and older with idiopathic generalized epilepsy,1
2569,2569,2569,2569,2569,2569,2569,3223,3223,3223,3223,3223,3223,3223,3223,3223,3223,3223,3223,3223,e4f06c0b-7cb1-49c9-97a4-2cfc21298495,rx only for use with the amicus separator only,4
2570,2570,2570,2570,2570,2570,2570,3224,3224,3224,3224,3224,3224,3224,3224,3224,3224,3224,3224,3224,e4f06c0b-7cb1-49c9-97a4-2cfc21298495, intersol solution is an isotonic solution designed to replace a proportion of the plasma used in the storage of amicus derived leukoreduced apheresis platelets under standard blood banking conditions,u
2571,2571,2571,2571,2571,2571,2571,3225,3225,3225,3225,3225,3225,3225,3225,3225,3225,3225,3225,3225,e4f06c0b-7cb1-49c9-97a4-2cfc21298495,there is no direct therapeutic effect to be expected from the formulation,0
2572,2572,2572,2572,2572,2572,2572,3226,3226,3226,3226,3226,3226,3226,3226,3226,3226,3226,3226,3226,e4f06c0b-7cb1-49c9-97a4-2cfc21298495,the solution should never be infused directly into a patient,4
2573,2573,2573,2573,2573,2573,2573,3227,3227,3227,3227,3227,3227,3227,3227,3227,3227,3227,3227,3227,e4f06c0b-7cb1-49c9-97a4-2cfc21298495,intersol platelets are leukocyte reduced apheresis platelet concentrates that are stored in a mix of 65 intersol and 35 plasma  nominal,0
2574,2574,2574,2574,2574,2574,2574,3228,3228,3228,3228,3228,3228,3228,3228,3228,3228,3228,3228,3228,e4f06c0b-7cb1-49c9-97a4-2cfc21298495,intersol platelets prepared within the range of table 1 may be stored for up to 5 days at 20 24 c  with continuous agitation,0
2575,2575,2575,2575,2575,2575,2575,3229,3229,3229,3229,3229,3229,3229,3229,3229,3229,3229,3229,3229,9da4121f-d62d-4da4-8dfb-0494da16015f, isotonic solution for irrigation only,1
2576,2576,2576,2576,2576,2576,2576,3231,3231,3231,3231,3231,3231,3231,3231,3231,3231,3231,3231,3231,333d672c-44bf-4544-bf8c-f6f72f3dfefe,75 injection ( multiple electrolytes and dextrose injection  type 3  usp ) is indicated as a source of water  electrolytes and calories or as an alkalinizing agent,1
2577,2577,2577,2577,2577,2577,2577,3232,3232,3232,3232,3232,3232,3232,3232,3232,3232,3232,3232,3232,08036dbd-55b3-47b9-9890-000f253544f3, elliotts b solution is indicated as a diluent for the intrathecal administration of methotrexate sodium and cytarabine for the prevention or treatment of meningeal leukemia or lymphocytic lymphoma,1
2578,2578,2578,2578,2578,2578,2578,3233,3233,3233,3233,3233,3233,3233,3233,3233,3233,3233,3233,3233,becc7410-0a25-49f5-b0c3-240078479dc8, potassium chloride in sodium chloride injection  usp is indicated as a source of water and electrolytes,1
2579,2579,2579,2579,2579,2579,2579,3234,3234,3234,3234,3234,3234,3234,3234,3234,3234,3234,3234,3234,b630fb8f-b6aa-4b94-a93c-d79f1626c05b, nulytely is indicated for bowel cleansing prior to colonoscopy,1
2580,2580,2580,2580,2580,2580,2580,3235,3235,3235,3235,3235,3235,3235,3235,3235,3235,3235,3235,3235,59ccc717-c374-41c0-be58-9647df881160, these intravenous solutions are indicated for use in adults and pediatric patients as sources of electrolytes  calories and water for hydration,1
2581,2581,2581,2581,2581,2581,2581,3236,3236,3236,3236,3236,3236,3236,3236,3236,3236,3236,3236,3236,d101c62c-9fd8-4bb6-e7a5-5074d189d35b, these solutions are indicated in patients requiring parenteral administration of potassium chloride with minimal carbohydrate calories and sodium chloride,1
2582,2582,2582,2582,2582,2582,2582,3237,3237,3237,3237,3237,3237,3237,3237,3237,3237,3237,3237,3237,f36c59fe-9024-4ca5-819f-f8a20550c9eb, these solutions are indicated for parenteral replacement of extracellular losses of fluid and electrolytes  with or without minimal carbohydrate calories  as required by the clinical condition of the patient,1
2583,2583,2583,2583,2583,2583,2583,3238,3238,3238,3238,3238,3238,3238,3238,3238,3238,3238,3238,3238,05f326e6-10e4-4ceb-8a23-f53c592f00b8, potassium chloride in lactated ringer s and 5 dextrose injection  usp are indicated as a source of water  electrolytes  and calories or as alkalinizing agents,1
2584,2584,2584,2584,2584,2584,2584,3239,3239,3239,3239,3239,3239,3239,3239,3239,3239,3239,3239,3239,01721071-af03-4894-95c1-10b8bc64b888, this solution is indicated for use in adults and pediatric patients as a source of electrolytes and water for hydration,1
2585,2585,2585,2585,2585,2585,2585,3240,3240,3240,3240,3240,3240,3240,3240,3240,3240,3240,3240,3240,"Active Ingredient UNII(s)
451W47IQ8X; 7TQO7W3VT8; 85H0HZU99M; EC2CNF7XFP; F446C597KA; ND2M416302    a7bceca8-7dda-4fff-80de-01858b90c928
451W47IQ8X; 7TQO7W3VT8; 85H0HZU99M; EC2CNF7XFP; F446C597KA; ND2M416302    a7bceca8-7dda-4fff-80de-01858b90c928
451W47IQ8X; 7TQO7W3VT8; 85H0HZU99M; EC2CNF7XFP; F446C597KA; ND2M416302    a7bceca8-7dda-4fff-80de-01858b90c928
451W47IQ8X; 7TQO7W3VT8; 85H0HZU99M; EC2CNF7XFP; F446C597KA; ND2M416302    a7bceca8-7dda-4fff-80de-01858b90c928
451W47IQ8X; 7TQO7W3VT8; 85H0HZU99M; EC2CNF7XFP; F446C597KA; ND2M416302    a7bceca8-7dda-4fff-80de-01858b90c928
451W47IQ8X; 7TQO7W3VT8; 85H0HZU99M; EC2CNF7XFP; F446C597KA; ND2M416302    a7bceca8-7dda-4fff-80de-01858b90c928
451W47IQ8X; 7TQO7W3VT8; 85H0HZU99M; EC2CNF7XFP; F446C597KA; ND2M416302    a7bceca8-7dda-4fff-80de-01858b90c928
Name: SET ID dtype: object",active ingredient unii ( s ) 451w47iq8x 7tqo7w3vt8 85h0hzu99m ec2cnf7xfp f446c597ka nd2m416302 active ingredient unii ( s ) 451w47iq8x 7tqo7w3v 451w47iq8x 7tqo7w3vt8 85h0hzu99m ec2cnf7xfp f446c597ka nd2m416302 active ingredient unii ( s ) 451w47iq8x 7tqo7w3v 451w47iq8x 7tqo7w3vt8 85h0hzu99m ec2cnf7xfp f446c597ka nd2m416302 active ingredient unii ( s ) 451w47iq8x 7tqo7w3v 451w47iq8x 7tqo7w3vt8 85h0hzu99m ec2cnf7xfp f446c597ka nd2m416302 active ingredient unii ( s ) 451w47iq8x 7tqo7w3v 451w47iq8x 7tqo7w3vt8 85h0hzu99m ec2cnf7xfp f446c597ka nd2m416302 active ingredient unii ( s ) 451w47iq8x 7tqo7w3v 451w47iq8x 7tqo7w3vt8 85h0hzu99m ec2cnf7xfp f446c597ka nd2m416302 active ingredient unii ( s ) 451w47iq8x 7tqo7w3v 451w47iq8x 7tqo7w3vt8 85h0hzu99m ec2cnf7xfp f446c597ka nd2m416302 active ingredient unii ( s ) 451w47iq8x 7tqo7w3v name content xml  dtype object,0
2586,2586,2586,2586,2586,2586,2586,3247,3247,3247,3247,3247,3247,3247,3247,3247,3247,3247,3247,3247,"Active Ingredient UNII(s)
451W47IQ8X; 7TQO7W3VT8; 85H0HZU99M; EC2CNF7XFP; ND2M416302    7861f17f-07a8-4679-93bf-bb307cee5143
451W47IQ8X; 7TQO7W3VT8; 85H0HZU99M; EC2CNF7XFP; ND2M416302    7861f17f-07a8-4679-93bf-bb307cee5143
451W47IQ8X; 7TQO7W3VT8; 85H0HZU99M; EC2CNF7XFP; ND2M416302    7861f17f-07a8-4679-93bf-bb307cee5143
451W47IQ8X; 7TQO7W3VT8; 85H0HZU99M; EC2CNF7XFP; ND2M416302    7861f17f-07a8-4679-93bf-bb307cee5143
Name: SET ID dtype: object",active ingredient unii ( s ) 451w47iq8x 7tqo7w3vt8 85h0hzu99m ec2cnf7xfp nd2m416302 active ingredient unii ( s ) 451w47iq8x 7tqo7w3v 451w47iq8x 7tqo7w3vt8 85h0hzu99m ec2cnf7xfp nd2m416302 active ingredient unii ( s ) 451w47iq8x 7tqo7w3v 451w47iq8x 7tqo7w3vt8 85h0hzu99m ec2cnf7xfp nd2m416302 active ingredient unii ( s ) 451w47iq8x 7tqo7w3v 451w47iq8x 7tqo7w3vt8 85h0hzu99m ec2cnf7xfp nd2m416302 active ingredient unii ( s ) 451w47iq8x 7tqo7w3v name content xml  dtype object,0
2587,2587,2587,2587,2587,2587,2587,3251,3251,3251,3251,3251,3251,3251,3251,3251,3251,3251,3251,3251,"Active Ingredient UNII(s)
451W47IQ8X; 7TQO7W3VT8; 85H0HZU99M; ND2M416302    c5b66f1b-105f-4e06-93b2-3ba9880d2f8b
451W47IQ8X; 7TQO7W3VT8; 85H0HZU99M; ND2M416302    c5b66f1b-105f-4e06-93b2-3ba9880d2f8b
451W47IQ8X; 7TQO7W3VT8; 85H0HZU99M; ND2M416302    c5b66f1b-105f-4e06-93b2-3ba9880d2f8b
451W47IQ8X; 7TQO7W3VT8; 85H0HZU99M; ND2M416302    c5b66f1b-105f-4e06-93b2-3ba9880d2f8b
Name: SET ID dtype: object",active ingredient unii ( s ) 451w47iq8x 7tqo7w3vt8 85h0hzu99m nd2m416302 active ingredient unii ( s ) 451w47iq8x 7tqo7w3v 451w47iq8x 7tqo7w3vt8 85h0hzu99m nd2m416302 active ingredient unii ( s ) 451w47iq8x 7tqo7w3v 451w47iq8x 7tqo7w3vt8 85h0hzu99m nd2m416302 active ingredient unii ( s ) 451w47iq8x 7tqo7w3v 451w47iq8x 7tqo7w3vt8 85h0hzu99m nd2m416302 active ingredient unii ( s ) 451w47iq8x 7tqo7w3v name content xml  dtype object,0
2588,2588,2588,2588,2588,2588,2588,3255,3255,3255,3255,3255,3255,3255,3255,3255,3255,3255,3255,3255,"Active Ingredient UNII(s)
451W47IQ8X; 7TQO7W3VT8; 85H0HZU99M; V13007Z41A    267e96fc-1d4c-2d8c-e054-00144ff88e88
451W47IQ8X; 7TQO7W3VT8; 85H0HZU99M; V13007Z41A    267e96fc-1d4c-2d8c-e054-00144ff88e88
Name: SET ID dtype: object",active ingredient unii ( s ) 451w47iq8x 7tqo7w3vt8 85h0hzu99m v13007z41a active ingredient unii ( s ) 451w47iq8x 7tqo7w3v 451w47iq8x 7tqo7w3vt8 85h0hzu99m v13007z41a active ingredient unii ( s ) 451w47iq8x 7tqo7w3v name content xml  dtype object,0
2589,2589,2589,2589,2589,2589,2589,3257,3257,3257,3257,3257,3257,3257,3257,3257,3257,3257,3257,3257,"Active Ingredient UNII(s)
451W47IQ8X; 85H0HZU99M; EC2CNF7XFP; ND2M416302    a610475d-b79c-46b4-8868-ea9f066f3df5
451W47IQ8X; 85H0HZU99M; EC2CNF7XFP; ND2M416302    a610475d-b79c-46b4-8868-ea9f066f3df5
451W47IQ8X; 85H0HZU99M; EC2CNF7XFP; ND2M416302    a610475d-b79c-46b4-8868-ea9f066f3df5
451W47IQ8X; 85H0HZU99M; EC2CNF7XFP; ND2M416302    a610475d-b79c-46b4-8868-ea9f066f3df5
Name: SET ID dtype: object",active ingredient unii ( s ) 451w47iq8x 85h0hzu99m ec2cnf7xfp nd2m416302 active ingredient unii ( s ) 451w47iq8x 85h0hzu9 451w47iq8x 85h0hzu99m ec2cnf7xfp nd2m416302 active ingredient unii ( s ) 451w47iq8x 85h0hzu9 451w47iq8x 85h0hzu99m ec2cnf7xfp nd2m416302 active ingredient unii ( s ) 451w47iq8x 85h0hzu9 451w47iq8x 85h0hzu99m ec2cnf7xfp nd2m416302 active ingredient unii ( s ) 451w47iq8x 85h0hzu9 name content xml  dtype object,0
2590,2590,2590,2590,2590,2590,2590,3261,3261,3261,3261,3261,3261,3261,3261,3261,3261,3261,3261,3261,6f90664e-f2ec-47ea-bfec-7be2bf2dc28c,1  hespan is indicated in the treatment of hypovolemia when plasma volume expansion is desired,1
2591,2591,2591,2591,2591,2591,2591,3262,3262,3262,3262,3262,3262,3262,3262,3262,3262,3262,3262,3262,6f90664e-f2ec-47ea-bfec-7be2bf2dc28c,it is not a substitute for blood or plasma,0
2592,2592,2592,2592,2592,2592,2592,3263,3263,3263,3263,3263,3263,3263,3263,3263,3263,3263,3263,3263,6f90664e-f2ec-47ea-bfec-7be2bf2dc28c,the adjunctive use of hespan in leukapheresis has also been shown to be safe and efficacious in improving the harvesting and increasing the yield of granulocytes by centrifugal means,1
2593,2593,2593,2593,2593,2593,2593,3264,3264,3264,3264,3264,3264,3264,3264,3264,3264,3264,3264,3264,6f90664e-f2ec-47ea-bfec-7be2bf2dc28c,hespan is a hetastarch indicated for treatment of hypovolemia when plasma volume expansion is desired,1
2594,2594,2594,2594,2594,2594,2594,3265,3265,3265,3265,3265,3265,3265,3265,3265,3265,3265,3265,3265,6f90664e-f2ec-47ea-bfec-7be2bf2dc28c,( 1 ) hespan in leukapheresis has shown to be safe and efficacious in improving the harvesting and increasing the yield of granulocytes by centrifugal means,1
2595,2595,2595,2595,2595,2595,2595,3266,3266,3266,3266,3266,3266,3266,3266,3266,3266,3266,3266,3266,3b952a55-6ef7-45c8-be21-16eefe37ec2e,1  meropenem for injection usp and sodium chloride injection usp is a penem antibacterial indicated for the treatment of complicated skin and skin structure infections ( adult patients and pediatric patients 3 months of age and older requiring the full adult dose only ),1
2596,2596,2596,2596,2596,2596,2596,3267,3267,3267,3267,3267,3267,3267,3267,3267,3267,3267,3267,3267,3b952a55-6ef7-45c8-be21-16eefe37ec2e,( 1 1 ) complicated intra abdominal infections ( adult patients and pediatric patients 3 months of age and older requiring the full adult dose only ),1
2597,2597,2597,2597,2597,2597,2597,3268,3268,3268,3268,3268,3268,3268,3268,3268,3268,3268,3268,3268,3b952a55-6ef7-45c8-be21-16eefe37ec2e,( 1 2 ) bacterial meningitis ( pediatric patients 3 months of age and older requiring the full adult dose only ),1
2598,2598,2598,2598,2598,2598,2598,3269,3269,3269,3269,3269,3269,3269,3269,3269,3269,3269,3269,3269,3b952a55-6ef7-45c8-be21-16eefe37ec2e,( 1 3 ) to reduce the development of drug resistant bacteria and maintain the effectiveness of meropenem for injection usp and sodium chloride injection usp and other antibacterial drugs  meropenem for injection usp and sodium chloride injection usp should only be used to treat infections that are proven or strongly suspected to be caused by susceptible bacteria,1
2599,2599,2599,2599,2599,2599,2599,3270,3270,3270,3270,3270,3270,3270,3270,3270,3270,3270,3270,3270,3b952a55-6ef7-45c8-be21-16eefe37ec2e,1 1 complicated skin and skin structure infections ( adult patients and pediatric patients 3 months of age and older requiring the full adult dose only ) meropenem for injection usp and sodium chloride injection usp is indicated for the treatment of complicated skin and skin structure infections ( csssi ) due to staphylococcus aureus ( methicillin susceptible isolates only )  streptococcus pyogenes  streptococcus agalactiae  viridans group streptococci  enterococcus faecalis ( vancomycin susceptible isolates only )  pseudomonas aeruginosa  escherichia coli  proteus mirabilis  bacteroides fragilis  and peptostreptococcus species,1
2600,2600,2600,2600,2600,2600,2600,3271,3271,3271,3271,3271,3271,3271,3271,3271,3271,3271,3271,3271,3b952a55-6ef7-45c8-be21-16eefe37ec2e,1 2 complicated intra abdominal infections ( adult patients and pediatric patients 3 months of age and older requiring the full adult dose only ) meropenem for injection usp and sodium chloride injection usp is indicated for the treatment of complicated appendicitis and peritonitis caused by viridans group streptococci  escherichia coli  klebsiella pneumoniae  pseudomonas aeruginosa  bacteroides fragilis  b thetaiotaomicron  and peptostreptococcus species,1
2601,2601,2601,2601,2601,2601,2601,3273,3273,3273,3273,3273,3273,3273,3273,3273,3273,3273,3273,3273,dcbf1907-1841-4afc-ab5d-a9893a2d7256, dextrose and sodium chloride injection  usp is indicated as a source of water  electrolytes  and calories,1
2602,2602,2602,2602,2602,2602,2602,3274,3274,3274,3274,3274,3274,3274,3274,3274,3274,3274,3274,3274,d7fabf08-d4e0-4bb5-8416-2e8ffe27c04b, sodium acetate injection  usp is indicated as a source of sodium  for addition to large volume iv fluids to prevent or correct hyponatremia in patients with restricted or no oral intake,1
2603,2603,2603,2603,2603,2603,2603,3275,3275,3275,3275,3275,3275,3275,3275,3275,3275,3275,3275,3275,d7fabf08-d4e0-4bb5-8416-2e8ffe27c04b,it is also useful as an additive for preparing specific iv fluid formulas when the needs of the patient cannot be met by standard electrolyte or nutrient solutions,0
2604,2604,2604,2604,2604,2604,2604,3276,3276,3276,3276,3276,3276,3276,3276,3276,3276,3276,3276,3276,b20a51ef-255e-1eb0-c0e1-461cde46b887, zonisamide capsules usp are indicated as adjunctive therapy in the treatment of partial seizures in adults with epilepsy,1
2605,2605,2605,2605,2605,2605,2605,3277,3277,3277,3277,3277,3277,3277,3277,3277,3277,3277,3277,3277,df731acd-7276-4fef-b037-bc7f30c112cb,1  intrarosa is a steroid indicated for the treatment of moderate to severe dyspareunia  a symptom of vulvar and vaginal atrophy  due to menopause,1
2606,2606,2606,2606,2606,2606,2606,3278,3278,3278,3278,3278,3278,3278,3278,3278,3278,3278,3278,3278,df731acd-7276-4fef-b037-bc7f30c112cb,intrarosa is a steroid indicated for the treatment of moderate to severe dyspareunia  a symptom of vulvar and vaginal atrophy  due to menopause,1
2607,2607,2607,2607,2607,2607,2607,3279,3279,3279,3279,3279,3279,3279,3279,3279,3279,3279,3279,3279,"Active Ingredient UNII(s)
459AG36T1B; WK2XYI10QM    d509cc4f-d92f-4216-a117-16b467a29126
459AG36T1B; WK2XYI10QM    d509cc4f-d92f-4216-a117-16b467a29126
Name: SET ID dtype: object",active ingredient unii ( s ) 459ag36t1b wk2xyi10qm active ingredient unii ( s ) 459ag36t1b wk2xyi10 459ag36t1b wk2xyi10qm active ingredient unii ( s ) 459ag36t1b wk2xyi10 name content xml  dtype object,0
2608,2608,2608,2608,2608,2608,2608,3281,3281,3281,3281,3281,3281,3281,3281,3281,3281,3281,3281,3281,7821bd40-4c84-4984-951b-6436ae20421a,1  viberzi is indicated in adults for the treatment of irritable bowel syndrome with diarrhea ( ibs d ),1
2609,2609,2609,2609,2609,2609,2609,3282,3282,3282,3282,3282,3282,3282,3282,3282,3282,3282,3282,3282,7821bd40-4c84-4984-951b-6436ae20421a,viberzi is a mu opioid receptor agonist  indicated in adults for the treatment of irritable bowel syndrome with diarrhea ( ibs d ),1
2610,2610,2610,2610,2610,2610,2610,3283,3283,3283,3283,3283,3283,3283,3283,3283,3283,3283,3283,3283,967bd870-7517-43bc-90eb-05e831d688ae,1  carbidopa  levodopa and entacapone tablets  a combination drug consisting of levodopa  carbidopa ( dopa decarboxylase inhibitor )  and entacapone ( catechol o methyltransferase comt inhibitor ) is indicated for the treatment of parkinson s disease,1
2611,2611,2611,2611,2611,2611,2611,3284,3284,3284,3284,3284,3284,3284,3284,3284,3284,3284,3284,3284,967bd870-7517-43bc-90eb-05e831d688ae,carbidopa  levodopa and entacapone tabletscan be used to substitute ( with equivalent strengths of each of the three components ) carbidopa levodopa and entacapone previously administered as individual products,u
2612,2612,2612,2612,2612,2612,2612,3285,3285,3285,3285,3285,3285,3285,3285,3285,3285,3285,3285,3285,967bd870-7517-43bc-90eb-05e831d688ae,to replace carbidopa levodopa therapy ( without entacapone ) when patients experience the signs and symptoms of end of dose wearing off and when they have been taking a total daily dose of levodopa of 600 mg or less and have not been experiencing dyskinesias,1
2613,2613,2613,2613,2613,2613,2613,3286,3286,3286,3286,3286,3286,3286,3286,3286,3286,3286,3286,3286,967bd870-7517-43bc-90eb-05e831d688ae,carbidopa  levodopa and entacapone tablets  a combination drug consisting of levodopa ( aromatic amino acid )  carbidopa ( aromatic amino acid decarboxylation inhibitor )  and entacapone ( catechol o methyltransferase ( comt ) inhibitor ) is indicated for the treatment of parkinson s disease,1
2614,2614,2614,2614,2614,2614,2614,3287,3287,3287,3287,3287,3287,3287,3287,3287,3287,3287,3287,3287,967bd870-7517-43bc-90eb-05e831d688ae,carbidopa  levodopa and entacapone tablets are to be used to substitute ( with equivalent strengths of each of the three components ) for carbidopa levodopa and entacapone previously administered as individual products ( 1 ) to replace carbidopa levodopa therapy ( without entacapone ) when patients experience the signs and symptoms of end of dose wearing off and when they have been taking a total daily dose of levodopa of 600 mg or less and have not been experiencing dyskinesias ( 1 ),1
2615,2615,2615,2615,2615,2615,2615,3288,3288,3288,3288,3288,3288,3288,3288,3288,3288,3288,3288,3288,fcef9088-ebab-4bd8-933f-c35f9c8bd50b,1  ninlaro is indicated in combination with lenalidomide and dexamethasone for the treatment of patients with multiple myeloma who have received at least one prior therapy,1
2616,2616,2616,2616,2616,2616,2616,3289,3289,3289,3289,3289,3289,3289,3289,3289,3289,3289,3289,3289,fcef9088-ebab-4bd8-933f-c35f9c8bd50b,ninlaro is a proteasome inhibitor indicated in combination with lenalidomide and dexamethasone for the treatment of patients with multiple myeloma who have received at least one prior therapy,1
2617,2617,2617,2617,2617,2617,2617,3290,3290,3290,3290,3290,3290,3290,3290,3290,3290,3290,3290,3290,02c91fba-9c47-43ef-ac78-e82369798834,1  natazia is an estrogen progestin coc indicated for use by women to prevent pregnancy,1
2618,2618,2618,2618,2618,2618,2618,3291,3291,3291,3291,3291,3291,3291,3291,3291,3291,3291,3291,3291,02c91fba-9c47-43ef-ac78-e82369798834,( 1 ) treatment of heavy menstrual bleeding in women without organic pathology who choose to use an oral contraceptive as their method of contraception,1
2619,2619,2619,2619,2619,2619,2619,3292,3292,3292,3292,3292,3292,3292,3292,3292,3292,3292,3292,3292,02c91fba-9c47-43ef-ac78-e82369798834,( 1 2 ) the efficacy of natazia in women with a body mass index ( bmi ) of 30 kg m2 has not been evaluated,0
2620,2620,2620,2620,2620,2620,2620,3293,3293,3293,3293,3293,3293,3293,3293,3293,3293,3293,3293,3293,02c91fba-9c47-43ef-ac78-e82369798834,( 1  8 8 ) 1 1 oral contraception natazia is indicated for use by women to prevent pregnancy,1
2621,2621,2621,2621,2621,2621,2621,3294,3294,3294,3294,3294,3294,3294,3294,3294,3294,3294,3294,3294,02c91fba-9c47-43ef-ac78-e82369798834,the efficacy of natazia in women with a body mass index ( bmi ) of 30 kg m2 has not been evaluated,0
2622,2622,2622,2622,2622,2622,2622,3295,3295,3295,3295,3295,3295,3295,3295,3295,3295,3295,3295,3295,02c91fba-9c47-43ef-ac78-e82369798834,1 2 heavy menstrual bleeding natazia is also indicated for the treatment of heavy menstrual bleeding in women without organic pathology who choose to use an oral contraceptive as their method of contraception see clinical studies ( 14 2 ),1
2623,2623,2623,2623,2623,2623,2623,3296,3296,3296,3296,3296,3296,3296,3296,3296,3296,3296,3296,3296,afcb9d60-3668-3890-5fed-f0794a12509d, peganone ( ethotoin tablets  usp ) is indicated for the control of tonic clonic ( grand mal ) and complex partial ( psychomotor ) seizures,1
2624,2624,2624,2624,2624,2624,2624,3297,3297,3297,3297,3297,3297,3297,3297,3297,3297,3297,3297,3297,571fe550-399d-4296-835c-37aa1ab9b409, carteolol hydrochloride ophthalmic solution 1 has been shown to be effective in lowering intraocular pressure and may be used in patients with chronic open angle glaucoma and intraocular hypertension,1
2625,2625,2625,2625,2625,2625,2625,3298,3298,3298,3298,3298,3298,3298,3298,3298,3298,3298,3298,3298,571fe550-399d-4296-835c-37aa1ab9b409,it may be used alone or in combination with other intraocular pressure lowering medications,4
2626,2626,2626,2626,2626,2626,2626,3299,3299,3299,3299,3299,3299,3299,3299,3299,3299,3299,3299,3299,125d8ede-db38-4eb9-a6be-19208687f36a, gynazole 1 butoconazole nitrate vaginal cream usp  2 is indicated for the local treatment of vulvovaginal candidiasis ( infections caused by candida ),1
2627,2627,2627,2627,2627,2627,2627,3300,3300,3300,3300,3300,3300,3300,3300,3300,3300,3300,3300,3300,125d8ede-db38-4eb9-a6be-19208687f36a,the diagnosis should be confirmed by koh smears and or cultures ( see clinical studies ),4
2628,2628,2628,2628,2628,2628,2628,3301,3301,3301,3301,3301,3301,3301,3301,3301,3301,3301,3301,3301,125d8ede-db38-4eb9-a6be-19208687f36a,note gynazole 1 butoconazole nitrate vaginal cream usp  2 is safe and effective in non pregnant women however  the safety and effectiveness of this product in pregnant women has not been established ( see precautions pregnancy ),0
2629,2629,2629,2629,2629,2629,2629,3307,3307,3307,3307,3307,3307,3307,3307,3307,3307,3307,3307,3307,4be76756-4114-4d50-a36c-fd410f6c773d,1  amlodipine besylate and atorvastatin calcium tablets are indicated in patients for whom treatment with both amlodipine and atorvastatin is appropriate,1
2630,2630,2630,2630,2630,2630,2630,3308,3308,3308,3308,3308,3308,3308,3308,3308,3308,3308,3308,3308,4be76756-4114-4d50-a36c-fd410f6c773d,amlodipine amlodipine besylate and atorvastatin calcium tablets are a combination of amlodipine besylate  a calcium channel blocker  and atorvastatin calcium  a hmg coa reductase inhibitor  indicated in patients for whom treatment with both amlodipine and atorvastatin is appropriate,1
2631,2631,2631,2631,2631,2631,2631,3309,3309,3309,3309,3309,3309,3309,3309,3309,3309,3309,3309,3309,4be76756-4114-4d50-a36c-fd410f6c773d,amlodipine is indicated for the treatment of hypertension  to lower blood pressure ( 1 1 ),1
2632,2632,2632,2632,2632,2632,2632,3310,3310,3310,3310,3310,3310,3310,3310,3310,3310,3310,3310,3310,4be76756-4114-4d50-a36c-fd410f6c773d,lowering blood pressure reduces the risk of fatal and non fatal cardiovascular events  primarily strokes and myocardial infarctions,0
2633,2633,2633,2633,2633,2633,2633,3311,3311,3311,3311,3311,3311,3311,3311,3311,3311,3311,3311,3311,4be76756-4114-4d50-a36c-fd410f6c773d,amlodipine is indicated for the treatment of coronary artery disease ( 1 2 ) atorvastatin is indicated as an adjunct therapy to diet for prevention of cardiovascular disease ( 1 3 ) and hyperlipidemia ( 1 4 ) 1 1 hypertension amlodipine is indicated for the treatment of hypertension  to lower blood pressure,1
2634,2634,2634,2634,2634,2634,2634,3313,3313,3313,3313,3313,3313,3313,3313,3313,3313,3313,3313,3313,4be76756-4114-4d50-a36c-fd410f6c773d,these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including amlodipine,0
2635,2635,2635,2635,2635,2635,2635,3319,3319,3319,3319,3319,3319,3319,3319,3319,3319,3319,3319,3319,4be76756-4114-4d50-a36c-fd410f6c773d,elevated systolic or diastolic pressure causes increased cardio,0
2636,2636,2636,2636,2636,2636,2636,3320,3320,3320,3320,3320,3320,3320,3320,3320,3320,3320,3320,3320,33b13b93-58ce-44c7-b9a2-af3b3a333f80, to reduce the development of drug resistant bacteria and maintain the effectiveness of cefotetan and other antibacterial drugs  cefotetan should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria,4
2637,2637,2637,2637,2637,2637,2637,3323,3323,3323,3323,3323,3323,3323,3323,3323,3323,3323,3323,3323,33b13b93-58ce-44c7-b9a2-af3b3a333f80,treatment cefotetan for injection  usp is indicated for the therapeutic treatment of the following infections when caused by susceptible strains of the designated organisms urinary tract infections caused by e coli  klebsiella spp ( including k pneumoniae )  proteus mirabilis and proteus spp ( which may include the organisms now called proteus vulgaris  providencia rettgeri  and morganella morganii ),1
2638,2638,2638,2638,2638,2638,2638,3324,3324,3324,3324,3324,3324,3324,3324,3324,3324,3324,3324,3324,33b13b93-58ce-44c7-b9a2-af3b3a333f80,lower respiratory tract infections caused by streptococcus pneumoniae  staphylococcus aureus ( penicillinase and nonpenicillinase producing strains )  haemophilus influenzae ( including ampicillin resistant strains )  klebsiella species ( including k pneumoniae )  e coli  proteus mirabilis  and serratia marcescens,1
2639,2639,2639,2639,2639,2639,2639,3326,3326,3326,3326,3326,3326,3326,3326,3326,3326,3326,3326,3326,33b13b93-58ce-44c7-b9a2-af3b3a333f80,gynecologic infections caused by staphylococcus aureus ( including penicillinase and nonpenicillinase producing strains )  staphylococcus epidermidis  streptococcus c,1
2640,2640,2640,2640,2640,2640,2640,3327,3327,3327,3327,3327,3327,3327,3327,3327,3327,3327,3327,3327,91556a42-5e16-4f86-bae9-a8cdd6b182a6,1  lanthanum carbonate chewable tablet is a phosphate binder indicated to reduce serum phosphate in patients with end stage renal disease ( esrd ),1
2641,2641,2641,2641,2641,2641,2641,3328,3328,3328,3328,3328,3328,3328,3328,3328,3328,3328,3328,3328,91556a42-5e16-4f86-bae9-a8cdd6b182a6,management of elevated serum phosphorus levels in end stage renal disease patients usually includes all of the following reduction in dietary intake of phosphate  removal of phosphate by dialysis and reduction of intestinal phosphate absorption with phosphate binders,u
2642,2642,2642,2642,2642,2642,2642,3329,3329,3329,3329,3329,3329,3329,3329,3329,3329,3329,3329,3329,91556a42-5e16-4f86-bae9-a8cdd6b182a6,lanthanum carbonate chewable tablets are phosphate binder indicated to reduce serum phosphate in patients with end stage renal disease ( esrd ),1
2643,2643,2643,2643,2643,2643,2643,3330,3330,3330,3330,3330,3330,3330,3330,3330,3330,3330,3330,3330,e1fc95fe-7816-47b6-b73d-b2f644f79872, for the management of moderately severe to severe essential hypertension and in uncomplicated cases of malignant hypertension,1
2644,2644,2644,2644,2644,2644,2644,3331,3331,3331,3331,3331,3331,3331,3331,3331,3331,3331,3331,3331,78987a51-82f7-4ca6-80ad-fa22d1f3e11a, helps loosen phlegm ( mucus ) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus  drain bronchial tubes and make coughs more productive,1
2645,2645,2645,2645,2645,2645,2645,3332,3332,3332,3332,3332,3332,3332,3332,3332,3332,3332,3332,3332,78987a51-82f7-4ca6-80ad-fa22d1f3e11a,helps loosen phlegm and thin bronchial secretions in patients with stable chronic bronchitis,1
2646,2646,2646,2646,2646,2646,2646,3333,3333,3333,3333,3333,3333,3333,3333,3333,3333,3333,3333,3333,98149172-3ec7-4212-9a37-5501bbfb5829,uses helps loosen phlegm ( mucus ) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and make coughs more productive temporarily relieves nasal congestion due to common cold hay fever upper respiratory allergies temporarily restores freer breathing through the nose promotes nasal and or sinus drainage temporarily relieves sinus congestion and pressure,1
2647,2647,2647,2647,2647,2647,2647,3334,3334,3334,3334,3334,3334,3334,3334,3334,3334,3334,3334,3334,74f259fb-0171-45ae-aabc-e663e7c9893c,indications 10 sodium sulfacetamide 5 sulfur cleanser ( in a urea vehicle ) is indicated in the topical control of acne vulgaris  acne rosacea and seborrheic dermatitis,1
2648,2648,2648,2648,2648,2648,2648,3335,3335,3335,3335,3335,3335,3335,3335,3335,3335,3335,3335,3335,9ed7adc9-bd0c-41af-b34c-43d15a7799d1,1  ribavirin is a nucleoside analogue indicated in combination with interferon alfa 2b ( nonpegylated ) for the treatment of chronic hepatitis c ( chc ) in patients 3 years of age or older with compensated liver disease,1
2649,2649,2649,2649,2649,2649,2649,3336,3336,3336,3336,3336,3336,3336,3336,3336,3336,3336,3336,3336,9ed7adc9-bd0c-41af-b34c-43d15a7799d1,( 1 1 ) patients with the following characteristics are less likely to benefit from re treatment after failing a course of therapy previous nonresponse  previous pegylated interferon treatment  significant bridging fibrosis or cirrhosis  and genotype 1 infection,u
2650,2650,2650,2650,2650,2650,2650,3337,3337,3337,3337,3337,3337,3337,3337,3337,3337,3337,3337,3337,9ed7adc9-bd0c-41af-b34c-43d15a7799d1,1 1 chronic hepatitis c ( chc ) ribavirin capsules  usp in combination with interferon alfa 2b ( nonpegylated ) is indicated for the treatment of chronic hepatitis c ( chc ) in patients 3 years of age and older with compensated liver disease see warnings and precautions ( 5 9  5 10 )  and use in specific populations ( 8 4 ),1
2651,2651,2651,2651,2651,2651,2651,3338,3338,3338,3338,3338,3338,3338,3338,3338,3338,3338,3338,3338,9ed7adc9-bd0c-41af-b34c-43d15a7799d1,the following points should be considered when initiating ribavirin capsules  usp combination therapy with intron a these indications are based on achieving undetectable hcv rna after treatment for 24 or 48 weeks and maintaining a sustained virologic response ( svr ) 24 weeks after the last dose,4
2652,2652,2652,2652,2652,2652,2652,3339,3339,3339,3339,3339,3339,3339,3339,3339,3339,3339,3339,3339,9ed7adc9-bd0c-41af-b34c-43d15a7799d1,patients with the following characteristics are less likely to benefit from retreatment after failing a course of therapy previous nonresponse  previous pegylated interferon treatment  significant bridging fibrosis or cirrhosis  and genotype 1 infection see clinical studies ( 14 ),4
2653,2653,2653,2653,2653,2653,2653,3340,3340,3340,3340,3340,3340,3340,3340,3340,3340,3340,3340,3340,9ed7adc9-bd0c-41af-b34c-43d15a7799d1,no safety and efficacy data are available for treatment of longer than one year,0
2654,2654,2654,2654,2654,2654,2654,3341,3341,3341,3341,3341,3341,3341,3341,3341,3341,3341,3341,3341,bbf0d8e4-b8e4-4958-b6b6-f0b9960f3b6a, nafcillin is indicated in the treatment of infections caused by penicillinase producing staphylococci which have demonstrated susceptibility to the drug,1
2655,2655,2655,2655,2655,2655,2655,3342,3342,3342,3342,3342,3342,3342,3342,3342,3342,3342,3342,3342,bbf0d8e4-b8e4-4958-b6b6-f0b9960f3b6a,culture and susceptibility tests should be performed initially to determine the causative organism and its susceptibility to the drug ( see clinical pharmacology susceptibility test methods ),4
2656,2656,2656,2656,2656,2656,2656,3343,3343,3343,3343,3343,3343,3343,3343,3343,3343,3343,3343,3343,bbf0d8e4-b8e4-4958-b6b6-f0b9960f3b6a,nafcillin may be used to initiate therapy in suspected cases of resistant staphylococcal infections prior to the availability of susceptibility test results,1
2657,2657,2657,2657,2657,2657,2657,3344,3344,3344,3344,3344,3344,3344,3344,3344,3344,3344,3344,3344,bbf0d8e4-b8e4-4958-b6b6-f0b9960f3b6a,nafcillin should not be used in infections caused by organisms susceptible to penicillin g if the susceptibility tests indicate that the infection is due to an organism other than a resistant staphylococcus  therapy should not be continued with nafcillin,2
2658,2658,2658,2658,2658,2658,2658,3345,3345,3345,3345,3345,3345,3345,3345,3345,3345,3345,3345,3345,bbf0d8e4-b8e4-4958-b6b6-f0b9960f3b6a,to reduce the development of drug resistant bacteria and maintain the effectiveness of nafcillin for injection and other antibacterial drugs  nafcillin for injection should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria,1
2659,2659,2659,2659,2659,2659,2659,3348,3348,3348,3348,3348,3348,3348,3348,3348,3348,3348,3348,3348,e9307620-36bd-46c2-a8b2-027d3fba87ba,1 indications usage oseltamivir phosphate capsules usp  is an influenza neuraminidase inhibitor ( nai ) indicated for treatment of acute  uncomplicated influenza a and b in patients 2 weeks of age and older who have been symptomatic for no more than 48 hours,1
2660,2660,2660,2660,2660,2660,2660,3349,3349,3349,3349,3349,3349,3349,3349,3349,3349,3349,3349,3349,e9307620-36bd-46c2-a8b2-027d3fba87ba,( 1 1 ) prophylaxis of influenza a and b in patients 1 year and older,1
2661,2661,2661,2661,2661,2661,2661,3350,3350,3350,3350,3350,3350,3350,3350,3350,3350,3350,3350,3350,e9307620-36bd-46c2-a8b2-027d3fba87ba,( 1 2 ) limitations of use not a substitute for annual influenza vaccination,0
2662,2662,2662,2662,2662,2662,2662,3351,3351,3351,3351,3351,3351,3351,3351,3351,3351,3351,3351,3351,e9307620-36bd-46c2-a8b2-027d3fba87ba,( 1 3 ) consider available information on influenza drug susceptibility patterns and treatment effects when deciding whether to use,0
2663,2663,2663,2663,2663,2663,2663,3352,3352,3352,3352,3352,3352,3352,3352,3352,3352,3352,3352,3352,e9307620-36bd-46c2-a8b2-027d3fba87ba,( 1 3 ) not recommended for patients with end stage renal disease not undergoing dialysis,2
2664,2664,2664,2664,2664,2664,2664,3353,3353,3353,3353,3353,3353,3353,3353,3353,3353,3353,3353,3353,e9307620-36bd-46c2-a8b2-027d3fba87ba,( 1 3 ) 1 1 treatment of influenza oseltamivir phosphate capsule is indicated for the treatment of acute  uncomplicated illness due to influenza a and b infection in patients 2 weeks of age and older who have been symptomatic for no more than 48 hours,1
2665,2665,2665,2665,2665,2665,2665,3354,3354,3354,3354,3354,3354,3354,3354,3354,3354,3354,3354,3354,e9307620-36bd-46c2-a8b2-027d3fba87ba,1 2 prophylaxis of influenza oseltamivir phosphate capsule is indicated for the prophylaxis of influenza a and b in patients 1 year and older,1
2666,2666,2666,2666,2666,2666,2666,3355,3355,3355,3355,3355,3355,3355,3355,3355,3355,3355,3355,3355,e9307620-36bd-46c2-a8b2-027d3fba87ba,1 3 limitations of use oseltamivir phosphate capsule is not a substitute for early influenza vaccination on an annual basis as recommended by the centers for disease control and prevention advisory committee on immunization practices,2
2667,2667,2667,2667,2667,2667,2667,3356,3356,3356,3356,3356,3356,3356,3356,3356,3356,3356,3356,3356,e9307620-36bd-46c2-a8b2-027d3fba87ba,influenza viruses change over time,0
2668,2668,2668,2668,2668,2668,2668,3357,3357,3357,3357,3357,3357,3357,3357,3357,3357,3357,3357,3357,e9307620-36bd-46c2-a8b2-027d3fba87ba,emergence of resistance substitutions could decrease drug effectiveness,0
2669,2669,2669,2669,2669,2669,2669,3358,3358,3358,3358,3358,3358,3358,3358,3358,3358,3358,3358,3358,e9307620-36bd-46c2-a8b2-027d3fba87ba,other factors ( for example  changes in viral virulence ) might also diminish clinical benefit of antiviral drugs,0
2670,2670,2670,2670,2670,2670,2670,3359,3359,3359,3359,3359,3359,3359,3359,3359,3359,3359,3359,3359,e9307620-36bd-46c2-a8b2-027d3fba87ba,prescribers should consider available information on influenza drug susceptibility patterns and treatment effects when deciding whether to use oseltamivir phosphate capsules see microbiology ( 12 4 ),0
2671,2671,2671,2671,2671,2671,2671,3360,3360,3360,3360,3360,3360,3360,3360,3360,3360,3360,3360,3360,e9307620-36bd-46c2-a8b2-027d3fba87ba,oseltamivir phosphate capsule is not recommended for patients with end stage renal disease not undergoing dialysis see dosage and administration ( 2 4 ) and use in specific populations ( 8 6 ),2
2672,2672,2672,2672,2672,2672,2672,3361,3361,3361,3361,3361,3361,3361,3361,3361,3361,3361,3361,3361,eee5217a-eba8-463a-812d-bf3c66f0934f,1  ondansetron is indicated for the prevention of nausea and vomiting associated with highly emetogenic cancer chemotherapy  including cisplatin greater than or equal to 50 mg m2 initial and repeat courses of moderately emetogenic cancer chemotherapy radiotherapy in patients receiving either total body irradiation  single high dose fraction to the abdomen  or daily fractions to the abdomen ondansetron is also indicated for the prevention of postoperative nausea and or vomiting,1
2673,2673,2673,2673,2673,2673,2673,3362,3362,3362,3362,3362,3362,3362,3362,3362,3362,3362,3362,3362,eee5217a-eba8-463a-812d-bf3c66f0934f,ondansetron is a 5 ht3 receptor antagonist indicated for the prevention of nausea and vomiting associated with highly emetogenic cancer chemotherapy  including cisplatin greater than or equal to 50 mg m2 ( 1 ) nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy ( 1 ) nausea and vomiting associated with radiotherapy in patients receiving either total body irradiation  single high dose fraction to the abdomen  or daily fractions to the abdomen ( 1 ) postoperative nausea and or vomiting ( 1 ),1
2674,2674,2674,2674,2674,2674,2674,3363,3363,3363,3363,3363,3363,3363,3363,3363,3363,3363,3363,3363,5adedc01-ebf0-11e3-ac10-0800200c9a66,1  aptensio xr is indicated for the treatment of attention deficit hyperactivity disorder ( adhd ) see clinical studies ( 14 ),1
2675,2675,2675,2675,2675,2675,2675,3364,3364,3364,3364,3364,3364,3364,3364,3364,3364,3364,3364,3364,5adedc01-ebf0-11e3-ac10-0800200c9a66,aptensio xr is a central nervous system ( cns ) stimulant indicated for the treatment of attention deficit hyperactivity disorder ( adhd ),1
2676,2676,2676,2676,2676,2676,2676,3365,3365,3365,3365,3365,3365,3365,3365,3365,3365,3365,3365,3365,54e21b7b-939c-4afa-9492-bde2b36dd352,1 indications usage zidovudine capsules are a nucleoside analogue reverse transcriptase inhibitor indicated for treatment of human immunodeficiency virus ( hiv 1 ) infection in combination with other antiretroviral agents,1
2677,2677,2677,2677,2677,2677,2677,3366,3366,3366,3366,3366,3366,3366,3366,3366,3366,3366,3366,3366,54e21b7b-939c-4afa-9492-bde2b36dd352,( 1 1 ) prevention of maternal fetal hiv 1 transmission,1
2678,2678,2678,2678,2678,2678,2678,3367,3367,3367,3367,3367,3367,3367,3367,3367,3367,3367,3367,3367,54e21b7b-939c-4afa-9492-bde2b36dd352,( 1 2 ) 1 1 treatment of hiv 1 zidovudine capsules  a nucleoside reverse transcriptase inhibitor  are indicated in combination with other antiretroviral agents for the treatment of hiv 1 infection,1
2679,2679,2679,2679,2679,2679,2679,3368,3368,3368,3368,3368,3368,3368,3368,3368,3368,3368,3368,3368,54e21b7b-939c-4afa-9492-bde2b36dd352,1 2 prevention of maternal fetal hiv 1 transmission zidovudine capsules are indicated for the prevention of maternal fetal hiv 1 transmission see dosage and administration ( 2 3 ),1
2680,2680,2680,2680,2680,2680,2680,3369,3369,3369,3369,3369,3369,3369,3369,3369,3369,3369,3369,3369,54e21b7b-939c-4afa-9492-bde2b36dd352,the indication is based on a dosing regimen that included 3 components antepartum therapy of hiv 1 infected mothers intrapartum therapy of hiv 1 infected mothers post partum therapy of hiv 1 exposed neonate points to consider prior to initiating zidovudine capsules in pregnant women for the prevention of maternal fetal hiv 1 transmission include in most cases  zidovudine capsules for prevention of maternal fetal hiv 1 transmission should be given in combination with other antiretroviral drugs,1
2681,2681,2681,2681,2681,2681,2681,3370,3370,3370,3370,3370,3370,3370,3370,3370,3370,3370,3370,3370,54e21b7b-939c-4afa-9492-bde2b36dd352,prevention of hiv 1 transmission in women who have received zidovudine capsules for a prolonged period before pregnancy has not been evaluated,0
2682,2682,2682,2682,2682,2682,2682,3371,3371,3371,3371,3371,3371,3371,3371,3371,3371,3371,3371,3371,54e21b7b-939c-4afa-9492-bde2b36dd352,because the fetus is most susceptible to the potential teratogenic effects of drugs during the first 10 weeks of gestation and the risks of therapy with zidovudine capsules during that period are not fully known  women in the first trimester of pregnancy who do not require immediate initiation of antiretroviral therapy for their own health may consider delaying use this indication is based on use after 14 weeks gestation,4
2683,2683,2683,2683,2683,2683,2683,3372,3372,3372,3372,3372,3372,3372,3372,3372,3372,3372,3372,3372,b92f9206-325e-4454-9518-4f7464b23f47,1  ciprofloxacin extended release tablets are indicated for the treatment of infections caused by susceptible isolates of the designated microorganisms in the conditions and patient populations listed below,1
2684,2684,2684,2684,2684,2684,2684,3373,3373,3373,3373,3373,3373,3373,3373,3373,3373,3373,3373,3373,b92f9206-325e-4454-9518-4f7464b23f47,ciprofloxacin extended release tablets are a fluoroquinolone antibacterial indicated in adults ( 18 years of age ) with infections caused by designated  susceptible bacteria,1
2685,2685,2685,2685,2685,2685,2685,3374,3374,3374,3374,3374,3374,3374,3374,3374,3374,3374,3374,3374,b92f9206-325e-4454-9518-4f7464b23f47,uncomplicated urinary tract infections ( 1 1 ) complicated urinary tract infections and acute uncomplicated pyelonephritis ( 1 2 ) usage to reduce the development of drug resistant bacteria and maintain the effectiveness of ciprofloxacin extended release tablets and other antibacterial drugs  ciprofloxacin extended release tablets should be used only to treat infections that are proven or strongly suspected to be caused by bacteria,1
2686,2686,2686,2686,2686,2686,2686,3375,3375,3375,3375,3375,3375,3375,3375,3375,3375,3375,3375,3375,b92f9206-325e-4454-9518-4f7464b23f47,( 1 4 ) 1 1 uncomplicated urinary tract infections ( acute cystitis ) ciprofloxacin extended release tablets are indicated for the treatment of uncomplicated urinary tract infections ( utis ) caused by escherichia coli  proteus mirabilis  enterococcus faecalis  or staphylococcus saprophyticus,1
2687,2687,2687,2687,2687,2687,2687,3376,3376,3376,3376,3376,3376,3376,3376,3376,3376,3376,3376,3376,b92f9206-325e-4454-9518-4f7464b23f47,because fluoroquinolones  including ciprofloxacin extended release tablets  have been associated with serious adverse reactions see warnings and precautions ( 5 1 to 5 15 ) and for some patients uncomplicated uti ( acute cystitis ) is self limiting  reserve ciprofloxacin extended release tablets for treatment of uncomplicated utis ( acute cystitis ) in patients who have no alternative treatment options,2
2688,2688,2688,2688,2688,2688,2688,3377,3377,3377,3377,3377,3377,3377,3377,3377,3377,3377,3377,3377,b92f9206-325e-4454-9518-4f7464b23f47,1 2 complicated urinary tract infections  and acute uncomplicated pyelonephritis ciprofloxacin extended release tablets are indicated for the treatment of complicated urinary tract infections ( cuti ) caused by escherichia coli  klebsiella pneumo,1
2689,2689,2689,2689,2689,2689,2689,3378,3378,3378,3378,3378,3378,3378,3378,3378,3378,3378,3378,3378,0ed518de-4ae1-43d1-84ff-26872d9e6a0f,1  ciprodex is indicated for the treatment of infections caused by susceptible isolates of the designated microorganisms in the specific conditions listed below acute otitis media in pediatric patients ( age 6 months and older ) with tympanostomy tubes due to staphylococcus aureus  streptococcus pneumoniae  haemophilus influenzae  moraxella catarrhalis  and pseudomonas aeruginosa,1
2690,2690,2690,2690,2690,2690,2690,3379,3379,3379,3379,3379,3379,3379,3379,3379,3379,3379,3379,3379,0ed518de-4ae1-43d1-84ff-26872d9e6a0f,acute otitis externa in pediatric ( age 6 months and older )  adult and elderly patients due to staphylococcus aureus and pseudomonas aeruginosa,1
2691,2691,2691,2691,2691,2691,2691,3380,3380,3380,3380,3380,3380,3380,3380,3380,3380,3380,3380,3380,0ed518de-4ae1-43d1-84ff-26872d9e6a0f,ciprodex is a combination of ciprofloxacin  a fluoroquinolone antibacterial and dexamethasone  a corticosteroid  indicated for the treatment of infections caused by susceptible isolates of the designated microorganisms in the specific conditions listed below acute otitis media in pediatric patients ( age 6 months and older ) with tympanostomy tubes due to staphylococcus aureus  streptococcus pneumoniae  haemophilus influenzae  moraxella catarrhalis  and pseudomonas aeruginosa,1
2692,2692,2692,2692,2692,2692,2692,3381,3381,3381,3381,3381,3381,3381,3381,3381,3381,3381,3381,3381,0ed518de-4ae1-43d1-84ff-26872d9e6a0f,( 1 ) acute otitis externa in pediatric ( age 6 months and older )  adult and elderly patients due to staphylococcus aureus and pseudomonas aeruginosa,1
2693,2693,2693,2693,2693,2693,2693,3382,3382,3382,3382,3382,3382,3382,3382,3382,3382,3382,3382,3382,598288ca-256a-4b9e-91e0-829f02cb8cd3, cipro hc otic is indicated for the treatment of acute otitis externa in adult and pediatric patients  one year and older  due to susceptible strains of pseudomonas aeruginosa  staphylococcus aureus  and proteus mirabilis,1
2694,2694,2694,2694,2694,2694,2694,3384,3384,3384,3384,3384,3384,3384,3384,3384,3384,3384,3384,3384,c07e21c5-7afc-4ae9-ae58-0e281a237361,1  fenofibric acid delayed release capsules are a peroxisome proliferator activated receptor ( ppar ) alpha agonist indicated as adjunctive therapy to diet to reduce tg in patients with severe hypertriglyceridemia ( 1 1 ),1
2695,2695,2695,2695,2695,2695,2695,3385,3385,3385,3385,3385,3385,3385,3385,3385,3385,3385,3385,3385,c07e21c5-7afc-4ae9-ae58-0e281a237361,reduce elevated ldl c  total c  tg and apo b  and to increase hdl c in patients with primary hypercholesterolemia or mixed dyslipidemia ( 1 2 ),u
2696,2696,2696,2696,2696,2696,2696,3386,3386,3386,3386,3386,3386,3386,3386,3386,3386,3386,3386,3386,c07e21c5-7afc-4ae9-ae58-0e281a237361,limitations of use fenofibrate at a dose equivalent to 135 mg of fenofibric acid delayed release capsules did not reduce coronary heart disease morbidity and mortality in patients with type 2 diabetes mellitus ( 5 1 ),2
2697,2697,2697,2697,2697,2697,2697,3387,3387,3387,3387,3387,3387,3387,3387,3387,3387,3387,3387,3387,c07e21c5-7afc-4ae9-ae58-0e281a237361,1 1 treatment of severe hypertriglyceridemia fenofibric acid delayed release capsules are indicated as adjunctive therapy to diet to reduce triglycerides ( tg ) in patients with severe hypertriglyceridemia,1
2698,2698,2698,2698,2698,2698,2698,3388,3388,3388,3388,3388,3388,3388,3388,3388,3388,3388,3388,3388,c07e21c5-7afc-4ae9-ae58-0e281a237361,improving glycemic control in diabetic patients showing fasting chylomicronemia will usually obviate the need for pharmacological intervention,0
2699,2699,2699,2699,2699,2699,2699,3389,3389,3389,3389,3389,3389,3389,3389,3389,3389,3389,3389,3389,c07e21c5-7afc-4ae9-ae58-0e281a237361,markedly elevated levels of serum triglycerides ( e g  2  000 mg dl ) may increase the risk of developing pancreatitis,0
2700,2700,2700,2700,2700,2700,2700,3390,3390,3390,3390,3390,3390,3390,3390,3390,3390,3390,3390,3390,c07e21c5-7afc-4ae9-ae58-0e281a237361,the effect of fenofibric acid delayed release capsules therapy on reducing this risk has not been adequately studied,0
2701,2701,2701,2701,2701,2701,2701,3391,3391,3391,3391,3391,3391,3391,3391,3391,3391,3391,3391,3391,c07e21c5-7afc-4ae9-ae58-0e281a237361,1 2 treatment of primary hypercholesterolemia or mixed dyslipidemia fenofibric acid delayed release capsules are indicated as adjunctive therapy to diet to reduce elevated low density lipoprotein cholesterol ( ldl c )  total cholesterol ( total c )  triglycerides ( tg )  and apolipoprotein b ( apo b )  and to increase high density lipoprotein cholesterol ( hdl c ) in patients with primary hypercholesterolemia or mixed dyslipidemia,1
2702,2702,2702,2702,2702,2702,2702,3392,3392,3392,3392,3392,3392,3392,3392,3392,3392,3392,3392,3392,c07e21c5-7afc-4ae9-ae58-0e281a237361,1 3 limitations of use fenofibrate at a dose equivalent to 135 mg of fenofibric acid delayed release capsules did not reduce coronary heart disease morbidity and mortality in 2 large  randomized controlled trials of patients with type 2 diabetes mellitus see warnings and precautions ( li,2
2703,2703,2703,2703,2703,2703,2703,3393,3393,3393,3393,3393,3393,3393,3393,3393,3393,3393,3393,3393,37eb1205-1743-4480-8631-b0bbcaeb8359, desoximetasone cream usp  0 05  desoximetasone cream usp  0 25  and desoximetasone gel usp  0 05 are indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid responsive dermatoses,1
2704,2704,2704,2704,2704,2704,2704,3394,3394,3394,3394,3394,3394,3394,3394,3394,3394,3394,3394,3394,628f0998-1206-4001-aeee-18133aa9f3bf,1  xgeva is a rank ligand ( rankl ) inhibitor indicated for prevention of skeletal related events in patients with multiple myeloma and in patients with bone metastases from solid tumors,1
2705,2705,2705,2705,2705,2705,2705,3395,3395,3395,3395,3395,3395,3395,3395,3395,3395,3395,3395,3395,628f0998-1206-4001-aeee-18133aa9f3bf,( 1 1 ) treatment of adults and skeletally mature adolescents with giant cell tumor of bone that is unresectable or where surgical resection is likely to result in severe morbidity,1
2706,2706,2706,2706,2706,2706,2706,3396,3396,3396,3396,3396,3396,3396,3396,3396,3396,3396,3396,3396,628f0998-1206-4001-aeee-18133aa9f3bf,( 1 2  14 3 ) treatment of hypercalcemia of malignancy refractory to bisphosphonate therapy,u
2707,2707,2707,2707,2707,2707,2707,3397,3397,3397,3397,3397,3397,3397,3397,3397,3397,3397,3397,3397,628f0998-1206-4001-aeee-18133aa9f3bf,( 1 3 ) 1 1 multiple myeloma and bone metastasis from solid tumors xgeva is indicated for the prevention of skeletal related events in patients with multiple myeloma and in patients with bone metastases from solid tumors,1
2708,2708,2708,2708,2708,2708,2708,3398,3398,3398,3398,3398,3398,3398,3398,3398,3398,3398,3398,3398,628f0998-1206-4001-aeee-18133aa9f3bf,1 2 giant cell tumor of bone xgeva is indicated for the treatment of adults and skeletally mature adolescents with giant cell tumor of bone that is unresectable or where surgical resection is likely to result in severe morbidity see clinical trials ( 14 2 ),1
2709,2709,2709,2709,2709,2709,2709,3399,3399,3399,3399,3399,3399,3399,3399,3399,3399,3399,3399,3399,628f0998-1206-4001-aeee-18133aa9f3bf,1 3 hypercalcemia of malignancy xgeva is indicated for the treatment of hypercalcemia of malignancy refractory to bisphosphonate therapy,1
2710,2710,2710,2710,2710,2710,2710,3400,3400,3400,3400,3400,3400,3400,3400,3400,3400,3400,3400,3400,"Active Ingredient UNII(s)
4EVE5946BQ; 7TQO7W3VT8; 85H0HZU99M; ND2M416302; V13007Z41A    35ffe071-8bc1-4c88-8c85-645847acf169
4EVE5946BQ; 7TQO7W3VT8; 85H0HZU99M; ND2M416302; V13007Z41A    35ffe071-8bc1-4c88-8c85-645847acf169
4EVE5946BQ; 7TQO7W3VT8; 85H0HZU99M; ND2M416302; V13007Z41A    35ffe071-8bc1-4c88-8c85-645847acf169
4EVE5946BQ; 7TQO7W3VT8; 85H0HZU99M; ND2M416302; V13007Z41A    35ffe071-8bc1-4c88-8c85-645847acf169
4EVE5946BQ; 7TQO7W3VT8; 85H0HZU99M; ND2M416302; V13007Z41A    35ffe071-8bc1-4c88-8c85-645847acf169
Name: SET ID dtype: object",active ingredient unii ( s ) 4eve5946bq 7tqo7w3vt8 85h0hzu99m nd2m416302 v13007z41a active ingredient unii ( s ) 4eve5946bq 7tqo7w3v 4eve5946bq 7tqo7w3vt8 85h0hzu99m nd2m416302 v13007z41a active ingredient unii ( s ) 4eve5946bq 7tqo7w3v 4eve5946bq 7tqo7w3vt8 85h0hzu99m nd2m416302 v13007z41a active ingredient unii ( s ) 4eve5946bq 7tqo7w3v 4eve5946bq 7tqo7w3vt8 85h0hzu99m nd2m416302 v13007z41a active ingredient unii ( s ) 4eve5946bq 7tqo7w3v 4eve5946bq 7tqo7w3vt8 85h0hzu99m nd2m416302 v13007z41a active ingredient unii ( s ) 4eve5946bq 7tqo7w3v name content xml  dtype object,0
2711,2711,2711,2711,2711,2711,2711,3405,3405,3405,3405,3405,3405,3405,3405,3405,3405,3405,3405,3405,"Active Ingredient UNII(s)
4EVE5946BQ; 7TQO7W3VT8; V13007Z41A    43402281-92b1-61aa-e054-00144ff88e88
4EVE5946BQ; 7TQO7W3VT8; V13007Z41A    43402281-92b1-61aa-e054-00144ff88e88
4EVE5946BQ; 7TQO7W3VT8; V13007Z41A    43402281-92b1-61aa-e054-00144ff88e88
Name: SET ID dtype: object",active ingredient unii ( s ) 4eve5946bq 7tqo7w3vt8 v13007z41a active ingredient unii ( s ) 4eve5946bq 7tqo7w3v 4eve5946bq 7tqo7w3vt8 v13007z41a active ingredient unii ( s ) 4eve5946bq 7tqo7w3v 4eve5946bq 7tqo7w3vt8 v13007z41a active ingredient unii ( s ) 4eve5946bq 7tqo7w3v name content xml  dtype object,0
2712,2712,2712,2712,2712,2712,2712,3408,3408,3408,3408,3408,3408,3408,3408,3408,3408,3408,3408,3408,"Active Ingredient UNII(s)
4EVE5946BQ; 85H0HZU99M; ND2M416302; V13007Z41A    ee0d396c-5caa-4a1a-9865-1a742d9d8d68
4EVE5946BQ; 85H0HZU99M; ND2M416302; V13007Z41A    ee0d396c-5caa-4a1a-9865-1a742d9d8d68
4EVE5946BQ; 85H0HZU99M; ND2M416302; V13007Z41A    ee0d396c-5caa-4a1a-9865-1a742d9d8d68
Name: SET ID dtype: object",active ingredient unii ( s ) 4eve5946bq 85h0hzu99m nd2m416302 v13007z41a active ingredient unii ( s ) 4eve5946bq 85h0hzu9 4eve5946bq 85h0hzu99m nd2m416302 v13007z41a active ingredient unii ( s ) 4eve5946bq 85h0hzu9 4eve5946bq 85h0hzu99m nd2m416302 v13007z41a active ingredient unii ( s ) 4eve5946bq 85h0hzu9 name content xml  dtype object,0
2713,2713,2713,2713,2713,2713,2713,3411,3411,3411,3411,3411,3411,3411,3411,3411,3411,3411,3411,3411,b172773b-3905-4a1c-ad95-bab4b6126563,1  rituxan ( rituximab ) is a cd20 directed cytolytic antibody indicated for the treatment of patients with non hodgkin 's lymphoma ( nhl ) ( 1 1 ) chronic lymphocytic leukemia ( cll ) ( 1 2 ) rheumatoid arthritis ( ra ) in combination with methotrexate in adult patients with moderately to severely active ra who have inadequate response to one or more tnf antagonist therapies ( 1 3 ) granulomatosis with polyangiitis ( gpa ) ( wegener 's granulomatosis ) and microscopic polyangiitis ( mpa ) in adult patients in combination with glucocorticoids ( 1 4 ) limitations of use rituxan is not recommended for use in patients with severe  active infections ( 1 5 ),1
2714,2714,2714,2714,2714,2714,2714,3412,3412,3412,3412,3412,3412,3412,3412,3412,3412,3412,3412,3412,b172773b-3905-4a1c-ad95-bab4b6126563,1 1 non hodgkin 's lymphoma ( nhl ) rituxan ( rituximab ) is indicated for the treatment of patients with relapsed or refractory  low grade or follicular  cd20 positive  b cell nhl as a single agent previously untreated follicular  cd20 positive  b cell nhl in combination with first line chemotherapy and  in patients achieving a complete or partial response to rituxan in combination with chemotherapy  as single agent maintenance therapy,1
2715,2715,2715,2715,2715,2715,2715,3413,3413,3413,3413,3413,3413,3413,3413,3413,3413,3413,3413,3413,b172773b-3905-4a1c-ad95-bab4b6126563,non progressing ( including stable disease )  low grade  cd20 positive  b cell nhl as a single agent after first line cvp chemotherapy previously untreated diffuse large b cell  cd20 positive nhl in combination with chop or other anthracycline based chemotherapy regimens 1 2 chronic lymphocytic leukemia ( cll ) rituxan ( rituximab ) is indicated  in combination with fludarabine and cyclophosphamide ( fc )  for the treatment of patients with previously untreated and previously treated cd20 positive cll,1
2716,2716,2716,2716,2716,2716,2716,3414,3414,3414,3414,3414,3414,3414,3414,3414,3414,3414,3414,3414,b172773b-3905-4a1c-ad95-bab4b6126563,1 3 rheumatoid arthritis ( ra ) rituxan ( rituximab ) in combination with methotrexate is indicated for the treatment of adult patients with moderately to severely active rheumatoid arthritis who have had an inadequate response to one or more tnf antagonist therapies,1
2717,2717,2717,2717,2717,2717,2717,3415,3415,3415,3415,3415,3415,3415,3415,3415,3415,3415,3415,3415,3e5b7e82-f018-4eaf-ae78-d6145a906b20,1  rituxan hycela is a combination of rituximab  a cd20 directed cytolytic antibody  and hyaluronidase human  an endoglycosidase  indicated for the treatment of adult patients with follicular lymphoma ( fl ) ( 1 1 ) relapsed or refractory  follicular lymphoma as a single agent previously untreated follicular lymphoma in combination with first line chemotherapy and  in patients achieving a complete or partial response to rituximab in combination with chemotherapy  as single agent maintenance therapy non progressing ( including stable disease )  follicular lymphoma as a single agent after first line cyclophosphamide  vincristine  and prednisone ( cvp ) chemotherapy diffuse large b cell lymphoma ( dlbcl ) ( 1 2 ) previously untreated diffuse large b cell lymphoma in combination with cyclophosphamide  doxorubicin  vincristine  prednisone ( chop ) or other anthracycline based chemotherapy regimens chronic lymphocytic leukemia ( cll ) ( 1 3 ) previously untreated and previously treated cll in combination with fludarabine and cyclophosphamide ( fc ) limitations of use initiate treatment with rituxan hycela only after patients have received at least one full dose of a rituximab product by intravenous infusion,1
2718,2718,2718,2718,2718,2718,2718,3416,3416,3416,3416,3416,3416,3416,3416,3416,3416,3416,3416,3416,3e5b7e82-f018-4eaf-ae78-d6145a906b20,rituxan hycela is not indicated for the treatment of non malignant conditions,2
2719,2719,2719,2719,2719,2719,2719,3417,3417,3417,3417,3417,3417,3417,3417,3417,3417,3417,3417,3417,3e5b7e82-f018-4eaf-ae78-d6145a906b20,( 1 4 ) 1 1 follicular lymphoma ( fl ) rituxan hycela is indicated for the treatment of adult patients with relapsed or refractory  follicular lymphoma as a single agent,1
2720,2720,2720,2720,2720,2720,2720,3418,3418,3418,3418,3418,3418,3418,3418,3418,3418,3418,3418,3418,3e5b7e82-f018-4eaf-ae78-d6145a906b20,previously untreated follicular lymphoma in combination with first line chemotherapy and  in patients achieving a complete or partial response to rituximab in combination with chemotherapy  as single agent maintenance therapy,1
2721,2721,2721,2721,2721,2721,2721,3419,3419,3419,3419,3419,3419,3419,3419,3419,3419,3419,3419,3419,3e5b7e82-f018-4eaf-ae78-d6145a906b20,non progressing ( including stable disease )  follicular lymphoma as a single agent after first line cyclophosphamide  vincristine  and prednisone ( cvp ) chemotherapy,1
2722,2722,2722,2722,2722,2722,2722,3420,3420,3420,3420,3420,3420,3420,3420,3420,3420,3420,3420,3420,8fef5bfd-a786-4442-b09b-f3b81812cdac,1  raloxifene hydrochloride tablet  usp is an estrogen agonist antagonist indicated for treatment of osteoporosis in postmenopausal women,1
2723,2723,2723,2723,2723,2723,2723,3421,3421,3421,3421,3421,3421,3421,3421,3421,3421,3421,3421,3421,8fef5bfd-a786-4442-b09b-f3b81812cdac,( 1 1 ) 1 1 treatment of osteoporosis in postmenopausal women raloxifene hydrochloride tablets  usp are indicated for the treatment of osteoporosis in postmenopausal women see clinical studies ( 14 1 ),1
2724,2724,2724,2724,2724,2724,2724,3422,3422,3422,3422,3422,3422,3422,3422,3422,3422,3422,3422,3422,981e9f3d-b608-4a5e-92f8-895b22da12f4,indications eczemol is indicated for the treatment of moderate to severe eczema and atopic dermatitis,1
2725,2725,2725,2725,2725,2725,2725,3424,3424,3424,3424,3424,3424,3424,3424,3424,3424,3424,3424,3424,7896794a-60bd-4dfa-abfe-aa29aaa6f74d,indications psorizide forte is indicated for the treatment of contact dermatitis due to nickel ( metal jewelry allergy  ) dyshidrotic hand foot eczema  and mild to severe psoriasis,1
2726,2726,2726,2726,2726,2726,2726,3426,3426,3426,3426,3426,3426,3426,3426,3426,3426,3426,3426,3426,7896794a-60bd-4dfa-abfe-aa29aaa6f74d,eczema  seborrhea and a variety of chronic pruritic inflammatory dermatoses generally respond well also,1
2727,2727,2727,2727,2727,2727,2727,3427,3427,3427,3427,3427,3427,3427,3427,3427,3427,3427,3427,3427,78d05c25-6817-4763-b662-6dbb0625fa84,indications psorizide ultra is indicated for the treatment of moderate to severe eczema  atopic dermatitis  seborrhea and seborrheic dermatitis,1
2728,2728,2728,2728,2728,2728,2728,3428,3428,3428,3428,3428,3428,3428,3428,3428,3428,3428,3428,3428,78d05c25-6817-4763-b662-6dbb0625fa84,it has been found to work well with variety of combination therapies,0
2729,2729,2729,2729,2729,2729,2729,3429,3429,3429,3429,3429,3429,3429,3429,3429,3429,3429,3429,3429,78d05c25-6817-4763-b662-6dbb0625fa84,psoriasis also responds  but generally has a more favorable response to psorizide forte ( ndc 61480 255 05 ),u
2730,2730,2730,2730,2730,2730,2730,3430,3430,3430,3430,3430,3430,3430,3430,3430,3430,3430,3430,3430,38b482a8-960b-4591-9857-5031ecb830aa, blincyto is a bispecific cd19 directed cd3 t cell engager indicated for the treatment of adults and children with b cell precursor acute lymphoblastic leukemia ( all ) in first or second complete remission with minimal residual disease ( mrd ) greater than or equal to 0 1,1
2731,2731,2731,2731,2731,2731,2731,3431,3431,3431,3431,3431,3431,3431,3431,3431,3431,3431,3431,3431,38b482a8-960b-4591-9857-5031ecb830aa,this indication is approved under accelerated approval based on mrd response rate and hematological relapse free survival,0
2732,2732,2732,2732,2732,2732,2732,3432,3432,3432,3432,3432,3432,3432,3432,3432,3432,3432,3432,3432,38b482a8-960b-4591-9857-5031ecb830aa,continued approval for this indication may be contingent upon verification and description of clinical benefit in the confirmatory trials,0
2733,2733,2733,2733,2733,2733,2733,3433,3433,3433,3433,3433,3433,3433,3433,3433,3433,3433,3433,3433,38b482a8-960b-4591-9857-5031ecb830aa,( 1 1 ) relapsed or refractory b cell precursor acute lymphoblastic leukemia ( all ),1
2734,2734,2734,2734,2734,2734,2734,3434,3434,3434,3434,3434,3434,3434,3434,3434,3434,3434,3434,3434,38b482a8-960b-4591-9857-5031ecb830aa,( 1 2 ) 1 1 mrd positive b cell precursor all blincyto is indicated for the treatment of b cell precursor acute lymphoblastic leukemia ( all ) in first or second complete remission with minimal residual disease ( mrd ) greater than or equal to 0 1 in adults and children,1
2735,2735,2735,2735,2735,2735,2735,3437,3437,3437,3437,3437,3437,3437,3437,3437,3437,3437,3437,3437,38b482a8-960b-4591-9857-5031ecb830aa,1 2 relapsed or refractory b cell precursor all blincyto is indicated for the treatment of relapsed or refractory b cell precursor acute lymphoblastic leukemia ( all ) in adults and children,1
2736,2736,2736,2736,2736,2736,2736,3438,3438,3438,3438,3438,3438,3438,3438,3438,3438,3438,3438,3438,d38d65c1-25bf-401d-9c7e-a2c3222da8af,1  levemir is indicated to improve glycemic control in adults and children with diabetes mellitus,1
2737,2737,2737,2737,2737,2737,2737,3439,3439,3439,3439,3439,3439,3439,3439,3439,3439,3439,3439,3439,d38d65c1-25bf-401d-9c7e-a2c3222da8af,important limitations of use levemir is not recommended for the treatment of diabetic ketoacidosis,2
2738,2738,2738,2738,2738,2738,2738,3440,3440,3440,3440,3440,3440,3440,3440,3440,3440,3440,3440,3440,d38d65c1-25bf-401d-9c7e-a2c3222da8af,intravenous rapid acting or short acting insulin is the preferred treatment for this condition,u
2739,2739,2739,2739,2739,2739,2739,3441,3441,3441,3441,3441,3441,3441,3441,3441,3441,3441,3441,3441,d38d65c1-25bf-401d-9c7e-a2c3222da8af,levemir is a long acting human insulin analog indicated to improve glycemic control in adults and children with diabetes mellitus,1
2740,2740,2740,2740,2740,2740,2740,3443,3443,3443,3443,3443,3443,3443,3443,3443,3443,3443,3443,3443,d38d65c1-25bf-401d-9c7e-a2c3222da8af,use intravenous  rapid acting or short acting insulin instead,0
2741,2741,2741,2741,2741,2741,2741,3444,3444,3444,3444,3444,3444,3444,3444,3444,3444,3444,3444,3444,34784acf-15ed-4715-b504-eb30430518e9,1  genvoya is indicated as a complete regimen for the treatment of hiv 1 infection in adults and pediatric patients weighing at least 25 kg who have no antiretroviral treatment history or to replace the current antiretroviral regimen in those who are virologically suppressed ( hiv 1 rna less than 50 copies per ml ) on a stable antiretroviral regimen for at least 6 months with no history of treatment failure and no known substitutions associated with resistance to the individual components of genvoya see clinical studies ( 14 ),1
2742,2742,2742,2742,2742,2742,2742,3445,3445,3445,3445,3445,3445,3445,3445,3445,3445,3445,3445,3445,34784acf-15ed-4715-b504-eb30430518e9,genvoya is a four drug combination of elvitegravir  an hiv 1 integrase strand transfer inhibitor ( insti )  cobicistat  a cyp3a inhibitor  and emtricitabine and tenofovir alafenamide ( taf )  both hiv 1 nucleoside analog reverse transcriptase inhibitors ( nrtis )  and is indicated as a complete regimen for the treatment of hiv 1 infection in adults and pediatric patients weighing at least 25 kg who have no antiretroviral treatment history or to replace the current antiretroviral regimen in those who are virologically suppressed ( hiv 1 rna less than 50 copies per ml ) on a stable antiretroviral regimen for at least 6 months with no history of treatment failure and no known substitutions associated with resistance to the individual components of genvoya,1
2743,2743,2743,2743,2743,2743,2743,3446,3446,3446,3446,3446,3446,3446,3446,3446,3446,3446,3446,3446,b1e0e3e2-f0f0-4cf9-99f1-adda63003b99,1  stribild is indicated as a complete regimen for the treatment of hiv 1 infection in adults and pediatric patients 12 years of age and older weighing at least 35 kg who have no antiretroviral treatment history or to replace the current antiretroviral regimen in those who are virologically suppressed ( hiv 1 rna less than 50 copies ml ) on a stable antiretroviral regimen for at least 6 months with no history of treatment failure and no known substitutions associated with resistance to the individual components of stribild see clinical studies ( 14 ),1
2744,2744,2744,2744,2744,2744,2744,3447,3447,3447,3447,3447,3447,3447,3447,3447,3447,3447,3447,3447,b1e0e3e2-f0f0-4cf9-99f1-adda63003b99,stribild is a four drug combination of elvitegravir  an hiv integrase strand transfer inhibitor ( hiv 1 insti )  cobicistat  a cyp3a inhibitor  and emtricitabine and tenofovir df  both hiv nucleoside analog reverse transcriptase inhibitors ( hiv nrti ) and is indicated as a complete regimen for the treatment of hiv 1 infection in adults and pediatric patients 12 years of age and older weighing at least 35 kg who have no antiretroviral treatment history or to replace the current antiretroviral regimen in those who are virologically suppressed ( hiv 1 rna less than 50 copies ml ) on a stable antiretroviral regimen for at least 6 months with no history of treatment failure and no known substitutions associated with resistance to the individual components of stribild,1
2745,2745,2745,2745,2745,2745,2745,3448,3448,3448,3448,3448,3448,3448,3448,3448,3448,3448,3448,3448,f5beed22-d71d-4c0d-8dca-2c7317d65d85,1  lonsurf is indicated for the treatment of patients with metastatic colorectal cancer who have been previously treated with fluoropyrimidine  oxaliplatin and irinotecan based chemotherapy  an anti vegf biological therapy  and if ras wild type  an anti egfr therapy,1
2746,2746,2746,2746,2746,2746,2746,3449,3449,3449,3449,3449,3449,3449,3449,3449,3449,3449,3449,3449,f5beed22-d71d-4c0d-8dca-2c7317d65d85,lonsurf is a combination of trifluridine  a nucleoside metabolic inhibitor  and tipiracil  a thymidine phosphorylase inhibitor  indicated for the treatment of patients with metastatic colorectal cancer who have been previously treated with fluoropyrimidine  oxaliplatin and irinotecan based chemotherapy  an anti vegf biological therapy  and if ras wild type  an anti egfr therapy,1
2747,2747,2747,2747,2747,2747,2747,3450,3450,3450,3450,3450,3450,3450,3450,3450,3450,3450,3450,3450,8f479bfe-2bfa-4cc5-9aee-1357364480b0,1  zinplava is indicated to reduce recurrence of clostridium difficile infection ( cdi ) in patients 18 years of age or older who are receiving antibacterial drug treatment of cdi and are at a high risk for cdi recurrence,1
2748,2748,2748,2748,2748,2748,2748,3451,3451,3451,3451,3451,3451,3451,3451,3451,3451,3451,3451,3451,8f479bfe-2bfa-4cc5-9aee-1357364480b0,zinplava is a human monoclonal antibody that binds to clostridium difficile toxin b  indicated to reduce recurrence of clostridium difficile infection ( cdi ) in patients 18 years of age or older who are receiving antibacterial drug treatment of cdi and are at a high risk for cdi recurrence,1
2749,2749,2749,2749,2749,2749,2749,3452,3452,3452,3452,3452,3452,3452,3452,3452,3452,3452,3452,3452,8f479bfe-2bfa-4cc5-9aee-1357364480b0,( 1 ) limitation of use zinplava is not indicated for the treatment of cdi,2
2750,2750,2750,2750,2750,2750,2750,3453,3453,3453,3453,3453,3453,3453,3453,3453,3453,3453,3453,3453,8f479bfe-2bfa-4cc5-9aee-1357364480b0,zinplava is not an antibacterial drug,0
2751,2751,2751,2751,2751,2751,2751,3454,3454,3454,3454,3454,3454,3454,3454,3454,3454,3454,3454,3454,8f479bfe-2bfa-4cc5-9aee-1357364480b0,zinplava should only be used in conjunction with antibacterial drug treatment of cdi,0
2752,2752,2752,2752,2752,2752,2752,3458,3458,3458,3458,3458,3458,3458,3458,3458,3458,3458,3458,3458,8f479bfe-2bfa-4cc5-9aee-1357364480b0,see dosage and administration ( 2 1 ),0
2753,2753,2753,2753,2753,2753,2753,3459,3459,3459,3459,3459,3459,3459,3459,3459,3459,3459,3459,3459,a44782cf-4ab5-4c8a-79b7-221f21e40a34, beconase aq nasal spray is indicated for the relief of the symptoms of seasonal or perennial allergic and nonallergic ( vasomotor ) rhinitis,1
2754,2754,2754,2754,2754,2754,2754,3460,3460,3460,3460,3460,3460,3460,3460,3460,3460,3460,3460,3460,a44782cf-4ab5-4c8a-79b7-221f21e40a34,results from 2 clinical trials have shown that significant symptomatic relief was obtained within 3 days,0
2755,2755,2755,2755,2755,2755,2755,3461,3461,3461,3461,3461,3461,3461,3461,3461,3461,3461,3461,3461,a44782cf-4ab5-4c8a-79b7-221f21e40a34,however  symptomatic relief may not occur in some patients for as long as 2 weeks,0
2756,2756,2756,2756,2756,2756,2756,3462,3462,3462,3462,3462,3462,3462,3462,3462,3462,3462,3462,3462,a44782cf-4ab5-4c8a-79b7-221f21e40a34,beconase aq nasal spray should not be continued beyond 3 weeks in the absence of significant symptomatic improvement,4
2757,2757,2757,2757,2757,2757,2757,3463,3463,3463,3463,3463,3463,3463,3463,3463,3463,3463,3463,3463,a44782cf-4ab5-4c8a-79b7-221f21e40a34,beconase aq nasal spray should not be used in the presence of untreated localized infection involving the nasal mucosa,4
2758,2758,2758,2758,2758,2758,2758,3464,3464,3464,3464,3464,3464,3464,3464,3464,3464,3464,3464,3464,a44782cf-4ab5-4c8a-79b7-221f21e40a34,beconase aq nasal spray is also indicated for the prevention of recurrence of nasal polyps following surgical removal,1
2759,2759,2759,2759,2759,2759,2759,3465,3465,3465,3465,3465,3465,3465,3465,3465,3465,3465,3465,3465,a44782cf-4ab5-4c8a-79b7-221f21e40a34,clinical studies have shown that treatment of the symptoms associated with nasal polyps may have to be continued for several weeks or more before a therapeutic result can be fully assessed,0
2760,2760,2760,2760,2760,2760,2760,3466,3466,3466,3466,3466,3466,3466,3466,3466,3466,3466,3466,3466,a44782cf-4ab5-4c8a-79b7-221f21e40a34,recurrence of symptoms due to polyps can occur after stopping treatment  depending on the severity of the disease,0
2761,2761,2761,2761,2761,2761,2761,3467,3467,3467,3467,3467,3467,3467,3467,3467,3467,3467,3467,3467,9e2bbe03-44cb-45d1-acdb-b61d9016055e, to reduce the development of drug resistant bacteria and maintain the effectiveness of dicloxacillin sodium capsules usp and other antibacterial drugs  dicloxacillin sodium capsules usp should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria,1
2762,2762,2762,2762,2762,2762,2762,3470,3470,3470,3470,3470,3470,3470,3470,3470,3470,3470,3470,3470,9e2bbe03-44cb-45d1-acdb-b61d9016055e,dicloxacillin is indicated in the treatment of infections caused by penicillinase producing staphylococci which have demonstrated susceptibility to the drug,1
2763,2763,2763,2763,2763,2763,2763,3471,3471,3471,3471,3471,3471,3471,3471,3471,3471,3471,3471,3471,9e2bbe03-44cb-45d1-acdb-b61d9016055e,cultures and susceptibility tests should be performed initially to determine the causative organisms and their sensitivity to the drug ( see clinical pharmacology susceptibility plate testing ),0
2764,2764,2764,2764,2764,2764,2764,3472,3472,3472,3472,3472,3472,3472,3472,3472,3472,3472,3472,3472,9e2bbe03-44cb-45d1-acdb-b61d9016055e,dicloxacillin may be used to initiate therapy in suspected cases of resistant staphylococcal infections prior to the availability of laboratory test results,1
2765,2765,2765,2765,2765,2765,2765,3473,3473,3473,3473,3473,3473,3473,3473,3473,3473,3473,3473,3473,9e2bbe03-44cb-45d1-acdb-b61d9016055e,the penicillinase resistant penicillins should not be used in infections caused by organisms susceptible to penicillin g if the susceptibility tests indicate that the infection is due to an organism other than a resistant staphylococcus  therapy should not be continued with a penicillinase resistant penicillin,2
2766,2766,2766,2766,2766,2766,2766,3474,3474,3474,3474,3474,3474,3474,3474,3474,3474,3474,3474,3474,8a5fb6a2-9fae-4872-8c5c-0f1ba03a57cb, nisoldipine is indicated for the treatment of hypertension,1
2767,2767,2767,2767,2767,2767,2767,3475,3475,3475,3475,3475,3475,3475,3475,3475,3475,3475,3475,3475,8a5fb6a2-9fae-4872-8c5c-0f1ba03a57cb,it may be used alone or in combination with other antihypertensive agents,4
2768,2768,2768,2768,2768,2768,2768,3476,3476,3476,3476,3476,3476,3476,3476,3476,3476,3476,3476,3476,04557ab3-6d21-49b4-b849-744c75b8a630,indicatons and usage for use in patients with elevated urinary ph,1
2769,2769,2769,2769,2769,2769,2769,3477,3477,3477,3477,3477,3477,3477,3477,3477,3477,3477,3477,3477,04557ab3-6d21-49b4-b849-744c75b8a630,k phos original helps keep calcium soluble and reduces odor and rash caused by ammoniacal urine,u
2770,2770,2770,2770,2770,2770,2770,3478,3478,3478,3478,3478,3478,3478,3478,3478,3478,3478,3478,3478,04557ab3-6d21-49b4-b849-744c75b8a630,also  by acidifying the urine  it increases the antibacterial activity of methenamine mandelate and methenamine hippurate,0
2771,2771,2771,2771,2771,2771,2771,3479,3479,3479,3479,3479,3479,3479,3479,3479,3479,3479,3479,3479,d0e359fe-a90b-44e2-960c-cd82babc4f4c, potassium phosphates injection  usp  3 mm p ml is indicated as a source of phosphorus  for addition to large volume intravenous fluids  to prevent or correct hypophosphatemia in patients with restricted or no oral intake,1
2772,2772,2772,2772,2772,2772,2772,3480,3480,3480,3480,3480,3480,3480,3480,3480,3480,3480,3480,3480,d0e359fe-a90b-44e2-960c-cd82babc4f4c,it is also useful as an additive for preparing specific intravenous fluid formulas when the needs of the patient cannot be met by standard electrolyte or nutrient solutions,1
2773,2773,2773,2773,2773,2773,2773,3481,3481,3481,3481,3481,3481,3481,3481,3481,3481,3481,3481,3481,d0e359fe-a90b-44e2-960c-cd82babc4f4c,the concomitant amount of potassium ( k 4 4 meq ml ) must be calculated into total electrolyte dose of such prepared solutions,0
2774,2774,2774,2774,2774,2774,2774,3482,3482,3482,3482,3482,3482,3482,3482,3482,3482,3482,3482,3482,9f446400-c403-4971-879e-1341f7f7d9da,indicatons and usage k phos no,u
2775,2775,2775,2775,2775,2775,2775,3483,3483,3483,3483,3483,3483,3483,3483,3483,3483,3483,3483,3483,9f446400-c403-4971-879e-1341f7f7d9da,2 is a highly effective urinary acidifier for use in patients with elevated urinary ph,1
2776,2776,2776,2776,2776,2776,2776,3484,3484,3484,3484,3484,3484,3484,3484,3484,3484,3484,3484,3484,9f446400-c403-4971-879e-1341f7f7d9da,this product helps keep calcium soluble and reduces odor and rash caused by ammoniacal urine,u
2777,2777,2777,2777,2777,2777,2777,3486,3486,3486,3486,3486,3486,3486,3486,3486,3486,3486,3486,3486,664cb8f0-1f65-441b-b0d9-ba3d798be309,1  biktarvy is indicated as a complete regimen for the treatment of human immunodeficiency virus type 1 ( hiv 1 ) infection in adults who have no antiretroviral treatment history or to replace the current antiretroviral regimen in those who are virologically suppressed ( hiv 1 rna less than 50 copies per ml ) on a stable antiretroviral regimen for at least 3 months with no history of treatment failure and no known substitutions associated with resistance to the individual components of biktarvy,1
2778,2778,2778,2778,2778,2778,2778,3487,3487,3487,3487,3487,3487,3487,3487,3487,3487,3487,3487,3487,664cb8f0-1f65-441b-b0d9-ba3d798be309,biktarvy is a three drug combination of bictegravir ( bic )  a human immunodeficiency virus type 1 ( hiv 1 ) integrase strand transfer inhibitor ( insti )  and emtricitabine ( ftc ) and tenofovir alafenamide ( taf )  both hiv 1 nucleoside analog reverse transcriptase inhibitors ( nrtis )  and is indicated as a complete regimen for the treatment of hiv 1 infection in adults who have no antiretroviral treatment history or to replace the current antiretroviral regimen in those who are virologically suppressed ( hiv 1 rna less than 50 copies per ml ) on a stable antiretroviral regimen for at least 3 months with no history of treatment failure and no known substitutions associated with resistance to the individual components of biktarvy,1
2779,2779,2779,2779,2779,2779,2779,3488,3488,3488,3488,3488,3488,3488,3488,3488,3488,3488,3488,3488,e9ef06a5-5a61-47df-9203-2573454c0591,s gallium citrate ga 67 injection may be useful in demonstrating the presence of the following malignancies hodgkins disease  lymphomas and bronchogenic carcinoma,1
2780,2780,2780,2780,2780,2780,2780,3489,3489,3489,3489,3489,3489,3489,3489,3489,3489,3489,3489,3489,e9ef06a5-5a61-47df-9203-2573454c0591,positive ga 67 uptake in the absence of prior symptoms warrants follow up as an indication of a potential disease state,0
2781,2781,2781,2781,2781,2781,2781,3490,3490,3490,3490,3490,3490,3490,3490,3490,3490,3490,3490,3490,e9ef06a5-5a61-47df-9203-2573454c0591,gallium citrate ga 67 injection may be useful as an aid in detecting some acute inflammatory lesions,1
2782,2782,2782,2782,2782,2782,2782,3491,3491,3491,3491,3491,3491,3491,3491,3491,3491,3491,3491,3491,d5aa1922-4766-4479-bcb9-010d679478cc,1  sodium fluoride f18 injection  usp is indicated for diagnostic positron emission tomography ( pet ) imaging of bone to define areas of altered osteogenic activity,1
2783,2783,2783,2783,2783,2783,2783,3492,3492,3492,3492,3492,3492,3492,3492,3492,3492,3492,3492,3492,d5aa1922-4766-4479-bcb9-010d679478cc,sodium fluoride f18 injection  usp is a radioactive diagnostic agent for positron emission tomography ( pet ) indicated for imaging of bone to define areas of altered osteogenic activity ( 1 ),1
2784,2784,2784,2784,2784,2784,2784,3493,3493,3493,3493,3493,3493,3493,3493,3493,3493,3493,3493,3493,7c91eee4-242b-4af2-a39b-7842a9d95143,1  altabax is indicated for use in adults and pediatric patients aged 9 months and older for the topical treatment of impetigo ( up to 100 cm2 in total area in adults or 2 total body surface area in pediatric patients aged 9 months or older ) due to staphylococcus aureus ( methicillin susceptible isolates only ) or streptococcus pyogenes see clinical studies ( 14 ),1
2785,2785,2785,2785,2785,2785,2785,3494,3494,3494,3494,3494,3494,3494,3494,3494,3494,3494,3494,3494,7c91eee4-242b-4af2-a39b-7842a9d95143,safety in patients younger than 9 months has not been established,0
2786,2786,2786,2786,2786,2786,2786,3495,3495,3495,3495,3495,3495,3495,3495,3495,3495,3495,3495,3495,7c91eee4-242b-4af2-a39b-7842a9d95143,to reduce the development of drug resistant bacteria and maintain the effectiveness of altabax and other antibacterial drugs  altabax should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria,4
2787,2787,2787,2787,2787,2787,2787,3496,3496,3496,3496,3496,3496,3496,3496,3496,3496,3496,3496,3496,7c91eee4-242b-4af2-a39b-7842a9d95143,altabax  a pleuromutilin antibacterial  is indicated for the topical treatment of impetigo due to staphylococcus aureus ( methicillin susceptible isolates only ) or streptococcus pyogenes in patients aged 9 months or older,1
2788,2788,2788,2788,2788,2788,2788,3497,3497,3497,3497,3497,3497,3497,3497,3497,3497,3497,3497,3497,7c91eee4-242b-4af2-a39b-7842a9d95143,( 1 ) safety in patients younger than 9 months has not been established,0
2789,2789,2789,2789,2789,2789,2789,3498,3498,3498,3498,3498,3498,3498,3498,3498,3498,3498,3498,3498,83db29d7-5d85-49d6-8cb6-740473365cf8,1  evotaz is indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency virus ( hiv 1 ) infection in adults,1
2790,2790,2790,2790,2790,2790,2790,3499,3499,3499,3499,3499,3499,3499,3499,3499,3499,3499,3499,3499,83db29d7-5d85-49d6-8cb6-740473365cf8,limitations of use use of evotaz in treatment experienced patients should be guided by the number of baseline primary protease inhibitor resistance substitutions see microbiology ( 12 4 ),4
2791,2791,2791,2791,2791,2791,2791,3500,3500,3500,3500,3500,3500,3500,3500,3500,3500,3500,3500,3500,83db29d7-5d85-49d6-8cb6-740473365cf8,evotaz is a two drug combination of atazanavir  a human immunodeficiency virus ( hiv 1 ) protease inhibitor  and cobicistat  a cyp3a inhibitor indicated for use in combination with other antiretroviral agents for the treatment of hiv 1 infection,1
2792,2792,2792,2792,2792,2792,2792,3501,3501,3501,3501,3501,3501,3501,3501,3501,3501,3501,3501,3501,83db29d7-5d85-49d6-8cb6-740473365cf8,( 1 ) limitations of use use of evotaz in treatment experienced patients should be guided by the number of baseline primary protease inhibitor resistance substitutions,4
2793,2793,2793,2793,2793,2793,2793,3502,3502,3502,3502,3502,3502,3502,3502,3502,3502,3502,3502,3502,33ff7919-c967-4874-8d16-30afbdfb9352,this product is for topical application as well as being used in beauty salons utensils that need to be desinfected before being used,u
2794,2794,2794,2794,2794,2794,2794,3503,3503,3503,3503,3503,3503,3503,3503,3503,3503,3503,3503,3503,6ab99d12-03a6-478e-b976-0a8031d94dcc,indications bp cleansing wash is indicated in the topical control of acne vulgaris  acne rosacea and seborrheic dermatitis,1
2795,2795,2795,2795,2795,2795,2795,3504,3504,3504,3504,3504,3504,3504,3504,3504,3504,3504,3504,3504,c68ebddc-dcb5-4695-a66b-d03a65a110f6, blephamide ophthalmic ointment is indicated for steroid responsive inflammatory ocular conditions for which a corticosteroid is indicated and where superficial bacterial ocular infection or a risk of bacterial ocular infection exists,1
2796,2796,2796,2796,2796,2796,2796,3505,3505,3505,3505,3505,3505,3505,3505,3505,3505,3505,3505,3505,c68ebddc-dcb5-4695-a66b-d03a65a110f6,ocular corticosteroids are indicated in inflammatory conditions of the palpebral and bulbar conjunctiva  cornea  and anterior segment of the globe where the inherent risk of corticosteroid use in certain infective conjunctivitides is accepted to obtain diminution in edema and inflammation,1
2797,2797,2797,2797,2797,2797,2797,3507,3507,3507,3507,3507,3507,3507,3507,3507,3507,3507,3507,3507,c68ebddc-dcb5-4695-a66b-d03a65a110f6,the use of a combination drug with an anti infective component is indicated where the risk of superficial ocular infection is high or where there is an expectation that potentially dangerous numbers of bacteria will be present in the eye,1
2798,2798,2798,2798,2798,2798,2798,3508,3508,3508,3508,3508,3508,3508,3508,3508,3508,3508,3508,3508,c68ebddc-dcb5-4695-a66b-d03a65a110f6,the particular antibacterial drug in this product is active against the following common bacterial eye pathogens escherichia coli  staphylococcus aureus  streptococcus pneumoniae  streptococcus ( viridans group )  haemophilus influenzae  klebsiella species  and enterobacter species,u
2799,2799,2799,2799,2799,2799,2799,3509,3509,3509,3509,3509,3509,3509,3509,3509,3509,3509,3509,3509,c68ebddc-dcb5-4695-a66b-d03a65a110f6,the product does not provide adequate coverage against neisseria species  pseudomonas species  and serratia marcescens,2
2800,2800,2800,2800,2800,2800,2800,3510,3510,3510,3510,3510,3510,3510,3510,3510,3510,3510,3510,3510,c68ebddc-dcb5-4695-a66b-d03a65a110f6,a significant percentage of staphylococcal isolates are completely resistant to sulfa drugs,0
2801,2801,2801,2801,2801,2801,2801,3511,3511,3511,3511,3511,3511,3511,3511,3511,3511,3511,3511,3511,9d71d7fd-2b25-4163-922f-018ed8c5171f, fml s ophthalmic suspension is indicated for steroid responsive inflammatory ocular conditions for which a corticosteroid is indicated and where superficial bacterial ocular infection or a risk of bacterial ocular infection exists,1
2802,2802,2802,2802,2802,2802,2802,3512,3512,3512,3512,3512,3512,3512,3512,3512,3512,3512,3512,3512,9d71d7fd-2b25-4163-922f-018ed8c5171f,ocular steroids are indicated in inflammatory conditions of the palpebral and bulbar conjunctiva  cornea and anterior segment of the globe  where the inherent risk of steroid use in certain infective conjunctivitides is accepted to obtain a diminution in edema and inflammation,1
2803,2803,2803,2803,2803,2803,2803,3515,3515,3515,3515,3515,3515,3515,3515,3515,3515,3515,3515,3515,9d71d7fd-2b25-4163-922f-018ed8c5171f,the anti infective drug in this product  sulfacetamide  is active against the following common bacterial eye pathogens escherichia coli  staphylococcus aureus  streptococcus pneumoniae  streptococcus ( viridans group )  haemophilus influenzae  klebsiella species  and enterobacter species,u
2804,2804,2804,2804,2804,2804,2804,3516,3516,3516,3516,3516,3516,3516,3516,3516,3516,3516,3516,3516,9d71d7fd-2b25-4163-922f-018ed8c5171f,this product does not provide adequate coverage against neisseria species and serratia marcescens,0
2805,2805,2805,2805,2805,2805,2805,3518,3518,3518,3518,3518,3518,3518,3518,3518,3518,3518,3518,3518,ccf29429-bf8e-4cce-bd12-1de56853fc5b,1  zevalin is a cd20 directed radiotherapeutic antibody administered as part of the zevalin therapeutic regimen indicated for the treatment of patients with relapsed or refractory  low grade or follicular b cell non hodgkin 's lymphoma ( nhl ) ( 1 1 ),1
2806,2806,2806,2806,2806,2806,2806,3519,3519,3519,3519,3519,3519,3519,3519,3519,3519,3519,3519,3519,ccf29429-bf8e-4cce-bd12-1de56853fc5b,previously untreated follicular nhl who achieve a partial or complete response to first line chemotherapy ( 1 2 ),1
2807,2807,2807,2807,2807,2807,2807,3520,3520,3520,3520,3520,3520,3520,3520,3520,3520,3520,3520,3520,ccf29429-bf8e-4cce-bd12-1de56853fc5b,1 1 relapsed or refractory  low grade or follicular nhl zevalin is indicated for the treatment of relapsed or refractory  low grade or follicular b cell non hodgkin 's lymphoma ( nhl ),1
2808,2808,2808,2808,2808,2808,2808,3521,3521,3521,3521,3521,3521,3521,3521,3521,3521,3521,3521,3521,ccf29429-bf8e-4cce-bd12-1de56853fc5b,1 2 previously untreated follicular nhl zevalin is indicated for the treatment of previously untreated follicular nhl in patients who achieve a partial or complete response to first line chemotherapy,1
2809,2809,2809,2809,2809,2809,2809,3522,3522,3522,3522,3522,3522,3522,3522,3522,3522,3522,3522,3522,7951139c-b271-45a4-b523-34b23800917b,1  apriso capsules are indicated for the maintenance of remission of ulcerative colitis in patients 18 years of age and older,1
2810,2810,2810,2810,2810,2810,2810,3523,3523,3523,3523,3523,3523,3523,3523,3523,3523,3523,3523,3523,7951139c-b271-45a4-b523-34b23800917b,apriso is a locally acting aminosalicylate indicated for the maintenance of remission of ulcerative colitis in adults,1
2811,2811,2811,2811,2811,2811,2811,3524,3524,3524,3524,3524,3524,3524,3524,3524,3524,3524,3524,3524,"Active Ingredient UNII(s)
4QD397987E; 57Y76R9ATQ    c957df9a-eb66-432f-a280-9cd74389d667
4QD397987E; 57Y76R9ATQ    c957df9a-eb66-432f-a280-9cd74389d667
Name: SET ID dtype: object",active ingredient unii ( s ) 4qd397987e 57y76r9atq active ingredient unii ( s ) 4qd397987e 57y76r9a 4qd397987e 57y76r9atq active ingredient unii ( s ) 4qd397987e 57y76r9a name content xml  dtype object,0
2812,2812,2812,2812,2812,2812,2812,3526,3526,3526,3526,3526,3526,3526,3526,3526,3526,3526,3526,3526,"Active Ingredient UNII(s)
4QD397987E; VG2QF83CGL    36780f92-a17f-4133-8f75-7c3769c40584
4QD397987E; VG2QF83CGL    36780f92-a17f-4133-8f75-7c3769c40584
4QD397987E; VG2QF83CGL    36780f92-a17f-4133-8f75-7c3769c40584
Name: SET ID dtype: object",active ingredient unii ( s ) 4qd397987e vg2qf83cgl active ingredient unii ( s ) 4qd397987e vg2qf83c 4qd397987e vg2qf83cgl active ingredient unii ( s ) 4qd397987e vg2qf83c 4qd397987e vg2qf83cgl active ingredient unii ( s ) 4qd397987e vg2qf83c name content xml  dtype object,0
2813,2813,2813,2813,2813,2813,2813,3529,3529,3529,3529,3529,3529,3529,3529,3529,3529,3529,3529,3529,6660b616-a82d-9109-19ce-2bdf9747acea, acetohydroxamic acid is indicated as adjunctive therapy in patients with chronic urea splitting urinary infection,1
2814,2814,2814,2814,2814,2814,2814,3530,3530,3530,3530,3530,3530,3530,3530,3530,3530,3530,3530,3530,6660b616-a82d-9109-19ce-2bdf9747acea,aha is intended to decrease urinary ammonia and alkalinity  but it should not be used in lieu of curative surgical treatment ( for patients with stones ) or antimicrobial treatment,u
2815,2815,2815,2815,2815,2815,2815,3531,3531,3531,3531,3531,3531,3531,3531,3531,3531,3531,3531,3531,6660b616-a82d-9109-19ce-2bdf9747acea,long term treatment with aha may be warranted to maintain urease inhibition as long as urea splitting infection is present,u
2816,2816,2816,2816,2816,2816,2816,3532,3532,3532,3532,3532,3532,3532,3532,3532,3532,3532,3532,3532,6660b616-a82d-9109-19ce-2bdf9747acea,experience with aha does not go beyond 7 years,0
2817,2817,2817,2817,2817,2817,2817,3533,3533,3533,3533,3533,3533,3533,3533,3533,3533,3533,3533,3533,6660b616-a82d-9109-19ce-2bdf9747acea,a patient package insert should be distributed to each patient who receives aha,0
2818,2818,2818,2818,2818,2818,2818,3534,3534,3534,3534,3534,3534,3534,3534,3534,3534,3534,3534,3534,a49c157e-6310-0011-7b7f-e26fc1820d59,1 indications usage simbrinza ( brinzolamide brimonidine tartrate ophthalmic suspension ) 1 0 2 is a fixed combination of a carbonic anhydrase inhibitor and an alpha 2 adrenergic receptor agonist indicated for the reduction of elevated intraocular pressure ( iop ) in patients with open angle glaucoma or ocular hypertension,1
2819,2819,2819,2819,2819,2819,2819,3535,3535,3535,3535,3535,3535,3535,3535,3535,3535,3535,3535,3535,a49c157e-6310-0011-7b7f-e26fc1820d59,simbrinza is a fixed combination of a carbonic anhydrase inhibitor and an alpha 2 adrenergic receptor agonist indicated for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension,1
2820,2820,2820,2820,2820,2820,2820,3536,3536,3536,3536,3536,3536,3536,3536,3536,3536,3536,3536,3536,feaf1480-a4b8-4486-992a-96be3a596243,1  combigan ( brimonidine tartrate timolol maleate ophthalmic solution ) 0 2 0 5 is an alpha adrenergic receptor agonist with a beta adrenergic receptor inhibitor indicated for the reduction of elevated intraocular pressure ( iop ) in patients with glaucoma or ocular hypertension who require adjunctive or replacement therapy due to inadequately controlled iop the iop lowering of combigan dosed twice a day was slightly less than that seen with the concomitant administration of 0 5 timolol maleate ophthalmic solution dosed twice a day and 0 2 brimonidine tartrate ophthalmic solution dosed three times per day,1
2821,2821,2821,2821,2821,2821,2821,3537,3537,3537,3537,3537,3537,3537,3537,3537,3537,3537,3537,3537,feaf1480-a4b8-4486-992a-96be3a596243,combigan is an alpha adrenergic receptor agonist with a beta adrenergic receptor inhibitor indicated for the reduction of elevated intraocular pressure ( iop ) in patients with glaucoma or ocular hypertension who require adjunctive or replacement therapy due to inadequately controlled iop the iop lowering of combigan dosed twice a day was slightly less than that seen with the concomitant administration of timolol maleate ophthalmic solution  0 5 dosed twice a day and brimonidine tartrate ophthalmic solution  0 2 dosed three times per day,1
2822,2822,2822,2822,2822,2822,2822,3538,3538,3538,3538,3538,3538,3538,3538,3538,3538,3538,3538,3538,5b11e596-3044-429b-9e48-33ba00946151, technetium tc 99m dmsa by intravenous administration is indicated as a static kidney imaging agent,1
2823,2823,2823,2823,2823,2823,2823,3539,3539,3539,3539,3539,3539,3539,3539,3539,3539,3539,3539,3539,d1cda4f7-cb33-46ea-b9ac-431f6452b1a5,1  erleada is indicated for the treatment of patients with non metastatic  castration resistant prostate cancer ( nm crpc ),1
2824,2824,2824,2824,2824,2824,2824,3540,3540,3540,3540,3540,3540,3540,3540,3540,3540,3540,3540,3540,d1cda4f7-cb33-46ea-b9ac-431f6452b1a5,erleada is an androgen receptor inhibitor indicated for the treatment of patients with non metastatic castration resistant prostate cancer,1
2825,2825,2825,2825,2825,2825,2825,3541,3541,3541,3541,3541,3541,3541,3541,3541,3541,3541,3541,3541,5423c0da-eb10-20cd-e054-00144ff8d46c, estradiol tablets are indicated in the treatment of moderate to severe vasomotor symptoms associated with the menopause,1
2826,2826,2826,2826,2826,2826,2826,3544,3544,3544,3544,3544,3544,3544,3544,3544,3544,3544,3544,3544,5423c0da-eb10-20cd-e054-00144ff8d46c,treatment of hypoestrogenism due to hypogonadism  castration or primary ovarian failure,1
2827,2827,2827,2827,2827,2827,2827,3545,3545,3545,3545,3545,3545,3545,3545,3545,3545,3545,3545,3545,5423c0da-eb10-20cd-e054-00144ff8d46c,treatment of breast cancer ( for palliation only ) in appropriately selected women and men with metastatic disease,1
2828,2828,2828,2828,2828,2828,2828,3546,3546,3546,3546,3546,3546,3546,3546,3546,3546,3546,3546,3546,5423c0da-eb10-20cd-e054-00144ff8d46c,treatment of advanced androgen dependent carcinoma of the prostate ( for palliation only ),1
2829,2829,2829,2829,2829,2829,2829,3547,3547,3547,3547,3547,3547,3547,3547,3547,3547,3547,3547,3547,5423c0da-eb10-20cd-e054-00144ff8d46c,when prescribing solely for the prevention of postmenopausal osteoporosis  therapy should only be considered for women at significant risk of osteoporosis and for whom non estrogen medications are not considered to be appropriate ( see clinical pharmacology  clinical studies ),u
2830,2830,2830,2830,2830,2830,2830,3548,3548,3548,3548,3548,3548,3548,3548,3548,3548,3548,3548,3548,5423c0da-eb10-20cd-e054-00144ff8d46c,the mainstays for decreasing the risk of postmenopausal osteoporosis are weight bearing exercise  adequate calcium and vitamin d intake  and when indicated  pharmacologic therapy,4
2831,2831,2831,2831,2831,2831,2831,3549,3549,3549,3549,3549,3549,3549,3549,3549,3549,3549,3549,3549,5423c0da-eb10-20cd-e054-00144ff8d46c,postmenopausal women require an average of 1500 mg day of elemental calcium,0
2832,2832,2832,2832,2832,2832,2832,3550,3550,3550,3550,3550,3550,3550,3550,3550,3550,3550,3550,3550,5423c0da-eb10-20cd-e054-00144ff8d46c,therefore  when not contraindicated  calcium supplementation may be helpful for women with suboptimal dietary intake,u
2833,2833,2833,2833,2833,2833,2833,3551,3551,3551,3551,3551,3551,3551,3551,3551,3551,3551,3551,3551,5423c0da-eb10-20cd-e054-00144ff8d46c,vitamin d supplementation of 400 to 800 iu day may also be required to ensure adequate daily intake in postmenopausal women,0
2834,2834,2834,2834,2834,2834,2834,3552,3552,3552,3552,3552,3552,3552,3552,3552,3552,3552,3552,3552,184d3092-7fc6-4375-816b-1ab06bb99cfd,1  climara pro is an estrogen plus progestin indicated in a woman with a uterus for treatment of moderate to severe vasomotor symptoms due to menopause ( 1 1 ) prevention of postmenopausal osteoporosis ( 1 2 ) 1 1 treatment of moderate to severe vasomotor symptoms due to menopause 1 2 prevention of postmenopausal osteoporosis limitation of use when prescribing solely for the prevention of postmenopausal osteoporosis  therapy should only be considered for women at significant risk of osteoporosis and non estrogen medication should be carefully considered,1
2835,2835,2835,2835,2835,2835,2835,3553,3553,3553,3553,3553,3553,3553,3553,3553,3553,3553,3553,3553,32a9f9a3-2940-251a-e054-00144ff88e88,1  activella is an estrogen and progestin combination indicated in a woman with a uterus for activella 1 mg 0 5 mg and 0 5 mg 0 1 mg are indicated in a woman with a uterus for treatment of moderate to severe vasomotor symptoms due to menopause ( 1 1 ) prevention of postmenopausal osteoporosis ( 1 3 ) activella 1 mg 0 5 mg is also indicated in a woman with a uterus for treatment of moderate to severe symptoms of vulvar and vaginal atrophy due to menopause ( 1 2 ) 1 1 treatment of moderate to severe vasomotor symptoms due to menopause,1
2836,2836,2836,2836,2836,2836,2836,3554,3554,3554,3554,3554,3554,3554,3554,3554,3554,3554,3554,3554,32a9f9a3-2940-251a-e054-00144ff88e88,1 2 treatment of moderate to severe symptoms of vulvar and vaginal atrophy due to menopause limitation of use when prescribing solely for the treatment of moderate to severe symptoms of vulvar and vaginal atrophy due to menopause  topical vaginal products should be considered,1
2837,2837,2837,2837,2837,2837,2837,3555,3555,3555,3555,3555,3555,3555,3555,3555,3555,3555,3555,3555,32a9f9a3-2940-251a-e054-00144ff88e88,1 3 prevention of postmenopausal osteoporosis limitation of use when prescribing solely for the prevention of postmenopausal osteoporosis  therapy should only be considered for women at significant risk of osteoporosis and non estrogen medication should be carefully considered,2
2838,2838,2838,2838,2838,2838,2838,3556,3556,3556,3556,3556,3556,3556,3556,3556,3556,3556,3556,3556,70d00600-b8d3-4820-8db6-40d4536a6f9e, prefest is indicated in women who have a uterus for the 1 treatment of moderate to severe vasomotor symptoms associated with the menopause,1
2839,2839,2839,2839,2839,2839,2839,3557,3557,3557,3557,3557,3557,3557,3557,3557,3557,3557,3557,3557,70d00600-b8d3-4820-8db6-40d4536a6f9e,2 treatment of moderate to severe symptoms of vulvar and vaginal atrophy associated with the menopause,1
2840,2840,2840,2840,2840,2840,2840,3558,3558,3558,3558,3558,3558,3558,3558,3558,3558,3558,3558,3558,70d00600-b8d3-4820-8db6-40d4536a6f9e,when prescribed solely for the treatment of symptoms of vulvar and vaginal atrophy  topical vaginal products should be considered,0
2841,2841,2841,2841,2841,2841,2841,3559,3559,3559,3559,3559,3559,3559,3559,3559,3559,3559,3559,3559,70d00600-b8d3-4820-8db6-40d4536a6f9e,3 prevention of postmenopausal osteoporosis,1
2842,2842,2842,2842,2842,2842,2842,3560,3560,3560,3560,3560,3560,3560,3560,3560,3560,3560,3560,3560,70d00600-b8d3-4820-8db6-40d4536a6f9e,when prescribing solely for the prevention of postmenopausal osteoporosis  therapy should only be considered for women at significant risk of osteoporosis and nonestrogen medications should be carefully considered,4
2843,2843,2843,2843,2843,2843,2843,3565,3565,3565,3565,3565,3565,3565,3565,3565,3565,3565,3565,3565,761834c2-6b61-4583-84c2-f1ca4a97c4f2,1  angeliq 0 25 mg drospirenone ( drsp ) 0 5 mg estradiol ( e2 ) is an estrogen progestin indicated in women with an intact uterus for the treatment of vasomotor symptoms due to menopause,1
2844,2844,2844,2844,2844,2844,2844,3566,3566,3566,3566,3566,3566,3566,3566,3566,3566,3566,3566,3566,761834c2-6b61-4583-84c2-f1ca4a97c4f2,( 1 1 ) angeliq 0 5 mg drsp 1 mg e2 is an estrogen progestin indicated in women with an intact uterus for the treatment of vasomotor symptoms due to menopause,1
2845,2845,2845,2845,2845,2845,2845,3567,3567,3567,3567,3567,3567,3567,3567,3567,3567,3567,3567,3567,761834c2-6b61-4583-84c2-f1ca4a97c4f2,( 1 1 ) vulvar and vaginal atrophy symptoms due to menopause,1
2846,2846,2846,2846,2846,2846,2846,3568,3568,3568,3568,3568,3568,3568,3568,3568,3568,3568,3568,3568,761834c2-6b61-4583-84c2-f1ca4a97c4f2,( 1 2 ) 1 1 treatment of moderate to severe vasomotor symptoms due to menopause angeliq 0 25 mg drospirenone ( drsp ) 0 5 mg estradiol ( e2 ) is indicated for the treatment of moderate to severe vasomotor symptoms due to menopause in women who have a uterus,1
2847,2847,2847,2847,2847,2847,2847,3569,3569,3569,3569,3569,3569,3569,3569,3569,3569,3569,3569,3569,761834c2-6b61-4583-84c2-f1ca4a97c4f2,angeliq 0 5 mg drsp 1 mg e2 is indicated for the treatment of moderate to severe vasomotor symptoms associated due to menopause in women who have a uterus,1
2848,2848,2848,2848,2848,2848,2848,3570,3570,3570,3570,3570,3570,3570,3570,3570,3570,3570,3570,3570,761834c2-6b61-4583-84c2-f1ca4a97c4f2,1 2 treatment of moderate to severe symptoms of vulvar and vaginal atrophy due to menopause angeliq 0 5 mg drsp 1 mg e2 is indicated for the treatment of moderate to severe symptoms of vulvar and vaginal atrophy due to menopause in women who have a uterus,1
2849,2849,2849,2849,2849,2849,2849,3571,3571,3571,3571,3571,3571,3571,3571,3571,3571,3571,3571,3571,3b8a7426-6f1c-470a-ac36-b8465b8679cd,1  amabelz is an estrogen and progestin combination indicated in a woman with a uterus for amabelz 1 mg 0 5 mg and 0 5 mg 0 1 mg are indicated in a woman with a uterus for treatment of moderate to severe vasomotor symptoms due to menopause ( 1 1 ) prevention of postmenopausal osteoporosis ( 1 3 ) amabelz 1 mg 0 5 mg is also indicated in a woman with a uterus for treatment of moderate to severe symptoms of vulvar and vaginal atrophy due to menopause ( 1 2 ) 1 1 treatment of moderate to severe vasomotor symptoms due to menopause 1 2 treatment of moderate to severe symptoms of vulvar and vaginal atrophy due to menopause limitation of use when prescribing solely for the treatment of moderate to severe symptoms of vulvar and vaginal atrophy due to menopause  topical vaginal products should be considered,1
2850,2850,2850,2850,2850,2850,2850,3572,3572,3572,3572,3572,3572,3572,3572,3572,3572,3572,3572,3572,3b8a7426-6f1c-470a-ac36-b8465b8679cd,1 3 prevention of postmenopausal osteoporosis limitation of use limitation of use when prescribing solely for the prevention of postmenopausal osteoporosis  therapy should only be considered for women at significant risk of osteoporosis and non estrogen medication should be carefully considered,4
2851,2851,2851,2851,2851,2851,2851,3573,3573,3573,3573,3573,3573,3573,3573,3573,3573,3573,3573,3573,7714a0ed-34bb-46e6-a0a5-b363908b22c2,1  promacta is a thrombopoietin receptor agonist indicated for the treatment of thrombocytopenia in adult and pediatric patients 1 year and older with chronic immune ( idiopathic ) thrombocytopenia ( itp ) who have had an insufficient response to corticosteroids  immunoglobulins  or splenectomy,1
2852,2852,2852,2852,2852,2852,2852,3574,3574,3574,3574,3574,3574,3574,3574,3574,3574,3574,3574,3574,7714a0ed-34bb-46e6-a0a5-b363908b22c2,promacta should be used only in patients with itp whose degree of thrombocytopenia and clinical condition increase the risk for bleeding,u
2853,2853,2853,2853,2853,2853,2853,3575,3575,3575,3575,3575,3575,3575,3575,3575,3575,3575,3575,3575,7714a0ed-34bb-46e6-a0a5-b363908b22c2,( 1 1 ) thrombocytopenia in patients with chronic hepatitis c to allow the initiation and maintenance of interferon based therapy,1
2854,2854,2854,2854,2854,2854,2854,3576,3576,3576,3576,3576,3576,3576,3576,3576,3576,3576,3576,3576,7714a0ed-34bb-46e6-a0a5-b363908b22c2,promacta should be used only in patients with chronic hepatitis c whose degree of thrombocytopenia prevents the initiation of interferon based therapy or limits the ability to maintain interferon based therapy,u
2855,2855,2855,2855,2855,2855,2855,3577,3577,3577,3577,3577,3577,3577,3577,3577,3577,3577,3577,3577,7714a0ed-34bb-46e6-a0a5-b363908b22c2,( 1 2 ) patients with severe aplastic anemia who have had an insufficient response to immunosuppressive therapy,1
2856,2856,2856,2856,2856,2856,2856,3578,3578,3578,3578,3578,3578,3578,3578,3578,3578,3578,3578,3578,7714a0ed-34bb-46e6-a0a5-b363908b22c2,( 1 3 ) limitations of use promacta is not indicated for the treatment of patients with myelodysplastic syndrome ( mds ),2
2857,2857,2857,2857,2857,2857,2857,3579,3579,3579,3579,3579,3579,3579,3579,3579,3579,3579,3579,3579,7714a0ed-34bb-46e6-a0a5-b363908b22c2,( 1 4 ) safety and efficacy have not been established in combination with direct acting antiviral agents used without interferon for treatment of chronic hepatitis c infection,0
2858,2858,2858,2858,2858,2858,2858,3580,3580,3580,3580,3580,3580,3580,3580,3580,3580,3580,3580,3580,7714a0ed-34bb-46e6-a0a5-b363908b22c2,( 1 4 ) 1 1 treatment of thrombocytopenia in patients with chronic itp promacta is indicated for the treatment of thrombocytopenia in adult and pediatric patients 1 year and older with chronic immune ( idiopathic ) thrombocytopenia ( itp ) who have had an insufficient response to corticosteroids  immunoglobulins  or splenectomy,1
2859,2859,2859,2859,2859,2859,2859,3582,3582,3582,3582,3582,3582,3582,3582,3582,3582,3582,3582,3582,7714a0ed-34bb-46e6-a0a5-b363908b22c2,1 2 treatment of thrombocytopenia in patients with hepatitis c infection promacta is indicated for the treatment of thrombocytopenia in patients with chronic hepatitis c to allow the initiation and maintenance of interferon based therapy,1
2860,2860,2860,2860,2860,2860,2860,3584,3584,3584,3584,3584,3584,3584,3584,3584,3584,3584,3584,3584,6b4de8c9-8a32-4a07-9183-419d6177ea08,indications oxytetracycline is indicated in infections caused by the following microorganisms rickettsiae ( rocky mountain spotted fever  typhus fever and the typhus group  q fever  rickettsialpox and tick fevers )  mycoplasma pneumoniae ( pplo  eaton agent )  agents of psittacosis and ornithosis  agents of lymphogranuloma venereum and granuloma inguinale  the spirochetal agent of relapsing fever ( borrelia recurrentis ),1
2861,2861,2861,2861,2861,2861,2861,3585,3585,3585,3585,3585,3585,3585,3585,3585,3585,3585,3585,3585,6b4de8c9-8a32-4a07-9183-419d6177ea08,the following gram negative microorganisms haemophilus ducreyi ( chancroid )  pasteurella pestis  and pasteurella tularensis  bartonella bacilliformis  bacteroides species  vibrio comma and vibrio fetus  brucella species ( in conjunction with streptomycin ),1
2862,2862,2862,2862,2862,2862,2862,3586,3586,3586,3586,3586,3586,3586,3586,3586,3586,3586,3586,3586,6b4de8c9-8a32-4a07-9183-419d6177ea08,because many strains of the following groups of microorganisms have been shown to be resistant to tetracyclines  culture and susceptibility testing are recommended,4
2863,2863,2863,2863,2863,2863,2863,3587,3587,3587,3587,3587,3587,3587,3587,3587,3587,3587,3587,3587,6b4de8c9-8a32-4a07-9183-419d6177ea08,oxytetracycline is indicated for treatment of infections caused by the following gram negative microorganisms  when bacteriologic testing indicates appropriate susceptibility to the drug escherichia coli  enterobacter aerogenes ( formerly aerobacter aerogenes )  shigella species  mima species and herellea species  haemophilus influenzae ( respiratory infections )  klebsiella species ( respiratory and urinary infections ),1
2864,2864,2864,2864,2864,2864,2864,3588,3588,3588,3588,3588,3588,3588,3588,3588,3588,3588,3588,3588,6b4de8c9-8a32-4a07-9183-419d6177ea08,oxytetracycline is indicated for treatment of infections caused by the following gram positive microorganisms when bacteriologic testing indicates appropriate susceptibility to the drug streptococcus species up to 44 percent of strains of streptococcus pyogenes and 74 percent of streptococcus faecalis have been found to be resistant to tetracycline drugs,1
2865,2865,2865,2865,2865,2865,2865,3589,3589,3589,3589,3589,3589,3589,3589,3589,3589,3589,3589,3589,6b4de8c9-8a32-4a07-9183-419d6177ea08,therefore  tetracyclines should not be used for streptococcal disease unless the organism has been demonstrated to be sensitive,0
2866,2866,2866,2866,2866,2866,2866,3590,3590,3590,3590,3590,3590,3590,3590,3590,3590,3590,3590,3590,6b4de8c9-8a32-4a07-9183-419d6177ea08,for upper respiratory infections due to group a beta hemolytic streptococci  penicillin is the usual drug of choice  including prophylaxis of rheumatic fever,1
2867,2867,2867,2867,2867,2867,2867,3591,3591,3591,3591,3591,3591,3591,3591,3591,3591,3591,3591,3591,6b4de8c9-8a32-4a07-9183-419d6177ea08,diplococcus pneumoniae  staphylococcus aureus  skin and soft tissue in,1
2868,2868,2868,2868,2868,2868,2868,3592,3592,3592,3592,3592,3592,3592,3592,3592,3592,3592,3592,3592,a3c2cddc-827b-4644-9060-e2fd2188b459, mepivacaine is indicated for production of local anesthesia for dental procedures by infiltration or nerve block in adults and pediatric patients,1
2869,2869,2869,2869,2869,2869,2869,3593,3593,3593,3593,3593,3593,3593,3593,3593,3593,3593,3593,3593,52fea941-0b47-41c1-b00d-f88150e8ab93, thioridazine hydrochloride tablets are indicated for the management of schizophrenic patients who fail to respond adequately to treatment with other antipsychotic drugs,1
2870,2870,2870,2870,2870,2870,2870,3594,3594,3594,3594,3594,3594,3594,3594,3594,3594,3594,3594,3594,52fea941-0b47-41c1-b00d-f88150e8ab93,due to the risk of significant  potentially life threatening  proarrhythmic effects with thioridazine treatment  thioridazine hydrochloride tablets should be used only in patients who have failed to respond adequately to treatment with appropriate courses of other antipsychotic drugs  either because of insufficient effectiveness or the inability to achieve an effective dose due to intolerable adverse effects from those drugs,4
2871,2871,2871,2871,2871,2871,2871,3595,3595,3595,3595,3595,3595,3595,3595,3595,3595,3595,3595,3595,52fea941-0b47-41c1-b00d-f88150e8ab93,consequently  before initiating treatment with thioridazine hydrochloride tablets  it is strongly recommended that a patient be given at least two trials  each with a different antipsychotic drug product  at an adequate dose  and for an adequate duration ( see warnings and contraindications ),4
2872,2872,2872,2872,2872,2872,2872,3596,3596,3596,3596,3596,3596,3596,3596,3596,3596,3596,3596,3596,52fea941-0b47-41c1-b00d-f88150e8ab93,however  the prescriber should be aware that thioridazine hydrochloride tablets have not been systematically evaluated in controlled trials in treatment refractory schizophrenic patients and its efficacy in such patients is unknown,0
2873,2873,2873,2873,2873,2873,2873,3597,3597,3597,3597,3597,3597,3597,3597,3597,3597,3597,3597,3597,fa1a5485-9404-4661-92c5-00a40a93f1af, relieves chest congestion mucus build up cough,1
2874,2874,2874,2874,2874,2874,2874,3598,3598,3598,3598,3598,3598,3598,3598,3598,3598,3598,3598,3598,cd5beee7-d8f5-4e1c-b990-98db641a20a2,uses helps prevent sunburn for skin that burns easily provides moderate protection against sunburn higher spf gives more sunburn protection directions for external use only when using this product keep out of eyes rinse with water to remove stop use and ask doctor if rash or irritation develops and lasts keep out of reach of children do not use on infants under 6 months of age,u
2875,2875,2875,2875,2875,2875,2875,3599,3599,3599,3599,3599,3599,3599,3599,3599,3599,3599,3599,3599,536a32e1-21a4-464b-aede-148c9abfd015,if used as directed  with other sun protection measures ( see directions )  decreases the risk of skin cancer and early skin aging caused by the sun,u
2876,2876,2876,2876,2876,2876,2876,3600,3600,3600,3600,3600,3600,3600,3600,3600,3600,3600,3600,3600,608d1bb0-10e2-476c-bf60-cc4980768545,directions helps prevent sunburn apply liberally 15 minutes before sun exposure use a water resistant sunscreen if swimming or sweating reapply at least every 2 hours sun protection measures,4
2877,2877,2877,2877,2877,2877,2877,3601,3601,3601,3601,3601,3601,3601,3601,3601,3601,3601,3601,3601,608d1bb0-10e2-476c-bf60-cc4980768545,spending time in the sun increases your risk of skin cancer and early skin aging,0
2878,2878,2878,2878,2878,2878,2878,3602,3602,3602,3602,3602,3602,3602,3602,3602,3602,3602,3602,3602,608d1bb0-10e2-476c-bf60-cc4980768545,to decrease this risk  regularly use a sunscreen with a broad spectrum spf of 15 or higher and other sun protection measures including limit time in the sun  especially from 10 a m 2 p m wear long sleeved shirts  pants  hats and sunglasses ask a doctor children under 6 months,4
2879,2879,2879,2879,2879,2879,2879,3603,3603,3603,3603,3603,3603,3603,3603,3603,3603,3603,3603,3603,4a0a2f1b-c5e4-4d23-a8f5-952d9a00a2e1,directions directions apply liberally 15 minutes bfore sun exposure reapply at least every 2 hours,4
2880,2880,2880,2880,2880,2880,2880,3604,3604,3604,3604,3604,3604,3604,3604,3604,3604,3604,3604,3604,4a0a2f1b-c5e4-4d23-a8f5-952d9a00a2e1,use a water resistant sunscreen if swimming or sweating,4
2881,2881,2881,2881,2881,2881,2881,3605,3605,3605,3605,3605,3605,3605,3605,3605,3605,3605,3605,3605,4a0a2f1b-c5e4-4d23-a8f5-952d9a00a2e1,children under 6 months of age ask a doctor,u
2882,2882,2882,2882,2882,2882,2882,3607,3607,3607,3607,3607,3607,3607,3607,3607,3607,3607,3607,3607,4a0a2f1b-c5e4-4d23-a8f5-952d9a00a2e1,to decrease this risk  regularly use a sunscreen with a broad spectrum spf value of 15 or higher and other sun protection measures including limit time in the sun  especially from 10 a m 2 p m wear long sleeved shirts  pants  hats  and sunglasses,4
2883,2883,2883,2883,2883,2883,2883,3608,3608,3608,3608,3608,3608,3608,3608,3608,3608,3608,3608,3608,f439d77f-ec5b-4534-a005-08f2e7af8d0c, the gradual bleaching of hyperpigmented skin conditions such as chloasma  melasma  freckles  senile lentigines  and other unwanted areas of melanin hyperpigmentation,1
2884,2884,2884,2884,2884,2884,2884,3609,3609,3609,3609,3609,3609,3609,3609,3609,3609,3609,3609,3609,f439d77f-ec5b-4534-a005-08f2e7af8d0c,obagi nu derm sunfader is intended for daytime use as it contains sunscreen agents,4
2885,2885,2885,2885,2885,2885,2885,3610,3610,3610,3610,3610,3610,3610,3610,3610,3610,3610,3610,3610,e5c450af-958e-41e3-9c2f-fda76b3596f5, for the gradual bleaching of hyperpigmented skin conditions such as chloasma  melasma  freckles  senile lentigines  and other unwanted areas of melanin hyperpigmentation,1
2886,2886,2886,2886,2886,2886,2886,3611,3611,3611,3611,3611,3611,3611,3611,3611,3611,3611,3611,3611,"Active Ingredient UNII(s)
4Y5P7MUD51; SOI2LOH54Z; XV74C1N1AE    36b030cc-024d-43f1-89b4-8d121f62aeff
4Y5P7MUD51; SOI2LOH54Z; XV74C1N1AE    36b030cc-024d-43f1-89b4-8d121f62aeff
4Y5P7MUD51; SOI2LOH54Z; XV74C1N1AE    36b030cc-024d-43f1-89b4-8d121f62aeff
Name: SET ID dtype: object",active ingredient unii ( s ) 4y5p7mud51 soi2loh54z xv74c1n1ae active ingredient unii ( s ) 4y5p7mud51 soi2loh5 4y5p7mud51 soi2loh54z xv74c1n1ae active ingredient unii ( s ) 4y5p7mud51 soi2loh5 4y5p7mud51 soi2loh54z xv74c1n1ae active ingredient unii ( s ) 4y5p7mud51 soi2loh5 name content xml  dtype object,0
2887,2887,2887,2887,2887,2887,2887,3614,3614,3614,3614,3614,3614,3614,3614,3614,3614,3614,3614,3614,a4d0efe9-5e54-467e-9eb4-56fa7d53b60b,1  darzalex is indicated in combination with lenalidomide and dexamethasone  or bortezomib and dexamethasone  for the treatment of patients with multiple myeloma who have received at least one prior therapy,1
2888,2888,2888,2888,2888,2888,2888,3615,3615,3615,3615,3615,3615,3615,3615,3615,3615,3615,3615,3615,a4d0efe9-5e54-467e-9eb4-56fa7d53b60b,in combination with pomalidomide and dexamethasone for the treatment of patients with multiple myeloma who have received at least two prior therapies including lenalidomide and a proteasome inhibitor,1
2889,2889,2889,2889,2889,2889,2889,3616,3616,3616,3616,3616,3616,3616,3616,3616,3616,3616,3616,3616,a4d0efe9-5e54-467e-9eb4-56fa7d53b60b,as monotherapy  for the treatment of patients with multiple myeloma who have received at least three prior lines of therapy including a proteasome inhibitor ( pi ) and an immunomodulatory agent or who are double refractory to a pi and an immunomodulatory agent,1
2890,2890,2890,2890,2890,2890,2890,3617,3617,3617,3617,3617,3617,3617,3617,3617,3617,3617,3617,3617,a4d0efe9-5e54-467e-9eb4-56fa7d53b60b,darzalex is a cd38 directed cytolytic antibody indicated in combination with lenalidomide and dexamethasone  or bortezomib and dexamethasone  for the treatment of patients with multiple myeloma who have received at least one prior therapy in combination with pomalidomide and dexamethasone for the treatment of patients with multiple myeloma who have received at least two prior therapies including lenalidomide and a proteasome inhibitor as monotherapy  for the treatment of patients with multiple myeloma who have received at least three prior lines of therapy including a proteasome inhibitor ( pi ) and an immunomodulatory agent or who are double refractory to a pi and an immunomodulatory agent,1
2891,2891,2891,2891,2891,2891,2891,3618,3618,3618,3618,3618,3618,3618,3618,3618,3618,3618,3618,3618,2eda833b-1357-4ed4-a093-194524fcb061,1  thalomid in combination with dexamethasone is indicated for the treatment of patients with newly diagnosed multiple myeloma ( mm ),1
2892,2892,2892,2892,2892,2892,2892,3619,3619,3619,3619,3619,3619,3619,3619,3619,3619,3619,3619,3619,2eda833b-1357-4ed4-a093-194524fcb061,( 1 1 ) thalomid is indicated for the acute treatment of the cutaneous manifestations of moderate to severe erythema nodosum leprosum ( enl ),1
2893,2893,2893,2893,2893,2893,2893,3620,3620,3620,3620,3620,3620,3620,3620,3620,3620,3620,3620,3620,2eda833b-1357-4ed4-a093-194524fcb061,thalomid is not indicated as monotherapy for such enl treatment in the presence of moderate to severe neuritis,2
2894,2894,2894,2894,2894,2894,2894,3621,3621,3621,3621,3621,3621,3621,3621,3621,3621,3621,3621,3621,2eda833b-1357-4ed4-a093-194524fcb061,thalomid is also indicated as maintenance therapy for prevention and suppression of the cutaneous manifestations of enl recurrence,1
2895,2895,2895,2895,2895,2895,2895,3622,3622,3622,3622,3622,3622,3622,3622,3622,3622,3622,3622,3622,2eda833b-1357-4ed4-a093-194524fcb061,( 1 2 ) 1 1 multiple myeloma thalomid in combination with dexamethasone is indicated for the treatment of patients with newly diagnosed multiple myeloma ( mm ) see clinical studies ( 14 1 ),1
2896,2896,2896,2896,2896,2896,2896,3623,3623,3623,3623,3623,3623,3623,3623,3623,3623,3623,3623,3623,2eda833b-1357-4ed4-a093-194524fcb061,1 2 erythema nodosum leprosum thalomid is indicated for the acute treatment of the cutaneous manifestations of moderate to severe erythema nodosum leprosum ( enl ),1
2897,2897,2897,2897,2897,2897,2897,3625,3625,3625,3625,3625,3625,3625,3625,3625,3625,3625,3625,3625,2eda833b-1357-4ed4-a093-194524fcb061,thalomid is also indicated as maintenance therapy for prevention and suppression of the cutaneous manifestations of enl recurrence see clinical studies ( 14 2 ),1
2898,2898,2898,2898,2898,2898,2898,3626,3626,3626,3626,3626,3626,3626,3626,3626,3626,3626,3626,3626,21318026-392a-4e66-959e-f793a9634e58,indications indications to be used for acute  self limiting conditions according to standard homeopathic indications,u
2899,2899,2899,2899,2899,2899,2899,3627,3627,3627,3627,3627,3627,3627,3627,3627,3627,3627,3627,3627,6153ef9e-77f0-4233-a5bc-3e3d1f732323, saluron is indicated as adjunctive therapy in edema associated with congestive heart failure  hepatic cirrhosis and corticosteroid and estrogen therapy,1
2900,2900,2900,2900,2900,2900,2900,3628,3628,3628,3628,3628,3628,3628,3628,3628,3628,3628,3628,3628,6153ef9e-77f0-4233-a5bc-3e3d1f732323,saluron has also been found useful in edema due to various forms of renal dysfunction  such as nephrotic syndrome  acute glomerulonephritis  and chronic renal failure,1
2901,2901,2901,2901,2901,2901,2901,3629,3629,3629,3629,3629,3629,3629,3629,3629,3629,3629,3629,3629,6153ef9e-77f0-4233-a5bc-3e3d1f732323,saluron is indicated in the management of hypertension  either as the sole therapeutic agent or to enhance the effectiveness of other antihypertensive drugs in the more severe forms of hypertension,1
2902,2902,2902,2902,2902,2902,2902,3630,3630,3630,3630,3630,3630,3630,3630,3630,3630,3630,3630,3630,6153ef9e-77f0-4233-a5bc-3e3d1f732323,usage in pregnancy the routine use of diuretics in an otherwise healthy woman is inappropriate and exposes mother and fetus to unnecessary risk,2
2903,2903,2903,2903,2903,2903,2903,3633,3633,3633,3633,3633,3633,3633,3633,3633,3633,3633,3633,3633,6153ef9e-77f0-4233-a5bc-3e3d1f732323,thiazides are indicated in pregnancy when edema is due to pathologic causes  just as they are in the absence of pregnancy ( however  see warnings below ),1
2904,2904,2904,2904,2904,2904,2904,3634,3634,3634,3634,3634,3634,3634,3634,3634,3634,3634,3634,3634,6153ef9e-77f0-4233-a5bc-3e3d1f732323,dependent edema in pregnancy  resulting from restriction of venous return by the expanded uterus  is properly treated through elevation of the lower extremities and use of support hose,4
2905,2905,2905,2905,2905,2905,2905,3635,3635,3635,3635,3635,3635,3635,3635,3635,3635,3635,3635,3635,6153ef9e-77f0-4233-a5bc-3e3d1f732323,use of diuretics to lower intravascular volume in this case is illogical and unnecessary,2
2906,2906,2906,2906,2906,2906,2906,3640,3640,3640,3640,3640,3640,3640,3640,3640,3640,3640,3640,3640,5f7be402-f25a-428e-b81f-6a4a00de894c, 3 3 sorbitol irrigation is indicated for use as a urologic irrigation fluid,1
2907,2907,2907,2907,2907,2907,2907,3641,3641,3641,3641,3641,3641,3641,3641,3641,3641,3641,3641,3641,f522cd6d-aa0f-4b44-92cc-ed952058eea0,1  valchlor is an alkylating drug indicated for the topical treatment of stage ia and ib mycosis fungoides type cutaneous t cell lymphoma in patients who have received prior skin directed therapy,1
2908,2908,2908,2908,2908,2908,2908,3642,3642,3642,3642,3642,3642,3642,3642,3642,3642,3642,3642,3642,f522cd6d-aa0f-4b44-92cc-ed952058eea0,valchlor is an alkylating drug indicated for the topical treatment of stage ia and ib mycosis fungoides type cutaneous t cell lymphoma in patients who have received prior skin directed therapy ( 1 ),1
2909,2909,2909,2909,2909,2909,2909,3643,3643,3643,3643,3643,3643,3643,3643,3643,3643,3643,3643,3643,f5bb0854-a477-4e59-914b-eeeaef92a596, when oral therapy is not feasible  and the strength  dosage form  and route of administration of the drug reasonably lend the preparation to the treatment of the condition  the intravenous or intramusculat use of solu cortef sterile powder is indicated as follows allergic states control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in asthma  atopic dermatitis  contact dermatitis  drug hypersensitivity reactions  perennial or seasonal allergic rhinitis  serum sickness  transfusion reactions,1
2910,2910,2910,2910,2910,2910,2910,3644,3644,3644,3644,3644,3644,3644,3644,3644,3644,3644,3644,3644,f5bb0854-a477-4e59-914b-eeeaef92a596,dermatologic diseases bullous dermatitis herpetiformis  exfoliative erythroderma  mycosis fungoides  pemphigus  severe erythema multiforme ( stevens johnson syndrome ),1
2911,2911,2911,2911,2911,2911,2911,3645,3645,3645,3645,3645,3645,3645,3645,3645,3645,3645,3645,3645,f5bb0854-a477-4e59-914b-eeeaef92a596,endocrine disorders primary or secondary adrenocortical insufficiency ( hydrocortisone or cortisone is the drug of choice synthetic analogs may be used in conjunction with mineralocorticoids where applicable in infancy  mineralocorticoid supplementation is of particular importance )  congenital adrenal hyperplasia  hypercalcemia associated with cancer  nonsuppurative thyroiditis,1
2912,2912,2912,2912,2912,2912,2912,3647,3647,3647,3647,3647,3647,3647,3647,3647,3647,3647,3647,3647,f5bb0854-a477-4e59-914b-eeeaef92a596,hematologic disorders acquired ( autoimmune ) hemolytic anemia  congenital ( erythroid ) hypoplastic anemia ( diamond blackfan anemia )  idiopathic thrombocytopenic purpura in adults ( intravenous administration only intramuscular administration is contraindicated )  pure red cell aplasia  select cases of secondary thrombocytopenia,1
2913,2913,2913,2913,2913,2913,2913,3648,3648,3648,3648,3648,3648,3648,3648,3648,3648,3648,3648,3648,f5bb0854-a477-4e59-914b-eeeaef92a596,section id id a10373e6 0db6 40ef 86ee 3be6,0
2914,2914,2914,2914,2914,2914,2914,3649,3649,3649,3649,3649,3649,3649,3649,3649,3649,3649,3649,3649,1b97597f-f2e7-4574-81a8-f35b769c957a, alomide ( lodoxamide tromethamine ophthalmic solution ) 0 1 is indicated in the treatment of the ocular disorders referred to by the terms vernal keratoconjunctivitis  vernal conjunctivitis  and vernal keratitis,1
2915,2915,2915,2915,2915,2915,2915,3650,3650,3650,3650,3650,3650,3650,3650,3650,3650,3650,3650,3650,4aeae21c-8c03-4fa9-a191-6b1e9000cbdb, ciclopirox topical suspension usp  0 77 ( lotion ) is indicated for the topical treatment of the following dermal infections tinea pedis  tinea cruris  and tinea corporis due to trichophyton rubrum  trichophyton mentagrophytes  epidermophyton floccosum  and microsporum canis cutaneous candidiasis ( moniliasis ) due to candida albicans and tinea ( pityriasis ) versicolor due to malassezia furfur,1
2916,2916,2916,2916,2916,2916,2916,3652,3652,3652,3652,3652,3652,3652,3652,3652,3652,3652,3652,3652,9803a6ff-8a3e-4c64-b3d0-7825c7123bf2,1  daklinza is indicated for use with sofosbuvir  with or without ribavirin  for the treatment of patients with chronic hepatitis c virus ( hcv ) genotype 1 or genotype 3 infection see dosage and administration ( 2 ) and clinical studies ( 14 ),1
2917,2917,2917,2917,2917,2917,2917,3653,3653,3653,3653,3653,3653,3653,3653,3653,3653,3653,3653,3653,9803a6ff-8a3e-4c64-b3d0-7825c7123bf2,limitations of use sustained virologic response ( svr12 ) rates are reduced in hcv genotype 3 infected patients with cirrhosis receiving daklinza in combination with sofosbuvir for 12 weeks see clinical studies ( 14 2 ),2
2918,2918,2918,2918,2918,2918,2918,3654,3654,3654,3654,3654,3654,3654,3654,3654,3654,3654,3654,3654,9803a6ff-8a3e-4c64-b3d0-7825c7123bf2,daklinza is a hepatitis c virus ( hcv ) ns5a inhibitor indicated for use with sofosbuvir  with or without ribavirin  for the treatment of chronic hcv genotype 1 or 3 infection,1
2919,2919,2919,2919,2919,2919,2919,3655,3655,3655,3655,3655,3655,3655,3655,3655,3655,3655,3655,3655,9803a6ff-8a3e-4c64-b3d0-7825c7123bf2,( 1 ) limitations of use sustained virologic response ( svr12 ) rates are reduced in genotype 3 patients with cirrhosis receiving daklinza in combination with sofosbuvir for 12 weeks,2
2920,2920,2920,2920,2920,2920,2920,3656,3656,3656,3656,3656,3656,3656,3656,3656,3656,3656,3656,3656,4cc59056-a5a8-696d-e054-00144ff88e88,use ( s ) to prevent or treat fainting,1
2921,2921,2921,2921,2921,2921,2921,3657,3657,3657,3657,3657,3657,3657,3657,3657,3657,3657,3657,3657,"Active Ingredient UNII(s)
5138Q19F1X; 85H0HZU99M; EC2CNF7XFP; F446C597KA    1156c8a9-e2c1-49cb-b395-93959820c14f
5138Q19F1X; 85H0HZU99M; EC2CNF7XFP; F446C597KA    1156c8a9-e2c1-49cb-b395-93959820c14f
5138Q19F1X; 85H0HZU99M; EC2CNF7XFP; F446C597KA    1156c8a9-e2c1-49cb-b395-93959820c14f
5138Q19F1X; 85H0HZU99M; EC2CNF7XFP; F446C597KA    1156c8a9-e2c1-49cb-b395-93959820c14f
Name: SET ID dtype: object",active ingredient unii ( s ) 5138q19f1x 85h0hzu99m ec2cnf7xfp f446c597ka active ingredient unii ( s ) 5138q19f1x 85h0hzu9 5138q19f1x 85h0hzu99m ec2cnf7xfp f446c597ka active ingredient unii ( s ) 5138q19f1x 85h0hzu9 5138q19f1x 85h0hzu99m ec2cnf7xfp f446c597ka active ingredient unii ( s ) 5138q19f1x 85h0hzu9 5138q19f1x 85h0hzu99m ec2cnf7xfp f446c597ka active ingredient unii ( s ) 5138q19f1x 85h0hzu9 name content xml  dtype object,0
2922,2922,2922,2922,2922,2922,2922,3661,3661,3661,3661,3661,3661,3661,3661,3661,3661,3661,3661,3661,"Active Ingredient UNII(s)
5138Q19F1X; 85H0HZU99M; F446C597KA; V13007Z41A    e25cfc22-29ba-473f-88c4-3c88e9f6863b
5138Q19F1X; 85H0HZU99M; F446C597KA; V13007Z41A    e25cfc22-29ba-473f-88c4-3c88e9f6863b
5138Q19F1X; 85H0HZU99M; F446C597KA; V13007Z41A    e25cfc22-29ba-473f-88c4-3c88e9f6863b
5138Q19F1X; 85H0HZU99M; F446C597KA; V13007Z41A    e25cfc22-29ba-473f-88c4-3c88e9f6863b
Name: SET ID dtype: object",active ingredient unii ( s ) 5138q19f1x 85h0hzu99m f446c597ka v13007z41a active ingredient unii ( s ) 5138q19f1x 85h0hzu9 5138q19f1x 85h0hzu99m f446c597ka v13007z41a active ingredient unii ( s ) 5138q19f1x 85h0hzu9 5138q19f1x 85h0hzu99m f446c597ka v13007z41a active ingredient unii ( s ) 5138q19f1x 85h0hzu9 5138q19f1x 85h0hzu99m f446c597ka v13007z41a active ingredient unii ( s ) 5138q19f1x 85h0hzu9 name content xml  dtype object,0
2923,2923,2923,2923,2923,2923,2923,3665,3665,3665,3665,3665,3665,3665,3665,3665,3665,3665,3665,3665,de3d9c26-572b-4ea4-9b2d-dd58a2b3e8fa,1  jevtana is indicated in combination with prednisone for the treatment of patients with metastatic castration resistant prostate cancer previously treated with a docetaxel containing treatment regimen,1
2924,2924,2924,2924,2924,2924,2924,3666,3666,3666,3666,3666,3666,3666,3666,3666,3666,3666,3666,3666,de3d9c26-572b-4ea4-9b2d-dd58a2b3e8fa,jevtana is a microtubule inhibitor indicated in combination with prednisone for treatment of patients with metastatic castration resistant prostate cancer previously treated with a docetaxel containing treatment regimen,1
2925,2925,2925,2925,2925,2925,2925,3667,3667,3667,3667,3667,3667,3667,3667,3667,3667,3667,3667,3667,5ccf0e9a-8935-4c8c-b883-b4967281eb4a, metastatic prostate cancer nilandron tablets are indicated for use in combination with surgical castration for the treatment of metastatic prostate cancer ( stage d2 ),1
2926,2926,2926,2926,2926,2926,2926,3668,3668,3668,3668,3668,3668,3668,3668,3668,3668,3668,3668,3668,5ccf0e9a-8935-4c8c-b883-b4967281eb4a,for maximum benefit  nilandron treatment must begin on the same day as or on the day after surgical castration,4
2927,2927,2927,2927,2927,2927,2927,3669,3669,3669,3669,3669,3669,3669,3669,3669,3669,3669,3669,3669,e28c05f0-081f-406d-8bfb-9160a6908307,1  etopophos is a topoisomerase inhibitor indicated for the treatment of patients with refractory testicular tumors  in combination with other chemotherapeutic drugs,1
2928,2928,2928,2928,2928,2928,2928,3670,3670,3670,3670,3670,3670,3670,3670,3670,3670,3670,3670,3670,e28c05f0-081f-406d-8bfb-9160a6908307,( 1 ) small cell lung cancer  in combination with cisplatin  as first line treatment,1
2929,2929,2929,2929,2929,2929,2929,3671,3671,3671,3671,3671,3671,3671,3671,3671,3671,3671,3671,3671,e28c05f0-081f-406d-8bfb-9160a6908307,( 1 ) 1 1 refractory testicular tumors etopophos is indicated  in combination with other chemotherapeutic drugs  for treatment of patients with refractory testicular tumors,1
2930,2930,2930,2930,2930,2930,2930,3672,3672,3672,3672,3672,3672,3672,3672,3672,3672,3672,3672,3672,e28c05f0-081f-406d-8bfb-9160a6908307,1 2 small cell lung cancer etopophos is indicated  in combination with cisplatin  for first line treatment of patients with small cell lung cancer,1
2931,2931,2931,2931,2931,2931,2931,3673,3673,3673,3673,3673,3673,3673,3673,3673,3673,3673,3673,3673,6fa682c9-a312-4932-9831-f286908660ee,1  tecentriq is a programmed death ligand 1 ( pd l1 ) blocking antibody indicated for the treatment of patients with locally advanced or metastatic urothelial carcinoma who are not eligible for cisplatin containing chemotherapy  or have disease progression during or following any platinum containing chemotherapy  or within 12 months of neoadjuvant or adjuvant chemotherapy,1
2932,2932,2932,2932,2932,2932,2932,3676,3676,3676,3676,3676,3676,3676,3676,3676,3676,3676,3676,3676,6fa682c9-a312-4932-9831-f286908660ee,( 1 1 ) metastatic non small cell lung cancer who have disease progression during or following platinum containing chemotherapy,1
2933,2933,2933,2933,2933,2933,2933,3677,3677,3677,3677,3677,3677,3677,3677,3677,3677,3677,3677,3677,6fa682c9-a312-4932-9831-f286908660ee,patients with egfr or alk genomic tumor aberrations should have disease progression on fda approved therapy for these aberrations prior to receiving tecentriq,u
2934,2934,2934,2934,2934,2934,2934,3678,3678,3678,3678,3678,3678,3678,3678,3678,3678,3678,3678,3678,6fa682c9-a312-4932-9831-f286908660ee,( 1 2 ) 1 1 locally advanced or metastatic urothelial carcinoma tecentriq ( atezolizumab ) is indicated for the treatment of patients with locally advanced or metastatic urothelial carcinoma who are not eligible for cisplatin containing chemotherapy  or have disease progression during or following any platinum containing chemotherapy  or within 12 months of neoadjuvant or adjuvant chemotherapy this indication is approved under accelerated approval based on tumor response rate and durability of response,1
2935,2935,2935,2935,2935,2935,2935,3680,3680,3680,3680,3680,3680,3680,3680,3680,3680,3680,3680,3680,6fa682c9-a312-4932-9831-f286908660ee,1 2 metastatic non small cell lung cancer tecentriq is indicated for the treatment of patients with metastatic non small cell lung cancer ( nsclc ) who have disease progression during or following platinum containing chemotherapy,1
2936,2936,2936,2936,2936,2936,2936,3681,3681,3681,3681,3681,3681,3681,3681,3681,3681,3681,3681,3681,6fa682c9-a312-4932-9831-f286908660ee,patients with egfr or alk genomic tumor aberrations should have disease progression on fda approved therapy for these aberrations prior to receiving tecentriq see clinical studies ( 14 2 ),u
2937,2937,2937,2937,2937,2937,2937,3682,3682,3682,3682,3682,3682,3682,3682,3682,3682,3682,3682,3682,01a914b7-51b5-4aab-952f-2eae56d25e9c, this product is indicated for the diagnosis and treatment ( hyposensitization therapy ) of patients who experience allergic symptoms due to exposure to cats and who exhibit type i skin sensitivity when tested to those specific allergens,1
2938,2938,2938,2938,2938,2938,2938,3683,3683,3683,3683,3683,3683,3683,3683,3683,3683,3683,3683,3683,01a914b7-51b5-4aab-952f-2eae56d25e9c,hyposensitization ( injection ) therapy is a treatment for patients exhibiting allergic reactions to seasonal pollens  dust mites  molds  animal danders  and various other inhalants  in situations where the offending allergen cannot be avoided,1
2939,2939,2939,2939,2939,2939,2939,3684,3684,3684,3684,3684,3684,3684,3684,3684,3684,3684,3684,3684,01a914b7-51b5-4aab-952f-2eae56d25e9c,prior to the initiation of therapy  clinical sensitivity should be established by careful evaluation of the patient 's history confirmed by diagnostic skin testing,0
2940,2940,2940,2940,2940,2940,2940,3685,3685,3685,3685,3685,3685,3685,3685,3685,3685,3685,3685,3685,01a914b7-51b5-4aab-952f-2eae56d25e9c,hyposensitization should not be prescribed for sensitivities to allergens which can be easily avoided,2
2941,2941,2941,2941,2941,2941,2941,3686,3686,3686,3686,3686,3686,3686,3686,3686,3686,3686,3686,3686,68089182-d4a2-4053-8d0d-fc97a901515d,1  dexrazoxane for injection is indicated for reducing the incidence and severity of cardiomyopathy associated with doxorubicin administration in women with metastatic breast cancer who have received a cumulative doxorubicin dose of 300 mg m2 and who will continue to receive doxorubicin therapy to maintain tumor control,1
2942,2942,2942,2942,2942,2942,2942,3687,3687,3687,3687,3687,3687,3687,3687,3687,3687,3687,3687,3687,68089182-d4a2-4053-8d0d-fc97a901515d,do not use with the initiation of doxorubicin therapy see warnings and precautions ( 5 2 ),2
2943,2943,2943,2943,2943,2943,2943,3688,3688,3688,3688,3688,3688,3688,3688,3688,3688,3688,3688,3688,68089182-d4a2-4053-8d0d-fc97a901515d,dexrazoxane for injection is a cytoprotective agent indicated for reducing the incidence and severity of cardiomyopathy associated with doxorubicin administration in women with metastatic breast cancer who have received a cumulative doxorubicin dose of 300 mg m2 and who will continue to receive doxorubicin therapy to maintain tumor control,1
2944,2944,2944,2944,2944,2944,2944,3689,3689,3689,3689,3689,3689,3689,3689,3689,3689,3689,3689,3689,68089182-d4a2-4053-8d0d-fc97a901515d,do not use dexrazoxane for injection with doxorubicin initiation,2
2945,2945,2945,2945,2945,2945,2945,3690,3690,3690,3690,3690,3690,3690,3690,3690,3690,3690,3690,3690,2a51b0de-47d6-455e-a94c-d2c737b04ff7,1  xalkori is indicated for the treatment of patients with metastatic non small cell lung cancer ( nsclc ) whose tumors are anaplastic lymphoma kinase ( alk ) or ros1 positive as detected by an fda approved test see clinical studies ( 14 1 and 14 2 ),1
2946,2946,2946,2946,2946,2946,2946,3691,3691,3691,3691,3691,3691,3691,3691,3691,3691,3691,3691,3691,2a51b0de-47d6-455e-a94c-d2c737b04ff7,xalkori is a kinase inhibitor indicated for the treatment of patients with metastatic non small cell lung cancer ( nsclc ) whose tumors are anaplastic lymphoma kinase ( alk ) or ros1 positive as detected by an fda approved test,1
2947,2947,2947,2947,2947,2947,2947,3692,3692,3692,3692,3692,3692,3692,3692,3692,3692,3692,3692,3692,adec4fd2-6858-4c99-91d4-531f5f2a2d79,1  ozempic is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus see clinical studies ( 14 1 ),1
2948,2948,2948,2948,2948,2948,2948,3693,3693,3693,3693,3693,3693,3693,3693,3693,3693,3693,3693,3693,adec4fd2-6858-4c99-91d4-531f5f2a2d79,limitations of use ozempic is not recommended as a first line therapy for patients who have inadequate glycemic control on diet and exercise because of the uncertain relevance of rodent c cell tumor findings to humans see warnings and precautions ( 5 1 ),2
2949,2949,2949,2949,2949,2949,2949,3694,3694,3694,3694,3694,3694,3694,3694,3694,3694,3694,3694,3694,adec4fd2-6858-4c99-91d4-531f5f2a2d79,ozempic has not been studied in patients with a history of pancreatitis,0
2950,2950,2950,2950,2950,2950,2950,3695,3695,3695,3695,3695,3695,3695,3695,3695,3695,3695,3695,3695,adec4fd2-6858-4c99-91d4-531f5f2a2d79,consider other antidiabetic therapies in patients with a history of pancreatitis see warnings and precautions ( 5 2 ),0
2951,2951,2951,2951,2951,2951,2951,3696,3696,3696,3696,3696,3696,3696,3696,3696,3696,3696,3696,3696,adec4fd2-6858-4c99-91d4-531f5f2a2d79,ozempic is not a substitute for insulin,0
2952,2952,2952,2952,2952,2952,2952,3697,3697,3697,3697,3697,3697,3697,3697,3697,3697,3697,3697,3697,adec4fd2-6858-4c99-91d4-531f5f2a2d79,ozempic is not indicated for use in patients with type 1 diabetes mellitusor for the treatment of patients with diabetic ketoacidosis  as it would not be effective in these settings,2
2953,2953,2953,2953,2953,2953,2953,3698,3698,3698,3698,3698,3698,3698,3698,3698,3698,3698,3698,3698,adec4fd2-6858-4c99-91d4-531f5f2a2d79,ozempic is a glucagon like peptide 1 ( glp 1 ) receptor agonist indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus ( 1 ),1
2954,2954,2954,2954,2954,2954,2954,3699,3699,3699,3699,3699,3699,3699,3699,3699,3699,3699,3699,3699,adec4fd2-6858-4c99-91d4-531f5f2a2d79,limitations of use not recommended as first line therapy for patients inadequately controlled on diet and exercise ( 1  5 1 ),0
2955,2955,2955,2955,2955,2955,2955,3700,3700,3700,3700,3700,3700,3700,3700,3700,3700,3700,3700,3700,adec4fd2-6858-4c99-91d4-531f5f2a2d79,has not been studied in patients with a history of pancreatitis,0
2956,2956,2956,2956,2956,2956,2956,3701,3701,3701,3701,3701,3701,3701,3701,3701,3701,3701,3701,3701,adec4fd2-6858-4c99-91d4-531f5f2a2d79,consider another antidiabetic therapy ( 1  5 2 ),0
2957,2957,2957,2957,2957,2957,2957,3702,3702,3702,3702,3702,3702,3702,3702,3702,3702,3702,3702,3702,adec4fd2-6858-4c99-91d4-531f5f2a2d79,not indicated for use in type 1 diabetes mellitus or treatment of diabetic ketoacidosis ( 1 ),2
2958,2958,2958,2958,2958,2958,2958,3703,3703,3703,3703,3703,3703,3703,3703,3703,3703,3703,3703,3703,bcb387ac-2e90-4f5e-94b2-d3635190678e,1  impavido ( miltefosine ) capsules are indicated in adults and adolescents 12 years of age weighing 30 kg for the treatment of visceral leishmaniasis caused by leishmania donovani see clinical trials ( 14 1 ),1
2959,2959,2959,2959,2959,2959,2959,3704,3704,3704,3704,3704,3704,3704,3704,3704,3704,3704,3704,3704,bcb387ac-2e90-4f5e-94b2-d3635190678e,cutaneous leishmaniasis caused by leishmania braziliensis  leishmania guyanensis  and leishmania panamensis see clinical trials ( 14 2 ),1
2960,2960,2960,2960,2960,2960,2960,3705,3705,3705,3705,3705,3705,3705,3705,3705,3705,3705,3705,3705,bcb387ac-2e90-4f5e-94b2-d3635190678e,mucosal leishmaniasis caused by leishmania braziliensis see clinical trials ( 14 3 ),1
2961,2961,2961,2961,2961,2961,2961,3706,3706,3706,3706,3706,3706,3706,3706,3706,3706,3706,3706,3706,bcb387ac-2e90-4f5e-94b2-d3635190678e,limitations of use leishmania species studied in clinical trials evaluating impavido were based on epidemiologic data see clinical trials ( 14 1  14 2 ),0
2962,2962,2962,2962,2962,2962,2962,3707,3707,3707,3707,3707,3707,3707,3707,3707,3707,3707,3707,3707,bcb387ac-2e90-4f5e-94b2-d3635190678e,there may be geographic variation in clinical response of the same leishmania species to impavido see clinical trials ( 14 1  14 2 ),0
2963,2963,2963,2963,2963,2963,2963,3708,3708,3708,3708,3708,3708,3708,3708,3708,3708,3708,3708,3708,bcb387ac-2e90-4f5e-94b2-d3635190678e,the efficacy of impavido in the treatment of other leishmania species has not been evaluated,0
2964,2964,2964,2964,2964,2964,2964,3709,3709,3709,3709,3709,3709,3709,3709,3709,3709,3709,3709,3709,bcb387ac-2e90-4f5e-94b2-d3635190678e,impavido is an antileishmanial drug indicated in adults and adolescents 12 years of age weighing 30 kg ( 66 lbs ) for treatment of visceral leishmaniasis due to leishmania donovani ( 1 ),1
2965,2965,2965,2965,2965,2965,2965,3710,3710,3710,3710,3710,3710,3710,3710,3710,3710,3710,3710,3710,bcb387ac-2e90-4f5e-94b2-d3635190678e,cutaneous leishmaniasis due to leishmania braziliensis  leishmania guyanensis  and leishmania panamensis ( 1 ),1
2966,2966,2966,2966,2966,2966,2966,3711,3711,3711,3711,3711,3711,3711,3711,3711,3711,3711,3711,3711,bcb387ac-2e90-4f5e-94b2-d3635190678e,mucosal leishmaniasis due to leishmania braziliensis ( 1 ),1
2967,2967,2967,2967,2967,2967,2967,3712,3712,3712,3712,3712,3712,3712,3712,3712,3712,3712,3712,3712,bcb387ac-2e90-4f5e-94b2-d3635190678e,limitations of use leishmania species evaluated in clinical trials were based on epidemiologic data,0
2968,2968,2968,2968,2968,2968,2968,3713,3713,3713,3713,3713,3713,3713,3713,3713,3713,3713,3713,3713,bcb387ac-2e90-4f5e-94b2-d3635190678e,there may be geographic variation in the response of the same leishmania species to impavido ( linkhtml href id bdddfa36 dd15 437a add5,0
2969,2969,2969,2969,2969,2969,2969,3714,3714,3714,3714,3714,3714,3714,3714,3714,3714,3714,3714,3714,fe44d24d-55cd-439c-895b-00a38cd59f65,1  imipenem and cilastatin for injection ( i v ),0
2970,2970,2970,2970,2970,2970,2970,3715,3715,3715,3715,3715,3715,3715,3715,3715,3715,3715,3715,3715,fe44d24d-55cd-439c-895b-00a38cd59f65,for intravenous use is a combination of imipenem  a penem antibacterial  and cilastatin  a renal dehydropeptidase inhibitor  indicated for the treatment of the following serious infections caused by designated susceptible bacteria lower respiratory tract infections,1
2971,2971,2971,2971,2971,2971,2971,3716,3716,3716,3716,3716,3716,3716,3716,3716,3716,3716,3716,3716,fe44d24d-55cd-439c-895b-00a38cd59f65,( 1 1 ) urinary tract infections,1
2972,2972,2972,2972,2972,2972,2972,3717,3717,3717,3717,3717,3717,3717,3717,3717,3717,3717,3717,3717,fe44d24d-55cd-439c-895b-00a38cd59f65,( 1 2 ) intra abdominal infections,1
2973,2973,2973,2973,2973,2973,2973,3718,3718,3718,3718,3718,3718,3718,3718,3718,3718,3718,3718,3718,fe44d24d-55cd-439c-895b-00a38cd59f65,( 1 5 ) bone and joint infections,1
2974,2974,2974,2974,2974,2974,2974,3719,3719,3719,3719,3719,3719,3719,3719,3719,3719,3719,3719,3719,fe44d24d-55cd-439c-895b-00a38cd59f65,( 1 6 ) skin and skin structure infections,1
2975,2975,2975,2975,2975,2975,2975,3720,3720,3720,3720,3720,3720,3720,3720,3720,3720,3720,3720,3720,fe44d24d-55cd-439c-895b-00a38cd59f65,( 1 8 ) limitations of use imipenem and cilastatin for injection ( i v ),0
2976,2976,2976,2976,2976,2976,2976,3721,3721,3721,3721,3721,3721,3721,3721,3721,3721,3721,3721,3721,fe44d24d-55cd-439c-895b-00a38cd59f65,is not indicated in patients with meningitis because safety and efficacy have not been established ( 1 9 ),2
2977,2977,2977,2977,2977,2977,2977,3722,3722,3722,3722,3722,3722,3722,3722,3722,3722,3722,3722,3722,fe44d24d-55cd-439c-895b-00a38cd59f65,imipenem and cilastatin for injection ( i v ),0
2978,2978,2978,2978,2978,2978,2978,3723,3723,3723,3723,3723,3723,3723,3723,3723,3723,3723,3723,3723,fe44d24d-55cd-439c-895b-00a38cd59f65,is not recommended in pediatric patients with cns infections because of the risk of seizures ( 1 9 ),2
2979,2979,2979,2979,2979,2979,2979,3725,3725,3725,3725,3725,3725,3725,3725,3725,3725,3725,3725,3725,fe44d24d-55cd-439c-895b-00a38cd59f65,is not recommended in pediatric patients weighing less than 30 kg with impaired renal function ( 1 9 ),2
2980,2980,2980,2980,2980,2980,2980,3726,3726,3726,3726,3726,3726,3726,3726,3726,3726,3726,3726,3726,fe44d24d-55cd-439c-895b-00a38cd59f65,usage to reduce the development of drug resistant bacteria and maintain the effectiveness of imipenem and cilastatin for injection ( i v ),0
2981,2981,2981,2981,2981,2981,2981,3727,3727,3727,3727,3727,3727,3727,3727,3727,3727,3727,3727,3727,fe44d24d-55cd-439c-895b-00a38cd59f65,and other antibacterial drugs  imipenem and cilastatin for injection ( i v ),0
2982,2982,2982,2982,2982,2982,2982,3728,3728,3728,3728,3728,3728,3728,3728,3728,3728,3728,3728,3728,fe44d24d-55cd-439c-895b-00a38cd59f65,should be used only to treat infections that are proven or strongly suspected to be caused by bacteria ( 1 10 ),4
2983,2983,2983,2983,2983,2983,2983,3729,3729,3729,3729,3729,3729,3729,3729,3729,3729,3729,3729,3729,fe44d24d-55cd-439c-895b-00a38cd59f65,1 1 lower respiratory tract infections imipenem and cilastatin for injection ( i v ),u
2984,2984,2984,2984,2984,2984,2984,3730,3730,3730,3730,3730,3730,3730,3730,3730,3730,3730,3730,3730,fe44d24d-55cd-439c-895b-00a38cd59f65,for intravenous use is indicated for the treatment of lower respiratory tract infections caused by susceptible strains of staphylococcus aureus ( penicillinase producing isolates )  acinetobacter species  enterobacter species  escherichia coli  haemophilus influenzae  haemophilus parainfluenzae  klebsiella species  serratia marcescens,1
2985,2985,2985,2985,2985,2985,2985,3731,3731,3731,3731,3731,3731,3731,3731,3731,3731,3731,3731,3731,e41387c8-2c74-4990-831f-64dc921ee138,1  to reduce the development of drug resistant bacteria and maintain the effectiveness of amoxicillin and clavulanate potassium extended release tablets and other antibacterial drugs  amoxicillin and clavulanate potassium extended release tablets should be used only to treat infections that are proven or strongly suspected to be caused by susceptible bacteria,1
2986,2986,2986,2986,2986,2986,2986,3734,3734,3734,3734,3734,3734,3734,3734,3734,3734,3734,3734,3734,e41387c8-2c74-4990-831f-64dc921ee138,amoxicillin and clavulanate potassium extended release tablets are indicated for the treatment of patients with community acquired pneumonia or acute bacterial sinusitis due to confirmed  or suspected lactamase producing pathogens ( i e  h influenzae  m catarrhalis  h parainfluenzae  k pneumoniae  or methicillin susceptible s aureus ) and s pneumoniae with reduced susceptibility to penicillin ( i e  penicillin mics 2 mcg ml ),1
2987,2987,2987,2987,2987,2987,2987,3735,3735,3735,3735,3735,3735,3735,3735,3735,3735,3735,3735,3735,e41387c8-2c74-4990-831f-64dc921ee138,amoxicillin and clavulanate potassium extended release tablets are not indicated for the treatment of infections due to s pneumoniae with penicillin mics 4 mcg ml,2
2988,2988,2988,2988,2988,2988,2988,3736,3736,3736,3736,3736,3736,3736,3736,3736,3736,3736,3736,3736,e41387c8-2c74-4990-831f-64dc921ee138,data are limited with regard to infections due to s pneumoniae with penicillin mics 4 mcg ml see clinical studies ( 14 ),0
2989,2989,2989,2989,2989,2989,2989,3737,3737,3737,3737,3737,3737,3737,3737,3737,3737,3737,3737,3737,e41387c8-2c74-4990-831f-64dc921ee138,in patients with community acquired pneumonia in whom penicillin resistant s pneumoniae is suspected  bacteriological studies should be performed to determine the causative organisms and their susceptibility when amoxicillin and clavulanate potassium extended release tablets are prescribed,0
2990,2990,2990,2990,2990,2990,2990,3738,3738,3738,3738,3738,3738,3738,3738,3738,3738,3738,3738,3738,e41387c8-2c74-4990-831f-64dc921ee138,acute bacterial sinusitis or community acquired pneumonia due to a penicillin susceptible strain of s pneumoniae plus a lactamase producing pathogen can be treated with another amoxicillin and clavulanate potassium product containing lower daily doses of amoxicillin ( i e  500 mg every 8 hours or 875 mg every 12 hours ),u
2991,2991,2991,2991,2991,2991,2991,3739,3739,3739,3739,3739,3739,3739,3739,3739,3739,3739,3739,3739,e41387c8-2c74-4990-831f-64dc921ee138,acute bacterial sinusitis or community acquired pneumonia due to s pneumoniae alone can be treated with amoxicillin,u
2992,2992,2992,2992,2992,2992,2992,3740,3740,3740,3740,3740,3740,3740,3740,3740,3740,3740,3740,3740,e41387c8-2c74-4990-831f-64dc921ee138,amoxicillin and clavulanate potassium extended release tablets are a combination of a penicillin class antibacterial drug and a beta lactamase inhibitor indicated for treatment of community acquired pneumonia and acute bacterial sinusitis ( 1 ),1
2993,2993,2993,2993,2993,2993,2993,3741,3741,3741,3741,3741,3741,3741,3741,3741,3741,3741,3741,3741,4c970164-cafb-421f-9eb5-c226ef0a3417,1  ingrezza is indicated for the treatment of adults with tardive dyskinesia see clinical studies ( 14 ),1
2994,2994,2994,2994,2994,2994,2994,3742,3742,3742,3742,3742,3742,3742,3742,3742,3742,3742,3742,3742,4c970164-cafb-421f-9eb5-c226ef0a3417,ingrezza is a vesicular monoamine transporter 2 ( vmat2 ) inhibitor indicated for the treatment of adults with tardive dyskinesia,1
2995,2995,2995,2995,2995,2995,2995,3743,3743,3743,3743,3743,3743,3743,3743,3743,3743,3743,3743,3743,21335fe4-d395-4501-ac2a-2f20d7520da9,1  xultophy 100 3 6 is a combination of insulin degludec and liraglutide and is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus inadequately controlled on basal insulin ( less than 50 units daily ) or liraglutide ( less than or equal to 1 8 mg daily ),1
2996,2996,2996,2996,2996,2996,2996,3744,3744,3744,3744,3744,3744,3744,3744,3744,3744,3744,3744,3744,21335fe4-d395-4501-ac2a-2f20d7520da9,limitations of use xultophy 100 3 6 is not recommended as first line therapy for patients who have inadequate glycemic control on diet and exercise because of the uncertain relevance of the rodent c cell tumor findings to humans see warnings and precautions ( 5 1 ),0
2997,2997,2997,2997,2997,2997,2997,3745,3745,3745,3745,3745,3745,3745,3745,3745,3745,3745,3745,3745,21335fe4-d395-4501-ac2a-2f20d7520da9,xultophy 100 3 6 has not been studied in patients with a history of pancreatitis see warnings and precautions ( 5 2 ),0
2998,2998,2998,2998,2998,2998,2998,3747,3747,3747,3747,3747,3747,3747,3747,3747,3747,3747,3747,3747,21335fe4-d395-4501-ac2a-2f20d7520da9,xultophy 100 3 6 is not recommended for use in combination with any other product containing liraglutide or another glp 1 receptor agonist see warnings and precautions ( 5 5 ),2
2999,2999,2999,2999,2999,2999,2999,3748,3748,3748,3748,3748,3748,3748,3748,3748,3748,3748,3748,3748,21335fe4-d395-4501-ac2a-2f20d7520da9,xultophy 100 3 6 is not indicated for use in patients with type 1 diabetes mellitus or for the treatment of diabetic ketoacidosis,2
3000,3000,3000,3000,3000,3000,3000,3749,3749,3749,3749,3749,3749,3749,3749,3749,3749,3749,3749,3749,21335fe4-d395-4501-ac2a-2f20d7520da9,xultophy 100 3 6 has not been studied in combination with prandial insulin,0
3001,3001,3001,3001,3001,3001,3001,3750,3750,3750,3750,3750,3750,3750,3750,3750,3750,3750,3750,3750,21335fe4-d395-4501-ac2a-2f20d7520da9,xultophy 100 3 6 is a combination of insulin degludec  a long acting human insulin analog  and liraglutide  a glucagon like peptide 1 ( glp 1 ) receptor agonist  indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus inadequately controlled on basal insulin ( less than 50 units daily ) or liraglutide ( less than or equal to 1 8 mg daily ) ( 1 ),1
3002,3002,3002,3002,3002,3002,3002,3751,3751,3751,3751,3751,3751,3751,3751,3751,3751,3751,3751,3751,21335fe4-d395-4501-ac2a-2f20d7520da9,limitations of use ( 1 ) not recommended as first line therapy for patients inadequately controlled on diet and exercise,0
3003,3003,3003,3003,3003,3003,3003,3754,3754,3754,3754,3754,3754,3754,3754,3754,3754,3754,3754,3754,21335fe4-d395-4501-ac2a-2f20d7520da9,not recommended for use in combination with any other product containing liraglutide or another glp 1 receptor agonist,2
3004,3004,3004,3004,3004,3004,3004,3757,3757,3757,3757,3757,3757,3757,3757,3757,3757,3757,3757,3757,a57ff449-e3b7-48b6-9acf-c719a9770e8a, methimazole tablets  usp are indicated in patients with graves disease with hyperthyroidism or toxic multinodular goiter for whom surgery or radioactive iodine therapy is not an appropriate treatment option,1
3005,3005,3005,3005,3005,3005,3005,3758,3758,3758,3758,3758,3758,3758,3758,3758,3758,3758,3758,3758,a57ff449-e3b7-48b6-9acf-c719a9770e8a,to ameliorate symptoms of hyperthyroidism in preparation for thyroidectomy or radioactive iodine therapy,1
3006,3006,3006,3006,3006,3006,3006,3759,3759,3759,3759,3759,3759,3759,3759,3759,3759,3759,3759,3759,eeaf70fd-46bd-4fec-ba9d-2366fdf07888,1  technetium tc 99m sulfur colloid injection is indicated in adults  to assist in the localization of lymph nodes draining a primary tumor in patients with breast cancer or malignant melanoma when used with a hand held gamma counter,1
3007,3007,3007,3007,3007,3007,3007,3760,3760,3760,3760,3760,3760,3760,3760,3760,3760,3760,3760,3760,eeaf70fd-46bd-4fec-ba9d-2366fdf07888,evaluation of peritoneo venous ( leveen ) shunt patency,1
3008,3008,3008,3008,3008,3008,3008,3761,3761,3761,3761,3761,3761,3761,3761,3761,3761,3761,3761,3761,eeaf70fd-46bd-4fec-ba9d-2366fdf07888,in adults and pediatric patients  for imaging areas of functioning reticuloendothelial cells in the liver  spleen and bone marrow,1
3009,3009,3009,3009,3009,3009,3009,3762,3762,3762,3762,3762,3762,3762,3762,3762,3762,3762,3762,3762,eeaf70fd-46bd-4fec-ba9d-2366fdf07888,studies of esophageal transit and  gastroesophageal reflux  and detection of pulmonary aspiration of gastric contents,1
3010,3010,3010,3010,3010,3010,3010,3763,3763,3763,3763,3763,3763,3763,3763,3763,3763,3763,3763,3763,eeaf70fd-46bd-4fec-ba9d-2366fdf07888,technetium tc 99m sulfur colloid injection is a radioactive diagnostic agent indicated ( 1 ) in adults  to assist in the localization of lymph nodes draining a primary tumor in patients with breast cancer or malignant melanoma when used with a hand held gamma counter,1
3011,3011,3011,3011,3011,3011,3011,3764,3764,3764,3764,3764,3764,3764,3764,3764,3764,3764,3764,3764,eeaf70fd-46bd-4fec-ba9d-2366fdf07888,evaluation of peritoneo venous ( leveen ) shunt patency in adults,1
3012,3012,3012,3012,3012,3012,3012,3766,3766,3766,3766,3766,3766,3766,3766,3766,3766,3766,3766,3766,eeaf70fd-46bd-4fec-ba9d-2366fdf07888,studies of esophageal transit and gastroesophageal reflux  and detection of pulmonary aspiration of gastric contents,1
3013,3013,3013,3013,3013,3013,3013,3767,3767,3767,3767,3767,3767,3767,3767,3767,3767,3767,3767,3767,c13cbd11-d12c-49a8-9252-97c0a23894fa, for temporary relief of allergies due to biting insects,1
3014,3014,3014,3014,3014,3014,3014,3768,3768,3768,3768,3768,3768,3768,3768,3768,3768,3768,3768,3768,5df64e19-0162-44f0-825d-6a0996581e6e, lyrica is indicated for management of neuropathic pain associated with diabetic peripheral neuropathy management of postherpetic neuralgia adjunctive therapy for adult patients with partial onset seizures management of fibromyalgia management of neuropathic pain associated with spinal cord injury,1
3015,3015,3015,3015,3015,3015,3015,3769,3769,3769,3769,3769,3769,3769,3769,3769,3769,3769,3769,3769,cb72936e-d185-4e18-8d59-01d07098c46b,used to destroy or kill the mail matrix ( matrixectomies ),u
3016,3016,3016,3016,3016,3016,3016,3770,3770,3770,3770,3770,3770,3770,3770,3770,3770,3770,3770,3770,cb72936e-d185-4e18-8d59-01d07098c46b,sodium hydroxide 10 forms a strongly alkaline and caustic solution,0
3017,3017,3017,3017,3017,3017,3017,3771,3771,3771,3771,3771,3771,3771,3771,3771,3771,3771,3771,3771,cb72936e-d185-4e18-8d59-01d07098c46b,as a caustic agent  it is used to destroy organic tissue by chemical action,u
3018,3018,3018,3018,3018,3018,3018,3772,3772,3772,3772,3772,3772,3772,3772,3772,3772,3772,3772,3772,cb72936e-d185-4e18-8d59-01d07098c46b,use two 10 second applications,4
3019,3019,3019,3019,3019,3019,3019,3773,3773,3773,3773,3773,3773,3773,3773,3773,3773,3773,3773,3773,cb72936e-d185-4e18-8d59-01d07098c46b,naoh must be neutralized with 5,4
3020,3020,3020,3020,3020,3020,3020,3774,3774,3774,3774,3774,3774,3774,3774,3774,3774,3774,3774,3774,ce00e4d9-178b-4ae1-af76-4042f7e6c822,1  vimpat is indicated in patients 17 years and older with partial onset seizures as monotherapy or adjunctive therapy,1
3021,3021,3021,3021,3021,3021,3021,3775,3775,3775,3775,3775,3775,3775,3775,3775,3775,3775,3775,3775,ce00e4d9-178b-4ae1-af76-4042f7e6c822,vimpat injection for intravenous use is an alternative when oral administration is temporarily not feasible,4
3022,3022,3022,3022,3022,3022,3022,3776,3776,3776,3776,3776,3776,3776,3776,3776,3776,3776,3776,3776,ce00e4d9-178b-4ae1-af76-4042f7e6c822,vimpat is indicated as monotherapy or adjunctive therapy in patients with partial onset seizures vimpat injection is indicated as short term replacement when oral administration is not feasible ( 1 ),1
3023,3023,3023,3023,3023,3023,3023,3777,3777,3777,3777,3777,3777,3777,3777,3777,3777,3777,3777,3777,b22d5a07-623a-4645-b87d-a151b86da8d5, tretinoin capsules are indicated for the induction of remission in patients with acute promyelocytic leukemia ( apl )  french american british ( fab ) classification m3 ( including the m3 variant )  characterized by the presence of the t ( 15 17 ) translocation and or the presence of the pml rar gene who are refractory to  or who have relapsed from  anthracycline chemotherapy  or for whom anthracycline based chemotherapy is contraindicated,1
3024,3024,3024,3024,3024,3024,3024,3778,3778,3778,3778,3778,3778,3778,3778,3778,3778,3778,3778,3778,b22d5a07-623a-4645-b87d-a151b86da8d5,tretinoin capsules are for the induction of remission only,0
3025,3025,3025,3025,3025,3025,3025,3779,3779,3779,3779,3779,3779,3779,3779,3779,3779,3779,3779,3779,b22d5a07-623a-4645-b87d-a151b86da8d5,the optimal consolidation or maintenance regimens have not been defined  but all patients should receive an accepted form of remission consolidation and or maintenance therapy for apl after completion of induction therapy with tretinoin capsules,0
3026,3026,3026,3026,3026,3026,3026,3780,3780,3780,3780,3780,3780,3780,3780,3780,3780,3780,3780,3780,f89298f4-ebf9-4568-825d-91b59146f2ee,uses extreme skin discoloration and dark spots,1
3027,3027,3027,3027,3027,3027,3027,3781,3781,3781,3781,3781,3781,3781,3781,3781,3781,3781,3781,3781,"Active Ingredient UNII(s)
5688UTC01R; L7T10EIP3A; SOI2LOH54Z    24682288-1be4-42af-e054-00144ff88e88
5688UTC01R; L7T10EIP3A; SOI2LOH54Z    24682288-1be4-42af-e054-00144ff88e88
Name: SET ID dtype: object",active ingredient unii ( s ) 5688utc01r l7t10eip3a soi2loh54z active ingredient unii ( s ) 5688utc01r l7t10eip 5688utc01r l7t10eip3a soi2loh54z active ingredient unii ( s ) 5688utc01r l7t10eip name content xml  dtype object,0
3028,3028,3028,3028,3028,3028,3028,3783,3783,3783,3783,3783,3783,3783,3783,3783,3783,3783,3783,3783,bbedb888-af22-4a92-9b6f-150cc5073ac1,purpose rx strength topical retinoid for treatment of acne  shaving bumps  and specific bumpy skin problems,1
3029,3029,3029,3029,3029,3029,3029,3784,3784,3784,3784,3784,3784,3784,3784,3784,3784,3784,3784,3784,bbedb888-af22-4a92-9b6f-150cc5073ac1,leaves skin smooth  clear and new,0
3030,3030,3030,3030,3030,3030,3030,3785,3785,3785,3785,3785,3785,3785,3785,3785,3785,3785,3785,3785,bbedb888-af22-4a92-9b6f-150cc5073ac1,uses acne and specific skin conditions,1
3031,3031,3031,3031,3031,3031,3031,3786,3786,3786,3786,3786,3786,3786,3786,3786,3786,3786,3786,3786,227291e5-9baa-476a-93b8-b2142e61a4fe, hypertension,1
3032,3032,3032,3032,3032,3032,3032,3787,3787,3787,3787,3787,3787,3787,3787,3787,3787,3787,3787,3787,96118395-557e-4998-842d-424a59d574b6, ganirelix acetate injection is indicated for the inhibition of premature lh surges in women undergoing controlled ovarian hyperstimulation,1
3033,3033,3033,3033,3033,3033,3033,3788,3788,3788,3788,3788,3788,3788,3788,3788,3788,3788,3788,3788,9fd1f18f-0b0f-4059-b603-19ecbf0ed63a,1  buprenorphine sublingual tablet is indicated for the treatment of opioid dependence and is preferred for induction,1
3034,3034,3034,3034,3034,3034,3034,3789,3789,3789,3789,3789,3789,3789,3789,3789,3789,3789,3789,3789,9fd1f18f-0b0f-4059-b603-19ecbf0ed63a,buprenorphine sublingual tablet should be used as part of a complete treatment plan to include counseling and psychosocial support,4
3035,3035,3035,3035,3035,3035,3035,3790,3790,3790,3790,3790,3790,3790,3790,3790,3790,3790,3790,3790,9fd1f18f-0b0f-4059-b603-19ecbf0ed63a,buprenorphine sublingual tablet  contains buprenorphine  a partial opioid agonist  and is indicated for the treatment of opioid dependence and is preferred for induction,1
3036,3036,3036,3036,3036,3036,3036,3791,3791,3791,3791,3791,3791,3791,3791,3791,3791,3791,3791,3791,9fd1f18f-0b0f-4059-b603-19ecbf0ed63a,buprenorphine sublingual tablet should be used as part of a complete treatment plan that includes counseling and psychosocial support,4
3037,3037,3037,3037,3037,3037,3037,3792,3792,3792,3792,3792,3792,3792,3792,3792,3792,3792,3792,3792,033f2324-09d4-ce5c-ff60-e3b03d0538c1,1  suboxone sublingual film is indicated for maintenance treatment of opioid dependence and should be used as part of a complete treatment plan to include counseling and psychosocial support,1
3038,3038,3038,3038,3038,3038,3038,3793,3793,3793,3793,3793,3793,3793,3793,3793,3793,3793,3793,3793,033f2324-09d4-ce5c-ff60-e3b03d0538c1,under the drug addiction treatment act ( data ) codified at 21 u s c,0
3039,3039,3039,3039,3039,3039,3039,3794,3794,3794,3794,3794,3794,3794,3794,3794,3794,3794,3794,3794,033f2324-09d4-ce5c-ff60-e3b03d0538c1,823 ( g )  prescription use of this product in the treatment of opioid dependence is limited to physicians who meet certain qualifying requirements  and who have notified the secretary of health and human services ( hhs ) of their intent to prescribe this product for the treatment of opioid dependence and have been assigned a unique identification number that must be included on every prescription,0
3040,3040,3040,3040,3040,3040,3040,3795,3795,3795,3795,3795,3795,3795,3795,3795,3795,3795,3795,3795,033f2324-09d4-ce5c-ff60-e3b03d0538c1,suboxone sublingual film is indicated for maintenance treatment of opioid dependence,1
3041,3041,3041,3041,3041,3041,3041,3796,3796,3796,3796,3796,3796,3796,3796,3796,3796,3796,3796,3796,033f2324-09d4-ce5c-ff60-e3b03d0538c1,prescription use of this product is limited under the drug addiction treatment act,0
3042,3042,3042,3042,3042,3042,3042,3797,3797,3797,3797,3797,3797,3797,3797,3797,3797,3797,3797,3797,3c39dcea-d8f7-8594-01e6-24e8d6fa4d2f, acthrel is indicated for use in differentiating pituitary and ectopic production of acth in patients with acth dependent cushing 's syndrome,1
3043,3043,3043,3043,3043,3043,3043,3798,3798,3798,3798,3798,3798,3798,3798,3798,3798,3798,3798,3798,3c39dcea-d8f7-8594-01e6-24e8d6fa4d2f,differential diagnosis there are two forms of cushing 's syndrome acth dependent ( 83 )  in which hypercortisolism is due either to pituitary hypersecretion of acth ( cushing 's disease ) resulting from an adenoma ( 40  usually microadenomas ) or nonadenomatous hyperplasia  possibly of hypothalamic origin ( 28 )  or to hypercortisolism that is secondary to ectopic secretion of acth ( 15 ) and  acth independent ( 17 )  in which hypercortisolism is due to autonomous cortisol secretion by an adrenal tumor ( 9 adenomas  8 carcinomas ),0
3044,3044,3044,3044,3044,3044,3044,3799,3799,3799,3799,3799,3799,3799,3799,3799,3799,3799,3799,3799,3c39dcea-d8f7-8594-01e6-24e8d6fa4d2f,after the establishment of hypercortisolism consistent with the presence of cushing 's syndrome  and following the elimination of autonomous adrenal hyperfunction as its cause  the corticorelin test is used to aid in establishing the source of excessive acth secretion,u
3045,3045,3045,3045,3045,3045,3045,3800,3800,3800,3800,3800,3800,3800,3800,3800,3800,3800,3800,3800,3c39dcea-d8f7-8594-01e6-24e8d6fa4d2f,the corticorelin stimulation test helps to differentiate between the etiologies of acth dependent hypercortisolism as follows 1 high basal plasma acth plus high basal plasma cortisol ( 20 40 mcg dl ),u
3046,3046,3046,3046,3046,3046,3046,3801,3801,3801,3801,3801,3801,3801,3801,3801,3801,3801,3801,3801,3c39dcea-d8f7-8594-01e6-24e8d6fa4d2f,acthrel injection ( 1 mcg kg ) results in increased plasma acth levels increased plasma cortisol levels diagnosis cushing 's disease ( acth of pituitary origin ) 2high basal plasma acth ( may be very high ) plus high basal plasma cortisol ( 20 40 mcg dl ),0
3047,3047,3047,3047,3047,3047,3047,3802,3802,3802,3802,3802,3802,3802,3802,3802,3802,3802,3802,3802,3c39dcea-d8f7-8594-01e6-24e8d6fa4d2f,acthrel injection ( 1 mcg kg ) results in little or no response of plasma acth levels little or no response of plasma cortisol levels diagnosis ectopic acth syndrome test methodology to evaluate the status of the pituitary adrenal axis in the differentiation of a pituitary source from an ectopic source of excessive acth secretion  a corticorelin test procedure requires a minimum of five blood samples,0
3048,3048,3048,3048,3048,3048,3048,3803,3803,3803,3803,3803,3803,3803,3803,3803,3803,3803,3803,3803,54c73290-bdc1-3453-e054-00144ff88e88,1  finasteride  is a 5 reductase inhibitor  indicated for the treatment of symptomatic benign prostatic hyperplasia ( bph ) in men with an enlarged prostate to ( 1 1 ) improve symptoms reduce the risk of the need for surgery including transurethral resection of the prostate ( turp ) and prostatectomy,1
3049,3049,3049,3049,3049,3049,3049,3804,3804,3804,3804,3804,3804,3804,3804,3804,3804,3804,3804,3804,54c73290-bdc1-3453-e054-00144ff88e88,finasteride administered in combination with the alpha blocker doxazosin is indicated to reduce the risk of symptomatic progression of bph ( a confirmed 4 point increase in american urological association ( aua ) symptom score ) ( 1 2 ),1
3050,3050,3050,3050,3050,3050,3050,3805,3805,3805,3805,3805,3805,3805,3805,3805,3805,3805,3805,3805,54c73290-bdc1-3453-e054-00144ff88e88,limitations of use finasteride is not approved for the prevention of prostate cancer ( 1 3 ),2
3051,3051,3051,3051,3051,3051,3051,3806,3806,3806,3806,3806,3806,3806,3806,3806,3806,3806,3806,3806,54c73290-bdc1-3453-e054-00144ff88e88,1 1 monotherapy finasteride tablets 5 mg are indicated for the treatment of symptomatic benign prostatic hyperplasia ( bph ) in men with an enlarged prostate to improve symptoms reduce the risk of the need for surgery including transurethral resection of the prostate ( turp ) and prostatectomy,1
3052,3052,3052,3052,3052,3052,3052,3807,3807,3807,3807,3807,3807,3807,3807,3807,3807,3807,3807,3807,54c73290-bdc1-3453-e054-00144ff88e88,1 2 combination with alpha blocker finasteride tablets 5 mg administered in combination with the alpha blocker doxazosin is indicated to reduce the risk of symptomatic progression of bph ( a confirmed 4 point increase in american urological association ( aua ) symptom score ),1
3053,3053,3053,3053,3053,3053,3053,3808,3808,3808,3808,3808,3808,3808,3808,3808,3808,3808,3808,3808,54c73290-bdc1-3453-e054-00144ff88e88,1 3 limitations of use finasteride is not approved for the prevention of prostate cancer,2
3054,3054,3054,3054,3054,3054,3054,3809,3809,3809,3809,3809,3809,3809,3809,3809,3809,3809,3809,3809,9b7f878e-613f-4831-9223-a6a07fb09f1b,1  greer standardized mite ( dermatophagoides farinae and or dermatophagoides pteronyssinus ) extracts are allergenic extracts indicated for skin test diagnosis of mite allergy treatment of patients with mite induced allergic asthma  rhinitis and conjunctivitis,1
3055,3055,3055,3055,3055,3055,3055,3810,3810,3810,3810,3810,3810,3810,3810,3810,3810,3810,3810,3810,9b7f878e-613f-4831-9223-a6a07fb09f1b,for immunotherapy  patients must show hypersensitivity to dermatophagoides farinae ( d farinae ) or dermatophagoides pteronyssinus ( d pteronyssinus ) based on their clinical history  allergen exposure history  and skin test reactivity,0
3056,3056,3056,3056,3056,3056,3056,3811,3811,3811,3811,3811,3811,3811,3811,3811,3811,3811,3811,3811,9b7f878e-613f-4831-9223-a6a07fb09f1b,greer standardized mite extracts are allergenic extracts indicated for diagnosis of skin test reactivity to dust mite allergen ( 1 ) treatment of mite induced allergic asthma  rhinitis and conjunctivitis in patients that show hypersensitivity to dust mites based on clinical history  allergen exposure history  and skin test reactivity ( 1 ),1
3057,3057,3057,3057,3057,3057,3057,3812,3812,3812,3812,3812,3812,3812,3812,3812,3812,3812,3812,3812,ed3ef3f8-8cb7-40db-9d75-e728ee607760,1  varubi is indicated in combination with other antiemetic agents in adults for the prevention of delayed nausea and vomiting associated with initial and repeat courses of emetogenic cancer chemotherapy  including  but not limited to  highly emetogenic chemotherapy,1
3058,3058,3058,3058,3058,3058,3058,3813,3813,3813,3813,3813,3813,3813,3813,3813,3813,3813,3813,3813,ed3ef3f8-8cb7-40db-9d75-e728ee607760,varubi is a substance p neurokinin 1 ( nk1 ) receptor antagonist indicated in combination with other antiemetic agents in adults for the prevention of delayed nausea and vomiting associated with initial and repeat courses of emetogenic cancer chemotherapy  including  but not limited to  highly emetogenic chemotherapy,1
3059,3059,3059,3059,3059,3059,3059,3814,3814,3814,3814,3814,3814,3814,3814,3814,3814,3814,3814,3814,5a2bedd7-3d9a-4f42-800b-14c814628089, nimodipine is indicated for the improvement of neurological outcome by reducing the incidence and severity of ischemic deficits in patients with subarachnoid hemorrhage from ruptured intracranial berry aneurysms regardless of their post ictus neurological condition ( i e  hunt and hess grades i v ),1
3060,3060,3060,3060,3060,3060,3060,3815,3815,3815,3815,3815,3815,3815,3815,3815,3815,3815,3815,3815,0879f244-ec2f-4091-b0e3-ca9c1475ab21, carefully consider the potential benefits and risks of naproxen  naproxen sodium and other treatment options before deciding to use naproxen and naproxen sodium tablets,0
3061,3061,3061,3061,3061,3061,3061,3817,3817,3817,3817,3817,3817,3817,3817,3817,3817,3817,3817,3817,0879f244-ec2f-4091-b0e3-ca9c1475ab21,naproxen as naproxen or naproxen sodium tablets are indicated for the relief of the signs and symptoms of rheumatoid arthritis for the relief of the signs and symptoms of osteoarthritis for the relief of the signs and symptoms of ankylosing spondylitis for the relief of the signs and symptoms of juvenile arthritis naproxen as naproxen suspension is recommended for juvenile rheumatoid arthritis in order to obtain the maximum dosage flexibility based on the patient s weight,1
3062,3062,3062,3062,3062,3062,3062,3818,3818,3818,3818,3818,3818,3818,3818,3818,3818,3818,3818,3818,0879f244-ec2f-4091-b0e3-ca9c1475ab21,naproxen as naproxen and naproxen sodium tablets are also indicated for relief of the signs and symptoms of tendonitis for relief of the signs and symptoms of bursitis for relief of the signs and symptoms of acute gout for the management of pain for the management of primary dysmenorrhea,1
3063,3063,3063,3063,3063,3063,3063,3819,3819,3819,3819,3819,3819,3819,3819,3819,3819,3819,3819,3819,8bff5df5-d856-4237-b6a8-ae445b454844, carefully consider the potential benefits and risks of naprosyn  ec naprosyn  anaprox  anaprox ds or naprosyn suspension and other treatment options before deciding to use naprosyn  ec naprosyn  anaprox  anaprox ds or naprosyn suspension,0
3064,3064,3064,3064,3064,3064,3064,3821,3821,3821,3821,3821,3821,3821,3821,3821,3821,3821,3821,3821,8bff5df5-d856-4237-b6a8-ae445b454844,naproxen as naprosyn  ec naprosyn  anaprox  anaprox ds or naprosyn suspension is indicated for the relief of the signs and symptoms of rheumatoid arthritis for the relief of the signs and symptoms of osteoarthritis for the relief of the signs and symptoms of ankylosing spondylitis for the relief of the signs and symptoms of juvenile arthritis naproxen as naprosyn suspension is recommended for juvenile rheumatoid arthritis in order to obtain the maximum dosage flexibility based on the patient s weight,1
3065,3065,3065,3065,3065,3065,3065,3822,3822,3822,3822,3822,3822,3822,3822,3822,3822,3822,3822,3822,8bff5df5-d856-4237-b6a8-ae445b454844,naproxen as naprosyn  anaprox  anaprox ds and naprosyn suspension is also indicated for relief of the signs and symptoms of tendonitis for relief of the signs and symptoms of bursitis for relief of the signs and symptoms of acute gout for the management of pain for the management of primary dysmenorrhea ec naprosyn is not recommended for initial treatment of acute pain because the absorption of naproxen is delayed compared to absorption from other naproxen containing products ( see clinical pharmacology and dosage and administration ),1
3066,3066,3066,3066,3066,3066,3066,3823,3823,3823,3823,3823,3823,3823,3823,3823,3823,3823,3823,3823,baa47781-7151-4c75-a9a2-d2eac0a7d55e,1  vimovo  a combination of naproxen and esomeprazole magnesium  is indicated in adult and adolescent patients 12 years of age and older weighing at least 38 kg  requiring naproxen for symptomatic relief of arthritis and esomeprazole magnesium to decrease the risk for developing naproxen associated gastric ulcers,1
3067,3067,3067,3067,3067,3067,3067,3824,3824,3824,3824,3824,3824,3824,3824,3824,3824,3824,3824,3824,baa47781-7151-4c75-a9a2-d2eac0a7d55e,the naproxen component of vimovo is indicated for relief of signs and symptoms of osteoarthritis  rheumatoid arthritis and ankylosing spondylitis in adults,1
3068,3068,3068,3068,3068,3068,3068,3825,3825,3825,3825,3825,3825,3825,3825,3825,3825,3825,3825,3825,baa47781-7151-4c75-a9a2-d2eac0a7d55e,juvenile idiopathic arthritis ( jia ) in adolescent patients,1
3069,3069,3069,3069,3069,3069,3069,3826,3826,3826,3826,3826,3826,3826,3826,3826,3826,3826,3826,3826,baa47781-7151-4c75-a9a2-d2eac0a7d55e,the esomeprazole magnesium component of vimovo is indicated to decrease the risk of developing naproxen associated gastric ulcers,1
3070,3070,3070,3070,3070,3070,3070,3827,3827,3827,3827,3827,3827,3827,3827,3827,3827,3827,3827,3827,baa47781-7151-4c75-a9a2-d2eac0a7d55e,vimovo is a combination of naproxen  a non steroidal anti inflammatory drug ( nsaid )  and esomeprazole magnesium  a proton pump inhibitor ( ppi ) indicated in adult and adolescent patients 12 years of age and older weighing at least 38 kg  requiring naproxen for symptomatic relief of arthritis and esomeprazole magnesium to decrease the risk of developing naproxen associated gastric ulcers,1
3071,3071,3071,3071,3071,3071,3071,3831,3831,3831,3831,3831,3831,3831,3831,3831,3831,3831,3831,3831,baa47781-7151-4c75-a9a2-d2eac0a7d55e,( 1 ) limitations of use do not substitute vimovo with the single ingredient products of naproxen and esomeprazole magnesium,2
3072,3072,3072,3072,3072,3072,3072,3832,3832,3832,3832,3832,3832,3832,3832,3832,3832,3832,3832,3832,baa47781-7151-4c75-a9a2-d2eac0a7d55e,( 1 ) vimovo is not recommended for initial treatment of acute pain because the absorption of naproxen is delayed compared to absorption from other naproxen containing products,2
3073,3073,3073,3073,3073,3073,3073,3833,3833,3833,3833,3833,3833,3833,3833,3833,3833,3833,3833,3833,baa47781-7151-4c75-a9a2-d2eac0a7d55e,( 1 ) controlled studies do not extend beyond 6 months,0
3074,3074,3074,3074,3074,3074,3074,3835,3835,3835,3835,3835,3835,3835,3835,3835,3835,3835,3835,3835,baa47781-7151-4c75-a9a2-d2eac0a7d55e,vimovo is not recommended for initial treatment of acute pain because the absorption of naproxen is delayed compared to absorption from other naproxen containing products,2
3075,3075,3075,3075,3075,3075,3075,3836,3836,3836,3836,3836,3836,3836,3836,3836,3836,3836,3836,3836,baa47781-7151-4c75-a9a2-d2eac0a7d55e,controlled studies do not extend beyond 6 months see use in specific populations ( 8 4 )  clinical studies ( 14 ),0
3076,3076,3076,3076,3076,3076,3076,3837,3837,3837,3837,3837,3837,3837,3837,3837,3837,3837,3837,3837,6ed2f2bd-9d2f-46af-a44c-95a02ca034de, for the treatment of superficial ocular infections involving the conjunctiva and or cornea caused by bacitracin susceptible organisms,1
3077,3077,3077,3077,3077,3077,3077,3838,3838,3838,3838,3838,3838,3838,3838,3838,3838,3838,3838,3838,cd86ee78-2781-468b-930c-3c4677bcc092,1  zolinza is indicated for the treatment of cutaneous manifestations in patients with cutaneous t cell lymphoma who have progressive  persistent or recurrent disease on or following two systemic therapies,1
3078,3078,3078,3078,3078,3078,3078,3839,3839,3839,3839,3839,3839,3839,3839,3839,3839,3839,3839,3839,cd86ee78-2781-468b-930c-3c4677bcc092,zolinza is a histone deacetylase ( hdac ) inhibitor indicated for the treatment of cutaneous manifestations in patients with cutaneous t cell lymphoma ( ctcl ) who have progressive  persistent or recurrent disease on or following two systemic therapies,1
3079,3079,3079,3079,3079,3079,3079,3840,3840,3840,3840,3840,3840,3840,3840,3840,3840,3840,3840,3840,3d83fdf7-78f7-4ea0-97a9-e7434c82067d, indiclor indium in 111 chloride is indicated for radiolabeling of prostascint ( capromab pendetide ) in preparations used for in vivo diagnostic imaging procedures,1
3080,3080,3080,3080,3080,3080,3080,3841,3841,3841,3841,3841,3841,3841,3841,3841,3841,3841,3841,3841,3d83fdf7-78f7-4ea0-97a9-e7434c82067d,indiclor is also indicated for radiolabeling zevalin ( ibritumomab tiuxetan ) in preparations used for radioimmunotherapy procedures,1
3081,3081,3081,3081,3081,3081,3081,3842,3842,3842,3842,3842,3842,3842,3842,3842,3842,3842,3842,3842,3d83fdf7-78f7-4ea0-97a9-e7434c82067d,please refer to the package insert for prostascint or zevalin for information regarding the radiolabeled product,0
3082,3082,3082,3082,3082,3082,3082,3843,3843,3843,3843,3843,3843,3843,3843,3843,3843,3843,3843,3843,93d8f3b2-1216-41dc-a63d-0e812b33891d, indium in 111 pentetreotide is an agent for the scintigraphic localization of primary and metastatic neuroendocrine tumors bearing somatostatin receptors,1
3083,3083,3083,3083,3083,3083,3083,3844,3844,3844,3844,3844,3844,3844,3844,3844,3844,3844,3844,3844,a4cf69bc-8142-1a08-2223-37a62820190b,1  acamprosate calcium delayed release tablets are indicated for the maintenance of abstinence from alcohol in patients with alcohol dependence who are abstinent at treatment initiation,1
3084,3084,3084,3084,3084,3084,3084,3845,3845,3845,3845,3845,3845,3845,3845,3845,3845,3845,3845,3845,a4cf69bc-8142-1a08-2223-37a62820190b,treatment with acamprosate calcium delayed release tablets should be part of a comprehensive management program that includes psychosocial support,4
3085,3085,3085,3085,3085,3085,3085,3846,3846,3846,3846,3846,3846,3846,3846,3846,3846,3846,3846,3846,a4cf69bc-8142-1a08-2223-37a62820190b,the efficacy of acamprosate calcium in promoting abstinence has not been demonstrated in subjects who have not undergone detoxification and not achieved alcohol abstinence prior to beginning acamprosate calcium delayed release tablets treatment,0
3086,3086,3086,3086,3086,3086,3086,3847,3847,3847,3847,3847,3847,3847,3847,3847,3847,3847,3847,3847,a4cf69bc-8142-1a08-2223-37a62820190b,the efficacy of acamprosate calcium in promoting abstinence from alcohol in polysubstance abusers has not been adequately assessed,0
3087,3087,3087,3087,3087,3087,3087,3848,3848,3848,3848,3848,3848,3848,3848,3848,3848,3848,3848,3848,a4cf69bc-8142-1a08-2223-37a62820190b,acamprosate calcium delayed release tablets are indicated for the maintenance of abstinence from alcohol in patients with alcohol dependence who are abstinent at treatment initiation ( 1  14 ),1
3088,3088,3088,3088,3088,3088,3088,3849,3849,3849,3849,3849,3849,3849,3849,3849,3849,3849,3849,3849,a4cf69bc-8142-1a08-2223-37a62820190b,treatment with acamprosate calcium delayed release tablets should be part of a comprehensive management program that includes psychosocial support ( 1 ),4
3089,3089,3089,3089,3089,3089,3089,3850,3850,3850,3850,3850,3850,3850,3850,3850,3850,3850,3850,3850,bc06c40f-81a0-45e5-80b6-61f67d445068,indication and usage rejuvesol solution is intended only to be used as an in vitro processing solution for the rejuvenation of a unit of rbc,4
3090,3090,3090,3090,3090,3090,3090,3851,3851,3851,3851,3851,3851,3851,3851,3851,3851,3851,3851,3851,bc06c40f-81a0-45e5-80b6-61f67d445068,rbc may be rejuvenated after storage in cpd ( non leukocyte reduced )  cpda 1  ( non leukocyte reduced )  cpd adsol ( cpd as 1 leukocyte reduced )  or cp2d nutricel ( cp2d as 3  leukocyte reduced ),4
3091,3091,3091,3091,3091,3091,3091,3852,3852,3852,3852,3852,3852,3852,3852,3852,3852,3852,3852,3852,bc06c40f-81a0-45e5-80b6-61f67d445068,the final concentration of atp and 2  3 dpg achieved after rejuvenation will vary depending on the number of days of liquid storage at 1 6 c prior to rejuvenation,4
3092,3092,3092,3092,3092,3092,3092,3853,3853,3853,3853,3853,3853,3853,3853,3853,3853,3853,3853,3853,bc06c40f-81a0-45e5-80b6-61f67d445068,note for simplicity  rbc stored in cpd ( non leukocyte reduced )  cpda 1 ( non leukocyte reduced )  cpd adsol ( cpd as 1 leukocyte reduced )  cp2d nutricel ( cp2d as 3  leukocyte reduced ) are referred to hereafter as cpd  cpda 1  cpd as 1  and cp2d as 3  respectively,0
3093,3093,3093,3093,3093,3093,3093,3854,3854,3854,3854,3854,3854,3854,3854,3854,3854,3854,3854,3854,bc06c40f-81a0-45e5-80b6-61f67d445068,citra labs  llc  recommends that rejuvenation of rbc be performed after 14 days or longer of liquid storage,4
3094,3094,3094,3094,3094,3094,3094,3855,3855,3855,3855,3855,3855,3855,3855,3855,3855,3855,3855,3855,bc06c40f-81a0-45e5-80b6-61f67d445068,rbc ( cpd  cpda 1  cpd as 1  and cp2d as 3 ) rejuvenated before 6 days of storage may achieve 2  3 dpg levels in excess of 2 times normal and atp levels in excess of 1 5 times normal 5  6 ( see warning and contraindications ),0
3095,3095,3095,3095,3095,3095,3095,3856,3856,3856,3856,3856,3856,3856,3856,3856,3856,3856,3856,3856,bc06c40f-81a0-45e5-80b6-61f67d445068,rejuvenation of cpd or cpda 1 rbc for immediate use or for cryopreservation rbc which have been collected and stored in cpd or cpda 1 anticoagulant may be rejuvenated up to three days after the expiration date of the rbc  as long as storage at 1 6 c is not interrupted,4
3096,3096,3096,3096,3096,3096,3096,3857,3857,3857,3857,3857,3857,3857,3857,3857,3857,3857,3857,3857,bc06c40f-81a0-45e5-80b6-61f67d445068,3  4 after rejuvenation  rbc ( cpd and cpda 1 ) must be either washed and stored at 1 6 c for up to 24 hours prior to transfusion or glycerolized and frozen at 80 c ( below 65 c ),4
3097,3097,3097,3097,3097,3097,3097,3858,3858,3858,3858,3858,3858,3858,3858,3858,3858,3858,3858,3858,bc06c40f-81a0-45e5-80b6-61f67d445068,red blood cells frozen rejuvenated which were collected and stored in cpd or cpda 1 may be stored frozen up to 10 years,4
3098,3098,3098,3098,3098,3098,3098,3859,3859,3859,3859,3859,3859,3859,3859,3859,3859,3859,3859,3859,bc06c40f-81a0-45e5-80b6-61f67d445068,10 when rbc are rejuvenated after maximum liquid storage  i e  cpd rbc at 24 days or cpda 1 rbc at 38 days  the concentrations of 2  3 dpg and atp increase typically to above normal,4
3099,3099,3099,3099,3099,3099,3099,3860,3860,3860,3860,3860,3860,3860,3860,3860,3860,3860,3860,3860,bc06c40f-81a0-45e5-80b6-61f67d445068,1  3 5  6 caution rbc collected in cpd or cpda 1 cannot be leukocyte reduced prior to rejuvenation,4
3100,3100,3100,3100,3100,3100,3100,3861,3861,3861,3861,3861,3861,3861,3861,3861,3861,3861,3861,3861,bc06c40f-81a0-45e5-80b6-61f67d445068,rejuvenation of cpd as 1 rbc or cp2d as 3 rejuvesol solution has not been approved for the rejuvenation of rbc stored in any additive systems other than as 1 or as 3,0
3101,3101,3101,3101,3101,3101,3101,3862,3862,3862,3862,3862,3862,3862,3862,3862,3862,3862,3862,3862,bc06c40f-81a0-45e5-80b6-61f67d445068,rbc stored in cpd as 1 or cp2d as 3 at 1 6 c may be rejuvenated up to  but not exceeding  42 days of storage as long as storage at 1 6 c is not interrupted,0
3102,3102,3102,3102,3102,3102,3102,3863,3863,3863,3863,3863,3863,3863,3863,3863,3863,3863,3863,3863,bc06c40f-81a0-45e5-80b6-61f67d445068,rejuvenated cpd as 1 rbc must be either washed and stored at 1 6 c for up to 24 hours prior to transfusion or glycerolized and frozen at 80 c ( below 65 c ),0
3103,3103,3103,3103,3103,3103,3103,3864,3864,3864,3864,3864,3864,3864,3864,3864,3864,3864,3864,3864,2ae628e7-3b33-6a9a-e054-00144ff8d46c,indication and usage me naphos mb hyo 1 tablets is indicated for the treatment of symptoms of irritative voiding,1
3104,3104,3104,3104,3104,3104,3104,3867,3867,3867,3867,3867,3867,3867,3867,3867,3867,3867,3867,3867,02d7399f-94cc-f718-f214-587301edd138, because of the potential for serious adverse effects  minoxidil tablets are indicated only in the treatment of hypertension that is symptomatic or associated with target organ damage and is not manageable with maximum therapeutic doses of a diuretic plus two other antihypertensive drugs,1
3105,3105,3105,3105,3105,3105,3105,3868,3868,3868,3868,3868,3868,3868,3868,3868,3868,3868,3868,3868,02d7399f-94cc-f718-f214-587301edd138,at the present time use in milder degrees of hypertension is not recommended because the benefit risk relationship in such patients has not been defined,2
3106,3106,3106,3106,3106,3106,3106,3869,3869,3869,3869,3869,3869,3869,3869,3869,3869,3869,3869,3869,02d7399f-94cc-f718-f214-587301edd138,minoxidil reduced supine diastolic blood pressure by 20 mm hg or to 90 mm hg or less in approximately 75 of patients  most of who had hypertension that could not be controlled by other drugs,u
3107,3107,3107,3107,3107,3107,3107,3870,3870,3870,3870,3870,3870,3870,3870,3870,3870,3870,3870,3870,da705339-c349-444f-a058-4f0cef2864bf,1  entecavir tablet is a hepatitis b virus nucleoside analog reverse transcriptase inhibitor indicated for the treatment of chronic hepatitis b virus infection in adults with evidence of active viral replication and either evidence of persistent elevations in serum aminotransferases ( alt or ast ) or histologically active disease,1
3108,3108,3108,3108,3108,3108,3108,3871,3871,3871,3871,3871,3871,3871,3871,3871,3871,3871,3871,3871,da705339-c349-444f-a058-4f0cef2864bf,( 1 ) entecavir tablet is indicated for the treatment of chronic hepatitis b virus infection in adults with evidence of active viral replication and either evidence of persistent elevations in serum aminotransferases ( alt or ast ) or histologically active disease,1
3109,3109,3109,3109,3109,3109,3109,3872,3872,3872,3872,3872,3872,3872,3872,3872,3872,3872,3872,3872,da705339-c349-444f-a058-4f0cef2864bf,the following points should be considered when initiating therapy with entecavir tablet in adult patients  this indication is based on clinical trial data in nucleoside inhibitor treatment na ve and lamivudine resistant subjects with hbeag positive and hbeag negative hbv infection and compensated liver disease and a more limited number of subjects with decompensated liver disease see clinical studies ( 14 1 ),1
3110,3110,3110,3110,3110,3110,3110,3873,3873,3873,3873,3873,3873,3873,3873,3873,3873,3873,3873,3873,da705339-c349-444f-a058-4f0cef2864bf,pediatric use information is approved for bristol myers squibb company 's baraclude ( entecavir ) tablets,0
3111,3111,3111,3111,3111,3111,3111,3874,3874,3874,3874,3874,3874,3874,3874,3874,3874,3874,3874,3874,da705339-c349-444f-a058-4f0cef2864bf,however  due to bristol myers squibb company 's marketing exclusivity rights  this drug product is not labeled with that information,0
3112,3112,3112,3112,3112,3112,3112,3875,3875,3875,3875,3875,3875,3875,3875,3875,3875,3875,3875,3875,e95afc93-130c-4715-a4f8-ed2de904e2d2, ionsys is indicated for the short term management of acute postoperative pain severe enough to require an opioid analgesic in the hospital and for which alternative treatments are inadequate,1
3113,3113,3113,3113,3113,3113,3113,3876,3876,3876,3876,3876,3876,3876,3876,3876,3876,3876,3876,3876,e95afc93-130c-4715-a4f8-ed2de904e2d2,limitations of use because of the risks of addiction  abuse  and misuse with opioids  even at recommended doses see warnings and precautions ( 5 3 )  reserve ionsys for use in patients for whom alternative treatment options e g  non opioid analgesics have not been tolerated  or are not expected to be tolerated  have not provided adequate analgesia  or are not expected to provide adequate analgesia,2
3114,3114,3114,3114,3114,3114,3114,3877,3877,3877,3877,3877,3877,3877,3877,3877,3877,3877,3877,3877,e95afc93-130c-4715-a4f8-ed2de904e2d2,ionsys is only for use in patients who are alert enough and have adequate cognitive ability to understand the directions for use,u
3115,3115,3115,3115,3115,3115,3115,3878,3878,3878,3878,3878,3878,3878,3878,3878,3878,3878,3878,3878,e95afc93-130c-4715-a4f8-ed2de904e2d2,ionsys is for use only in patients in the hospital,u
3116,3116,3116,3116,3116,3116,3116,3879,3879,3879,3879,3879,3879,3879,3879,3879,3879,3879,3879,3879,e95afc93-130c-4715-a4f8-ed2de904e2d2,discontinue treatment with ionsys before patients leave the hospital,0
3117,3117,3117,3117,3117,3117,3117,3880,3880,3880,3880,3880,3880,3880,3880,3880,3880,3880,3880,3880,e95afc93-130c-4715-a4f8-ed2de904e2d2,for use after patients have been titrated to an acceptable level of analgesia using alternate opioid analgesics,1
3118,3118,3118,3118,3118,3118,3118,3881,3881,3881,3881,3881,3881,3881,3881,3881,3881,3881,3881,3881,e95afc93-130c-4715-a4f8-ed2de904e2d2,ionsys contains fentanyl  an opioid agonist,0
3119,3119,3119,3119,3119,3119,3119,3882,3882,3882,3882,3882,3882,3882,3882,3882,3882,3882,3882,3882,e95afc93-130c-4715-a4f8-ed2de904e2d2,ionsys is indicated for the short term management of acute postoperative pain severe enough to require an opioid analgesic in the hospital and for which alternative treatments are inadequate,1
3120,3120,3120,3120,3120,3120,3120,3883,3883,3883,3883,3883,3883,3883,3883,3883,3883,3883,3883,3883,e95afc93-130c-4715-a4f8-ed2de904e2d2,( 1 ) limitations of use because of the risks of addiction  abuse  and misuse with opioids  even at recommended doses  reserve ionsys for use in patients for whom alternative treatment options e g  non opioid analgesics have not been tolerated  or are not expected to be tolerated  have not provided adequate analgesia  or are not expected to provide adequate analgesia ionsys is only for use in patients who are alert enough and have adequate cognitive ability to understand the directions for use,2
3121,3121,3121,3121,3121,3121,3121,3886,3886,3886,3886,3886,3886,3886,3886,3886,3886,3886,3886,3886,e95afc93-130c-4715-a4f8-ed2de904e2d2,( 1 ) for use after patients have been titrated to an acceptable level of analgesia using alternate opioid analgesics,1
3122,3122,3122,3122,3122,3122,3122,3887,3887,3887,3887,3887,3887,3887,3887,3887,3887,3887,3887,3887,da8a8a19-ac1b-4160-aac4-c4c57598eb5d,indications paremyd solution is indicated for mydriasis in routine diagnostic procedures and in conditions where short term pupil dilation is desired,1
3123,3123,3123,3123,3123,3123,3123,3888,3888,3888,3888,3888,3888,3888,3888,3888,3888,3888,3888,3888,da8a8a19-ac1b-4160-aac4-c4c57598eb5d,paremyd provides clinically significant mydriasis with partial cycloplegia,0
3124,3124,3124,3124,3124,3124,3124,3889,3889,3889,3889,3889,3889,3889,3889,3889,3889,3889,3889,3889,937e679e-1e86-48de-a69f-83ed7a98e76e, midodrine hydrochloride tablets  usp are indicated for the treatment of symptomatic orthostatic hypotension ( oh ),1
3125,3125,3125,3125,3125,3125,3125,3890,3890,3890,3890,3890,3890,3890,3890,3890,3890,3890,3890,3890,937e679e-1e86-48de-a69f-83ed7a98e76e,because midodrine hydrochloride tablets  usp can cause marked elevation of supine blood pressure ( bp 200 mmhg systolic )  it should be used in patients whose lives are considerably impaired despite standard clinical care  including non pharmacologic treatment ( such as support stockings )  fluid expansion and lifestyle alterations,u
3126,3126,3126,3126,3126,3126,3126,3891,3891,3891,3891,3891,3891,3891,3891,3891,3891,3891,3891,3891,937e679e-1e86-48de-a69f-83ed7a98e76e,the indication is based on midodrine hydrochloride tablet  usp 's effect on increases in 1 minute standing systolic blood pressure  a surrogate marker considered likely to correspond to a clinical benefit,u
3127,3127,3127,3127,3127,3127,3127,3892,3892,3892,3892,3892,3892,3892,3892,3892,3892,3892,3892,3892,937e679e-1e86-48de-a69f-83ed7a98e76e,at present  however  clinical benefits of midodrine hydrochloride tablets  usp principally improved ability to perform life activities  have not been established,0
3128,3128,3128,3128,3128,3128,3128,3893,3893,3893,3893,3893,3893,3893,3893,3893,3893,3893,3893,3893,937e679e-1e86-48de-a69f-83ed7a98e76e,further clinical trials are underway to verify and describe the clinical benefits of midodrine hydrochloride tablets  usp,0
3129,3129,3129,3129,3129,3129,3129,3894,3894,3894,3894,3894,3894,3894,3894,3894,3894,3894,3894,3894,937e679e-1e86-48de-a69f-83ed7a98e76e,after initiation of treatment  midodrine hydrochloride tablets  usp should be continued only for patients who report significant symptomatic improvement,0
3130,3130,3130,3130,3130,3130,3130,3895,3895,3895,3895,3895,3895,3895,3895,3895,3895,3895,3895,3895,13ddf5e6-ac0e-41e6-b95d-d5bdd6b26fcd, lindane shampoo is indicated for the treatment of head lice ( infestations of pediculus humanus capitis )  crab lice ( infestations of pthirus pubis )  and their ova only in patients who cannot tolerate other approved therapies  or have failed treatment with other approved therapies,1
3131,3131,3131,3131,3131,3131,3131,3896,3896,3896,3896,3896,3896,3896,3896,3896,3896,3896,3896,3896,13ddf5e6-ac0e-41e6-b95d-d5bdd6b26fcd,lindane shampoo should be used in the context of an overall lice management program that includes visual inspection to ensure that the patient is currently infested with live lice ( empty egg casings or nits can remain on hair shaft long after true infestation ),u
3132,3132,3132,3132,3132,3132,3132,3897,3897,3897,3897,3897,3897,3897,3897,3897,3897,3897,3897,3897,13ddf5e6-ac0e-41e6-b95d-d5bdd6b26fcd,manual removal of nits using a comb designed for this purpose and or individual removal with tweezers followed by close examination of the hair and scalp,
3133,3133,3133,3133,3133,3133,3133,3898,3898,3898,3898,3898,3898,3898,3898,3898,3898,3898,3898,3898,13ddf5e6-ac0e-41e6-b95d-d5bdd6b26fcd,evaluation and treatment of sexual contacts simultaneously,0
3134,3134,3134,3134,3134,3134,3134,3899,3899,3899,3899,3899,3899,3899,3899,3899,3899,3899,3899,3899,13ddf5e6-ac0e-41e6-b95d-d5bdd6b26fcd,sexual contacts should be prescribed lindane shampoo only if they either have failed to respond to adequate doses of other approved therapies or are intolerant of other approved therapies,1
3135,3135,3135,3135,3135,3135,3135,3900,3900,3900,3900,3900,3900,3900,3900,3900,3900,3900,3900,3900,13ddf5e6-ac0e-41e6-b95d-d5bdd6b26fcd,all recently worn clothing  underwear  pajamas  used sheets  pillowcases  and towels should be washed in very hot water or dry cleaned,0
3136,3136,3136,3136,3136,3136,3136,3901,3901,3901,3901,3901,3901,3901,3901,3901,3901,3901,3901,3901,13ddf5e6-ac0e-41e6-b95d-d5bdd6b26fcd,caregivers applying this product to patients should wear gloves less permeable to lindane such as nitrile  latex with neoprene or sheer vinyl  and thoroughly clean hands after application,4
3137,3137,3137,3137,3137,3137,3137,3902,3902,3902,3902,3902,3902,3902,3902,3902,3902,3902,3902,3902,13ddf5e6-ac0e-41e6-b95d-d5bdd6b26fcd,natural latex gloves should be avoided because they are more permeable to lindane,4
3138,3138,3138,3138,3138,3138,3138,3903,3903,3903,3903,3903,3903,3903,3903,3903,3903,3903,3903,3903,13ddf5e6-ac0e-41e6-b95d-d5bdd6b26fcd,lindane shampoo does not prevent infestation or reinfestation and should not be used to ward off a possible infestation,0
3139,3139,3139,3139,3139,3139,3139,3904,3904,3904,3904,3904,3904,3904,3904,3904,3904,3904,3904,3904,59341250-deac-ed71-3823-a4f5d64dbd77,1  naglazyme ( galsulfase ) is indicated for patients with mucopolysaccharidosis vi ( mps vi  maroteaux lamy syndrome ),1
3140,3140,3140,3140,3140,3140,3140,3905,3905,3905,3905,3905,3905,3905,3905,3905,3905,3905,3905,3905,59341250-deac-ed71-3823-a4f5d64dbd77,naglazyme has been shown to improve walking and stair climbing capacity,u
3141,3141,3141,3141,3141,3141,3141,3906,3906,3906,3906,3906,3906,3906,3906,3906,3906,3906,3906,3906,59341250-deac-ed71-3823-a4f5d64dbd77,naglazyme is a hydrolytic lysosomal glycosaminoglycan ( gag ) specific enzyme indicated for patients with mucopolysaccharidosis vi ( mps vi maroteaux lamy syndrome ),1
3142,3142,3142,3142,3142,3142,3142,3907,3907,3907,3907,3907,3907,3907,3907,3907,3907,3907,3907,3907,59341250-deac-ed71-3823-a4f5d64dbd77,naglazyme has been shown to improve walking and stair climbing capacity ( 1 ),u
3143,3143,3143,3143,3143,3143,3143,3908,3908,3908,3908,3908,3908,3908,3908,3908,3908,3908,3908,3908,6f2753dc-5f0c-4f49-9335-e519afb69ba6, paser is indicated for the treatment of tuberculosis in combination with other active agents,1
3144,3144,3144,3144,3144,3144,3144,3909,3909,3909,3909,3909,3909,3909,3909,3909,3909,3909,3909,3909,6f2753dc-5f0c-4f49-9335-e519afb69ba6,it is most commonly used in patients with multi drug resistant tb ( mdr tb ) or in situations when therapy with isoniazid and rifampin is not possible due to a combination of resistance and or intolerance,0
3145,3145,3145,3145,3145,3145,3145,3910,3910,3910,3910,3910,3910,3910,3910,3910,3910,3910,3910,3910,6f2753dc-5f0c-4f49-9335-e519afb69ba6,when paser is added to the treatment regimen in patients proven or suspected drug resistance  it should be accompanied by at least one and preferably two other new agents to which the patient 's organism is known or expected to be susceptible,4
3146,3146,3146,3146,3146,3146,3146,3911,3911,3911,3911,3911,3911,3911,3911,3911,3911,3911,3911,3911,0e1a7861-e097-4b0c-bfe3-6d2d98a8bedb,1  qvar is a corticosteroid indicated for maintenance treatment of asthma as prophylactic therapy in patients 5 years of age and older,1
3147,3147,3147,3147,3147,3147,3147,3912,3912,3912,3912,3912,3912,3912,3912,3912,3912,3912,3912,3912,0e1a7861-e097-4b0c-bfe3-6d2d98a8bedb,( 1 1 ) treatment of asthma in patients who require oral corticosteroid therapy,1
3148,3148,3148,3148,3148,3148,3148,3913,3913,3913,3913,3913,3913,3913,3913,3913,3913,3913,3913,3913,0e1a7861-e097-4b0c-bfe3-6d2d98a8bedb,qvar may reduce or eliminate the need for the systemic corticosteroids,u
3149,3149,3149,3149,3149,3149,3149,3914,3914,3914,3914,3914,3914,3914,3914,3914,3914,3914,3914,3914,0e1a7861-e097-4b0c-bfe3-6d2d98a8bedb,( 1 1 ) important limitations not indicated for the relief of acute bronchospasm,2
3150,3150,3150,3150,3150,3150,3150,3915,3915,3915,3915,3915,3915,3915,3915,3915,3915,3915,3915,3915,0e1a7861-e097-4b0c-bfe3-6d2d98a8bedb,( 1 1 ) 1 1 treatment of asthma qvar is indicated in the maintenance treatment of asthma as prophylactic therapy in patients 5 years of age and older,1
3151,3151,3151,3151,3151,3151,3151,3916,3916,3916,3916,3916,3916,3916,3916,3916,3916,3916,3916,3916,0e1a7861-e097-4b0c-bfe3-6d2d98a8bedb,qvar is also indicated for asthma patients who require systemic corticosteroid administration  where adding qvar may reduce or eliminate the need for the systemic corticosteroids,1
3152,3152,3152,3152,3152,3152,3152,3917,3917,3917,3917,3917,3917,3917,3917,3917,3917,3917,3917,3917,0e1a7861-e097-4b0c-bfe3-6d2d98a8bedb,important limitations of use qvar is not indicated for the relief of acute bronchospasm,2
3153,3153,3153,3153,3153,3153,3153,3918,3918,3918,3918,3918,3918,3918,3918,3918,3918,3918,3918,3918,5fcad939-76e7-49cf-af94-4e6aef17901f,1  tanzeum is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus see clinical studies ( 14 ),1
3154,3154,3154,3154,3154,3154,3154,3919,3919,3919,3919,3919,3919,3919,3919,3919,3919,3919,3919,3919,5fcad939-76e7-49cf-af94-4e6aef17901f,limitations of use tanzeum is not recommended as first line therapy for patients inadequately controlled on diet and exercise because of the uncertain relevance of the rodent c cell tumor findings to humans,2
3155,3155,3155,3155,3155,3155,3155,3920,3920,3920,3920,3920,3920,3920,3920,3920,3920,3920,3920,3920,5fcad939-76e7-49cf-af94-4e6aef17901f,prescribe tanzeum only to patients for whom the potential benefits are considered to outweigh the potential risk see warnings and precautions ( 5 1 ),0
3156,3156,3156,3156,3156,3156,3156,3921,3921,3921,3921,3921,3921,3921,3921,3921,3921,3921,3921,3921,5fcad939-76e7-49cf-af94-4e6aef17901f,tanzeum has not been studied in patients with a history of pancreatitis see warnings and precautions ( 5 2 ),0
3157,3157,3157,3157,3157,3157,3157,3923,3923,3923,3923,3923,3923,3923,3923,3923,3923,3923,3923,3923,5fcad939-76e7-49cf-af94-4e6aef17901f,tanzeum is not indicated in the treatment of patients with type 1 diabetes mellitus or for the treatment of patients with diabetic ketoacidosis,2
3158,3158,3158,3158,3158,3158,3158,3924,3924,3924,3924,3924,3924,3924,3924,3924,3924,3924,3924,3924,5fcad939-76e7-49cf-af94-4e6aef17901f,tanzeum is not a substitute for insulin in these patients,0
3159,3159,3159,3159,3159,3159,3159,3925,3925,3925,3925,3925,3925,3925,3925,3925,3925,3925,3925,3925,5fcad939-76e7-49cf-af94-4e6aef17901f,tanzeum has not been studied in patients with severe gastrointestinal disease  including severe gastroparesis,0
3160,3160,3160,3160,3160,3160,3160,3926,3926,3926,3926,3926,3926,3926,3926,3926,3926,3926,3926,3926,5fcad939-76e7-49cf-af94-4e6aef17901f,the use of tanzeum is not recommended in patients with pre existing severe gastrointestinal disease see adverse reactions ( 6 1 ),0
3161,3161,3161,3161,3161,3161,3161,3927,3927,3927,3927,3927,3927,3927,3927,3927,3927,3927,3927,3927,5fcad939-76e7-49cf-af94-4e6aef17901f,tanzeum has not been studied in combination with prandial insulin,0
3162,3162,3162,3162,3162,3162,3162,3928,3928,3928,3928,3928,3928,3928,3928,3928,3928,3928,3928,3928,5fcad939-76e7-49cf-af94-4e6aef17901f,tanzeum is a glp 1 receptor agonist indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus,1
3163,3163,3163,3163,3163,3163,3163,3929,3929,3929,3929,3929,3929,3929,3929,3929,3929,3929,3929,3929,5fcad939-76e7-49cf-af94-4e6aef17901f,( 1 ) limitations of use not recommended as first line therapy for patients inadequately controlled on diet and exercise,2
3164,3164,3164,3164,3164,3164,3164,3930,3930,3930,3930,3930,3930,3930,3930,3930,3930,3930,3930,3930,5fcad939-76e7-49cf-af94-4e6aef17901f,( 1  5 1 ) has not been studied in patients with a history of pancreatitis,0
3165,3165,3165,3165,3165,3165,3165,3932,3932,3932,3932,3932,3932,3932,3932,3932,3932,3932,3932,3932,5fcad939-76e7-49cf-af94-4e6aef17901f,( 1  5 2 ) not for treatment of type 1 diabetes mellitus or diabetic ketoacidosis,u
3166,3166,3166,3166,3166,3166,3166,3933,3933,3933,3933,3933,3933,3933,3933,3933,3933,3933,3933,3933,5fcad939-76e7-49cf-af94-4e6aef17901f,( 1 ) not for patients with pre existing severe gastrointestinal disease,2
3167,3167,3167,3167,3167,3167,3167,3934,3934,3934,3934,3934,3934,3934,3934,3934,3934,3934,3934,3934,5fcad939-76e7-49cf-af94-4e6aef17901f,( 1 ) has not been studied in combination with prandial insulin,0
3168,3168,3168,3168,3168,3168,3168,3935,3935,3935,3935,3935,3935,3935,3935,3935,3935,3935,3935,3935,7049f870-6741-4a67-8033-398c36126a06,1  ciprofloxacin injection is a fluoroquinolone antibacterial indicated in adults ( 18 years of age ) with the following infections caused by designated  susceptible bacteria and in pediatric patients where indicated skin and skin structure infections ( 1 1 ) bone and joint infections ( 1 2 ) complicated intra abdominal infections ( 1 3 ) nosocomial pneumonia ( 1 4 ) empirical therapy for febrile neutropenic patients ( 1 5 ) inhalational anthrax post exposure in adult and pediatric patients ( 1 6 ) plague in adult and pediatric patients ( 1 7 ) chronic bacterial prostatitis ( 1 8 ) lower respiratory tract infections ( 1 9 ) acute exacerbation of chronic bronchitis urinary tract infections ( 1 10 ) urinary tract infections ( uti ) complicated uti and pyelonephritis in pediatric patients acute sinusitis ( 1 11 ) usage to reduce the development of drug resistant bacteria and maintain the effectiveness of ciprofloxacin injection and other antibacterial drugs  ciprofloxacin injection should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria,1
3169,3169,3169,3169,3169,3169,3169,3936,3936,3936,3936,3936,3936,3936,3936,3936,3936,3936,3936,3936,7049f870-6741-4a67-8033-398c36126a06,( 1 12 ) 1 1 skin and skin structure infections ciprofloxacin injection ( in 5 dextrose injection ) is indicated in adult patients for treatment of skin and skin structure infections caused by escherichia coli  klebsiella pneumoniae  enterobacter cloacae  proteus mirabilis  proteus vulgaris  providencia stuartii  morganella morganii  citrobacter freundii  pseudomonas aeruginosa  methicillin susceptible staphylococcus aureus  methicillin susceptible staphylococcus epidermidis  or streptococcus pyogenes,1
3170,3170,3170,3170,3170,3170,3170,3937,3937,3937,3937,3937,3937,3937,3937,3937,3937,3937,3937,3937,7049f870-6741-4a67-8033-398c36126a06,1 2 bone and joint infections ciprofloxacin injection is indicated in adult patients for treatment of bone and joint infect,1
3171,3171,3171,3171,3171,3171,3171,3938,3938,3938,3938,3938,3938,3938,3938,3938,3938,3938,3938,3938,a7a23b87-f892-4e2c-8e2e-ebf841220f90,1  uptravi is a prostacyclin receptor agonist indicated for the treatment of pulmonary arterial hypertension ( pah  who group i ) to delay disease progression and reduce the risk of hospitalization for pah,1
3172,3172,3172,3172,3172,3172,3172,3939,3939,3939,3939,3939,3939,3939,3939,3939,3939,3939,3939,3939,a7a23b87-f892-4e2c-8e2e-ebf841220f90,( 1 1 ) 1 1 pulmonary arterial hypertension uptravi is indicated for the treatment of pulmonary arterial hypertension ( pah  who group i ) to delay disease progression and reduce the risk of hospitalization for pah,1
3173,3173,3173,3173,3173,3173,3173,3940,3940,3940,3940,3940,3940,3940,3940,3940,3940,3940,3940,3940,a7a23b87-f892-4e2c-8e2e-ebf841220f90,effectiveness was established in a long term study in pah patients with who functional class ii iii symptoms,0
3174,3174,3174,3174,3174,3174,3174,3941,3941,3941,3941,3941,3941,3941,3941,3941,3941,3941,3941,3941,a7a23b87-f892-4e2c-8e2e-ebf841220f90,patients had idiopathic and heritable pah ( 58 )  pah associated with connective tissue disease ( 29 )  pah associated with congenital heart disease with repaired shunts ( 10 ) see clinical studies ( 14 1 ),0
3175,3175,3175,3175,3175,3175,3175,3942,3942,3942,3942,3942,3942,3942,3942,3942,3942,3942,3942,3942,f65ace26-19dc-49ce-832d-96994cfe36e3,indications for professional use in gonioscopic examinations,1
3176,3176,3176,3176,3176,3176,3176,3943,3943,3943,3943,3943,3943,3943,3943,3943,3943,3943,3943,3943,f0dbe0b1-b1ba-4b2c-a179-739145c39aa7,olive leaf throat spray a homeopathic remedy for the temporary relief of mouth and throat irritations,1
3177,3177,3177,3177,3177,3177,3177,3944,3944,3944,3944,3944,3944,3944,3944,3944,3944,3944,3944,3944,10175e73-5172-4dde-a508-8a88b7afc0a1, carbaglu is a carbamoyl phosphate synthetase 1 ( cps 1 ) activator indicated as adjunctive therapy for the treatment of acute hyperammonemia due to the deficiency of the hepatic enzyme n acetylglutamate synthase ( nags ),1
3178,3178,3178,3178,3178,3178,3178,3945,3945,3945,3945,3945,3945,3945,3945,3945,3945,3945,3945,3945,10175e73-5172-4dde-a508-8a88b7afc0a1,( 1 1 ) maintenance therapy for the treatment of chronic hyperammonemia due to the deficiency of the hepatic enzyme n acetylglutamate synthase ( nags ),1
3179,3179,3179,3179,3179,3179,3179,3946,3946,3946,3946,3946,3946,3946,3946,3946,3946,3946,3946,3946,10175e73-5172-4dde-a508-8a88b7afc0a1,( 1 2 ) 1 1 acute hyperammonemia in patients with nags deficiency carbaglu is indicated as an adjunctive therapy in pediatric and adult patients for the treatment of acute hyperammonemia due to the deficiency of the hepatic enzyme n acetylglutamate synthase ( nags ),1
3180,3180,3180,3180,3180,3180,3180,3947,3947,3947,3947,3947,3947,3947,3947,3947,3947,3947,3947,3947,10175e73-5172-4dde-a508-8a88b7afc0a1,during acute hyperammonemic episodes  concomitant administration of carbaglu with other ammonia lowering therapies  such as alternate pathway medications  hemodialysis  and dietary protein restriction  is recommended,1
3181,3181,3181,3181,3181,3181,3181,3948,3948,3948,3948,3948,3948,3948,3948,3948,3948,3948,3948,3948,10175e73-5172-4dde-a508-8a88b7afc0a1,1 2 chronic hyperammonemia in patients with nags deficiency carbaglu is indicated as maintenance therapy in pediatric and adult patients for the treatment of chronic hyperammonemia due to deficiency of the hepatic enzyme n acetylglutamate synthase ( nags ),1
3182,3182,3182,3182,3182,3182,3182,3949,3949,3949,3949,3949,3949,3949,3949,3949,3949,3949,3949,3949,10175e73-5172-4dde-a508-8a88b7afc0a1,during maintenance therapy  the concomitant use of other ammonia lowering therapies and protein restriction may be needed based on plasma ammonia levels,4
3183,3183,3183,3183,3183,3183,3183,3950,3950,3950,3950,3950,3950,3950,3950,3950,3950,3950,3950,3950,1f0cbd23-2fb3-43b7-b8af-7de246151149, technetium tc 99m pyrophosphate injection is a bone imaging agent used to demonstrate areas of altered osteogenesis  and a cardiac imaging agent used as an adjunct in the diagnosis of acute myocardial infarction,1
3184,3184,3184,3184,3184,3184,3184,3951,3951,3951,3951,3951,3951,3951,3951,3951,3951,3951,3951,3951,1f0cbd23-2fb3-43b7-b8af-7de246151149,kit for the preparation of technetium tc 99m pyrophosphate injection is a blood pool imaging agent which may be used for gated blood pool imaging and for the detection of sites of gastrointestinal bleeding,0
3185,3185,3185,3185,3185,3185,3185,3952,3952,3952,3952,3952,3952,3952,3952,3952,3952,3952,3952,3952,1f0cbd23-2fb3-43b7-b8af-7de246151149,when reconstituted with sterile non pyrogenic isotonic saline and administered intravenously 30 minutes prior to the intravenous administration of sodium pertechnetate tc 99m injection  approximately 76 of the injected radioactivity remains in the blood pool,0
3186,3186,3186,3186,3186,3186,3186,3953,3953,3953,3953,3953,3953,3953,3953,3953,3953,3953,3953,3953,456a34c7-8511-4000-99a7-ad8f8de6d35e,1  glatiramer acetate injection is indicated for the treatment of patients with relapsing forms of multiple sclerosis,1
3187,3187,3187,3187,3187,3187,3187,3954,3954,3954,3954,3954,3954,3954,3954,3954,3954,3954,3954,3954,456a34c7-8511-4000-99a7-ad8f8de6d35e,glatiramer acetate injection is indicated for the treatment of patients with relapsing forms of multiple sclerosis ( 1 ),1
3188,3188,3188,3188,3188,3188,3188,3955,3955,3955,3955,3955,3955,3955,3955,3955,3955,3955,3955,3955,b29124f7-c238-4961-b810-f4e7fabe4bb1, tetracaine hydrochloride is indicated for the production of spinal anesthesia for procedures requiring two to three hours,1
3189,3189,3189,3189,3189,3189,3189,3956,3956,3956,3956,3956,3956,3956,3956,3956,3956,3956,3956,3956,af1773c5-5d5b-4278-b551-30ad2df6d5b5,indications cetacaine is a topical anesthetic indicated for the production of anesthesia of all accessible mucous membrane except the eyes,1
3190,3190,3190,3190,3190,3190,3190,3957,3957,3957,3957,3957,3957,3957,3957,3957,3957,3957,3957,3957,af1773c5-5d5b-4278-b551-30ad2df6d5b5,cetacaine spray is indicated for use to control pain or gagging,1
3191,3191,3191,3191,3191,3191,3191,3958,3958,3958,3958,3958,3958,3958,3958,3958,3958,3958,3958,3958,af1773c5-5d5b-4278-b551-30ad2df6d5b5,cetacaine in all forms is indicated to control pain and for use for surgical or endoscopic or other procedures in the ear  nose  mouth  pharynx  larynx  trachea  bronchi  and esophagus,1
3192,3192,3192,3192,3192,3192,3192,3959,3959,3959,3959,3959,3959,3959,3959,3959,3959,3959,3959,3959,af1773c5-5d5b-4278-b551-30ad2df6d5b5,it may also be used for vaginal or rectal procedures when feasible,1
3193,3193,3193,3193,3193,3193,3193,3960,3960,3960,3960,3960,3960,3960,3960,3960,3960,3960,3960,3960,d2af5404-3cfe-445d-8328-19e667ecdc43,1  kovanaze tm is indicated for regional anesthesia when performing a restorative procedure on teeth 4 13 and a j in adults and children who weigh 40 kg or more,1
3194,3194,3194,3194,3194,3194,3194,3961,3961,3961,3961,3961,3961,3961,3961,3961,3961,3961,3961,3961,d2af5404-3cfe-445d-8328-19e667ecdc43,kovanaze contains tetracaine hcl  an ester local anesthetic  and oxymetazoline hcl  a vasoconstrictor,0
3195,3195,3195,3195,3195,3195,3195,3962,3962,3962,3962,3962,3962,3962,3962,3962,3962,3962,3962,3962,d2af5404-3cfe-445d-8328-19e667ecdc43,kovanaze is indicated for regional anesthesia when performing a restorative procedure on teeth 4 13 and a j in adults and children who weigh 40 kg or more ( 1 ),1
3196,3196,3196,3196,3196,3196,3196,3963,3963,3963,3963,3963,3963,3963,3963,3963,3963,3963,3963,3963,89c9ff5e-8929-4e63-bc11-459aa9ce7110, benzonatate capsule is indicated for the symptomatic relief of cough,1
3197,3197,3197,3197,3197,3197,3197,3964,3964,3964,3964,3964,3964,3964,3964,3964,3964,3964,3964,3964,7134ae7c-6c64-470d-ab4e-81e35413b839,1  brovana inhalation solution is a long acting beta2 adrenergic agonist ( beta2 agonist ) indicated for long term  twice daily ( morning and evening ) administration in the maintenance treatment of bronchoconstriction in patients with chronic obstructive pulmonary disease ( copd )  including chronic bronchitis and emphysema,1
3198,3198,3198,3198,3198,3198,3198,3965,3965,3965,3965,3965,3965,3965,3965,3965,3965,3965,3965,3965,7134ae7c-6c64-470d-ab4e-81e35413b839,( 1 1 ) important limitations of use brovana inhalation solution is not indicated to treat acute deteriorations of chronic obstructive pulmonary disease,0
3199,3199,3199,3199,3199,3199,3199,3966,3966,3966,3966,3966,3966,3966,3966,3966,3966,3966,3966,3966,7134ae7c-6c64-470d-ab4e-81e35413b839,( 1 2  5 2 ) brovana inhalation solution is not indicated to treat asthma,2
3200,3200,3200,3200,3200,3200,3200,3967,3967,3967,3967,3967,3967,3967,3967,3967,3967,3967,3967,3967,7134ae7c-6c64-470d-ab4e-81e35413b839,( 1 2 ) 1 1 maintenance treatment of copd brovana ( arformoterol tartrate ) inhalation solution is indicated for the long term  twice daily ( morning and evening ) maintenance treatment of bronchoconstriction in patients with chronic obstructive pulmonary disease ( copd )  including chronic bronchitis and emphysema,1
3201,3201,3201,3201,3201,3201,3201,3968,3968,3968,3968,3968,3968,3968,3968,3968,3968,3968,3968,3968,7134ae7c-6c64-470d-ab4e-81e35413b839,brovana inhalation solution is for use by nebulization only,0
3202,3202,3202,3202,3202,3202,3202,3969,3969,3969,3969,3969,3969,3969,3969,3969,3969,3969,3969,3969,7134ae7c-6c64-470d-ab4e-81e35413b839,1 2 important limitations of use brovana inhalation solution is not indicated to treat acute deteriorations of chronic obstructive pulmonary disease see warnings and precautions ( 5 2 ),2
3203,3203,3203,3203,3203,3203,3203,3970,3970,3970,3970,3970,3970,3970,3970,3970,3970,3970,3970,3970,7134ae7c-6c64-470d-ab4e-81e35413b839,brovana inhalation solution is not indicated to treat asthma,2
3204,3204,3204,3204,3204,3204,3204,3971,3971,3971,3971,3971,3971,3971,3971,3971,3971,3971,3971,3971,7134ae7c-6c64-470d-ab4e-81e35413b839,the safety and effectiveness of brovana inhalation solution in asthma have not been established,0
3205,3205,3205,3205,3205,3205,3205,3972,3972,3972,3972,3972,3972,3972,3972,3972,3972,3972,3972,3972,3f11df27-710b-4903-a985-74ee4674a844,indications corzide ( nadolol and bendroflumethiazide tablets ) is indicated for the treatment of hypertension  to lower blood pressure,1
3206,3206,3206,3206,3206,3206,3206,3974,3974,3974,3974,3974,3974,3974,3974,3974,3974,3974,3974,3974,3f11df27-710b-4903-a985-74ee4674a844,these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including the classes to which this drug principally belongs,0
3207,3207,3207,3207,3207,3207,3207,3975,3975,3975,3975,3975,3975,3975,3975,3975,3975,3975,3975,3975,3f11df27-710b-4903-a985-74ee4674a844,there are no controlled trials demonstrating risk reduction with corzide,0
3208,3208,3208,3208,3208,3208,3208,3985,3985,3985,3985,3985,3985,3985,3985,3985,3985,3985,3985,3985,3f11df27-710b-4903-a985-74ee4674a844,corzide ( nadolol and bendroflumethiazide tablets ) is not indicated for initial therapy of hypertension,0
3209,3209,3209,3209,3209,3209,3209,3986,3986,3986,3986,3986,3986,3986,3986,3986,3986,3986,3986,3986,3f11df27-710b-4903-a985-74ee4674a844,if the fixed combination represents the dose titrated to the individual patient 's needs  it may be more convenient than the separate components,0
3210,3210,3210,3210,3210,3210,3210,3987,3987,3987,3987,3987,3987,3987,3987,3987,3987,3987,3987,3987,f56aec67-c662-477c-b866-bfc23e8809cf,1  kalbitor ( ecallantide ) is indicated for treatment of acute attacks of hereditary angioedema ( hae ) in patients 12 years of age and older,1
3211,3211,3211,3211,3211,3211,3211,3988,3988,3988,3988,3988,3988,3988,3988,3988,3988,3988,3988,3988,f56aec67-c662-477c-b866-bfc23e8809cf,kalbitor is a plasma kallikrein inhibitor indicated for treatment of acute attacks of hereditary angioedema ( hae ) in patients 12 years of age and older,1
3212,3212,3212,3212,3212,3212,3212,3989,3989,3989,3989,3989,3989,3989,3989,3989,3989,3989,3989,3989,3cf4c3f5-5230-277e-e054-00144ff8d46c,1  ruconest is a c1 esterase inhibitor recombinant indicated for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema ( hae ),1
3213,3213,3213,3213,3213,3213,3213,3990,3990,3990,3990,3990,3990,3990,3990,3990,3990,3990,3990,3990,3cf4c3f5-5230-277e-e054-00144ff8d46c,limitation of use effectiveness was not established in hae patients with laryngeal attacks,0
3214,3214,3214,3214,3214,3214,3214,3991,3991,3991,3991,3991,3991,3991,3991,3991,3991,3991,3991,3991,3cf4c3f5-5230-277e-e054-00144ff8d46c,ruconest is a c1 esterase inhibitor recombinant indicated for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema ( hae ),1
3215,3215,3215,3215,3215,3215,3215,3992,3992,3992,3992,3992,3992,3992,3992,3992,3992,3992,3992,3992,3cf4c3f5-5230-277e-e054-00144ff8d46c,( 1 ) limitation of use effectiveness was not established in hae patients with laryngeal attacks,0
3216,3216,3216,3216,3216,3216,3216,3993,3993,3993,3993,3993,3993,3993,3993,3993,3993,3993,3993,3993,b85f7b42-3012-4cbb-a805-74ea665636e6, famotidine is indicated in short term treatment of active duodenal ulcer,1
3217,3217,3217,3217,3217,3217,3217,3994,3994,3994,3994,3994,3994,3994,3994,3994,3994,3994,3994,3994,b85f7b42-3012-4cbb-a805-74ea665636e6,most adult patients heal within 4 weeks there is rarely reason to use famotidine at full dosage for longer than 6 to 8 weeks,0
3218,3218,3218,3218,3218,3218,3218,3995,3995,3995,3995,3995,3995,3995,3995,3995,3995,3995,3995,3995,b85f7b42-3012-4cbb-a805-74ea665636e6,studies have not assessed the safety of famotidine in uncomplicated active duodenal ulcer for periods of more than eight weeks,0
3219,3219,3219,3219,3219,3219,3219,3996,3996,3996,3996,3996,3996,3996,3996,3996,3996,3996,3996,3996,b85f7b42-3012-4cbb-a805-74ea665636e6,maintenance therapy for duodenal ulcer patients at reduced dosage after healing of an active ulcer,1
3220,3220,3220,3220,3220,3220,3220,3997,3997,3997,3997,3997,3997,3997,3997,3997,3997,3997,3997,3997,b85f7b42-3012-4cbb-a805-74ea665636e6,controlled studies in adults have not extended beyond one year,0
3221,3221,3221,3221,3221,3221,3221,3998,3998,3998,3998,3998,3998,3998,3998,3998,3998,3998,3998,3998,b85f7b42-3012-4cbb-a805-74ea665636e6,short term treatment of active benign gastric ulcer,1
3222,3222,3222,3222,3222,3222,3222,3999,3999,3999,3999,3999,3999,3999,3999,3999,3999,3999,3999,3999,b85f7b42-3012-4cbb-a805-74ea665636e6,most adult patients heal within 6 weeks,0
3223,3223,3223,3223,3223,3223,3223,4000,4000,4000,4000,4000,4000,4000,4000,4000,4000,4000,4000,4000,b85f7b42-3012-4cbb-a805-74ea665636e6,studies have not assessed the safety or efficacy of famotidine in uncomplicated active benign gastric ulcer for periods of more than 8 weeks,0
3224,3224,3224,3224,3224,3224,3224,4001,4001,4001,4001,4001,4001,4001,4001,4001,4001,4001,4001,4001,b85f7b42-3012-4cbb-a805-74ea665636e6,short term treatment of gastroesophageal reflux disease ( gerd ),1
3225,3225,3225,3225,3225,3225,3225,4002,4002,4002,4002,4002,4002,4002,4002,4002,4002,4002,4002,4002,b85f7b42-3012-4cbb-a805-74ea665636e6,famotidine is indicated for short term treatment of patients with symptoms of gerd ( see clinical pharmacology in adults  clinical studies ),1
3226,3226,3226,3226,3226,3226,3226,4003,4003,4003,4003,4003,4003,4003,4003,4003,4003,4003,4003,4003,b85f7b42-3012-4cbb-a805-74ea665636e6,famotidine is also indicated for the short term treatment of esophagitis due to gerd including erosive or ulcerative disease diagnosed by endoscopy ( see clinical pharmacology in adults  clinical studies ),1
3227,3227,3227,3227,3227,3227,3227,4004,4004,4004,4004,4004,4004,4004,4004,4004,4004,4004,4004,4004,b85f7b42-3012-4cbb-a805-74ea665636e6,treatment of pathological hypersecretory conditions ( e g  zollinger ellison syndrome  multiple endocrine adenomas ) ( see clinical pharmacology in adults  clinical studies ),1
3228,3228,3228,3228,3228,3228,3228,4005,4005,4005,4005,4005,4005,4005,4005,4005,4005,4005,4005,4005,558b9f26-37b2-423b-932d-25a37afe57ec,1  duexis  a combination of the nsaid ibuprofen and the histamine h2 receptor antagonist famotidine  is indicated for the relief of signs and symptoms of rheumatoid arthritis and osteoarthritis and to decrease the risk of developing upper gastrointestinal ulcers  which in the clinical trials was defined as a gastric and or duodenal ulcer  in patients who are taking ibuprofen for those indications,1
3229,3229,3229,3229,3229,3229,3229,4006,4006,4006,4006,4006,4006,4006,4006,4006,4006,4006,4006,4006,558b9f26-37b2-423b-932d-25a37afe57ec,the clinical trials primarily enrolled patients less than 65 years of age without a prior history of gastrointestinal ulcer,0
3230,3230,3230,3230,3230,3230,3230,4007,4007,4007,4007,4007,4007,4007,4007,4007,4007,4007,4007,4007,558b9f26-37b2-423b-932d-25a37afe57ec,controlled trials do not extend beyond 6 months see clinical studies ( 14 ) and use in specific populations ( 8 5 ),0
3231,3231,3231,3231,3231,3231,3231,4008,4008,4008,4008,4008,4008,4008,4008,4008,4008,4008,4008,4008,558b9f26-37b2-423b-932d-25a37afe57ec,duexis  a combination of a nonsteroidal anti inflammatory drug ( nsaid ) ibuprofen and the histamine h2 receptor antagonist famotidine  is indicated for the relief of signs and symptoms of rheumatoid arthritis and osteoarthritis and to decrease the risk of developing upper gastrointestinal ulcers  which in the clinical trials was defined as a gastric and or duodenal ulcer  in patients who are taking ibuprofen for those indications,1
3232,3232,3232,3232,3232,3232,3232,4010,4010,4010,4010,4010,4010,4010,4010,4010,4010,4010,4010,4010,558b9f26-37b2-423b-932d-25a37afe57ec,controlled trials do not extend beyond 6 months,0
3233,3233,3233,3233,3233,3233,3233,4011,4011,4011,4011,4011,4011,4011,4011,4011,4011,4011,4011,4011,7b74f590-e698-02da-9878-5dc80902dbb4, strontium chloride sr 89 injection  usp is indicated for the relief of bone pain in patients with painful skeletal metastases,1
3234,3234,3234,3234,3234,3234,3234,4012,4012,4012,4012,4012,4012,4012,4012,4012,4012,4012,4012,4012,7b74f590-e698-02da-9878-5dc80902dbb4,the presence of bone metastases should be confirmed prior to therapy,0
3235,3235,3235,3235,3235,3235,3235,4013,4013,4013,4013,4013,4013,4013,4013,4013,4013,4013,4013,4013,8a5cc930-0b36-48a8-9ad0-de633b208742, ethosuximide is indicated for the control of absence ( petit mal ) epilepsy,1
3236,3236,3236,3236,3236,3236,3236,4014,4014,4014,4014,4014,4014,4014,4014,4014,4014,4014,4014,4014,cab0d668-f4a4-4848-ba93-fa2c2246096c, cephalexin capsules  usp are indicated for the treatment of the following infections when caused by susceptible strains of the designated microorganisms respiratory tract infections caused by streptococcus pneumoniae and streptococcus pyogenes ( penicillin is the usual drug of choice in the treatment and prevention of streptococcal infections  including the prophylaxis of rheumatic fever,1
3237,3237,3237,3237,3237,3237,3237,4015,4015,4015,4015,4015,4015,4015,4015,4015,4015,4015,4015,4015,cab0d668-f4a4-4848-ba93-fa2c2246096c,cephalexin capsules  usp are generally effective in the eradication of streptococci from the nasopharynx however  substantial data establishing the efficacy of cephalexin capsules  usp in the subsequent prevention of rheumatic fever are not available at present ),u
3238,3238,3238,3238,3238,3238,3238,4016,4016,4016,4016,4016,4016,4016,4016,4016,4016,4016,4016,4016,cab0d668-f4a4-4848-ba93-fa2c2246096c,otitis media due to streptococcus pneumoniae  haemophilus influenzae  staphylococcus aureus  streptococcus pyogenes  and moraxella catarrhalis skin and skin structure infections caused by staphylococcus aureus and or streptococcus pyogenes bone infections caused by staphylococcus aureus and or proteus mirabilis genitourinary tract infections  including acute prostatitis  caused by escherichia coli  proteus mirabilis  and klebsiella pneumoniae note culture and susceptibility tests should be initiated prior to and during therapy,1
3239,3239,3239,3239,3239,3239,3239,4018,4018,4018,4018,4018,4018,4018,4018,4018,4018,4018,4018,4018,cab0d668-f4a4-4848-ba93-fa2c2246096c,to reduce the development of drug resistant bacteria and maintain the effectiveness of cephalexin capsules  usp and other antibacterial drugs  cephalexin capsules  usp should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria,4
3240,3240,3240,3240,3240,3240,3240,4021,4021,4021,4021,4021,4021,4021,4021,4021,4021,4021,4021,4021,8cd23ff7-71ba-4391-95bd-a3a7f347713d,1  tolterodine tartrate extended release capsules are indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence  urgency  and frequency see clinical studies ( 14 ),1
3241,3241,3241,3241,3241,3241,3241,4022,4022,4022,4022,4022,4022,4022,4022,4022,4022,4022,4022,4022,8cd23ff7-71ba-4391-95bd-a3a7f347713d,tolterodine tartrate extended release capsules are an antimuscarinic indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence  urgency  and frequency,1
3242,3242,3242,3242,3242,3242,3242,4023,4023,4023,4023,4023,4023,4023,4023,4023,4023,4023,4023,4023,b82d7d65-9ef4-4f05-9a7d-10440683332e, sumatriptan tablets are indicated for the acute treatment of migraine attacks with or without aura in adults,1
3243,3243,3243,3243,3243,3243,3243,4024,4024,4024,4024,4024,4024,4024,4024,4024,4024,4024,4024,4024,b82d7d65-9ef4-4f05-9a7d-10440683332e,sumatriptan tablets are not intended for the prophylactic therapy of migraine or for use in the management of hemiplegic or basilar migraine ( see contraindications ),2
3244,3244,3244,3244,3244,3244,3244,4025,4025,4025,4025,4025,4025,4025,4025,4025,4025,4025,4025,4025,b82d7d65-9ef4-4f05-9a7d-10440683332e,safety and effectiveness of sumatriptan tablets have not been established for cluster headache  which is present in an older  predominantly male population,0
3245,3245,3245,3245,3245,3245,3245,4026,4026,4026,4026,4026,4026,4026,4026,4026,4026,4026,4026,4026,4a645652-ae1f-3811-e054-00144ff8d46c,1  escitalopram oxalate usp is a selective serotonin reuptake inhibitor ( ssri ) indicated for acute and maintenance treatment of major depressive disorder ( mdd ) in adults and adolescents aged 12 to 17 years ( 1 1 ) acute treatment of generalized anxiety disorder ( gad ) in adults ( 1 2 ) 1 1 major depressive disorder escitalopram tablet usp is indicated for the acute and maintenance treatment of major depressive disorder in adults and in adolescents 12 to 17 years of age see clinical studies ( 14 1 ),1
3246,3246,3246,3246,3246,3246,3246,4027,4027,4027,4027,4027,4027,4027,4027,4027,4027,4027,4027,4027,4a645652-ae1f-3811-e054-00144ff8d46c,a major depressive episode ( dsm iv ) implies a prominent and relatively persistent ( nearly every day for at least 2 weeks ) depressed or dysphoric mood that usually interferes with daily functioning  and includes at least five of the following nine symptoms depressed mood  loss of interest in usual activities  significant change in weight and or appetite  insomnia or hypersomnia  psychomotor agitation or retardation  increased fatigue  feelings of guilt or worthlessness  slowed thinking or impaired concentration  a suicide attempt or suicidal ideation,0
3247,3247,3247,3247,3247,3247,3247,4028,4028,4028,4028,4028,4028,4028,4028,4028,4028,4028,4028,4028,4a645652-ae1f-3811-e054-00144ff8d46c,1 2 generalized anxiety disorder escitalopram tablet usp is indicated for the acute treatment of generalized anxiety disorder ( gad ) in adults see clinical studies ( 14 2 ),1
3248,3248,3248,3248,3248,3248,3248,4029,4029,4029,4029,4029,4029,4029,4029,4029,4029,4029,4029,4029,4a645652-ae1f-3811-e054-00144ff8d46c,generalized anxiety disorder ( dsm iv ) is characterized by excessive anxiety and worry ( apprehensive expectation ) that is persistent for at least 6 months and which the person finds difficult to control,0
3249,3249,3249,3249,3249,3249,3249,4030,4030,4030,4030,4030,4030,4030,4030,4030,4030,4030,4030,4030,4a645652-ae1f-3811-e054-00144ff8d46c,it must be associated with at least 3 of the following symptoms restlessness or feeling keyed up or on edge  being easily fatigued  difficulty concentrating or mind going blank  irritability  muscle tension  and sleep disturbance,0
3250,3250,3250,3250,3250,3250,3250,4031,4031,4031,4031,4031,4031,4031,4031,4031,4031,4031,4031,4031,fe712217-e56d-49f7-a791-0351f5e61896,indications to be used according to standard homeopathic indications,0
3251,3251,3251,3251,3251,3251,3251,4034,4034,4034,4034,4034,4034,4034,4034,4034,4034,4034,4034,4034,dbc63b6e-f8c5-4fd0-8ec3-4f5e19125313,1  ultiva is indicated for intravenous ( iv ) administration as an analgesic agent for use during the induction and maintenance of general anesthesia for inpatient and outpatient procedures,1
3252,3252,3252,3252,3252,3252,3252,4035,4035,4035,4035,4035,4035,4035,4035,4035,4035,4035,4035,4035,dbc63b6e-f8c5-4fd0-8ec3-4f5e19125313,for continuation as an analgesic into the immediate postoperative period in adult patients under the direct supervision of an anesthesia practitioner in a postoperative anesthesia care unit or intensive care setting,1
3253,3253,3253,3253,3253,3253,3253,4036,4036,4036,4036,4036,4036,4036,4036,4036,4036,4036,4036,4036,dbc63b6e-f8c5-4fd0-8ec3-4f5e19125313,as an analgesic component of monitored anesthesia care in adult patients,1
3254,3254,3254,3254,3254,3254,3254,4037,4037,4037,4037,4037,4037,4037,4037,4037,4037,4037,4037,4037,dbc63b6e-f8c5-4fd0-8ec3-4f5e19125313,ultiva is an opioid agonist indicated for intravenous administration as an analgesic agent for use during the induction and maintenance of general anesthesia for inpatient and outpatient procedures,1
3255,3255,3255,3255,3255,3255,3255,4038,4038,4038,4038,4038,4038,4038,4038,4038,4038,4038,4038,4038,dbc63b6e-f8c5-4fd0-8ec3-4f5e19125313,( 1 ) for continuation as an analgesic into the immediate postoperative period in adult patients under the direct supervision of an anesthesia practitioner in a postoperative anesthesia care unit or intensive care setting,1
3256,3256,3256,3256,3256,3256,3256,4039,4039,4039,4039,4039,4039,4039,4039,4039,4039,4039,4039,4039,dbc63b6e-f8c5-4fd0-8ec3-4f5e19125313,( 1 ) as an analgesic component of monitored anesthesia care in adult patients,1
3257,3257,3257,3257,3257,3257,3257,4040,4040,4040,4040,4040,4040,4040,4040,4040,4040,4040,4040,4040,bcf57b31-4811-4104-82b3-46fb91a53ee0,1  valproate sodium injection  usp is an anti epileptic drug and is indicated as an intravenous alternative in patients in whom oral administration of valproate products is temporarily not feasible in the following conditions monotherapy and adjunctive therapy of complex partial seizures and simple and complex absence seizures adjunctive therapy in patients with multiple seizure types that include absence seizures ( 1 ) 1 1 epilepsy valproate sodium injection  usp is indicated as an intravenous alternative in patients for whom oral administration of valproate products is temporarily not feasible in the following conditions valproate sodium injection  usp is indicated as monotherapy and adjunctive therapy in the treatment of patients with complex partial seizures that occur either in isolation or in association with other types of seizures,1
3258,3258,3258,3258,3258,3258,3258,4041,4041,4041,4041,4041,4041,4041,4041,4041,4041,4041,4041,4041,bcf57b31-4811-4104-82b3-46fb91a53ee0,valproate sodium injection  usp is also indicated for use as sole and adjunctive therapy in the treatment of patients with simple and complex absence seizures  and adjunctively in patients with multiple seizure types that include absence seizures,1
3259,3259,3259,3259,3259,3259,3259,4042,4042,4042,4042,4042,4042,4042,4042,4042,4042,4042,4042,4042,bcf57b31-4811-4104-82b3-46fb91a53ee0,simple absence is defined as very brief clouding of the sensorium or loss of consciousness accompanied by certain generalized epileptic discharges without other detectable clinical signs,0
3260,3260,3260,3260,3260,3260,3260,4043,4043,4043,4043,4043,4043,4043,4043,4043,4043,4043,4043,4043,bcf57b31-4811-4104-82b3-46fb91a53ee0,complex absence is the term used when other signs are also present,0
3261,3261,3261,3261,3261,3261,3261,4044,4044,4044,4044,4044,4044,4044,4044,4044,4044,4044,4044,4044,bcf57b31-4811-4104-82b3-46fb91a53ee0,see warnings and precautions ( 5 1 ) for statement regarding fatal hepatic dysfunction,0
3262,3262,3262,3262,3262,3262,3262,4045,4045,4045,4045,4045,4045,4045,4045,4045,4045,4045,4045,4045,bcf57b31-4811-4104-82b3-46fb91a53ee0,1 2 important limitations because of the risk to the fetus of decreased iq  neural tube defects  and other major congenital malformations  which may occur very early in pregnancy  valproate should not be administered to a woman of childbearing potential unless the drug is essential to the management of her medical condition see warnings and precautions ( 5 2  5 3  5 4 )  use in specific populations ( 8 1 )  and patient counseling information ( 17 ),2
3263,3263,3263,3263,3263,3263,3263,4046,4046,4046,4046,4046,4046,4046,4046,4046,4046,4046,4046,4046,0a5a6d93-cc1e-4d7f-8da1-446c134503b3, idamycin pfs injection in combination with other approved antileukemic drugs is indicated for the treatment of acute myeloid leukemia ( aml ) in adults,1
3264,3264,3264,3264,3264,3264,3264,4047,4047,4047,4047,4047,4047,4047,4047,4047,4047,4047,4047,4047,0a5a6d93-cc1e-4d7f-8da1-446c134503b3,this includes french american british ( fab ) classifications m1 through m7,0
3265,3265,3265,3265,3265,3265,3265,4048,4048,4048,4048,4048,4048,4048,4048,4048,4048,4048,4048,4048,15d161ed-9e7b-4c92-ba45-0556d2423e67, zanosar is indicated in the treatment of metastatic islet cell carcinoma of the pancreas,1
3266,3266,3266,3266,3266,3266,3266,4049,4049,4049,4049,4049,4049,4049,4049,4049,4049,4049,4049,4049,15d161ed-9e7b-4c92-ba45-0556d2423e67,responses have been obtained with both functional and nonfunctional carcinomas,0
3267,3267,3267,3267,3267,3267,3267,4050,4050,4050,4050,4050,4050,4050,4050,4050,4050,4050,4050,4050,15d161ed-9e7b-4c92-ba45-0556d2423e67,because of its inherent renal toxicity  therapy with this drug should be limited to patients with symptomatic or progressive metastatic disease,0
3268,3268,3268,3268,3268,3268,3268,4051,4051,4051,4051,4051,4051,4051,4051,4051,4051,4051,4051,4051,aaf0eb2a-f88a-4f26-a445-0fd30176c326,1  liletta is indicated for prevention of pregnancy for up to 4 years,1
3269,3269,3269,3269,3269,3269,3269,4052,4052,4052,4052,4052,4052,4052,4052,4052,4052,4052,4052,4052,aaf0eb2a-f88a-4f26-a445-0fd30176c326,the system should be replaced after 4 years if continued use is desired,0
3270,3270,3270,3270,3270,3270,3270,4053,4053,4053,4053,4053,4053,4053,4053,4053,4053,4053,4053,4053,aaf0eb2a-f88a-4f26-a445-0fd30176c326,liletta is a sterile  levonorgestrel releasing intrauterine system indicated for prevention of pregnancy for up to 4 years,1
3271,3271,3271,3271,3271,3271,3271,4054,4054,4054,4054,4054,4054,4054,4054,4054,4054,4054,4054,4054,60cba843-5aab-4dd7-96dc-66648d413be3,1  elaprase is indicated for patients with hunter syndrome ( mucopolysaccharidosis ii  mps ii ),1
3272,3272,3272,3272,3272,3272,3272,4055,4055,4055,4055,4055,4055,4055,4055,4055,4055,4055,4055,4055,60cba843-5aab-4dd7-96dc-66648d413be3,elaprase has been shown to improve walking capacity in patients 5 years and older,u
3273,3273,3273,3273,3273,3273,3273,4056,4056,4056,4056,4056,4056,4056,4056,4056,4056,4056,4056,4056,60cba843-5aab-4dd7-96dc-66648d413be3,in patients 16 months to 5 years of age  no data are available to demonstrate improvement in disease related symptoms or long term clinical outcome however  treatment with elaprase has reduced spleen volume similarly to that of adults and children 5 years of age and older,u
3274,3274,3274,3274,3274,3274,3274,4057,4057,4057,4057,4057,4057,4057,4057,4057,4057,4057,4057,4057,60cba843-5aab-4dd7-96dc-66648d413be3,the safety and efficacy of elaprase have not been established in pediatric patients less than 16 months of age see use in specific populations ( 8 4 ),0
3275,3275,3275,3275,3275,3275,3275,4058,4058,4058,4058,4058,4058,4058,4058,4058,4058,4058,4058,4058,60cba843-5aab-4dd7-96dc-66648d413be3,elaprase is a hydrolytic lysosomal glycosaminoglycan ( gag ) specific enzyme indicated for patients with hunter syndrome ( mucopolysaccharidosis ii  mps ii ),1
3276,3276,3276,3276,3276,3276,3276,4061,4061,4061,4061,4061,4061,4061,4061,4061,4061,4061,4061,4061,60cba843-5aab-4dd7-96dc-66648d413be3,the safety and efficacy of elaprase have not been established in pediatric patients less than 16 months of age ( 1 ),0
3277,3277,3277,3277,3277,3277,3277,4062,4062,4062,4062,4062,4062,4062,4062,4062,4062,4062,4062,4062,98591a51-82a8-4dc3-a5aa-384646c597e6,1  oxymorphone hydrochloride extended release tablets are indicated for the management of pain severe enough to require daily  around the clock  long term opioid treatment and for which alternative treatment options are inadequate,1
3278,3278,3278,3278,3278,3278,3278,4063,4063,4063,4063,4063,4063,4063,4063,4063,4063,4063,4063,4063,98591a51-82a8-4dc3-a5aa-384646c597e6,oxymorphone hydrochloride extended release tablets are an opioid agonist indicated for the management of pain severe enough to require daily  around the clock  long term opioid treatment and for which alternative treatment options are inadequate,1
3279,3279,3279,3279,3279,3279,3279,4064,4064,4064,4064,4064,4064,4064,4064,4064,4064,4064,4064,4064,98591a51-82a8-4dc3-a5aa-384646c597e6,( 1 ) limitations of use because of the risks of addiction  abuse  and misuse with opioids  even at recommended doses  and because of the greater risks of overdose and death with extended release opioid formulations  reserve oxymorphone hydrochloride extended release tablets for use in patients for whom alternative treatment options ( e g  non opioid analgesics or immediate release opioids ) are ineffective  not tolerated  or would be otherwise inadequate to provide sufficient management of pain,2
3280,3280,3280,3280,3280,3280,3280,4065,4065,4065,4065,4065,4065,4065,4065,4065,4065,4065,4065,4065,98591a51-82a8-4dc3-a5aa-384646c597e6,( 1 ) oxymorphone hydrochloride extended release tablets are not indicated as an as needed ( prn ) analgesic,2
3281,3281,3281,3281,3281,3281,3281,4066,4066,4066,4066,4066,4066,4066,4066,4066,4066,4066,4066,4066,98591a51-82a8-4dc3-a5aa-384646c597e6,( 1 ) limitations of usage because of the risks of addiction  abuse  and misuse with opioids  even at recommended doses  and because of the greater risks of overdose and death with extended release opioid formulations  reserve oxymorphone hydrochloride extended release tablets for use in patients for whom alternative treatment options ( e g  non opioid analgesics or immediate release opioids ) are ineffective  not tolerated  or would be otherwise inadequate to provide sufficient management of pain,4
3282,3282,3282,3282,3282,3282,3282,4067,4067,4067,4067,4067,4067,4067,4067,4067,4067,4067,4067,4067,98591a51-82a8-4dc3-a5aa-384646c597e6,oxymorphone hydrochloride extended release tablets are not indicated as an as needed ( prn ) analgesic,2
3283,3283,3283,3283,3283,3283,3283,4068,4068,4068,4068,4068,4068,4068,4068,4068,4068,4068,4068,4068,af5da799-76bf-415a-9dc7-99c7ddc62bc4, trh is indicated as an adjunctive agent in the diagnostic assessment of thyroid function,1
3284,3284,3284,3284,3284,3284,3284,4069,4069,4069,4069,4069,4069,4069,4069,4069,4069,4069,4069,4069,af5da799-76bf-415a-9dc7-99c7ddc62bc4,as an adjunct to other diagnostic procedures  testing with trh ( protirelin ) may yield useful information in patients with pituitary or hypothalamic dysfunction,u
3285,3285,3285,3285,3285,3285,3285,4070,4070,4070,4070,4070,4070,4070,4070,4070,4070,4070,4070,4070,af5da799-76bf-415a-9dc7-99c7ddc62bc4,trh is indicated as an adjunct to evaluate the effectiveness of thyrotropin suppression with a particular dose of t4 in patients with nodular or diffuse goiter,1
3286,3286,3286,3286,3286,3286,3286,4071,4071,4071,4071,4071,4071,4071,4071,4071,4071,4071,4071,4071,af5da799-76bf-415a-9dc7-99c7ddc62bc4,a normal tsh baseline value and a minimal difference between the 30 minute and baseline response to trh injection would indicate adequate suppression of the pituitary secretion of tsh,4
3287,3287,3287,3287,3287,3287,3287,4072,4072,4072,4072,4072,4072,4072,4072,4072,4072,4072,4072,4072,af5da799-76bf-415a-9dc7-99c7ddc62bc4,trh may be used  adjunctively  for adjustment of thyroid hormone dosage given to patients with primary hypothyroidism,1
3288,3288,3288,3288,3288,3288,3288,4073,4073,4073,4073,4073,4073,4073,4073,4073,4073,4073,4073,4073,af5da799-76bf-415a-9dc7-99c7ddc62bc4,a normal or slightly blunted tsh response  thirty minutes following trh injection  would indicate adequate replacement therapy,4
3289,3289,3289,3289,3289,3289,3289,4074,4074,4074,4074,4074,4074,4074,4074,4074,4074,4074,4074,4074,1a04cc23-61fa-455b-9718-2cdcf54036e0, lithium is indicated in the treatment of manic episodes of bipolar disorder,1
3290,3290,3290,3290,3290,3290,3290,4075,4075,4075,4075,4075,4075,4075,4075,4075,4075,4075,4075,4075,1a04cc23-61fa-455b-9718-2cdcf54036e0,bipolar disorder  manic ( dsm iii ) is equivalent to manic depressive illness  manic  in the older dsm ii terminology,0
3291,3291,3291,3291,3291,3291,3291,4076,4076,4076,4076,4076,4076,4076,4076,4076,4076,4076,4076,4076,1a04cc23-61fa-455b-9718-2cdcf54036e0,lithium is also indicated as a maintenance treatment for individuals with a diagnosis of bipolar disorder,1
3292,3292,3292,3292,3292,3292,3292,4080,4080,4080,4080,4080,4080,4080,4080,4080,4080,4080,4080,4080,dd70cd5f-b0fc-4ba4-a5ea-89a34778bd94,1  spinraza is indicated for the treatment of spinal muscular atrophy ( sma ) in pediatric and adult patients,1
3293,3293,3293,3293,3293,3293,3293,4081,4081,4081,4081,4081,4081,4081,4081,4081,4081,4081,4081,4081,dd70cd5f-b0fc-4ba4-a5ea-89a34778bd94,spinraza is a survival motor neuron 2 ( smn2 ) directed antisense oligonucleotide indicated for the treatment of spinal muscular atrophy ( sma ) in pediatric and adult patients ( 1 ),1
3294,3294,3294,3294,3294,3294,3294,4082,4082,4082,4082,4082,4082,4082,4082,4082,4082,4082,4082,4082,fffa5d75-0dba-4ad7-a252-5f60fa28489a,1  arranon is indicated for the treatment of patients with t cell acute lymphoblastic leukemia and t cell lymphoblastic lymphoma whose disease has not responded to or has relapsed following treatment with at least two chemotherapy regimens,1
3295,3295,3295,3295,3295,3295,3295,4083,4083,4083,4083,4083,4083,4083,4083,4083,4083,4083,4083,4083,fffa5d75-0dba-4ad7-a252-5f60fa28489a,this use is based on the induction of complete responses,u
3296,3296,3296,3296,3296,3296,3296,4084,4084,4084,4084,4084,4084,4084,4084,4084,4084,4084,4084,4084,fffa5d75-0dba-4ad7-a252-5f60fa28489a,randomized trials demonstrating increased survival or other clinical benefit have not been conducted,0
3297,3297,3297,3297,3297,3297,3297,4085,4085,4085,4085,4085,4085,4085,4085,4085,4085,4085,4085,4085,fffa5d75-0dba-4ad7-a252-5f60fa28489a,arranon is a nucleoside metabolic inhibitor indicated for the treatment of patients with t cell acute lymphoblastic leukemia and t cell lymphoblastic lymphoma whose disease has not responded to or has relapsed following treatment with at least two chemotherapy regimens,1
3298,3298,3298,3298,3298,3298,3298,4088,4088,4088,4088,4088,4088,4088,4088,4088,4088,4088,4088,4088,eccd8340-ead3-4363-8902-0c19d33aa2ac, brevital can be used in adults as follows 1 for intravenous induction of anesthesia prior to the use of other general anesthetic agents,1
3299,3299,3299,3299,3299,3299,3299,4089,4089,4089,4089,4089,4089,4089,4089,4089,4089,4089,4089,4089,eccd8340-ead3-4363-8902-0c19d33aa2ac,2 for intravenous induction of anesthesia and as an adjunct to subpotent inhalational anesthetic agents ( such as nitrous oxide in oxygen ) for short surgical procedures brevital may be given by infusion or intermittent injection,1
3300,3300,3300,3300,3300,3300,3300,4090,4090,4090,4090,4090,4090,4090,4090,4090,4090,4090,4090,4090,eccd8340-ead3-4363-8902-0c19d33aa2ac,3 for use along with other parenteral agents  usually narcotic analgesics  to supplement subpotent inhalational anesthetic agents ( such as nitrous oxide in oxygen ) for longer surgical procedures,1
3301,3301,3301,3301,3301,3301,3301,4091,4091,4091,4091,4091,4091,4091,4091,4091,4091,4091,4091,4091,eccd8340-ead3-4363-8902-0c19d33aa2ac,4 as intravenous anesthesia for short surgical  diagnostic  or therapeutic procedures associated with minimal painful stimuli ( see warnings ),1
3302,3302,3302,3302,3302,3302,3302,4092,4092,4092,4092,4092,4092,4092,4092,4092,4092,4092,4092,4092,eccd8340-ead3-4363-8902-0c19d33aa2ac,5 as an agent for inducing a hypnotic state,1
3303,3303,3303,3303,3303,3303,3303,4093,4093,4093,4093,4093,4093,4093,4093,4093,4093,4093,4093,4093,eccd8340-ead3-4363-8902-0c19d33aa2ac,brevital can be used in pediatric patients older than 1 month as follows 1 for rectal or intramuscular induction of anesthesia prior to the use of other general anesthetic agents,1
3304,3304,3304,3304,3304,3304,3304,4094,4094,4094,4094,4094,4094,4094,4094,4094,4094,4094,4094,4094,eccd8340-ead3-4363-8902-0c19d33aa2ac,2 for rectal or intramuscular induction of anesthesia and as an adjunct to subpotent inhalational anesthetic agents for short surgical procedures,1
3305,3305,3305,3305,3305,3305,3305,4095,4095,4095,4095,4095,4095,4095,4095,4095,4095,4095,4095,4095,eccd8340-ead3-4363-8902-0c19d33aa2ac,3 as rectal or intramuscular anesthesia for short surgical  diagnostic  or therapeutic procedures associated with minimal painful stimuli,1
3306,3306,3306,3306,3306,3306,3306,4096,4096,4096,4096,4096,4096,4096,4096,4096,4096,4096,4096,4096,693da40b-26d4-40d6-87d1-158e256f40ab, mexiletine hydrochloride capsules usp are indicated for the treatment of documented ventricular arrhythmias  such as sustained ventricular tachycardia  that  in the judgment of the physician  are life threatening,1
3307,3307,3307,3307,3307,3307,3307,4097,4097,4097,4097,4097,4097,4097,4097,4097,4097,4097,4097,4097,693da40b-26d4-40d6-87d1-158e256f40ab,because of the proarrhythmic effects of mexiletine  its use with lesser arrhythmias is generally not recommended,2
3308,3308,3308,3308,3308,3308,3308,4098,4098,4098,4098,4098,4098,4098,4098,4098,4098,4098,4098,4098,693da40b-26d4-40d6-87d1-158e256f40ab,treatment of patients with asymptomatic ventricular premature contractions should be avoided,2
3309,3309,3309,3309,3309,3309,3309,4099,4099,4099,4099,4099,4099,4099,4099,4099,4099,4099,4099,4099,693da40b-26d4-40d6-87d1-158e256f40ab,initiation of mexiletine treatment  as with other antiarrhythmic agents used to treat life threatening arrhythmias  should be carried out in the hospital,4
3310,3310,3310,3310,3310,3310,3310,4100,4100,4100,4100,4100,4100,4100,4100,4100,4100,4100,4100,4100,693da40b-26d4-40d6-87d1-158e256f40ab,antiarrhythmic drugs have not been shown to enhance survival in patients with ventricular arrhythmias,0
3311,3311,3311,3311,3311,3311,3311,4103,4103,4103,4103,4103,4103,4103,4103,4103,4103,4103,4103,4103,0132f17c-981e-45cf-a808-3bfc69ba6f8d,these statements have not been evaluated by the food and drug administration,0
3312,3312,3312,3312,3312,3312,3312,4104,4104,4104,4104,4104,4104,4104,4104,4104,4104,4104,4104,4104,0132f17c-981e-45cf-a808-3bfc69ba6f8d,this product is not intended to diagnose  treat  cure or prevent any disease,0
3313,3313,3313,3313,3313,3313,3313,4105,4105,4105,4105,4105,4105,4105,4105,4105,4105,4105,4105,4105,be4bc0de-0fdc-4d46-8d25-be43c79e6a06,1  verzenio ( abemaciclib ) is indicated in combination with an aromatase inhibitor as initial endocrine based therapy for the treatment of postmenopausal women with hormone receptor ( hr ) positive  human epidermal growth factor receptor 2 ( her2 ) negative advanced or metastatic breast cancer,1
3314,3314,3314,3314,3314,3314,3314,4106,4106,4106,4106,4106,4106,4106,4106,4106,4106,4106,4106,4106,be4bc0de-0fdc-4d46-8d25-be43c79e6a06,in combination with fulvestrant for the treatment of women with hormone receptor ( hr ) positive  human epidermal growth factor receptor 2 ( her2 ) negative advanced or metastatic breast cancer with disease progression following endocrine therapy,1
3315,3315,3315,3315,3315,3315,3315,4107,4107,4107,4107,4107,4107,4107,4107,4107,4107,4107,4107,4107,be4bc0de-0fdc-4d46-8d25-be43c79e6a06,as monotherapy for the treatment of adult patients with hr positive  her2 negative advanced or metastatic breast cancer with disease progression following endocrine therapy and prior chemotherapy in the metastatic setting,1
3316,3316,3316,3316,3316,3316,3316,4108,4108,4108,4108,4108,4108,4108,4108,4108,4108,4108,4108,4108,be4bc0de-0fdc-4d46-8d25-be43c79e6a06,verzenio is a kinase inhibitor indicated in combination with an aromatase inhibitor as initial endocrine based therapy for the treatment of postmenopausal women with hormone receptor ( hr ) positive  human epidermal growth factor receptor 2 ( her2 ) negative advanced or metastatic breast cancer,1
3317,3317,3317,3317,3317,3317,3317,4109,4109,4109,4109,4109,4109,4109,4109,4109,4109,4109,4109,4109,be4bc0de-0fdc-4d46-8d25-be43c79e6a06,( 1 ) in combination with fulvestrant for the treatment of women with hormone receptor ( hr ) positive  human epidermal growth factor receptor 2 ( her2 ) negative advanced or metastatic breast cancer with disease progression following endocrine therapy,1
3318,3318,3318,3318,3318,3318,3318,4110,4110,4110,4110,4110,4110,4110,4110,4110,4110,4110,4110,4110,be4bc0de-0fdc-4d46-8d25-be43c79e6a06,( 1 ) as monotherapy for the treatment of adult patients with hr positive  her2 negative advanced or metastatic breast cancer with disease progression following endocrine therapy and prior chemotherapy in the metastatic setting,1
3319,3319,3319,3319,3319,3319,3319,4111,4111,4111,4111,4111,4111,4111,4111,4111,4111,4111,4111,4111,c0cc4511-e656-4b6d-96cd-e02e76173b9d, warfarin sodium tablets  are indicated for prophylaxis and treatment of venous thrombosis and its extension  pulmonary embolism ( pe ),1
3320,3320,3320,3320,3320,3320,3320,4112,4112,4112,4112,4112,4112,4112,4112,4112,4112,4112,4112,4112,c0cc4511-e656-4b6d-96cd-e02e76173b9d,prophylaxis and treatment of thromboembolic complications associated with atrial fibrillation ( af ) and or cardiac valve replacement,1
3321,3321,3321,3321,3321,3321,3321,4113,4113,4113,4113,4113,4113,4113,4113,4113,4113,4113,4113,4113,c0cc4511-e656-4b6d-96cd-e02e76173b9d,reduction in the risk of death  recurrent myocardial infarction ( mi )  and thromboembolic events such as stroke or systemic embolization after myocardial infarction,1
3322,3322,3322,3322,3322,3322,3322,4114,4114,4114,4114,4114,4114,4114,4114,4114,4114,4114,4114,4114,c0cc4511-e656-4b6d-96cd-e02e76173b9d,limitations of use warfarin sodium tablets have no direct effect on an established thrombus  nor does it reverse ischemic tissue damage,0
3323,3323,3323,3323,3323,3323,3323,4115,4115,4115,4115,4115,4115,4115,4115,4115,4115,4115,4115,4115,c0cc4511-e656-4b6d-96cd-e02e76173b9d,once a thrombus has occurred  however  the goals of anticoagulant treatment are to prevent further extension of the formed clot and to prevent secondary thromboembolic complications that may result in serious and possibly fatal sequelae,0
3324,3324,3324,3324,3324,3324,3324,4116,4116,4116,4116,4116,4116,4116,4116,4116,4116,4116,4116,4116,c0cc4511-e656-4b6d-96cd-e02e76173b9d,warfarin sodium tablets are vitamin k antagonist indicated for prophylaxis and treatment of venous thrombosis and its extension  pulmonary embolism ( 1 ) prophylaxis and treatment of thromboembolic complications associated with atrial fibrillation and or cardiac valve replacement ( 1 ) reduction in the risk of death  recurrent myocardial infarction  and thromboembolic events such as stroke or systemic embolization after myocardial infarction ( 1 ) limitation of use warfarin sodium tablets  have no direct effect on an established thrombus  nor does it reverse ischemic tissue damage,1
3325,3325,3325,3325,3325,3325,3325,4117,4117,4117,4117,4117,4117,4117,4117,4117,4117,4117,4117,4117,051742b5-b0f0-44a5-8d31-3288527b0638,1  dilantin is indicated for the treatment of tonic clonic ( grand mal ) and psychomotor ( temporal lobe ) seizures,1
3326,3326,3326,3326,3326,3326,3326,4118,4118,4118,4118,4118,4118,4118,4118,4118,4118,4118,4118,4118,051742b5-b0f0-44a5-8d31-3288527b0638,dilantin is indicated for the treatment of tonic clonic ( grand mal ) and psychomotor ( temporal lobe ) seizures,1
3327,3327,3327,3327,3327,3327,3327,4119,4119,4119,4119,4119,4119,4119,4119,4119,4119,4119,4119,4119,77237c50-aeb5-44a0-a1e6-ce1551b49f75, fem ph is indicated as adjunctive therapy in those cases where restoration and maintenance of vaginal acidity is desirable,1
3328,3328,3328,3328,3328,3328,3328,4120,4120,4120,4120,4120,4120,4120,4120,4120,4120,4120,4120,4120,2dd58c88-142f-41ad-bc31-0a4fff074970, cedax ( ceftibuten ) is indicated for the treatment of individuals with mild to moderate infections caused by susceptible strains of the designated microorganisms in the specific conditions listed below ( see dosage and administration and clinical studies sections ),1
3329,3329,3329,3329,3329,3329,3329,4121,4121,4121,4121,4121,4121,4121,4121,4121,4121,4121,4121,4121,2dd58c88-142f-41ad-bc31-0a4fff074970,acute bacterial exacerbations of chronic bronchitis due to haemophilus influenzae ( including lactamase producing strains )  moraxella catarrhalis ( including lactamase producing strains )  or streptococcus pneumoniae ( penicillin susceptible strains only ),1
3330,3330,3330,3330,3330,3330,3330,4122,4122,4122,4122,4122,4122,4122,4122,4122,4122,4122,4122,4122,2dd58c88-142f-41ad-bc31-0a4fff074970,note in acute bacterial exacerbations of chronic bronchitis clinical trials where moraxella catarrhalis was isolated from infected sputum at baseline  ceftibuten clinical efficacy was 22 less than control,0
3331,3331,3331,3331,3331,3331,3331,4123,4123,4123,4123,4123,4123,4123,4123,4123,4123,4123,4123,4123,2dd58c88-142f-41ad-bc31-0a4fff074970,acute bacterial otitis media due to haemophilus influenzae ( including lactamase producing strains )  moraxella catarrhalis ( including lactamase producing strains )  or streptococcus pyogenes,1
3332,3332,3332,3332,3332,3332,3332,4124,4124,4124,4124,4124,4124,4124,4124,4124,4124,4124,4124,4124,2dd58c88-142f-41ad-bc31-0a4fff074970,note although ceftibuten used empirically was equivalent to comparators in the treatment of clinically and or microbiologically documented acute otitis media  the efficacy against streptococcus pneumoniae was 23 less than control,0
3333,3333,3333,3333,3333,3333,3333,4125,4125,4125,4125,4125,4125,4125,4125,4125,4125,4125,4125,4125,2dd58c88-142f-41ad-bc31-0a4fff074970,therefore  ceftibuten should be given empirically only when adequate antimicrobial coverage against streptococcus pneumoniae has been previously administered,1
3334,3334,3334,3334,3334,3334,3334,4126,4126,4126,4126,4126,4126,4126,4126,4126,4126,4126,4126,4126,2dd58c88-142f-41ad-bc31-0a4fff074970,pharyngitis and tonsillitis due to streptococcus pyogenes,1
3335,3335,3335,3335,3335,3335,3335,4128,4128,4128,4128,4128,4128,4128,4128,4128,4128,4128,4128,4128,2dd58c88-142f-41ad-bc31-0a4fff074970,ceftibuten is generally effective in the eradication of streptococcus pyogenes from the oropharynx however  data establishing the efficacy of the cedax product for the prophylaxis of subsequent rheumatic fever,u
3336,3336,3336,3336,3336,3336,3336,4129,4129,4129,4129,4129,4129,4129,4129,4129,4129,4129,4129,4129,f1756c28-dcd2-4b49-be62-07ca20682018, sotradecol ( sodium tetradecyl sulfate injection ) is indicated in the treatment of small uncomplicated varicose veins of the lower extremities that show simple dilation with competent valves,1
3337,3337,3337,3337,3337,3337,3337,4130,4130,4130,4130,4130,4130,4130,4130,4130,4130,4130,4130,4130,f1756c28-dcd2-4b49-be62-07ca20682018,the benefit to risk ratio should be considered in selected patients who are great surgical risks,0
3338,3338,3338,3338,3338,3338,3338,4131,4131,4131,4131,4131,4131,4131,4131,4131,4131,4131,4131,4131,164dc02a-9180-426a-b8b5-04ab39d2bbd4,1  zepatier is indicated for the treatment of chronic hepatitis c virus ( hcv ) genotype 1 or 4 infection in adults,1
3339,3339,3339,3339,3339,3339,3339,4132,4132,4132,4132,4132,4132,4132,4132,4132,4132,4132,4132,4132,164dc02a-9180-426a-b8b5-04ab39d2bbd4,zepatier is indicated for use with ribavirin in certain patient populations see dosage and administration ( 2 2 ),1
3340,3340,3340,3340,3340,3340,3340,4133,4133,4133,4133,4133,4133,4133,4133,4133,4133,4133,4133,4133,164dc02a-9180-426a-b8b5-04ab39d2bbd4,zepatier is a fixed dose combination product containing elbasvir  a hepatitis c virus ( hcv ) ns5a inhibitor  and grazoprevir  an hcv ns3 4a protease inhibitor  and is indicated for treatment of chronic hcv genotype 1 or 4 infection in adults,1
3341,3341,3341,3341,3341,3341,3341,4134,4134,4134,4134,4134,4134,4134,4134,4134,4134,4134,4134,4134,164dc02a-9180-426a-b8b5-04ab39d2bbd4,zepatier is indicated for use with ribavirin in certain patient populations,1
3342,3342,3342,3342,3342,3342,3342,4135,4135,4135,4135,4135,4135,4135,4135,4135,4135,4135,4135,4135,27cfe684-7d11-4f37-9c8b-b2bdd6b5348e,indications haldol ( haloperidol ) is indicated for use in the treatment of schizophrenia,1
3343,3343,3343,3343,3343,3343,3343,4136,4136,4136,4136,4136,4136,4136,4136,4136,4136,4136,4136,4136,27cfe684-7d11-4f37-9c8b-b2bdd6b5348e,haldol is indicated for the control of tics and vocal utterances of tourette 's disorder,1
3344,3344,3344,3344,3344,3344,3344,4137,4137,4137,4137,4137,4137,4137,4137,4137,4137,4137,4137,4137,216a7517-bf53-48d1-9613-78c9536c4ebf, to reduce the development of drug resistant bacteria and maintain the effectiveness of ery tab and other antibacterial drugs  ery tab should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria,4
3345,3345,3345,3345,3345,3345,3345,4140,4140,4140,4140,4140,4140,4140,4140,4140,4140,4140,4140,4140,216a7517-bf53-48d1-9613-78c9536c4ebf,ery tab tablets are indicated in the treatment of infections caused by susceptible strains of the designated microorganisms in the diseases listed below upper respiratory tract infections of mild to moderate degree caused by streptococcus pyogenes streptococcus pneumoniae haemophilus influenzae ( when used concomitantly with adequate doses of sulfonamides  since many strains of h influenzae are not susceptible to the erythromycin concentrations ordinarily achieved ),1
3346,3346,3346,3346,3346,3346,3346,4142,4142,4142,4142,4142,4142,4142,4142,4142,4142,4142,4142,4142,216a7517-bf53-48d1-9613-78c9536c4ebf,lower respiratory tract infections of mild to moderate severity caused by streptococcus pyogenes or streptococcus pneumoniae,1
3347,3347,3347,3347,3347,3347,3347,4143,4143,4143,4143,4143,4143,4143,4143,4143,4143,4143,4143,4143,216a7517-bf53-48d1-9613-78c9536c4ebf,listeriosis caused by listeria monocytogenes,1
3348,3348,3348,3348,3348,3348,3348,4145,4145,4145,4145,4145,4145,4145,4145,4145,4145,4145,4145,4145,216a7517-bf53-48d1-9613-78c9536c4ebf,skin and skin structure infections of mild to moderate severity caused by streptococcus pyogenes or staphylococcus aureus ( resistant staphylococci may emerge during treatment ),1
3349,3349,3349,3349,3349,3349,3349,4146,4146,4146,4146,4146,4146,4146,4146,4146,4146,4146,4146,4146,216a7517-bf53-48d1-9613-78c9536c4ebf,pertussis ( whooping cough ) caused by bordetella pertussis,1
3350,3350,3350,3350,3350,3350,3350,4147,4147,4147,4147,4147,4147,4147,4147,4147,4147,4147,4147,4147,216a7517-bf53-48d1-9613-78c9536c4ebf,erythromycin is effective in eliminating the organism from the nasopharynx of infected individuals  rendering them noninfectious,u
3351,3351,3351,3351,3351,3351,3351,4148,4148,4148,4148,4148,4148,4148,4148,4148,4148,4148,4148,4148,216a7517-bf53-48d1-9613-78c9536c4ebf,some clinical studies suggest that erythromycin may be helpful in the prophylaxis of pertussis in exposed susceptible individuals,u
3352,3352,3352,3352,3352,3352,3352,4149,4149,4149,4149,4149,4149,4149,4149,4149,4149,4149,4149,4149,216a7517-bf53-48d1-9613-78c9536c4ebf,diphtheria infections due to corynebacterium diphtheriae  as an adjunct to antitoxin  to prevent establishment of carriers and to eradicate the organism in carriers,1
3353,3353,3353,3353,3353,3353,3353,4151,4151,4151,4151,4151,4151,4151,4151,4151,4151,4151,4151,4151,216a7517-bf53-48d1-9613-78c9536c4ebf,intestinal amebiasis caused by entamoeba histolytica ( oral erythromycins only ),1
3354,3354,3354,3354,3354,3354,3354,4152,4152,4152,4152,4152,4152,4152,4152,4152,4152,4152,4152,4152,216a7517-bf53-48d1-9613-78c9536c4ebf,extraenteric amebiasis requires treatment with other agents,0
3355,3355,3355,3355,3355,3355,3355,4153,4153,4153,4153,4153,4153,4153,4153,4153,4153,4153,4153,4153,216a7517-bf53-48d1-9613-78c9536c4ebf,acute pelvic inflammatory disease caused by neisseria gonorrhoeae erythrocin lactobionate i v,1
3356,3356,3356,3356,3356,3356,3356,4154,4154,4154,4154,4154,4154,4154,4154,4154,4154,4154,4154,4154,216a7517-bf53-48d1-9613-78c9536c4ebf,( erythromycin lactobionate for injection  usp ) followed by erythromycin base orally  as an alternative drug in treatment,u
3357,3357,3357,3357,3357,3357,3357,4155,4155,4155,4155,4155,4155,4155,4155,4155,4155,4155,4155,4155,dc8549bd-eb87-4520-bc1f-9890055659b4, aktipak tm is indicated for the topical treatment of acne vulgaris,1
3358,3358,3358,3358,3358,3358,3358,4156,4156,4156,4156,4156,4156,4156,4156,4156,4156,4156,4156,4156,9d6654c8-3c7b-4717-af97-6bc53e6adb3d,uses temporarily relieves throbbing  tearing  stinging  or radiating pain with numbness  tingling or weakness,1
3359,3359,3359,3359,3359,3359,3359,4157,4157,4157,4157,4157,4157,4157,4157,4157,4157,4157,4157,4157,603c6f3e-5d02-0746-e053-2a91aa0a579b, childbirth support formulated for emotional and physical symptoms during final stages of pregnancy  labor and delivery,1
3360,3360,3360,3360,3360,3360,3360,4158,4158,4158,4158,4158,4158,4158,4158,4158,4158,4158,4158,4158,54722d55-d620-488f-87eb-e1e3b129c2f9, clorazepate dipotassium tablets are indicated for the management of anxiety disorders or for the short term relief of the symptoms of anxiety,1
3361,3361,3361,3361,3361,3361,3361,4160,4160,4160,4160,4160,4160,4160,4160,4160,4160,4160,4160,4160,54722d55-d620-488f-87eb-e1e3b129c2f9,clorazepate dipotassium tablets are indicated as adjunctive therapy in the management of partial seizures,1
3362,3362,3362,3362,3362,3362,3362,4161,4161,4161,4161,4161,4161,4161,4161,4161,4161,4161,4161,4161,54722d55-d620-488f-87eb-e1e3b129c2f9,the effectiveness of clorazepate dipotassium tablets in long term management of anxiety  that is  more than 4 months  has not been assessed by systematic clinical studies,0
3363,3363,3363,3363,3363,3363,3363,4162,4162,4162,4162,4162,4162,4162,4162,4162,4162,4162,4162,4162,54722d55-d620-488f-87eb-e1e3b129c2f9,long term studies in epileptic patients  however  have shown continued therapeutic activity,0
3364,3364,3364,3364,3364,3364,3364,4163,4163,4163,4163,4163,4163,4163,4163,4163,4163,4163,4163,4163,54722d55-d620-488f-87eb-e1e3b129c2f9,the physician should reassess periodically the usefulness of the drug for the individual patient,0
3365,3365,3365,3365,3365,3365,3365,4164,4164,4164,4164,4164,4164,4164,4164,4164,4164,4164,4164,4164,54722d55-d620-488f-87eb-e1e3b129c2f9,clorazepate dipotassium tablets are indicated for the symptomatic relief of acute alcohol withdrawal,1
3366,3366,3366,3366,3366,3366,3366,4167,4167,4167,4167,4167,4167,4167,4167,4167,4167,4167,4167,4167,a683e58a-63ea-44b8-a326-1a99a537bcf2, ovidrel prefilled syringe ( choriogonadotropin alfa injection ) is indicated for the induction of final follicular maturation and early luteinization in infertile women who have undergone pituitary desensitization and who have been appropriately pretreated with follicle stimulating hormones as part of an assisted reproductive technology ( art ) program such as in vitro fertilization and embryo transfer,1
3367,3367,3367,3367,3367,3367,3367,4168,4168,4168,4168,4168,4168,4168,4168,4168,4168,4168,4168,4168,a683e58a-63ea-44b8-a326-1a99a537bcf2,ovidrel prefilled syringe is also indicated for the induction of ovulation ( oi ) and pregnancy in anovulatory infertile patients in whom the cause of infertility is functional and not due to primary ovarian failure,1
3368,3368,3368,3368,3368,3368,3368,4169,4169,4169,4169,4169,4169,4169,4169,4169,4169,4169,4169,4169,a683e58a-63ea-44b8-a326-1a99a537bcf2,selection of patients before treatment with gonadotropins is instituted  a thorough gynecologic and endocrinologic evaluation must be performed,0
3369,3369,3369,3369,3369,3369,3369,4170,4170,4170,4170,4170,4170,4170,4170,4170,4170,4170,4170,4170,a683e58a-63ea-44b8-a326-1a99a537bcf2,this should include an assessment of pelvic anatomy,0
3370,3370,3370,3370,3370,3370,3370,4171,4171,4171,4171,4171,4171,4171,4171,4171,4171,4171,4171,4171,a683e58a-63ea-44b8-a326-1a99a537bcf2,patients with tubal obstruction should receive ovidrel prefilled syringe only if enrolled in an in vitro fertilization program,u
3371,3371,3371,3371,3371,3371,3371,4172,4172,4172,4172,4172,4172,4172,4172,4172,4172,4172,4172,4172,a683e58a-63ea-44b8-a326-1a99a537bcf2,primary ovarian failure should be excluded by the determination of gonadotropin levels,0
3372,3372,3372,3372,3372,3372,3372,4173,4173,4173,4173,4173,4173,4173,4173,4173,4173,4173,4173,4173,a683e58a-63ea-44b8-a326-1a99a537bcf2,appropriate evaluation should be performed to exclude pregnancy,0
3373,3373,3373,3373,3373,3373,3373,4174,4174,4174,4174,4174,4174,4174,4174,4174,4174,4174,4174,4174,a683e58a-63ea-44b8-a326-1a99a537bcf2,patients in later reproductive life have a greater predisposition to endometrial carcinoma as well as a higher incidence of anovulatory disorders,0
3374,3374,3374,3374,3374,3374,3374,4175,4175,4175,4175,4175,4175,4175,4175,4175,4175,4175,4175,4175,a683e58a-63ea-44b8-a326-1a99a537bcf2,a thorough diagnostic evaluation should always be performed in patients who demonstrate abnormal uterine bleeding or other signs of endometrial abnormalities before starting fsh and ovidrel prefilled syringe therapy,0
3375,3375,3375,3375,3375,3375,3375,4176,4176,4176,4176,4176,4176,4176,4176,4176,4176,4176,4176,4176,a683e58a-63ea-44b8-a326-1a99a537bcf2,evaluation of the partner 's fertility potential should be included in the initial evaluation,0
3376,3376,3376,3376,3376,3376,3376,4177,4177,4177,4177,4177,4177,4177,4177,4177,4177,4177,4177,4177,34ce1cdd-648e-4f1e-8512-bf3d4cc22eb9, biltricide is indicated for the treatment of infections due to all species of schistosoma ( for example  schistosoma mekongi  schistosoma japonicum  schistosoma mansoni and schistosoma hematobium )  and infections due to the liver flukes  clonorchis sinensis opisthorchis viverrini ( approval of this indication was based on studies in which the two species were not differentiated ),1
3377,3377,3377,3377,3377,3377,3377,4178,4178,4178,4178,4178,4178,4178,4178,4178,4178,4178,4178,4178,c76c3c6f-c3e0-4e35-ab01-5468585e0d9d, dipyridamole is a coronary vasodilator and is indicated as an alternative to exercise in thallium myocardial perfusion imaging for the evaluation of coronary artery disease in patients who cannot exercise adequately,1
3378,3378,3378,3378,3378,3378,3378,4179,4179,4179,4179,4179,4179,4179,4179,4179,4179,4179,4179,4179,1f2d0b28-9cc5-4523-80b8-637fdaf3f7a5,1  epogen is an erythropoiesis stimulating agent ( esa ) indicated for treatment of anemia due to chronic kidney disease ( ckd ) in patients on dialysis and not on dialysis ( 1 1 ),1
3379,3379,3379,3379,3379,3379,3379,4180,4180,4180,4180,4180,4180,4180,4180,4180,4180,4180,4180,4180,1f2d0b28-9cc5-4523-80b8-637fdaf3f7a5,zidovudine in patients with hiv infection ( 1 2 ),u
3380,3380,3380,3380,3380,3380,3380,4181,4181,4181,4181,4181,4181,4181,4181,4181,4181,4181,4181,4181,1f2d0b28-9cc5-4523-80b8-637fdaf3f7a5,the effects of concomitant myelosuppressive chemotherapy  and upon initiation  there is a minimum of two additional months of planned chemotherapy ( 1 3 ),u
3381,3381,3381,3381,3381,3381,3381,4182,4182,4182,4182,4182,4182,4182,4182,4182,4182,4182,4182,4182,1f2d0b28-9cc5-4523-80b8-637fdaf3f7a5,reduction of allogeneic rbc transfusions in patients undergoing elective  noncardiac  nonvascular surgery ( 1 4 ),1
3382,3382,3382,3382,3382,3382,3382,4183,4183,4183,4183,4183,4183,4183,4183,4183,4183,4183,4183,4183,1f2d0b28-9cc5-4523-80b8-637fdaf3f7a5,limitations of use epogen has not been shown to improve quality of life  fatigue  or patient well being ( 1 5 ),0
3383,3383,3383,3383,3383,3383,3383,4184,4184,4184,4184,4184,4184,4184,4184,4184,4184,4184,4184,4184,1f2d0b28-9cc5-4523-80b8-637fdaf3f7a5,epogen is not indicated for use in patients with cancer receiving hormonal agents  biologic products  or radiotherapy  unless also receiving concomitant myelosuppressive chemotherapy ( 1 5 ),2
3384,3384,3384,3384,3384,3384,3384,4185,4185,4185,4185,4185,4185,4185,4185,4185,4185,4185,4185,4185,1f2d0b28-9cc5-4523-80b8-637fdaf3f7a5,in patients with cancer receiving myelosuppressive chemotherapy when the anticipated outcome is cure ( 1 5 ),2
3385,3385,3385,3385,3385,3385,3385,4186,4186,4186,4186,4186,4186,4186,4186,4186,4186,4186,4186,4186,1f2d0b28-9cc5-4523-80b8-637fdaf3f7a5,in patients with cancer receiving myelosuppressive chemotherapy in whom the anemia can be managed by transfusion ( 1 5 ),2
3386,3386,3386,3386,3386,3386,3386,4187,4187,4187,4187,4187,4187,4187,4187,4187,4187,4187,4187,4187,1f2d0b28-9cc5-4523-80b8-637fdaf3f7a5,in patients scheduled for surgery who are willing to donate autologous blood ( 1 5 ),2
3387,3387,3387,3387,3387,3387,3387,4188,4188,4188,4188,4188,4188,4188,4188,4188,4188,4188,4188,4188,1f2d0b28-9cc5-4523-80b8-637fdaf3f7a5,in patients undergoing cardiac or vascular surgery ( 1 5 ),2
3388,3388,3388,3388,3388,3388,3388,4189,4189,4189,4189,4189,4189,4189,4189,4189,4189,4189,4189,4189,1f2d0b28-9cc5-4523-80b8-637fdaf3f7a5,as a substitute for rbc transfusions in patients who require immediate correction of anemia ( 1 5 ),2
3389,3389,3389,3389,3389,3389,3389,4190,4190,4190,4190,4190,4190,4190,4190,4190,4190,4190,4190,4190,1f2d0b28-9cc5-4523-80b8-637fdaf3f7a5,1 1 anemia due to chronic kidney disease epogen is indicated for the treatment of anemia due to chronic kidney disease ( ckd )  including patients on dialysis and not on dialysis to decrease the need for red blood cell ( rbc ) transfusion,1
3390,3390,3390,3390,3390,3390,3390,4191,4191,4191,4191,4191,4191,4191,4191,4191,4191,4191,4191,4191,1f2d0b28-9cc5-4523-80b8-637fdaf3f7a5,1 2 anemia due to zidovudine in patients with hiv infection epogen is indicated for the treatment of anemia due to zidovudine administered at 4200 mg week in patients with hiv infection with endogenous serum erythropoietin levels of 500 munits ml,1
3391,3391,3391,3391,3391,3391,3391,4192,4192,4192,4192,4192,4192,4192,4192,4192,4192,4192,4192,4192,365cbabe-535b-4c34-852b-6cd63782e3e5, perennial allergic rhinitis cetirizine hydrochloride is indicated for the relief of symptoms associated with perennial allergic rhinitis due to allergens such as dust mites  animal dander and molds in children 6 to 23 months of age,1
3392,3392,3392,3392,3392,3392,3392,4193,4193,4193,4193,4193,4193,4193,4193,4193,4193,4193,4193,4193,365cbabe-535b-4c34-852b-6cd63782e3e5,symptoms treated effectively include sneezing  rhinorrhea  postnasal discharge  nasal pruritus  ocular pruritus  and tearing,1
3393,3393,3393,3393,3393,3393,3393,4194,4194,4194,4194,4194,4194,4194,4194,4194,4194,4194,4194,4194,365cbabe-535b-4c34-852b-6cd63782e3e5,chronic urticaria cetirizine hydrochloride is indicated for the treatment of the uncomplicated skin manifestations of chronic idiopathic urticaria in children 6 months to 5 years of age,1
3394,3394,3394,3394,3394,3394,3394,4195,4195,4195,4195,4195,4195,4195,4195,4195,4195,4195,4195,4195,365cbabe-535b-4c34-852b-6cd63782e3e5,it significantly reduces the occurrence  severity  and duration of hives and significantly reduces pruritus,1
3395,3395,3395,3395,3395,3395,3395,4196,4196,4196,4196,4196,4196,4196,4196,4196,4196,4196,4196,4196,21fbd12e-4a12-4ad1-ad01-964cd5ec9996,1  vitrase ( hyaluronidase injection ) ovine is indicated as an adjuvant in subcutaneous fluid administration for achieving hydration,1
3396,3396,3396,3396,3396,3396,3396,4197,4197,4197,4197,4197,4197,4197,4197,4197,4197,4197,4197,4197,21fbd12e-4a12-4ad1-ad01-964cd5ec9996,( 1 1 ) to increase the dispersion and absorption of the other injected drugs,u
3397,3397,3397,3397,3397,3397,3397,4198,4198,4198,4198,4198,4198,4198,4198,4198,4198,4198,4198,4198,21fbd12e-4a12-4ad1-ad01-964cd5ec9996,( 1 2 ) in subcutaneous urography for improving resorption of radiopaque agents,1
3398,3398,3398,3398,3398,3398,3398,4199,4199,4199,4199,4199,4199,4199,4199,4199,4199,4199,4199,4199,21fbd12e-4a12-4ad1-ad01-964cd5ec9996,( 1 3 ) 1 1 subcutaneous fluid administration vitrase ( hyaluronidase injection ) ovine is indicated as an adjuvant in subcutaneous fluid administration for achieving hydration,1
3399,3399,3399,3399,3399,3399,3399,4200,4200,4200,4200,4200,4200,4200,4200,4200,4200,4200,4200,4200,21fbd12e-4a12-4ad1-ad01-964cd5ec9996,1 2 dispersion and absorption of injected drugs vitrase ( hyaluronidase injection ) ovine is indicated as an adjuvant to increase dispersion and absorption of other injected drugs,1
3400,3400,3400,3400,3400,3400,3400,4201,4201,4201,4201,4201,4201,4201,4201,4201,4201,4201,4201,4201,21fbd12e-4a12-4ad1-ad01-964cd5ec9996,1 3 subcutaneous urography vitrase ( hyaluronidase injection ) ovine is indicated as an adjuvant in subcutaneous urography for improving resorption of radiopaque agents,1
3401,3401,3401,3401,3401,3401,3401,4202,4202,4202,4202,4202,4202,4202,4202,4202,4202,4202,4202,4202,f49c6978-ca7b-4a66-919b-757f8f92ef64,1  movantik ( naloxegol ) is indicated for the treatment of opioid induced constipation ( oic ) in adult patients with chronic non cancer pain  including patients with chronic pain related to prior cancer or its treatment who do not require frequent ( e g  weekly ) opioid dosage escalation,1
3402,3402,3402,3402,3402,3402,3402,4203,4203,4203,4203,4203,4203,4203,4203,4203,4203,4203,4203,4203,f49c6978-ca7b-4a66-919b-757f8f92ef64,movantik is an opioid antagonist indicated for the treatment of opioid induced constipation ( oic ) in adult patients with chronic non cancer pain  including patients with chronic pain related to prior cancer or its treatment who do not require frequent ( e g  weekly ) opioid dosage escalation ( 1 ),1
3403,3403,3403,3403,3403,3403,3403,4204,4204,4204,4204,4204,4204,4204,4204,4204,4204,4204,4204,4204,5d9a5433-857e-44ea-b3d6-2a400ca0cef5,1  striverdi respimat inhalation spray is a long acting beta2 adrenergic agonist indicated for the long term  once daily maintenance bronchodilator treatment of airflow obstruction in patients with chronic obstructive pulmonary disease ( copd )  including chronic bronchitis and or emphysema ( 1 1 ) important limitations striverdi respimat is not indicated to treat acute deterioration of copd ( 1 2 ) striverdi respimat is not indicated to treat asthma ( 1 2 ) 1 1 maintenance treatment of copd striverdi respimat is a long acting beta2 agonist indicated for long term  once daily maintenance bronchodilator treatment of airflow obstruction in patients with chronic obstructive pulmonary disease ( copd )  including chronic bronchitis and or emphysema,1
3404,3404,3404,3404,3404,3404,3404,4205,4205,4205,4205,4205,4205,4205,4205,4205,4205,4205,4205,4205,5d9a5433-857e-44ea-b3d6-2a400ca0cef5,1 2 important limitations of use striverdi respimat is not indicated to treat acute deteriorations of copd see warnings and precautions ( 5 2 ),2
3405,3405,3405,3405,3405,3405,3405,4206,4206,4206,4206,4206,4206,4206,4206,4206,4206,4206,4206,4206,5d9a5433-857e-44ea-b3d6-2a400ca0cef5,striverdi respimat is not indicated to treat asthma,2
3406,3406,3406,3406,3406,3406,3406,4207,4207,4207,4207,4207,4207,4207,4207,4207,4207,4207,4207,4207,5d9a5433-857e-44ea-b3d6-2a400ca0cef5,the safety and effectiveness of striverdi respimat in asthma have not been established,0
3407,3407,3407,3407,3407,3407,3407,4208,4208,4208,4208,4208,4208,4208,4208,4208,4208,4208,4208,4208,01e15aee-40e0-23f3-537f-c96dd63e2cb1,1  stiolto respimat is a combination of tiotropium  an anticholinergic and olodaterol  a long acting beta2 adrenergic agonist ( laba ) indicated for the long term  once daily maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease ( copd ) ( 1 1 ) important limitations stiolto respimat is not indicated to treat acute deterioration of copd,1
3408,3408,3408,3408,3408,3408,3408,4209,4209,4209,4209,4209,4209,4209,4209,4209,4209,4209,4209,4209,01e15aee-40e0-23f3-537f-c96dd63e2cb1,( 1 2 ) stiolto respimat is not indicated to treat asthma,2
3409,3409,3409,3409,3409,3409,3409,4210,4210,4210,4210,4210,4210,4210,4210,4210,4210,4210,4210,4210,01e15aee-40e0-23f3-537f-c96dd63e2cb1,( 1 2 ) 1 1 maintenance treatment of copd stiolto respimat is a combination of tiotropium and olodaterol indicated for long term  once daily maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease ( copd )  including chronic bronchitis and or emphysema,1
3410,3410,3410,3410,3410,3410,3410,4211,4211,4211,4211,4211,4211,4211,4211,4211,4211,4211,4211,4211,01e15aee-40e0-23f3-537f-c96dd63e2cb1,important limitations of use stiolto respimat is not indicated to treat acute deteriorations of copd see warnings and precautions ( 5 2 ),2
3411,3411,3411,3411,3411,3411,3411,4212,4212,4212,4212,4212,4212,4212,4212,4212,4212,4212,4212,4212,01e15aee-40e0-23f3-537f-c96dd63e2cb1,stiolto respimat is not indicated to treat asthma,2
3412,3412,3412,3412,3412,3412,3412,4213,4213,4213,4213,4213,4213,4213,4213,4213,4213,4213,4213,4213,01e15aee-40e0-23f3-537f-c96dd63e2cb1,the safety and effectiveness of stiolto respimat in asthma have not been established,0
3413,3413,3413,3413,3413,3413,3413,4214,4214,4214,4214,4214,4214,4214,4214,4214,4214,4214,4214,4214,e4826a4c-b224-4cf9-8524-b2086c83f4d6, because of reports of intestinal and gastric ulceration and bleeding with controlledrelease potassium chloride preparations  these drugs should be reserved for those patients who cannot tolerate or refuse to take liquid or effervescent potassium preparations or for patients in whom there is a problem of compliance with these preparations,4
3414,3414,3414,3414,3414,3414,3414,4215,4215,4215,4215,4215,4215,4215,4215,4215,4215,4215,4215,4215,e4826a4c-b224-4cf9-8524-b2086c83f4d6,for the treatment of patients with hypokalemia with or without metabolic alkalosis  in digitalis intoxications  and in patients with hypokalemic familial periodic paralysis,1
3415,3415,3415,3415,3415,3415,3415,4216,4216,4216,4216,4216,4216,4216,4216,4216,4216,4216,4216,4216,e4826a4c-b224-4cf9-8524-b2086c83f4d6,if hypokalemia is the result of diuretic therapy  consideration should be given to the use of a lower dose of diuretic  which may be sufficient without leading to hypokalemia,4
3416,3416,3416,3416,3416,3416,3416,4217,4217,4217,4217,4217,4217,4217,4217,4217,4217,4217,4217,4217,e4826a4c-b224-4cf9-8524-b2086c83f4d6,for the prevention of hypokalemia in patients who would be at particular risk if hypokalemia were to develop e g  digitalized patients or patients with significant cardiac arrhythmias  hepatic cirrhosis with ascites  states of aldosterone excess with normal renal function  potassium losing nephropathy  and certain diarrheal states,1
3417,3417,3417,3417,3417,3417,3417,4218,4218,4218,4218,4218,4218,4218,4218,4218,4218,4218,4218,4218,e4826a4c-b224-4cf9-8524-b2086c83f4d6,the use of potassium salts in patients receiving diuretics for uncomplicated essential hypertension is often unnecessary when such patients have a normal dietary pattern and when low doses of the diuretic are used,0
3418,3418,3418,3418,3418,3418,3418,4219,4219,4219,4219,4219,4219,4219,4219,4219,4219,4219,4219,4219,e4826a4c-b224-4cf9-8524-b2086c83f4d6,serum potassium should be checked periodically  however  and if hypokalemia occurs  dietary supplementation with potassium containing foods may be adequate to control milder cases,4
3419,3419,3419,3419,3419,3419,3419,4220,4220,4220,4220,4220,4220,4220,4220,4220,4220,4220,4220,4220,e4826a4c-b224-4cf9-8524-b2086c83f4d6,in more severe cases  and if dose adjustment of the diuretic is ineffective or unwarranted  supplementation with potassium salts may be indicated,1
3420,3420,3420,3420,3420,3420,3420,4221,4221,4221,4221,4221,4221,4221,4221,4221,4221,4221,4221,4221,d5a02700-b888-43b0-85c5-ac8938438c9e,1,0
3421,3421,3421,3421,3421,3421,3421,4222,4222,4222,4222,4222,4222,4222,4222,4222,4222,4222,4222,4222,d5a02700-b888-43b0-85c5-ac8938438c9e,for therapeutic use in patients with hypokalemia with or without metabolic alkalosis  in digitalis intoxication and in patients with hypokalemic familial periodic paralysis,1
3422,3422,3422,3422,3422,3422,3422,4223,4223,4223,4223,4223,4223,4223,4223,4223,4223,4223,4223,4223,d5a02700-b888-43b0-85c5-ac8938438c9e,for prevention of potassium depletion when the dietary intake of potassium is inadequate in the following conditions patients receiving digitalis and diuretics for congestive heart failure hepatic cirrhosis with ascities states of aldosterone excess with normal renal function potassium losing nephropathy  and certain diarrheal states,1
3423,3423,3423,3423,3423,3423,3423,4224,4224,4224,4224,4224,4224,4224,4224,4224,4224,4224,4224,4224,d5a02700-b888-43b0-85c5-ac8938438c9e,the use of potassium salts in patients receiving diuretics for uncomplicated essential hypertension is often unnecessary when such patients have a normal dietary pattern,0
3424,3424,3424,3424,3424,3424,3424,4225,4225,4225,4225,4225,4225,4225,4225,4225,4225,4225,4225,4225,d5a02700-b888-43b0-85c5-ac8938438c9e,serum potassium should be checked periodically  however  and  if hypokalemia occurs  dietary supplementation with potassium containing foods may be adequate to control milder cases,4
3425,3425,3425,3425,3425,3425,3425,4226,4226,4226,4226,4226,4226,4226,4226,4226,4226,4226,4226,4226,d5a02700-b888-43b0-85c5-ac8938438c9e,in more severe cases supplementation with potassium salts may be indicated,u
3426,3426,3426,3426,3426,3426,3426,4227,4227,4227,4227,4227,4227,4227,4227,4227,4227,4227,4227,4227,e5bbb3e1-ab50-4ec7-a2b4-ce4091712e23, this intravenous solution is indicated for use in adults and pediatric patients as a source of electrolytes  calories  and water for hydration,1
3427,3427,3427,3427,3427,3427,3427,4228,4228,4228,4228,4228,4228,4228,4228,4228,4228,4228,4228,4228,6888a502-6fe6-4e4d-7c9f-be6d37700d8a, these solutions are indicated in patients requiring parenteral administration of potassium chloride with minimal carbohydrate calories,1
3428,3428,3428,3428,3428,3428,3428,4229,4229,4229,4229,4229,4229,4229,4229,4229,4229,4229,4229,4229,872b81a0-8c13-4848-85a8-50f12d8ffa26,1  repaglinide tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus,1
3429,3429,3429,3429,3429,3429,3429,4230,4230,4230,4230,4230,4230,4230,4230,4230,4230,4230,4230,4230,872b81a0-8c13-4848-85a8-50f12d8ffa26,limitation of use repaglinide tablets should not be used in patients with type 1 diabetes mellitus or for the treatment of diabetic ketoacidosis,2
3430,3430,3430,3430,3430,3430,3430,4231,4231,4231,4231,4231,4231,4231,4231,4231,4231,4231,4231,4231,872b81a0-8c13-4848-85a8-50f12d8ffa26,repaglinide tablets are a glinide indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus,1
3431,3431,3431,3431,3431,3431,3431,4232,4232,4232,4232,4232,4232,4232,4232,4232,4232,4232,4232,4232,872b81a0-8c13-4848-85a8-50f12d8ffa26,limitation of use not for treatment of type 1 diabetes mellitus or diabetic ketoacidosis,2
3432,3432,3432,3432,3432,3432,3432,4233,4233,4233,4233,4233,4233,4233,4233,4233,4233,4233,4233,4233,fdd3b379-f8e5-41bc-8b13-a1b810ba01c8,1  repaglinide and metformin hydrochloride tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus who are already treated with a glinide and metformin or who have inadequate glycemic control on a glinide alone or metformin alone,1
3433,3433,3433,3433,3433,3433,3433,4234,4234,4234,4234,4234,4234,4234,4234,4234,4234,4234,4234,4234,fdd3b379-f8e5-41bc-8b13-a1b810ba01c8,limitation of use repaglinide and metformin hydrochloride tablets should not be used in patients with type 1 diabetes mellitus or for the treatment of diabetic ketoacidosis,2
3434,3434,3434,3434,3434,3434,3434,4235,4235,4235,4235,4235,4235,4235,4235,4235,4235,4235,4235,4235,fdd3b379-f8e5-41bc-8b13-a1b810ba01c8,repaglinide and metformin hydrochloride tablets are a combination of repaglinide  a glinide  and metformin  a biguanide  indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus who are already treated with a glinide and metformin or who have inadequate glycemic control on a glinide alone or metformin alone,1
3435,3435,3435,3435,3435,3435,3435,4236,4236,4236,4236,4236,4236,4236,4236,4236,4236,4236,4236,4236,fdd3b379-f8e5-41bc-8b13-a1b810ba01c8,( 1 ) limitation of use not for treatment of type 1 diabetes mellitus or diabetic ketoacidosis ( 1 ),2
3436,3436,3436,3436,3436,3436,3436,4237,4237,4237,4237,4237,4237,4237,4237,4237,4237,4237,4237,4237,698aaa0a-9fd3-40c2-ec93-0dc2170a75ba, chloramphenicol should be used only in those serious infections for which less potentially dangerous drugs are ineffective or contraindicated,u
3437,3437,3437,3437,3437,3437,3437,4238,4238,4238,4238,4238,4238,4238,4238,4238,4238,4238,4238,4238,698aaa0a-9fd3-40c2-ec93-0dc2170a75ba,bacteriological studies should be performed to determine the causative organisms and their sensitivity to chloramphenicol ( see boxed warning ),4
3438,3438,3438,3438,3438,3438,3438,4239,4239,4239,4239,4239,4239,4239,4239,4239,4239,4239,4239,4239,698aaa0a-9fd3-40c2-ec93-0dc2170a75ba,chloromycetin ophthalmic ointment  1 ( chloramphenicol ophthalmic ointment  usp ) is indicated for the treatment of surface ocular infections involving the conjunctiva and or cornea caused by chloramphenicol susceptible organisms,1
3439,3439,3439,3439,3439,3439,3439,4240,4240,4240,4240,4240,4240,4240,4240,4240,4240,4240,4240,4240,698aaa0a-9fd3-40c2-ec93-0dc2170a75ba,the particular antiinfective drug in this product is active against the following common bacterial eye pathogens staphylococcus aureus streptococcus  including streptococcus pneumoniae escherichia coli haemophilus influenzae klebsiella enterobacter species moraxella lucunata ( morax axenfeld bacillus ) neisseria species this product does not provide adequate coverage against pseudomonas aeruginosa serratia marcescens,u
3440,3440,3440,3440,3440,3440,3440,4241,4241,4241,4241,4241,4241,4241,4241,4241,4241,4241,4241,4241,8e0b016c-4bda-487e-b525-63abfb772761, paricalcitol injection  usp is indicated for the prevention and treatment of secondary hyperparathyroidism associated with chronic kidney disease stage 5,1
3441,3441,3441,3441,3441,3441,3441,4242,4242,4242,4242,4242,4242,4242,4242,4242,4242,4242,4242,4242,77a67dc6-35d3-48ff-9d18-292d4d442f70,1  entereg is indicated to accelerate the time to upper and lower gastrointestinal recovery following surgeries that include partial bowel resection with primary anastomosis,1
3442,3442,3442,3442,3442,3442,3442,4243,4243,4243,4243,4243,4243,4243,4243,4243,4243,4243,4243,4243,77a67dc6-35d3-48ff-9d18-292d4d442f70,entereg is an opioid antagonist indicated to accelerate the time to upper and lower gastrointestinal recovery following surgeries that include partial bowel resection with primary anastomosis,1
3443,3443,3443,3443,3443,3443,3443,4244,4244,4244,4244,4244,4244,4244,4244,4244,4244,4244,4244,4244,af67a2f3-65b7-4a6e-9a51-315a280f976b, neutrospectm technetium ( 99m tc ) fanolesomab is indicated for scintigraphic imaging of patients with equivocal signs and symptoms of appendicitis who are five years of age or older,1
3444,3444,3444,3444,3444,3444,3444,4245,4245,4245,4245,4245,4245,4245,4245,4245,4245,4245,4245,4245,dc3a6462-0f2c-4306-b5ef-c7b47395e959, ammonium lactate lotion  12 is indicated for the treatment of dry  scaly skin ( xerosis ) and ichthyosis vulgaris  and for the temporary relief of itching associated with these conditions,1
3445,3445,3445,3445,3445,3445,3445,4246,4246,4246,4246,4246,4246,4246,4246,4246,4246,4246,4246,4246,21e4e0c0-18c7-480a-af4e-7b553fe8b68c, ultravate ointment 0 05 is a super high potency corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid responsive dermatoses,1
3446,3446,3446,3446,3446,3446,3446,4247,4247,4247,4247,4247,4247,4247,4247,4247,4247,4247,4247,4247,21e4e0c0-18c7-480a-af4e-7b553fe8b68c,treatment beyond two consecutive weeks is not recommended  and the total dosage should not exceed 50 g week because of the potential for the drug to suppress the hypothalamic pituitary adrenal ( hpa ) axis,4
3447,3447,3447,3447,3447,3447,3447,4248,4248,4248,4248,4248,4248,4248,4248,4248,4248,4248,4248,4248,21e4e0c0-18c7-480a-af4e-7b553fe8b68c,use in children under 12 years of age is not recommended,2
3448,3448,3448,3448,3448,3448,3448,4249,4249,4249,4249,4249,4249,4249,4249,4249,4249,4249,4249,4249,21e4e0c0-18c7-480a-af4e-7b553fe8b68c,as with other highly active corticosteroids  therapy should be discontinued when control has been achieved,4
3449,3449,3449,3449,3449,3449,3449,4250,4250,4250,4250,4250,4250,4250,4250,4250,4250,4250,4250,4250,21e4e0c0-18c7-480a-af4e-7b553fe8b68c,if no improvement is seen within 2 weeks  reassessment of the diagnosis may be necessary,0
3450,3450,3450,3450,3450,3450,3450,4251,4251,4251,4251,4251,4251,4251,4251,4251,4251,4251,4251,4251,a1de8bba-3b1d-4c9d-ab8a-32d2c05e67c8,1  xeloda ( capecitabine ) is a nucleoside metabolic inhibitor with antineoplastic activity indicated for adjuvant colon cancer ( 1 1 ) patients with dukes' c colon cancer metastatic colorectal cancer ( 1 1 ) first line as monotherapy when treatment with fluoropyrimidine therapy alone is preferred metastatic breast cancer ( 1 2 ) in combination with docetaxel after failure of prior anthracycline containing therapy as monotherapy in patients resistant to both paclitaxel and an anthracycline containing regimen 1 1 colorectal cancer xeloda is indicated as a single agent for adjuvant treatment in patients with dukes' c colon cancer who have undergone complete resection of the primary tumor when treatment with fluoropyrimidine therapy alone is preferred,1
3451,3451,3451,3451,3451,3451,3451,4252,4252,4252,4252,4252,4252,4252,4252,4252,4252,4252,4252,4252,a1de8bba-3b1d-4c9d-ab8a-32d2c05e67c8,xeloda was non inferior to 5 fluorouracil and leucovorin ( 5 fu lv ) for disease free survival ( dfs ),0
3452,3452,3452,3452,3452,3452,3452,4253,4253,4253,4253,4253,4253,4253,4253,4253,4253,4253,4253,4253,a1de8bba-3b1d-4c9d-ab8a-32d2c05e67c8,physicians should consider results of combination chemotherapy trials  which have shown improvement in dfs and os  when prescribing single agent xeloda in the adjuvant treatment of dukes' c colon cancer,4
3453,3453,3453,3453,3453,3453,3453,4254,4254,4254,4254,4254,4254,4254,4254,4254,4254,4254,4254,4254,a1de8bba-3b1d-4c9d-ab8a-32d2c05e67c8,xeloda is indicated as first line treatment of patients with metastatic colorectal carcinoma when treatment with fluoropyrimidine therapy alone is preferred,1
3454,3454,3454,3454,3454,3454,3454,4255,4255,4255,4255,4255,4255,4255,4255,4255,4255,4255,4255,4255,a1de8bba-3b1d-4c9d-ab8a-32d2c05e67c8,combination chemotherapy has shown a survival benefit compared to 5 fu lv alone,u
3455,3455,3455,3455,3455,3455,3455,4256,4256,4256,4256,4256,4256,4256,4256,4256,4256,4256,4256,4256,a1de8bba-3b1d-4c9d-ab8a-32d2c05e67c8,a survival benefit over 5 fu lv has not been demonstrated with xeloda monotherapy,0
3456,3456,3456,3456,3456,3456,3456,4257,4257,4257,4257,4257,4257,4257,4257,4257,4257,4257,4257,4257,a1de8bba-3b1d-4c9d-ab8a-32d2c05e67c8,use of xeloda instead of 5 fu lv in combinations has not been adequately studied to assure safety or preservation of the survival advantage,0
3457,3457,3457,3457,3457,3457,3457,4258,4258,4258,4258,4258,4258,4258,4258,4258,4258,4258,4258,4258,a1de8bba-3b1d-4c9d-ab8a-32d2c05e67c8,1 2 breast cancer xeloda in combination with docetaxel is indicated for the treatment of patients with metastatic breast cancer after failure of prior anthracycline containing chemotherapy,1
3458,3458,3458,3458,3458,3458,3458,4259,4259,4259,4259,4259,4259,4259,4259,4259,4259,4259,4259,4259,a1de8bba-3b1d-4c9d-ab8a-32d2c05e67c8,xeloda monotherapy is also indicated for the treatment of patients with metastatic breast cancer resistant to both paclitaxe,1
3459,3459,3459,3459,3459,3459,3459,4260,4260,4260,4260,4260,4260,4260,4260,4260,4260,4260,4260,4260,d132d29d-723e-4357-87f2-0d760afa50a4,1  pantoprazole sodium delayed release tablets are indicated for pantoprazole sodium delayed release tablets are a proton pump inhibitor indicated for the following short term treatment of erosive esophagitis associated with gastroesophageal reflux disease ( gerd ) ( 1 1 ) maintenance of healing of erosive esophagitis ( 1 2 ) pathological hypersecretory conditions including zollinger ellison syndrome ( 1 3 ) 1 1 short term treatment of erosive esophagitis associated with gastroesophageal reflux disease ( gerd ) pantoprazole sodium delayed release tablets are indicated in adults and pediatric patients five years of age and older for the short term treatment ( up to 8 weeks ) in the healing and symptomatic relief of erosive esophagitis,1
3460,3460,3460,3460,3460,3460,3460,4261,4261,4261,4261,4261,4261,4261,4261,4261,4261,4261,4261,4261,d132d29d-723e-4357-87f2-0d760afa50a4,for those adult patients who have not healed after 8 weeks of treatment  an additional 8 week course of pantoprazole sodium delayed release tablets may be considered,4
3461,3461,3461,3461,3461,3461,3461,4262,4262,4262,4262,4262,4262,4262,4262,4262,4262,4262,4262,4262,d132d29d-723e-4357-87f2-0d760afa50a4,safety of treatment beyond 8 weeks in pediatric patients has not been established,0
3462,3462,3462,3462,3462,3462,3462,4263,4263,4263,4263,4263,4263,4263,4263,4263,4263,4263,4263,4263,d132d29d-723e-4357-87f2-0d760afa50a4,1 2 maintenance of healing of erosive esophagitis pantoprazole sodium delayed release tablets are indicated for maintenance of healing of erosive esophagitis and reduction in relapse rates of daytime and nighttime heartburn symptoms in adult patients with gerd,1
3463,3463,3463,3463,3463,3463,3463,4264,4264,4264,4264,4264,4264,4264,4264,4264,4264,4264,4264,4264,d132d29d-723e-4357-87f2-0d760afa50a4,controlled studies did not extend beyond 12 months,0
3464,3464,3464,3464,3464,3464,3464,4265,4265,4265,4265,4265,4265,4265,4265,4265,4265,4265,4265,4265,d132d29d-723e-4357-87f2-0d760afa50a4,1 3 pathological hypersecretory conditions including zollinger ellison syndrome pantoprazole sodium delayed release tablets are indicated for the long term treatment of pathological hypersecretory conditions  including zollinger ellison syndrome,1
3465,3465,3465,3465,3465,3465,3465,4266,4266,4266,4266,4266,4266,4266,4266,4266,4266,4266,4266,4266,517b4a19-45b3-4286-9f6a-ced4e10447de,1  injectafer is indicated for the treatment of iron deficiency anemia in adult patients who have intolerance to oral iron or have had unsatisfactory response to oral iron who have non dialysis dependent chronic kidney disease,1
3466,3466,3466,3466,3466,3466,3466,4267,4267,4267,4267,4267,4267,4267,4267,4267,4267,4267,4267,4267,517b4a19-45b3-4286-9f6a-ced4e10447de,injectafer is an iron replacement product indicated for the treatment of iron deficiency anemia in adult patients who have intolerance to oral iron or have had unsatisfactory response to oral iron who have non dialysis dependent chronic kidney disease,1
3467,3467,3467,3467,3467,3467,3467,4268,4268,4268,4268,4268,4268,4268,4268,4268,4268,4268,4268,4268,e4412a6a-ed4d-410d-8abb-86e1d7b72a3c, propafenone extended release capsules are indicated to prolong the time to recurrence of symptomatic atrial fibrillation in patients without structural heart disease,1
3468,3468,3468,3468,3468,3468,3468,4269,4269,4269,4269,4269,4269,4269,4269,4269,4269,4269,4269,4269,e4412a6a-ed4d-410d-8abb-86e1d7b72a3c,the use of propafenone er capsules in patients with permanent atrial fibrillation or in patients exclusively with atrial flutter or psvt has not been evaluated,0
3469,3469,3469,3469,3469,3469,3469,4270,4270,4270,4270,4270,4270,4270,4270,4270,4270,4270,4270,4270,e4412a6a-ed4d-410d-8abb-86e1d7b72a3c,propafenone er capsules should not be used to control ventricular rate during atrial fibrillation,2
3470,3470,3470,3470,3470,3470,3470,4271,4271,4271,4271,4271,4271,4271,4271,4271,4271,4271,4271,4271,e4412a6a-ed4d-410d-8abb-86e1d7b72a3c,the effect of propafenone er capsules on mortality has not been determined ( see black box warnings ),0
3471,3471,3471,3471,3471,3471,3471,4272,4272,4272,4272,4272,4272,4272,4272,4272,4272,4272,4272,4272,63c966f5-21e5-47ae-96ba-c91b5477830f, hydrocodone bitartrate and homatropine methylbromide syrup is indicated for the symptomatic relief of cough in adults and children 6 years of age and older,1
3472,3472,3472,3472,3472,3472,3472,4273,4273,4273,4273,4273,4273,4273,4273,4273,4273,4273,4273,4273,7b6f6a5e-f456-4db9-a3da-44d870ee6547, jeanotope i 125 is indicated for use in the determination of total blood and plasma volume,1
3473,3473,3473,3473,3473,3473,3473,4274,4274,4274,4274,4274,4274,4274,4274,4274,4274,4274,4274,4274,a56d11c0-b033-4201-85ff-fc710506481a, pyridoxine hydrochloride injection is effective for the treatment of pyridoxine deficiency as seen in the following inadequate dietary intake,1
3474,3474,3474,3474,3474,3474,3474,4275,4275,4275,4275,4275,4275,4275,4275,4275,4275,4275,4275,4275,a56d11c0-b033-4201-85ff-fc710506481a,drug induced deficiency  as from isoniazid ( inh ) or oral contraceptives,1
3475,3475,3475,3475,3475,3475,3475,4276,4276,4276,4276,4276,4276,4276,4276,4276,4276,4276,4276,4276,a56d11c0-b033-4201-85ff-fc710506481a,inborn errors of metabolism  e g  vitamin b6 dependent convulsions or vitamin b6 responsive anemia,1
3476,3476,3476,3476,3476,3476,3476,4277,4277,4277,4277,4277,4277,4277,4277,4277,4277,4277,4277,4277,a56d11c0-b033-4201-85ff-fc710506481a,the parenteral route is indicated when oral administration is not feasible as in anorexia  nausea and vomiting  and preoperative and postoperative conditions,1
3477,3477,3477,3477,3477,3477,3477,4278,4278,4278,4278,4278,4278,4278,4278,4278,4278,4278,4278,4278,a56d11c0-b033-4201-85ff-fc710506481a,it is also indicated when gastrointestinal absorption is impaired,1
3478,3478,3478,3478,3478,3478,3478,4279,4279,4279,4279,4279,4279,4279,4279,4279,4279,4279,4279,4279,39082010-47e1-4bb1-a580-0f054bfaf3a0,indicat ions and usage methaver is indicated for the distinct nutritional requirements of patients in need of dietary supplementation as determined by a licensed medical practitioner,1
3479,3479,3479,3479,3479,3479,3479,4280,4280,4280,4280,4280,4280,4280,4280,4280,4280,4280,4280,4280,39082010-47e1-4bb1-a580-0f054bfaf3a0,methaver should be administered under the supervision o f a licensed medical practitioner,4
3480,3480,3480,3480,3480,3480,3480,4281,4281,4281,4281,4281,4281,4281,4281,4281,4281,4281,4281,4281,8b23f206-43eb-454b-9608-b9cb985209cd, vp ggr b6 is indicated for the distinct nutritional requirements of patients in need of prenatal dietary supplementation as determined by a licensed medical practitioner,1
3481,3481,3481,3481,3481,3481,3481,4282,4282,4282,4282,4282,4282,4282,4282,4282,4282,4282,4282,4282,8b23f206-43eb-454b-9608-b9cb985209cd,vp ggr b6 should be administered under the supervision of a licensed medical practitioner,4
3482,3482,3482,3482,3482,3482,3482,4283,4283,4283,4283,4283,4283,4283,4283,4283,4283,4283,4283,4283,a0c87255-6105-4ae6-a698-dae0115265ab, foltabs 800 is a multivitamin prescription supplement indicated for the use in improving the nutritional status of patients as prescribed by their physician,1
3483,3483,3483,3483,3483,3483,3483,4284,4284,4284,4284,4284,4284,4284,4284,4284,4284,4284,4284,4284,dba60bb4-54ff-4e06-b8d2-acbbd3717666,1  bonjesta is indicated for the treatment of nausea and vomiting of pregnancy in women who do not respond to conservative management,1
3484,3484,3484,3484,3484,3484,3484,4285,4285,4285,4285,4285,4285,4285,4285,4285,4285,4285,4285,4285,dba60bb4-54ff-4e06-b8d2-acbbd3717666,limitations of use bonjesta has not been studied in women with hyperemesis gravidarum,2
3485,3485,3485,3485,3485,3485,3485,4286,4286,4286,4286,4286,4286,4286,4286,4286,4286,4286,4286,4286,dba60bb4-54ff-4e06-b8d2-acbbd3717666,bonjesta is a fixed dose combination drug product of 20 mg doxylamine succinate  an antihistamine  and 20 mg pyridoxine hydrochloride  a vitamin b6 analog  indicated for the treatment of nausea and vomiting of pregnancy in women who do not respond to conservative management,1
3486,3486,3486,3486,3486,3486,3486,4287,4287,4287,4287,4287,4287,4287,4287,4287,4287,4287,4287,4287,735f92e3-cc92-4d9b-afe8-f935a685ee78, p32 sodium phosphate is indicated for the treatment of polycythemia vera and is effective for the treatment of chronic myelocytic leukemia and chronic lymphocytic leukemia,1
3487,3487,3487,3487,3487,3487,3487,4288,4288,4288,4288,4288,4288,4288,4288,4288,4288,4288,4288,4288,735f92e3-cc92-4d9b-afe8-f935a685ee78,it may also be used in the palliative treatment of selected patients with multiple areas of skeletal metastases mechanism of action radioactive phosphorous concentrates to a very high degree in rapidly proliferating tissues,1
3488,3488,3488,3488,3488,3488,3488,4289,4289,4289,4289,4289,4289,4289,4289,4289,4289,4289,4289,4289,d21a1fdb-7111-4038-975f-f93de44d63a7, methenamine mandelate is indicated for the suppression or elimination of bacteriuria associated with pyelonephritis  cystitis  and other chronic urinary tract infections also those neurologic diseases leading to an infected residual urine,1
3489,3489,3489,3489,3489,3489,3489,4290,4290,4290,4290,4290,4290,4290,4290,4290,4290,4290,4290,4290,d21a1fdb-7111-4038-975f-f93de44d63a7,when used as recommended  methenamine mandelate is particularly suitable for long term therapy because of its safety and because resistance to the nonspecific bactericidal action of formaldehyde does not develop,u
3490,3490,3490,3490,3490,3490,3490,4291,4291,4291,4291,4291,4291,4291,4291,4291,4291,4291,4291,4291,d21a1fdb-7111-4038-975f-f93de44d63a7,pathogens resistant to other antibacterial agents may respond to methenamine mandelate because of the nonspecific effect of formaldehyde formed in an acid urine,u
3491,3491,3491,3491,3491,3491,3491,4292,4292,4292,4292,4292,4292,4292,4292,4292,4292,4292,4292,4292,d21a1fdb-7111-4038-975f-f93de44d63a7,prophylactic use rationale urine is a good culture medium for many urinary pathogens,0
3492,3492,3492,3492,3492,3492,3492,4293,4293,4293,4293,4293,4293,4293,4293,4293,4293,4293,4293,4293,d21a1fdb-7111-4038-975f-f93de44d63a7,inoculation by a few organisms ( relapse or reinfection ) may lead to bacteriuria in susceptible individuals,0
3493,3493,3493,3493,3493,3493,3493,4294,4294,4294,4294,4294,4294,4294,4294,4294,4294,4294,4294,4294,d21a1fdb-7111-4038-975f-f93de44d63a7,thus  the rationale of management in recurring urinary tract infection ( bacteriuria ) is to change the urine from a growth supporting to a growth inhibiting medium,u
3494,3494,3494,3494,3494,3494,3494,4295,4295,4295,4295,4295,4295,4295,4295,4295,4295,4295,4295,4295,d21a1fdb-7111-4038-975f-f93de44d63a7,there is a growing body of evidence that long term administration of methenamine mandelate can prevent the recurrence of bacteriuria in patients with chronic pyelonephritis,u
3495,3495,3495,3495,3495,3495,3495,4296,4296,4296,4296,4296,4296,4296,4296,4296,4296,4296,4296,4296,d21a1fdb-7111-4038-975f-f93de44d63a7,therapeutic use rationale methenamine mandelate helps to sterilize the urine  and in some situations in which underlying pathologic conditions prevent sterilization by any means  it can help to suppress the bacteriuria,u
3496,3496,3496,3496,3496,3496,3496,4297,4297,4297,4297,4297,4297,4297,4297,4297,4297,4297,4297,4297,d21a1fdb-7111-4038-975f-f93de44d63a7,methenamine mandelate should not be used alone for acute infections with parenchymal involvement causing systemic symptoms such as chills and fever,2
3497,3497,3497,3497,3497,3497,3497,4298,4298,4298,4298,4298,4298,4298,4298,4298,4298,4298,4298,4298,d21a1fdb-7111-4038-975f-f93de44d63a7,a thorough diagnostic investigation as a part of the overall management of the urinary tract infection should accompany the use of methenamine mandelate,4
3498,3498,3498,3498,3498,3498,3498,4299,4299,4299,4299,4299,4299,4299,4299,4299,4299,4299,4299,4299,4a64fde2-1db7-5878-e054-00144ff8d46c, phendimetrazine tartrate is indicated in the management of exogenous obesity as a short term adjunct ( a few weeks ) in a regimen of weight reduction based on caloric restriction in patients with an initial body mass index ( bmi ) of 30 kg m2 or higher who have not responded to appropriate weight reducing regimen ( diet and or exercise ) alone,1
3499,3499,3499,3499,3499,3499,3499,4303,4303,4303,4303,4303,4303,4303,4303,4303,4303,4303,4303,4303,4a64fde2-1db7-5878-e054-00144ff8d46c,body mass index ( bmi )  kg m2 height ( feet  inches ) weight ( pounds ) 5 0 5 3 5 6 5 9 6 0 6 3 140 27 25 23 21 19 18 150 29 27 24 22 20 19 160 31 28 26 24 22 20 170 33 30 28 25 23 21 180 35 32 29 27 25 23 190 37 34 31 28 26 24 200 39 36 32 30 27 25 210 41 37 34 31 29 26 220 43 39 36 33 30 28 230 45 41 37 34 31 29 240 47 43 39 36 33 30 250 49 44 40 37 34 31 phendimetrazine tartrate is indicated for use as monotherapy only,0
3500,3500,3500,3500,3500,3500,3500,4304,4304,4304,4304,4304,4304,4304,4304,4304,4304,4304,4304,4304,4a64fde2-1db7-5878-e054-00144ff8d46c,please review the manufacturer 's complete drug information available from the fda at www fda gov permanent link https dailymed nlm nih gov dailymed druginfo cfm ? setid 07bf3488 09e7 436f af3f 94c35a7be025,0
3501,3501,3501,3501,3501,3501,3501,4305,4305,4305,4305,4305,4305,4305,4305,4305,4305,4305,4305,4305,67508df6-b96f-46fa-a792-0afcdfa9810e,1  docetaxel injection is a microtubule inhibitor indicated for breast cancer ( bc ) single agent for locally advanced or metastatic bc after chemotherapy failure and with doxorubicin and cyclophosphamide as adjuvant treatment of operable node positive bc ( 1 1 ) non small cell lung cancer ( nsclc ) single agent for locally advanced or metastatic nsclc after platinum therapy failure and with cisplatin for unresectable  locally advanced or metastatic untreated nsclc ( 1 2 ) hormone refractory prostate cancer ( hrpc ) with prednisone in androgen independent ( hormone refractory ) metastatic prostate cancer ( 1 3 ) gastric adenocarcinoma ( gc ) with cisplatin and fluorouracil for untreated  advanced gc  including the gastroesophageal junction ( 1 4 ) squamous cell carcinoma of the head and neck cancer ( scchn ) with cisplatin and fluorouracil for induction treatment of locally advanced scchn ( 1 5 ) 1 1 breast cancer docetaxel injection is indicated for the treatment of patients with locally advanced or metastatic breast cancer after failure of prior chemotherapy,1
3502,3502,3502,3502,3502,3502,3502,4307,4307,4307,4307,4307,4307,4307,4307,4307,4307,4307,4307,4307,67508df6-b96f-46fa-a792-0afcdfa9810e,1 2 non small cell lung cancer docetaxel injection as a single agent is indicated for the treatment of patients with locally advanced or metastatic non small cell lung cancer after failure of prior platinum based chemotherapy,1
3503,3503,3503,3503,3503,3503,3503,4309,4309,4309,4309,4309,4309,4309,4309,4309,4309,4309,4309,4309,67508df6-b96f-46fa-a792-0afcdfa9810e,code code 42229 5 codesystem 2 16 840 1 113883 6 1 displayname,0
3504,3504,3504,3504,3504,3504,3504,4310,4310,4310,4310,4310,4310,4310,4310,4310,4310,4310,4310,4310,1521d321-e724-4ffc-adad-34bf4f44fac7,1  velcade is a proteasome inhibitor indicated for treatment of patients with multiple myeloma ( 1 1 ) treatment of patients with mantle cell lymphoma ( 1 2 ) 1 1 multiple myeloma velcade ( bortezomib ) is indicated for the treatment of patients with multiple myeloma,1
3505,3505,3505,3505,3505,3505,3505,4311,4311,4311,4311,4311,4311,4311,4311,4311,4311,4311,4311,4311,1521d321-e724-4ffc-adad-34bf4f44fac7,1 2 mantle cell lymphoma velcade is indicated for the treatment of patients with mantle cell lymphoma,1
3506,3506,3506,3506,3506,3506,3506,4312,4312,4312,4312,4312,4312,4312,4312,4312,4312,4312,4312,4312,5961ae05-39c8-41af-8ae0-721c7a3c2cdf, cefaclor is indicated in the treatment of the following infections when caused by susceptible strains of the designated microorganisms otitis media caused by streptococcus pneumoniae  haemophilus influenzae  staphylococci  and streptococcus pyogenes note lactamase negative  ampicillin resistant ( blnar ) strains of haemophilus influenzae should be considered resistant to cefaclor despite apparent in vitro susceptibility of some blnar strains,1
3507,3507,3507,3507,3507,3507,3507,4313,4313,4313,4313,4313,4313,4313,4313,4313,4313,4313,4313,4313,5961ae05-39c8-41af-8ae0-721c7a3c2cdf,lower respiratory tract infections  including pneumonia  caused by streptococcus pneumoniae  haemophilus influenzae  and streptococcus pyogenes note lactamase negative  ampicillin resistant ( blnar ) strains of haemophilus influenzae should be considered resistant to cefaclor despite apparent in vitro susceptibility of some blnar strains,
3508,3508,3508,3508,3508,3508,3508,4314,4314,4314,4314,4314,4314,4314,4314,4314,4314,4314,4314,4314,5961ae05-39c8-41af-8ae0-721c7a3c2cdf,pharyngitis and tonsillitis  caused by streptococcus pyogenes note penicillin is the usual drug of choice in the treatment and prevention of streptococcal infections  including the prophylaxis of rheumatic fever,u
3509,3509,3509,3509,3509,3509,3509,4315,4315,4315,4315,4315,4315,4315,4315,4315,4315,4315,4315,4315,5961ae05-39c8-41af-8ae0-721c7a3c2cdf,cefaclor is generally effective in the eradication of streptococci from the nasopharynx however  substantial data establishing the efficacy of cefaclor in the subsequent prevention of rheumatic fever are not available at present,u
3510,3510,3510,3510,3510,3510,3510,4316,4316,4316,4316,4316,4316,4316,4316,4316,4316,4316,4316,4316,5961ae05-39c8-41af-8ae0-721c7a3c2cdf,urinary tract infections  including pyelonephritis and cystitis  caused by escherichia coli  proteus mirabilis  klebsiella spp  and coagulase negative staphylococci compon,1
3511,3511,3511,3511,3511,3511,3511,4317,4317,4317,4317,4317,4317,4317,4317,4317,4317,4317,4317,4317,e0fa4bca-f245-4d92-ae29-b0c630a315c2,1  vectibix is an epidermal growth factor receptor ( egfr ) antagonist indicated for the treatment of wild type ras ( defined as wild type in both kras and nras as determined by an fda approved test for this use ) metastatic colorectal cancer ( mcrc ) in combination with folfox for first line treatment,1
3512,3512,3512,3512,3512,3512,3512,4318,4318,4318,4318,4318,4318,4318,4318,4318,4318,4318,4318,4318,e0fa4bca-f245-4d92-ae29-b0c630a315c2,( 1 1  14 2 ) as monotherapy following disease progression after prior treatment with fluoropyrimidine  oxaliplatin  and irinotecan containing chemotherapy,1
3513,3513,3513,3513,3513,3513,3513,4319,4319,4319,4319,4319,4319,4319,4319,4319,4319,4319,4319,4319,e0fa4bca-f245-4d92-ae29-b0c630a315c2,( 1 1  14 1 ) limitation of use vectibix is not indicated for the treatment of patients with ras mutant mcrc or for whom ras mutation status is unknown,2
3514,3514,3514,3514,3514,3514,3514,4320,4320,4320,4320,4320,4320,4320,4320,4320,4320,4320,4320,4320,e0fa4bca-f245-4d92-ae29-b0c630a315c2,( 1 1  2 1  5 2  12 1 ) 1 1 metastatic colorectal cancer vectibix is indicated for the treatment of patients with wild type ras ( defined as wild type in both kras and nras as determined by an fda approved test for this use ) metastatic colorectal cancer ( mcrc ) see dos age and administration ( 2 1 ) as first line therapy in combination with folfox see clinical studies ( 14 2 ),1
3515,3515,3515,3515,3515,3515,3515,4321,4321,4321,4321,4321,4321,4321,4321,4321,4321,4321,4321,4321,e0fa4bca-f245-4d92-ae29-b0c630a315c2,as monotherapy following disease progression after prior treatment with fluoropyrimidine  oxaliplatin  and irinotecan containing chemotherapy see,1
3516,3516,3516,3516,3516,3516,3516,4322,4322,4322,4322,4322,4322,4322,4322,4322,4322,4322,4322,4322,d0182933-afae-4db4-9aa1-a869dcf39658, tizanidine tablet is a short acting drug for the management of spasticity,1
3517,3517,3517,3517,3517,3517,3517,4323,4323,4323,4323,4323,4323,4323,4323,4323,4323,4323,4323,4323,d0182933-afae-4db4-9aa1-a869dcf39658,because of the short duration of effect  treatment with tizanidine should be reserved for those daily activities and times when relief of spasticity is most important ( see dosage and administration ),4
3518,3518,3518,3518,3518,3518,3518,4324,4324,4324,4324,4324,4324,4324,4324,4324,4324,4324,4324,4324,fd5534d0-92c8-41bf-9eca-8259405fbfc2,1  kengreal is indicated as an adjunct to percutaneous coronary intervention ( pci ) to reduce the risk of periprocedural myocardial infarction ( mi )  repeat coronary revascularization  and stent thrombosis ( st ) in patients who have not been treated with a p2y12 platelet inhibitor and are not being given a glycoprotein iib iiia inhibitor see clinical studies ( 14 1 ),
3519,3519,3519,3519,3519,3519,3519,4325,4325,4325,4325,4325,4325,4325,4325,4325,4325,4325,4325,4325,fd5534d0-92c8-41bf-9eca-8259405fbfc2,kengreal is a p2y12 platelet inhibitor indicated as an adjunct to percutaneous coronary intervention ( pci ) for reducing the risk of periprocedural myocardial infarction ( mi )  repeat coronary revascularization  and stent thrombosis ( st ) in patients in who have not been treated with a p2y12 platelet inhibitor and are not being given a glycoprotein iib iiia inhibitor,1
3520,3520,3520,3520,3520,3520,3520,4326,4326,4326,4326,4326,4326,4326,4326,4326,4326,4326,4326,4326,3f027582-7e4e-4318-be75-d5db7aaa7f35,1  gabapentin is indicated for adjunctive therapy in the treatment of partial onset seizures  with and without secondary generalization  in adults and pediatric patients 3 years and older with epilepsy gabapentin is indicated for adjunctive therapy in the treatment of partial onset seizures  with and without secondary generalization  in adults and pediatric patients 3 years and older with epilepsy ( 1 ),1
3521,3521,3521,3521,3521,3521,3521,4327,4327,4327,4327,4327,4327,4327,4327,4327,4327,4327,4327,4327,d63a086a-32e2-49e2-949e-64e4c922775a, tablets of mixed salts of a single entity amphetamine product are indicated for the treatment of attention deficit hyperactivity disorder ( adhd ) and narcolepsy,1
3522,3522,3522,3522,3522,3522,3522,4328,4328,4328,4328,4328,4328,4328,4328,4328,4328,4328,4328,4328,d63a086a-32e2-49e2-949e-64e4c922775a,attention deficit hyperactivity disorder ( adhd ) a diagnosis of attention deficit hyperactivity disorder ( adhd dsm iv ) implies the presence of hyperactive impulsive or inattentive symptoms that caused impairment and were present before age 7 years,0
3523,3523,3523,3523,3523,3523,3523,4334,4334,4334,4334,4334,4334,4334,4334,4334,4334,4334,4334,4334,d63a086a-32e2-49e2-949e-64e4c922775a,special diagnostic considerations specific etiology of this syndrome is unknown  and there is no single diagnostic test,0
3524,3524,3524,3524,3524,3524,3524,4337,4337,4337,4337,4337,4337,4337,4337,4337,4337,4337,4337,4337,d63a086a-32e2-49e2-949e-64e4c922775a,the diagnosis must be based upon a complete history and evaluation of the child and not solely on the presence of the required number of dsm iv characterostocs need for comprehensive treatment program tablets of mixed salts of a single entity amphetamine product are indicated as an integral part of a total treatment program for adhd that may include other measures ( psychological  educational  social ) for patients with this syndrome,0
3525,3525,3525,3525,3525,3525,3525,4338,4338,4338,4338,4338,4338,4338,4338,4338,4338,4338,4338,4338,d63a086a-32e2-49e2-949e-64e4c922775a,drug treatment may not be indicated for all children with this syndrome,0
3526,3526,3526,3526,3526,3526,3526,4339,4339,4339,4339,4339,4339,4339,4339,4339,4339,4339,4339,4339,d63a086a-32e2-49e2-949e-64e4c922775a,stimulants are not intended for use in the child who exhibits symptoms secondary to environmental factors and or other primary psychiatric disorders  including psychosis,2
3527,3527,3527,3527,3527,3527,3527,4340,4340,4340,4340,4340,4340,4340,4340,4340,4340,4340,4340,4340,d63a086a-32e2-49e2-949e-64e4c922775a,appropriate educational placement is essential and psychosocial intervention is often helpful,0
3528,3528,3528,3528,3528,3528,3528,4341,4341,4341,4341,4341,4341,4341,4341,4341,4341,4341,4341,4341,d63a086a-32e2-49e2-949e-64e4c922775a,when remedial measures alone are insufficient  the decision to prescribe stimulant medication will depend upon the physician 's assessment of the chronicity and severity of the child 's symptoms,0
3529,3529,3529,3529,3529,3529,3529,4342,4342,4342,4342,4342,4342,4342,4342,4342,4342,4342,4342,4342,d63a086a-32e2-49e2-949e-64e4c922775a,long term use the effectiveness of tablets of mixed salts of a single entity amphetamine product for long term use has not been systematically evaluated in controlled trials,0
3530,3530,3530,3530,3530,3530,3530,4343,4343,4343,4343,4343,4343,4343,4343,4343,4343,4343,4343,4343,d63a086a-32e2-49e2-949e-64e4c922775a,therefore  the physician who elects to use tablets of mixed salts of a single entity amphetamine product for extended periods should periodically re evaluate the long term usefulness of the drug for the individual patient,4
3531,3531,3531,3531,3531,3531,3531,4344,4344,4344,4344,4344,4344,4344,4344,4344,4344,4344,4344,4344,72ddd1c9-ddbd-4c95-acd9-003189a353a3, mixed salts of a single entity amphetamine product are indicated for the treatment of attention deficit hyperactivity disorder ( adhd ) and narcolepsy,1
3532,3532,3532,3532,3532,3532,3532,4354,4354,4354,4354,4354,4354,4354,4354,4354,4354,4354,4354,4354,72ddd1c9-ddbd-4c95-acd9-003189a353a3,the diagnosis must be based upon a complete history and evaluation of the child and not solely on the presence of the required number of dsm iv characteristics,0
3533,3533,3533,3533,3533,3533,3533,4355,4355,4355,4355,4355,4355,4355,4355,4355,4355,4355,4355,4355,72ddd1c9-ddbd-4c95-acd9-003189a353a3,need for comprehensive treatment program mixed salts of a single entity amphetamine product are indicated as an integral part of a total treatment program for adhd that may include other measures ( psychological  educational  social ) for patients with this syndrome,1
3534,3534,3534,3534,3534,3534,3534,4357,4357,4357,4357,4357,4357,4357,4357,4357,4357,4357,4357,4357,72ddd1c9-ddbd-4c95-acd9-003189a353a3,stimulants are not intended for use in the child who exhibits symptoms secondary to env,2
3535,3535,3535,3535,3535,3535,3535,4358,4358,4358,4358,4358,4358,4358,4358,4358,4358,4358,4358,4358,04e873d3-bc40-4f6c-bc7e-7658a23cdba1, chloroquine phosphate tablets are indicated for the suppressive treatment and for acute attacks of malaria due to p vivax  p malariae  p ovale  and susceptible strains of p falciparum,1
3536,3536,3536,3536,3536,3536,3536,4359,4359,4359,4359,4359,4359,4359,4359,4359,4359,4359,4359,4359,04e873d3-bc40-4f6c-bc7e-7658a23cdba1,the drug is also indicated for the treatment of extraintestinal amebiasis,1
3537,3537,3537,3537,3537,3537,3537,4360,4360,4360,4360,4360,4360,4360,4360,4360,4360,4360,4360,4360,04e873d3-bc40-4f6c-bc7e-7658a23cdba1,chloroquine phosphate tablets does not prevent relapses in patients with vivax or malariae malaria because it is not effective against exoerythrocytic forms of the parasite  nor will it prevent vivax or malariae infection when administered as a prophylactic,2
3538,3538,3538,3538,3538,3538,3538,4361,4361,4361,4361,4361,4361,4361,4361,4361,4361,4361,4361,4361,04e873d3-bc40-4f6c-bc7e-7658a23cdba1,it is highly effective as a suppressive agent in patients with vivax or malariae malaria  in terminating acute attacks  and significantly lengthening the interval between treatment and relapse,1
3539,3539,3539,3539,3539,3539,3539,4362,4362,4362,4362,4362,4362,4362,4362,4362,4362,4362,4362,4362,04e873d3-bc40-4f6c-bc7e-7658a23cdba1,in patients with falciparum malaria it abolishes the acute attack and effects complete cure of the infection  unless due to a resistant strain of p falciparum,1
3540,3540,3540,3540,3540,3540,3540,4363,4363,4363,4363,4363,4363,4363,4363,4363,4363,4363,4363,4363,4ade94bb-6c39-13cd-e054-00144ff8d46c, to reduce the development of drug resistant bacteria and maintain the effectiveness of cefdinir for oral suspension usp and other antibacterial drugs  cefdinir for oral suspension usp should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria,1
3541,3541,3541,3541,3541,3541,3541,4366,4366,4366,4366,4366,4366,4366,4366,4366,4366,4366,4366,4366,4ade94bb-6c39-13cd-e054-00144ff8d46c,cefdinir for oral suspension usp is indicated for the treatment of patients with mild to moderate infections caused by susceptible strains of the designated microorganisms in the conditions listed below,1
3542,3542,3542,3542,3542,3542,3542,4367,4367,4367,4367,4367,4367,4367,4367,4367,4367,4367,4367,4367,4ade94bb-6c39-13cd-e054-00144ff8d46c,adults and adolescents community acquired pneumonia caused by haemophilus influenzae ( including lactamase producing strains )  haemophilus parainfluenzae ( including lactamase producing strains )  streptococcus pneumoniae ( penicillin susceptible strains only )  and moraxella catarrhalis ( including lactamase producing strains ) ( see clinical studies ),1
3543,3543,3543,3543,3543,3543,3543,4368,4368,4368,4368,4368,4368,4368,4368,4368,4368,4368,4368,4368,4ade94bb-6c39-13cd-e054-00144ff8d46c,acute exacerbations of chronic bronchitis caused by haemophilus influenzae ( including lactamase producing strains )  haemophilus parainfluenzae ( including lactamase producing strains )  streptococcus pneumoniae ( penicillin susceptible strains only )  and moraxella catarrhalis ( including lactamase producing strains ),1
3544,3544,3544,3544,3544,3544,3544,4369,4369,4369,4369,4369,4369,4369,4369,4369,4369,4369,4369,4369,4ade94bb-6c39-13cd-e054-00144ff8d46c,acute maxillary sinusitis caused by,u
3545,3545,3545,3545,3545,3545,3545,4370,4370,4370,4370,4370,4370,4370,4370,4370,4370,4370,4370,4370,17b3356e-458d-47f6-89a5-80828ab48d4c,indications usage trazodone hydrochloride tablets usp are indicated for the treatment of major depressive disorder ( mdd ) in adults,1
3546,3546,3546,3546,3546,3546,3546,4371,4371,4371,4371,4371,4371,4371,4371,4371,4371,4371,4371,4371,17b3356e-458d-47f6-89a5-80828ab48d4c,the efficacy of trazodone hydrochloride tablets usp has been established in trials with the immediate release formulation of trazodone see clinical studies ( 14 ),0
3547,3547,3547,3547,3547,3547,3547,4372,4372,4372,4372,4372,4372,4372,4372,4372,4372,4372,4372,4372,"Active Ingredient UNII(s)
6E8ZO8LRNM; N91BDP6H0X    d5f0457f-b722-48b7-8901-61da7fbb4090
6E8ZO8LRNM; N91BDP6H0X    d5f0457f-b722-48b7-8901-61da7fbb4090
Name: SET ID dtype: object",active ingredient unii ( s ) 6e8zo8lrnm n91bdp6h0x active ingredient unii ( s ) 6e8zo8lrnm n91bdp6h 6e8zo8lrnm n91bdp6h0x active ingredient unii ( s ) 6e8zo8lrnm n91bdp6h name content xml  dtype object,0
3548,3548,3548,3548,3548,3548,3548,4374,4374,4374,4374,4374,4374,4374,4374,4374,4374,4374,4374,4374,b9c93f78-eac8-46e9-9505-35a2346e04df, for temporary relief of pellagra and vasoconstriction,1
3549,3549,3549,3549,3549,3549,3549,4375,4375,4375,4375,4375,4375,4375,4375,4375,4375,4375,4375,4375,12d9728e-6b5c-4aee-bfb0-745e542ed2e4,1  serevent diskus is a laba indicated for treatment of asthma in patients aged 4 years and older,1
3550,3550,3550,3550,3550,3550,3550,4376,4376,4376,4376,4376,4376,4376,4376,4376,4376,4376,4376,4376,12d9728e-6b5c-4aee-bfb0-745e542ed2e4,( 1 1 ) prevention of exercise induced bronchospasm ( eib ) in patients aged 4 years and older,1
3551,3551,3551,3551,3551,3551,3551,4377,4377,4377,4377,4377,4377,4377,4377,4377,4377,4377,4377,4377,12d9728e-6b5c-4aee-bfb0-745e542ed2e4,( 1 2 ) maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease ( copd ),1
3552,3552,3552,3552,3552,3552,3552,4378,4378,4378,4378,4378,4378,4378,4378,4378,4378,4378,4378,4378,12d9728e-6b5c-4aee-bfb0-745e542ed2e4,( 1 3 ) important limitation not indicated for relief of acute bronchospasm,2
3553,3553,3553,3553,3553,3553,3553,4379,4379,4379,4379,4379,4379,4379,4379,4379,4379,4379,4379,4379,12d9728e-6b5c-4aee-bfb0-745e542ed2e4,( 1 1  1 3 ) 1 1 treatment of asthma serevent diskus is indicated for the treatment of asthma and in the prevention of bronchospasm only as concomitant therapy with a long term asthma control medication  such as an inhaled corticosteroid  in patients aged 4 years and older with reversible obstructive airway disease  including patients with symptoms of nocturnal asthma,1
3554,3554,3554,3554,3554,3554,3554,4380,4380,4380,4380,4380,4380,4380,4380,4380,4380,4380,4380,4380,12d9728e-6b5c-4aee-bfb0-745e542ed2e4,laba  such as salmeterol  the active ingredient in serevent diskus  increase the risk of asthma related death see warnings and precautions ( 5 1 ),0
3555,3555,3555,3555,3555,3555,3555,4381,4381,4381,4381,4381,4381,4381,4381,4381,4381,4381,4381,4381,12d9728e-6b5c-4aee-bfb0-745e542ed2e4,use of serevent diskus for the treatment of asthma without concomitant use of a long term asthma control medication  such as an inhaled corticosteroid  is contraindicated see contraindications ( 4 ),2
3556,3556,3556,3556,3556,3556,3556,4382,4382,4382,4382,4382,4382,4382,4382,4382,4382,4382,4382,4382,12d9728e-6b5c-4aee-bfb0-745e542ed2e4,use serevent diskus only as additional therapy for patients with asthma who are currently taking but are inadequately controlled on a long term asthma control medication  such as an inhaled corticosteroid,1
3557,3557,3557,3557,3557,3557,3557,4383,4383,4383,4383,4383,4383,4383,4383,4383,4383,4383,4383,4383,12d9728e-6b5c-4aee-bfb0-745e542ed2e4,once asthma control is achieved and maintained  assess the patient at regular intervals and step down therapy ( e g  discontinue serevent diskus ) if possible without loss of asthma control and maintain the patient on a long term asthma control medication  such as an inhaled corticosteroid,4
3558,3558,3558,3558,3558,3558,3558,4384,4384,4384,4384,4384,4384,4384,4384,4384,4384,4384,4384,4384,12d9728e-6b5c-4aee-bfb0-745e542ed2e4,do not use serevent diskus for patients whose asthma is adequately controlled on low or medium dose inhaled corticosteroids,2
3559,3559,3559,3559,3559,3559,3559,4385,4385,4385,4385,4385,4385,4385,4385,4385,4385,4385,4385,4385,12d9728e-6b5c-4aee-bfb0-745e542ed2e4,pediatric and adolescent patients available data from controlled clinical trials suggest that laba increase the risk of asthma related hospitalization in pediatric and adolescent patients,0
3560,3560,3560,3560,3560,3560,3560,4386,4386,4386,4386,4386,4386,4386,4386,4386,4386,4386,4386,4386,12d9728e-6b5c-4aee-bfb0-745e542ed2e4,for pediatric and adolescent patients with asthma who require addition of a laba to an inhaled corticosteroid  a fixed dose combination product containing both an inhaled corticosteroid and a laba should ordinarily be used to ensure adherence with both drugs,0
3561,3561,3561,3561,3561,3561,3561,4387,4387,4387,4387,4387,4387,4387,4387,4387,4387,4387,4387,4387,12d9728e-6b5c-4aee-bfb0-745e542ed2e4,in cases where use of a separate long term as,0
3562,3562,3562,3562,3562,3562,3562,4388,4388,4388,4388,4388,4388,4388,4388,4388,4388,4388,4388,4388,c387579e-cee0-4334-bd1e-73f93ac1bde6,1  cotellic is indicated for the treatment of patients with unresectable or metastatic melanoma with a braf v600e or v600k mutation  in combination with vemurafenib,1
3563,3563,3563,3563,3563,3563,3563,4389,4389,4389,4389,4389,4389,4389,4389,4389,4389,4389,4389,4389,c387579e-cee0-4334-bd1e-73f93ac1bde6,cotellic is a kinase inhibitor indicated for the treatment of patients with unresectable or metastatic melanoma with a braf v600e or v600k mutation  in combination with vemurafenib,1
3564,3564,3564,3564,3564,3564,3564,4390,4390,4390,4390,4390,4390,4390,4390,4390,4390,4390,4390,4390,83a504ef-cf92-467d-9ecf-d251194a3484,1  synribo is indicated for the treatment of adult patients with chronic or accelerated phase chronic myeloid leukemia ( cml ) with resistance and or intolerance to two or more tyrosine kinase inhibitors ( tki ),1
3565,3565,3565,3565,3565,3565,3565,4391,4391,4391,4391,4391,4391,4391,4391,4391,4391,4391,4391,4391,83a504ef-cf92-467d-9ecf-d251194a3484,synribo for injection is indicated for the treatment of adult patients with chronic or accelerated phase chronic myeloid leukemia ( cml ) with resistance and or intolerance to two or more tyrosine kinase inhibitors ( tki ) ( 1 ),1
3566,3566,3566,3566,3566,3566,3566,4392,4392,4392,4392,4392,4392,4392,4392,4392,4392,4392,4392,4392,9c1a2828-1583-4414-ab22-a60480e8e508,1  vascepa ( icosapent ethyl ) is indicated as an adjunct to diet to reduce triglyceride ( tg ) levels in adult patients with severe ( 500 mg dl ) hypertriglyceridemia,1
3567,3567,3567,3567,3567,3567,3567,4393,4393,4393,4393,4393,4393,4393,4393,4393,4393,4393,4393,4393,9c1a2828-1583-4414-ab22-a60480e8e508,vascepa is an ethyl ester of eicosapentaenoic acid ( epa ) indicated as an adjunct to diet to reduce triglyceride ( tg ) levels in adult patients with severe ( 500 mg dl ) hypertriglyceridemia,1
3568,3568,3568,3568,3568,3568,3568,4394,4394,4394,4394,4394,4394,4394,4394,4394,4394,4394,4394,4394,9c1a2828-1583-4414-ab22-a60480e8e508,( 1 ) limitations of use the effect of vascepa on the risk for pancreatitis in patients with severe hypertriglyceridemia has not been determined,2
3569,3569,3569,3569,3569,3569,3569,4395,4395,4395,4395,4395,4395,4395,4395,4395,4395,4395,4395,4395,9c1a2828-1583-4414-ab22-a60480e8e508,( 1 ) the effect of vascepa on cardiovascular mortality and morbidity in patients with severe hypertriglyceridemia has not been determined,2
3570,3570,3570,3570,3570,3570,3570,4396,4396,4396,4396,4396,4396,4396,4396,4396,4396,4396,4396,4396,9c1a2828-1583-4414-ab22-a60480e8e508,( 1 ) usage considerations patients should be placed on an appropriate lipid lowering diet and exercise regimen before receiving vascepa and should continue this diet and exercise regimen with vascepa,4
3571,3571,3571,3571,3571,3571,3571,4397,4397,4397,4397,4397,4397,4397,4397,4397,4397,4397,4397,4397,9c1a2828-1583-4414-ab22-a60480e8e508,attempts should be made to control any medical problems such as diabetes mellitus  hypothyroidism  and alcohol intake that may contribute to lipid abnormalities,0
3572,3572,3572,3572,3572,3572,3572,4398,4398,4398,4398,4398,4398,4398,4398,4398,4398,4398,4398,4398,9c1a2828-1583-4414-ab22-a60480e8e508,medications known to exacerbate hypertriglyceridemia ( such as beta blockers  thiazides  estrogens ) should be discontinued or changed  if possible  prior to consideration of tg lowering drug therapy,4
3573,3573,3573,3573,3573,3573,3573,4399,4399,4399,4399,4399,4399,4399,4399,4399,4399,4399,4399,4399,9c1a2828-1583-4414-ab22-a60480e8e508,limitations of use the effect of vascepa on the risk for pancreatitis in patients with severe hypertriglyceridemia has not been determined,2
3574,3574,3574,3574,3574,3574,3574,4400,4400,4400,4400,4400,4400,4400,4400,4400,4400,4400,4400,4400,9c1a2828-1583-4414-ab22-a60480e8e508,the effect of vascepa on cardiovascular mortality and morbidity in patients with severe hypertriglyceridemia has not been determined,0
3575,3575,3575,3575,3575,3575,3575,4401,4401,4401,4401,4401,4401,4401,4401,4401,4401,4401,4401,4401,4be13bd5-0c39-43c3-9232-b1226ccd4dbc,1  levofloxacin is a fluoroquinolone antibacterial indicated in adults ( 18 years of age ) with infections caused by designated  susceptible bacteria ( 1  12 4 ),1
3576,3576,3576,3576,3576,3576,3576,4402,4402,4402,4402,4402,4402,4402,4402,4402,4402,4402,4402,4402,4be13bd5-0c39-43c3-9232-b1226ccd4dbc,pneumonia nosocomial ( 1 1 ) and community acquired ( 1 2  1 3 ) skin and skin structure infections complicated ( 1 4 ) and uncomplicated ( 1 5 ) chronic bacterial prostatitis ( 1 6 ) inhalational anthrax  post exposure ( 1 7 ) plague ( 1 8 ) urinary tract infections complicated ( 1 9  1 10 ) and uncomplicated ( 1 12 ) acute pyelonephritis ( 1 11 ) acute bacterial exacerbation of chronic bronchitis ( 1 13 ) acute bacterial sinusitis ( 1 14 ) usage to reduce the development of drug resistant bacteria and maintain the effectiveness of levofloxacin and other antibacterial drugs  levofloxacin tablets should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria ( 1 15 ),1
3577,3577,3577,3577,3577,3577,3577,4403,4403,4403,4403,4403,4403,4403,4403,4403,4403,4403,4403,4403,4be13bd5-0c39-43c3-9232-b1226ccd4dbc,levofloxacin tablets are indicated for the treatment of adults ( 18 years of age ) with mild  moderate  and severe infections caused by susceptible isolates of the designated microorganisms in the conditions listed in this section,1
3578,3578,3578,3578,3578,3578,3578,4404,4404,4404,4404,4404,4404,4404,4404,4404,4404,4404,4404,4404,4be13bd5-0c39-43c3-9232-b1226ccd4dbc,1 1 nosocomial pneumonia levofloxacin tablets are indicated for the treatment of nosocomial pneumonia due to methicillin susceptible staphylococcus aureus  pseudomonas aeruginosa  serratia marcescens  escherichia coli  klebsiella pneumoniae  haemophilus influenzae  or streptococcus pneumoniae,1
3579,3579,3579,3579,3579,3579,3579,4405,4405,4405,4405,4405,4405,4405,4405,4405,4405,4405,4405,4405,4be13bd5-0c39-43c3-9232-b1226ccd4dbc,adjunctive therapy should be used as clinically indicated,0
3580,3580,3580,3580,3580,3580,3580,4406,4406,4406,4406,4406,4406,4406,4406,4406,4406,4406,4406,4406,4be13bd5-0c39-43c3-9232-b1226ccd4dbc,where pseudomonas aeruginosa is a documented or presumptive pathogen  combination therapy with an anti pseudomonal lactam is recommended see clinical studies ( 14 1 ),1
3581,3581,3581,3581,3581,3581,3581,4407,4407,4407,4407,4407,4407,4407,4407,4407,4407,4407,4407,4407,4be13bd5-0c39-43c3-9232-b1226ccd4dbc,1 2 community acquired pneumonia 7 to 14 day treatment regimen levofloxacin tablets are indicated for the treatment of community acqu,1
3582,3582,3582,3582,3582,3582,3582,4408,4408,4408,4408,4408,4408,4408,4408,4408,4408,4408,4408,4408,03440821-831c-4085-98f9-faa88e98c503, oxazepam capsules  usp are indicated for the management of anxiety disorders or for the short term relief of the symptoms of anxiety,1
3583,3583,3583,3583,3583,3583,3583,4410,4410,4410,4410,4410,4410,4410,4410,4410,4410,4410,4410,4410,03440821-831c-4085-98f9-faa88e98c503,anxiety associated with depression is also responsive to oxazepam therapy,1
3584,3584,3584,3584,3584,3584,3584,4411,4411,4411,4411,4411,4411,4411,4411,4411,4411,4411,4411,4411,03440821-831c-4085-98f9-faa88e98c503,this product has been found particularly useful in the management of anxiety  tension  agitation  and irritability in older patients,u
3585,3585,3585,3585,3585,3585,3585,4412,4412,4412,4412,4412,4412,4412,4412,4412,4412,4412,4412,4412,03440821-831c-4085-98f9-faa88e98c503,alcoholics with acute tremulousness  inebriation  or with anxiety  associated with alcohol withdrawal are responsive to therapy,u
3586,3586,3586,3586,3586,3586,3586,4413,4413,4413,4413,4413,4413,4413,4413,4413,4413,4413,4413,4413,03440821-831c-4085-98f9-faa88e98c503,the effectiveness of oxazepam in long term use  that is  more than 4 months  has not been assessed by systematic clinical studies,0
3587,3587,3587,3587,3587,3587,3587,4414,4414,4414,4414,4414,4414,4414,4414,4414,4414,4414,4414,4414,03440821-831c-4085-98f9-faa88e98c503,the physician should periodically reassess the usefulness of the drug for the individual patient,0
3588,3588,3588,3588,3588,3588,3588,4415,4415,4415,4415,4415,4415,4415,4415,4415,4415,4415,4415,4415,fe0ced75-ccbf-4d2e-bd0d-b57e60ab913f,1  aggrastat is indicated to reduce the rate of thrombotic cardiovascular events ( combined endpoint of death  myocardial infarction  or refractory ischemia repeat cardiac procedure ) in patients with non st elevation acute coronary syndrome ( nste acs ),1
3589,3589,3589,3589,3589,3589,3589,4416,4416,4416,4416,4416,4416,4416,4416,4416,4416,4416,4416,4416,fe0ced75-ccbf-4d2e-bd0d-b57e60ab913f,aggrastat is a platelet aggregation inhibitor indicated to reduce the rate of thrombotic cardiovascular events ( combined endpoint of death  myocardial infarction  or refractory ischemia repeat cardiac procedure ) in patients with non st elevation acute coronary syndrome ( nste acs ),1
3590,3590,3590,3590,3590,3590,3590,4417,4417,4417,4417,4417,4417,4417,4417,4417,4417,4417,4417,4417,5159b279-8f5a-4f8a-bf12-d7aac89b5d1d,uses temporarily relieves red  hot  swollen joints  stiff joints  cracking in joints  or stitching pain,1
3591,3591,3591,3591,3591,3591,3591,4418,4418,4418,4418,4418,4418,4418,4418,4418,4418,4418,4418,4418,13f76667-ec2f-4fa7-a9e8-12502d8224db,1  artiss is indicated to adhere autologous skin grafts to surgically prepared wound beds resulting from burns in adult and pediatric populations greater than or equal to 1 year of age,1
3592,3592,3592,3592,3592,3592,3592,4419,4419,4419,4419,4419,4419,4419,4419,4419,4419,4419,4419,4419,13f76667-ec2f-4fa7-a9e8-12502d8224db,artiss is not indicated for hemostasis,0
3593,3593,3593,3593,3593,3593,3593,4420,4420,4420,4420,4420,4420,4420,4420,4420,4420,4420,4420,4420,13f76667-ec2f-4fa7-a9e8-12502d8224db,artiss is indicated to adhere autologous skin grafts to surgically prepared wound beds resulting from burns in adult and pediatric populations greater than or equal to 1 year of age ( 1 ) artiss is not indicated for hemostasis ( 1 ),1
3594,3594,3594,3594,3594,3594,3594,4421,4421,4421,4421,4421,4421,4421,4421,4421,4421,4421,4421,4421,5845e789-8191-46f9-bbd0-79fb0c716601, esterified estrogens and methyltestosterone tablets full strength and half strength are indicated in the treatment of moderate to severe vasomotor symptoms associated with the menopause in those patients not improved by estrogens alone,1
3595,3595,3595,3595,3595,3595,3595,4423,4423,4423,4423,4423,4423,4423,4423,4423,4423,4423,4423,4423,5845e789-8191-46f9-bbd0-79fb0c716601,esterified estrogens and methyltestosterone tablets full strength and half strength have not been shown to be effective for any purpose during pregnancy and its use may cause severe harm to the fetus ( see boxed warning ),2
3596,3596,3596,3596,3596,3596,3596,4424,4424,4424,4424,4424,4424,4424,4424,4424,4424,4424,4424,4424,d162c78f-d176-4150-8dda-2c4a5d215014,1  glimepiride tablets  usp are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus see clinical studies ( 14 1 ),1
3597,3597,3597,3597,3597,3597,3597,4425,4425,4425,4425,4425,4425,4425,4425,4425,4425,4425,4425,4425,d162c78f-d176-4150-8dda-2c4a5d215014,glimepiride is a sulfonylurea indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus ( 1 1 ),1
3598,3598,3598,3598,3598,3598,3598,4426,4426,4426,4426,4426,4426,4426,4426,4426,4426,4426,4426,4426,d162c78f-d176-4150-8dda-2c4a5d215014,important limitations of use not for treating type 1 diabetes mellitus or diabetic ketoacidosis ( 1 1 ),2
3599,3599,3599,3599,3599,3599,3599,4427,4427,4427,4427,4427,4427,4427,4427,4427,4427,4427,4427,4427,d162c78f-d176-4150-8dda-2c4a5d215014,1 1 important limitations of use glimepiride tablets  usp should not be used for the treatment of type 1 diabetes mellitus or diabetic ketoacidosis  as it would not be effective in these settings,2
3600,3600,3600,3600,3600,3600,3600,4428,4428,4428,4428,4428,4428,4428,4428,4428,4428,4428,4428,4428,ea385b3d-cb4c-4550-97b0-93a86533f6dc,1  pioglitazone and glimepiride tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus who are already treated with a thiazolidinedione and sulfonylurea or who have inadequate glycemic control on a thiazolidinedione alone or a sulfonylurea alone see clinical studies ( 14 ),1
3601,3601,3601,3601,3601,3601,3601,4429,4429,4429,4429,4429,4429,4429,4429,4429,4429,4429,4429,4429,ea385b3d-cb4c-4550-97b0-93a86533f6dc,pioglitazone and glimepiride tablets are a thiazolidinedione and a sulfonylurea combination product indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both pioglitazone and glimepiride is appropriate,1
3602,3602,3602,3602,3602,3602,3602,4430,4430,4430,4430,4430,4430,4430,4430,4430,4430,4430,4430,4430,ea385b3d-cb4c-4550-97b0-93a86533f6dc,( 1 ) important limitations of use not for treatment of type 1 diabetes or diabetic ketoacidosis,2
3603,3603,3603,3603,3603,3603,3603,4431,4431,4431,4431,4431,4431,4431,4431,4431,4431,4431,4431,4431,ea385b3d-cb4c-4550-97b0-93a86533f6dc,( 1 ) important limitations of use pioglitazone exerts its antihyperglycemic effect only in the presence of endogenous insulin,2
3604,3604,3604,3604,3604,3604,3604,4432,4432,4432,4432,4432,4432,4432,4432,4432,4432,4432,4432,4432,ea385b3d-cb4c-4550-97b0-93a86533f6dc,pioglitazone and glimepiride tablets should not be used to treat type 1 diabetes or diabetic ketoacidosis  as it would not be effective in these settings,2
3605,3605,3605,3605,3605,3605,3605,4433,4433,4433,4433,4433,4433,4433,4433,4433,4433,4433,4433,4433,ea385b3d-cb4c-4550-97b0-93a86533f6dc,use caution in patients with liver disease see warnings and precautions ( 5 5 ),2
3606,3606,3606,3606,3606,3606,3606,4434,4434,4434,4434,4434,4434,4434,4434,4434,4434,4434,4434,4434,62245d7d-b50d-48d9-9f03-071c61620ccf, nicotrol inhaler is indicated as an aid to smoking cessation for the relief of nicotine withdrawal symptoms,1
3607,3607,3607,3607,3607,3607,3607,4435,4435,4435,4435,4435,4435,4435,4435,4435,4435,4435,4435,4435,62245d7d-b50d-48d9-9f03-071c61620ccf,nicotrol inhaler therapy is recommended for use as part of a comprehensive behavioral smoking cessation program,1
3608,3608,3608,3608,3608,3608,3608,4436,4436,4436,4436,4436,4436,4436,4436,4436,4436,4436,4436,4436,7fcf6a87-7b3e-4cef-8c47-c8a008cfea82,1  amlodipine and olmesartan medoxomil tablets are indicated for the treatment of hypertension  alone or with other antihypertensive agents  to lower blood pressure,1
3609,3609,3609,3609,3609,3609,3609,4449,4449,4449,4449,4449,4449,4449,4449,4449,4449,4449,4449,4449,7fcf6a87-7b3e-4cef-8c47-c8a008cfea82,amlodipine and olmesartan medoxomil tablets may also be used as initial therapy in patients who are likely to need multiple antihypertensive agents to achieve their blood pressure goals,1
3610,3610,3610,3610,3610,3610,3610,4450,4450,4450,4450,4450,4450,4450,4450,4450,4450,4450,4450,4450,7fcf6a87-7b3e-4cef-8c47-c8a008cfea82,patients with moderate or severe hypertension are at relatively high risk for cardiovascular events ( such as strokes  heart attacks  and heart failure )  kidney failure  and vision problems  so prompt treatment is clinically relevant,u
3611,3611,3611,3611,3611,3611,3611,4451,4451,4451,4451,4451,4451,4451,4451,4451,4451,4451,4451,4451,7fcf6a87-7b3e-4cef-8c47-c8a008cfea82,the decision to use a combination as initial therapy should be individualized and should be shaped by considerations such as baseline blood pressure  the target goal  and the incremental likelihood of achieving goal with a combination compared to monotherapy,4
3612,3612,3612,3612,3612,3612,3612,4453,4453,4453,4453,4453,4453,4453,4453,4453,4453,4453,4453,4453,c7961b19-3f23-4372-b071-34423124d801, for the management of schizophrenia,1
3613,3613,3613,3613,3613,3613,3613,4454,4454,4454,4454,4454,4454,4454,4454,4454,4454,4454,4454,4454,c7961b19-3f23-4372-b071-34423124d801,trifluoperazine hcl is effective for the short term treatment of generalized non psychotic anxiety,1
3614,3614,3614,3614,3614,3614,3614,4455,4455,4455,4455,4455,4455,4455,4455,4455,4455,4455,4455,4455,c7961b19-3f23-4372-b071-34423124d801,however  trifluoperazine hcl is not the first drug to be used in therapy for most patients with non psychotic anxiety because certain risks associated with its use are not shared by common alternative treatments ( i e  benzodiazepines ),0
3615,3615,3615,3615,3615,3615,3615,4456,4456,4456,4456,4456,4456,4456,4456,4456,4456,4456,4456,4456,c7961b19-3f23-4372-b071-34423124d801,when used in the treatment of non psychotic anxiety  trifluoperazine hcl should not be administered at doses of more than 6 mg per day or for longer than 12 weeks because the use of trifluoperazine hcl at higher doses or for longer intervals may cause persistent tardive dyskinesia that may prove irreversible ( see warnings ),2
3616,3616,3616,3616,3616,3616,3616,4457,4457,4457,4457,4457,4457,4457,4457,4457,4457,4457,4457,4457,c7961b19-3f23-4372-b071-34423124d801,the effectiveness of trifluoperazine hcl as a treatment for non psychotic anxiety was established in a four week clinical multicenter study of outpatients with generalized anxiety disorder ( dsm iii ),u
3617,3617,3617,3617,3617,3617,3617,4458,4458,4458,4458,4458,4458,4458,4458,4458,4458,4458,4458,4458,c7961b19-3f23-4372-b071-34423124d801,this evidence does not predict that trifluoperazine hcl will be useful in patients with other non psychotic conditions in which anxiety  or signs that mimic anxiety  are found ( i e  physical illness  organic mental conditions  agitated depression  character pathologies  etc ),0
3618,3618,3618,3618,3618,3618,3618,4459,4459,4459,4459,4459,4459,4459,4459,4459,4459,4459,4459,4459,c7961b19-3f23-4372-b071-34423124d801,trifluoperazine hcl has not been shown effective in the management of behavioral complications in patients with mental retardation,0
3619,3619,3619,3619,3619,3619,3619,4460,4460,4460,4460,4460,4460,4460,4460,4460,4460,4460,4460,4460,6dfedeff-a807-4405-a482-2f7109ad31c9, etoposide injection  usp is indicated in the management of the following neoplasms refractory testicular tumors etoposide injection in combination therapy with other approved chemotherapeutic agents in patients with refractory testicular tumors who have already received appropriate surgical  chemotherapeutic  and radiotherapeutic therapy,1
3620,3620,3620,3620,3620,3620,3620,4461,4461,4461,4461,4461,4461,4461,4461,4461,4461,4461,4461,4461,6dfedeff-a807-4405-a482-2f7109ad31c9,small cell lung cancer etoposide injection and or capsules in combination with other approved chemotherapeutic agents as first line treatment in patients with small cell lung cancer,1
3621,3621,3621,3621,3621,3621,3621,4462,4462,4462,4462,4462,4462,4462,4462,4462,4462,4462,4462,4462,eadc4b49-5a03-4057-97ca-5cfecc4d1795,indications usage armour thyroid tablets are indicated as replacement or supplemental therapy in patients with hypothyroidism of any etiology  except transient hypothyroidism during the recovery phase of subacute thyroiditis,1
3622,3622,3622,3622,3622,3622,3622,4463,4463,4463,4463,4463,4463,4463,4463,4463,4463,4463,4463,4463,eadc4b49-5a03-4057-97ca-5cfecc4d1795,this category includes cretinism  myxedema  and ordinary hypothyroidism in patients of any age ( children  adults  the elderly )  or state ( including pregnancy ) primary hypothyroidism resulting from functional deficiency  primary atrophy  partial or total absence of thyroid gland  or the effects of surgery  radiation  or drugs  with or without the presence of goiter and secondary ( pituitary )  or tertiary ( hypothalamic ) hypothyroidism ( seewarnings ),u
3623,3623,3623,3623,3623,3623,3623,4465,4465,4465,4465,4465,4465,4465,4465,4465,4465,4465,4465,4465,4c294bea-5a61-4756-af3c-17ed30f2c0d8,this product is for topical application directly on the hair follicle,4
3624,3624,3624,3624,3624,3624,3624,4466,4466,4466,4466,4466,4466,4466,4466,4466,4466,4466,4466,4466,50fa1766-1db6-4360-97b1-c1550695c75c, tl hem 150 is indicated in the treatment of most megaloblastic  macrocytic and iron deficiency anemias  in the anemias of pregnancy  in those anemias occurring in a variety of malabsorption syndromes  and those of nutritional origin,1
3625,3625,3625,3625,3625,3625,3625,4467,4467,4467,4467,4467,4467,4467,4467,4467,4467,4467,4467,4467,50fa1766-1db6-4360-97b1-c1550695c75c,it is a useful adjuvant in patients in whom erythropoiesis is suppressed due to severe infections  malignancies or to the toxic effects of certain chemotherapeutic agents,u
3626,3626,3626,3626,3626,3626,3626,4468,4468,4468,4468,4468,4468,4468,4468,4468,4468,4468,4468,4468,50fa1766-1db6-4360-97b1-c1550695c75c,a deficiency of vitamin e may increase the fragility of red blood cells  with resultants enhanced hemolysis,0
3627,3627,3627,3627,3627,3627,3627,4469,4469,4469,4469,4469,4469,4469,4469,4469,4469,4469,4469,4469,50fa1766-1db6-4360-97b1-c1550695c75c,tl hem 150 is a hematinic preparation containing multiple ingredients essential to normal erythropoiesis  plus a stool softener to counteract the possible constipating effects of iron,0
3628,3628,3628,3628,3628,3628,3628,4470,4470,4470,4470,4470,4470,4470,4470,4470,4470,4470,4470,4470,50fa1766-1db6-4360-97b1-c1550695c75c,vitamin c is present to aid the absorption of iron,0
3629,3629,3629,3629,3629,3629,3629,4471,4471,4471,4471,4471,4471,4471,4471,4471,4471,4471,4471,4471,47e3ae30-64ac-462c-95eb-2e29506d9a7b,indications feriva fa is a multivitamin multimineral dietary supplement indicated for use in improving the nutritional status of women throughout pregnancy and in the postnatal period for both lactating and nonlactating mothers,1
3630,3630,3630,3630,3630,3630,3630,4472,4472,4472,4472,4472,4472,4472,4472,4472,4472,4472,4472,4472,c6c3da51-fc45-4d5c-b983-1576830c95dd, tranexamic acid injection is indicated in patients with hemophilia for short term use ( two to eight days ) to reduce or prevent hemorrhage and reduce the need for replacement therapy during and following tooth extraction,1
3631,3631,3631,3631,3631,3631,3631,4473,4473,4473,4473,4473,4473,4473,4473,4473,4473,4473,4473,4473,2265ef30-253e-11df-8a39-0800200c9a66,1  yervoy is a human cytotoxic t lymphocyte antigen 4 ( ctla 4 ) blocking antibody indicated for treatment of unresectable or metastatic melanoma in adults and pediatric patients ( 12 years and older ),1
3632,3632,3632,3632,3632,3632,3632,4474,4474,4474,4474,4474,4474,4474,4474,4474,4474,4474,4474,4474,2265ef30-253e-11df-8a39-0800200c9a66,( 1 1 ) adjuvant treatment of patients with cutaneous melanoma with pathologic involvement of regional lymph nodes of more than 1 mm who have undergone complete resection  including total lymphadenectomy,1
3633,3633,3633,3633,3633,3633,3633,4475,4475,4475,4475,4475,4475,4475,4475,4475,4475,4475,4475,4475,2265ef30-253e-11df-8a39-0800200c9a66,( 1 2 ) 1 1 unresectable or metastatic melanoma yervoy is indicated for the treatment of unresectable or metastatic melanoma in adults and pediatric patients ( 12 years and older ) see clinical studies ( 14 1 ),1
3634,3634,3634,3634,3634,3634,3634,4476,4476,4476,4476,4476,4476,4476,4476,4476,4476,4476,4476,4476,2265ef30-253e-11df-8a39-0800200c9a66,1 2 adjuvant treatment of melanoma yervoy is indicated for the adjuvant treatment of patients with cutaneous melanoma with pathologic involvement of regional lymph nodes of more than 1 mm who have undergone complete resection  including total lymphadenectomy see clinical studies ( 14 2 ),1
3635,3635,3635,3635,3635,3635,3635,4477,4477,4477,4477,4477,4477,4477,4477,4477,4477,4477,4477,4477,b073b082-7b57-4423-8c06-4fd4263d6f84,1  noxafil is an azole antifungal agent indicated for injection  delayed release tablets  and oral suspension prophylaxis of invasive aspergillus and candida infections in patients who are at high risk of developing these infections due to being severely immunocompromised  such as hsct recipients with gvhd or those with hematologic malignancies with prolonged neutropenia from chemotherapy,1
3636,3636,3636,3636,3636,3636,3636,4478,4478,4478,4478,4478,4478,4478,4478,4478,4478,4478,4478,4478,b073b082-7b57-4423-8c06-4fd4263d6f84,( 1 1 ) oral suspension treatment of oropharyngeal candidiasis ( opc )  including opc refractory ( ropc ) to itraconazole and or fluconazole,1
3637,3637,3637,3637,3637,3637,3637,4479,4479,4479,4479,4479,4479,4479,4479,4479,4479,4479,4479,4479,b073b082-7b57-4423-8c06-4fd4263d6f84,( 1 2 ) 1 1 prophylaxis of invasive aspergillus and candida infections noxafil injection  delayed release tablets  and oral suspension are indicated for prophylaxis of invasive aspergillus and candida infections in patients who are at high risk of developing these infections due to being severely immunocompromised  such as hematopoietic stem cell transplant ( hsct ) recipients with graft versus host disease ( gvhd ) or those with hematologic malignancies with prolonged neutropenia from chemotherapy,1
3638,3638,3638,3638,3638,3638,3638,4480,4480,4480,4480,4480,4480,4480,4480,4480,4480,4480,4480,4480,b073b082-7b57-4423-8c06-4fd4263d6f84,noxafil injection is indicated in patients 18 years of age and older,u
3639,3639,3639,3639,3639,3639,3639,4481,4481,4481,4481,4481,4481,4481,4481,4481,4481,4481,4481,4481,b073b082-7b57-4423-8c06-4fd4263d6f84,noxafil delayed release tablets and oral suspension are indicated in patients 13 years of age and older,u
3640,3640,3640,3640,3640,3640,3640,4482,4482,4482,4482,4482,4482,4482,4482,4482,4482,4482,4482,4482,b073b082-7b57-4423-8c06-4fd4263d6f84,1 2 treatment of oropharyngeal candidiasis including oropharyngeal candidiasis refractory to itraconazole and or fluconazole noxafil oral suspension is indicated for the treatment of oropharyngeal candidiasis  including oropharyngeal candidiasis refractory to itraconazole and or fluconazole,1
3641,3641,3641,3641,3641,3641,3641,4483,4483,4483,4483,4483,4483,4483,4483,4483,4483,4483,4483,4483,40ac6155-eb0e-799c-9fb6-bb5ffdd40356,uses temporarily relieves nasal congestion due to the common cold  hay fever or other upper respiratory allergies temporarily relieves sinus congestion and pressure,1
3642,3642,3642,3642,3642,3642,3642,4485,4485,4485,4485,4485,4485,4485,4485,4485,4485,4485,4485,4485,de1dd7a8-cb5e-4ba9-b469-a374fca55939,indications atuss ds tannate suspension is indicated for temporary relief of nasal congestion and cough associated with respiratory tract infections and related conditions such as sinusitis  pharyngitis  bronchitis and asthma when these conditions are complicated by tenacious mucus and or mucous plugs and congestion,1
3643,3643,3643,3643,3643,3643,3643,4486,4486,4486,4486,4486,4486,4486,4486,4486,4486,4486,4486,4486,de1dd7a8-cb5e-4ba9-b469-a374fca55939,atuss ds tannate suspension is effective in a productive as well as a nonproductive cough  but is of particular value in a dry nonproductive cough which tends to injure the mucous membrane of the air passages,u
3644,3644,3644,3644,3644,3644,3644,4487,4487,4487,4487,4487,4487,4487,4487,4487,4487,4487,4487,4487,d86c6a13-9e5f-43c2-92f5-c7ed7bfcedfc, semprex d capsules are indicated for relief of symptoms associated with seasonal allergic rhinitis such as sneezing  rhinorrhea  pruritus  lacrimation  and nasal congestion,1
3645,3645,3645,3645,3645,3645,3645,4488,4488,4488,4488,4488,4488,4488,4488,4488,4488,4488,4488,4488,d86c6a13-9e5f-43c2-92f5-c7ed7bfcedfc,semprex d capsules should be administered when both the antihistaminic activity of acrivastine and the nasal decongestant activity of pseudoephedrine are desired ( see clinical pharmacology ),4
3646,3646,3646,3646,3646,3646,3646,4489,4489,4489,4489,4489,4489,4489,4489,4489,4489,4489,4489,4489,d86c6a13-9e5f-43c2-92f5-c7ed7bfcedfc,the efficacy of semprex d capsules beyond 14 days of continuous treatment in patients with seasonal allergic rhinitis has not been adequately investigated in clinical trials,0
3647,3647,3647,3647,3647,3647,3647,4490,4490,4490,4490,4490,4490,4490,4490,4490,4490,4490,4490,4490,d86c6a13-9e5f-43c2-92f5-c7ed7bfcedfc,semprex d capsules have not been adequately studied for effectiveness in relieving the symptoms of the common cold,0
3648,3648,3648,3648,3648,3648,3648,4491,4491,4491,4491,4491,4491,4491,4491,4491,4491,4491,4491,4491,6cc01bb7-27c5-43c4-8e21-64ecbfbb4fa2, triacin c is indicated for temporary relief of coughs and upper respiratory symptoms  including nasal congestion  associated with allergy or the common cold,1
3649,3649,3649,3649,3649,3649,3649,4492,4492,4492,4492,4492,4492,4492,4492,4492,4492,4492,4492,4492,5ab09c98-cb39-43be-b306-5eff3c31b563,1  hydrocodone bitartrate  chlorpheniramine maleate and pseudoephedrine hydrochloride oral solution is a combination product containing an antitussive  an antihistamine  and a nasal decongestant indicated for relief of cough and nasal congestion associated with common cold ( 1 1 ) relief of symptoms including nasal congestion associated with upper respiratory allergies ( 1 2 ) important limitations of use not indicated for pediatric patients under 18 years of age 1 1 common cold hydrocodone bitartrate  chlorpheniramine maleate and pseudoephedrine hydrochloride oral solution is indicated for relief of cough and nasal congestion associated with the common cold in adults 18 years of age and older,1
3650,3650,3650,3650,3650,3650,3650,4493,4493,4493,4493,4493,4493,4493,4493,4493,4493,4493,4493,4493,5ab09c98-cb39-43be-b306-5eff3c31b563,1 2 upper respiratory allergies hydrocodone bitartrate  chlorpheniramine maleate and pseudoephedrine hydrochloride oral solution is indicated for relief of symptoms including nasal congestion associated with upper respiratory allergies in adults 18 years of age and older,1
3651,3651,3651,3651,3651,3651,3651,4494,4494,4494,4494,4494,4494,4494,4494,4494,4494,4494,4494,4494,5ab09c98-cb39-43be-b306-5eff3c31b563,important limitations of use not indicated for pediatric patients under 18 years of age see pediatric use ( 8 4 ),2
3652,3652,3652,3652,3652,3652,3652,4495,4495,4495,4495,4495,4495,4495,4495,4495,4495,4495,4495,4495,7249b0f9-b24c-4f7f-81f2-22473a4d5b0c,uses temporarily relieves these symptoms associated with the common cold or flu fever sinus pressure nasal congestion headache minor body aches and pains,1
3653,3653,3653,3653,3653,3653,3653,4496,4496,4496,4496,4496,4496,4496,4496,4496,4496,4496,4496,4496,bb5a5043-0f51-11df-8a39-0800200c9a66,1  amyvid is indicated for positron emission tomography ( pet ) imaging of the brain to estimate amyloid neuritic plaque density in adult patients with cognitive impairment who are being evaluated for alzheimer 's disease ( ad ) and other causes of cognitive decline,1
3654,3654,3654,3654,3654,3654,3654,4497,4497,4497,4497,4497,4497,4497,4497,4497,4497,4497,4497,4497,bb5a5043-0f51-11df-8a39-0800200c9a66,a negative amyvid scan indicates sparse to no neuritic plaques and is inconsistent with a neuropathological diagnosis of ad at the time of image acquisition a negative scan result reduces the likelihood that a patient 's cognitive impairment is due to ad,0
3655,3655,3655,3655,3655,3655,3655,4498,4498,4498,4498,4498,4498,4498,4498,4498,4498,4498,4498,4498,bb5a5043-0f51-11df-8a39-0800200c9a66,a positive amyvid scan indicates moderate to frequent amyloid neuritic plaques neuropathological examination has shown this amount of amyloid neuritic plaque is present in patients with ad  but may also be present in patients with other types of neurologic conditions as well as older people with normal cognition,0
3656,3656,3656,3656,3656,3656,3656,4499,4499,4499,4499,4499,4499,4499,4499,4499,4499,4499,4499,4499,bb5a5043-0f51-11df-8a39-0800200c9a66,amyvid is an adjunct to other diagnostic evaluations,0
3657,3657,3657,3657,3657,3657,3657,4500,4500,4500,4500,4500,4500,4500,4500,4500,4500,4500,4500,4500,bb5a5043-0f51-11df-8a39-0800200c9a66,amyvid is a radioactive diagnostic agent for positron emission tomography ( pet ) imaging of the brain to estimate amyloid neuritic plaque density in adult patients with cognitive impairment who are being evaluated for alzheimer 's disease ( ad ) and other causes of cognitive decline,1
3658,3658,3658,3658,3658,3658,3658,4501,4501,4501,4501,4501,4501,4501,4501,4501,4501,4501,4501,4501,bb5a5043-0f51-11df-8a39-0800200c9a66,a negative amyvid scan indicates sparse to no neuritic plaques  and is inconsistent with a neuropathological diagnosis of ad at the time of image acquisition a negative scan result reduces the likelihood that a patient 's cognitive impairment is due to ad,0
3659,3659,3659,3659,3659,3659,3659,4503,4503,4503,4503,4503,4503,4503,4503,4503,4503,4503,4503,4503,bb5a5043-0f51-11df-8a39-0800200c9a66,amyvid is an adjunct to other diagnostic evaluations ( 1 ),0
3660,3660,3660,3660,3660,3660,3660,4504,4504,4504,4504,4504,4504,4504,4504,4504,4504,4504,4504,4504,bb5a5043-0f51-11df-8a39-0800200c9a66,limitations of use a positive amyvid scan does not establish a diagnosis of ad or other cognitive disorder ( 1 ),0
3661,3661,3661,3661,3661,3661,3661,4505,4505,4505,4505,4505,4505,4505,4505,4505,4505,4505,4505,4505,bb5a5043-0f51-11df-8a39-0800200c9a66,safety and effectiveness of amyvid have not been established for predicting development of dementia or other neurologic condition monitoring responses to therapies ( 1 ),0
3662,3662,3662,3662,3662,3662,3662,4506,4506,4506,4506,4506,4506,4506,4506,4506,4506,4506,4506,4506,bb5a5043-0f51-11df-8a39-0800200c9a66,limitations of use a positive amyvid scan does not establish a diagnosis of ad or other cognitive disorder,0
3663,3663,3663,3663,3663,3663,3663,4507,4507,4507,4507,4507,4507,4507,4507,4507,4507,4507,4507,4507,bb5a5043-0f51-11df-8a39-0800200c9a66,safety and effectiveness of amyvid have not been established for predicting development of dementia or other neurologic condition,0
3664,3664,3664,3664,3664,3664,3664,4508,4508,4508,4508,4508,4508,4508,4508,4508,4508,4508,4508,4508,68bbf6a0-c4b5-47c1-8a1c-08220fbdbce6,1  bepreve ( bepotastine besilate ophthalmic solution ) 1 5 is a histamine h1 receptor antagonist indicated for the treatment of itching associated with signs and symptoms of allergic conjunctivitis,1
3665,3665,3665,3665,3665,3665,3665,4509,4509,4509,4509,4509,4509,4509,4509,4509,4509,4509,4509,4509,68bbf6a0-c4b5-47c1-8a1c-08220fbdbce6,bepreve is a histamine h1 receptor antagonist indicated for the treatment of itching associated with allergic conjunctivitis,1
3666,3666,3666,3666,3666,3666,3666,4510,4510,4510,4510,4510,4510,4510,4510,4510,4510,4510,4510,4510,1924db3d-6a16-4496-cfd0-6903be146925, selegiline capsules  usp are indicated as an adjunct in the management of parkinsonian patients being treated with levodopa carbidopa who exhibit deterioration in the quality of their response to this therapy,1
3667,3667,3667,3667,3667,3667,3667,4511,4511,4511,4511,4511,4511,4511,4511,4511,4511,4511,4511,4511,1924db3d-6a16-4496-cfd0-6903be146925,there is no evidence from controlled studies that selegiline has any beneficial effect in the absence of concurrent levodopa therapy,0
3668,3668,3668,3668,3668,3668,3668,4512,4512,4512,4512,4512,4512,4512,4512,4512,4512,4512,4512,4512,1924db3d-6a16-4496-cfd0-6903be146925,evidence supporting this claim was obtained in randomized controlled clinical investigations that compared the effects of added selegiline or placebo in patients receiving levodopa carbidopa,0
3669,3669,3669,3669,3669,3669,3669,4513,4513,4513,4513,4513,4513,4513,4513,4513,4513,4513,4513,4513,1924db3d-6a16-4496-cfd0-6903be146925,selegiline was significantly superior to placebo on all three principal outcome measures employed change from baseline in daily levodopa carbidopa dose  the amount of 'off' time  and patient self rating of treatment success,0
3670,3670,3670,3670,3670,3670,3670,4514,4514,4514,4514,4514,4514,4514,4514,4514,4514,4514,4514,4514,1924db3d-6a16-4496-cfd0-6903be146925,beneficial effects were also observed on other measures of treatment success ( e g  measures of reduced end of dose akinesia  decreased tremor and sialorrhea  improved speech and dressing ability and improved overall disability as assessed by walking and comparison to previous state ),0
3671,3671,3671,3671,3671,3671,3671,4515,4515,4515,4515,4515,4515,4515,4515,4515,4515,4515,4515,4515,63004034-123d-c9c8-e053-2991aa0a359a,citranatal bloom dha is a multi vitamin mineral prescription drug indicated for use in improving the nutritional status of women prior to conception  throughout pregnancy  and in the postnatal period for both lactating and nonlactating mothers,1
3672,3672,3672,3672,3672,3672,3672,4516,4516,4516,4516,4516,4516,4516,4516,4516,4516,4516,4516,4516,878e22cc-9f69-3074-3212-2b36763b2a65, bioferr 90 is indicated for the treatment of all anemias that are responsive to oral iron therapy,1
3673,3673,3673,3673,3673,3673,3673,4518,4518,4518,4518,4518,4518,4518,4518,4518,4518,4518,4518,4518,bf716efe-0a9f-43b1-9d8a-c69330b82e18, betaxolol is indicated in the management of hypertension,1
3674,3674,3674,3674,3674,3674,3674,4519,4519,4519,4519,4519,4519,4519,4519,4519,4519,4519,4519,4519,bf716efe-0a9f-43b1-9d8a-c69330b82e18,it may be used alone or concomitantly with other antihypertensive agents  particularly thiazide type diuretics,4
3675,3675,3675,3675,3675,3675,3675,4520,4520,4520,4520,4520,4520,4520,4520,4520,4520,4520,4520,4520,"Active Ingredient UNII(s)
6XC1PAD3KF    eb5dbd0a-6a12-4613-8053-ee378ace8c7f
6XC1PAD3KF    eb5dbd0a-6a12-4613-8053-ee378ace8c7f
Name: SET ID dtype: object",active ingredient unii ( s ) 6xc1pad3kf active ingredient unii ( s ) 6xc1pad3kf active in 6xc1pad3kf active ingredient unii ( s ) 6xc1pad3kf active in name content xml  dtype object,0
3676,3676,3676,3676,3676,3676,3676,4526,4526,4526,4526,4526,4526,4526,4526,4526,4526,4526,4526,4526,1a550c33-456a-4833-814e-8591aea7c688,1  siliq is indicated for the treatment of moderate to severe plaque psoriasis in adult patients who are candidates for systemic therapy or phototherapy and have failed to respond or have lost response to other systemic therapies,1
3677,3677,3677,3677,3677,3677,3677,4527,4527,4527,4527,4527,4527,4527,4527,4527,4527,4527,4527,4527,1a550c33-456a-4833-814e-8591aea7c688,siliq is a human interleukin 17 receptor a ( il 17ra ) antagonist indicated for the treatment of moderate to severe plaque psoriasis in adult patients who are candidates for systemic therapy or phototherapy and have failed to respond or have lost response to other systemic therapies,1
3678,3678,3678,3678,3678,3678,3678,4528,4528,4528,4528,4528,4528,4528,4528,4528,4528,4528,4528,4528,899f97fb-85f1-4e78-9708-b916a1646129,indications niferex is a multivitamin multimineral dietary supplement indicated for use in improving the nutritional status of patients with iron deficiency,1
3679,3679,3679,3679,3679,3679,3679,4529,4529,4529,4529,4529,4529,4529,4529,4529,4529,4529,4529,4529,13c5ed58-6333-498f-9ace-1049d7ae3552,indications chromagen is a multivitamin multimineral dietary supplement indicated for use in improving the nutritional status of patients with iron deficiency,1
3680,3680,3680,3680,3680,3680,3680,4530,4530,4530,4530,4530,4530,4530,4530,4530,4530,4530,4530,4530,c36cb9d3-f0a3-4d34-92f2-8ab281b26b7d,indications for the treatment of all anemias responsive to oral iron therapy  such as hypochromic anemia associated with pregnancy  chronic or acute blood loss  dietary restriction  metabolic disease and post surgical convalescence,1
3681,3681,3681,3681,3681,3681,3681,4531,4531,4531,4531,4531,4531,4531,4531,4531,4531,4531,4531,4531,a05158b5-ae28-4889-881c-6a7883c96f4c, engystol injection solution is a homeopathic drug product indicated for the support of the immune system to reduce severity and duration of symptoms in viral infections  particularly in the early stages of colds and influenza like illnesses,1
3682,3682,3682,3682,3682,3682,3682,4532,4532,4532,4532,4532,4532,4532,4532,4532,4532,4532,4532,4532,50605463-2dc2-4b27-bc51-4d87bb9a8539,1  tigecycline for injection is a tetracycline class antibacterial indicated in patients 18 years of age and older for complicated skin and skin structure infections ( 1 1 ) complicated intra abdominal infections ( 1 2 ) community acquired bacterial pneumonia ( 1 3 ) limitations of use tigecycline for injection is not indicated for treatment of diabetic foot infection or hospital acquired pneumonia  including ventilator associated pneumonia ( 1 4 ),1
3683,3683,3683,3683,3683,3683,3683,4533,4533,4533,4533,4533,4533,4533,4533,4533,4533,4533,4533,4533,50605463-2dc2-4b27-bc51-4d87bb9a8539,to reduce the development of drug resistant bacteria and maintain the effectiveness of tigecycline for injection and other antibacterial drugs  tigecycline for injection should be used only to treat infections that are proven or strongly suspected to be caused by bacteria,4
3684,3684,3684,3684,3684,3684,3684,4534,4534,4534,4534,4534,4534,4534,4534,4534,4534,4534,4534,4534,50605463-2dc2-4b27-bc51-4d87bb9a8539,1 1 complicated skin and skin structure infections tigecycline for injection is indicated in patients 18 years of age and older for the treatment of complicated skin and skin structure infections caused by susceptible isolates of escherichia coli  enterococcus faecalis ( vancomycin susceptible isolates )  staphylococcus aureus ( methicillin susceptible and resistant isolates )  streptococcus agalactiae  streptococcus anginosus grp,1
3685,3685,3685,3685,3685,3685,3685,4535,4535,4535,4535,4535,4535,4535,4535,4535,4535,4535,4535,4535,50605463-2dc2-4b27-bc51-4d87bb9a8539,( includes s anginosus  s intermedius  and s constellatus )  streptococcus pyogenes  enterobacter cloacae  klebsiella pneumoniae  and bacteroides fragilis,1
3686,3686,3686,3686,3686,3686,3686,4536,4536,4536,4536,4536,4536,4536,4536,4536,4536,4536,4536,4536,50605463-2dc2-4b27-bc51-4d87bb9a8539,1 2 complicated intra abdominal infections tigecycline for injection is indicated in patients 18 years of age and older for the treatment of complicated intra abdominal infections caused by susceptible isolates of citrobacter freundii  enterobacter cloacae  escherichia coli  klebsiella oxytoca  klebsiella pneumoniae  enterococcus faecalis ( vancomycin susceptible isolates )  staphylococcus aureus ( methicillin susceptible and resistant isolates )  content,1
3687,3687,3687,3687,3687,3687,3687,4537,4537,4537,4537,4537,4537,4537,4537,4537,4537,4537,4537,4537,da6aca1a-19ed-44a4-abb7-696c7d58b784,1  fasenra is indicated for the add on maintenance treatment of patients with severe asthma aged 12 years and older  and with an eosinophilic phenotype see clinical studies ( 14 ),1
3688,3688,3688,3688,3688,3688,3688,4538,4538,4538,4538,4538,4538,4538,4538,4538,4538,4538,4538,4538,da6aca1a-19ed-44a4-abb7-696c7d58b784,limitations of use fasenra is not indicated for treatment of other eosinophilic conditions,2
3689,3689,3689,3689,3689,3689,3689,4539,4539,4539,4539,4539,4539,4539,4539,4539,4539,4539,4539,4539,da6aca1a-19ed-44a4-abb7-696c7d58b784,fasenra is not indicated for the relief of acute bronchospasm or status asthmaticus,2
3690,3690,3690,3690,3690,3690,3690,4540,4540,4540,4540,4540,4540,4540,4540,4540,4540,4540,4540,4540,da6aca1a-19ed-44a4-abb7-696c7d58b784,fasenra is an interleukin 5 receptor alpha directed cytolytic monoclonal antibody ( igg1  kappa ) indicated for the add on maintenance treatment of patients with severe asthma aged 12 years and older  and with an eosinophilic phenotype,1
3691,3691,3691,3691,3691,3691,3691,4541,4541,4541,4541,4541,4541,4541,4541,4541,4541,4541,4541,4541,da6aca1a-19ed-44a4-abb7-696c7d58b784,( 1 ) limitations of use not for treatment of other eosinophilic conditions,2
3692,3692,3692,3692,3692,3692,3692,4542,4542,4542,4542,4542,4542,4542,4542,4542,4542,4542,4542,4542,da6aca1a-19ed-44a4-abb7-696c7d58b784,( 1 ) not for relief of acute bronchospasm or status asthmaticus,2
3693,3693,3693,3693,3693,3693,3693,4543,4543,4543,4543,4543,4543,4543,4543,4543,4543,4543,4543,4543,ed15e6c9-26c4-4d31-acbd-09a513a188e1, vancomycin hydrochloride for injection  usp is indicated for the treatment of serious or severe infections caused by susceptible strains of methicillin resistant ( lactam resistant ) staphylococci,1
3694,3694,3694,3694,3694,3694,3694,4544,4544,4544,4544,4544,4544,4544,4544,4544,4544,4544,4544,4544,ed15e6c9-26c4-4d31-acbd-09a513a188e1,it is indicated for penicillin allergic patients  for patients who cannot receive or who have failed to respond to other drugs  including the penicillins or cephalosporins  and for infections caused by vancomycin susceptible organisms that are resistant to other antimicrobial drugs,1
3695,3695,3695,3695,3695,3695,3695,4545,4545,4545,4545,4545,4545,4545,4545,4545,4545,4545,4545,4545,ed15e6c9-26c4-4d31-acbd-09a513a188e1,vancomycin hydrochloride for injection  usp is indicated for initial therapy when methicillin resistant staphylococci are suspected  but after susceptibility data are available  therapy should be adjusted accordingly,1
3696,3696,3696,3696,3696,3696,3696,4546,4546,4546,4546,4546,4546,4546,4546,4546,4546,4546,4546,4546,ed15e6c9-26c4-4d31-acbd-09a513a188e1,vancomycin hydrochloride for injection  usp is effective in the treatment of staphylococcal endocarditis,1
3697,3697,3697,3697,3697,3697,3697,4547,4547,4547,4547,4547,4547,4547,4547,4547,4547,4547,4547,4547,ed15e6c9-26c4-4d31-acbd-09a513a188e1,its effectiveness has been documented in other infections due to staphylococci  including septicemia  bone infections  lower respiratory tract infections  skin and skin structure infections,0
3698,3698,3698,3698,3698,3698,3698,4548,4548,4548,4548,4548,4548,4548,4548,4548,4548,4548,4548,4548,ed15e6c9-26c4-4d31-acbd-09a513a188e1,when staphylococcal infections are localized and purulent  antibiotics are used as adjuncts to appropriate surgical measures,0
3699,3699,3699,3699,3699,3699,3699,4549,4549,4549,4549,4549,4549,4549,4549,4549,4549,4549,4549,4549,ed15e6c9-26c4-4d31-acbd-09a513a188e1,vancomycin hydrochloride for injection  usp has been reported to be effective alone or in combination with an aminoglycoside for endocarditis caused by s viridans or s bovis,0
3700,3700,3700,3700,3700,3700,3700,4550,4550,4550,4550,4550,4550,4550,4550,4550,4550,4550,4550,4550,ed15e6c9-26c4-4d31-acbd-09a513a188e1,for endocarditis caused by enterococci ( e g  e faecalis )  vancomycin has been reported to be effective only in combination with an aminoglycoside,0
3701,3701,3701,3701,3701,3701,3701,4551,4551,4551,4551,4551,4551,4551,4551,4551,4551,4551,4551,4551,ed15e6c9-26c4-4d31-acbd-09a513a188e1,vancomycin hydrochloride for injection  usp has been reported to be effective for the treatment of diphtheroid endocarditis,0
3702,3702,3702,3702,3702,3702,3702,4552,4552,4552,4552,4552,4552,4552,4552,4552,4552,4552,4552,4552,ed15e6c9-26c4-4d31-acbd-09a513a188e1,vancomycin hydrochloride for injection  usp has been used successfully in combination with either rifampin  an aminoglycoside  or both in early onset prosthetic valve endocarditis caused by s epidermidis or diphtheroids,4
3703,3703,3703,3703,3703,3703,3703,4553,4553,4553,4553,4553,4553,4553,4553,4553,4553,4553,4553,4553,ed15e6c9-26c4-4d31-acbd-09a513a188e1,specimens for bacteriologic cultures should be obtained in order to isolate and identify causative organisms and to determine their susceptibilities to vancomycin,0
3704,3704,3704,3704,3704,3704,3704,4554,4554,4554,4554,4554,4554,4554,4554,4554,4554,4554,4554,4554,ed15e6c9-26c4-4d31-acbd-09a513a188e1,to reduce the development of drug resistant bacteria and maintain the effectiveness of vancomycin hydrochloride for injection  usp and other antibacterial drugs  vancomycin hydrochloride for injection  usp should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria,4
3705,3705,3705,3705,3705,3705,3705,4557,4557,4557,4557,4557,4557,4557,4557,4557,4557,4557,4557,4557,ed15e6c9-26c4-4d31-acbd-09a513a188e1,the parenteral form of vancomycin hydrochloride may be administered orally for treatment of antibiotic associated pseudomembranous colitis produced by c difficile and for staphylococcal enterocolitis,4
3706,3706,3706,3706,3706,3706,3706,4558,4558,4558,4558,4558,4558,4558,4558,4558,4558,4558,4558,4558,ed15e6c9-26c4-4d31-acbd-09a513a188e1,parenteral administration of vancomycin hydrochloride alone is of unproven benefit for these indications,0
3707,3707,3707,3707,3707,3707,3707,4559,4559,4559,4559,4559,4559,4559,4559,4559,4559,4559,4559,4559,ed15e6c9-26c4-4d31-acbd-09a513a188e1,vancomycin is not effective by the oral route for other types of infections,0
3708,3708,3708,3708,3708,3708,3708,4560,4560,4560,4560,4560,4560,4560,4560,4560,4560,4560,4560,4560,a57c49ae-d659-49fa-84e3-cf6d1f9e6f97, propylthiouracil tablets  usp are indicated in patients with graves disease with hyperthyroidism or toxic multinodular goiter who are intolerant of methimazole and for whom surgery or radioactive iodine therapy is not an appropriate treatment option to ameliorate symptoms of hyperthyroidism in preparation for thyroidectomy or radioactive iodine therapy in patients who are intolerant of methimazole,1
3709,3709,3709,3709,3709,3709,3709,4564,4564,4564,4564,4564,4564,4564,4564,4564,4564,4564,4564,4564,9d7f26d5-d8a9-4610-8d78-80ca3d442a79, 1 ursodiol is indicated for patients with radiolucent  noncalcified gallbladder stones 20 mm in greatest diameter in whom elective cholecystectomy would be undertaken except for the presence of increased surgical risk due to systemic disease  advanced age  idiosyncratic reaction to general anesthesia  or for those patients who refuse surgery,1
3710,3710,3710,3710,3710,3710,3710,4565,4565,4565,4565,4565,4565,4565,4565,4565,4565,4565,4565,4565,9d7f26d5-d8a9-4610-8d78-80ca3d442a79,safety of use of ursodiol beyond 24 months is not established,0
3711,3711,3711,3711,3711,3711,3711,4566,4566,4566,4566,4566,4566,4566,4566,4566,4566,4566,4566,4566,9d7f26d5-d8a9-4610-8d78-80ca3d442a79,2 ursodiol is indicated for the prevention of gallstone formation in obese patients experiencing rapid weight loss,1
3712,3712,3712,3712,3712,3712,3712,4567,4567,4567,4567,4567,4567,4567,4567,4567,4567,4567,4567,4567,4aea30ff-eb0d-45c1-b114-3127966328ff,1  symlin is indicated as an adjunctive treatment in patients with type 1 or type 2 diabetes who use mealtime insulin therapy and who have failed to achieve desired glucose control despite optimal insulin therapy,1
3713,3713,3713,3713,3713,3713,3713,4568,4568,4568,4568,4568,4568,4568,4568,4568,4568,4568,4568,4568,4aea30ff-eb0d-45c1-b114-3127966328ff,symlin is an amylin analog indicated for patients with type 1 or type 2 diabetes who use mealtime insulin and have failed to achieve desired glycemic control despite optimal insulin therapy,1
3714,3714,3714,3714,3714,3714,3714,4569,4569,4569,4569,4569,4569,4569,4569,4569,4569,4569,4569,4569,cd270093-c6a8-4596-a4ab-e6aa0a2c8a0c,1  parsabiv is indicated for the treatment of secondary hyperparathyroidism ( hpt ) in adult patients with chronic kidney disease ( ckd ) on hemodialysis,1
3715,3715,3715,3715,3715,3715,3715,4570,4570,4570,4570,4570,4570,4570,4570,4570,4570,4570,4570,4570,cd270093-c6a8-4596-a4ab-e6aa0a2c8a0c,limitations of use parsabiv has not been studied in adult patients with parathyroid carcinoma  primary hyperparathyroidism  or with chronic kidney disease who are not on hemodialysis and is not recommended for use in these populations,0
3716,3716,3716,3716,3716,3716,3716,4571,4571,4571,4571,4571,4571,4571,4571,4571,4571,4571,4571,4571,cd270093-c6a8-4596-a4ab-e6aa0a2c8a0c,parsabiv is a calcium sensing receptor agonist indicated for secondary hyperparathyroidism ( hpt ) in adult patients with chronic kidney disease ( ckd ) on hemodialysis,1
3717,3717,3717,3717,3717,3717,3717,4572,4572,4572,4572,4572,4572,4572,4572,4572,4572,4572,4572,4572,cd270093-c6a8-4596-a4ab-e6aa0a2c8a0c,( 1 ) limitations of use parsabiv has not been studied in adult patients with parathyroid carcinoma  primary hyperparathyroidism  or with ckd who are not on hemodialysis and is not recommended for use in these populations,0
3718,3718,3718,3718,3718,3718,3718,4573,4573,4573,4573,4573,4573,4573,4573,4573,4573,4573,4573,4573,ea66eb30-e665-4693-99a1-a9d3b4bbe2d6,1  kyprolis is a proteasome inhibitor that is indicated in combination with dexamethasone or with lenalidomide plus dexamethasone for the treatment of patients with relapsed or refractory multiple myeloma who have received one to three lines of therapy,1
3719,3719,3719,3719,3719,3719,3719,4574,4574,4574,4574,4574,4574,4574,4574,4574,4574,4574,4574,4574,ea66eb30-e665-4693-99a1-a9d3b4bbe2d6,( 1  14 ) as a single agent for the treatment of patients with relapsed or refractory multiple myeloma who have received one or more lines of therapy,u
3720,3720,3720,3720,3720,3720,3720,4575,4575,4575,4575,4575,4575,4575,4575,4575,4575,4575,4575,4575,ea66eb30-e665-4693-99a1-a9d3b4bbe2d6,( 1  14 ) 1 1 relapsed or refractory multiple myeloma kyprolis is indicated in combination with dexamethasone or with lenalidomide plus dexamethasone for the treatment of patients with relapsed or refractory multiple myeloma who have received one to three lines of therapy see clinical studies ( 14 1 ),1
3721,3721,3721,3721,3721,3721,3721,4576,4576,4576,4576,4576,4576,4576,4576,4576,4576,4576,4576,4576,ea66eb30-e665-4693-99a1-a9d3b4bbe2d6,kyprolis is indicated as a single agent for the treatment of patients with relapsed or refractory multiple myeloma who have received one or more lines of therapy see clinical studies ( 14 2  14 3 ),1
3722,3722,3722,3722,3722,3722,3722,4577,4577,4577,4577,4577,4577,4577,4577,4577,4577,4577,4577,4577,90306296-77ef-4123-9f86-8a662523cc58,indication and usage cortrosyn ( cosyntropin ) for injection is intended for use as a diagnostic agent in the screening of patients presumed to have adrenocortical insufficiency,1
3723,3723,3723,3723,3723,3723,3723,4578,4578,4578,4578,4578,4578,4578,4578,4578,4578,4578,4578,4578,90306296-77ef-4123-9f86-8a662523cc58,because of its rapid effect on the adrenal cortex it may be utilized to perform a 30 minute test of adrenal function ( plasma cortisol response ) as an office or outpatient procedure  using only 2 venipunctures ( seedosage and administration section ),u
3724,3724,3724,3724,3724,3724,3724,4579,4579,4579,4579,4579,4579,4579,4579,4579,4579,4579,4579,4579,90306296-77ef-4123-9f86-8a662523cc58,severe hypofunction of the pituitary adrenal axis is usually associated with subnormal plasma cortisol values but a low basal level is not per se evidence of adrenal insufficiency and does not suffice to make the diagnosis,0
3725,3725,3725,3725,3725,3725,3725,4580,4580,4580,4580,4580,4580,4580,4580,4580,4580,4580,4580,4580,90306296-77ef-4123-9f86-8a662523cc58,many patients with proven insufficiency will have normal basal levels and will develop signs of insufficiency only when stressed,0
3726,3726,3726,3726,3726,3726,3726,4581,4581,4581,4581,4581,4581,4581,4581,4581,4581,4581,4581,4581,90306296-77ef-4123-9f86-8a662523cc58,for this reason a criterion which should be used in establishing the diagnosis is the failure to respond to adequate corticotropin stimulation,0
3727,3727,3727,3727,3727,3727,3727,4582,4582,4582,4582,4582,4582,4582,4582,4582,4582,4582,4582,4582,90306296-77ef-4123-9f86-8a662523cc58,when presumptive adrenal insufficiency is diagnosed by a subnormal cortrosyn test  further studies are indicated to determine if it is primary or secondary,0
3728,3728,3728,3728,3728,3728,3728,4583,4583,4583,4583,4583,4583,4583,4583,4583,4583,4583,4583,4583,90306296-77ef-4123-9f86-8a662523cc58,primary adrenal insufficiency ( addison 's disease ) is the result of an intrinsic disease process  such as tuberculosis within the gland,0
3729,3729,3729,3729,3729,3729,3729,4584,4584,4584,4584,4584,4584,4584,4584,4584,4584,4584,4584,4584,90306296-77ef-4123-9f86-8a662523cc58,the production of adrenocortical hormones is deficient despite high acth levels ( feedback mechanism ),0
3730,3730,3730,3730,3730,3730,3730,4585,4585,4585,4585,4585,4585,4585,4585,4585,4585,4585,4585,4585,90306296-77ef-4123-9f86-8a662523cc58,secondary or relative insufficiency arises as the result of defective production of acth leading in turn to disuse atrophy of the adrenal cortex,0
3731,3731,3731,3731,3731,3731,3731,4586,4586,4586,4586,4586,4586,4586,4586,4586,4586,4586,4586,4586,90306296-77ef-4123-9f86-8a662523cc58,it is commonly seen  for example  as result of corticosteroid therapy  sheehan 's syndrome and pituitary tumors or ablation,0
3732,3732,3732,3732,3732,3732,3732,4587,4587,4587,4587,4587,4587,4587,4587,4587,4587,4587,4587,4587,90306296-77ef-4123-9f86-8a662523cc58,the differentiation of both types is based on the premise that a primarily defective gland cannot be stimulated by acth whereas a secondarily defective gland is potentially functional and will respond to adequate stimulation with acth,0
3733,3733,3733,3733,3733,3733,3733,4588,4588,4588,4588,4588,4588,4588,4588,4588,4588,4588,4588,4588,90306296-77ef-4123-9f86-8a662523cc58,patients selected for further study as the result of a subnormal cortrosyn test should be given a 3 or 4 day course of treatment with repository corticotropin injection usp and then retested,0
3734,3734,3734,3734,3734,3734,3734,4589,4589,4589,4589,4589,4589,4589,4589,4589,4589,4589,4589,4589,90306296-77ef-4123-9f86-8a662523cc58,suggested doses are 40 usp units twice daily for 4 days or 60 usp units twice daily for 3 days,0
3735,3735,3735,3735,3735,3735,3735,4590,4590,4590,4590,4590,4590,4590,4590,4590,4590,4590,4590,4590,90306296-77ef-4123-9f86-8a662523cc58,under these conditions little or no increase in plasma cortisol levels will be seen in addison 's disease whereas higher or even normal levels will be seen in cases with secondary adrenal insufficiency,0
3736,3736,3736,3736,3736,3736,3736,4591,4591,4591,4591,4591,4591,4591,4591,4591,4591,4591,4591,4591,040477e0-abc7-455b-b15e-74a9ba5fff36, diphenoxylate hcl and atropine sulfate tablets are indicated as adjunctive therapy in the management of diarrhea in patients 13 years of age and older,1
3737,3737,3737,3737,3737,3737,3737,4592,4592,4592,4592,4592,4592,4592,4592,4592,4592,4592,4592,4592,61e84808-0999-4923-910c-2a480d5f971a,indications quadramet is indicated for relief of pain in patients with confirmed osteoblastic metastatic bone lesions that enhance on radionuclide bone scan,1
3738,3738,3738,3738,3738,3738,3738,4593,4593,4593,4593,4593,4593,4593,4593,4593,4593,4593,4593,4593,2fa3c528-1777-4628-8a55-a69dae2381a3,1  benlysta ( belimumab ) is indicated for the treatment of adult patients with active  autoantibody positive  systemic lupus erythematosus ( sle ) who are receiving standard therapy,1
3739,3739,3739,3739,3739,3739,3739,4594,4594,4594,4594,4594,4594,4594,4594,4594,4594,4594,4594,4594,2fa3c528-1777-4628-8a55-a69dae2381a3,limitations of use the efficacy of benlysta has not been evaluated in patients with severe active lupus nephritis or severe active central nervous system lupus,2
3740,3740,3740,3740,3740,3740,3740,4595,4595,4595,4595,4595,4595,4595,4595,4595,4595,4595,4595,4595,2fa3c528-1777-4628-8a55-a69dae2381a3,benlysta has not been studied in combination with other biologics or intravenous cyclophosphamide,0
3741,3741,3741,3741,3741,3741,3741,4596,4596,4596,4596,4596,4596,4596,4596,4596,4596,4596,4596,4596,2fa3c528-1777-4628-8a55-a69dae2381a3,use of benlysta is not recommended in these situations,2
3742,3742,3742,3742,3742,3742,3742,4597,4597,4597,4597,4597,4597,4597,4597,4597,4597,4597,4597,4597,2fa3c528-1777-4628-8a55-a69dae2381a3,benlysta is a b lymphocyte stimulator ( blys ) specific inhibitor indicated for the treatment of adult patients with active  autoantibody positive  systemic lupus erythematosus who are receiving standard therapy,1
3743,3743,3743,3743,3743,3743,3743,4598,4598,4598,4598,4598,4598,4598,4598,4598,4598,4598,4598,4598,2fa3c528-1777-4628-8a55-a69dae2381a3,( 1 ) limitations of use the efficacy of benlysta has not been evaluated in patients with severe active lupus nephritis or severe active central nervous system lupus,2
3744,3744,3744,3744,3744,3744,3744,4601,4601,4601,4601,4601,4601,4601,4601,4601,4601,4601,4601,4601,48cad559-c17b-4d41-a154-e664e958c1c0,1  digoxin tablets  usp are a cardiac glycoside indicated for treatment of mild to moderate heart failure in adults,1
3745,3745,3745,3745,3745,3745,3745,4602,4602,4602,4602,4602,4602,4602,4602,4602,4602,4602,4602,4602,48cad559-c17b-4d41-a154-e664e958c1c0,( 1 1 ) increasing myocardial contractility in pediatric patients with heart failure,1
3746,3746,3746,3746,3746,3746,3746,4603,4603,4603,4603,4603,4603,4603,4603,4603,4603,4603,4603,4603,48cad559-c17b-4d41-a154-e664e958c1c0,( 1 2 ) control of resting ventricular rate in patients with chronic atrial fibrillation in adults,1
3747,3747,3747,3747,3747,3747,3747,4604,4604,4604,4604,4604,4604,4604,4604,4604,4604,4604,4604,4604,48cad559-c17b-4d41-a154-e664e958c1c0,( 1 3 ) 1 1 heart failure in adults digoxin tablets  usp are indicated for the treatment of mild to moderate heart failure in adults,1
3748,3748,3748,3748,3748,3748,3748,4605,4605,4605,4605,4605,4605,4605,4605,4605,4605,4605,4605,4605,48cad559-c17b-4d41-a154-e664e958c1c0,digoxin tablets  usp increase left ventricular ejection fraction and improve heart failure symptoms as evidenced by improved exercise capacity and decreased heart failure related hospitalizations and emergency care  while having no effect on mortality,1
3749,3749,3749,3749,3749,3749,3749,4606,4606,4606,4606,4606,4606,4606,4606,4606,4606,4606,4606,4606,48cad559-c17b-4d41-a154-e664e958c1c0,where possible  digoxin tablets  usp should be used in combination with a diuretic and an angiotensin converting enzyme ( ace ) inhibitor,1
3750,3750,3750,3750,3750,3750,3750,4607,4607,4607,4607,4607,4607,4607,4607,4607,4607,4607,4607,4607,48cad559-c17b-4d41-a154-e664e958c1c0,1 2 heart failure in pediatric patients digoxin tablets  usp increase myocardial contractility in pediatric patients with heart failure,1
3751,3751,3751,3751,3751,3751,3751,4608,4608,4608,4608,4608,4608,4608,4608,4608,4608,4608,4608,4608,48cad559-c17b-4d41-a154-e664e958c1c0,1 3 atrial fibrillation in adults digoxin tablets  usp are indicated for the control of ventricular response rate in adult patients with chronic atrial fibrillation,1
3752,3752,3752,3752,3752,3752,3752,4609,4609,4609,4609,4609,4609,4609,4609,4609,4609,4609,4609,4609,3c91d0d8-6cc5-834c-bda0-aa83a873b9fb,indications usage mdp 25 ( kit for the preparation of technetium tc 99m medronate ) may be used as a bone imaging agent to delineate areas of altered osteogenesis,u
3753,3753,3753,3753,3753,3753,3753,4610,4610,4610,4610,4610,4610,4610,4610,4610,4610,4610,4610,4610,88ecef82-6c3c-419b-9138-921fea04913a,indications usage methazel is indicated for the distinct nutritional requirements of patients in need of dietary supplementation as determined by a licensed medical practitioner,1
3754,3754,3754,3754,3754,3754,3754,4611,4611,4611,4611,4611,4611,4611,4611,4611,4611,4611,4611,4611,88ecef82-6c3c-419b-9138-921fea04913a,methazel should be administered under the supervision o f a licensed medical practitioner,4
3755,3755,3755,3755,3755,3755,3755,4612,4612,4612,4612,4612,4612,4612,4612,4612,4612,4612,4612,4612,9984267a-4d57-4444-9bb5-16bca7dea691,1  panhematin is a hemin for injection indicated for the amelioration of recurrent attacks of acute intermittent porphyria temporally related to the menstrual cycle in susceptible women  after initial carbohydrate therapy is known or suspected to be inadequate,1
3756,3756,3756,3756,3756,3756,3756,4613,4613,4613,4613,4613,4613,4613,4613,4613,4613,4613,4613,4613,9984267a-4d57-4444-9bb5-16bca7dea691,limitations of use before administering panhematin  consider an appropriate period of carbohydrate loading ( i e  400 g glucose day for 1 to 2 days ) see dosage and administration ( 2 1 ),4
3757,3757,3757,3757,3757,3757,3757,4614,4614,4614,4614,4614,4614,4614,4614,4614,4614,4614,4614,4614,9984267a-4d57-4444-9bb5-16bca7dea691,attacks of porphyria may progress to a point where irreversible neuronal damage has occurred,0
3758,3758,3758,3758,3758,3758,3758,4615,4615,4615,4615,4615,4615,4615,4615,4615,4615,4615,4615,4615,9984267a-4d57-4444-9bb5-16bca7dea691,panhematin therapy is intended to prevent an attack from reaching the critical stage of neuronal degeneration,u
3759,3759,3759,3759,3759,3759,3759,4616,4616,4616,4616,4616,4616,4616,4616,4616,4616,4616,4616,4616,9984267a-4d57-4444-9bb5-16bca7dea691,panhematin is not effective in repairing neuronal damage,0
3760,3760,3760,3760,3760,3760,3760,4617,4617,4617,4617,4617,4617,4617,4617,4617,4617,4617,4617,4617,9984267a-4d57-4444-9bb5-16bca7dea691,panhematin is a hemin for injection indicated for amelioration of recurrent attacks of acute intermittent porphyria temporally related to the menstrual cycle in susceptible women  after initial carbohydrate therapy is known or suspected to be inadequate,1
3761,3761,3761,3761,3761,3761,3761,4618,4618,4618,4618,4618,4618,4618,4618,4618,4618,4618,4618,4618,9984267a-4d57-4444-9bb5-16bca7dea691,( 1 ) limitations of use before administering panhematin  consider an appropriate period of carbohydrate loading ( i e  400 g glucose day for 1 to 2 days ),4
3762,3762,3762,3762,3762,3762,3762,4619,4619,4619,4619,4619,4619,4619,4619,4619,4619,4619,4619,4619,9984267a-4d57-4444-9bb5-16bca7dea691,( 1 ) panhematin is not effective in repairing neuronal damage due to progression of porphyria attacks,0
3763,3763,3763,3763,3763,3763,3763,4620,4620,4620,4620,4620,4620,4620,4620,4620,4620,4620,4620,4620,3023cc56-ed4b-4e87-b3a1-81b20943f658,1  hylenex recombinant is an endoglycosidase indicated as an adjuvant in subcutaneous fluid administration for achieving hydration ( 1 1 ) to increase the dispersion and absorption of other injected drugs ( 1 2 ) in subcutaneous urography for improving resorption of radiopaque agents ( 1 3 ) 1 1 subcutaneous fluid administration hylenex recombinant is indicated as an adjuvant in subcutaneous fluid administration for achieving hydration,1
3764,3764,3764,3764,3764,3764,3764,4621,4621,4621,4621,4621,4621,4621,4621,4621,4621,4621,4621,4621,3023cc56-ed4b-4e87-b3a1-81b20943f658,1 2 dispersion and absorption of injected drugs hylenex recombinant is indicated as an adjuvant to increase the dispersion and absorption of other injected drugs,1
3765,3765,3765,3765,3765,3765,3765,4622,4622,4622,4622,4622,4622,4622,4622,4622,4622,4622,4622,4622,3023cc56-ed4b-4e87-b3a1-81b20943f658,1 3 subcutaneous urography hylenex recombinant is indicated as an adjunct in subcutaneous urography for improving resorption of radiopaque agents,1
3766,3766,3766,3766,3766,3766,3766,4623,4623,4623,4623,4623,4623,4623,4623,4623,4623,4623,4623,4623,1727cc16-4f86-4f13-b8b5-804d4984fa8c,1  adlyxin is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus,1
3767,3767,3767,3767,3767,3767,3767,4624,4624,4624,4624,4624,4624,4624,4624,4624,4624,4624,4624,4624,1727cc16-4f86-4f13-b8b5-804d4984fa8c,adlyxin is a glucagon like peptide 1 ( glp 1 ) receptor agonist indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus ( 1 ),1
3768,3768,3768,3768,3768,3768,3768,4625,4625,4625,4625,4625,4625,4625,4625,4625,4625,4625,4625,4625,1727cc16-4f86-4f13-b8b5-804d4984fa8c,limitations of use ( 1 ) has not been studied in patients with chronic pancreatitis or a history of unexplained pancreatitis,0
3769,3769,3769,3769,3769,3769,3769,4627,4627,4627,4627,4627,4627,4627,4627,4627,4627,4627,4627,4627,1727cc16-4f86-4f13-b8b5-804d4984fa8c,not for treatment of type 1 diabetes or diabetic ketoacidosis,0
3770,3770,3770,3770,3770,3770,3770,4628,4628,4628,4628,4628,4628,4628,4628,4628,4628,4628,4628,4628,1727cc16-4f86-4f13-b8b5-804d4984fa8c,has not been studied in combination with short acting insulin,0
3771,3771,3771,3771,3771,3771,3771,4629,4629,4629,4629,4629,4629,4629,4629,4629,4629,4629,4629,4629,1727cc16-4f86-4f13-b8b5-804d4984fa8c,has not been studied in patients with gastroparesis and is not recommended in patients with gastroparesis,2
3772,3772,3772,3772,3772,3772,3772,4630,4630,4630,4630,4630,4630,4630,4630,4630,4630,4630,4630,4630,1727cc16-4f86-4f13-b8b5-804d4984fa8c,limitations of use adlyxin has not been studied in patients with chronic pancreatitis or a history of unexplained pancreatitis,0
3773,3773,3773,3773,3773,3773,3773,4632,4632,4632,4632,4632,4632,4632,4632,4632,4632,4632,4632,4632,1727cc16-4f86-4f13-b8b5-804d4984fa8c,adlyxin is not a substitute for insulin,0
3774,3774,3774,3774,3774,3774,3774,4633,4633,4633,4633,4633,4633,4633,4633,4633,4633,4633,4633,4633,1727cc16-4f86-4f13-b8b5-804d4984fa8c,adlyxin is not indicated for use in patients with type 1 diabetes mellitus or for treatment of diabetic ketoacidosis,0
3775,3775,3775,3775,3775,3775,3775,4634,4634,4634,4634,4634,4634,4634,4634,4634,4634,4634,4634,4634,1727cc16-4f86-4f13-b8b5-804d4984fa8c,the concurrent use of adlyxin with short acting insulin has not been studied and is not recommended,2
3776,3776,3776,3776,3776,3776,3776,4635,4635,4635,4635,4635,4635,4635,4635,4635,4635,4635,4635,4635,1727cc16-4f86-4f13-b8b5-804d4984fa8c,adlyxin has not been studied in patients with gastroparesis and is not recommended in patients with gastroparesis,2
3777,3777,3777,3777,3777,3777,3777,4636,4636,4636,4636,4636,4636,4636,4636,4636,4636,4636,4636,4636,ebaa2dd9-257e-4a68-ab6a-fb2791bb62ce,1  bevyxxa is indicated for the prophylaxis of venous thromboembolism ( vte ) in adult patients hospitalized for an acute medical illness who are at risk for thromboembolic complications due to moderate or severe restricted mobility and other risk factors for vte see clinical studies ( 14 ),1
3778,3778,3778,3778,3778,3778,3778,4637,4637,4637,4637,4637,4637,4637,4637,4637,4637,4637,4637,4637,ebaa2dd9-257e-4a68-ab6a-fb2791bb62ce,bevyxxa is a factor xa ( fxa ) inhibitor indicated for the prophylaxis of venous thromboembolism ( vte ) in adult patients hospitalized for an acute medical illness who are at risk for thromboembolic complications due to moderate or severe restricted mobility and other risk factors for vte,1
3779,3779,3779,3779,3779,3779,3779,4638,4638,4638,4638,4638,4638,4638,4638,4638,4638,4638,4638,4638,ebaa2dd9-257e-4a68-ab6a-fb2791bb62ce,( 1 ) limitations of use safety and efficacy of bevyxxa have not been established in patients with prosthetic heart valves because this population has not been studied,0
3780,3780,3780,3780,3780,3780,3780,4639,4639,4639,4639,4639,4639,4639,4639,4639,4639,4639,4639,4639,ebaa2dd9-257e-4a68-ab6a-fb2791bb62ce,( 1 ) limitations of use the safety and effectiveness of bevyxxa have not been established in patients with prosthetic heart valves because this population has not been studied,0
3781,3781,3781,3781,3781,3781,3781,4640,4640,4640,4640,4640,4640,4640,4640,4640,4640,4640,4640,4640,be485a4c-aba3-43fa-9904-403595bc3f96,1  alfuzosin hydrochloride extended release tablets are indicated for the treatment of signs and symptoms of benign prostatic hyperplasia,1
3782,3782,3782,3782,3782,3782,3782,4641,4641,4641,4641,4641,4641,4641,4641,4641,4641,4641,4641,4641,be485a4c-aba3-43fa-9904-403595bc3f96,alfuzosin hydrochloride extended release tablets  an alpha adrenergic antagonist  are indicated for the treatment of signs and symptoms of benign prostatic hyperplasia,1
3783,3783,3783,3783,3783,3783,3783,4642,4642,4642,4642,4642,4642,4642,4642,4642,4642,4642,4642,4642,be485a4c-aba3-43fa-9904-403595bc3f96,( 1 ) important limitations of use alfuzosin hydrochloride extended release tablets are not indicated for treatment of hypertension,0
3784,3784,3784,3784,3784,3784,3784,4643,4643,4643,4643,4643,4643,4643,4643,4643,4643,4643,4643,4643,be485a4c-aba3-43fa-9904-403595bc3f96,( 1 1 ) alfuzosin hydrochloride extended release tablets are not indicated for use in the pediatric population,0
3785,3785,3785,3785,3785,3785,3785,4644,4644,4644,4644,4644,4644,4644,4644,4644,4644,4644,4644,4644,be485a4c-aba3-43fa-9904-403595bc3f96,( 1 1  8 4  12 3 ) 1 1 important limitations of use alfuzosin hydrochloride extended release tablets are not indicated for the treatment of hypertension,2
3786,3786,3786,3786,3786,3786,3786,4645,4645,4645,4645,4645,4645,4645,4645,4645,4645,4645,4645,4645,be485a4c-aba3-43fa-9904-403595bc3f96,alfuzosin hydrochloride extended release tablets are not indicated for use in the pediatric population,2
3787,3787,3787,3787,3787,3787,3787,4646,4646,4646,4646,4646,4646,4646,4646,4646,4646,4646,4646,4646,048f5b08-71ff-4b14-bafa-922ce27a6213,1  flurazepam hydrochloride capsules  usp are indicated for the treatment of insomnia characterized by difficulty in falling asleep  frequent nocturnal awakenings  and or early morning awakenings see clinical studies ( 14 ),1
3788,3788,3788,3788,3788,3788,3788,4647,4647,4647,4647,4647,4647,4647,4647,4647,4647,4647,4647,4647,048f5b08-71ff-4b14-bafa-922ce27a6213,since insomnia is often transient and intermittent  short term use is usually sufficient,4
3789,3789,3789,3789,3789,3789,3789,4648,4648,4648,4648,4648,4648,4648,4648,4648,4648,4648,4648,4648,048f5b08-71ff-4b14-bafa-922ce27a6213,prolonged use of hypnotics is usually not indicated and should only be undertaken concomitantly with appropriate evaluation of the patient,0
3790,3790,3790,3790,3790,3790,3790,4649,4649,4649,4649,4649,4649,4649,4649,4649,4649,4649,4649,4649,048f5b08-71ff-4b14-bafa-922ce27a6213,flurazepam  a gamma aminobutyric ( gaba a ) agonist  is indicated for the treatment of insomnia characterized by difficulty falling asleep  frequent nocturnal awakenings  and or early morning awakenings,1
3791,3791,3791,3791,3791,3791,3791,4650,4650,4650,4650,4650,4650,4650,4650,4650,4650,4650,4650,4650,a9b01bc6-95ac-46f9-befa-d845a74d53c1, emcyt capsules are indicated in the palliative treatment of patients with metastatic and or progressive carcinoma of the prostate,1
3792,3792,3792,3792,3792,3792,3792,4651,4651,4651,4651,4651,4651,4651,4651,4651,4651,4651,4651,4651,5150d9d9-01dc-4a52-9858-214c66d8caea,1  vaprisol is indicated to raise serum sodium in hospitalized patients with euvolemic and hypervolemic hyponatremia,1
3793,3793,3793,3793,3793,3793,3793,4652,4652,4652,4652,4652,4652,4652,4652,4652,4652,4652,4652,4652,5150d9d9-01dc-4a52-9858-214c66d8caea,vaprisol is a vasopressin receptor antagonist indicated to raise serum sodium in hospitalized patients with euvolemic and hypervolemic hyponatremia ( 1 ),1
3794,3794,3794,3794,3794,3794,3794,4653,4653,4653,4653,4653,4653,4653,4653,4653,4653,4653,4653,4653,5150d9d9-01dc-4a52-9858-214c66d8caea,limitations of use vaprisol has not been shown to be effective for the treatment of the signs and symptoms of heart failure ( 1 ),0
3795,3795,3795,3795,3795,3795,3795,4654,4654,4654,4654,4654,4654,4654,4654,4654,4654,4654,4654,4654,5150d9d9-01dc-4a52-9858-214c66d8caea,it has not been established that raising serum sodium with vaprisol provides a symptomatic benefit to patients ( 1 ),0
3796,3796,3796,3796,3796,3796,3796,4655,4655,4655,4655,4655,4655,4655,4655,4655,4655,4655,4655,4655,5150d9d9-01dc-4a52-9858-214c66d8caea,limitations of use vaprisol has not been shown to be effective for the treatment of the signs and symptoms of heart failure and is not approved for this indication,0
3797,3797,3797,3797,3797,3797,3797,4656,4656,4656,4656,4656,4656,4656,4656,4656,4656,4656,4656,4656,5150d9d9-01dc-4a52-9858-214c66d8caea,it has not been established that raising serum sodium with vaprisol provides a symptomatic benefit to patients,0
3798,3798,3798,3798,3798,3798,3798,4657,4657,4657,4657,4657,4657,4657,4657,4657,4657,4657,4657,4657,4c486fc7-c8c4-4c6c-b30c-366dabaeaadd,1  horizant is indicated for treatment of moderate to severe primary restless legs syndrome ( rls ) in adults,1
3799,3799,3799,3799,3799,3799,3799,4658,4658,4658,4658,4658,4658,4658,4658,4658,4658,4658,4658,4658,4c486fc7-c8c4-4c6c-b30c-366dabaeaadd,( 1 1 ) management of postherpetic neuralgia ( phn ) in adults,1
3800,3800,3800,3800,3800,3800,3800,4659,4659,4659,4659,4659,4659,4659,4659,4659,4659,4659,4659,4659,4c486fc7-c8c4-4c6c-b30c-366dabaeaadd,( 1 2 ) 1 1 treatment of restless legs syndrome horizant ( gabapentin enacarbil ) extended release tablets are indicated for the treatment of moderate to severe primary restless legs syndrome ( rls ) in adults,1
3801,3801,3801,3801,3801,3801,3801,4660,4660,4660,4660,4660,4660,4660,4660,4660,4660,4660,4660,4660,4c486fc7-c8c4-4c6c-b30c-366dabaeaadd,horizant is not recommended for patients who are required to sleep during the daytime and remain awake at night,2
3802,3802,3802,3802,3802,3802,3802,4661,4661,4661,4661,4661,4661,4661,4661,4661,4661,4661,4661,4661,4c486fc7-c8c4-4c6c-b30c-366dabaeaadd,1 2 management of postherpetic neuralgia horizant ( gabapentin enacarbil ) extended release tablets are indicated for the management of postherpetic neuralgia ( phn ) in adults,1
3803,3803,3803,3803,3803,3803,3803,4662,4662,4662,4662,4662,4662,4662,4662,4662,4662,4662,4662,4662,4e2c9856-1836-49f0-9472-4dbeeb408f39, acromegaly sandostatin ( octreotide acetate ) is indicated to reduce blood levels of growth hormone and igf i ( somatomedin c ) in acromegaly patients who have had inadequate response to or cannot be treated with surgical resection  pituitary irradiation  and bromocriptine mesylate at maximally tolerated doses,1
3804,3804,3804,3804,3804,3804,3804,4663,4663,4663,4663,4663,4663,4663,4663,4663,4663,4663,4663,4663,4e2c9856-1836-49f0-9472-4dbeeb408f39,the goal is to achieve normalization of growth hormone and igf i ( somatomedin c ) levels ( see dosage and administration ),0
3805,3805,3805,3805,3805,3805,3805,4664,4664,4664,4664,4664,4664,4664,4664,4664,4664,4664,4664,4664,4e2c9856-1836-49f0-9472-4dbeeb408f39,in patients with acromegaly  sandostatin reduces growth hormone to within normal ranges in 50 of patients and reduces igf i ( somatomedin c ) to within normal ranges in 50 60 of patients,0
3806,3806,3806,3806,3806,3806,3806,4665,4665,4665,4665,4665,4665,4665,4665,4665,4665,4665,4665,4665,4e2c9856-1836-49f0-9472-4dbeeb408f39,since the effects of pituitary irradiation may not become maximal for several years  adjunctive therapy with sandostatin to reduce blood levels of growth hormone and igf i ( somatomedin c ) offers potential benefit before the effects of irradiation are manifested,u
3807,3807,3807,3807,3807,3807,3807,4666,4666,4666,4666,4666,4666,4666,4666,4666,4666,4666,4666,4666,4e2c9856-1836-49f0-9472-4dbeeb408f39,improvement in clinical signs and symptoms or reduction in tumor size or rate of growth were not shown in clinical trials performed with sandostatin these trials were not optimally designed to detect such effects,0
3808,3808,3808,3808,3808,3808,3808,4667,4667,4667,4667,4667,4667,4667,4667,4667,4667,4667,4667,4667,4e2c9856-1836-49f0-9472-4dbeeb408f39,carcinoid tumors sandostatin is indicated for the symptomatic treatment of patients with metastatic carcinoid tumors where it suppresses or inhibits the severe diarrhea and flushing episodes associated with the disease,1
3809,3809,3809,3809,3809,3809,3809,4668,4668,4668,4668,4668,4668,4668,4668,4668,4668,4668,4668,4668,4e2c9856-1836-49f0-9472-4dbeeb408f39,sandostatin studies were not designed to show an effect on the size  rate of growth or development of metastases,0
3810,3810,3810,3810,3810,3810,3810,4669,4669,4669,4669,4669,4669,4669,4669,4669,4669,4669,4669,4669,4e2c9856-1836-49f0-9472-4dbeeb408f39,vasoactive intestinal peptide tumors ( vipomas ) sandostatin is indicated for the treatment of the profuse watery diarrhea associated with vip secreting tumors,1
3811,3811,3811,3811,3811,3811,3811,4671,4671,4671,4671,4671,4671,4671,4671,4671,4671,4671,4671,4671,31fe1e75-da67-4e6d-a529-8b82905dad45, vivotif ( typhoid vaccine live oral ty21a ) is indicated for immunization of adults and children greater than 6 years of age against disease caused by salmonella typhi,1
3812,3812,3812,3812,3812,3812,3812,4672,4672,4672,4672,4672,4672,4672,4672,4672,4672,4672,4672,4672,31fe1e75-da67-4e6d-a529-8b82905dad45,routine typhoid vaccination is not recommended in the united states of america,u
3813,3813,3813,3813,3813,3813,3813,4673,4673,4673,4673,4673,4673,4673,4673,4673,4673,4673,4673,4673,31fe1e75-da67-4e6d-a529-8b82905dad45,selective immunization against typhoid fever is recommended for the following groups 1 ) travelers to areas in which there is a recognized risk of exposure to s typhi  2 ) persons with intimate exposure ( e g,u
3814,3814,3814,3814,3814,3814,3814,4674,4674,4674,4674,4674,4674,4674,4674,4674,4674,4674,4674,4674,31fe1e75-da67-4e6d-a529-8b82905dad45,household contact ) to a s typhi carrier  and 3 ) microbiology laboratorians who work frequently with s typhi ( 7 ),u
3815,3815,3815,3815,3815,3815,3815,4675,4675,4675,4675,4675,4675,4675,4675,4675,4675,4675,4675,4675,31fe1e75-da67-4e6d-a529-8b82905dad45,there is no evidence to support the use of typhoid vaccine to control common source outbreaks  disease following natural disasters or in persons attending rural summer camps,0
3816,3816,3816,3816,3816,3816,3816,4676,4676,4676,4676,4676,4676,4676,4676,4676,4676,4676,4676,4676,31fe1e75-da67-4e6d-a529-8b82905dad45,not all recipients of vivotif will be fully protected against typhoid fever,0
3817,3817,3817,3817,3817,3817,3817,4677,4677,4677,4677,4677,4677,4677,4677,4677,4677,4677,4677,4677,31fe1e75-da67-4e6d-a529-8b82905dad45,vaccinated individuals should continue to take personal precautions against exposure to typhoid organisms,0
3818,3818,3818,3818,3818,3818,3818,4678,4678,4678,4678,4678,4678,4678,4678,4678,4678,4678,4678,4678,31fe1e75-da67-4e6d-a529-8b82905dad45,the vaccine will not afford protection against species of salmonella other than salmonella typhi or other bacteria that cause enteric disease,0
3819,3819,3819,3819,3819,3819,3819,4679,4679,4679,4679,4679,4679,4679,4679,4679,4679,4679,4679,4679,31fe1e75-da67-4e6d-a529-8b82905dad45,the vaccine is not suitable for treatment of acute infections with s typhi,0
3820,3820,3820,3820,3820,3820,3820,4680,4680,4680,4680,4680,4680,4680,4680,4680,4680,4680,4680,4680,2fbcc40c-f102-4abe-bce5-a93de95874fe, prepen is indicated for the assessment of sensitization to penicillin ( benzylpenicillin or penicillin g ) in patients suspected to have clinical penicillin hypersensitivity,1
3821,3821,3821,3821,3821,3821,3821,4681,4681,4681,4681,4681,4681,4681,4681,4681,4681,4681,4681,4681,2fbcc40c-f102-4abe-bce5-a93de95874fe,a negative skin test to prepen is associated with an incidence of immediate allergic reactions of less than 5 after the administration of therapeutic penicillin  whereas the incidence may be more than 50 in a history positive patient with a positive skin test to prepen,0
3822,3822,3822,3822,3822,3822,3822,4682,4682,4682,4682,4682,4682,4682,4682,4682,4682,4682,4682,4682,2fbcc40c-f102-4abe-bce5-a93de95874fe,these allergic reactions are predominantly dermatologic,0
3823,3823,3823,3823,3823,3823,3823,4683,4683,4683,4683,4683,4683,4683,4683,4683,4683,4683,4683,4683,2fbcc40c-f102-4abe-bce5-a93de95874fe,whether a negative skin test to prepen predicts a lower risk of anaphylaxis is not established,0
3824,3824,3824,3824,3824,3824,3824,4684,4684,4684,4684,4684,4684,4684,4684,4684,4684,4684,4684,4684,2fbcc40c-f102-4abe-bce5-a93de95874fe,similarly  when deciding the risk of proposed penicillin treatment  there are not enough data at present to permit relative weighing in individual cases of a history of clinical penicillin hypersensitivity as compared to positive skin tests to prepen and or minor penicillin determinants,0
3825,3825,3825,3825,3825,3825,3825,4685,4685,4685,4685,4685,4685,4685,4685,4685,4685,4685,4685,4685,417aa15d-ac74-4fa8-a312-6e51e82ba70c,1  amitiza is a chloride channel activator indicated for treatment of chronic idiopathic constipation in adults ( 1 1 ) treatment of irritable bowel syndrome with constipation in women 18 years old ( 1 2 ) 1 1 chronic idiopathic constipation amitiza is indicated for the treatment of chronic idiopathic constipation in adults,1
3826,3826,3826,3826,3826,3826,3826,4686,4686,4686,4686,4686,4686,4686,4686,4686,4686,4686,4686,4686,417aa15d-ac74-4fa8-a312-6e51e82ba70c,1 2 irritable bowel syndrome with constipation amitiza is indicated for the treatment of irritable bowel syndrome with constipation ( ibs c ) in women 18 years old,1
3827,3827,3827,3827,3827,3827,3827,4687,4687,4687,4687,4687,4687,4687,4687,4687,4687,4687,4687,4687,65deb389-5367-4a16-8160-06d9d850781b, for symptomatic relief of anxiety and tension associated with psychoneurosis and as an adjunct in organic disease states in which anxiety is manifested,1
3828,3828,3828,3828,3828,3828,3828,4688,4688,4688,4688,4688,4688,4688,4688,4688,4688,4688,4688,4688,65deb389-5367-4a16-8160-06d9d850781b,useful in the management of pruritus due to allergic conditions such as chronic urticaria and atopic and contact dermatoses and in histamine mediated pruritus,1
3829,3829,3829,3829,3829,3829,3829,4689,4689,4689,4689,4689,4689,4689,4689,4689,4689,4689,4689,4689,65deb389-5367-4a16-8160-06d9d850781b,as a sedative when used as a premedication and following general anesthesia  hydroxyzine may potentiate meperidine and barbiturates  so their use in pre anesthetic adjunctive therapy should be modified on an individual basis,u
3830,3830,3830,3830,3830,3830,3830,4690,4690,4690,4690,4690,4690,4690,4690,4690,4690,4690,4690,4690,65deb389-5367-4a16-8160-06d9d850781b,atropine and other belladonna alkaloids are not affected by the drug,0
3831,3831,3831,3831,3831,3831,3831,4691,4691,4691,4691,4691,4691,4691,4691,4691,4691,4691,4691,4691,65deb389-5367-4a16-8160-06d9d850781b,hydroxyzine is not known to interfere with the action of digitalis in any way and it may be used concurrently with this agent,0
3832,3832,3832,3832,3832,3832,3832,4692,4692,4692,4692,4692,4692,4692,4692,4692,4692,4692,4692,4692,65deb389-5367-4a16-8160-06d9d850781b,the effectiveness of hydroxyzine as an antianxiety agent for long term use  that is more than 4 months  has not been assessed by systematic clinical studies,0
3833,3833,3833,3833,3833,3833,3833,4694,4694,4694,4694,4694,4694,4694,4694,4694,4694,4694,4694,4694,5accc7a5-8209-4680-b0ae-2a6963500419,1  picato gel is indicated for the topical treatment of actinic keratosis,1
3834,3834,3834,3834,3834,3834,3834,4695,4695,4695,4695,4695,4695,4695,4695,4695,4695,4695,4695,4695,5accc7a5-8209-4680-b0ae-2a6963500419,picato gel is an inducer of cell death indicated for the topical treatment of actinic keratosis,1
3835,3835,3835,3835,3835,3835,3835,4696,4696,4696,4696,4696,4696,4696,4696,4696,4696,4696,4696,4696,e2a5697a-cc41-4cf1-b3a8-59b0268740d7, opium tincture is useful for the treatment of diarrhea,1
3836,3836,3836,3836,3836,3836,3836,4697,4697,4697,4697,4697,4697,4697,4697,4697,4697,4697,4697,4697,f143db10-e889-41c3-84ed-603a0ab02f61, for the treatment of hypoglycemia glucagon is indicated as a treatment for severe hypoglycemia,1
3837,3837,3837,3837,3837,3837,3837,4698,4698,4698,4698,4698,4698,4698,4698,4698,4698,4698,4698,4698,f143db10-e889-41c3-84ed-603a0ab02f61,because patients with type 1 diabetes may have less of an increase in blood glucose levels compared with a stable type 2 patient  supplementary carbohydrate should be given as soon as possible  especially to a pediatric patient,0
3838,3838,3838,3838,3838,3838,3838,4699,4699,4699,4699,4699,4699,4699,4699,4699,4699,4699,4699,4699,f143db10-e889-41c3-84ed-603a0ab02f61,for use as a diagnostic aid glucagon is indicated as a diagnostic aid in the radiologic examination of the stomach  duodenum  small bowel  and colon when diminished intestinal motility would be advantageous,1
3839,3839,3839,3839,3839,3839,3839,4700,4700,4700,4700,4700,4700,4700,4700,4700,4700,4700,4700,4700,f143db10-e889-41c3-84ed-603a0ab02f61,glucagon is as effective for this examination as are the anticholinergic drugs,0
3840,3840,3840,3840,3840,3840,3840,4701,4701,4701,4701,4701,4701,4701,4701,4701,4701,4701,4701,4701,f143db10-e889-41c3-84ed-603a0ab02f61,however  the addition of the anticholinergic agent may result in increased side effects,0
3841,3841,3841,3841,3841,3841,3841,4702,4702,4702,4702,4702,4702,4702,4702,4702,4702,4702,4702,4702,328910be-4d0e-4d7b-a062-e3ce0cf793b9, flutamide capsules are indicated for use in combination with lhrh agonists for the management of locally confined stage b2 c and stage d2 metastatic carcinoma of the prostate,1
3842,3842,3842,3842,3842,3842,3842,4703,4703,4703,4703,4703,4703,4703,4703,4703,4703,4703,4703,4703,328910be-4d0e-4d7b-a062-e3ce0cf793b9,stage b2 c prostatic carcinoma treatment with flutamide capsules and the goserelin acetate implant should start 8 weeks prior to initiating radiation therapy and continue during radiation therapy,4
3843,3843,3843,3843,3843,3843,3843,4704,4704,4704,4704,4704,4704,4704,4704,4704,4704,4704,4704,4704,328910be-4d0e-4d7b-a062-e3ce0cf793b9,stage d2 metastatic carcinoma to achieve benefit from treatment  flutamide capsules should be initiated with the lhrh agonist and continued until progression,4
3844,3844,3844,3844,3844,3844,3844,4705,4705,4705,4705,4705,4705,4705,4705,4705,4705,4705,4705,4705,e19405d9-d9a1-4072-5b9e-40cd3ae4bf1f, crixivan in combination with antiretroviral agents is indicated for the treatment of hiv infection,1
3845,3845,3845,3845,3845,3845,3845,4706,4706,4706,4706,4706,4706,4706,4706,4706,4706,4706,4706,4706,e19405d9-d9a1-4072-5b9e-40cd3ae4bf1f,this indication is based on two clinical trials of approximately 1 year duration that demonstrated 1 ) a reduction in the risk of aids defining illnesses or death 2 ) a prolonged suppression of hiv rna,0
3846,3846,3846,3846,3846,3846,3846,4707,4707,4707,4707,4707,4707,4707,4707,4707,4707,4707,4707,4707,e19405d9-d9a1-4072-5b9e-40cd3ae4bf1f,description of studies in all clinical studies  with the exception of actg 320  the amplicor hiv monitor assay was used to determine the level of circulating hiv rna in serum,0
3847,3847,3847,3847,3847,3847,3847,4708,4708,4708,4708,4708,4708,4708,4708,4708,4708,4708,4708,4708,e19405d9-d9a1-4072-5b9e-40cd3ae4bf1f,this is an experimental use of the assay,0
3848,3848,3848,3848,3848,3848,3848,4709,4709,4709,4709,4709,4709,4709,4709,4709,4709,4709,4709,4709,e19405d9-d9a1-4072-5b9e-40cd3ae4bf1f,hiv rna results should not be directly compared to results from other trials using different hiv rna assays or using other sample sources,0
3849,3849,3849,3849,3849,3849,3849,4710,4710,4710,4710,4710,4710,4710,4710,4710,4710,4710,4710,4710,e19405d9-d9a1-4072-5b9e-40cd3ae4bf1f,study actg 320 was a multicenter  randomized  double blind clinical endpoint trial to compare the effect of crixivan in combination with zidovudine and lamivudine with that of zidovudine plus lamivudine on the progression to an aids defining illness ( adi ) or death,0
3850,3850,3850,3850,3850,3850,3850,4711,4711,4711,4711,4711,4711,4711,4711,4711,4711,4711,4711,4711,e19405d9-d9a1-4072-5b9e-40cd3ae4bf1f,patients were protease inhibitor and lamivudine naive and zidovudine experienced  with cd4 cell counts of 200 cells mm3,0
3851,3851,3851,3851,3851,3851,3851,4712,4712,4712,4712,4712,4712,4712,4712,4712,4712,4712,4712,4712,e19405d9-d9a1-4072-5b9e-40cd3ae4bf1f,the study enrolled 1156 hiv infected patients ( 17 female  28 black  18 hispanic  mean age 39 years ),0
3852,3852,3852,3852,3852,3852,3852,4713,4713,4713,4713,4713,4713,4713,4713,4713,4713,4713,4713,4713,e19405d9-d9a1-4072-5b9e-40cd3ae4bf1f,the mean baseline cd4 cell count was 87 cells mm3,0
3853,3853,3853,3853,3853,3853,3853,4714,4714,4714,4714,4714,4714,4714,4714,4714,4714,4714,4714,4714,e19405d9-d9a1-4072-5b9e-40cd3ae4bf1f,the mean baseline hiv rna was 4 95 log10 copies ml ( 89  035 copies ml ),0
3854,3854,3854,3854,3854,3854,3854,4715,4715,4715,4715,4715,4715,4715,4715,4715,4715,4715,4715,4715,e19405d9-d9a1-4072-5b9e-40cd3ae4bf1f,the study was terminated after a planned interim analysis  resulting in a median follow up of 38 weeks and a maximum follow up of 52 weeks,0
3855,3855,3855,3855,3855,3855,3855,4716,4716,4716,4716,4716,4716,4716,4716,4716,4716,4716,4716,4716,e19405d9-d9a1-4072-5b9e-40cd3ae4bf1f,results are shown in table 4 and figures 1 2,0
3856,3856,3856,3856,3856,3856,3856,4717,4717,4717,4717,4717,4717,4717,4717,4717,4717,4717,4717,4717,e19405d9-d9a1-4072-5b9e-40cd3ae4bf1f,table 4 actg 320 number ( ) of patients with aids defining illness or death endpoint idv zdv l ( n 577 ) zdv l ( n 579 ) idv indinavir  zdv zidovudine  l lamivudine hiv progression or death 35 ( 6 1 ) 63 ( 10 9 ) td align left valign top colspan 2 st,0
3857,3857,3857,3857,3857,3857,3857,4718,4718,4718,4718,4718,4718,4718,4718,4718,4718,4718,4718,4718,c155d6ba-9a16-406c-919e-65a149689ab9,1  decitabine for injection is indicated for treatment of patients with myelodysplastic syndromes ( mds ) including previously treated and untreated  de novo and secondary mds of all french american british subtypes ( refractory anemia  refractory anemia with ringed sideroblasts  refractory anemia with excess blasts  refractory anemia with excess blasts in transformation  and chronic myelomonocytic leukemia ) and intermediate 1  intermediate 2  and high risk international prognostic scoring system groups,1
3858,3858,3858,3858,3858,3858,3858,4719,4719,4719,4719,4719,4719,4719,4719,4719,4719,4719,4719,4719,c155d6ba-9a16-406c-919e-65a149689ab9,decitabine for injection is a nucleoside metabolic inhibitor indicated for treatment of patients with myelodysplastic syndromes ( mds ) including previously treated and untreated  de novo and secondary mds of all french american british subtypes ( refractory anemia  refractory anemia with ringed sideroblasts  refractory anemia with excess blasts  refractory anemia with excess blasts in transformation  and chronic myelomonocytic leukemia ) and intermediate 1  intermediate 2  and high risk international prognostic scoring system groups,1
3859,3859,3859,3859,3859,3859,3859,4724,4724,4724,4724,4724,4724,4724,4724,4724,4724,4724,4724,4724,4abecc19-e956-4d05-a51e-73dba23dc131,1  clobetasol propionate lotion  0 05  is a corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid responsive dermatoses  in patients 18 years of age or older ( 1 1 ),1
3860,3860,3860,3860,3860,3860,3860,4725,4725,4725,4725,4725,4725,4725,4725,4725,4725,4725,4725,4725,4abecc19-e956-4d05-a51e-73dba23dc131,limitations of use do not use on the face  axillae or groin,2
3861,3861,3861,3861,3861,3861,3861,4726,4726,4726,4726,4726,4726,4726,4726,4726,4726,4726,4726,4726,4abecc19-e956-4d05-a51e-73dba23dc131,( 1 2 ) do not use if atrophy is present at the treatment site,2
3862,3862,3862,3862,3862,3862,3862,4727,4727,4727,4727,4727,4727,4727,4727,4727,4727,4727,4727,4727,4abecc19-e956-4d05-a51e-73dba23dc131,( 1 2 ) do not use for rosacea or perioral dermatitis,2
3863,3863,3863,3863,3863,3863,3863,4728,4728,4728,4728,4728,4728,4728,4728,4728,4728,4728,4728,4728,4abecc19-e956-4d05-a51e-73dba23dc131,( 1 2 ) 1 1 indication clobetasol propionate lotion  0 05 is a super high potent topical corticosteroid formulation indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid responsive dermatoses only in patients 18 years of age or older,1
3864,3864,3864,3864,3864,3864,3864,4729,4729,4729,4729,4729,4729,4729,4729,4729,4729,4729,4729,4729,4abecc19-e956-4d05-a51e-73dba23dc131,treatment should be limited to 2 consecutive weeks,0
3865,3865,3865,3865,3865,3865,3865,4730,4730,4730,4730,4730,4730,4730,4730,4730,4730,4730,4730,4730,4abecc19-e956-4d05-a51e-73dba23dc131,for moderate to severe plaque psoriasis  treatment may be extended for an additional 2 weeks for localized lesions ( less than 10 body surface area ) that have not sufficiently improved after the initial 2 week treatment,0
3866,3866,3866,3866,3866,3866,3866,4731,4731,4731,4731,4731,4731,4731,4731,4731,4731,4731,4731,4731,4abecc19-e956-4d05-a51e-73dba23dc131,any additional benefits of extending treatment should be weighed against the risk of hypothalamic pituitary adrenal ( hpa ) axis suppression before prescribing for more than 2 weeks,3
3867,3867,3867,3867,3867,3867,3867,4732,4732,4732,4732,4732,4732,4732,4732,4732,4732,4732,4732,4732,4abecc19-e956-4d05-a51e-73dba23dc131,the total dosage should not exceed 50 g ( 50 ml or 1 75 fl,0
3868,3868,3868,3868,3868,3868,3868,4733,4733,4733,4733,4733,4733,4733,4733,4733,4733,4733,4733,4733,4abecc19-e956-4d05-a51e-73dba23dc131,patients should be instructed to use clobetasol propionate lotion  0 05  for the minimum amount of time necessary to achieve the desired results see dosage and administration ( 2 ),4
3869,3869,3869,3869,3869,3869,3869,4734,4734,4734,4734,4734,4734,4734,4734,4734,4734,4734,4734,4734,4abecc19-e956-4d05-a51e-73dba23dc131,use in patients under 18 years of age is not recommended due to numerically high rates of hpa axis suppression see warnings and precautions ( 5 1 ) and use in specific populations ( 8 4 ),0
3870,3870,3870,3870,3870,3870,3870,4735,4735,4735,4735,4735,4735,4735,4735,4735,4735,4735,4735,4735,4abecc19-e956-4d05-a51e-73dba23dc131,1 2 limitations of use clobetasol propionate lotion  0 05  should not be used on the face  axillae  or groin and should not be used if there is atrophy at the treatment site,2
3871,3871,3871,3871,3871,3871,3871,4736,4736,4736,4736,4736,4736,4736,4736,4736,4736,4736,4736,4736,4abecc19-e956-4d05-a51e-73dba23dc131,clobetasol propionate lotion  0 05 should not be used in the treatment of rosacea or perioral dermatitis,2
3872,3872,3872,3872,3872,3872,3872,4737,4737,4737,4737,4737,4737,4737,4737,4737,4737,4737,4737,4737,3e898141-8d40-49f1-e054-00144ff88e88, loperamide hydrochloride capsules are indicated for the control and symptomatic relief of acute nonspecific diarrhea and of chronic diarrhea associated with inflammatory bowel disease,1
3873,3873,3873,3873,3873,3873,3873,4738,4738,4738,4738,4738,4738,4738,4738,4738,4738,4738,4738,4738,3e898141-8d40-49f1-e054-00144ff88e88,loperamide hydrochloride capsules are also indicated for reducing the volume of discharge from ileostomies,1
3874,3874,3874,3874,3874,3874,3874,4739,4739,4739,4739,4739,4739,4739,4739,4739,4739,4739,4739,4739,bd936e35-1af8-42da-bcc0-f22489d68574, diuril is indicated as adjunctive therapy in edema associated with congestive heart failure  hepatic cirrhosis  and corticosteroid and estrogen therapy,1
3875,3875,3875,3875,3875,3875,3875,4740,4740,4740,4740,4740,4740,4740,4740,4740,4740,4740,4740,4740,bd936e35-1af8-42da-bcc0-f22489d68574,diuril has also been found useful in edema due to various forms of renal dysfunction such as nephrotic syndrome  acute glomerulonephritis  and chronic renal failure,u
3876,3876,3876,3876,3876,3876,3876,4741,4741,4741,4741,4741,4741,4741,4741,4741,4741,4741,4741,4741,bd936e35-1af8-42da-bcc0-f22489d68574,diuril is indicated in the management of hypertension either as the sole therapeutic agent or to enhance the effectiveness of other antihypertensive drugs in the more severe forms of hypertension,1
3877,3877,3877,3877,3877,3877,3877,4742,4742,4742,4742,4742,4742,4742,4742,4742,4742,4742,4742,4742,bd936e35-1af8-42da-bcc0-f22489d68574,routine use of diuretics during normal pregnancy is inappropriate and exposes mother and fetus to unnecessary hazard,0
3878,3878,3878,3878,3878,3878,3878,4743,4743,4743,4743,4743,4743,4743,4743,4743,4743,4743,4743,4743,bd936e35-1af8-42da-bcc0-f22489d68574,diuretics do not prevent development of toxemia of pregnancy and there is no satisfactory evidence that they are useful in the treatment of toxemia,0
3879,3879,3879,3879,3879,3879,3879,4744,4744,4744,4744,4744,4744,4744,4744,4744,4744,4744,4744,4744,bd936e35-1af8-42da-bcc0-f22489d68574,edema during pregnancy may arise from pathologic causes or from the physiologic and mechanical consequences of pregnancy,0
3880,3880,3880,3880,3880,3880,3880,4745,4745,4745,4745,4745,4745,4745,4745,4745,4745,4745,4745,4745,bd936e35-1af8-42da-bcc0-f22489d68574,thiazides are indicated in pregnancy when edema is due to pathologic causes  just as they are in the absence of pregnancy ( see precautions  pregnancy ),1
3881,3881,3881,3881,3881,3881,3881,4746,4746,4746,4746,4746,4746,4746,4746,4746,4746,4746,4746,4746,bd936e35-1af8-42da-bcc0-f22489d68574,dependent edema in pregnancy  resulting from restriction of venous return by the gravid uterus  is properly treated through elevation of the lower extremities and use of support stockings,0
3882,3882,3882,3882,3882,3882,3882,4747,4747,4747,4747,4747,4747,4747,4747,4747,4747,4747,4747,4747,bd936e35-1af8-42da-bcc0-f22489d68574,use of diuretics to lower intravascular volume in this instance is illogical and unnecessary,0
3883,3883,3883,3883,3883,3883,3883,4748,4748,4748,4748,4748,4748,4748,4748,4748,4748,4748,4748,4748,bd936e35-1af8-42da-bcc0-f22489d68574,during normal pregnancy there is hypervolemia which is not harmful to the fetus or the mother in the absence of cardiovascular disease,0
3884,3884,3884,3884,3884,3884,3884,4749,4749,4749,4749,4749,4749,4749,4749,4749,4749,4749,4749,4749,bd936e35-1af8-42da-bcc0-f22489d68574,however  it may be associated with edema  rarely generalized edema,0
3885,3885,3885,3885,3885,3885,3885,4750,4750,4750,4750,4750,4750,4750,4750,4750,4750,4750,4750,4750,bd936e35-1af8-42da-bcc0-f22489d68574,if such edema causes discomfort  increased recumbency will often provide relief,0
3886,3886,3886,3886,3886,3886,3886,4751,4751,4751,4751,4751,4751,4751,4751,4751,4751,4751,4751,4751,bd936e35-1af8-42da-bcc0-f22489d68574,rarely this edema may cause extreme discomfort which is not relieved by rest,0
3887,3887,3887,3887,3887,3887,3887,4752,4752,4752,4752,4752,4752,4752,4752,4752,4752,4752,4752,4752,bd936e35-1af8-42da-bcc0-f22489d68574,in these instances  a short course of diuretic therapy may provide relief and be appropriate,u
3888,3888,3888,3888,3888,3888,3888,4753,4753,4753,4753,4753,4753,4753,4753,4753,4753,4753,4753,4753,ac8a0f7b-9f69-4495-abbc-3a47cd75a859,1  xigduo xr ( dapagliflozin and metformin hcl extended release ) is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both dapagliflozin and metformin is appropriate see clinical studies ( 14 ),1
3889,3889,3889,3889,3889,3889,3889,4754,4754,4754,4754,4754,4754,4754,4754,4754,4754,4754,4754,4754,ac8a0f7b-9f69-4495-abbc-3a47cd75a859,xigduo xr is a combination of dapagliflozin  a sodium glucose cotransporter 2 ( sglt2 ) inhibitor  and metformin  a biguanide  indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both dapagliflozin and metformin is appropriate,1
3890,3890,3890,3890,3890,3890,3890,4755,4755,4755,4755,4755,4755,4755,4755,4755,4755,4755,4755,4755,ac8a0f7b-9f69-4495-abbc-3a47cd75a859,( 1 ) limitation of use not for treatment of type 1 diabetes mellitus or diabetic ketoacidosis,0
3891,3891,3891,3891,3891,3891,3891,4756,4756,4756,4756,4756,4756,4756,4756,4756,4756,4756,4756,4756,ac8a0f7b-9f69-4495-abbc-3a47cd75a859,( 1 1 ) 1 1 limitations of use xigduo xr is not recommended for patients with type 1 diabetes mellitus or diabetic ketoacidosis,0
3892,3892,3892,3892,3892,3892,3892,4757,4757,4757,4757,4757,4757,4757,4757,4757,4757,4757,4757,4757,14d98490-4f8f-4d2f-a4e9-7a3d7a0199ba,1  alogliptin and metformin hcl tablets are a dipeptidyl peptidase 4 ( dpp 4 ) inhibitor and a biguanide combination product indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus,1
3893,3893,3893,3893,3893,3893,3893,4758,4758,4758,4758,4758,4758,4758,4758,4758,4758,4758,4758,4758,14d98490-4f8f-4d2f-a4e9-7a3d7a0199ba,( 1 1 ) important limitations of use not for treatment of type 1 diabetes or diabetic ketoacidosis,2
3894,3894,3894,3894,3894,3894,3894,4759,4759,4759,4759,4759,4759,4759,4759,4759,4759,4759,4759,4759,14d98490-4f8f-4d2f-a4e9-7a3d7a0199ba,( 1 1 ) 1 1 monotherapy and combination therapy alogliptin and metformin hcl tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both alogliptin and metformin is appropriate see clinical studies ( 14 ),1
3895,3895,3895,3895,3895,3895,3895,4760,4760,4760,4760,4760,4760,4760,4760,4760,4760,4760,4760,4760,14d98490-4f8f-4d2f-a4e9-7a3d7a0199ba,important limitations of use alogliptin and metformin hcl tablets are not indicated for the treatment of type 1 diabetes mellitus or diabetic ketoacidosis  as it would not be effective in these settings,2
3896,3896,3896,3896,3896,3896,3896,4761,4761,4761,4761,4761,4761,4761,4761,4761,4761,4761,4761,4761,0fdd0255-0055-65f3-b2c0-db8fbb87beae,1  synjardy is a combination of empagliflozin and metformin hydrochloride indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both empagliflozin and metformin hydrochloride is appropriate,1
3897,3897,3897,3897,3897,3897,3897,4762,4762,4762,4762,4762,4762,4762,4762,4762,4762,4762,4762,4762,0fdd0255-0055-65f3-b2c0-db8fbb87beae,empagliflozin is indicated to reduce the risk of cardiovascular death in adults with type 2 diabetes mellitus and established cardiovascular disease see clinical studies ( 14 2 ),1
3898,3898,3898,3898,3898,3898,3898,4763,4763,4763,4763,4763,4763,4763,4763,4763,4763,4763,4763,4763,0fdd0255-0055-65f3-b2c0-db8fbb87beae,however  the effectiveness of synjardy on reducing the risk of cardiovascular death in adults with type 2 diabetes mellitus and cardiovascular disease has not been established,0
3899,3899,3899,3899,3899,3899,3899,4764,4764,4764,4764,4764,4764,4764,4764,4764,4764,4764,4764,4764,0fdd0255-0055-65f3-b2c0-db8fbb87beae,limitations of use synjardy is not recommended for patients with type 1 diabetes or for the treatment of diabetic ketoacidosis see warnings and precautions ( 5 3 ),2
3900,3900,3900,3900,3900,3900,3900,4765,4765,4765,4765,4765,4765,4765,4765,4765,4765,4765,4765,4765,0fdd0255-0055-65f3-b2c0-db8fbb87beae,synjardy is a combination of empagliflozin  a sodium glucose co transporter 2 ( sglt2 ) inhibitor and metformin hydrochloride  a biguanide  indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both empagliflozin and metformin hydrochloride is appropriate,1
3901,3901,3901,3901,3901,3901,3901,4766,4766,4766,4766,4766,4766,4766,4766,4766,4766,4766,4766,4766,0fdd0255-0055-65f3-b2c0-db8fbb87beae,empagliflozin is indicated to reduce the risk of cardiovascular death in adults with type 2 diabetes mellitus and established cardiovascular disease,1
3902,3902,3902,3902,3902,3902,3902,4768,4768,4768,4768,4768,4768,4768,4768,4768,4768,4768,4768,4768,0fdd0255-0055-65f3-b2c0-db8fbb87beae,( 1 ) limitations of use not recommended for patients with type 1 diabetes or for the treatment of diabetic ketoacidosis ( 1 ),2
3903,3903,3903,3903,3903,3903,3903,4769,4769,4769,4769,4769,4769,4769,4769,4769,4769,4769,4769,4769,5ff2cd9e-a579-48f5-845f-c37a68372a34,1 indications usage pioglitazone and metformin hydrochloride tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both pioglitazone and metformin is appropriate see clinical studies ( 14 ),1
3904,3904,3904,3904,3904,3904,3904,4770,4770,4770,4770,4770,4770,4770,4770,4770,4770,4770,4770,4770,5ff2cd9e-a579-48f5-845f-c37a68372a34,important limitations of use pioglitazone exerts its antihyperglycemic effect only in the presence of endogenous insulin,0
3905,3905,3905,3905,3905,3905,3905,4771,4771,4771,4771,4771,4771,4771,4771,4771,4771,4771,4771,4771,5ff2cd9e-a579-48f5-845f-c37a68372a34,pioglitazone and metformin hydrochloride tablets should not be used to treat type 1 diabetes or diabetic ketoacidosis  as it would not be effective in these settings,2
3906,3906,3906,3906,3906,3906,3906,4773,4773,4773,4773,4773,4773,4773,4773,4773,4773,4773,4773,4773,5ff2cd9e-a579-48f5-845f-c37a68372a34,pioglitazone and metformin hydrochloride tablets are a thiazolidinedione and biguanide combination product indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both pioglitazone and metformin is appropriate,1
3907,3907,3907,3907,3907,3907,3907,4774,4774,4774,4774,4774,4774,4774,4774,4774,4774,4774,4774,4774,5ff2cd9e-a579-48f5-845f-c37a68372a34,( 1  14 ) important limitation of use not for treatment of type 1 diabetes or diabetic ketoacidosis,2
3908,3908,3908,3908,3908,3908,3908,4775,4775,4775,4775,4775,4775,4775,4775,4775,4775,4775,4775,4775,0789dc6b-db34-44a6-8a5d-fdcc8e4ce8fd,1  after consultation with a healthcare professional who has considered and advised the patient of the risks and benefits of rosiglitazone  avandamet is indicated as an adjunct to diet and exercise to improve glycemic control when treatment with both rosiglitazone and metformin is appropriate in adults with type 2 diabetes mellitus who either are already taking rosiglitazone  or not already taking rosiglitazone and unable to achieve glycemic control on other diabetes medications and  in consultation with their healthcare provider  have decided not to take pioglitazone ( actos ) or pioglitazone containing products ( actoplus met  actoplus met xr  duetact ) for medical reasons,1
3909,3909,3909,3909,3909,3909,3909,4776,4776,4776,4776,4776,4776,4776,4776,4776,4776,4776,4776,4776,0789dc6b-db34-44a6-8a5d-fdcc8e4ce8fd,other important limitations of use due to its mechanism of action  rosiglitazone is active only in the presence of endogenous insulin,0
3910,3910,3910,3910,3910,3910,3910,4777,4777,4777,4777,4777,4777,4777,4777,4777,4777,4777,4777,4777,0789dc6b-db34-44a6-8a5d-fdcc8e4ce8fd,therefore  avandamet should not be used in patients with type 1 diabetes,2
3911,3911,3911,3911,3911,3911,3911,4778,4778,4778,4778,4778,4778,4778,4778,4778,4778,4778,4778,4778,0789dc6b-db34-44a6-8a5d-fdcc8e4ce8fd,coadministration of avandamet with insulin is not recommended see warnings and precautions ( 5 2  5 3 ),2
3912,3912,3912,3912,3912,3912,3912,4779,4779,4779,4779,4779,4779,4779,4779,4779,4779,4779,4779,4779,0789dc6b-db34-44a6-8a5d-fdcc8e4ce8fd,avandamet is a combination antidiabetic product containing a thiazolidinedione and a biguanide,0
3913,3913,3913,3913,3913,3913,3913,4780,4780,4780,4780,4780,4780,4780,4780,4780,4780,4780,4780,4780,0789dc6b-db34-44a6-8a5d-fdcc8e4ce8fd,after consultation with a healthcare professional who has considered and advised the patient of the risks and benefits of rosiglitazone  this drug is indicated as an adjunct to diet and exercise to improve glycemic control when treatment with both rosiglitazone and metformin is appropriate in adults with type 2 diabetes mellitus who either are already taking rosiglitazone  or not already taking rosiglitazone and are unable to achieve glycemic control on other diabetes medications and  in consultation with their healthcare provider  have decided not to take pioglitazone ( actos ) or pioglitazone containing products ( actoplus met  actoplus met xr  duetact ) for medical reasons,1
3914,3914,3914,3914,3914,3914,3914,4781,4781,4781,4781,4781,4781,4781,4781,4781,4781,4781,4781,4781,0789dc6b-db34-44a6-8a5d-fdcc8e4ce8fd,( 1 ) other important limitations of use should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis,2
3915,3915,3915,3915,3915,3915,3915,4782,4782,4782,4782,4782,4782,4782,4782,4782,4782,4782,4782,4782,0789dc6b-db34-44a6-8a5d-fdcc8e4ce8fd,( 1 ) coadministration with insulin is not recommended,2
3916,3916,3916,3916,3916,3916,3916,4783,4783,4783,4783,4783,4783,4783,4783,4783,4783,4783,4783,4783,a6aeb99a-ce49-4125-90ce-642df3f1ebad,1  segluromet is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus who are not adequately controlled on a regimen containing ertugliflozin or metformin  or in patients who are already treated with both ertugliflozin and metformin,1
3917,3917,3917,3917,3917,3917,3917,4784,4784,4784,4784,4784,4784,4784,4784,4784,4784,4784,4784,4784,a6aeb99a-ce49-4125-90ce-642df3f1ebad,segluromet is a combination of ertugliflozin  a sodium glucose co transporter 2 ( sglt2 ) inhibitor  and metformin  a biguanide  indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus who are not adequately controlled on a regimen containing ertugliflozin or metformin  or in patients who are already treated with both ertugliflozin and metformin,1
3918,3918,3918,3918,3918,3918,3918,4785,4785,4785,4785,4785,4785,4785,4785,4785,4785,4785,4785,4785,a6aeb99a-ce49-4125-90ce-642df3f1ebad,( 1 ) limitations of use not for the treatment of type 1 diabetes mellitus or diabetic ketoacidosis,2
3919,3919,3919,3919,3919,3919,3919,4786,4786,4786,4786,4786,4786,4786,4786,4786,4786,4786,4786,4786,a6aeb99a-ce49-4125-90ce-642df3f1ebad,( 1 ) limitations of use segluromet is not recommended in patients with type 1 diabetes mellitus or for the treatment of diabetic ketoacidosis,2
3920,3920,3920,3920,3920,3920,3920,4787,4787,4787,4787,4787,4787,4787,4787,4787,4787,4787,4787,4787,d105a64e-2e69-49bf-acda-e589fb1ca161, glyburide and metformin hydrochloride tablets usp are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus,1
3921,3921,3921,3921,3921,3921,3921,4788,4788,4788,4788,4788,4788,4788,4788,4788,4788,4788,4788,4788,d19c7ed0-ad5c-426e-b2df-722508f97d67,1  janumet is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both sitagliptin and metformin is appropriate,1
3922,3922,3922,3922,3922,3922,3922,4789,4789,4789,4789,4789,4789,4789,4789,4789,4789,4789,4789,4789,d19c7ed0-ad5c-426e-b2df-722508f97d67,important limitations of use janumet should not be used in patients with type 1 diabetes mellitus or for the treatment of diabetic ketoacidosis,2
3923,3923,3923,3923,3923,3923,3923,4790,4790,4790,4790,4790,4790,4790,4790,4790,4790,4790,4790,4790,d19c7ed0-ad5c-426e-b2df-722508f97d67,janumet has not been studied in patients with a history of pancreatitis,0
3924,3924,3924,3924,3924,3924,3924,4791,4791,4791,4791,4791,4791,4791,4791,4791,4791,4791,4791,4791,d19c7ed0-ad5c-426e-b2df-722508f97d67,it is unknown whether patients with a history of pancreatitis are at increased risk for the development of pancreatitis while using janumet,0
3925,3925,3925,3925,3925,3925,3925,4792,4792,4792,4792,4792,4792,4792,4792,4792,4792,4792,4792,4792,d19c7ed0-ad5c-426e-b2df-722508f97d67,see warnings and precautions ( 5 2 ),0
3926,3926,3926,3926,3926,3926,3926,4793,4793,4793,4793,4793,4793,4793,4793,4793,4793,4793,4793,4793,d19c7ed0-ad5c-426e-b2df-722508f97d67,janumet is a dipeptidyl peptidase 4 ( dpp 4 ) inhibitor and biguanide combination product indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both sitagliptin and metformin is appropriate,1
3927,3927,3927,3927,3927,3927,3927,4794,4794,4794,4794,4794,4794,4794,4794,4794,4794,4794,4794,4794,d19c7ed0-ad5c-426e-b2df-722508f97d67,( 1  14 ) important limitations of use janumet should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis,2
3928,3928,3928,3928,3928,3928,3928,4795,4795,4795,4795,4795,4795,4795,4795,4795,4795,4795,4795,4795,d19c7ed0-ad5c-426e-b2df-722508f97d67,( 1 ) janumet has not been studied in patients with a history of pancreatitis,0
3929,3929,3929,3929,3929,3929,3929,4796,4796,4796,4796,4796,4796,4796,4796,4796,4796,4796,4796,4796,"Active Ingredient UNII(s)
786Z46389E; Z8J84YIX6L    fbd25da4-ebe6-45c9-beb8-93523d11a0b4
786Z46389E; Z8J84YIX6L    fbd25da4-ebe6-45c9-beb8-93523d11a0b4
Name: SET ID dtype: object",active ingredient unii ( s ) 786z46389e z8j84yix6l active ingredient unii ( s ) 786z46389e z8j84yix 786z46389e z8j84yix6l active ingredient unii ( s ) 786z46389e z8j84yix name content xml  dtype object,0
3930,3930,3930,3930,3930,3930,3930,4798,4798,4798,4798,4798,4798,4798,4798,4798,4798,4798,4798,4798,5ea7ce51-b87a-485e-b841-99466a07a4b2, paragard is indicated for intrauterine contraception for up to 10 years,1
3931,3931,3931,3931,3931,3931,3931,4799,4799,4799,4799,4799,4799,4799,4799,4799,4799,4799,4799,4799,5ea7ce51-b87a-485e-b841-99466a07a4b2,the pregnancy rate in clinical studies has been less than 1 pregnancy per 100 women each year,0
3932,3932,3932,3932,3932,3932,3932,4800,4800,4800,4800,4800,4800,4800,4800,4800,4800,4800,4800,4800,5ea7ce51-b87a-485e-b841-99466a07a4b2,table 1 percentage of women experiencing an unintended pregnancy during the first year of typical use and first year of perfect use of contraception and the percentage continuing use at the end of the first year united states of women experiencing an accidental pregnancy within the first year of use of women continuing use at one year 3 method ( 1 ) typical use 1 ( 2 ) perfect use 2 ( 3 ) ( 4 ) chance4 85 85 spermicides5 26 6 40 periodic abstinence calendar ovulation method sympto thermal6 post ovulation 25 9 3 2 1 63 cap7 parous women nulliparous women 40 20 t,0
3933,3933,3933,3933,3933,3933,3933,4801,4801,4801,4801,4801,4801,4801,4801,4801,4801,4801,4801,4801,b6f17ff2-72d9-4228-ab86-887fd79ea105, ocuvel is indicated for dietary management of patients with unique nutritional needs requiring increased folate levels and other nutritional supplementation,1
3934,3934,3934,3934,3934,3934,3934,4802,4802,4802,4802,4802,4802,4802,4802,4802,4802,4802,4802,4802,1c90b649-5536-417c-82cb-89663137f14f, spectracef ( cefditoren pivoxil ) is indicated for the treatment of mild to moderate infections in adults and adolescents ( 12 years of age or older ) which are caused by susceptible strains of the designated microorganisms in the conditions listed below,1
3935,3935,3935,3935,3935,3935,3935,4803,4803,4803,4803,4803,4803,4803,4803,4803,4803,4803,4803,4803,1c90b649-5536-417c-82cb-89663137f14f,acute bacterial exacerbation of chronic bronchitis caused by haemophilus influenzae ( including lactamase producing strains )  haemophilus parainfluenzae ( including lactamase producing strains )  streptococcus pneumoniae ( penicillin susceptible strains only )  or moraxella catarrhalis ( including lactamase producing strains ),1
3936,3936,3936,3936,3936,3936,3936,4804,4804,4804,4804,4804,4804,4804,4804,4804,4804,4804,4804,4804,1c90b649-5536-417c-82cb-89663137f14f,community acquired pneumonia caused by haemophilus influenzae ( including lactamase producing strains )  haemophilus parainfluenzae ( including lactamase producing strains )  streptococcus pneumoniae ( penicillin susceptible strains only )  or moraxella catarrhalis ( including lactamase producing strains ),1
3937,3937,3937,3937,3937,3937,3937,4805,4805,4805,4805,4805,4805,4805,4805,4805,4805,4805,4805,4805,1c90b649-5536-417c-82cb-89663137f14f,pharyngitis tonsillitis caused by streptococcus pyogenes,1
3938,3938,3938,3938,3938,3938,3938,4806,4806,4806,4806,4806,4806,4806,4806,4806,4806,4806,4806,4806,1c90b649-5536-417c-82cb-89663137f14f,note spectracef is effective in the eradication of streptococcus pyogenes from the oropharynx,1
3939,3939,3939,3939,3939,3939,3939,4807,4807,4807,4807,4807,4807,4807,4807,4807,4807,4807,4807,4807,1c90b649-5536-417c-82cb-89663137f14f,spectracef has not been studied for the prevention of rheumatic fever following streptococcus pyogenes pharyngitis tonsillitis,0
3940,3940,3940,3940,3940,3940,3940,4808,4808,4808,4808,4808,4808,4808,4808,4808,4808,4808,4808,4808,1c90b649-5536-417c-82cb-89663137f14f,only intramuscular penicillin has been demonstrated to be effective for the prevention of rheumatic fever,u
3941,3941,3941,3941,3941,3941,3941,4809,4809,4809,4809,4809,4809,4809,4809,4809,4809,4809,4809,4809,1c90b649-5536-417c-82cb-89663137f14f,uncomplicated skin and skin structure infections caused by staphylococcus aureus ( including lactamase producing strains ) or streptococcus pyogenes,1
3942,3942,3942,3942,3942,3942,3942,4810,4810,4810,4810,4810,4810,4810,4810,4810,4810,4810,4810,4810,1c90b649-5536-417c-82cb-89663137f14f,to reduce the development of drug resistant bacteria and maintain the effectiveness of spectracef and other antibacterial drugs  spectracef should be used only to treat infections that are proven or strongly suspected to be caused by susceptible bacteria,4
3943,3943,3943,3943,3943,3943,3943,4813,4813,4813,4813,4813,4813,4813,4813,4813,4813,4813,4813,4813,f6927e91-bb46-47b3-ab66-f9d8a9d7b12a,1  raxibacumab is indicated for the treatment of adult and pediatric patients with inhalational anthrax due to bacillus anthracis in combination with appropriate antibacterial drugs  and for prophylaxis of inhalational anthrax when alternative therapies are not available or are not appropriate,1
3944,3944,3944,3944,3944,3944,3944,4814,4814,4814,4814,4814,4814,4814,4814,4814,4814,4814,4814,4814,f6927e91-bb46-47b3-ab66-f9d8a9d7b12a,( 1 ) limitations of use the effectiveness of raxibacumab is based solely on efficacy studies in animal models of inhalational anthrax,0
3945,3945,3945,3945,3945,3945,3945,4815,4815,4815,4815,4815,4815,4815,4815,4815,4815,4815,4815,4815,f6927e91-bb46-47b3-ab66-f9d8a9d7b12a,( 1 2  14 1 ) there have been no studies of raxibacumab in the pediatric population,0
3946,3946,3946,3946,3946,3946,3946,4816,4816,4816,4816,4816,4816,4816,4816,4816,4816,4816,4816,4816,f6927e91-bb46-47b3-ab66-f9d8a9d7b12a,dosing in pediatric patients was derived using an extrapolation approach,0
3947,3947,3947,3947,3947,3947,3947,4817,4817,4817,4817,4817,4817,4817,4817,4817,4817,4817,4817,4817,f6927e91-bb46-47b3-ab66-f9d8a9d7b12a,( 1 2  8 4 ) raxibacumab does not cross the blood brain barrier and does not prevent or treat meningitis,0
3948,3948,3948,3948,3948,3948,3948,4818,4818,4818,4818,4818,4818,4818,4818,4818,4818,4818,4818,4818,f6927e91-bb46-47b3-ab66-f9d8a9d7b12a,raxibacumab should be used in combination with appropriate antibacterial drugs,4
3949,3949,3949,3949,3949,3949,3949,4819,4819,4819,4819,4819,4819,4819,4819,4819,4819,4819,4819,4819,f6927e91-bb46-47b3-ab66-f9d8a9d7b12a,( 1 2 ) 1 1 inhalational anthrax raxibacumab is indicated for the treatment of adult and pediatric patients with inhalational anthrax due to bacillus anthracis in combination with appropriate antibacterial drugs,1
3950,3950,3950,3950,3950,3950,3950,4820,4820,4820,4820,4820,4820,4820,4820,4820,4820,4820,4820,4820,f6927e91-bb46-47b3-ab66-f9d8a9d7b12a,raxibacumab is also indicated for prophylaxis of inhalational anthrax when alternative therapies are not available or are not appropriate,1
3951,3951,3951,3951,3951,3951,3951,4821,4821,4821,4821,4821,4821,4821,4821,4821,4821,4821,4821,4821,f6927e91-bb46-47b3-ab66-f9d8a9d7b12a,1 2 limitations of use the effectiveness of raxibacumab is based solely on efficacy studies in animal models of inhalational anthrax,0
3952,3952,3952,3952,3952,3952,3952,4822,4822,4822,4822,4822,4822,4822,4822,4822,4822,4822,4822,4822,f6927e91-bb46-47b3-ab66-f9d8a9d7b12a,it is not ethical or feasible to conduct controlled clinical trials with intentional exposure of humans to anthrax,0
3953,3953,3953,3953,3953,3953,3953,4823,4823,4823,4823,4823,4823,4823,4823,4823,4823,4823,4823,4823,f6927e91-bb46-47b3-ab66-f9d8a9d7b12a,safety and pharmacokinetics ( pk ) of raxibacumab have been studied in adult healthy volunteers,0
3954,3954,3954,3954,3954,3954,3954,4824,4824,4824,4824,4824,4824,4824,4824,4824,4824,4824,4824,4824,f6927e91-bb46-47b3-ab66-f9d8a9d7b12a,there have been no trials of safety or pk of raxibacumab in the pediatric population,0
3955,3955,3955,3955,3955,3955,3955,4825,4825,4825,4825,4825,4825,4825,4825,4825,4825,4825,4825,4825,f6927e91-bb46-47b3-ab66-f9d8a9d7b12a,an extrapolation approach was used to derive dosing regimens that are predicted to provide pediatric patients with exposure comparable to the observed exposure in adults,0
3956,3956,3956,3956,3956,3956,3956,4826,4826,4826,4826,4826,4826,4826,4826,4826,4826,4826,4826,4826,f6927e91-bb46-47b3-ab66-f9d8a9d7b12a,see use in specific populations ( 8 4 ),0
3957,3957,3957,3957,3957,3957,3957,4827,4827,4827,4827,4827,4827,4827,4827,4827,4827,4827,4827,4827,f6927e91-bb46-47b3-ab66-f9d8a9d7b12a,raxibacumab binds to the protective antigen,0
3958,3958,3958,3958,3958,3958,3958,4828,4828,4828,4828,4828,4828,4828,4828,4828,4828,4828,4828,4828,bbefaa05-1dc0-3ae7-7264-ce1eddf0da2b, technetium tc 99m albumin aggregated injection is a lung imaging agent which may be used as an adjunct in the evaluation of pulmonary perfusion in adults and pediatric patients,1
3959,3959,3959,3959,3959,3959,3959,4829,4829,4829,4829,4829,4829,4829,4829,4829,4829,4829,4829,4829,bbefaa05-1dc0-3ae7-7264-ce1eddf0da2b,technetium tc 99m albumin aggregated injection may be used in adults as an imaging agent to aid in the evaluation of peritoneovenous ( leveen ) shunt patency,1
3960,3960,3960,3960,3960,3960,3960,4835,4835,4835,4835,4835,4835,4835,4835,4835,4835,4835,4835,4835,becdab53-f7a7-7280-6930-21f3a61b99e7,1  draximage dtpa  after radiolabeling with technetium tc 99m  is indicated for draximage dtpa is a kit for the preparation of technetium tc 99m pentetate injection,u
3961,3961,3961,3961,3961,3961,3961,4836,4836,4836,4836,4836,4836,4836,4836,4836,4836,4836,4836,4836,becdab53-f7a7-7280-6930-21f3a61b99e7,technetium tc 99m pentetate is a radioactive diagnostic agent indicated for brain imaging in adults ( 1 1 ),1
3962,3962,3962,3962,3962,3962,3962,4837,4837,4837,4837,4837,4837,4837,4837,4837,4837,4837,4837,4837,becdab53-f7a7-7280-6930-21f3a61b99e7,renal visualization  assessment of renal perfusion  and estimation of glomerular filtration rate in adult and pediatric patients ( 1 2 ),1
3963,3963,3963,3963,3963,3963,3963,4838,4838,4838,4838,4838,4838,4838,4838,4838,4838,4838,4838,4838,becdab53-f7a7-7280-6930-21f3a61b99e7,lung ventilation imaging and evaluation of pulmonary embolism when paired with perfusion imaging in adult and pediatric patients ( 1 3 ),1
3964,3964,3964,3964,3964,3964,3964,4839,4839,4839,4839,4839,4839,4839,4839,4839,4839,4839,4839,4839,becdab53-f7a7-7280-6930-21f3a61b99e7,1 1 brain imaging brain imaging in adults by intravenous administration,1
3965,3965,3965,3965,3965,3965,3965,4840,4840,4840,4840,4840,4840,4840,4840,4840,4840,4840,4840,4840,becdab53-f7a7-7280-6930-21f3a61b99e7,1 2 renal scintigraphy renal visualization  assessment of renal perfusion  and estimation of glomerular filtration rate in adult and pediatric patients by intravenous administration,1
3966,3966,3966,3966,3966,3966,3966,4841,4841,4841,4841,4841,4841,4841,4841,4841,4841,4841,4841,4841,becdab53-f7a7-7280-6930-21f3a61b99e7,1 3 lung ventilation imaging lung ventilation imaging and evaluation of pulmonary embolism when paired with perfusion imaging in adult and pediatric patients when administered by nebulizer for inhalation,1
3967,3967,3967,3967,3967,3967,3967,4842,4842,4842,4842,4842,4842,4842,4842,4842,4842,4842,4842,4842,1f65158a-fb5e-4864-845f-daf6fed271f4,uses temporarily relieves these symptoms due to hay fever or other upper respiratory allergies sneezing itchy  watery eyes runny nose itching of the nose or throat temporarily relieves nasal congestion due to the common cold  hay fever or other upper respiratory allergies reduces swelling of nasal passages temporarily relieves sinus congestion and pressure temporarily restores freer breathing through the nose,1
3968,3968,3968,3968,3968,3968,3968,4843,4843,4843,4843,4843,4843,4843,4843,4843,4843,4843,4843,4843,dbb64747-1505-49d7-9a33-99dd402e96d3,1  incruse ellipta is indicated for the long term  once daily  maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease ( copd )  including chronic bronchitis and or emphysema,1
3969,3969,3969,3969,3969,3969,3969,4844,4844,4844,4844,4844,4844,4844,4844,4844,4844,4844,4844,4844,dbb64747-1505-49d7-9a33-99dd402e96d3,incruse ellipta is an anticholinergic indicated for the long term  once daily  maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease ( copd ),1
3970,3970,3970,3970,3970,3970,3970,4845,4845,4845,4845,4845,4845,4845,4845,4845,4845,4845,4845,4845,d2ae30c6-ad64-47ed-b371-778eaebeeddf, based on a review of this drug by the national academy of sciences national research council and or other information  fda has classified the indications as follows possibly effective contact or atopic dermatitis impetiginized eczema nummular eczema infantile eczema endogenous chronic infectious dermatitis stasis dermatitis pyoderma nuchal eczema and chronic eczematoid otitis externa acne urticata localized or disseminated neurodermatitis lichen simplex chronicus anogenital pruritus ( vulvae  scroti  ani ) folliculitis bacterial dermatoses mycotic dermatoses such as tinea ( capitis  cruris  corporis  pedis ) moniliasis intertrigo,1
3971,3971,3971,3971,3971,3971,3971,4847,4847,4847,4847,4847,4847,4847,4847,4847,4847,4847,4847,4847,"Active Ingredient UNII(s)
7BK02SCL3W; 7TQO7W3VT8; 85H0HZU99M; ND2M416302; TI05AO53L7    1c157964-1977-4617-9f01-76ca01fb0f8f
7BK02SCL3W; 7TQO7W3VT8; 85H0HZU99M; ND2M416302; TI05AO53L7    1c157964-1977-4617-9f01-76ca01fb0f8f
7BK02SCL3W; 7TQO7W3VT8; 85H0HZU99M; ND2M416302; TI05AO53L7    1c157964-1977-4617-9f01-76ca01fb0f8f
7BK02SCL3W; 7TQO7W3VT8; 85H0HZU99M; ND2M416302; TI05AO53L7    1c157964-1977-4617-9f01-76ca01fb0f8f
Name: SET ID dtype: object",active ingredient unii ( s ) 7bk02scl3w 7tqo7w3vt8 85h0hzu99m nd2m416302 ti05ao53l7 active ingredient unii ( s ) 7bk02scl3w 7tqo7w3v 7bk02scl3w 7tqo7w3vt8 85h0hzu99m nd2m416302 ti05ao53l7 active ingredient unii ( s ) 7bk02scl3w 7tqo7w3v 7bk02scl3w 7tqo7w3vt8 85h0hzu99m nd2m416302 ti05ao53l7 active ingredient unii ( s ) 7bk02scl3w 7tqo7w3v 7bk02scl3w 7tqo7w3vt8 85h0hzu99m nd2m416302 ti05ao53l7 active ingredient unii ( s ) 7bk02scl3w 7tqo7w3v name content xml  dtype object,0
3972,3972,3972,3972,3972,3972,3972,4851,4851,4851,4851,4851,4851,4851,4851,4851,4851,4851,4851,4851,"Active Ingredient UNII(s)
7BK02SCL3W; 7TQO7W3VT8; 85H0HZU99M; ND2M416302; TI05AO53L7; V13007Z41A    9a6a3871-4e02-47f9-a20e-a256b3f3c498
7BK02SCL3W; 7TQO7W3VT8; 85H0HZU99M; ND2M416302; TI05AO53L7; V13007Z41A    9a6a3871-4e02-47f9-a20e-a256b3f3c498
7BK02SCL3W; 7TQO7W3VT8; 85H0HZU99M; ND2M416302; TI05AO53L7; V13007Z41A    9a6a3871-4e02-47f9-a20e-a256b3f3c498
7BK02SCL3W; 7TQO7W3VT8; 85H0HZU99M; ND2M416302; TI05AO53L7; V13007Z41A    9a6a3871-4e02-47f9-a20e-a256b3f3c498
7BK02SCL3W; 7TQO7W3VT8; 85H0HZU99M; ND2M416302; TI05AO53L7; V13007Z41A    9a6a3871-4e02-47f9-a20e-a256b3f3c498
Name: SET ID dtype: object",active ingredient unii ( s ) 7bk02scl3w 7tqo7w3vt8 85h0hzu99m nd2m416302 ti05ao53l7 v13007z41a active ingredient unii ( s ) 7bk02scl3w 7tqo7w3v 7bk02scl3w 7tqo7w3vt8 85h0hzu99m nd2m416302 ti05ao53l7 v13007z41a active ingredient unii ( s ) 7bk02scl3w 7tqo7w3v 7bk02scl3w 7tqo7w3vt8 85h0hzu99m nd2m416302 ti05ao53l7 v13007z41a active ingredient unii ( s ) 7bk02scl3w 7tqo7w3v 7bk02scl3w 7tqo7w3vt8 85h0hzu99m nd2m416302 ti05ao53l7 v13007z41a active ingredient unii ( s ) 7bk02scl3w 7tqo7w3v 7bk02scl3w 7tqo7w3vt8 85h0hzu99m nd2m416302 ti05ao53l7 v13007z41a active ingredient unii ( s ) 7bk02scl3w 7tqo7w3v name content xml  dtype object,0
3973,3973,3973,3973,3973,3973,3973,4856,4856,4856,4856,4856,4856,4856,4856,4856,4856,4856,4856,4856,"Active Ingredient UNII(s)
7BK02SCL3W; 7TQO7W3VT8; TI05AO53L7; V13007Z41A    432c2026-99ec-49e0-e054-00144ff8d46c
7BK02SCL3W; 7TQO7W3VT8; TI05AO53L7; V13007Z41A    432c2026-99ec-49e0-e054-00144ff8d46c
7BK02SCL3W; 7TQO7W3VT8; TI05AO53L7; V13007Z41A    432c2026-99ec-49e0-e054-00144ff8d46c
Name: SET ID dtype: object",active ingredient unii ( s ) 7bk02scl3w 7tqo7w3vt8 ti05ao53l7 v13007z41a active ingredient unii ( s ) 7bk02scl3w 7tqo7w3v 7bk02scl3w 7tqo7w3vt8 ti05ao53l7 v13007z41a active ingredient unii ( s ) 7bk02scl3w 7tqo7w3v 7bk02scl3w 7tqo7w3vt8 ti05ao53l7 v13007z41a active ingredient unii ( s ) 7bk02scl3w 7tqo7w3v name content xml  dtype object,0
3974,3974,3974,3974,3974,3974,3974,4859,4859,4859,4859,4859,4859,4859,4859,4859,4859,4859,4859,4859,"Active Ingredient UNII(s)
7BK02SCL3W; 85H0HZU99M; ND2M416302; TI05AO53L7; V13007Z41A    9664b7c3-1bbe-436d-a65f-e48647d120aa
7BK02SCL3W; 85H0HZU99M; ND2M416302; TI05AO53L7; V13007Z41A    9664b7c3-1bbe-436d-a65f-e48647d120aa
7BK02SCL3W; 85H0HZU99M; ND2M416302; TI05AO53L7; V13007Z41A    9664b7c3-1bbe-436d-a65f-e48647d120aa
7BK02SCL3W; 85H0HZU99M; ND2M416302; TI05AO53L7; V13007Z41A    9664b7c3-1bbe-436d-a65f-e48647d120aa
Name: SET ID dtype: object",active ingredient unii ( s ) 7bk02scl3w 85h0hzu99m nd2m416302 ti05ao53l7 v13007z41a active ingredient unii ( s ) 7bk02scl3w 85h0hzu9 7bk02scl3w 85h0hzu99m nd2m416302 ti05ao53l7 v13007z41a active ingredient unii ( s ) 7bk02scl3w 85h0hzu9 7bk02scl3w 85h0hzu99m nd2m416302 ti05ao53l7 v13007z41a active ingredient unii ( s ) 7bk02scl3w 85h0hzu9 7bk02scl3w 85h0hzu99m nd2m416302 ti05ao53l7 v13007z41a active ingredient unii ( s ) 7bk02scl3w 85h0hzu9 name content xml  dtype object,0
3975,3975,3975,3975,3975,3975,3975,4863,4863,4863,4863,4863,4863,4863,4863,4863,4863,4863,4863,4863,7f77526b-4c40-409c-82ea-d0f934d89cc2,1  gleostine is an alkylating drug indicated for the treatment of patients with brain tumors  primary and metastatic  following appropriate surgical and or radiotherapeutic procedures,1
3976,3976,3976,3976,3976,3976,3976,4864,4864,4864,4864,4864,4864,4864,4864,4864,4864,4864,4864,4864,7f77526b-4c40-409c-82ea-d0f934d89cc2,( 1 ) hodgkin 's lymphoma in combination with other chemotherapies  following disease progression with initial chemotherapy,1
3977,3977,3977,3977,3977,3977,3977,4865,4865,4865,4865,4865,4865,4865,4865,4865,4865,4865,4865,4865,7f77526b-4c40-409c-82ea-d0f934d89cc2,( 1 ) 1 1 brain tumors gleostine is indicated for the treatment of patients with primary and metastatic brain tumors following appropriate surgical and or radiotherapeutic procedures,1
3978,3978,3978,3978,3978,3978,3978,4866,4866,4866,4866,4866,4866,4866,4866,4866,4866,4866,4866,4866,7f77526b-4c40-409c-82ea-d0f934d89cc2,1 2 hodgkin 's lymphoma gleostine is indicated as a component of combination chemotherapy for the treatment of patients with hodgkin 's lymphoma whose disease has progressed following initial chemotherapy,1
3979,3979,3979,3979,3979,3979,3979,4867,4867,4867,4867,4867,4867,4867,4867,4867,4867,4867,4867,4867,e2d4307d-da8f-49f5-aac0-02355dd9ffb7, the atropen auto injector is indicated for the treatment of poisoning by susceptible organophosphorous nerve agents having cholinesterase activity as well as organophosphorous or carbamate insecticides,1
3980,3980,3980,3980,3980,3980,3980,4868,4868,4868,4868,4868,4868,4868,4868,4868,4868,4868,4868,4868,e2d4307d-da8f-49f5-aac0-02355dd9ffb7,the atropen auto injector should be used by persons who have had adequate training in the recognition and treatment of nerve agent or insecticide intoxication,4
3981,3981,3981,3981,3981,3981,3981,4869,4869,4869,4869,4869,4869,4869,4869,4869,4869,4869,4869,4869,e2d4307d-da8f-49f5-aac0-02355dd9ffb7,pralidoxime chloride may serve as an important adjunct to atropine therapy,u
3982,3982,3982,3982,3982,3982,3982,4870,4870,4870,4870,4870,4870,4870,4870,4870,4870,4870,4870,4870,e2d4307d-da8f-49f5-aac0-02355dd9ffb7,the atropen is intended as an initial treatment of the muscarinic symptoms of insecticide or nerve agent poisonings ( generally breathing difficulties due to increased secretions ) definitive medical care should be sought immediately,1
3983,3983,3983,3983,3983,3983,3983,4871,4871,4871,4871,4871,4871,4871,4871,4871,4871,4871,4871,4871,e2d4307d-da8f-49f5-aac0-02355dd9ffb7,the atropen auto injector should be administered as soon as symptoms of organophosphorous or carbamate poisoning appear ( usually tearing  excessive oral secretions  wheezing  muscle fasciculations  etc ),1
3984,3984,3984,3984,3984,3984,3984,4872,4872,4872,4872,4872,4872,4872,4872,4872,4872,4872,4872,4872,e2d4307d-da8f-49f5-aac0-02355dd9ffb7,in moderate to severe poisoning  the administration of more than one atropen may be required until atropinization is achieved ( flushing  mydriasis  tachycardia  dryness of the mouth and nose ),4
3985,3985,3985,3985,3985,3985,3985,4873,4873,4873,4873,4873,4873,4873,4873,4873,4873,4873,4873,4873,e2d4307d-da8f-49f5-aac0-02355dd9ffb7,( see dosage and administration ) in severe poisonings  it may also be desirable to concurrently administer an anticonvulsant if seizure is suspected in the unconscious individual since the classic tonic clonic jerking may not be apparent due to the effects of the poison,1
3986,3986,3986,3986,3986,3986,3986,4874,4874,4874,4874,4874,4874,4874,4874,4874,4874,4874,4874,4874,e2d4307d-da8f-49f5-aac0-02355dd9ffb7,in poisonings due to organophosphorous nerve agents and insecticides it may also be helpful to concurrently administer a cholinesterase reactivator such as pralidoxime chloride,u
3987,3987,3987,3987,3987,3987,3987,4875,4875,4875,4875,4875,4875,4875,4875,4875,4875,4875,4875,4875,c3ca69e6-1ea0-4c2c-abcb-7264b2e79a87, maprotiline hydrochloride tablets are indicated for the treatment of depressive illness in patients with depressive neurosis ( dysthymic disorder ) and manic depressive illness  depressed type ( major depressive disorder ),1
3988,3988,3988,3988,3988,3988,3988,4876,4876,4876,4876,4876,4876,4876,4876,4876,4876,4876,4876,4876,c3ca69e6-1ea0-4c2c-abcb-7264b2e79a87,maprotiline is also effective for the relief of anxiety associated with depression,1
3989,3989,3989,3989,3989,3989,3989,4877,4877,4877,4877,4877,4877,4877,4877,4877,4877,4877,4877,4877,0836c6ac-ee37-5640-2fed-a3185a0b16eb,1  orencia is a selective t cell costimulation modulator indicated for adult rheumatoid arthritis ( ra ) ( 1 1 ) moderately to severely active ra in adults,1
3990,3990,3990,3990,3990,3990,3990,4878,4878,4878,4878,4878,4878,4878,4878,4878,4878,4878,4878,4878,0836c6ac-ee37-5640-2fed-a3185a0b16eb,orencia may be used as monotherapy or concomitantly with dmards other than tnf antagonists ( 1 1 ),4
3991,3991,3991,3991,3991,3991,3991,4879,4879,4879,4879,4879,4879,4879,4879,4879,4879,4879,4879,4879,0836c6ac-ee37-5640-2fed-a3185a0b16eb,juvenile idiopathic arthritis ( 1 2 ) moderately to severely active polyarticular juvenile idiopathic arthritis in patients 2 years of age and older,1
3992,3992,3992,3992,3992,3992,3992,4880,4880,4880,4880,4880,4880,4880,4880,4880,4880,4880,4880,4880,0836c6ac-ee37-5640-2fed-a3185a0b16eb,orencia may be used as monotherapy or concomitantly with methotrexate ( 1 2 ),1
3993,3993,3993,3993,3993,3993,3993,4881,4881,4881,4881,4881,4881,4881,4881,4881,4881,4881,4881,4881,0836c6ac-ee37-5640-2fed-a3185a0b16eb,adult psoriatic arthritis ( psa ) ( 1 3 ) active psa in adults,1
3994,3994,3994,3994,3994,3994,3994,4882,4882,4882,4882,4882,4882,4882,4882,4882,4882,4882,4882,4882,0836c6ac-ee37-5640-2fed-a3185a0b16eb,( 1 3 ) important limitations of use ( 1 4 ) should not be given concomitantly with tnf antagonists ( 1 4  5 1 ),2
3995,3995,3995,3995,3995,3995,3995,4883,4883,4883,4883,4883,4883,4883,4883,4883,4883,4883,4883,4883,0836c6ac-ee37-5640-2fed-a3185a0b16eb,1 1 adult rheumatoid arthritis ( ra ) orencia is indicated for reducing signs and symptoms  inducing major clinical response  inhibiting the progression of structural damage  and improving physical function in adult patients with moderately to severely active rheumatoid arthritis,1
3996,3996,3996,3996,3996,3996,3996,4884,4884,4884,4884,4884,4884,4884,4884,4884,4884,4884,4884,4884,0836c6ac-ee37-5640-2fed-a3185a0b16eb,orencia may be used as monotherapy or concomitantly with disease modifying antirheumatic drugs ( dmards ) other than tumor necrosis factor ( tnf ) antagonists,u
3997,3997,3997,3997,3997,3997,3997,4885,4885,4885,4885,4885,4885,4885,4885,4885,4885,4885,4885,4885,0836c6ac-ee37-5640-2fed-a3185a0b16eb,1 2 juvenile idiopathic arthritis orencia is indicated for reducing signs and symptoms in patients 2 years of age and older with moderately to severely active polyarticular juvenile idiopathic arthritis,1
3998,3998,3998,3998,3998,3998,3998,4886,4886,4886,4886,4886,4886,4886,4886,4886,4886,4886,4886,4886,0836c6ac-ee37-5640-2fed-a3185a0b16eb,orencia may be used as monotherapy or concomitantly with methotrexate ( mtx ),4
3999,3999,3999,3999,3999,3999,3999,4887,4887,4887,4887,4887,4887,4887,4887,4887,4887,4887,4887,4887,0836c6ac-ee37-5640-2fed-a3185a0b16eb,code code 42229 5 codesystem 2 16 840 1 113883 6 1 dis,0
4000,4000,4000,4000,4000,4000,4000,4888,4888,4888,4888,4888,4888,4888,4888,4888,4888,4888,4888,4888,5cdfdcb3-eaa5-63b9-e053-2a91aa0ae17f,venlafaxine tablets  usp are indicated for the treatment of major depressive disorder,1
4001,4001,4001,4001,4001,4001,4001,4889,4889,4889,4889,4889,4889,4889,4889,4889,4889,4889,4889,4889,5cdfdcb3-eaa5-63b9-e053-2a91aa0ae17f,the efficacy of venlafaxine tablets  usp in the treatment of major depressive disorder was established in 6 week controlled trials of adult outpatients whose diagnoses corresponded most closely to the dsm iii or dsm iii r category of major depression and in a 4 week controlled trial of inpatients meeting diagnostic criteria for major depression with melancholia ( see clinical trials ),0
4002,4002,4002,4002,4002,4002,4002,4891,4891,4891,4891,4891,4891,4891,4891,4891,4891,4891,4891,4891,5cdfdcb3-eaa5-63b9-e053-2a91aa0ae17f,the efficacy of venlafaxine hydrochloride extended release capsules in maintaining an antidepressant response for up to 26 weeks following 8 weeks of acute treatment was demonstrated in a placebo controlled trial,0
4003,4003,4003,4003,4003,4003,4003,4892,4892,4892,4892,4892,4892,4892,4892,4892,4892,4892,4892,4892,5cdfdcb3-eaa5-63b9-e053-2a91aa0ae17f,the efficacy of venlafaxine tablets  usp in maintaining an antidepressant response in patients with recurrent depression who had responded and continued to be improved during an initial 26 weeks of treatment and were then followed for a period of up to 52 weeks was demonstrated in a second placebo controlled trial ( see clinical trials ),0
4004,4004,4004,4004,4004,4004,4004,4893,4893,4893,4893,4893,4893,4893,4893,4893,4893,4893,4893,4893,5cdfdcb3-eaa5-63b9-e053-2a91aa0ae17f,nevertheless  the physician who elects to use venlafaxine tablets  usp venlafaxine hydrochloride extended release capsules for extended periods should periodically re evaluate the long term usefulness of the drug for the individual patient,0
4005,4005,4005,4005,4005,4005,4005,4894,4894,4894,4894,4894,4894,4894,4894,4894,4894,4894,4894,4894,7fc3d37f-df69-484f-9ab1-7ba1c4947898,1  oncaspar is an asparagine specific enzyme indicated as a component of a multi agent chemotherapeutic regimen for treatment of patients with first line acute lymphoblastic leukemia ( 1 1 ) acute lymphoblastic leukemia and hypersensitivity to asparaginase ( 1 2 ) 1 1 first line acute lymphoblastic leukemia ( all ) oncaspar is indicated as a component of a multi agent chemotherapeutic regimen for the first line treatment of patients with all,1
4006,4006,4006,4006,4006,4006,4006,4895,4895,4895,4895,4895,4895,4895,4895,4895,4895,4895,4895,4895,7fc3d37f-df69-484f-9ab1-7ba1c4947898,1 2 acute lymphoblastic leukemia and hypersensitivity to asparaginase oncaspar is indicated as a component of a multi agent chemotherapeutic regimen for the treatment of patients with all and hypersensitivity to native forms of l asparaginase,1
4007,4007,4007,4007,4007,4007,4007,4896,4896,4896,4896,4896,4896,4896,4896,4896,4896,4896,4896,4896,9a4229fd-fecd-4ac1-9c4f-6d442533457f, depo estradiol injection is indicated in the treatment of moderate to severe vasomotor symptoms associated with the menopause,1
4008,4008,4008,4008,4008,4008,4008,4897,4897,4897,4897,4897,4897,4897,4897,4897,4897,4897,4897,4897,9a4229fd-fecd-4ac1-9c4f-6d442533457f,hypoestrogenism due to hypogonadism,1
4009,4009,4009,4009,4009,4009,4009,4898,4898,4898,4898,4898,4898,4898,4898,4898,4898,4898,4898,4898,bd72fd53-ae0c-4080-9b7f-2d294b14cc86,indications and dosage metastatic breast cancer tamoxifen citrate is effective in the treatment of metastatic breast cancer in women and men,1
4010,4010,4010,4010,4010,4010,4010,4899,4899,4899,4899,4899,4899,4899,4899,4899,4899,4899,4899,4899,bd72fd53-ae0c-4080-9b7f-2d294b14cc86,in premenopausal women with metastatic breast cancer  tamoxifen citrate is an alternative to oophorectomy or ovarian irradiation,1
4011,4011,4011,4011,4011,4011,4011,4900,4900,4900,4900,4900,4900,4900,4900,4900,4900,4900,4900,4900,bd72fd53-ae0c-4080-9b7f-2d294b14cc86,available evidence indicates that patients whose tumors are estrogen receptor positive are more likely to benefit from tamoxifen citrate therapy,0
4012,4012,4012,4012,4012,4012,4012,4901,4901,4901,4901,4901,4901,4901,4901,4901,4901,4901,4901,4901,bd72fd53-ae0c-4080-9b7f-2d294b14cc86,adjuvant treatment of breast cancer tamoxifen citrate is indicated for the treatment of node positive breast cancer in postmenopausal women following total mastectomy or segmental mastectomy  axillary dissection  and breast irradiation,1
4013,4013,4013,4013,4013,4013,4013,4902,4902,4902,4902,4902,4902,4902,4902,4902,4902,4902,4902,4902,bd72fd53-ae0c-4080-9b7f-2d294b14cc86,in some tamoxifen citrate adjuvant studies  most of the benefit to date has been in the subgroup with four or more positive axillary nodes,0
4014,4014,4014,4014,4014,4014,4014,4903,4903,4903,4903,4903,4903,4903,4903,4903,4903,4903,4903,4903,bd72fd53-ae0c-4080-9b7f-2d294b14cc86,tamoxifen citrate is indicated for the treatment of axillary node negative breast cancer in women following total mastectomy or segmental mastectomy  axillary dissection  and breast irradiation,1
4015,4015,4015,4015,4015,4015,4015,4904,4904,4904,4904,4904,4904,4904,4904,4904,4904,4904,4904,4904,bd72fd53-ae0c-4080-9b7f-2d294b14cc86,the estrogen and progesterone receptor values may help to predict whether adjuvant tamoxifen citrate therapy is likely to be beneficial,0
4016,4016,4016,4016,4016,4016,4016,4905,4905,4905,4905,4905,4905,4905,4905,4905,4905,4905,4905,4905,bd72fd53-ae0c-4080-9b7f-2d294b14cc86,tamoxifen citrate reduces the occurrence of contralateral breast cancer in patients receiving adjuvant tamoxifen citrate therapy for breast cancer,0
4017,4017,4017,4017,4017,4017,4017,4906,4906,4906,4906,4906,4906,4906,4906,4906,4906,4906,4906,4906,bd72fd53-ae0c-4080-9b7f-2d294b14cc86,ductal carcinoma in situ ( dcis ) in women with dcis  following breast surgery and radiation  tamoxifen citrate is indicated to reduce the risk of invasive breast cancer ( see boxed warning at the beginning of the label ),1
4018,4018,4018,4018,4018,4018,4018,4907,4907,4907,4907,4907,4907,4907,4907,4907,4907,4907,4907,4907,bd72fd53-ae0c-4080-9b7f-2d294b14cc86,the decision regarding therapy with tamoxifen for the reduction in breast cancer incidence should be based upon an individual assessment of the benefits and risks of tamoxifen therapy,0
4019,4019,4019,4019,4019,4019,4019,4908,4908,4908,4908,4908,4908,4908,4908,4908,4908,4908,4908,4908,bd72fd53-ae0c-4080-9b7f-2d294b14cc86,current data from clinical trials support five years of adjuvant tamoxifen citrate therapy for patients with breast cancer,0
4020,4020,4020,4020,4020,4020,4020,4909,4909,4909,4909,4909,4909,4909,4909,4909,4909,4909,4909,4909,bd72fd53-ae0c-4080-9b7f-2d294b14cc86,reduction in breast cancer incidence in high risk women tamoxifen citrate is indicated to reduce the incidence of breast cancer in women at high risk for breast cancer,1
4021,4021,4021,4021,4021,4021,4021,4910,4910,4910,4910,4910,4910,4910,4910,4910,4910,4910,4910,4910,bd72fd53-ae0c-4080-9b7f-2d294b14cc86,this effect was shown in a study of 5 years planned duration with a median follow up of 4 2 years,0
4022,4022,4022,4022,4022,4022,4022,4911,4911,4911,4911,4911,4911,4911,4911,4911,4911,4911,4911,4911,bd72fd53-ae0c-4080-9b7f-2d294b14cc86,twenty five percent of the participants received drug for 5 years,0
4023,4023,4023,4023,4023,4023,4023,4912,4912,4912,4912,4912,4912,4912,4912,4912,4912,4912,4912,4912,bd72fd53-ae0c-4080-9b7f-2d294b14cc86,the longer term effects are not known,0
4024,4024,4024,4024,4024,4024,4024,4913,4913,4913,4913,4913,4913,4913,4913,4913,4913,4913,4913,4913,bd72fd53-ae0c-4080-9b7f-2d294b14cc86,in this study  there was no impact of tamoxifen on overall or breast cancer related mortality ( see linkhtml hr,0
4025,4025,4025,4025,4025,4025,4025,4914,4914,4914,4914,4914,4914,4914,4914,4914,4914,4914,4914,4914,ad155d62-9b49-4a50-a2ae-d3aad8155936, monurol is indicated only for the treatment of uncomplicated urinary tract infections ( acute cystitis ) in women due to susceptible strains of escherichia coli and enterococcus faecalis,1
4026,4026,4026,4026,4026,4026,4026,4915,4915,4915,4915,4915,4915,4915,4915,4915,4915,4915,4915,4915,ad155d62-9b49-4a50-a2ae-d3aad8155936,monurol is not indicated for the treatment of pyelonephritis or perinephric abscess,2
4027,4027,4027,4027,4027,4027,4027,4916,4916,4916,4916,4916,4916,4916,4916,4916,4916,4916,4916,4916,ad155d62-9b49-4a50-a2ae-d3aad8155936,if persistence or reappearance of bacteriuria occurs after treatment with monurol  other therapeutic agents should be selected,0
4028,4028,4028,4028,4028,4028,4028,4917,4917,4917,4917,4917,4917,4917,4917,4917,4917,4917,4917,4917,ad155d62-9b49-4a50-a2ae-d3aad8155936,( see precautions and clinical studies section ),0
4029,4029,4029,4029,4029,4029,4029,4918,4918,4918,4918,4918,4918,4918,4918,4918,4918,4918,4918,4918,926eb076-a4a8-45e4-91ef-411f0aa4f3ca,1  limitations of use xyrem may only be dispensed to patients enrolled in the xyrem rems program see warnings and precautions ( 5 3 ),0
4030,4030,4030,4030,4030,4030,4030,4919,4919,4919,4919,4919,4919,4919,4919,4919,4919,4919,4919,4919,926eb076-a4a8-45e4-91ef-411f0aa4f3ca,xyrem is a central nervous system depressant indicated for the treatment of cataplexy in narcolepsy ( 1 1 ) excessive daytime sleepiness ( eds ) in narcolepsy ( 1 2 ) xyrem may only be dispensed to patients enrolled in the xyrem rems program ( 1 ),1
4031,4031,4031,4031,4031,4031,4031,4920,4920,4920,4920,4920,4920,4920,4920,4920,4920,4920,4920,4920,926eb076-a4a8-45e4-91ef-411f0aa4f3ca,1 1 cataplexy in narcolepsy xyrem ( sodium oxybate ) oral solution is indicated for the treatment of cataplexy in narcolepsy,1
4032,4032,4032,4032,4032,4032,4032,4921,4921,4921,4921,4921,4921,4921,4921,4921,4921,4921,4921,4921,926eb076-a4a8-45e4-91ef-411f0aa4f3ca,1 2 excessive daytime sleepiness in narcolepsy xyrem ( sodium oxybate ) oral solution is indicated for the treatment of excessive daytime sleepiness ( eds ) in narcolepsy,1
4033,4033,4033,4033,4033,4033,4033,4922,4922,4922,4922,4922,4922,4922,4922,4922,4922,4922,4922,4922,26e91082-7698-4680-beab-07c47802f0f9, dacarbazine for injection usp is indicated in the treatment of metastatic malignant melanoma,1
4034,4034,4034,4034,4034,4034,4034,4923,4923,4923,4923,4923,4923,4923,4923,4923,4923,4923,4923,4923,26e91082-7698-4680-beab-07c47802f0f9,in addition  dacarbazine for injection usp is also indicated for hodgkin 's disease as a secondary line therapy when used in combination with other effective agents,1
4035,4035,4035,4035,4035,4035,4035,4924,4924,4924,4924,4924,4924,4924,4924,4924,4924,4924,4924,4924,a8b27a1b-a611-4f91-ad22-76d4b390c3ae,1  increlex ( mecasermin rdna origin injection ) is indicated for the treatment of growth failure in children with severe primary igf 1 deficiency or with growth hormone ( gh ) gene deletion who have developed neutralizing antibodies to gh,1
4036,4036,4036,4036,4036,4036,4036,4925,4925,4925,4925,4925,4925,4925,4925,4925,4925,4925,4925,4925,a8b27a1b-a611-4f91-ad22-76d4b390c3ae,( 1 1 ) limitations of use increlex is not a substitute to gh for approved gh indications,0
4037,4037,4037,4037,4037,4037,4037,4926,4926,4926,4926,4926,4926,4926,4926,4926,4926,4926,4926,4926,a8b27a1b-a611-4f91-ad22-76d4b390c3ae,1 1 severe primary igf 1 deficiency ( primary igfd ) increlex ( mecasermin rdna origin injection ) is indicated for the treatment of growth failure in children with severe primary igf 1 deficiency,1
4038,4038,4038,4038,4038,4038,4038,4927,4927,4927,4927,4927,4927,4927,4927,4927,4927,4927,4927,4927,a8b27a1b-a611-4f91-ad22-76d4b390c3ae,growth hormone ( gh ) gene deletion who have developed neutralizing antibodies to gh,1
4039,4039,4039,4039,4039,4039,4039,4928,4928,4928,4928,4928,4928,4928,4928,4928,4928,4928,4928,4928,a8b27a1b-a611-4f91-ad22-76d4b390c3ae,severe primary igf 1 deficiency ( igfd ) is defined by height standard deviation score 3 0 and basal igf 1 standard deviation score 3 0 and normal or elevated growth hormone ( gh ),0
4040,4040,4040,4040,4040,4040,4040,4929,4929,4929,4929,4929,4929,4929,4929,4929,4929,4929,4929,4929,a8b27a1b-a611-4f91-ad22-76d4b390c3ae,severe primary igfd includes classical and other forms of growth hormone insensitivity,0
4041,4041,4041,4041,4041,4041,4041,4930,4930,4930,4930,4930,4930,4930,4930,4930,4930,4930,4930,4930,a8b27a1b-a611-4f91-ad22-76d4b390c3ae,patients with primary igfd may have mutations in the gh receptor ( ghr )  post ghr signaling pathway including the igf 1 gene,0
4042,4042,4042,4042,4042,4042,4042,4931,4931,4931,4931,4931,4931,4931,4931,4931,4931,4931,4931,4931,a8b27a1b-a611-4f91-ad22-76d4b390c3ae,they are not gh deficient  and therefore  they cannot be expected to respond adequately to exogenous gh treatment,0
4043,4043,4043,4043,4043,4043,4043,4932,4932,4932,4932,4932,4932,4932,4932,4932,4932,4932,4932,4932,a8b27a1b-a611-4f91-ad22-76d4b390c3ae,increlex is not intended for use in subjects with secondary forms of igf 1 deficiency  such as gh deficiency  malnutrition  hypothyroidism  or chronic treatment with pharmacologic doses of anti inflammatory steroids,2
4044,4044,4044,4044,4044,4044,4044,4933,4933,4933,4933,4933,4933,4933,4933,4933,4933,4933,4933,4933,a8b27a1b-a611-4f91-ad22-76d4b390c3ae,thyroid and nutritional deficiencies should be corrected before initiating increlex treatment,0
4045,4045,4045,4045,4045,4045,4045,4934,4934,4934,4934,4934,4934,4934,4934,4934,4934,4934,4934,4934,a8b27a1b-a611-4f91-ad22-76d4b390c3ae,limitations of use increlex is not a substitute to gh for approved gh indications,2
4046,4046,4046,4046,4046,4046,4046,4935,4935,4935,4935,4935,4935,4935,4935,4935,4935,4935,4935,4935,b3d24364-f4fc-4aac-ac5c-651ae7f6f9b6, oxandrolone is indicated as adjunctive therapy to offset the protein catabolism associated with prolonged administration of corticosteroids  and for the relief of the bone pain frequently accompanying osteoporosis ( see dosage and administration ),1
4047,4047,4047,4047,4047,4047,4047,4936,4936,4936,4936,4936,4936,4936,4936,4936,4936,4936,4936,4936,f1766455-79a2-409f-9325-0e3d6743acc7,1  trulance is indicated in adults for the treatment of chronic idiopathic constipation ( cic ),1
4048,4048,4048,4048,4048,4048,4048,4937,4937,4937,4937,4937,4937,4937,4937,4937,4937,4937,4937,4937,f1766455-79a2-409f-9325-0e3d6743acc7,irritable bowel syndrome with constipation ( ibs c ) trulance is a guanylate cyclase c agonist indicated in adults for treatment of chronic idiopathic constipation ( cic ),1
4049,4049,4049,4049,4049,4049,4049,4938,4938,4938,4938,4938,4938,4938,4938,4938,4938,4938,4938,4938,f1766455-79a2-409f-9325-0e3d6743acc7,( 1 ) irritable bowel syndrome with constipation ( ibs c ),1
4050,4050,4050,4050,4050,4050,4050,4939,4939,4939,4939,4939,4939,4939,4939,4939,4939,4939,4939,4939,68b4168b-5782-4e68-a25a-5b4e4408dbce, dronabinol capsules are indicated for the treatment of 1 anorexia associated with weight loss in patients with aids and 2 nausea and vomiting associated with cancer chemotherapy in patients who have failed to respond adequately to conventional antiemetic treatments,1
4051,4051,4051,4051,4051,4051,4051,4940,4940,4940,4940,4940,4940,4940,4940,4940,4940,4940,4940,4940,cc1f7c53-0023-4184-a0bc-3262884d8c1d, dopamine hydrochloride in 5 dextrose injection usp is indicated for the correction of hemodynamic imbalances present in the shock syndrome due to myocardial infarctions  trauma  endotoxic septicemia  open heart surgery  renal failure  and chronic cardiac decompensation as in congestive heart failure,1
4052,4052,4052,4052,4052,4052,4052,4941,4941,4941,4941,4941,4941,4941,4941,4941,4941,4941,4941,4941,cc1f7c53-0023-4184-a0bc-3262884d8c1d,where appropriate  restoration of blood volume with a suitable plasma expander or whole blood should be instituted or completed prior to administration of dopamine,0
4053,4053,4053,4053,4053,4053,4053,4942,4942,4942,4942,4942,4942,4942,4942,4942,4942,4942,4942,4942,cc1f7c53-0023-4184-a0bc-3262884d8c1d,patients most likely to respond adequately to administration of dopamine are those in whom physiological parameters such as urine flow  myocardial function  and blood pressure  have not undergone profound deterioration,0
4054,4054,4054,4054,4054,4054,4054,4943,4943,4943,4943,4943,4943,4943,4943,4943,4943,4943,4943,4943,cc1f7c53-0023-4184-a0bc-3262884d8c1d,multiclinic trials indicate that the shorter the time interval between onset of signs and symptoms and initiation of therapy with volume correction and dopamine  the better the prognosis,0
4055,4055,4055,4055,4055,4055,4055,4944,4944,4944,4944,4944,4944,4944,4944,4944,4944,4944,4944,4944,cc1f7c53-0023-4184-a0bc-3262884d8c1d,poor perfusion of vital organs urine flow appears to be one of the diagnostic signs by which adequacy of vital organ perfusion can be monitored,0
4056,4056,4056,4056,4056,4056,4056,4945,4945,4945,4945,4945,4945,4945,4945,4945,4945,4945,4945,4945,cc1f7c53-0023-4184-a0bc-3262884d8c1d,nevertheless  the physician should also observe the patient for signs of reversal of confusion or comatose condition,0
4057,4057,4057,4057,4057,4057,4057,4946,4946,4946,4946,4946,4946,4946,4946,4946,4946,4946,4946,4946,cc1f7c53-0023-4184-a0bc-3262884d8c1d,loss of pallor increase in toe temperature  and or adequacy of nail bed capillary filling may also be used as indices of adequate dosage,0
4058,4058,4058,4058,4058,4058,4058,4947,4947,4947,4947,4947,4947,4947,4947,4947,4947,4947,4947,4947,cc1f7c53-0023-4184-a0bc-3262884d8c1d,clinical studies have shown that when dopamine is administered before urine flow had diminished to levels approximately 0 3 ml minute  prognosis is more favorable,0
4059,4059,4059,4059,4059,4059,4059,4948,4948,4948,4948,4948,4948,4948,4948,4948,4948,4948,4948,4948,cc1f7c53-0023-4184-a0bc-3262884d8c1d,nevertheless  in a number of oliguric or anuric patients  administration of dopamine has resulted in an increase in urine flow which in some cases reached normal levels,0
4060,4060,4060,4060,4060,4060,4060,4949,4949,4949,4949,4949,4949,4949,4949,4949,4949,4949,4949,4949,cc1f7c53-0023-4184-a0bc-3262884d8c1d,dopamine may also increase urine flow in patients whose output is within normal limits and thus may be of value in reducing the degree of pre existing fluid accumulation,0
4061,4061,4061,4061,4061,4061,4061,4950,4950,4950,4950,4950,4950,4950,4950,4950,4950,4950,4950,4950,cc1f7c53-0023-4184-a0bc-3262884d8c1d,it should be noted that at doses above those optimal for the individual patient  urine flow may decrease  necessitating reduction of dosage,0
4062,4062,4062,4062,4062,4062,4062,4951,4951,4951,4951,4951,4951,4951,4951,4951,4951,4951,4951,4951,cc1f7c53-0023-4184-a0bc-3262884d8c1d,concurrent administration of dopamine and diuretic agents may produce an additive or potentiating effect,0
4063,4063,4063,4063,4063,4063,4063,4952,4952,4952,4952,4952,4952,4952,4952,4952,4952,4952,4952,4952,cc1f7c53-0023-4184-a0bc-3262884d8c1d,low cardiac output increased cardiac output is related to dopamine s direct inotropic effect on the myocardium,u
4064,4064,4064,4064,4064,4064,4064,4953,4953,4953,4953,4953,4953,4953,4953,4953,4953,4953,4953,4953,cc1f7c53-0023-4184-a0bc-3262884d8c1d,increased cardiac output at low or moderate doses appears to be related to a favorable prognosis,
4065,4065,4065,4065,4065,4065,4065,4954,4954,4954,4954,4954,4954,4954,4954,4954,4954,4954,4954,4954,cc1f7c53-0023-4184-a0bc-3262884d8c1d,increase in cardiac output has been associated with either static or decreased systemic vascular resistance ( svr ),0
4066,4066,4066,4066,4066,4066,4066,4955,4955,4955,4955,4955,4955,4955,4955,4955,4955,4955,4955,4955,cc1f7c53-0023-4184-a0bc-3262884d8c1d,static or decreased svr associated with low or moderate increments in cardiac output is believed to be a reflection of differential effects on specific vascular beds with increased resistance in peripheral beds ( e g  femoral ) and concomitant decreases in mesenteric and renal vascular beds,0
4067,4067,4067,4067,4067,4067,4067,4956,4956,4956,4956,4956,4956,4956,4956,4956,4956,4956,4956,4956,cc1f7c53-0023-4184-a0bc-3262884d8c1d,redistribution of blood flow parallels these changes so that an increase in cardiac output is accompanied by an increase in mesenteric and renal blood flow,0
4068,4068,4068,4068,4068,4068,4068,4957,4957,4957,4957,4957,4957,4957,4957,4957,4957,4957,4957,4957,cc1f7c53-0023-4184-a0bc-3262884d8c1d,in many instances the renal fraction of the total cardiac output has been found to increase,0
4069,4069,4069,4069,4069,4069,4069,4958,4958,4958,4958,4958,4958,4958,4958,4958,4958,4958,4958,4958,cc1f7c53-0023-4184-a0bc-3262884d8c1d,increase in cardiac output produced by dopamine is not associated with substantial decreases in systemic vascular resistance as may occur with isoproterenol,0
4070,4070,4070,4070,4070,4070,4070,4959,4959,4959,4959,4959,4959,4959,4959,4959,4959,4959,4959,4959,cc1f7c53-0023-4184-a0bc-3262884d8c1d,hypotension hypotension due to inadequate cardiac output can be managed by administration of low to moderate doses of dopamine ,u
4071,4071,4071,4071,4071,4071,4071,4960,4960,4960,4960,4960,4960,4960,4960,4960,4960,4960,4960,4960,ba1f7351-76cd-a872-c9e0-57db929e84de,1  riluzole tablets are indicated for the treatment of amyotrophic lateral sclerosis ( als ),1
4072,4072,4072,4072,4072,4072,4072,4961,4961,4961,4961,4961,4961,4961,4961,4961,4961,4961,4961,4961,ba1f7351-76cd-a872-c9e0-57db929e84de,riluzole tablets are indicated for the treatment of amyotrophic lateral sclerosis ( als ) ( 1 ),1
4073,4073,4073,4073,4073,4073,4073,4962,4962,4962,4962,4962,4962,4962,4962,4962,4962,4962,4962,4962,aa5e4446-19cd-4235-a382-5b48bf6c3b2f,1  the kisqali femara co pack is indicated as initial endocrine based therapy for the treatment of postmenopausal women with hormone receptor ( hr ) positive  human epidermal growth factor receptor 2 ( her2 ) negative advanced or metastatic breast cancer,1
4074,4074,4074,4074,4074,4074,4074,4963,4963,4963,4963,4963,4963,4963,4963,4963,4963,4963,4963,4963,aa5e4446-19cd-4235-a382-5b48bf6c3b2f,kisqali femara co pack  a co packaged product containing ribociclib  a kinase inhibitor  and letrozole  an aromatase inhibitor  is indicated as initial endocrine based therapy for the treatment of postmenopausal women with hormone receptor ( hr ) positive  human epidermal growth factor receptor 2 ( her2 ) negative advanced or metastatic breast cancer,1
4075,4075,4075,4075,4075,4075,4075,4964,4964,4964,4964,4964,4964,4964,4964,4964,4964,4964,4964,4964,34d7b9da-327d-45a7-a87a-f8b6d5e80a7b,use first aid antiseptic to help prevent the risk of infection in minor cuts  scrapes and burns,u
4076,4076,4076,4076,4076,4076,4076,4965,4965,4965,4965,4965,4965,4965,4965,4965,4965,4965,4965,4965,16fdc381-0a5b-419e-afaa-9cb2e61bd32e, amiloride hcl tablets are indicated as adjunctive treatment with thiazide diuretics or other kaliureticdiuretic agents in congestive heart failure or hypertension to a help restore normal serum potassium levels in patients who develop hypokalemia on the kaliuretic diuretic b prevent development of hypokalemia in patients who would be exposed to particular risk if hypokalemia were to develop  e g  digitalized patients or patients with significant cardiac arrhythmias,1
4077,4077,4077,4077,4077,4077,4077,4967,4967,4967,4967,4967,4967,4967,4967,4967,4967,4967,4967,4967,16fdc381-0a5b-419e-afaa-9cb2e61bd32e,amiloride hcl tablets have little additive diuretic or antihypertensive effect when added to a thiazide diuretic,0
4078,4078,4078,4078,4078,4078,4078,4968,4968,4968,4968,4968,4968,4968,4968,4968,4968,4968,4968,4968,16fdc381-0a5b-419e-afaa-9cb2e61bd32e,amiloride hcl tablets should rarely be used alone,4
4079,4079,4079,4079,4079,4079,4079,4969,4969,4969,4969,4969,4969,4969,4969,4969,4969,4969,4969,4969,16fdc381-0a5b-419e-afaa-9cb2e61bd32e,it has weak ( compared with thiazides ) diuretic and antihypertensive effects,0
4080,4080,4080,4080,4080,4080,4080,4970,4970,4970,4970,4970,4970,4970,4970,4970,4970,4970,4970,4970,16fdc381-0a5b-419e-afaa-9cb2e61bd32e,used as single agents  potassium sparing diuretics  including amiloride hcl tablets  result in an increased risk of hyperkalemia ( approximately 10 with amiloride ),3
4081,4081,4081,4081,4081,4081,4081,4971,4971,4971,4971,4971,4971,4971,4971,4971,4971,4971,4971,4971,16fdc381-0a5b-419e-afaa-9cb2e61bd32e,amiloride hcl tablets should be used alone only when persistent hypokalemia has been documented and only with careful titration of the dose and close monitoring of serum electrolytes,4
4082,4082,4082,4082,4082,4082,4082,4972,4972,4972,4972,4972,4972,4972,4972,4972,4972,4972,4972,4972,2483adba-fab6-4d1b-96c5-c195577ed071,1  hemlibra is indicated for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adult and pediatric patients with hemophilia a ( congenital factor viii deficiency ) with factor viii inhibitors,1
4083,4083,4083,4083,4083,4083,4083,4973,4973,4973,4973,4973,4973,4973,4973,4973,4973,4973,4973,4973,2483adba-fab6-4d1b-96c5-c195577ed071,hemlibra is a bispecific factor ixa and factor x directed antibody indicated for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adult and pediatric patients with hemophilia a ( congenital factor viii deficiency ) with factor viii inhibitors,1
4084,4084,4084,4084,4084,4084,4084,4974,4974,4974,4974,4974,4974,4974,4974,4974,4974,4974,4974,4974,a1bf6bf0-9197-4fc1-af9f-df7b9a1ad6ce,1  oravig is indicated for the local treatment of oropharyngeal candidiasis ( opc ) in adults,1
4085,4085,4085,4085,4085,4085,4085,4975,4975,4975,4975,4975,4975,4975,4975,4975,4975,4975,4975,4975,a1bf6bf0-9197-4fc1-af9f-df7b9a1ad6ce,oravig is an azole antifungal indicated for the local treatment of oropharyngeal candidiasis in adults ( 1 ),1
4086,4086,4086,4086,4086,4086,4086,4976,4976,4976,4976,4976,4976,4976,4976,4976,4976,4976,4976,4976,3ecde48b-75a2-4beb-9999-369f3f61bb8a, teflaro is a cephalosporin antibacterial indicated in adult and pediatric patients 2 months of age and older for the treatment of the following infections caused by designated susceptible bacteria acute bacterial skin and skin structure infections ( absssi ) ( 1 1 ) community acquired bacterial pneumonia ( cabp ) ( 1 2 ) to reduce the development of drug resistant bacteria and maintain the effectiveness of teflaro and other antibacterial drugs  teflaro should be used only to treat infections that are proven or strongly suspected to be caused by bacteria ( 1 3 ),1
4087,4087,4087,4087,4087,4087,4087,4977,4977,4977,4977,4977,4977,4977,4977,4977,4977,4977,4977,4977,3ecde48b-75a2-4beb-9999-369f3f61bb8a,1 1 acute bacterial skin and skin structure infections teflaro is indicated in adult and pediatric patients 2 months of age and older for the treatment of acute bacterial skin and skin structure infections ( absssi ) caused by susceptible isolates of the following gram positive and gram negative microorganisms staphylococcus aureus ( including methicillin susceptible and resistant isolates )  streptococcus pyogenes  streptococcus agalactiae  escherichia coli  klebsiella pneumoniae  and klebsiella oxytoca,1
4088,4088,4088,4088,4088,4088,4088,4978,4978,4978,4978,4978,4978,4978,4978,4978,4978,4978,4978,4978,3ecde48b-75a2-4beb-9999-369f3f61bb8a,1 2 community acquired bacterial pneumonia teflaro is indicated in adult and pediatric patients 2 months of age and older for the treatment of community acquired bacterial pneumonia ( cabp ) caused by susceptible isolates of the following gram positive and gram negative microorganisms streptococcus pneumoniae ( including cases with concurrent bacteremia )  staphylococcus aureus ( methicillin susceptible isolates only )  haemophilus influenzae  klebsiella pneumoniae  klebsiella oxytoca  and escherichia coli,1
4089,4089,4089,4089,4089,4089,4089,4979,4979,4979,4979,4979,4979,4979,4979,4979,4979,4979,4979,4979,3ecde48b-75a2-4beb-9999-369f3f61bb8a,1 3 usage to reduce the development of drug resistant bacteria and maintain the effectiveness of teflaro and other antibacterial drugs  teflaro should be used to treat only absssi or cabp that are proven or strongly suspected to be caused by susceptible,4
4090,4090,4090,4090,4090,4090,4090,4980,4980,4980,4980,4980,4980,4980,4980,4980,4980,4980,4980,4980,11492bd5-2ade-4eb4-a23c-b9be99c0d51a, technetium tc 99m mebrofenin is indicated as a hepatobiliary imaging agent,1
4091,4091,4091,4091,4091,4091,4091,4981,4981,4981,4981,4981,4981,4981,4981,4981,4981,4981,4981,4981,70ac1d90-eff3-4f0b-9f46-5846c571b32f,1  zerbaxa ( ceftolozane and tazobactam ) for injection is indicated for the treatment of patients 18 years or older with the following infections caused by designated susceptible microorganisms,1
4092,4092,4092,4092,4092,4092,4092,4982,4982,4982,4982,4982,4982,4982,4982,4982,4982,4982,4982,4982,70ac1d90-eff3-4f0b-9f46-5846c571b32f,zerbaxa ( ceftolozane and tazobactam ) is a combination product consisting of a cephalosporin class antibacterial drug and a beta lactamase inhibitor indicated for the treatment of the following infections caused by designated susceptible microorganisms complicated intra abdominal infections  used in combination with metronidazole ( 1 1 ) complicated urinary tract infections  including pyelonephritis ( 1 2 ) to reduce the development of drug resistant bacteria and maintain the effectiveness of zerbaxa and other antibacterial drugs  zerbaxa should be used only to treat infections that are proven or strongly suspected to be caused by susceptible bacteria,1
4093,4093,4093,4093,4093,4093,4093,4983,4983,4983,4983,4983,4983,4983,4983,4983,4983,4983,4983,4983,70ac1d90-eff3-4f0b-9f46-5846c571b32f,( 1 3 ) 1 1 complicated intra abdominal infections zerbaxa used in combination with metronidazole is indicated for the treatment of complicated intra abdominal infections ( ciai ) caused by the following gram negative and gram positive microorganisms enterobacter cloacae  escherichia coli  klebsiella oxytoca  klebsiella pneumoniae  proteus mirabilis  pseudomonas aeruginosa  bacteroides fragilis  streptococcus anginosus  streptococcus constellatus  and streptococcus salivarius,1
4094,4094,4094,4094,4094,4094,4094,4984,4984,4984,4984,4984,4984,4984,4984,4984,4984,4984,4984,4984,70ac1d90-eff3-4f0b-9f46-5846c571b32f,1 2 complicated urinary tract infections  including pyelonephritis zerbaxa is indicated for the treatment of complicated urinary tract infections ( cuti )  including pyelonephritis  caused by the following gram negative microorganisms escherichia coli  klebsiella pneumoniae  proteus mirabilis  and pseudomonas aeruginosa,1
4095,4095,4095,4095,4095,4095,4095,4985,4985,4985,4985,4985,4985,4985,4985,4985,4985,4985,4985,4985,70ac1d90-eff3-4f0b-9f46-5846c571b32f,1 3 usage to reduce the development of drug resistant bacteria and maintain the effectiveness of zerbaxa and other antibacterial drugs  zerbaxa should be used only to treat infections that are proven or strongly suspected to be caused by susceptible bacteria,4
4096,4096,4096,4096,4096,4096,4096,4986,4986,4986,4986,4986,4986,4986,4986,4986,4986,4986,4986,4986,70ac1d90-eff3-4f0b-9f46-5846c571b32f,when culture and susceptibility information are available  they should be considered in selecting or modifyin,0
4097,4097,4097,4097,4097,4097,4097,4987,4987,4987,4987,4987,4987,4987,4987,4987,4987,4987,4987,4987,89e1d458-7caa-430f-9c54-360889899a73, allergic states control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in asthma  atopic dermatitis  contact dermatitis  drug hypersensitivity reactions  perennial or seasonal allergic rhinitis  and serum sickness,1
4098,4098,4098,4098,4098,4098,4098,4988,4988,4988,4988,4988,4988,4988,4988,4988,4988,4988,4988,4988,89e1d458-7caa-430f-9c54-360889899a73,dermatologic diseases bullous dermatitis herpetiformis  exfoliative erythroderma  mycosis fungoides  pemphigus  and severe erythema multiforme ( stevens johnson syndrome ),1
4099,4099,4099,4099,4099,4099,4099,4989,4989,4989,4989,4989,4989,4989,4989,4989,4989,4989,4989,4989,89e1d458-7caa-430f-9c54-360889899a73,endocrine disorders primary or secondary adrenocortical insufficiency ( hydrocortisone or cortisone is the drug of choice may be used in conjunction with synthetic mineralocorticoid analogs where applicable in infancy mineralocorticoid supplementation is of particular importance )  congenital adrenal hyperplasia  hypercalcemia associated with cancer  and nonsuppurative thyroiditis,1
4100,4100,4100,4100,4100,4100,4100,4990,4990,4990,4990,4990,4990,4990,4990,4990,4990,4990,4990,4990,89e1d458-7caa-430f-9c54-360889899a73,gastrointestinal diseases to tide the patient over a critical period of the disease in regional enteritis and ulcerative colitis,1
4101,4101,4101,4101,4101,4101,4101,4991,4991,4991,4991,4991,4991,4991,4991,4991,4991,4991,4991,4991,89e1d458-7caa-430f-9c54-360889899a73,hematologic disorders acquired ( autoimmune ) hemolytic anemia  congenital ( erythroid ) hypoplastic anemia ( diamond blackfan anemia )  idiopathic thrombocytopenic purpura in adults  pure red cell aplasia  and selected cases of secondary thrombocytopenia,1
4102,4102,4102,4102,4102,4102,4102,4992,4992,4992,4992,4992,4992,4992,4992,4992,4992,4992,4992,4992,89e1d458-7caa-430f-9c54-360889899a73,miscellaneous diagnostic testing of adrenocortical hyperfunction  trichinosis with neurologic or myocardial involvement  tuberculous meningitis with subarachnoid block or impending block when used with appropriate antituberculous chemo,1
4103,4103,4103,4103,4103,4103,4103,4993,4993,4993,4993,4993,4993,4993,4993,4993,4993,4993,4993,4993,d1d48422-8cfc-4e9e-a7f8-56c274d8eb83,1  tobradex st ophthalmic suspension is indicated for steroid responsive inflammatory ocular conditions for which a corticosteroid is indicated and where superficial bacterial ocular infection or a risk of bacterial ocular infection exists,1
4104,4104,4104,4104,4104,4104,4104,4994,4994,4994,4994,4994,4994,4994,4994,4994,4994,4994,4994,4994,d1d48422-8cfc-4e9e-a7f8-56c274d8eb83,ocular steroids are indicated in inflammatory conditions of the palpebral and bulbar conjunctiva  cornea and anterior segment of the globe where the inherent risk of steroid use in certain infective conjunctivitides is accepted to obtain a diminution in edema and inflammation,1
4105,4105,4105,4105,4105,4105,4105,4995,4995,4995,4995,4995,4995,4995,4995,4995,4995,4995,4995,4995,d1d48422-8cfc-4e9e-a7f8-56c274d8eb83,they are also indicated in chronic anterior uveitis and corneal injury from chemical  radiation or thermal burns  or penetration of foreign bodies,1
4106,4106,4106,4106,4106,4106,4106,4997,4997,4997,4997,4997,4997,4997,4997,4997,4997,4997,4997,4997,d1d48422-8cfc-4e9e-a7f8-56c274d8eb83,the particular anti infective drug in this product is active against the following common bacterial eye pathogens staphylococci  including s aureus and s epidermidis ( coagulase positive and coagulase negative )  including penicillin resistant isolates,u
4107,4107,4107,4107,4107,4107,4107,4998,4998,4998,4998,4998,4998,4998,4998,4998,4998,4998,4998,4998,d1d48422-8cfc-4e9e-a7f8-56c274d8eb83,streptococci  including some group a and other beta hemolytic species  some nonhemolytic species  and some streptococcus pneumoniae  pseudomonas aeruginosa  escherichia coli  klebsiella pneumoniae  enterobacter aerogenes  proteus mirabilis  morganella morganii  most proteus vulgaris isolates  haemophilus influenzae  h aegyptius  moraxella lacunata  acinetobacter calcoaceticus and some neisseria species,1
4108,4108,4108,4108,4108,4108,4108,4999,4999,4999,4999,4999,4999,4999,4999,4999,4999,4999,4999,4999,d1d48422-8cfc-4e9e-a7f8-56c274d8eb83,tobradex st is a topical antibiotic and corticosteroid combination for steroid responsive inflammatory ocular conditions for which a corticosteroid is indicated and where superficial bacterial ocular infection or a risk of bacterial ocular infection exists,1
4109,4109,4109,4109,4109,4109,4109,5000,5000,5000,5000,5000,5000,5000,5000,5000,5000,5000,5000,5000,d02af310-d097-4886-86e5-adcf6bca0533, metvixia cream in combination with 570 to 670 nm wavelength red light illumination using the curelight broadband model curelight 01 lamp is indicated for treatment of non hyperkeratotic actinic keratoses of the face and scalp in immunocompetent patients when used in conjunction with lesion preparation ( debridement using a sharp dermal curette ) in the physician s office when other therapies are unacceptable or considered medically less appropriate,1
4110,4110,4110,4110,4110,4110,4110,5001,5001,5001,5001,5001,5001,5001,5001,5001,5001,5001,5001,5001,72b10d15-8337-49ab-ad8d-0e990192598e,1  sterile talc powder is indicated to decrease the recurrence of malignant pleural effusions in symptomatic patients following maximal drainage of the pleural effusion,1
4111,4111,4111,4111,4111,4111,4111,5002,5002,5002,5002,5002,5002,5002,5002,5002,5002,5002,5002,5002,72b10d15-8337-49ab-ad8d-0e990192598e,sterile talc powder is a sclerosing agent indicated to decrease the recurrence of malignant pleural effusions in symptomatic patients following maximal drainage of the pleural effusion,1
4112,4112,4112,4112,4112,4112,4112,5003,5003,5003,5003,5003,5003,5003,5003,5003,5003,5003,5003,5003,a6eaedb3-5c96-4859-be43-a48c9c818bc7,1  calcitonin salmon nasal solution is a calcitonin  indicated for the treatment of postmenopausal osteoporosis in women greater than 5 years postmenopause when alternative treatments are not suitable,1
4113,4113,4113,4113,4113,4113,4113,5004,5004,5004,5004,5004,5004,5004,5004,5004,5004,5004,5004,5004,a6eaedb3-5c96-4859-be43-a48c9c818bc7,fracture reduction efficacy has not been demonstrated,0
4114,4114,4114,4114,4114,4114,4114,5005,5005,5005,5005,5005,5005,5005,5005,5005,5005,5005,5005,5005,a6eaedb3-5c96-4859-be43-a48c9c818bc7,( 1 1 ) limitations of use due to the possible association between malignancy and calcitonin salmon use  the need for continued therapy should be re evaluated on a periodic basis,0
4115,4115,4115,4115,4115,4115,4115,5006,5006,5006,5006,5006,5006,5006,5006,5006,5006,5006,5006,5006,a6eaedb3-5c96-4859-be43-a48c9c818bc7,( 1 2  5 4 ) calcitonin salmon nasal solution has not been shown to increase bone mineral density in early postmenopausal women,0
4116,4116,4116,4116,4116,4116,4116,5007,5007,5007,5007,5007,5007,5007,5007,5007,5007,5007,5007,5007,a6eaedb3-5c96-4859-be43-a48c9c818bc7,( 1 2 ) 1 1 treatment of postmenopausal osteoporosis calcitonin salmon nasal solution is indicated for the treatment of postmenopausal osteoporosis in women greater than 5 years postmenopause,1
4117,4117,4117,4117,4117,4117,4117,5009,5009,5009,5009,5009,5009,5009,5009,5009,5009,5009,5009,5009,a6eaedb3-5c96-4859-be43-a48c9c818bc7,calcitonin salmon nasal solution should be reserved for patients for whom alternative treatments are not suitable ( e g  patients for whom other therapies are contraindicated or for patients who are intolerant or unwilling to use other therapies ),4
4118,4118,4118,4118,4118,4118,4118,5010,5010,5010,5010,5010,5010,5010,5010,5010,5010,5010,5010,5010,a6eaedb3-5c96-4859-be43-a48c9c818bc7,1 2 important limitations of use due to the possible association between malignancy and calcitonin salmon use  the need for continued therapy should be re evaluated on a periodic basis see warnings and precautions ( 5 4 ),4
4119,4119,4119,4119,4119,4119,4119,5011,5011,5011,5011,5011,5011,5011,5011,5011,5011,5011,5011,5011,a6eaedb3-5c96-4859-be43-a48c9c818bc7,calcitonin salmon nasal solution has not been shown to increase spinal bone mineral density in early postmenopausal women,0
4120,4120,4120,4120,4120,4120,4120,5012,5012,5012,5012,5012,5012,5012,5012,5012,5012,5012,5012,5012,d66bdf0d-9d65-45de-ae5b-a58617c27492,1  unituxin ( dinutuximab ) is indicated  in combination with granulocyte macrophage colony stimulating factor ( gm csf )  interleukin 2 ( il 2 ) and 13 cis retinoic acid ( ra )  for the treatment of pediatric patients with high risk neuroblastoma who achieve at least a partial response to prior first line multiagent  multimodality therapy see clinical studies ( 14 ),1
4121,4121,4121,4121,4121,4121,4121,5013,5013,5013,5013,5013,5013,5013,5013,5013,5013,5013,5013,5013,d66bdf0d-9d65-45de-ae5b-a58617c27492,unituxin is a gd2 binding monoclonal antibody indicated  in combination with granulocyte macrophage colony stimulating factor ( gm csf )  interleukin 2 ( il 2 )  and 13 cis retinoic acid ( ra )  for the treatment of pediatric patients with high risk neuroblastoma who achieve at least a partial response to prior first line multiagent  multimodality therapy,1
4122,4122,4122,4122,4122,4122,4122,5014,5014,5014,5014,5014,5014,5014,5014,5014,5014,5014,5014,5014,"Active Ingredient UNII(s)
7TQO7W3VT8; 85H0HZU99M; AI9376Y64P; ND2M416302    94472ddb-ae1d-4a11-a673-81254d562e6b
7TQO7W3VT8; 85H0HZU99M; AI9376Y64P; ND2M416302    94472ddb-ae1d-4a11-a673-81254d562e6b
7TQO7W3VT8; 85H0HZU99M; AI9376Y64P; ND2M416302    94472ddb-ae1d-4a11-a673-81254d562e6b
7TQO7W3VT8; 85H0HZU99M; AI9376Y64P; ND2M416302    94472ddb-ae1d-4a11-a673-81254d562e6b
Name: SET ID dtype: object",active ingredient unii ( s ) 7tqo7w3vt8 85h0hzu99m ai9376y64p nd2m416302 active ingredient unii ( s ) 7tqo7w3vt8 85h0hzu9 7tqo7w3vt8 85h0hzu99m ai9376y64p nd2m416302 active ingredient unii ( s ) 7tqo7w3vt8 85h0hzu9 7tqo7w3vt8 85h0hzu99m ai9376y64p nd2m416302 active ingredient unii ( s ) 7tqo7w3vt8 85h0hzu9 7tqo7w3vt8 85h0hzu99m ai9376y64p nd2m416302 active ingredient unii ( s ) 7tqo7w3vt8 85h0hzu9 name content xml  dtype object,0
4123,4123,4123,4123,4123,4123,4123,5018,5018,5018,5018,5018,5018,5018,5018,5018,5018,5018,5018,5018,"Active Ingredient UNII(s)
7TQO7W3VT8; 85H0HZU99M; AI9376Y64P; ND2M416302; V13007Z41A    fd895819-b7d4-43bd-b804-f7b0722a00e9
7TQO7W3VT8; 85H0HZU99M; AI9376Y64P; ND2M416302; V13007Z41A    fd895819-b7d4-43bd-b804-f7b0722a00e9
7TQO7W3VT8; 85H0HZU99M; AI9376Y64P; ND2M416302; V13007Z41A    fd895819-b7d4-43bd-b804-f7b0722a00e9
7TQO7W3VT8; 85H0HZU99M; AI9376Y64P; ND2M416302; V13007Z41A    fd895819-b7d4-43bd-b804-f7b0722a00e9
7TQO7W3VT8; 85H0HZU99M; AI9376Y64P; ND2M416302; V13007Z41A    fd895819-b7d4-43bd-b804-f7b0722a00e9
Name: SET ID dtype: object",active ingredient unii ( s ) 7tqo7w3vt8 85h0hzu99m ai9376y64p nd2m416302 v13007z41a active ingredient unii ( s ) 7tqo7w3vt8 85h0hzu9 7tqo7w3vt8 85h0hzu99m ai9376y64p nd2m416302 v13007z41a active ingredient unii ( s ) 7tqo7w3vt8 85h0hzu9 7tqo7w3vt8 85h0hzu99m ai9376y64p nd2m416302 v13007z41a active ingredient unii ( s ) 7tqo7w3vt8 85h0hzu9 7tqo7w3vt8 85h0hzu99m ai9376y64p nd2m416302 v13007z41a active ingredient unii ( s ) 7tqo7w3vt8 85h0hzu9 7tqo7w3vt8 85h0hzu99m ai9376y64p nd2m416302 v13007z41a active ingredient unii ( s ) 7tqo7w3vt8 85h0hzu9 name content xml  dtype object,0
4124,4124,4124,4124,4124,4124,4124,5023,5023,5023,5023,5023,5023,5023,5023,5023,5023,5023,5023,5023,"Active Ingredient UNII(s)
7TQO7W3VT8; 85H0HZU99M; EC2CNF7XFP; F446C597KA    481aeef5-01cb-4567-a67f-896e6929b2ed
7TQO7W3VT8; 85H0HZU99M; EC2CNF7XFP; F446C597KA    481aeef5-01cb-4567-a67f-896e6929b2ed
7TQO7W3VT8; 85H0HZU99M; EC2CNF7XFP; F446C597KA    481aeef5-01cb-4567-a67f-896e6929b2ed
7TQO7W3VT8; 85H0HZU99M; EC2CNF7XFP; F446C597KA    481aeef5-01cb-4567-a67f-896e6929b2ed
Name: SET ID dtype: object",active ingredient unii ( s ) 7tqo7w3vt8 85h0hzu99m ec2cnf7xfp f446c597ka active ingredient unii ( s ) 7tqo7w3vt8 85h0hzu9 7tqo7w3vt8 85h0hzu99m ec2cnf7xfp f446c597ka active ingredient unii ( s ) 7tqo7w3vt8 85h0hzu9 7tqo7w3vt8 85h0hzu99m ec2cnf7xfp f446c597ka active ingredient unii ( s ) 7tqo7w3vt8 85h0hzu9 7tqo7w3vt8 85h0hzu99m ec2cnf7xfp f446c597ka active ingredient unii ( s ) 7tqo7w3vt8 85h0hzu9 name content xml  dtype object,0
4125,4125,4125,4125,4125,4125,4125,5027,5027,5027,5027,5027,5027,5027,5027,5027,5027,5027,5027,5027,"Active Ingredient UNII(s)
7TQO7W3VT8; 85H0HZU99M; F446C597KA    9d485952-e8f5-4ec9-bab2-6ee4217e807a
7TQO7W3VT8; 85H0HZU99M; F446C597KA    9d485952-e8f5-4ec9-bab2-6ee4217e807a
7TQO7W3VT8; 85H0HZU99M; F446C597KA    9d485952-e8f5-4ec9-bab2-6ee4217e807a
Name: SET ID dtype: object",active ingredient unii ( s ) 7tqo7w3vt8 85h0hzu99m f446c597ka active ingredient unii ( s ) 7tqo7w3vt8 85h0hzu9 7tqo7w3vt8 85h0hzu99m f446c597ka active ingredient unii ( s ) 7tqo7w3vt8 85h0hzu9 7tqo7w3vt8 85h0hzu99m f446c597ka active ingredient unii ( s ) 7tqo7w3vt8 85h0hzu9 name content xml  dtype object,0
4126,4126,4126,4126,4126,4126,4126,5030,5030,5030,5030,5030,5030,5030,5030,5030,5030,5030,5030,5030,"Active Ingredient UNII(s)
7TQO7W3VT8; 85H0HZU99M; F446C597KA; V13007Z41A    0cd42a2f-d202-447d-998e-8877ac3c0d38
7TQO7W3VT8; 85H0HZU99M; F446C597KA; V13007Z41A    0cd42a2f-d202-447d-998e-8877ac3c0d38
7TQO7W3VT8; 85H0HZU99M; F446C597KA; V13007Z41A    0cd42a2f-d202-447d-998e-8877ac3c0d38
7TQO7W3VT8; 85H0HZU99M; F446C597KA; V13007Z41A    0cd42a2f-d202-447d-998e-8877ac3c0d38
Name: SET ID dtype: object",active ingredient unii ( s ) 7tqo7w3vt8 85h0hzu99m f446c597ka v13007z41a active ingredient unii ( s ) 7tqo7w3vt8 85h0hzu9 7tqo7w3vt8 85h0hzu99m f446c597ka v13007z41a active ingredient unii ( s ) 7tqo7w3vt8 85h0hzu9 7tqo7w3vt8 85h0hzu99m f446c597ka v13007z41a active ingredient unii ( s ) 7tqo7w3vt8 85h0hzu9 7tqo7w3vt8 85h0hzu99m f446c597ka v13007z41a active ingredient unii ( s ) 7tqo7w3vt8 85h0hzu9 name content xml  dtype object,0
4127,4127,4127,4127,4127,4127,4127,5034,5034,5034,5034,5034,5034,5034,5034,5034,5034,5034,5034,5034,"Active Ingredient UNII(s)
7TQO7W3VT8; 85H0HZU99M; ND2M416302; V13007Z41A    1fe460e7-208d-410e-84c5-cd63005cff47
7TQO7W3VT8; 85H0HZU99M; ND2M416302; V13007Z41A    1fe460e7-208d-410e-84c5-cd63005cff47
7TQO7W3VT8; 85H0HZU99M; ND2M416302; V13007Z41A    1fe460e7-208d-410e-84c5-cd63005cff47
7TQO7W3VT8; 85H0HZU99M; ND2M416302; V13007Z41A    1fe460e7-208d-410e-84c5-cd63005cff47
Name: SET ID dtype: object",active ingredient unii ( s ) 7tqo7w3vt8 85h0hzu99m nd2m416302 v13007z41a active ingredient unii ( s ) 7tqo7w3vt8 85h0hzu9 7tqo7w3vt8 85h0hzu99m nd2m416302 v13007z41a active ingredient unii ( s ) 7tqo7w3vt8 85h0hzu9 7tqo7w3vt8 85h0hzu99m nd2m416302 v13007z41a active ingredient unii ( s ) 7tqo7w3vt8 85h0hzu9 7tqo7w3vt8 85h0hzu99m nd2m416302 v13007z41a active ingredient unii ( s ) 7tqo7w3vt8 85h0hzu9 name content xml  dtype object,0
4128,4128,4128,4128,4128,4128,4128,5038,5038,5038,5038,5038,5038,5038,5038,5038,5038,5038,5038,5038,"Active Ingredient UNII(s)
7TQO7W3VT8; 85H0HZU99M; V13007Z41A    e942a88a-7cb1-4c99-b70f-4c48994bb84e
7TQO7W3VT8; 85H0HZU99M; V13007Z41A    e942a88a-7cb1-4c99-b70f-4c48994bb84e
7TQO7W3VT8; 85H0HZU99M; V13007Z41A    e942a88a-7cb1-4c99-b70f-4c48994bb84e
Name: SET ID dtype: object",active ingredient unii ( s ) 7tqo7w3vt8 85h0hzu99m v13007z41a active ingredient unii ( s ) 7tqo7w3vt8 85h0hzu9 7tqo7w3vt8 85h0hzu99m v13007z41a active ingredient unii ( s ) 7tqo7w3vt8 85h0hzu9 7tqo7w3vt8 85h0hzu99m v13007z41a active ingredient unii ( s ) 7tqo7w3vt8 85h0hzu9 name content xml  dtype object,0
4129,4129,4129,4129,4129,4129,4129,5041,5041,5041,5041,5041,5041,5041,5041,5041,5041,5041,5041,5041,"Active Ingredient UNII(s)
7TQO7W3VT8; AI9376Y64P; F446C597KA; ND2M416302    84fffebe-8468-42be-adab-6220e737499a
7TQO7W3VT8; AI9376Y64P; F446C597KA; ND2M416302    84fffebe-8468-42be-adab-6220e737499a
7TQO7W3VT8; AI9376Y64P; F446C597KA; ND2M416302    84fffebe-8468-42be-adab-6220e737499a
7TQO7W3VT8; AI9376Y64P; F446C597KA; ND2M416302    84fffebe-8468-42be-adab-6220e737499a
7TQO7W3VT8; AI9376Y64P; F446C597KA; ND2M416302    84fffebe-8468-42be-adab-6220e737499a
7TQO7W3VT8; AI9376Y64P; F446C597KA; ND2M416302    84fffebe-8468-42be-adab-6220e737499a
Name: SET ID dtype: object",active ingredient unii ( s ) 7tqo7w3vt8 ai9376y64p f446c597ka nd2m416302 active ingredient unii ( s ) 7tqo7w3vt8 ai9376y6 7tqo7w3vt8 ai9376y64p f446c597ka nd2m416302 active ingredient unii ( s ) 7tqo7w3vt8 ai9376y6 7tqo7w3vt8 ai9376y64p f446c597ka nd2m416302 active ingredient unii ( s ) 7tqo7w3vt8 ai9376y6 7tqo7w3vt8 ai9376y64p f446c597ka nd2m416302 active ingredient unii ( s ) 7tqo7w3vt8 ai9376y6 7tqo7w3vt8 ai9376y64p f446c597ka nd2m416302 active ingredient unii ( s ) 7tqo7w3vt8 ai9376y6 7tqo7w3vt8 ai9376y64p f446c597ka nd2m416302 active ingredient unii ( s ) 7tqo7w3vt8 ai9376y6 name content xml  dtype object,0
4130,4130,4130,4130,4130,4130,4130,5047,5047,5047,5047,5047,5047,5047,5047,5047,5047,5047,5047,5047,"Active Ingredient UNII(s)
7TQO7W3VT8; AI9376Y64P; ND2M416302    bb133ea1-0fae-4f15-a1d2-a5b5c8e2c6c1
7TQO7W3VT8; AI9376Y64P; ND2M416302    bb133ea1-0fae-4f15-a1d2-a5b5c8e2c6c1
7TQO7W3VT8; AI9376Y64P; ND2M416302    bb133ea1-0fae-4f15-a1d2-a5b5c8e2c6c1
7TQO7W3VT8; AI9376Y64P; ND2M416302    bb133ea1-0fae-4f15-a1d2-a5b5c8e2c6c1
7TQO7W3VT8; AI9376Y64P; ND2M416302    bb133ea1-0fae-4f15-a1d2-a5b5c8e2c6c1
Name: SET ID dtype: object",active ingredient unii ( s ) 7tqo7w3vt8 ai9376y64p nd2m416302 active ingredient unii ( s ) 7tqo7w3vt8 ai9376y6 7tqo7w3vt8 ai9376y64p nd2m416302 active ingredient unii ( s ) 7tqo7w3vt8 ai9376y6 7tqo7w3vt8 ai9376y64p nd2m416302 active ingredient unii ( s ) 7tqo7w3vt8 ai9376y6 7tqo7w3vt8 ai9376y64p nd2m416302 active ingredient unii ( s ) 7tqo7w3vt8 ai9376y6 7tqo7w3vt8 ai9376y64p nd2m416302 active ingredient unii ( s ) 7tqo7w3vt8 ai9376y6 name content xml  dtype object,0
4131,4131,4131,4131,4131,4131,4131,5052,5052,5052,5052,5052,5052,5052,5052,5052,5052,5052,5052,5052,"Active Ingredient UNII(s)
7TQO7W3VT8; AI9376Y64P; V13007Z41A    433c1e4f-b7b7-4eda-e054-00144ff88e88
7TQO7W3VT8; AI9376Y64P; V13007Z41A    433c1e4f-b7b7-4eda-e054-00144ff88e88
7TQO7W3VT8; AI9376Y64P; V13007Z41A    433c1e4f-b7b7-4eda-e054-00144ff88e88
Name: SET ID dtype: object",active ingredient unii ( s ) 7tqo7w3vt8 ai9376y64p v13007z41a active ingredient unii ( s ) 7tqo7w3vt8 ai9376y6 7tqo7w3vt8 ai9376y64p v13007z41a active ingredient unii ( s ) 7tqo7w3vt8 ai9376y6 7tqo7w3vt8 ai9376y64p v13007z41a active ingredient unii ( s ) 7tqo7w3vt8 ai9376y6 name content xml  dtype object,0
4132,4132,4132,4132,4132,4132,4132,5055,5055,5055,5055,5055,5055,5055,5055,5055,5055,5055,5055,5055,"Active Ingredient UNII(s)
7TQO7W3VT8; F446C597KA; V13007Z41A    280f9437-8d0b-1a25-e054-00144ff8d46c
7TQO7W3VT8; F446C597KA; V13007Z41A    280f9437-8d0b-1a25-e054-00144ff8d46c
7TQO7W3VT8; F446C597KA; V13007Z41A    280f9437-8d0b-1a25-e054-00144ff8d46c
Name: SET ID dtype: object",active ingredient unii ( s ) 7tqo7w3vt8 f446c597ka v13007z41a active ingredient unii ( s ) 7tqo7w3vt8 f446c597 7tqo7w3vt8 f446c597ka v13007z41a active ingredient unii ( s ) 7tqo7w3vt8 f446c597 7tqo7w3vt8 f446c597ka v13007z41a active ingredient unii ( s ) 7tqo7w3vt8 f446c597 name content xml  dtype object,0
4133,4133,4133,4133,4133,4133,4133,5058,5058,5058,5058,5058,5058,5058,5058,5058,5058,5058,5058,5058,"Active Ingredient UNII(s)
7TQO7W3VT8; V13007Z41A    28115cb6-118b-612a-e054-00144ff88e88
7TQO7W3VT8; V13007Z41A    28115cb6-118b-612a-e054-00144ff88e88
Name: SET ID dtype: object",active ingredient unii ( s ) 7tqo7w3vt8 v13007z41a active ingredient unii ( s ) 7tqo7w3vt8 v13007z4 7tqo7w3vt8 v13007z41a active ingredient unii ( s ) 7tqo7w3vt8 v13007z4 name content xml  dtype object,0
4134,4134,4134,4134,4134,4134,4134,5060,5060,5060,5060,5060,5060,5060,5060,5060,5060,5060,5060,5060,961c81a1-4dfc-4cfc-d8aa-94fe79f8b2d2, sensorcaine ( bupivacaine hcl ) is indicated for the production of local or regional anesthesia or analgesia for surgery  for oral surgery procedures  for diagnostic and therapeutic procedures  and for obstetrical procedures,1
4135,4135,4135,4135,4135,4135,4135,5062,5062,5062,5062,5062,5062,5062,5062,5062,5062,5062,5062,5062,961c81a1-4dfc-4cfc-d8aa-94fe79f8b2d2,experience with non obstetrical surgical procedures in pregnant patients is not sufficient to recommend use of the 0 75 concentration in these patients,u
4136,4136,4136,4136,4136,4136,4136,5063,5063,5063,5063,5063,5063,5063,5063,5063,5063,5063,5063,5063,961c81a1-4dfc-4cfc-d8aa-94fe79f8b2d2,sensorcaine is not recommended for intravenous regional anesthesia ( bier block ),2
4137,4137,4137,4137,4137,4137,4137,5064,5064,5064,5064,5064,5064,5064,5064,5064,5064,5064,5064,5064,961c81a1-4dfc-4cfc-d8aa-94fe79f8b2d2,the routes of administration and indicated sensorcaine concentrations are local infiltration 0 25 peripheral nerve block 0 25  0 5 retrobulbar block 0 75 sympathetic block 0 25 lumbar epidural 0 25  0 5 and 0 75 ( non obstetrical ) caudal 0 25  0 5 epidural test dose ( see precautions ) ( see dosage and administration for additional information ),4
4138,4138,4138,4138,4138,4138,4138,5065,5065,5065,5065,5065,5065,5065,5065,5065,5065,5065,5065,5065,961c81a1-4dfc-4cfc-d8aa-94fe79f8b2d2,standard textbooks should be consulted to determine the accepted procedures and techniques for the administration of sensorcaine,0
4139,4139,4139,4139,4139,4139,4139,5066,5066,5066,5066,5066,5066,5066,5066,5066,5066,5066,5066,5066,961c81a1-4dfc-4cfc-d8aa-94fe79f8b2d2,use only the single dose ampules and single dose vials for caudal or epidural anesthesia the multiple dose vials contain a preservative and  therefore  should not be used for these procedures,4
4140,4140,4140,4140,4140,4140,4140,5067,5067,5067,5067,5067,5067,5067,5067,5067,5067,5067,5067,5067,a4f9f620-e6e4-4a03-a9a7-79007c8c2cfe,1  cnj 016 vaccinia immune globulin intravenous ( human ) ( vigiv ) is indicated for the treatment and or modification of the following conditions eczema vaccinatum progressive vaccinia severe generalized vaccinia vaccinia infections in individuals who have skin conditions such as burns  impetigo  varicella zoster  or poison ivy or in individuals who have eczematous skin lesions because of either the activity or extensiveness of such lesions aberrant infections induced by vaccinia virus that include its accidental implantation in eyes ( except in cases of isolated keratitis )  mouth  or other areas where vaccinia infection would constitute a special hazard,1
4141,4141,4141,4141,4141,4141,4141,5068,5068,5068,5068,5068,5068,5068,5068,5068,5068,5068,5068,5068,a4f9f620-e6e4-4a03-a9a7-79007c8c2cfe,exercise caution when using vigiv in the treatment of patients having complication due to vaccinia vaccination that include concomitant vaccinia keratitis  since a single study in rabbits has demonstrated increased corneal scarring upon intramuscular vaccinia immune globulin administration in vaccinia keratitis ( 1 ),4
4142,4142,4142,4142,4142,4142,4142,5069,5069,5069,5069,5069,5069,5069,5069,5069,5069,5069,5069,5069,a4f9f620-e6e4-4a03-a9a7-79007c8c2cfe,vigiv is not considered to be effective in the treatment of postvaccinial encephalitis,2
4143,4143,4143,4143,4143,4143,4143,5070,5070,5070,5070,5070,5070,5070,5070,5070,5070,5070,5070,5070,a4f9f620-e6e4-4a03-a9a7-79007c8c2cfe,cnj 016 is an immune globulin intravenous ( human )  5 liquid  indicated for the treatment of complications due to vaccinia vaccination ( 1 )  including eczema vaccinatum progressive vaccinia severe generalized vaccinia vaccinia infections in individuals who have skin conditions aberrant infections induced by vaccinia virus ( except in cases of isolated keratitis ) cnj 016 is not indicated for isolated vaccinia keratitis or postvaccinial encephalitis ( 1 ),1
4144,4144,4144,4144,4144,4144,4144,5071,5071,5071,5071,5071,5071,5071,5071,5071,5071,5071,5071,5071,aa3bd304-ff60-48a1-8576-be99de02e5f6, in 111 dtpa is indicated for use in radionuclide cisternography,1
4145,4145,4145,4145,4145,4145,4145,5072,5072,5072,5072,5072,5072,5072,5072,5072,5072,5072,5072,5072,fe91cb6f-c77b-4a9f-9df5-a413cd5dbbd7,1  jetrea is a proteolytic enzyme indicated for the treatment of symptomatic vitreomacular adhesion,1
4146,4146,4146,4146,4146,4146,4146,5073,5073,5073,5073,5073,5073,5073,5073,5073,5073,5073,5073,5073,fe91cb6f-c77b-4a9f-9df5-a413cd5dbbd7,jetrea is a proteolytic enzyme indicated for the treatment of symptomatic vitreomacular adhesion,1
4147,4147,4147,4147,4147,4147,4147,5074,5074,5074,5074,5074,5074,5074,5074,5074,5074,5074,5074,5074,39b58213-b9e2-4847-9010-99e187c1b778, fosphenytoin sodium injection  usp is indicated for the control of generalized tonic clonic status epilepticus and prevention and treatment of seizures occurring during neurosurgery,1
4148,4148,4148,4148,4148,4148,4148,5075,5075,5075,5075,5075,5075,5075,5075,5075,5075,5075,5075,5075,39b58213-b9e2-4847-9010-99e187c1b778,fosphenytoin can also be substituted  short term  for oral phenytoin,0
4149,4149,4149,4149,4149,4149,4149,5076,5076,5076,5076,5076,5076,5076,5076,5076,5076,5076,5076,5076,39b58213-b9e2-4847-9010-99e187c1b778,fosphenytoin should be used only when oral phenytoin administration is not possible,4
4150,4150,4150,4150,4150,4150,4150,5077,5077,5077,5077,5077,5077,5077,5077,5077,5077,5077,5077,5077,39b58213-b9e2-4847-9010-99e187c1b778,fosphenytoin must not be given orally,4
4151,4151,4151,4151,4151,4151,4151,5078,5078,5078,5078,5078,5078,5078,5078,5078,5078,5078,5078,5078,af4c413b-c228-48f0-9ad0-6434d1f921b9, topical corticosteroids are indicated for relief of the inflammatory and pruritic manifestations of corticosteroid responsive dermatoses,1
4152,4152,4152,4152,4152,4152,4152,5079,5079,5079,5079,5079,5079,5079,5079,5079,5079,5079,5079,5079,e7af6a7a-8046-4fb4-9979-4ec4230b23aa,1  apidra is indicated to improve glycemic control in adults and children with diabetes mellitus,1
4153,4153,4153,4153,4153,4153,4153,5080,5080,5080,5080,5080,5080,5080,5080,5080,5080,5080,5080,5080,e7af6a7a-8046-4fb4-9979-4ec4230b23aa,apidra is a rapid acting human insulin analog indicated to improve glycemic control in adults and children with diabetes mellitus,1
4154,4154,4154,4154,4154,4154,4154,5081,5081,5081,5081,5081,5081,5081,5081,5081,5081,5081,5081,5081,3904f8dd-1aef-3490-e48f-bd55f32ed67f,1  adcetris is a cd30 directed antibody drug conjugate indicated for treatment of adult patients with previously untreated stage iii or iv classical hodgkin lymphoma ( chl )  in combination with chemotherapy ( 1 1 ),1
4155,4155,4155,4155,4155,4155,4155,5082,5082,5082,5082,5082,5082,5082,5082,5082,5082,5082,5082,5082,3904f8dd-1aef-3490-e48f-bd55f32ed67f,classical hodgkin lymphoma at high risk of relapse or progression as post autologous hematopoietic stem cell transplantation ( auto hsct ) consolidation ( 1 2 ),1
4156,4156,4156,4156,4156,4156,4156,5083,5083,5083,5083,5083,5083,5083,5083,5083,5083,5083,5083,5083,3904f8dd-1aef-3490-e48f-bd55f32ed67f,classical hodgkin lymphoma after failure of auto hsct or after failure of at least two prior multi agent chemotherapy regimens in patients who are not auto hsct candidates ( 1 3 ),1
4157,4157,4157,4157,4157,4157,4157,5084,5084,5084,5084,5084,5084,5084,5084,5084,5084,5084,5084,5084,3904f8dd-1aef-3490-e48f-bd55f32ed67f,systemic anaplastic large cell lymphoma ( salcl ) after failure of at least one prior multi agent chemotherapy regimen ( 1 4 ),1
4158,4158,4158,4158,4158,4158,4158,5085,5085,5085,5085,5085,5085,5085,5085,5085,5085,5085,5085,5085,3904f8dd-1aef-3490-e48f-bd55f32ed67f,primary cutaneous anaplastic large cell lymphoma ( pcalcl ) or cd30 expressing mycosis fungoides ( mf ) who have received prior systemic therapy ( 1 5 ),1
4159,4159,4159,4159,4159,4159,4159,5086,5086,5086,5086,5086,5086,5086,5086,5086,5086,5086,5086,5086,3904f8dd-1aef-3490-e48f-bd55f32ed67f,1 1 previously untreated stage iii or iv classical hodgkin lymphoma ( chl )  in combination with chemotherapy,1
4160,4160,4160,4160,4160,4160,4160,5087,5087,5087,5087,5087,5087,5087,5087,5087,5087,5087,5087,5087,3904f8dd-1aef-3490-e48f-bd55f32ed67f,adcetris is indicated for the treatment of adult patients with previously untreated stage iii or iv chl  in combination with chemotherapy,1
4161,4161,4161,4161,4161,4161,4161,5088,5088,5088,5088,5088,5088,5088,5088,5088,5088,5088,5088,5088,3904f8dd-1aef-3490-e48f-bd55f32ed67f,1 2 chl consolidation adcetris is indicated for the treatment of adult patients with chl at high risk of relapse or progression as post autologous hematopoietic stem cell transplantation ( auto hsct ) consolidation,1
4162,4162,4162,4162,4162,4162,4162,5089,5089,5089,5089,5089,5089,5089,5089,5089,5089,5089,5089,5089,3904f8dd-1aef-3490-e48f-bd55f32ed67f,1 3 relapsed chl adcetris is indicated for the treatment of adult patients with chl after failure of auto hsct or after failure of at least two prior multi agent chemotherapy regimens in patients who are not auto hsct candidates,1
4163,4163,4163,4163,4163,4163,4163,5090,5090,5090,5090,5090,5090,5090,5090,5090,5090,5090,5090,5090,3904f8dd-1aef-3490-e48f-bd55f32ed67f,code code 42229 5 codesystem 2 16 840 1 113883 6 1 displayname spl unclassified section,0
4164,4164,4164,4164,4164,4164,4164,5091,5091,5091,5091,5091,5091,5091,5091,5091,5091,5091,5091,5091,f7be6506-4d20-401e-a0ff-02ad7c33158a, ambisome is indicated for the following empirical therapy for presumed fungal infection in febrile  neutropenic patients,1
4165,4165,4165,4165,4165,4165,4165,5092,5092,5092,5092,5092,5092,5092,5092,5092,5092,5092,5092,5092,f7be6506-4d20-401e-a0ff-02ad7c33158a,treatment of cryptococcal meningitis in hiv infected patients ( see description of clinical studies ),1
4166,4166,4166,4166,4166,4166,4166,5093,5093,5093,5093,5093,5093,5093,5093,5093,5093,5093,5093,5093,f7be6506-4d20-401e-a0ff-02ad7c33158a,treatment of patients with aspergillus species  candida species and or cryptococcus species infections ( see above for the treatment of cryptococcal meningitis ) refractory to amphotericin b deoxycholate  or in patients where renal impairment or unacceptable toxicity precludes the use of amphotericin b deoxycholate,1
4167,4167,4167,4167,4167,4167,4167,5094,5094,5094,5094,5094,5094,5094,5094,5094,5094,5094,5094,5094,f7be6506-4d20-401e-a0ff-02ad7c33158a,treatment of visceral leishmaniasis,1
4168,4168,4168,4168,4168,4168,4168,5095,5095,5095,5095,5095,5095,5095,5095,5095,5095,5095,5095,5095,f7be6506-4d20-401e-a0ff-02ad7c33158a,in immunocompromised patients with visceral leishmaniasis treated with ambisome  relapse rates were high following initial clearance of parasites ( see description of clinical studies ),1
4169,4169,4169,4169,4169,4169,4169,5096,5096,5096,5096,5096,5096,5096,5096,5096,5096,5096,5096,5096,f7be6506-4d20-401e-a0ff-02ad7c33158a,see dosage and administration for recommended doses by indication,0
4170,4170,4170,4170,4170,4170,4170,5097,5097,5097,5097,5097,5097,5097,5097,5097,5097,5097,5097,5097,5587db37-f21a-4a39-a319-e1077032ced9, abelcet is indicated for the treatment of invasive fungal infections in patients who are refractory to or intolerant of conventional amphotericin b therapy,1
4171,4171,4171,4171,4171,4171,4171,5098,5098,5098,5098,5098,5098,5098,5098,5098,5098,5098,5098,5098,5587db37-f21a-4a39-a319-e1077032ced9,this is based on open label treatment of patients judged by their physicians to be intolerant to or failing conventional amphotericin b therapy ( see description of clinical studies ),0
4172,4172,4172,4172,4172,4172,4172,5099,5099,5099,5099,5099,5099,5099,5099,5099,5099,5099,5099,5099,5587db37-f21a-4a39-a319-e1077032ced9,description of clinical studies fungal infections data from 473 patients were pooled from three open label studies in which abelcet was provided for the treatment of patients with invasive fungal infections who were judged by their physicians to be refractory to or intolerant of conventional amphotericin b  or who had preexisting nephrotoxicity,0
4173,4173,4173,4173,4173,4173,4173,5100,5100,5100,5100,5100,5100,5100,5100,5100,5100,5100,5100,5100,5587db37-f21a-4a39-a319-e1077032ced9,results of these studies demonstrated effectiveness of abelcet in the treatment of invasive fungal infections as a second line therapy,u
4174,4174,4174,4174,4174,4174,4174,5101,5101,5101,5101,5101,5101,5101,5101,5101,5101,5101,5101,5101,5587db37-f21a-4a39-a319-e1077032ced9,patients were defined by their individual physician as being refractory to or failing conventional amphotericin b therapy based on overall clinical judgement after receiving a minimum total dose of 500 mg of amphotericin b nephrotoxicity was defined as a serum creatinine that had increased to 2 5 mg dl in adults and 1 5 mg dl in pediatric patients  or a creatinine clearance of 25 ml min while receiving conventional amphotericin b therapy,u
4175,4175,4175,4175,4175,4175,4175,5102,5102,5102,5102,5102,5102,5102,5102,5102,5102,5102,5102,5102,5587db37-f21a-4a39-a319-e1077032ced9,of the 473 patients  four were enrolled more than once each enrollment contributed separately to the denominator,0
4176,4176,4176,4176,4176,4176,4176,5103,5103,5103,5103,5103,5103,5103,5103,5103,5103,5103,5103,5103,5587db37-f21a-4a39-a319-e1077032ced9,the median age was 39 years ( range of 1 to 93 years ) 307 patients were male and 166 female,0
4177,4177,4177,4177,4177,4177,4177,5104,5104,5104,5104,5104,5104,5104,5104,5104,5104,5104,5104,5104,5587db37-f21a-4a39-a319-e1077032ced9,patients were caucasian ( 381  81 )  african american ( 41  9 )  hispanic ( 27  6 )  asian ( 10  2 )  and various other races ( 14  3 ),0
4178,4178,4178,4178,4178,4178,4178,5105,5105,5105,5105,5105,5105,5105,5105,5105,5105,5105,5105,5105,5587db37-f21a-4a39-a319-e1077032ced9,the median baseline neutrophil count was 4  000 pmn mm3 of these  101 ( 21 ) had a baseline neutrophil count 500 mm3,0
4179,4179,4179,4179,4179,4179,4179,5106,5106,5106,5106,5106,5106,5106,5106,5106,5106,5106,5106,5106,5587db37-f21a-4a39-a319-e1077032ced9,two hundred eighty two patients of the 473 patients were considered evaluable for response to therapy the other 191 patients were excluded on the basis of unconfirmed diagnosis  confounding factors  concomitant systemic antifungal therapy  or receiving 4 doses or less of abelcet,0
4180,4180,4180,4180,4180,4180,4180,5107,5107,5107,5107,5107,5107,5107,5107,5107,5107,5107,5107,5107,5587db37-f21a-4a39-a319-e1077032ced9,for evaluable patients  the following fungal infections were treated ( n 282 ) aspergillosis ( n 111 )  candidiasis ( n 87 )  zygomycosis ( n 25 )  cryptococcosis ( n 16 )  and fusariosis ( n 11 ),u
4181,4181,4181,4181,4181,4181,4181,5108,5108,5108,5108,5108,5108,5108,5108,5108,5108,5108,5108,5108,5587db37-f21a-4a39-a319-e1077032ced9,there were fewer than 10 evaluable patients for each of several other fungal species treated,0
4182,4182,4182,4182,4182,4182,4182,5109,5109,5109,5109,5109,5109,5109,5109,5109,5109,5109,5109,5109,5587db37-f21a-4a39-a319-e1077032ced9,for each type of fungal infection listed above there were some patients successfully treated,0
4183,4183,4183,4183,4183,4183,4183,5110,5110,5110,5110,5110,5110,5110,5110,5110,5110,5110,5110,5110,5587db37-f21a-4a39-a319-e1077032ced9,however  in the absence of controlled studies it is unknown how response would have compared to either continuing conventional amphotericin b therapy or the use of alternative antifungal agents,0
4184,4184,4184,4184,4184,4184,4184,5111,5111,5111,5111,5111,5111,5111,5111,5111,5111,5111,5111,5111,5587db37-f21a-4a39-a319-e1077032ced9,renal function patients with aspergillosis who initiated treatment with abelcet when serum creatinine was above 2 5 mg dl experienced a decline in serum creatinine during treatment ( figure 1 ),u
4185,4185,4185,4185,4185,4185,4185,5112,5112,5112,5112,5112,5112,5112,5112,5112,5112,5112,5112,5112,5587db37-f21a-4a39-a319-e1077032ced9,serum creatinine levels were also lower during treatment with abelcet when compared to the serum creatinine levels of patients treated with conventional amphotericin b in a retrospective historical control study,u
4186,4186,4186,4186,4186,4186,4186,5113,5113,5113,5113,5113,5113,5113,5113,5113,5113,5113,5113,5113,5587db37-f21a-4a39-a319-e1077032ced9,meaningful statistical testing of the differences between these two groups is precluded since these data were obtained from two separate studies,0
4187,4187,4187,4187,4187,4187,4187,5114,5114,5114,5114,5114,5114,5114,5114,5114,5114,5114,5114,5114,925d4e21-fd98-474d-a34d-a0b3558ed750,1  mepsevii is indicated in pediatric and adult patients for the treatment of mucopolysaccharidosis vii ( mps vii  sly syndrome ),1
4188,4188,4188,4188,4188,4188,4188,5115,5115,5115,5115,5115,5115,5115,5115,5115,5115,5115,5115,5115,925d4e21-fd98-474d-a34d-a0b3558ed750,limitations of use the effect of mepsevii on the central nervous system manifestations of mps vii has not been determined,2
4189,4189,4189,4189,4189,4189,4189,5116,5116,5116,5116,5116,5116,5116,5116,5116,5116,5116,5116,5116,925d4e21-fd98-474d-a34d-a0b3558ed750,mepsevii is a recombinant human lysosomal beta glucuronidase indicated in pediatric and adult patients for the treatment of mucopolysaccharidosis vii ( mps vii  sly syndrome ),1
4190,4190,4190,4190,4190,4190,4190,5118,5118,5118,5118,5118,5118,5118,5118,5118,5118,5118,5118,5118,e89d6458-428c-4256-97a3-f1fa851293c1, males testosterone enanthate injection  usp is indicated for replacement therapy in conditions associated with a deficiency or absence of endogenous testosterone,1
4191,4191,4191,4191,4191,4191,4191,5119,5119,5119,5119,5119,5119,5119,5119,5119,5119,5119,5119,5119,e89d6458-428c-4256-97a3-f1fa851293c1,primary hypogonadism ( congenital or acquired ) testicular failure due to cryptorchidism  bilateral torsion  orchitis  vanishing testis syndrome  or orchidectomy,1
4192,4192,4192,4192,4192,4192,4192,5120,5120,5120,5120,5120,5120,5120,5120,5120,5120,5120,5120,5120,e89d6458-428c-4256-97a3-f1fa851293c1,hypogonadotropic hypogonadism ( congenital or acquired ) gonadotropin or luteinizing hormone releasing hormone ( lhrh ) deficiency  or pituitary hypothalamic injury from tumors  trauma  or radiation,1
4193,4193,4193,4193,4193,4193,4193,5121,5121,5121,5121,5121,5121,5121,5121,5121,5121,5121,5121,5121,e89d6458-428c-4256-97a3-f1fa851293c1,( appropriate adrenal cortical and thyroid hormone replacement therapy are still necessary  however  and are actually of primary importance ),0
4194,4194,4194,4194,4194,4194,4194,5122,5122,5122,5122,5122,5122,5122,5122,5122,5122,5122,5122,5122,e89d6458-428c-4256-97a3-f1fa851293c1,if the above conditions occur prior to puberty  androgen replacement therapy will be needed during the adolescent years for development of secondary sexual characteristics,4
4195,4195,4195,4195,4195,4195,4195,5123,5123,5123,5123,5123,5123,5123,5123,5123,5123,5123,5123,5123,e89d6458-428c-4256-97a3-f1fa851293c1,prolonged androgen treatment will be required to maintain sexual characteristics in these and other males who develop testosterone deficiency after puberty,4
4196,4196,4196,4196,4196,4196,4196,5124,5124,5124,5124,5124,5124,5124,5124,5124,5124,5124,5124,5124,e89d6458-428c-4256-97a3-f1fa851293c1,safety and efficacy of testosterone enanthate injection  usp in men with age related hypogonadism have not been established,0
4197,4197,4197,4197,4197,4197,4197,5125,5125,5125,5125,5125,5125,5125,5125,5125,5125,5125,5125,5125,e89d6458-428c-4256-97a3-f1fa851293c1,delayed puberty testosterone enanthate injection  usp may be used to stimulate puberty in carefully selected males with clearly delayed puberty,1
4198,4198,4198,4198,4198,4198,4198,5126,5126,5126,5126,5126,5126,5126,5126,5126,5126,5126,5126,5126,e89d6458-428c-4256-97a3-f1fa851293c1,these patients usually have a familial pattern of delayed puberty that is not secondary to a pathological disorder puberty is expected to occur spontaneously at a relatively late date,u
4199,4199,4199,4199,4199,4199,4199,5127,5127,5127,5127,5127,5127,5127,5127,5127,5127,5127,5127,5127,e89d6458-428c-4256-97a3-f1fa851293c1,brief treatment with conservative doses may occasionally be justified in these patients if they do not respond to psychological support,0
4200,4200,4200,4200,4200,4200,4200,5128,5128,5128,5128,5128,5128,5128,5128,5128,5128,5128,5128,5128,e89d6458-428c-4256-97a3-f1fa851293c1,the potential adverse effect on bone maturation should be discussed with the patient and parents prior to androgen administration,0
4201,4201,4201,4201,4201,4201,4201,5129,5129,5129,5129,5129,5129,5129,5129,5129,5129,5129,5129,5129,e89d6458-428c-4256-97a3-f1fa851293c1,an x ray of the hand and wrist to determine bone age should be obtained every six months to assess the effect of treatment on the epiphyseal centers ( see warnings ),0
4202,4202,4202,4202,4202,4202,4202,5130,5130,5130,5130,5130,5130,5130,5130,5130,5130,5130,5130,5130,e89d6458-428c-4256-97a3-f1fa851293c1,females metastatic mammary cancer testosterone enanthate injection  usp may be used secondarily in women with advancing inoperable metastatic ( skeletal ) mammary cancer who are one to five years postmenopausal,1
4203,4203,4203,4203,4203,4203,4203,5131,5131,5131,5131,5131,5131,5131,5131,5131,5131,5131,5131,5131,e89d6458-428c-4256-97a3-f1fa851293c1,primary goals of therapy in these women include ablation of the ovaries,u
4204,4204,4204,4204,4204,4204,4204,5132,5132,5132,5132,5132,5132,5132,5132,5132,5132,5132,5132,5132,e89d6458-428c-4256-97a3-f1fa851293c1,other methods of counteracting estrogen activity are adrenalecto,0
4205,4205,4205,4205,4205,4205,4205,5133,5133,5133,5133,5133,5133,5133,5133,5133,5133,5133,5133,5133,17d37e8d-7825-424b-b6ca-0a85d0bf4694,1  lastacaft is an h1 histamine receptor antagonist indicated for the prevention of itching associated with allergic conjunctivitis,1
4206,4206,4206,4206,4206,4206,4206,5134,5134,5134,5134,5134,5134,5134,5134,5134,5134,5134,5134,5134,17d37e8d-7825-424b-b6ca-0a85d0bf4694,lastacaft is an h1 histamine receptor antagonist indicated for the prevention of itching associated with allergic conjunctivitis,1
4207,4207,4207,4207,4207,4207,4207,5135,5135,5135,5135,5135,5135,5135,5135,5135,5135,5135,5135,5135,cd45db80-3cf3-4714-989b-de11f249bdfb,indications for the treatment of major depressive episode without melancholia,1
4208,4208,4208,4208,4208,4208,4208,5136,5136,5136,5136,5136,5136,5136,5136,5136,5136,5136,5136,5136,cd45db80-3cf3-4714-989b-de11f249bdfb,tranylcypromine sulfate should be used in adult patients who can be closely supervised,u
4209,4209,4209,4209,4209,4209,4209,5137,5137,5137,5137,5137,5137,5137,5137,5137,5137,5137,5137,5137,cd45db80-3cf3-4714-989b-de11f249bdfb,it should rarely be the first antidepressant drug given,4
4210,4210,4210,4210,4210,4210,4210,5138,5138,5138,5138,5138,5138,5138,5138,5138,5138,5138,5138,5138,cd45db80-3cf3-4714-989b-de11f249bdfb,rather  the drug is suited for patients who have failed to respond to the drugs more commonly administered for depression,4
4211,4211,4211,4211,4211,4211,4211,5139,5139,5139,5139,5139,5139,5139,5139,5139,5139,5139,5139,5139,cd45db80-3cf3-4714-989b-de11f249bdfb,the effectiveness of tranylcypromine sulfate has been established in adult outpatients  most of whom had a depressive illness which would correspond to a diagnosis of major depressive episode without melancholia,0
4212,4212,4212,4212,4212,4212,4212,5140,5140,5140,5140,5140,5140,5140,5140,5140,5140,5140,5140,5140,cd45db80-3cf3-4714-989b-de11f249bdfb,as described in the american psychiatric association 's diagnostic and statistical manual  third edition ( dsm iii )  major depressive episode implies a prominent and relatively persistent ( nearly every day for at least 2 weeks ) depressed or dysphoric mood that usually interferes with daily functioning and includes at least 4 of the following 8 symptoms change in appetite  change in sleep  psychomotor agitation or retardation  loss of interest in usual activities or decrease in sexual drive  increased fatigability  feelings of guilt or worthlessness  slowed thinking or impaired concentration  and suicidal ideation or attempts,0
4213,4213,4213,4213,4213,4213,4213,5141,5141,5141,5141,5141,5141,5141,5141,5141,5141,5141,5141,5141,cd45db80-3cf3-4714-989b-de11f249bdfb,the effectiveness of tranylcypromine sulfate in patients who meet the criteria for major depressive episode with melancholia ( endogenous features ) has not been established,0
4214,4214,4214,4214,4214,4214,4214,5142,5142,5142,5142,5142,5142,5142,5142,5142,5142,5142,5142,5142,cf1626a1-ccf6-4759-b2ab-22c7f3873d84, cimetidine tablets usp are indicated in 1,0
4215,4215,4215,4215,4215,4215,4215,5143,5143,5143,5143,5143,5143,5143,5143,5143,5143,5143,5143,5143,cf1626a1-ccf6-4759-b2ab-22c7f3873d84,short term treatment of active duodenal ulcer,1
4216,4216,4216,4216,4216,4216,4216,5144,5144,5144,5144,5144,5144,5144,5144,5144,5144,5144,5144,5144,cf1626a1-ccf6-4759-b2ab-22c7f3873d84,most patients heal within 4 weeks and there is rarely reason to use cimetidine at full dosage for longer than 6 to 8 weeks ( see dosage and administration  duodenal ulcer ),0
4217,4217,4217,4217,4217,4217,4217,5145,5145,5145,5145,5145,5145,5145,5145,5145,5145,5145,5145,5145,cf1626a1-ccf6-4759-b2ab-22c7f3873d84,concomitant antacids should be given as needed for relief of pain,1
4218,4218,4218,4218,4218,4218,4218,5146,5146,5146,5146,5146,5146,5146,5146,5146,5146,5146,5146,5146,cf1626a1-ccf6-4759-b2ab-22c7f3873d84,however  simultaneous administration of oral cimetidine and antacids is not recommended  since antacids have been reported to interfere with the absorption of oral cimetidine,2
4219,4219,4219,4219,4219,4219,4219,5147,5147,5147,5147,5147,5147,5147,5147,5147,5147,5147,5147,5147,cf1626a1-ccf6-4759-b2ab-22c7f3873d84,maintenance therapy for duodenal ulcer patients at reduced dosage after healing of active ulcer,1
4220,4220,4220,4220,4220,4220,4220,5148,5148,5148,5148,5148,5148,5148,5148,5148,5148,5148,5148,5148,cf1626a1-ccf6-4759-b2ab-22c7f3873d84,patients have been maintained on continued treatment with cimetidine 400 mg at bedtime for periods of up to five years,0
4221,4221,4221,4221,4221,4221,4221,5150,5150,5150,5150,5150,5150,5150,5150,5150,5150,5150,5150,5150,cf1626a1-ccf6-4759-b2ab-22c7f3873d84,there is no information concerning usefulness of treatment periods of longer than 8 weeks,0
4222,4222,4222,4222,4222,4222,4222,5151,5151,5151,5151,5151,5151,5151,5151,5151,5151,5151,5151,5151,cf1626a1-ccf6-4759-b2ab-22c7f3873d84,erosive gastroesophageal reflux disease ( gerd ),1
4223,4223,4223,4223,4223,4223,4223,5152,5152,5152,5152,5152,5152,5152,5152,5152,5152,5152,5152,5152,cf1626a1-ccf6-4759-b2ab-22c7f3873d84,erosive esophagitis diagnosed by endoscopy,1
4224,4224,4224,4224,4224,4224,4224,5153,5153,5153,5153,5153,5153,5153,5153,5153,5153,5153,5153,5153,cf1626a1-ccf6-4759-b2ab-22c7f3873d84,treatment is indicated for 12 weeks for healing of lesions and control of symptoms,4
4225,4225,4225,4225,4225,4225,4225,5154,5154,5154,5154,5154,5154,5154,5154,5154,5154,5154,5154,5154,cf1626a1-ccf6-4759-b2ab-22c7f3873d84,the use of cimetidine beyond 12 weeks has not been established see dosage and administration  erosive gastroesophageal reflux ( gerd ),0
4226,4226,4226,4226,4226,4226,4226,5155,5155,5155,5155,5155,5155,5155,5155,5155,5155,5155,5155,5155,cf1626a1-ccf6-4759-b2ab-22c7f3873d84,the treatment of pathological hypersecretory conditions ( i e  zollinger ellison syndrome  systemic mastocytosis  multiple endocrine adenomas ),1
4227,4227,4227,4227,4227,4227,4227,5156,5156,5156,5156,5156,5156,5156,5156,5156,5156,5156,5156,5156,49dd44b2-74fa-43e7-ac36-b0b84cdc17c9, amoxicillin is indicated in the treatment of infections due to susceptible ( only lactamase negative ) strains of the designated microorganisms in the conditions listed below infections of the ear  nose  and throat due to streptococcus spp,1
4228,4228,4228,4228,4228,4228,4228,5157,5157,5157,5157,5157,5157,5157,5157,5157,5157,5157,5157,5157,49dd44b2-74fa-43e7-ac36-b0b84cdc17c9,( and hemolytic strains only )  s pneumoniae  staphylococcus spp  or h influenzae,1
4229,4229,4229,4229,4229,4229,4229,5158,5158,5158,5158,5158,5158,5158,5158,5158,5158,5158,5158,5158,49dd44b2-74fa-43e7-ac36-b0b84cdc17c9,infections of the genitourinary tract due to e coli  p mirabilis  or e faecalis,1
4230,4230,4230,4230,4230,4230,4230,5159,5159,5159,5159,5159,5159,5159,5159,5159,5159,5159,5159,5159,49dd44b2-74fa-43e7-ac36-b0b84cdc17c9,infections of the skin and skin structure due to streptococcus spp,1
4231,4231,4231,4231,4231,4231,4231,5160,5160,5160,5160,5160,5160,5160,5160,5160,5160,5160,5160,5160,49dd44b2-74fa-43e7-ac36-b0b84cdc17c9,( and hemolytic strains only )  staphylococcus spp  or e coli,1
4232,4232,4232,4232,4232,4232,4232,5161,5161,5161,5161,5161,5161,5161,5161,5161,5161,5161,5161,5161,49dd44b2-74fa-43e7-ac36-b0b84cdc17c9,infections of the lower respiratory tract due to streptococcus spp,1
4233,4233,4233,4233,4233,4233,4233,5163,5163,5163,5163,5163,5163,5163,5163,5163,5163,5163,5163,5163,49dd44b2-74fa-43e7-ac36-b0b84cdc17c9,gonorrhea  acute uncomplicated ( ano genital and urethral infections ) due to n gonorrhoeae ( males and females ),1
4234,4234,4234,4234,4234,4234,4234,5164,5164,5164,5164,5164,5164,5164,5164,5164,5164,5164,5164,5164,49dd44b2-74fa-43e7-ac36-b0b84cdc17c9,h pylori eradication to reduce the risk of duodenal ulcer recurrence,1
4235,4235,4235,4235,4235,4235,4235,5165,5165,5165,5165,5165,5165,5165,5165,5165,5165,5165,5165,5165,49dd44b2-74fa-43e7-ac36-b0b84cdc17c9,triple therapy amoxicillin clarithromycin lansoprazole amoxicillin  in combination with clarithromycin plus lansoprazole as triple therapy  is indicated for the treatment of patients with h pylori infection and duodenal ulcer disease ( active or 1 year history of a duodenal ulcer ) to eradicate h pylori,1
4236,4236,4236,4236,4236,4236,4236,5166,5166,5166,5166,5166,5166,5166,5166,5166,5166,5166,5166,5166,49dd44b2-74fa-43e7-ac36-b0b84cdc17c9,eradication of h pylori has been shown to reduce the risk of duodenal ulcer recurrence,1
4237,4237,4237,4237,4237,4237,4237,5167,5167,5167,5167,5167,5167,5167,5167,5167,5167,5167,5167,5167,49dd44b2-74fa-43e7-ac36-b0b84cdc17c9,( see clinical studies and dosage and administration sections ),0
4238,4238,4238,4238,4238,4238,4238,5168,5168,5168,5168,5168,5168,5168,5168,5168,5168,5168,5168,5168,49dd44b2-74fa-43e7-ac36-b0b84cdc17c9,dual therapy amoxicillin lansoprazole amoxicillin  in combination with lansoprazole delayed release capsules as dual therapy  is indicated for the treatment of patients with h pylori infection and duodenal ulcer disease ( active or 1 year history of a duodenal ulcer ) who are either allergic or intolerant to clarithromycin or in whom resistance to clarithromycin is known or suspected,1
4239,4239,4239,4239,4239,4239,4239,5169,5169,5169,5169,5169,5169,5169,5169,5169,5169,5169,5169,5169,49dd44b2-74fa-43e7-ac36-b0b84cdc17c9,( see the clarithromycin package insert  microbiology section ),0
4240,4240,4240,4240,4240,4240,4240,5172,5172,5172,5172,5172,5172,5172,5172,5172,5172,5172,5172,5172,49dd44b2-74fa-43e7-ac36-b0b84cdc17c9,to reduce the development of drug resistant bacteria and maintain the effectiveness of amoxicillin and other antibacterial drugs  amoxicillin should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria,u
4241,4241,4241,4241,4241,4241,4241,5176,5176,5176,5176,5176,5176,5176,5176,5176,5176,5176,5176,5176,9e52c29a-fdbe-4a4d-b280-d700eba5b94f,1  to reduce the development of drug resistant bacteria and maintain the effectiveness of omeclamox pak and other antibacterial drugs  omeclamox pak should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria,u
4242,4242,4242,4242,4242,4242,4242,5179,5179,5179,5179,5179,5179,5179,5179,5179,5179,5179,5179,5179,9e52c29a-fdbe-4a4d-b280-d700eba5b94f,omeclamox pak  a copackaged product containing a proton pump inhibitor  a macrolide antimicrobial  and a penicillin class antibacterial  is indicated for the treatment of patients with helicobacter pylori infection and duodenal ulcer disease ( active or up to one year history ) to eradicate h pylori,1
4243,4243,4243,4243,4243,4243,4243,5180,5180,5180,5180,5180,5180,5180,5180,5180,5180,5180,5180,5180,9e52c29a-fdbe-4a4d-b280-d700eba5b94f,( 1 1 ) 1 1 eradication of helicobacter pylori in patients with active duodenal ulcer or history of duodenal ulcer disease omeprazole delayed release capsules  clarithromycin tablets  and amoxicillin capsules taken together are indicated for the treatment of patients with helicobacter pylori infection and duodenal ulcer disease ( active or one year history ) to eradicate h pylori in adults,1
4244,4244,4244,4244,4244,4244,4244,5181,5181,5181,5181,5181,5181,5181,5181,5181,5181,5181,5181,5181,9e52c29a-fdbe-4a4d-b280-d700eba5b94f,eradication of h pylori has been shown to reduce the risk of duodenal ulcer recurrence see clinical studies ( 14 1 ),u
4245,4245,4245,4245,4245,4245,4245,5182,5182,5182,5182,5182,5182,5182,5182,5182,5182,5182,5182,5182,9e52c29a-fdbe-4a4d-b280-d700eba5b94f,in patients who fail therapy with omeclamox pak  perform susceptibility testing,0
4246,4246,4246,4246,4246,4246,4246,5183,5183,5183,5183,5183,5183,5183,5183,5183,5183,5183,5183,5183,9e52c29a-fdbe-4a4d-b280-d700eba5b94f,if re sistance to clarithromycin is demonstrated or susceptibility testing is not possible  institute alternative antimicrobial therapy see clinical pharmacology  microbiology ( 12 4 ),0
4247,4247,4247,4247,4247,4247,4247,5184,5184,5184,5184,5184,5184,5184,5184,5184,5184,5184,5184,5184,909c85de-c076-4444-b63c-cd8bdc556f36, to reduce the development of drug resistant bacteria and maintain the effectiveness of amoxicillin and clavulanate potassium tablets  usp and other antibacterial drugs  amoxicillin and clavulanate potassium tablets  usp should be used only to treat infections that are proven or strongly suspected to be caused by susceptible bacteria,4
4248,4248,4248,4248,4248,4248,4248,5187,5187,5187,5187,5187,5187,5187,5187,5187,5187,5187,5187,5187,909c85de-c076-4444-b63c-cd8bdc556f36,amoxicillin and clavulanate potassium tablets  usp are a combination penicillin class antibacterial and beta lactamase inhibitor indicated in the treatment of infections due to susceptible isolates of the designated bacteria in the conditions listed below 1 1 lower respiratory tract infections caused by beta lactamase producing isolates of haemophilus influenzae and moraxella catarrhalis,1
4249,4249,4249,4249,4249,4249,4249,5189,5189,5189,5189,5189,5189,5189,5189,5189,5189,5189,5189,5189,909c85de-c076-4444-b63c-cd8bdc556f36,1 3 sinusitis caused by beta lactamase producing isolates of h influenzae and m catarrhalis,1
4250,4250,4250,4250,4250,4250,4250,5190,5190,5190,5190,5190,5190,5190,5190,5190,5190,5190,5190,5190,909c85de-c076-4444-b63c-cd8bdc556f36,1 4 skin and skin structure infections caused by beta lactamase producing isolates of staphylococcus aureus  escherichia coli  and klebsiella species,1
4251,4251,4251,4251,4251,4251,4251,5191,5191,5191,5191,5191,5191,5191,5191,5191,5191,5191,5191,5191,909c85de-c076-4444-b63c-cd8bdc556f36,1 5 urinary tract infections caused by beta lactamase producing isolates of e coli  klebsiella species  and enterobacter species,1
4252,4252,4252,4252,4252,4252,4252,5192,5192,5192,5192,5192,5192,5192,5192,5192,5192,5192,5192,5192,909c85de-c076-4444-b63c-cd8bdc556f36,1 6 limitations of use when susceptibility test results show susceptibility to amoxicillin  indicating no beta lactamase production  amoxicillin and clavulanate potassium tablets  usp should not be used,2
4253,4253,4253,4253,4253,4253,4253,5193,5193,5193,5193,5193,5193,5193,5193,5193,5193,5193,5193,5193,909c85de-c076-4444-b63c-cd8bdc556f36,please view the manufacturer 's complete drug information at the fda site http dailymed nlm nih gov dailymed lookup cfm ? setid ffb158a1 83ba 4100 9221 175aa986dc3e,0
4254,4254,4254,4254,4254,4254,4254,5194,5194,5194,5194,5194,5194,5194,5194,5194,5194,5194,5194,5194,df73d781-65d8-4aaa-9b0f-de4341f639ec,1  prexxartan is an angiotensin ii receptor blocker ( arb ) indicated for hypertension in adults and children six years and older  to lower blood pressure,1
4255,4255,4255,4255,4255,4255,4255,5195,5195,5195,5195,5195,5195,5195,5195,5195,5195,5195,5195,5195,df73d781-65d8-4aaa-9b0f-de4341f639ec,lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events  primarily strokes and myocardial infarctions ( 1 1 ) heart failure ( nyha class ii iv ) prexxartan significantly reduces hospitalization for heart failure in patients who are unable to swallow valsartan tablets ( 1 2 ) stable left ventricular failure or left ventricular dysfunction following myocardial infarction prexxartan reduces cardiovascular mortality in patients who are unable to swallow valsartan tablets ( 1 3 ) 1 1 hypertension prexxartan is indicated for the treatment of hypertension in adults and children six years and older  to lower blood pressure,1
4256,4256,4256,4256,4256,4256,4256,5197,5197,5197,5197,5197,5197,5197,5197,5197,5197,5197,5197,5197,df73d781-65d8-4aaa-9b0f-de4341f639ec,these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including the class to which valsartan principally belongs,0
4257,4257,4257,4257,4257,4257,4257,5198,5198,5198,5198,5198,5198,5198,5198,5198,5198,5198,5198,5198,df73d781-65d8-4aaa-9b0f-de4341f639ec,there are no controlled trials in hypertensive patients demonstrating risk reduction with valsartan,0
4258,4258,4258,4258,4258,4258,4258,5204,5204,5204,5204,5204,5204,5204,5204,5204,5204,5204,5204,5204,df73d781-65d8-4aaa-9b0f-de4341f639ec,elevated systolic or diastolic pressure causes increased cardiovascular ri,0
4259,4259,4259,4259,4259,4259,4259,5205,5205,5205,5205,5205,5205,5205,5205,5205,5205,5205,5205,5205,b4ad6a5b-e69d-4b39-9fe3-58569a964978,1  byvalson is indicated for the treatment of hypertension  to lower blood pressure,1
4260,4260,4260,4260,4260,4260,4260,5207,5207,5207,5207,5207,5207,5207,5207,5207,5207,5207,5207,5207,b4ad6a5b-e69d-4b39-9fe3-58569a964978,these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes  including the blocker class to which nebivolol principally belongs and the arb class to which valsartan principally belongs,0
4261,4261,4261,4261,4261,4261,4261,5208,5208,5208,5208,5208,5208,5208,5208,5208,5208,5208,5208,5208,b4ad6a5b-e69d-4b39-9fe3-58569a964978,there are no controlled trials demonstrating risk reduction with byvalson,0
4262,4262,4262,4262,4262,4262,4262,5214,5214,5214,5214,5214,5214,5214,5214,5214,5214,5214,5214,5214,b4ad6a5b-e69d-4b39-9fe3-58569a964978,elevated systolic or diastolic pressure causes increased cardiovascular risk  and the absolute risk increase per mm hg is greater at higher blood pressures  so that even modest reductions of severe hypertension can provide substantial benefit,0
4263,4263,4263,4263,4263,4263,4263,5218,5218,5218,5218,5218,5218,5218,5218,5218,5218,5218,5218,5218,b4ad6a5b-e69d-4b39-9fe3-58569a964978,byvalson may be used alone or in combination with other antihypertensive agents,4
4264,4264,4264,4264,4264,4264,4264,5219,5219,5219,5219,5219,5219,5219,5219,5219,5219,5219,5219,5219,b4ad6a5b-e69d-4b39-9fe3-58569a964978,byvalson is a beta adrenergic blocker and an angiotensin ii receptor blocker ( arb ) indicated for the treatment of hypertension  to lower blood pressure,1
4265,4265,4265,4265,4265,4265,4265,5221,5221,5221,5221,5221,5221,5221,5221,5221,5221,5221,5221,5221,b37d42a4-1e54-4dab-a437-ea307c4b5400,indications usage wellmindtm vertigo tablets are a homeopathic drug product indicated for the treatment of vertigo dizziness ofvarious origins mild cognitive impairment ( mci ) such as lack of concentration and forgetfulness,1
4266,4266,4266,4266,4266,4266,4266,5222,5222,5222,5222,5222,5222,5222,5222,5222,5222,5222,5222,5222,14312de6-67d4-4de2-854c-ef764090dd83,1  gatifloxacin ophthalmic solution  0 5 is indicated for the treatment of bacterial conjunctivitis caused by susceptible strains of the following organisms aerobic gram positive bacteria staphylococcus aureus staphylococcus epidermidis streptococcus mitis group streptococcus oralis streptococcus pneumoniae aerobic gram negative bacteria haemophilus influenzae efficacy for this organism was studied in fewer than 10 infections,1
4267,4267,4267,4267,4267,4267,4267,5223,5223,5223,5223,5223,5223,5223,5223,5223,5223,5223,5223,5223,14312de6-67d4-4de2-854c-ef764090dd83,gatifloxacin ophthalmic solution is a topical fluoroquinolone anti infective indicated for the treatment of bacterial conjunctivitis caused by susceptible strains of the following organisms haemophilus influenzae  staphylococcus aureus  staphylococcus epidermidis  streptococcus mitis group  streptococcus oralis  streptococcus pneumoniae efficacy for this organism was studied in fewer than 10 infections,1
4268,4268,4268,4268,4268,4268,4268,5224,5224,5224,5224,5224,5224,5224,5224,5224,5224,5224,5224,5224,3d7acd55-33b1-4a24-99ae-01f87b0dca1f, betimol is indicated in the treatment of elevated intraocular pressure in patients with ocular hypertension or open angle glaucoma,1
4269,4269,4269,4269,4269,4269,4269,5225,5225,5225,5225,5225,5225,5225,5225,5225,5225,5225,5225,5225,3fbec3be-9f30-448e-89b9-367a55ed4c97, dihydroergotamine mesylate injection  usp is indicated for the acute treatment of migraine headaches with or without aura and the acute treatment of cluster headache episodes,1
4270,4270,4270,4270,4270,4270,4270,5226,5226,5226,5226,5226,5226,5226,5226,5226,5226,5226,5226,5226,fa5caf83-29d5-8229-b125-d7736928f132,1  tazarotene cream 0 1 is a retinoid indicated for the topical treatment of plaque psoriasis,1
4271,4271,4271,4271,4271,4271,4271,5227,5227,5227,5227,5227,5227,5227,5227,5227,5227,5227,5227,5227,fa5caf83-29d5-8229-b125-d7736928f132,( 1 1 ) tazarotene cream 0 1 is indicated for the topical treatment of acne vulgaris,1
4272,4272,4272,4272,4272,4272,4272,5228,5228,5228,5228,5228,5228,5228,5228,5228,5228,5228,5228,5228,fa5caf83-29d5-8229-b125-d7736928f132,( 1 2 ) 1 1 plaque psoriasis tazarotene cream  0 1 is indicated for the topical treatment of patients with plaque psoriasis,1
4273,4273,4273,4273,4273,4273,4273,5229,5229,5229,5229,5229,5229,5229,5229,5229,5229,5229,5229,5229,fa5caf83-29d5-8229-b125-d7736928f132,1 2 acne vulgaris tazarotene cream  0 1 is also indicated for the topical treatment of patients with acne vulgaris,1
4274,4274,4274,4274,4274,4274,4274,5230,5230,5230,5230,5230,5230,5230,5230,5230,5230,5230,5230,5230,a8c46363-f739-4f6e-bca8-1ce5e8d3f78d, emverm ( mebendazole ) chewable tablet  usp is indicated for the treatment of enterobius vermicularis ( pinworm )  trichuris trichiura ( whipworm )  ascaris lumbricoides ( common roundworm )  ancylostoma duodenale ( common hookworm )  necator americanus ( american hookworm ) in single or mixed infections,1
4275,4275,4275,4275,4275,4275,4275,5231,5231,5231,5231,5231,5231,5231,5231,5231,5231,5231,5231,5231,a8c46363-f739-4f6e-bca8-1ce5e8d3f78d,efficacy varies as a function of such factors as preexisting diarrhea and gastrointestinal transit time  degree of infection  and helminth strains,0
4276,4276,4276,4276,4276,4276,4276,5232,5232,5232,5232,5232,5232,5232,5232,5232,5232,5232,5232,5232,a8c46363-f739-4f6e-bca8-1ce5e8d3f78d,efficacy rates derived from various studies are shown in the table below,0
4277,4277,4277,4277,4277,4277,4277,5233,5233,5233,5233,5233,5233,5233,5233,5233,5233,5233,5233,5233,a8c46363-f739-4f6e-bca8-1ce5e8d3f78d,pinworm ( enterobiasis ) whipworm ( trichuriasis ) common roundworm ( ascariasis ) hookworm cure rates mean 95 68 98 96 egg reduction mean 93 99 99,
4278,4278,4278,4278,4278,4278,4278,5234,5234,5234,5234,5234,5234,5234,5234,5234,5234,5234,5234,5234,5c20f3f4-65f8-4cdb-bdd1-5774da1c551b, positive skin test control histamine is indicated as an adjunct in allergy skin test for diagnosis  as a positive control to test wheal flare response of skin for evaluation of skin test response to allergenic extracts,1
4279,4279,4279,4279,4279,4279,4279,5235,5235,5235,5235,5235,5235,5235,5235,5235,5235,5235,5235,5235,17c2c1b4-bf20-6e61-e054-00144ff8d46c,uses helps in reducing high blood sugar,u
4280,4280,4280,4280,4280,4280,4280,5236,5236,5236,5236,5236,5236,5236,5236,5236,5236,5236,5236,5236,f0ff4f27-5185-4881-a749-c6b7a0ca5696,1  chantix is indicated for use as an aid to smoking cessation treatment,1
4281,4281,4281,4281,4281,4281,4281,5237,5237,5237,5237,5237,5237,5237,5237,5237,5237,5237,5237,5237,f0ff4f27-5185-4881-a749-c6b7a0ca5696,chantix is a nicotinic receptor partial agonist indicated for use as an aid to smoking cessation treatment,1
4282,4282,4282,4282,4282,4282,4282,5238,5238,5238,5238,5238,5238,5238,5238,5238,5238,5238,5238,5238,e947a6be-90ae-40d8-b9dd-afa14a66bb9d,clotrimazole and betamethasone dipropionate cream is indicated in patients 17 years and older for the topical treatment of symptomatic inflammatory tinea pedis  tinea cruris and tinea corporis due to epidermophyton floccosum  trichophyton mentagrophytes  and trichophyton rubrum,1
4283,4283,4283,4283,4283,4283,4283,5239,5239,5239,5239,5239,5239,5239,5239,5239,5239,5239,5239,5239,e947a6be-90ae-40d8-b9dd-afa14a66bb9d,effective treatment without the risks associated with topical corticosteroid use may be obtained using a topical antifungal agent that does not contain a corticosteroid  especially for noninflammatory tinea infections,u
4284,4284,4284,4284,4284,4284,4284,5240,5240,5240,5240,5240,5240,5240,5240,5240,5240,5240,5240,5240,e947a6be-90ae-40d8-b9dd-afa14a66bb9d,the efficacy of clotrimazole and betamethasone dipropionate cream for the treatment of infections caused by zoophilic dermatophytes ( e g  microsporum canis ) has not been established,0
4285,4285,4285,4285,4285,4285,4285,5241,5241,5241,5241,5241,5241,5241,5241,5241,5241,5241,5241,5241,e947a6be-90ae-40d8-b9dd-afa14a66bb9d,several cases of treatment failure of clotrimazole and betamethasone dipropionate cream in the treatment of infections caused by microsporum canis have been reported,0
4286,4286,4286,4286,4286,4286,4286,5242,5242,5242,5242,5242,5242,5242,5242,5242,5242,5242,5242,5242,"Active Ingredient UNII(s)
826Y60901U; G07GZ97H65; SOI2LOH54Z    c47f8a9c-9c86-4068-814e-05ab2090d19e
826Y60901U; G07GZ97H65; SOI2LOH54Z    c47f8a9c-9c86-4068-814e-05ab2090d19e
Name: SET ID dtype: object",active ingredient unii ( s ) 826y60901u g07gz97h65 soi2loh54z active ingredient unii ( s ) 826y60901u g07gz97h 826y60901u g07gz97h65 soi2loh54z active ingredient unii ( s ) 826y60901u g07gz97h name content xml  dtype object,0
4287,4287,4287,4287,4287,4287,4287,5244,5244,5244,5244,5244,5244,5244,5244,5244,5244,5244,5244,5244,291512ba-6e0e-4cd0-9e1c-9c6277372f78,1  calcipotriene 0 005 and betamethasone dipropionate 0 064 ointment is indicated for the topical treatment of plaque psoriasis in patients 12 years of age and older,1
4288,4288,4288,4288,4288,4288,4288,5245,5245,5245,5245,5245,5245,5245,5245,5245,5245,5245,5245,5245,291512ba-6e0e-4cd0-9e1c-9c6277372f78,calcipotriene 0 005 and betamethasone dipropionate 0 064 ointment is a vitamin d analogue and corticosteroid combination product indicated for the topical treatment of plaque psoriasis in patients 12 years of age and older,1
4289,4289,4289,4289,4289,4289,4289,5246,5246,5246,5246,5246,5246,5246,5246,5246,5246,5246,5246,5246,0f153c1e-efce-4276-8273-d9e4c8455d16,1  doxorubicin is an anthracycline topoisomerase ii inhibitor indicated as a component of multiagent adjuvant chemotherapy for treatment of women with axillary lymph node involvement following resection of primary breast cancer ( 1 1 ),1
4290,4290,4290,4290,4290,4290,4290,5247,5247,5247,5247,5247,5247,5247,5247,5247,5247,5247,5247,5247,0f153c1e-efce-4276-8273-d9e4c8455d16,for the treatment of acute lymphoblastic leukemia  acute myeloblastic leukemia  hodgkin lymphoma  non hodgkin lymphoma  metastatic breast cancer  metastatic wilms tumor  metastatic neuroblastoma  metastatic soft tissue sarcoma  metastatic bone sarcomas  metastatic ovarian carcinoma  metastatic transitional cell bladder carcinoma  metastatic thyroid carcinoma  metastatic gastric carcinoma  metastatic bronchogenic carcinoma ( 1 2 ),1
4291,4291,4291,4291,4291,4291,4291,5248,5248,5248,5248,5248,5248,5248,5248,5248,5248,5248,5248,5248,0f153c1e-efce-4276-8273-d9e4c8455d16,1 1 adjuvant breast cancer adriamycin ( doxorubicin hcl ) injection  usp and adriamycin ( doxorubicin hcl ) for injection  usp is indicated as a component of multi agent adjuvant chemotherapy for treatment of women with axillary lymph node involvement following resection of primary breast cancer see clinical studies ( 14 1 ),1
4292,4292,4292,4292,4292,4292,4292,5249,5249,5249,5249,5249,5249,5249,5249,5249,5249,5249,5249,5249,0f153c1e-efce-4276-8273-d9e4c8455d16,1 2 other cancers doxorubicin is indicated for the treatment of acute lymphoblastic leukemia acute myeloblastic leukemia hodgkin lymphoma non hodgkin lymphoma ( nhl ) metastatic breast cancer metastatic wilms tumor metastatic neuroblastoma metastatic soft tissue sarcoma metastatic bone sarcoma metastatic ovarian carcinoma,1
4293,4293,4293,4293,4293,4293,4293,5250,5250,5250,5250,5250,5250,5250,5250,5250,5250,5250,5250,5250,f1c82580-87ae-11e0-bc84-0002a5d5c51b, jakafi is a kinase inhibitor indicated for treatment of patients with intermediate or high risk myelofibrosis  including primary myelofibrosis  post polycythemia vera myelofibrosis and post essential thrombocythemia myelofibrosis,1
4294,4294,4294,4294,4294,4294,4294,5251,5251,5251,5251,5251,5251,5251,5251,5251,5251,5251,5251,5251,f1c82580-87ae-11e0-bc84-0002a5d5c51b,( 1 1 ) polycythemia vera who have had an inadequate response to or are intolerant of hydroxyurea,1
4295,4295,4295,4295,4295,4295,4295,5252,5252,5252,5252,5252,5252,5252,5252,5252,5252,5252,5252,5252,f1c82580-87ae-11e0-bc84-0002a5d5c51b,( 1 2 ) 1 1 myelofibrosis jakafi is indicated for treatment of patients with intermediate or high risk myelofibrosis ( mf )  including primary mf  post polycythemia vera mf and post essential thrombocythemia mf,1
4296,4296,4296,4296,4296,4296,4296,5253,5253,5253,5253,5253,5253,5253,5253,5253,5253,5253,5253,5253,f1c82580-87ae-11e0-bc84-0002a5d5c51b,1 2 polycythemia vera jakafi is indicated for treatment of patients with polycythemia vera ( pv ) who have had an inadequate response to or are intolerant of hydroxyurea,1
4297,4297,4297,4297,4297,4297,4297,5254,5254,5254,5254,5254,5254,5254,5254,5254,5254,5254,5254,5254,3946d389-0926-4f77-a708-0acb8153b143,1  saxenda is indicated as an adjunct to a reduced calorie diet and increased physical activity for chronic weight management in adult patients with an initial body mass index ( bmi ) of 30 kg m2 or greater ( obese )  or 27 kg m2 or greater ( overweight ) in the presence of at least one weight related comorbid condition ( e g  hypertension  type 2 diabetes mellitus  or dyslipidemia ) limitations of use saxenda is not indicated for the treatment of type 2 diabetes mellitus,1
4298,4298,4298,4298,4298,4298,4298,5255,5255,5255,5255,5255,5255,5255,5255,5255,5255,5255,5255,5255,3946d389-0926-4f77-a708-0acb8153b143,saxenda and victoza both contain the same active ingredient  liraglutide  and therefore should not be used together,0
4299,4299,4299,4299,4299,4299,4299,5256,5256,5256,5256,5256,5256,5256,5256,5256,5256,5256,5256,5256,3946d389-0926-4f77-a708-0acb8153b143,saxenda should not be used in combination with any other glp 1 receptor agonist,2
4300,4300,4300,4300,4300,4300,4300,5257,5257,5257,5257,5257,5257,5257,5257,5257,5257,5257,5257,5257,3946d389-0926-4f77-a708-0acb8153b143,saxenda has not been studied in patients taking insulin,0
4301,4301,4301,4301,4301,4301,4301,5258,5258,5258,5258,5258,5258,5258,5258,5258,5258,5258,5258,5258,3946d389-0926-4f77-a708-0acb8153b143,saxenda and insulin should not be used together see warnings and precautions ( 5 4 ),2
4302,4302,4302,4302,4302,4302,4302,5259,5259,5259,5259,5259,5259,5259,5259,5259,5259,5259,5259,5259,3946d389-0926-4f77-a708-0acb8153b143,the effects of saxenda on cardiovascular morbidity and mortality have not been established,0
4303,4303,4303,4303,4303,4303,4303,5260,5260,5260,5260,5260,5260,5260,5260,5260,5260,5260,5260,5260,3946d389-0926-4f77-a708-0acb8153b143,the safety and effectiveness of saxenda in combination with other products intended for weight loss  including prescription drugs  over the counter drugs  and herbal preparations  have not been established,0
4304,4304,4304,4304,4304,4304,4304,5261,5261,5261,5261,5261,5261,5261,5261,5261,5261,5261,5261,5261,3946d389-0926-4f77-a708-0acb8153b143,saxenda has not been studied in patients with a history of pancreatitis see warnings and precautions ( 5 2 ),0
4305,4305,4305,4305,4305,4305,4305,5262,5262,5262,5262,5262,5262,5262,5262,5262,5262,5262,5262,5262,3946d389-0926-4f77-a708-0acb8153b143,saxenda is a glucagon like peptide 1 ( glp 1 ) receptor agonist indicated as an adjunct to a reduced calorie diet and increased physical activity for chronic weight management in adult patients with an initial body mass index ( bmi ) of 30 kg m2 or greater ( obese ) ( 1 ) or 27 kg m2 or greater ( overweight ) in the presence of at least one weight related comorbid condition ( e g,1
4306,4306,4306,4306,4306,4306,4306,5263,5263,5263,5263,5263,5263,5263,5263,5263,5263,5263,5263,5263,3946d389-0926-4f77-a708-0acb8153b143,hypertension  type 2 diabetes mellitus  or dyslipidemia ) ( 1 ),u
4307,4307,4307,4307,4307,4307,4307,5264,5264,5264,5264,5264,5264,5264,5264,5264,5264,5264,5264,5264,3946d389-0926-4f77-a708-0acb8153b143,limitations of use saxenda is not indicated for the treatment of type 2 diabetes ( 1 ),2
4308,4308,4308,4308,4308,4308,4308,5265,5265,5265,5265,5265,5265,5265,5265,5265,5265,5265,5265,5265,3946d389-0926-4f77-a708-0acb8153b143,saxenda should not be used in combination with any other glp 1 receptor agonist ( 1 ),2
4309,4309,4309,4309,4309,4309,4309,5266,5266,5266,5266,5266,5266,5266,5266,5266,5266,5266,5266,5266,3946d389-0926-4f77-a708-0acb8153b143,saxenda should not be used with insulin ( 1  5 4 ),2
4310,4310,4310,4310,4310,4310,4310,5267,5267,5267,5267,5267,5267,5267,5267,5267,5267,5267,5267,5267,bfe5cfb9-591d-4df8-12a3-6555cde3185d, kinlytic is indicated in adults for the lysis of acute massive pulmonary emboli  defined as obstruction of blood flow to a lobe or multiple segments,1
4311,4311,4311,4311,4311,4311,4311,5268,5268,5268,5268,5268,5268,5268,5268,5268,5268,5268,5268,5268,bfe5cfb9-591d-4df8-12a3-6555cde3185d,for the lysis of pulmonary emboli accompanied by unstable hemodynamics  i e  failure to maintain blood pressure without supportive measures,1
4312,4312,4312,4312,4312,4312,4312,5269,5269,5269,5269,5269,5269,5269,5269,5269,5269,5269,5269,5269,bfe5cfb9-591d-4df8-12a3-6555cde3185d,the diagnosis should be confirmed by objective means  such as pulmonary angiography or non invasive procedures such as lung scanning,0
4313,4313,4313,4313,4313,4313,4313,5270,5270,5270,5270,5270,5270,5270,5270,5270,5270,5270,5270,5270,e7165673-8ab1-4fc8-85e5-a67135af7a7f, kidney  liver  and heart transplantation cyclosporine capsules  usp modified and cyclosporine oral solution  usp modified are indicated for the prophylaxis of organ rejection in kidney  liver  and heart allogeneic transplants,1
4314,4314,4314,4314,4314,4314,4314,5271,5271,5271,5271,5271,5271,5271,5271,5271,5271,5271,5271,5271,e7165673-8ab1-4fc8-85e5-a67135af7a7f,cyclosporine capsules  usp modified and cyclosporine oral solution  usp modified have been used in combination with azathioprine and corticosteroids,4
4315,4315,4315,4315,4315,4315,4315,5272,5272,5272,5272,5272,5272,5272,5272,5272,5272,5272,5272,5272,e7165673-8ab1-4fc8-85e5-a67135af7a7f,rheumatoid arthritis cyclosporine capsules  usp modified and cyclosporine oral solution  usp modified are indicated for the treatment of patients with severe active  rheumatoid arthritis where the disease has not adequately responded to methotrexate,1
4316,4316,4316,4316,4316,4316,4316,5273,5273,5273,5273,5273,5273,5273,5273,5273,5273,5273,5273,5273,e7165673-8ab1-4fc8-85e5-a67135af7a7f,cyclosporine capsules  usp modified and cyclosporine oral solution  usp modified can be used in combination with methotrexate in rheumatoid arthritis patients who do not respond adequately to methotrexate alone,4
4317,4317,4317,4317,4317,4317,4317,5274,5274,5274,5274,5274,5274,5274,5274,5274,5274,5274,5274,5274,e7165673-8ab1-4fc8-85e5-a67135af7a7f,psoriasis cyclosporine capsules  usp modified and cyclosporine oral solution  usp modified are indicated for the treatment of adult  nonimmunocompromised patients with severe ( i e  extensive and or disabling )  recalcitrant  plaque psoriasis who have failed to respond to at least one systemic therapy ( e g  puva  retinoids  or methotrexate ) or in patients for whom other systemic therapies are contraindicated  or cannot be tolerated,1
4318,4318,4318,4318,4318,4318,4318,5275,5275,5275,5275,5275,5275,5275,5275,5275,5275,5275,5275,5275,e7165673-8ab1-4fc8-85e5-a67135af7a7f,while rebound rarely occurs  most patients will experience relapse with cyclosporine  usp modified as with other therapies upon cessation of treatment,u
4319,4319,4319,4319,4319,4319,4319,5276,5276,5276,5276,5276,5276,5276,5276,5276,5276,5276,5276,5276,616fd0c5-39c8-4276-9bcd-b045a08d08de,1 indications usage pediatric use information for patients 7 to 17 years of age is approved for astrazeneca s crestor ( rosuvastatin calcium ) tablets,1
4320,4320,4320,4320,4320,4320,4320,5277,5277,5277,5277,5277,5277,5277,5277,5277,5277,5277,5277,5277,616fd0c5-39c8-4276-9bcd-b045a08d08de,however  due to astrazeneca s marketing exclusivity rights  this drug product is not labeled with that pediatric information,0
4321,4321,4321,4321,4321,4321,4321,5278,5278,5278,5278,5278,5278,5278,5278,5278,5278,5278,5278,5278,616fd0c5-39c8-4276-9bcd-b045a08d08de,rosuvastatin calcium tablet is an hmg co a reductase inhibitor indicated for adult patients with hypertriglyceridemia as an adjunct to diet ( 1 3 ) adult patients with primary dysbetalipoproteinemia ( type iii hyperlipoproteinemia ) as an adjunct to diet ( 1 4 ) adult patients with homozygous familial hypercholesterolemia ( hofh ) to reduce ldl c  total c  and apob ( 1 5 ) limitations of use ( 1 8 ) rosuvastatin calcium tablets have not been studied in fredrickson type i and v dyslipidemias,1
4322,4322,4322,4322,4322,4322,4322,5279,5279,5279,5279,5279,5279,5279,5279,5279,5279,5279,5279,5279,616fd0c5-39c8-4276-9bcd-b045a08d08de,1 3 hypertriglyceridemia rosuvastatin calcium tablets are indicated as adjunctive therapy to diet for the treatment of adult patients with hypertriglyceridemia,1
4323,4323,4323,4323,4323,4323,4323,5280,5280,5280,5280,5280,5280,5280,5280,5280,5280,5280,5280,5280,616fd0c5-39c8-4276-9bcd-b045a08d08de,1 4 primary dysbetalipoproteinemia ( type iii hyperlipoproteinemia ) rosuvastatin calcium tablets are indicated as an adjunct to diet for the treatment of adult patients with primary dysbetalipoproteinemia ( type iii hyperlipoproteinemia ),1
4324,4324,4324,4324,4324,4324,4324,5281,5281,5281,5281,5281,5281,5281,5281,5281,5281,5281,5281,5281,616fd0c5-39c8-4276-9bcd-b045a08d08de,1 5 adult patients with homozygous familial hypercholesterolemia rosuvastatin calcium tablets are indicated as adjunctive therapy to other lipid lowering treatments ( e g  ldl apheresis ) or alone if such treatments are unavailable to reduce ldl c  total c  and apob in adult patients with homozygous familial hypercholesterolemia,1
4325,4325,4325,4325,4325,4325,4325,5282,5282,5282,5282,5282,5282,5282,5282,5282,5282,5282,5282,5282,616fd0c5-39c8-4276-9bcd-b045a08d08de,1 8 limitations of use rosuvastatin calcium tablets have not been studied in fredrickson type i and v dyslipidemias,0
4326,4326,4326,4326,4326,4326,4326,5283,5283,5283,5283,5283,5283,5283,5283,5283,5283,5283,5283,5283,7c679424-c3f7-ed02-892f-20ca0d775089,1  echocardiography lumason is indicated for use in adult patients with suboptimal echocardiograms to opacify the left ventricular chamber and to improve the delineation of the left ventricular endocardial border,1
4327,4327,4327,4327,4327,4327,4327,5284,5284,5284,5284,5284,5284,5284,5284,5284,5284,5284,5284,5284,7c679424-c3f7-ed02-892f-20ca0d775089,ultrasonography of the liver lumason is indicated for use with ultrasound of the liver in adult and pediatric patients to characterize focal liver lesions,1
4328,4328,4328,4328,4328,4328,4328,5285,5285,5285,5285,5285,5285,5285,5285,5285,5285,5285,5285,5285,7c679424-c3f7-ed02-892f-20ca0d775089,ultrasonography of the urinary tract lumason is indicated for use in ultrasonography of the urinary tract in pediatric patients for the evaluation of suspected or known vesicoureteral reflux,1
4329,4329,4329,4329,4329,4329,4329,5286,5286,5286,5286,5286,5286,5286,5286,5286,5286,5286,5286,5286,7c679424-c3f7-ed02-892f-20ca0d775089,lumason is an ultrasound contrast agent indicated for use in echocardiography to opacify the left ventricular chamber and to improve the delineation of the left ventricular endocardial border in adult patients with suboptimal echocardiograms ( 1 ) in ultrasonography of the liver for characterization of focal liver lesions in adult and pediatric patients ( 1 ) in ultrasonography of the urinary tract for the evaluation of suspected or known vesicoureteral reflux in pediatric patients ( 1 ),1
4330,4330,4330,4330,4330,4330,4330,5287,5287,5287,5287,5287,5287,5287,5287,5287,5287,5287,5287,5287,adc84ad5-a04d-4fee-9ba8-91f7abd928e3,1  bosulif is indicated for the treatment of adult patients with newly diagnosed chronic phase ( cp ) philadelphia chromosome positive chronic myelogenous leukemia ( ph cml ),1
4331,4331,4331,4331,4331,4331,4331,5288,5288,5288,5288,5288,5288,5288,5288,5288,5288,5288,5288,5288,adc84ad5-a04d-4fee-9ba8-91f7abd928e3,this indication is approved under accelerated approval based on molecular and cytogenetic response rates see clinical studies ( 14 1 ),0
4332,4332,4332,4332,4332,4332,4332,5289,5289,5289,5289,5289,5289,5289,5289,5289,5289,5289,5289,5289,adc84ad5-a04d-4fee-9ba8-91f7abd928e3,continued approval for this indication may be contingent upon verification and confirmation of clinical benefit in an ongoing long term follow up trial,0
4333,4333,4333,4333,4333,4333,4333,5290,5290,5290,5290,5290,5290,5290,5290,5290,5290,5290,5290,5290,adc84ad5-a04d-4fee-9ba8-91f7abd928e3,chronic phase  accelerated phase ( ap )  or blast phase ( bp ) ph cml with resistance or intolerance to prior therapy,u
4334,4334,4334,4334,4334,4334,4334,5291,5291,5291,5291,5291,5291,5291,5291,5291,5291,5291,5291,5291,adc84ad5-a04d-4fee-9ba8-91f7abd928e3,bosulif is a kinase inhibitor indicated for the treatment of adult patients with newly diagnosed chronic phase ph chronic myelogenous leukemia ( cml ),1
4335,4335,4335,4335,4335,4335,4335,5292,5292,5292,5292,5292,5292,5292,5292,5292,5292,5292,5292,5292,adc84ad5-a04d-4fee-9ba8-91f7abd928e3,this indication is approved under accelerated approval based on molecular and cytogenetic response rates,u
4336,4336,4336,4336,4336,4336,4336,5294,5294,5294,5294,5294,5294,5294,5294,5294,5294,5294,5294,5294,adc84ad5-a04d-4fee-9ba8-91f7abd928e3,( 1  14 ) chronic  accelerated  or blast phase ph cml with resistance or intolerance to prior therapy,u
4337,4337,4337,4337,4337,4337,4337,5295,5295,5295,5295,5295,5295,5295,5295,5295,5295,5295,5295,5295,cc0f4113-e627-4caf-b2d4-95b4106e57f5, paromomycin sulfate is indicated for intestinal amebiasis acute and chronic ( note it is not effective in extraintestinal amebiasis ) management of hepatic coma as adjunctive therapy,1
4338,4338,4338,4338,4338,4338,4338,5296,5296,5296,5296,5296,5296,5296,5296,5296,5296,5296,5296,5296,cc0f4113-e627-4caf-b2d4-95b4106e57f5,to reduce the development of drug resistant bacteria and maintain the effectiveness of paromomycin sulfate capsules and other antibacterial drugs  paromomycin sulfate capsules should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria,4
4339,4339,4339,4339,4339,4339,4339,5299,5299,5299,5299,5299,5299,5299,5299,5299,5299,5299,5299,5299,d539c8b2-13fe-4ba2-994e-b4d0ee1ef490,1  omniscan is a gadolinium based contrast agent for diagnostic magnetic resonance imaging ( mri ) indicated for intravenous use to visualize lesions with abnormal vascularity in the brain  spine  and associated tissues ( 1 1 ) facilitate the visualization of lesions with abnormal vascularity within the thoracic  abdominal  pelvic cavities  and the retroperitoneal space ( 1 2 ) 1 1 cns ( central nervous system ) omniscan is a gadolinium based contrast agent indicated for intravenous use in mri to visualize lesions with abnormal vascularity ( or those thought to cause abnormalities in the blood brain barrier ) in the brain ( intracranial lesions )  spine  and associated tissues see clinical studies ( 14 1 ),1
4340,4340,4340,4340,4340,4340,4340,5300,5300,5300,5300,5300,5300,5300,5300,5300,5300,5300,5300,5300,d539c8b2-13fe-4ba2-994e-b4d0ee1ef490,1 2 body ( intrathoracic noncardiac  intra abdominal  pelvic and retroperitoneal regions ) omniscan is a gadolinium based contrast agent indicated for intravenous use in mri to facilitate the visualization of lesions with abnormal vascularity within the thoracic ( noncardiac )  abdominal  pelvic cavities  and the retroperitoneal space see clinical studies ( 14 2 ),1
4341,4341,4341,4341,4341,4341,4341,5301,5301,5301,5301,5301,5301,5301,5301,5301,5301,5301,5301,5301,b026de1b-9949-4557-ac49-c7b0038c24cd, betadine 5 sterile ophthalmic prep solution for the eye is indicated for prepping of the periocular region ( lids  brow  and cheek ) and irrigation of the ocular surface ( cornea  conjunctiva  and palpebral fornices ),1
4342,4342,4342,4342,4342,4342,4342,5302,5302,5302,5302,5302,5302,5302,5302,5302,5302,5302,5302,5302,"Active Ingredient UNII(s)
85H0HZU99M; AI9376Y64P; ND2M416302    5d6b905f-ed31-1ab7-e053-2a91aa0a816b
85H0HZU99M; AI9376Y64P; ND2M416302    5d6b905f-ed31-1ab7-e053-2a91aa0a816b
85H0HZU99M; AI9376Y64P; ND2M416302    5d6b905f-ed31-1ab7-e053-2a91aa0a816b
Name: SET ID dtype: object",active ingredient unii ( s ) 85h0hzu99m ai9376y64p nd2m416302 active ingredient unii ( s ) 85h0hzu99m ai9376y6 85h0hzu99m ai9376y64p nd2m416302 active ingredient unii ( s ) 85h0hzu99m ai9376y6 85h0hzu99m ai9376y64p nd2m416302 active ingredient unii ( s ) 85h0hzu99m ai9376y6 name content xml  dtype object,0
4343,4343,4343,4343,4343,4343,4343,5305,5305,5305,5305,5305,5305,5305,5305,5305,5305,5305,5305,5305,"Active Ingredient UNII(s)
85H0HZU99M; AI9376Y64P; ND2M416302; V13007Z41A    65428186-5fbb-4e1a-ae60-8824f3d62179
85H0HZU99M; AI9376Y64P; ND2M416302; V13007Z41A    65428186-5fbb-4e1a-ae60-8824f3d62179
85H0HZU99M; AI9376Y64P; ND2M416302; V13007Z41A    65428186-5fbb-4e1a-ae60-8824f3d62179
85H0HZU99M; AI9376Y64P; ND2M416302; V13007Z41A    65428186-5fbb-4e1a-ae60-8824f3d62179
Name: SET ID dtype: object",active ingredient unii ( s ) 85h0hzu99m ai9376y64p nd2m416302 v13007z41a active ingredient unii ( s ) 85h0hzu99m ai9376y6 85h0hzu99m ai9376y64p nd2m416302 v13007z41a active ingredient unii ( s ) 85h0hzu99m ai9376y6 85h0hzu99m ai9376y64p nd2m416302 v13007z41a active ingredient unii ( s ) 85h0hzu99m ai9376y6 85h0hzu99m ai9376y64p nd2m416302 v13007z41a active ingredient unii ( s ) 85h0hzu99m ai9376y6 name content xml  dtype object,0
4344,4344,4344,4344,4344,4344,4344,5309,5309,5309,5309,5309,5309,5309,5309,5309,5309,5309,5309,5309,"Active Ingredient UNII(s)
85H0HZU99M; F446C597KA; ND2M416302    b0ffed4f-350e-4d0d-93cc-f56ca5101d9b
85H0HZU99M; F446C597KA; ND2M416302    b0ffed4f-350e-4d0d-93cc-f56ca5101d9b
85H0HZU99M; F446C597KA; ND2M416302    b0ffed4f-350e-4d0d-93cc-f56ca5101d9b
85H0HZU99M; F446C597KA; ND2M416302    b0ffed4f-350e-4d0d-93cc-f56ca5101d9b
Name: SET ID dtype: object",active ingredient unii ( s ) 85h0hzu99m f446c597ka nd2m416302 active ingredient unii ( s ) 85h0hzu99m f446c597 85h0hzu99m f446c597ka nd2m416302 active ingredient unii ( s ) 85h0hzu99m f446c597 85h0hzu99m f446c597ka nd2m416302 active ingredient unii ( s ) 85h0hzu99m f446c597 85h0hzu99m f446c597ka nd2m416302 active ingredient unii ( s ) 85h0hzu99m f446c597 name content xml  dtype object,0
4345,4345,4345,4345,4345,4345,4345,5313,5313,5313,5313,5313,5313,5313,5313,5313,5313,5313,5313,5313,"Active Ingredient UNII(s)
85H0HZU99M; F446C597KA; ND2M416302; V13007Z41A    6ac1a90b-cbff-49b5-bc7d-5839d332cb85
85H0HZU99M; F446C597KA; ND2M416302; V13007Z41A    6ac1a90b-cbff-49b5-bc7d-5839d332cb85
85H0HZU99M; F446C597KA; ND2M416302; V13007Z41A    6ac1a90b-cbff-49b5-bc7d-5839d332cb85
85H0HZU99M; F446C597KA; ND2M416302; V13007Z41A    6ac1a90b-cbff-49b5-bc7d-5839d332cb85
Name: SET ID dtype: object",active ingredient unii ( s ) 85h0hzu99m f446c597ka nd2m416302 v13007z41a active ingredient unii ( s ) 85h0hzu99m f446c597 85h0hzu99m f446c597ka nd2m416302 v13007z41a active ingredient unii ( s ) 85h0hzu99m f446c597 85h0hzu99m f446c597ka nd2m416302 v13007z41a active ingredient unii ( s ) 85h0hzu99m f446c597 85h0hzu99m f446c597ka nd2m416302 v13007z41a active ingredient unii ( s ) 85h0hzu99m f446c597 name content xml  dtype object,0
4346,4346,4346,4346,4346,4346,4346,5317,5317,5317,5317,5317,5317,5317,5317,5317,5317,5317,5317,5317,"Active Ingredient UNII(s)
85H0HZU99M; F446C597KA; V13007Z41A    069e145d-7992-4f56-9fcb-20782ecc2d53
85H0HZU99M; F446C597KA; V13007Z41A    069e145d-7992-4f56-9fcb-20782ecc2d53
85H0HZU99M; F446C597KA; V13007Z41A    069e145d-7992-4f56-9fcb-20782ecc2d53
Name: SET ID dtype: object",active ingredient unii ( s ) 85h0hzu99m f446c597ka v13007z41a active ingredient unii ( s ) 85h0hzu99m f446c597 85h0hzu99m f446c597ka v13007z41a active ingredient unii ( s ) 85h0hzu99m f446c597 85h0hzu99m f446c597ka v13007z41a active ingredient unii ( s ) 85h0hzu99m f446c597 name content xml  dtype object,0
4347,4347,4347,4347,4347,4347,4347,5320,5320,5320,5320,5320,5320,5320,5320,5320,5320,5320,5320,5320,1cec7a02-b7a5-49e1-ab64-3a4dab4149d2,1 indications usage amlodipine besylate tablets are a calcium channel blocker and may be used alone or in combination with other antihypertensive and antianginal agents for the treatment of hypertension ( 1 1 ) o amlodipine besylate tablets are indicated for the tretament of hypertension  to lower blood pressure,1
4348,4348,4348,4348,4348,4348,4348,5321,5321,5321,5321,5321,5321,5321,5321,5321,5321,5321,5321,5321,1cec7a02-b7a5-49e1-ab64-3a4dab4149d2,lowering blood pressure reduces the risk of fatal and nonfatal cerdiovascular events  primarily strokes and myocardial infarctions,0
4349,4349,4349,4349,4349,4349,4349,5322,5322,5322,5322,5322,5322,5322,5322,5322,5322,5322,5322,5322,1cec7a02-b7a5-49e1-ab64-3a4dab4149d2,coronary artery disease ( 1 2 ) o chronic stable angina o vasospastic angina ( prinzmetal 's or variant angina ) o angiographically documented coronary artery disease in patients without heart failure or an ejection fraction 40,1
4350,4350,4350,4350,4350,4350,4350,5323,5323,5323,5323,5323,5323,5323,5323,5323,5323,5323,5323,5323,1cec7a02-b7a5-49e1-ab64-3a4dab4149d2,1 1 hypertension amlodipine besylate tablets are indicated for the treatment of hypertension  to lower blood pressure,1
4351,4351,4351,4351,4351,4351,4351,5325,5325,5325,5325,5325,5325,5325,5325,5325,5325,5325,5325,5325,1cec7a02-b7a5-49e1-ab64-3a4dab4149d2,these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including amlodipine besylate tablets,0
4352,4352,4352,4352,4352,4352,4352,5333,5333,5333,5333,5333,5333,5333,5333,5333,5333,5333,5333,5333,1cec7a02-b7a5-49e1-ab64-3a4dab4149d2,some antihypertensive drugs have smaller blood pressure effects ( as monotherapy ) in black patients  and many antihypertensive drugs have additional approved indications and effects ( e g  on angina  heart failure  or diabetic k,u
4353,4353,4353,4353,4353,4353,4353,5334,5334,5334,5334,5334,5334,5334,5334,5334,5334,5334,5334,5334,"Active Ingredient UNII(s)
864V2Q084H; 94ZLA3W45F    2fcc87a4-74ef-46bd-8ee9-bd2f3cf3d0c2
864V2Q084H; 94ZLA3W45F    2fcc87a4-74ef-46bd-8ee9-bd2f3cf3d0c2
Name: SET ID dtype: object",active ingredient unii ( s ) 864v2q084h 94zla3w45f active ingredient unii ( s ) 864v2q084h 94zla3w4 864v2q084h 94zla3w45f active ingredient unii ( s ) 864v2q084h 94zla3w4 name content xml  dtype object,0
4354,4354,4354,4354,4354,4354,4354,5336,5336,5336,5336,5336,5336,5336,5336,5336,5336,5336,5336,5336,43464a6b-a3b8-445b-b020-cf60f0b5e8a4,1  template amlodipine besylate and benazepril hydrochloride capsules is a combination capsule of amlodipine  a dihydropyridine calcium channel blocker ( dhp ccb ) and benazepril  an angiotensin converting enzyme ( ace ) inhibitor,0
4355,4355,4355,4355,4355,4355,4355,5337,5337,5337,5337,5337,5337,5337,5337,5337,5337,5337,5337,5337,43464a6b-a3b8-445b-b020-cf60f0b5e8a4,amlodipine besylate and benazepril hydrochloride capsules are indicated for the treatment of hypertension ( 1 ) in patients not adequately controlled on monotherapy with either agent 1 1 hypertension amlodipine besylate and benazepril hydrochloride capsules are indicated for the treatment of hypertension in patients not adequately controlled on monotherapy with either agent,1
4356,4356,4356,4356,4356,4356,4356,5338,5338,5338,5338,5338,5338,5338,5338,5338,5338,5338,5338,5338,98cc3e47-3463-4162-96ac-bf97d77eb041,1  prestalia contains perindopril arginine  an angiotensin converting enzyme inhibitor  and amlodipine  a dihydropyridine calcium channel blocker  and is indicated for the treatment of hypertension  to lower blood pressure,1
4357,4357,4357,4357,4357,4357,4357,5339,5339,5339,5339,5339,5339,5339,5339,5339,5339,5339,5339,5339,98cc3e47-3463-4162-96ac-bf97d77eb041,prestalia may be used in patients whose blood pressure is not adequately controlled on monotherapy,u
4358,4358,4358,4358,4358,4358,4358,5340,5340,5340,5340,5340,5340,5340,5340,5340,5340,5340,5340,5340,98cc3e47-3463-4162-96ac-bf97d77eb041,prestalia may be used as initial therapy in patients likely to need multiple drugs to achieve blood pressure goals,u
4359,4359,4359,4359,4359,4359,4359,5342,5342,5342,5342,5342,5342,5342,5342,5342,5342,5342,5342,5342,98cc3e47-3463-4162-96ac-bf97d77eb041,these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes  including amlodipine and the ace inhibitor class to which perindopril principally belongs,0
4360,4360,4360,4360,4360,4360,4360,5343,5343,5343,5343,5343,5343,5343,5343,5343,5343,5343,5343,5343,98cc3e47-3463-4162-96ac-bf97d77eb041,there are no controlled trials demonstrating risk reduction with prestalia,0
4361,4361,4361,4361,4361,4361,4361,5353,5353,5353,5353,5353,5353,5353,5353,5353,5353,5353,5353,5353,98cc3e47-3463-4162-96ac-bf97d77eb041,in a clinical trial of prestalia  treatment with prestalia 14 10 mg did not provide additional antihypertensive effect beyond that achieved with use of amlodipine 10 mg in black and diabetic patients see clinical studies ( 14 ),0
4362,4362,4362,4362,4362,4362,4362,5354,5354,5354,5354,5354,5354,5354,5354,5354,5354,5354,5354,5354,98cc3e47-3463-4162-96ac-bf97d77eb041,the choice of prestalia as initial therapy for hypertension should be based on an assessment of potential benefits and risks including whether the patient is likely to tolerate the starting dos,0
4363,4363,4363,4363,4363,4363,4363,5355,5355,5355,5355,5355,5355,5355,5355,5355,5355,5355,5355,5355,ca60a4d5-ace7-4889-94ee-e2265fd63811,1  telmisartan and amlodipine tablets are indicated for the treatment of hypertension  alone or with other antihypertensive agents to lower blood pressure,1
4364,4364,4364,4364,4364,4364,4364,5357,5357,5357,5357,5357,5357,5357,5357,5357,5357,5357,5357,5357,ca60a4d5-ace7-4889-94ee-e2265fd63811,these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including angiotensin ii receptor blockers and dihydropyridine calcium channel blockers,0
4365,4365,4365,4365,4365,4365,4365,5358,5358,5358,5358,5358,5358,5358,5358,5358,5358,5358,5358,5358,ca60a4d5-ace7-4889-94ee-e2265fd63811,there are no controlled trials demonstrating risk reduction with telmisartan and amlodipine tablets,0
4366,4366,4366,4366,4366,4366,4366,5368,5368,5368,5368,5368,5368,5368,5368,5368,5368,5368,5368,5368,ca60a4d5-ace7-4889-94ee-e2265fd63811,telmisartan and amlodipine tablets may also be used as initial therapy in patients who are likely to need multiple drugs to achieve their blood pressure goals,u
4367,4367,4367,4367,4367,4367,4367,5369,5369,5369,5369,5369,5369,5369,5369,5369,5369,5369,5369,5369,ca60a4d5-ace7-4889-94ee-e2265fd63811,base the choice of telmisartan and amlodipine tablets as initial therapy for hypertension on an assessment of potential benefits and risks including whether the patient is likely to tolerate the starting dose of telmisartan and amlodipine tablets,4
4368,4368,4368,4368,4368,4368,4368,5371,5371,5371,5371,5371,5371,5371,5371,5371,5371,5371,5371,5371,ca60a4d5-ace7-4889-94ee-e2265fd63811,consider the patient 's baseline blood pressure  the target goal  and the incremental likelihood of achieving goal with a co,0
4369,4369,4369,4369,4369,4369,4369,5372,5372,5372,5372,5372,5372,5372,5372,5372,5372,5372,5372,5372,084e8f27-dcec-4cb0-9b37-fe0fd7f75712,1  macrilen is indicated for the diagnosis of adult growth hormone deficiency ( aghd ),1
4370,4370,4370,4370,4370,4370,4370,5373,5373,5373,5373,5373,5373,5373,5373,5373,5373,5373,5373,5373,084e8f27-dcec-4cb0-9b37-fe0fd7f75712,macrilen is a growth hormone ( gh ) secretagogue receptor agonist indicated for the diagnosis of adult growth hormone deficiency ( 1 ),1
4371,4371,4371,4371,4371,4371,4371,5374,5374,5374,5374,5374,5374,5374,5374,5374,5374,5374,5374,5374,084e8f27-dcec-4cb0-9b37-fe0fd7f75712,limitations of use the safety and diagnostic performance has not been established for subjects with bmi 40kg m2 ( 1 ),2
4372,4372,4372,4372,4372,4372,4372,5375,5375,5375,5375,5375,5375,5375,5375,5375,5375,5375,5375,5375,084e8f27-dcec-4cb0-9b37-fe0fd7f75712,limitations of use the safety and diagnostic performance of macrilen have not been established for subjects with a body mass index ( bmi ) 40 kg m2,2
4373,4373,4373,4373,4373,4373,4373,5376,5376,5376,5376,5376,5376,5376,5376,5376,5376,5376,5376,5376,9a1914a0-e195-4233-c1be-bc2075580eb8, zinc 1 mg ml ( zinc chloride injection  usp ) is indicated for use as a supplement to intravenous solutions given for tpn,1
4374,4374,4374,4374,4374,4374,4374,5377,5377,5377,5377,5377,5377,5377,5377,5377,5377,5377,5377,5377,9a1914a0-e195-4233-c1be-bc2075580eb8,administration helps to maintain zinc serum levels and to prevent depletion of endogenous stores  and subsequent deficiency symptoms,u
4375,4375,4375,4375,4375,4375,4375,5378,5378,5378,5378,5378,5378,5378,5378,5378,5378,5378,5378,5378,5db8c103-2bfd-a235-d50d-4c1a356d44d2, hypercalcemia of malignancy pamidronate disodium for injection usp  in conjunction with adequate hydration  is indicated for the treatment of moderate or severe hypercalcemia associated with malignancy  with or without bone metastases,1
4376,4376,4376,4376,4376,4376,4376,5379,5379,5379,5379,5379,5379,5379,5379,5379,5379,5379,5379,5379,5db8c103-2bfd-a235-d50d-4c1a356d44d2,patients who have either epidermoid or non epidermoid tumors respond to treatment with pamidronate disodium for injection usp,1
4377,4377,4377,4377,4377,4377,4377,5380,5380,5380,5380,5380,5380,5380,5380,5380,5380,5380,5380,5380,5db8c103-2bfd-a235-d50d-4c1a356d44d2,vigorous saline hydration  an integral part of hypercalcemia therapy  should be initiated promptly and an attempt should be made to restore the urine output to about 2 l day throughout treatment,4
4378,4378,4378,4378,4378,4378,4378,5381,5381,5381,5381,5381,5381,5381,5381,5381,5381,5381,5381,5381,5db8c103-2bfd-a235-d50d-4c1a356d44d2,mild or asymptomatic hypercalcemia may be treated with conservative measures ( i e  saline hydration  with or without loop diuretics ),u
4379,4379,4379,4379,4379,4379,4379,5382,5382,5382,5382,5382,5382,5382,5382,5382,5382,5382,5382,5382,5db8c103-2bfd-a235-d50d-4c1a356d44d2,patients should be hydrated adequately throughout the treatment  but overhydration  especially in those patients who have cardiac failure  must be avoided,0
4380,4380,4380,4380,4380,4380,4380,5383,5383,5383,5383,5383,5383,5383,5383,5383,5383,5383,5383,5383,5db8c103-2bfd-a235-d50d-4c1a356d44d2,diuretic therapy should not be employed prior to correction of hypovolemia,4
4381,4381,4381,4381,4381,4381,4381,5384,5384,5384,5384,5384,5384,5384,5384,5384,5384,5384,5384,5384,5db8c103-2bfd-a235-d50d-4c1a356d44d2,the safety and efficacy of pamidronate disodium for injection usp in the treatment of hypercalcemia associated with hyperparathyroidism or with other non tumor related conditions has not been established,0
4382,4382,4382,4382,4382,4382,4382,5385,5385,5385,5385,5385,5385,5385,5385,5385,5385,5385,5385,5385,5db8c103-2bfd-a235-d50d-4c1a356d44d2,paget 's disease pamidronate disodium for injection usp is indicated for the treatment of patients with moderate to severe paget s disease of bone,1
4383,4383,4383,4383,4383,4383,4383,5386,5386,5386,5386,5386,5386,5386,5386,5386,5386,5386,5386,5386,5db8c103-2bfd-a235-d50d-4c1a356d44d2,the effectiveness of pamidronate disodium for injection usp was demonstrated primarily in patients with serum alkaline phosphatase 3 times the upper limit of normal,u
4384,4384,4384,4384,4384,4384,4384,5387,5387,5387,5387,5387,5387,5387,5387,5387,5387,5387,5387,5387,5db8c103-2bfd-a235-d50d-4c1a356d44d2,pamidronate disodium for injection usp therapy in patients with paget s disease has been effective in reducing serum alkaline phosphatase and urinary hydroxyproline levels by 50 in at least 50 of patients  and by 30 in at least 80 of patients,u
4385,4385,4385,4385,4385,4385,4385,5388,5388,5388,5388,5388,5388,5388,5388,5388,5388,5388,5388,5388,5db8c103-2bfd-a235-d50d-4c1a356d44d2,pamidronate disodium for injection usp therapy has also been effective in reducing these biochemical markers in patients with paget s disease who failed to respond  or no longer responded to other treatments,u
4386,4386,4386,4386,4386,4386,4386,5389,5389,5389,5389,5389,5389,5389,5389,5389,5389,5389,5389,5389,5db8c103-2bfd-a235-d50d-4c1a356d44d2,osteolytic bone metastases of breast cancer and osteolytic lesions of multiple myeloma pamidronate disodium for injection usp is indicated  in conjunction with standard antineoplastic therapy  for the treatment of osteolytic bone metastases of breast cancer and osteolytic lesions of multiple myeloma,1
4387,4387,4387,4387,4387,4387,4387,5390,5390,5390,5390,5390,5390,5390,5390,5390,5390,5390,5390,5390,5db8c103-2bfd-a235-d50d-4c1a356d44d2,the pamidronate disodium for injection usp treatment effect appeared to be smaller in the study of breast cancer patients receiving hormonal therapy than in the study of those receiving chemotherapy  however ,0
4388,4388,4388,4388,4388,4388,4388,5391,5391,5391,5391,5391,5391,5391,5391,5391,5391,5391,5391,5391,237da26c-f38c-4faa-93ad-735e71c9d0c1,1  velphoro ( sucroferric oxyhydroxide ) is a phosphate binder indicated for the control of serum phosphorus levels in patients with chronic kidney disease on dialysis,1
4389,4389,4389,4389,4389,4389,4389,5392,5392,5392,5392,5392,5392,5392,5392,5392,5392,5392,5392,5392,237da26c-f38c-4faa-93ad-735e71c9d0c1,velphoro is a phosphate binder indicated for the control of serum phosphorus levels in patients with chronic kidney disease on dialysis,1
4390,4390,4390,4390,4390,4390,4390,5393,5393,5393,5393,5393,5393,5393,5393,5393,5393,5393,5393,5393,939e28c5-f3a9-42c0-9a2d-8d471d82a6e0,1  neupro is a dopamine agonist indicated for the treatment of parkinson 's disease ( 1 1 ) moderate to severe primary restless legs syndrome ( 1 2 ) 1 1 parkinson 's disease ( pd ) neupro is indicated for the treatment of parkinson 's disease,1
4391,4391,4391,4391,4391,4391,4391,5394,5394,5394,5394,5394,5394,5394,5394,5394,5394,5394,5394,5394,939e28c5-f3a9-42c0-9a2d-8d471d82a6e0,1 2 restless legs syndrome ( rls ) neupro is indicated for the treatment of moderate to severe primary restless legs syndrome,1
4392,4392,4392,4392,4392,4392,4392,5396,5396,5396,5396,5396,5396,5396,5396,5396,5396,5396,5396,5396,85cfed58-e5f1-4170-8d83-60e6bebd3610,endocrine disorders primary or secondary adrenocortical insufficiency ( hydrocortisone or cortisone is the first choice synthetic analogs may be used in conjunction with mineralocorticoids where applicable in infancy mineralocorticoid supplementation is of particular importance ),1
4393,4393,4393,4393,4393,4393,4393,5397,5397,5397,5397,5397,5397,5397,5397,5397,5397,5397,5397,5397,85cfed58-e5f1-4170-8d83-60e6bebd3610,congenital adrenal hyperplasia nonsuppurative thyroiditis hypercalcemia associated with cancer 2,1
4394,4394,4394,4394,4394,4394,4394,5398,5398,5398,5398,5398,5398,5398,5398,5398,5398,5398,5398,5398,85cfed58-e5f1-4170-8d83-60e6bebd3610,rheumatic disorders as adjunctive therapy for short term administration ( to tide the patient over an acute episode or exacerbation ) in psoriatic arthritis rheumatoid arthritis  including juvenile rheumatoid arthritis ( selected cases may require low dose maintenance therapy ) ankylosing spondylitis acute and subacute bursitis acute nonspecific tenosynovitis acute gouty arthritis post traumatic osteoarthritis synovitis of osteoarthritis epicondylitis 3,1
4395,4395,4395,4395,4395,4395,4395,5399,5399,5399,5399,5399,5399,5399,5399,5399,5399,5399,5399,5399,85cfed58-e5f1-4170-8d83-60e6bebd3610,collagen diseases during an exacerbation or as maintenance therapy in selected cases of systemic lupus erythematosus acute rheumatic carditis systemic dermatomyositis ( polymyositis ) 4,1
4396,4396,4396,4396,4396,4396,4396,5400,5400,5400,5400,5400,5400,5400,5400,5400,5400,5400,5400,5400,85cfed58-e5f1-4170-8d83-60e6bebd3610,dermatologic diseases pemphigus bullous dermatitis herpetiformis severe erythema multiforme ( stevens johnson syndrome ) exfoliative dermatitis mycosis fungoides severe psoriasis severe seborrheic dermatitis 5,1
4397,4397,4397,4397,4397,4397,4397,5401,5401,5401,5401,5401,5401,5401,5401,5401,5401,5401,5401,5401,85cfed58-e5f1-4170-8d83-60e6bebd3610,allergic states control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment seasonal or perennial allergic rhinitis bronchial asthma contact dermatitis atopic dermatitis serum sickness drug hypersensitivity reactions 6,1
4398,4398,4398,4398,4398,4398,4398,5402,5402,5402,5402,5402,5402,5402,5402,5402,5402,5402,5402,5402,85cfed58-e5f1-4170-8d83-60e6bebd3610,ophthalmic diseases severe acute and chronic allergic and inflammatory processes involving the eye and its adnexa  such as allergic conjunctivitis keratitis allergic corneal marginal ulcers herpes zoster ophthalmicus iritis and iridocyclitis chorioretinitis anterior segment inflammation diffuse posterior uveitis and choroiditis optic neuritis sympathetic ophthalmia 7,1
4399,4399,4399,4399,4399,4399,4399,5403,5403,5403,5403,5403,5403,5403,5403,5403,5403,5403,5403,5403,85cfed58-e5f1-4170-8d83-60e6bebd3610,respiratory diseases symptomatic sarcoidosis loeffler s syndrome not manageable by other means berylliosis fulminating or disseminated pulmonary tuberculosis when used concurrently with appropriate antituberculosis chemotherapy aspiration pneumonitis 8,1
4400,4400,4400,4400,4400,4400,4400,5404,5404,5404,5404,5404,5404,5404,5404,5404,5404,5404,5404,5404,85cfed58-e5f1-4170-8d83-60e6bebd3610,hematologic disorders idiopathic thrombocytopenic purpura in adults secondary thrombocytopenia in adults acquired ( autoimmune ) hemolytic anemia erythroblastopenia ( rbc anemia ) congenital ( erythroid ) hypoplastic anemia 9,1
4401,4401,4401,4401,4401,4401,4401,5405,5405,5405,5405,5405,5405,5405,5405,5405,5405,5405,5405,5405,85cfed58-e5f1-4170-8d83-60e6bebd3610,neoplastic diseases for palliative management of leukemias and lymphomas in adults acute leukemia of childhood 10,1
4402,4402,4402,4402,4402,4402,4402,5406,5406,5406,5406,5406,5406,5406,5406,5406,5406,5406,5406,5406,85cfed58-e5f1-4170-8d83-60e6bebd3610,edematous states to induce a diuresis or remission of proteinuria in the nephrotic syndrome  without uremia  of the idiopathic type or that due to lupu,1
4403,4403,4403,4403,4403,4403,4403,5407,5407,5407,5407,5407,5407,5407,5407,5407,5407,5407,5407,5407,7439bbb3-92f0-49ce-a61a-5aca9d4217dc, ranitidine syrup ( ranitidine oral solution usp ) is indicated in 1 short term treatment of active duodenal ulcer,1
4404,4404,4404,4404,4404,4404,4404,5408,5408,5408,5408,5408,5408,5408,5408,5408,5408,5408,5408,5408,7439bbb3-92f0-49ce-a61a-5aca9d4217dc,most patients heal within 4 weeks,0
4405,4405,4405,4405,4405,4405,4405,5409,5409,5409,5409,5409,5409,5409,5409,5409,5409,5409,5409,5409,7439bbb3-92f0-49ce-a61a-5aca9d4217dc,studies available to date have not assessed the safety of ranitidine in uncomplicated duodenal ulcer for periods of more than 8 weeks,0
4406,4406,4406,4406,4406,4406,4406,5410,5410,5410,5410,5410,5410,5410,5410,5410,5410,5410,5410,5410,7439bbb3-92f0-49ce-a61a-5aca9d4217dc,2 maintenance therapy for duodenal ulcer patients at reduced dosage after healing of acute ulcers,1
4407,4407,4407,4407,4407,4407,4407,5411,5411,5411,5411,5411,5411,5411,5411,5411,5411,5411,5411,5411,7439bbb3-92f0-49ce-a61a-5aca9d4217dc,no placebo controlled comparative studies have been carried out for periods of longer than 1 year,0
4408,4408,4408,4408,4408,4408,4408,5412,5412,5412,5412,5412,5412,5412,5412,5412,5412,5412,5412,5412,7439bbb3-92f0-49ce-a61a-5aca9d4217dc,3 the treatment of pathological hypersecretory conditions ( e g  zollinger ellison syndrome and systemic mastocytosis ),1
4409,4409,4409,4409,4409,4409,4409,5413,5413,5413,5413,5413,5413,5413,5413,5413,5413,5413,5413,5413,7439bbb3-92f0-49ce-a61a-5aca9d4217dc,4 short term treatment of active  benign gastric ulcer,1
4410,4410,4410,4410,4410,4410,4410,5414,5414,5414,5414,5414,5414,5414,5414,5414,5414,5414,5414,5414,7439bbb3-92f0-49ce-a61a-5aca9d4217dc,most patients heal within 6 weeks and the usefulness of further treatment has not been demonstrated,0
4411,4411,4411,4411,4411,4411,4411,5415,5415,5415,5415,5415,5415,5415,5415,5415,5415,5415,5415,5415,7439bbb3-92f0-49ce-a61a-5aca9d4217dc,studies available to date have not assessed the safety of ranitidine in uncomplicated  benign gastric ulcer for periods of more than 6 weeks,0
4412,4412,4412,4412,4412,4412,4412,5416,5416,5416,5416,5416,5416,5416,5416,5416,5416,5416,5416,5416,7439bbb3-92f0-49ce-a61a-5aca9d4217dc,5 maintenance therapy for gastric ulcer patients at reduced dosage after healing of acute ulcers,1
4413,4413,4413,4413,4413,4413,4413,5417,5417,5417,5417,5417,5417,5417,5417,5417,5417,5417,5417,5417,7439bbb3-92f0-49ce-a61a-5aca9d4217dc,placebo controlled studies have been carried out for 1 year,0
4414,4414,4414,4414,4414,4414,4414,5418,5418,5418,5418,5418,5418,5418,5418,5418,5418,5418,5418,5418,7439bbb3-92f0-49ce-a61a-5aca9d4217dc,symptomatic relief commonly occurs within 24 hours after starting therapy with ranitidine 150 mg twice daily,0
4415,4415,4415,4415,4415,4415,4415,5419,5419,5419,5419,5419,5419,5419,5419,5419,5419,5419,5419,5419,7439bbb3-92f0-49ce-a61a-5aca9d4217dc,7 treatment of endoscopically diagnosed erosive esophagitis,1
4416,4416,4416,4416,4416,4416,4416,5420,5420,5420,5420,5420,5420,5420,5420,5420,5420,5420,5420,5420,7439bbb3-92f0-49ce-a61a-5aca9d4217dc,symptomatic relief of heartburn commonly occurs within 24 hours of therapy initiation with ranitidine 150 mg 4 times daily,u
4417,4417,4417,4417,4417,4417,4417,5421,5421,5421,5421,5421,5421,5421,5421,5421,5421,5421,5421,5421,7439bbb3-92f0-49ce-a61a-5aca9d4217dc,8 maintenance of healing of erosive esophagitis,0
4418,4418,4418,4418,4418,4418,4418,5422,5422,5422,5422,5422,5422,5422,5422,5422,5422,5422,5422,5422,7439bbb3-92f0-49ce-a61a-5aca9d4217dc,placebo controlled trials have been carried out for 48 weeks,0
4419,4419,4419,4419,4419,4419,4419,5423,5423,5423,5423,5423,5423,5423,5423,5423,5423,5423,5423,5423,7439bbb3-92f0-49ce-a61a-5aca9d4217dc,concomitant antacids should be given as needed for pain relief to patients with active duodenal ulcer active  benign gastric ulcer hypersecretory states gerd and erosive esophagitis,0
4420,4420,4420,4420,4420,4420,4420,5424,5424,5424,5424,5424,5424,5424,5424,5424,5424,5424,5424,5424,b1d5b166-ab06-4ab5-b0c6-31126238118a,1  soolantra cream is indicated for the treatment of inflammatory lesions of rosacea,0
4421,4421,4421,4421,4421,4421,4421,5425,5425,5425,5425,5425,5425,5425,5425,5425,5425,5425,5425,5425,b1d5b166-ab06-4ab5-b0c6-31126238118a,soolantra cream is indicated for the treatment of inflammatory lesions of rosacea,0
4422,4422,4422,4422,4422,4422,4422,5426,5426,5426,5426,5426,5426,5426,5426,5426,5426,5426,5426,5426,d613bb7f-c3f4-462e-81a2-da2347cc4b6b, sucraid ( sacrosidase ) oral solution is indicated as oral replacement therapy of the genetically determined sucrase deficiency  which is part of congenital sucrase isomaltase deficiency ( csid ),0
4423,4423,4423,4423,4423,4423,4423,5427,5427,5427,5427,5427,5427,5427,5427,5427,5427,5427,5427,5427,980b3c11-a502-4235-bbff-af83a17ebcdf,1  flo pred ( prednisolone acetate oral suspension ) is indicated in the treatment of the following diseases or conditions flo pred is a corticosteroid indicated as an anti inflammatory or immunosuppressive agent for certain allergic  dermatologic  gastrointestinal  hematologic  ophthalmologic  nervous system  renal  respiratory  rheumatologic  specific infectious diseases or conditions and organ transplantation ( 1 ) for the treatment of certain endocrine conditions ( 1 ) for palliation of certain neoplastic conditions ( 1 ) 1 1 allergic conditions control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in adults and pediatric populations with atopic dermatitis drug hypersensitivity reactions seasonal or perennial allergic rhinitis serum sickness 1 2 dermatologic diseases bullous dermatitis herpetiformis contact dermatitis exfoliative erythroderma mycosis fungoides pemphigus severe erythema multiforme ( stevens johnson syndrome ) 1 3 endocrine conditions congenital adrenal hyperplasia hypercalcemia of malignancy nonsuppurative thyroiditis primary or secondary adrenocortical insufficiency hydrocortisone or cortisone is the first choice synthetic analogs may be used in conjunction with mineralocorticoids where applicable 1 4 gastrointestinal diseases during acute episodes in crohn 's disease ulcerative colitis cod,0
4424,4424,4424,4424,4424,4424,4424,5428,5428,5428,5428,5428,5428,5428,5428,5428,5428,5428,5428,5428,a76fce5c-81b4-4fa6-904b-34c2313a0828, pred g ophthalmic ointment is indicated for steroid responsive inflammatory ocular conditions for which a corticosteroid is indicated and where superficial bacterial ocular infection or a risk of bacterial ocular infection exists,0
4425,4425,4425,4425,4425,4425,4425,5430,5430,5430,5430,5430,5430,5430,5430,5430,5430,5430,5430,5430,a76fce5c-81b4-4fa6-904b-34c2313a0828,they are also indicated in chronic anterior uveitis and corneal injury from chemical  radiation  or thermal burns or penetration of foreign bodies,0
4426,4426,4426,4426,4426,4426,4426,5432,5432,5432,5432,5432,5432,5432,5432,5432,5432,5432,5432,5432,a76fce5c-81b4-4fa6-904b-34c2313a0828,the particular anti infective drug in this product is active against the following common bacterial eye pathogens staphylococcus aureaus  streptococcus pyogenes  streptococcus pneumoniae  enterobacter aerogenes  escherichia coli  haemophilus influenzae  klebsiella pneumoniae  neisseria gonorrhoeae  pseudomonas aeruginosa  and serratia marcescens,0
4427,4427,4427,4427,4427,4427,4427,5433,5433,5433,5433,5433,5433,5433,5433,5433,5433,5433,5433,5433,4e8dd668-bf83-4479-9cb9-88250bb6ef84, pred g suspension is indicated for steroid responsive inflammatory ocular conditions for which a corticosteroid is indicated and where superficial bacterial ocular infection or a risk of bacterial ocular infection exists,0
4428,4428,4428,4428,4428,4428,4428,5437,5437,5437,5437,5437,5437,5437,5437,5437,5437,5437,5437,5437,4e8dd668-bf83-4479-9cb9-88250bb6ef84,the particular anti infective drug in this product is active against the following common bacterial eye pathogens staphylococcus aureus  streptococcus pyogenes  streptococcus pneumoniae  enterobacter aerogenes  escherichia coli  haemophilus influenzae  klebsiella pneumoniae  neisseria gonorrhoeae  pseudomonas aeruginosa  and serratia marcescens,0
4429,4429,4429,4429,4429,4429,4429,5438,5438,5438,5438,5438,5438,5438,5438,5438,5438,5438,5438,5438,144a5072-341b-4591-8705-773b63044bcc,1  bromsite ( bromfenac ophthalmic solution ) 0 075 is indicated for the treatment of postoperative inflammation and prevention of ocular pain in patients undergoing cataract surgery,0
4430,4430,4430,4430,4430,4430,4430,5439,5439,5439,5439,5439,5439,5439,5439,5439,5439,5439,5439,5439,144a5072-341b-4591-8705-773b63044bcc,bromsite is a nonsteroidal anti inflammatory drug ( nsaid ) indicated for the treatment of postoperative inflammation and prevention of ocular pain in patients undergoing cataract surgery,0
4431,4431,4431,4431,4431,4431,4431,5440,5440,5440,5440,5440,5440,5440,5440,5440,5440,5440,5440,5440,"Active Ingredient UNII(s)
8ENZ0QJW4H    d0aa57cb-d2f4-46d7-af43-7c8b06aa81a6
8ENZ0QJW4H    d0aa57cb-d2f4-46d7-af43-7c8b06aa81a6
Name: SET ID dtype: object",active ingredient unii ( s ) 8enz0qjw4h active ingredient unii ( s ) 8enz0qjw4h active in 8enz0qjw4h active ingredient unii ( s ) 8enz0qjw4h active in name content xml  dtype object,0
4432,4432,4432,4432,4432,4432,4432,5442,5442,5442,5442,5442,5442,5442,5442,5442,5442,5442,5442,5442,63ae1d4a-c425-6657-e053-2991aa0af037, nolix cream is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid responsive dermatoses,0
4433,4433,4433,4433,4433,4433,4433,5443,5443,5443,5443,5443,5443,5443,5443,5443,5443,5443,5443,5443,f11c21f8-f725-445e-b38e-1e4c5b05bcc6,1  xermelo is indicated for the treatment of carcinoid syndrome diarrhea in combination with somatostatin analog ( ssa ) therapy in adults inadequately controlled by ssa therapy,0
4434,4434,4434,4434,4434,4434,4434,5444,5444,5444,5444,5444,5444,5444,5444,5444,5444,5444,5444,5444,f11c21f8-f725-445e-b38e-1e4c5b05bcc6,xermelo is a tryptophan hydroxylase inhibitor indicated for the treatment of carcinoid syndrome diarrhea in combination with somatostatin analog ( ssa ) therapy in adults inadequately controlled by ssa therapy,0
4435,4435,4435,4435,4435,4435,4435,5445,5445,5445,5445,5445,5445,5445,5445,5445,5445,5445,5445,5445,32fd2bb2-1cfa-4250-feb8-d7956c794e05,1  mylotarg is a cd33 directed antibody drug conjugate indicated for treatment of newly diagnosed cd33 positive acute myeloid leukemia ( aml ) in adults ( 1 1 ),0
4436,4436,4436,4436,4436,4436,4436,5446,5446,5446,5446,5446,5446,5446,5446,5446,5446,5446,5446,5446,32fd2bb2-1cfa-4250-feb8-d7956c794e05,treatment of relapsed or refractory cd33 positive amlin adults and in pediatric patients 2 years and older ( 1 2 ),0
4437,4437,4437,4437,4437,4437,4437,5447,5447,5447,5447,5447,5447,5447,5447,5447,5447,5447,5447,5447,32fd2bb2-1cfa-4250-feb8-d7956c794e05,1 1 newly diagnosed cd33 positive acute myeloid leukemia ( aml ) mylotarg is indicated for the treatment of newly diagnosed cd33 positive acute myeloid leukemia in adults,0
4438,4438,4438,4438,4438,4438,4438,5448,5448,5448,5448,5448,5448,5448,5448,5448,5448,5448,5448,5448,32fd2bb2-1cfa-4250-feb8-d7956c794e05,1 2 relapsed or refractory cd33 positive aml mylotarg is indicated for the treatment of relapsed or refractory cd33 positive acute myeloid leukemia in adults and in pediatric patients 2 years and older,0
4439,4439,4439,4439,4439,4439,4439,5449,5449,5449,5449,5449,5449,5449,5449,5449,5449,5449,5449,5449,e30ca373-d9c0-4cad-b5c3-3be9c299dddc, mometasone furoate nasal spray is a corticosteroid indicated for 5 treatment of nasal symptoms of allergic rhinitis in patients 2 years of age ( 1 1 ) 6 treatment of nasal congestion associated with seasonal allergic rhinitis in patients 2 years of age ( 1 2 ) 7 prophylaxis of seasonal allergic rhinitis in patients 12 years of age ( 1 3 ) 8 treatment of nasal polyps in patients 18 years of age ( 1 4 ) 1 1 treatment of allergic rhinitis mometasone furoate nasal spray 50 mcg is indicated for the treatment of the nasal symptoms of seasonal allergic and perennial allergic rhinitis  in adults and pediatric patients 2 years of age and older,0
4440,4440,4440,4440,4440,4440,4440,5453,5453,5453,5453,5453,5453,5453,5453,5453,5453,5453,5453,5453,6681aa14-5ae3-4143-9d58-c2d92a143c03,1  lymphoseek is a radioactive diagnostic agent indicated with or without scintigraphic imaging for lymphatic mapping using a handheld gamma counter to locate lymph nodes draining a primary tumor site in patients with solid tumors for which this procedure is a component of intraoperative management,0
4441,4441,4441,4441,4441,4441,4441,5454,5454,5454,5454,5454,5454,5454,5454,5454,5454,5454,5454,5454,6681aa14-5ae3-4143-9d58-c2d92a143c03,guiding sentinel lymph node biopsy using a handheld gamma counter in patients with clinically node negative squamous cell carcinoma of the oral cavity  breast cancer or melanoma,0
4442,4442,4442,4442,4442,4442,4442,5455,5455,5455,5455,5455,5455,5455,5455,5455,5455,5455,5455,5455,6681aa14-5ae3-4143-9d58-c2d92a143c03,lymphoseek is a radioactive diagnostic agent indicated with or without scintigraphic imaging for lymphatic mapping using a handheld gamma counter to locate lymph nodes draining a primary tumor site in patients with solid tumors for which this procedure is a component of intraoperative management,0
4443,4443,4443,4443,4443,4443,4443,5456,5456,5456,5456,5456,5456,5456,5456,5456,5456,5456,5456,5456,6681aa14-5ae3-4143-9d58-c2d92a143c03,( 1 ) guiding sentinel lymph node biopsy using a handheld gamma counter in patients with clinically node negative squamous cell carcinoma of the oral cavity  breast cancer or melanoma,0
4444,4444,4444,4444,4444,4444,4444,5457,5457,5457,5457,5457,5457,5457,5457,5457,5457,5457,5457,5457,282f4099-e848-432a-bac1-e041c192a5ba,1  arcalyst ( rilonacept ) is an interleukin 1 blocker indicated for the treatment of cryopyrin associated periodic syndromes ( caps )  including familial cold auto inflammatory syndrome ( fcas ) and muckle wells syndrome ( mws ) in adults and children 12 and older,0
4445,4445,4445,4445,4445,4445,4445,5458,5458,5458,5458,5458,5458,5458,5458,5458,5458,5458,5458,5458,282f4099-e848-432a-bac1-e041c192a5ba,arcalyst ( rilonacept ) is an interleukin 1 blocker indicated for the treatment of cryopyrin associated periodic syndromes ( caps )  including familial cold auto inflammatory syndrome ( fcas ) and muckle wells syndrome ( mws ) in adults and children 12 and older,0
4446,4446,4446,4446,4446,4446,4446,5459,5459,5459,5459,5459,5459,5459,5459,5459,5459,5459,5459,5459,8396ea96-7cb5-4e26-87a4-90bca9c3c6dd,1  amphadase is indicated as an adjuvant in subcutaneous fluid administration for achieving hydration ( 1 1 ) to increase absorption and dispersion of other injected drugs ( 1 2 ) in subcutaneous urography for improving resorption of radiopaque agents ( 1 3 ) 1 1 subcutaneous fluid administration amphadase is indicated as an adjuvant in subcutaneous fluid administration for achieving hydration,0
4447,4447,4447,4447,4447,4447,4447,5460,5460,5460,5460,5460,5460,5460,5460,5460,5460,5460,5460,5460,8396ea96-7cb5-4e26-87a4-90bca9c3c6dd,1 2 dispersion and absorption of injected drugs amphadase is indicated as an adjuvant to increase the dispersion and absorption of other injected drugs,0
4448,4448,4448,4448,4448,4448,4448,5461,5461,5461,5461,5461,5461,5461,5461,5461,5461,5461,5461,5461,8396ea96-7cb5-4e26-87a4-90bca9c3c6dd,1 3 subcutaneous urography amphadase is indicated as an adjunct in subcutaneous urography for improving resorption of radiopaque agents,0
4449,4449,4449,4449,4449,4449,4449,5462,5462,5462,5462,5462,5462,5462,5462,5462,5462,5462,5462,5462,c0625060-29c7-4cda-b6f9-cfa15e59775e, enjuvia tablets are indicated in the treatment of moderate to severe vasomotor symptoms associated with menopause,0
4450,4450,4450,4450,4450,4450,4450,5463,5463,5463,5463,5463,5463,5463,5463,5463,5463,5463,5463,5463,c0625060-29c7-4cda-b6f9-cfa15e59775e,treatment of moderate to severe vaginal dryness and pain with intercourse  symptoms of vulvar and vaginal atrophy  associated with menopause,1
4451,4451,4451,4451,4451,4451,4451,5464,5464,5464,5464,5464,5464,5464,5464,5464,5464,5464,5464,5464,c0625060-29c7-4cda-b6f9-cfa15e59775e,when prescribing solely for the treatment of moderate to severe vaginal dryness and pain with intercourse  topical vaginal products should be considered,0
4452,4452,4452,4452,4452,4452,4452,5465,5465,5465,5465,5465,5465,5465,5465,5465,5465,5465,5465,5465,f45ef7b7-1ea3-4c99-a850-31305aabb55d, neut ( 4 sodium bicarbonate additive solution ) is indicated for use asa an additive to raise the ph of acid solutions administered intravenously to reduce the incidence of chemical phlebitis and patient discomfort due to vein irritation at or near the site of infusion,1
4453,4453,4453,4453,4453,4453,4453,5466,5466,5466,5466,5466,5466,5466,5466,5466,5466,5466,5466,5466,cc8ef530-dd8c-40f5-af7e-4622c9e01d52, duodenal ulcer zegerid with magnesium hydroxide is indicated for short term treatment of active duodenal ulcer,1
4454,4454,4454,4454,4454,4454,4454,5469,5469,5469,5469,5469,5469,5469,5469,5469,5469,5469,5469,5469,cc8ef530-dd8c-40f5-af7e-4622c9e01d52,gastric ulcer zegerid with magnesium hydroxide is indicated for short term treatment ( 4 8 weeks ) of active benign gastric ulcer,1
4455,4455,4455,4455,4455,4455,4455,5470,5470,5470,5470,5470,5470,5470,5470,5470,5470,5470,5470,5470,cc8ef530-dd8c-40f5-af7e-4622c9e01d52,( see clinical pharmacology  clinical studies  gastric ulcer ),0
4456,4456,4456,4456,4456,4456,4456,5471,5471,5471,5471,5471,5471,5471,5471,5471,5471,5471,5471,5471,cc8ef530-dd8c-40f5-af7e-4622c9e01d52,treatment of gastroesophageal reflux disease ( gerd ) symptomatic gerd zegerid with magnesium hydroxide is indicated for the treatment of heartburn and other symptoms associated with gerd,1
4457,4457,4457,4457,4457,4457,4457,5472,5472,5472,5472,5472,5472,5472,5472,5472,5472,5472,5472,5472,cc8ef530-dd8c-40f5-af7e-4622c9e01d52,erosive esophagitis zegerid with magnesium hydroxide is indicated for the short term treatment ( 4 8 weeks ) of erosive esophagitis which has been diagnosed by endoscopy,1
4458,4458,4458,4458,4458,4458,4458,5473,5473,5473,5473,5473,5473,5473,5473,5473,5473,5473,5473,5473,cc8ef530-dd8c-40f5-af7e-4622c9e01d52,( see clinical pharmacology  clinical studies ),0
4459,4459,4459,4459,4459,4459,4459,5474,5474,5474,5474,5474,5474,5474,5474,5474,5474,5474,5474,5474,cc8ef530-dd8c-40f5-af7e-4622c9e01d52,the efficacy of zegerid with magnesium hydroxide used for longer than 8 weeks in these patients has not been established,0
4460,4460,4460,4460,4460,4460,4460,5475,5475,5475,5475,5475,5475,5475,5475,5475,5475,5475,5475,5475,cc8ef530-dd8c-40f5-af7e-4622c9e01d52,in the rare instance of a patient not responding to 8 weeks of treatment  it may be helpful to give up to an additional 4 weeks of treatment,0
4461,4461,4461,4461,4461,4461,4461,5476,5476,5476,5476,5476,5476,5476,5476,5476,5476,5476,5476,5476,cc8ef530-dd8c-40f5-af7e-4622c9e01d52,if there is recurrence of erosive esophagitis or gerd symptoms ( eg  heartburn )  additional 4 8 week courses of omeprazole may be considered,0
4462,4462,4462,4462,4462,4462,4462,5477,5477,5477,5477,5477,5477,5477,5477,5477,5477,5477,5477,5477,cc8ef530-dd8c-40f5-af7e-4622c9e01d52,maintenance of healing of erosive esophagitis zegerid with magnesium hydroxide is indicated to maintain healing of erosive esophagitis,1
4463,4463,4463,4463,4463,4463,4463,5478,5478,5478,5478,5478,5478,5478,5478,5478,5478,5478,5478,5478,cc8ef530-dd8c-40f5-af7e-4622c9e01d52,controlled studies do not extend beyond 1,0
4464,4464,4464,4464,4464,4464,4464,5479,5479,5479,5479,5479,5479,5479,5479,5479,5479,5479,5479,5479,64fbc500-3b77-4c9c-8576-b3ec5f6655a5, eprosartan mesylate tablets are indicated for the treatment of hypertension,1
4465,4465,4465,4465,4465,4465,4465,5480,5480,5480,5480,5480,5480,5480,5480,5480,5480,5480,5480,5480,64fbc500-3b77-4c9c-8576-b3ec5f6655a5,they may be used alone or in combination with other antihypertensives such as diuretics and calcium channel blockers,4
4466,4466,4466,4466,4466,4466,4466,5481,5481,5481,5481,5481,5481,5481,5481,5481,5481,5481,5481,5481,369e6911-66bd-4544-9901-cf887fdf1dc2,1  cyclophosphamide is an alkylating drug indicated for treatment of malignant diseases malignant lymphomas hodgkin s disease  lymphocytic lymphoma  mixed cell type lymphoma  histiocytic lymphoma  burkitt s lymphoma multiple myeloma  leukemias  mycosis fungoides  neuroblastoma  adenocarcinoma of ovary  retinoblastoma  breast carcinoma ( 1 1 ) minimal change nephrotic syndrome in pediatric patients biopsy proven minimal change nephrotic syndrome patients who failed to adequately respond to or are unable to tolerate adrenocorticosteroid therapy ( 1 2 ) limitations of use the safety and effectiveness for the treatment of nephrotic syndrome in adults or other renal disease has not been established,1
4467,4467,4467,4467,4467,4467,4467,5482,5482,5482,5482,5482,5482,5482,5482,5482,5482,5482,5482,5482,369e6911-66bd-4544-9901-cf887fdf1dc2,1 1 malignant diseases cyclophosphamide is indicated for the treatment of malignant lymphomas ( stages iii and iv of the ann arbor staging system )  hodgkin s disease  lymphocytic lymphoma ( nodular or diffuse )  mixed cell type lymphoma  histiocytic lymphoma  burkitt s lymphoma multiple myeloma leukemias chronic lymphocytic leukemia  chronic granulocytic leukemia ( it is usually ineffective in acute blastic crisis )  acute myelogenous and monocytic leukemia  acute lymphoblastic ( stem cell ) leukemia ( cyclophosphamide given during remission is effective in prolonging its duration ) mycosis fungoides ( advanced disease ) neuroblastoma ( disseminated disease ) adenocarcinoma of the ovary retinoblastoma carcinoma of the breast cyclophosphamide  although effective alone in susceptible malignancies  is more frequently used concurrently or sequentially with other antineoplastic drugs,1
4468,4468,4468,4468,4468,4468,4468,5483,5483,5483,5483,5483,5483,5483,5483,5483,5483,5483,5483,5483,369e6911-66bd-4544-9901-cf887fdf1dc2,1 2 minimal change nephrotic syndrome in pediatric patients cyclophosphamide is indicated for the,u
4469,4469,4469,4469,4469,4469,4469,5484,5484,5484,5484,5484,5484,5484,5484,5484,5484,5484,5484,5484,290c3e9c-c0c6-440a-1a9c-46e3e2b07a77, endrate ( edetate disodium injection  usp ) is indicated in selected patients for the emergency treatment of hypercalcemia and for the control of ventricular arrhythmias associated with digitalis toxicity,1
4470,4470,4470,4470,4470,4470,4470,5485,5485,5485,5485,5485,5485,5485,5485,5485,5485,5485,5485,5485,5017a927-2a24-4f27-89f9-27c805bf7d59,1  lovenox is a low molecular weight heparin ( lmwh ) indicated for prophylaxis of deep vein thrombosis ( dvt ) in abdominal surgery  hip replacement surgery  knee replacement surgery  or medical patients with severely restricted mobility during acute illness ( 1 1 ) inpatient treatment of acute dvt with or without pulmonary embolism ( 1 2 ) outpatient treatment of acute dvt without pulmonary embolism ( 1 2 ) prophylaxis of ischemic complications of unstable angina and non q wave myocardial infarction ( mi ) ( 1 3 ) treatment of acute st segment elevation myocardial infarction ( stemi ) managed medically or with subsequent percutaneous coronary intervention ( pci ) ( 1 4 ) 1 1 prophylaxis of deep vein thrombosis lovenox is indicated for the prophylaxis of deep vein thrombosis ( dvt )  which may lead to pulmonary embolism ( pe ) in patients undergoing abdominal surgery who are at risk for thromboembolic complications see clinical studies ( 14 1 ) in patients undergoing hip replacement surgery  during and following hospitalization in patients undergoing knee replacement surgery in medical patients who are at risk for thromboembolic complications due to severely restricted mobility during acute illness 1 2 treatment of acute deep vein thrombosis lovenox is indicated for the inpatient treatment of acute deep vein thrombosis with or without pulmonary embolism  when administered in conjunction with warfarin sodium the outpatient treatment of acute deep vein thrombosis without pulmonary embolism when administered in conjunction with warfarin sodium 1 3 prophylaxis of ischemic complications of unstable angina and non q wave myocardial infarction lovenox is indicated for the prophylaxis of ischemic complications of unstable angina and non q wave myocardial infarction  whe,1
4471,4471,4471,4471,4471,4471,4471,5486,5486,5486,5486,5486,5486,5486,5486,5486,5486,5486,5486,5486,d262661c-860d-482e-aa8d-3cf1f252b32a, natacyn ( natamycin ophthalmic suspension ) 5 is indicated for the treatment of fungal blepharitis  conjunctivitis  and keratitis caused by susceptible organisms including fusarium solani keratitis,1
4472,4472,4472,4472,4472,4472,4472,5487,5487,5487,5487,5487,5487,5487,5487,5487,5487,5487,5487,5487,d262661c-860d-482e-aa8d-3cf1f252b32a,as in other forms of suppurative keratitis  initial and sustained therapy of fungal keratitis should be determined by the clinical diagnosis  laboratory diagnosis by smear and culture of corneal scrapings and drug response,
4473,4473,4473,4473,4473,4473,4473,5488,5488,5488,5488,5488,5488,5488,5488,5488,5488,5488,5488,5488,d262661c-860d-482e-aa8d-3cf1f252b32a,whenever possible the in vitro activity of natamycin against the responsible fungus should be determined,0
4474,4474,4474,4474,4474,4474,4474,5489,5489,5489,5489,5489,5489,5489,5489,5489,5489,5489,5489,5489,d262661c-860d-482e-aa8d-3cf1f252b32a,the effectiveness of natamycin as a single agent in fungal endophthalmitis has not been established,0
4475,4475,4475,4475,4475,4475,4475,5490,5490,5490,5490,5490,5490,5490,5490,5490,5490,5490,5490,5490,24a4243f-0855-44c1-bb78-ba6f14b273f9, terazosin capsules are indicated for the treatment of symptomatic benign prostatic hyperplasia ( bph ),1
4476,4476,4476,4476,4476,4476,4476,5491,5491,5491,5491,5491,5491,5491,5491,5491,5491,5491,5491,5491,24a4243f-0855-44c1-bb78-ba6f14b273f9,there is a rapid response  with approximately 70 of patients experiencing an increase in urinary flow and improvement in symptoms of bph when treated with terazosin capsules,0
4477,4477,4477,4477,4477,4477,4477,5492,5492,5492,5492,5492,5492,5492,5492,5492,5492,5492,5492,5492,24a4243f-0855-44c1-bb78-ba6f14b273f9,the long term effects of terazosin capsules on the incidence of surgery  acute urinary obstruction or other complications of bph are yet to be determined,0
4478,4478,4478,4478,4478,4478,4478,5493,5493,5493,5493,5493,5493,5493,5493,5493,5493,5493,5493,5493,24a4243f-0855-44c1-bb78-ba6f14b273f9,terazosin capsules are also indicated for the treatment of hypertension,1
4479,4479,4479,4479,4479,4479,4479,5494,5494,5494,5494,5494,5494,5494,5494,5494,5494,5494,5494,5494,24a4243f-0855-44c1-bb78-ba6f14b273f9,it can be used alone or in combination with other antihypertensive agents such as diuretics or beta adrenergic blocking agents,4
4480,4480,4480,4480,4480,4480,4480,5495,5495,5495,5495,5495,5495,5495,5495,5495,5495,5495,5495,5495,64efe12a-cc43-47e6-b3dc-21dab6ddae06,1  sumatriptan nasal spray  usp is indicated for the acute treatment of migraine with or without aura in adults,1
4481,4481,4481,4481,4481,4481,4481,5496,5496,5496,5496,5496,5496,5496,5496,5496,5496,5496,5496,5496,64efe12a-cc43-47e6-b3dc-21dab6ddae06,limitations of use use only if a clear diagnosis of migraine headache has been established,u
4482,4482,4482,4482,4482,4482,4482,5497,5497,5497,5497,5497,5497,5497,5497,5497,5497,5497,5497,5497,64efe12a-cc43-47e6-b3dc-21dab6ddae06,if a patient has no response to the first migraine attack treated with sumatriptan nasal spray  usp  reconsider the diagnosis of migraine before sumatriptan nasal spray  usp is administered to treat any subsequent attacks,0
4483,4483,4483,4483,4483,4483,4483,5498,5498,5498,5498,5498,5498,5498,5498,5498,5498,5498,5498,5498,64efe12a-cc43-47e6-b3dc-21dab6ddae06,sumatriptan nasal spray  usp is not indicated for the prevention of migraine attacks,2
4484,4484,4484,4484,4484,4484,4484,5499,5499,5499,5499,5499,5499,5499,5499,5499,5499,5499,5499,5499,64efe12a-cc43-47e6-b3dc-21dab6ddae06,safety and effectiveness of sumatriptan nasal spray  usp have not been established for cluster headache,0
4485,4485,4485,4485,4485,4485,4485,5500,5500,5500,5500,5500,5500,5500,5500,5500,5500,5500,5500,5500,64efe12a-cc43-47e6-b3dc-21dab6ddae06,sumatriptan is a serotonin ( 5 ht1b 1d ) receptor agonist ( triptan ) indicated for acute treatment of migraine with or without aura in adults,1
4486,4486,4486,4486,4486,4486,4486,5501,5501,5501,5501,5501,5501,5501,5501,5501,5501,5501,5501,5501,64efe12a-cc43-47e6-b3dc-21dab6ddae06,( 1 ) limitations of use use only if a clear diagnosis of migraine headache has been established,2
4487,4487,4487,4487,4487,4487,4487,5504,5504,5504,5504,5504,5504,5504,5504,5504,5504,5504,5504,5504,be5b414e-d598-4721-80ee-5836156ad210, to reduce the development of drug resistant bacteria and maintain the effectiveness of gentamicin injection  usp and other antibacterial drugs  gentamicin injection  usp should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria,u
4488,4488,4488,4488,4488,4488,4488,5507,5507,5507,5507,5507,5507,5507,5507,5507,5507,5507,5507,5507,be5b414e-d598-4721-80ee-5836156ad210,gentamicin injection is indicated in the treatment of serious infections caused by susceptible strains of the following microorganisms pseudomonas aeruginosa  proteus species ( indole positive and indole negative )  escherichia coli  klebsiella enterobacter serratia species  citrobacter species  and staphylococcus species ( coagulase positive and coagulase negative ),1
4489,4489,4489,4489,4489,4489,4489,5508,5508,5508,5508,5508,5508,5508,5508,5508,5508,5508,5508,5508,be5b414e-d598-4721-80ee-5836156ad210,clinical studies have shown gentamicin injection to be effective in bacterial neonatal sepsis bacterial septicemia and serious bacterial infections of the central nervous system ( meningitis )  urinary tract  respiratory tract  gastrointestinal tract ( including peritonitis )  skin  bone and soft tissue ( including burns ),u
4490,4490,4490,4490,4490,4490,4490,5509,5509,5509,5509,5509,5509,5509,5509,5509,5509,5509,5509,5509,be5b414e-d598-4721-80ee-5836156ad210,aminoglycosides  including gentamicin  are not indicated in uncomplicated initial episodes of urinary tract infections unless the causative organisms are susceptible to these antibiotics and are not susceptible to antibiotics having less potential for toxicity,u
4491,4491,4491,4491,4491,4491,4491,5510,5510,5510,5510,5510,5510,5510,5510,5510,5510,5510,5510,5510,be5b414e-d598-4721-80ee-5836156ad210,specimens for bacterial culture should be obtained to isolate and identify causative organisms and to determine their susceptibility to gentamicin,0
4492,4492,4492,4492,4492,4492,4492,5511,5511,5511,5511,5511,5511,5511,5511,5511,5511,5511,5511,5511,be5b414e-d598-4721-80ee-5836156ad210,gentamicin may be considered as initial therapy in suspected or confirmed gram negative infections  and therapy may be instituted before obtaining results of susceptibility testing,u
4493,4493,4493,4493,4493,4493,4493,5512,5512,5512,5512,5512,5512,5512,5512,5512,5512,5512,5512,5512,be5b414e-d598-4721-80ee-5836156ad210,the decision to continue therapy with this drug should be based on the results of susceptibility tests  the severity of the infection  and the important additional concepts contained in the boxed warnings above,0
4494,4494,4494,4494,4494,4494,4494,5513,5513,5513,5513,5513,5513,5513,5513,5513,5513,5513,5513,5513,be5b414e-d598-4721-80ee-5836156ad210,if the causative organisms are resistant to gentamicin  other appropriate therapy should be instituted,0
4495,4495,4495,4495,4495,4495,4495,5514,5514,5514,5514,5514,5514,5514,5514,5514,5514,5514,5514,5514,be5b414e-d598-4721-80ee-5836156ad210,in serious infections when the causative organisms are unknown  gentamicin may be administered as initial therapy in conjunction with a penicillin type or cephalosporin type drug before obtaining results of susceptibility testing,1
4496,4496,4496,4496,4496,4496,4496,5515,5515,5515,5515,5515,5515,5515,5515,5515,5515,5515,5515,5515,be5b414e-d598-4721-80ee-5836156ad210,if anaerobic organisms are suspected as etiologic agents  consideration should be given to using other suitable antimicrobial therapy in conjunction with gentamicin,0
4497,4497,4497,4497,4497,4497,4497,5516,5516,5516,5516,5516,5516,5516,5516,5516,5516,5516,5516,5516,be5b414e-d598-4721-80ee-5836156ad210,following identification of the organism and its susceptibility  appropriate antibiotic therapy should then be continued,0
4498,4498,4498,4498,4498,4498,4498,5517,5517,5517,5517,5517,5517,5517,5517,5517,5517,5517,5517,5517,be5b414e-d598-4721-80ee-5836156ad210,gentamicin has been used effectively in combination with carbenicillin for the treatment of life threatening infections caused by pseudomonas aeruginosa,u
4499,4499,4499,4499,4499,4499,4499,5518,5518,5518,5518,5518,5518,5518,5518,5518,5518,5518,5518,5518,be5b414e-d598-4721-80ee-5836156ad210,it has also been found effective when used in conjunction wit,0
4500,4500,4500,4500,4500,4500,4500,5519,5519,5519,5519,5519,5519,5519,5519,5519,5519,5519,5519,5519,f28d7a56-e079-4a8b-ad81-9a97c780de67, intraocular use for obtaining miosis during surgery,1
4501,4501,4501,4501,4501,4501,4501,5520,5520,5520,5520,5520,5520,5520,5520,5520,5520,5520,5520,5520,f28d7a56-e079-4a8b-ad81-9a97c780de67,in addition  miostat ( carbachol intraocular solution  usp ) reduces the intensity of intraocular pressure elevation in the first 24 hours after cataract surgery,u
4502,4502,4502,4502,4502,4502,4502,5521,5521,5521,5521,5521,5521,5521,5521,5521,5521,5521,5521,5521,ba4a725e-ba46-427c-b309-a5ddc3c881ab, administration of sodium iodide i 123 is indicated as a diagnostic procedure to be used in evaluating thyroid function and or morphology,1
4503,4503,4503,4503,4503,4503,4503,5522,5522,5522,5522,5522,5522,5522,5522,5522,5522,5522,5522,5522,b7c0a768-7e8a-40b9-876f-b86d3dc5e848, a dental caries preventive  for once daily self applied topical use,1
4504,4504,4504,4504,4504,4504,4504,5523,5523,5523,5523,5523,5523,5523,5523,5523,5523,5523,5523,5523,b7c0a768-7e8a-40b9-876f-b86d3dc5e848,it is well established that 1 1 sodium fluoride is safe and extraordinarily effective as a caries preventive when applied frequently with mouthpiece applicators 1 4 sf 1 1 brush on gel in a squeeze tube is easily applied onto a toothbrush as well as a mouthpiece tray,0
4505,4505,4505,4505,4505,4505,4505,5524,5524,5524,5524,5524,5524,5524,5524,5524,5524,5524,5524,5524,b7c0a768-7e8a-40b9-876f-b86d3dc5e848,this prescription dental gel should be used once daily following use of a regular toothpaste unless otherwise instructed by your dental professional,4
4506,4506,4506,4506,4506,4506,4506,5525,5525,5525,5525,5525,5525,5525,5525,5525,5525,5525,5525,5525,b7c0a768-7e8a-40b9-876f-b86d3dc5e848,may be used whether or not drinking water is fluoridated since topical fluoride cannot produce fluorosis,0
4507,4507,4507,4507,4507,4507,4507,5526,5526,5526,5526,5526,5526,5526,5526,5526,5526,5526,5526,5526,601774d5-f4de-01bc-e053-2991aa0a7f4f,1  fluoridex toothpaste is indicated for use as part of a professional program for the prevention and control of dental caries,1
4508,4508,4508,4508,4508,4508,4508,5527,5527,5527,5527,5527,5527,5527,5527,5527,5527,5527,5527,5527,d9d74915-6606-4570-9c52-c4001d3177de,1  kineret is an interleukin 1 receptor antagonist indicated for rheumatoid arthritis ( ra ) reduction in signs and symptoms and slowing the progression of structural damage in moderately to severely active rheumatoid arthritis  in patients 18 years of age or older who have failed 1 or more disease modifying antirheumatic drugs ( dmards ) ( 1 1 ) cryopyrin associated periodic syndromes ( caps ) treatment of neonatal onset multisystem inflammatory disease ( nomid ) ( 1 2 ) 1 1 active rheumatoid arthritis kineret is indicated for the reduction in signs and symptoms and slowing the progression of structural damage in moderately to severely active rheumatoid arthritis ( ra )  in patients 18 years of age or older who have failed 1 or more disease modifying antirheumatic drugs ( dmards ),1
4509,4509,4509,4509,4509,4509,4509,5528,5528,5528,5528,5528,5528,5528,5528,5528,5528,5528,5528,5528,d9d74915-6606-4570-9c52-c4001d3177de,kineret can be used alone or in combination with dmards other than tumor necrosis factor ( tnf ) blocking agents see warnings and precautions ( 5 2 ),4
4510,4510,4510,4510,4510,4510,4510,5529,5529,5529,5529,5529,5529,5529,5529,5529,5529,5529,5529,5529,d9d74915-6606-4570-9c52-c4001d3177de,1 2 cryopyrin associated periodic syndromes ( caps ) kineret is indicated for the treatment of neonatal onset multisystem inflammatory disease ( nomid ),1
4511,4511,4511,4511,4511,4511,4511,5530,5530,5530,5530,5530,5530,5530,5530,5530,5530,5530,5530,5530,9de82310-70e8-47b9-b1fc-6c6848b99455,1  rozerem is indicated for the treatment of insomnia characterized by difficulty with sleep onset,1
4512,4512,4512,4512,4512,4512,4512,5531,5531,5531,5531,5531,5531,5531,5531,5531,5531,5531,5531,5531,9de82310-70e8-47b9-b1fc-6c6848b99455,the clinical trials performed in support of efficacy were up to 6 months in duration,0
4513,4513,4513,4513,4513,4513,4513,5532,5532,5532,5532,5532,5532,5532,5532,5532,5532,5532,5532,5532,9de82310-70e8-47b9-b1fc-6c6848b99455,the final formal assessments of sleep latency were performed after 2 days of treatment during the crossover study ( elderly only )  at 5 weeks in the 6 week studies ( adults and elderly )  and at the end of the 6 month study ( adults and elderly ) see clinical studies ( 14 ),0
4514,4514,4514,4514,4514,4514,4514,5533,5533,5533,5533,5533,5533,5533,5533,5533,5533,5533,5533,5533,9de82310-70e8-47b9-b1fc-6c6848b99455,rozerem is indicated for the treatment of insomnia characterized by difficulty with sleep onset,1
4515,4515,4515,4515,4515,4515,4515,5534,5534,5534,5534,5534,5534,5534,5534,5534,5534,5534,5534,5534,510ceafd-8254-428c-b2ff-a167f283cda7, duloxetine delayed release capsules  usp are a serotonin and norepinephrine reuptake inhibitor ( snri ) indicated for major depressive disorder ( mdd ) ( 1 1 ) generalized anxiety disorder ( gad ) ( 1 2 ) diabetic peripheral neuropathic pain ( dpnp ) ( 1 3 ) chronic musculoskeletal pain ( 1 5 ) 1 1 major depressive disorder duloxetine delayed release capsules  usp are indicated for the treatment of major depressive disorder ( mdd ),1
4516,4516,4516,4516,4516,4516,4516,5535,5535,5535,5535,5535,5535,5535,5535,5535,5535,5535,5535,5535,510ceafd-8254-428c-b2ff-a167f283cda7,the efficacy of duloxetine delayed release capsules  usp was established in four short term and one maintenance trial in adults see clinical studies ( 14 1 ),0
4517,4517,4517,4517,4517,4517,4517,5536,5536,5536,5536,5536,5536,5536,5536,5536,5536,5536,5536,5536,510ceafd-8254-428c-b2ff-a167f283cda7,a major depressive episode ( dsm iv ) implies a prominent and relatively persistent ( nearly every day for at least 2 weeks ) depressed or dysphoric mood that usually interferes with daily functioning  and includes at least 5 of the following 9 symptoms depressed mood  loss of interest in usual activities  significant change in weight and or appetite  insomnia or hypersomnia  psychomotor agitation or retardation  increased fatigue  feelings of guilt or worthlessness  slowed thinking or impaired concentration  or a suicide attempt or suicidal ideation,0
4518,4518,4518,4518,4518,4518,4518,5537,5537,5537,5537,5537,5537,5537,5537,5537,5537,5537,5537,5537,510ceafd-8254-428c-b2ff-a167f283cda7,1 2 generalized anxiety disorder duloxetine delayed release capsules  usp are indicated for the treatment of generalized anxiety disorder ( gad ),1
4519,4519,4519,4519,4519,4519,4519,5538,5538,5538,5538,5538,5538,5538,5538,5538,5538,5538,5538,5538,510ceafd-8254-428c-b2ff-a167f283cda7,the efficacy of duloxetine delayed release capsules  usp was established in three short term trials and one maintenance trial in adults see clinical studies ( 14 2 ),0
4520,4520,4520,4520,4520,4520,4520,5539,5539,5539,5539,5539,5539,5539,5539,5539,5539,5539,5539,5539,510ceafd-8254-428c-b2ff-a167f283cda7,generalized anxiety disorder is defined by the dsm iv as excessive anxiety and worry  present more days than not  for at least 6 months,0
4521,4521,4521,4521,4521,4521,4521,5540,5540,5540,5540,5540,5540,5540,5540,5540,5540,5540,5540,5540,510ceafd-8254-428c-b2ff-a167f283cda7,the excessive anxiety and worry must be difficult to control and must cause significant distress or impairment in normal functioning,0
4522,4522,4522,4522,4522,4522,4522,5541,5541,5541,5541,5541,5541,5541,5541,5541,5541,5541,5541,5541,510ceafd-8254-428c-b2ff-a167f283cda7,it must be associated with at least 3 of the following 6 symptoms restlessness or feeling keyed up or on edge  being easily fatigued  difficulty concentrating or mind going blank  irritability  muscle tension  and or sleep disturbance,0
4523,4523,4523,4523,4523,4523,4523,5542,5542,5542,5542,5542,5542,5542,5542,5542,5542,5542,5542,5542,510ceafd-8254-428c-b2ff-a167f283cda7,1 3 diabetic peripheral neuropathic pain duloxetine delayed release capsules  usp are indicated for the management of neuropathic pain ( dpnp ) associated with diabetic peripheral neuropathy see clinical studies ( 14 3 ),1
4524,4524,4524,4524,4524,4524,4524,5543,5543,5543,5543,5543,5543,5543,5543,5543,5543,5543,5543,5543,b19b03db-471d-4ee7-b1b8-6eccc39c41b0, thiotepa for injection  usp has been tried with varying results in the palliation of a wide variety of neoplastic diseases,0
4525,4525,4525,4525,4525,4525,4525,5544,5544,5544,5544,5544,5544,5544,5544,5544,5544,5544,5544,5544,b19b03db-471d-4ee7-b1b8-6eccc39c41b0,however  the most consistent results have been seen in the following tumors 1 adenocarcinoma of the breast,1
4526,4526,4526,4526,4526,4526,4526,5545,5545,5545,5545,5545,5545,5545,5545,5545,5545,5545,5545,5545,b19b03db-471d-4ee7-b1b8-6eccc39c41b0,3 for controlling intracavitary effusions secondary to diffuse or localized neoplastic diseases of various serosal cavities,1
4527,4527,4527,4527,4527,4527,4527,5546,5546,5546,5546,5546,5546,5546,5546,5546,5546,5546,5546,5546,b19b03db-471d-4ee7-b1b8-6eccc39c41b0,4 for the treatment of superficial papillary carcinoma of the urinary bladder,1
4528,4528,4528,4528,4528,4528,4528,5547,5547,5547,5547,5547,5547,5547,5547,5547,5547,5547,5547,5547,b19b03db-471d-4ee7-b1b8-6eccc39c41b0,while now largely superseded by other treatments  thiotepa has been effective against other lymphomas  such as lymphosarcoma and hodgkin 's disease,u
4529,4529,4529,4529,4529,4529,4529,5548,5548,5548,5548,5548,5548,5548,5548,5548,5548,5548,5548,5548,28546bff-d242-48a4-9e01-232687e6027a, for temporary relief of symptoms associated with chronic fatigue syndrome  fibromyalgia and lyme disease,1
4530,4530,4530,4530,4530,4530,4530,5549,5549,5549,5549,5549,5549,5549,5549,5549,5549,5549,5549,5549,f41380e7-b830-432d-a5f5-a872932f107e,1  triptodur is indicated for the treatment of pediatric patients 2 years of age and older with central precocious puberty ( cpp ),1
4531,4531,4531,4531,4531,4531,4531,5550,5550,5550,5550,5550,5550,5550,5550,5550,5550,5550,5550,5550,f41380e7-b830-432d-a5f5-a872932f107e,triptodur is a gonadotropin releasing hormone ( gnrh ) agonist indicated for the treatment of pediatric patients 2 years and older with central precocious puberty,1
4532,4532,4532,4532,4532,4532,4532,5551,5551,5551,5551,5551,5551,5551,5551,5551,5551,5551,5551,5551,fefb887c-e4ac-431e-8893-e9d1a5a63fea,1  nucala is an interleukin 5 antagonist monoclonal antibody ( igg1 kappa ) indicated for add on maintenance treatment of patients with severe asthma aged 12 years and older  and with an eosinophilic phenotype,1
4533,4533,4533,4533,4533,4533,4533,5552,5552,5552,5552,5552,5552,5552,5552,5552,5552,5552,5552,5552,fefb887c-e4ac-431e-8893-e9d1a5a63fea,( 1 1 ) the treatment of adult patients with eosinophilic granulomatosis with polyangiitis ( egpa ),1
4534,4534,4534,4534,4534,4534,4534,5553,5553,5553,5553,5553,5553,5553,5553,5553,5553,5553,5553,5553,fefb887c-e4ac-431e-8893-e9d1a5a63fea,( 1 2 ) limitation of use not for relief of acute bronchospasm or status asthmaticus,2
4535,4535,4535,4535,4535,4535,4535,5554,5554,5554,5554,5554,5554,5554,5554,5554,5554,5554,5554,5554,fefb887c-e4ac-431e-8893-e9d1a5a63fea,( 1 1 ) 1 1 maintenance treatment of severe asthma nucala is indicated for the add on maintenance treatment of patients with severe asthma aged 12 years and older  and with an eosinophilic phenotype see clinical studies ( 14 1 ),1
4536,4536,4536,4536,4536,4536,4536,5555,5555,5555,5555,5555,5555,5555,5555,5555,5555,5555,5555,5555,fefb887c-e4ac-431e-8893-e9d1a5a63fea,limitation of use nucala is not indicated for the relief of acute bronchospasm or status asthmaticus,2
4537,4537,4537,4537,4537,4537,4537,5556,5556,5556,5556,5556,5556,5556,5556,5556,5556,5556,5556,5556,fefb887c-e4ac-431e-8893-e9d1a5a63fea,1 2 eosinophilic granulomatosis with polyangiitis nucala is indicated for the treatment of adult patients with eosinophilic granulomatosis with polyangiitis ( egpa ),1
4538,4538,4538,4538,4538,4538,4538,5557,5557,5557,5557,5557,5557,5557,5557,5557,5557,5557,5557,5557,f0ba651e-3d8a-11df-8fbe-119855d89593, elmiron ( pentosan polysulfate sodium ) is indicated for the relief of bladder pain or discomfort associated with interstitial cystitis,1
4539,4539,4539,4539,4539,4539,4539,5558,5558,5558,5558,5558,5558,5558,5558,5558,5558,5558,5558,5558,9e260a47-55af-4c92-8d88-a86ccc767fff,1  simponi aria is a tumor necrosis factor ( tnf ) blocker indicated for the treatment of adult patients with moderately to severely active rheumatoid arthritis ( ra ) in combination with methotrexate ( 1 1 ) active psoriatic arthritis ( psa ) ( 1 2 ) active ankylosing spondylitis ( as ) ( 1 3 ) 1 1 rheumatoid arthritis ( ra ) simponi aria  in combination with methotrexate ( mtx )  is indicated for the treatment of adult patients with moderately to severely active rheumatoid arthritis,1
4540,4540,4540,4540,4540,4540,4540,5559,5559,5559,5559,5559,5559,5559,5559,5559,5559,5559,5559,5559,9e260a47-55af-4c92-8d88-a86ccc767fff,1 2 psoriatic arthritis ( psa ) simponi aria is indicated for the treatment of adult patients with active psoriatic arthritis,1
4541,4541,4541,4541,4541,4541,4541,5560,5560,5560,5560,5560,5560,5560,5560,5560,5560,5560,5560,5560,9e260a47-55af-4c92-8d88-a86ccc767fff,1 3 ankylosing spondylitis ( as ) simponi aria is indicated for the treatment of adult patients with active ankylosing spondylitis,1
4542,4542,4542,4542,4542,4542,4542,5561,5561,5561,5561,5561,5561,5561,5561,5561,5561,5561,5561,5561,42b4b9c2-24d7-439b-a90a-f1fcba0a1948, chlordiazepoxide hydrochloride clidinium bromide is indicated to control the emotional and somatic factors in gastrointestinal disorders,1
4543,4543,4543,4543,4543,4543,4543,5562,5562,5562,5562,5562,5562,5562,5562,5562,5562,5562,5562,5562,42b4b9c2-24d7-439b-a90a-f1fcba0a1948,chlordiazepoxide hydrochloride clidinium bromide may also be used as adjunctive therapy in the treatment of peptic ulcer and in the treatment of irritable bowel syndrome ( irritable colon  spastic colon  mucous colitis ) and acute enterocolitis,1
4544,4544,4544,4544,4544,4544,4544,5563,5563,5563,5563,5563,5563,5563,5563,5563,5563,5563,5563,5563,37241e87-4af4-4dc3-a1aa-ea6f20d8dc40, renal  cardiac  and hepatic transplant cellcept is indicated for the prophylaxis of organ rejection in patients receiving allogeneic renal  cardiac or hepatic transplants,1
4545,4545,4545,4545,4545,4545,4545,5564,5564,5564,5564,5564,5564,5564,5564,5564,5564,5564,5564,5564,37241e87-4af4-4dc3-a1aa-ea6f20d8dc40,cellcept should be used concomitantly with cyclosporine and corticosteroids,4
4546,4546,4546,4546,4546,4546,4546,5565,5565,5565,5565,5565,5565,5565,5565,5565,5565,5565,5565,5565,37241e87-4af4-4dc3-a1aa-ea6f20d8dc40,cellcept intravenous is an alternative dosage form to cellcept capsules  tablets and oral suspension,0
4547,4547,4547,4547,4547,4547,4547,5566,5566,5566,5566,5566,5566,5566,5566,5566,5566,5566,5566,5566,37241e87-4af4-4dc3-a1aa-ea6f20d8dc40,cellcept intravenous should be administered within 24 hours following transplantation,4
4548,4548,4548,4548,4548,4548,4548,5567,5567,5567,5567,5567,5567,5567,5567,5567,5567,5567,5567,5567,37241e87-4af4-4dc3-a1aa-ea6f20d8dc40,cellcept intravenous can be administered for up to 14 days patients should be switched to oral cellcept as soon as they can tolerate oral medication,4
4549,4549,4549,4549,4549,4549,4549,5568,5568,5568,5568,5568,5568,5568,5568,5568,5568,5568,5568,5568,05f25774-f56a-48ef-bac3-8af663f8581a, nitrofurantoin capsules  usp ( macrocrystals ) is specifically indicated for the treatment of urinary tract infections when due to susceptible strains of escherichia coli  enterococci  staphylococcus aureus  and certain susceptible strains of klebsiella and enterobacter species,1
4550,4550,4550,4550,4550,4550,4550,5569,5569,5569,5569,5569,5569,5569,5569,5569,5569,5569,5569,5569,05f25774-f56a-48ef-bac3-8af663f8581a,nitrofurantoin is not indicated for the treatment of pyelonephritis or perinephric abscesses,2
4551,4551,4551,4551,4551,4551,4551,5570,5570,5570,5570,5570,5570,5570,5570,5570,5570,5570,5570,5570,05f25774-f56a-48ef-bac3-8af663f8581a,to reduce the development of drug resistant bacteria and maintain the effectiveness of nitrofurantoin capsules  usp ( macrocrystals ) and other antibacterial drugs  nitrofurantoin capsules  usp ( macrocrystals ) should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria,4
4552,4552,4552,4552,4552,4552,4552,5573,5573,5573,5573,5573,5573,5573,5573,5573,5573,5573,5573,5573,05f25774-f56a-48ef-bac3-8af663f8581a,nitrofurantoins lack the broader tissue distribution of other therapeutic agents approved for urinary tract infections,0
4553,4553,4553,4553,4553,4553,4553,5574,5574,5574,5574,5574,5574,5574,5574,5574,5574,5574,5574,5574,05f25774-f56a-48ef-bac3-8af663f8581a,consequently  many patients who are treated with nitrofurantoin capsules  usp ( macrocrystals ) are predisposed to persistence or reappearance of bacteriuria,0
4554,4554,4554,4554,4554,4554,4554,5575,5575,5575,5575,5575,5575,5575,5575,5575,5575,5575,5575,5575,05f25774-f56a-48ef-bac3-8af663f8581a,urine specimens for culture and susceptibility testing should be obtained before and after completion of therapy,0
4555,4555,4555,4555,4555,4555,4555,5576,5576,5576,5576,5576,5576,5576,5576,5576,5576,5576,5576,5576,05f25774-f56a-48ef-bac3-8af663f8581a,if persistence or reappearance of bacteriuria occurs after treatment with nitrofurantoin capsules  usp ( macrocrystals )  other therapeutic agents with broader tissue distribution should be selected,0
4556,4556,4556,4556,4556,4556,4556,5577,5577,5577,5577,5577,5577,5577,5577,5577,5577,5577,5577,5577,05f25774-f56a-48ef-bac3-8af663f8581a,in considering the use of nitrofurantoin capsules  usp ( macrocrystals )  lower eradication rates should be balanced against the increased potential for systemic toxicity and for the development of antimicrobial resistance when agents with broader tissue distribution are utilized,0
4557,4557,4557,4557,4557,4557,4557,5578,5578,5578,5578,5578,5578,5578,5578,5578,5578,5578,5578,5578,babdbce2-5cbd-4943-bc38-9ebdd696a77a, herpes simplex infections in immunocompromised patients acyclovir for injection is indicated for the treatment of initial and recurrent mucosal and cutaneous herpes simplex ( hsv 1 and hsv 2 ) in immunocompromised patients,1
4558,4558,4558,4558,4558,4558,4558,5579,5579,5579,5579,5579,5579,5579,5579,5579,5579,5579,5579,5579,babdbce2-5cbd-4943-bc38-9ebdd696a77a,initial episodes of herpes genitalis acyclovir for injection is indicated for the treatment of severe initial clinical episodes of herpes genitalis in immunocompetent patients,1
4559,4559,4559,4559,4559,4559,4559,5580,5580,5580,5580,5580,5580,5580,5580,5580,5580,5580,5580,5580,babdbce2-5cbd-4943-bc38-9ebdd696a77a,herpes simplex encephalitis acyclovir for injection is indicated for the treatment of herpes simplex encephalitis,1
4560,4560,4560,4560,4560,4560,4560,5581,5581,5581,5581,5581,5581,5581,5581,5581,5581,5581,5581,5581,babdbce2-5cbd-4943-bc38-9ebdd696a77a,neonatal herpes simplex virus infection acyclovir for injection is indicated for the treatment of neonatal herpes infections,1
4561,4561,4561,4561,4561,4561,4561,5582,5582,5582,5582,5582,5582,5582,5582,5582,5582,5582,5582,5582,babdbce2-5cbd-4943-bc38-9ebdd696a77a,varicella zoster infections in immunocompromised patients acyclovir for injection is indicated for the treatment of varicella zoster ( shingles ) infections in immunocompromised patients,1
4562,4562,4562,4562,4562,4562,4562,5583,5583,5583,5583,5583,5583,5583,5583,5583,5583,5583,5583,5583,adb54fe50fcc4a01afc64aa3d3db45bb, fluxid is indicated in 1,u
4563,4563,4563,4563,4563,4563,4563,5593,5593,5593,5593,5593,5593,5593,5593,5593,5593,5593,5593,5593,adb54fe50fcc4a01afc64aa3d3db45bb,fluxid is indicated for short term treatment of patients with symptoms of gerd ( see clinical pharmacology in adults  clinical studies ),1
4564,4564,4564,4564,4564,4564,4564,5594,5594,5594,5594,5594,5594,5594,5594,5594,5594,5594,5594,5594,adb54fe50fcc4a01afc64aa3d3db45bb,fluxid is also indicated for the short term treatment of esophagitis due to gerd including erosive or ulcerative disease diagnosed by endoscopy ( see clinical pharmacology in adults  clinical studies ),1
4565,4565,4565,4565,4565,4565,4565,5596,5596,5596,5596,5596,5596,5596,5596,5596,5596,5596,5596,5596,"Active Ingredient UNII(s)
92RU3N3Y1O; 98PI200987    57c4672d-37b1-4af3-a9fc-d8390016338d
92RU3N3Y1O; 98PI200987    57c4672d-37b1-4af3-a9fc-d8390016338d
Name: SET ID dtype: object",active ingredient unii ( s ) 92ru3n3y1o 98pi200987 active ingredient unii ( s ) 92ru3n3y1o 98pi2009 92ru3n3y1o 98pi200987 active ingredient unii ( s ) 92ru3n3y1o 98pi2009 name content xml  dtype object,0
4566,4566,4566,4566,4566,4566,4566,5598,5598,5598,5598,5598,5598,5598,5598,5598,5598,5598,5598,5598,"Active Ingredient UNII(s)
92RU3N3Y1O; D0GX863OA5; MOR84MUD8E    689e372f-af18-4caa-a167-9e5bdbd4df69
92RU3N3Y1O; D0GX863OA5; MOR84MUD8E    689e372f-af18-4caa-a167-9e5bdbd4df69
92RU3N3Y1O; D0GX863OA5; MOR84MUD8E    689e372f-af18-4caa-a167-9e5bdbd4df69
Name: SET ID dtype: object",active ingredient unii ( s ) 92ru3n3y1o d0gx863oa5 mor84mud8e active ingredient unii ( s ) 92ru3n3y1o d0gx863o 92ru3n3y1o d0gx863oa5 mor84mud8e active ingredient unii ( s ) 92ru3n3y1o d0gx863o 92ru3n3y1o d0gx863oa5 mor84mud8e active ingredient unii ( s ) 92ru3n3y1o d0gx863o name content xml  dtype object,0
4567,4567,4567,4567,4567,4567,4567,5601,5601,5601,5601,5601,5601,5601,5601,5601,5601,5601,5601,5601,"Active Ingredient UNII(s)
92RU3N3Y1O; MOR84MUD8E    2687330c-50dc-0339-e054-00144ff88e88
92RU3N3Y1O; MOR84MUD8E    2687330c-50dc-0339-e054-00144ff88e88
Name: SET ID dtype: object",active ingredient unii ( s ) 92ru3n3y1o mor84mud8e active ingredient unii ( s ) 92ru3n3y1o mor84mud 92ru3n3y1o mor84mud8e active ingredient unii ( s ) 92ru3n3y1o mor84mud name content xml  dtype object,0
4568,4568,4568,4568,4568,4568,4568,5603,5603,5603,5603,5603,5603,5603,5603,5603,5603,5603,5603,5603,726bb436-69e3-452f-9f28-153b58bf3ca5, folic acid  usp is effective in the treatment of megaloblastic anemias due to a deficiency of folic acid  usp ( as may be seen in tropical or nontropical sprue ) and in anemias of nutritional origin  pregnancy  infancy  or childhood,1
4569,4569,4569,4569,4569,4569,4569,5604,5604,5604,5604,5604,5604,5604,5604,5604,5604,5604,5604,5604,4f1ed114-b401-4d47-836e-4f0d61e336bc,indications and dosage purefolix is indicated for dietary management of patients with unique nutritional needs requiring increased folate levels and vitamin d supplementation,1
4570,4570,4570,4570,4570,4570,4570,5605,5605,5605,5605,5605,5605,5605,5605,5605,5605,5605,5605,5605,4f1ed114-b401-4d47-836e-4f0d61e336bc,purefolix can be taken by women of childbearing age  pregnant women  and lactating and nonlactating mothers,0
4571,4571,4571,4571,4571,4571,4571,5606,5606,5606,5606,5606,5606,5606,5606,5606,5606,5606,5606,5606,743244ce-428a-4714-bada-42d92cc27b39, natelle one is indicated to provide vitamin mineral and dha omega 3 fatty acid supplementation to women throughout pregnancy  during the postnatal period for both lactating and non lactating mothers  and throughout the childbearing years,1
4572,4572,4572,4572,4572,4572,4572,5607,5607,5607,5607,5607,5607,5607,5607,5607,5607,5607,5607,5607,743244ce-428a-4714-bada-42d92cc27b39,natelle one may be beneficial in improving the nutritional status of women prior to conception,u
4573,4573,4573,4573,4573,4573,4573,5608,5608,5608,5608,5608,5608,5608,5608,5608,5608,5608,5608,5608,0be2918e-55b3-4c66-aba0-09099a1c7770, ferralet 90 is indicated for the treatment of all anemias that are responsive to oral iron therapy,1
4574,4574,4574,4574,4574,4574,4574,5609,5609,5609,5609,5609,5609,5609,5609,5609,5609,5609,5609,5609,0be2918e-55b3-4c66-aba0-09099a1c7770,these include hypochromic anemia associated with pregnancy  chronic and or acute blood loss  metabolic disease  postsurgical convalescence  and dietary needs,1
4575,4575,4575,4575,4575,4575,4575,5610,5610,5610,5610,5610,5610,5610,5610,5610,5610,5610,5610,5610,ed2308e3-5310-41bd-9333-615c26183493, myferon 150 forte is indicated for the prevention and treatment of iron deficiency anemia and or nutritional megaloblastic anemias,1
4576,4576,4576,4576,4576,4576,4576,5611,5611,5611,5611,5611,5611,5611,5611,5611,5611,5611,5611,5611,99121923-2b2d-427a-865a-e8b7dd052569, folbic tablets are indicated for the distrinct nutritional requirements of individuals under a physician 's supervision for hyperhomocysteinemia with particular emphasis for individuals with or at risk for atheroscierotic vascular disease in the coronary  peripheral  or cerebral vessels  or vitamin b12 dificiency,1
4577,4577,4577,4577,4577,4577,4577,5612,5612,5612,5612,5612,5612,5612,5612,5612,5612,5612,5612,5612,dfc69d93-0796-4ae5-888e-0f7d81f19b2e, for the treatment of all anemias responsive to oral iron therapy  such as hypochromic anemia associated with pregnancy  chronic or acute blood loss  dietary restriction  metabolic disease and post surgical convalescence,1
4578,4578,4578,4578,4578,4578,4578,5613,5613,5613,5613,5613,5613,5613,5613,5613,5613,5613,5613,5613,b129fdc9-1d8e-425c-a5a9-8a2ed36dfbdf,1  xtandi is indicated for the treatment of patients with metastatic castration resistant prostate cancer ( crpc ),1
4579,4579,4579,4579,4579,4579,4579,5614,5614,5614,5614,5614,5614,5614,5614,5614,5614,5614,5614,5614,b129fdc9-1d8e-425c-a5a9-8a2ed36dfbdf,xtandi is an androgen receptor inhibitor indicated for the treatment of patients with metastatic castration resistant prostate cancer,1
4580,4580,4580,4580,4580,4580,4580,5615,5615,5615,5615,5615,5615,5615,5615,5615,5615,5615,5615,5615,ebb3883c-71f6-4fd0-a7e6-0ba8e1136dd9,1  fluorescite injection 10 is indicated in diagnostic fluorescein angiography or angioscopy of the retina and iris vasculature,1
4581,4581,4581,4581,4581,4581,4581,5616,5616,5616,5616,5616,5616,5616,5616,5616,5616,5616,5616,5616,ebb3883c-71f6-4fd0-a7e6-0ba8e1136dd9,fluorescite injection 10 is indicated in diagnostic fluorescein angiography or angioscopy of the retina and iris vasculature,1
4582,4582,4582,4582,4582,4582,4582,5617,5617,5617,5617,5617,5617,5617,5617,5617,5617,5617,5617,5617,71a652d5-ba61-4f0e-8f62-1dc2b8d3b231,for procedures requiring a disclosing agent in combination with an anesthetic agent such as tonometry  gonioscopy  removal of corneal foreign bodies and other short corneal or conjunctival procedures,1
4583,4583,4583,4583,4583,4583,4583,5618,5618,5618,5618,5618,5618,5618,5618,5618,5618,5618,5618,5618,e9ea2ae7-1b98-4034-9fba-8ce2225e0145,1  azopt ( brinzolamide ophthalmic suspension ) 1 is a carbonic anhydrase inhibitor indicated in the treatment of elevated intraocular pressure in patients with ocular hypertension or open angle glaucoma,1
4584,4584,4584,4584,4584,4584,4584,5619,5619,5619,5619,5619,5619,5619,5619,5619,5619,5619,5619,5619,e9ea2ae7-1b98-4034-9fba-8ce2225e0145,azopt is a carbonic anhydrase inhibitor indicated for in the treatment of elevated intraocular pressure in patients with ocular hypertension or open angle glaucoma ( 1 ),1
4585,4585,4585,4585,4585,4585,4585,5620,5620,5620,5620,5620,5620,5620,5620,5620,5620,5620,5620,5620,96f19af4-de8f-4fd7-90d8-55fe6ebdd81d, carefully consider the potential benefits and risks of meclofenamate sodium capsules  usp and other treatment options before deciding to use meclofenamate sodium capsules,0
4586,4586,4586,4586,4586,4586,4586,5622,5622,5622,5622,5622,5622,5622,5622,5622,5622,5622,5622,5622,96f19af4-de8f-4fd7-90d8-55fe6ebdd81d,meclofenamate sodium capsules are indicated for reduction of fever in adults for relief of mild to moderate pain in adults for relief of signs and symptoms of juvenile arthritis,1
4587,4587,4587,4587,4587,4587,4587,5623,5623,5623,5623,5623,5623,5623,5623,5623,5623,5623,5623,5623,96f19af4-de8f-4fd7-90d8-55fe6ebdd81d,for relief of the signs and symptoms of rheumatoid arthritis for relief of the signs and symptoms of osteoarthritis,1
4588,4588,4588,4588,4588,4588,4588,5625,5625,5625,5625,5625,5625,5625,5625,5625,5625,5625,5625,5625,96f19af4-de8f-4fd7-90d8-55fe6ebdd81d,for acute or long term use in the relief of signs and symptoms of the following 1 ankylosing spondylitis 2 acute painful shoulder ( acute subacromial bursitis supraspinatus tendinitis ) 3 acute gouty arthritis meclofenamate sodium capsules are also indicated for the treatment of idiopathic heavy menstrual blood loss ( see clinical pharmacology and precautions ),1
4589,4589,4589,4589,4589,4589,4589,5626,5626,5626,5626,5626,5626,5626,5626,5626,5626,5626,5626,5626,96f19af4-de8f-4fd7-90d8-55fe6ebdd81d,as with all nonsteroidal anti inflammatory drugs  selection of meclofenamate sodium capsules require a careful assessment of the benefit risk ratio ( see warnings  precautions and adverse reactions ),0
4590,4590,4590,4590,4590,4590,4590,5627,5627,5627,5627,5627,5627,5627,5627,5627,5627,5627,5627,5627,96f19af4-de8f-4fd7-90d8-55fe6ebdd81d,meclofenamate sodium capsules are not recommended in children because adequate studies to demonstrate safety and efficacy have not been carried out,2
4591,4591,4591,4591,4591,4591,4591,5628,5628,5628,5628,5628,5628,5628,5628,5628,5628,5628,5628,5628,"Active Ingredient UNII(s)
94ZLA3W45F; E7199S1YWR    787c1115-61fa-41d1-a0b2-32318f1e20f5
94ZLA3W45F; E7199S1YWR    787c1115-61fa-41d1-a0b2-32318f1e20f5
Name: SET ID dtype: object",active ingredient unii ( s ) 94zla3w45f e7199s1ywr active ingredient unii ( s ) 94zla3w45f e7199s1y 94zla3w45f e7199s1ywr active ingredient unii ( s ) 94zla3w45f e7199s1y name content xml  dtype object,0
4592,4592,4592,4592,4592,4592,4592,5630,5630,5630,5630,5630,5630,5630,5630,5630,5630,5630,5630,5630,"Active Ingredient UNII(s)
94ZLA3W45F; JEI07OOS8Y    870089d6-87e4-46b9-bcfb-c5b82cf06c3f
94ZLA3W45F; JEI07OOS8Y    870089d6-87e4-46b9-bcfb-c5b82cf06c3f
Name: SET ID dtype: object",active ingredient unii ( s ) 94zla3w45f jei07oos8y active ingredient unii ( s ) 94zla3w45f jei07oos 94zla3w45f jei07oos8y active ingredient unii ( s ) 94zla3w45f jei07oos name content xml  dtype object,0
4593,4593,4593,4593,4593,4593,4593,5632,5632,5632,5632,5632,5632,5632,5632,5632,5632,5632,5632,5632,"Active Ingredient UNII(s)
94ZLA3W45F; W5S57Y3A5L    89db8bac-b418-4c84-b0f2-a56c6b2848f4
94ZLA3W45F; W5S57Y3A5L    89db8bac-b418-4c84-b0f2-a56c6b2848f4
Name: SET ID dtype: object",active ingredient unii ( s ) 94zla3w45f w5s57y3a5l active ingredient unii ( s ) 94zla3w45f w5s57y3a 94zla3w45f w5s57y3a5l active ingredient unii ( s ) 94zla3w45f w5s57y3a name content xml  dtype object,0
4594,4594,4594,4594,4594,4594,4594,5634,5634,5634,5634,5634,5634,5634,5634,5634,5634,5634,5634,5634,d8c78a7e-ff99-48f3-8952-643ec2ea0f86,1  pulmozyme ( dornase alfa ) is indicated for daily administration in conjunction with standard therapies for the management of cystic fibrosis ( cf ) patients to improve pulmonary function,1
4595,4595,4595,4595,4595,4595,4595,5635,5635,5635,5635,5635,5635,5635,5635,5635,5635,5635,5635,5635,d8c78a7e-ff99-48f3-8952-643ec2ea0f86,in cf patients with an fvc 40 of predicted  daily administration of pulmozyme has also been shown to reduce the risk of respiratory tract infections requiring parenteral antibiotics,u
4596,4596,4596,4596,4596,4596,4596,5636,5636,5636,5636,5636,5636,5636,5636,5636,5636,5636,5636,5636,d8c78a7e-ff99-48f3-8952-643ec2ea0f86,pulmozyme is a recombinant dnase enzyme indicated in conjunction with standard therapies for the management of cystic fibrosis ( cf ) patients to improve pulmonary function,1
4597,4597,4597,4597,4597,4597,4597,5637,5637,5637,5637,5637,5637,5637,5637,5637,5637,5637,5637,5637,4d5107c6-5077-4006-994f-1cd351775b80,indications rose bengal ophthalmic strips are used as a diagnostic agent in routine ocular examinations or when superficial conjunctiva or corneal tissue change is suspected,1
4598,4598,4598,4598,4598,4598,4598,5638,5638,5638,5638,5638,5638,5638,5638,5638,5638,5638,5638,5638,4d5107c6-5077-4006-994f-1cd351775b80,rose bengal ophthalmic strips can also serve as an effective aid in the diagnosis of keratoconjunctivitis sicca  keratitis  abrasions or corrosions as well as the detection of foreign bodies,1
4599,4599,4599,4599,4599,4599,4599,5639,5639,5639,5639,5639,5639,5639,5639,5639,5639,5639,5639,5639,1d4e1cce-c57e-4a8b-be96-f95a2778e221,1  topotecan injection is indicated for the treatment of patients with small cell lung cancer with platinum sensitive disease who progressed at least 60 days after initiation of first line chemotherapy,1
4600,4600,4600,4600,4600,4600,4600,5640,5640,5640,5640,5640,5640,5640,5640,5640,5640,5640,5640,5640,1d4e1cce-c57e-4a8b-be96-f95a2778e221,topotecan injection is a topoisomerase inhibitor indicated for small cell lung cancer platinum sensitive disease in patients who progressed after first line chemotherapy,1
4601,4601,4601,4601,4601,4601,4601,5641,5641,5641,5641,5641,5641,5641,5641,5641,5641,5641,5641,5641,f19cf6d7-a1c8-42ec-844c-c798512139d9, teniposide injection  in combination with other approved anticancer agents  is indicated for induction therapy in patients with refractory childhood acute lymphoblastic leukemia,1
4602,4602,4602,4602,4602,4602,4602,5642,5642,5642,5642,5642,5642,5642,5642,5642,5642,5642,5642,5642,8c4f8326-af2e-4658-a247-e29cd1c0fd68,indications for cauterization of skin or mucous membrane and for removing warts and granulated tissue,1
4603,4603,4603,4603,4603,4603,4603,5643,5643,5643,5643,5643,5643,5643,5643,5643,5643,5643,5643,5643,8c4f8326-af2e-4658-a247-e29cd1c0fd68,directions the healthcare professional moistens the applicator tip with distilled water and applies the silver nitrate to the affected area by holding  rubbing  or rotating the tip along the affected tissue,4
4604,4604,4604,4604,4604,4604,4604,5644,5644,5644,5644,5644,5644,5644,5644,5644,5644,5644,5644,5644,8c4f8326-af2e-4658-a247-e29cd1c0fd68,the strength of the action is controlled by the dilution with distilled water,4
4605,4605,4605,4605,4605,4605,4605,5645,5645,5645,5645,5645,5645,5645,5645,5645,5645,5645,5645,5645,8c4f8326-af2e-4658-a247-e29cd1c0fd68,one grafco silver nitrate applicator is generally sufficient for each application,4
4606,4606,4606,4606,4606,4606,4606,5646,5646,5646,5646,5646,5646,5646,5646,5646,5646,5646,5646,5646,6240792b-9224-2d10-e053-2a91aa0a2c3e,1  xenical is indicated for obesity management including weight loss and weight maintenance when used in conjunction with a reduced calorie diet,1
4607,4607,4607,4607,4607,4607,4607,5647,5647,5647,5647,5647,5647,5647,5647,5647,5647,5647,5647,5647,6240792b-9224-2d10-e053-2a91aa0a2c3e,xenical is also indicated to reduce the risk for weight regain after prior weight loss,1
4608,4608,4608,4608,4608,4608,4608,5648,5648,5648,5648,5648,5648,5648,5648,5648,5648,5648,5648,5648,6240792b-9224-2d10-e053-2a91aa0a2c3e,xenical is indicated for obese patients with an initial body mass index ( bmi ) 30 kg m 2 or 27 kg m 2 in the presence of other risk factors ( e g  hypertension  diabetes  dyslipidemia ),1
4609,4609,4609,4609,4609,4609,4609,5649,5649,5649,5649,5649,5649,5649,5649,5649,5649,5649,5649,5649,6240792b-9224-2d10-e053-2a91aa0a2c3e,table 1 illustrates body mass index ( bmi ) according to a variety of weights and heights,0
4610,4610,4610,4610,4610,4610,4610,5650,5650,5650,5650,5650,5650,5650,5650,5650,5650,5650,5650,5650,6240792b-9224-2d10-e053-2a91aa0a2c3e,the bmi is calculated by dividing weight in kilograms by height in meters squared,0
4611,4611,4611,4611,4611,4611,4611,5651,5651,5651,5651,5651,5651,5651,5651,5651,5651,5651,5651,5651,6240792b-9224-2d10-e053-2a91aa0a2c3e,for example  a person who weighs 180 lbs and is 5 ' 5 would have a bmi of 30,0
4612,4612,4612,4612,4612,4612,4612,5652,5652,5652,5652,5652,5652,5652,5652,5652,5652,5652,5652,5652,6240792b-9224-2d10-e053-2a91aa0a2c3e,table 1 body mass index ( bmi )  kg m 2 conversion factors weight in lbs 2 2 weight in kilograms ( kg ) height in inches 0 0254 height in meters ( m ) 1 foot 12 inches xenical is a reversible inhibitor of gastrointestinal lipases indicated for obesity management including weight loss and weight maintenance when used in conjunction with a reduced calorie diet,0
4613,4613,4613,4613,4613,4613,4613,5653,5653,5653,5653,5653,5653,5653,5653,5653,5653,5653,5653,5653,6240792b-9224-2d10-e053-2a91aa0a2c3e,( 1 ) xenical is also indicated to reduce the risk for weight regain after prior weight loss,1
4614,4614,4614,4614,4614,4614,4614,5654,5654,5654,5654,5654,5654,5654,5654,5654,5654,5654,5654,5654,999625d5-3a6b-4753-059a-4f19d04c85a5, novocain is indicated for spinal anesthesia,1
4615,4615,4615,4615,4615,4615,4615,5655,5655,5655,5655,5655,5655,5655,5655,5655,5655,5655,5655,5655,a09299d5-9c55-4cef-aed0-3a6a45532289,indications cmv retinitis foscavir is indicated for the treatment of cmv retinitis in patients with acquired immunodeficiency syndrome ( aids ),1
4616,4616,4616,4616,4616,4616,4616,5656,5656,5656,5656,5656,5656,5656,5656,5656,5656,5656,5656,5656,a09299d5-9c55-4cef-aed0-3a6a45532289,combination therapy with foscavir and ganciclovir is indicated for patients who have relapsed after monotherapy with either drug,1
4617,4617,4617,4617,4617,4617,4617,5657,5657,5657,5657,5657,5657,5657,5657,5657,5657,5657,5657,5657,a09299d5-9c55-4cef-aed0-3a6a45532289,safety and efficacy of foscavir have not been established for treatment of other cmv infections ( e g  pneumonitis  gastroenteritis ) congenital or neonatal cmv disease or nonimmunocompromised individuals,u
4618,4618,4618,4618,4618,4618,4618,5658,5658,5658,5658,5658,5658,5658,5658,5658,5658,5658,5658,5658,a09299d5-9c55-4cef-aed0-3a6a45532289,mucocutaneous acyclovir resistant hsv infections foscavir is indicated for the treatment of acyclovir resistant mucocutaneous hsv infections in immunocompromised patients,1
4619,4619,4619,4619,4619,4619,4619,5659,5659,5659,5659,5659,5659,5659,5659,5659,5659,5659,5659,5659,a09299d5-9c55-4cef-aed0-3a6a45532289,safety and efficacy of foscavir have not been established for treatment of other hsv infections ( e g  retinitis  encephalitis ) congenital or neonatal hsv disease or hsv in nonimmunocompromised individuals,0
4620,4620,4620,4620,4620,4620,4620,5660,5660,5660,5660,5660,5660,5660,5660,5660,5660,5660,5660,5660,16d804b6-4957-43ee-b18c-3b36ec37c5ac,1  iclusig ( ponatinib ) is a kinase inhibitor indicated for the treatment of adult patients with chronic phase  accelerated phase  or blast phase chronic myeloid leukemia ( cml ) or ph all for whom no other tyrosine kinase inhibitor ( tki ) therapy is indicated,1
4621,4621,4621,4621,4621,4621,4621,5661,5661,5661,5661,5661,5661,5661,5661,5661,5661,5661,5661,5661,16d804b6-4957-43ee-b18c-3b36ec37c5ac,treatment of adult patients with t315i positive cml ( chronic phase  accelerated phase  or blast phase ) or t315i positive philadelphia chromosome positive acute lymphoblastic leukemia ( ph all ),1
4622,4622,4622,4622,4622,4622,4622,5662,5662,5662,5662,5662,5662,5662,5662,5662,5662,5662,5662,5662,16d804b6-4957-43ee-b18c-3b36ec37c5ac,iclusig is a kinase inhibitor indicated for the treatment of adult patients with chronic phase  accelerated phase  or blast phase chronic myeloid leukemia ( cml ) or ph all for whom no other tyrosine kinase inhibitor ( tki ) therapy is indicated,1
4623,4623,4623,4623,4623,4623,4623,5663,5663,5663,5663,5663,5663,5663,5663,5663,5663,5663,5663,5663,16d804b6-4957-43ee-b18c-3b36ec37c5ac,( 1 ) treatment of adult patients with t315i positive cml ( chronic phase  accelerated phase  or blast phase ) or t315i positive philadelphia chromosome positive acute lymphoblastic leukemia ( ph all ),1
4624,4624,4624,4624,4624,4624,4624,5664,5664,5664,5664,5664,5664,5664,5664,5664,5664,5664,5664,5664,16d804b6-4957-43ee-b18c-3b36ec37c5ac,( 1 ) limitations of use iclusig is not indicated and is not recommended for the treatment of patients with newly diagnosed chronic phase cml ( 5 7 ),2
4625,4625,4625,4625,4625,4625,4625,5665,5665,5665,5665,5665,5665,5665,5665,5665,5665,5665,5665,5665,16d804b6-4957-43ee-b18c-3b36ec37c5ac,limitations of use iclusig is not indicated and is not recommended for the treatment of patients with newly diagnosed chronic phase cml see warnings and precautions ( 5 7 ),2
4626,4626,4626,4626,4626,4626,4626,5666,5666,5666,5666,5666,5666,5666,5666,5666,5666,5666,5666,5666,8626e756-767a-4a14-9188-658b58185254,1  myocardial imaging technetium tc 99m sestamibi injection is a myocardial perfusion agent that is indicated for detecting coronary artery disease by localizing myocardial ischemia ( reversible defects ) and infarction ( non reversible defects )  in evaluating myocardial function and developing information for use in patient management decisions,1
4627,4627,4627,4627,4627,4627,4627,5667,5667,5667,5667,5667,5667,5667,5667,5667,5667,5667,5667,5667,8626e756-767a-4a14-9188-658b58185254,technetium tc 99m sestamibi evaluation of myocardial ischemia can be accomplished with rest and cardiovascular stress techniques ( e g  exercise or pharmacologic stress in accordance with the pharmacologic stress agent s labeling ),u
4628,4628,4628,4628,4628,4628,4628,5668,5668,5668,5668,5668,5668,5668,5668,5668,5668,5668,5668,5668,8626e756-767a-4a14-9188-658b58185254,it is usually not possible to determine the age of a myocardial infarction or to differentiate a recent myocardial infarction from ischemia,0
4629,4629,4629,4629,4629,4629,4629,5669,5669,5669,5669,5669,5669,5669,5669,5669,5669,5669,5669,5669,8626e756-767a-4a14-9188-658b58185254,breast imaging technetium tc 99m sestamibi is indicated for planar imaging as a second line diagnostic drug after mammography to assist in the evaluation of breast lesions in patients with an abnormal mammogram or a palpable breast mass,1
4630,4630,4630,4630,4630,4630,4630,5670,5670,5670,5670,5670,5670,5670,5670,5670,5670,5670,5670,5670,8626e756-767a-4a14-9188-658b58185254,technetium tc 99m sestamibi is not indicated for breast cancer screening  to confirm the presence or absence of malignancy  and it is not an alternative to biopsy,2
4631,4631,4631,4631,4631,4631,4631,5671,5671,5671,5671,5671,5671,5671,5671,5671,5671,5671,5671,5671,8626e756-767a-4a14-9188-658b58185254,technetium tc 99m sestamibi is a myocardial perfusion agent indicated for detecting coronary artery disease by localizing myocardial ischemia ( reversible defects ) and infarction ( non reversible defects ) ( 1 ) evaluating myocardial function and developing information for use in patient management decisions ( 1 ),1
4632,4632,4632,4632,4632,4632,4632,5672,5672,5672,5672,5672,5672,5672,5672,5672,5672,5672,5672,5672,c7400f8a-dcf4-a6df-6d07-983081b1bf34,1  praxbind is indicated in patients treated with pradaxa when reversal of the anticoagulant effects of dabigatran is needed for emergency surgery urgent procedures in life threatening or uncontrolled bleeding this indication is approved under accelerated approval based on a reduction in unbound dabigatran and normalization of coagulation parameters in healthy volunteers see clinical studies ( 14 ),1
4633,4633,4633,4633,4633,4633,4633,5673,5673,5673,5673,5673,5673,5673,5673,5673,5673,5673,5673,5673,c7400f8a-dcf4-a6df-6d07-983081b1bf34,continued approval for this indication may be contingent upon the results of an ongoing cohort case series study,0
4634,4634,4634,4634,4634,4634,4634,5674,5674,5674,5674,5674,5674,5674,5674,5674,5674,5674,5674,5674,c7400f8a-dcf4-a6df-6d07-983081b1bf34,praxbind is a humanized monoclonal antibody fragment ( fab ) indicated in patients treated with pradaxa when reversal of the anticoagulant effects of dabigatran is needed for emergency surgery urgent procedures in life threatening or uncontrolled bleeding ( 1 ) this indication is approved under accelerated approval based on a reduction in unbound dabigatran and normalization of coagulation parameters in healthy volunteers,1
4635,4635,4635,4635,4635,4635,4635,5676,5676,5676,5676,5676,5676,5676,5676,5676,5676,5676,5676,5676,39d53698-57fa-7c99-fc5b-f52a55684826,1  treanda is an alkylating drug indicated for treatment of patients with chronic lymphocytic leukemia ( cll ),1
4636,4636,4636,4636,4636,4636,4636,5677,5677,5677,5677,5677,5677,5677,5677,5677,5677,5677,5677,5677,39d53698-57fa-7c99-fc5b-f52a55684826,efficacy relative to first line therapies other than chlorambucil has not been established,0
4637,4637,4637,4637,4637,4637,4637,5678,5678,5678,5678,5678,5678,5678,5678,5678,5678,5678,5678,5678,39d53698-57fa-7c99-fc5b-f52a55684826,( 1 1 ) indolent b cell non hodgkin lymphoma ( nhl ) that has progressed during or within six months of treatment with rituximab or a rituximab containing regimen,0
4638,4638,4638,4638,4638,4638,4638,5679,5679,5679,5679,5679,5679,5679,5679,5679,5679,5679,5679,5679,39d53698-57fa-7c99-fc5b-f52a55684826,( 1 2 ) 1 1 chronic lymphocytic leukemia ( cll ) treanda is indicated for the treatment of patients with chronic lymphocytic leukemia,1
4639,4639,4639,4639,4639,4639,4639,5681,5681,5681,5681,5681,5681,5681,5681,5681,5681,5681,5681,5681,39d53698-57fa-7c99-fc5b-f52a55684826,1 2 non hodgkin lymphoma ( nhl ) treanda is indicated for the treatment of patients with indolent b cell non hodgkin lymphoma that has progressed during or within six months of treatment with rituximab or a rituximab containing regimen,1
4640,4640,4640,4640,4640,4640,4640,5682,5682,5682,5682,5682,5682,5682,5682,5682,5682,5682,5682,5682,3995eed8-39ec-ce5e-8cc2-062f93445c8d, tolbutamide tablets are indicated as an adjunct to diet to lower the blood glucose in patients with non insulin dependent diabetes mellitus ( type ii ) whose hyperglycemia cannot be controlled by diet alone,1
4641,4641,4641,4641,4641,4641,4641,5683,5683,5683,5683,5683,5683,5683,5683,5683,5683,5683,5683,5683,3995eed8-39ec-ce5e-8cc2-062f93445c8d,in initiating treatment for non insulin dependent diabetes  diet should be emphasized as the primary form of treatment,0
4642,4642,4642,4642,4642,4642,4642,5684,5684,5684,5684,5684,5684,5684,5684,5684,5684,5684,5684,5684,3995eed8-39ec-ce5e-8cc2-062f93445c8d,caloric restriction and weight loss are essential in the obese diabetic patient,0
4643,4643,4643,4643,4643,4643,4643,5685,5685,5685,5685,5685,5685,5685,5685,5685,5685,5685,5685,5685,3995eed8-39ec-ce5e-8cc2-062f93445c8d,proper dietary management alone may be effective in controlling the blood glucose and symptoms of hyperglycemia,0
4644,4644,4644,4644,4644,4644,4644,5686,5686,5686,5686,5686,5686,5686,5686,5686,5686,5686,5686,5686,3995eed8-39ec-ce5e-8cc2-062f93445c8d,the importance of regular physical activity should also be stressed  and cardiovascular risk factors should be identified and corrective measures taken where possible,0
4645,4645,4645,4645,4645,4645,4645,5687,5687,5687,5687,5687,5687,5687,5687,5687,5687,5687,5687,5687,3995eed8-39ec-ce5e-8cc2-062f93445c8d,if this treatment program fails to reduce symptoms and or blood glucose  the use of an oral sulfonylurea or insulin should be considered,0
4646,4646,4646,4646,4646,4646,4646,5688,5688,5688,5688,5688,5688,5688,5688,5688,5688,5688,5688,5688,3995eed8-39ec-ce5e-8cc2-062f93445c8d,use of tolbutamide tablets must be viewed by both the physician and patient as a treatment in addition to diet  and not as a substitute for diet or as a convenient mechanism for avoiding dietary restraint,4
4647,4647,4647,4647,4647,4647,4647,5689,5689,5689,5689,5689,5689,5689,5689,5689,5689,5689,5689,5689,3995eed8-39ec-ce5e-8cc2-062f93445c8d,furthermore  loss of blood glucose control on diet alone may be transient  thus requiring only short term administration of tolbutamide tablets,0
4648,4648,4648,4648,4648,4648,4648,5690,5690,5690,5690,5690,5690,5690,5690,5690,5690,5690,5690,5690,3995eed8-39ec-ce5e-8cc2-062f93445c8d,during maintenance programs  tolbutamide tablets should be discontinued if satisfactory lowering of blood glucose is no longer achieved,0
4649,4649,4649,4649,4649,4649,4649,5691,5691,5691,5691,5691,5691,5691,5691,5691,5691,5691,5691,5691,3995eed8-39ec-ce5e-8cc2-062f93445c8d,judgments should be based on regular clinical and laboratory evaluations,0
4650,4650,4650,4650,4650,4650,4650,5692,5692,5692,5692,5692,5692,5692,5692,5692,5692,5692,5692,5692,3995eed8-39ec-ce5e-8cc2-062f93445c8d,in considering the use of tolbutamide tablets in asymptomatic patients  it should be recognized that controlling the blood glucose in non insulin dependent diabetes has not been definitely established to be effective in preventing the long term cardiovascular or neural complications of diabetes,0
4651,4651,4651,4651,4651,4651,4651,5693,5693,5693,5693,5693,5693,5693,5693,5693,5693,5693,5693,5693,8de2c303-5d99-46b6-ad6d-a4caadea3604, profenal ophthalmic solution is indicated for inhibition of intraoperative miosis,1
4652,4652,4652,4652,4652,4652,4652,5694,5694,5694,5694,5694,5694,5694,5694,5694,5694,5694,5694,5694,91152af4-a9c8-4b14-acbb-e4b6f2be145a,1  viracept in combination with other antiretroviral agents is indicated for the treatment of hiv 1 infection,1
4653,4653,4653,4653,4653,4653,4653,5695,5695,5695,5695,5695,5695,5695,5695,5695,5695,5695,5695,5695,91152af4-a9c8-4b14-acbb-e4b6f2be145a,viracept is a protease inhibitor indicated for the treatment of hiv 1 infection in combination with other antiretroviral agents,1
4654,4654,4654,4654,4654,4654,4654,5696,5696,5696,5696,5696,5696,5696,5696,5696,5696,5696,5696,5696,442f0d9d-5c7d-4b81-b329-d71be8cf2be2,1  signifor is a somatostatin analog indicated for the treatment of adult patients with cushing s disease for whom pituitary surgery is not an option or has not been curative ( 1 ) 1 1 cushing s disease signifor is indicated for the treatment of adult patients with cushing s disease for whom pituitary surgery is not an option or has not been curative,1
4655,4655,4655,4655,4655,4655,4655,5697,5697,5697,5697,5697,5697,5697,5697,5697,5697,5697,5697,5697,36c6a85c-022c-4f83-aa2f-738c33614596,uses temporarily relieves mild to moderate aches and pains of muscles and joints associated with muscle soreness strains sprains arthritis simple backache muscle stiffness bruises,1
4656,4656,4656,4656,4656,4656,4656,5698,5698,5698,5698,5698,5698,5698,5698,5698,5698,5698,5698,5698,ea3d8bfe-b66f-4702-8cb5-583c5cd1543a,uses for the temporary relief of minor aches and pains of muscles and joints associated with arthritis  simple backache  strains  sprains  muscle soreness and stiffness,1
4657,4657,4657,4657,4657,4657,4657,5699,5699,5699,5699,5699,5699,5699,5699,5699,5699,5699,5699,5699,"Active Ingredient UNII(s)
98PI200987; ND2M416302    135c324b-0c9a-48a3-be0a-c7e7c5f4de20
98PI200987; ND2M416302    135c324b-0c9a-48a3-be0a-c7e7c5f4de20
Name: SET ID dtype: object",active ingredient unii ( s ) 98pi200987 nd2m416302 active ingredient unii ( s ) 98pi200987 nd2m4163 98pi200987 nd2m416302 active ingredient unii ( s ) 98pi200987 nd2m4163 name content xml  dtype object,0
4658,4658,4658,4658,4658,4658,4658,5701,5701,5701,5701,5701,5701,5701,5701,5701,5701,5701,5701,5701,1af01887-b69d-444b-91ed-ebfe12784440, simulect ( basiliximab ) is indicated for the prophylaxis of acute organ rejection in patients receiving renal transplantation when used as part of an immunosuppressive regimen that includes cyclosporine  usp ( modified ) and corticosteroids,1
4659,4659,4659,4659,4659,4659,4659,5702,5702,5702,5702,5702,5702,5702,5702,5702,5702,5702,5702,5702,1af01887-b69d-444b-91ed-ebfe12784440,the efficacy of simulect for the prophylaxis of acute rejection in recipients of other solid organ allografts has not been demonstrated,0
4660,4660,4660,4660,4660,4660,4660,5703,5703,5703,5703,5703,5703,5703,5703,5703,5703,5703,5703,5703,f03a68d5-ed00-8a2d-af68-28be909ea85f, attention deficit disorder with hyperactivity desoxyn tablets are indicated as an integral part of a total treatment program which typically includes other remedial measures ( psychological  educational  social ) for a stabilizing effect in children over 6 years of age with a behavioral syndrome characterized by the following group of developmentally inappropriate symptoms moderate to severe distractibility  short attention span  hyperactivity  emotional lability  and impulsivity,1
4661,4661,4661,4661,4661,4661,4661,5704,5704,5704,5704,5704,5704,5704,5704,5704,5704,5704,5704,5704,f03a68d5-ed00-8a2d-af68-28be909ea85f,the diagnosis of this syndrome should not be made with finality when these symptoms are only of comparatively recent origin,0
4662,4662,4662,4662,4662,4662,4662,5705,5705,5705,5705,5705,5705,5705,5705,5705,5705,5705,5705,5705,f03a68d5-ed00-8a2d-af68-28be909ea85f,nonlocalizing ( soft ) neurological signs  learning disability  and abnormal eeg may or may not be present  and a diagnosis of central nervous system dysfunction may or may not be warranted,0
4663,4663,4663,4663,4663,4663,4663,5706,5706,5706,5706,5706,5706,5706,5706,5706,5706,5706,5706,5706,f03a68d5-ed00-8a2d-af68-28be909ea85f,exogenous obesity as a short term ( i e  a few weeks ) adjunct in a regimen of weight reduction based on caloric restriction  for patients in whom obesity is refractory to alternative therapy  e g  repeated diets  group programs  and other drugs,u
4664,4664,4664,4664,4664,4664,4664,5707,5707,5707,5707,5707,5707,5707,5707,5707,5707,5707,5707,5707,f03a68d5-ed00-8a2d-af68-28be909ea85f,the limited usefulness of desoxyn tablets ( see clinical pharmacology ) should be weighed against possible risks inherent in use of the drug  such as those described below,0
4665,4665,4665,4665,4665,4665,4665,5708,5708,5708,5708,5708,5708,5708,5708,5708,5708,5708,5708,5708,b3e740ad-46d9-48f5-85ab-7c319919ceb1,1  nevirapine is indicated for combination antiretroviral treatment of hiv 1 infection in adults and in pediatric patients 15 days and older see clinical studies 14 1  14 2 ),1
4666,4666,4666,4666,4666,4666,4666,5709,5709,5709,5709,5709,5709,5709,5709,5709,5709,5709,5709,5709,b3e740ad-46d9-48f5-85ab-7c319919ceb1,additional important information regarding the use of nevirapine for the treatment of hiv 1 infection based on serious and life threatening hepatotoxicity observed in controlled and uncontrolled trials  nevirapine should not be initiated in adult females with cd4 cell counts greater than 250 cells mm3 or in adult males with cd4 cell counts greater than 400 cells mm3 unless the benefit outweighs the risk see boxed warning and warnings and precautions ( 5 1 ),0
4667,4667,4667,4667,4667,4667,4667,5710,5710,5710,5710,5710,5710,5710,5710,5710,5710,5710,5710,5710,b3e740ad-46d9-48f5-85ab-7c319919ceb1,the 14 day lead in period with nevirapine 200 mg daily dosing must be strictly followed it has been demonstrated to reduce the frequency of rash see dosage and administration ( 2 4 ) and warnings and precautions ( 5 2 ),4
4668,4668,4668,4668,4668,4668,4668,5711,5711,5711,5711,5711,5711,5711,5711,5711,5711,5711,5711,5711,b3e740ad-46d9-48f5-85ab-7c319919ceb1,if rash persists beyond the 14 day lead in period  do not dose escalate to 200 mg twice daily,0
4669,4669,4669,4669,4669,4669,4669,5712,5712,5712,5712,5712,5712,5712,5712,5712,5712,5712,5712,5712,b3e740ad-46d9-48f5-85ab-7c319919ceb1,the 200 mg once daily dosing regimen should not be continued beyond 28 days  at which point an alternative regimen should be sought,0
4670,4670,4670,4670,4670,4670,4670,5713,5713,5713,5713,5713,5713,5713,5713,5713,5713,5713,5713,5713,b3e740ad-46d9-48f5-85ab-7c319919ceb1,nevirapine is an nnrti indicated for combination antiretroviral treatment of hiv 1 infection in adults and in pediatric patients 15 days and older,1
4671,4671,4671,4671,4671,4671,4671,5714,5714,5714,5714,5714,5714,5714,5714,5714,5714,5714,5714,5714,b3e740ad-46d9-48f5-85ab-7c319919ceb1,important considerations initiation of treatment is not recommended in the following populations unless the benefits outweigh the risks,0
4672,4672,4672,4672,4672,4672,4672,5715,5715,5715,5715,5715,5715,5715,5715,5715,5715,5715,5715,5715,b3e740ad-46d9-48f5-85ab-7c319919ceb1,( 1  5 1 ) adult females with cd4 cell counts greater than 250 cells mm3 adult males with cd4 cell counts greater than 400 cells mm3 the 14 day lead in period must be strictly followed it has been demonstrated to reduce the frequency of rash,0
4673,4673,4673,4673,4673,4673,4673,5716,5716,5716,5716,5716,5716,5716,5716,5716,5716,5716,5716,5716,b4260d7e-2ab3-49f6-aa57-bae19a23d82a, flavoxate hydrochloride tablets are indicated for symptomatic relief of dysuria  urgency  nocturia  suprapubic pain  frequency and incontinence as may occur in cystitis  prostatitis  urethritis  urethrocystitis urethrotrigonitis,1
4674,4674,4674,4674,4674,4674,4674,5717,5717,5717,5717,5717,5717,5717,5717,5717,5717,5717,5717,5717,b4260d7e-2ab3-49f6-aa57-bae19a23d82a,flavoxate hydrochloride tablets are not indicated for definitive treatment  but are compatible with drugs used for the treatment of urinary tract infections,u
4675,4675,4675,4675,4675,4675,4675,5718,5718,5718,5718,5718,5718,5718,5718,5718,5718,5718,5718,5718,484e0918-3442-49dc-8ccf-177f1f3ee9f3,1  nuedexta is indicated for the treatment of pseudobulbar affect ( pba ),1
4676,4676,4676,4676,4676,4676,4676,5719,5719,5719,5719,5719,5719,5719,5719,5719,5719,5719,5719,5719,484e0918-3442-49dc-8ccf-177f1f3ee9f3,pba occurs secondary to a variety of otherwise unrelated neurologic conditions  and is characterized by involuntary  sudden  and frequent episodes of laughing and or crying,0
4677,4677,4677,4677,4677,4677,4677,5720,5720,5720,5720,5720,5720,5720,5720,5720,5720,5720,5720,5720,484e0918-3442-49dc-8ccf-177f1f3ee9f3,pba episodes typically occur out of proportion or incongruent to the underlying emotional state,0
4678,4678,4678,4678,4678,4678,4678,5721,5721,5721,5721,5721,5721,5721,5721,5721,5721,5721,5721,5721,484e0918-3442-49dc-8ccf-177f1f3ee9f3,pba is a specific condition  distinct from other types of emotional lability that may occur in patients with neurological disease or injury,0
4679,4679,4679,4679,4679,4679,4679,5722,5722,5722,5722,5722,5722,5722,5722,5722,5722,5722,5722,5722,484e0918-3442-49dc-8ccf-177f1f3ee9f3,nuedexta is a combination product containing dextromethorphan hydrobromide ( an uncompetitive nmda receptor antagonist and sigma 1 agonist ) and quinidine sulfate ( a cyp450 2d6 inhibitor ) indicated for the treatment of pseudobulbar affect ( pba ),1
4680,4680,4680,4680,4680,4680,4680,5723,5723,5723,5723,5723,5723,5723,5723,5723,5723,5723,5723,5723,7c99f10f-6982-4c08-b4d3-d90c4e8aaa2e, promethazine hydrochloride and dextromethorphan hydrobromide oral solution is indicated for the temporary relief of coughs and upper respiratory symptoms associated with allergy or the common cold,1
4681,4681,4681,4681,4681,4681,4681,5724,5724,5724,5724,5724,5724,5724,5724,5724,5724,5724,5724,5724,65ed6e70-f1ee-437e-965c-d1b1fdadd832, hypertension captopril tablets  usp are indicated for the treatment of hypertension,1
4682,4682,4682,4682,4682,4682,4682,5725,5725,5725,5725,5725,5725,5725,5725,5725,5725,5725,5725,5725,65ed6e70-f1ee-437e-965c-d1b1fdadd832,in using captopril tablets  usp  consideration should be given to the risk of neutropenia agranulocytosis ( see warnings ),0
4683,4683,4683,4683,4683,4683,4683,5726,5726,5726,5726,5726,5726,5726,5726,5726,5726,5726,5726,5726,65ed6e70-f1ee-437e-965c-d1b1fdadd832,captopril tablets  usp may be used as initial therapy for patients with normal renal function  in whom the risk is relatively low,u
4684,4684,4684,4684,4684,4684,4684,5727,5727,5727,5727,5727,5727,5727,5727,5727,5727,5727,5727,5727,65ed6e70-f1ee-437e-965c-d1b1fdadd832,in patients with impaired renal function  particularly those with collagen vascular disease  captopril should be reserved for hypertensives who have either developed unacceptable side effects on other drugs  or have failed to respond satisfactorily to drug combinations,4
4685,4685,4685,4685,4685,4685,4685,5728,5728,5728,5728,5728,5728,5728,5728,5728,5728,5728,5728,5728,65ed6e70-f1ee-437e-965c-d1b1fdadd832,captopril tablets  usp are effective alone and in combination with other antihypertensive agents  especially thiazide type diuretics,u
4686,4686,4686,4686,4686,4686,4686,5730,5730,5730,5730,5730,5730,5730,5730,5730,5730,5730,5730,5730,65ed6e70-f1ee-437e-965c-d1b1fdadd832,heart failure captopril tablets  usp are indicated in the treatment of congestive heart failure usually in combination with diuretics and digitalis,1
4687,4687,4687,4687,4687,4687,4687,5731,5731,5731,5731,5731,5731,5731,5731,5731,5731,5731,5731,5731,65ed6e70-f1ee-437e-965c-d1b1fdadd832,the beneficial effect of captopril in heart failure does not require the presence of digitalis  however  most controlled clinical trial experience with captopril has been in patients receiving digitalis  as well as diuretic treatment,0
4688,4688,4688,4688,4688,4688,4688,5732,5732,5732,5732,5732,5732,5732,5732,5732,5732,5732,5732,5732,65ed6e70-f1ee-437e-965c-d1b1fdadd832,left ventricular dysfunction after myocardial infarction captopril tablets  usp are indicated to improve survival following myocardial infarction in clinically stable patients with left ventricular dysfunction manifested as an ejection fraction 40 and to reduce the incidence of overt heart failure and subsequent hospitalizations for congestive heart failure in these patients,1
4689,4689,4689,4689,4689,4689,4689,5733,5733,5733,5733,5733,5733,5733,5733,5733,5733,5733,5733,5733,65ed6e70-f1ee-437e-965c-d1b1fdadd832,diabetic nephropathy captopril tablets  usp are indicated for the treatment of diabetic ne,1
4690,4690,4690,4690,4690,4690,4690,5734,5734,5734,5734,5734,5734,5734,5734,5734,5734,5734,5734,5734,4d930f24-4ddb-488d-9e79-3f495972733b, engerix b is indicated for immunization against infection caused by all known subtypes of hepatitis b virus,1
4691,4691,4691,4691,4691,4691,4691,5735,5735,5735,5735,5735,5735,5735,5735,5735,5735,5735,5735,5735,4d930f24-4ddb-488d-9e79-3f495972733b,as hepatitis d ( caused by the delta virus ) does not occur in the absence of hepatitis b infection  it can be expected that hepatitis d will also be prevented by engerix b vaccination,u
4692,4692,4692,4692,4692,4692,4692,5736,5736,5736,5736,5736,5736,5736,5736,5736,5736,5736,5736,5736,4d930f24-4ddb-488d-9e79-3f495972733b,engerix b will not prevent hepatitis caused by other agents  such as hepatitis a  c  and e viruses  or other pathogens known to infect the liver,0
4693,4693,4693,4693,4693,4693,4693,5737,5737,5737,5737,5737,5737,5737,5737,5737,5737,5737,5737,5737,4d930f24-4ddb-488d-9e79-3f495972733b,immunization is recommended in persons of all ages  especially those who are  or will be  at increased risk of exposure to hepatitis b virus  1 for example infants  including those born of hbsag positive mothers ( see dosage and administration ),u
4694,4694,4694,4694,4694,4694,4694,5738,5738,5738,5738,5738,5738,5738,5738,5738,5738,5738,5738,5738,4d930f24-4ddb-488d-9e79-3f495972733b,adolescents ( see clinical pharmacology ),0
4695,4695,4695,4695,4695,4695,4695,5739,5739,5739,5739,5739,5739,5739,5739,5739,5739,5739,5739,5739,4d930f24-4ddb-488d-9e79-3f495972733b,healthcare personnel dentists and oral surgeons,u
4696,4696,4696,4696,4696,4696,4696,5740,5740,5740,5740,5740,5740,5740,5740,5740,5740,5740,5740,5740,4d930f24-4ddb-488d-9e79-3f495972733b,dental  medical  and nursing students,u
4697,4697,4697,4697,4697,4697,4697,5741,5741,5741,5741,5741,5741,5741,5741,5741,5741,5741,5741,5741,4d930f24-4ddb-488d-9e79-3f495972733b,physicians  surgeons  and podiatrists,u
4698,4698,4698,4698,4698,4698,4698,5742,5742,5742,5742,5742,5742,5742,5742,5742,5742,5742,5742,5742,4d930f24-4ddb-488d-9e79-3f495972733b,paramedical and ambulance personnel and custodial staff who may be exposed to the virus via blood or other patient specimens,u
4699,4699,4699,4699,4699,4699,4699,5743,5743,5743,5743,5743,5743,5743,5743,5743,5743,5743,5743,5743,4d930f24-4ddb-488d-9e79-3f495972733b,dental hygienists and dental nurses,u
4700,4700,4700,4700,4700,4700,4700,5744,5744,5744,5744,5744,5744,5744,5744,5744,5744,5744,5744,5744,4d930f24-4ddb-488d-9e79-3f495972733b,laboratory and blood bank personnel handling blood  blood products  and other patient specimens,u
4701,4701,4701,4701,4701,4701,4701,5745,5745,5745,5745,5745,5745,5745,5745,5745,5745,5745,5745,5745,4d930f24-4ddb-488d-9e79-3f495972733b,hospital cleaning staff who handle waste,0
4702,4702,4702,4702,4702,4702,4702,5746,5746,5746,5746,5746,5746,5746,5746,5746,5746,5746,5746,5746,4d930f24-4ddb-488d-9e79-3f495972733b,selected patients and patient contacts patients and staff in hemodialysis units and hematology oncology units,u
4703,4703,4703,4703,4703,4703,4703,5747,5747,5747,5747,5747,5747,5747,5747,5747,5747,5747,5747,5747,4d930f24-4ddb-488d-9e79-3f495972733b,patients requiring frequent and or large volume blood transfusions or clotting factor concentrates ( e g  persons with hemophilia  thalassemia  sickle cell anemia  cirrhosis ),u
4704,4704,4704,4704,4704,4704,4704,5748,5748,5748,5748,5748,5748,5748,5748,5748,5748,5748,5748,5748,4d930f24-4ddb-488d-9e79-3f495972733b,clients ( residents ) and staff of institutions for the mentally handicapped,u
4705,4705,4705,4705,4705,4705,4705,5749,5749,5749,5749,5749,5749,5749,5749,5749,5749,5749,5749,5749,4d930f24-4ddb-488d-9e79-3f495972733b,classroom contacts of deinstitutionalized mentally handicapped persons who have persistent hepatitis b surface antigenemia and who show aggressive behavior,u
4706,4706,4706,4706,4706,4706,4706,5750,5750,5750,5750,5750,5750,5750,5750,5750,5750,5750,5750,5750,4d930f24-4ddb-488d-9e79-3f495972733b,household and other intimate contacts of persons with persistent hepatitis b surface antigenemia,u
4707,4707,4707,4707,4707,4707,4707,5751,5751,5751,5751,5751,5751,5751,5751,5751,5751,5751,5751,5751,4d930f24-4ddb-488d-9e79-3f495972733b,subpopulations with a known high incidence of the disease  such as alaskan eskimos,u
4708,4708,4708,4708,4708,4708,4708,5752,5752,5752,5752,5752,5752,5752,5752,5752,5752,5752,5752,5752,4d930f24-4ddb-488d-9e79-3f495972733b,refugees from other hbv endemic areas,u
4709,4709,4709,4709,4709,4709,4709,5753,5753,5753,5753,5753,5753,5753,5753,5753,5753,5753,5753,5753,4d930f24-4ddb-488d-9e79-3f495972733b,all infants of women born in areas where the infection is highly endemic,u
4710,4710,4710,4710,4710,4710,4710,5754,5754,5754,5754,5754,5754,5754,5754,5754,5754,5754,5754,5754,4d930f24-4ddb-488d-9e79-3f495972733b,individuals with chronic hepatitis c risk factors for hepatitis c are similar to those for hepatitis b consequently  immunization with hepatitis b vaccine is recommended for individuals with chronic hepatitis c persons who may be exposed to the hepatitis b virus by travel to high risk areas ( see acip guidelines  1990 ),u
4711,4711,4711,4711,4711,4711,4711,5755,5755,5755,5755,5755,5755,5755,5755,5755,5755,5755,5755,5755,4d930f24-4ddb-488d-9e79-3f495972733b,military personnel identified as being at increased risk morticians and embalmers persons at increased risk of the disease due to their sexual practices  1  16 such as persons with more than 1 sexual partner in a 6 month period,u
4712,4712,4712,4712,4712,4712,4712,5756,5756,5756,5756,5756,5756,5756,5756,5756,5756,5756,5756,5756,4d930f24-4ddb-488d-9e79-3f495972733b,persons who have contracted a sexually transmitted disease,u
4713,4713,4713,4713,4713,4713,4713,5757,5757,5757,5757,5757,5757,5757,5757,5757,5757,5757,5757,5757,4d930f24-4ddb-488d-9e79-3f495972733b,prisoners users of illicit injectable drugs others police and fire department personnel who render first aid or medical assistance  and any others who  through their work or pers,u
4714,4714,4714,4714,4714,4714,4714,5758,5758,5758,5758,5758,5758,5758,5758,5758,5758,5758,5758,5758,a88d9010-55fb-4a02-baff-042cd27688ea,1  eraxis is indicated for use in adults for the treatment of the following fungal infections listed below,1
4715,4715,4715,4715,4715,4715,4715,5759,5759,5759,5759,5759,5759,5759,5759,5759,5759,5759,5759,5759,a88d9010-55fb-4a02-baff-042cd27688ea,specimens for fungal culture and other relevant laboratory studies ( including histopathology ) should be obtained prior to therapy to isolate and identify causative organism ( s ),0
4716,4716,4716,4716,4716,4716,4716,5760,5760,5760,5760,5760,5760,5760,5760,5760,5760,5760,5760,5760,a88d9010-55fb-4a02-baff-042cd27688ea,therapy may be instituted before the results of the cultures and other laboratory studies known,0
4717,4717,4717,4717,4717,4717,4717,5762,5762,5762,5762,5762,5762,5762,5762,5762,5762,5762,5762,5762,a88d9010-55fb-4a02-baff-042cd27688ea,anidulafungin is an echinocandin antifungal indicated in adults for the treatment of candidemia and other forms of candida infections ( intra abdominal abscess and peritonitis ) ( 1 1 ) esophageal candidiasis ( 1 2 ) limitations of use has not been studied in endocarditis  osteomyelitis and meningitis due to candida or in sufficient numbers of neutropenic patients ( 1 3 ) 1 1 candidemia and other forms of candida infections ( intra abdominal abscess and peritonitis ) eraxis is indicated for the treatment of candidemia and the following candida infections intra abdominal abscess and peritonitis see clinical studies ( 14 1 ) and clinical pharmacology  microbiology ( 12 4 ),1
4718,4718,4718,4718,4718,4718,4718,5763,5763,5763,5763,5763,5763,5763,5763,5763,5763,5763,5763,5763,a88d9010-55fb-4a02-baff-042cd27688ea,1 2 esophageal candidiasis eraxis is indicated for the treatment of esophageal candidiasis see clinical studies ( 14 2 )  table 12 for higher relapse rates off eraxis therapy,1
4719,4719,4719,4719,4719,4719,4719,5764,5764,5764,5764,5764,5764,5764,5764,5764,5764,5764,5764,5764,a88d9010-55fb-4a02-baff-042cd27688ea,1 3 limitation of use eraxis has not been studied in endocarditis  osteomyelitis  and meningitis due to candida  and has not been studied in sufficient numbers of neutropenic patients to determine efficacy in this group,0
4720,4720,4720,4720,4720,4720,4720,5765,5765,5765,5765,5765,5765,5765,5765,5765,5765,5765,5765,5765,2150f73a-179b-4afc-b8ce-67c85cc72f04,1  afinitor is a kinase inhibitor indicated for the treatment of postmenopausal women with advanced hormone receptor positive  her2 negative breast cancer ( advanced hr bc ) in combination with exemestane after failure of treatment with letrozole or anastrozole,1
4721,4721,4721,4721,4721,4721,4721,5766,5766,5766,5766,5766,5766,5766,5766,5766,5766,5766,5766,5766,2150f73a-179b-4afc-b8ce-67c85cc72f04,( 1 1 ) adults with progressive neuroendocrine tumors of pancreatic origin ( pnet ) and adults with progressive  well differentiated  non functional neuroendocrine tumors ( net ) of gastrointestinal ( gi ) or lung origin that are unresectable  locally advanced or metastatic,u
4722,4722,4722,4722,4722,4722,4722,5767,5767,5767,5767,5767,5767,5767,5767,5767,5767,5767,5767,5767,2150f73a-179b-4afc-b8ce-67c85cc72f04,afinitor is not indicated for the treatment of patients with functional carcinoid tumors,2
4723,4723,4723,4723,4723,4723,4723,5768,5768,5768,5768,5768,5768,5768,5768,5768,5768,5768,5768,5768,2150f73a-179b-4afc-b8ce-67c85cc72f04,( 1 2 ) adults with advanced renal cell carcinoma ( rcc ) after failure of treatment with sunitinib or sorafenib,1
4724,4724,4724,4724,4724,4724,4724,5769,5769,5769,5769,5769,5769,5769,5769,5769,5769,5769,5769,5769,2150f73a-179b-4afc-b8ce-67c85cc72f04,( 1 3 ) adults with renal angiomyolipoma and tuberous sclerosis complex ( tsc )  not requiring immediate surgery,1
4725,4725,4725,4725,4725,4725,4725,5770,5770,5770,5770,5770,5770,5770,5770,5770,5770,5770,5770,5770,2150f73a-179b-4afc-b8ce-67c85cc72f04,( 1 4 ) afinitor and afinitor disperz are kinase inhibitors indicated for the treatment of pediatric and adult patients with tuberous sclerosis complex ( tsc ) who have subependymal giant cell astrocytoma ( sega ) that requires therapeutic intervention but cannot be curatively resected,1
4726,4726,4726,4726,4726,4726,4726,5771,5771,5771,5771,5771,5771,5771,5771,5771,5771,5771,5771,5771,2150f73a-179b-4afc-b8ce-67c85cc72f04,( 1 5 ) 1 1 advanced hormone receptor positive  her2 negative breast cancer ( advanced hr bc ) afinitor is indicated for the treatment of postmenopausal women with advanced hormone receptor positive  her2 negative breast cancer ( advanced hr bc ) in combination with exemestane  after failure of treatment with letrozole or anastrozole,1
4727,4727,4727,4727,4727,4727,4727,5772,5772,5772,5772,5772,5772,5772,5772,5772,5772,5772,5772,5772,2150f73a-179b-4afc-b8ce-67c85cc72f04,1 2 advanced neuroendocrine tumors ( net ) afinitor is indicated for the treatment of adult patients with progressive neuroendocrine tumors of pancreatic origin ( pnet ) with unresectable  locally advanced or metastatic disease,1
4728,4728,4728,4728,4728,4728,4728,5773,5773,5773,5773,5773,5773,5773,5773,5773,5773,5773,5773,5773,2150f73a-179b-4afc-b8ce-67c85cc72f04,afinitor is indicated for the treatment of adult patients with progressive  well differentiated  non functional neuroendocrine tumors ( net ) of gastrointestinal ( gi ) or lung origin with unresectable  locally advanced or metastatic disease,1
4729,4729,4729,4729,4729,4729,4729,5774,5774,5774,5774,5774,5774,5774,5774,5774,5774,5774,5774,5774,2150f73a-179b-4afc-b8ce-67c85cc72f04,afinitor is not indicated for the treatment of patients with functional carcinoid tumors see clinical studies ( 14 2 ),2
4730,4730,4730,4730,4730,4730,4730,5775,5775,5775,5775,5775,5775,5775,5775,5775,5775,5775,5775,5775,3b255bcd-0218-44f8-830b-971f5ec45276, meprobamate tablets are indicated for the management of anxiety disorders or for the short term relief of the symptoms of anxiety,1
4731,4731,4731,4731,4731,4731,4731,5776,5776,5776,5776,5776,5776,5776,5776,5776,5776,5776,5776,5776,3b255bcd-0218-44f8-830b-971f5ec45276,anxiety or tension associated with the stress of everyday life usually do not require treatment with an anxiolytic,0
4732,4732,4732,4732,4732,4732,4732,5777,5777,5777,5777,5777,5777,5777,5777,5777,5777,5777,5777,5777,3b255bcd-0218-44f8-830b-971f5ec45276,the effectiveness of meprobamate tablets in long term use  that is  more than 4 months  has not been assessed by systematic clinical studies,0
4733,4733,4733,4733,4733,4733,4733,5779,5779,5779,5779,5779,5779,5779,5779,5779,5779,5779,5779,5779,"Active Ingredient UNII(s)
9I7LNY769Q; R16CO5Y76E    941e1ec2-1f14-4153-a5ea-cf7669d5efd1
9I7LNY769Q; R16CO5Y76E    941e1ec2-1f14-4153-a5ea-cf7669d5efd1
Name: SET ID dtype: object",active ingredient unii ( s ) 9i7lny769q r16co5y76e active ingredient unii ( s ) 9i7lny769q r16co5y7 9i7lny769q r16co5y76e active ingredient unii ( s ) 9i7lny769q r16co5y7 name content xml  dtype object,0
4734,4734,4734,4734,4734,4734,4734,5781,5781,5781,5781,5781,5781,5781,5781,5781,5781,5781,5781,5781,f67bb80b-9eaf-45e4-9f3c-10fcd692b6f7,indications for temporary relief of symptoms related to the addictive cravings of chocolate and alcohol  food cravings  thymus dysfunction  obsessive compulsive behavior  headache  depression and poor memory,1
4735,4735,4735,4735,4735,4735,4735,5782,5782,5782,5782,5782,5782,5782,5782,5782,5782,5782,5782,5782,36b4f524-90e6-415c-8c0c-8983da2c7fd4,1  rivastigmine tartrate capsules are an acetylcholinesterase inhibitor indicated for treatment of mild to moderate dementia of the alzheimer s type ( 1 1 ) mild to moderate dementia associated with parkinson s disease ( 1 2 ) 1 1 alzheimer s disease rivastigmine tartrate capsules are indicated for the treatment of mild to moderate dementia of the alzheimer 's type,1
4736,4736,4736,4736,4736,4736,4736,5783,5783,5783,5783,5783,5783,5783,5783,5783,5783,5783,5783,5783,36b4f524-90e6-415c-8c0c-8983da2c7fd4,1 2 parkinson s disease dementia rivastigmine tartrate capsules are indicated for the treatment of mild to moderate dementia associated with parkinson s disease,1
4737,4737,4737,4737,4737,4737,4737,5784,5784,5784,5784,5784,5784,5784,5784,5784,5784,5784,5784,5784,bd1ce5e4-9dd5-4bd5-ae5e-c88822c04f98, levothyroxine sodium is used for the following indications hypothyroidism as replacement or supplemental therapy in congenital or acquired hypothyroidism of any etiology  except transient hypothyroidism during the recovery phase of subacute thyroiditis,1
4738,4738,4738,4738,4738,4738,4738,5785,5785,5785,5785,5785,5785,5785,5785,5785,5785,5785,5785,5785,bd1ce5e4-9dd5-4bd5-ae5e-c88822c04f98,specific indications include primary ( thyroidal )  secondary ( pituitary )  and tertiary ( hypothalamic ) hypothyroidism and subclinical hypothyroidism,1
4739,4739,4739,4739,4739,4739,4739,5786,5786,5786,5786,5786,5786,5786,5786,5786,5786,5786,5786,5786,bd1ce5e4-9dd5-4bd5-ae5e-c88822c04f98,primary hypothyroidism may result from functional deficiency  primary atrophy  partial or total congenital absence of the thyroid gland  or from the effects of surgery  radiation  or drugs  with or without the presence of goiter,c
4740,4740,4740,4740,4740,4740,4740,5787,5787,5787,5787,5787,5787,5787,5787,5787,5787,5787,5787,5787,bd1ce5e4-9dd5-4bd5-ae5e-c88822c04f98,pituitary tsh suppression in the treatment or prevention of various types of euthyroid goiters ( see warnings and precautions )  including thyroid nodules ( see warnings and precautions )  subacute or chronic iymphocytic thyroiditis ( hashimoto 's thyroiditis )  multinodular goiter ( see warnings and precautions )  and  as an adjunct to surgery and radioiodine therapy in the management of thyrotropin dependent well differentiated thyroid cancer,1
4741,4741,4741,4741,4741,4741,4741,5788,5788,5788,5788,5788,5788,5788,5788,5788,5788,5788,5788,5788,7d028b83-5166-4b2e-b442-ba6cbfefbfd6, thyrolar tablets are indicated as replacement or supplemental therapy in patients with hypothyroidism of any etiology  except transient hypothyroidism during the recovery phase of subacute thyroiditis,1
4742,4742,4742,4742,4742,4742,4742,5790,5790,5790,5790,5790,5790,5790,5790,5790,5790,5790,5790,5790,7d028b83-5166-4b2e-b442-ba6cbfefbfd6,as pituitary tsh suppressants  in the treatment or prevention of various types of euthyroid goiters  including thyroid nodules  sub acute or chronic iymphocytic thyroiditis ( hashimoto 's )  multinodular goiter  and in the management of thyroid cancer,1
4743,4743,4743,4743,4743,4743,4743,5791,5791,5791,5791,5791,5791,5791,5791,5791,5791,5791,5791,5791,5328c194-5650-4d1f-9e28-8cea038cce81, males androxy tablets are indicated for replacement therapy in conditions associated with a deficiency or absence of endogenous testosterone,1
4744,4744,4744,4744,4744,4744,4744,5793,5793,5793,5793,5793,5793,5793,5793,5793,5793,5793,5793,5793,5328c194-5650-4d1f-9e28-8cea038cce81,hypogonadotropic hypogonadism ( congenital or acquired ) idiopathic gonadotropin or luteinizing hormone releasing hormone ( lhrh ) deficiency  or pituitary hypothalamic injury from tumors  trauma  or radiation,1
4745,4745,4745,4745,4745,4745,4745,5797,5797,5797,5797,5797,5797,5797,5797,5797,5797,5797,5797,5797,5328c194-5650-4d1f-9e28-8cea038cce81,delayed puberty androxy ( fluoxymesterone tablets  usp ) may be used to stimulate puberty in carefully selected males with clearly delayed puberty,1
4746,4746,4746,4746,4746,4746,4746,5802,5802,5802,5802,5802,5802,5802,5802,5802,5802,5802,5802,5802,e049b79d-d174-440e-88fa-a602ce666900, milrinone lactate in 5 dextrose injection is indicated for the short term intravenous treatment of patients with acute decompensated heart failure,1
4747,4747,4747,4747,4747,4747,4747,5803,5803,5803,5803,5803,5803,5803,5803,5803,5803,5803,5803,5803,e049b79d-d174-440e-88fa-a602ce666900,patients receiving milrinone should be observed closely with appropriate electrocardiographic equipment,4
4748,4748,4748,4748,4748,4748,4748,5804,5804,5804,5804,5804,5804,5804,5804,5804,5804,5804,5804,5804,e049b79d-d174-440e-88fa-a602ce666900,the facility for immediate treatment of potential cardiac events  which may include life threatening ventricular arrhythmias  must be available,0
4749,4749,4749,4749,4749,4749,4749,5805,5805,5805,5805,5805,5805,5805,5805,5805,5805,5805,5805,5805,e049b79d-d174-440e-88fa-a602ce666900,the majority of experience with intravenous milrinone has been in patients receiving digoxin and diuretics,0
4750,4750,4750,4750,4750,4750,4750,5806,5806,5806,5806,5806,5806,5806,5806,5806,5806,5806,5806,5806,e049b79d-d174-440e-88fa-a602ce666900,there is no experience in controlled trials with infusions of milrinone for periods exceeding 48 hours,0
4751,4751,4751,4751,4751,4751,4751,5807,5807,5807,5807,5807,5807,5807,5807,5807,5807,5807,5807,5807,c25d21e7-6136-4a7a-b139-12f53116fc3d, ibutilide fumarate injection is indicated for the rapid conversion of atrial fibrillation or atrial flutter of recent onset to sinus rhythm,1
4752,4752,4752,4752,4752,4752,4752,5808,5808,5808,5808,5808,5808,5808,5808,5808,5808,5808,5808,5808,c25d21e7-6136-4a7a-b139-12f53116fc3d,patients with atrial arrhythmias of longer duration are less likely to respond to ibutilide fumarate injection,u
4753,4753,4753,4753,4753,4753,4753,5809,5809,5809,5809,5809,5809,5809,5809,5809,5809,5809,5809,5809,c25d21e7-6136-4a7a-b139-12f53116fc3d,the effectiveness of ibutilide has not been determined in patients with arrhythmias of more than 90 days in duration,0
4754,4754,4754,4754,4754,4754,4754,5810,5810,5810,5810,5810,5810,5810,5810,5810,5810,5810,5810,5810,16978114-7c7b-0f77-e054-00144ff8d46c, 1  sodium fluoride f 18 injection is indicated for diagnostic positron emission tomography ( pet ) imaging of bone to define areas of altered osteogenic activity,1
4755,4755,4755,4755,4755,4755,4755,5811,5811,5811,5811,5811,5811,5811,5811,5811,5811,5811,5811,5811,16978114-7c7b-0f77-e054-00144ff8d46c,sodium fluoride f 18 injection is a radioactive diagnostic agent for positron emission tomography ( pet ) indicated for imaging of bone to define areas of altered osteogenic activity ( 1 ),1
4756,4756,4756,4756,4756,4756,4756,5812,5812,5812,5812,5812,5812,5812,5812,5812,5812,5812,5812,5812,5c707089-fb5b-4016-8ca7-11bbcfb57854, therapy with lovastatin should be a component of multiple risk factor intervention in those individuals with dyslipidemia at risk for atherosclerotic vascular disease,1
4757,4757,4757,4757,4757,4757,4757,5813,5813,5813,5813,5813,5813,5813,5813,5813,5813,5813,5813,5813,5c707089-fb5b-4016-8ca7-11bbcfb57854,lovastatin should be used in addition to a diet restricted in saturated fat and cholesterol as part of a treatment strategy to lower total c and ldl c to target levels when the response to diet and other nonpharmacological measures alone has been inadequate to reduce risk,1
4758,4758,4758,4758,4758,4758,4758,5814,5814,5814,5814,5814,5814,5814,5814,5814,5814,5814,5814,5814,5c707089-fb5b-4016-8ca7-11bbcfb57854,primary prevention of coronary heart disease in individuals without symptomatic cardiovascular disease  average to moderately elevated total c and ldl c  and below average hdl c  lovastatin is indicated to reduce the risk of myocardial infarction unstable angina coronary revascularization procedures ( see clinical pharmacology  clinical studies ),1
4759,4759,4759,4759,4759,4759,4759,5815,5815,5815,5815,5815,5815,5815,5815,5815,5815,5815,5815,5815,5c707089-fb5b-4016-8ca7-11bbcfb57854,coronary heart disease lovastatin is indicated to slow the progression of coronary atherosclerosis in patients with coronary heart disease as part of a treatment strategy to lower total c and ldl c to target levels,1
4760,4760,4760,4760,4760,4760,4760,5816,5816,5816,5816,5816,5816,5816,5816,5816,5816,5816,5816,5816,5c707089-fb5b-4016-8ca7-11bbcfb57854,hypercholesterolemia therapy with lipid altering agents should be a component of multiple risk factor intervention in those individuals at significantly increased risk for artherosclerotic vascular disease due to hypercholesterolemia,u
4761,4761,4761,4761,4761,4761,4761,5817,5817,5817,5817,5817,5817,5817,5817,5817,5817,5817,5817,5817,5c707089-fb5b-4016-8ca7-11bbcfb57854,lovastatin is indicated as an adjunct to diet for the reduction of elevated total c and ldl c levels in patients with primary hypercholesterolemia ( types iia and iib 2 )  when the response to diet restricted in saturated fat and cholesterol and to other nonpharmacological measures alone has been inadequate,1
4762,4762,4762,4762,4762,4762,4762,5818,5818,5818,5818,5818,5818,5818,5818,5818,5818,5818,5818,5818,5c707089-fb5b-4016-8ca7-11bbcfb57854,adolescent patients with heterozygous familial hypercholesterolemia lovastatin is indicated as an adjunct to diet to reduce total c  ldl c and apolipoprotein b levels in adolescent boys and girls who are at least one year post menarche  10 to 17 years of age  with,1
4763,4763,4763,4763,4763,4763,4763,5819,5819,5819,5819,5819,5819,5819,5819,5819,5819,5819,5819,5819,ee2767d3-6b3d-4ea4-ae4d-3a6a0a10d3cc, tolazamide tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus,1
4764,4764,4764,4764,4764,4764,4764,5820,5820,5820,5820,5820,5820,5820,5820,5820,5820,5820,5820,5820,1ab5ae3e-e303-4499-4c89-472d7cc1e46c, tazicef ( ceftazidime for injection  usp ) is indicated for the treatment of patients with infections caused by susceptible strains of the designated organisms in the following diseases 1,1
4765,4765,4765,4765,4765,4765,4765,5821,5821,5821,5821,5821,5821,5821,5821,5821,5821,5821,5821,5821,1ab5ae3e-e303-4499-4c89-472d7cc1e46c,lower respiratory tract infections  including pneumonia  caused by pseudomonas aeruginosa and other pseudomonas spp,1
4766,4766,4766,4766,4766,4766,4766,5822,5822,5822,5822,5822,5822,5822,5822,5822,5822,5822,5822,5822,1ab5ae3e-e303-4499-4c89-472d7cc1e46c,haemophilus influenzae  including ampicillin resistant strains klebsiella spp,1
4767,4767,4767,4767,4767,4767,4767,5823,5823,5823,5823,5823,5823,5823,5823,5823,5823,5823,5823,5823,1ab5ae3e-e303-4499-4c89-472d7cc1e46c,proteus mirabilis escherichia coli serratia spp,1
4768,4768,4768,4768,4768,4768,4768,5824,5824,5824,5824,5824,5824,5824,5824,5824,5824,5824,5824,5824,1ab5ae3e-e303-4499-4c89-472d7cc1e46c,streptococcus pneumoniae and staphylococcus aureus ( methicillin susceptible strains ),1
4769,4769,4769,4769,4769,4769,4769,5825,5825,5825,5825,5825,5825,5825,5825,5825,5825,5825,5825,5825,1ab5ae3e-e303-4499-4c89-472d7cc1e46c,skin and skin structure infections caused by pseudomonas aeruginosa klebsiella spp,1
4770,4770,4770,4770,4770,4770,4770,5826,5826,5826,5826,5826,5826,5826,5826,5826,5826,5826,5826,5826,1ab5ae3e-e303-4499-4c89-472d7cc1e46c,escherichia coli proteus spp  including proteus mirabilis and indole positive proteus enterobacter spp,1
4771,4771,4771,4771,4771,4771,4771,5827,5827,5827,5827,5827,5827,5827,5827,5827,5827,5827,5827,5827,1ab5ae3e-e303-4499-4c89-472d7cc1e46c,staphylococcus aureus ( methicillin susceptible strains ) and streptococcus pyogenes ( group a beta hemolytic streptococci ),1
4772,4772,4772,4772,4772,4772,4772,5828,5828,5828,5828,5828,5828,5828,5828,5828,5828,5828,5828,5828,1ab5ae3e-e303-4499-4c89-472d7cc1e46c,urinary tract infections  both complicated and uncomplicated  caused by pseudomonas aeruginosa enterobacter spp,1
4773,4773,4773,4773,4773,4773,4773,5829,5829,5829,5829,5829,5829,5829,5829,5829,5829,5829,5829,5829,1ab5ae3e-e303-4499-4c89-472d7cc1e46c,proteus spp  including proteus mirabilis and indole positive cont,1
4774,4774,4774,4774,4774,4774,4774,5830,5830,5830,5830,5830,5830,5830,5830,5830,5830,5830,5830,5830,d9c2803f-dc9c-4b19-b4a3-8303bc8c15fd,1  avycaz is a combination of ceftazidime  a cephalosporin  and avibactam  a beta lactamase inhibitor  indicated for the treatment of patients 18 years or older with the following infections caused by designated susceptible gram negative microorganisms complicated intra abdominal infections ( ciai )  used in combination with metronidazole ( 1 1 ) complicated urinary tract infections ( cuti )  including pyelonephritis ( 1 2 ) hospital acquired bacterial pneumonia and ventilator associated bacterial pneumonia ( habp vabp ) ( 1 3 ) to reduce the development of drug resistant bacteria and maintain the effectiveness of avycaz and other antibacterial drugs  avycaz should be used only to treat infections that are proven or strongly suspected to be caused by susceptible bacteria,1
4775,4775,4775,4775,4775,4775,4775,5831,5831,5831,5831,5831,5831,5831,5831,5831,5831,5831,5831,5831,d9c2803f-dc9c-4b19-b4a3-8303bc8c15fd,1 complicated intra a bdominal infections ( ciai ) avycaz ( ceftazidime and avibactam ) in combination with metronidazole  is indicated for the treatment of complicated intra abdominal infections ( ciai ) caused by the following susceptible gram negative microorganisms escherichia coli  klebsiella pneumoniae  proteus mirabilis  enterobacter cloacae  klebsiella oxytoca  citrobacter freundii complex  and pseudomonas aeruginosa in patients 18 years or older,1
4776,4776,4776,4776,4776,4776,4776,5832,5832,5832,5832,5832,5832,5832,5832,5832,5832,5832,5832,5832,d9c2803f-dc9c-4b19-b4a3-8303bc8c15fd,2 complicated urinary tract infections ( cuti )  including pyelonephritis,1
4777,4777,4777,4777,4777,4777,4777,5833,5833,5833,5833,5833,5833,5833,5833,5833,5833,5833,5833,5833,0f799e5c-f782-4f3d-bdb6-52bd413a19cf, tramadol hydrochloride er tablets are indicated for the management of moderate to moderately severe chronic pain in adults who require around the clock treatment of their pain for an extended period of time,1
4778,4778,4778,4778,4778,4778,4778,5834,5834,5834,5834,5834,5834,5834,5834,5834,5834,5834,5834,5834,d0e105f6-28f3-45ee-83bd-7d458835242b,1  xarelto is a factor xa inhibitor indicated to reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation ( 1 1 ) for the treatment of deep vein thrombosis ( dvt )  pulmonary embolism ( pe )  and for the reduction in the risk of recurrence of dvt and of pe ( 1 2  1 3  1 4 ) for the prophylaxis of dvt  which may lead to pe in patients undergoing knee or hip replacement surgery ( 1 5 ) 1 1 reduction of risk of stroke and systemic embolism in nonvalvular atrial fibrillation xarelto is indicated to reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation,1
4779,4779,4779,4779,4779,4779,4779,5835,5835,5835,5835,5835,5835,5835,5835,5835,5835,5835,5835,5835,d0e105f6-28f3-45ee-83bd-7d458835242b,there are limited data on the relative effectiveness of xarelto and warfarin in reducing the risk of stroke and systemic embolism when warfarin therapy is well controlled see clinical studies ( 14 1 ),u
4780,4780,4780,4780,4780,4780,4780,5836,5836,5836,5836,5836,5836,5836,5836,5836,5836,5836,5836,5836,d0e105f6-28f3-45ee-83bd-7d458835242b,1 2 treatment of deep vein thrombosis xarelto is indicated for the treatment of deep vein thrombosis ( dvt ),1
4781,4781,4781,4781,4781,4781,4781,5837,5837,5837,5837,5837,5837,5837,5837,5837,5837,5837,5837,5837,d0e105f6-28f3-45ee-83bd-7d458835242b,1 3 treatment of pulmonary embolism xarelto is indicated for the treatment of pulmonary embolism ( pe ),1
4782,4782,4782,4782,4782,4782,4782,5838,5838,5838,5838,5838,5838,5838,5838,5838,5838,5838,5838,5838,d0e105f6-28f3-45ee-83bd-7d458835242b,1 4 reduction in the risk of recurrence of deep vein thrombosis and of pulmonary embolism xarelto is indicated for the reduction in the risk of recurrence of deep vein thrombosis and of pulmonary embolism following initial 6 months treatment for dvt and or pe,1
4783,4783,4783,4783,4783,4783,4783,5839,5839,5839,5839,5839,5839,5839,5839,5839,5839,5839,5839,5839,d0e105f6-28f3-45ee-83bd-7d458835242b,1 5 prophylaxis of deep vein thrombosis following hip or knee replacement surgery xarelto is indicated for the prophy,1
4784,4784,4784,4784,4784,4784,4784,5840,5840,5840,5840,5840,5840,5840,5840,5840,5840,5840,5840,5840,0571c18b-1d5e-47bd-bddf-54d74ce1b442, technetium tc 99m mertiatide is a renal imaging agent for use in the diagnosis of congenital and acquired abnormalities  renal failure  urinary tract obstruction  and calculi in adults and pediatric patients,1
4785,4785,4785,4785,4785,4785,4785,5841,5841,5841,5841,5841,5841,5841,5841,5841,5841,5841,5841,5841,0571c18b-1d5e-47bd-bddf-54d74ce1b442,it is a diagnostic aid in providing renal function  split function  renal angiograms  and renogram curves for whole kidney and renal cortex,1
4786,4786,4786,4786,4786,4786,4786,5842,5842,5842,5842,5842,5842,5842,5842,5842,5842,5842,5842,5842,4984b255-e03b-0f7b-e054-00144ff88e88,hypertension enalapril maleate is indicated for the treatment of hypertension,1
4787,4787,4787,4787,4787,4787,4787,5843,5843,5843,5843,5843,5843,5843,5843,5843,5843,5843,5843,5843,4984b255-e03b-0f7b-e054-00144ff88e88,enalapril maleate is effective alone or in combination with other antihypertensive agents  especially thiazide type diuretics,4
4788,4788,4788,4788,4788,4788,4788,5844,5844,5844,5844,5844,5844,5844,5844,5844,5844,5844,5844,5844,4984b255-e03b-0f7b-e054-00144ff88e88,the blood pressure lowering effects of enalapril maleate and thiazides are approximately additive,0
4789,4789,4789,4789,4789,4789,4789,5845,5845,5845,5845,5845,5845,5845,5845,5845,5845,5845,5845,5845,4984b255-e03b-0f7b-e054-00144ff88e88,heart failure enalapril maleate is indicated for the treatment of symptomatic congestive heart failure  usually in combination with diuretics and digitalis,1
4790,4790,4790,4790,4790,4790,4790,5846,5846,5846,5846,5846,5846,5846,5846,5846,5846,5846,5846,5846,4984b255-e03b-0f7b-e054-00144ff88e88,in these patients enalapril maleate improves symptoms  increases survival  and decreases the frequency of hospitalization ( see clinical pharmacology  heart failure  mortality trials for details and limitations of survival trials ),u
4791,4791,4791,4791,4791,4791,4791,5847,5847,5847,5847,5847,5847,5847,5847,5847,5847,5847,5847,5847,4984b255-e03b-0f7b-e054-00144ff88e88,asymptomatic left ventricular dysfunction in clinically stable asymptomatic patients with left ventricular dysfunction ( ejection fraction 35 percent )  enalapril maleate decreases the rate of development of overt heart failure and decreases the incidence of hospitalization for heart failure ( see clinical pharmacology  heart failure  mortality trials for details and limitations of survival trials ),u
4792,4792,4792,4792,4792,4792,4792,5848,5848,5848,5848,5848,5848,5848,5848,5848,5848,5848,5848,5848,4984b255-e03b-0f7b-e054-00144ff88e88,in using enalapril maleate consideration should be given to the fact that another angiotensin converting enzyme inhibitor  captopril  has caused agranulocytosis  particularly in patients with renal impairment or collagen vascular disease  and that available data are insufficient to show that enalapril maleate does not have a similar risk ( see warnings ),0
4793,4793,4793,4793,4793,4793,4793,5849,5849,5849,5849,5849,5849,5849,5849,5849,5849,5849,5849,5849,4984b255-e03b-0f7b-e054-00144ff88e88,in considering use of enalapril maleate it should be noted that in controlled clinical trials ace inhibitors have an effect on blood pressure that is less in black patients than in non blacks,0
4794,4794,4794,4794,4794,4794,4794,5850,5850,5850,5850,5850,5850,5850,5850,5850,5850,5850,5850,5850,4984b255-e03b-0f7b-e054-00144ff88e88,in addition  it should be noted that black patients receiving ace inhibitors have been reported to have a higher incidence of angioedema compared to non blacks ( see warnings  head and neck angioedema ),3
4795,4795,4795,4795,4795,4795,4795,5851,5851,5851,5851,5851,5851,5851,5851,5851,5851,5851,5851,5851,169b8128-1698-4b21-e054-00144ff8d46c, 1  ammonia n 13 injection is indicated for diagnostic positron emission tomography ( pet ) imaging of the myocardium under rest or pharmacologic stress conditions to evaluate myocardial perfusion in patients with suspected or existing coronary artery disease,1
4796,4796,4796,4796,4796,4796,4796,5852,5852,5852,5852,5852,5852,5852,5852,5852,5852,5852,5852,5852,169b8128-1698-4b21-e054-00144ff8d46c, ammonia n 13 injection is a radioactive diagnostic agent for positron emission tomography ( pet ) indicated for diagnostic pet imaging of the myocardium under rest or pharmacologic stress conditions to evaluate myocardial perfusion in patients with suspected or existing coronary artery disease ( 1 ),1
4797,4797,4797,4797,4797,4797,4797,5853,5853,5853,5853,5853,5853,5853,5853,5853,5853,5853,5853,5853,2d18cfc4-e0de-4814-a712-c1b7c504bff5,1  bydureon bcise is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus see clinical studies ( 14 ),1
4798,4798,4798,4798,4798,4798,4798,5854,5854,5854,5854,5854,5854,5854,5854,5854,5854,5854,5854,5854,2d18cfc4-e0de-4814-a712-c1b7c504bff5,limitations of use bydureon bcise is not recommended as first line therapy for patients who have inadequate glycemic control on diet and exercise because of the uncertain relevance of the rat thyroid c cell tumor findings to humans see warnings and precautions ( 5 1 ),2
4799,4799,4799,4799,4799,4799,4799,5855,5855,5855,5855,5855,5855,5855,5855,5855,5855,5855,5855,5855,2d18cfc4-e0de-4814-a712-c1b7c504bff5,bydureon bcise is not a substitute for insulin,0
4800,4800,4800,4800,4800,4800,4800,5856,5856,5856,5856,5856,5856,5856,5856,5856,5856,5856,5856,5856,2d18cfc4-e0de-4814-a712-c1b7c504bff5,bydureon bcise is not indicated for use in patients with type 1 diabetes mellitus or for the treatment of diabetic ketoacidosis  as it would not be effective in these settings,0
4801,4801,4801,4801,4801,4801,4801,5857,5857,5857,5857,5857,5857,5857,5857,5857,5857,5857,5857,5857,2d18cfc4-e0de-4814-a712-c1b7c504bff5,the concurrent use of bydureon bcise with insulin has not been studied and is not recommended,2
4802,4802,4802,4802,4802,4802,4802,5858,5858,5858,5858,5858,5858,5858,5858,5858,5858,5858,5858,5858,2d18cfc4-e0de-4814-a712-c1b7c504bff5,bydureon bcise is an extended release formulation of exenatide,0
4803,4803,4803,4803,4803,4803,4803,5859,5859,5859,5859,5859,5859,5859,5859,5859,5859,5859,5859,5859,2d18cfc4-e0de-4814-a712-c1b7c504bff5,bydureon bcise should not be used with other products containing the active ingredient exenatide,2
4804,4804,4804,4804,4804,4804,4804,5860,5860,5860,5860,5860,5860,5860,5860,5860,5860,5860,5860,5860,2d18cfc4-e0de-4814-a712-c1b7c504bff5,bydureon bcise has not been studied in patients with a history of pancreatitis,0
4805,4805,4805,4805,4805,4805,4805,5861,5861,5861,5861,5861,5861,5861,5861,5861,5861,5861,5861,5861,2d18cfc4-e0de-4814-a712-c1b7c504bff5,consider other antidiabetic therapies in patients with a history of pancreatitis see warnings and precautions ( 5 2 ) and adverse reactions ( 6 3 ),0
4806,4806,4806,4806,4806,4806,4806,5862,5862,5862,5862,5862,5862,5862,5862,5862,5862,5862,5862,5862,2d18cfc4-e0de-4814-a712-c1b7c504bff5,bydureon bcise is a glucagon like peptide 1 ( glp 1 ) receptor agonist indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus,1
4807,4807,4807,4807,4807,4807,4807,5863,5863,5863,5863,5863,5863,5863,5863,5863,5863,5863,5863,5863,2d18cfc4-e0de-4814-a712-c1b7c504bff5,( 1  14 ) limitations of use not recommended as first line therapy for patients inadequately controlled on diet and exercise,2
4808,4808,4808,4808,4808,4808,4808,5864,5864,5864,5864,5864,5864,5864,5864,5864,5864,5864,5864,5864,2d18cfc4-e0de-4814-a712-c1b7c504bff5,( 1 ) should not be used to treat type 1 diabetes or diabetic ketoacidosis,2
4809,4809,4809,4809,4809,4809,4809,5865,5865,5865,5865,5865,5865,5865,5865,5865,5865,5865,5865,5865,2d18cfc4-e0de-4814-a712-c1b7c504bff5,( 1 ) use with insulin has not been studied and is not recommended,2
4810,4810,4810,4810,4810,4810,4810,5866,5866,5866,5866,5866,5866,5866,5866,5866,5866,5866,5866,5866,2d18cfc4-e0de-4814-a712-c1b7c504bff5,( 1 ) bydureon bcise is an extended release formulation of exenatide,0
4811,4811,4811,4811,4811,4811,4811,5867,5867,5867,5867,5867,5867,5867,5867,5867,5867,5867,5867,5867,2d18cfc4-e0de-4814-a712-c1b7c504bff5,do not coadminister with other exenatide containing products,0
4812,4812,4812,4812,4812,4812,4812,5868,5868,5868,5868,5868,5868,5868,5868,5868,5868,5868,5868,5868,2d18cfc4-e0de-4814-a712-c1b7c504bff5,( 1 ) has not been studied in patients with a history of pancreatitis,0
4813,4813,4813,4813,4813,4813,4813,5871,5871,5871,5871,5871,5871,5871,5871,5871,5871,5871,5871,5871,863ad743-eec0-46f0-beba-c1556384c636,primary or secondary adrenocortical insufficiency ( hydrocortisone or cortisone is the first choice synthetic analogs may be used in conjunction with mineralocorticoids where applicable in infancy mineralocorticoid supplementation is of particular importance ),1
4814,4814,4814,4814,4814,4814,4814,5873,5873,5873,5873,5873,5873,5873,5873,5873,5873,5873,5873,5873,863ad743-eec0-46f0-beba-c1556384c636,as adjunctive therapy for short term administration ( to tide the patient over an acute episode or exacerbation ) in psoriatic arthritis rheumatoid arthritis including juvenile rheumatoid arthritis ( selected cases may require low dose maintenance therapy ) ankylosing spondylitis acute and subacute bursitis acute nonspecific tenosynovitis acute gouty arthritis post traumatic osteoarthritis synovitis of osteoarthritis epicondylitis 3,1
4815,4815,4815,4815,4815,4815,4815,5874,5874,5874,5874,5874,5874,5874,5874,5874,5874,5874,5874,5874,863ad743-eec0-46f0-beba-c1556384c636,during an exacerbation or as maintenance therapy in selected cases of systemic lupus erythematosus acute rheumatic carditis systemic dermatomyositis ( poly my ositis ),1
4816,4816,4816,4816,4816,4816,4816,5875,5875,5875,5875,5875,5875,5875,5875,5875,5875,5875,5875,5875,863ad743-eec0-46f0-beba-c1556384c636,dermatologic diseases pemphigus bullous dermatitis herpetiformis severe erythema multiforme ( ste vens johnson syndrome ) exfoliative dermatitis mycosis fungoides severe psoriasis severe seborrheic dermatitis,
4817,4817,4817,4817,4817,4817,4817,5876,5876,5876,5876,5876,5876,5876,5876,5876,5876,5876,5876,5876,863ad743-eec0-46f0-beba-c1556384c636,control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment seasonal or perennial allergic rhinitis serum sickness bronchial asthma contact dermatitis atopic dermatitis drug hypersensitivity reactions 6,1
4818,4818,4818,4818,4818,4818,4818,5877,5877,5877,5877,5877,5877,5877,5877,5877,5877,5877,5877,5877,863ad743-eec0-46f0-beba-c1556384c636,severe acute and chronic allergic and inflammatory processes involving the eye and its adnexa such as allergic conjunctivitis keratitis allergic corneal marginal ulcers herpes zoster ophthalmicus iritis and iridocyclitis chorioretinitis anterior segment inflammation diffuse posterior uveitis and choroiditis optic neuritis sympathetic ophthalmia 7,1
4819,4819,4819,4819,4819,4819,4819,5878,5878,5878,5878,5878,5878,5878,5878,5878,5878,5878,5878,5878,863ad743-eec0-46f0-beba-c1556384c636,respiratory diseases symptomatic sarcoidosis loeffler s syndrome not manageable by other means berylliosis,1
4820,4820,4820,4820,4820,4820,4820,5879,5879,5879,5879,5879,5879,5879,5879,5879,5879,5879,5879,5879,0cc2c204-c14d-456b-b630-9e50d683a937, cr51 is indicated for use in determining red blood cell volume or mass  studying red blood cell survival time ( in conditions such as hemolytic anemia )  and evaluating blood loss mechanism of action the chromium in this agent is present as the dianionic chromate ion in which form it appears to bind to the red blood cell in two steps  initially by a rapid but reversible attachment to the cell membrane followed by a slower nearly irreversible binding to intracellular hemoglobin and reduction to the anionic state,1
4821,4821,4821,4821,4821,4821,4821,5880,5880,5880,5880,5880,5880,5880,5880,5880,5880,5880,5880,5880,0cc2c204-c14d-456b-b630-9e50d683a937,it has been suggested that the slow rate of uptake is dependent on the rate at which chromate can penetrate the cell membrane,0
4822,4822,4822,4822,4822,4822,4822,5881,5881,5881,5881,5881,5881,5881,5881,5881,5881,5881,5881,5881,0cc2c204-c14d-456b-b630-9e50d683a937,binding is maintained until the red blood cells are sequestered by the spleen or until elution of the chromium occurs into the plasma,0
4823,4823,4823,4823,4823,4823,4823,5882,5882,5882,5882,5882,5882,5882,5882,5882,5882,5882,5882,5882,0cc2c204-c14d-456b-b630-9e50d683a937,the chromium is then readily excreted mainly in the urine,0
4824,4824,4824,4824,4824,4824,4824,5883,5883,5883,5883,5883,5883,5883,5883,5883,5883,5883,5883,5883,0cc2c204-c14d-456b-b630-9e50d683a937,once liberated by elution or erythrocyte senescence  chromium 51 is not available for relabeling of red cells,0
4825,4825,4825,4825,4825,4825,4825,5884,5884,5884,5884,5884,5884,5884,5884,5884,5884,5884,5884,5884,0cc2c204-c14d-456b-b630-9e50d683a937,in normal individuals the erythrocyte survival half time t as measured by the chromium 51 random labeling technique  generally ranges between 25 and 35 days,0
4826,4826,4826,4826,4826,4826,4826,5885,5885,5885,5885,5885,5885,5885,5885,5885,5885,5885,5885,5885,0cc2c204-c14d-456b-b630-9e50d683a937,this apparent short survival time  when compared to the 120 day life span of the red blood cells  is due to the elution of chromium from the cells and to cell damage that probably occurs during the process of withdrawing them from the body and labeling,0
4827,4827,4827,4827,4827,4827,4827,5886,5886,5886,5886,5886,5886,5886,5886,5886,5886,5886,5886,5886,0cc2c204-c14d-456b-b630-9e50d683a937,subnormal t may be indicative of blood toss  sequestration of red blood cells by the spleen  or shortened cell viability  as occurs in hemolytic anemia,u
4828,4828,4828,4828,4828,4828,4828,5887,5887,5887,5887,5887,5887,5887,5887,5887,5887,5887,5887,5887,d1e41dcf-e82a-47c2-a0ad-6c6eef621834,1  nerlynx is indicated for the extended adjuvant treatment of adult patients with early stage her2 overexpressed amplified breast cancer  to follow adjuvant trastuzumab based therapy see clinical studies ( 14 ),1
4829,4829,4829,4829,4829,4829,4829,5888,5888,5888,5888,5888,5888,5888,5888,5888,5888,5888,5888,5888,d1e41dcf-e82a-47c2-a0ad-6c6eef621834,nerlynx is a kinase inhibitor indicated for the extended adjuvant treatment of adult patients with early stage her2 overexpressed amplified breast cancer  to follow adjuvant trastuzumab based therapy,1
4830,4830,4830,4830,4830,4830,4830,5889,5889,5889,5889,5889,5889,5889,5889,5889,5889,5889,5889,5889,6e94621c-1a95-4af9-98d1-52b9e6f1949c,1  entyvio is an integrin receptor antagonist indicated for adult ulcerative colitis ( uc ) ( 1 1 ) adult patients with moderately to severely active uc who have had an inadequate response with  lost response to  or were intolerant to a tumor necrosis factor ( tnf ) blocker or immunomodulator or had an inadequate response with  were intolerant to  or demonstrated dependence on corticosteroids inducing and maintaining clinical response inducing and maintaining clinical remission improving endoscopic appearance of the mucosa achieving corticosteroid free remission adult crohn 's disease ( cd ) ( 1 2 ) adult patients with moderately to severely active cd who have had an inadequate response with  lost response to  or were intolerant to a tnf blocker or immunomodulator or had an inadequate response with  were intolerant to  or demonstrated dependence on corticosteroids achieving clinical response achieving clinical remission achieving corticosteroid free remission 1 1 adult ulcerative colitis entyvio ( vedolizumab ) is indicated for inducing and maintaining clinical response  inducing and maintaining clinical remission  improving the endoscopic appearance of the mucosa  and achieving corticosteroid free remission in adult patients with moderately to severely active ulcerative colitis who have had an inadequate response with  lost response to  or were intolerant to a tumor necrosis factor ( tnf ) blocker or immunomodulator or had an inadequate response with  were intolerant to  or demonstrated dependence on corticosteroids,1
4831,4831,4831,4831,4831,4831,4831,5890,5890,5890,5890,5890,5890,5890,5890,5890,5890,5890,5890,5890,64cb920c-36e8-4d62-9d08-3ddf3989d313, norethindrone acetate tablets  usp is indicated for the treatment of secondary amenorrhea  endometriosis  and abnormal uterine bleeding due to hormonal imbalance in the absence of organic pathology  such as submucous fibroids or uterine cancer,1
4832,4832,4832,4832,4832,4832,4832,5891,5891,5891,5891,5891,5891,5891,5891,5891,5891,5891,5891,5891,64cb920c-36e8-4d62-9d08-3ddf3989d313,norethindrone acetate tablets  usp are not intended  recommended or approved to be used with concomitant estrogen therapy in postmenopausal women for endometrial protection,2
4833,4833,4833,4833,4833,4833,4833,5898,5898,5898,5898,5898,5898,5898,5898,5898,5898,5898,5898,5898,f5a860f3-37ec-429c-ae04-9c88d7c55c08,1  alimta is a folate analog metabolic inhibitor indicated for the initial treatment of patients with locally advanced or metastatic non squamous  non small cell lung cancer ( nsclc ) in combination with cisplatin,1
4834,4834,4834,4834,4834,4834,4834,5899,5899,5899,5899,5899,5899,5899,5899,5899,5899,5899,5899,5899,f5a860f3-37ec-429c-ae04-9c88d7c55c08,( 1 1 ) maintenance treatment of patients with locally advanced or metastatic  non squamous nsclc whose disease has not progressed after four cycles of platinum based first line chemotherapy  as a single agent,1
4835,4835,4835,4835,4835,4835,4835,5900,5900,5900,5900,5900,5900,5900,5900,5900,5900,5900,5900,5900,f5a860f3-37ec-429c-ae04-9c88d7c55c08,( 1 1 ) treatment of patients with recurrent  metastatic non squamous  nsclc after prior chemotherapy  as a single agent,1
4836,4836,4836,4836,4836,4836,4836,5901,5901,5901,5901,5901,5901,5901,5901,5901,5901,5901,5901,5901,f5a860f3-37ec-429c-ae04-9c88d7c55c08,( 1 1 ) limitations of use alimta is not indicated for the treatment of patients with squamous cell nsclc,2
4837,4837,4837,4837,4837,4837,4837,5902,5902,5902,5902,5902,5902,5902,5902,5902,5902,5902,5902,5902,f5a860f3-37ec-429c-ae04-9c88d7c55c08,( 1 1 ) initial treatment  in combination with cisplatin  of patients with malignant pleural mesothelioma whose disease is unresectable or who are otherwise not candidates for curative surgery,1
4838,4838,4838,4838,4838,4838,4838,5903,5903,5903,5903,5903,5903,5903,5903,5903,5903,5903,5903,5903,f5a860f3-37ec-429c-ae04-9c88d7c55c08,( 1 2 ) 1 1 non squamous non small cell lung cancer ( nsclc ) alimta is indicated for initial treatment of patients with locally advanced or metastatic  non squamous  non small cell lung cancer ( nsclc ) in combination with cisplatin,1
4839,4839,4839,4839,4839,4839,4839,5904,5904,5904,5904,5904,5904,5904,5904,5904,5904,5904,5904,5904,f5a860f3-37ec-429c-ae04-9c88d7c55c08,maintenance treatment of patients with locally advanced or metastatic  non squamous nsclc whose disease has not progressed after four cycles of platinum based first line chemotherapy  as a single agent,1
4840,4840,4840,4840,4840,4840,4840,5905,5905,5905,5905,5905,5905,5905,5905,5905,5905,5905,5905,5905,f5a860f3-37ec-429c-ae04-9c88d7c55c08,treatment of patients with recurrent  metastatic non squamous  nsclc after prior chemotherapy  as a single agent,1
4841,4841,4841,4841,4841,4841,4841,5906,5906,5906,5906,5906,5906,5906,5906,5906,5906,5906,5906,5906,f5a860f3-37ec-429c-ae04-9c88d7c55c08,limitations of use alimta is not indicated for the treatment of patients with squamous cell  non small cell lung cancer see clinical studies 14 1,2
4842,4842,4842,4842,4842,4842,4842,5907,5907,5907,5907,5907,5907,5907,5907,5907,5907,5907,5907,5907,f5a860f3-37ec-429c-ae04-9c88d7c55c08,1 2 mesothelioma alimta is indicated  in combination with cisplatin  for the initial treatment of patients with malignant pleural mesothelioma whose disease is unresectable or who are otherwise not candidates for curative surgery,1
4843,4843,4843,4843,4843,4843,4843,5908,5908,5908,5908,5908,5908,5908,5908,5908,5908,5908,5908,5908,00a746cd-5c7e-4b41-b4ac-3cfec36a5e2d, carefully consider the potential benefits and risks of naproxen sodium tablets  usp and other treatment options before deciding to use naproxen sodium tablets  usp,0
4844,4844,4844,4844,4844,4844,4844,5910,5910,5910,5910,5910,5910,5910,5910,5910,5910,5910,5910,5910,00a746cd-5c7e-4b41-b4ac-3cfec36a5e2d,naproxen suspension is recommended for juvenile rheumatoid arthritis in order to obtain the maximum dosage flexibility based on the patient 's weight,1
4845,4845,4845,4845,4845,4845,4845,5911,5911,5911,5911,5911,5911,5911,5911,5911,5911,5911,5911,5911,00a746cd-5c7e-4b41-b4ac-3cfec36a5e2d,naproxen as naproxen sodium tablets are indicated for the relief of the signs and symptoms of rheumatoid arthritis for the relief of the signs and symptoms of osteoarthritis for the relief of the signs and symptoms of ankylosing spondylitis for the relief of the signs and symptoms of juvenile arthritis for relief of the signs and symptoms of tendonitis for relief of the signs and symptoms of bursitis for relief of the signs and symptoms of acute gout for the management of pain for the management of primary dysmenorrhea,1
4846,4846,4846,4846,4846,4846,4846,5912,5912,5912,5912,5912,5912,5912,5912,5912,5912,5912,5912,5912,0f19e4ed-c90a-4330-a7fa-bf911aa98f09, for the treatment of constipation,1
4847,4847,4847,4847,4847,4847,4847,5913,5913,5913,5913,5913,5913,5913,5913,5913,5913,5913,5913,5913,0f19e4ed-c90a-4330-a7fa-bf911aa98f09,in patients with a history of chronic constipation  lactulose solution therapy increases the number of bowel movements per day and the number of days on which bowel movements occur,u
4848,4848,4848,4848,4848,4848,4848,5914,5914,5914,5914,5914,5914,5914,5914,5914,5914,5914,5914,5914,173018f5-fd76-4480-90f8-4b7efe328444, treatment maxaquin ( lomefloxacin hcl ) film coated tablets are indicated for the treatment of adults with mild to moderate infections caused by susceptible strains of the designated microorganisms in the conditions listed below ( see dosage and administration for specific dosing recommendations ),1
4849,4849,4849,4849,4849,4849,4849,5915,5915,5915,5915,5915,5915,5915,5915,5915,5915,5915,5915,5915,173018f5-fd76-4480-90f8-4b7efe328444,lower respiratory tract acute bacterial exacerbation of chronic bronchitis caused by haemophilus influenzae or moraxella catarrhalis,1
4850,4850,4850,4850,4850,4850,4850,5916,5916,5916,5916,5916,5916,5916,5916,5916,5916,5916,5916,5916,173018f5-fd76-4480-90f8-4b7efe328444,although treatment of infections due to this microorganism in this organ system demonstrated a clinically acceptable overall outcome  efficacy was studied in fewer than 10 infections,0
4851,4851,4851,4851,4851,4851,4851,5917,5917,5917,5917,5917,5917,5917,5917,5917,5917,5917,5917,5917,173018f5-fd76-4480-90f8-4b7efe328444,note maxaquin is not indicated for the empiric treatment of acute bacterial exacerbation of chronic bronchitis when it is probable that s pneumoniae is a causative pathogen,2
4852,4852,4852,4852,4852,4852,4852,5918,5918,5918,5918,5918,5918,5918,5918,5918,5918,5918,5918,5918,173018f5-fd76-4480-90f8-4b7efe328444,s pneumoniae exhibits in vitro resistance to lomefloxacin  and the safety and efficacy of lomefloxacin in the treatment of patients with acute bacterial exacerbation of chronic bronchitis caused by s pneumoniae have not been demonstrated,0
4853,4853,4853,4853,4853,4853,4853,5919,5919,5919,5919,5919,5919,5919,5919,5919,5919,5919,5919,5919,173018f5-fd76-4480-90f8-4b7efe328444,if lomefloxacin is to be prescribed for gram stain guided empiric therapy of acute bacterial exacerbation of chronic bronchitis  it should be used only if sputum gram stain demonstrates an adequate quality of specimen ( 25 pmns lpf ) and there is both a predominance of gram negative microorganisms and not a predominance of gram positive microorganisms,u
4854,4854,4854,4854,4854,4854,4854,5920,5920,5920,5920,5920,5920,5920,5920,5920,5920,5920,5920,5920,173018f5-fd76-4480-90f8-4b7efe328444,urinary tract uncomplicated urinary tract infections ( cystitis ) caused by escherichia coli  klebsiella pneumoniae  proteus mirabilis  or staphylococcus saprophyticus,1
4855,4855,4855,4855,4855,4855,4855,5921,5921,5921,5921,5921,5921,5921,5921,5921,5921,5921,5921,5921,173018f5-fd76-4480-90f8-4b7efe328444,( see dosage and administration and clinical studies uncomplicated cystitis ),0
4856,4856,4856,4856,4856,4856,4856,5922,5922,5922,5922,5922,5922,5922,5922,5922,5922,5922,5922,5922,1eb20ef6-7a56-5b3e-e054-00144ff88e88,omega 3 acid ethyl esters capsules  usp are indicated as an adjunct to diet to reduce triglyceride ( tg ) levels in adult patients with severe ( 500 mg dl ) hypertriglyceridemia ( htg ),1
4857,4857,4857,4857,4857,4857,4857,5923,5923,5923,5923,5923,5923,5923,5923,5923,5923,5923,5923,5923,1eb20ef6-7a56-5b3e-e054-00144ff88e88,usage considerations patients should be placed on an appropriate lipid lowering diet before receiving omega 3 acid ethyl esters capsules  usp and should continue this diet during treatment with omega 3 acid ethyl esters capsules  usp,4
4858,4858,4858,4858,4858,4858,4858,5924,5924,5924,5924,5924,5924,5924,5924,5924,5924,5924,5924,5924,1eb20ef6-7a56-5b3e-e054-00144ff88e88,laboratory studies should be done to ascertain that the lipid levels are consistently abnormal before instituting therapy with omega 3 acid ethyl esters,0
4859,4859,4859,4859,4859,4859,4859,5925,5925,5925,5925,5925,5925,5925,5925,5925,5925,5925,5925,5925,1eb20ef6-7a56-5b3e-e054-00144ff88e88,every attempt should be made to control serum lipids with appropriate diet  exercise  weight loss in obese patients  and control of any medical problems such as diabetes mellitus and hypothyroidism that are contributing to the lipid abnormalities,0
4860,4860,4860,4860,4860,4860,4860,5926,5926,5926,5926,5926,5926,5926,5926,5926,5926,5926,5926,5926,1eb20ef6-7a56-5b3e-e054-00144ff88e88,medications known to exacerbate hypertriglyceridemia ( such as beta blockers  thiazides  estrogens ) should be discontinued or changed if possible prior to consideration of triglyceride lowering drug therapy,4
4861,4861,4861,4861,4861,4861,4861,5927,5927,5927,5927,5927,5927,5927,5927,5927,5927,5927,5927,5927,1eb20ef6-7a56-5b3e-e054-00144ff88e88,limitations of use sections or subsections omitted from the full prescribing information are not listed,0
4862,4862,4862,4862,4862,4862,4862,5928,5928,5928,5928,5928,5928,5928,5928,5928,5928,5928,5928,5928,1eb20ef6-7a56-5b3e-e054-00144ff88e88,the effect of omega 3 acid ethyl esters capsules  usp on the risk for pancreatitis has not been determined,0
4863,4863,4863,4863,4863,4863,4863,5929,5929,5929,5929,5929,5929,5929,5929,5929,5929,5929,5929,5929,1eb20ef6-7a56-5b3e-e054-00144ff88e88,the effect of omega 3 acid ethyl esters capsules  usp on cardiovascular mortality and morbidity has not been determined,0
4864,4864,4864,4864,4864,4864,4864,5930,5930,5930,5930,5930,5930,5930,5930,5930,5930,5930,5930,5930,7883bbc0-0874-11dc-a818-0002a5d5c51b, butisol sodium ( butabarbital sodium tablets  usp and butabarbital sodium oral solution  usp ) is indicated for use as a sedative or hypnotic,1
4865,4865,4865,4865,4865,4865,4865,5931,5931,5931,5931,5931,5931,5931,5931,5931,5931,5931,5931,5931,7883bbc0-0874-11dc-a818-0002a5d5c51b,since barbiturates appear to lose their effectiveness for sleep induction and sleep maintenance after 2 weeks  use of butisol sodium in treating insomnia should be limited to this time ( see clinical pharmacology above ),4
4866,4866,4866,4866,4866,4866,4866,5932,5932,5932,5932,5932,5932,5932,5932,5932,5932,5932,5932,5932,805cecd0-fd1f-11dd-87af-0800200c9a66,1  xiaflex is indicated for the treatment of adult patients with dupuytren s contracture with a palpable cord,1
4867,4867,4867,4867,4867,4867,4867,5933,5933,5933,5933,5933,5933,5933,5933,5933,5933,5933,5933,5933,805cecd0-fd1f-11dd-87af-0800200c9a66,xiaflex is indicated for the treatment of adult men with peyronie s disease with a palpable plaque and curvature deformity of at least 30 degrees at the start of therapy,1
4868,4868,4868,4868,4868,4868,4868,5934,5934,5934,5934,5934,5934,5934,5934,5934,5934,5934,5934,5934,805cecd0-fd1f-11dd-87af-0800200c9a66,xiaflex is a combination of bacterial collagenases indicated for the treatment of adult patients with dupuytren s contracture with a palpable cord ( 1 ) the treatment of adult men with peyronie s disease with a palpable plaque and curvature deformity of at least 30 degrees at the start of therapy ( 1 ),1
4869,4869,4869,4869,4869,4869,4869,5935,5935,5935,5935,5935,5935,5935,5935,5935,5935,5935,5935,5935,f40d6d72-31c3-4ef8-b86c-0230e06a9383, primsol solution is indicated for the treatment of infections caused by susceptible strains of the designated microorganisms in the conditions listed below,1
4870,4870,4870,4870,4870,4870,4870,5936,5936,5936,5936,5936,5936,5936,5936,5936,5936,5936,5936,5936,f40d6d72-31c3-4ef8-b86c-0230e06a9383,pediatric patients acute otitis media for the treatment of acute otitis media due to susceptible strains of streptococcus pneumoniae and haemophilus influenzae,1
4871,4871,4871,4871,4871,4871,4871,5937,5937,5937,5937,5937,5937,5937,5937,5937,5937,5937,5937,5937,f40d6d72-31c3-4ef8-b86c-0230e06a9383,note moraxella catarrhalis isolates were found consistently resistant to trimethoprim in vitro,0
4872,4872,4872,4872,4872,4872,4872,5938,5938,5938,5938,5938,5938,5938,5938,5938,5938,5938,5938,5938,f40d6d72-31c3-4ef8-b86c-0230e06a9383,therefore  when infection with moraxella catarrhalis is suspected  the use of alternative antimicrobial agents should be considered,0
4873,4873,4873,4873,4873,4873,4873,5939,5939,5939,5939,5939,5939,5939,5939,5939,5939,5939,5939,5939,f40d6d72-31c3-4ef8-b86c-0230e06a9383,primsol is not indicated for prophylactic or prolonged administration in otitis media at any age,2
4874,4874,4874,4874,4874,4874,4874,5940,5940,5940,5940,5940,5940,5940,5940,5940,5940,5940,5940,5940,f40d6d72-31c3-4ef8-b86c-0230e06a9383,adults urinary tract infections for the treatment of initial episodes of uncomplicated urinary tract infections due to susceptible strains of the following organisms escherichia coli  proteus mirabilis  klebsiella pneumoniae  enterobacter species and coagulase negative staphylococcus species  including s saprophyticus,1
4875,4875,4875,4875,4875,4875,4875,5941,5941,5941,5941,5941,5941,5941,5941,5941,5941,5941,5941,5941,f40d6d72-31c3-4ef8-b86c-0230e06a9383,cultures and susceptibility tests should be performed to determine the susceptibility of the bacteria to trimethoprim,0
4876,4876,4876,4876,4876,4876,4876,5942,5942,5942,5942,5942,5942,5942,5942,5942,5942,5942,5942,5942,f40d6d72-31c3-4ef8-b86c-0230e06a9383,therapy may be initiated prior to obtaining the results of these tests,0
4877,4877,4877,4877,4877,4877,4877,5943,5943,5943,5943,5943,5943,5943,5943,5943,5943,5943,5943,5943,bd0a89ab-91c4-42b3-aa88-1e3295d0d344,1  sevelamer carbonate tablets are indicated for the control of serum phosphorus in adults with chronic kidney disease ( ckd ) on dialysis,1
4878,4878,4878,4878,4878,4878,4878,5944,5944,5944,5944,5944,5944,5944,5944,5944,5944,5944,5944,5944,bd0a89ab-91c4-42b3-aa88-1e3295d0d344,pediatric use information is approved for genzyme corporation s renvela ( sevelamer carbonate ) tablets and renvela ( sevelamer carbonate ) for oral suspension,1
4879,4879,4879,4879,4879,4879,4879,5945,5945,5945,5945,5945,5945,5945,5945,5945,5945,5945,5945,5945,bd0a89ab-91c4-42b3-aa88-1e3295d0d344,however  due to genzyme corporation s marketing exclusivity rights  these drug products are not labeled with that pediatric information,0
4880,4880,4880,4880,4880,4880,4880,5946,5946,5946,5946,5946,5946,5946,5946,5946,5946,5946,5946,5946,bd0a89ab-91c4-42b3-aa88-1e3295d0d344,sevelamer carbonate tablets are a phosphate binder indicated for the control of serum phosphorus in adults with chronic kidney disease on dialysis,1
4881,4881,4881,4881,4881,4881,4881,5947,5947,5947,5947,5947,5947,5947,5947,5947,5947,5947,5947,5947,b50667e4-5ebc-4968-a646-d605058dbef0,1  nexavar is a kinase inhibitor indicated for the treatment of unresectable hepatocellular carcinoma ( 1 1 ) advanced renal cell carcinoma ( 1 2 ) locally recurrent or metastatic  progressive  differentiated thyroid carcinoma refractory to radioactive iodine treatment ( 1 3 ) 1 1 hepatocellular carcinoma nexavar is indicated for the treatment of patients with unresectable hepatocellular carcinoma ( hcc ),1
4882,4882,4882,4882,4882,4882,4882,5948,5948,5948,5948,5948,5948,5948,5948,5948,5948,5948,5948,5948,b50667e4-5ebc-4968-a646-d605058dbef0,1 2 renal cell carcinoma nexavar is indicated for the treatment of patients with advanced renal cell carcinoma ( rcc ),1
4883,4883,4883,4883,4883,4883,4883,5949,5949,5949,5949,5949,5949,5949,5949,5949,5949,5949,5949,5949,b50667e4-5ebc-4968-a646-d605058dbef0,1 3 differentiated thyroid carcinoma nexavar is indicated for the treatment of patients with locally recurrent or metastatic  progressive  differentiated thyroid carcinoma ( dtc ) that is refractory to radioactive iodine treatment,1
4884,4884,4884,4884,4884,4884,4884,5950,5950,5950,5950,5950,5950,5950,5950,5950,5950,5950,5950,5950,e0b0c8f1-75be-4f25-898a-7b97b608c615, phytonadione is indicated in the following coagulation disorders which are due to faulty formation of factors ii  vii  ix and x when caused by vitamin k deficiency or interference with vitamin k activity,1
4885,4885,4885,4885,4885,4885,4885,5951,5951,5951,5951,5951,5951,5951,5951,5951,5951,5951,5951,5951,e0b0c8f1-75be-4f25-898a-7b97b608c615,phytonadione injectable emulsion  usp is indicated in anticoagulant induced prothrombin deficiency caused by coumarin or indanedione derivatives prophylaxis and therapy of hemorrhagic disease of the newborn hypoprothrombinemia due to antibacterial therapy hypoprothrombinemia secondary to factors limiting absorption or synthesis of vitamin k  e g  obstructive jaundice  biliary fistula  sprue  ulcerative colitis  celiac disease  intestinal resection  cystic fibrosis of the pancreas  and regional enteritis other drug induced hypoprothrombinemia where it is definitely shown that the result is due to interference with vitamin k metabolism  e g  salicylates,1
4886,4886,4886,4886,4886,4886,4886,5952,5952,5952,5952,5952,5952,5952,5952,5952,5952,5952,5952,5952,b4dfe70f-0a86-4488-9ba1-dcd8f86cbfcd, chirhostim is indicated for the stimulation of pancreatic secretions  including bicarbonate  to aid in the diagnosis of pancreatic exocrine dysfunction,1
4887,4887,4887,4887,4887,4887,4887,5953,5953,5953,5953,5953,5953,5953,5953,5953,5953,5953,5953,5953,b4dfe70f-0a86-4488-9ba1-dcd8f86cbfcd,gastrin secretion to aid in the diagnosis of gastrinoma  and pancreatic secretions to facilitate the identification of the ampulla of vater and accessory papilla during endoscopic retrograde cholangiopancreatography ( ercp ),1
4888,4888,4888,4888,4888,4888,4888,5954,5954,5954,5954,5954,5954,5954,5954,5954,5954,5954,5954,5954,b4dfe70f-0a86-4488-9ba1-dcd8f86cbfcd,chirhostim is a secretin class hormone indicated for stimulation of pancreatic secretions  including bicarbonate  to aid in the diagnosis of exocrine pancreas dysfunction ( 1 ) gastrin secretion to aid in the diagnosis of gastrinoma ( 1 ) pancreatic secretions to facilitate the identification of the ampulla of vater and the accessory papilla during endoscopic retrograde cholangiopancreatography ( ercp ) ( 1 ),1
4889,4889,4889,4889,4889,4889,4889,5955,5955,5955,5955,5955,5955,5955,5955,5955,5955,5955,5955,5955,5f670c12-cca5-4d73-8a88-241f753d1bc7, gallium citrate ga 67 injection may be useful to demonstrate the presence and extent of hodgkin 's disease  lymphoma  and bronchogenic carcinoma,1
4890,4890,4890,4890,4890,4890,4890,5956,5956,5956,5956,5956,5956,5956,5956,5956,5956,5956,5956,5956,5f670c12-cca5-4d73-8a88-241f753d1bc7,positive gallium ga 67 uptake in the absence of prior symptoms warrants follow up as an indication of a potential disease state,u
4891,4891,4891,4891,4891,4891,4891,5958,5958,5958,5958,5958,5958,5958,5958,5958,5958,5958,5958,5958,65ab2356-9f16-52b9-e053-2a91aa0abd05,the radiogenix system is a technetium tc 99m generator used to produce sterile  non pyrogenic sodium pertechnetate tc 99m injection,0
4892,4892,4892,4892,4892,4892,4892,5959,5959,5959,5959,5959,5959,5959,5959,5959,5959,5959,5959,5959,65ab2356-9f16-52b9-e053-2a91aa0abd05,sodium pertechnetate tc 99m injection is indicated for use in the preparation of fda approved diagnostic radiopharmaceuticals,1
4893,4893,4893,4893,4893,4893,4893,5960,5960,5960,5960,5960,5960,5960,5960,5960,5960,5960,5960,5960,65ab2356-9f16-52b9-e053-2a91aa0abd05,sodium pertechnetate tc 99m injection is also indicated in adults for thyroid imaging salivary gland imaging urinary bladder imaging ( direct isotopic cystography ) for detection of vesicoureteral reflux nasolacrimal drainage system imaging ( dacryoscintigraphy ) in pediatric patients for thyroid imaging urinary bladder imaging ( direct isotopic cystography ) for the detection of vesicoureteral reflux,1
4894,4894,4894,4894,4894,4894,4894,5961,5961,5961,5961,5961,5961,5961,5961,5961,5961,5961,5961,5961,8e26fbf0-511c-44d9-b484-372d7b50b55e,1  bicalutamide 50 mg is an androgen receptor inhibitor indicated for use in combination therapy with a luteinizing hormone releasing hormone ( lhrh ) analog for the treatment of stage d2 metastatic carcinoma of the prostate ( 1 ) bicalutamide 150 mg daily is not approved for use alone or with other treatments ( 1 ) bicalutamide tablets 50 mg daily is indicated for use in combination therapy with a luteinizing hormone releasing hormone ( lhrh ) analog for the treatment of stage d2 metastatic carcinoma of the prostate,1
4895,4895,4895,4895,4895,4895,4895,5962,5962,5962,5962,5962,5962,5962,5962,5962,5962,5962,5962,5962,8e26fbf0-511c-44d9-b484-372d7b50b55e,bicalutamide tablets 150 mg daily is not approved for use alone or with other treatments see clinical studies ( 14 2 ),0
4896,4896,4896,4896,4896,4896,4896,5963,5963,5963,5963,5963,5963,5963,5963,5963,5963,5963,5963,5963,9da42362-3bb5-4b83-b4bb-b59fd4e55f0d,1  ocrevus is indicated for the treatment of adult patients with relapsing or primary progressive forms of multiple sclerosis,1
4897,4897,4897,4897,4897,4897,4897,5964,5964,5964,5964,5964,5964,5964,5964,5964,5964,5964,5964,5964,9da42362-3bb5-4b83-b4bb-b59fd4e55f0d,ocrevus is a cd20 directed cytolytic antibody indicated for the treatment of patients with relapsing or primary progressive forms of multiple sclerosis ( 1 ),1
4898,4898,4898,4898,4898,4898,4898,5965,5965,5965,5965,5965,5965,5965,5965,5965,5965,5965,5965,5965,77d619f8-05a3-408a-a6f8-1511694b6a24, ticlopidine hydrochloride tablets usp are indicated to reduce the risk of thrombotic stroke ( fatal or nonfatal ) in patients who have experienced stroke precursors  and in patients who have had a completed thrombotic stroke,1
4899,4899,4899,4899,4899,4899,4899,5966,5966,5966,5966,5966,5966,5966,5966,5966,5966,5966,5966,5966,77d619f8-05a3-408a-a6f8-1511694b6a24,because ticlopidine is associated with a risk of life threatening blood dyscrasias including thrombotic thrombocytopenic purpura ( ttp )  neutropenia agranulocytosis and aplastic anemia ( see and )  ticlopidine should be reserved for patients who are intolerant or allergic to aspirin therapy or who have failed aspirin therapy,4
4900,4900,4900,4900,4900,4900,4900,5967,5967,5967,5967,5967,5967,5967,5967,5967,5967,5967,5967,5967,77d619f8-05a3-408a-a6f8-1511694b6a24,boxed warning warnings as adjunctive therapy with aspirin to reduce the incidence of subacute stent thrombosis in patients undergoing successful coronary stent implantation ( see ),1
4901,4901,4901,4901,4901,4901,4901,5968,5968,5968,5968,5968,5968,5968,5968,5968,5968,5968,5968,5968,a28450a0-ac93-4235-b9a6-58cdf24773cb, pentazocine and naloxone tablets are indicated for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate,1
4902,4902,4902,4902,4902,4902,4902,5969,5969,5969,5969,5969,5969,5969,5969,5969,5969,5969,5969,5969,a28450a0-ac93-4235-b9a6-58cdf24773cb,limitations of use because of the risks of addiction  abuse  and misuse  with opioids  even at recommended doses  reserve pentazocine and naloxone tablets for use in patients for whom alternative treatment options e g  non opioid analgesics have not been tolerated  or are not expected to be tolerated  have not provided adequate analgesia  or are not expected to provide adequate analgesia,0
4903,4903,4903,4903,4903,4903,4903,5970,5970,5970,5970,5970,5970,5970,5970,5970,5970,5970,5970,5970,ebcd67fa-b4d1-4a22-b33d-ee8bf6b9c722,1  soliris is a complement inhibitor indicated for the treatment of patients with paroxysmal nocturnal hemoglobinuria ( pnh ) to reduce hemolysis ( 1 1 ),1
4904,4904,4904,4904,4904,4904,4904,5971,5971,5971,5971,5971,5971,5971,5971,5971,5971,5971,5971,5971,ebcd67fa-b4d1-4a22-b33d-ee8bf6b9c722,the treatment of patients with atypical hemolytic uremic syndrome ( ahus ) to inhibit complement mediated thrombotic microangiopathy ( 1 2 ),1
4905,4905,4905,4905,4905,4905,4905,5972,5972,5972,5972,5972,5972,5972,5972,5972,5972,5972,5972,5972,ebcd67fa-b4d1-4a22-b33d-ee8bf6b9c722,limitation of use soliris is not indicated for the treatment of patients with shiga toxin e coli related hemolytic uremic syndrome ( stec hus ),2
4906,4906,4906,4906,4906,4906,4906,5973,5973,5973,5973,5973,5973,5973,5973,5973,5973,5973,5973,5973,ebcd67fa-b4d1-4a22-b33d-ee8bf6b9c722,the treatment of adult patients with generalized myasthenia gravis ( gmg ) who are anti acetylcholine receptor ( achr ) antibody positive ( 1 3 ),1
4907,4907,4907,4907,4907,4907,4907,5974,5974,5974,5974,5974,5974,5974,5974,5974,5974,5974,5974,5974,ebcd67fa-b4d1-4a22-b33d-ee8bf6b9c722,1 1 paroxysmal nocturnal hemoglobinuria ( pnh ) soliris is indicated for the treatment of patients with paroxysmal nocturnal hemoglobinuria ( pnh ) to reduce hemolysis,1
4908,4908,4908,4908,4908,4908,4908,5975,5975,5975,5975,5975,5975,5975,5975,5975,5975,5975,5975,5975,ebcd67fa-b4d1-4a22-b33d-ee8bf6b9c722,1 2 atypical hemolytic uremic syndrome ( ahus ) soliris is indicated for the treatment of patients with atypical hemolytic uremic syndrome ( ahus ) to inhibit complement mediated thrombotic microangiopathy,1
4909,4909,4909,4909,4909,4909,4909,5977,5977,5977,5977,5977,5977,5977,5977,5977,5977,5977,5977,5977,ebcd67fa-b4d1-4a22-b33d-ee8bf6b9c722,1 3 generalized myasthenia gravis ( gmg ) soliris is indicated for the treatment of adult patients with generalized myasthenia gravis ( gmg ) who are anti acetylcholine receptor ( achr ) antibody positive,1
4910,4910,4910,4910,4910,4910,4910,5978,5978,5978,5978,5978,5978,5978,5978,5978,5978,5978,5978,5978,9410215d-828c-454c-a44e-ad0fb0c65f68, bexarotene capsules are indicated for the treatment of cutaneous manifestations of cutaneous t cell lymphoma in patients who are refractory to at least one prior systemic therapy,1
4911,4911,4911,4911,4911,4911,4911,5979,5979,5979,5979,5979,5979,5979,5979,5979,5979,5979,5979,5979,6616d1a2-09a6-429c-8d19-0ac6354980bb, sotalol hydrochloride tablets ( af ) are indicated for the maintenance of normal sinus rhythm delay in time to recurrence of atrial fibrillation atrial flutter ( afib afl ) in patients with symptomatic afib afl who are currently in sinus rhythm,1
4912,4912,4912,4912,4912,4912,4912,5980,5980,5980,5980,5980,5980,5980,5980,5980,5980,5980,5980,5980,6616d1a2-09a6-429c-8d19-0ac6354980bb,because sotalol hydrochloride tablets ( af ) can cause life threatening ventricular arrhythmias  it should be reserved for patients in whom afib afl is highly symptomatic,4
4913,4913,4913,4913,4913,4913,4913,5981,5981,5981,5981,5981,5981,5981,5981,5981,5981,5981,5981,5981,6616d1a2-09a6-429c-8d19-0ac6354980bb,patients with paroxysmal afib afl that is easily reversed ( by valsalva maneuver  for example ) should usually not be given sotalol hydrochloride tablets ( af ) ( see warnings ),2
4914,4914,4914,4914,4914,4914,4914,5982,5982,5982,5982,5982,5982,5982,5982,5982,5982,5982,5982,5982,6616d1a2-09a6-429c-8d19-0ac6354980bb,in general  antiarrhythmic therapy for afib afl aims to prolong the time in normal sinus rhythm,0
4915,4915,4915,4915,4915,4915,4915,5983,5983,5983,5983,5983,5983,5983,5983,5983,5983,5983,5983,5983,6616d1a2-09a6-429c-8d19-0ac6354980bb,recurrence is expected in some patients ( see clinical studies ),0
4916,4916,4916,4916,4916,4916,4916,5984,5984,5984,5984,5984,5984,5984,5984,5984,5984,5984,5984,5984,6616d1a2-09a6-429c-8d19-0ac6354980bb,sotalol is also indicated for the treatment of documented life threatening ventricular arrhythmias and is marketed under the brand name betapace ( sotalol hydrochloride ),1
4917,4917,4917,4917,4917,4917,4917,5985,5985,5985,5985,5985,5985,5985,5985,5985,5985,5985,5985,5985,6616d1a2-09a6-429c-8d19-0ac6354980bb,betapace  however  must not be substituted for sotalol hydrochloride tablets ( af ) because of significant differences in labeling ( i e,4
4918,4918,4918,4918,4918,4918,4918,5986,5986,5986,5986,5986,5986,5986,5986,5986,5986,5986,5986,5986,6616d1a2-09a6-429c-8d19-0ac6354980bb,patient package insert  dosing administration and safety information ),0
4919,4919,4919,4919,4919,4919,4919,5987,5987,5987,5987,5987,5987,5987,5987,5987,5987,5987,5987,5987,5e4cf15b-bf7b-4b83-863e-e9ef27741a51,1  folotyn is indicated for the treatment of patients with relapsed or refractory peripheral t cell lymphoma ( ptcl ),1
4920,4920,4920,4920,4920,4920,4920,5988,5988,5988,5988,5988,5988,5988,5988,5988,5988,5988,5988,5988,5e4cf15b-bf7b-4b83-863e-e9ef27741a51,this indication is based on overall response rate,0
4921,4921,4921,4921,4921,4921,4921,5989,5989,5989,5989,5989,5989,5989,5989,5989,5989,5989,5989,5989,5e4cf15b-bf7b-4b83-863e-e9ef27741a51,clinical benefit such as improvement in progression free survival or overall survival has not been demonstrated,0
4922,4922,4922,4922,4922,4922,4922,5990,5990,5990,5990,5990,5990,5990,5990,5990,5990,5990,5990,5990,5e4cf15b-bf7b-4b83-863e-e9ef27741a51,folotyn is a folate analog metabolic inhibitor indicated for the treatment of patients with relapsed or refractory peripheral t cell lymphoma ( ptcl ),1
4923,4923,4923,4923,4923,4923,4923,5993,5993,5993,5993,5993,5993,5993,5993,5993,5993,5993,5993,5993,62ca4278-8cc9-46b7-8f3c-303ce6a9c155, megatope ( iodinated i 131 albumin injection ) is indicated for use in determinations of total blood and plasma volumes  cardiac output  cardiac and pulmonary blood volumes and circulation times  and in protein turnover studies  heart and great vessel dilineation  localization of the placenta  and localization of celebral neospasms,1
4924,4924,4924,4924,4924,4924,4924,5994,5994,5994,5994,5994,5994,5994,5994,5994,5994,5994,5994,5994,76eb7ac8-e0ee-4409-a4e7-e326c6725836,1  miglustat is a glucosylceramide synthase inhibitor indicated as monotherapy for treatment of adult patients with mild moderate type 1 gaucher disease for whom enzyme replacement therapy is not a therapeutic option ( 1 1 ),1
4925,4925,4925,4925,4925,4925,4925,5995,5995,5995,5995,5995,5995,5995,5995,5995,5995,5995,5995,5995,76eb7ac8-e0ee-4409-a4e7-e326c6725836,1 1 type 1 gaucher disease miglustat is a glucosylceramide synthase inhibitor indicated as monotherapy for the treatment of adult patients with mild to moderate type 1 gaucher disease for whom enzyme replacement therapy is not a therapeutic option ( e g,1
4926,4926,4926,4926,4926,4926,4926,5996,5996,5996,5996,5996,5996,5996,5996,5996,5996,5996,5996,5996,76eb7ac8-e0ee-4409-a4e7-e326c6725836,due to allergy  hypersensitivity  or poor venous access ),0
4927,4927,4927,4927,4927,4927,4927,5997,5997,5997,5997,5997,5997,5997,5997,5997,5997,5997,5997,5997,218ab3f0-4d1e-4c33-a7e8-27807f029d83,1  xopenex hfa is a beta2 adrenergic agonist indicated for the treatment or prevention of bronchospasm in patients 4 years of age and older with reversible obstructive airway disease,1
4928,4928,4928,4928,4928,4928,4928,5998,5998,5998,5998,5998,5998,5998,5998,5998,5998,5998,5998,5998,218ab3f0-4d1e-4c33-a7e8-27807f029d83,( 1 1 ) 1 1 bronchospasm xopenex hfa is indicated for the treatment or prevention of bronchospasm in adults  adolescents  and children 4 years of age and older with reversible obstructive airway disease,1
4929,4929,4929,4929,4929,4929,4929,5999,5999,5999,5999,5999,5999,5999,5999,5999,5999,5999,5999,5999,72d1a024-00b7-418a-b36e-b2cb48f2ab55,1  lutathera is indicated for the treatment of somatostatin receptor positive gastroenteropancreatic neuroendocrine tumors ( gep nets )  including foregut  midgut  and hindgut neuroendocrine tumors in adults,1
4930,4930,4930,4930,4930,4930,4930,6000,6000,6000,6000,6000,6000,6000,6000,6000,6000,6000,6000,6000,72d1a024-00b7-418a-b36e-b2cb48f2ab55,lutathera is a radiolabeled somatostatin analog indicated for the treatment of somatostatin receptor positive gastroenteropancreatic neuroendocrine tumors ( gep nets )  including foregut  midgut  and hindgut neuroendocrine tumors in adults,1
4931,4931,4931,4931,4931,4931,4931,6001,6001,6001,6001,6001,6001,6001,6001,6001,6001,6001,6001,6001,e701ef07-9499-4b56-931f-f4eb3eedbe24, to obtain miosis of the iris in seconds after delivery of the lens in cataract surgery  in penetrating keratoplasty  iridectomy  and other anterior segment surgery where rapid miosis may be required,1
4932,4932,4932,4932,4932,4932,4932,6004,6004,6004,6004,6004,6004,6004,6004,6004,6004,6004,6004,6004,2f58df9c-59fb-4d13-65be-4aff52f223e2,vytorin  which contains a cholesterol absorption inhibitor and an hmg coa reductase inhibitor ( statin )  is indicated as adjunctive therapy to diet to reduce elevated total c  ldl c  apo b  tg  and non hdl c  and to increase hdl c in patients with primary ( heterozygous familial and non familial ) hyperlipidemia or mixed hyperlipidemia,1
4933,4933,4933,4933,4933,4933,4933,6005,6005,6005,6005,6005,6005,6005,6005,6005,6005,6005,6005,6005,2f58df9c-59fb-4d13-65be-4aff52f223e2,( 1 1 ) reduce elevated total c and ldl c in patients with homozygous familial hypercholesterolemia ( hofh )  as an adjunct to other lipid lowering treatments,1
4934,4934,4934,4934,4934,4934,4934,6006,6006,6006,6006,6006,6006,6006,6006,6006,6006,6006,6006,6006,2f58df9c-59fb-4d13-65be-4aff52f223e2,( 1 2 ) limitations of use ( 1 3 ) no incremental benefit of vytorin on cardiovascular morbidity and mortality over and above that demonstrated for simvastatin has been established,0
4935,4935,4935,4935,4935,4935,4935,6007,6007,6007,6007,6007,6007,6007,6007,6007,6007,6007,6007,6007,2f58df9c-59fb-4d13-65be-4aff52f223e2,vytorin has not been studied in fredrickson type i  iii  iv  and v dyslipidemias,0
4936,4936,4936,4936,4936,4936,4936,6008,6008,6008,6008,6008,6008,6008,6008,6008,6008,6008,6008,6008,2f58df9c-59fb-4d13-65be-4aff52f223e2,1 1 primary hyperlipidemia vytorin is indicated for the reduction of elevated total cholesterol ( total c )  low density lipoprotein cholesterol ( ldl c )  apolipoprotein b ( apo b )  triglycerides ( tg )  and non high density lipoprotein cholesterol ( non hdl c )  and to increase high density lipoprotein cholesterol ( hdl c ) in patients with primary ( heterozygous familial and non familial ) hyperlipidemia or mixed hyperlipidemia,1
4937,4937,4937,4937,4937,4937,4937,6009,6009,6009,6009,6009,6009,6009,6009,6009,6009,6009,6009,6009,2f58df9c-59fb-4d13-65be-4aff52f223e2,1 2 homozygous familial hypercholesterolemia ( hofh ) vytorin is indicated for the reduction of elevated total c and ldl c in patients with homozygous familial hypercholesterolemia  as an adjunct to other lipid lowering treatments ( e g  ldl apheresis ) or if such treatments are unavailable,1
4938,4938,4938,4938,4938,4938,4938,6010,6010,6010,6010,6010,6010,6010,6010,6010,6010,6010,6010,6010,5564ee46-7bd7-4b2a-ad51-d01f7fda0461,by intravenous or intramuscular injection when oral therapy is not feasible 1,0
4939,4939,4939,4939,4939,4939,4939,6011,6011,6011,6011,6011,6011,6011,6011,6011,6011,6011,6011,6011,5564ee46-7bd7-4b2a-ad51-d01f7fda0461,endocrine disorders primary or secondary adrenocortical insufficiency ( hydrocortisone or cortisone is the drug of choice synthetic analogs may be used in conjunction with mineralocorticoids where applicable in infancy  mineralocorticoid supplementation is of particular importance ),1
4940,4940,4940,4940,4940,4940,4940,6012,6012,6012,6012,6012,6012,6012,6012,6012,6012,6012,6012,6012,5564ee46-7bd7-4b2a-ad51-d01f7fda0461,acute adrenocortical insufficiency ( hydrocortisone or cortisone is the drug of choice mineralocorticoid supplementation may be necessary  particularly when synthetic analogs are used ),1
4941,4941,4941,4941,4941,4941,4941,6013,6013,6013,6013,6013,6013,6013,6013,6013,6013,6013,6013,6013,5564ee46-7bd7-4b2a-ad51-d01f7fda0461,preoperatively  and in the event of serious trauma or illness  in patients with known adrenal insufficiency or when adrenocortical reserve is doubtful,0
4942,4942,4942,4942,4942,4942,4942,6014,6014,6014,6014,6014,6014,6014,6014,6014,6014,6014,6014,6014,5564ee46-7bd7-4b2a-ad51-d01f7fda0461,shock unresponsive to conventional therapy if adrenocortical insufficiency exists or is suspected,0
4943,4943,4943,4943,4943,4943,4943,6015,6015,6015,6015,6015,6015,6015,6015,6015,6015,6015,6015,6015,5564ee46-7bd7-4b2a-ad51-d01f7fda0461,congenital adrenal hyperplasia,1
4944,4944,4944,4944,4944,4944,4944,6016,6016,6016,6016,6016,6016,6016,6016,6016,6016,6016,6016,6016,5564ee46-7bd7-4b2a-ad51-d01f7fda0461,hypercalcemia associated with cancer,1
4945,4945,4945,4945,4945,4945,4945,6017,6017,6017,6017,6017,6017,6017,6017,6017,6017,6017,6017,6017,5564ee46-7bd7-4b2a-ad51-d01f7fda0461,rheumatic disorders as adjunctive therapy for short term administration ( to tide the patient over an acute episode or exacerbation ) in post traumatic osteoarthritis,1
4946,4946,4946,4946,4946,4946,4946,6018,6018,6018,6018,6018,6018,6018,6018,6018,6018,6018,6018,6018,5564ee46-7bd7-4b2a-ad51-d01f7fda0461,rheumatoid arthritis  including juvenile rheumatoid arthritis ( selected cases may require low dose maintenance therapy ),1
4947,4947,4947,4947,4947,4947,4947,6019,6019,6019,6019,6019,6019,6019,6019,6019,6019,6019,6019,6019,5564ee46-7bd7-4b2a-ad51-d01f7fda0461,acute nonspecific tenosynovitis,1
4948,4948,4948,4948,4948,4948,4948,6020,6020,6020,6020,6020,6020,6020,6020,6020,6020,6020,6020,6020,5564ee46-7bd7-4b2a-ad51-d01f7fda0461,collagen diseases during an exacerbation or as maintenance therapy in selected cases of systemic lupus erythematosus,1
4949,4949,4949,4949,4949,4949,4949,6021,6021,6021,6021,6021,6021,6021,6021,6021,6021,6021,6021,6021,5564ee46-7bd7-4b2a-ad51-d01f7fda0461,dermatologic diseases pemphigus,1
4950,4950,4950,4950,4950,4950,4950,6022,6022,6022,6022,6022,6022,6022,6022,6022,6022,6022,6022,6022,5564ee46-7bd7-4b2a-ad51-d01f7fda0461,( stevens johnson syndrome ) exfoliative dermatitis,1
4951,4951,4951,4951,4951,4951,4951,6023,6023,6023,6023,6023,6023,6023,6023,6023,6023,6023,6023,6023,5564ee46-7bd7-4b2a-ad51-d01f7fda0461,bullous dermatitis herpetiformis,1
4952,4952,4952,4952,4952,4952,4952,6024,6024,6024,6024,6024,6024,6024,6024,6024,6024,6024,6024,6024,33bff678-7829-479e-9110-b8e33a0bc0aa,1  exondys 51 is indicated for the treatment of duchenne muscular dystrophy ( dmd ) in patients who have a confirmed mutation of the dmd gene that is amenable to exon 51 skipping,1
4953,4953,4953,4953,4953,4953,4953,6025,6025,6025,6025,6025,6025,6025,6025,6025,6025,6025,6025,6025,33bff678-7829-479e-9110-b8e33a0bc0aa,this indication is approved under accelerated approval based on an increase in dystrophin in skeletal muscle observed in some patients treated with exondys 51 see clinical studies ( 14 ),0
4954,4954,4954,4954,4954,4954,4954,6026,6026,6026,6026,6026,6026,6026,6026,6026,6026,6026,6026,6026,33bff678-7829-479e-9110-b8e33a0bc0aa,a clinical benefit of exondys 51 has not been established,0
4955,4955,4955,4955,4955,4955,4955,6027,6027,6027,6027,6027,6027,6027,6027,6027,6027,6027,6027,6027,33bff678-7829-479e-9110-b8e33a0bc0aa,continued approval for this indication may be contingent upon verification of a clinical benefit in confirmatory trials,0
4956,4956,4956,4956,4956,4956,4956,6028,6028,6028,6028,6028,6028,6028,6028,6028,6028,6028,6028,6028,33bff678-7829-479e-9110-b8e33a0bc0aa,exondys 51 is an antisense oligonucleotide indicated for the treatment of duchenne muscular dystrophy ( dmd ) in patients who have a confirmed mutation of the dmd gene that is amenable to exon 51 skipping,1
4957,4957,4957,4957,4957,4957,4957,6032,6032,6032,6032,6032,6032,6032,6032,6032,6032,6032,6032,6032,9ffe79a1-ac91-4a7b-a9e3-7c84bfa9ddf0, azathioprine sodium for injection  usp is indicated as an adjunct for the prevention of rejection in renal homotransplantation,1
4958,4958,4958,4958,4958,4958,4958,6033,6033,6033,6033,6033,6033,6033,6033,6033,6033,6033,6033,6033,9ffe79a1-ac91-4a7b-a9e3-7c84bfa9ddf0,it is also indicated for the management of active rheumatoid arthritis to reduce signs and symptoms,1
4959,4959,4959,4959,4959,4959,4959,6034,6034,6034,6034,6034,6034,6034,6034,6034,6034,6034,6034,6034,9ffe79a1-ac91-4a7b-a9e3-7c84bfa9ddf0,renal homotransplantation azathioprine is indicated as an adjunct for the prevention of rejection in renal homotransplantation,1
4960,4960,4960,4960,4960,4960,4960,6035,6035,6035,6035,6035,6035,6035,6035,6035,6035,6035,6035,6035,9ffe79a1-ac91-4a7b-a9e3-7c84bfa9ddf0,experience with over 16  000 transplants shows a five year patient survival of 35 to 55  but this is dependent on donor  match for hla antigens  anti donor or anti b cell alloantigen antibody and other variables,0
4961,4961,4961,4961,4961,4961,4961,6036,6036,6036,6036,6036,6036,6036,6036,6036,6036,6036,6036,6036,9ffe79a1-ac91-4a7b-a9e3-7c84bfa9ddf0,the effect of azathioprine on these variables has not been tested in controlled trials,0
4962,4962,4962,4962,4962,4962,4962,6037,6037,6037,6037,6037,6037,6037,6037,6037,6037,6037,6037,6037,9ffe79a1-ac91-4a7b-a9e3-7c84bfa9ddf0,rheumatoid arthritis azathioprine is indicated for the treatment of active rheumatoid arthritis ( ra ) to reduce signs and symptoms,1
4963,4963,4963,4963,4963,4963,4963,6038,6038,6038,6038,6038,6038,6038,6038,6038,6038,6038,6038,6038,9ffe79a1-ac91-4a7b-a9e3-7c84bfa9ddf0,aspirin  non steroidal anti inflammatory drugs and or low dose glucocorticoids may be continued during treatment with azathioprine,0
4964,4964,4964,4964,4964,4964,4964,6039,6039,6039,6039,6039,6039,6039,6039,6039,6039,6039,6039,6039,9ffe79a1-ac91-4a7b-a9e3-7c84bfa9ddf0,the combined use of azathioprine with disease modifying anti rheumatic drugs ( dmards ) has not been studied for either added benefit or unexpected adverse effects,0
4965,4965,4965,4965,4965,4965,4965,6040,6040,6040,6040,6040,6040,6040,6040,6040,6040,6040,6040,6040,9ffe79a1-ac91-4a7b-a9e3-7c84bfa9ddf0,the use of azathioprine with these agents cannot be recommended,2
4966,4966,4966,4966,4966,4966,4966,6041,6041,6041,6041,6041,6041,6041,6041,6041,6041,6041,6041,6041,249e938d-f181-47c4-a082-372d65462f33,indications usage to reduce the development of drug resistant bacteria and maintain the effectiveness of trimethoprim tablets  usp and other antibacterial drugs  trimethoprim tablets  usp should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria,4
4967,4967,4967,4967,4967,4967,4967,6044,6044,6044,6044,6044,6044,6044,6044,6044,6044,6044,6044,6044,249e938d-f181-47c4-a082-372d65462f33,for the treatment of initial episodes of uncomplicated urinary tract infections due to susceptible strains of the following organisms escherichia coli  proteus mirabilis  klebsiella pneumoniae  enterobacter species  and coagulase negative staphylococcus species  including s saprophyticus,1
4968,4968,4968,4968,4968,4968,4968,6047,6047,6047,6047,6047,6047,6047,6047,6047,6047,6047,6047,6047,b6e213da-e882-49d0-9add-7629b35294ce, trihexyphenidyl hcl is indicated as an adjunct in the treatment of all forms of parkinsonism ( postencephalitic  arteriosclerotic  and idiopathic ),1
4969,4969,4969,4969,4969,4969,4969,6048,6048,6048,6048,6048,6048,6048,6048,6048,6048,6048,6048,6048,b6e213da-e882-49d0-9add-7629b35294ce,it is often useful as adjuvant therapy when treating these forms of parkinsonism with levodopa,u
4970,4970,4970,4970,4970,4970,4970,6049,6049,6049,6049,6049,6049,6049,6049,6049,6049,6049,6049,6049,b6e213da-e882-49d0-9add-7629b35294ce,additionally  it is indicated for the control of extrapyramidal disorders caused by central nervous system drugs such as the dibenzoxazepines  phenothiazines  thioxanthenes  and butyrophenones,1
4971,4971,4971,4971,4971,4971,4971,6050,6050,6050,6050,6050,6050,6050,6050,6050,6050,6050,6050,6050,a293cece-e97a-4e67-be72-b187568e3b11, enablex ( darifenacin ) extended release tablets are indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence  urgency and frequency,1
4972,4972,4972,4972,4972,4972,4972,6051,6051,6051,6051,6051,6051,6051,6051,6051,6051,6051,6051,6051,31ce4750-ded5-4a0b-95e9-f229fa6bc822,1  halaven is a microtubule inhibitor indicated for the treatment of patients with metastatic breast cancer who have previously received at least two chemotherapeutic regimens for the treatment of metastatic disease,1
4973,4973,4973,4973,4973,4973,4973,6052,6052,6052,6052,6052,6052,6052,6052,6052,6052,6052,6052,6052,31ce4750-ded5-4a0b-95e9-f229fa6bc822,prior therapy should have included an anthracycline and a taxane in either the adjuvant or metastatic setting,u
4974,4974,4974,4974,4974,4974,4974,6053,6053,6053,6053,6053,6053,6053,6053,6053,6053,6053,6053,6053,31ce4750-ded5-4a0b-95e9-f229fa6bc822,( 1 1 ) unresectable or metastatic liposarcoma who have received a prior anthracycline containing regimen,1
4975,4975,4975,4975,4975,4975,4975,6054,6054,6054,6054,6054,6054,6054,6054,6054,6054,6054,6054,6054,31ce4750-ded5-4a0b-95e9-f229fa6bc822,( 1 2 ) 1 1 me tastatic breast cancer halaven is indicated for the treatment of patients with metastatic breast cancer who have previously received at least two chemotherapeutic regimens for the treatment of metastatic disease,1
4976,4976,4976,4976,4976,4976,4976,6055,6055,6055,6055,6055,6055,6055,6055,6055,6055,6055,6055,6055,31ce4750-ded5-4a0b-95e9-f229fa6bc822,prior therapy should have included an anthracycline and a taxane in either the adjuvant or metastatic setting see clinical studies ( 14 1 ),u
4977,4977,4977,4977,4977,4977,4977,6056,6056,6056,6056,6056,6056,6056,6056,6056,6056,6056,6056,6056,31ce4750-ded5-4a0b-95e9-f229fa6bc822,1 2 liposarcoma halaven is indicated for the treatment of patients with unresectable or metastatic liposarcoma who have received a prior anthracycline containing regimen see clinical studies ( 14 2 ),1
4978,4978,4978,4978,4978,4978,4978,6057,6057,6057,6057,6057,6057,6057,6057,6057,6057,6057,6057,6057,712143d9-e21e-4013-bb3b-3426a21060a8,1  tymlos is indicated for the treatment of postmenopausal women with osteoporosis at high risk for fracture defined as a history of osteoporotic fracture  multiple risk factors for fracture  or patients who have failed or are intolerant to other available osteoporosis therapy,1
4979,4979,4979,4979,4979,4979,4979,6058,6058,6058,6058,6058,6058,6058,6058,6058,6058,6058,6058,6058,712143d9-e21e-4013-bb3b-3426a21060a8,in postmenopausal women with osteoporosis  tymlos reduces the risk of vertebral fractures and nonvertebral fractures see clinical studies ( 14 ),0
4980,4980,4980,4980,4980,4980,4980,6059,6059,6059,6059,6059,6059,6059,6059,6059,6059,6059,6059,6059,712143d9-e21e-4013-bb3b-3426a21060a8,limitations of use because of the unknown relevance of the rodent osteosarcoma findings to humans  cumulative use of tymlos and parathyroid hormone analogs ( e g  teriparatide ) for more than 2 years during a patient s lifetime is not recommended see warnings and precautions ( 5 1 ),2
4981,4981,4981,4981,4981,4981,4981,6060,6060,6060,6060,6060,6060,6060,6060,6060,6060,6060,6060,6060,712143d9-e21e-4013-bb3b-3426a21060a8,tymlos is a human parathyroid hormone related peptide pthrp ( 1 34 ) analog indicated for the treatment of postmenopausal women with osteoporosis at high risk for fracture,1
4982,4982,4982,4982,4982,4982,4982,6061,6061,6061,6061,6061,6061,6061,6061,6061,6061,6061,6061,6061,b52dfa36-f90b-4e19-9b5e-26db9d04df2b,1  thyrogen is a thyroid stimulating hormone indicated for diagnostic use as an adjunctive diagnostic tool for serum thyroglobulin ( tg ) testing with or without radioiodine imaging in the follow up of patients with well differentiated thyroid cancer who have previously undergone thyroidectomy,1
4983,4983,4983,4983,4983,4983,4983,6062,6062,6062,6062,6062,6062,6062,6062,6062,6062,6062,6062,6062,b52dfa36-f90b-4e19-9b5e-26db9d04df2b,( 1 1 ) limitations of use thyrogen stimulated tg levels are generally lower than  and do not correlate with tg levels after thyroid hormone withdrawal,0
4984,4984,4984,4984,4984,4984,4984,6063,6063,6063,6063,6063,6063,6063,6063,6063,6063,6063,6063,6063,b52dfa36-f90b-4e19-9b5e-26db9d04df2b,even when thyrogen tg testing is performed in combination with radioiodine imaging  there remains a risk of missing a diagnosis of thyroid cancer or underestimating the extent of the disease,0
4985,4985,4985,4985,4985,4985,4985,6064,6064,6064,6064,6064,6064,6064,6064,6064,6064,6064,6064,6064,b52dfa36-f90b-4e19-9b5e-26db9d04df2b,anti tg antibodies may confound the tg assay and render tg levels uninterpretable,0
4986,4986,4986,4986,4986,4986,4986,6065,6065,6065,6065,6065,6065,6065,6065,6065,6065,6065,6065,6065,b52dfa36-f90b-4e19-9b5e-26db9d04df2b,ablation use as an adjunctive treatment for radioiodine ablation of thyroid tissue remnants in patients who have undergone a near total or total thyroidectomy for well differentiated thyroid cancer and who do not have evidence of distant metastatic thyroid cancer,1
4987,4987,4987,4987,4987,4987,4987,6066,6066,6066,6066,6066,6066,6066,6066,6066,6066,6066,6066,6066,b52dfa36-f90b-4e19-9b5e-26db9d04df2b,( 1 2 ) limitations of use the effect of thyrogen on long term thyroid cancer outcomes has not been determined,0
4988,4988,4988,4988,4988,4988,4988,6067,6067,6067,6067,6067,6067,6067,6067,6067,6067,6067,6067,6067,b52dfa36-f90b-4e19-9b5e-26db9d04df2b,1 1 adjunctive diagnostic tool for serum thyroglobulin testing in well differentiated thyroid cancer thyrogen is indicated for use as an adjunctive diagnostic tool for serum thyroglobulin ( tg ) testing with or without radioiodine imaging in the follow up of patients with well differentiated thyroid cancer who have previously undergone thyroidectomy,1
4989,4989,4989,4989,4989,4989,4989,6068,6068,6068,6068,6068,6068,6068,6068,6068,6068,6068,6068,6068,b52dfa36-f90b-4e19-9b5e-26db9d04df2b,limitations of use thyrogen stimulated tg levels are generally lower than  and do not correlate with  tg levels after thyroid hormone withdrawal see clinical studies ( 14 1 ),0
4990,4990,4990,4990,4990,4990,4990,6069,6069,6069,6069,6069,6069,6069,6069,6069,6069,6069,6069,6069,b52dfa36-f90b-4e19-9b5e-26db9d04df2b,even when thyrogen stimulated tg testing is performed in combination with radioiodine imaging  there remains a risk of missing a diagnosis of thyroid cancer or of underestimating the extent of disease,0
4991,4991,4991,4991,4991,4991,4991,6070,6070,6070,6070,6070,6070,6070,6070,6070,6070,6070,6070,6070,b52dfa36-f90b-4e19-9b5e-26db9d04df2b,anti tg antibodies may confound the tg assay and render tg levels uninterpretable see clinical studies ( 14 1 ),0
4992,4992,4992,4992,4992,4992,4992,6071,6071,6071,6071,6071,6071,6071,6071,6071,6071,6071,6071,6071,ed3eaf69-1cbd-4b01-a6fa-1fe02c90c3e1,1  atryn is a recombinant antithrombin indicated for the prevention of peri operative and peri partum thromboembolic events in hereditary antithrombin deficient patients1,1
4993,4993,4993,4993,4993,4993,4993,6072,6072,6072,6072,6072,6072,6072,6072,6072,6072,6072,6072,6072,ed3eaf69-1cbd-4b01-a6fa-1fe02c90c3e1,it is not indicated for treatment of thromboembolic events in hereditary antithrombin deficient patients,2
4994,4994,4994,4994,4994,4994,4994,6073,6073,6073,6073,6073,6073,6073,6073,6073,6073,6073,6073,6073,ed3eaf69-1cbd-4b01-a6fa-1fe02c90c3e1,atryn is a recombinant antithrombin indicated for the prevention of peri operative and peri partum thromboembolic events in hereditary antithrombin deficient patients,1
4995,4995,4995,4995,4995,4995,4995,6074,6074,6074,6074,6074,6074,6074,6074,6074,6074,6074,6074,6074,ed3eaf69-1cbd-4b01-a6fa-1fe02c90c3e1,( 1 ) it is not indicated for treatment of thromboembolic events in hereditary antithrombin deficient patients,2
4996,4996,4996,4996,4996,4996,4996,6075,6075,6075,6075,6075,6075,6075,6075,6075,6075,6075,6075,6075,f9adbcd5-1ac1-42d8-b18a-a76c9204014c,indications neurolite single photon emission computerized tomography ( spect ) is indicated as an adjunct to conventional ct or mri imaging in the localization of stroke in patients in whom stroke has already been diagnosed,1
4997,4997,4997,4997,4997,4997,4997,6076,6076,6076,6076,6076,6076,6076,6076,6076,6076,6076,6076,6076,f9adbcd5-1ac1-42d8-b18a-a76c9204014c,neurolite is not indicated for assessment of functional viability of brain tissue,2
4998,4998,4998,4998,4998,4998,4998,6077,6077,6077,6077,6077,6077,6077,6077,6077,6077,6077,6077,6077,f9adbcd5-1ac1-42d8-b18a-a76c9204014c,also  neurolite is not indicated for distinguishing between stroke and other brain lesions,2
4999,4999,4999,4999,4999,4999,4999,6078,6078,6078,6078,6078,6078,6078,6078,6078,6078,6078,6078,6078,ff68a002-d46d-4f9f-0705-427844ea3655,indications usage hypertension acebutolol hydrochloride capsules are indicated for the management of hypertension in adults,1
5000,5000,5000,5000,5000,5000,5000,6079,6079,6079,6079,6079,6079,6079,6079,6079,6079,6079,6079,6079,ff68a002-d46d-4f9f-0705-427844ea3655,it may be used alone or in combination with other antihypertensive agents  especially thiazide type diuretics,4
5001,5001,5001,5001,5001,5001,5001,6080,6080,6080,6080,6080,6080,6080,6080,6080,6080,6080,6080,6080,ff68a002-d46d-4f9f-0705-427844ea3655,ventricular arrhythmias acebutolol hydrochloride capsules are indicated in the management of ventricular premature beats it reduces the total number of premature beats  as well as the number of paired and multiform ventricular ectopic beats  and r on t beats,1
5002,5002,5002,5002,5002,5002,5002,6081,6081,6081,6081,6081,6081,6081,6081,6081,6081,6081,6081,6081,8462d6ab-e3cd-4efa-a360-75bf8f917287, osphena is indicated for the treatment of moderate to severe dyspareunia  a symptom of vulvar and vaginal atrophy  due to menopause,1
5003,5003,5003,5003,5003,5003,5003,6082,6082,6082,6082,6082,6082,6082,6082,6082,6082,6082,6082,6082,8462d6ab-e3cd-4efa-a360-75bf8f917287,osphena is an estrogen agonist antagonist indicated for the treatment of moderate to severe dyspareunia  a symptom of vulvar and vaginal atrophy  due to menopause ( 1 ),1
5004,5004,5004,5004,5004,5004,5004,6083,6083,6083,6083,6083,6083,6083,6083,6083,6083,6083,6083,6083,5bcd261e-ebba-4ecb-af22-e5aaeb04499b, anticoagulant citrate dextrose solution  solution a  u s p,
5005,5005,5005,5005,5005,5005,5005,6084,6084,6084,6084,6084,6084,6084,6084,6084,6084,6084,6084,6084,5bcd261e-ebba-4ecb-af22-e5aaeb04499b,( acd a )  is intended for use as an anticoagulant in the extracorporeal blood processing with autologous prp systems in production of platelet rich plasma ( prp ),1
5006,5006,5006,5006,5006,5006,5006,6085,6085,6085,6085,6085,6085,6085,6085,6085,6085,6085,6085,6085,5bcd261e-ebba-4ecb-af22-e5aaeb04499b,refer to the manufacturer 's operator 's manual of the autologous prp system for the directions for use,0
5007,5007,5007,5007,5007,5007,5007,6086,6086,6086,6086,6086,6086,6086,6086,6086,6086,6086,6086,6086,fee1e6b1-e1a5-4254-9f2e-a70e0f8dbdea,1  tafinlar is a kinase inhibitor indicated as a single agent for the treatment of patients with unresectable or metastatic melanoma with braf v600e mutation as detected by an fda approved test,1
5008,5008,5008,5008,5008,5008,5008,6087,6087,6087,6087,6087,6087,6087,6087,6087,6087,6087,6087,6087,fee1e6b1-e1a5-4254-9f2e-a70e0f8dbdea,( 1 1 ) tafinlar is indicated  in combination with trametinib  for the treatment of patients with unresectable or metastatic melanoma with braf v600e or v600k mutations as detected by an fda approved test,1
5009,5009,5009,5009,5009,5009,5009,6088,6088,6088,6088,6088,6088,6088,6088,6088,6088,6088,6088,6088,fee1e6b1-e1a5-4254-9f2e-a70e0f8dbdea,( 1 2 ) metastatic non small cell lung cancer ( nsclc ) with braf v600e mutation as detected by an fda approved test,1
5010,5010,5010,5010,5010,5010,5010,6089,6089,6089,6089,6089,6089,6089,6089,6089,6089,6089,6089,6089,fee1e6b1-e1a5-4254-9f2e-a70e0f8dbdea,( 1 3 ) limitation of use tafinlar is not indicated for treatment of patients with wild type braf melanoma or wild type braf nsclc,2
5011,5011,5011,5011,5011,5011,5011,6090,6090,6090,6090,6090,6090,6090,6090,6090,6090,6090,6090,6090,fee1e6b1-e1a5-4254-9f2e-a70e0f8dbdea,( 1 4  5 2 ) 1 1 braf v600e mutation positive unresectable or metastatic melanoma tafinlar is indicated as a single agent for the treatment of patients with unresectable or metastatic melanoma with braf v600e mutation as detected by an fda approved test,1
5012,5012,5012,5012,5012,5012,5012,6091,6091,6091,6091,6091,6091,6091,6091,6091,6091,6091,6091,6091,fee1e6b1-e1a5-4254-9f2e-a70e0f8dbdea,1 2 braf v600e or v600k mutation positive unresectable or metastatic melanoma tafinlar is indicated  in combination with trametinib  for the treatment of patients with unresectable or metastatic melanoma with braf v600e or v600k mutations  as detected by an fda approved test,1
5013,5013,5013,5013,5013,5013,5013,6092,6092,6092,6092,6092,6092,6092,6092,6092,6092,6092,6092,6092,fee1e6b1-e1a5-4254-9f2e-a70e0f8dbdea,1 3 braf v600e mutation positive metastatic nsclc tafinlar is indicated  in combination with trametinib  for the treatment of patients with metastatic non small cell lung cancer ( nsclc ) with braf v600e mutation as detected by an fda approved test,1
5014,5014,5014,5014,5014,5014,5014,6093,6093,6093,6093,6093,6093,6093,6093,6093,6093,6093,6093,6093,fee1e6b1-e1a5-4254-9f2e-a70e0f8dbdea,1 4 limitation of use tafinlar is not indicated for treatment of patients with wild type b,1
5015,5015,5015,5015,5015,5015,5015,6094,6094,6094,6094,6094,6094,6094,6094,6094,6094,6094,6094,6094,3827e1be-f328-45f7-b113-311b57039f8c,1  renflexis is a tumor necrosis factor ( tnf ) blocker indicated for crohn 's disease ( 1 1 ) reducing signs and symptoms and inducing and maintaining clinical remission in adult patients with moderately to severely active disease who have had an inadequate response to conventional therapy,1
5016,5016,5016,5016,5016,5016,5016,6095,6095,6095,6095,6095,6095,6095,6095,6095,6095,6095,6095,6095,3827e1be-f328-45f7-b113-311b57039f8c,reducing the number of draining enterocutaneous and rectovaginal fistulas and maintaining fistula closure in adult patients with fistulizing disease,1
5017,5017,5017,5017,5017,5017,5017,6096,6096,6096,6096,6096,6096,6096,6096,6096,6096,6096,6096,6096,3827e1be-f328-45f7-b113-311b57039f8c,pediatric crohn 's disease ( 1 2 ) reducing signs and symptoms and inducing and maintaining clinical remission in pediatric patients with moderately to severely active disease who have had an inadequate response to conventional therapy,1
5018,5018,5018,5018,5018,5018,5018,6097,6097,6097,6097,6097,6097,6097,6097,6097,6097,6097,6097,6097,3827e1be-f328-45f7-b113-311b57039f8c,ulcerative colitis ( 1 3 ) reducing signs and symptoms  inducing and maintaining clinical remission and mucosal healing  and eliminating corticosteroid use in adult patients with moderately to severely active disease who have had an inadequate response to conventional therapy,1
5019,5019,5019,5019,5019,5019,5019,6098,6098,6098,6098,6098,6098,6098,6098,6098,6098,6098,6098,6098,3827e1be-f328-45f7-b113-311b57039f8c,rheumatoid arthritis ( 1 4 ) in combination with methotrexate reducing signs and symptoms  inhibiting the progression of structural damage  and improving physical function in patients with moderately to severely active disease,1
5020,5020,5020,5020,5020,5020,5020,6099,6099,6099,6099,6099,6099,6099,6099,6099,6099,6099,6099,6099,3827e1be-f328-45f7-b113-311b57039f8c,ankylosing spondylitis ( 1 5 ) reducing signs and symptoms in patients with active disease,1
5021,5021,5021,5021,5021,5021,5021,6100,6100,6100,6100,6100,6100,6100,6100,6100,6100,6100,6100,6100,3827e1be-f328-45f7-b113-311b57039f8c,psoriatic arthritis ( 1 6 ) reducing signs and symptoms of active arthritis  inhibiting the progression of structural damage  and improving physical function,1
5022,5022,5022,5022,5022,5022,5022,6101,6101,6101,6101,6101,6101,6101,6101,6101,6101,6101,6101,6101,3827e1be-f328-45f7-b113-311b57039f8c,plaque psoriasis ( 1 7 ) treatment of adult patients with chronic severe ( i e  extensive and or disabling ) plaque psoriasis who are candidates for systemic therapy and when other systemic therapies are medically less appropriate,1
5023,5023,5023,5023,5023,5023,5023,6102,6102,6102,6102,6102,6102,6102,6102,6102,6102,6102,6102,6102,3827e1be-f328-45f7-b113-311b57039f8c,1 1 crohn 's disease renflexis is indicated for reducing signs and symptoms and inducing and maintaining clinical remissi,1
5024,5024,5024,5024,5024,5024,5024,6103,6103,6103,6103,6103,6103,6103,6103,6103,6103,6103,6103,6103,17a8d11b-73b0-4833-a0b4-cf1ef85edefb,1  aristada is indicated for treatment of schizophrenia see clinical studies ( 14 ),1
5025,5025,5025,5025,5025,5025,5025,6104,6104,6104,6104,6104,6104,6104,6104,6104,6104,6104,6104,6104,17a8d11b-73b0-4833-a0b4-cf1ef85edefb,aristada is an atypical antipsychotic indicated for the treatment of schizophrenia ( 1 ),1
5026,5026,5026,5026,5026,5026,5026,6105,6105,6105,6105,6105,6105,6105,6105,6105,6105,6105,6105,6105,e4bb53c7-9061-43fc-878f-dc1b19801bfc, glaucoma chronic open angle glaucoma,1
5027,5027,5027,5027,5027,5027,5027,6106,6106,6106,6106,6106,6106,6106,6106,6106,6106,6106,6106,6106,e4bb53c7-9061-43fc-878f-dc1b19801bfc,subacute or chronic angle closure glaucoma after iridectomy or where surgery is refused or contraindicated,1
5028,5028,5028,5028,5028,5028,5028,6107,6107,6107,6107,6107,6107,6107,6107,6107,6107,6107,6107,6107,e4bb53c7-9061-43fc-878f-dc1b19801bfc,certain non uveitic secondary types of glaucoma  especially glaucoma following cataract surgery,1
5029,5029,5029,5029,5029,5029,5029,6108,6108,6108,6108,6108,6108,6108,6108,6108,6108,6108,6108,6108,e4bb53c7-9061-43fc-878f-dc1b19801bfc,accommodative esotropia concomitant esotropias with a significant accommodative component,1
5030,5030,5030,5030,5030,5030,5030,6109,6109,6109,6109,6109,6109,6109,6109,6109,6109,6109,6109,6109,52f4cc49-6553-426f-9778-0bd34e31b942,indication and usage eskata is indicated for the treatment of seborrheic keratoses that are raised,1
5031,5031,5031,5031,5031,5031,5031,6110,6110,6110,6110,6110,6110,6110,6110,6110,6110,6110,6110,6110,52f4cc49-6553-426f-9778-0bd34e31b942,eskata is indicated for the treatment of seborrheic keratoses that are raised,1
5032,5032,5032,5032,5032,5032,5032,6111,6111,6111,6111,6111,6111,6111,6111,6111,6111,6111,6111,6111,"Active Ingredient UNII(s)
BBX060AN9V; MOR84MUD8E    bf6aa711-8693-443e-9a0b-f59084bfe345
BBX060AN9V; MOR84MUD8E    bf6aa711-8693-443e-9a0b-f59084bfe345
Name: SET ID dtype: object",active ingredient unii ( s ) bbx060an9v mor84mud8e active ingredient unii ( s ) bbx060an9v mor84mud bbx060an9v mor84mud8e active ingredient unii ( s ) bbx060an9v mor84mud name content xml  dtype object,0
5033,5033,5033,5033,5033,5033,5033,6113,6113,6113,6113,6113,6113,6113,6113,6113,6113,6113,6113,6113,6599b544-60bd-ab30-e053-2a91aa0a67b6, nystatin cream usp is indicated in the treatment of cutaneous or mucocutaneous mycotic infections caused by candida albicans and other susceptible candida species,1
5034,5034,5034,5034,5034,5034,5034,6114,6114,6114,6114,6114,6114,6114,6114,6114,6114,6114,6114,6114,6599b544-60bd-ab30-e053-2a91aa0a67b6,nystatin cream usp is not indicated for systemic  oral  intravaginal or ophthalmic use,2
5035,5035,5035,5035,5035,5035,5035,6115,6115,6115,6115,6115,6115,6115,6115,6115,6115,6115,6115,6115,06237703-b962-4e9b-9851-fc06070ed1a6, nystatin and triamcinolone acetonide cream and ointment are indicated for the treatment of cutaneous candidiasis it has been demonstrated that the nystatin steroid combination provides greater benefit than the nystatin component alone during the first few days of treatment,1
5036,5036,5036,5036,5036,5036,5036,6116,6116,6116,6116,6116,6116,6116,6116,6116,6116,6116,6116,6116,3d0c9554-eaeb-4694-8089-00133fcadce3,1  aptiom is indicated for the treatment of partial onset seizures in patients 4 years of age and older,1
5037,5037,5037,5037,5037,5037,5037,6117,6117,6117,6117,6117,6117,6117,6117,6117,6117,6117,6117,6117,3d0c9554-eaeb-4694-8089-00133fcadce3,aptiom is indicated for the treatment of partial onset seizures in patients 4 years of age and older,1
5038,5038,5038,5038,5038,5038,5038,6118,6118,6118,6118,6118,6118,6118,6118,6118,6118,6118,6118,6118,f3ffd601-182f-4f04-b1cc-8175bc2e32fe, a moderately long acting mydriatic and cycloplegic for cycloplegic refraction and in the treatment of inflammatory conditions of the uveal tract,1
5039,5039,5039,5039,5039,5039,5039,6119,6119,6119,6119,6119,6119,6119,6119,6119,6119,6119,6119,6119,f3ffd601-182f-4f04-b1cc-8175bc2e32fe,for pre and postoperative states when mydriasis is required,1
5040,5040,5040,5040,5040,5040,5040,6120,6120,6120,6120,6120,6120,6120,6120,6120,6120,6120,6120,6120,f3ffd601-182f-4f04-b1cc-8175bc2e32fe,use as an optical aid in some cases of axial lens opacities,1
5041,5041,5041,5041,5041,5041,5041,6121,6121,6121,6121,6121,6121,6121,6121,6121,6121,6121,6121,6121,b111b1ab-10b0-4378-8aef-e51d5274306c,1  besivance ( besifloxacin ophthalmic suspension ) 0 6  is indicated for the treatment of bacterial conjunctivitis caused by susceptible isolates of the following bacteria aerococcus viridans cdc coryneform group g corynebacterium pseudodiphtheriticum corynebacterium striatum haemophilus influenzae moraxella catarrhalis moraxella lacunata pseudomonas aeruginosa staphylococcus aureus staphylococcus epidermidis staphylococcus hominis staphylococcus lugdunensis staphylococcus warneri streptococcus mitis group streptococcus oralis streptococcus pneumoniae streptococcus salivarius efficacy for this organism was studied in fewer than 10 infections,1
5042,5042,5042,5042,5042,5042,5042,6122,6122,6122,6122,6122,6122,6122,6122,6122,6122,6122,6122,6122,b111b1ab-10b0-4378-8aef-e51d5274306c,besivance ( besifloxacin ophthalmic suspension ) 0 6  is a quinolone antimicrobial indicated for the treatment of bacterial conjunctivitis caused by susceptible isolates of the following bacteria aerococcus viridans  cdc coryneform group g  corynebacterium pseudodiphtheriticum  corynebacterium striatum  haemophilus influenzae  moraxella catarrhalis  moraxella lacunata  pseudomonas aeruginosa  staphylococcus aureus  staphylococcus epidermidis  staphylococcus hominis  staphylococcus lugdunensis  staphylococcus warneri  streptococcus mitis group  streptococcus oralis  streptococcus pneumoniae  streptococcus salivarius efficacy for this organism was studied in fewer than 10 infections,1
5043,5043,5043,5043,5043,5043,5043,6123,6123,6123,6123,6123,6123,6123,6123,6123,6123,6123,6123,6123,87608ae1-fbd7-41b2-a2a4-8963e0b834be,indications initial treatment of advanced ovarian carcinoma carboplatin injection is indicated for the initial treatment of advanced ovarian carcinoma in established combination with other approved chemotherapeutic agents,1
5044,5044,5044,5044,5044,5044,5044,6124,6124,6124,6124,6124,6124,6124,6124,6124,6124,6124,6124,6124,87608ae1-fbd7-41b2-a2a4-8963e0b834be,one established combination regimen consists of carboplatin and cyclophosphamide,0
5045,5045,5045,5045,5045,5045,5045,6125,6125,6125,6125,6125,6125,6125,6125,6125,6125,6125,6125,6125,87608ae1-fbd7-41b2-a2a4-8963e0b834be,two randomized controlled studies conducted by the ncic and swog with carboplatin versus cisplatin  both in combination with cyclophosphamide  have demonstrated equivalent overall survival between the two groups ( see clinical studies ),0
5046,5046,5046,5046,5046,5046,5046,6126,6126,6126,6126,6126,6126,6126,6126,6126,6126,6126,6126,6126,87608ae1-fbd7-41b2-a2a4-8963e0b834be,there is limited statistical power to demonstrate equivalence in overall pathologic complete response rates and long term survival ( 3 years ) because of the small number of patients with these outcomes the small number of patients with residual tumor 2 cm after initial surgery also limits the statistical power to demonstrate equivalence in this subgroup,0
5047,5047,5047,5047,5047,5047,5047,6127,6127,6127,6127,6127,6127,6127,6127,6127,6127,6127,6127,6127,87608ae1-fbd7-41b2-a2a4-8963e0b834be,secondary treatment of advanced ovarian carcinoma carboplatin injection is indicated for the palliative treatment of patients with ovarian carcinoma recurrent after prior chemotherapy  including patients who have been previously treated with cisplatin,1
5048,5048,5048,5048,5048,5048,5048,6128,6128,6128,6128,6128,6128,6128,6128,6128,6128,6128,6128,6128,87608ae1-fbd7-41b2-a2a4-8963e0b834be,within the group of patients previously treated with cisplatin  those who have developed progressive disease while receiving cisplatin therapy may have a decreased response rate,0
5049,5049,5049,5049,5049,5049,5049,6137,6137,6137,6137,6137,6137,6137,6137,6137,6137,6137,6137,6137,05f08d62-9de9-4af9-931e-10b93c70e39e,1 3 limitations of use fenofibrate at a dose equivalent to 135 mg of fenofibric acid delayed release capsules did not reduce coronary heart disease morbidity and mortality in 2 large  randomized controlled trials of patients with type 2 diabetes mellitus see warnings and precautions ( 5 1 ),0
5050,5050,5050,5050,5050,5050,5050,6138,6138,6138,6138,6138,6138,6138,6138,6138,6138,6138,6138,6138,fea0fab5-d29a-47ce-b34e-d6033aa9ca66,1  doripenem for injection is a penem antibacterial indicated in the treatment of the following infections caused by designated susceptible bacteria complicated intra abdominal infections ( 1 1 ) complicated urinary tract infections  including pyelonephritis ( 1 2 ) to reduce the development of drug resistant bacteria and maintain the effectiveness of doripenem for injection and other antibacterial drugs  doripenem for injection should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria,1
5051,5051,5051,5051,5051,5051,5051,6139,6139,6139,6139,6139,6139,6139,6139,6139,6139,6139,6139,6139,fea0fab5-d29a-47ce-b34e-d6033aa9ca66,( 1 3 ) 1 1 complicated intra abdominal infections doripenem for injection is indicated as a single agent for the treatment of complicated intra abdominal infections caused by escherichia coli  klebsiella pneumoniae  pseudomonas aeruginosa  bacteroides caccae  bacteroides fragilis  bacteroides thetaiotaomicron  bacteroides uniformis  bacteroides vulgatus  streptococcus intermedius  streptococcus constellatus  and peptostreptococcus micros,1
5052,5052,5052,5052,5052,5052,5052,6140,6140,6140,6140,6140,6140,6140,6140,6140,6140,6140,6140,6140,fea0fab5-d29a-47ce-b34e-d6033aa9ca66,1 2 complicated urinary tract infections  including pyelonephritis doripenem for injection is indicated as a single agent for the treatment of complicated urinary tract infections  including pyelonephritis caused by escherichia coli including cases with concurrent bacteremia  klebsiella pneumoniae  proteus mirabilis  pseudomonas aeruginosa  and acinetobacter baumannii,1
5053,5053,5053,5053,5053,5053,5053,6141,6141,6141,6141,6141,6141,6141,6141,6141,6141,6141,6141,6141,fea0fab5-d29a-47ce-b34e-d6033aa9ca66,1 3 usage to reduce the development of drug resistant bacteria and maintain the effectiveness of doripenem for injection and other antibacterial drugs  doripenem for injection should be used only to treat infections that are proven or strongly suspected to be caused by susceptible bacteria,1
5054,5054,5054,5054,5054,5054,5054,6142,6142,6142,6142,6142,6142,6142,6142,6142,6142,6142,6142,6142,fea0fab5-d29a-47ce-b34e-d6033aa9ca66,when culture and susceptibility information are available  they should be considered in selecting and modifying antibacterial therapy,0
5055,5055,5055,5055,5055,5055,5055,6143,6143,6143,6143,6143,6143,6143,6143,6143,6143,6143,6143,6143,fea0fab5-d29a-47ce-b34e-d6033aa9ca66,in the absence of such data  local epidemiology and susceptibility pa,0
5056,5056,5056,5056,5056,5056,5056,6144,6144,6144,6144,6144,6144,6144,6144,6144,6144,6144,6144,6144,0648878e-ba6e-4901-948e-f6dcff9fe082, pindolol tablets are indicated in the management of hypertension,1
5057,5057,5057,5057,5057,5057,5057,6145,6145,6145,6145,6145,6145,6145,6145,6145,6145,6145,6145,6145,0648878e-ba6e-4901-948e-f6dcff9fe082,it may be used alone or concomitantly with other antihypertensive agents  particularly with a thiazide type diuretic,4
5058,5058,5058,5058,5058,5058,5058,6146,6146,6146,6146,6146,6146,6146,6146,6146,6146,6146,6146,6146,"Active Ingredient UNII(s)
BK76465IHM; N91BDP6H0X    f0a096a0-bde2-494f-a1af-2f778bb7c5c1
BK76465IHM; N91BDP6H0X    f0a096a0-bde2-494f-a1af-2f778bb7c5c1
Name: SET ID dtype: object",active ingredient unii ( s ) bk76465ihm n91bdp6h0x active ingredient unii ( s ) bk76465ihm n91bdp6h bk76465ihm n91bdp6h0x active ingredient unii ( s ) bk76465ihm n91bdp6h name content xml  dtype object,0
5059,5059,5059,5059,5059,5059,5059,6148,6148,6148,6148,6148,6148,6148,6148,6148,6148,6148,6148,6148,1dab5315-5027-57ad-e054-00144ff8d46c,ranitdine ranitidine is indicated in short term treatment of active duodenal ulcer,1
5060,5060,5060,5060,5060,5060,5060,6151,6151,6151,6151,6151,6151,6151,6151,6151,6151,6151,6151,6151,1dab5315-5027-57ad-e054-00144ff8d46c,maintenance therapy for duodenal ulcer patients at reduced dosage after healing of acute ulcers,1
5061,5061,5061,5061,5061,5061,5061,6153,6153,6153,6153,6153,6153,6153,6153,6153,6153,6153,6153,6153,1dab5315-5027-57ad-e054-00144ff8d46c,the treatment of pathological hypersecretory conditions ( e g  zollinger ellison syndrome and systemic mastocytosis ),1
5062,5062,5062,5062,5062,5062,5062,6154,6154,6154,6154,6154,6154,6154,6154,6154,6154,6154,6154,6154,1dab5315-5027-57ad-e054-00144ff8d46c,short term treatment of active  benign gastric ulcer,1
5063,5063,5063,5063,5063,5063,5063,6157,6157,6157,6157,6157,6157,6157,6157,6157,6157,6157,6157,6157,1dab5315-5027-57ad-e054-00144ff8d46c,maintenance therapy for gastric ulcer patients at reduced dosage after healing of acute ulcers,1
5064,5064,5064,5064,5064,5064,5064,6159,6159,6159,6159,6159,6159,6159,6159,6159,6159,6159,6159,6159,1dab5315-5027-57ad-e054-00144ff8d46c,symptomatic relief commonly occurs within 24 hours after starting therapy with ranitidine 150 mg two times a day,0
5065,5065,5065,5065,5065,5065,5065,6160,6160,6160,6160,6160,6160,6160,6160,6160,6160,6160,6160,6160,1dab5315-5027-57ad-e054-00144ff8d46c,treatment of endoscopically diagnosed erosive esophagitis,1
5066,5066,5066,5066,5066,5066,5066,6162,6162,6162,6162,6162,6162,6162,6162,6162,6162,6162,6162,6162,1dab5315-5027-57ad-e054-00144ff8d46c,maintenance of healing of erosive esophagitis,1
5067,5067,5067,5067,5067,5067,5067,6165,6165,6165,6165,6165,6165,6165,6165,6165,6165,6165,6165,6165,"Active Ingredient UNII(s)
BK76465IHM; QTG126297Q; UW86K581WY    1b49b08b-8494-3f71-e054-00144ff88e88
BK76465IHM; QTG126297Q; UW86K581WY    1b49b08b-8494-3f71-e054-00144ff88e88
BK76465IHM; QTG126297Q; UW86K581WY    1b49b08b-8494-3f71-e054-00144ff88e88
Name: SET ID dtype: object",active ingredient unii ( s ) bk76465ihm qtg126297q uw86k581wy active ingredient unii ( s ) bk76465ihm qtg12629 bk76465ihm qtg126297q uw86k581wy active ingredient unii ( s ) bk76465ihm qtg12629 bk76465ihm qtg126297q uw86k581wy active ingredient unii ( s ) bk76465ihm qtg12629 name content xml  dtype object,0
5068,5068,5068,5068,5068,5068,5068,6168,6168,6168,6168,6168,6168,6168,6168,6168,6168,6168,6168,6168,1210d63d-e036-41c4-bbd4-027b9308205c,1  stavudine capsules  usp in combination with other antiretroviral agents  are indicated for the treatment of human immunodeficiency virus ( hiv ) 1 infection see clinical studies ( 14 ),1
5069,5069,5069,5069,5069,5069,5069,6169,6169,6169,6169,6169,6169,6169,6169,6169,6169,6169,6169,6169,1210d63d-e036-41c4-bbd4-027b9308205c,stavudine is a nucleoside reverse transcriptase inhibitor for use in combination with other antiretroviral agents for the treatment of human immunodeficiency virus ( hiv ) 1 infection,1
5070,5070,5070,5070,5070,5070,5070,6170,6170,6170,6170,6170,6170,6170,6170,6170,6170,6170,6170,6170,0002ad27-779d-42ab-83b5-bc65453412a1,1  mekinist is a kinase inhibitor indicated as a single agent for the treatment of patients with unresectable or metastatic melanoma with braf v600e or v600k mutations as detected by an fda approved test,1
5071,5071,5071,5071,5071,5071,5071,6171,6171,6171,6171,6171,6171,6171,6171,6171,6171,6171,6171,6171,0002ad27-779d-42ab-83b5-bc65453412a1,( 1 1 ) mekinist is indicated  in combination with dabrafenib  for the treatment of patients with unresectable or metastatic melanoma with braf v600e or v600k mutations as detected by an fda approved test,1
5072,5072,5072,5072,5072,5072,5072,6172,6172,6172,6172,6172,6172,6172,6172,6172,6172,6172,6172,6172,0002ad27-779d-42ab-83b5-bc65453412a1,( 1 1 ) metastatic non small cell lung cancer ( nsclc ) with braf v600e mutation as detected by an fda approved test,1
5073,5073,5073,5073,5073,5073,5073,6173,6173,6173,6173,6173,6173,6173,6173,6173,6173,6173,6173,6173,0002ad27-779d-42ab-83b5-bc65453412a1,( 1 2 ) limitation of use mekinist is not indicated for treatment of patients with melanoma who have progressed on prior braf inhibitor therapy,2
5074,5074,5074,5074,5074,5074,5074,6174,6174,6174,6174,6174,6174,6174,6174,6174,6174,6174,6174,6174,0002ad27-779d-42ab-83b5-bc65453412a1,( 1 3 ) 1 1 braf v600e or v600k mutation positive unresectable or metastatic melanoma mekinist is indicated  as a single agent or in combination with dabrafenib  for the treatment of patients with unresectable or metastatic melanoma with braf v600e or v600k mutations  as detected by an fda approved test see clinical studies ( 14 1 ),1
5075,5075,5075,5075,5075,5075,5075,6175,6175,6175,6175,6175,6175,6175,6175,6175,6175,6175,6175,6175,0002ad27-779d-42ab-83b5-bc65453412a1,1 2 braf v600e mutation positive metastatic nsclc mekinist is indicated  in combination with dabrafenib  for the treatment of patients with metastatic non small cell lung cancer ( nsclc ) with braf v600e mutation as detected by an fda approved test see clinical studies ( 14 2 ),1
5076,5076,5076,5076,5076,5076,5076,6176,6176,6176,6176,6176,6176,6176,6176,6176,6176,6176,6176,6176,0002ad27-779d-42ab-83b5-bc65453412a1,1 3 limitation of use mekinist is not indicated for treatment of patients with melanoma who have progressed on prior braf inhibitor therapy see clinical studies ( 14 3 ),2
5077,5077,5077,5077,5077,5077,5077,6177,6177,6177,6177,6177,6177,6177,6177,6177,6177,6177,6177,6177,ac96658a-d7dc-4c7c-8928-2adcdf4318b2,1  taltz is a humanized interleukin 17a antagonist indicated for the treatment of adults with moderate to severe plaque psoriasis who are candidates for systemic therapy or phototherapy,1
5078,5078,5078,5078,5078,5078,5078,6178,6178,6178,6178,6178,6178,6178,6178,6178,6178,6178,6178,6178,ac96658a-d7dc-4c7c-8928-2adcdf4318b2,( 1 1 ) active psoriatic arthritis,1
5079,5079,5079,5079,5079,5079,5079,6179,6179,6179,6179,6179,6179,6179,6179,6179,6179,6179,6179,6179,ac96658a-d7dc-4c7c-8928-2adcdf4318b2,( 1 2 ) 1 1 plaque psoriasis taltz is indicated for the treatment of adults with moderate to severe plaque psoriasis who are candidates for systemic therapy or phototherapy,1
5080,5080,5080,5080,5080,5080,5080,6180,6180,6180,6180,6180,6180,6180,6180,6180,6180,6180,6180,6180,ac96658a-d7dc-4c7c-8928-2adcdf4318b2,1 2 psoriatic arthritis taltz is indicated for the treatment of adult patients with active psoriatic arthritis,1
5081,5081,5081,5081,5081,5081,5081,6181,6181,6181,6181,6181,6181,6181,6181,6181,6181,6181,6181,6181,7ca86c66-409b-4852-8631-c3ada6e60738,1  phentermine resin extended release capsules are indicated as a short term ( a few weeks ) adjunct in a regimen of weight reduction based on exercise  behavioral modification and caloric restriction in the management of exogenous obesity for patients with an initial body mass index 30 kg m2  or 27 kg m2 in the presence of other risk factors ( e g  controlled hypertension  diabetes  hyperlipidemia ),1
5082,5082,5082,5082,5082,5082,5082,6185,6185,6185,6185,6185,6185,6185,6185,6185,6185,6185,6185,6185,7ca86c66-409b-4852-8631-c3ada6e60738,body mass index ( bmi )  kg m2 height ( feet  inches ) weight ( pounds ) 5 0 5 3 5 6 5 9 6 0 6 3 140 27 25 23 21 19 18 150 29 27 24 22,0
5083,5083,5083,5083,5083,5083,5083,6187,6187,6187,6187,6187,6187,6187,6187,6187,6187,6187,6187,6187,946b4df5-f1dc-42a7-acb9-1d2543c9bb44, oxycodone and aspirin tablets are indicated for the management of moderate to moderately severe pain,1
5084,5084,5084,5084,5084,5084,5084,6188,6188,6188,6188,6188,6188,6188,6188,6188,6188,6188,6188,6188,a598f735-d2e2-43ad-be77-8627ea4a9b78, oxycodone and aspirin tablets are indicated for the management of moderate to moderately severe pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate,1
5085,5085,5085,5085,5085,5085,5085,6189,6189,6189,6189,6189,6189,6189,6189,6189,6189,6189,6189,6189,a598f735-d2e2-43ad-be77-8627ea4a9b78,limitations of use because of the risks of addiction  abuse  and misuse  with opioids  even at recommended doses see warnings  reserve oxycodone and aspirin tablets for use in patients for whom alternative treatment options e g  non opioid analgesics have not been tolerated  or are not expected to be tolerated  have not provided adequate analgesia  or are not expected to provide adequate analgesia,2
5086,5086,5086,5086,5086,5086,5086,6190,6190,6190,6190,6190,6190,6190,6190,6190,6190,6190,6190,6190,ac0f82eb-6b88-491d-bf61-2d3e93fc78c6, oxycodone hydrochloride and ibuprofen tablets are indicated for the management of short term ( no more than 7 days ) acute to moderate pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate,1
5087,5087,5087,5087,5087,5087,5087,6191,6191,6191,6191,6191,6191,6191,6191,6191,6191,6191,6191,6191,ac0f82eb-6b88-491d-bf61-2d3e93fc78c6,limitations of use carefully consider the potential benefits and risks of oxycodone hydrochloride and ibuprofen tablets and other treatment options before deciding to use oxycodone hydrochloride and ibuprofen tablets,4
5088,5088,5088,5088,5088,5088,5088,6192,6192,6192,6192,6192,6192,6192,6192,6192,6192,6192,6192,6192,ac0f82eb-6b88-491d-bf61-2d3e93fc78c6,use the lowest effective dose for the shortest duration consistent with individual patient treatment goals see warnings cardiovascular thrombotic events  and gastrointestinal bleeding  ulceration  and perforation,4
5089,5089,5089,5089,5089,5089,5089,6193,6193,6193,6193,6193,6193,6193,6193,6193,6193,6193,6193,6193,ac0f82eb-6b88-491d-bf61-2d3e93fc78c6,because of the risks of addiction  abuse  and misuse  with opioids  even at recommended doses see warnings addiction  abuse  and misuse  reserve oxycodone hydrochloride and ibuprofen tablets for use in patients for whom alternative treatment options e g  non opioid analgesics have not been tolerated  or are not expected to be tolerated  have not provided adequate analgesia  or are not expected to provide adequate analgesia,4
5090,5090,5090,5090,5090,5090,5090,6194,6194,6194,6194,6194,6194,6194,6194,6194,6194,6194,6194,6194,b15e5520-0a87-4943-9bbb-ead066456273, intravenous theophylline is indicated as an adjunct to inhaled beta 2 selective agonists and systemically administered corticosteroids for the treatment of acute exacerbations of the symptoms and reversible airflow obstruction associated with asthma and other chronic lung diseases  e g  emphysema and chronic bronchitis,1
5091,5091,5091,5091,5091,5091,5091,6195,6195,6195,6195,6195,6195,6195,6195,6195,6195,6195,6195,6195,0930a471-6ff1-43a1-b3ea-948ca3f99d06, medroxyprogesterone acetate tablets are indicated for the treatment of secondary amenorrhea and abnormal uterine bleeding due to hormonal imbalance in the absence of organic pathology  such as fibroids or uterine cancer,1
5092,5092,5092,5092,5092,5092,5092,6196,6196,6196,6196,6196,6196,6196,6196,6196,6196,6196,6196,6196,0930a471-6ff1-43a1-b3ea-948ca3f99d06,they are also indicated for use in the prevention of endometrial hyperplasia in nonhysterectomized postmenopausal women who are receiving daily oral conjugated estrogens 0 625 mg tablets,1
5093,5093,5093,5093,5093,5093,5093,6197,6197,6197,6197,6197,6197,6197,6197,6197,6197,6197,6197,6197,fd0c0836-5d23-2183-da81-9dc7f4287052,1  prempro premphase is an estrogen plus progestin indicated in a woman with a uterus for treatment of moderate to severe vasomotor symptoms due to menopause ( 1 1 ) treatment of moderate to severe vulvar and vaginal atrophy due to menopause ( 1 2 ) prevention of postmenopausal osteoporosis ( 1 3 ) 1 1 treatment of moderate to severe vasomotor symptoms due to menopause 1 2 treatment of moderate to severe vulvar and vaginal atrophy due to menopause 1 3 prevention of postmenopausal osteoporosis,1
5094,5094,5094,5094,5094,5094,5094,6198,6198,6198,6198,6198,6198,6198,6198,6198,6198,6198,6198,6198,7b481eda-7e7a-41b5-b698-bd7d7fa59cfb,1  to reduce the development of drug resistant bacteria and maintain the effectiveness of moxifloxacin hydrochloride tablets and other antibacterial drugs  moxifloxacin hydrochloride tablets should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria,1
5095,5095,5095,5095,5095,5095,5095,6201,6201,6201,6201,6201,6201,6201,6201,6201,6201,6201,6201,6201,7b481eda-7e7a-41b5-b698-bd7d7fa59cfb,moxifloxacin hydrochloride tablets are indicated for the treatment of adults ( 18 years of age ) with infections caused by susceptible isolates of the designated microorganisms in the conditions listed below see dosage and administration ( 2 ) and use in specific populations ( 8 5 ),1
5096,5096,5096,5096,5096,5096,5096,6202,6202,6202,6202,6202,6202,6202,6202,6202,6202,6202,6202,6202,7b481eda-7e7a-41b5-b698-bd7d7fa59cfb,culture and susceptibility testing appropriate culture and susceptibility tests should be performed before treatment in order to isolate and identify organisms causing infection and to determine their susceptibility to moxifloxacin see clinical pharmacology ( 12 4 ),0
5097,5097,5097,5097,5097,5097,5097,6203,6203,6203,6203,6203,6203,6203,6203,6203,6203,6203,6203,6203,7b481eda-7e7a-41b5-b698-bd7d7fa59cfb,therapy with moxifloxacin hydrochloride tablets may be initiated before results of these tests are known once results become available  appropriate therapy should be continued,0
5098,5098,5098,5098,5098,5098,5098,6204,6204,6204,6204,6204,6204,6204,6204,6204,6204,6204,6204,6204,7b481eda-7e7a-41b5-b698-bd7d7fa59cfb,moxifloxacin hydrochloride tablet is a fluoroquinolone antibacterial indicated for treating infections in adults 18 years of age caused by designated  susceptible bacteria,1
5099,5099,5099,5099,5099,5099,5099,6205,6205,6205,6205,6205,6205,6205,6205,6205,6205,6205,6205,6205,7b481eda-7e7a-41b5-b698-bd7d7fa59cfb,( 1  12 4 ) acute bacterial sinusitis ( 1 1 ) acute bacterial exacerbation of chronic bronchitis ( 1 2 ) community acquired pneumonia ( 1 3 ) skin and skin structure infections uncomplicated ( 1 4 ) and complicated ( 1 5 ) complicated intra abdominal infections ( 1 6 ) 1 1 acute bacterial sinusitis moxifloxacin hydrochloride tablets are indicated for the treatment of acute bacterial sinusitis caused by streptococcus pneumoniae  haemophilus influenzae  or moraxella catarrhalis,1
5100,5100,5100,5100,5100,5100,5100,6206,6206,6206,6206,6206,6206,6206,6206,6206,6206,6206,6206,6206,"Active Ingredient UNII(s)
C5N25H3803    53240ab5-98e7-4050-b640-e09c1271899a
C5N25H3803    53240ab5-98e7-4050-b640-e09c1271899a
Name: SET ID dtype: object",active ingredient unii ( s ) c5n25h3803 active ingredient unii ( s ) c5n25h3803 active in c5n25h3803 active ingredient unii ( s ) c5n25h3803 active in name content xml  dtype object,0
5101,5101,5101,5101,5101,5101,5101,6208,6208,6208,6208,6208,6208,6208,6208,6208,6208,6208,6208,6208,494a714e-923c-cd57-df6c-12886afb265a, thiola is indicated for the prevention of cystine ( kidney ) stone formation in patients with severe homozygous cystinuria with urinary cystine greater than 500 mg day  who are resistant to treatment with conservative measures of high fluid intake  alkali and diet modification  or who have adverse reactions to d penicillamine,1
5102,5102,5102,5102,5102,5102,5102,6209,6209,6209,6209,6209,6209,6209,6209,6209,6209,6209,6209,6209,494a714e-923c-cd57-df6c-12886afb265a,cystine stones typically occur in approximately 10  000 persons in the united states who are homozygous for cystinuria,0
5103,5103,5103,5103,5103,5103,5103,6210,6210,6210,6210,6210,6210,6210,6210,6210,6210,6210,6210,6210,494a714e-923c-cd57-df6c-12886afb265a,these persons excrete abnormal amounts of cystine in urine of over 250 mg g creatinine  as well as excessive amounts of other dibasic amino acids ( lysine  arginine and ornithine ),0
5104,5104,5104,5104,5104,5104,5104,6211,6211,6211,6211,6211,6211,6211,6211,6211,6211,6211,6211,6211,494a714e-923c-cd57-df6c-12886afb265a,in addition  they show varying intestinal transport defects for these same amino acids,0
5105,5105,5105,5105,5105,5105,5105,6212,6212,6212,6212,6212,6212,6212,6212,6212,6212,6212,6212,6212,494a714e-923c-cd57-df6c-12886afb265a,the stone formation is the result of poor aqueous solubility of cystine,0
5106,5106,5106,5106,5106,5106,5106,6213,6213,6213,6213,6213,6213,6213,6213,6213,6213,6213,6213,6213,494a714e-923c-cd57-df6c-12886afb265a,since there are no known inhibitors of the crystallization of cystine  the stone formation is determined primarily by the urinary supersaturation of cystine,0
5107,5107,5107,5107,5107,5107,5107,6214,6214,6214,6214,6214,6214,6214,6214,6214,6214,6214,6214,6214,494a714e-923c-cd57-df6c-12886afb265a,thus  cystine stones could theoretically form whenever urinary cystine concentration exceeds the solubility limit,0
5108,5108,5108,5108,5108,5108,5108,6215,6215,6215,6215,6215,6215,6215,6215,6215,6215,6215,6215,6215,494a714e-923c-cd57-df6c-12886afb265a,cystine solubility in urine is ph dependent  and ranges from 170 300 mg liter at ph 5  190 400 mg liter at ph 7 and 220 500 mg liter at ph 7 5,0
5109,5109,5109,5109,5109,5109,5109,6216,6216,6216,6216,6216,6216,6216,6216,6216,6216,6216,6216,6216,494a714e-923c-cd57-df6c-12886afb265a,the goal of therapy is to reduce urinary cystine concentration below its solubility limit,0
5110,5110,5110,5110,5110,5110,5110,6217,6217,6217,6217,6217,6217,6217,6217,6217,6217,6217,6217,6217,494a714e-923c-cd57-df6c-12886afb265a,it may be accomplished by dietary means aimed at reducing cystine synthesis and by a high fluid intake in order to increase urine volume and thereby lower cystine concentration,u
5111,5111,5111,5111,5111,5111,5111,6218,6218,6218,6218,6218,6218,6218,6218,6218,6218,6218,6218,6218,494a714e-923c-cd57-df6c-12886afb265a,unfortunately  the above conservative measures alone may be ineffective in controlling cystine stone formation in some homozygous patients with severe cystinuria ( urinary cystine exceeding 500 mg day ),0
5112,5112,5112,5112,5112,5112,5112,6219,6219,6219,6219,6219,6219,6219,6219,6219,6219,6219,6219,6219,494a714e-923c-cd57-df6c-12886afb265a,in such patients  d penicillamine has been used as an additional therapy,u
5113,5113,5113,5113,5113,5113,5113,6220,6220,6220,6220,6220,6220,6220,6220,6220,6220,6220,6220,6220,494a714e-923c-cd57-df6c-12886afb265a,like thiola  dpenicillamine undergoes thiol disulfide exchange with cystine  thereby lowering the amount of sparingly soluble cystine in urine,
5114,5114,5114,5114,5114,5114,5114,6221,6221,6221,6221,6221,6221,6221,6221,6221,6221,6221,6221,6221,494a714e-923c-cd57-df6c-12886afb265a,however  d penicillamine treatment is frequently accompanied by adverse reactions  such as dermatologic complications  hypersensitivity reactions  hematologic abnormalities and renal disturbances,2
5115,5115,5115,5115,5115,5115,5115,6222,6222,6222,6222,6222,6222,6222,6222,6222,6222,6222,6222,6222,494a714e-923c-cd57-df6c-12886afb265a,thiola may have a particular therapeutic role in such patients,0
5116,5116,5116,5116,5116,5116,5116,6223,6223,6223,6223,6223,6223,6223,6223,6223,6223,6223,6223,6223,7866ec19-dfac-47d4-a53f-511a12643cbf,1  coartem ( artemether lumefantrine ) tablets are indicated for treatment of acute  uncomplicated malaria infections due to plasmodium falciparum in patients of 5 kg bodyweight and above,1
5117,5117,5117,5117,5117,5117,5117,6224,6224,6224,6224,6224,6224,6224,6224,6224,6224,6224,6224,6224,7866ec19-dfac-47d4-a53f-511a12643cbf,coartem tablets have been shown to be effective in geographical regions where resistance to chloroquine has been reported see clinical studies ( 14 1 ),u
5118,5118,5118,5118,5118,5118,5118,6225,6225,6225,6225,6225,6225,6225,6225,6225,6225,6225,6225,6225,7866ec19-dfac-47d4-a53f-511a12643cbf,limitations of use coartem tablets are not approved for patients with severe or complicated p falciparum malaria,2
5119,5119,5119,5119,5119,5119,5119,6226,6226,6226,6226,6226,6226,6226,6226,6226,6226,6226,6226,6226,7866ec19-dfac-47d4-a53f-511a12643cbf,coartem tablets are not approved for the prevention of malaria,0
5120,5120,5120,5120,5120,5120,5120,6227,6227,6227,6227,6227,6227,6227,6227,6227,6227,6227,6227,6227,7866ec19-dfac-47d4-a53f-511a12643cbf,coartem ( artemether and lumefantrine ) tablets are indicated for treatment of acute  uncomplicated malaria infections due to plasmodium falciparum in patients of 5 kg bodyweight and above,1
5121,5121,5121,5121,5121,5121,5121,6228,6228,6228,6228,6228,6228,6228,6228,6228,6228,6228,6228,6228,7866ec19-dfac-47d4-a53f-511a12643cbf,( 1 ) coartem tablets have been shown to be effective in geographical regions where resistance to chloroquine has been reported,0
5122,5122,5122,5122,5122,5122,5122,6229,6229,6229,6229,6229,6229,6229,6229,6229,6229,6229,6229,6229,7866ec19-dfac-47d4-a53f-511a12643cbf,( 1 ) coartem tablets should not be used to treat severe malaria or to prevent malaria,0
5123,5123,5123,5123,5123,5123,5123,6230,6230,6230,6230,6230,6230,6230,6230,6230,6230,6230,6230,6230,8a903e31-936e-4ed7-8a59-59f32374f338,1  inlyta is indicated for the treatment of advanced renal cell carcinoma ( rcc ) after failure of one prior systemic therapy,1
5124,5124,5124,5124,5124,5124,5124,6231,6231,6231,6231,6231,6231,6231,6231,6231,6231,6231,6231,6231,8a903e31-936e-4ed7-8a59-59f32374f338,inlyta is a kinase inhibitor indicated for the treatment of advanced renal cell carcinoma after failure of one prior systemic therapy,1
5125,5125,5125,5125,5125,5125,5125,6232,6232,6232,6232,6232,6232,6232,6232,6232,6232,6232,6232,6232,a70e9bff-5f9e-43e8-a9ef-6da73bab7d31,indication propoxyphene hydrochloride capsule is indicated for the relief of mild to moderate pain,1
5126,5126,5126,5126,5126,5126,5126,6233,6233,6233,6233,6233,6233,6233,6233,6233,6233,6233,6233,6233,1fe028ff-42ac-4329-b1a5-a9dadfcb79f6,1  ferrlecit is indicated for the treatment of iron deficiency anemia in adult patients and in pediatric patients age 6 years and older with chronic kidney disease receiving hemodialysis who are receiving supplemental epoetin therapy,1
5127,5127,5127,5127,5127,5127,5127,6234,6234,6234,6234,6234,6234,6234,6234,6234,6234,6234,6234,6234,1fe028ff-42ac-4329-b1a5-a9dadfcb79f6,ferrlecit is an iron replacement product for treatment of iron deficiency anemia in adult patients and in pediatric patients age 6 years and older with chronic kidney disease receiving hemodialysis who are receiving supplemental epoetin therapy,1
5128,5128,5128,5128,5128,5128,5128,6235,6235,6235,6235,6235,6235,6235,6235,6235,6235,6235,6235,6235,b0a5ded2-8ee2-49ca-a86c-2b28ae40f60c,1  xtampza er is indicated for the management of pain severe enough to require daily  around the clock  long term opioid treatment and for which alternative treatment options are inadequate,1
5129,5129,5129,5129,5129,5129,5129,6236,6236,6236,6236,6236,6236,6236,6236,6236,6236,6236,6236,6236,b0a5ded2-8ee2-49ca-a86c-2b28ae40f60c,xtampza er is an opioid agonist indicated for the management of pain severe enough to require daily  around the clock  long term opioid treatment and for which alternative treatment options are inadequate,1
5130,5130,5130,5130,5130,5130,5130,6237,6237,6237,6237,6237,6237,6237,6237,6237,6237,6237,6237,6237,b0a5ded2-8ee2-49ca-a86c-2b28ae40f60c,( 1 ) limitations of use because of the risks of addiction  abuse  and misuse with opioids  even at recommended doses  and because of the greater risks of overdose and death with extended release opioid formulations  reserve xtampza er for use in patients for whom alternative treatment options ( e g  non opioid analgesics or immediate release opioids ) are ineffective  not tolerated  or would be otherwise inadequate to provide sufficient management of pain,4
5131,5131,5131,5131,5131,5131,5131,6238,6238,6238,6238,6238,6238,6238,6238,6238,6238,6238,6238,6238,b0a5ded2-8ee2-49ca-a86c-2b28ae40f60c,( 1 ) xtampza er is not indicated as an as needed ( prn ) analgesic,2
5132,5132,5132,5132,5132,5132,5132,6240,6240,6240,6240,6240,6240,6240,6240,6240,6240,6240,6240,6240,b0a5ded2-8ee2-49ca-a86c-2b28ae40f60c,xtampza er is not indicated as an as needed ( prn ) analgesic,2
5133,5133,5133,5133,5133,5133,5133,6241,6241,6241,6241,6241,6241,6241,6241,6241,6241,6241,6241,6241,"Active Ingredient UNII(s)
CHB1QD2QSS; N91BDP6H0X    a4231f67-6c04-4ce6-8c3d-6db52afaadbe
CHB1QD2QSS; N91BDP6H0X    a4231f67-6c04-4ce6-8c3d-6db52afaadbe
Name: SET ID dtype: object",active ingredient unii ( s ) chb1qd2qss n91bdp6h0x active ingredient unii ( s ) chb1qd2qss n91bdp6h chb1qd2qss n91bdp6h0x active ingredient unii ( s ) chb1qd2qss n91bdp6h name content xml  dtype object,0
5134,5134,5134,5134,5134,5134,5134,6243,6243,6243,6243,6243,6243,6243,6243,6243,6243,6243,6243,6243,a0e47a9d-78e7-4523-983a-aa259f221736,indications tasmar is indicated as an adjunct to levodopa and carbidopa for the treatment of the signs and symptoms of idiopathic parkinson 's disease,1
5135,5135,5135,5135,5135,5135,5135,6244,6244,6244,6244,6244,6244,6244,6244,6244,6244,6244,6244,6244,a0e47a9d-78e7-4523-983a-aa259f221736,because of the risk of potentially fatal  acute fulminant liver failure  tasmar ( tolcapone ) should ordinarily be used in patients with parkinson 's disease on l dopa carbidopa who are experiencing symptom fluctuations and are not responding satisfactorily to or are not appropriate candidates for other adjunctive therapies,u
5136,5136,5136,5136,5136,5136,5136,6245,6245,6245,6245,6245,6245,6245,6245,6245,6245,6245,6245,6245,a0e47a9d-78e7-4523-983a-aa259f221736,because of the risk of liver injury and because tasmar  when it is effective  provides an observable symptomatic benefit  the patient who fails to show substantial clinical benefit within 3 weeks of initiation of treatment  should be withdrawn from tasmar,0
5137,5137,5137,5137,5137,5137,5137,6246,6246,6246,6246,6246,6246,6246,6246,6246,6246,6246,6246,6246,a0e47a9d-78e7-4523-983a-aa259f221736,the effectiveness of tasmar was demonstrated in randomized controlled trials in patients receiving concomitant levodopa therapy with carbidopa or another aromatic amino acid decarboxylase inhibitor who experienced end of dose wearing off phenomena as well as in patients who did not experience such phenomena ( see clinical pharmacology clinical studies ),u
5138,5138,5138,5138,5138,5138,5138,6247,6247,6247,6247,6247,6247,6247,6247,6247,6247,6247,6247,6247,8ab9c79c-1b5c-4e86-899c-cc74686f070a,1  activated definity ( perflutren lipid microsphere ) injectable suspension is indicated for use in patients with suboptimal echocardiograms to opacify the left ventricular chamber and to improve the delineation of the left ventricular endocardial border,1
5139,5139,5139,5139,5139,5139,5139,6248,6248,6248,6248,6248,6248,6248,6248,6248,6248,6248,6248,6248,8ab9c79c-1b5c-4e86-899c-cc74686f070a,definity is an ultrasound contrast agent indicated for use in patients with suboptimal echocardiograms to opacify the left ventricular chamber and to improve the delineation of the left ventricular endocardial border,1
5140,5140,5140,5140,5140,5140,5140,6249,6249,6249,6249,6249,6249,6249,6249,6249,6249,6249,6249,6249,46bcf276-d423-408a-a410-f11383406a94,1  optison is indicated for use in patients with suboptimal echocardiograms to opacify the left ventricle and to improve the delineation of the left ventricular endocardial borders,1
5141,5141,5141,5141,5141,5141,5141,6250,6250,6250,6250,6250,6250,6250,6250,6250,6250,6250,6250,6250,46bcf276-d423-408a-a410-f11383406a94,optison is an ultrasound contrast agent indicated for use in patients with suboptimal echocardiograms to opacify the left ventricle and to improve the delineation of the left ventricular endocardial borders,1
5142,5142,5142,5142,5142,5142,5142,6251,6251,6251,6251,6251,6251,6251,6251,6251,6251,6251,6251,6251,a8a7eb93-4192-4826-bbf1-82c06634f553, dyanavel xr is a central nervous system ( cns ) stimulant indicated for the treatment of attention deficit hyperactivity disorder ( adhd ) see clinical studies ( 14 ),1
5143,5143,5143,5143,5143,5143,5143,6252,6252,6252,6252,6252,6252,6252,6252,6252,6252,6252,6252,6252,a8a7eb93-4192-4826-bbf1-82c06634f553,dyanavel xr is a central nervous system ( cns ) stimulant indicated for the treatment of attention deficit hyperactivity disorder ( adhd ) ( 1 ),1
5144,5144,5144,5144,5144,5144,5144,6253,6253,6253,6253,6253,6253,6253,6253,6253,6253,6253,6253,6253,32b0e320-a739-11dc-a704-0002a5d5c51b,1  feraheme is indicated for the treatment of iron deficiency anemia ( ida ) in adult patients who have intolerance to oral iron or have had unsatisfactory response to oral iron or who have chronic kidney disease ( ckd ),1
5145,5145,5145,5145,5145,5145,5145,6254,6254,6254,6254,6254,6254,6254,6254,6254,6254,6254,6254,6254,32b0e320-a739-11dc-a704-0002a5d5c51b,feraheme is an iron replacement product indicated for the treatment of iron deficiency anemia ( ida ) in adult patients who have intolerance to oral iron or have had unsatisfactory response to oral iron ( 1 ) or who have chronic kidney disease ( ckd ),1
5146,5146,5146,5146,5146,5146,5146,6255,6255,6255,6255,6255,6255,6255,6255,6255,6255,6255,6255,6255,da10031f-9da8-49a2-a019-5ce80c4b7ede, for the treatment of functional bowel irritable bowel syndrome,1
5147,5147,5147,5147,5147,5147,5147,6256,6256,6256,6256,6256,6256,6256,6256,6256,6256,6256,6256,6256,9f6952c8-e547-4f3e-a978-a88d6ea9dc10,1  darifenacin is muscarinic antagonist indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence  urgency and frequency,1
5148,5148,5148,5148,5148,5148,5148,6257,6257,6257,6257,6257,6257,6257,6257,6257,6257,6257,6257,6257,9f6952c8-e547-4f3e-a978-a88d6ea9dc10,darifenacin extended release tablets are muscarinic antagonist indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence  urgency and frequency,1
5149,5149,5149,5149,5149,5149,5149,6258,6258,6258,6258,6258,6258,6258,6258,6258,6258,6258,6258,6258,21ba0e18-3dbc-4feb-a3a4-f6470c00910a,1  desflurane  usp  liquid for inhalation  a general anesthetic  is an inhalation agent indicated for induction and or maintenance of anesthesia in adults ( 1 1 ) for maintenance of anesthesia in pediatric patients following induction with agents other than desflurane  usp  liquid for inhalation and intubation,1
5150,5150,5150,5150,5150,5150,5150,6259,6259,6259,6259,6259,6259,6259,6259,6259,6259,6259,6259,6259,21ba0e18-3dbc-4feb-a3a4-f6470c00910a,1 1 induction of anesthesia desflurane  usp  liquid for inhalation is indicated as an inhalation agent for induction of anesthesia for inpatient and outpatient surgery in adults,1
5151,5151,5151,5151,5151,5151,5151,6260,6260,6260,6260,6260,6260,6260,6260,6260,6260,6260,6260,6260,21ba0e18-3dbc-4feb-a3a4-f6470c00910a,desflurane  usp  liquid for inhalation is contraindicated as an inhalation agent for the induction of anesthesia in pediatric patients because of a high incidence of moderate to severe upper airway adverse events,2
5152,5152,5152,5152,5152,5152,5152,6261,6261,6261,6261,6261,6261,6261,6261,6261,6261,6261,6261,6261,21ba0e18-3dbc-4feb-a3a4-f6470c00910a,1 2 maintenance of anesthesia desflurane  usp  liquid for inhalation is indicated as an inhalation agent for maintenance of anesthesia for inpatient and outpatient surgery in adults and in pediatric patients,1
5153,5153,5153,5153,5153,5153,5153,6262,6262,6262,6262,6262,6262,6262,6262,6262,6262,6262,6262,6262,21ba0e18-3dbc-4feb-a3a4-f6470c00910a,after induction of anesthesia with agents other than desflurane  usp  liquid for inhalation  and tracheal intubation  desflurane  usp  liquid for inhalation is indicated for maintenance of anesthesia in infants and children,1
5154,5154,5154,5154,5154,5154,5154,6263,6263,6263,6263,6263,6263,6263,6263,6263,6263,6263,6263,6263,21ba0e18-3dbc-4feb-a3a4-f6470c00910a,desflurane  usp  liquid for inhalation is not approved for maintenance of anesthesia in non intubated children due to an increased incidence of respiratory adverse reactions  including coughing  laryngospasm  and secretions see warnings and precautions ( 5 3 ) and clinical studies ( 14 5 ),2
5155,5155,5155,5155,5155,5155,5155,6264,6264,6264,6264,6264,6264,6264,6264,6264,6264,6264,6264,6264,752604e5-4ea2-44f4-83ed-1569373f6412,1  feiba is an anti inhibitor coagulant complex indicated for use in hemophilia a and b patients with inhibitors for control and prevention of bleeding episodes perioperative management routine prophylaxis to prevent or reduce the frequency of bleeding episodes,1
5156,5156,5156,5156,5156,5156,5156,6265,6265,6265,6265,6265,6265,6265,6265,6265,6265,6265,6265,6265,752604e5-4ea2-44f4-83ed-1569373f6412,feiba is not indicated for the treatment of bleeding episodes resulting from coagulation factor deficiencies in the absence of inhibitors to coagulation factor viii or coagulation factor ix,2
5157,5157,5157,5157,5157,5157,5157,6266,6266,6266,6266,6266,6266,6266,6266,6266,6266,6266,6266,6266,752604e5-4ea2-44f4-83ed-1569373f6412,feiba is an anti inhibitor coagulant complex indicated for use in hemophilia a and b patients with inhibitors for control and prevention of bleeding episodes,1
5158,5158,5158,5158,5158,5158,5158,6267,6267,6267,6267,6267,6267,6267,6267,6267,6267,6267,6267,6267,752604e5-4ea2-44f4-83ed-1569373f6412,routine prophylaxis to prevent or reduce the frequency of bleeding episodes,1
5159,5159,5159,5159,5159,5159,5159,6268,6268,6268,6268,6268,6268,6268,6268,6268,6268,6268,6268,6268,752604e5-4ea2-44f4-83ed-1569373f6412,feiba is not indicated for the treatment of bleeding episodes resulting from coagulation factor deficiencies in the absence of inhibitors to factor viii or factor ix,2
5160,5160,5160,5160,5160,5160,5160,6269,6269,6269,6269,6269,6269,6269,6269,6269,6269,6269,6269,6269,5429f134-839f-4ffc-9944-55f51238def8,1  saphris is indicated for schizophrenia in adults see clinical studies ( 14 1 ) bipolar i disorder see clinical studies ( 14 2 ) acute monotherapy of manic or mixed episodes  in adults and pediatric patients 10 to 17 years of age adjunctive treatment to lithium or valproate in adults maintenance monotherapy treatment in adults saphris is an atypical antipsychotic indicated for ( 1 ) schizophrenia in adults bipolar i disorder acute monotherapy treatment of manic or mixed episodes  in adults and pediatric patients 10 to 17 years of age adjunctive treatment to lithium or valproate in adults maintenance monotherapy treatment in adults,1
5161,5161,5161,5161,5161,5161,5161,6270,6270,6270,6270,6270,6270,6270,6270,6270,6270,6270,6270,6270,6ced5f68-cb45-44d2-b88a-f5edd2761137,1  zinbryta is indicated for the treatment of adult patients with relapsing forms of multiple sclerosis ( ms ),1
5162,5162,5162,5162,5162,5162,5162,6271,6271,6271,6271,6271,6271,6271,6271,6271,6271,6271,6271,6271,6ced5f68-cb45-44d2-b88a-f5edd2761137,because of its safety profile  the use of zinbryta should generally be reserved for patients who have had an inadequate response to two or more drugs indicated for the treatment of ms zinbryta is an interleukin 2 receptor blocking antibody indicated for the treatment of adult patients with relapsing forms of multiple sclerosis ( ms ),1
5163,5163,5163,5163,5163,5163,5163,6272,6272,6272,6272,6272,6272,6272,6272,6272,6272,6272,6272,6272,6ced5f68-cb45-44d2-b88a-f5edd2761137,because of its safety profile  the use of zinbryta should generally be reserved for patients who have had an inadequate response to two or more drugs indicated for the treatment of ms ( 1 ),4
5164,5164,5164,5164,5164,5164,5164,6273,6273,6273,6273,6273,6273,6273,6273,6273,6273,6273,6273,6273,abd1f64e-4283-4370-aae8-3666316aa36e, streptomycin is indicated for the treatment of individuals with moderate to severe infections caused by susceptibile strains of microorganisms in the specific conditions listed below mycobacterium tuberculosis the advisory council for the elimination of tuberculosis  the american thoracic society  and the center for disease control recommend that either streptomycin or ethambutol be added as a fourth drug in a regimen containing isoniazid ( inh )  rifampin and pyrazinamide for initial treatment of tuberculosis unless the likelihood of inh or rifampin resistance is very low,1
5165,5165,5165,5165,5165,5165,5165,6274,6274,6274,6274,6274,6274,6274,6274,6274,6274,6274,6274,6274,abd1f64e-4283-4370-aae8-3666316aa36e,the need for a fourth drug should be reassessed when the results of susceptibility testing are known,0
5166,5166,5166,5166,5166,5166,5166,6275,6275,6275,6275,6275,6275,6275,6275,6275,6275,6275,6275,6275,abd1f64e-4283-4370-aae8-3666316aa36e,in the past when the national rate of primary drug resistance to isoniazid was known to be less than 4 and was either stable or declining  therapy with two and three drug regimens was considered adequate,0
5167,5167,5167,5167,5167,5167,5167,6276,6276,6276,6276,6276,6276,6276,6276,6276,6276,6276,6276,6276,abd1f64e-4283-4370-aae8-3666316aa36e,if community rates of inh resistance are currently less than 4  an initial treatment regimen with less than four drugs may be considered,0
5168,5168,5168,5168,5168,5168,5168,6277,6277,6277,6277,6277,6277,6277,6277,6277,6277,6277,6277,6277,abd1f64e-4283-4370-aae8-3666316aa36e,streptomycin is also indicated for therapy of tuberculosis when one or more of the above drugs is contraindicated because of toxicity or intolerance,1
5169,5169,5169,5169,5169,5169,5169,6278,6278,6278,6278,6278,6278,6278,6278,6278,6278,6278,6278,6278,abd1f64e-4283-4370-aae8-3666316aa36e,the management of tuberculosis has become more complex as a consequence of increasing rates of drug resistance and concomitant hiv infection,0
5170,5170,5170,5170,5170,5170,5170,6279,6279,6279,6279,6279,6279,6279,6279,6279,6279,6279,6279,6279,abd1f64e-4283-4370-aae8-3666316aa36e,additional consultation from experts in the treatment of tuberculosis may be desirable in those settings,0
5171,5171,5171,5171,5171,5171,5171,6280,6280,6280,6280,6280,6280,6280,6280,6280,6280,6280,6280,6280,abd1f64e-4283-4370-aae8-3666316aa36e,non tuberculosis infections the use of streptomycin should be limited to the treatment of infections caused by bacteria which have been shown to be susceptible to the antibacterial effects of streptomycin and which are not amenable to therapy with less potentially toxic agents,4
5172,5172,5172,5172,5172,5172,5172,6281,6281,6281,6281,6281,6281,6281,6281,6281,6281,6281,6281,6281,abd1f64e-4283-4370-aae8-3666316aa36e,pasteurella pestis ( plague )  francisella tularensis ( tularemia )  brucella  calymmatobacterium granulomatis ( donovanosis  granuloma inguinale )  h ducreyi ( chancroid )  h influenzae ( in respiratory  endocardial  and meningeal infections concomitantly with another antibacterial agent )  k pneumoniae pneumonia ( concomitantly with another antibacterial agent )  e coli  proteus  a aerogenes  k pneumoniae  and enterococcus faecalis in urinary tract infections  streptococcus viridans  enterococcus faecalis ( in endo,1
5173,5173,5173,5173,5173,5173,5173,6282,6282,6282,6282,6282,6282,6282,6282,6282,6282,6282,6282,6282,dfb26527-c5ab-44d0-9236-24b1600e0db4,indications usage isoflurane may be used forinduction and maintenance of general anesthesia,1
5174,5174,5174,5174,5174,5174,5174,6283,6283,6283,6283,6283,6283,6283,6283,6283,6283,6283,6283,6283,dfb26527-c5ab-44d0-9236-24b1600e0db4,adequate data have notbeen developed to establish its application in obstetrical anesthesia,0
5175,5175,5175,5175,5175,5175,5175,6284,6284,6284,6284,6284,6284,6284,6284,6284,6284,6284,6284,6284,a7f2ee4d-8428-47bb-a856-bef69e9089d9,1  olopatadine hydrochloride ophthalmic solution 0 2 is a mast cell stabilizer indicated for the treatment of ocular itching associated with allergic conjunctivitis,1
5176,5176,5176,5176,5176,5176,5176,6285,6285,6285,6285,6285,6285,6285,6285,6285,6285,6285,6285,6285,a7f2ee4d-8428-47bb-a856-bef69e9089d9,( 1 ) olopatadine hydrochloride ophthalmic solution 0 2 is indicated for the treatment of ocular itching associated with allergic conjunctivitis,1
5177,5177,5177,5177,5177,5177,5177,6286,6286,6286,6286,6286,6286,6286,6286,6286,6286,6286,6286,6286,626483a8-a543-4183-99bd-7293767881ad,1  frovatriptan succinate tablets are indicated for the acute treatment of migraine with or without aura in adults,1
5178,5178,5178,5178,5178,5178,5178,6288,6288,6288,6288,6288,6288,6288,6288,6288,6288,6288,6288,6288,626483a8-a543-4183-99bd-7293767881ad,if a patient has no response for the first migraine attack treated with frovatriptan succinate tablets  reconsider the diagnosis of migraine before frovatriptan succinate tablets are administered to treat any subsequent attacks,0
5179,5179,5179,5179,5179,5179,5179,6289,6289,6289,6289,6289,6289,6289,6289,6289,6289,6289,6289,6289,626483a8-a543-4183-99bd-7293767881ad,frovatriptan succinate tablets are not indicated for the prevention of migraine attacks,2
5180,5180,5180,5180,5180,5180,5180,6290,6290,6290,6290,6290,6290,6290,6290,6290,6290,6290,6290,6290,626483a8-a543-4183-99bd-7293767881ad,safety and effectiveness of frovatriptan succinate tablets have not been established for cluster headache,0
5181,5181,5181,5181,5181,5181,5181,6291,6291,6291,6291,6291,6291,6291,6291,6291,6291,6291,6291,6291,626483a8-a543-4183-99bd-7293767881ad,frovatriptan is a serotonin ( 5 ht1b 1d ) receptor agonist ( triptan ) indicated for the acute treatment of migraine with or without aura in adults ( 1 ) limitations of use use only after a clear diagnosis of migraine has been established ( 1 ) not indicated for the prophylactic therapy of migraine ( 1 ) not indicated for the treatment of cluster headache ( 1 ),1
5182,5182,5182,5182,5182,5182,5182,6292,6292,6292,6292,6292,6292,6292,6292,6292,6292,6292,6292,6292,1612d931-d86e-4dba-bbd7-0aac3eaee131, hms ( medrysone ophthalmic suspension ) is indicated for the treatment of allergic conjunctivitis  vernal conjunctivitis  episcleritis  and epinephrine sensitivity,1
5183,5183,5183,5183,5183,5183,5183,6293,6293,6293,6293,6293,6293,6293,6293,6293,6293,6293,6293,6293,2b25ef01-5c9e-11e1-b86c-0800200c9a66,1  pomalyst is a thalidomide analogue indicated  in combination with dexamethasone  for patients with multiple myeloma who have received at least two prior therapies including lenalidomide and a proteasome inhibitor and have demonstrated disease progression on or within 60 days of completion of the last therapy ( 1 1 ),1
5184,5184,5184,5184,5184,5184,5184,6294,6294,6294,6294,6294,6294,6294,6294,6294,6294,6294,6294,6294,2b25ef01-5c9e-11e1-b86c-0800200c9a66,1 1 multiple myeloma pomalyst  in combination with dexamethasone  is indicated for patients with multiple myeloma who have received at least two prior therapies including lenalidomide and a proteasome inhibitor and have demonstrated disease progression on or within 60 days of completion of the last therapy,1
5185,5185,5185,5185,5185,5185,5185,6295,6295,6295,6295,6295,6295,6295,6295,6295,6295,6295,6295,6295,de798d0d-a93c-40fb-95ea-10a4e6b287b7, iopidine 0 5 ophthalmic solution is indicated for short term adjunctive therapy in patients on maximally tolerated medical therapy  who require additional iop reduction,1
5186,5186,5186,5186,5186,5186,5186,6296,6296,6296,6296,6296,6296,6296,6296,6296,6296,6296,6296,6296,de798d0d-a93c-40fb-95ea-10a4e6b287b7,patients on maximally tolerated medical therapy  who are treated with iopidine 0 5 ophthalmic solution to delay surgery  should have frequent follow up examinations and treatment should be discontinued if the iop rises significantly,0
5187,5187,5187,5187,5187,5187,5187,6297,6297,6297,6297,6297,6297,6297,6297,6297,6297,6297,6297,6297,de798d0d-a93c-40fb-95ea-10a4e6b287b7,the addition of iopidine 0 5 ophthalmic solution to patients already using two aqueous suppressing drugs ( i e  beta blocker plus carbonic anhydrase inhibitor ) as part of their maximally tolerated medical therapy may not provide additional benefit,u
5188,5188,5188,5188,5188,5188,5188,6298,6298,6298,6298,6298,6298,6298,6298,6298,6298,6298,6298,6298,de798d0d-a93c-40fb-95ea-10a4e6b287b7,this is because iopidine 0 5 ophthalmic solution is an aqueous suppressing drug and the addition of a third aqueous suppressant may not significantly reduce iop,0
5189,5189,5189,5189,5189,5189,5189,6299,6299,6299,6299,6299,6299,6299,6299,6299,6299,6299,6299,6299,de798d0d-a93c-40fb-95ea-10a4e6b287b7,the iop lowering efficacy of iopidine 0 5 ophthalmic solution diminishes over time in some patients,0
5190,5190,5190,5190,5190,5190,5190,6300,6300,6300,6300,6300,6300,6300,6300,6300,6300,6300,6300,6300,de798d0d-a93c-40fb-95ea-10a4e6b287b7,this loss of effect  or tachyphylaxis  appears to be an individual occurrence with a variable time of onset and should be closely monitored,0
5191,5191,5191,5191,5191,5191,5191,6301,6301,6301,6301,6301,6301,6301,6301,6301,6301,6301,6301,6301,de798d0d-a93c-40fb-95ea-10a4e6b287b7,the benefit for most patients is less than one month,0
5192,5192,5192,5192,5192,5192,5192,6302,6302,6302,6302,6302,6302,6302,6302,6302,6302,6302,6302,6302,af1c3db8-940a-47bc-b30d-4ae428b9a029, terazosin capsules  usp are indicated for the treatment of symptomatic benign prostatic hyperplasia ( bph ),1
5193,5193,5193,5193,5193,5193,5193,6303,6303,6303,6303,6303,6303,6303,6303,6303,6303,6303,6303,6303,af1c3db8-940a-47bc-b30d-4ae428b9a029,there is a rapid response  with approximately 70 of patients experiencing an increase in urinary flow and improvement in symptoms of bph when treated with terazosin capsules  usp,u
5194,5194,5194,5194,5194,5194,5194,6304,6304,6304,6304,6304,6304,6304,6304,6304,6304,6304,6304,6304,af1c3db8-940a-47bc-b30d-4ae428b9a029,the long term effects of terazosin capsules  usp on the incidence of surgery  acute urinary obstruction or other complications of bph are yet to be determined,0
5195,5195,5195,5195,5195,5195,5195,6305,6305,6305,6305,6305,6305,6305,6305,6305,6305,6305,6305,6305,af1c3db8-940a-47bc-b30d-4ae428b9a029,terazosin capsules  usp are also indicated for the treatment of hypertension,1
5196,5196,5196,5196,5196,5196,5196,6306,6306,6306,6306,6306,6306,6306,6306,6306,6306,6306,6306,6306,af1c3db8-940a-47bc-b30d-4ae428b9a029,terazosin capsules  usp can be used alone or in combination with other antihypertensive agents such as diuretics or beta adrenergic blocking agents,4
5197,5197,5197,5197,5197,5197,5197,6307,6307,6307,6307,6307,6307,6307,6307,6307,6307,6307,6307,6307,8d66803a-6811-4c29-9c57-e16acfa87f21,1  emend for injection  in combination with other antiemetic agents  is indicated in adults for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of highly emetogenic cancer chemotherapy ( hec ) including high dose cisplatin,1
5198,5198,5198,5198,5198,5198,5198,6308,6308,6308,6308,6308,6308,6308,6308,6308,6308,6308,6308,6308,8d66803a-6811-4c29-9c57-e16acfa87f21,delayed nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy ( mec ),1
5199,5199,5199,5199,5199,5199,5199,6309,6309,6309,6309,6309,6309,6309,6309,6309,6309,6309,6309,6309,8d66803a-6811-4c29-9c57-e16acfa87f21,emend for injection is a substance p neurokinin 1 ( nk1 ) receptor antagonist  indicated in adults  in combination with other antiemetic agents  for the prevention of ( 1 ) acute and delayed nausea and vomiting associated with initial and repeat courses of highly emetogenic cancer chemotherapy ( hec ) including high dose cisplatin,1
5200,5200,5200,5200,5200,5200,5200,6311,6311,6311,6311,6311,6311,6311,6311,6311,6311,6311,6311,6311,8d66803a-6811-4c29-9c57-e16acfa87f21,limitations of use ( 1 ) emend has not been studied for treatment of established nausea and vomiting,0
5201,5201,5201,5201,5201,5201,5201,6312,6312,6312,6312,6312,6312,6312,6312,6312,6312,6312,6312,6312,8d66803a-6811-4c29-9c57-e16acfa87f21,limitations of use emend has not been studied for the treatment of established nausea and vomiting,0
5202,5202,5202,5202,5202,5202,5202,6313,6313,6313,6313,6313,6313,6313,6313,6313,6313,6313,6313,6313,c6f0dfc8-63b1-4bc1-96eb-3cd0c3d5d4c2, originally employed as a kidney function test  the chief application of indigo carmine at present is localizing ureteral orifices during cystoscopy and ureteral catheterization,1
5203,5203,5203,5203,5203,5203,5203,6314,6314,6314,6314,6314,6314,6314,6314,6314,6314,6314,6314,6314,dc23f53b-94b9-4bff-baf3-1fb785928175,1  cysview is an optical imaging agent indicated for use in the cystoscopic detection of non muscle invasive papillary cancer of the bladder among patients suspected or known to have lesion ( s ) on the basis of a prior cystoscopy,1
5204,5204,5204,5204,5204,5204,5204,6315,6315,6315,6315,6315,6315,6315,6315,6315,6315,6315,6315,6315,dc23f53b-94b9-4bff-baf3-1fb785928175,cysview is used with the karl storz d light c photodynamic diagnostic ( pdd ) system to perform cystoscopy with the blue light setting ( mode 2 ) as an adjunct to the white light setting ( mode 1 ),4
5205,5205,5205,5205,5205,5205,5205,6316,6316,6316,6316,6316,6316,6316,6316,6316,6316,6316,6316,6316,dc23f53b-94b9-4bff-baf3-1fb785928175,cysview is an optical imaging agent indicated for use in the cystoscopic detection of non muscle invasive papillary cancer of the bladder among patients suspected or known to have lesion ( s ) on the basis of a prior cystoscopy,1
5206,5206,5206,5206,5206,5206,5206,6318,6318,6318,6318,6318,6318,6318,6318,6318,6318,6318,6318,6318,dc23f53b-94b9-4bff-baf3-1fb785928175,important limitations of use not a replacement for random bladder biopsies or other procedures used in the detection of bladder cancer,0
5207,5207,5207,5207,5207,5207,5207,6319,6319,6319,6319,6319,6319,6319,6319,6319,6319,6319,6319,6319,dc23f53b-94b9-4bff-baf3-1fb785928175,( 1 1  5 2 ) not for repetitive use,0
5208,5208,5208,5208,5208,5208,5208,6320,6320,6320,6320,6320,6320,6320,6320,6320,6320,6320,6320,6320,dc23f53b-94b9-4bff-baf3-1fb785928175,( 1 1  5 1 ) 1 1 limitations of use cysview is not a replacement for random bladder biopsies or other procedures used in the detection of bladder cancer see warnings and precautions ( 5 2 ),0
5209,5209,5209,5209,5209,5209,5209,6321,6321,6321,6321,6321,6321,6321,6321,6321,6321,6321,6321,6321,dc23f53b-94b9-4bff-baf3-1fb785928175,the potential risks associated with repetitive exposure  including sensitization and adverse effects of blue light have not been evaluated see warnings and precautions ( 5 1 ),0
5210,5210,5210,5210,5210,5210,5210,6322,6322,6322,6322,6322,6322,6322,6322,6322,6322,6322,6322,6322,096cf052-6510-412a-abf3-24e5a33ea316, carticel is indicated for the repair of symptomatic cartilage defects of the femoral condyle ( medial  lateral or trochlea )  caused by acute or repetitive trauma  in patients who have had an inadequate response to a prior arthroscopic or other surgical repair procedure ( e g  debridement  microfracture  drilling abrasion arthroplasty  or osteochondral allograft autograft ),1
5211,5211,5211,5211,5211,5211,5211,6323,6323,6323,6323,6323,6323,6323,6323,6323,6323,6323,6323,6323,096cf052-6510-412a-abf3-24e5a33ea316,carticel should be used only in conjunction with debridement  placement of a periosteal flap and rehabilitation,4
5212,5212,5212,5212,5212,5212,5212,6324,6324,6324,6324,6324,6324,6324,6324,6324,6324,6324,6324,6324,096cf052-6510-412a-abf3-24e5a33ea316,the independent contributions of the autologous cultured chondrocytes and other components of the therapy to outcome are unknown,0
5213,5213,5213,5213,5213,5213,5213,6325,6325,6325,6325,6325,6325,6325,6325,6325,6325,6325,6325,6325,096cf052-6510-412a-abf3-24e5a33ea316,carticel is not indicated for the treatment of cartilage damage associated with generalized osteoarthritis,0
5214,5214,5214,5214,5214,5214,5214,6326,6326,6326,6326,6326,6326,6326,6326,6326,6326,6326,6326,6326,096cf052-6510-412a-abf3-24e5a33ea316,carticel is not recommended for patients with total meniscectomy unless surgically reconstructed prior to or concurrent with carticel implantation,u
5215,5215,5215,5215,5215,5215,5215,6327,6327,6327,6327,6327,6327,6327,6327,6327,6327,6327,6327,6327,096cf052-6510-412a-abf3-24e5a33ea316,carticel is an autologous cellular product indicated for the repair of symptomatic cartilage defects of the femoral condyle ( medial  lateral or trochlea )  caused by acute or repetitive trauma  in patients who have had an inadequate response to a prior arthroscopic or other surgical repair procedure ( e g  debridement  microfracture  drilling abrasion arthroplasty  or osteochondral allograft autograft ),1
5216,5216,5216,5216,5216,5216,5216,6328,6328,6328,6328,6328,6328,6328,6328,6328,6328,6328,6328,6328,096cf052-6510-412a-abf3-24e5a33ea316,( 1 ) carticel should be used only in conjunction with debridement  placement of a periosteal flap and rehabilitation,4
5217,5217,5217,5217,5217,5217,5217,6329,6329,6329,6329,6329,6329,6329,6329,6329,6329,6329,6329,6329,096cf052-6510-412a-abf3-24e5a33ea316,( 1 ) carticel is not indicated for treatment of cartilage damage associated with generalized osteoarthritis,2
5218,5218,5218,5218,5218,5218,5218,6330,6330,6330,6330,6330,6330,6330,6330,6330,6330,6330,6330,6330,096cf052-6510-412a-abf3-24e5a33ea316,( 1 ) patients with total meniscectomy unless surgically reconstructed prior to or concurrent with carticel implantation,1
5219,5219,5219,5219,5219,5219,5219,6332,6332,6332,6332,6332,6332,6332,6332,6332,6332,6332,6332,6332,30bdf2ea-008b-4cbb-81e4-c3474f2ad286,1  erwinaze ( asparaginase erwinia chrysanthemi ) is indicated as a component of a multi agent chemotherapeutic regimen for the treatment of patients with acute lymphoblastic leukemia ( all ) who have developed hypersensitivity to e coli derived asparaginase,1
5220,5220,5220,5220,5220,5220,5220,6333,6333,6333,6333,6333,6333,6333,6333,6333,6333,6333,6333,6333,30bdf2ea-008b-4cbb-81e4-c3474f2ad286,erwinaze ( asparaginase erwinia chrysanthemi ) is an asparagine specific enzyme indicated as a component of a multi agent chemotherapeutic regimen for the treatment of patients with acute lymphoblastic leukemia ( all ) who have developed hypersensitivity to e coli derived asparaginase,1
5221,5221,5221,5221,5221,5221,5221,6334,6334,6334,6334,6334,6334,6334,6334,6334,6334,6334,6334,6334,2e8c3537-36d7-4de5-9b5c-7a624b9a9e6e,1  esbriet is indicated for the treatment of idiopathic pulmonary fibrosis ( ipf ),1
5222,5222,5222,5222,5222,5222,5222,6335,6335,6335,6335,6335,6335,6335,6335,6335,6335,6335,6335,6335,2e8c3537-36d7-4de5-9b5c-7a624b9a9e6e,esbriet is a pyridone indicated for the treatment of idiopathic pulmonary fibrosis ( ipf ),1
5223,5223,5223,5223,5223,5223,5223,6336,6336,6336,6336,6336,6336,6336,6336,6336,6336,6336,6336,6336,bbd8ab99-552e-4b81-aca4-6b0c7af8b9ae,1  thymoglobulin is indicated for the prophylaxis and treatment of acute rejection in patients receiving a kidney transplant,1
5224,5224,5224,5224,5224,5224,5224,6337,6337,6337,6337,6337,6337,6337,6337,6337,6337,6337,6337,6337,bbd8ab99-552e-4b81-aca4-6b0c7af8b9ae,thymoglobulin is to be used in conjunction with concomitant immunosuppression,4
5225,5225,5225,5225,5225,5225,5225,6338,6338,6338,6338,6338,6338,6338,6338,6338,6338,6338,6338,6338,bbd8ab99-552e-4b81-aca4-6b0c7af8b9ae,thymoglobulin is an immunoglobulin g indicated for the prophylaxis and treatment of acute rejection in patients receiving a kidney transplant,1
5226,5226,5226,5226,5226,5226,5226,6339,6339,6339,6339,6339,6339,6339,6339,6339,6339,6339,6339,6339,bbd8ab99-552e-4b81-aca4-6b0c7af8b9ae,( 1 ) use in conjunction with concomitant immunosuppression,4
5227,5227,5227,5227,5227,5227,5227,6340,6340,6340,6340,6340,6340,6340,6340,6340,6340,6340,6340,6340,5ada82f0-a5fd-46c9-aecc-f106f614c9f0,1  lovaza ( omega 3 acid ethyl esters ) is indicated as an adjunct to diet to reduce triglyceride ( tg ) levels in adult patients with severe ( greater than or equal to 500 mg per dl ) hypertriglyceridemia ( htg ),1
5228,5228,5228,5228,5228,5228,5228,6341,6341,6341,6341,6341,6341,6341,6341,6341,6341,6341,6341,6341,5ada82f0-a5fd-46c9-aecc-f106f614c9f0,usage considerations patients should be placed on an appropriate lipid lowering diet before receiving lovaza and should continue this diet during treatment with lovaza,4
5229,5229,5229,5229,5229,5229,5229,6342,6342,6342,6342,6342,6342,6342,6342,6342,6342,6342,6342,6342,5ada82f0-a5fd-46c9-aecc-f106f614c9f0,laboratory studies should be done to ascertain that the lipid levels are consistently abnormal before instituting therapy with lovaza,0
5230,5230,5230,5230,5230,5230,5230,6345,6345,6345,6345,6345,6345,6345,6345,6345,6345,6345,6345,6345,5ada82f0-a5fd-46c9-aecc-f106f614c9f0,limitations of use the effect of lovaza on the risk for pancreatitis has not been determined,0
5231,5231,5231,5231,5231,5231,5231,6346,6346,6346,6346,6346,6346,6346,6346,6346,6346,6346,6346,6346,5ada82f0-a5fd-46c9-aecc-f106f614c9f0,the effect of lovaza on cardiovascular mortality and morbidity has not been determined,0
5232,5232,5232,5232,5232,5232,5232,6347,6347,6347,6347,6347,6347,6347,6347,6347,6347,6347,6347,6347,5ada82f0-a5fd-46c9-aecc-f106f614c9f0,lovaza is a combination of ethyl esters of omega 3 fatty acids  principally epa and dha  indicated as an adjunct to diet to reduce triglyceride ( tg ) levels in adult patients with severe ( 500 mg dl ) hypertriglyceridemia ( htg ),1
5233,5233,5233,5233,5233,5233,5233,6348,6348,6348,6348,6348,6348,6348,6348,6348,6348,6348,6348,6348,5ada82f0-a5fd-46c9-aecc-f106f614c9f0,( 1 ) limitations of use the effect of lovaza on the risk for pancreatitis has not been determined,0
5234,5234,5234,5234,5234,5234,5234,6349,6349,6349,6349,6349,6349,6349,6349,6349,6349,6349,6349,6349,5ada82f0-a5fd-46c9-aecc-f106f614c9f0,( 1 ) the effect of lovaza on cardiovascular mortality and morbidity has not been determined,0
5235,5235,5235,5235,5235,5235,5235,6350,6350,6350,6350,6350,6350,6350,6350,6350,6350,6350,6350,6350,3a1e73a2-3009-40d0-876c-b4cb2be56fc5,1  novolog is a rapid acting human insulin analog indicated to improve glycemic control in adults and children with diabetes mellitus,1
5236,5236,5236,5236,5236,5236,5236,6351,6351,6351,6351,6351,6351,6351,6351,6351,6351,6351,6351,6351,3a1e73a2-3009-40d0-876c-b4cb2be56fc5,novolog is rapid acting human insulin analog indicated to improve glycemic control in adults and children with diabetes mellitus ( 1 ),1
5237,5237,5237,5237,5237,5237,5237,6352,6352,6352,6352,6352,6352,6352,6352,6352,6352,6352,6352,6352,c6080942-dee6-423e-b688-1272c2ae90d4,1  cyramza is a human vascular endothelial growth factor receptor 2 ( vegfr2 ) antagonist indicated as a single agent or in combination with paclitaxel  for treatment of advanced gastric or gastro esophageal junction adenocarcinoma  with disease progression on or after prior fluoropyrimidine or platinum containing chemotherapy,1
5238,5238,5238,5238,5238,5238,5238,6353,6353,6353,6353,6353,6353,6353,6353,6353,6353,6353,6353,6353,c6080942-dee6-423e-b688-1272c2ae90d4,( 1 1 ) in combination with docetaxel  for treatment of metastatic non small cell lung cancer with disease progression on or after platinum based chemotherapy,1
5239,5239,5239,5239,5239,5239,5239,6354,6354,6354,6354,6354,6354,6354,6354,6354,6354,6354,6354,6354,c6080942-dee6-423e-b688-1272c2ae90d4,patients with egfr or alk genomic tumor aberrations should have disease progression on fda approved therapy for these aberrations prior to receiving cyramza,0
5240,5240,5240,5240,5240,5240,5240,6355,6355,6355,6355,6355,6355,6355,6355,6355,6355,6355,6355,6355,c6080942-dee6-423e-b688-1272c2ae90d4,( 1 2 ) in combination with folfiri  for the treatment of metastatic colorectal cancer with disease progression on or after prior therapy with bevacizumab  oxaliplatin  and a fluoropyrimidine,1
5241,5241,5241,5241,5241,5241,5241,6356,6356,6356,6356,6356,6356,6356,6356,6356,6356,6356,6356,6356,c6080942-dee6-423e-b688-1272c2ae90d4,( 1 3 ) 1 1 gastric cancer cyramza as a single agent  or in combination with paclitaxel  is indicated for the treatment of patients with advanced or metastatic  gastric or gastro esophageal junction adenocarcinoma with disease progression on or after prior fluoropyrimidine or platinum containing chemotherapy,1
5242,5242,5242,5242,5242,5242,5242,6357,6357,6357,6357,6357,6357,6357,6357,6357,6357,6357,6357,6357,c6080942-dee6-423e-b688-1272c2ae90d4,1 2 non small cell lung cancer cyramza  in combination with docetaxel  is indicated for the treatment of patients with metastatic non small cell lung cancer ( nsclc ) with disease progression on or after platinum based chemotherapy,1
5243,5243,5243,5243,5243,5243,5243,6359,6359,6359,6359,6359,6359,6359,6359,6359,6359,6359,6359,6359,c6080942-dee6-423e-b688-1272c2ae90d4,1 3 colorectal cancer cyramza  in combination with folfiri ( irinotecan  folinic acid  and 5 fluorouracil )  is indicated for the treatment of patients with metastatic colorectal cancer ( mcrc ) with disease progression on or after prior therapy with bevacizumab  oxaliplatin  and a fluoropyrimidine,1
5244,5244,5244,5244,5244,5244,5244,6360,6360,6360,6360,6360,6360,6360,6360,6360,6360,6360,6360,6360,57bccb29-1c47-4c64-ab6a-77960a91cc20,1  tarceva is a kinase inhibitor indicated for the treatment of patients with metastatic non small cell lung cancer ( nsclc ) whose tumors have epidermal growth factor receptor ( egfr ) exon 19 deletions or exon 21 ( l858r ) substitution mutations as detected by an fda approved test receiving first line  maintenance  or second or greater line treatment after progression following at least one prior chemotherapy regimen,1
5245,5245,5245,5245,5245,5245,5245,6361,6361,6361,6361,6361,6361,6361,6361,6361,6361,6361,6361,6361,57bccb29-1c47-4c64-ab6a-77960a91cc20,( 1 1 ) first line treatment of patients with locally advanced  unresectable or metastatic pancreatic cancer  in combination with gemcitabine,1
5246,5246,5246,5246,5246,5246,5246,6362,6362,6362,6362,6362,6362,6362,6362,6362,6362,6362,6362,6362,57bccb29-1c47-4c64-ab6a-77960a91cc20,( 1 2 ) limitations of use safety and efficacy of tarceva have not been established in patients with nsclc whose tumors have other egfr mutations,0
5247,5247,5247,5247,5247,5247,5247,6363,6363,6363,6363,6363,6363,6363,6363,6363,6363,6363,6363,6363,57bccb29-1c47-4c64-ab6a-77960a91cc20,( 1 1 ) tarceva is not recommended for use in combination with platinum based chemotherapy,0
5248,5248,5248,5248,5248,5248,5248,6364,6364,6364,6364,6364,6364,6364,6364,6364,6364,6364,6364,6364,57bccb29-1c47-4c64-ab6a-77960a91cc20,( 1 1 ) 1 1 non small cell lung cancer ( nsclc ) tarceva is indicated for the treatment of patients with metastatic non small cell lung cancer ( nsclc ) whose tumors have epidermal growth factor receptor ( egfr ) exon 19 deletions or exon 21 ( l858r ) substitution mutations as detected by an fda approved test receiving first line  maintenance  or second or greater line treatment after progression following at least one prior chemotherapy regimen see clinical studies ( 14 1  14 3 ),1
5249,5249,5249,5249,5249,5249,5249,6365,6365,6365,6365,6365,6365,6365,6365,6365,6365,6365,6365,6365,57bccb29-1c47-4c64-ab6a-77960a91cc20,limitations of use safety and efficacy of tarceva have not been established in patients with nsclc whose tumors have other egfr mutations see clinical studies ( 14 1  14 2 ),0
5250,5250,5250,5250,5250,5250,5250,6366,6366,6366,6366,6366,6366,6366,6366,6366,6366,6366,6366,6366,57bccb29-1c47-4c64-ab6a-77960a91cc20,tarceva is not recommended for use in combination with platinum based chemotherapy see linkhtml href id cb27c096 0252 4cda 9e75 be9be,0
5251,5251,5251,5251,5251,5251,5251,6367,6367,6367,6367,6367,6367,6367,6367,6367,6367,6367,6367,6367,df502787-46ec-4dd1-a2c0-be90f6d95a5d,1  veletri is indicated for the treatment of pulmonary arterial hypertension ( pah ) ( who group 1 ) to improve exercise capacity,1
5252,5252,5252,5252,5252,5252,5252,6368,6368,6368,6368,6368,6368,6368,6368,6368,6368,6368,6368,6368,df502787-46ec-4dd1-a2c0-be90f6d95a5d,studies establishing effectiveness included predominantly patients with nyha functional class iii iv symptoms and etiologies of idiopathic or heritable pah or pah associated with connective tissue diseases,0
5253,5253,5253,5253,5253,5253,5253,6369,6369,6369,6369,6369,6369,6369,6369,6369,6369,6369,6369,6369,df502787-46ec-4dd1-a2c0-be90f6d95a5d,veletri is a prostanoid vasodilator indicated for the treatment of pulmonary arterial hypertension ( pah ) ( who group 1 ) to improve exercise capacity,1
5254,5254,5254,5254,5254,5254,5254,6371,6371,6371,6371,6371,6371,6371,6371,6371,6371,6371,6371,6371,be306d60-553d-4b8c-8aad-539da646d8e9, in accordance with the statements in the warning box  the use of intramuscular bacitracin is limited to the treatment of infants with pneumonia and empyema caused by staphylococci shown to be susceptible to the drug,u
5255,5255,5255,5255,5255,5255,5255,6372,6372,6372,6372,6372,6372,6372,6372,6372,6372,6372,6372,6372,be306d60-553d-4b8c-8aad-539da646d8e9,to reduce the development of drug resistant bacteria and maintain the effectiveness of bacitracin and other antibacterial drugs  bacitracin should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria,4
5256,5256,5256,5256,5256,5256,5256,6375,6375,6375,6375,6375,6375,6375,6375,6375,6375,6375,6375,6375,a58f95fa-18f9-4938-8e3f-f33244f68298, isoproterenol hydrochloride injection is indicated for mild or transient episodes of heart block that do not require electric shock or pacemaker therapy,1
5257,5257,5257,5257,5257,5257,5257,6376,6376,6376,6376,6376,6376,6376,6376,6376,6376,6376,6376,6376,a58f95fa-18f9-4938-8e3f-f33244f68298,for serious episodes of heart block and adams stokes attacks ( except when caused by ventricular tachycardia or fibrillation ) ( see contraindications ),1
5258,5258,5258,5258,5258,5258,5258,6377,6377,6377,6377,6377,6377,6377,6377,6377,6377,6377,6377,6377,a58f95fa-18f9-4938-8e3f-f33244f68298,for use in cardiac arrest until electric shock or pacemaker therapy  the treatments of choice  is available ( see contraindications ),1
5259,5259,5259,5259,5259,5259,5259,6378,6378,6378,6378,6378,6378,6378,6378,6378,6378,6378,6378,6378,a58f95fa-18f9-4938-8e3f-f33244f68298,for bronchospasm occurring during anesthesia,1
5260,5260,5260,5260,5260,5260,5260,6379,6379,6379,6379,6379,6379,6379,6379,6379,6379,6379,6379,6379,a58f95fa-18f9-4938-8e3f-f33244f68298,as an adjunct to fluid and electrolyte replacement therapy and the use of other drugs and procedures in the treatment of hypovolemic and septic shock  low cardiac output ( hypoperfusion ) states  congestive heart failure  and cardiogenic shock ( see warnings ),1
5261,5261,5261,5261,5261,5261,5261,6380,6380,6380,6380,6380,6380,6380,6380,6380,6380,6380,6380,6380,ac5d0d81-5c64-4344-850d-34946b3252b1, osteoarthritis  rheumatoid arthritis and acute painful shoulder salicylates are considered the base therapy of choice in the arthritides and choline magnesium trisalicylate preparation is indicated for the relief of the signs and symptoms of rheumatoid arthritis  osteoarthritis and other arthritides,1
5262,5262,5262,5262,5262,5262,5262,6381,6381,6381,6381,6381,6381,6381,6381,6381,6381,6381,6381,6381,ac5d0d81-5c64-4344-850d-34946b3252b1,choline magnesium trisalicylate liquid is indicated in the long term management of these diseases and especially in the acute flare of rheumatoid arthritis,1
5263,5263,5263,5263,5263,5263,5263,6382,6382,6382,6382,6382,6382,6382,6382,6382,6382,6382,6382,6382,ac5d0d81-5c64-4344-850d-34946b3252b1,choline magnesium trisalicylate liquid is also indicated for the treatment of acute painful shoulder,1
5264,5264,5264,5264,5264,5264,5264,6383,6383,6383,6383,6383,6383,6383,6383,6383,6383,6383,6383,6383,ac5d0d81-5c64-4344-850d-34946b3252b1,choline magnesium trisalicylate liquid is effective and generally well tolerated  and is logical choice whenever salicylate treatment is indicated,0
5265,5265,5265,5265,5265,5265,5265,6384,6384,6384,6384,6384,6384,6384,6384,6384,6384,6384,6384,6384,ac5d0d81-5c64-4344-850d-34946b3252b1,it is particularly suitable when a once a day or b i d,0
5266,5266,5266,5266,5266,5266,5266,6385,6385,6385,6385,6385,6385,6385,6385,6385,6385,6385,6385,6385,ac5d0d81-5c64-4344-850d-34946b3252b1,dosage regimen is important to patient compliance when gastrointestinal intolerance to aspirin is encountered when gastrointestinal microbleeding or hematologic effects of aspirin are considered a patient hazard and when interference ( or the risk of interference ) with normal platelet function by aspirin or by propionic acid derivatives is considered to be clinically undesirable,0
5267,5267,5267,5267,5267,5267,5267,6386,6386,6386,6386,6386,6386,6386,6386,6386,6386,6386,6386,6386,ac5d0d81-5c64-4344-850d-34946b3252b1,use of choline magnesium trisalicylate liquid is appropriate when a liquid dosage form is preferred  as in the elderly patient,u
5268,5268,5268,5268,5268,5268,5268,6387,6387,6387,6387,6387,6387,6387,6387,6387,6387,6387,6387,6387,ac5d0d81-5c64-4344-850d-34946b3252b1,the efficacy of choline magnesium trisalicylate liquid has not been studied in those patients who are designated by the american rheumatism association as belonging in functional class iv ( incapacitated  largely or wholly bedridden or confined to a wheelchair  with little or no self care ),0
5269,5269,5269,5269,5269,5269,5269,6388,6388,6388,6388,6388,6388,6388,6388,6388,6388,6388,6388,6388,ac5d0d81-5c64-4344-850d-34946b3252b1,analgesic and antipyretic action choline magnesium trisalicylate liquid is also indicated for the relief of mild to moderate pain and for antipyresis,1
5270,5270,5270,5270,5270,5270,5270,6389,6389,6389,6389,6389,6389,6389,6389,6389,6389,6389,6389,6389,ac5d0d81-5c64-4344-850d-34946b3252b1,pediatric use in children  choline magnesium trisalicylate liquid is indicated for conditions requiring anti inflammatory or analgesic action such as juvenile rheumatoid arthritis and other appropriate conditions,1
5271,5271,5271,5271,5271,5271,5271,6390,6390,6390,6390,6390,6390,6390,6390,6390,6390,6390,6390,6390,318b3c36-89f8-4423-984e-361cf0d51c8b, colistimethate for injection  usp is indicated for the treatment of acute or chronic infections due to sensitive strains of certain gram negative bacilli,1
5272,5272,5272,5272,5272,5272,5272,6391,6391,6391,6391,6391,6391,6391,6391,6391,6391,6391,6391,6391,318b3c36-89f8-4423-984e-361cf0d51c8b,it is particularly indicated when the infection is caused by sensitive strains of pseudomonas aeruginosa,1
5273,5273,5273,5273,5273,5273,5273,6392,6392,6392,6392,6392,6392,6392,6392,6392,6392,6392,6392,6392,318b3c36-89f8-4423-984e-361cf0d51c8b,this antibiotic is not indicated for infections due to proteus or neisseria,2
5274,5274,5274,5274,5274,5274,5274,6393,6393,6393,6393,6393,6393,6393,6393,6393,6393,6393,6393,6393,318b3c36-89f8-4423-984e-361cf0d51c8b,colistimethate for injection  usp has proven clinically effective in treatment of infections due to the following gram negative organisms enterobacter aerogenes  escherichia coli  klebsiella pneumoniae and pseudomonas aeruginosa,u
5275,5275,5275,5275,5275,5275,5275,6394,6394,6394,6394,6394,6394,6394,6394,6394,6394,6394,6394,6394,318b3c36-89f8-4423-984e-361cf0d51c8b,colistimethate for injection  usp may be used to initiate therapy in serious infections that are suspected to be due to gram negative organisms and in the treatment of infections due to susceptible gram negative pathogenic bacilli,1
5276,5276,5276,5276,5276,5276,5276,6395,6395,6395,6395,6395,6395,6395,6395,6395,6395,6395,6395,6395,318b3c36-89f8-4423-984e-361cf0d51c8b,to reduce the development of drug resistant bacteria and maintain the effectiveness of colistimethate for injection  usp and other antibacterial drugs  colistimethate for injection  usp should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria,4
5277,5277,5277,5277,5277,5277,5277,6398,6398,6398,6398,6398,6398,6398,6398,6398,6398,6398,6398,6398,cb93bfad-3e37-4a27-92f6-f21703ae7bdf,1  scopolamine transdermal system is an anticholinergic agent indicated in adults for the prevention of nausea and vomiting associated with motion sickness ( 1 1 ) post operative nausea and vomiting ( ponv ) ( 1 2 ) 1 1 motion sickness scopolamine transdermal system is indicated in adults for prevention of nausea and vomiting associated with motion sickness,1
5278,5278,5278,5278,5278,5278,5278,6399,6399,6399,6399,6399,6399,6399,6399,6399,6399,6399,6399,6399,cb93bfad-3e37-4a27-92f6-f21703ae7bdf,see clinical studies ( 14 1 ) 1 2 post operative nausea and vomiting ( ponv ) scopolamine transdermal system is indicated in adults for prevention of nausea and vomiting associated with recovery from anesthesia and or opiate analgesia and surgery,1
5279,5279,5279,5279,5279,5279,5279,6400,6400,6400,6400,6400,6400,6400,6400,6400,6400,6400,6400,6400,77c4b13e-7df3-42d4-81db-3d0cddb7f67a,1  cosentyx is a human interleukin 17a antagonist indicated for the treatment of moderate to severe plaque psoriasis in adult patients who are candidates for systemic therapy or phototherapy ( 1 1 ) adults with active psoriatic arthritis ( psa ) ( 1 2 ) adults with active ankylosing spondylitis ( as ) ( 1 3 ) 1 1 plaque psoriasis cosentyx is indicated for the treatment of moderate to severe plaque psoriasis in adult patients who are candidates for systemic therapy or phototherapy,1
5280,5280,5280,5280,5280,5280,5280,6401,6401,6401,6401,6401,6401,6401,6401,6401,6401,6401,6401,6401,77c4b13e-7df3-42d4-81db-3d0cddb7f67a,1 2 psoriatic arthritis cosentyx is indicated for the treatment of adult patients with active psoriatic arthritis,1
5281,5281,5281,5281,5281,5281,5281,6402,6402,6402,6402,6402,6402,6402,6402,6402,6402,6402,6402,6402,77c4b13e-7df3-42d4-81db-3d0cddb7f67a,1 3 ankylosing spondylitis cosentyx is indicated for the treatment of adult patients with active ankylosing spondylitis,1
5282,5282,5282,5282,5282,5282,5282,6403,6403,6403,6403,6403,6403,6403,6403,6403,6403,6403,6403,6403,32fb2f2f-34b5-4cd5-9145-c3ab37c5ca92, demser is indicated in the treatment of patients with pheochromocytoma for 1,1
5283,5283,5283,5283,5283,5283,5283,6404,6404,6404,6404,6404,6404,6404,6404,6404,6404,6404,6404,6404,32fb2f2f-34b5-4cd5-9145-c3ab37c5ca92,preoperative preparation of patients for surgery 2,1
5284,5284,5284,5284,5284,5284,5284,6405,6405,6405,6405,6405,6405,6405,6405,6405,6405,6405,6405,6405,32fb2f2f-34b5-4cd5-9145-c3ab37c5ca92,management of patients when surgery is contraindicated 3,1
5285,5285,5285,5285,5285,5285,5285,6406,6406,6406,6406,6406,6406,6406,6406,6406,6406,6406,6406,6406,32fb2f2f-34b5-4cd5-9145-c3ab37c5ca92,chronic treatment of patients with malignant pheochromocytoma,1
5286,5286,5286,5286,5286,5286,5286,6407,6407,6407,6407,6407,6407,6407,6407,6407,6407,6407,6407,6407,32fb2f2f-34b5-4cd5-9145-c3ab37c5ca92,demser is not recommended for the control of essential hypertension,2
5287,5287,5287,5287,5287,5287,5287,6408,6408,6408,6408,6408,6408,6408,6408,6408,6408,6408,6408,6408,9333c79b-d487-4538-a9f0-71b91a02b287,1  keytruda is a programmed death receptor 1 ( pd 1 ) blocking antibody indicated in melanoma for the treatment of patients with unresectable or metastatic melanoma,1
5288,5288,5288,5288,5288,5288,5288,6409,6409,6409,6409,6409,6409,6409,6409,6409,6409,6409,6409,6409,9333c79b-d487-4538-a9f0-71b91a02b287,( 1 1 ) non small cell lung cancer ( nsclc ) as a single agent for the first line treatment of patients with metastatic nsclc whose tumors have high pd l1 expression ( tumor proportion score ( tps ) 50 ) as determined by an fda approved test  with no egfr or alk genomic tumor aberrations,1
5289,5289,5289,5289,5289,5289,5289,6410,6410,6410,6410,6410,6410,6410,6410,6410,6410,6410,6410,6410,9333c79b-d487-4538-a9f0-71b91a02b287,( 1 2 ) as a single agent for the treatment of patients with metastatic nsclc whose tumors express pd l1 ( tps 1 ) as determined by an fda approved test  with disease progression on or after platinum containing chemotherapy,1
5290,5290,5290,5290,5290,5290,5290,6411,6411,6411,6411,6411,6411,6411,6411,6411,6411,6411,6411,6411,9333c79b-d487-4538-a9f0-71b91a02b287,patients with egfr or alk genomic tumor aberrations should have disease progression on fda approved therapy for these aberrations prior to receiving keytruda,4
5291,5291,5291,5291,5291,5291,5291,6412,6412,6412,6412,6412,6412,6412,6412,6412,6412,6412,6412,6412,9333c79b-d487-4538-a9f0-71b91a02b287,( 1 2 ) in combination with pemetrexed and carboplatin  as first line treatment of patients with metastatic nonsquamous nsclc,1
5292,5292,5292,5292,5292,5292,5292,6413,6413,6413,6413,6413,6413,6413,6413,6413,6413,6413,6413,6413,9333c79b-d487-4538-a9f0-71b91a02b287,this indication is approved under accelerated approval based on tumor response rate and progression free survival,0
5293,5293,5293,5293,5293,5293,5293,6415,6415,6415,6415,6415,6415,6415,6415,6415,6415,6415,6415,6415,9333c79b-d487-4538-a9f0-71b91a02b287,( 1 2 ) head and neck squamous cell cancer ( hnscc ) for the treatment of patients with recurrent or metastatic hnscc with disease progression on or after platinum containing chemotherapy,1
5294,5294,5294,5294,5294,5294,5294,6416,6416,6416,6416,6416,6416,6416,6416,6416,6416,6416,6416,6416,9333c79b-d487-4538-a9f0-71b91a02b287,this indication is approved under accelerated approval based on tumor response rate and durability of response,0
5295,5295,5295,5295,5295,5295,5295,6418,6418,6418,6418,6418,6418,6418,6418,6418,6418,6418,6418,6418,9333c79b-d487-4538-a9f0-71b91a02b287,( 1 3 ) classical hodgkin lymphoma ( chl ) for the treatment of adult and pediatric patients with refractory chl  or who have relapsed after 3 or more prior lines of therapy,1
5296,5296,5296,5296,5296,5296,5296,6421,6421,6421,6421,6421,6421,6421,6421,6421,6421,6421,6421,6421,9333c79b-d487-4538-a9f0-71b91a02b287,( 1 4 ) urothelial carcinoma for the treatment of patients with locally advanced or metastatic urothelial carcinoma who are not eligible for cisplatin containing chemotherapy,1
5297,5297,5297,5297,5297,5297,5297,6423,6423,6423,6423,6423,6423,6423,6423,6423,6423,6423,6423,6423,9333c79b-d487-4538-a9f0-71b91a02b287,continued approval for this indication may be contingent upon verification and description of clinical benefit in c,0
5298,5298,5298,5298,5298,5298,5298,6424,6424,6424,6424,6424,6424,6424,6424,6424,6424,6424,6424,6424,8e35c4c8-bf56-458f-a73c-8f5733829788,1  1  synagis is indicated for the prevention of serious lower respiratory tract disease caused by respiratory syncytial virus ( rsv ) in pediatric patients with a history of premature birth ( less than or equal to 35 weeks gestational age ) and who are 6 months of age or younger at the beginning of rsv season  with bronchopulmonary dysplasia ( bpd ) that required medical treatment within the previous 6 months and who are 24 months of age or younger at the beginning of rsv season  with hemodynamically significant congenital heart disease ( chd ) and who are 24 months of age or younger at the beginning of rsv season see clinical studies ( 14 ),1
5299,5299,5299,5299,5299,5299,5299,6425,6425,6425,6425,6425,6425,6425,6425,6425,6425,6425,6425,6425,8e35c4c8-bf56-458f-a73c-8f5733829788,limitations of use the safety and efficacy of synagis have not been established for treatment of rsv disease see warnings and precautions ( 5 4 ),0
5300,5300,5300,5300,5300,5300,5300,6426,6426,6426,6426,6426,6426,6426,6426,6426,6426,6426,6426,6426,8e35c4c8-bf56-458f-a73c-8f5733829788,synagis is a respiratory syncytial virus ( rsv ) f protein inhibitor monoclonal antibody indicated for the prevention of serious lower respiratory tract disease caused by respiratory syncytial virus ( rsv ) in pediatric patients with a history of premature birth ( less than or equal to 35 weeks gestational age ) and who are 6 months of age or younger at the beginning of rsv season  with bronchopulmonary dysplasia ( bpd ) that required medical treatment within the previous 6 months and who are 24 months of age or younger at the beginning of rsv season  with hemodynamically significant congenital heart disease ( chd ) and who are 24 months of age or younger at the beginning of rsv season,1
5301,5301,5301,5301,5301,5301,5301,6427,6427,6427,6427,6427,6427,6427,6427,6427,6427,6427,6427,6427,8e35c4c8-bf56-458f-a73c-8f5733829788,limitations of use the safety and efficacy of synagis have not been established for treatment of rsv disease,0
5302,5302,5302,5302,5302,5302,5302,6428,6428,6428,6428,6428,6428,6428,6428,6428,6428,6428,6428,6428,e7b63b16-d911-478b-a445-b690a1360b48,1  retavase is indicated for use in acute st elevation myocardial infarction ( stemi ) to reduce the risk of death and heart failure,1
5303,5303,5303,5303,5303,5303,5303,6429,6429,6429,6429,6429,6429,6429,6429,6429,6429,6429,6429,6429,e7b63b16-d911-478b-a445-b690a1360b48,limitation of use the risk of stroke may outweigh the benefit produced by thrombolytic therapy in patients whose stemi puts them at low risk for death or heart failure,2
5304,5304,5304,5304,5304,5304,5304,6430,6430,6430,6430,6430,6430,6430,6430,6430,6430,6430,6430,6430,e7b63b16-d911-478b-a445-b690a1360b48,retavase is a tissue plasminogen activator ( tpa ) indicated for treatment of acute st elevation myocardial infarction ( stemi ) to reduce the risk of death and heart failure,1
5305,5305,5305,5305,5305,5305,5305,6431,6431,6431,6431,6431,6431,6431,6431,6431,6431,6431,6431,6431,e7b63b16-d911-478b-a445-b690a1360b48,( 1 ) limitation of use the risk of stroke may outweigh the benefit produced by thrombolytic therapy in patients whose stemi puts them at low risk for death or heart failure,2
5306,5306,5306,5306,5306,5306,5306,6432,6432,6432,6432,6432,6432,6432,6432,6432,6432,6432,6432,6432,7036c6df-6527-4701-b484-6b962914b52a, tiagabine hydrochloride tablets are indicated as adjunctive therapy in adults and children 12 years and older in the treatment of partial seizures,1
5307,5307,5307,5307,5307,5307,5307,6433,6433,6433,6433,6433,6433,6433,6433,6433,6433,6433,6433,6433,819f828a-b888-4e46-83fc-94d774a28a83,1  cerdelga is indicated for the long term treatment of adult patients with gaucher disease type 1 ( gd1 ) who are cyp2d6 extensive metabolizers ( ems )  intermediate metabolizers ( ims )  or poor metabolizers ( pms ) as detected by an fda cleared test see dosage and administration ( 2 1 ),1
5308,5308,5308,5308,5308,5308,5308,6434,6434,6434,6434,6434,6434,6434,6434,6434,6434,6434,6434,6434,819f828a-b888-4e46-83fc-94d774a28a83,cerdelga is a glucosylceramide synthase inhibitor indicated for the long term treatment of adult patients with gaucher disease type 1 who are cyp2d6 extensive metabolizers ( ems )  intermediate metabolizers ( ims )  or poor metabolizers ( pms ) as detected by an fda cleared test,1
5309,5309,5309,5309,5309,5309,5309,6435,6435,6435,6435,6435,6435,6435,6435,6435,6435,6435,6435,6435,819f828a-b888-4e46-83fc-94d774a28a83,( 1 ) limitations of use cyp2d6 ultra rapid metabolizers may not achieve adequate concentrations of cerdelga to achieve a therapeutic effect ( 1 ) a specific dosage cannot be recommended for cyp2d6 indeterminate metabolizers ( 1 ) limitations of use patients who are cyp2d6 ultra rapid metabolizers ( urms ) may not achieve adequate concentrations of cerdelga to achieve a therapeutic effect see clinical studies ( 14 ),4
5310,5310,5310,5310,5310,5310,5310,6436,6436,6436,6436,6436,6436,6436,6436,6436,6436,6436,6436,6436,819f828a-b888-4e46-83fc-94d774a28a83,a specific dosage cannot be recommended for those patients whose cyp2d6 genotype cannot be determined ( indeterminate metabolizers ) see clinical studies ( 14 ),4
5311,5311,5311,5311,5311,5311,5311,6437,6437,6437,6437,6437,6437,6437,6437,6437,6437,6437,6437,6437,a8726f90-9329-46ca-9379-2b50c78fe0e2,1  stendra is a phosphodiesterase 5 ( pde5 ) inhibitor indicated for the treatment of erectile dysfunction,1
5312,5312,5312,5312,5312,5312,5312,6438,6438,6438,6438,6438,6438,6438,6438,6438,6438,6438,6438,6438,a8726f90-9329-46ca-9379-2b50c78fe0e2,stendra is a phosphodiesterase 5 ( pde5 ) inhibitor indicated for the treatment of erectile dysfunction ( 1 ),1
5313,5313,5313,5313,5313,5313,5313,6439,6439,6439,6439,6439,6439,6439,6439,6439,6439,6439,6439,6439,3850cce2-6137-42e5-a792-d318c4a4b3b5,1  cabometyx is indicated for the treatment of patients with advanced renal cell carcinoma ( rcc ),1
5314,5314,5314,5314,5314,5314,5314,6440,6440,6440,6440,6440,6440,6440,6440,6440,6440,6440,6440,6440,3850cce2-6137-42e5-a792-d318c4a4b3b5,cabometyx is a kinase inhibitor indicated for the treatment of patients with advanced renal cell carcinoma ( rcc ),1
5315,5315,5315,5315,5315,5315,5315,6441,6441,6441,6441,6441,6441,6441,6441,6441,6441,6441,6441,6441,d6bfbc45-2d34-439e-8aad-59ee2d53d4df,1  lumizyme ( alglucosidase alfa ) see description ( 11 ) is a hydrolytic lysosomal glycogen specific enzyme indicated for patients with pompe disease ( acid glucosidase ( gaa ) deficiency ),1
5316,5316,5316,5316,5316,5316,5316,6442,6442,6442,6442,6442,6442,6442,6442,6442,6442,6442,6442,6442,d6bfbc45-2d34-439e-8aad-59ee2d53d4df,lumizyme ( alglucosidase alfa ) is a hydrolytic lysosomal glycogen specific enzyme indicated for patients with pompe disease ( gaa deficiency ) ( 1 ),1
5317,5317,5317,5317,5317,5317,5317,6443,6443,6443,6443,6443,6443,6443,6443,6443,6443,6443,6443,6443,62035612-9505-3a3f-1ac8-e2dbd711d24e, chemet is indicated for the treatment of lead poisoning in pediatric patients with blood lead levels above 45 mcg dl,1
5318,5318,5318,5318,5318,5318,5318,6444,6444,6444,6444,6444,6444,6444,6444,6444,6444,6444,6444,6444,62035612-9505-3a3f-1ac8-e2dbd711d24e,chemet is not indicated for prophylaxis of lead poisoning in a lead containing environment the use of chemet should always be accompanied by identification and removal of the source of the lead exposure,2
5319,5319,5319,5319,5319,5319,5319,6446,6446,6446,6446,6446,6446,6446,6446,6446,6446,6446,6446,6446,71313a04-1349-4c26-b840-a39e4a3ddaed,1  dysport is an acetylcholine release inhibitor and a neuromuscular blocking agent indicated for the treatment of adults with cervical dystonia ( 1 1 ) the temporary improvement in the appearance of moderate to severe glabellar lines associated with procerus and corrugator muscle activity in adult patients 65 years of age ( 1 2 ) the treatment of spasticity in adults ( 1 3 ) the treatment of lower limb spasticity in pediatric patients 2 years of age and older ( 1 4 ) 1 1 cervical dystonia dysport is indicated for the treatment of adults with cervical dystonia,1
5320,5320,5320,5320,5320,5320,5320,6447,6447,6447,6447,6447,6447,6447,6447,6447,6447,6447,6447,6447,71313a04-1349-4c26-b840-a39e4a3ddaed,1 2 glabellar lines dysport is indicated for the temporary improvement in the appearance of moderate to severe glabellar lines associated with procerus and corrugator muscle activity in adult patients less than 65 years of age,1
5321,5321,5321,5321,5321,5321,5321,6448,6448,6448,6448,6448,6448,6448,6448,6448,6448,6448,6448,6448,71313a04-1349-4c26-b840-a39e4a3ddaed,1 3 spasticity in adults dysport is indicated for the treatment spasticity in adult patients,1
5322,5322,5322,5322,5322,5322,5322,6449,6449,6449,6449,6449,6449,6449,6449,6449,6449,6449,6449,6449,71313a04-1349-4c26-b840-a39e4a3ddaed,1 4 lower limb spasticity in pediatric patients dysport is indicated for the treatment of lower limb spasticity in pediatric patients 2 years of age and older,1
5323,5323,5323,5323,5323,5323,5323,6450,6450,6450,6450,6450,6450,6450,6450,6450,6450,6450,6450,6450,c16ac648-d5d2-9f7d-8637-e2328572754e,1  nulojix is a selective t cell costimulation blocker indicated for prophylaxis of organ rejection in adult patients receiving a kidney transplant,1
5324,5324,5324,5324,5324,5324,5324,6451,6451,6451,6451,6451,6451,6451,6451,6451,6451,6451,6451,6451,c16ac648-d5d2-9f7d-8637-e2328572754e,( 1 1 ) use in combination with basiliximab induction  mycophenolate mofetil  and corticosteroids,/
5325,5325,5325,5325,5325,5325,5325,6452,6452,6452,6452,6452,6452,6452,6452,6452,6452,6452,6452,6452,c16ac648-d5d2-9f7d-8637-e2328572754e,( 1 1 ) limitations of use use only in patients who are ebv seropositive,4
5326,5326,5326,5326,5326,5326,5326,6453,6453,6453,6453,6453,6453,6453,6453,6453,6453,6453,6453,6453,c16ac648-d5d2-9f7d-8637-e2328572754e,( 1 2  4  5 1 ) use has not been established for the prophylaxis of organ rejection in transplanted organs other than the kidney,0
5327,5327,5327,5327,5327,5327,5327,6454,6454,6454,6454,6454,6454,6454,6454,6454,6454,6454,6454,6454,c16ac648-d5d2-9f7d-8637-e2328572754e,( 1 2  5 6 ) 1 1 adult kidney transplant recipients nulojix ( belatacept ) is indicated for prophylaxis of organ rejection in adult patients receiving a kidney transplant,1
5328,5328,5328,5328,5328,5328,5328,6455,6455,6455,6455,6455,6455,6455,6455,6455,6455,6455,6455,6455,c16ac648-d5d2-9f7d-8637-e2328572754e,nulojix is to be used in combination with basiliximab induction  mycophenolate mofetil  and corticosteroids,4
5329,5329,5329,5329,5329,5329,5329,6456,6456,6456,6456,6456,6456,6456,6456,6456,6456,6456,6456,6456,c16ac648-d5d2-9f7d-8637-e2328572754e,1 2 limitations of use use nulojix only in patients who are ebv seropositive see contraindications ( 4 ) and warnings and precautions ( 5 1 ),4
5330,5330,5330,5330,5330,5330,5330,6457,6457,6457,6457,6457,6457,6457,6457,6457,6457,6457,6457,6457,c16ac648-d5d2-9f7d-8637-e2328572754e,use of nulojix for the prophylaxis of organ rejection in transplanted organs other than kidney has not been established see warnings and precautions ( 5 6 ),0
5331,5331,5331,5331,5331,5331,5331,6458,6458,6458,6458,6458,6458,6458,6458,6458,6458,6458,6458,6458,1dac198e-49bb-725b-e054-00144ff8d46c,indication pain  nausea  diarrhea  neuritis  or other indications,1
5332,5332,5332,5332,5332,5332,5332,6459,6459,6459,6459,6459,6459,6459,6459,6459,6459,6459,6459,6459,6494d2d9-0ce4-4126-b1c7-49684395942b,1  aplenzin is an aminoketone antidepressant  indicated for the treatment of major depressive disorder ( mdd ) and seasonal affective disorder ( sad ),1
5333,5333,5333,5333,5333,5333,5333,6460,6460,6460,6460,6460,6460,6460,6460,6460,6460,6460,6460,6460,6494d2d9-0ce4-4126-b1c7-49684395942b,periodically reevaluate long term usefulness for the individual patient,0
5334,5334,5334,5334,5334,5334,5334,6461,6461,6461,6461,6461,6461,6461,6461,6461,6461,6461,6461,6461,6494d2d9-0ce4-4126-b1c7-49684395942b,( 1 ) 1 1 major depressive disorder aplenzin ( bupropion hydrobromide extended release tablets ) is indicated for the treatment of major depressive disorder ( mdd )  as defined by the diagnostic and statistical manual ( dsm ),1
5335,5335,5335,5335,5335,5335,5335,6462,6462,6462,6462,6462,6462,6462,6462,6462,6462,6462,6462,6462,6494d2d9-0ce4-4126-b1c7-49684395942b,the efficacy of the immediate release formulation of bupropion was established in two 4 week controlled inpatient trials and one 6 week controlled outpatient trial of adult patients with mdd,0
5336,5336,5336,5336,5336,5336,5336,6463,6463,6463,6463,6463,6463,6463,6463,6463,6463,6463,6463,6463,6494d2d9-0ce4-4126-b1c7-49684395942b,the efficacy of the sustained release formulation of bupropion in the maintenance treatment of mdd was established in a long term ( up to 44 weeks )  placebo controlled trial in patients who had responded to bupropion in an 8 week study of acute treatment see clinical studies ( 14 1 ),0
5337,5337,5337,5337,5337,5337,5337,6464,6464,6464,6464,6464,6464,6464,6464,6464,6464,6464,6464,6464,6494d2d9-0ce4-4126-b1c7-49684395942b,1 2 seasonal affective disorder aplenzin is indicated for the prevention of seasonal major depressive episodes in patients with a diagnosis of seasonal affective disorder ( sad ),1
5338,5338,5338,5338,5338,5338,5338,6465,6465,6465,6465,6465,6465,6465,6465,6465,6465,6465,6465,6465,6494d2d9-0ce4-4126-b1c7-49684395942b,the efficacy of bupropion hydrochloride extended release tablets in the prevention of seasonal major depressive episodes was established in 3 placebo controlled trials in adult outpatients with a history of mdd with an autumn winter seasonal pattern as defined in the dsm see clinical studies ( 14 2 ),u
5339,5339,5339,5339,5339,5339,5339,6466,6466,6466,6466,6466,6466,6466,6466,6466,6466,6466,6466,6466,e1632619-67ec-4c5b-9670-19c3fe3c583c,1  lisinopril tablets are an angiotensin converting enzyme ( ace ) inhibitor indicated for treatment of hypertension in adults and pediatric patients 6 years of age and older ( 1 1 ) adjunct therapy for heart failure ( 1 2 ) treatment of acute myocardial infarction ( 1 3 ) 1 1 hypertension lisinopril tablets are indicated for the treatment of hypertension in adult patients and pediatric patients 6 years of age and older to lower blood pressure,1
5340,5340,5340,5340,5340,5340,5340,6467,6467,6467,6467,6467,6467,6467,6467,6467,6467,6467,6467,6467,e1632619-67ec-4c5b-9670-19c3fe3c583c,lowering blood pressure lowers the risk of fatal and non fatal cardiovascular events  primarily strokes and myocardial infarctions,0
5341,5341,5341,5341,5341,5341,5341,6468,6468,6468,6468,6468,6468,6468,6468,6468,6468,6468,6468,6468,e1632619-67ec-4c5b-9670-19c3fe3c583c,these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes,0
5342,5342,5342,5342,5342,5342,5342,6476,6476,6476,6476,6476,6476,6476,6476,6476,6476,6476,6476,6476,e1632619-67ec-4c5b-9670-19c3fe3c583c,some antihypertensive drugs have smaller blood pressure effects ( as monotherapy ) in black patients  and many antihypertensive drugs have additional approv,0
5343,5343,5343,5343,5343,5343,5343,6477,6477,6477,6477,6477,6477,6477,6477,6477,6477,6477,6477,6477,15904472-4c32-4224-95d3-eb131a7ff9c8, mercaptopurine tablets are indicated for maintenance therapy of acute lymphatic ( lymphocytic  lymphoblastic ) leukemia as part of a combination regimen,1
5344,5344,5344,5344,5344,5344,5344,6478,6478,6478,6478,6478,6478,6478,6478,6478,6478,6478,6478,6478,15904472-4c32-4224-95d3-eb131a7ff9c8,the response to this agent depends upon the particular subclassification of acute lymphatic leukemia and the age of the patient ( pediatric or adult ),u
5345,5345,5345,5345,5345,5345,5345,6479,6479,6479,6479,6479,6479,6479,6479,6479,6479,6479,6479,6479,15904472-4c32-4224-95d3-eb131a7ff9c8,mercaptopurine tablets are not effective for prophylaxis or treatment of central nervous system leukemia,0
5346,5346,5346,5346,5346,5346,5346,6480,6480,6480,6480,6480,6480,6480,6480,6480,6480,6480,6480,6480,15904472-4c32-4224-95d3-eb131a7ff9c8,mercaptopurine tablets are not effective in acute myelogenous leukemia  chronic lymphatic leukemia  the lymphomas ( including hodgkins disease )  or solid tumors,0
5347,5347,5347,5347,5347,5347,5347,6481,6481,6481,6481,6481,6481,6481,6481,6481,6481,6481,6481,6481,5bb99cd0-a9e6-4df6-a694-a27430c8f996, xylocaine ( lidocaine hcl ) injections are indicated for production of local or regioinal anesthesia by infiltration techniques such as percutaneous injection and intravenous regional anesthesia by peripheral nerve block techniques such as brachial plexus and intercostal and by central neural techniques such as lumbar and caudal epidural blocks  when the accepted procedures for these techniques as described in standard textbooks are observed,1
5348,5348,5348,5348,5348,5348,5348,6482,6482,6482,6482,6482,6482,6482,6482,6482,6482,6482,6482,6482,"Active Ingredient UNII(s)
EC2CNF7XFP; F5UM2KM3W7; PDC6A3C0OX    f51bb899-9186-4654-afe6-e6f89ad8370d
EC2CNF7XFP; F5UM2KM3W7; PDC6A3C0OX    f51bb899-9186-4654-afe6-e6f89ad8370d
EC2CNF7XFP; F5UM2KM3W7; PDC6A3C0OX    f51bb899-9186-4654-afe6-e6f89ad8370d
Name: SET ID dtype: object",active ingredient unii ( s ) ec2cnf7xfp f5um2km3w7 pdc6a3c0ox active ingredient unii ( s ) ec2cnf7xfp f5um2km3 ec2cnf7xfp f5um2km3w7 pdc6a3c0ox active ingredient unii ( s ) ec2cnf7xfp f5um2km3 ec2cnf7xfp f5um2km3w7 pdc6a3c0ox active ingredient unii ( s ) ec2cnf7xfp f5um2km3 name content xml  dtype object,0
5349,5349,5349,5349,5349,5349,5349,6485,6485,6485,6485,6485,6485,6485,6485,6485,6485,6485,6485,6485,"Active Ingredient UNII(s)
EC2CNF7XFP; L7T10EIP3A; QTG126297Q    1fd81eb8-6363-4b92-96e4-339c6f871681
EC2CNF7XFP; L7T10EIP3A; QTG126297Q    1fd81eb8-6363-4b92-96e4-339c6f871681
Name: SET ID dtype: object",active ingredient unii ( s ) ec2cnf7xfp l7t10eip3a qtg126297q active ingredient unii ( s ) ec2cnf7xfp l7t10eip ec2cnf7xfp l7t10eip3a qtg126297q active ingredient unii ( s ) ec2cnf7xfp l7t10eip name content xml  dtype object,0
5350,5350,5350,5350,5350,5350,5350,6487,6487,6487,6487,6487,6487,6487,6487,6487,6487,6487,6487,6487,7dff29d9-522d-40eb-a9d9-42377912d640, lidocaine hydrochloride administered intravenously is specifically indicated in the acute management of ( 1 ) ventricular arrhythmias occurring during cardiac manipulations  such as cardiac surgery and ( 2 ) life threatening arrhythmias which are ventricular in origin  such as occur during acute myocardial infarction,1
5351,5351,5351,5351,5351,5351,5351,6488,6488,6488,6488,6488,6488,6488,6488,6488,6488,6488,6488,6488,"Active Ingredient UNII(s)
EC2CNF7XFP; PDC6A3C0OX    f6439264-2bb1-4eb7-8b9e-337a487c6c8e
EC2CNF7XFP; PDC6A3C0OX    f6439264-2bb1-4eb7-8b9e-337a487c6c8e
Name: SET ID dtype: object",active ingredient unii ( s ) ec2cnf7xfp pdc6a3c0ox active ingredient unii ( s ) ec2cnf7xfp pdc6a3c0 ec2cnf7xfp pdc6a3c0ox active ingredient unii ( s ) ec2cnf7xfp pdc6a3c0 name content xml  dtype object,0
5352,5352,5352,5352,5352,5352,5352,6490,6490,6490,6490,6490,6490,6490,6490,6490,6490,6490,6490,6490,195030df-bf46-49f7-9fc0-1351100a7d41, lidocaine hydrochloride injection  usp is indicated for production of local or regional anesthesia by infiltration techniques such as percutaneous injection and intravenous regional anesthesia by peripheral nerve block techniques such as brachial plexus and intercostal and by central neural techniques such as lumbar and caudal epidural blocks  when the accepted procedures for these techniques as described in standard textbooks are observed,1
5353,5353,5353,5353,5353,5353,5353,6491,6491,6491,6491,6491,6491,6491,6491,6491,6491,6491,6491,6491,51d90ac3-ff37-4c56-b996-cfbffbbe713a, lidocaine hydrochloride and epinephrine injection  usp is indicated for production of local or regional anesthesia by infiltration techniques such as percutaneous injection  by peripheral nerve block techniques such as brachial plexus and intercostal and by central neural techniques such as lumbar and caudal epidural blocks  when the accepted procedures for these techniques as described in standard textbooks are observed,1
5354,5354,5354,5354,5354,5354,5354,6492,6492,6492,6492,6492,6492,6492,6492,6492,6492,6492,6492,6492,163dfa7c-aad3-4290-9fe9-d9592b0ba317,1  levalbuterol inhalation solution  usp is indicated for the treatment or prevention of bronchospasm in adults  adolescents  and children 6 years of age and older with reversible obstructive airway disease,1
5355,5355,5355,5355,5355,5355,5355,6493,6493,6493,6493,6493,6493,6493,6493,6493,6493,6493,6493,6493,163dfa7c-aad3-4290-9fe9-d9592b0ba317,levalbuterol inhalation solution  usp is a beta2 adrenergic agonist indicated for treatment or prevention of bronchospasm in adults  adolescents  and children 6 years of age and older with reversible obstructive airway disease,1
5356,5356,5356,5356,5356,5356,5356,6494,6494,6494,6494,6494,6494,6494,6494,6494,6494,6494,6494,6494,f4bedd21-efde-44c6-9d9c-b48b78d7ed1e,1  lenvima is a kinase inhibitor that is indicated for differentiated thyroid cancer ( dtc ) single agent for patients with locally recurrent or metastatic  progressive  radioactive iodine refractory dtc,1
5357,5357,5357,5357,5357,5357,5357,6495,6495,6495,6495,6495,6495,6495,6495,6495,6495,6495,6495,6495,f4bedd21-efde-44c6-9d9c-b48b78d7ed1e,( 1 1 ) renal cell cancer ( rcc ) in combination with everolimus  for patients with advanced rcc following one prior anti angiogenic therapy,1
5358,5358,5358,5358,5358,5358,5358,6496,6496,6496,6496,6496,6496,6496,6496,6496,6496,6496,6496,6496,f4bedd21-efde-44c6-9d9c-b48b78d7ed1e,( 1 2 ) 1 1 differentiated thyroid cancer lenvima is indicated for the treatment of patients with locally recurrent or metastatic  progressive  radioactive iodine refractory dtc,1
5359,5359,5359,5359,5359,5359,5359,6497,6497,6497,6497,6497,6497,6497,6497,6497,6497,6497,6497,6497,f4bedd21-efde-44c6-9d9c-b48b78d7ed1e,1 2 renal cell carcinoma lenvima is indicated in combination with everolimus for the treatment of patients with advanced rcc following one prior anti angiogenic therapy,1
5360,5360,5360,5360,5360,5360,5360,6498,6498,6498,6498,6498,6498,6498,6498,6498,6498,6498,6498,6498,7485b87a-5621-4744-9b64-757730f7f449,1  urocit k is a citrate salt of potassium indicated for the management of renal tubular acidosis ( rta ) with calcium stones ( 1 1 ) hypocitraturic calcium oxalate nephrolithiasis of any etiology ( 1 2 ) uric acid lithiasis with or without calcium stones ( 1 3 ) 1 1 renal tubular acidosis ( rta ) with calcium stones potassium citrate is indicated for the management of renal tubular acidosis see clinical studies ( 14 1 ),1
5361,5361,5361,5361,5361,5361,5361,6499,6499,6499,6499,6499,6499,6499,6499,6499,6499,6499,6499,6499,7485b87a-5621-4744-9b64-757730f7f449,1 2 hypocitraturic calcium oxalate nephrolithiasis of any etiology potassium citrate is indicated for the management of hypocitraturic calcium oxalate nephrolithiasis see clinical studies ( 14 2 ),1
5362,5362,5362,5362,5362,5362,5362,6500,6500,6500,6500,6500,6500,6500,6500,6500,6500,6500,6500,6500,7485b87a-5621-4744-9b64-757730f7f449,1 3 uric acid lithiasis with or without calcium stones potassium citrate is indicated for the management of uric acid lithiasis with or without calcium stones see clinical studies ( 14 3 ),1
5363,5363,5363,5363,5363,5363,5363,6501,6501,6501,6501,6501,6501,6501,6501,6501,6501,6501,6501,6501,a3768c7e-aa4c-44d3-bc53-43bb7346c0b0,1  nesina is a dipeptidyl peptidase 4 ( dpp 4 ) inhibitor indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus,1
5364,5364,5364,5364,5364,5364,5364,6502,6502,6502,6502,6502,6502,6502,6502,6502,6502,6502,6502,6502,a3768c7e-aa4c-44d3-bc53-43bb7346c0b0,( 1 1  14 ) important limitations of use not for treatment of type 1 diabetes or diabetic ketoacidosis,2
5365,5365,5365,5365,5365,5365,5365,6503,6503,6503,6503,6503,6503,6503,6503,6503,6503,6503,6503,6503,a3768c7e-aa4c-44d3-bc53-43bb7346c0b0,( 1 1 ) 1 1 monotherapy and combination therapy nesina is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus see clinical studies ( 14 ),1
5366,5366,5366,5366,5366,5366,5366,6504,6504,6504,6504,6504,6504,6504,6504,6504,6504,6504,6504,6504,a3768c7e-aa4c-44d3-bc53-43bb7346c0b0,important limitations of use nesina is not indicated for the treatment of type 1 diabetes mellitus or diabetic ketoacidosis  as it would not be effective in these settings,2
5367,5367,5367,5367,5367,5367,5367,6505,6505,6505,6505,6505,6505,6505,6505,6505,6505,6505,6505,6505,4c619ed9-fe3e-4158-9938-80c6c3493d55,1  oseni is a dipeptidyl peptidase 4 inhibitor and thiazolidinedione combination product indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus,1
5368,5368,5368,5368,5368,5368,5368,6507,6507,6507,6507,6507,6507,6507,6507,6507,6507,6507,6507,6507,4c619ed9-fe3e-4158-9938-80c6c3493d55,( 1 1 ) 1 1 monotherapy and combination therapy oseni is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both alogliptin and pioglitazone is appropriate see clinical studies ( 14 ),1
5369,5369,5369,5369,5369,5369,5369,6508,6508,6508,6508,6508,6508,6508,6508,6508,6508,6508,6508,6508,4c619ed9-fe3e-4158-9938-80c6c3493d55,important limitations of use oseni is not indicated for the treatment of type 1 diabetes mellitus or diabetic ketoacidosis  as it would not be effective in these settings,2
5370,5370,5370,5370,5370,5370,5370,6509,6509,6509,6509,6509,6509,6509,6509,6509,6509,6509,6509,6509,abc92ef1-f9c3-4eac-a273-9b8705b36c29, anacidity ( diagnosis ) pentagastrin is indicated as a diagnostic aid for evaluation of gastric acid secretory function,1
5371,5371,5371,5371,5371,5371,5371,6510,6510,6510,6510,6510,6510,6510,6510,6510,6510,6510,6510,6510,abc92ef1-f9c3-4eac-a273-9b8705b36c29,it is effective in testing for anacidity ( achlorhydria ) in patients with suspected pernicious anemia  atrophic gastritis  or gastric carcinoma,u
5372,5372,5372,5372,5372,5372,5372,6511,6511,6511,6511,6511,6511,6511,6511,6511,6511,6511,6511,6511,abc92ef1-f9c3-4eac-a273-9b8705b36c29,it is also effective in determining the reduction in acid output after operations for peptic ulcer  such as vagotomy or gastric resection,u
5373,5373,5373,5373,5373,5373,5373,6512,6512,6512,6512,6512,6512,6512,6512,6512,6512,6512,6512,6512,abc92ef1-f9c3-4eac-a273-9b8705b36c29,hypersecretory conditions  gastric ( diagnosis ) pentagastrin is indicated as a diagnostic aid in testing for gastric hypersecretion in patients with suspected duodenal ulcer or postoperative stomal ulcer  and for the diagnosis of zollinger ellison tumor,1
5374,5374,5374,5374,5374,5374,5374,6513,6513,6513,6513,6513,6513,6513,6513,6513,6513,6513,6513,6513,27b3cf26-f22e-5b70-1c24-009933b7c6ee, severe recalcitrant nodular acne zenatane is indicated for the treatment of severe recalcitrant nodular acne,1
5375,5375,5375,5375,5375,5375,5375,6514,6514,6514,6514,6514,6514,6514,6514,6514,6514,6514,6514,6514,27b3cf26-f22e-5b70-1c24-009933b7c6ee,nodules are inflammatory lesions with a diameter of 5 mm or greater,0
5376,5376,5376,5376,5376,5376,5376,6515,6515,6515,6515,6515,6515,6515,6515,6515,6515,6515,6515,6515,27b3cf26-f22e-5b70-1c24-009933b7c6ee,the nodules may become suppurative or hemorrhagic,0
5377,5377,5377,5377,5377,5377,5377,6516,6516,6516,6516,6516,6516,6516,6516,6516,6516,6516,6516,6516,27b3cf26-f22e-5b70-1c24-009933b7c6ee,severe  by definition  2 means many as opposed to few or several nodules,0
5378,5378,5378,5378,5378,5378,5378,6517,6517,6517,6517,6517,6517,6517,6517,6517,6517,6517,6517,6517,27b3cf26-f22e-5b70-1c24-009933b7c6ee,because of significant adverse effects associated with its use  zenatane should be reserved for patients with severe nodular acne who are unresponsive to conventional therapy  including systemic antibiotics,u
5379,5379,5379,5379,5379,5379,5379,6518,6518,6518,6518,6518,6518,6518,6518,6518,6518,6518,6518,6518,27b3cf26-f22e-5b70-1c24-009933b7c6ee,in addition  zenatane is indicated only for those female patients who are not pregnant  because zenatane can cause severe birth defects ( see boxed contraindications and warnings ),u
5380,5380,5380,5380,5380,5380,5380,6519,6519,6519,6519,6519,6519,6519,6519,6519,6519,6519,6519,6519,27b3cf26-f22e-5b70-1c24-009933b7c6ee,a single course of therapy for 15 to 20 weeks has been shown to result in complete and prolonged remission of disease in many patients 1  3  4 if a second course of therapy is needed  it should not be initiated until at least 8 weeks after completion of the first course  because experience has shown that patients may continue to improve while off zenatane,0
5381,5381,5381,5381,5381,5381,5381,6520,6520,6520,6520,6520,6520,6520,6520,6520,6520,6520,6520,6520,27b3cf26-f22e-5b70-1c24-009933b7c6ee,the optimal interval before retreatment has not been defined for patients who have not completed skeletal growth ( see warnings skeletal bone mineral density  hyperostosis  and premature epiphyseal closure ),0
5382,5382,5382,5382,5382,5382,5382,6521,6521,6521,6521,6521,6521,6521,6521,6521,6521,6521,6521,6521,f7b4e985-719a-4547-b624-94612d520991,clinical studies in one 12 week multicenter  randomized  evaluator blind  vehicle controlled  parallel comparison clinical trial in which patients used clindagel ( clindamycin phosphate topical gel  1 ) once daily or the vehicle gel once daily  in the treatment of acne vulgaris of mild to moderate severity  clindagel applied once daily was more effective than the vehicle applied once daily,0
5383,5383,5383,5383,5383,5383,5383,6522,6522,6522,6522,6522,6522,6522,6522,6522,6522,6522,6522,6522,f7b4e985-719a-4547-b624-94612d520991,the mean percent reductions in lesion counts at the end of treatment in this study are shown in the following table lesions clindagel qd n 162 vehicle gel qd n 82 inflammatory 51 40 p 0 05 noninflammatory 25 12 total 38 27 there was a trend in the investigator 's global assessment of the results  which favored clindagel qd over the vehicle qd,0
5384,5384,5384,5384,5384,5384,5384,6523,6523,6523,6523,6523,6523,6523,6523,6523,6523,6523,6523,6523,f7b4e985-719a-4547-b624-94612d520991,in a contact sensitization study  four of the 200 subjects appeared to develop suggestive evidence of allergic contact sensitization to clindagel,0
5385,5385,5385,5385,5385,5385,5385,6524,6524,6524,6524,6524,6524,6524,6524,6524,6524,6524,6524,6524,f7b4e985-719a-4547-b624-94612d520991,there was no signal for contact sensitization in the clinical trials under normal use conditions,0
5386,5386,5386,5386,5386,5386,5386,6525,6525,6525,6525,6525,6525,6525,6525,6525,6525,6525,6525,6525,58a02e8b-93af-45b4-b243-602adbf61699,1  toviaz is a muscarinic antagonist indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence  urgency  and frequency,1
5387,5387,5387,5387,5387,5387,5387,6526,6526,6526,6526,6526,6526,6526,6526,6526,6526,6526,6526,6526,58a02e8b-93af-45b4-b243-602adbf61699,toviaz is a muscarinic antagonist indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence  urgency  and frequency,1
5388,5388,5388,5388,5388,5388,5388,6527,6527,6527,6527,6527,6527,6527,6527,6527,6527,6527,6527,6527,85130606-e6a4-cf08-4bac-a460a30b0984,1  technivie is indicated in combination with ribavirin for the treatment of patients with genotype 4 chronic hepatitis c virus ( hcv ) infection without cirrhosis or with compensated cirrhosis see clinical studies ( 14 ),1
5389,5389,5389,5389,5389,5389,5389,6528,6528,6528,6528,6528,6528,6528,6528,6528,6528,6528,6528,6528,85130606-e6a4-cf08-4bac-a460a30b0984,technivie is a fixed dose combination of ombitasvir  a hepatitis c virus ns5a inhibitor  paritaprevir  a hepatitis c virus ns3 4a protease inhibitor  and ritonavir  a cyp3a inhibitor and is indicated in combination with ribavirin for the treatment of patients with genotype 4 chronic hepatitis c virus ( hcv ) infection without cirrhosis or with compensated cirrhosis,1
5390,5390,5390,5390,5390,5390,5390,6529,6529,6529,6529,6529,6529,6529,6529,6529,6529,6529,6529,6529,ab74e474-9fd6-902c-9bd9-16dc9541edd0,1  viekira pak is indicated for the treatment of adult patients with chronic hepatitis c virus ( hcv ) see dosage and administration ( 2 2 ) and clinical studies ( 14 ) genotype 1b without cirrhosis or with compensated cirrhosis genotype 1a without cirrhosis or with compensated cirrhosis for use in combination with ribavirin,1
5391,5391,5391,5391,5391,5391,5391,6530,6530,6530,6530,6530,6530,6530,6530,6530,6530,6530,6530,6530,ab74e474-9fd6-902c-9bd9-16dc9541edd0,viekira pak is indicated for the treatment of adult patients with chronic hepatitis c virus ( hcv ) genotype 1b without cirrhosis or with compensated cirrhosis genotype 1a without cirrhosis or with compensated cirrhosis for use in combination with ribavirin,1
5392,5392,5392,5392,5392,5392,5392,6531,6531,6531,6531,6531,6531,6531,6531,6531,6531,6531,6531,6531,ab74e474-9fd6-902c-9bd9-16dc9541edd0,viekira pak includes ombitasvir  a hepatitis c virus ns5a inhibitor  paritaprevir  a hepatitis c virus ns3 4a protease inhibitor  ritonavir  a cyp3a inhibitor and dasabuvir  a hepatitis c virus non nucleoside ns5b palm polymerase inhibitor,0
5393,5393,5393,5393,5393,5393,5393,6532,6532,6532,6532,6532,6532,6532,6532,6532,6532,6532,6532,6532,a9314bc0-fd5d-477b-bef5-3bee532774c0,1  carvedilol phosphate extended release capsules are an alpha beta adrenergic blocking agent indicated for the treatment of hypertension ( 1 3 ) 1 3 hypertension carvedilol phosphate extended release capsules are indicated for the management of essential hypertension see clinical studies ( 14 3  14 4 ),1
5394,5394,5394,5394,5394,5394,5394,6534,6534,6534,6534,6534,6534,6534,6534,6534,6534,6534,6534,6534,5171d883-fe8f-482c-97ab-40b00975b64a,1  bridion is indicated for the reversal of neuromuscular blockade induced by rocuronium bromide and vecuronium bromide in adults undergoing surgery,1
5395,5395,5395,5395,5395,5395,5395,6535,6535,6535,6535,6535,6535,6535,6535,6535,6535,6535,6535,6535,5171d883-fe8f-482c-97ab-40b00975b64a,bridion is indicated for the reversal of neuromuscular blockade induced by rocuronium bromide and vecuronium bromide in adults undergoing surgery,1
5396,5396,5396,5396,5396,5396,5396,6536,6536,6536,6536,6536,6536,6536,6536,6536,6536,6536,6536,6536,2fe8d7ad-2158-4169-94b0-719ad20242b7, alocril ophthalmic solution is indicated for the treatment of itching associated with allergic conjunctivitis,1
5397,5397,5397,5397,5397,5397,5397,6542,6542,6542,6542,6542,6542,6542,6542,6542,6542,6542,6542,6542,1c85221a-6604-47b9-925c-b5a6e7e74883, indapamide tablets are indicated for the treatment of hypertension  alone or in combination with other antihypertensive drugs,1
5398,5398,5398,5398,5398,5398,5398,6543,6543,6543,6543,6543,6543,6543,6543,6543,6543,6543,6543,6543,1c85221a-6604-47b9-925c-b5a6e7e74883,indapamide tablets are also indicated for the treatment of salt and fluid retention associated with congestive heart failure,1
5399,5399,5399,5399,5399,5399,5399,6544,6544,6544,6544,6544,6544,6544,6544,6544,6544,6544,6544,6544,1c85221a-6604-47b9-925c-b5a6e7e74883,usage in pregnancy the routine use of diuretics in an otherwise healthy woman is inappropriate and exposes mother and fetus to unnecessary hazard ( see precautions ),0
5400,5400,5400,5400,5400,5400,5400,6547,6547,6547,6547,6547,6547,6547,6547,6547,6547,6547,6547,6547,1c85221a-6604-47b9-925c-b5a6e7e74883,indapamide is indicated in pregnancy when edema is due to pathologic causes  just as it is in the absence of pregnancy ( however  see precautions ),1
5401,5401,5401,5401,5401,5401,5401,6549,6549,6549,6549,6549,6549,6549,6549,6549,6549,6549,6549,6549,1c85221a-6604-47b9-925c-b5a6e7e74883,there is hypervolemia during normal pregnancy which is not harmful to either the fetus or the mother ( in the absence of cardiovascular disease )  but which is associated with edema  including generalized edema in the majority of pregnant women,0
5402,5402,5402,5402,5402,5402,5402,6553,6553,6553,6553,6553,6553,6553,6553,6553,6553,6553,6553,6553,5fa97bf5-28a2-48f1-8955-f56012d296be,1  revlimid is a thalidomide analogue indicated for the treatment of patients with multiple myeloma ( mm )  in combination with dexamethasone ( 1 1 ),1
5403,5403,5403,5403,5403,5403,5403,6554,6554,6554,6554,6554,6554,6554,6554,6554,6554,6554,6554,6554,5fa97bf5-28a2-48f1-8955-f56012d296be,mm  as maintenance following autologous hematopoietic stem cell transplantation ( auto hsct ) ( 1 1 ),1
5404,5404,5404,5404,5404,5404,5404,6555,6555,6555,6555,6555,6555,6555,6555,6555,6555,6555,6555,6555,5fa97bf5-28a2-48f1-8955-f56012d296be,transfusion dependent anemia due to low or intermediate 1 risk myelodysplastic syndromes ( mds ) associated with a deletion 5q abnormality with or without additional cytogenetic abnormalities ( 1 2 ),1
5405,5405,5405,5405,5405,5405,5405,6556,6556,6556,6556,6556,6556,6556,6556,6556,6556,6556,6556,6556,5fa97bf5-28a2-48f1-8955-f56012d296be,mantle cell lymphoma ( mcl ) whose disease has relapsed or progressed after two prior therapies  one of which included bortezomib ( 1 3 ),1
5406,5406,5406,5406,5406,5406,5406,6557,6557,6557,6557,6557,6557,6557,6557,6557,6557,6557,6557,6557,5fa97bf5-28a2-48f1-8955-f56012d296be,limitations of use revlimid is not indicated and is not recommended for the treatment of patients with chronic lymphocytic leukemia ( cll ) outside of controlled clinical trials ( 1 4 ),0
5407,5407,5407,5407,5407,5407,5407,6558,6558,6558,6558,6558,6558,6558,6558,6558,6558,6558,6558,6558,5fa97bf5-28a2-48f1-8955-f56012d296be,1 1 multiple myeloma revlimid in combination with dexamethasone is indicated for the treatment of patients with multiple myeloma ( mm ),1
5408,5408,5408,5408,5408,5408,5408,6559,6559,6559,6559,6559,6559,6559,6559,6559,6559,6559,6559,6559,5fa97bf5-28a2-48f1-8955-f56012d296be,revlimid is indicated as maintenance therapy in patients with mm following autologous hematopoietic stem cell transplantation ( auto hsct ),1
5409,5409,5409,5409,5409,5409,5409,6560,6560,6560,6560,6560,6560,6560,6560,6560,6560,6560,6560,6560,5fa97bf5-28a2-48f1-8955-f56012d296be,1 2 myelodysplastic syndromes revlimid is indicated for the treatment of patients with transfusion dependent anemia due to low or intermediate 1 risk myelodysplastic syndromes ( mds ) associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormalities,1
5410,5410,5410,5410,5410,5410,5410,6561,6561,6561,6561,6561,6561,6561,6561,6561,6561,6561,6561,6561,5fa97bf5-28a2-48f1-8955-f56012d296be,1 3 mantle cell lymphoma revlimid is indicated for the treatment of patients with mantle cell lymphoma ( mcl ) whose disease has relapsed or progressed after two prior therapies  one of which included bortezomib,1
5411,5411,5411,5411,5411,5411,5411,6562,6562,6562,6562,6562,6562,6562,6562,6562,6562,6562,6562,6562,ee95aa18-9f2f-40eb-9b4c-583bea6f36bf,1  cardiogen 82 is a closed system used to produce rubidium rb 82 chloride injection for intravenous administration,1
5412,5412,5412,5412,5412,5412,5412,6563,6563,6563,6563,6563,6563,6563,6563,6563,6563,6563,6563,6563,ee95aa18-9f2f-40eb-9b4c-583bea6f36bf,rubidium rb 82 chloride injection is indicated for positron emission tomography ( pet ) imaging of the myocardium under rest or pharmacologic stress conditions to evaluate regional myocardial perfusion in adult patients with suspected or existing coronary artery disease,1
5413,5413,5413,5413,5413,5413,5413,6564,6564,6564,6564,6564,6564,6564,6564,6564,6564,6564,6564,6564,ee95aa18-9f2f-40eb-9b4c-583bea6f36bf,cardiogen 82 is a closed system used to produce rubidium rb 82 chloride injection for intravenous use,u
5414,5414,5414,5414,5414,5414,5414,6565,6565,6565,6565,6565,6565,6565,6565,6565,6565,6565,6565,6565,ee95aa18-9f2f-40eb-9b4c-583bea6f36bf,rubidium rb 82 chloride injection is a radioactive diagnostic agent indicated for positron emission tomography ( pet ) imaging of the myocardium under rest or pharmacologic stress conditions to evaluate regional myocardial perfusion in adult patients with suspected or existing coronary artery disease,1
5415,5415,5415,5415,5415,5415,5415,6566,6566,6566,6566,6566,6566,6566,6566,6566,6566,6566,6566,6566,e7953a64-3fa6-464c-bbce-8fc7efeebb91, hyoscyamine sulfate is indicated whenever antispasmodic or anticholinergic therapy is desired,1
5416,5416,5416,5416,5416,5416,5416,6567,6567,6567,6567,6567,6567,6567,6567,6567,6567,6567,6567,6567,e7953a64-3fa6-464c-bbce-8fc7efeebb91,the high degree of purity allows effective action at very low dosage  with a minimal incidence of unwanted side effects,0
5417,5417,5417,5417,5417,5417,5417,6568,6568,6568,6568,6568,6568,6568,6568,6568,6568,6568,6568,6568,3235535d-9ef9-4657-8b2a-176a807d091c,1  apokyn ( apomorphine hydrochloride injection ) is indicated for the acute  intermittent treatment of hypomobility  off episodes ( end of dose wearing off and unpredictable on off episodes ) in patients with advanced parkinson 's disease,1
5418,5418,5418,5418,5418,5418,5418,6569,6569,6569,6569,6569,6569,6569,6569,6569,6569,6569,6569,6569,3235535d-9ef9-4657-8b2a-176a807d091c,apokyn has been studied as an adjunct to other medications see clinical studies ( 14 ),0
5419,5419,5419,5419,5419,5419,5419,6570,6570,6570,6570,6570,6570,6570,6570,6570,6570,6570,6570,6570,3235535d-9ef9-4657-8b2a-176a807d091c,apokyn is a non ergoline dopamine agonist indicated for the acute  intermittent treatment of hypomobility  off episodes ( end of dose wearing off and unpredictable on off episodes ) associated with advanced parkinson 's disease ( 1 ),1
5420,5420,5420,5420,5420,5420,5420,6571,6571,6571,6571,6571,6571,6571,6571,6571,6571,6571,6571,6571,6093952a-5248-45cb-ad17-33716a411146,1  tasigna is a kinase inhibitor indicated for the treatment of adult and pediatric patients greater than or equal to 1 year of age with newly diagnosed philadelphia chromosome positive chronic myeloid leukemia ( ph cml ) in chronic phase,1
5421,5421,5421,5421,5421,5421,5421,6572,6572,6572,6572,6572,6572,6572,6572,6572,6572,6572,6572,6572,6093952a-5248-45cb-ad17-33716a411146,( 1 1 ) adult patients with chronic phase ( cp ) and accelerated phase ( ap ) ph cml resistant to or intolerant to prior therapy that included imatinib,0
5422,5422,5422,5422,5422,5422,5422,6573,6573,6573,6573,6573,6573,6573,6573,6573,6573,6573,6573,6573,6093952a-5248-45cb-ad17-33716a411146,( 1 2 ) pediatric patients greater than or equal to 1 year of age with ph cml cp resistant or intolerant to prior tyrosine kinase inhibitor ( tki ) therapy,0
5423,5423,5423,5423,5423,5423,5423,6574,6574,6574,6574,6574,6574,6574,6574,6574,6574,6574,6574,6574,6093952a-5248-45cb-ad17-33716a411146,( 1 3 ) 1 1 adult and pediatric patients with newly diagnosed ph cml cp tasigna ( nilotinib ) is indicated for the treatment of adult and pediatric patients greater than or equal to 1 year of age with newly diagnosed philadelphia chromosome positive chronic myeloid leukemia ( ph cml ) in chronic phase,1
5424,5424,5424,5424,5424,5424,5424,6575,6575,6575,6575,6575,6575,6575,6575,6575,6575,6575,6575,6575,6093952a-5248-45cb-ad17-33716a411146,1 2 adult patients with resistant or intolerant ph cml cp and cml ap tasigna is indicated for the treatment of adult patients with chronic phase and accelerated phase philadelphia chromosome positive chronic myelogenous leukemia ( ph cml ) resistant or intolerant to prior therapy that included imatinib,1
5425,5425,5425,5425,5425,5425,5425,6576,6576,6576,6576,6576,6576,6576,6576,6576,6576,6576,6576,6576,6093952a-5248-45cb-ad17-33716a411146,1 3 pediatric patients with resistant or intolerant ph cml cp tasigna is indicated for the treatment of pediatric patients greater than or equal to 1 year of age with chronic phase philadelphia chromosome positive chronic myeloid leukemia ( ph cml ) with resistance or intolerance to prior tyrosine kinase inhibitor ( tki ) therapy,1
5426,5426,5426,5426,5426,5426,5426,6577,6577,6577,6577,6577,6577,6577,6577,6577,6577,6577,6577,6577,68fc4863-595a-48f2-809b-98425d9607f4, intramuscular where oral therapy is not feasible  injectable corticosteroid therapy  including kenalog 40 injection ( triamcinolone acetonide injectable suspension  usp ) is indicated for intramuscular use as follows allergic states control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in asthma  atopic dermatitis  contact dermatitis  drug hypersensitivity reactions  perennial or seasonal allergic rhinitis  serum sickness  transfusion reactions,1
5427,5427,5427,5427,5427,5427,5427,6581,6581,6581,6581,6581,6581,6581,6581,6581,6581,6581,6581,6581,68fc4863-595a-48f2-809b-98425d9607f4,hematologic disorders acquired ( autoimmune ) hemolytic anemia  diamond blackfan anemia  pure red cell aplasia  selected cases of secondary thrombocytopenia,1
5428,5428,5428,5428,5428,5428,5428,6582,6582,6582,6582,6582,6582,6582,6582,6582,6582,6582,6582,6582,68fc4863-595a-48f2-809b-98425d9607f4,miscellaneous trichinosis with neurologic or myocardial involvement  tuberculous meningitis with subarachnoid block or impending block when used with appropriate antituberculous chemotherapy,1
5429,5429,5429,5429,5429,5429,5429,6583,6583,6583,6583,6583,6583,6583,6583,6583,6583,6583,6583,6583,68fc4863-595a-48f2-809b-98425d9607f4,neoplastic diseases for the palliative management of leukemias and lymphomas,1
5430,5430,5430,5430,5430,5430,5430,6585,6585,6585,6585,6585,6585,6585,6585,6585,6585,6585,6585,6585,68fc4863-595a-48f2-809b-98425d9607f4,ophthalmic diseases sympathetic ophthalmia  temporal arteritis  uveitis  and ocular inflammatory conditions unresponsive to topical corticosteroids,1
5431,5431,5431,5431,5431,5431,5431,6586,6586,6586,6586,6586,6586,6586,6586,6586,6586,6586,6586,6586,68fc4863-595a-48f2-809b-98425d9607f4,renal diseases to induce diuresis or remission of proteinuria in idiopathic nephrotic syndrome or that due to lupus erythematosus,1
5432,5432,5432,5432,5432,5432,5432,6588,6588,6588,6588,6588,6588,6588,6588,6588,6588,6588,6588,6588,84b2e16e-f0d1-4757-8da8-79dfa83aab79,1  beleodaq is indicated for the treatment of patients with relapsed or refractory peripheral t cell lymphoma ( ptcl ),1
5433,5433,5433,5433,5433,5433,5433,6589,6589,6589,6589,6589,6589,6589,6589,6589,6589,6589,6589,6589,84b2e16e-f0d1-4757-8da8-79dfa83aab79,this indication is approved under accelerated approval based on tumor response rate and duration of response see clinical studies ( 14 ),0
5434,5434,5434,5434,5434,5434,5434,6591,6591,6591,6591,6591,6591,6591,6591,6591,6591,6591,6591,6591,84b2e16e-f0d1-4757-8da8-79dfa83aab79,continued approval for this indication may be contingent upon verification and description of clinical benefit in the confirmatory trial,0
5435,5435,5435,5435,5435,5435,5435,6592,6592,6592,6592,6592,6592,6592,6592,6592,6592,6592,6592,6592,84b2e16e-f0d1-4757-8da8-79dfa83aab79,beleodaq is a histone deacetylase inhibitor indicated for the treatment of patients with relapsed or refractory peripheral t cell lymphoma ( ptcl ),1
5436,5436,5436,5436,5436,5436,5436,6596,6596,6596,6596,6596,6596,6596,6596,6596,6596,6596,6596,6596,a295fc1e-d82c-4f44-bc2d-a552bf594c98,1  caverject is a prostaglandin e1 agonist indicated for the treatment of erectile dysfunction ( 1 1 ),1
5437,5437,5437,5437,5437,5437,5437,6597,6597,6597,6597,6597,6597,6597,6597,6597,6597,6597,6597,6597,a295fc1e-d82c-4f44-bc2d-a552bf594c98,as an adjunct to other diagnostic tests in the diagnosis of erectile dysfunction ( 1 2 ),1
5438,5438,5438,5438,5438,5438,5438,6598,6598,6598,6598,6598,6598,6598,6598,6598,6598,6598,6598,6598,a295fc1e-d82c-4f44-bc2d-a552bf594c98,1 1 erectile dysfunction caverject is indicated for the treatment of erectile dysfunction,1
5439,5439,5439,5439,5439,5439,5439,6599,6599,6599,6599,6599,6599,6599,6599,6599,6599,6599,6599,6599,a295fc1e-d82c-4f44-bc2d-a552bf594c98,1 2 diagnostic testing for erectile dysfunction caverject is indicated as an adjunct to other diagnostic tests in the diagnosis of erectile dysfunction,1
5440,5440,5440,5440,5440,5440,5440,6600,6600,6600,6600,6600,6600,6600,6600,6600,6600,6600,6600,6600,dddcd321-4d2e-4643-bf3c-7b752b33ba39,1  risedronate sodium tablets are a bisphosphonate indicated for treatment and prevention of postmenopausal osteoporosis ( 1 1 ) treatment to increase bone mass in men with osteoporosis ( 1 2 ) treatment and prevention of glucocorticoid induced osteoporosis ( 1 3 ) treatment of paget s disease ( 1 4 ) limitations of use optimal duration of use has not been determined,1
5441,5441,5441,5441,5441,5441,5441,6602,6602,6602,6602,6602,6602,6602,6602,6602,6602,6602,6602,6602,dddcd321-4d2e-4643-bf3c-7b752b33ba39,( 1 5 ) 1 1 postmenopausal osteoporosis risedronate sodium tablets are indicated for the treatment and prevention of osteoporosis in postmenopausal women,1
5442,5442,5442,5442,5442,5442,5442,6603,6603,6603,6603,6603,6603,6603,6603,6603,6603,6603,6603,6603,dddcd321-4d2e-4643-bf3c-7b752b33ba39,in postmenopausal women with osteoporosis  risedronate sodium tablets reduce the incidence of vertebral fractures and a composite endpoint of nonvertebral osteoporosis related fractures see clinical studies ( 14 1  14 2 ),u
5443,5443,5443,5443,5443,5443,5443,6604,6604,6604,6604,6604,6604,6604,6604,6604,6604,6604,6604,6604,dddcd321-4d2e-4643-bf3c-7b752b33ba39,1 2 osteoporosis in men risedronate sodium tablets are indicated for treatment to increase bone mass in men with osteoporosis,1
5444,5444,5444,5444,5444,5444,5444,6605,6605,6605,6605,6605,6605,6605,6605,6605,6605,6605,6605,6605,dddcd321-4d2e-4643-bf3c-7b752b33ba39,1 3 glucocorticoid induced osteoporosis risedronate sodium tablets are indicated for the treatment and prevention of glucocorticoid induced osteoporosis in men and women who are either initiating or continuing systemic glucocorticoid treatment ( daily dosage of greater than or equal to 7 5 mg prednisone or equivalent ) for chronic diseases,1
5445,5445,5445,5445,5445,5445,5445,6606,6606,6606,6606,6606,6606,6606,6606,6606,6606,6606,6606,6606,dddcd321-4d2e-4643-bf3c-7b752b33ba39,patients treated with glucocorticoids should receive adequate amounts of calcium and vitamin d id root 4cb2987b dc12 45b,4
5446,5446,5446,5446,5446,5446,5446,6607,6607,6607,6607,6607,6607,6607,6607,6607,6607,6607,6607,6607,24ed00e0-25e2-49a8-97fc-66c1b417dc0b,1  actonel is a bisphosphonate indicated for treatment and prevention of postmenopausal osteoporosis ( 1 1 ) treatment to increase bone mass in men with osteoporosis ( 1 2 ) treatment and prevention of glucocorticoid induced osteoporosis ( 1 3 ) treatment of paget s disease ( 1 4 ) limitations of use optimal duration of use has not been determined,1
5447,5447,5447,5447,5447,5447,5447,6609,6609,6609,6609,6609,6609,6609,6609,6609,6609,6609,6609,6609,24ed00e0-25e2-49a8-97fc-66c1b417dc0b,( 1 5 ) 1 1 postmenopausal osteoporosis actonel is indicated for the treatment and prevention of osteoporosis in postmenopausal women,1
5448,5448,5448,5448,5448,5448,5448,6610,6610,6610,6610,6610,6610,6610,6610,6610,6610,6610,6610,6610,24ed00e0-25e2-49a8-97fc-66c1b417dc0b,in postmenopausal women with osteoporosis  actonel reduces the incidence of vertebral fractures and a composite endpoint of nonvertebral osteoporosis related fractures see clinical studies ( 14 1  14 2 ),u
5449,5449,5449,5449,5449,5449,5449,6611,6611,6611,6611,6611,6611,6611,6611,6611,6611,6611,6611,6611,24ed00e0-25e2-49a8-97fc-66c1b417dc0b,1 2 osteoporosis in men actonel is indicated for treatment to increase bone mass in men with osteoporosis,1
5450,5450,5450,5450,5450,5450,5450,6612,6612,6612,6612,6612,6612,6612,6612,6612,6612,6612,6612,6612,24ed00e0-25e2-49a8-97fc-66c1b417dc0b,1 3 glucocorticoid induced osteoporosis actonel is indicated for the treatment and prevention of glucocorticoid induced osteoporosis in men and women who are either initiating or continuing systemic glucocorticoid treatment ( daily dosage of greater than or equal to 7 5 mg of prednisone or equivalent ) for chronic diseases,1
5451,5451,5451,5451,5451,5451,5451,6613,6613,6613,6613,6613,6613,6613,6613,6613,6613,6613,6613,6613,24ed00e0-25e2-49a8-97fc-66c1b417dc0b,patients treated with glucocorticoids should receive adequate amounts of calcium and vitamin d 1 4 paget s disease te,4
5452,5452,5452,5452,5452,5452,5452,6614,6614,6614,6614,6614,6614,6614,6614,6614,6614,6614,6614,6614,db7454bc-4f18-4632-b771-2e86db889bae, selenium injection is indicated for use as a supplement to intravenous solutions given for total parenteral nutrition ( tpn ),1
5453,5453,5453,5453,5453,5453,5453,6615,6615,6615,6615,6615,6615,6615,6615,6615,6615,6615,6615,6615,db7454bc-4f18-4632-b771-2e86db889bae,administration of selenium in tpn solutions helps to maintain plasma selenium levels and to prevent depletion of endogenous stores and subsequent deficiency symptoms,u
5454,5454,5454,5454,5454,5454,5454,6616,6616,6616,6616,6616,6616,6616,6616,6616,6616,6616,6616,6616,ef63bbe8-ebf8-436c-b38d-6cb92bc91ac0, this formulation is indicated for use as a supplement to intravenous solutions given for tpn,u
5455,5455,5455,5455,5455,5455,5455,6617,6617,6617,6617,6617,6617,6617,6617,6617,6617,6617,6617,6617,ef63bbe8-ebf8-436c-b38d-6cb92bc91ac0,administration of the solution in tpn solutions helps to maintain plasma levels of zinc  copper  manganese  selenium and chromium and to prevent depletion of endogenous stores of these trace elements and subsequent deficiency symptoms,u
5456,5456,5456,5456,5456,5456,5456,6618,6618,6618,6618,6618,6618,6618,6618,6618,6618,6618,6618,6618,4b5f7c65-aa2d-452a-b3db-bc85c06ff12f, vraylar is indicated for the treatment of schizophrenia in adults see clinical studies ( 14 1 ) acute treatment of manic or mixed episodes associated with bipolar i disorder in adults see clinical studies ( 14 2 ),1
5457,5457,5457,5457,5457,5457,5457,6619,6619,6619,6619,6619,6619,6619,6619,6619,6619,6619,6619,6619,4b5f7c65-aa2d-452a-b3db-bc85c06ff12f,vraylar is an atypical antipsychotic indicated for the treatment of schizophrenia in adults ( 1 ) acute treatment of manic or mixed episodes associated with bipolar i disorder in adults ( 1 ),1
5458,5458,5458,5458,5458,5458,5458,6620,6620,6620,6620,6620,6620,6620,6620,6620,6620,6620,6620,6620,6accf33f-9841-4327-8923-93c42020ef12, r gene 10 is indicated as an intravenous stimulant to the pituitary for the release of human growth hormone in patients where the measurement of pituitary reserve for hgh can be of diagnostic usefulness,1
5459,5459,5459,5459,5459,5459,5459,6621,6621,6621,6621,6621,6621,6621,6621,6621,6621,6621,6621,6621,6accf33f-9841-4327-8923-93c42020ef12,it can be used as a diagnostic aid in such conditions as panhypopituitarism  pituitary dwarfism  chromophobe adenoma  postsurgical craniopharyngioma  hypophysectomy  pituitary trauma  acromegaly  gigantism and problems of growth and stature,1
5460,5460,5460,5460,5460,5460,5460,6622,6622,6622,6622,6622,6622,6622,6622,6622,6622,6622,6622,6622,6accf33f-9841-4327-8923-93c42020ef12,if the insulin hypoglycemia test has indicated a deficiency of pituitary reserve for hgh  a test with r gene 10 is advisable to confirm the negative response,0
5461,5461,5461,5461,5461,5461,5461,6623,6623,6623,6623,6623,6623,6623,6623,6623,6623,6623,6623,6623,6accf33f-9841-4327-8923-93c42020ef12,this can be done after a waiting period of one day,0
5462,5462,5462,5462,5462,5462,5462,6624,6624,6624,6624,6624,6624,6624,6624,6624,6624,6624,6624,6624,6accf33f-9841-4327-8923-93c42020ef12,as patients may not respond to r gene 10 ( arginine hydrochloride injection  usp ) during the first test  the unresponsive patient should be tested again to confirm the negative result,0
5463,5463,5463,5463,5463,5463,5463,6625,6625,6625,6625,6625,6625,6625,6625,6625,6625,6625,6625,6625,6accf33f-9841-4327-8923-93c42020ef12,a second test can be performed after a waiting period of one day,0
5464,5464,5464,5464,5464,5464,5464,6626,6626,6626,6626,6626,6626,6626,6626,6626,6626,6626,6626,6626,6accf33f-9841-4327-8923-93c42020ef12,some patients who respond to r gene 10 do not respond to insulin and vice versa,0
5465,5465,5465,5465,5465,5465,5465,6627,6627,6627,6627,6627,6627,6627,6627,6627,6627,6627,6627,6627,6accf33f-9841-4327-8923-93c42020ef12,the rate of false positive responses for r gene 10 is approximately 32  and the rate of false negatives is approximately 27,0
5466,5466,5466,5466,5466,5466,5466,6628,6628,6628,6628,6628,6628,6628,6628,6628,6628,6628,6628,6628,d197466a-c6c9-4d47-91f3-5f26b07bb943,indications usage cardiac arrhythmias intravenous administration is usually reserved for life threatening arrhythmias or those occurring under anesthesia,1
5467,5467,5467,5467,5467,5467,5467,6629,6629,6629,6629,6629,6629,6629,6629,6629,6629,6629,6629,6629,d197466a-c6c9-4d47-91f3-5f26b07bb943,supraventricular arrhythmias intravenous propranolol is indicated for the short term treatment of supraventricular tachycardia  including wolff parkinson white syndrome and thyrotoxicosis  to decrease ventricular rate,1
5468,5468,5468,5468,5468,5468,5468,6630,6630,6630,6630,6630,6630,6630,6630,6630,6630,6630,6630,6630,d197466a-c6c9-4d47-91f3-5f26b07bb943,use in patients with atrial flutter or atrial fibrillation should be reserved for arrythmias unresponsive to standard therapy or when more prolonged control is required,1
5469,5469,5469,5469,5469,5469,5469,6631,6631,6631,6631,6631,6631,6631,6631,6631,6631,6631,6631,6631,d197466a-c6c9-4d47-91f3-5f26b07bb943,reversion to normal sinus rhythm has occasionally been observed  predominantly in patients with sinus or atrial tachycardia,u
5470,5470,5470,5470,5470,5470,5470,6632,6632,6632,6632,6632,6632,6632,6632,6632,6632,6632,6632,6632,d197466a-c6c9-4d47-91f3-5f26b07bb943,ventricular tachycardias with the exception of those induced by catecholamines or digitalis  propranolol is not the drug of first choice,u
5471,5471,5471,5471,5471,5471,5471,6633,6633,6633,6633,6633,6633,6633,6633,6633,6633,6633,6633,6633,d197466a-c6c9-4d47-91f3-5f26b07bb943,in critical situations when cardioversion techniques or other drugs are not indicated or are not effective  propranolol may be considered,1
5472,5472,5472,5472,5472,5472,5472,6634,6634,6634,6634,6634,6634,6634,6634,6634,6634,6634,6634,6634,d197466a-c6c9-4d47-91f3-5f26b07bb943,if  after consideration of the risks involved  propranolol is used  it should be given intravenously in low dosage and very slowly  as the failing heart requires some sympathetic drive for maintenance of myocardial tone ( see dosage and administration ),4
5473,5473,5473,5473,5473,5473,5473,6635,6635,6635,6635,6635,6635,6635,6635,6635,6635,6635,6635,6635,d197466a-c6c9-4d47-91f3-5f26b07bb943,some patients may respond with complete reversion to normal sinus rhythm  but reduction in ventricular rate is more likely,0
5474,5474,5474,5474,5474,5474,5474,6636,6636,6636,6636,6636,6636,6636,6636,6636,6636,6636,6636,6636,d197466a-c6c9-4d47-91f3-5f26b07bb943,ventricular arrhythmias do not respond to propranolol as predictably as do the supraventricular arrhythmias,0
5475,5475,5475,5475,5475,5475,5475,6637,6637,6637,6637,6637,6637,6637,6637,6637,6637,6637,6637,6637,d197466a-c6c9-4d47-91f3-5f26b07bb943,intravenous propranolol is indicated for the treatment of persistent premature ventricular extrasystoles that impair the well being of the patient and do not respond to conventional measures,1
5476,5476,5476,5476,5476,5476,5476,6638,6638,6638,6638,6638,6638,6638,6638,6638,6638,6638,6638,6638,d197466a-c6c9-4d47-91f3-5f26b07bb943,tachyarrhythmias of digitalis intoxication intravenous propranolol is indicated to control ventricular rate in life threatening digitalis induced arrhythmias,1
5477,5477,5477,5477,5477,5477,5477,6639,6639,6639,6639,6639,6639,6639,6639,6639,6639,6639,6639,6639,d197466a-c6c9-4d47-91f3-5f26b07bb943,severe bradycardia may occur ( see overdosage ),3
5478,5478,5478,5478,5478,5478,5478,6640,6640,6640,6640,6640,6640,6640,6640,6640,6640,6640,6640,6640,d197466a-c6c9-4d47-91f3-5f26b07bb943,resistant tachyarrhythmias due to excessive catecholamine action during anesthesia intravenous propranolol is indicated to abolish tachyarrhythmias due to excessive catecholamine action during anesthesia when other measures fail,1
5479,5479,5479,5479,5479,5479,5479,6641,6641,6641,6641,6641,6641,6641,6641,6641,6641,6641,6641,6641,d197466a-c6c9-4d47-91f3-5f26b07bb943,these arrhythmias may arise because of release of endogenous catecholamines or administration of catecholamines,0
5480,5480,5480,5480,5480,5480,5480,6642,6642,6642,6642,6642,6642,6642,6642,6642,6642,6642,6642,6642,d197466a-c6c9-4d47-91f3-5f26b07bb943,all general inhalation anesthetics produce some degree of myocardial depression,0
5481,5481,5481,5481,5481,5481,5481,6643,6643,6643,6643,6643,6643,6643,6643,6643,6643,6643,6643,6643,d197466a-c6c9-4d47-91f3-5f26b07bb943,therefore  when propranolol is used to treat arrhythmias during anesthesia  it should be used with extreme caution  usually with constant monitoring of the ecg and central venous pressure ( see warnings ),4
5482,5482,5482,5482,5482,5482,5482,6644,6644,6644,6644,6644,6644,6644,6644,6644,6644,6644,6644,6644,53e2801a-323d-448e-8278-92d672904b0f, azithromycin is indicated for the treatment of patients with mild to moderate infections caused by susceptible strains of the designated microorganisms in the specific conditions listed below,1
5483,5483,5483,5483,5483,5483,5483,6645,6645,6645,6645,6645,6645,6645,6645,6645,6645,6645,6645,6645,53e2801a-323d-448e-8278-92d672904b0f,sexually transmitted diseases non gonococcal urethritis and cervicitis due to chlamydia trachomatis,1
5484,5484,5484,5484,5484,5484,5484,6646,6646,6646,6646,6646,6646,6646,6646,6646,6646,6646,6646,6646,53e2801a-323d-448e-8278-92d672904b0f,azithromycin at the recommended dose  should not be relied upon to treat gonorrhea or syphilis,u
5485,5485,5485,5485,5485,5485,5485,6647,6647,6647,6647,6647,6647,6647,6647,6647,6647,6647,6647,6647,53e2801a-323d-448e-8278-92d672904b0f,antimicrobial agents used in high doses for short periods of time to treat non gonococcal urethritis may mask or delay the symptoms of incubating gonorrhea or syphilis,0
5486,5486,5486,5486,5486,5486,5486,6648,6648,6648,6648,6648,6648,6648,6648,6648,6648,6648,6648,6648,53e2801a-323d-448e-8278-92d672904b0f,all patients with sexually transmitted urethritis or cervicitis should have a serologic test for syphilis and appropriate cultures for gonorrhea performed at the time of diagnosis,0
5487,5487,5487,5487,5487,5487,5487,6649,6649,6649,6649,6649,6649,6649,6649,6649,6649,6649,6649,6649,53e2801a-323d-448e-8278-92d672904b0f,appropriate antimicrobial therapy and follow up tests for these diseases should be initiated if infection is confirmed,0
5488,5488,5488,5488,5488,5488,5488,6650,6650,6650,6650,6650,6650,6650,6650,6650,6650,6650,6650,6650,53e2801a-323d-448e-8278-92d672904b0f,appropriate culture and susceptibility tests should be performed before treatment to determine the causative organism and its susceptibility to azithromycin,0
5489,5489,5489,5489,5489,5489,5489,6651,6651,6651,6651,6651,6651,6651,6651,6651,6651,6651,6651,6651,53e2801a-323d-448e-8278-92d672904b0f,therapy with azithromycin may be initiated before results of these tests are known once the results become available  antimicrobial therapy should be adjusted accordingly,0
5490,5490,5490,5490,5490,5490,5490,6652,6652,6652,6652,6652,6652,6652,6652,6652,6652,6652,6652,6652,53e2801a-323d-448e-8278-92d672904b0f,to reduce the development of drug resistant bacteria and maintain the effectiveness of azithromycin and other antibacterial drugs  azithromycin should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria,4
5491,5491,5491,5491,5491,5491,5491,6655,6655,6655,6655,6655,6655,6655,6655,6655,6655,6655,6655,6655,53e2801a-323d-448e-8278-92d672904b0f,mycobacterial infections prophylaxis of disseminated mycobacterium avium complex ( mac ) disease azithromycin taken alone or in combination with rifabutin at its approved dose  is indicated for the prevention of disseminated mycobacterium avium complex ( mac ) disease in persons with advanced hiv infection,1
5492,5492,5492,5492,5492,5492,5492,6656,6656,6656,6656,6656,6656,6656,6656,6656,6656,6656,6656,6656,53e2801a-323d-448e-8278-92d672904b0f,( see dosage and administration  clinical studies ) treatment of disseminated mycobacterium avium complex ( mac ) disease,1
5493,5493,5493,5493,5493,5493,5493,6657,6657,6657,6657,6657,6657,6657,6657,6657,6657,6657,6657,6657,18297bc9-5ea2-48ff-9ba4-e9b9492e9cdc, essential hypertension  alone or as an adjunct,u
5494,5494,5494,5494,5494,5494,5494,6658,6658,6658,6658,6658,6658,6658,6658,6658,6658,6658,6658,6658,e1e63cd5-d1e4-4af5-bad5-1ad41ea46b00,1  bidil is a combination of isosorbide dinitrate  a nitrate vasodilator  and hydralazine hydrochloride  an arteriolar vasodilator  indicated for the treatment of heart failure as an adjunct therapy to standard therapy in self identified black patients to improve survival  prolong time to hospitalization for heart failure and to improve patient reported functional status ( 1 1 ) limitations of use there is little experience in patients with nyha class iv heart failure ( 1 2 ) 1 1 treatment of heart failure in self identified black patients bidil is indicated for the treatment of heart failure as an adjunct to standard therapy in self identified black patients to improve survival  to prolong time to hospitalization for heart failure  and to improve patient reported functional status,1
5495,5495,5495,5495,5495,5495,5495,6659,6659,6659,6659,6659,6659,6659,6659,6659,6659,6659,6659,6659,e1e63cd5-d1e4-4af5-bad5-1ad41ea46b00,1 2 limitations of use there is little experience in patients with nyha class iv heart failure,0
5496,5496,5496,5496,5496,5496,5496,6660,6660,6660,6660,6660,6660,6660,6660,6660,6660,6660,6660,6660,3e719d6a-342e-428b-93d3-377d31cb15c7,1  cycloset is a dopamine receptor agonist indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus,1
5497,5497,5497,5497,5497,5497,5497,6661,6661,6661,6661,6661,6661,6661,6661,6661,6661,6661,6661,6661,3e719d6a-342e-428b-93d3-377d31cb15c7,( 1 1  11 ) important limitations of use should not be used to treat type 1 diabetes or diabetic ketoacidosis,2
5498,5498,5498,5498,5498,5498,5498,6662,6662,6662,6662,6662,6662,6662,6662,6662,6662,6662,6662,6662,3e719d6a-342e-428b-93d3-377d31cb15c7,( 1 2 ) limited efficacy data in combination with thiazolidinediones,0
5499,5499,5499,5499,5499,5499,5499,6663,6663,6663,6663,6663,6663,6663,6663,6663,6663,6663,6663,6663,3e719d6a-342e-428b-93d3-377d31cb15c7,( 1 2 ) efficacy has not been confirmed in combination with insulin,0
5500,5500,5500,5500,5500,5500,5500,6664,6664,6664,6664,6664,6664,6664,6664,6664,6664,6664,6664,6664,3e719d6a-342e-428b-93d3-377d31cb15c7,( 1 2 ) 1 1 type 2 diabetes mellitus cycloset is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus,1
5501,5501,5501,5501,5501,5501,5501,6665,6665,6665,6665,6665,6665,6665,6665,6665,6665,6665,6665,6665,3e719d6a-342e-428b-93d3-377d31cb15c7,1 2 important limitations of use cycloset should not be used to treat type 1 diabetes or diabetic ketoacidosis,2
5502,5502,5502,5502,5502,5502,5502,6666,6666,6666,6666,6666,6666,6666,6666,6666,6666,6666,6666,6666,3e719d6a-342e-428b-93d3-377d31cb15c7,limited efficacy data in combination with thiazolidinediones,0
5503,5503,5503,5503,5503,5503,5503,6667,6667,6667,6667,6667,6667,6667,6667,6667,6667,6667,6667,6667,3e719d6a-342e-428b-93d3-377d31cb15c7,efficacy has not been confirmed in combination with insulin,0
5504,5504,5504,5504,5504,5504,5504,6668,6668,6668,6668,6668,6668,6668,6668,6668,6668,6668,6668,6668,a0c72bff-20f3-4241-b966-34a95178d1a3, zinc acetate therapy is indicated for maintenance treatment of patients with wilson s disease who have been initially treated with a chelating agent ( see precautions monitoring patients ),1
5505,5505,5505,5505,5505,5505,5505,6669,6669,6669,6669,6669,6669,6669,6669,6669,6669,6669,6669,6669,1967dc24-f2a5-4095-baa9-a9d1c5410311, fluphenazine decanoate injection  usp is a long acting parenteral antipsychotic drug intended for use in the management of patients requiring prolonged parenteral neuroleptic therapy ( e g  chronic schizophrenics ),1
5506,5506,5506,5506,5506,5506,5506,6670,6670,6670,6670,6670,6670,6670,6670,6670,6670,6670,6670,6670,1967dc24-f2a5-4095-baa9-a9d1c5410311,fluphenazine decanoate injection  usp has not been shown effective in the management of behavioral complications in patients with mental retardation,0
5507,5507,5507,5507,5507,5507,5507,6671,6671,6671,6671,6671,6671,6671,6671,6671,6671,6671,6671,6671,665d7e74-036c-5f68-5b67-ab84b9b49151,1  tecfidera is indicated for the treatment of patients with relapsing forms of multiple sclerosis,1
5508,5508,5508,5508,5508,5508,5508,6672,6672,6672,6672,6672,6672,6672,6672,6672,6672,6672,6672,6672,665d7e74-036c-5f68-5b67-ab84b9b49151,tecfidera is indicated for the treatment of patients with relapsing forms of multiple sclerosis ( 1 ),1
5509,5509,5509,5509,5509,5509,5509,6673,6673,6673,6673,6673,6673,6673,6673,6673,6673,6673,6673,6673,aad16dc1-aa6a-4ff8-a0e9-43d30e0da265,usage p bloc sterile aqueous solution is indicated for the temporary relief of symptoms associated with neurologic pain,1
5510,5510,5510,5510,5510,5510,5510,6674,6674,6674,6674,6674,6674,6674,6674,6674,6674,6674,6674,6674,4490128b-e73f-4849-9d6e-e8591639d771, a ) acute nonlymphocytic leukemias tabloid brand thioguanine is indicated for remission induction and remission consolidation treatment of acute nonlymphocytic leukemias,1
5511,5511,5511,5511,5511,5511,5511,6675,6675,6675,6675,6675,6675,6675,6675,6675,6675,6675,6675,6675,4490128b-e73f-4849-9d6e-e8591639d771,however  it is not recommended for use during maintenance therapy or similar long term continuous treatments due to the high risk of liver toxicity ( see warnings and adverse reactions ),3
5512,5512,5512,5512,5512,5512,5512,6676,6676,6676,6676,6676,6676,6676,6676,6676,6676,6676,6676,6676,4490128b-e73f-4849-9d6e-e8591639d771,the response to this agent depends upon the age of the patient ( younger patients faring better than older ) and whether thioguanine is used in previously treated or previously untreated patients,0
5513,5513,5513,5513,5513,5513,5513,6677,6677,6677,6677,6677,6677,6677,6677,6677,6677,6677,6677,6677,4490128b-e73f-4849-9d6e-e8591639d771,reliance upon thioguanine alone is seldom justified for initial remission induction of acute nonlymphocytic leukemias because combination chemotherapy including thioguanine results in more frequent remission induction and longer duration of remission than thioguanine alone,0
5514,5514,5514,5514,5514,5514,5514,6678,6678,6678,6678,6678,6678,6678,6678,6678,6678,6678,6678,6678,4490128b-e73f-4849-9d6e-e8591639d771,b ) other neoplasms tabloid brand thioguanine is not effective in chronic lymphocytic leukemia  hodgkin s lymphoma  multiple myeloma  or solid tumors,0
5515,5515,5515,5515,5515,5515,5515,6679,6679,6679,6679,6679,6679,6679,6679,6679,6679,6679,6679,6679,4490128b-e73f-4849-9d6e-e8591639d771,although thioguanine is one of several agents with activity in the treatment of the chronic phase of chronic myelogenous leukemia  more objective responses are observed with myleran ( busulfan )  and therefore busulfan is usually regarded as the preferred drug,0
5516,5516,5516,5516,5516,5516,5516,6680,6680,6680,6680,6680,6680,6680,6680,6680,6680,6680,6680,6680,c77a9664-e3bb-4023-b400-127aa53bca2b,1  stelara is a human interleukin 12 and 23 antagonist indicated for the treatment of adult patients with moderate to severe plaque psoriasis ( ps ) who are candidates for phototherapy or systemic therapy,1
5517,5517,5517,5517,5517,5517,5517,6681,6681,6681,6681,6681,6681,6681,6681,6681,6681,6681,6681,6681,c77a9664-e3bb-4023-b400-127aa53bca2b,( 1 1 ) active psoriatic arthritis ( psa )  alone or in combination with methotrexate,1
5518,5518,5518,5518,5518,5518,5518,6682,6682,6682,6682,6682,6682,6682,6682,6682,6682,6682,6682,6682,c77a9664-e3bb-4023-b400-127aa53bca2b,( 1 2 ) moderately to severely active crohn 's disease ( cd ) who have failed or were intolerant to treatment with immunomodulators or corticosteroids  but never failed a tumor necrosis factor ( tnf ) blocker or failed or were intolerant to treatment with one or more tnf blockers,1
5519,5519,5519,5519,5519,5519,5519,6683,6683,6683,6683,6683,6683,6683,6683,6683,6683,6683,6683,6683,c77a9664-e3bb-4023-b400-127aa53bca2b,( 1 3 ) adolescent patients ( 12 years or older ) with moderate to severe plaque psoriasis  who are candidates for phototherapy or systemic therapy,1
5520,5520,5520,5520,5520,5520,5520,6684,6684,6684,6684,6684,6684,6684,6684,6684,6684,6684,6684,6684,c77a9664-e3bb-4023-b400-127aa53bca2b,( 1 1 ) 1 1 psoriasis ( ps ) stelara is indicated for the treatment of patients 12 years or older with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy,1
5521,5521,5521,5521,5521,5521,5521,6685,6685,6685,6685,6685,6685,6685,6685,6685,6685,6685,6685,6685,c77a9664-e3bb-4023-b400-127aa53bca2b,1 2 psoriatic arthritis ( psa ) stelara is indicated for the treatment of adult patients with active psoriatic arthritis,1
5522,5522,5522,5522,5522,5522,5522,6686,6686,6686,6686,6686,6686,6686,6686,6686,6686,6686,6686,6686,c77a9664-e3bb-4023-b400-127aa53bca2b,stelara can be used alone or in combination with methotrexate ( mtx ),4
5523,5523,5523,5523,5523,5523,5523,6687,6687,6687,6687,6687,6687,6687,6687,6687,6687,6687,6687,6687,c77a9664-e3bb-4023-b400-127aa53bca2b,1 3 crohn 's disease ( cd ) stelara is indicated for the treatment of adult patients with moderately to severely active crohn 's disease who have failed or were intolerant to treatment with immunomodulators or corticosteroids  but never failed treatment with a tumor necrosis factor ( tnf ) blocker or failed or were intolerant to treatment with one or more tnf blockers,1
5524,5524,5524,5524,5524,5524,5524,6688,6688,6688,6688,6688,6688,6688,6688,6688,6688,6688,6688,6688,"Active Ingredient UNII(s)
FV9J3JU8B1    185181e3-c004-4d61-b992-5df94fe57a90
FV9J3JU8B1    185181e3-c004-4d61-b992-5df94fe57a90
FV9J3JU8B1    185181e3-c004-4d61-b992-5df94fe57a90
FV9J3JU8B1    185181e3-c004-4d61-b992-5df94fe57a90
Name: SET ID dtype: object",active ingredient unii ( s ) fv9j3ju8b1 active ingredient unii ( s ) fv9j3ju8b1 active in fv9j3ju8b1 active ingredient unii ( s ) fv9j3ju8b1 active in fv9j3ju8b1 active ingredient unii ( s ) fv9j3ju8b1 active in fv9j3ju8b1 active ingredient unii ( s ) fv9j3ju8b1 active in name content xml  dtype object,0
5525,5525,5525,5525,5525,5525,5525,6692,6692,6692,6692,6692,6692,6692,6692,6692,6692,6692,6692,6692,2a90b899-7746-43dc-ac8a-e754428eb30c,1  desloratadine tablets are h1 receptor antagonist indicated for seasonal allergic rhinitis relief of nasal and non nasal symptoms in patients 12 years of age and older,1
5526,5526,5526,5526,5526,5526,5526,6693,6693,6693,6693,6693,6693,6693,6693,6693,6693,6693,6693,6693,2a90b899-7746-43dc-ac8a-e754428eb30c,( 1 1 ) perennial allergic rhinitis relief of nasal and non nasal symptoms in patients 12 years of age and older,1
5527,5527,5527,5527,5527,5527,5527,6694,6694,6694,6694,6694,6694,6694,6694,6694,6694,6694,6694,6694,2a90b899-7746-43dc-ac8a-e754428eb30c,( 1 2 ) 1 1 seasonal allergic rhinitis desloratadine tablets are indicated for the relief of the nasal and non nasal symptoms of seasonal allergic rhinitis in patients 12 years of age and older,1
5528,5528,5528,5528,5528,5528,5528,6695,6695,6695,6695,6695,6695,6695,6695,6695,6695,6695,6695,6695,2a90b899-7746-43dc-ac8a-e754428eb30c,1 2 perennial allergic rhinitis desloratadine tablets are indicated for the relief of the nasal and non nasal symptoms of perennial allergic rhinitis in patients 12 years of age and older,1
5529,5529,5529,5529,5529,5529,5529,6696,6696,6696,6696,6696,6696,6696,6696,6696,6696,6696,6696,6696,61a1562b-46c6-40ed-af02-305342e76e2f,1  clarinex d 12 hour is a combination product containing an h1 receptor antagonist and a sympathomimetic amine indicated for relief of nasal and non nasal symptoms of seasonal allergic rhinitis  including nasal congestion  in adults and adolescents 12 years of age and older,1
5530,5530,5530,5530,5530,5530,5530,6697,6697,6697,6697,6697,6697,6697,6697,6697,6697,6697,6697,6697,61a1562b-46c6-40ed-af02-305342e76e2f,( 1 1 ) 1 1 seasonal allergic rhinitis clarinex d 12 hour extended release tablets is indicated for the relief of the nasal and non nasal symptoms of seasonal allergic rhinitis  including nasal congestion  in adults and adolescents 12 years of age and older,1
5531,5531,5531,5531,5531,5531,5531,6698,6698,6698,6698,6698,6698,6698,6698,6698,6698,6698,6698,6698,61a1562b-46c6-40ed-af02-305342e76e2f,clarinex d 12 hour extended release tablets should be administered when the antihistaminic properties of desloratadine and the nasal decongestant properties of pseudoephedrine are desired see clinical pharmacology ( 12 ),u
5532,5532,5532,5532,5532,5532,5532,6699,6699,6699,6699,6699,6699,6699,6699,6699,6699,6699,6699,6699,72e6b33c-0351-4070-9172-eeaa186c01d2,1  vemlidy is indicated for the treatment of chronic hepatitis b virus ( hbv ) infection in adults with compensated liver disease see clinical studies ( 14 ),1
5533,5533,5533,5533,5533,5533,5533,6700,6700,6700,6700,6700,6700,6700,6700,6700,6700,6700,6700,6700,72e6b33c-0351-4070-9172-eeaa186c01d2,vemlidy is a hepatitis b virus ( hbv ) nucleoside analog reverse transcriptase inhibitor and is indicated for the treatment of chronic hepatitis b virus infection in adults with compensated liver disease,1
5534,5534,5534,5534,5534,5534,5534,6701,6701,6701,6701,6701,6701,6701,6701,6701,6701,6701,6701,6701,06f66e98-e6ee-4538-9506-6c1282cc14c1,1  descovy is indicated  in combination with other antiretroviral agents  for the treatment of hiv 1 infection in adults and pediatric patients weighing at least 35 kg,1
5535,5535,5535,5535,5535,5535,5535,6702,6702,6702,6702,6702,6702,6702,6702,6702,6702,6702,6702,6702,06f66e98-e6ee-4538-9506-6c1282cc14c1,descovy is also indicated  in combination with other antiretroviral agents other than protease inhibitors that require a cyp3a inhibitor  for the treatment of hiv 1 infection in pediatric patients weighing at least 25 kg and less than 35 kg,1
5536,5536,5536,5536,5536,5536,5536,6703,6703,6703,6703,6703,6703,6703,6703,6703,6703,6703,6703,6703,06f66e98-e6ee-4538-9506-6c1282cc14c1,descovy is a two drug combination of emtricitabine ( ftc ) and tenofovir alafenamide ( taf )  both hiv nucleoside analog reverse transcriptase inhibitors ( nrtis )  and is indicated in combination with other antiretroviral agents for the treatment of hiv 1 infection in adults and pediatric patients weighing at least 35kg,1
5537,5537,5537,5537,5537,5537,5537,6704,6704,6704,6704,6704,6704,6704,6704,6704,6704,6704,6704,6704,06f66e98-e6ee-4538-9506-6c1282cc14c1,in combination with other antiretroviral agents other than protease inhibitors that require a cyp3a inhibitor for the treatment of hiv 1 infection in pediatric patients weighing at least 25 kg and less than 35 kg,u
5538,5538,5538,5538,5538,5538,5538,6705,6705,6705,6705,6705,6705,6705,6705,6705,6705,6705,6705,6705,06f66e98-e6ee-4538-9506-6c1282cc14c1,( 1 ) limitations of use descovy is not indicated for use as pre exposure prophylaxis ( prep ) to reduce the risk of sexually acquired hiv 1 in adults at high risk,0
5539,5539,5539,5539,5539,5539,5539,6706,6706,6706,6706,6706,6706,6706,6706,6706,6706,6706,6706,6706,06f66e98-e6ee-4538-9506-6c1282cc14c1,limitations of use descovy is not indicated for use as pre exposure prophylaxis ( prep ) to reduce the risk of sexually acquired hiv 1 in adults at high risk,0
5540,5540,5540,5540,5540,5540,5540,6707,6707,6707,6707,6707,6707,6707,6707,6707,6707,6707,6707,6707,"Active Ingredient UNII(s)
FYS6T7F842; ND2M416302    608d4f0d-b19f-46d3-749a-7159aa5f933d
FYS6T7F842; ND2M416302    608d4f0d-b19f-46d3-749a-7159aa5f933d
FYS6T7F842; ND2M416302    608d4f0d-b19f-46d3-749a-7159aa5f933d
FYS6T7F842; ND2M416302    608d4f0d-b19f-46d3-749a-7159aa5f933d
FYS6T7F842; ND2M416302    608d4f0d-b19f-46d3-749a-7159aa5f933d
FYS6T7F842; ND2M416302    608d4f0d-b19f-46d3-749a-7159aa5f933d
Name: SET ID dtype: object",active ingredient unii ( s ) fys6t7f842 nd2m416302 active ingredient unii ( s ) fys6t7f842 nd2m4163 fys6t7f842 nd2m416302 active ingredient unii ( s ) fys6t7f842 nd2m4163 fys6t7f842 nd2m416302 active ingredient unii ( s ) fys6t7f842 nd2m4163 fys6t7f842 nd2m416302 active ingredient unii ( s ) fys6t7f842 nd2m4163 fys6t7f842 nd2m416302 active ingredient unii ( s ) fys6t7f842 nd2m4163 fys6t7f842 nd2m416302 active ingredient unii ( s ) fys6t7f842 nd2m4163 name content xml  dtype object,0
5541,5541,5541,5541,5541,5541,5541,6713,6713,6713,6713,6713,6713,6713,6713,6713,6713,6713,6713,6713,626dc9e5-c6b4-4f9c-9bf4-774fd3ae619a,1  venofer is indicated for the treatment of iron deficiency anemia in patients with chronic kidney disease ( ckd ),1
5542,5542,5542,5542,5542,5542,5542,6714,6714,6714,6714,6714,6714,6714,6714,6714,6714,6714,6714,6714,626dc9e5-c6b4-4f9c-9bf4-774fd3ae619a,venofer is an iron replacement product indicated for the treatment of iron deficiency anemia in patients with chronic kidney disease ( ckd ),1
5543,5543,5543,5543,5543,5543,5543,6722,6722,6722,6722,6722,6722,6722,6722,6722,6722,6722,6722,6722,a2523317-e071-4e04-9d9f-9053286e0ce2, a sedative b hypnotic  for the short term treatment of insomnia  since it appears to lose its effectiveness for sleep induction and sleep maintenance after 2 weeks ( see clinical pharmacology ),1
5544,5544,5544,5544,5544,5544,5544,6723,6723,6723,6723,6723,6723,6723,6723,6723,6723,6723,6723,6723,f6898117-14f3-42d2-bc0e-d296add3ad70, clotrimazole cream usp is indicated for the topical treatment of candidiasis due to candida albicans and tinea versicolor due to malassezia furfur,1
5545,5545,5545,5545,5545,5545,5545,6724,6724,6724,6724,6724,6724,6724,6724,6724,6724,6724,6724,6724,f6898117-14f3-42d2-bc0e-d296add3ad70,clotrimazole is also available as a nonprescription item which is indicated for the topical treatment of the following dermal infections tinea pedis  tinea cruris  and tinea corporis due to trichophyton rubrum  trichophyton mentagrophytes  epidermophyton floccosum  and microsporum canis,1
5546,5546,5546,5546,5546,5546,5546,6725,6725,6725,6725,6725,6725,6725,6725,6725,6725,6725,6725,6725,4149d750-44e3-47e7-84f2-1e5cc839733b, oxacillin is indicated in the treatment of infections caused by penicillinase producing staphylococci which have demonstrated susceptibility to the drug,1
5547,5547,5547,5547,5547,5547,5547,6726,6726,6726,6726,6726,6726,6726,6726,6726,6726,6726,6726,6726,4149d750-44e3-47e7-84f2-1e5cc839733b,cultures and susceptibility tests should be performed initially to determine the causative organism and its susceptibility to the drug ( see clinical pharmacology susceptibility test methods ),4
5548,5548,5548,5548,5548,5548,5548,6727,6727,6727,6727,6727,6727,6727,6727,6727,6727,6727,6727,6727,4149d750-44e3-47e7-84f2-1e5cc839733b,oxacillin may be used to initiate therapy in suspected cases of resistant staphylococcal infections prior to the availability of susceptibility test results,4
5549,5549,5549,5549,5549,5549,5549,6728,6728,6728,6728,6728,6728,6728,6728,6728,6728,6728,6728,6728,4149d750-44e3-47e7-84f2-1e5cc839733b,oxacillin should not be used in infections caused by organisms susceptible to penicillin g if the susceptibility tests indicate that the infection is due to an organism other than a resistant staphylococcus  therapy should not be continued with oxacillin,0
5550,5550,5550,5550,5550,5550,5550,6729,6729,6729,6729,6729,6729,6729,6729,6729,6729,6729,6729,6729,4149d750-44e3-47e7-84f2-1e5cc839733b,to reduce the development of drug resistant bacteria and maintain the effectiveness of oxacillin for injection  usp and other antibacterial drugs  oxacillin for injection  usp should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria,4
5551,5551,5551,5551,5551,5551,5551,6732,6732,6732,6732,6732,6732,6732,6732,6732,6732,6732,6732,6732,e5b67402-8550-4604-97a0-c7b149fbf753,1  cholbam is a bile acid indicated for treatment of bile acid synthesis disorders due to single enzyme defects ( seds ),1
5552,5552,5552,5552,5552,5552,5552,6733,6733,6733,6733,6733,6733,6733,6733,6733,6733,6733,6733,6733,e5b67402-8550-4604-97a0-c7b149fbf753,( 1 1 ) adjunctive treatment of peroxisomal disorders ( pds ) including zellweger spectrum disorders in patients who exhibit manifestations of liver disease  steatorrhea or complications from decreased fat soluble vitamin absorption ( 1 2 ) limitation of use the safety and effectiveness of cholbam on extrahepatic manifestations of bile acid synthesis disorders due to seds or pds including zellweger spectrum disorders have not been established,1
5553,5553,5553,5553,5553,5553,5553,6734,6734,6734,6734,6734,6734,6734,6734,6734,6734,6734,6734,6734,e5b67402-8550-4604-97a0-c7b149fbf753,1 1 bile acid synthesis disorders due to single enzyme defects cholbam is indicated for the treatment of bile acid synthesis disorders due to single enzyme defects ( seds ) see clinical trials ( 14 1 ),1
5554,5554,5554,5554,5554,5554,5554,6735,6735,6735,6735,6735,6735,6735,6735,6735,6735,6735,6735,6735,e5b67402-8550-4604-97a0-c7b149fbf753,1 2 peroxisomal disorders including zellweger spectrum disorders cholbam is indicated for adjunctive treatment of peroxisomal disorders ( pds ) including zellweger spectrum disorders in patients who exhibit manifestations of liver disease  steatorrhea or complications from decreased fat soluble vitamin absorption see clinical trials ( 14 2 ),1
5555,5555,5555,5555,5555,5555,5555,6736,6736,6736,6736,6736,6736,6736,6736,6736,6736,6736,6736,6736,e5b67402-8550-4604-97a0-c7b149fbf753,1 3 limitation of use the safety and effectiveness of cholbam on extrahepatic manifestations of bile acid synthesis disorders due to seds or pds including zellweger spectrum disorders have not been established,0
5556,5556,5556,5556,5556,5556,5556,6737,6737,6737,6737,6737,6737,6737,6737,6737,6737,6737,6737,6737,d0fe44f9-7747-4909-b927-3b24aa6e7e09,1  busulfan injection is indicated for use in combination with cyclophosphamide as a conditioning regimen prior to allogeneic hematopoietic progenitor cell transplantation for chronic myelogenous leukemia,1
5557,5557,5557,5557,5557,5557,5557,6738,6738,6738,6738,6738,6738,6738,6738,6738,6738,6738,6738,6738,d0fe44f9-7747-4909-b927-3b24aa6e7e09,busulfan injection is an alkylating drug indicated for use in combination with cyclophosphamide as a conditioning regimen prior to allogeneic hematopoietic progenitor cell transplantation for chronic myelogenous leukemia ( cml ) ( 1 ),1
5558,5558,5558,5558,5558,5558,5558,6739,6739,6739,6739,6739,6739,6739,6739,6739,6739,6739,6739,6739,6ea1fd48-c649-4e05-856e-bb123ce40a3f, exametazime is a diagnostic agent used as an adjunct in the detection of altered cerebral perfusion in stroke patients and is also indicated for white blood cell labeling as an adjunct in the localization of abdominal infections and inflammatory bowel disease,1
5559,5559,5559,5559,5559,5559,5559,6740,6740,6740,6740,6740,6740,6740,6740,6740,6740,6740,6740,6740,67300ca3-8c53-4ce4-8e86-2c03be1f9b8a,1  cayston is indicated to improve respiratory symptoms in cystic fibrosis ( cf ) patients with pseudomonas aeruginosa,1
5560,5560,5560,5560,5560,5560,5560,6741,6741,6741,6741,6741,6741,6741,6741,6741,6741,6741,6741,6741,67300ca3-8c53-4ce4-8e86-2c03be1f9b8a,safety and effectiveness have not been established in pediatric patients below the age of 7 years  patients with fev1 25 or 75 predicted  or patients colonized with burkholderia cepacia see clinical studies ( 14 ),0
5561,5561,5561,5561,5561,5561,5561,6742,6742,6742,6742,6742,6742,6742,6742,6742,6742,6742,6742,6742,67300ca3-8c53-4ce4-8e86-2c03be1f9b8a,to reduce the development of drug resistant bacteria and maintain the effectiveness of cayston and other antibacterial drugs  cayston should be used only to treat patients with cf known to have pseudomonas aeruginosa in the lungs,u
5562,5562,5562,5562,5562,5562,5562,6743,6743,6743,6743,6743,6743,6743,6743,6743,6743,6743,6743,6743,67300ca3-8c53-4ce4-8e86-2c03be1f9b8a,cayston is a monobactam antibacterial indicated to improve respiratory symptoms in cystic fibrosis ( cf ) patients with pseudomonas aeruginosa,1
5563,5563,5563,5563,5563,5563,5563,6744,6744,6744,6744,6744,6744,6744,6744,6744,6744,6744,6744,6744,67300ca3-8c53-4ce4-8e86-2c03be1f9b8a,safety and effectiveness have not been established in pediatric patients below the age of 7 years  patients with fev1 25 or 75 predicted  or patients colonized with burkholderia cepacia,0
5564,5564,5564,5564,5564,5564,5564,6745,6745,6745,6745,6745,6745,6745,6745,6745,6745,6745,6745,6745,e464e9bb-48e8-4b9f-9fff-e220cfbac0c5, nitroglycerin ointment is indicated for the prevention of angina pectoris due to coronary artery disease,1
5565,5565,5565,5565,5565,5565,5565,6746,6746,6746,6746,6746,6746,6746,6746,6746,6746,6746,6746,6746,e464e9bb-48e8-4b9f-9fff-e220cfbac0c5,the onset of action of transdermal nitroglycerin is not sufficiently rapid for this product to be useful in aborting an acute anginal episode,0
5566,5566,5566,5566,5566,5566,5566,6747,6747,6747,6747,6747,6747,6747,6747,6747,6747,6747,6747,6747,82ceb312-3aaa-4a5c-9849-7f246cc06ded, feridex i v,0
5567,5567,5567,5567,5567,5567,5567,6748,6748,6748,6748,6748,6748,6748,6748,6748,6748,6748,6748,6748,82ceb312-3aaa-4a5c-9849-7f246cc06ded,administration as an adjunct to mri ( in adult patients ) to enhance the t2 weighted images used in the detection and evaluation of lesions of the liver that are associated with an alteration in the res,1
5568,5568,5568,5568,5568,5568,5568,6749,6749,6749,6749,6749,6749,6749,6749,6749,6749,6749,6749,6749,5e308bec-7277-4cea-a112-f86839f64609,1  atripla is indicated for use alone as a complete regimen or in combination with other antiretroviral agents for the treatment of hiv 1 infection in adults and pediatric patients 12 years of age and older,1
5569,5569,5569,5569,5569,5569,5569,6750,6750,6750,6750,6750,6750,6750,6750,6750,6750,6750,6750,6750,5e308bec-7277-4cea-a112-f86839f64609,atripla  a combination of 2 nucleoside analog hiv 1 reverse transcriptase inhibitors and 1 non nucleoside hiv 1 reverse transcriptase inhibitor  is indicated for use alone as a complete regimen or in combination with other antiretroviral agents for the treatment of hiv 1 infection in adults and pediatric patients 12 years of age and older,1
5570,5570,5570,5570,5570,5570,5570,6751,6751,6751,6751,6751,6751,6751,6751,6751,6751,6751,6751,6751,00b4b5b5-7220-410c-8db2-dd940498cfc2,1  truvada is a combination of emtriva and viread  both nucleoside analog hiv 1 reverse transcriptase inhibitors,1
5571,5571,5571,5571,5571,5571,5571,6752,6752,6752,6752,6752,6752,6752,6752,6752,6752,6752,6752,6752,00b4b5b5-7220-410c-8db2-dd940498cfc2,truvada is indicated in combination with other antiretroviral agents for the treatment of hiv 1 infection in adults and pediatric patients weighing at least 17 kg,1
5572,5572,5572,5572,5572,5572,5572,6753,6753,6753,6753,6753,6753,6753,6753,6753,6753,6753,6753,6753,00b4b5b5-7220-410c-8db2-dd940498cfc2,( 1 ) truvada is indicated in combination with safer sex practices for pre exposure prophylaxis ( prep ) to reduce the risk of sexually acquired hiv 1 in adults at high risk,1
5573,5573,5573,5573,5573,5573,5573,6754,6754,6754,6754,6754,6754,6754,6754,6754,6754,6754,6754,6754,00b4b5b5-7220-410c-8db2-dd940498cfc2,( 1 ) 1 1 treatment of hiv 1 infection truvada  a combination of emtriva and viread  is indicated in combination with other antiretroviral agents for the treatment of hiv 1 infection in adults and pediatric patients weighing at least 17 kg see dosage and administration ( 2 ) and clinical studies ( 14 ),1
5574,5574,5574,5574,5574,5574,5574,6755,6755,6755,6755,6755,6755,6755,6755,6755,6755,6755,6755,6755,00b4b5b5-7220-410c-8db2-dd940498cfc2,the following points should be considered when initiating therapy with truvada for the treatment of hiv 1 infection it is not recommended that truvada be used as a component of a triple nucleoside regimen,0
5575,5575,5575,5575,5575,5575,5575,6756,6756,6756,6756,6756,6756,6756,6756,6756,6756,6756,6756,6756,00b4b5b5-7220-410c-8db2-dd940498cfc2,truvada should not be coadministered with atripla  complera  descovy  emtriva  genvoya  odefsey  stribild  vemlidy  viread  or lamivudine containing products see warnings and precautions ( 5 4 ),2
5576,5576,5576,5576,5576,5576,5576,6757,6757,6757,6757,6757,6757,6757,6757,6757,6757,6757,6757,6757,00b4b5b5-7220-410c-8db2-dd940498cfc2,in treatment experienced patients  the use of truvada should be guided by laboratory testing and treatment history see microbiology ( 12 4 ),4
5577,5577,5577,5577,5577,5577,5577,6758,6758,6758,6758,6758,6758,6758,6758,6758,6758,6758,6758,6758,00b4b5b5-7220-410c-8db2-dd940498cfc2,1 2 pre exposure prophylaxis truvada is indicated in combination with safer sex practices for pre exposure prophylaxis ( prep ) to reduce the risk of sexually acquired hiv 1 in adults at high risk,1
5578,5578,5578,5578,5578,5578,5578,6759,6759,6759,6759,6759,6759,6759,6759,6759,6759,6759,6759,6759,00b4b5b5-7220-410c-8db2-dd940498cfc2,this indication is based on clinical trials in men who have sex with men ( msm ) at high risk for hiv 1 infection and in heterosexual serodiscordant couples see clinical studies ( 14 2  14 3 ),0
5579,5579,5579,5579,5579,5579,5579,6760,6760,6760,6760,6760,6760,6760,6760,6760,6760,6760,6760,6760,00b4b5b5-7220-410c-8db2-dd940498cfc2,when considering truvada for pre exposure prophylaxis the following factors may help to identify individuals at high risk has partner ( s ) known to be hiv 1 infected  or engages in sexual acti,0
5580,5580,5580,5580,5580,5580,5580,6761,6761,6761,6761,6761,6761,6761,6761,6761,6761,6761,6761,6761,bc563e90-10e5-475d-aa84-b0e3d582ae95,1  ca dtpa is indicated for treatment of individuals with known or suspected internal contamination with plutonium  americium  or curium to increase the rates of elimination,1
5581,5581,5581,5581,5581,5581,5581,6762,6762,6762,6762,6762,6762,6762,6762,6762,6762,6762,6762,6762,bc563e90-10e5-475d-aa84-b0e3d582ae95,pentetate calcium trisodium injection is a radiomitigation chelator indicated for treatment of individuals with known or suspected internal contamination with plutonium  americium  or curium to increase the rates of elimination,1
5582,5582,5582,5582,5582,5582,5582,6763,6763,6763,6763,6763,6763,6763,6763,6763,6763,6763,6763,6763,eee37f88-ec6a-4c30-b8aa-e2c71f93088c,1  tykerb is indicated in combination with capecitabine for the treatment of patients with advanced or metastatic breast cancer whose tumors overexpress human epidermal growth factor receptor 2 ( her2 ) and who have received prior therapy including an anthracycline  a taxane  and trastuzumab,1
5583,5583,5583,5583,5583,5583,5583,6764,6764,6764,6764,6764,6764,6764,6764,6764,6764,6764,6764,6764,eee37f88-ec6a-4c30-b8aa-e2c71f93088c,limitation of use patients should have disease progression on trastuzumab prior to initiation of treatment with tykerb in combination with capecitabine,u
5584,5584,5584,5584,5584,5584,5584,6765,6765,6765,6765,6765,6765,6765,6765,6765,6765,6765,6765,6765,eee37f88-ec6a-4c30-b8aa-e2c71f93088c,letrozole for the treatment of postmenopausal women with hormone receptor positive metastatic breast cancer that overexpresses the her2 receptor for whom hormonal therapy is indicated,1
5585,5585,5585,5585,5585,5585,5585,6766,6766,6766,6766,6766,6766,6766,6766,6766,6766,6766,6766,6766,eee37f88-ec6a-4c30-b8aa-e2c71f93088c,tykerb in combination with an aromatase inhibitor has not been compared to a trastuzumab containing chemotherapy regimen for the treatment of metastatic breast cancer,0
5586,5586,5586,5586,5586,5586,5586,6767,6767,6767,6767,6767,6767,6767,6767,6767,6767,6767,6767,6767,eee37f88-ec6a-4c30-b8aa-e2c71f93088c,tykerb is a kinase inhibitor indicated in combination with ( 1 ) capecitabine  for the treatment of patients with advanced or metastatic breast cancer whose tumors overexpress human epidermal growth factor receptor 2 ( her2 ) and who have received prior therapy including an anthracycline  a taxane  and trastuzumab,1
5587,5587,5587,5587,5587,5587,5587,6771,6771,6771,6771,6771,6771,6771,6771,6771,6771,6771,6771,6771,b70816bb-913a-467f-acb8-67ef62cf8dac,1  pegintron is an antiviral indicated for treatment of chronic hepatitis c ( chc ) in patients with compensated liver disease,1
5588,5588,5588,5588,5588,5588,5588,6772,6772,6772,6772,6772,6772,6772,6772,6772,6772,6772,6772,6772,b70816bb-913a-467f-acb8-67ef62cf8dac,( 1 1 ) 1 1 chronic hepatitis c ( chc ) pegintron  as part of a combination regimen  is indicated for the treatment of chronic hepatitis c ( chc ) in patients with compensated liver disease,1
5589,5589,5589,5589,5589,5589,5589,6773,6773,6773,6773,6773,6773,6773,6773,6773,6773,6773,6773,6773,b70816bb-913a-467f-acb8-67ef62cf8dac,pegintron in combination with rebetol ( ribavirin ) and an approved hepatitis c virus ( hcv ) ns3 4a protease inhibitor is indicated in adult patients with hcv genotype 1 infection ( see labeling of the specific hcv ns3 4a protease inhibitor for further information ),1
5590,5590,5590,5590,5590,5590,5590,6774,6774,6774,6774,6774,6774,6774,6774,6774,6774,6774,6774,6774,b70816bb-913a-467f-acb8-67ef62cf8dac,pegintron in combination with rebetol is indicated in patients with genotypes other than 1  pediatric patients ( 3 17 years of age )  or in patients with genotype 1 infection where use of an hcv ns3 4a protease inhibitor is not warranted based on tolerability  contraindications or other clinical factors,1
5591,5591,5591,5591,5591,5591,5591,6775,6775,6775,6775,6775,6775,6775,6775,6775,6775,6775,6775,6775,b70816bb-913a-467f-acb8-67ef62cf8dac,pegintron monotherapy should only be used in the treatment of chc in patients with compensated liver disease if there are contraindications to or significant intolerance of rebetol and is indicated for use only in previously untreated adult patients,1
5592,5592,5592,5592,5592,5592,5592,6776,6776,6776,6776,6776,6776,6776,6776,6776,6776,6776,6776,6776,b70816bb-913a-467f-acb8-67ef62cf8dac,combination therapy provides substantially better response rates than monotherapy see clinical studies ( 14 1  14 2 ),0
5593,5593,5593,5593,5593,5593,5593,6777,6777,6777,6777,6777,6777,6777,6777,6777,6777,6777,6777,6777,cc9e1c8c-0e2b-44e2-878b-27057f786be9,1  gilenya is indicated for the treatment of patients with relapsing forms of multiple sclerosis ( ms ) to reduce the frequency of clinical exacerbations and to delay the accumulation of physical disability,1
5594,5594,5594,5594,5594,5594,5594,6778,6778,6778,6778,6778,6778,6778,6778,6778,6778,6778,6778,6778,cc9e1c8c-0e2b-44e2-878b-27057f786be9,gilenya is a sphingosine 1 phosphate receptor modulator indicated for treatment of patients with relapsing forms of multiple sclerosis ( ms ) to reduce the frequency of clinical exacerbations and to delay the accumulation of physical disability,1
5595,5595,5595,5595,5595,5595,5595,6779,6779,6779,6779,6779,6779,6779,6779,6779,6779,6779,6779,6779,e0e6412f-50b4-4fd4-9364-62818d121a07,1  ibrance is indicated for the treatment of hr positive  her2 negative advanced or metastatic breast cancer in combination with an aromatase inhibitor as initial endocrine based therapy in postmenopausal women or fulvestrant in women with disease progression following endocrine therapy,1
5596,5596,5596,5596,5596,5596,5596,6780,6780,6780,6780,6780,6780,6780,6780,6780,6780,6780,6780,6780,e0e6412f-50b4-4fd4-9364-62818d121a07,ibrance is a kinase inhibitor indicated for the treatment of hormone receptor ( hr ) positive  human epidermal growth factor receptor 2 ( her2 ) negative advanced or metastatic breast cancer in combination with an aromatase inhibitor as initial endocrine based therapy in postmenopausal women or fulvestrant in women with disease progression following endocrine therapy,1
5597,5597,5597,5597,5597,5597,5597,6781,6781,6781,6781,6781,6781,6781,6781,6781,6781,6781,6781,6781,03ca9e2a-5a27-43ff-a1cd-9c617a415b62, thyroid hormone drugs are indicated as replacement or supplemental therapy in patients with hypothyroidism of any etiology  except transient hypothyroidism during the recovery phase of subacute thyroiditis,1
5598,5598,5598,5598,5598,5598,5598,6782,6782,6782,6782,6782,6782,6782,6782,6782,6782,6782,6782,6782,03ca9e2a-5a27-43ff-a1cd-9c617a415b62,this category includes cretinism  myxedema and ordinary hypothyroidism in patients of any age ( pediatric patients  adults  the elderly )  or state ( including pregnancy ) primary hypothyroidism resulting from functional deficiency  primary atrophy  partial or total absence of thyroid gland  or the effects of surgery  radiation  or drugs  with or without the presence of goiter and secondary ( pituitary ) or tertiary ( hypothalamic ) hypothyroidism ( see warnings ),1
5599,5599,5599,5599,5599,5599,5599,6783,6783,6783,6783,6783,6783,6783,6783,6783,6783,6783,6783,6783,03ca9e2a-5a27-43ff-a1cd-9c617a415b62,as pituitary thyroid stimulating hormone ( tsh ) suppressants  in the treatment or prevention of various types of euthyroid goiters  including thyroid nodules  subacute or chronic lymphocytic thyroiditis ( hashimoto 's ) and multinodular goiter,1
5600,5600,5600,5600,5600,5600,5600,6784,6784,6784,6784,6784,6784,6784,6784,6784,6784,6784,6784,6784,03ca9e2a-5a27-43ff-a1cd-9c617a415b62,as diagnostic agents in suppression tests to differentiate suspected mild hyperthyroidism or thyroid gland autonomy,1
5601,5601,5601,5601,5601,5601,5601,6785,6785,6785,6785,6785,6785,6785,6785,6785,6785,6785,6785,6785,03ca9e2a-5a27-43ff-a1cd-9c617a415b62,liothyronine sodium tablets  usp can be used in patients allergic to desiccated thyroid or thyroid extract derived from pork or beef,1
5602,5602,5602,5602,5602,5602,5602,6786,6786,6786,6786,6786,6786,6786,6786,6786,6786,6786,6786,6786,79ad21fe-93cb-49a5-876c-eea77911f469,indications indicated as a disinfectant and devitalizing solution used as part of endodontic treatment,1
5603,5603,5603,5603,5603,5603,5603,6787,6787,6787,6787,6787,6787,6787,6787,6787,6787,6787,6787,6787,8ff37968-22a1-4904-a139-977463790f12,1  epinastine hcl ophthalmic solution 0 05 is indicated for the prevention of itching associated with allergic conjunctivitis,1
5604,5604,5604,5604,5604,5604,5604,6788,6788,6788,6788,6788,6788,6788,6788,6788,6788,6788,6788,6788,8ff37968-22a1-4904-a139-977463790f12,epinastine hcl ophthalmic solution 0 05 is an h1 histamine receptor antagonist indicated for the prevention of itching associated with allergic conjunctivitis,1
5605,5605,5605,5605,5605,5605,5605,6789,6789,6789,6789,6789,6789,6789,6789,6789,6789,6789,6789,6789,c73da51a-1899-45ad-b6cf-9c52c36a25dd, humalog mix75 25  a mixture of 75 insulin lispro protamine suspension and 25 insulin lispro injection  ( rdna origin )  is indicated in the treatment of patients with diabetes mellitus for the control of hyperglycemia,1
5606,5606,5606,5606,5606,5606,5606,6790,6790,6790,6790,6790,6790,6790,6790,6790,6790,6790,6790,6790,c73da51a-1899-45ad-b6cf-9c52c36a25dd,humalog mix75 25 has a more rapid onset of glucose lowering activity compared with humulin 70 30 while having a similar duration of action,0
5607,5607,5607,5607,5607,5607,5607,6791,6791,6791,6791,6791,6791,6791,6791,6791,6791,6791,6791,6791,c73da51a-1899-45ad-b6cf-9c52c36a25dd,this profile is achieved by combining the rapid onset of humalog with the intermediate action of insulin lispro protamine suspension,0
5608,5608,5608,5608,5608,5608,5608,6792,6792,6792,6792,6792,6792,6792,6792,6792,6792,6792,6792,6792,cf566e38-f6ff-4b86-9537-8684943b36eb, metaproterenol sulfate tablets are indicated as a bronchodilator for bronchial asthma and for reversible bronchospasm which may occur in association with bronchitis and emphysema,1
5609,5609,5609,5609,5609,5609,5609,6793,6793,6793,6793,6793,6793,6793,6793,6793,6793,6793,6793,6793,5e30120b-f2bf-43a0-86b2-44ae996dc681,1  renagel ( sevelamer hydrochloride ) is indicated for the control of serum phosphorus in patients with chronic kidney disease ( ckd ) on dialysis,1
5610,5610,5610,5610,5610,5610,5610,6794,6794,6794,6794,6794,6794,6794,6794,6794,6794,6794,6794,6794,5e30120b-f2bf-43a0-86b2-44ae996dc681,the safety and efficacy of renagel in ckd patients who are not on dialysis have not been studied,0
5611,5611,5611,5611,5611,5611,5611,6795,6795,6795,6795,6795,6795,6795,6795,6795,6795,6795,6795,6795,5e30120b-f2bf-43a0-86b2-44ae996dc681,renagel is a phosphate binder indicated for the control of serum phosphorus in patients with chronic kidney disease on dialysis,1
5612,5612,5612,5612,5612,5612,5612,6796,6796,6796,6796,6796,6796,6796,6796,6796,6796,6796,6796,6796,c45f9a58-37c1-4f76-8e36-97d38c577037,1  nplate is indicated for the treatment of thrombocytopenia in patients with chronic immune thrombocytopenia ( itp ) who have had an insufficient response to corticosteroids  immunoglobulins  or splenectomy,1
5613,5613,5613,5613,5613,5613,5613,6797,6797,6797,6797,6797,6797,6797,6797,6797,6797,6797,6797,6797,c45f9a58-37c1-4f76-8e36-97d38c577037,limitations of use nplate is not indicated for the treatment of thrombocytopenia due to myelodysplastic syndrome ( mds ) or any cause of thrombocytopenia other than chronic itp see warnings and precautions ( 5 1 ),2
5614,5614,5614,5614,5614,5614,5614,6798,6798,6798,6798,6798,6798,6798,6798,6798,6798,6798,6798,6798,c45f9a58-37c1-4f76-8e36-97d38c577037,nplate should be used only in patients with itp whose degree of thrombocytopenia and clinical condition increases the risk for bleeding see warnings and precautions ( 5 2 ),u
5615,5615,5615,5615,5615,5615,5615,6799,6799,6799,6799,6799,6799,6799,6799,6799,6799,6799,6799,6799,c45f9a58-37c1-4f76-8e36-97d38c577037,nplate should not be used in an attempt to normalize platelet counts see warnings and precautions ( 5 2 ),2
5616,5616,5616,5616,5616,5616,5616,6800,6800,6800,6800,6800,6800,6800,6800,6800,6800,6800,6800,6800,c45f9a58-37c1-4f76-8e36-97d38c577037,nplate is a thrombopoietin receptor agonist indicated for the treatment of thrombocytopenia in patients with chronic immune thrombocytopenia ( itp ) who have had an insufficient response to corticosteroids  immunoglobulins  or splenectomy,1
5617,5617,5617,5617,5617,5617,5617,6801,6801,6801,6801,6801,6801,6801,6801,6801,6801,6801,6801,6801,c45f9a58-37c1-4f76-8e36-97d38c577037,limitations of use nplate is not indicated for the treatment of thrombocytopenia due to myelodysplastic syndrome ( mds ) or any cause of thrombocytopenia other than chronic itp,2
5618,5618,5618,5618,5618,5618,5618,6802,6802,6802,6802,6802,6802,6802,6802,6802,6802,6802,6802,6802,c45f9a58-37c1-4f76-8e36-97d38c577037,nplate should be used only in patients with itp whose degree of thrombocytopenia and clinical condition increases the risk for bleeding,u
5619,5619,5619,5619,5619,5619,5619,6803,6803,6803,6803,6803,6803,6803,6803,6803,6803,6803,6803,6803,c45f9a58-37c1-4f76-8e36-97d38c577037,nplate should not be used in an attempt to normalize platelet counts,2
5620,5620,5620,5620,5620,5620,5620,6804,6804,6804,6804,6804,6804,6804,6804,6804,6804,6804,6804,6804,a5d389d2-d0e1-4395-a2a2-b552808e7f98,1  sabril is indicated for the treatment of refractory complex partial seizures as adjunctive therapy in patients 10 years of age who have responded inadequately to several alternative treatments sabril is not indicated as a first line agent ( 1 1 ) infantile spasms monotherapy in infants 1 month to 2 years of age for whom the potential benefits outweigh the potential risk of vision loss ( 1 2 ) 1 1 refractory complex partial seizures ( cps ) sabril is indicated as adjunctive therapy for adults and pediatric patients 10 years of age and older with refractory complex partial seizures who have inadequately responded to several alternative treatments and for whom the potential benefits outweigh the risk of vision loss see warnings and precautions ( 5 1 ),1
5621,5621,5621,5621,5621,5621,5621,6805,6805,6805,6805,6805,6805,6805,6805,6805,6805,6805,6805,6805,a5d389d2-d0e1-4395-a2a2-b552808e7f98,sabril is not indicated as a first line agent for complex partial seizures,2
5622,5622,5622,5622,5622,5622,5622,6806,6806,6806,6806,6806,6806,6806,6806,6806,6806,6806,6806,6806,a5d389d2-d0e1-4395-a2a2-b552808e7f98,1 2 infantile spasms ( is ) sabril is indicated as monotherapy for pediatric patients with infantile spasms 1 month to 2 years of age for whom the potential benefits outweigh the potential risk of vision loss see warnings and precautions ( 5 1 ),1
5623,5623,5623,5623,5623,5623,5623,6807,6807,6807,6807,6807,6807,6807,6807,6807,6807,6807,6807,6807,164046da-3953-437b-bc8e-a8cb0465f616, promethazine with codeine oral solution is indicated for the temporary relief of coughs and upper respiratory symptoms associated with allergy or the common cold,1
5624,5624,5624,5624,5624,5624,5624,6808,6808,6808,6808,6808,6808,6808,6808,6808,6808,6808,6808,6808,f3114cff-d638-4562-9e11-88130677363c,1  codeine phosphate and chlorpheniramine maleate is indicated for the relief of cough and symptoms associated with upper respiratory allergies or a common cold in adults 18 years of age and older,1
5625,5625,5625,5625,5625,5625,5625,6809,6809,6809,6809,6809,6809,6809,6809,6809,6809,6809,6809,6809,f3114cff-d638-4562-9e11-88130677363c,important limitations of use not indicated for pediatric patients under 18 years of age see use in special population ( 8 4 ) codeine phosphate and chlorpheniramine maleate is a combination of codeine phosphate  an opiate agonist antitussive  and chlorpheniramine maleate  a histamine 1 ( h1 ) receptor antagonist indicated for the relief of cough and symptoms associated with upper respiratory allergies or a common cold,1
5626,5626,5626,5626,5626,5626,5626,6810,6810,6810,6810,6810,6810,6810,6810,6810,6810,6810,6810,6810,f3114cff-d638-4562-9e11-88130677363c,( 1 ) important limitations of use not indicated for pediatric patients under 18 years of age ( 8 4 ) ),2
5627,5627,5627,5627,5627,5627,5627,6811,6811,6811,6811,6811,6811,6811,6811,6811,6811,6811,6811,6811,eabae489-e254-4987-ab90-7cda20a6f856, enalaprilat injection  usp is indicated for the treatment of hypertension when oral therapy is not practical,1
5628,5628,5628,5628,5628,5628,5628,6812,6812,6812,6812,6812,6812,6812,6812,6812,6812,6812,6812,6812,eabae489-e254-4987-ab90-7cda20a6f856,enalaprilat injection  usp has been studied with only one other antihypertensive agent  furosemide  which showed approximately additive effects on blood pressure,0
5629,5629,5629,5629,5629,5629,5629,6813,6813,6813,6813,6813,6813,6813,6813,6813,6813,6813,6813,6813,eabae489-e254-4987-ab90-7cda20a6f856,enalapril  the pro drug of enalaprilat  has been used extensively with a variety of other antihypertensive agents  without apparent difficulty except for occasional hypotension,0
5630,5630,5630,5630,5630,5630,5630,6814,6814,6814,6814,6814,6814,6814,6814,6814,6814,6814,6814,6814,eabae489-e254-4987-ab90-7cda20a6f856,in using enalaprilat injection  usp  consideration should be given to the fact that another angiotensin converting enzyme inhibitor  captopril  has caused agranulocytosis  particularly in patients with renal impairment or collagen vascular disease  and that available data are insufficient to show that enalaprilat injection  usp does not have a similar risk,u
5631,5631,5631,5631,5631,5631,5631,6815,6815,6815,6815,6815,6815,6815,6815,6815,6815,6815,6815,6815,eabae489-e254-4987-ab90-7cda20a6f856,in considering use of enalaprilat injection  usp  it should be noted that in controlled clinical trials ace inhibitors have an effect on blood pressure that is less in black patients than in non blacks,0
5632,5632,5632,5632,5632,5632,5632,6816,6816,6816,6816,6816,6816,6816,6816,6816,6816,6816,6816,6816,eabae489-e254-4987-ab90-7cda20a6f856,in addition  it should be noted that black patients receiving ace inhibitors have been reported to have a higher incidence of angioedema compared to non blacks,0
5633,5633,5633,5633,5633,5633,5633,6817,6817,6817,6817,6817,6817,6817,6817,6817,6817,6817,6817,6817,222f3d0a-7649-44ad-99b2-b2dc8c298e7b, primaquine phosphate is indicated for the radical cure ( prevention of relapse ) of vivax malaria,1
5634,5634,5634,5634,5634,5634,5634,6818,6818,6818,6818,6818,6818,6818,6818,6818,6818,6818,6818,6818,f80f025b-17d8-40af-8739-20ce07902045,1  aveed is indicated for testosterone replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous testosterone,1
5635,5635,5635,5635,5635,5635,5635,6819,6819,6819,6819,6819,6819,6819,6819,6819,6819,6819,6819,6819,f80f025b-17d8-40af-8739-20ce07902045,primary hypogonadism ( congenital or acquired ) testicular failure due to cryptorchidism  bilateral torsion  orchitis  vanishing testis syndrome  orchiectomy  klinefelter s syndrome  chemotherapy  or toxic damage from alcohol or heavy metals,1
5636,5636,5636,5636,5636,5636,5636,6820,6820,6820,6820,6820,6820,6820,6820,6820,6820,6820,6820,6820,f80f025b-17d8-40af-8739-20ce07902045,these men usually have low serum testosterone concentrations and gonadotropins ( follicle stimulating hormone fsh  luteinizing hormone lh ) above the normal range,0
5637,5637,5637,5637,5637,5637,5637,6821,6821,6821,6821,6821,6821,6821,6821,6821,6821,6821,6821,6821,f80f025b-17d8-40af-8739-20ce07902045,hypogonadotropic hypogonadism ( congenital or acquired ) gonadotropin or luteinizing hormone releasing hormone ( lhrh ) deficiency or pituitary hypothalamic injury from tumors  trauma  or radiation,1
5638,5638,5638,5638,5638,5638,5638,6822,6822,6822,6822,6822,6822,6822,6822,6822,6822,6822,6822,6822,f80f025b-17d8-40af-8739-20ce07902045,these men have low testosterone serum concentrations but have gonadotropins in the normal or low range,0
5639,5639,5639,5639,5639,5639,5639,6823,6823,6823,6823,6823,6823,6823,6823,6823,6823,6823,6823,6823,f80f025b-17d8-40af-8739-20ce07902045,aveed should only be used in patients who require testosterone replacement therapy and in whom the benefits of the product outweigh the serious risks of pulmonary oil microembolism and anaphylaxis,u
5640,5640,5640,5640,5640,5640,5640,6824,6824,6824,6824,6824,6824,6824,6824,6824,6824,6824,6824,6824,f80f025b-17d8-40af-8739-20ce07902045,limitations of use safety and efficacy of aveed in men with age related hypogonadism ( also referred to as late onset hypogonadism ) have not been established,0
5641,5641,5641,5641,5641,5641,5641,6825,6825,6825,6825,6825,6825,6825,6825,6825,6825,6825,6825,6825,f80f025b-17d8-40af-8739-20ce07902045,safety and efficacy of aveed in males less than 18 years old have not been established see use in specific populations ( 8 4 ),0
5642,5642,5642,5642,5642,5642,5642,6826,6826,6826,6826,6826,6826,6826,6826,6826,6826,6826,6826,6826,f80f025b-17d8-40af-8739-20ce07902045,aveed ( testosterone undecanoate ) injection is an androgen indicated for testosterone replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous testosterone o primary hypogonadism ( congenital or acquired ) ( 1 ) o hypogonadotropic hypogonadism ( congenital or acquired ) ( 1 ) aveed should only be used in patients who require testosterone replacement therapy and in whom the benefits of the product outweigh the serious risks of pulmonary oil microembolism and anaphylaxis ( 1 ),1
5643,5643,5643,5643,5643,5643,5643,6827,6827,6827,6827,6827,6827,6827,6827,6827,6827,6827,6827,6827,f80f025b-17d8-40af-8739-20ce07902045,limitations of use safety and efficacy of aveed in men with age related hypogonadism have not been established ( 1 ),0
5644,5644,5644,5644,5644,5644,5644,6828,6828,6828,6828,6828,6828,6828,6828,6828,6828,6828,6828,6828,f80f025b-17d8-40af-8739-20ce07902045,safety and efficacy of aveed in males less than 18 years old have not been established ( 1  8 4 ),0
5645,5645,5645,5645,5645,5645,5645,6829,6829,6829,6829,6829,6829,6829,6829,6829,6829,6829,6829,6829,3f059e04-1ebc-40bb-a49c-f9d90d41b1cb, nandrolone decanoate is indicated for the management of the anemia of renal insufficiency and has been shown to increase hemoglobin and red cell mass,1
5646,5646,5646,5646,5646,5646,5646,6830,6830,6830,6830,6830,6830,6830,6830,6830,6830,6830,6830,6830,3f059e04-1ebc-40bb-a49c-f9d90d41b1cb,surgically induced anephric patients have been reported to be less responsive,0
5647,5647,5647,5647,5647,5647,5647,6831,6831,6831,6831,6831,6831,6831,6831,6831,6831,6831,6831,6831,c86f7dc5-7187-46c2-854f-a0876c510a96,indications usage bethanechol chloride is indicated for the treatment of acute postoperative and postpartum nonobstructive ( functional ) urinary retention and for neurogenic atony of the urinary bladder with retention,1
5648,5648,5648,5648,5648,5648,5648,6832,6832,6832,6832,6832,6832,6832,6832,6832,6832,6832,6832,6832,781ab6e3-b8c4-56f6-8a08-c100b3172df0, baclofen is useful for the alleviation of signs and symptoms of spasticity resulting from multiple sclerosis  particularly for the relief of flexor spasms and concomitant pain  clonus  and muscular rigidity,1
5649,5649,5649,5649,5649,5649,5649,6833,6833,6833,6833,6833,6833,6833,6833,6833,6833,6833,6833,6833,781ab6e3-b8c4-56f6-8a08-c100b3172df0,patients should have reversible spasticity so that baclofen treatment will aid in restoring residual function,u
5650,5650,5650,5650,5650,5650,5650,6834,6834,6834,6834,6834,6834,6834,6834,6834,6834,6834,6834,6834,781ab6e3-b8c4-56f6-8a08-c100b3172df0,baclofen may also be of some value in patients with spinal cord injuries and other spinal cord diseases,u
5651,5651,5651,5651,5651,5651,5651,6835,6835,6835,6835,6835,6835,6835,6835,6835,6835,6835,6835,6835,781ab6e3-b8c4-56f6-8a08-c100b3172df0,baclofen is not indicated in the treatment of skeletal muscle spasm resulting from rheumatic disorders,2
5652,5652,5652,5652,5652,5652,5652,6836,6836,6836,6836,6836,6836,6836,6836,6836,6836,6836,6836,6836,781ab6e3-b8c4-56f6-8a08-c100b3172df0,the efficacy of baclofen in stroke  cerebral palsy  and parkinson 's disease has not been established and  therefore  it is not recommended for these conditions,2
5653,5653,5653,5653,5653,5653,5653,6837,6837,6837,6837,6837,6837,6837,6837,6837,6837,6837,6837,6837,71cf3309-e182-473c-8b0b-280cabd0e122,1  fycompa  a non competitive ampa glutamate receptor antagonist  is indicated for treatment of partial onset seizures with or without secondarily generalized seizures in patients with epilepsy 12 years of age and older ( 1 1 ) adjunctive therapy in the treatment of primary generalized tonic clonic seizures in patients with epilepsy 12 years of age and older ( 1 2 ) 1 1 partial onset seizures fycompa is indicated for the treatment of partial onset seizures with or without secondarily generalized seizures in patients with epilepsy 12 years of age and older,1
5654,5654,5654,5654,5654,5654,5654,6838,6838,6838,6838,6838,6838,6838,6838,6838,6838,6838,6838,6838,71cf3309-e182-473c-8b0b-280cabd0e122,1 2 primary generalized tonic clonic seizures fycompa is indicated as adjunctive therapy for the treatment of primary generalized tonic clonic seizures in patients with epilepsy 12 years of age and older,1
5655,5655,5655,5655,5655,5655,5655,6839,6839,6839,6839,6839,6839,6839,6839,6839,6839,6839,6839,6839,6fc2e41e-a1bf-4e0f-924a-88be0372d4af, technescan hdp tc 99m is a diagnostic skeletal imaging agent used to demonstrate areas of altered osteogenesis in adult and pediatric patients,1
5656,5656,5656,5656,5656,5656,5656,6840,6840,6840,6840,6840,6840,6840,6840,6840,6840,6840,6840,6840,07c33315-90c9-4a73-bf1d-bca70c7e0ff5,1  nucynta ( tapentadol ) is indicated for the relief of moderate to severe acute pain in patients 18 years of age or older,1
5657,5657,5657,5657,5657,5657,5657,6841,6841,6841,6841,6841,6841,6841,6841,6841,6841,6841,6841,6841,df4cd207-c3b8-4008-5290-02f296c2b4a6,1  fenoldopam injection is a dopaminergic agonist indicated in adult patients for short term management of severe hypertension when rapid and reversible reduction of blood pressure is clinically indicated  including for malignant hypertension with deteriorating end organ function ( 1 1 ),1
5658,5658,5658,5658,5658,5658,5658,6842,6842,6842,6842,6842,6842,6842,6842,6842,6842,6842,6842,6842,df4cd207-c3b8-4008-5290-02f296c2b4a6,in pediatric patients for short term reduction in blood pressure ( 1 2 ),1
5659,5659,5659,5659,5659,5659,5659,6843,6843,6843,6843,6843,6843,6843,6843,6843,6843,6843,6843,6843,df4cd207-c3b8-4008-5290-02f296c2b4a6,1 1 adult patients fenoldopam is indicated for in hospital  short term ( up to 48 hours ) management of severe hypertension when rapid  but quickly reversible  emergency reduction of blood pressure is clinically indicated  including malignant hypertension with deteriorating end organ function,1
5660,5660,5660,5660,5660,5660,5660,6844,6844,6844,6844,6844,6844,6844,6844,6844,6844,6844,6844,6844,df4cd207-c3b8-4008-5290-02f296c2b4a6,transition to oral therapy with another agent can begin at any time after blood pressure is stable during fenoldopam infusion,0
5661,5661,5661,5661,5661,5661,5661,6845,6845,6845,6845,6845,6845,6845,6845,6845,6845,6845,6845,6845,df4cd207-c3b8-4008-5290-02f296c2b4a6,1 2 pediatric patients fenoldopam is indicated for in hospital  short term ( up to 4 hours ) reduction in blood pressure see clinical pharmacology ( 12 2 ),1
5662,5662,5662,5662,5662,5662,5662,6846,6846,6846,6846,6846,6846,6846,6846,6846,6846,6846,6846,6846,56879738-8662-4f5c-8386-761ab2b5e46f, sotalol hydrochloride tablets are an antiarrhythmic indicated for the treatment of life threatening ventricular arrhythmias ( 1 1 ) limitations of use avoid use in patients with asymptomatic ventricular premature contraction ( 1 1 ) 1 1 life threatening ventricular arrhythmias sotalol hydrochloride tablets are indicated for the treatment of life threatening  documented ventricular arrhythmias  such as sustained ventricular tachycardia ( vt ),1
5663,5663,5663,5663,5663,5663,5663,6847,6847,6847,6847,6847,6847,6847,6847,6847,6847,6847,6847,6847,56879738-8662-4f5c-8386-761ab2b5e46f,limitation of use sotalol hydrochloride tablets may not enhance survival in patients with ventricular arrhythmias,0
5664,5664,5664,5664,5664,5664,5664,6848,6848,6848,6848,6848,6848,6848,6848,6848,6848,6848,6848,6848,56879738-8662-4f5c-8386-761ab2b5e46f,because of the proarrhythmic effects of sotalol hydrochloride tablets  including a 1 5 to 2 rate of torsade de pointes ( tdp ) or new ventricular tachycardia fibrillation ( vt vf ) in patients with either non sustained ventricular tachycardia ( nsvt ) or supraventricular arrhythmias ( svt )  its use in patients with less severe arrhythmias  even if the patients are symptomatic  is generally not recommended,2
5665,5665,5665,5665,5665,5665,5665,6849,6849,6849,6849,6849,6849,6849,6849,6849,6849,6849,6849,6849,56879738-8662-4f5c-8386-761ab2b5e46f,avoid treatment of patients with asymptomatic ventricular premature contractions see warnings and precautions ( 5 2 ),2
5666,5666,5666,5666,5666,5666,5666,6850,6850,6850,6850,6850,6850,6850,6850,6850,6850,6850,6850,6850,ac8134d9-a726-4508-b8b9-a536ef17243d, tobramycin is indicated for the treatment of serious bacterial infections caused by susceptible strains of the designated microorganisms in the diseases listed below septicemia in the neonate  child  and adult caused by p aeruginosa  e coli  and klebsiella sp,1
5667,5667,5667,5667,5667,5667,5667,6851,6851,6851,6851,6851,6851,6851,6851,6851,6851,6851,6851,6851,ac8134d9-a726-4508-b8b9-a536ef17243d,lower respiratory tract infections caused by p aeruginosa  klebsiella sp  enterobacter sp  serratia sp  e coli  and s aureus ( penicillinase and non penicillinase producing strains ),1
5668,5668,5668,5668,5668,5668,5668,6852,6852,6852,6852,6852,6852,6852,6852,6852,6852,6852,6852,6852,ac8134d9-a726-4508-b8b9-a536ef17243d,serious central nervous system infections ( meningitis ) caused by susceptible organisms,1
5669,5669,5669,5669,5669,5669,5669,6853,6853,6853,6853,6853,6853,6853,6853,6853,6853,6853,6853,6853,ac8134d9-a726-4508-b8b9-a536ef17243d,intra abdominal infections  including peritonitis  caused by e coli  klebsiella sp  and enterobacter sp,1
5670,5670,5670,5670,5670,5670,5670,6854,6854,6854,6854,6854,6854,6854,6854,6854,6854,6854,6854,6854,ac8134d9-a726-4508-b8b9-a536ef17243d,skin  bone  and skin structure infections caused by p aeruginosa  proteus sp  e coli  klebsiella sp  enterobacter sp  and s aureus,1
5671,5671,5671,5671,5671,5671,5671,6855,6855,6855,6855,6855,6855,6855,6855,6855,6855,6855,6855,6855,ac8134d9-a726-4508-b8b9-a536ef17243d,complicated and recurrent urinary tract infections caused by p aeruginosa  proteus sp ( indole positive and indole negative )  e coli  klebsiella sp  enterobacter sp  serratia sp  s aureus  providencia sp  and citrobacter sp,1
5672,5672,5672,5672,5672,5672,5672,6856,6856,6856,6856,6856,6856,6856,6856,6856,6856,6856,6856,6856,ac8134d9-a726-4508-b8b9-a536ef17243d,aminoglycosides  including tobramycin sulfate  are not indicated in uncomplicated initial episodes of urinary tract infections unless the causative organisms are not susceptible to antibiotics having less potential toxicity,u
5673,5673,5673,5673,5673,5673,5673,6857,6857,6857,6857,6857,6857,6857,6857,6857,6857,6857,6857,6857,ac8134d9-a726-4508-b8b9-a536ef17243d,tobramycin may be considered in serious staphylococcal infections when penicillin or other potentially less toxic drugs are contraindicated and when bacterial susceptibility testing and clinical judgment indicate its use,u
5674,5674,5674,5674,5674,5674,5674,6858,6858,6858,6858,6858,6858,6858,6858,6858,6858,6858,6858,6858,ac8134d9-a726-4508-b8b9-a536ef17243d,bacterial cultures should be obtained prior to and during treatment to isolate and identify etiologic organisms and to test their susceptibility to tobramycin,0
5675,5675,5675,5675,5675,5675,5675,6859,6859,6859,6859,6859,6859,6859,6859,6859,6859,6859,6859,6859,ac8134d9-a726-4508-b8b9-a536ef17243d,if susceptibility tests show that the causative organisms are resistant to tobramycin  other appropriate therapy should be instituted,0
5676,5676,5676,5676,5676,5676,5676,6860,6860,6860,6860,6860,6860,6860,6860,6860,6860,6860,6860,6860,ac8134d9-a726-4508-b8b9-a536ef17243d,in patients in whom a serious life threatening gram negative infection is suspected  including those in whom concurrent therapy with a penicillin or cephalosporin and an aminoglycoside may be indicated  treatment with tobramycin sulfate may be initiated before the results of susceptibility studies are obtained,u
5677,5677,5677,5677,5677,5677,5677,6861,6861,6861,6861,6861,6861,6861,6861,6861,6861,6861,6861,6861,ac8134d9-a726-4508-b8b9-a536ef17243d,the decision to continue therapy with tobramycin should be based on the results of susceptibility studies  the severity of the infection  and the important additional concepts discussed in the warnings box above,0
5678,5678,5678,5678,5678,5678,5678,6862,6862,6862,6862,6862,6862,6862,6862,6862,6862,6862,6862,6862,ac8134d9-a726-4508-b8b9-a536ef17243d,to reduce the development of drug resistant bacteria and maintain the effectiveness of tobramycin and other antibacterial drugs  tobramycin should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria,0
5679,5679,5679,5679,5679,5679,5679,6864,6864,6864,6864,6864,6864,6864,6864,6864,6864,6864,6864,6864,731d4e0d-e73b-41ef-a39f-c356d999734d,for the treatment of patients with hypokalemia  with or without metabolic alkalosis in digitalis intoxication and in patients with hypokalemic familial periodic paralysis,1
5680,5680,5680,5680,5680,5680,5680,6866,6866,6866,6866,6866,6866,6866,6866,6866,6866,6866,6866,6866,731d4e0d-e73b-41ef-a39f-c356d999734d,for the prevention of hypokalemia in patients who would be at particular risk if hypokalemia were to develop ( e g  digitalized patients or patients with significant cardiac arrhythmias ),1
5681,5681,5681,5681,5681,5681,5681,6870,6870,6870,6870,6870,6870,6870,6870,6870,6870,6870,6870,6870,0fe9d533-67a9-4981-978a-1e84755ae30b,1  zejula is indicated for the maintenance treatment of adult patients with recurrent epithelial ovarian  fallopian tube  or primary peritoneal cancer who are in a complete or partial response to platinum based chemotherapy,1
5682,5682,5682,5682,5682,5682,5682,6871,6871,6871,6871,6871,6871,6871,6871,6871,6871,6871,6871,6871,0fe9d533-67a9-4981-978a-1e84755ae30b,zejula is a poly ( adp ribose ) polymerase ( parp ) inhibitor indicated for the maintenance treatment of adult patients with recurrent epithelial ovarian  fallopian tube  or primary peritoneal cancer who are in a complete or partial response to platinum based chemotherapy,1
5683,5683,5683,5683,5683,5683,5683,6872,6872,6872,6872,6872,6872,6872,6872,6872,6872,6872,6872,6872,7774972a-eeaa-4b9a-9e56-3fc1b968e86a,1  farydak  a histone deacetylase inhibitor  in combination with bortezomib and dexamethasone  is indicated for the treatment of patients with multiple myeloma who have received at least 2 prior regimens  including bortezomib and an immunomodulatory agent,1
5684,5684,5684,5684,5684,5684,5684,6873,6873,6873,6873,6873,6873,6873,6873,6873,6873,6873,6873,6873,7774972a-eeaa-4b9a-9e56-3fc1b968e86a,this indication is approved under accelerated approval based on progression free survival see clinical studies ( 14 1 ),0
5685,5685,5685,5685,5685,5685,5685,6875,6875,6875,6875,6875,6875,6875,6875,6875,6875,6875,6875,6875,7774972a-eeaa-4b9a-9e56-3fc1b968e86a,farydak  a histone deacetylase inhibitor  in combination with bortezomib and dexamethasone  is indicated for the treatment of patients with multiple myeloma who have received at least 2 prior regimens  including bortezomib and an immunomodulatory agent,1
5686,5686,5686,5686,5686,5686,5686,6876,6876,6876,6876,6876,6876,6876,6876,6876,6876,6876,6876,6876,7774972a-eeaa-4b9a-9e56-3fc1b968e86a,this indication is approved under accelerated approval based on progression free survival,0
5687,5687,5687,5687,5687,5687,5687,6878,6878,6878,6878,6878,6878,6878,6878,6878,6878,6878,6878,6878,6218b1e1-cbc3-4c14-bec7-528ac163a561,1  eovist is indicated for intravenous use in magnetic resonance imaging ( mri ) of the liver to detect and characterize lesions in patients with known or suspected focal liver disease,1
5688,5688,5688,5688,5688,5688,5688,6879,6879,6879,6879,6879,6879,6879,6879,6879,6879,6879,6879,6879,6218b1e1-cbc3-4c14-bec7-528ac163a561,eovist is a gadolinium based contrast agent indicated for use in magnetic resonance imaging ( mri ) of the liver to detect and characterize lesions in patients with known or suspected focal liver disease ( 1 ),1
5689,5689,5689,5689,5689,5689,5689,6880,6880,6880,6880,6880,6880,6880,6880,6880,6880,6880,6880,6880,d7fbf301-0b08-4b19-bfa0-e0c0067cb5ab,1  mycophenolic acid delayed release tablets are an antimetabolite immunosuppressant indicated for prophylaxis of organ rejection in adult patients receiving kidney transplants and in pediatric patients at least 5 years of age and older who are at least 6 months post kidney transplant,1
5690,5690,5690,5690,5690,5690,5690,6881,6881,6881,6881,6881,6881,6881,6881,6881,6881,6881,6881,6881,d7fbf301-0b08-4b19-bfa0-e0c0067cb5ab,( 1 1 ) use in combination with cyclosporine and corticosteroids,1
5691,5691,5691,5691,5691,5691,5691,6882,6882,6882,6882,6882,6882,6882,6882,6882,6882,6882,6882,6882,d7fbf301-0b08-4b19-bfa0-e0c0067cb5ab,( 1 1 ) limitations of use mycophenolic acid delayed release tablets and mycophenolate mofetil tablets and capsules should not be used interchangeably,0
5692,5692,5692,5692,5692,5692,5692,6883,6883,6883,6883,6883,6883,6883,6883,6883,6883,6883,6883,6883,d7fbf301-0b08-4b19-bfa0-e0c0067cb5ab,( 1 2 ) 1 1 prophylaxis of organ rejection in kidney transplant mycophenolic acid delayed release tablets are indicated for the prophylaxis of organ rejection in adult patients receiving a kidney transplant,1
5693,5693,5693,5693,5693,5693,5693,6884,6884,6884,6884,6884,6884,6884,6884,6884,6884,6884,6884,6884,d7fbf301-0b08-4b19-bfa0-e0c0067cb5ab,mycophenolic acid delayed release tablets are indicated for the prophylaxis of organ rejection in pediatric patients 5 years of age and older who are at least 6 months post kidney transplant,1
5694,5694,5694,5694,5694,5694,5694,6885,6885,6885,6885,6885,6885,6885,6885,6885,6885,6885,6885,6885,d7fbf301-0b08-4b19-bfa0-e0c0067cb5ab,mycophenolic acid delayed release tablets are to be used in combination with cyclosporine and corticosteroids,4
5695,5695,5695,5695,5695,5695,5695,6886,6886,6886,6886,6886,6886,6886,6886,6886,6886,6886,6886,6886,d7fbf301-0b08-4b19-bfa0-e0c0067cb5ab,1 2 limitations of use mycophenolic acid delayed release tablets and mycophenolate mofetil ( mmf ) tablets and capsules should not be used interchangeably without physician supervision because the rate of absorption following the administration of these two products is not equivalent,4
5696,5696,5696,5696,5696,5696,5696,6887,6887,6887,6887,6887,6887,6887,6887,6887,6887,6887,6887,6887,9880b900-ea23-11dc-ad56-0002a5d5c51b, adagen ( pegademase bovine ) injection is indicated for enzyme replacement therapy for adenosine deaminase ( ada ) deficiency in patients with severe combined immunodeficiency disease ( scid ) who are not suitable candidates for or who have failed bone marrow transplantation,1
5697,5697,5697,5697,5697,5697,5697,6888,6888,6888,6888,6888,6888,6888,6888,6888,6888,6888,6888,6888,9880b900-ea23-11dc-ad56-0002a5d5c51b,adagen ( pegademase bovine ) injection is recommended for use in infants from birth or in children of any age at the time of diagnosis,1
5698,5698,5698,5698,5698,5698,5698,6889,6889,6889,6889,6889,6889,6889,6889,6889,6889,6889,6889,6889,9880b900-ea23-11dc-ad56-0002a5d5c51b,adagen ( pegademase bovine ) injection is not intended as a replacement for hla identical bone marrow transplant therapy,0
5699,5699,5699,5699,5699,5699,5699,6890,6890,6890,6890,6890,6890,6890,6890,6890,6890,6890,6890,6890,9880b900-ea23-11dc-ad56-0002a5d5c51b,adagen ( pegademase bovine ) injection is also not intended to replace continued close medical supervision and the initiation of appropriate diagnostic tests and therapy ( e g  antibiotics  nutrition  oxygen  gammaglobulin ) as indicated for intercurrent illnesses,0
5700,5700,5700,5700,5700,5700,5700,6891,6891,6891,6891,6891,6891,6891,6891,6891,6891,6891,6891,6891,e9d87b8c-7695-4c0f-8e81-000dedb5f66d,1  visipaque is indicated in for visipaque injection is a radiographic contrast agent indicated for the following intra arterial procedures ( 1 1 ) adults and pediatric patients 12 years of age and over intra arterial digital subtraction angiography ( 270 and 320 mg iodine ml ),1
5701,5701,5701,5701,5701,5701,5701,6892,6892,6892,6892,6892,6892,6892,6892,6892,6892,6892,6892,6892,e9d87b8c-7695-4c0f-8e81-000dedb5f66d,angiocardiography ( left ventriculography and selective coronary arteriography )  peripheral arteriography  visceral arteriography  and cerebral arteriography ( 320 mg iodine ml ),1
5702,5702,5702,5702,5702,5702,5702,6893,6893,6893,6893,6893,6893,6893,6893,6893,6893,6893,6893,6893,e9d87b8c-7695-4c0f-8e81-000dedb5f66d,pediatric patients less than 12 years of age angiocardiography  cerebral arteriography  and visceral arteriography ( 320 mg iodine ml ),1
5703,5703,5703,5703,5703,5703,5703,6894,6894,6894,6894,6894,6894,6894,6894,6894,6894,6894,6894,6894,e9d87b8c-7695-4c0f-8e81-000dedb5f66d,intravenous procedures ( 1 2 ) adults and pediatric patients 12 years of age and over computed tomography ( ct ) imaging head and body and excretory urography ( 270 and 320 mg iodine ml ),1
5704,5704,5704,5704,5704,5704,5704,6895,6895,6895,6895,6895,6895,6895,6895,6895,6895,6895,6895,6895,e9d87b8c-7695-4c0f-8e81-000dedb5f66d,peripheral venography ( 270 mg iodine ml ),1
5705,5705,5705,5705,5705,5705,5705,6896,6896,6896,6896,6896,6896,6896,6896,6896,6896,6896,6896,6896,e9d87b8c-7695-4c0f-8e81-000dedb5f66d,coronary computed tomography angiography ( ccta ) to assist diagnostic evaluation of patients with suspected coronary artery disease ( 320 mg iodine ml ),1
5706,5706,5706,5706,5706,5706,5706,6897,6897,6897,6897,6897,6897,6897,6897,6897,6897,6897,6897,6897,e9d87b8c-7695-4c0f-8e81-000dedb5f66d,pediatric patients less than 12 years of age ct imaging of the head and body and excretory urography ( 270 mg iodine ml ),1
5707,5707,5707,5707,5707,5707,5707,6898,6898,6898,6898,6898,6898,6898,6898,6898,6898,6898,6898,6898,e9d87b8c-7695-4c0f-8e81-000dedb5f66d,1 1 intra arterial procedures adult and pediatric patients 12 years of age and older ( 270 and 320 mg iodine ml ) intra arterial digital subtraction angiography ( ia dsa ),1
5708,5708,5708,5708,5708,5708,5708,6899,6899,6899,6899,6899,6899,6899,6899,6899,6899,6899,6899,6899,e9d87b8c-7695-4c0f-8e81-000dedb5f66d,( 320 mg iodine ml ) angiocardiography ( left ventriculography and selective coronary arteriography )  peripheral arteriography  visceral arteriography  and cerebral arteriography,1
5709,5709,5709,5709,5709,5709,5709,6900,6900,6900,6900,6900,6900,6900,6900,6900,6900,6900,6900,6900,e9d87b8c-7695-4c0f-8e81-000dedb5f66d,pediatric patients less than 12 years of age,1
5710,5710,5710,5710,5710,5710,5710,6901,6901,6901,6901,6901,6901,6901,6901,6901,6901,6901,6901,6901,82f55408-2de9-463d-85e8-b39c3b259f0b,1  sodium thiosulfate injection is indicated for sequential use with sodium nitrite for the treatment of acute cyanide poisoning that is judged to be serious or life threatening,1
5711,5711,5711,5711,5711,5711,5711,6902,6902,6902,6902,6902,6902,6902,6902,6902,6902,6902,6902,6902,82f55408-2de9-463d-85e8-b39c3b259f0b,when the diagnosis of cyanide poisoning is uncertain  the potential risks associated with sodium thiosulfate injection should be carefully weighed against the potential benefits  especially if the patient is not in extremis,0
5712,5712,5712,5712,5712,5712,5712,6903,6903,6903,6903,6903,6903,6903,6903,6903,6903,6903,6903,6903,82f55408-2de9-463d-85e8-b39c3b259f0b,sodium thiosulfate injection is indicated for sequential use with sodium nitrite for treatment of acute cyanide poisoning that is judged to be serious or life threatening,1
5713,5713,5713,5713,5713,5713,5713,6904,6904,6904,6904,6904,6904,6904,6904,6904,6904,6904,6904,6904,82f55408-2de9-463d-85e8-b39c3b259f0b,( 1 ) use with caution if the diagnosis of cyanide poisoning is uncertain,4
5714,5714,5714,5714,5714,5714,5714,6905,6905,6905,6905,6905,6905,6905,6905,6905,6905,6905,6905,6905,ff4941b3-9901-4aab-adcf-c5327bede34e,1  nithiodote is indicated for the treatment of acute cyanide poisoning that is judged to be serious or life threatening,1
5715,5715,5715,5715,5715,5715,5715,6906,6906,6906,6906,6906,6906,6906,6906,6906,6906,6906,6906,6906,ff4941b3-9901-4aab-adcf-c5327bede34e,when the diagnosis of cyanide poisoning is uncertain  carefully weigh the potentially life threatening risks associated with nithiodote against the potential benefits  especially if the patient is not in extremis,4
5716,5716,5716,5716,5716,5716,5716,6907,6907,6907,6907,6907,6907,6907,6907,6907,6907,6907,6907,6907,ff4941b3-9901-4aab-adcf-c5327bede34e,nithiodote  an antidote  is indicated for the treatment of acute cyanide poisoning that is judged to be serious or life threatening,1
5717,5717,5717,5717,5717,5717,5717,6909,6909,6909,6909,6909,6909,6909,6909,6909,6909,6909,6909,6909,48fe6f49-c0fa-0430-e054-00144ff8d46c, ampicillin capsules  usp are indicated in the treatment of infections caused by susceptible strains of the designated organism listed below infections of the genitourinary tract including gonorrhea e coli  p mirabilis  enterococci  shigella  s typhosa and other salmonella  and nonpenicillinase producing n gonorrhoeae,1
5718,5718,5718,5718,5718,5718,5718,6910,6910,6910,6910,6910,6910,6910,6910,6910,6910,6910,6910,6910,48fe6f49-c0fa-0430-e054-00144ff8d46c,infections of the respiratory tract nonpenicillinase producing h influenzae and staphylococci  and streptococci including streptococcus pneumoniae,1
5719,5719,5719,5719,5719,5719,5719,6911,6911,6911,6911,6911,6911,6911,6911,6911,6911,6911,6911,6911,48fe6f49-c0fa-0430-e054-00144ff8d46c,infections of the gastrointestinal tract shigella  s typhosa and other salmonella  e coli  p mirabilis  and enterococci,1
5720,5720,5720,5720,5720,5720,5720,6912,6912,6912,6912,6912,6912,6912,6912,6912,6912,6912,6912,6912,48fe6f49-c0fa-0430-e054-00144ff8d46c,to reduce the development of drug resistant bacteria and maintain the effectiveness of ampicillin and other antibacterial drugs  ampicillin should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria,4
5721,5721,5721,5721,5721,5721,5721,6915,6915,6915,6915,6915,6915,6915,6915,6915,6915,6915,6915,6915,48fe6f49-c0fa-0430-e054-00144ff8d46c,bacteriology studies to determine the causative organisms and their susceptibility to ampicillin should be performed,0
5722,5722,5722,5722,5722,5722,5722,6916,6916,6916,6916,6916,6916,6916,6916,6916,6916,6916,6916,6916,48fe6f49-c0fa-0430-e054-00144ff8d46c,therapy may be instituted prior to the results of susceptibility testing,0
5723,5723,5723,5723,5723,5723,5723,6919,6919,6919,6919,6919,6919,6919,6919,6919,6919,6919,6919,6919,0fe9ff20-d402-41f3-bc1e-7002ea7007db,1  alunbrig is indicated for the treatment of patients with anaplastic lymphoma kinase ( alk ) positive metastatic non small cell lung cancer ( nsclc ) who have progressed on or are intolerant to crizotinib,1
5724,5724,5724,5724,5724,5724,5724,6922,6922,6922,6922,6922,6922,6922,6922,6922,6922,6922,6922,6922,0fe9ff20-d402-41f3-bc1e-7002ea7007db,alunbrig is a kinase inhibitor indicated for the treatment of patients with anaplastic lymphoma kinase ( alk ) positive metastatic non small cell lung cancer ( nsclc ) who have progressed on or are intolerant to crizotinib,1
5725,5725,5725,5725,5725,5725,5725,6925,6925,6925,6925,6925,6925,6925,6925,6925,6925,6925,6925,6925,2e5365ff-cb2a-4b16-b2c7-e35c6bf2de13,1  actemra ( tocilizumab ) is an interleukin 6 ( il 6 ) receptor antagonist indicated for treatment of rheumatoid arthritis ( ra ) ( 1 1 ) adult patients with moderately to severely active rheumatoid arthritis who have had an inadequate response to one or more disease modifying anti rheumatic drugs ( dmards ),1
5726,5726,5726,5726,5726,5726,5726,6926,6926,6926,6926,6926,6926,6926,6926,6926,6926,6926,6926,6926,2e5365ff-cb2a-4b16-b2c7-e35c6bf2de13,giant cell arteritis ( gca ) ( 1 2 ) adult patients with giant cell arteritis,1
5727,5727,5727,5727,5727,5727,5727,6927,6927,6927,6927,6927,6927,6927,6927,6927,6927,6927,6927,6927,2e5365ff-cb2a-4b16-b2c7-e35c6bf2de13,polyarticular juvenile idiopathic arthritis ( pjia ) ( 1 3 ) patients 2 years of age and older with active polyarticular juvenile idiopathic arthritis,1
5728,5728,5728,5728,5728,5728,5728,6928,6928,6928,6928,6928,6928,6928,6928,6928,6928,6928,6928,6928,2e5365ff-cb2a-4b16-b2c7-e35c6bf2de13,systemic juvenile idiopathic arthritis ( sjia ) ( 1 4 ) patients 2 years of age and older with active systemic juvenile idiopathic arthritis,1
5729,5729,5729,5729,5729,5729,5729,6929,6929,6929,6929,6929,6929,6929,6929,6929,6929,6929,6929,6929,2e5365ff-cb2a-4b16-b2c7-e35c6bf2de13,cytokine release syndrome ( crs ) ( 1 5 ) adults and pediatric patients 2 years of age and older with chimeric antigen receptor ( car ) t cell induced severe or life threatening cytokine release syndrome,1
5730,5730,5730,5730,5730,5730,5730,6930,6930,6930,6930,6930,6930,6930,6930,6930,6930,6930,6930,6930,2e5365ff-cb2a-4b16-b2c7-e35c6bf2de13,1 1 rheumatoid arthritis ( ra ) actemra ( tocilizumab ) is indicated for the treatment of adult patients with moderately to severely active rheumatoid arthritis who have had an inadequate response to one or more disease modifying anti rheumatic drugs ( dmards ),1
5731,5731,5731,5731,5731,5731,5731,6931,6931,6931,6931,6931,6931,6931,6931,6931,6931,6931,6931,6931,2e5365ff-cb2a-4b16-b2c7-e35c6bf2de13,1 2 giant cell arteritis ( gca ) actemra ( tocilizumab ) is indicated for the treatment of giant cell arteritis ( gca ) in adult patients,1
5732,5732,5732,5732,5732,5732,5732,6932,6932,6932,6932,6932,6932,6932,6932,6932,6932,6932,6932,6932,2e5365ff-cb2a-4b16-b2c7-e35c6bf2de13,1 3 polyarticular juvenile idiopathic arthritis ( pjia ) actemra ( tocilizumab ) is indicated for the treatment of active polyarticular juvenile idiopathic arthritis in patients 2 years of ag,1
5733,5733,5733,5733,5733,5733,5733,6934,6934,6934,6934,6934,6934,6934,6934,6934,6934,6934,6934,6934,4014a0f4-d388-4199-89ca-e955b3a34b36, citalopram tablets  usp are indicated for the treatment of depression,1
5734,5734,5734,5734,5734,5734,5734,6935,6935,6935,6935,6935,6935,6935,6935,6935,6935,6935,6935,6935,4014a0f4-d388-4199-89ca-e955b3a34b36,the efficacy of citalopram tablets in the treatment of depression was established in 4 to 6 week  controlled trials of outpatients whose diagnosis corresponded most closely to the dsm iii and dsm iii r category of major depressive disorder ( see clinical pharmacology ),0
5735,5735,5735,5735,5735,5735,5735,6937,6937,6937,6937,6937,6937,6937,6937,6937,6937,6937,6937,6937,4014a0f4-d388-4199-89ca-e955b3a34b36,the antidepressant action of citalopram tablets in hospitalized depressed patients has not been adequately studied,0
5736,5736,5736,5736,5736,5736,5736,6938,6938,6938,6938,6938,6938,6938,6938,6938,6938,6938,6938,6938,4014a0f4-d388-4199-89ca-e955b3a34b36,the efficacy of citalopram tablets in maintaining an antidepressant response for up to 24 weeks following 6 to 8 weeks of acute treatment was demonstrated in two placebo controlled trials ( see clinical pharmacology ),0
5737,5737,5737,5737,5737,5737,5737,6939,6939,6939,6939,6939,6939,6939,6939,6939,6939,6939,6939,6939,4014a0f4-d388-4199-89ca-e955b3a34b36,nevertheless  the physician who elects to use citalopram tablets for extended periods should periodically re evaluate the long term usefulness of the drug for the individual patient,0
5738,5738,5738,5738,5738,5738,5738,6940,6940,6940,6940,6940,6940,6940,6940,6940,6940,6940,6940,6940,"Active Ingredient UNII(s)
I1E9D14F36; N91BDP6H0X    b0e39608-a7ed-464a-91c9-867ad7cd293c
I1E9D14F36; N91BDP6H0X    b0e39608-a7ed-464a-91c9-867ad7cd293c
Name: SET ID dtype: object",active ingredient unii ( s ) i1e9d14f36 n91bdp6h0x active ingredient unii ( s ) i1e9d14f36 n91bdp6h i1e9d14f36 n91bdp6h0x active ingredient unii ( s ) i1e9d14f36 n91bdp6h name content xml  dtype object,0
5739,5739,5739,5739,5739,5739,5739,6942,6942,6942,6942,6942,6942,6942,6942,6942,6942,6942,6942,6942,fc77a504-4642-47c1-b2e3-c5db11e5816d, for control of severe nausea and vomiting,1
5740,5740,5740,5740,5740,5740,5740,6943,6943,6943,6943,6943,6943,6943,6943,6943,6943,6943,6943,6943,fc77a504-4642-47c1-b2e3-c5db11e5816d,for the treatment of schizophrenia,1
5741,5741,5741,5741,5741,5741,5741,6944,6944,6944,6944,6944,6944,6944,6944,6944,6944,6944,6944,6944,fc77a504-4642-47c1-b2e3-c5db11e5816d,prochlorperazine is effective for the short term treatment of generalized non psychotic anxiety,1
5742,5742,5742,5742,5742,5742,5742,6945,6945,6945,6945,6945,6945,6945,6945,6945,6945,6945,6945,6945,fc77a504-4642-47c1-b2e3-c5db11e5816d,however  prochlorperazine is not the first drug to be used in therapy for most patients with non psychotic anxiety  because certain risks associated with its use are not shared by common alternative treatments ( e g  benzodiazepines ),4
5743,5743,5743,5743,5743,5743,5743,6946,6946,6946,6946,6946,6946,6946,6946,6946,6946,6946,6946,6946,fc77a504-4642-47c1-b2e3-c5db11e5816d,when used in the treatment of non psychotic anxiety  prochlorperazine should not be administered at doses of more than 20 mg per day or for longer than 12 weeks  because the use of prochlorperazine at higher doses or for longer intervals may cause persistent tardive dyskinesia that may prove irreversible ( see warnings ),4
5744,5744,5744,5744,5744,5744,5744,6947,6947,6947,6947,6947,6947,6947,6947,6947,6947,6947,6947,6947,fc77a504-4642-47c1-b2e3-c5db11e5816d,the effectiveness of prochlorperazine as treatment for non psychotic anxiety was established in 4 week clinical studies of outpatients with generalized anxiety disorder,u
5745,5745,5745,5745,5745,5745,5745,6948,6948,6948,6948,6948,6948,6948,6948,6948,6948,6948,6948,6948,fc77a504-4642-47c1-b2e3-c5db11e5816d,this evidence does not predict that prochlorperazine will be useful in patients with other non psychotic conditions in which anxiety  or signs that mimic anxiety  are found ( e g  physical illness  organic mental conditions  agitated depression  character pathologies  etc ),0
5746,5746,5746,5746,5746,5746,5746,6949,6949,6949,6949,6949,6949,6949,6949,6949,6949,6949,6949,6949,fc77a504-4642-47c1-b2e3-c5db11e5816d,prochlorperazine has not been shown effective in the management of behavioral complications in patients with mental retardation,0
5747,5747,5747,5747,5747,5747,5747,6950,6950,6950,6950,6950,6950,6950,6950,6950,6950,6950,6950,6950,a44bc2ef-3d7f-4125-a7f7-c5969b1b4142,visionblue 0 06  visionblue 0 06 is indicated for use as an aid in ophthalmic surgery by staining the anterior capsule of the lens,1
5748,5748,5748,5748,5748,5748,5748,6951,6951,6951,6951,6951,6951,6951,6951,6951,6951,6951,6951,6951,a44bc2ef-3d7f-4125-a7f7-c5969b1b4142,highlights of prescribing information these highlights do not include all the information needed to use visionblue 0 06 safely and effectively,0
5749,5749,5749,5749,5749,5749,5749,6952,6952,6952,6952,6952,6952,6952,6952,6952,6952,6952,6952,6952,a44bc2ef-3d7f-4125-a7f7-c5969b1b4142,see full prescribing information for visionblue 0 06,0
5750,5750,5750,5750,5750,5750,5750,6953,6953,6953,6953,6953,6953,6953,6953,6953,6953,6953,6953,6953,a44bc2ef-3d7f-4125-a7f7-c5969b1b4142,visionblue ( trypan blue ophthalmic solution ) 0 06 initial u s approval 2004 visionblue 0 06 is an acid di azo group dye indicated for use as an aid in ophthalmic surgery by staining the anterior capsule of the lens,1
5751,5751,5751,5751,5751,5751,5751,6954,6954,6954,6954,6954,6954,6954,6954,6954,6954,6954,6954,6954,dd4835ef-e1bc-4997-a399-1ffa2556fbfe,1  calquence is indicated for the treatment of adult patients with mantle cell lymphoma ( mcl ) who have received at least one prior therapy,1
5752,5752,5752,5752,5752,5752,5752,6955,6955,6955,6955,6955,6955,6955,6955,6955,6955,6955,6955,6955,dd4835ef-e1bc-4997-a399-1ffa2556fbfe,this indication is approved under accelerated approval based on overall response rate see clinical studies ( 14 ),0
5753,5753,5753,5753,5753,5753,5753,6957,6957,6957,6957,6957,6957,6957,6957,6957,6957,6957,6957,6957,dd4835ef-e1bc-4997-a399-1ffa2556fbfe,calquence is a kinase inhibitor indicated for the treatment of adult patients with mantle cell lymphoma ( mcl ) who have received at least one prior therapy,1
5754,5754,5754,5754,5754,5754,5754,6958,6958,6958,6958,6958,6958,6958,6958,6958,6958,6958,6958,6958,dd4835ef-e1bc-4997-a399-1ffa2556fbfe,( 1 ) this indication is approved under accelerated approval based on overall response rate,0
5755,5755,5755,5755,5755,5755,5755,6960,6960,6960,6960,6960,6960,6960,6960,6960,6960,6960,6960,6960,60ce7900-a677-4fc2-88d0-1603baa9dbd4,1  vyzulta ( latanoprostene bunod ophthalmic solution ) 0 024 is indicated for the reduction of intraocular pressure ( iop ) in patients with open angle glaucoma or ocular hypertension,1
5756,5756,5756,5756,5756,5756,5756,6961,6961,6961,6961,6961,6961,6961,6961,6961,6961,6961,6961,6961,60ce7900-a677-4fc2-88d0-1603baa9dbd4,vyzulta is a prostaglandin analog indicated for the reduction of intraocular pressure in patients with open angle glaucoma or ocular hypertension,1
5757,5757,5757,5757,5757,5757,5757,6962,6962,6962,6962,6962,6962,6962,6962,6962,6962,6962,6962,6962,f280d8f5-4224-4f3b-be1b-ceb7587b15c3, the intra articular or soft tissue administration of aristospan ( triamcinolone hexacetonide injectable suspension  usp ) 20 mg ml is indicated as adjunctive therapy for short term administration ( to tide the patient over an acute episode or exacerbation ) in acute gouty arthritis  acute and subacute bursitis  acute nonspecific tenosynovitis  epicondylitis  rheumatoid arthritis  synovitis of osteoarthritis,1
5758,5758,5758,5758,5758,5758,5758,6963,6963,6963,6963,6963,6963,6963,6963,6963,6963,6963,6963,6963,a4a732e9-b8ee-4e6d-8b9a-6a9d2c36bfcd, tubersol  tuberculin purified protein derivative ( mantoux )  is indicated to aid diagnosis of tuberculosis infection ( tb ) in persons at increased risk of developing active disease,1
5759,5759,5759,5759,5759,5759,5759,6964,6964,6964,6964,6964,6964,6964,6964,6964,6964,6964,6964,6964,a4a732e9-b8ee-4e6d-8b9a-6a9d2c36bfcd,the centers for disease control and prevention ( cdc ) have published guidelines regarding populations that would benefit from tuberculin skin testing ( tst ),0
5760,5760,5760,5760,5760,5760,5760,6965,6965,6965,6965,6965,6965,6965,6965,6965,6965,6965,6965,6965,a4a732e9-b8ee-4e6d-8b9a-6a9d2c36bfcd,current recommendations can be accessed at http www cdc gov tb publications factsheets testing htm,0
5761,5761,5761,5761,5761,5761,5761,6966,6966,6966,6966,6966,6966,6966,6966,6966,6966,6966,6966,6966,a4a732e9-b8ee-4e6d-8b9a-6a9d2c36bfcd,previous bcg vaccination is not a contraindication to tuberculin testing,0
5762,5762,5762,5762,5762,5762,5762,6967,6967,6967,6967,6967,6967,6967,6967,6967,6967,6967,6967,6967,a4a732e9-b8ee-4e6d-8b9a-6a9d2c36bfcd,the skin test results of bcg vaccinated persons can be used to support or exclude the diagnosis of tb infection,4
5763,5763,5763,5763,5763,5763,5763,6968,6968,6968,6968,6968,6968,6968,6968,6968,6968,6968,6968,6968,a4a732e9-b8ee-4e6d-8b9a-6a9d2c36bfcd,however  an fda approved interferon gamma release assay is preferred over tuberculin skin test for persons 5 years of age and older who were previously vaccinated with bcg,0
5764,5764,5764,5764,5764,5764,5764,6969,6969,6969,6969,6969,6969,6969,6969,6969,6969,6969,6969,6969,08f0ea03-4e6d-195d-aef4-886e32befa95,1  plegridy ( peginterferon beta 1a ) is indicated for the treatment of patients with relapsing forms of multiple sclerosis,1
5765,5765,5765,5765,5765,5765,5765,6970,6970,6970,6970,6970,6970,6970,6970,6970,6970,6970,6970,6970,08f0ea03-4e6d-195d-aef4-886e32befa95,plegridy is an interferon beta indicated for the treatment of patients with relapsing forms of multiple sclerosis ( 1 ),1
5766,5766,5766,5766,5766,5766,5766,6971,6971,6971,6971,6971,6971,6971,6971,6971,6971,6971,6971,6971,f5f78ed2-4640-8528-c51c-d7bffa045d48,1  olanzapine and fluoxetine capsules usp combine olanzapine  an atypical antipsychotic and fluoxetine  a selective serotonin reuptake inhibitor  indicated for acute treatment of depressive episodes associated with bipolar i disorder ( 1 1 ) 1 1 depressive episodes associated with bipolar i disorder olanzapine and fluoxetine capsules usp are indicated for the acute treatment of depressive episodes associated with bipolar i disorder see clinical studies ( 14 1 ),1
5767,5767,5767,5767,5767,5767,5767,6972,6972,6972,6972,6972,6972,6972,6972,6972,6972,6972,6972,6972,"Active Ingredient UNII(s)
I9W7N6B1KJ; N91BDP6H0X    35fee753-acd7-4da2-bd60-973dc6c0b21f
I9W7N6B1KJ; N91BDP6H0X    35fee753-acd7-4da2-bd60-973dc6c0b21f
I9W7N6B1KJ; N91BDP6H0X    35fee753-acd7-4da2-bd60-973dc6c0b21f
Name: SET ID dtype: object",active ingredient unii ( s ) i9w7n6b1kj n91bdp6h0x active ingredient unii ( s ) i9w7n6b1kj n91bdp6h i9w7n6b1kj n91bdp6h0x active ingredient unii ( s ) i9w7n6b1kj n91bdp6h i9w7n6b1kj n91bdp6h0x active ingredient unii ( s ) i9w7n6b1kj n91bdp6h name content xml  dtype object,0
5768,5768,5768,5768,5768,5768,5768,6975,6975,6975,6975,6975,6975,6975,6975,6975,6975,6975,6975,6975,11fa7725-cb19-46f6-9468-01a0a430492c, isosorbide dinitrate extended release tablets are indicated for the prevention of angina pectoris due to coronary artery disease,1
5769,5769,5769,5769,5769,5769,5769,6976,6976,6976,6976,6976,6976,6976,6976,6976,6976,6976,6976,6976,11fa7725-cb19-46f6-9468-01a0a430492c,the onset of action of controlled release oral isosorbide dinitrate is not sufficiently rapid for this product to be useful in aborting an acute anginal episode,0
5770,5770,5770,5770,5770,5770,5770,6977,6977,6977,6977,6977,6977,6977,6977,6977,6977,6977,6977,6977,472bd78e-be17-4b9d-90f4-9482c3aec9ff,1  yondelis is indicated for the treatment of patients with unresectable or metastatic liposarcoma or leiomyosarcoma who received a prior anthracycline containing regimen see clinical studies ( 14 ),1
5771,5771,5771,5771,5771,5771,5771,6978,6978,6978,6978,6978,6978,6978,6978,6978,6978,6978,6978,6978,472bd78e-be17-4b9d-90f4-9482c3aec9ff,yondelis is an alkylating drug indicated for the treatment of patients with unresectable or metastatic liposarcoma or leiomyosarcoma who received a prior anthracycline containing regimen ( 1 ),1
5772,5772,5772,5772,5772,5772,5772,6979,6979,6979,6979,6979,6979,6979,6979,6979,6979,6979,6979,6979,24feb9be-32a6-45fd-a896-f3e202edd8a9,1  lexiva is indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency virus ( hiv 1 ) infection,1
5773,5773,5773,5773,5773,5773,5773,6980,6980,6980,6980,6980,6980,6980,6980,6980,6980,6980,6980,6980,24feb9be-32a6-45fd-a896-f3e202edd8a9,the following points should be considered when initiating therapy with lexiva plus ritonavir in protease inhibitor experienced patients the protease inhibitor experienced patient trial was not large enough to reach a definitive conclusion that lexiva plus ritonavir and lopinavir plus ritonavir are clinically equivalent see clinical studies ( 14 2 ),0
5774,5774,5774,5774,5774,5774,5774,6981,6981,6981,6981,6981,6981,6981,6981,6981,6981,6981,6981,6981,24feb9be-32a6-45fd-a896-f3e202edd8a9,once daily administration of lexiva plus ritonavir is not recommended for adult protease inhibitor experienced patients or any pediatric patients see dosage and administration ( 2 2  2 3 )  clinical studies ( 14 2  14 3 ),0
5775,5775,5775,5775,5775,5775,5775,6982,6982,6982,6982,6982,6982,6982,6982,6982,6982,6982,6982,6982,24feb9be-32a6-45fd-a896-f3e202edd8a9,dosing of lexiva plus ritonavir is not recommended for protease inhibitor experienced pediatric patients younger than 6 months see clinical pharmacology ( 12 3 ),2
5776,5776,5776,5776,5776,5776,5776,6983,6983,6983,6983,6983,6983,6983,6983,6983,6983,6983,6983,6983,24feb9be-32a6-45fd-a896-f3e202edd8a9,lexiva is an hiv protease inhibitor indicated in combination with other antiretroviral agents for the treatment of hiv 1 infection,1
5777,5777,5777,5777,5777,5777,5777,6984,6984,6984,6984,6984,6984,6984,6984,6984,6984,6984,6984,6984,11fa3fc9-6776-49a6-b1c1-653f627c3e58,1  rydapt is a kinase inhibitor indicated for the treatment of adult patients with newly diagnosed acute myeloid leukemia ( aml ) that is flt3 mutation positive as detected by an fda approved test  in combination with standard cytarabine and daunorubicin induction and cytarabine consolidation ( 1 1 ),1
5778,5778,5778,5778,5778,5778,5778,6985,6985,6985,6985,6985,6985,6985,6985,6985,6985,6985,6985,6985,11fa3fc9-6776-49a6-b1c1-653f627c3e58,limitations of use rydapt is not indicated as a single agent induction therapy for the treatment of patients with aml,2
5779,5779,5779,5779,5779,5779,5779,6986,6986,6986,6986,6986,6986,6986,6986,6986,6986,6986,6986,6986,11fa3fc9-6776-49a6-b1c1-653f627c3e58,aggressive systemic mastocytosis ( asm )  systemic mastocytosis with associated hematological neoplasm ( sm ahn )  or mast cell leukemia ( mcl ),1
5780,5780,5780,5780,5780,5780,5780,6987,6987,6987,6987,6987,6987,6987,6987,6987,6987,6987,6987,6987,11fa3fc9-6776-49a6-b1c1-653f627c3e58,( 1 2 ) 1 1 acute myeloid leukemia rydapt is indicated  in combination with standard cytarabine and daunorubicin induction and cytarabine consolidation chemotherapy  for the treatment of adult patients with newly diagnosed acute myeloid leukemia ( aml ) who are flt3 mutation positive  as detected by a fda approved test see dosage and administration ( 2 1 )  clinical studies ( 14 1 ),1
5781,5781,5781,5781,5781,5781,5781,6989,6989,6989,6989,6989,6989,6989,6989,6989,6989,6989,6989,6989,11fa3fc9-6776-49a6-b1c1-653f627c3e58,1 2 systemic mastocytosis rydapt is indicated for the treatment of adult patients with aggressive systemic mastocytosis ( asm )  systemic mastocytosis with associated hematological neoplasm ( sm ahn )  or mast cell leukemia ( mcl ),1
5782,5782,5782,5782,5782,5782,5782,6991,6991,6991,6991,6991,6991,6991,6991,6991,6991,6991,6991,6991,6e4a41fd-a753-4362-87ee-8cc56ed3660d,1  somatuline depot is a somatostatin analog indicated for the long term treatment of acromegalic patients who have had an inadequate response to or cannot be treated with surgery and or radiotherapy,1
5783,5783,5783,5783,5783,5783,5783,6992,6992,6992,6992,6992,6992,6992,6992,6992,6992,6992,6992,6992,6e4a41fd-a753-4362-87ee-8cc56ed3660d,( 1 1 ) the treatment of adult patients with unresectable  well or moderately differentiated  locally advanced or metastatic gastroenteropancreatic neuroendocrine tumors ( gep nets ) to improve progression free survival,1
5784,5784,5784,5784,5784,5784,5784,6993,6993,6993,6993,6993,6993,6993,6993,6993,6993,6993,6993,6993,6e4a41fd-a753-4362-87ee-8cc56ed3660d,( 1 2 ) the treatment of adults with carcinoid syndrome when used  it reduces the frequency of short acting somatostatin analog rescue therapy,1
5785,5785,5785,5785,5785,5785,5785,6994,6994,6994,6994,6994,6994,6994,6994,6994,6994,6994,6994,6994,6e4a41fd-a753-4362-87ee-8cc56ed3660d,( 1 3 ) 1 1 acromegaly somatuline depot is indicated for the long term treatment of acromegalic patients who have had an inadequate response to surgery and or radiotherapy  or for whom surgery and or radiotherapy is not an option,1
5786,5786,5786,5786,5786,5786,5786,6995,6995,6995,6995,6995,6995,6995,6995,6995,6995,6995,6995,6995,6e4a41fd-a753-4362-87ee-8cc56ed3660d,the goal of treatment in acromegaly is to reduce growth hormone ( gh ) and insulin growth factor 1 ( igf 1 ) levels to normal,0
5787,5787,5787,5787,5787,5787,5787,6996,6996,6996,6996,6996,6996,6996,6996,6996,6996,6996,6996,6996,6e4a41fd-a753-4362-87ee-8cc56ed3660d,1 2 gastroenteropancreatic neuroendocrine tumors somatuline depot is indicated for the treatment of adult patients with unresectable  well or moderately differentiated  locally advanced or metastatic gastroenteropancreatic neuroendocrine tumors ( gep nets ) to improve progression free survival,1
5788,5788,5788,5788,5788,5788,5788,6997,6997,6997,6997,6997,6997,6997,6997,6997,6997,6997,6997,6997,6e4a41fd-a753-4362-87ee-8cc56ed3660d,1 3 carcinoid syndrome somatuline depot is indicated for the treatment of adults with carcinoid syndrome when used  it reduces the frequency of short acting somatostatin analog rescue therapy,1
5789,5789,5789,5789,5789,5789,5789,6998,6998,6998,6998,6998,6998,6998,6998,6998,6998,6998,6998,6998,b98ee838-ed23-42a9-93b5-72579e490fba,1  cystaran is a cystine depleting agent indicated for the treatment of corneal cystine crystal accumulation in patients with cystinosis,1
5790,5790,5790,5790,5790,5790,5790,6999,6999,6999,6999,6999,6999,6999,6999,6999,6999,6999,6999,6999,b98ee838-ed23-42a9-93b5-72579e490fba,cystaran is a cystine depleting agent indicated for the treatment of corneal cystine crystal accumulation in patients with cystinosis,1
5791,5791,5791,5791,5791,5791,5791,7000,7000,7000,7000,7000,7000,7000,7000,7000,7000,7000,7000,7000,f001f406-8cf1-40a4-bbf5-1775fe020122,1  zontivity is a protease activated receptor 1 ( par 1 ) antagonist indicated for the reduction of thrombotic cardiovascular events in patients with a history of myocardial infarction ( mi ) or with peripheral arterial disease ( pad ),1
5792,5792,5792,5792,5792,5792,5792,7001,7001,7001,7001,7001,7001,7001,7001,7001,7001,7001,7001,7001,f001f406-8cf1-40a4-bbf5-1775fe020122,zontivity has been shown to reduce the rate of a combined endpoint of cardiovascular death  mi  stroke  and urgent coronary revascularization,u
5793,5793,5793,5793,5793,5793,5793,7002,7002,7002,7002,7002,7002,7002,7002,7002,7002,7002,7002,7002,f001f406-8cf1-40a4-bbf5-1775fe020122,( 1 1 ) 1 1 patients with history of myocardial infarction ( mi ) or with peripheral arterial disease ( pad ) zontivity is indicated for the reduction of thrombotic cardiovascular events in patients with a history of myocardial infarction ( mi ) or with peripheral arterial disease ( pad ),1
5794,5794,5794,5794,5794,5794,5794,7003,7003,7003,7003,7003,7003,7003,7003,7003,7003,7003,7003,7003,f001f406-8cf1-40a4-bbf5-1775fe020122,zontivity has been shown to reduce the rate of a combined endpoint of cardiovascular death  mi  stroke  and urgent coronary revascularization ( ucr ),u
5795,5795,5795,5795,5795,5795,5795,7004,7004,7004,7004,7004,7004,7004,7004,7004,7004,7004,7004,7004,bc234dd7-5221-4a68-b153-aa0393c75bbf,1  mycamine is indicated in adult and pediatric patients 4 months and older for mycamine is an echinocandin indicated in adult and pediatric patients 4 months and older for treatment of patients with candidemia  acute disseminated candidiasis  candida peritonitis and abscesses ( 1 1 ) treatment of patients with esophageal candidiasis ( 1 2 ) prophylaxis of candida infections in patients undergoing hematopoietic stem cell transplantation ( 1 3 ) 1 1 treatment of patients with candidemia  acute disseminated candidiasis  candida peritonitis and abscesses see clinical studies ( 14 1 ),1
5796,5796,5796,5796,5796,5796,5796,7005,7005,7005,7005,7005,7005,7005,7005,7005,7005,7005,7005,7005,bc234dd7-5221-4a68-b153-aa0393c75bbf,mycamine has not been adequately studied in patients with endocarditis  osteomyelitis and meningitis due to candida infections,0
5797,5797,5797,5797,5797,5797,5797,7006,7006,7006,7006,7006,7006,7006,7006,7006,7006,7006,7006,7006,bc234dd7-5221-4a68-b153-aa0393c75bbf,1 2 treatment of patients with esophageal candidiasis see clinical studies ( 14 2 ),1
5798,5798,5798,5798,5798,5798,5798,7007,7007,7007,7007,7007,7007,7007,7007,7007,7007,7007,7007,7007,bc234dd7-5221-4a68-b153-aa0393c75bbf,1 3 prophylaxis of candida infections in patients undergoing hematopoietic stem cell transplantation see clinical studies ( 14 3 ),1
5799,5799,5799,5799,5799,5799,5799,7008,7008,7008,7008,7008,7008,7008,7008,7008,7008,7008,7008,7008,77108624-4771-4886-a3e2-b2625c444d1b,1  spherusol is a skin test antigen indicated for the detection of delayed type hypersensitivity to coccidioides immitis in individuals with a history of pulmonary coccidioidomycosis,1
5800,5800,5800,5800,5800,5800,5800,7009,7009,7009,7009,7009,7009,7009,7009,7009,7009,7009,7009,7009,77108624-4771-4886-a3e2-b2625c444d1b,spherusol is approved for use in individuals 18 64 years of age,u
5801,5801,5801,5801,5801,5801,5801,7010,7010,7010,7010,7010,7010,7010,7010,7010,7010,7010,7010,7010,77108624-4771-4886-a3e2-b2625c444d1b,the use of spherusol to detect delayed type hypersensitivity responses in a general population with unknown exposure to c immitis has not been evaluated,0
5802,5802,5802,5802,5802,5802,5802,7011,7011,7011,7011,7011,7011,7011,7011,7011,7011,7011,7011,7011,77108624-4771-4886-a3e2-b2625c444d1b,persons with acute or disseminated coccidioidomycosis may not develop a delayed type hypersensitivity response to spherusol,0
5803,5803,5803,5803,5803,5803,5803,7012,7012,7012,7012,7012,7012,7012,7012,7012,7012,7012,7012,7012,77108624-4771-4886-a3e2-b2625c444d1b,persons with immunodeficiency and a history of coccidioidomycosis may not develop a delayed type hypersensitivity response to spherusol,0
5804,5804,5804,5804,5804,5804,5804,7013,7013,7013,7013,7013,7013,7013,7013,7013,7013,7013,7013,7013,77108624-4771-4886-a3e2-b2625c444d1b,spherusol is a skin test antigen indicated for the detection of delayed type hypersensitivity to coccidioides immitis in individuals with a history of pulmonary coccidioidomycosis,1
5805,5805,5805,5805,5805,5805,5805,7018,7018,7018,7018,7018,7018,7018,7018,7018,7018,7018,7018,7018,87e2da8d-432c-4ed5-67a1-dc26294b2295, premarin intravenous ( conjugated estrogens  usp ) for injection is indicated in the treatment of abnormal uterine bleeding due to hormonal imbalance in the absence of organic pathology,1
5806,5806,5806,5806,5806,5806,5806,7019,7019,7019,7019,7019,7019,7019,7019,7019,7019,7019,7019,7019,87e2da8d-432c-4ed5-67a1-dc26294b2295,premarin intravenous is indicated for short term use only  to provide a rapid and temporary increase in estrogen levels,1
5807,5807,5807,5807,5807,5807,5807,7020,7020,7020,7020,7020,7020,7020,7020,7020,7020,7020,7020,7020,e1b75458-2e5b-46b9-92c6-fa6daba3770f,1  duavee is indicated in women with a uterus for duavee is a combination of conjugated estrogens with an estrogen agonist antagonist indicated for treatment of the following conditions in women with a uterus treatment of moderate to severe vasomotor symptoms associated with menopause ( 1 1 ) prevention of postmenopausal osteoporosis ( 1 2 ) limitation of use duavee should be used for the shortest duration consistent with treatment goals and risks for the individual woman ( 1 3 ) 1 1 treatment of moderate to severe vasomotor symptoms associated with menopause 1 2 prevention of postmenopausal osteoporosis 1 3 important limitations of use use duavee for the shortest duration consistent with treatment goals and risks for the individual woman,1
5808,5808,5808,5808,5808,5808,5808,7021,7021,7021,7021,7021,7021,7021,7021,7021,7021,7021,7021,7021,e1b75458-2e5b-46b9-92c6-fa6daba3770f,postmenopausal women should be re evaluated periodically as clinically appropriate to determine if treatment is still necessary,0
5809,5809,5809,5809,5809,5809,5809,7022,7022,7022,7022,7022,7022,7022,7022,7022,7022,7022,7022,7022,e1b75458-2e5b-46b9-92c6-fa6daba3770f,when prescribing solely for the prevention of postmenopausal osteoporosis  therapy should only be considered for women at significant risk of osteoporosis and non estrogen medication should be carefully considered,0
5810,5810,5810,5810,5810,5810,5810,7023,7023,7023,7023,7023,7023,7023,7023,7023,7023,7023,7023,7023,316650b7-5770-4f1a-867d-68a72c60c8f2, esterified estrogens and methyltestosterone tablets and esterified estrogens and methyltestosterone tablets h s,1
5811,5811,5811,5811,5811,5811,5811,7024,7024,7024,7024,7024,7024,7024,7024,7024,7024,7024,7024,7024,316650b7-5770-4f1a-867d-68a72c60c8f2,are indicated in the treatment of moderate to severe vasomotor symptoms associated with the menopause in those patients not improved by estrogens alone,1
5812,5812,5812,5812,5812,5812,5812,7026,7026,7026,7026,7026,7026,7026,7026,7026,7026,7026,7026,7026,316650b7-5770-4f1a-867d-68a72c60c8f2,esterified estrogens and methyltestosterone tablets and esterified estrogens and methyltestosterone tablets h s,
5813,5813,5813,5813,5813,5813,5813,7027,7027,7027,7027,7027,7027,7027,7027,7027,7027,7027,7027,7027,316650b7-5770-4f1a-867d-68a72c60c8f2,have not been shown to be effective for any purpose during pregnancy and its use may cause severe harm to the fetus,0
5814,5814,5814,5814,5814,5814,5814,7028,7028,7028,7028,7028,7028,7028,7028,7028,7028,7028,7028,7028,f6581324-a1dc-4e2e-be05-871798920dea,1  prednisolone sodium phosphate orally disintegrating tablets are indicated in the treatment of the following diseases or conditions prednisolone sodium phosphate is a corticosteroid indicated as an anti inflammatory or immunosuppressive agent for certain allergic  dermatologic  gastrointestinal  hematologic  ophthalmologic  nervous system  renal  respiratory  rheumatologic  specific infectious diseases or conditions and organ transplantation ( 1 ) for the treatment of certain endocrine conditions ( 1 ) for palliation of certain neoplastic conditions ( 1 ) 1 1 allergic conditions control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in adult and pediatric populations with atopic dermatitis drug hypersensitivity reactions seasonal or perennial allergic rhinitis serum sickness 1 2 dermatologic diseases bullous dermatitis herpetiformis contact dermatitis exfoliative erythroderma mycosis fungoides pemphigus severe erythema multiforme ( stevens johnson syndrome ) 1 3 endocrine conditions congenital adrenal hyperplasia hypercalcemia of malignancy nonsuppurat,1
5815,5815,5815,5815,5815,5815,5815,7029,7029,7029,7029,7029,7029,7029,7029,7029,7029,7029,7029,7029,cea3f6aa-cd1c-4152-98bb-bbb7b977497a,1  argatroban is a direct thrombin inhibitor indicated for prophylaxis or treatment of thrombosis in adult patients with heparin induced thrombocytopenia ( hit ) ( 1 1 ) as an anticoagulant in adults patients with or at risk for hit undergoing percutaneous coronary intervention ( pci ) ( 1 2 ) 1 1 heparin induced thrombocytopenia argatroban injection is indicated for prophylaxis or treatment of thrombosis in adult patients with heparin induced thrombocytopenia ( hit ),1
5816,5816,5816,5816,5816,5816,5816,7030,7030,7030,7030,7030,7030,7030,7030,7030,7030,7030,7030,7030,cea3f6aa-cd1c-4152-98bb-bbb7b977497a,1 2 percutaneous coronary intervention argatroban injection is indicated as an anticoagulant in adult patients with or at risk for hit undergoing percutaneous coronary intervention ( pci ),1
5817,5817,5817,5817,5817,5817,5817,7031,7031,7031,7031,7031,7031,7031,7031,7031,7031,7031,7031,7031,8ccb10fe-75a5-440b-8cd4-b11f4e98f7b0, 70 dextrose injection usp is indicated as a caloric component in a parenteral nutrition regimen,1
5818,5818,5818,5818,5818,5818,5818,7032,7032,7032,7032,7032,7032,7032,7032,7032,7032,7032,7032,7032,8ccb10fe-75a5-440b-8cd4-b11f4e98f7b0,70 dextrose injection usp is used with an appropriate protein ( nitrogen ) source in the prevention of nitrogen loss or in the treatment of negative nitrogen balance in patients where ( 1 ) the alimentary tract cannot or should not be used  ( 2 ) gastrointestinal absorption of protein is impaired  or ( 3 ) metabolic requirements for protein are substantially increased  as with extensive burns,u
5819,5819,5819,5819,5819,5819,5819,7033,7033,7033,7033,7033,7033,7033,7033,7033,7033,7033,7033,7033,98a1caaf-aaf0-47bf-8bdc-1eae486444f9, whole blood for use in blood collection,1
5820,5820,5820,5820,5820,5820,5820,7034,7034,7034,7034,7034,7034,7034,7034,7034,7034,7034,7034,7034,44dcbf97-99ec-427c-ba50-207e0069d6d2,1  drug therapy should be one component of multiple risk factor intervention in individuals who require modifications of their lipid profile,4
5821,5821,5821,5821,5821,5821,5821,7035,7035,7035,7035,7035,7035,7035,7035,7035,7035,7035,7035,7035,44dcbf97-99ec-427c-ba50-207e0069d6d2,lipid altering agents should be used in addition to a diet restricted in saturated fat and cholesterol only when the response to diet and other nonpharmacological measures has been inadequate,4
5822,5822,5822,5822,5822,5822,5822,7036,7036,7036,7036,7036,7036,7036,7036,7036,7036,7036,7036,7036,44dcbf97-99ec-427c-ba50-207e0069d6d2,livalo is a hmg coa reductase inhibitor indicated for patients with primary hyperlipidemia or mixed dyslipidemia as an adjunctive therapy to diet to reduce elevated total cholesterol ( tc )  low density lipoprotein cholesterol ( ldl c )  apolipoprotein b ( apo b )  triglycerides ( tg )  and to increase high density lipoprotein cholesterol ( hdl c ) ( 1 1 ) limitations of use ( 1 2 ) doses of livalo greater than 4 mg once daily were associated with an increased risk for severe myopathy in premarketing clinical studies,1
5823,5823,5823,5823,5823,5823,5823,7037,7037,7037,7037,7037,7037,7037,7037,7037,7037,7037,7037,7037,44dcbf97-99ec-427c-ba50-207e0069d6d2,do not exceed 4 mg once daily dosing of livalo,0
5824,5824,5824,5824,5824,5824,5824,7038,7038,7038,7038,7038,7038,7038,7038,7038,7038,7038,7038,7038,44dcbf97-99ec-427c-ba50-207e0069d6d2,the effect of livalo on cardiovascular morbidity and mortality has not been determined,0
5825,5825,5825,5825,5825,5825,5825,7039,7039,7039,7039,7039,7039,7039,7039,7039,7039,7039,7039,7039,44dcbf97-99ec-427c-ba50-207e0069d6d2,livalo has not been studied in fredrickson type i  iii  and v dyslipidemias,0
5826,5826,5826,5826,5826,5826,5826,7040,7040,7040,7040,7040,7040,7040,7040,7040,7040,7040,7040,7040,44dcbf97-99ec-427c-ba50-207e0069d6d2,1 1 primary hyperlipidemia and mixed dyslipidemia livalo is indicated as an adjunctive therapy to diet to reduce elevated total cholesterol ( tc )  low density lipoprotein cholesterol ( ldl c )  apolipoprotein b ( apo b )  triglycerides ( tg )  and to increase hdl c in adult patients with primary hyperlipidemia or mixed dyslipidemia,1
5827,5827,5827,5827,5827,5827,5827,7041,7041,7041,7041,7041,7041,7041,7041,7041,7041,7041,7041,7041,44dcbf97-99ec-427c-ba50-207e0069d6d2,1 2 limitations of use doses of livalo greater than 4 mg once daily were associated with an increased risk for severe myopathy in premarketing clinical studies,3
5828,5828,5828,5828,5828,5828,5828,7045,7045,7045,7045,7045,7045,7045,7045,7045,7045,7045,7045,7045,f94d9c49-245a-8081-42c4-785113fce498,1  ibandronate sodium tablet is a bisphosphonate indicated for the treatment and prevention of postmenopausal osteoporosis,1
5829,5829,5829,5829,5829,5829,5829,7046,7046,7046,7046,7046,7046,7046,7046,7046,7046,7046,7046,7046,f94d9c49-245a-8081-42c4-785113fce498,( 1 1 ) limitations of use the optimal duration of use has not been determined,0
5830,5830,5830,5830,5830,5830,5830,7048,7048,7048,7048,7048,7048,7048,7048,7048,7048,7048,7048,7048,f94d9c49-245a-8081-42c4-785113fce498,1 1 treatment and prevention of postmenopausal osteoporosis ibandronate sodium tablets are indicated for the treatment and prevention of osteoporosis in postmenopausal women,1
5831,5831,5831,5831,5831,5831,5831,7049,7049,7049,7049,7049,7049,7049,7049,7049,7049,7049,7049,7049,f94d9c49-245a-8081-42c4-785113fce498,ibandronate sodium tablets increases bone mineral density ( bmd ) and reduces the incidence of vertebral fractures,1
5832,5832,5832,5832,5832,5832,5832,7050,7050,7050,7050,7050,7050,7050,7050,7050,7050,7050,7050,7050,f94d9c49-245a-8081-42c4-785113fce498,1 2 important limitations of use the optimal duration of use has not been determined,0
5833,5833,5833,5833,5833,5833,5833,7051,7051,7051,7051,7051,7051,7051,7051,7051,7051,7051,7051,7051,f94d9c49-245a-8081-42c4-785113fce498,the safety and effectiveness of ibandronate sodium tablets for the treatment of osteoporosis are based on clinical data of three years duration,0
5834,5834,5834,5834,5834,5834,5834,7054,7054,7054,7054,7054,7054,7054,7054,7054,7054,7054,7054,7054,f94d9c49-245a-8081-42c4-785113fce498,patients who discontinue therapy should have their risk for fracture re evaluated periodically,0
5835,5835,5835,5835,5835,5835,5835,7055,7055,7055,7055,7055,7055,7055,7055,7055,7055,7055,7055,7055,8a1d477f-bfa8-40f4-90a7-9d39f7cb4672,1  abacavir tablets  in combination with other antiretroviral agents  are indicated for the treatment of human immunodeficiency virus ( hiv 1 ) infection,1
5836,5836,5836,5836,5836,5836,5836,7056,7056,7056,7056,7056,7056,7056,7056,7056,7056,7056,7056,7056,8a1d477f-bfa8-40f4-90a7-9d39f7cb4672,abacavir tablets  a nucleoside analogue human immunodeficiency virus ( hiv 1 ) reverse transcriptase inhibitor  are indicated in combination with other antiretroviral agents for the treatment of hiv 1 infection,1
5837,5837,5837,5837,5837,5837,5837,7057,7057,7057,7057,7057,7057,7057,7057,7057,7057,7057,7057,7057,64c10d60-1af5-11e3-a19b-0800200c9a66,1  verdeso ( desonide ) foam  0 05 is indicated for the treatment of mild to moderate atopic dermatitis in patients 3 months of age and older,1
5838,5838,5838,5838,5838,5838,5838,7058,7058,7058,7058,7058,7058,7058,7058,7058,7058,7058,7058,7058,64c10d60-1af5-11e3-a19b-0800200c9a66,patients should be instructed to use verdeso foam for the minimum amount of time necessary to achieve the desired results because of the potential for verdeso foam to suppress the hypothalamic pituitary adrenal ( hpa ) axis,4
5839,5839,5839,5839,5839,5839,5839,7059,7059,7059,7059,7059,7059,7059,7059,7059,7059,7059,7059,7059,64c10d60-1af5-11e3-a19b-0800200c9a66,treatment should not exceed 4 consecutive weeks,0
5840,5840,5840,5840,5840,5840,5840,7060,7060,7060,7060,7060,7060,7060,7060,7060,7060,7060,7060,7060,64c10d60-1af5-11e3-a19b-0800200c9a66,verdeso foam is a corticosteroid indicated for the topical treatment of mild to moderate atopic dermatitis in patients 3 months of age and older,1
5841,5841,5841,5841,5841,5841,5841,7061,7061,7061,7061,7061,7061,7061,7061,7061,7061,7061,7061,7061,"Active Ingredient UNII(s)
J28GE0ROVX    fdfbfc04-5473-404d-b1c8-a035beb1fe6c
J28GE0ROVX    fdfbfc04-5473-404d-b1c8-a035beb1fe6c
Name: SET ID dtype: object",active ingredient unii ( s ) j28ge0rovx active ingredient unii ( s ) j28ge0rovx active in j28ge0rovx active ingredient unii ( s ) j28ge0rovx active in name content xml  dtype object,0
5842,5842,5842,5842,5842,5842,5842,7063,7063,7063,7063,7063,7063,7063,7063,7063,7063,7063,7063,7063,e503b3cd-574e-ed6a-c7ed-3368115f7f72,1  clozapine tablets are an atypical antipsychotic indicated for treatment resistant schizophrenia,1
5843,5843,5843,5843,5843,5843,5843,7064,7064,7064,7064,7064,7064,7064,7064,7064,7064,7064,7064,7064,e503b3cd-574e-ed6a-c7ed-3368115f7f72,efficacy was established in an active controlled study,0
5844,5844,5844,5844,5844,5844,5844,7065,7065,7065,7065,7065,7065,7065,7065,7065,7065,7065,7065,7065,e503b3cd-574e-ed6a-c7ed-3368115f7f72,( 1 1  14 1 ) reducing suicidal behavior in patients with schizophrenia or schizoaffective disorder,1
5845,5845,5845,5845,5845,5845,5845,7067,7067,7067,7067,7067,7067,7067,7067,7067,7067,7067,7067,7067,e503b3cd-574e-ed6a-c7ed-3368115f7f72,( 1 2  14 2 ) 1 1 treatment resistant schizophrenia clozapine tablets are indicated for the treatment of severely ill patients with schizophrenia who fail to respond adequately to standard antipsychotic treatment,1
5846,5846,5846,5846,5846,5846,5846,7068,7068,7068,7068,7068,7068,7068,7068,7068,7068,7068,7068,7068,e503b3cd-574e-ed6a-c7ed-3368115f7f72,because of the risks of severe neutropenia and of seizure associated with its use  clozapine tablets should be used only in patients who have failed to respond adequately to standard antipsychotic treatment see warnings and precautions ( 5 1  5 5 ),u
5847,5847,5847,5847,5847,5847,5847,7069,7069,7069,7069,7069,7069,7069,7069,7069,7069,7069,7069,7069,e503b3cd-574e-ed6a-c7ed-3368115f7f72,the effectiveness of clozapine tablets in treatment resistant schizophrenia was demonstrated in a 6 week  randomized  double blind  active controlled study comparing clozapine and chlorpromazine in patients who had failed other antipsychotics see clinical studies ( 14 1 ),u
5848,5848,5848,5848,5848,5848,5848,7070,7070,7070,7070,7070,7070,7070,7070,7070,7070,7070,7070,7070,e503b3cd-574e-ed6a-c7ed-3368115f7f72,1 2 reduction in the risk of recurrent suicidal behavior in schizophrenia or schizoaffective disorder clozapine tablets are indicated for reducing the risk of recurrent suicidal behavior in patients with schizophrenia or schizoaffective disorder who are judged to be at chronic risk for re experiencing suicidal behavior  based on history and recent clinical state,1
5849,5849,5849,5849,5849,5849,5849,7071,7071,7071,7071,7071,7071,7071,7071,7071,7071,7071,7071,7071,e503b3cd-574e-ed6a-c7ed-3368115f7f72,suicidal behavior refers to actions by a patient that put him herself at risk for death,0
5850,5850,5850,5850,5850,5850,5850,7072,7072,7072,7072,7072,7072,7072,7072,7072,7072,7072,7072,7072,e503b3cd-574e-ed6a-c7ed-3368115f7f72,the effectiveness of clozapine tablets in reducing the risk of recurrent suicidal behavior was demonstrated over a two year treatment period in the intersept trial see clinical studies ( 14 2 ),0
5851,5851,5851,5851,5851,5851,5851,7073,7073,7073,7073,7073,7073,7073,7073,7073,7073,7073,7073,7073,0ac0cc44-3924-447d-9051-f84c44312380, haloperidol is indicated for use in the management of manifestations of psychotic disorders,1
5852,5852,5852,5852,5852,5852,5852,7074,7074,7074,7074,7074,7074,7074,7074,7074,7074,7074,7074,7074,0ac0cc44-3924-447d-9051-f84c44312380,haloperidol is indicated for the control of tics and vocal utterances of tourette s disorder in children and adults,1
5853,5853,5853,5853,5853,5853,5853,7075,7075,7075,7075,7075,7075,7075,7075,7075,7075,7075,7075,7075,0ac0cc44-3924-447d-9051-f84c44312380,haloperidol is effective for the treatment of severe behavior problems in children of combative  explosive hyperexcitability ( which cannot be accounted for by immediate provocation ),1
5854,5854,5854,5854,5854,5854,5854,7076,7076,7076,7076,7076,7076,7076,7076,7076,7076,7076,7076,7076,0ac0cc44-3924-447d-9051-f84c44312380,haloperidol is also effective in the short term treatment of hyperactive children who show excessive motor activity with accompanying conduct disorders consisting of some or all of the following symptoms impulsivity  difficulty sustaining attention  aggressivity  mood lability  and poor frustration tolerance,1
5855,5855,5855,5855,5855,5855,5855,7077,7077,7077,7077,7077,7077,7077,7077,7077,7077,7077,7077,7077,0ac0cc44-3924-447d-9051-f84c44312380,haloperidol should be reserved for these two groups of children only after failure to respond to psychotherapy or medications other than antipsychotics,4
5856,5856,5856,5856,5856,5856,5856,7078,7078,7078,7078,7078,7078,7078,7078,7078,7078,7078,7078,7078,2179f02c-48d7-48eb-8007-5ae43d8d16bc,1  northera is indicated for the treatment of orthostatic dizziness  lightheadedness  or the feeling that you are about to black out in adult patients with symptomatic neurogenic orthostatic hypotension ( noh ) caused by primary autonomic failure ( parkinson 's disease pd  multiple system atrophy  and pure autonomic failure )  dopamine beta hydroxylase deficiency  and non diabetic autonomic neuropathy,1
5857,5857,5857,5857,5857,5857,5857,7079,7079,7079,7079,7079,7079,7079,7079,7079,7079,7079,7079,7079,2179f02c-48d7-48eb-8007-5ae43d8d16bc,effectiveness beyond 2 weeks of treatment has not been established,0
5858,5858,5858,5858,5858,5858,5858,7080,7080,7080,7080,7080,7080,7080,7080,7080,7080,7080,7080,7080,2179f02c-48d7-48eb-8007-5ae43d8d16bc,the continued effectiveness of northera should be assessed periodically,0
5859,5859,5859,5859,5859,5859,5859,7081,7081,7081,7081,7081,7081,7081,7081,7081,7081,7081,7081,7081,2179f02c-48d7-48eb-8007-5ae43d8d16bc,northera is indicated for the treatment of orthostatic dizziness  lightheadedness  or the feeling that you are about to black out in adult patients with symptomatic neurogenic orthostatic hypotension ( noh ) caused by primary autonomic failure ( parkinson 's disease pd  multiple system atrophy  and pure autonomic failure )  dopamine beta hydroxylase deficiency  and non diabetic autonomic neuropathy,1
5860,5860,5860,5860,5860,5860,5860,7083,7083,7083,7083,7083,7083,7083,7083,7083,7083,7083,7083,7083,2179f02c-48d7-48eb-8007-5ae43d8d16bc,the continued effectiveness of northera should be assessed periodically ( 1 ),0
5861,5861,5861,5861,5861,5861,5861,7084,7084,7084,7084,7084,7084,7084,7084,7084,7084,7084,7084,7084,922d4d25-c530-11e1-9b21-0800200c9a66,1  jublia ( efinaconazole ) topical solution  10 is an azole antifungal indicated for the topical treatment of onychomycosis of the toenail ( s ) due to trichophyton rubrum and trichophyton mentagrophytes,1
5862,5862,5862,5862,5862,5862,5862,7085,7085,7085,7085,7085,7085,7085,7085,7085,7085,7085,7085,7085,922d4d25-c530-11e1-9b21-0800200c9a66,jublia is an azole antifungal indicated for the topical treatment of onychomycosis of the toenails due to trichophyton rubrum and trichophyton mentagrophytes,1
5863,5863,5863,5863,5863,5863,5863,7089,7089,7089,7089,7089,7089,7089,7089,7089,7089,7089,7089,7089,a3a7d398-59a7-468b-b05e-fb87e8311b32, to reduce the development of drug resistant bacteria and maintain the effectiveness of cefadroxil tablets and cefadroxil capsules and other antibacterial drugs  cefadroxil tablets and cefadroxil capsules should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria,1
5864,5864,5864,5864,5864,5864,5864,7092,7092,7092,7092,7092,7092,7092,7092,7092,7092,7092,7092,7092,a3a7d398-59a7-468b-b05e-fb87e8311b32,cefadroxil is indicated for the treatment of patients with infection caused by susceptible strains of the designated organisms in the following diseases urinary tract infections caused by e coli  p mirabilis  and klebsiella species,1
5865,5865,5865,5865,5865,5865,5865,7096,7096,7096,7096,7096,7096,7096,7096,7096,7096,7096,7096,7096,a3a7d398-59a7-468b-b05e-fb87e8311b32,cefadroxil is generally effective in the eradication of streptococci from the oropharynx,u
5866,5866,5866,5866,5866,5866,5866,7097,7097,7097,7097,7097,7097,7097,7097,7097,7097,7097,7097,7097,a3a7d398-59a7-468b-b05e-fb87e8311b32,however  data establishing the efficacy of cefadroxil for the prophylaxis of subsequent rheumatic fever are not available,0
5867,5867,5867,5867,5867,5867,5867,7100,7100,7100,7100,7100,7100,7100,7100,7100,7100,7100,7100,7100,bc71539e-1a33-4709-8a24-c2894e8dbc1c, dimenhydrinate injection  usp is indicated for the prevention and treatment of nausea  vomiting  or vertigo of motion sickness,1
5868,5868,5868,5868,5868,5868,5868,7101,7101,7101,7101,7101,7101,7101,7101,7101,7101,7101,7101,7101,a645dfcd-7343-4c79-af8b-1117e4a5b113, carefully consider the potential benefits and risks of celebrex and other treatment options before deciding to use celebrex,0
5869,5869,5869,5869,5869,5869,5869,7102,7102,7102,7102,7102,7102,7102,7102,7102,7102,7102,7102,7102,a645dfcd-7343-4c79-af8b-1117e4a5b113,use the lowest effective dose for the shortest duration consistent with individual patient treatment goals see warnings and precautions ( 5 ) 1 1 osteoarthritis ( oa ) celebrex is indicated for relief of the signs and symptoms of oa see clinical studies ( 14 1 ) 1 2 rheumatoid arthritis ( ra ) celebrex is indicated for relief of the signs and symptoms of ra see clinical studies ( 14 2 ) 1 3 juvenile rheumatoid arthritis ( jra ) celebrex is indicated for relief of the signs and symptoms of jra in patients 2 years and older see clinical studies ( 14 3 ) 1 4 ankylosing spondylitis ( as ) celebrex is indicated for the relief of signs and symptoms of as see clinical studies ( 14 4 ) 1 5 acute pain ( ap ) celebrex is indicated for the management of ap in adults see clinical studies ( 14 5 ) 1 6 primary dysmenorrhea ( pd ) celebrex is indicated for the treatment of pd see clinical studies ( 14 5 ),1
5870,5870,5870,5870,5870,5870,5870,7103,7103,7103,7103,7103,7103,7103,7103,7103,7103,7103,7103,7103,"Active Ingredient UNII(s)
JCX84Q7J1L; L7T10EIP3A; LAV5U5022Y; S07O44R1ZM    64bc6acc-58bf-0881-e053-2a91aa0a35e4
JCX84Q7J1L; L7T10EIP3A; LAV5U5022Y; S07O44R1ZM    64bc6acc-58bf-0881-e053-2a91aa0a35e4
Name: SET ID dtype: object",active ingredient unii ( s ) jcx84q7j1l l7t10eip3a lav5u5022y s07o44r1zm active ingredient unii ( s ) jcx84q7j1l l7t10eip jcx84q7j1l l7t10eip3a lav5u5022y s07o44r1zm active ingredient unii ( s ) jcx84q7j1l l7t10eip name content xml  dtype object,0
5871,5871,5871,5871,5871,5871,5871,7105,7105,7105,7105,7105,7105,7105,7105,7105,7105,7105,7105,7105,c58db6e8-0451-4908-8a1b-709f7306eb77,1  sustiva ( efavirenz ) in combination with other antiretroviral agents is indicated for the treatment of human immunodeficiency virus type 1 ( hiv 1 ) infection in adults and in pediatric patients at least 3 months old and weighing at least 3 5 kg,1
5872,5872,5872,5872,5872,5872,5872,7106,7106,7106,7106,7106,7106,7106,7106,7106,7106,7106,7106,7106,c58db6e8-0451-4908-8a1b-709f7306eb77,sustiva is a non nucleoside reverse transcriptase inhibitor indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency virus type 1 infection in adults and in pediatric patients at least 3 months old and weighing at least 3 5 kg,1
5873,5873,5873,5873,5873,5873,5873,7107,7107,7107,7107,7107,7107,7107,7107,7107,7107,7107,7107,7107,d3bebc1c-f032-402a-bbc9-aff024276ed1, ventavis is a synthetic analog of prostacyclin indicated for the treatment of pulmonary arterial hypertension ( pah ) ( who group 1 ) to improve a composite endpoint consisting of exercise tolerance  symptoms ( nyha class )  and lack of deterioration,1
5874,5874,5874,5874,5874,5874,5874,7108,7108,7108,7108,7108,7108,7108,7108,7108,7108,7108,7108,7108,d3bebc1c-f032-402a-bbc9-aff024276ed1,studies establishing effectiveness included predominately patients with nyha functional class iii iv symptoms and etiologies of idiopathic or heritable pah ( 65 ) or pah associated with connective tissue diseases ( 23 ),0
5875,5875,5875,5875,5875,5875,5875,7109,7109,7109,7109,7109,7109,7109,7109,7109,7109,7109,7109,7109,d3bebc1c-f032-402a-bbc9-aff024276ed1,1 1 pulmonary arterial hypertension ventavis is indicated for the treatment of pulmonary arterial hypertension ( pah ) ( who group 1 ) to improve a composite endpoint consisting of exercise tolerance  symptoms ( nyha class )  and lack of deterioration,1
5876,5876,5876,5876,5876,5876,5876,7110,7110,7110,7110,7110,7110,7110,7110,7110,7110,7110,7110,7110,d3bebc1c-f032-402a-bbc9-aff024276ed1,studies establishing effectiveness included predominately patients with nyha functional class iii iv symptoms and etiologies of idiopathic or heritable pah ( 65 ) or pah associated with connective tissue diseases ( 23 ) see clinical studies ( 14 ),0
5877,5877,5877,5877,5877,5877,5877,7111,7111,7111,7111,7111,7111,7111,7111,7111,7111,7111,7111,7111,1597dc56-a4ae-4906-ba55-f268b3cb8262, flumadine is indicated for the prophylaxis and treatment of illness caused by various strains of influenza a virus in adults ( 17 years and older ),1
5878,5878,5878,5878,5878,5878,5878,7112,7112,7112,7112,7112,7112,7112,7112,7112,7112,7112,7112,7112,1597dc56-a4ae-4906-ba55-f268b3cb8262,flumadine is indicated for prophylaxis against influenza a virus in children ( 1 year to 16 years of age ),1
5879,5879,5879,5879,5879,5879,5879,7113,7113,7113,7113,7113,7113,7113,7113,7113,7113,7113,7113,7113,1597dc56-a4ae-4906-ba55-f268b3cb8262,prophylaxis in controlled studies of children ( 1 year to 16 years of age )  healthy adults ( 17 years and older )  and elderly patients ( 65 yeas of age and older )  flumadine has been shown to be safe and effective in preventing signs and symptoms of infection caused by various strains of influenza a virus,0
5880,5880,5880,5880,5880,5880,5880,7114,7114,7114,7114,7114,7114,7114,7114,7114,7114,7114,7114,7114,1597dc56-a4ae-4906-ba55-f268b3cb8262,since flumadine does not completely prevent the host immune response to influenza a infection  individuals who take this drug may still develop immune responses to natural disease or vaccination and may be protected when later exposed to antigenically related viruses,4
5881,5881,5881,5881,5881,5881,5881,7115,7115,7115,7115,7115,7115,7115,7115,7115,7115,7115,7115,7115,1597dc56-a4ae-4906-ba55-f268b3cb8262,following vaccination during an influenza outbreak  flumadine prophylaxis should be considered for the 2 to 4 week time period required to develop an antibody response,4
5882,5882,5882,5882,5882,5882,5882,7116,7116,7116,7116,7116,7116,7116,7116,7116,7116,7116,7116,7116,1597dc56-a4ae-4906-ba55-f268b3cb8262,however  the safety and effectiveness of flumadine prophylaxis have not been demonstrated for longer than 6 weeks,0
5883,5883,5883,5883,5883,5883,5883,7117,7117,7117,7117,7117,7117,7117,7117,7117,7117,7117,7117,7117,1597dc56-a4ae-4906-ba55-f268b3cb8262,treatment flumadine therapy should be considered for adults ( 17 years and older ) who develop an influenza like illness during known or suspected influenza a infection in the community,0
5884,5884,5884,5884,5884,5884,5884,7118,7118,7118,7118,7118,7118,7118,7118,7118,7118,7118,7118,7118,1597dc56-a4ae-4906-ba55-f268b3cb8262,when administered within 48 hours after onset of signs and symptoms of infection caused by influenza a virus strains  flumadine has been shown to reduce the duration of fever and systemic symptoms,0
5885,5885,5885,5885,5885,5885,5885,7119,7119,7119,7119,7119,7119,7119,7119,7119,7119,7119,7119,7119,1597dc56-a4ae-4906-ba55-f268b3cb8262,the following points should be considered before initiating treatment or prophylaxis with flumadine flumadine is not a substitute for early vaccination on an annual basis as recommended by the centers for disease control and prevention advisory committee on immunization practices,0
5886,5886,5886,5886,5886,5886,5886,7121,7121,7121,7121,7121,7121,7121,7121,7121,7121,7121,7121,7121,1597dc56-a4ae-4906-ba55-f268b3cb8262,emergence of resistance mutations could decrease drug effectiveness,0
5887,5887,5887,5887,5887,5887,5887,7123,7123,7123,7123,7123,7123,7123,7123,7123,7123,7123,7123,7123,1597dc56-a4ae-4906-ba55-f268b3cb8262,prescribers should consider available information on influenza drug susceptibility patterns and treatment effects when deciding whether to use flumadine,0
5888,5888,5888,5888,5888,5888,5888,7124,7124,7124,7124,7124,7124,7124,7124,7124,7124,7124,7124,7124,f7d63f3f-5303-48ab-bce2-35fd62c45799,1  quazepam is indicated for the treatment of insomnia characterized by difficulty in falling asleep  frequent nocturnal awakenings  and or early morning awakenings,1
5889,5889,5889,5889,5889,5889,5889,7125,7125,7125,7125,7125,7125,7125,7125,7125,7125,7125,7125,7125,f7d63f3f-5303-48ab-bce2-35fd62c45799,the effectiveness of quazepam has been established in placebo controlled clinical studies of 5 nights duration in acute and chronic insomnia,0
5890,5890,5890,5890,5890,5890,5890,7126,7126,7126,7126,7126,7126,7126,7126,7126,7126,7126,7126,7126,f7d63f3f-5303-48ab-bce2-35fd62c45799,the sustained effectiveness of quazepam has been established in chronic insomnia in a sleep lab ( polysomnographic ) study of 28 nights duration,0
5891,5891,5891,5891,5891,5891,5891,7127,7127,7127,7127,7127,7127,7127,7127,7127,7127,7127,7127,7127,f7d63f3f-5303-48ab-bce2-35fd62c45799,because insomnia is often transient and intermittent  the prolonged administration of quazepam tablets is generally not necessary or recommended,0
5892,5892,5892,5892,5892,5892,5892,7129,7129,7129,7129,7129,7129,7129,7129,7129,7129,7129,7129,7129,f7d63f3f-5303-48ab-bce2-35fd62c45799,quazepam  a gamma aminobutyric ( gabaa ) agonist  is indicated for the treatment of insomnia characterized by difficulty falling asleep  frequent nocturnal awakenings  and or early morning awakenings,1
5893,5893,5893,5893,5893,5893,5893,7130,7130,7130,7130,7130,7130,7130,7130,7130,7130,7130,7130,7130,bb25e3c5-a271-45a5-bef1-7f565eacba70, to reduce the development of drug resistant bacteria and maintain the effectiveness of ampicillin and other antibacterial drugs  ampicillin should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria,4
5894,5894,5894,5894,5894,5894,5894,7133,7133,7133,7133,7133,7133,7133,7133,7133,7133,7133,7133,7133,bb25e3c5-a271-45a5-bef1-7f565eacba70,ampicillin is indicated in the treatment of infections caused by susceptible strains of the designated organisms in the conditions listed below respiratory tract infections caused by s pneumoniae ( formerly d pneumoniae )  staphylococcus aureus ( penicillinase and non penicillinase producing )  h influenzae and group a beta hemolytic streptococci,1
5895,5895,5895,5895,5895,5895,5895,7134,7134,7134,7134,7134,7134,7134,7134,7134,7134,7134,7134,7134,bb25e3c5-a271-45a5-bef1-7f565eacba70,bacterial meningitis caused by e coli  group b streptococci  and other gram negative bacteria ( listeria monocytogenes  n meningitidis ),1
5896,5896,5896,5896,5896,5896,5896,7135,7135,7135,7135,7135,7135,7135,7135,7135,7135,7135,7135,7135,bb25e3c5-a271-45a5-bef1-7f565eacba70,the addition of an aminoglycoside with ampicillin may increase its effectiveness against gram negative bacteria,4
5897,5897,5897,5897,5897,5897,5897,7136,7136,7136,7136,7136,7136,7136,7136,7136,7136,7136,7136,7136,bb25e3c5-a271-45a5-bef1-7f565eacba70,septicemia and endocarditis caused by susceptible gram positive organisms including streptococcus spp  penicillin g susceptible staphylococci and enterococci,1
5898,5898,5898,5898,5898,5898,5898,7137,7137,7137,7137,7137,7137,7137,7137,7137,7137,7137,7137,7137,bb25e3c5-a271-45a5-bef1-7f565eacba70,gram negative sepsis caused by e coli  proteus mirabilis and salmonella spp,1
5899,5899,5899,5899,5899,5899,5899,7138,7138,7138,7138,7138,7138,7138,7138,7138,7138,7138,7138,7138,bb25e3c5-a271-45a5-bef1-7f565eacba70,endocarditis due to enterococcal strains usually respond to intravenous therapy,1
5900,5900,5900,5900,5900,5900,5900,7139,7139,7139,7139,7139,7139,7139,7139,7139,7139,7139,7139,7139,bb25e3c5-a271-45a5-bef1-7f565eacba70,the addition of an aminoglycoside may enhance the effectiveness of ampicillin when treating streptococcal endocarditis,4
5901,5901,5901,5901,5901,5901,5901,7140,7140,7140,7140,7140,7140,7140,7140,7140,7140,7140,7140,7140,bb25e3c5-a271-45a5-bef1-7f565eacba70,urinary tract infections caused by sensitive strains of e coli and proteus mirabilis,1
5902,5902,5902,5902,5902,5902,5902,7141,7141,7141,7141,7141,7141,7141,7141,7141,7141,7141,7141,7141,bb25e3c5-a271-45a5-bef1-7f565eacba70,gastrointestinal infections caused by salmonella typhosa ( typhoid fever )  other salmonella spp,1
5903,5903,5903,5903,5903,5903,5903,7142,7142,7142,7142,7142,7142,7142,7142,7142,7142,7142,7142,7142,bb25e3c5-a271-45a5-bef1-7f565eacba70,( dysentery ) usually respond to oral or intravenous therapy,u
5904,5904,5904,5904,5904,5904,5904,7144,7144,7144,7144,7144,7144,7144,7144,7144,7144,7144,7144,7144,bb25e3c5-a271-45a5-bef1-7f565eacba70,therapy may be instituted prior to obtaining results of susceptibility testing,0
5905,5905,5905,5905,5905,5905,5905,7145,7145,7145,7145,7145,7145,7145,7145,7145,7145,7145,7145,7145,bb25e3c5-a271-45a5-bef1-7f565eacba70,it is advisable to reserve the parenteral form of this drug for moderately severe and severe infections and for patients who are unable to take the oral forms,0
5906,5906,5906,5906,5906,5906,5906,7146,7146,7146,7146,7146,7146,7146,7146,7146,7146,7146,7146,7146,bb25e3c5-a271-45a5-bef1-7f565eacba70,a change to oral ampicillin may be made as soon as appropriate,0
5907,5907,5907,5907,5907,5907,5907,7148,7148,7148,7148,7148,7148,7148,7148,7148,7148,7148,7148,7148,8f98d499-f68f-4148-8ec3-8c66ef184a83,1 indications usage  ( 1 1 ) 12 2011 nebivolol tablets are a beta adrenergic blocking agent indicated for the treatment of hypertension  to lower blood pressure,1
5908,5908,5908,5908,5908,5908,5908,7150,7150,7150,7150,7150,7150,7150,7150,7150,7150,7150,7150,7150,8f98d499-f68f-4148-8ec3-8c66ef184a83,( 1 1 ) 1 1 hypertension nebivolol tablets are indicated for the treatment of hypertension  to lower blood pressure see clinical studies ( 14 1 ),1
5909,5909,5909,5909,5909,5909,5909,7151,7151,7151,7151,7151,7151,7151,7151,7151,7151,7151,7151,7151,8f98d499-f68f-4148-8ec3-8c66ef184a83,nebivolol tablets may be used alone or in combination with other antihypertensive agents see drug interactions ( 7 ),4
5910,5910,5910,5910,5910,5910,5910,7153,7153,7153,7153,7153,7153,7153,7153,7153,7153,7153,7153,7153,8f98d499-f68f-4148-8ec3-8c66ef184a83,these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes  including the class to which this drug principally belongs,0
5911,5911,5911,5911,5911,5911,5911,7154,7154,7154,7154,7154,7154,7154,7154,7154,7154,7154,7154,7154,8f98d499-f68f-4148-8ec3-8c66ef184a83,there are no controlled trials demonstrating risk reduction with nebivolol,0
5912,5912,5912,5912,5912,5912,5912,7157,7157,7157,7157,7157,7157,7157,7157,7157,7157,7157,7157,7157,8f98d499-f68f-4148-8ec3-8c66ef184a83,for specific advice on goals and management  see published guidelines  such as those of the national high bloodpressure education program 's joint national committee on prevention  detection  evaluation  and treatment of high blood pressure ( jnc ),0
5913,5913,5913,5913,5913,5913,5913,7162,7162,7162,7162,7162,7162,7162,7162,7162,7162,7162,7162,7162,90639fc6-0295-4115-98f0-054b783850ce,indication and usage vistide is indicated for the treatment of cmv retinitis in patients with acquired immunodeficiency syndrome ( aids ),1
5914,5914,5914,5914,5914,5914,5914,7163,7163,7163,7163,7163,7163,7163,7163,7163,7163,7163,7163,7163,90639fc6-0295-4115-98f0-054b783850ce,the safety and efficacy of vistide have not been established for treatment of other cmv infections ( such as pneumonitis or gastroenteritis )  congenital or neonatal cmv disease  or cmv disease in non hiv infected individuals,0
5915,5915,5915,5915,5915,5915,5915,7164,7164,7164,7164,7164,7164,7164,7164,7164,7164,7164,7164,7164,822ed86d-c311-42fd-834f-d147fdf27b49, dextroamphetamine sulfate extended release capsules are indicated in narcolepsy attention deficit disorder with hyperactivity as an integral part of a total treatment program that typically includes other measures ( psychological  educational  social ) for patients ( ages 6 years to 16 years ) with this syndrome,1
5916,5916,5916,5916,5916,5916,5916,7165,7165,7165,7165,7165,7165,7165,7165,7165,7165,7165,7165,7165,822ed86d-c311-42fd-834f-d147fdf27b49,a diagnosis of attention deficit hyperactivity disorder ( adhd dsm iv ) implies the presence of the hyperactive impulsive or inattentive symptoms that caused impairment and were present before age 7 years,0
5917,5917,5917,5917,5917,5917,5917,7166,7166,7166,7166,7166,7166,7166,7166,7166,7166,7166,7166,7166,822ed86d-c311-42fd-834f-d147fdf27b49,the symptoms must cause clinically significant impairment  e g  in social  academic  or occupational functioning  and be present in 2 or more settings  e g  school ( or work ) and at home,0
5918,5918,5918,5918,5918,5918,5918,7168,7168,7168,7168,7168,7168,7168,7168,7168,7168,7168,7168,7168,822ed86d-c311-42fd-834f-d147fdf27b49,for the inattentive type  at least 6 of the following symptoms must have persisted for at least 6 months lack of attention to details careless mistakes lack of sustained attention poor listener failure to follow through on tasks poor organization avoids tasks requiring sustained mental effort loses things easily distracted forgetful,0
5919,5919,5919,5919,5919,5919,5919,7169,7169,7169,7169,7169,7169,7169,7169,7169,7169,7169,7169,7169,822ed86d-c311-42fd-834f-d147fdf27b49,for the hyperactive impulsive type  at least 6 of the following symptoms must have persisted for at least 6 months fidgeting squirming leaving seat inappropriate running climbing difficulty with quiet activities on the go excessive talking blurting answers ca n't wait turn intrusive,0
5920,5920,5920,5920,5920,5920,5920,7172,7172,7172,7172,7172,7172,7172,7172,7172,7172,7172,7172,7172,822ed86d-c311-42fd-834f-d147fdf27b49,adequate diagnosis requires the use of medical and special psychological  educational  and social resources,0
5921,5921,5921,5921,5921,5921,5921,7174,7174,7174,7174,7174,7174,7174,7174,7174,7174,7174,7174,7174,822ed86d-c311-42fd-834f-d147fdf27b49,the diagnosis must be based upon a complete history and evaluation of the patient and not solely on the presences of the required number of dsm iv characteristics,0
5922,5922,5922,5922,5922,5922,5922,7175,7175,7175,7175,7175,7175,7175,7175,7175,7175,7175,7175,7175,822ed86d-c311-42fd-834f-d147fdf27b49,need for comprehensive treatment program dextroamphetamine sulfate extended release capsules are indicated as an integral part of a total treatment program for adhd that may include other measures ( psychological  educati,1
5923,5923,5923,5923,5923,5923,5923,7176,7176,7176,7176,7176,7176,7176,7176,7176,7176,7176,7176,7176,1cd07b54-f66f-4040-9058-462324267196, cenestin therapy is indicated for the 1,0
5924,5924,5924,5924,5924,5924,5924,7177,7177,7177,7177,7177,7177,7177,7177,7177,7177,7177,7177,7177,1cd07b54-f66f-4040-9058-462324267196,treatment of moderate to severe vasomotor symptoms associated with the menopause,1
5925,5925,5925,5925,5925,5925,5925,7178,7178,7178,7178,7178,7178,7178,7178,7178,7178,7178,7178,7178,1cd07b54-f66f-4040-9058-462324267196,0 45 mg cenestin 0 625 mg cenestin 0 9 mg cenestin 1 25 mg cenestin 2,0
5926,5926,5926,5926,5926,5926,5926,7181,7181,7181,7181,7181,7181,7181,7181,7181,7181,7181,7181,7181,3bd4006a-8bad-4909-ac6d-b6d84390155c,1  multaq is indicated to reduce the risk of hospitalization for atrial fibrillation in patients in sinus rhythm with a history of paroxysmal or persistent atrial fibrillation ( af ) see clinical studies ( 14 ),1
5927,5927,5927,5927,5927,5927,5927,7182,7182,7182,7182,7182,7182,7182,7182,7182,7182,7182,7182,7182,3bd4006a-8bad-4909-ac6d-b6d84390155c,multaq is an antiarrhythmic drug indicated to reduce the risk of hospitalization for atrial fibrillation ( af ) in patients in sinus rhythm with a history of paroxysmal or persistent af ( 1  14 ),1
5928,5928,5928,5928,5928,5928,5928,7183,7183,7183,7183,7183,7183,7183,7183,7183,7183,7183,7183,7183,50f193ee-1691-486d-9370-a664df63695c,1  arnuity ellipta is a corticosteroid indicated for once daily maintenance treatment of asthma as prophylactic therapy in patients aged 12 years and older,1
5929,5929,5929,5929,5929,5929,5929,7184,7184,7184,7184,7184,7184,7184,7184,7184,7184,7184,7184,7184,50f193ee-1691-486d-9370-a664df63695c,( 1 1 ) important limitation not indicated for relief of acute bronchospasm,0
5930,5930,5930,5930,5930,5930,5930,7185,7185,7185,7185,7185,7185,7185,7185,7185,7185,7185,7185,7185,50f193ee-1691-486d-9370-a664df63695c,( 1 1  5 2 ) 1 1 treatment of asthma arnuity ellipta is indicated for the once daily maintenance treatment of asthma as prophylactic therapy in patients aged 12 years and older,1
5931,5931,5931,5931,5931,5931,5931,7186,7186,7186,7186,7186,7186,7186,7186,7186,7186,7186,7186,7186,50f193ee-1691-486d-9370-a664df63695c,important limitation of use arnuity ellipta is not indicated for the relief of acute bronchospasm,0
5932,5932,5932,5932,5932,5932,5932,7187,7187,7187,7187,7187,7187,7187,7187,7187,7187,7187,7187,7187,19c74245-9681-4623-8166-cd29bb4957b9,1  memantine hydrochloride extended release capsules are indicated for the treatment of moderate to severe dementia of the alzheimer s type,1
5933,5933,5933,5933,5933,5933,5933,7188,7188,7188,7188,7188,7188,7188,7188,7188,7188,7188,7188,7188,19c74245-9681-4623-8166-cd29bb4957b9,memantine hydrochloride extended release capsules are an nmda receptor antagonist indicated for the treatment of moderate to severe dementia of the alzheimer s type ( 1 ),1
5934,5934,5934,5934,5934,5934,5934,7189,7189,7189,7189,7189,7189,7189,7189,7189,7189,7189,7189,7189,a71129ae-8266-4064-a3f5-6f2897e62981, technetium tc99m dextran by intravenous administration is indicated as a cardiac blood pool imaging agent and as an adjunct in the diagnosis of pericardial effusion  ventricular aneurysm  or gi bleed,1
5935,5935,5935,5935,5935,5935,5935,7190,7190,7190,7190,7190,7190,7190,7190,7190,7190,7190,7190,7190,7b48ddec-e815-45f4-9ca0-5c0daaf56f30,acthar gel is an adrenocorticotropic hormone ( acth ) analogue indicated as monotherapy for the treatment of infantile spasms in infants and children under 2 years of age,1
5936,5936,5936,5936,5936,5936,5936,7191,7191,7191,7191,7191,7191,7191,7191,7191,7191,7191,7191,7191,7b48ddec-e815-45f4-9ca0-5c0daaf56f30,acthar gel is indicated for the treatment of exacerbations of multiple sclerosis in adults,1
5937,5937,5937,5937,5937,5937,5937,7192,7192,7192,7192,7192,7192,7192,7192,7192,7192,7192,7192,7192,7b48ddec-e815-45f4-9ca0-5c0daaf56f30,acthar gel may be used for the following disorders and diseases rheumatic collagen dermatologic allergic states ophthalmic respiratory and edematous state,1
5938,5938,5938,5938,5938,5938,5938,7193,7193,7193,7193,7193,7193,7193,7193,7193,7193,7193,7193,7193,7b48ddec-e815-45f4-9ca0-5c0daaf56f30,( 1 3 to 1 9 ) 1 1 infantile spasms h p,1
5939,5939,5939,5939,5939,5939,5939,7194,7194,7194,7194,7194,7194,7194,7194,7194,7194,7194,7194,7194,7b48ddec-e815-45f4-9ca0-5c0daaf56f30,acthar gel ( repository corticotropin injection ) is indicated as monotherapy for the treatment of infantile spasms in infants and children under 2 years of age,1
5940,5940,5940,5940,5940,5940,5940,7195,7195,7195,7195,7195,7195,7195,7195,7195,7195,7195,7195,7195,7b48ddec-e815-45f4-9ca0-5c0daaf56f30,acthar gel ( repository corticotropin injection ) is indicated for the treatment of acute exacerbations of multiple sclerosis in adults,1
5941,5941,5941,5941,5941,5941,5941,7196,7196,7196,7196,7196,7196,7196,7196,7196,7196,7196,7196,7196,7b48ddec-e815-45f4-9ca0-5c0daaf56f30,controlled clinical trials have shown h p,0
5942,5942,5942,5942,5942,5942,5942,7197,7197,7197,7197,7197,7197,7197,7197,7197,7197,7197,7197,7197,7b48ddec-e815-45f4-9ca0-5c0daaf56f30,acthar gel to be effective in speeding the resolution of acute exacerbations of multiple sclerosis,0
5943,5943,5943,5943,5943,5943,5943,7198,7198,7198,7198,7198,7198,7198,7198,7198,7198,7198,7198,7198,7b48ddec-e815-45f4-9ca0-5c0daaf56f30,however  there is no evidence that it affects the ultimate outcome or natural history of the disease,0
5944,5944,5944,5944,5944,5944,5944,7199,7199,7199,7199,7199,7199,7199,7199,7199,7199,7199,7199,7199,7b48ddec-e815-45f4-9ca0-5c0daaf56f30,1 3 rheumatic disorders as adjunctive therapy for short term administration ( to tide the patient over an acute episode or exacerbation ) in psoriatic arthritis rheumatoid arthritis  including juvenile rheumatoid arthritis ( selected cases may require low dose maintenance therapy )  ankylosing spondylitis,1
5945,5945,5945,5945,5945,5945,5945,7200,7200,7200,7200,7200,7200,7200,7200,7200,7200,7200,7200,7200,7b48ddec-e815-45f4-9ca0-5c0daaf56f30,1 4 collagen diseases during an exacerbation or as maintenance therapy in selected cases of systemic lupus erythematosus  systemic dermatomyositis ( polymyositis ),1
5946,5946,5946,5946,5946,5946,5946,7201,7201,7201,7201,7201,7201,7201,7201,7201,7201,7201,7201,7201,1ae61072-bca0-43f0-a741-07bda2d50c87,1  kerydin ( tavaborole ) topical solution  5 is an oxaborole antifungal indicated for the treatment of onychomycosis of the toenails due to trichophyton rubrum or trichophyton mentagrophytes,1
5947,5947,5947,5947,5947,5947,5947,7202,7202,7202,7202,7202,7202,7202,7202,7202,7202,7202,7202,7202,1ae61072-bca0-43f0-a741-07bda2d50c87,kerydin is an oxaborole antifungal indicated for the topical treatment of onychomycosis of the toenails due to trichophyton rubrum or trichophyton mentagrophytes,1
5948,5948,5948,5948,5948,5948,5948,7208,7208,7208,7208,7208,7208,7208,7208,7208,7208,7208,7208,7208,17f85d17-ab71-4f5b-9fe3-0b8c822f69ff,1  perjeta is a her2 neu receptor antagonist indicated for use in combination with trastuzumab and docetaxel for treatment of patients with her2 positive metastatic breast cancer ( mbc ) who have not received prior anti her2 therapy or chemotherapy for metastatic disease,1
5949,5949,5949,5949,5949,5949,5949,7209,7209,7209,7209,7209,7209,7209,7209,7209,7209,7209,7209,7209,17f85d17-ab71-4f5b-9fe3-0b8c822f69ff,( 1 1 ) use in combination with trastuzumab and chemotherapy as neoadjuvant treatment of patients with her2 positive  locally advanced  inflammatory  or early stage breast cancer ( either greater than 2 cm in diameter or node positive ) as part of a complete treatment regimen for early breast cancer,4
5950,5950,5950,5950,5950,5950,5950,7210,7210,7210,7210,7210,7210,7210,7210,7210,7210,7210,7210,7210,17f85d17-ab71-4f5b-9fe3-0b8c822f69ff,( 1 2  2 2  14 2 ) adjuvant treatment of patients with her2 positive early breast cancer at high risk of recurrence ( 1 2  2 2  14 3 ) 1 1 metastatic breast cancer ( mbc ) perjeta is indicated for use in combination with trastuzumab and docetaxel for the treatment of patients with her2 positive metastatic breast cancer who have not received prior anti her2 therapy or chemotherapy for metastatic disease see dosage and administration ( 2 2 ) and clinical studies ( 14 1 ),1
5951,5951,5951,5951,5951,5951,5951,7211,7211,7211,7211,7211,7211,7211,7211,7211,7211,7211,7211,7211,17f85d17-ab71-4f5b-9fe3-0b8c822f69ff,1 2 early breast cancer ( ebc ) perjeta is indicated for use in combination with trastuzumab and chemotherapy for the neoadjuvant treatment of patients with her2 positive  locally advanced  inflammatory  or early stage breast cancer ( either greater than 2 cm in diameter or node positive ) as part of a complete treatment regimen for early breast cancer see dosage and administration ( 2 2 ) and clinical studies ( 14 2 ),1
5952,5952,5952,5952,5952,5952,5952,7212,7212,7212,7212,7212,7212,7212,7212,7212,7212,7212,7212,7212,17f85d17-ab71-4f5b-9fe3-0b8c822f69ff,the adjuvant treatment of patients with her2 positive early breast cancer at high risk of recurrence see dosage and administration ( 2 2 ) and clinical studies ( 14 3 ),1
5953,5953,5953,5953,5953,5953,5953,7213,7213,7213,7213,7213,7213,7213,7213,7213,7213,7213,7213,7213,1482f8a2-c2c0-45a1-8e90-b427227f0b28,indications studies have shown that properly performed an interpreted skin tests with ragweed pollen extract are useful in the diagnosis of allergy to ragweed pollen 7  8  20  21,0
5954,5954,5954,5954,5954,5954,5954,7214,7214,7214,7214,7214,7214,7214,7214,7214,7214,7214,7214,7214,1482f8a2-c2c0-45a1-8e90-b427227f0b28,immunotherapy with the appropriate dosage of short ragweed pollen extract is effective in reducing symptoms of hay fever and asthma resulting from exposure to short ragweed pollen ( 9  10  11 )  and it is believed to be effective with extract of giant ragweed  although carefully controlled studies are unavailable,u
5955,5955,5955,5955,5955,5955,5955,7215,7215,7215,7215,7215,7215,7215,7215,7215,7215,7215,7215,7215,1482f8a2-c2c0-45a1-8e90-b427227f0b28,however  clinical observations and known cross reactivity between short and giant ragweed pollens have led to the practice of using a mixture of the two species for skin testing and treatment 22  23  24  25  26  27,0
5956,5956,5956,5956,5956,5956,5956,7216,7216,7216,7216,7216,7216,7216,7216,7216,7216,7216,7216,7216,1482f8a2-c2c0-45a1-8e90-b427227f0b28,this form of treatment is recommended for patients who cannot avoid exposure to pollen and who do not obtain satisfactory relief of symptoms from other medications  such as antihistamines,0
5957,5957,5957,5957,5957,5957,5957,7217,7217,7217,7217,7217,7217,7217,7217,7217,7217,7217,7217,7217,1482f8a2-c2c0-45a1-8e90-b427227f0b28,immunologic changes resulting from treatment with short ragweed pollen extract are believed to include the induction of specific anti ragweed igg antibodies commonly referred to as blocking antibodies 12  13,0
5958,5958,5958,5958,5958,5958,5958,7218,7218,7218,7218,7218,7218,7218,7218,7218,7218,7218,7218,7218,1482f8a2-c2c0-45a1-8e90-b427227f0b28,a decrease in the elevation of ragweed specific ige during and immediately following the ragweed pollen season 14,u
5959,5959,5959,5959,5959,5959,5959,7219,7219,7219,7219,7219,7219,7219,7219,7219,7219,7219,7219,7219,1482f8a2-c2c0-45a1-8e90-b427227f0b28,a reduction of circulating anti ragweed ige after long term immunotherapy 15,u
5960,5960,5960,5960,5960,5960,5960,7220,7220,7220,7220,7220,7220,7220,7220,7220,7220,7220,7220,7220,1482f8a2-c2c0-45a1-8e90-b427227f0b28,a decrease in skin reactivity to the extract 16 and a decrease in leukocyte sensitivity to histamine release 17 after long term immunotherapy,u
5961,5961,5961,5961,5961,5961,5961,7221,7221,7221,7221,7221,7221,7221,7221,7221,7221,7221,7221,7221,241f0b1e-8b95-470d-876f-bf1804daaf18,1  ixempra ( ixabepilone ) is indicated in combination with capecitabine for the treatment of patients with metastatic or locally advanced breast cancer resistant to treatment with an anthracycline and a taxane  or whose cancer is taxane resistant and for whom further anthracycline therapy is contraindicated,1
5962,5962,5962,5962,5962,5962,5962,7222,7222,7222,7222,7222,7222,7222,7222,7222,7222,7222,7222,7222,241f0b1e-8b95-470d-876f-bf1804daaf18,anthracycline resistance is defined as progression while on therapy or within 6 months in the adjuvant setting or 3 months in the metastatic setting,0
5963,5963,5963,5963,5963,5963,5963,7223,7223,7223,7223,7223,7223,7223,7223,7223,7223,7223,7223,7223,241f0b1e-8b95-470d-876f-bf1804daaf18,taxane resistance is defined as progression while on therapy or within 12 months in the adjuvant setting or 4 months in the metastatic setting,0
5964,5964,5964,5964,5964,5964,5964,7224,7224,7224,7224,7224,7224,7224,7224,7224,7224,7224,7224,7224,241f0b1e-8b95-470d-876f-bf1804daaf18,ixempra is indicated as monotherapy for the treatment of metastatic or locally advanced breast cancer in patients whose tumors are resistant or refractory to anthracyclines  taxanes  and capecitabine,1
5965,5965,5965,5965,5965,5965,5965,7225,7225,7225,7225,7225,7225,7225,7225,7225,7225,7225,7225,7225,241f0b1e-8b95-470d-876f-bf1804daaf18,ixempra  a microtubule inhibitor  in combination with capecitabine is indicated for the treatment of metastatic or locally advanced breast cancer in patients after failure of an anthracycline and a taxane ( 1 ),1
5966,5966,5966,5966,5966,5966,5966,7226,7226,7226,7226,7226,7226,7226,7226,7226,7226,7226,7226,7226,241f0b1e-8b95-470d-876f-bf1804daaf18,ixempra as monotherapy is indicated for the treatment of metastatic or locally advanced breast cancer in patients after failure of an anthracycline  a taxane  and capecitabine ( 1 ),1
5967,5967,5967,5967,5967,5967,5967,7227,7227,7227,7227,7227,7227,7227,7227,7227,7227,7227,7227,7227,b3ad0449-fd60-482a-9ba7-afd8f5555b83,1  didanosine delayed release capsules  also known as ddi  in combination with other antiretroviral agents are indicated for the treatment of human immunodeficiency virus ( hiv ) 1 infection see clinical studies ( 14 ),1
5968,5968,5968,5968,5968,5968,5968,7228,7228,7228,7228,7228,7228,7228,7228,7228,7228,7228,7228,7228,b3ad0449-fd60-482a-9ba7-afd8f5555b83,didanosine delayed release capsules are a nucleoside reverse transcriptase inhibitor for use in combination with other antiretroviral agents for the treatment of human immunodeficiency virus ( hiv ) 1 infection,u
5969,5969,5969,5969,5969,5969,5969,7229,7229,7229,7229,7229,7229,7229,7229,7229,7229,7229,7229,7229,3c273512-84e2-2cea-b201-12345a6bd1fe, lmd ( dextran 40 ) is indicated for use in the adjunctive treatment of shock or impending shock due to hemorrhage  burns  surgery or other trauma,1
5970,5970,5970,5970,5970,5970,5970,7230,7230,7230,7230,7230,7230,7230,7230,7230,7230,7230,7230,7230,3c273512-84e2-2cea-b201-12345a6bd1fe,it is not indicated as a replacement for whole blood or blood components if they are available,0
5971,5971,5971,5971,5971,5971,5971,7231,7231,7231,7231,7231,7231,7231,7231,7231,7231,7231,7231,7231,3c273512-84e2-2cea-b201-12345a6bd1fe,it should not replace other forms of therapy known to be of value in the treatment of shock,0
5972,5972,5972,5972,5972,5972,5972,7232,7232,7232,7232,7232,7232,7232,7232,7232,7232,7232,7232,7232,3c273512-84e2-2cea-b201-12345a6bd1fe,lmd is also indicated for use as a priming fluid  either as a sole prime or as an additive  in pump oxygenators during extracorporeal circulation,1
5973,5973,5973,5973,5973,5973,5973,7233,7233,7233,7233,7233,7233,7233,7233,7233,7233,7233,7233,7233,3c273512-84e2-2cea-b201-12345a6bd1fe,lmd is also indicated for use in prophylaxis of venous thrombosis and pulmonary embolism in patients undergoing procedures known to be associated with a high incidence of thromboembolic complications  such as hip surgery,1
5974,5974,5974,5974,5974,5974,5974,7234,7234,7234,7234,7234,7234,7234,7234,7234,7234,7234,7234,7234,fff5d805-4ffd-4e8e-8e63-6f129697563e,1  zykadia is indicated for the treatment of patients with metastatic non small cell lung cancer ( nsclc ) whose tumors are anaplastic lymphoma kinase ( alk ) positive as detected by an fda approved test,1
5975,5975,5975,5975,5975,5975,5975,7235,7235,7235,7235,7235,7235,7235,7235,7235,7235,7235,7235,7235,fff5d805-4ffd-4e8e-8e63-6f129697563e,zykadia is a kinase inhibitor indicated for the treatment of patients with metastatic non small cell lung cancer ( nsclc ) whose tumors are anaplastic lymphoma kinase ( alk ) positive as detected by an fda approved test,1
5976,5976,5976,5976,5976,5976,5976,7236,7236,7236,7236,7236,7236,7236,7236,7236,7236,7236,7236,7236,3313ed5d-7991-408f-872b-d5a701aa6d83, ethacrynate sodium is indicated for treatment of edema when an agent with greater diuretic potential than those commonly employed is required,1
5977,5977,5977,5977,5977,5977,5977,7237,7237,7237,7237,7237,7237,7237,7237,7237,7237,7237,7237,7237,3313ed5d-7991-408f-872b-d5a701aa6d83,1 treatment of the edema associated with congestive heart failure  cirrhosis of the liver  and renal disease  including the nephrotic syndrome,u
5978,5978,5978,5978,5978,5978,5978,7238,7238,7238,7238,7238,7238,7238,7238,7238,7238,7238,7238,7238,3313ed5d-7991-408f-872b-d5a701aa6d83,2 short term management of ascites due to malignancy  idiopathic edema  and lymphedema,1
5979,5979,5979,5979,5979,5979,5979,7239,7239,7239,7239,7239,7239,7239,7239,7239,7239,7239,7239,7239,3313ed5d-7991-408f-872b-d5a701aa6d83,3 short term management of hospitalized pediatric patients  other than infants  with congenital heart disease or the nephrotic syndrome,1
5980,5980,5980,5980,5980,5980,5980,7240,7240,7240,7240,7240,7240,7240,7240,7240,7240,7240,7240,7240,3313ed5d-7991-408f-872b-d5a701aa6d83,4 intravenous ethacrynate sodium is indicated when a rapid onset of diuresis is desired  e g  in acute pulmonary edema  or when gastrointestinal absorption is impaired or oral medication is not practicable,1
5981,5981,5981,5981,5981,5981,5981,7241,7241,7241,7241,7241,7241,7241,7241,7241,7241,7241,7241,7241,1efe378e-fee1-4ae9-8ea5-0fe2265fe2d8, edecrin is indicated for treatment of edema when an agent with greater diuretic potential than those commonly employed is required,1
5982,5982,5982,5982,5982,5982,5982,7242,7242,7242,7242,7242,7242,7242,7242,7242,7242,7242,7242,7242,1efe378e-fee1-4ae9-8ea5-0fe2265fe2d8,treatment of the edema associated with congestive heart failure  cirrhosis of the liver  and renal disease  including the nephrotic syndrome,1
5983,5983,5983,5983,5983,5983,5983,7243,7243,7243,7243,7243,7243,7243,7243,7243,7243,7243,7243,7243,1efe378e-fee1-4ae9-8ea5-0fe2265fe2d8,short term management of ascites due to malignancy  idiopathic edema  and lymphedema,1
5984,5984,5984,5984,5984,5984,5984,7244,7244,7244,7244,7244,7244,7244,7244,7244,7244,7244,7244,7244,1efe378e-fee1-4ae9-8ea5-0fe2265fe2d8,short term management of hospitalized pediatric patients  other than infants  with congenital heart disease or the nephrotic syndrome,1
5985,5985,5985,5985,5985,5985,5985,7245,7245,7245,7245,7245,7245,7245,7245,7245,7245,7245,7245,7245,1efe378e-fee1-4ae9-8ea5-0fe2265fe2d8,intravenous sodium edecrin is indicated when a rapid onset of diuresis is desired  e g  in acute pulmonary edema  or when gastrointestinal absorption is impaired or oral medication is not practicable,1
5986,5986,5986,5986,5986,5986,5986,7246,7246,7246,7246,7246,7246,7246,7246,7246,7246,7246,7246,7246,83a77b9d-42f0-4645-8420-786285da7326,1  kanuma is indicated for the treatment of patients with a diagnosis of lysosomal acid lipase ( lal ) deficiency,1
5987,5987,5987,5987,5987,5987,5987,7247,7247,7247,7247,7247,7247,7247,7247,7247,7247,7247,7247,7247,83a77b9d-42f0-4645-8420-786285da7326,kanuma is a hydrolytic lysosomal cholesteryl ester and triacylglycerol specific enzyme indicated for the treatment of patients with a diagnosis of lysosomal acid lipase ( lal ) deficiency,1
5988,5988,5988,5988,5988,5988,5988,7248,7248,7248,7248,7248,7248,7248,7248,7248,7248,7248,7248,7248,0d58f812-37bf-439f-b3f2-c31f8eefe22e, cardene i v,0
5989,5989,5989,5989,5989,5989,5989,7249,7249,7249,7249,7249,7249,7249,7249,7249,7249,7249,7249,7249,0d58f812-37bf-439f-b3f2-c31f8eefe22e,premixed injection is a calcium channel blocker indicated for the short term treatment of hypertension when oral therapy is not feasible,1
5990,5990,5990,5990,5990,5990,5990,7250,7250,7250,7250,7250,7250,7250,7250,7250,7250,7250,7250,7250,0d58f812-37bf-439f-b3f2-c31f8eefe22e,( nicardipine hydrochloride ) premixed injection is indicated for the short term treatment of hypertension when oral therapy is not feasible or not desirable,1
5991,5991,5991,5991,5991,5991,5991,7251,7251,7251,7251,7251,7251,7251,7251,7251,7251,7251,7251,7251,0d58f812-37bf-439f-b3f2-c31f8eefe22e,for prolonged control of blood pressure  transfer patients to oral medication as soon as their clinical condition permits see dosage and administration ( 2 1 ),4
5992,5992,5992,5992,5992,5992,5992,7252,7252,7252,7252,7252,7252,7252,7252,7252,7252,7252,7252,7252,00fd1905-27e4-420e-8dc5-a69e4ddc1526,1  nityr is indicated for the treatment of patients with hereditary tyrosinemia type 1 ( ht 1 ) in combination with dietary restriction of tyrosine and phenylalanine,1
5993,5993,5993,5993,5993,5993,5993,7253,7253,7253,7253,7253,7253,7253,7253,7253,7253,7253,7253,7253,00fd1905-27e4-420e-8dc5-a69e4ddc1526,nityr is a hydroxyphenyl pyruvate dioxygenase inhibitor indicated for the treatment of hereditary tyrosinemia type 1 ( ht 1 ) in combination with dietary restriction of tyrosine and phenylalanine,1
5994,5994,5994,5994,5994,5994,5994,7254,7254,7254,7254,7254,7254,7254,7254,7254,7254,7254,7254,7254,7fd858aa-f4ef-427b-a91c-c860cd27da9d,1  adenosine injection is indicated as an adjunct to thallium 201 myocardial perfusion scintigraphy in patients unable to exercise adequately,1
5995,5995,5995,5995,5995,5995,5995,7255,7255,7255,7255,7255,7255,7255,7255,7255,7255,7255,7255,7255,7fd858aa-f4ef-427b-a91c-c860cd27da9d,adenosine injection  a pharmacologic stress agent  is indicated as an adjunct to thallium 201 myocardial perfusion scintigraphy in patients unable to exercise adequately ( 1 ),1
5996,5996,5996,5996,5996,5996,5996,7256,7256,7256,7256,7256,7256,7256,7256,7256,7256,7256,7256,7256,49fd02f8-12b8-460c-ae1f-f26738d86998, revex is indicated for the complete or partial reversal of opioid drug effects  including respiratory depression  induced by either natural or synthetic opioids,1
5997,5997,5997,5997,5997,5997,5997,7257,7257,7257,7257,7257,7257,7257,7257,7257,7257,7257,7257,7257,49fd02f8-12b8-460c-ae1f-f26738d86998,revex is indicated in the management of known or suspected opioid overdose,u
5998,5998,5998,5998,5998,5998,5998,7258,7258,7258,7258,7258,7258,7258,7258,7258,7258,7258,7258,7258,ab03de5b-782c-4f81-a8dc-7ef9969dd0cf, prepidil gel is indicated for ripening an unfavorable cervix in pregnant women at or near term with a medical or obstetrical need for labor induction,1
5999,5999,5999,5999,5999,5999,5999,7259,7259,7259,7259,7259,7259,7259,7259,7259,7259,7259,7259,7259,1ba1cc5b-4f7f-491b-a5af-a6a14fb5affd,1  rhofade cream is indicated for the topical treatment of persistent facial erythema associated with rosacea in adults,1
6000,6000,6000,6000,6000,6000,6000,7260,7260,7260,7260,7260,7260,7260,7260,7260,7260,7260,7260,7260,1ba1cc5b-4f7f-491b-a5af-a6a14fb5affd,rhofade is an alpha1a adrenoceptor agonist indicated for the topical treatment of persistent facial erythema associated with rosacea in adults,1
6001,6001,6001,6001,6001,6001,6001,7261,7261,7261,7261,7261,7261,7261,7261,7261,7261,7261,7261,7261,20dee37f-1412-44ed-9e8b-f4379ce23eb0,1  oxytrol is a muscarinic antagonist indicated for the treatment of overactive bladder in men with symptoms of urge urinary incontinence  urgency  and frequency,1
6002,6002,6002,6002,6002,6002,6002,7262,7262,7262,7262,7262,7262,7262,7262,7262,7262,7262,7262,7262,20dee37f-1412-44ed-9e8b-f4379ce23eb0,oxytrol is a muscarinic antagonist indicated for the treatment of overactive bladder in men with symptoms of urge urinary incontinence  urgency  and frequency,1
6003,6003,6003,6003,6003,6003,6003,7263,7263,7263,7263,7263,7263,7263,7263,7263,7263,7263,7263,7263,b4d01ebb-a36e-44b7-028c-43c0ab2d13b4, chromium 4 mcg ml ( chromic chloride injection  usp ) is indicated for use as a supplement to intravenous solutions given for total parenteral nutrition ( tpn ),1
6004,6004,6004,6004,6004,6004,6004,7264,7264,7264,7264,7264,7264,7264,7264,7264,7264,7264,7264,7264,b4d01ebb-a36e-44b7-028c-43c0ab2d13b4,administration helps to maintain chromium serum levels and to prevent depletion of endogenous stores and subsequent deficiency symptoms,u
6005,6005,6005,6005,6005,6005,6005,7265,7265,7265,7265,7265,7265,7265,7265,7265,7265,7265,7265,7265,5ee6a685-3c35-467b-8d4d-79efdd0bfa8e, this formulation is indicated for use as a supplement to intravenous solutions given for tpn for children up to 11 years of age,1
6006,6006,6006,6006,6006,6006,6006,7266,7266,7266,7266,7266,7266,7266,7266,7266,7266,7266,7266,7266,5ee6a685-3c35-467b-8d4d-79efdd0bfa8e,administration of the solution in tpn solutions helps to maintain plasma levels of zinc  copper  manganese  and chromium and to prevent depletion of endogenous stores of these trace elements and subsequent deficiency symptoms,u
6007,6007,6007,6007,6007,6007,6007,7267,7267,7267,7267,7267,7267,7267,7267,7267,7267,7267,7267,7267,99bef307-00bd-4379-9f45-ede1380e74d4,1  curosurf ( poractant alfa ) intratracheal suspension is indicated for the rescue treatment of respiratory distress syndrome ( rds ) in premature infants,1
6008,6008,6008,6008,6008,6008,6008,7268,7268,7268,7268,7268,7268,7268,7268,7268,7268,7268,7268,7268,99bef307-00bd-4379-9f45-ede1380e74d4,curosurf reduces mortality and pneumothoraces associated with rds,1
6009,6009,6009,6009,6009,6009,6009,7269,7269,7269,7269,7269,7269,7269,7269,7269,7269,7269,7269,7269,99bef307-00bd-4379-9f45-ede1380e74d4,curosurf is a surfactant indicated for the rescue treatment  including the reduction of mortality and pneumothoraces  of respiratory distress syndrome ( rds ) in premature infants,1
6010,6010,6010,6010,6010,6010,6010,7270,7270,7270,7270,7270,7270,7270,7270,7270,7270,7270,7270,7270,f567d5c7-ea5d-49a7-a035-b47208135f73,1  quinine sulfate capsules  usp are an antimalarial drug indicated only for treatment of uncomplicated plasmodium falciparum malaria,1
6011,6011,6011,6011,6011,6011,6011,7271,7271,7271,7271,7271,7271,7271,7271,7271,7271,7271,7271,7271,f567d5c7-ea5d-49a7-a035-b47208135f73,quinine sulfate has been shown to be effective in geographical regions where resistance to chloroquine has been documented see clinical studies ( 14 ),u
6012,6012,6012,6012,6012,6012,6012,7272,7272,7272,7272,7272,7272,7272,7272,7272,7272,7272,7272,7272,f567d5c7-ea5d-49a7-a035-b47208135f73,quinine sulfate capsules  usp are not approved for treatment of severe or complicated p falciparum malaria,0
6013,6013,6013,6013,6013,6013,6013,7273,7273,7273,7273,7273,7273,7273,7273,7273,7273,7273,7273,7273,f567d5c7-ea5d-49a7-a035-b47208135f73,treatment or prevention of nocturnal leg cramps see warnings and precautions ( 5 1 ),1
6014,6014,6014,6014,6014,6014,6014,7274,7274,7274,7274,7274,7274,7274,7274,7274,7274,7274,7274,7274,f567d5c7-ea5d-49a7-a035-b47208135f73,quinine sulfate capsules  usp are a cinchona alkaloid indicated for treatment of uncomplicated plasmodium falciparum malaria ( 1 ),1
6015,6015,6015,6015,6015,6015,6015,7275,7275,7275,7275,7275,7275,7275,7275,7275,7275,7275,7275,7275,"Active Ingredient UNII(s)
KG60484QX9; QTG126297Q; UW86K581WY    af65f614-a715-4653-8ce3-7702f46becf8
KG60484QX9; QTG126297Q; UW86K581WY    af65f614-a715-4653-8ce3-7702f46becf8
KG60484QX9; QTG126297Q; UW86K581WY    af65f614-a715-4653-8ce3-7702f46becf8
KG60484QX9; QTG126297Q; UW86K581WY    af65f614-a715-4653-8ce3-7702f46becf8
Name: SET ID dtype: object",active ingredient unii ( s ) kg60484qx9 qtg126297q uw86k581wy active ingredient unii ( s ) kg60484qx9 qtg12629 kg60484qx9 qtg126297q uw86k581wy active ingredient unii ( s ) kg60484qx9 qtg12629 kg60484qx9 qtg126297q uw86k581wy active ingredient unii ( s ) kg60484qx9 qtg12629 kg60484qx9 qtg126297q uw86k581wy active ingredient unii ( s ) kg60484qx9 qtg12629 name content xml  dtype object,0
6016,6016,6016,6016,6016,6016,6016,7279,7279,7279,7279,7279,7279,7279,7279,7279,7279,7279,7279,7279,ba1cca98-f350-4655-88e3-6ef990779fb9, ketek tablets are indicated for the treatment of community acquired pneumonia ( of mild to moderate severity ) due to streptococcus pneumoniae  ( including multi drug resistant isolates mdrspmdrsp  multi drug resistant streptococcus pneumoniae includes isolates known as prsp ( penicillin resistant streptococcus pneumoniae )  and are isolates resistant to two or more of the following antibiotics penicillin  2nd generation cephalosporins  e g  cefuroxime  macrolides  tetracyclines and trimethoprim sulfamethoxazole,1
6017,6017,6017,6017,6017,6017,6017,7280,7280,7280,7280,7280,7280,7280,7280,7280,7280,7280,7280,7280,ba1cca98-f350-4655-88e3-6ef990779fb9,)  haemophilus influenzae  moraxella catarrhalis  chlamydophila pneumoniae  or mycoplasma pneumoniae  for patients 18 years old and above,1
6018,6018,6018,6018,6018,6018,6018,7281,7281,7281,7281,7281,7281,7281,7281,7281,7281,7281,7281,7281,ba1cca98-f350-4655-88e3-6ef990779fb9,to reduce the development of drug resistant bacteria and maintain the effectiveness of ketek and other antibacterial drugs  ketek should be used only to treat infections that are proven or strongly suspected to be caused by susceptible bacteria,4
6019,6019,6019,6019,6019,6019,6019,7284,7284,7284,7284,7284,7284,7284,7284,7284,7284,7284,7284,7284,31b347d2-f156-4055-9d8f-7cf0df420296,1  emflaza is indicated for the treatment of duchenne muscular dystrophy ( dmd ) in patients 5 years of age and older,1
6020,6020,6020,6020,6020,6020,6020,7285,7285,7285,7285,7285,7285,7285,7285,7285,7285,7285,7285,7285,31b347d2-f156-4055-9d8f-7cf0df420296,emflaza is a corticosteroid indicated for the treatment of duchenne muscular dystrophy ( dmd ) in patients 5 years of age and older ( 1 ),1
6021,6021,6021,6021,6021,6021,6021,7286,7286,7286,7286,7286,7286,7286,7286,7286,7286,7286,7286,7286,ec682aec-e98f-41a1-9d21-eb7580ea3a8a,1  avandia is a thiazolidinedione antidiabetic agent indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus,1
6022,6022,6022,6022,6022,6022,6022,7287,7287,7287,7287,7287,7287,7287,7287,7287,7287,7287,7287,7287,ec682aec-e98f-41a1-9d21-eb7580ea3a8a,important limitations of use due to its mechanism of action  avandia is active only in the presence of endogenous insulin,0
6023,6023,6023,6023,6023,6023,6023,7288,7288,7288,7288,7288,7288,7288,7288,7288,7288,7288,7288,7288,ec682aec-e98f-41a1-9d21-eb7580ea3a8a,therefore  avandia should not be used in patients with type 1 diabetes mellitus or for the treatment of diabetic ketoacidosis,2
6024,6024,6024,6024,6024,6024,6024,7289,7289,7289,7289,7289,7289,7289,7289,7289,7289,7289,7289,7289,ec682aec-e98f-41a1-9d21-eb7580ea3a8a,the coadministration of avandia and insulin is not recommended see warnings and precautions ( 5 1 ),2
6025,6025,6025,6025,6025,6025,6025,7290,7290,7290,7290,7290,7290,7290,7290,7290,7290,7290,7290,7290,ec682aec-e98f-41a1-9d21-eb7580ea3a8a,avandia is a thiazolidinedione antidiabetic agent indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus,1
6026,6026,6026,6026,6026,6026,6026,7291,7291,7291,7291,7291,7291,7291,7291,7291,7291,7291,7291,7291,ec682aec-e98f-41a1-9d21-eb7580ea3a8a,( 1 ) important limitations of use avandia should not be used in patients with type 1 diabetes mellitus or for the treatment of diabetic ketoacidosis,2
6027,6027,6027,6027,6027,6027,6027,7292,7292,7292,7292,7292,7292,7292,7292,7292,7292,7292,7292,7292,ec682aec-e98f-41a1-9d21-eb7580ea3a8a,( 1 ) coadministration of avandia and insulin is not recommended,2
6028,6028,6028,6028,6028,6028,6028,7293,7293,7293,7293,7293,7293,7293,7293,7293,7293,7293,7293,7293,5cd725a1-2fa4-408a-a651-57a7b84b2118,1  bavencio is a programmed death ligand 1 ( pd l1 ) blocking antibody indicated for the treatment of adults and pediatric patients 12 years and older with metastatic merkel cell carcinoma ( mcc ),1
6029,6029,6029,6029,6029,6029,6029,7296,7296,7296,7296,7296,7296,7296,7296,7296,7296,7296,7296,7296,5cd725a1-2fa4-408a-a651-57a7b84b2118,( 1 1  14 1 ) patients with locally advanced or metastatic urothelial carcinoma ( uc ) who have disease progression during or following platinum containing chemotherapy ( 1 2 ) have disease progression within 12 months of neoadjuvant or adjuvant treatment with platinum containing chemotherapy ( 1 2 ) this indication is approved under accelerated approval based on tumor response rate and duration of response,1
6030,6030,6030,6030,6030,6030,6030,7298,7298,7298,7298,7298,7298,7298,7298,7298,7298,7298,7298,7298,5cd725a1-2fa4-408a-a651-57a7b84b2118,( 1 2  14 2 ) 1 1 metastatic merkel cell carcinoma bavencio ( avelumab ) is indicated for the treatment of adults and pediatric patients 12 years and older with metastatic merkel cell carcinoma ( mcc ),1
6031,6031,6031,6031,6031,6031,6031,7301,7301,7301,7301,7301,7301,7301,7301,7301,7301,7301,7301,7301,5cd725a1-2fa4-408a-a651-57a7b84b2118,1 2 locally advanced or metastatic urothelial carcinoma bavencio is indicated for the treatment of patients with locally advanced or metastatic urothelial carcinoma ( uc ) who have disease progression during or following platinum containing chemotherapy have disease progression within 12 months of neoadjuvant or adjuvant treatment with platinum containing chemotherapy this indication is approved under accelerated approval based on tumor response rate and duration of response,1
6032,6032,6032,6032,6032,6032,6032,7302,7302,7302,7302,7302,7302,7302,7302,7302,7302,7302,7302,7302,e2c4a5ac-2df2-4cf4-a2d3-6fbe2d898ebc,1  dotarem is a gadolinium based contrast agent indicated for intravenous use with magnetic resonance imaging ( mri ) in brain ( intracranial )  spine and associated tissues in adult and pediatric patients ( including term neonates ) to detect and visualize areas with disruption of the blood brain barrier ( bbb ) and or abnormal vascularity,1
6033,6033,6033,6033,6033,6033,6033,7303,7303,7303,7303,7303,7303,7303,7303,7303,7303,7303,7303,7303,e2c4a5ac-2df2-4cf4-a2d3-6fbe2d898ebc,dotarem is a gadolinium based contrast agent indicated for intravenous use with magnetic resonance imaging ( mri ) in brain ( intracranial )  spine and associated tissues in adult and pediatric patients ( including term neonates ) to detect and visualize areas with disruption of the blood brain barrier ( bbb ) and or abnormal vascularity,1
6034,6034,6034,6034,6034,6034,6034,7304,7304,7304,7304,7304,7304,7304,7304,7304,7304,7304,7304,7304,ac9f0c4b-d0b0-489a-896d-a92d40f21b7e, tc 99m glucoheptonate may be used to image the kidney and brain and to assess renal and brain perfusion,1
6035,6035,6035,6035,6035,6035,6035,7305,7305,7305,7305,7305,7305,7305,7305,7305,7305,7305,7305,7305,ad0f8925-f817-4460-aa6b-172a043a440b, neutrexin ( trimetrexate glucuronate for injection ) with concurrent leucovorin administration ( leucovorin protection ) is indicated as an alternative therapy for the treatment of moderate to severe pneumocystis carinii pneumonia ( pcp ) in immunocompromised patients  including patients with the acquired immunodeficiency syndrome ( aids )  who are intolerant of  or are refractory to  trimethoprim sulfamethoxazole therapy or for whom trimethoprim sulfamethoxazole is contraindicated,1
6036,6036,6036,6036,6036,6036,6036,7306,7306,7306,7306,7306,7306,7306,7306,7306,7306,7306,7306,7306,ad0f8925-f817-4460-aa6b-172a043a440b,this indication is based on the results of a randomized  controlled double blind trial comparing neutrexin with concurrent leucovorin protection ( tmtx lv ) to trimethoprim sulfamethoxazole ( tmp smx ) in patients with moderate to severe pneumocystis carinii pneumonia  as well as results of a treatment ind,1
6037,6037,6037,6037,6037,6037,6037,7307,7307,7307,7307,7307,7307,7307,7307,7307,7307,7307,7307,7307,ad0f8925-f817-4460-aa6b-172a043a440b,these studies are summarized below neutrexin comparative study with tmp smx this double blind  randomized trial initiated by the aids clinical trials group ( actg ) in 1988 was designed to compare the safety and efficacy of tmtx lv to that of tmp smx for the treatment of histologically confirmed  moderate to severe pcp  defined as ( a a ) baseline gradient 30 mmhg  in patients with aids,0
6038,6038,6038,6038,6038,6038,6038,7308,7308,7308,7308,7308,7308,7308,7308,7308,7308,7308,7308,7308,ad0f8925-f817-4460-aa6b-172a043a440b,of the 220 patients with histologically confirmed pcp  109 were randomized to receive tmtx lv and 111 to tmp smx,0
6039,6039,6039,6039,6039,6039,6039,7309,7309,7309,7309,7309,7309,7309,7309,7309,7309,7309,7309,7309,ad0f8925-f817-4460-aa6b-172a043a440b,study patients randomized to tmtx lv treatment were to receive 45 mg m2 of tmtx daily for 21 days plus 20 mg m2 of lv every 6 hours for 24 days,0
6040,6040,6040,6040,6040,6040,6040,7310,7310,7310,7310,7310,7310,7310,7310,7310,7310,7310,7310,7310,ad0f8925-f817-4460-aa6b-172a043a440b,those randomized to tmp smx were to receive 5 mg kg tmp plus 25 mg kg smx four times daily for 21 days,0
6041,6041,6041,6041,6041,6041,6041,7311,7311,7311,7311,7311,7311,7311,7311,7311,7311,7311,7311,7311,ad0f8925-f817-4460-aa6b-172a043a440b,response to therapy  defined as alive and off ventilatory support at completion of therapy  with no change in anti pneumocystis therapy  or addition of supraphysiologic doses of steroids  occurred in fifty percent of patients in each treatment group,0
6042,6042,6042,6042,6042,6042,6042,7312,7312,7312,7312,7312,7312,7312,7312,7312,7312,7312,7312,7312,ad0f8925-f817-4460-aa6b-172a043a440b,the observed mortality in the tmtx lv treatment group was approximately twice that in the tmp smx treatment group ( 95 ci 0 99 4 11 ),0
6043,6043,6043,6043,6043,6043,6043,7313,7313,7313,7313,7313,7313,7313,7313,7313,7313,7313,7313,7313,ad0f8925-f817-4460-aa6b-172a043a440b,thirty of 109 ( 27 ) patients treated with tmtx lv and 18 of 111 ( 16 ) patients receiving tmp smx died during the 21 day treatment course or 4 week follow up period,0
6044,6044,6044,6044,6044,6044,6044,7314,7314,7314,7314,7314,7314,7314,7314,7314,7314,7314,7314,7314,ad0f8925-f817-4460-aa6b-172a043a440b,twenty seven of 30 deaths in the tmtx lv arm were attributed to pcp all 18 deaths in the tmp smx arm were attributed to pcp,0
6045,6045,6045,6045,6045,6045,6045,7315,7315,7315,7315,7315,7315,7315,7315,7315,7315,7315,7315,7315,ad0f8925-f817-4460-aa6b-172a043a440b,a significantly smaller proportion of patients who received tmtx lv compared to tmp smx failed therapy due to toxicity ( 10 vs 25 )  and a significantly greater proportion of patients failed due to lack of efficacy ( 40 vs 24 ),0
6046,6046,6046,6046,6046,6046,6046,7316,7316,7316,7316,7316,7316,7316,7316,7316,7316,7316,7316,7316,ad0f8925-f817-4460-aa6b-172a043a440b,six patients ( 12 ) who responded to tmtx lv relapsed during the one month follow up period no patient responding to tmp smx relapsed during t,0
6047,6047,6047,6047,6047,6047,6047,7317,7317,7317,7317,7317,7317,7317,7317,7317,7317,7317,7317,7317,6af07697-5203-43e0-ba35-83683af851c3, podofilox topical solution 0 5 is indicated for the topical treatment of external genital warts ( condyloma acuminatum ),1
6048,6048,6048,6048,6048,6048,6048,7318,7318,7318,7318,7318,7318,7318,7318,7318,7318,7318,7318,7318,6af07697-5203-43e0-ba35-83683af851c3,this product is not indicated in the treatment of perianal or mucous membrane warts ( see precautions ),2
6049,6049,6049,6049,6049,6049,6049,7319,7319,7319,7319,7319,7319,7319,7319,7319,7319,7319,7319,7319,6af07697-5203-43e0-ba35-83683af851c3,diagnosis although genital warts have a characteristic appearance  histopathologic confirmation should be obtained if there is any doubt of the diagnosis,0
6050,6050,6050,6050,6050,6050,6050,7320,7320,7320,7320,7320,7320,7320,7320,7320,7320,7320,7320,7320,6af07697-5203-43e0-ba35-83683af851c3,differentiating warts from squamous cell carcinoma ( so called bowenoid papulosis ) is of particular concern,0
6051,6051,6051,6051,6051,6051,6051,7321,7321,7321,7321,7321,7321,7321,7321,7321,7321,7321,7321,7321,6af07697-5203-43e0-ba35-83683af851c3,squamous cell carcinoma may also be associated with human papillomavirus but should not be treated with podofilox topical solution 0 5,0
6052,6052,6052,6052,6052,6052,6052,7322,7322,7322,7322,7322,7322,7322,7322,7322,7322,7322,7322,7322,7afafa63-3236-4212-9589-045db6b01c0b,1  to reduce the development of drug resistant bacteria and maintain the effectiveness of xifaxan and other antibacterial drugs  xifaxan when used to treat infection should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria,4
6053,6053,6053,6053,6053,6053,6053,7325,7325,7325,7325,7325,7325,7325,7325,7325,7325,7325,7325,7325,7afafa63-3236-4212-9589-045db6b01c0b,xifaxan is a rifamycin antibacterial indicated for treatment of travelers diarrhea ( td ) caused by noninvasive strains of escherichia coli in adult and pediatric patients 12 years of age and older ( 1 1 ) reduction in risk of overt hepatic encephalopathy ( he ) recurrence in adults ( 1 2 ) treatment of irritable bowel syndrome with diarrhea ( ibs d ) in adults ( 1 3 ) limitations of use td do not use in patients with diarrhea complicated by fever or blood in the stool or diarrhea due to pathogens other than escherichia coli ( 1 1  5 1 ) 1 1 travelers diarrhea xifaxan is indicated for the treatment of travelers diarrhea ( td ) caused by noninvasive strains of escherichia coli in adults and pediatric patients 12 years of age and older,1
6054,6054,6054,6054,6054,6054,6054,7326,7326,7326,7326,7326,7326,7326,7326,7326,7326,7326,7326,7326,7afafa63-3236-4212-9589-045db6b01c0b,limitations of use xifaxan should not be used in patients with diarrhea complicated by fever or blood in the stool or diarrhea due to pathogens other than escherichia coli see warnings and precautions ( 5 1 )  clinical pharmacology ( 12 4 )  clinical studies ( 14 1 ),2
6055,6055,6055,6055,6055,6055,6055,7327,7327,7327,7327,7327,7327,7327,7327,7327,7327,7327,7327,7327,7afafa63-3236-4212-9589-045db6b01c0b,code code 42229 5 codesystem 2 16 840 1 113883 6 1 displayname spl unclas,0
6056,6056,6056,6056,6056,6056,6056,7328,7328,7328,7328,7328,7328,7328,7328,7328,7328,7328,7328,7328,4910dad2-c533-4232-85bf-e6b0235379c2, methyclothiazide tablets are indicated in the management of hypertension either as the sole therapeutic agent or to enhance the effect of other antihypertensive drugs in the more severe forms of hypertension,1
6057,6057,6057,6057,6057,6057,6057,7329,7329,7329,7329,7329,7329,7329,7329,7329,7329,7329,7329,7329,4910dad2-c533-4232-85bf-e6b0235379c2,methyclothiazide tablets are indicated as adjunctive therapy in edema associated with congestive heart failure  hepatic cirrhosis  and corticosteroid and estrogen therapy,1
6058,6058,6058,6058,6058,6058,6058,7330,7330,7330,7330,7330,7330,7330,7330,7330,7330,7330,7330,7330,4910dad2-c533-4232-85bf-e6b0235379c2,methyclothiazide tablets have also been found useful in edema due to various forms of renal dysfunction such as the nephrotic syndrome  acute glomerulonephritis  and chronic renal failure,1
6059,6059,6059,6059,6059,6059,6059,7331,7331,7331,7331,7331,7331,7331,7331,7331,7331,7331,7331,7331,4910dad2-c533-4232-85bf-e6b0235379c2,usage in pregnancy the routine use of diuretics in an otherwise healthy pregnant woman is inappropriate and exposes mother and fetus to unnecessary hazard,2
6060,6060,6060,6060,6060,6060,6060,7333,7333,7333,7333,7333,7333,7333,7333,7333,7333,7333,7333,7333,4910dad2-c533-4232-85bf-e6b0235379c2,edema during pregnancy may arise from pathological causes or from the physiological and mechanical consequences of pregnancy,0
6061,6061,6061,6061,6061,6061,6061,7334,7334,7334,7334,7334,7334,7334,7334,7334,7334,7334,7334,7334,4910dad2-c533-4232-85bf-e6b0235379c2,thiazides are indicated in pregnancy when edema is due to pathological causes  just as they are in the absence of pregnancy ( see precautions pregnancy ),1
6062,6062,6062,6062,6062,6062,6062,7336,7336,7336,7336,7336,7336,7336,7336,7336,7336,7336,7336,7336,4910dad2-c533-4232-85bf-e6b0235379c2,there is hypervolemia during normal pregnancy that is harmful to neither the fetus nor the mother ( in the absence of cardiovascular disease )  but that is associated with edema  including generalized edema  in the majority of pregnant women,0
6063,6063,6063,6063,6063,6063,6063,7338,7338,7338,7338,7338,7338,7338,7338,7338,7338,7338,7338,7338,4910dad2-c533-4232-85bf-e6b0235379c2,in rare instances  this edema may cause extreme discomfort that is not relieved by rest,0
6064,6064,6064,6064,6064,6064,6064,7340,7340,7340,7340,7340,7340,7340,7340,7340,7340,7340,7340,7340,b3558f16-8f9a-4e55-8d9c-836427ebaa57,1  vizamyl is indicated for positron emission tomography ( pet ) imaging of the brain to estimate amyloid neuritic plaque density in adult patients with cognitive impairment who are being evaluated for alzheimer 's disease ( ad ) and other causes of cognitive decline,1
6065,6065,6065,6065,6065,6065,6065,7341,7341,7341,7341,7341,7341,7341,7341,7341,7341,7341,7341,7341,b3558f16-8f9a-4e55-8d9c-836427ebaa57,a negative vizamyl scan indicates sparse to no neuritic plaques and is inconsistent with a neuropathological diagnosis of ad at the time of image acquisition a negative scan result reduces the likelihood that a patient 's cognitive impairment is due to ad,0
6066,6066,6066,6066,6066,6066,6066,7342,7342,7342,7342,7342,7342,7342,7342,7342,7342,7342,7342,7342,b3558f16-8f9a-4e55-8d9c-836427ebaa57,a positive vizamyl scan indicates moderate to frequent amyloid neuritic plaques neuropathological examination has shown this amount of amyloid neuritic plaque is present in patients with ad  but may also be present in patients with other types of neurologic conditions as well as in older people with normal cognition,u
6067,6067,6067,6067,6067,6067,6067,7343,7343,7343,7343,7343,7343,7343,7343,7343,7343,7343,7343,7343,b3558f16-8f9a-4e55-8d9c-836427ebaa57,vizamyl is an adjunct to other diagnostic evaluations,u
6068,6068,6068,6068,6068,6068,6068,7344,7344,7344,7344,7344,7344,7344,7344,7344,7344,7344,7344,7344,b3558f16-8f9a-4e55-8d9c-836427ebaa57,limitations of use a positive vizamyl scan does not establish a diagnosis of ad or other cognitive disorder,0
6069,6069,6069,6069,6069,6069,6069,7345,7345,7345,7345,7345,7345,7345,7345,7345,7345,7345,7345,7345,b3558f16-8f9a-4e55-8d9c-836427ebaa57,safety and effectiveness of vizamyl have not been established for predicting development of dementia or other neurologic condition,0
6070,6070,6070,6070,6070,6070,6070,7346,7346,7346,7346,7346,7346,7346,7346,7346,7346,7346,7346,7346,b3558f16-8f9a-4e55-8d9c-836427ebaa57,monitoring responses to therapies,0
6071,6071,6071,6071,6071,6071,6071,7347,7347,7347,7347,7347,7347,7347,7347,7347,7347,7347,7347,7347,b3558f16-8f9a-4e55-8d9c-836427ebaa57,vizamyl is a radioactive diagnostic agent indicated for positron emission tomography ( pet ) imaging of the brain to estimate amyloid neuritic plaque density in adult patients with cognitive impairment who are being evaluated for alzheimer 's disease ( ad ) or other causes of cognitive decline,1
6072,6072,6072,6072,6072,6072,6072,7348,7348,7348,7348,7348,7348,7348,7348,7348,7348,7348,7348,7348,b3558f16-8f9a-4e55-8d9c-836427ebaa57,a negative vizamyl scan indicates sparse to no neuritic plaques  and is inconsistent with a neuropathological diagnosis of ad at the time of image acquisition a negative scan result reduces the likelihood that a patient 's cognitive impairment is due to ad,0
6073,6073,6073,6073,6073,6073,6073,7349,7349,7349,7349,7349,7349,7349,7349,7349,7349,7349,7349,7349,b3558f16-8f9a-4e55-8d9c-836427ebaa57,a positive vizamyl scan indicates moderate to frequent amyloid neuritic plaques neuropathological examination has shown this amount of neuritic plaque is present in patients with ad  but may also be present in patients with other types of neurologic conditions  as well as older people with normal cognition,0
6074,6074,6074,6074,6074,6074,6074,7350,7350,7350,7350,7350,7350,7350,7350,7350,7350,7350,7350,7350,b3558f16-8f9a-4e55-8d9c-836427ebaa57,vizamyl is an adjunct to other diagnostic evaluations ( 1 ),0
6075,6075,6075,6075,6075,6075,6075,7351,7351,7351,7351,7351,7351,7351,7351,7351,7351,7351,7351,7351,b3558f16-8f9a-4e55-8d9c-836427ebaa57,limitations of use a positive vizamyl scan does not establish a diagnosis of ad or other cognitive disorder ( 1 ) safety and effectiveness of vizamyl have not been established for predicting development of dementia or other neurological condition ( 1 ) monitoring responses to therapies ( 1 ),0
6076,6076,6076,6076,6076,6076,6076,7352,7352,7352,7352,7352,7352,7352,7352,7352,7352,7352,7352,7352,1728cd89-1bb4-4b55-8e1c-9181702e4c51, carefully consider the potential benefits and risks of diclofenac potassium tablets  usp and other treatment options before deciding to use diclofenac potassium tablets  usp,4
6077,6077,6077,6077,6077,6077,6077,7354,7354,7354,7354,7354,7354,7354,7354,7354,7354,7354,7354,7354,1728cd89-1bb4-4b55-8e1c-9181702e4c51,diclofenac potassium tablets  usp are indicated for treatment of primary dysmenorrhea for relief of mild to moderate pain for relief of the signs and symptoms of osteoarthritis for relief of the signs and symptoms of rheumatoid arthritis,1
6078,6078,6078,6078,6078,6078,6078,7355,7355,7355,7355,7355,7355,7355,7355,7355,7355,7355,7355,7355,820839ef-e53d-47e8-a3b9-d911ff92e6a9,1  spiriva handihaler ( tiotropium bromide inhalation powder ) is indicated for the long term  once daily  maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease ( copd )  including chronic bronchitis and emphysema,1
6079,6079,6079,6079,6079,6079,6079,7356,7356,7356,7356,7356,7356,7356,7356,7356,7356,7356,7356,7356,820839ef-e53d-47e8-a3b9-d911ff92e6a9,spiriva handihaler is indicated to reduce exacerbations in copd patients,1
6080,6080,6080,6080,6080,6080,6080,7357,7357,7357,7357,7357,7357,7357,7357,7357,7357,7357,7357,7357,820839ef-e53d-47e8-a3b9-d911ff92e6a9,spiriva handihaler is an anticholinergic indicated for the long term  once daily  maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease ( copd )  and for reducing copd exacerbations ( 1 ),1
6081,6081,6081,6081,6081,6081,6081,7358,7358,7358,7358,7358,7358,7358,7358,7358,7358,7358,7358,7358,d7c3bcc3-0c0d-4068-fd80-88cf54a376ef,1  relenza  an influenza neuraminidase inhibitor ( nai )  is indicated for treatment of influenza in patients aged 7 years and older who have been symptomatic for no more than 2 days,1
6082,6082,6082,6082,6082,6082,6082,7359,7359,7359,7359,7359,7359,7359,7359,7359,7359,7359,7359,7359,d7c3bcc3-0c0d-4068-fd80-88cf54a376ef,( 1 1 ) prophylaxis of influenza in patients aged 5 years and older,1
6083,6083,6083,6083,6083,6083,6083,7360,7360,7360,7360,7360,7360,7360,7360,7360,7360,7360,7360,7360,d7c3bcc3-0c0d-4068-fd80-88cf54a376ef,( 1 2 ) important limitations on use of relenza not recommended for treatment or prophylaxis of influenza in individuals with underlying airways disease,2
6084,6084,6084,6084,6084,6084,6084,7361,7361,7361,7361,7361,7361,7361,7361,7361,7361,7361,7361,7361,d7c3bcc3-0c0d-4068-fd80-88cf54a376ef,( 5 1 ) not proven effective for treatment in individuals with underlying airways disease,0
6085,6085,6085,6085,6085,6085,6085,7362,7362,7362,7362,7362,7362,7362,7362,7362,7362,7362,7362,7362,d7c3bcc3-0c0d-4068-fd80-88cf54a376ef,( 1 3 ) prophylaxis in nursing home residents,1
6086,6086,6086,6086,6086,6086,6086,7363,7363,7363,7363,7363,7363,7363,7363,7363,7363,7363,7363,7363,d7c3bcc3-0c0d-4068-fd80-88cf54a376ef,( 1 3 ) not a substitute for annual influenza vaccination,0
6087,6087,6087,6087,6087,6087,6087,7364,7364,7364,7364,7364,7364,7364,7364,7364,7364,7364,7364,7364,d7c3bcc3-0c0d-4068-fd80-88cf54a376ef,( 1 3 ) consider available information on influenza drug susceptibility patterns and treatment effects when deciding whether to use relenza,0
6088,6088,6088,6088,6088,6088,6088,7365,7365,7365,7365,7365,7365,7365,7365,7365,7365,7365,7365,7365,d7c3bcc3-0c0d-4068-fd80-88cf54a376ef,( 1 3 ) 1 1 treatment of influenza relenza ( zanamivir ) inhalation powder is indicated for treatment of uncomplicated acute illness due to influenza a and b virus in adults and pediatric patients aged 7 years and older who have been symptomatic for no more than 2 days,1
6089,6089,6089,6089,6089,6089,6089,7366,7366,7366,7366,7366,7366,7366,7366,7366,7366,7366,7366,7366,d7c3bcc3-0c0d-4068-fd80-88cf54a376ef,1 2 prophylaxis of influenza relenza is indicated for prophylaxis of influenza in adults and pediatric patients aged 5 years and older,1
6090,6090,6090,6090,6090,6090,6090,7367,7367,7367,7367,7367,7367,7367,7367,7367,7367,7367,7367,7367,d7c3bcc3-0c0d-4068-fd80-88cf54a376ef,id root 5607e6b0 a6da 4836 a8b8 9035b874c432,0
6091,6091,6091,6091,6091,6091,6091,7368,7368,7368,7368,7368,7368,7368,7368,7368,7368,7368,7368,7368,15d22ca4-503e-2751-e054-00144ff8d46c,debacterol is indicated in the topical treatment of ulcerating lesions of the oral cavity such as recurrent aphthous stomatitis ( canker sores ),1
6092,6092,6092,6092,6092,6092,6092,7369,7369,7369,7369,7369,7369,7369,7369,7369,7369,7369,7369,7369,15d22ca4-503e-2751-e054-00144ff8d46c,debacterol provides relief from the pain and discomfort of oral mucosal ulcers,0
6093,6093,6093,6093,6093,6093,6093,7370,7370,7370,7370,7370,7370,7370,7370,7370,7370,7370,7370,7370,15d22ca4-503e-2751-e054-00144ff8d46c,debacterol is not intended for the treatment of vesicular lesions  such as cold sores or fever blisters,0
6094,6094,6094,6094,6094,6094,6094,7371,7371,7371,7371,7371,7371,7371,7371,7371,7371,7371,7371,7371,4b9c6c34-9cb2-4d70-b70e-c7ce2fda4212, anadrol 50 tablets is indicated in the treatment of anemias caused by deficient red cell production,1
6095,6095,6095,6095,6095,6095,6095,7372,7372,7372,7372,7372,7372,7372,7372,7372,7372,7372,7372,7372,4b9c6c34-9cb2-4d70-b70e-c7ce2fda4212,acquired aplastic anemia  congenital aplastic anemia  myelofibrosis and the hypoplastic anemias due to the administration of myelotoxic drugs often respond,1
6096,6096,6096,6096,6096,6096,6096,7373,7373,7373,7373,7373,7373,7373,7373,7373,7373,7373,7373,7373,4b9c6c34-9cb2-4d70-b70e-c7ce2fda4212,anadrol 50 tablets should not replace other supportive measures such as transfusion  correction of iron  folic acid  vitamin b12 or pyridoxine deficiency  antibacterial therapy and the appropriate use of corticosteroids,0
6097,6097,6097,6097,6097,6097,6097,7374,7374,7374,7374,7374,7374,7374,7374,7374,7374,7374,7374,7374,2c3db989-d7ad-41ed-9ebf-698dcf6c24ec,1  defitelio is indicated for the treatment of adult and pediatric patients with hepatic veno occlusive disease ( vod )  also known as sinusoidal obstruction syndrome ( sos )  with renal or pulmonary dysfunction following hematopoietic stem cell transplantation ( hsct ),1
6098,6098,6098,6098,6098,6098,6098,7375,7375,7375,7375,7375,7375,7375,7375,7375,7375,7375,7375,7375,2c3db989-d7ad-41ed-9ebf-698dcf6c24ec,defitelio is indicated for the treatment of adult and pediatric patients with hepatic veno occlusive disease ( vod )  also known as sinusoidal obstruction syndrome ( sos )  with renal or pulmonary dysfunction following hematopoietic stem cell transplantation ( hsct ),1
6099,6099,6099,6099,6099,6099,6099,7376,7376,7376,7376,7376,7376,7376,7376,7376,7376,7376,7376,7376,"Active Ingredient UNII(s)
L7T10EIP3A; LAV5U5022Y; LW0TIW155Z; S07O44R1ZM    67903a9b-b94e-1f65-e053-2991aa0a0e43
L7T10EIP3A; LAV5U5022Y; LW0TIW155Z; S07O44R1ZM    67903a9b-b94e-1f65-e053-2991aa0a0e43
Name: SET ID dtype: object",active ingredient unii ( s ) l7t10eip3a lav5u5022y lw0tiw155z s07o44r1zm active ingredient unii ( s ) l7t10eip3a lav5u502 l7t10eip3a lav5u5022y lw0tiw155z s07o44r1zm active ingredient unii ( s ) l7t10eip3a lav5u502 name content xml  dtype object,0
6100,6100,6100,6100,6100,6100,6100,7379,7379,7379,7379,7379,7379,7379,7379,7379,7379,7379,7379,7379,"Active Ingredient UNII(s)
L7T10EIP3A; LAV5U5022Y; S07O44R1ZM; VG2QF83CGL    67621cf4-e701-66e2-e053-2a91aa0ae8f0
L7T10EIP3A; LAV5U5022Y; S07O44R1ZM; VG2QF83CGL    67621cf4-e701-66e2-e053-2a91aa0ae8f0
Name: SET ID dtype: object",active ingredient unii ( s ) l7t10eip3a lav5u5022y s07o44r1zm vg2qf83cgl active ingredient unii ( s ) l7t10eip3a lav5u502 l7t10eip3a lav5u5022y s07o44r1zm vg2qf83cgl active ingredient unii ( s ) l7t10eip3a lav5u502 name content xml  dtype object,0
6101,6101,6101,6101,6101,6101,6101,7381,7381,7381,7381,7381,7381,7381,7381,7381,7381,7381,7381,7381,"Active Ingredient UNII(s)
L7T10EIP3A; LAV5U5022Y; S07O44R1ZM; WK2XYI10QM    673b54ec-a6b2-4236-e053-2a91aa0aec86
L7T10EIP3A; LAV5U5022Y; S07O44R1ZM; WK2XYI10QM    673b54ec-a6b2-4236-e053-2a91aa0aec86
Name: SET ID dtype: object",active ingredient unii ( s ) l7t10eip3a lav5u5022y s07o44r1zm wk2xyi10qm active ingredient unii ( s ) l7t10eip3a lav5u502 l7t10eip3a lav5u5022y s07o44r1zm wk2xyi10qm active ingredient unii ( s ) l7t10eip3a lav5u502 name content xml  dtype object,0
6102,6102,6102,6102,6102,6102,6102,7383,7383,7383,7383,7383,7383,7383,7383,7383,7383,7383,7383,7383,"Active Ingredient UNII(s)
L7T10EIP3A; QTG126297Q    527f16a6-d735-4603-86f8-319aea59caec
L7T10EIP3A; QTG126297Q    527f16a6-d735-4603-86f8-319aea59caec
Name: SET ID dtype: object",active ingredient unii ( s ) l7t10eip3a qtg126297q active ingredient unii ( s ) l7t10eip3a qtg12629 l7t10eip3a qtg126297q active ingredient unii ( s ) l7t10eip3a qtg12629 name content xml  dtype object,0
6103,6103,6103,6103,6103,6103,6103,7385,7385,7385,7385,7385,7385,7385,7385,7385,7385,7385,7385,7385,8459a675-dc5c-4fe1-a54c-37ad0db43a49, bioaches patch is indicated for the temporary relief of minor aches and muscle pains associated with arthritis  simple backache  strains  muscle soreness and stiffness,1
6104,6104,6104,6104,6104,6104,6104,7386,7386,7386,7386,7386,7386,7386,7386,7386,7386,7386,7386,7386,8459a675-dc5c-4fe1-a54c-37ad0db43a49,bioaches patch is an external analgesic counterirritant,0
6105,6105,6105,6105,6105,6105,6105,7387,7387,7387,7387,7387,7387,7387,7387,7387,7387,7387,7387,7387,10d1bcb7-c2f3-1145-e054-00144ff88e88,temporary relief of pain associated with minor cuts  scrapes and minor skin irritations,1
6106,6106,6106,6106,6106,6106,6106,7392,7392,7392,7392,7392,7392,7392,7392,7392,7392,7392,7392,7392,6af396c2-af3e-436d-ba9a-583637495910, acitretin capsules  usp are indicated for the treatment of severe psoriasis in adults,1
6107,6107,6107,6107,6107,6107,6107,7393,7393,7393,7393,7393,7393,7393,7393,7393,7393,7393,7393,7393,6af396c2-af3e-436d-ba9a-583637495910,because of significant adverse effects associated with its use  acitretin capsules  usp should be prescribed only by those knowledgeable in the systemic use of retinoids,0
6108,6108,6108,6108,6108,6108,6108,7394,7394,7394,7394,7394,7394,7394,7394,7394,7394,7394,7394,7394,6af396c2-af3e-436d-ba9a-583637495910,in females of reproductive potential  acitretin capsules  usp should be reserved for non pregnant patients who are unresponsive to other therapies or whose clinical condition contraindicates the use of other treatments ( see boxed contraindications and warnings acitretin capsules  usp can cause severe birth defects ),0
6109,6109,6109,6109,6109,6109,6109,7395,7395,7395,7395,7395,7395,7395,7395,7395,7395,7395,7395,7395,6af396c2-af3e-436d-ba9a-583637495910,most patients experience relapse of psoriasis after discontinuing therapy,0
6110,6110,6110,6110,6110,6110,6110,7396,7396,7396,7396,7396,7396,7396,7396,7396,7396,7396,7396,7396,6af396c2-af3e-436d-ba9a-583637495910,subsequent courses  when clinically indicated  have produced efficacy results similar to the initial course of therapy,0
6111,6111,6111,6111,6111,6111,6111,7397,7397,7397,7397,7397,7397,7397,7397,7397,7397,7397,7397,7397,e86fbda8-00e4-4d54-841a-59dea6c15e70, when oral therapy is not feasible  and the strength  dosage form  and route of administration of the drug reasonably lend the preparation to the treatment of the condition  the intravenous or intramuscular use of methylprednisolone sodium succinate for injection is indicated as follows allergic states control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in asthma  atopic dermatitis  contact dermatitis  drug hypersensitivity reactions  perennial or seasonal allergic rhinitis  serum sickness  transfusion reactions,1
6112,6112,6112,6112,6112,6112,6112,7401,7401,7401,7401,7401,7401,7401,7401,7401,7401,7401,7401,7401,e86fbda8-00e4-4d54-841a-59dea6c15e70,hematologic disorders acquired ( autoimmune ) hemolytic anemia  congenital ( erythroid ) hypoplastic anemia ( diamond blackfan anemia )  idiopathic thrombocytopenic purpura in adults ( intravenous administration only intramuscular administration is contraindicated )  pure red cell aplasia  selected cases of secondary thrombocytopenia,1
6113,6113,6113,6113,6113,6113,6113,7404,7404,7404,7404,7404,7404,7404,7404,7404,7404,7404,7404,7404,e86fbda8-00e4-4d54-841a-59dea6c15e70,nervous system acute exacerbations of multiple sclerosis cerebral edema associated with primary or metastatic brain tumor  or craniotomy,1
6114,6114,6114,6114,6114,6114,6114,7405,7405,7405,7405,7405,7405,7405,7405,7405,7405,7405,7405,7405,e86fbda8-00e4-4d54-841a-59dea6c15e70,ophthalmic diseases sympathetic ophthalmia  uveitis and ocular inflammatory conditions unresponsive to topical corticosteroids,1
6115,6115,6115,6115,6115,6115,6115,7408,7408,7408,7408,7408,7408,7408,7408,7408,7408,7408,7408,7408,e86fbda8-00e4-4d54-841a-59dea6c15e70,rheumatic disorders as adjunctive therapy for short term administration ( to tide the patient over an acute episode or exacerbation ) in acute gouty arthritis acute rheumatic carditis ankylosing spondyli,1
6116,6116,6116,6116,6116,6116,6116,7409,7409,7409,7409,7409,7409,7409,7409,7409,7409,7409,7409,7409,257148b5-869e-4a06-89ca-8b8686e8e528,1  adasuve is a typical antipsychotic indicated for the acute treatment of agitation associated with schizophrenia or bipolar i disorder in adults,1
6117,6117,6117,6117,6117,6117,6117,7410,7410,7410,7410,7410,7410,7410,7410,7410,7410,7410,7410,7410,257148b5-869e-4a06-89ca-8b8686e8e528,psychomotor agitation is defined in dsm iv as excessive motor activity associated with a feeling of inner tension patients experiencing agitation often manifest behaviors that interfere with their care ( e g  threatening behaviors  escalating or urgently distressing behavior  self exhausting behavior )  leading clinicians to the use of rapidly absorbed antipsychotic medications to achieve immediate control of the agitation see clinical studies ( 14 ),0
6118,6118,6118,6118,6118,6118,6118,7411,7411,7411,7411,7411,7411,7411,7411,7411,7411,7411,7411,7411,257148b5-869e-4a06-89ca-8b8686e8e528,the efficacy of adasuve was established in one study of acute agitation in patients with schizophrenia and one study of acute agitation in patients with bipolar i disorder see clinical studies ( 14 ),u
6119,6119,6119,6119,6119,6119,6119,7412,7412,7412,7412,7412,7412,7412,7412,7412,7412,7412,7412,7412,257148b5-869e-4a06-89ca-8b8686e8e528,limitations of use as part of the adasuve rems program to mitigate the risk of bronchospasm  adasuve must be administered only in an enrolled healthcare facility see warnings and precautions ( 5 2 ),4
6120,6120,6120,6120,6120,6120,6120,7413,7413,7413,7413,7413,7413,7413,7413,7413,7413,7413,7413,7413,257148b5-869e-4a06-89ca-8b8686e8e528,adasuve is a typical antipsychotic indicated for the acute treatment of agitation associated with schizophrenia or bipolar i disorder in adults,1
6121,6121,6121,6121,6121,6121,6121,7414,7414,7414,7414,7414,7414,7414,7414,7414,7414,7414,7414,7414,257148b5-869e-4a06-89ca-8b8686e8e528,efficacy was demonstrated in 2 trials in acute agitation one in schizophrenia and one in bipolar i disorder ( 1  14 ) limitations of use adasuve must be administered only in an enrolled healthcare facility ( 1 ),0
6122,6122,6122,6122,6122,6122,6122,7415,7415,7415,7415,7415,7415,7415,7415,7415,7415,7415,7415,7415,67d362c1-078c-11e4-9191-0800200c9a66,1  egrifta ( tesamorelin for injection ) is indicated for the reduction of excess abdominal fat in hiv infected patients with lipodystrophy see clinical studies ( 14 ),1
6123,6123,6123,6123,6123,6123,6123,7416,7416,7416,7416,7416,7416,7416,7416,7416,7416,7416,7416,7416,67d362c1-078c-11e4-9191-0800200c9a66,limitations of use since the long term cardiovascular safety and potential long term cardiovascular benefit of egrifta treatment have not been studied and are not known  careful consideration should be given whether to continue egrifta treatment in patients who do not show a clear efficacy response as judged by the degree of reduction in visceral adipose tissue measured by waist circumference or ct scan,0
6124,6124,6124,6124,6124,6124,6124,7417,7417,7417,7417,7417,7417,7417,7417,7417,7417,7417,7417,7417,67d362c1-078c-11e4-9191-0800200c9a66,egrifta is not indicated for weight loss management ( weight neutral effect ),0
6125,6125,6125,6125,6125,6125,6125,7418,7418,7418,7418,7418,7418,7418,7418,7418,7418,7418,7418,7418,67d362c1-078c-11e4-9191-0800200c9a66,there are no data to support improved compliance with anti retroviral therapies in hiv positive patients taking egrifta,0
6126,6126,6126,6126,6126,6126,6126,7419,7419,7419,7419,7419,7419,7419,7419,7419,7419,7419,7419,7419,67d362c1-078c-11e4-9191-0800200c9a66,egrifta is a growth hormone releasing factor ( grf ) analog indicated for the reduction of excess abdominal fat in hiv infected patients with lipodystrophy,1
6127,6127,6127,6127,6127,6127,6127,7420,7420,7420,7420,7420,7420,7420,7420,7420,7420,7420,7420,7420,67d362c1-078c-11e4-9191-0800200c9a66,( 1 ) limitations of use long term cardiovascular benefit and safety of egrifta have not been studied,0
6128,6128,6128,6128,6128,6128,6128,7421,7421,7421,7421,7421,7421,7421,7421,7421,7421,7421,7421,7421,67d362c1-078c-11e4-9191-0800200c9a66,( 1 ) not indicated for weight loss management ( weight neutral effect ),0
6129,6129,6129,6129,6129,6129,6129,7422,7422,7422,7422,7422,7422,7422,7422,7422,7422,7422,7422,7422,67d362c1-078c-11e4-9191-0800200c9a66,( 1 ) there are no data to support improved compliance with anti retroviral therapies in hiv positive patients taking egrifta,0
6130,6130,6130,6130,6130,6130,6130,7423,7423,7423,7423,7423,7423,7423,7423,7423,7423,7423,7423,7423,e802c83c-e581-4a11-b83d-1df47120078d,1  rasagiline tablets are indicated for the treatment of parkinson s disease ( pd ),1
6131,6131,6131,6131,6131,6131,6131,7424,7424,7424,7424,7424,7424,7424,7424,7424,7424,7424,7424,7424,e802c83c-e581-4a11-b83d-1df47120078d,rasagiline  a monoamine oxidase ( mao ) b inhibitor ( maoi )  is indicated for the treatment of parkinson s disease ( 1 ),1
6132,6132,6132,6132,6132,6132,6132,7425,7425,7425,7425,7425,7425,7425,7425,7425,7425,7425,7425,7425,7054c4ea-fee2-4627-aff2-e99ceb1080c7,indications indicated for the control of minor hemorrhage during dental restorative procedures,1
6133,6133,6133,6133,6133,6133,6133,7426,7426,7426,7426,7426,7426,7426,7426,7426,7426,7426,7426,7426,5754f979-32b7-4406-a3a9-ed36aac6a37a,1  ulesfia lotion is a pediculicide indicated for the topical treatment of head lice infestation in patients 6 months of age and older,1
6134,6134,6134,6134,6134,6134,6134,7427,7427,7427,7427,7427,7427,7427,7427,7427,7427,7427,7427,7427,5754f979-32b7-4406-a3a9-ed36aac6a37a,( 1 1 ) ulesfia lotion does not have ovocidal activity,0
6135,6135,6135,6135,6135,6135,6135,7428,7428,7428,7428,7428,7428,7428,7428,7428,7428,7428,7428,7428,5754f979-32b7-4406-a3a9-ed36aac6a37a,( 1 2 ) 1 1 indication ulesfia lotion is indicated for the topical treatment of head lice infestation in patients 6 months of age and older,1
6136,6136,6136,6136,6136,6136,6136,7429,7429,7429,7429,7429,7429,7429,7429,7429,7429,7429,7429,7429,5754f979-32b7-4406-a3a9-ed36aac6a37a,1 2 limitation of use ulesfia lotion does not have ovocidal activity,0
6137,6137,6137,6137,6137,6137,6137,7430,7430,7430,7430,7430,7430,7430,7430,7430,7430,7430,7430,7430,5754f979-32b7-4406-a3a9-ed36aac6a37a,1 3 adjunctive measures ulesfia lotion should be used in the context of an overall lice management program wash ( in hot water ) or dry clean all recently worn clothing  hats  used bedding  and towels,4
6138,6138,6138,6138,6138,6138,6138,7431,7431,7431,7431,7431,7431,7431,7431,7431,7431,7431,7431,7431,5754f979-32b7-4406-a3a9-ed36aac6a37a,wash personal care items such as combs  brushes and hair clips in hot water,0
6139,6139,6139,6139,6139,6139,6139,7432,7432,7432,7432,7432,7432,7432,7432,7432,7432,7432,7432,7432,5754f979-32b7-4406-a3a9-ed36aac6a37a,a fine tooth comb or special nit comb may be used to remove dead lice and nits,0
6140,6140,6140,6140,6140,6140,6140,7433,7433,7433,7433,7433,7433,7433,7433,7433,7433,7433,7433,7433,74b61e8a-7ae9-4996-85ec-df23c56de16f, cabergoline tablets usp are indicated for the treatment of hyperprolactinemic disorders  either idiopathic or due to pituitary adenomas,1
6141,6141,6141,6141,6141,6141,6141,7434,7434,7434,7434,7434,7434,7434,7434,7434,7434,7434,7434,7434,22c56f2a-f73c-60e7-e054-00144ff88e88,1  mircera is an erythropoiesis stimulating agent ( esa ) indicated for the treatment of anemia associated with chronic kidney disease ( ckd in adult patients on dialysis and patients not on dialysis ( 1 1 ),1
6142,6142,6142,6142,6142,6142,6142,7435,7435,7435,7435,7435,7435,7435,7435,7435,7435,7435,7435,7435,22c56f2a-f73c-60e7-e054-00144ff88e88,limitations of use mircera is not indicated and is not recommended for use in the treatment of anemia due to cancer chemotherapy ( 1 2 ),2
6143,6143,6143,6143,6143,6143,6143,7436,7436,7436,7436,7436,7436,7436,7436,7436,7436,7436,7436,7436,22c56f2a-f73c-60e7-e054-00144ff88e88,as a substitute for rbc transfusions in patients who require immediate correction of anemia ( 1 2 ) mircera has not been shown to improve quality of life  fatigue  or patient well being,0
6144,6144,6144,6144,6144,6144,6144,7437,7437,7437,7437,7437,7437,7437,7437,7437,7437,7437,7437,7437,22c56f2a-f73c-60e7-e054-00144ff88e88,1 1 anemia due to chronic kidney disease mircera is indicated for the treatment of anemia associated with chronic kidney disease ( ckd ) in adult patients on dialysis and patients not on dialysis,1
6145,6145,6145,6145,6145,6145,6145,7438,7438,7438,7438,7438,7438,7438,7438,7438,7438,7438,7438,7438,22c56f2a-f73c-60e7-e054-00144ff88e88,1 2 limitations of use mircera is not indicated and is not recommended in the treatment of anemia due to cancer chemotherapy see warnings and precautions ( 5 2 ) as a substitute for rbc transfusions in patients who require immediate correction of anemia see clinical pharmacology ( 12 2 ) mircera has not been shown to improve symptoms  physical functioning or health related quality of life,2
6146,6146,6146,6146,6146,6146,6146,7439,7439,7439,7439,7439,7439,7439,7439,7439,7439,7439,7439,7439,e21e24d5-0535-4962-b9ed-7957fe4ed3db, chloroprocaine hydrochloride injection 2 and 3  in single dose vials  without methylparaben preservative  without edta  is indicated for the production of local anesthesia by infiltration  peripheral and central nerve block  including lumbar and caudal epidural blocks,1
6147,6147,6147,6147,6147,6147,6147,7440,7440,7440,7440,7440,7440,7440,7440,7440,7440,7440,7440,7440,e21e24d5-0535-4962-b9ed-7957fe4ed3db,chloroprocaine hydrochloride injection is not to be used for subarachnoid administration,2
6148,6148,6148,6148,6148,6148,6148,7441,7441,7441,7441,7441,7441,7441,7441,7441,7441,7441,7441,7441,43a4d7f8-48ae-4a63-9108-2fa8e3ea9d9c,1  sutent is a kinase inhibitor indicated for the treatment of gastrointestinal stromal tumor ( gist ) after disease progression on or intolerance to imatinib mesylate,1
6149,6149,6149,6149,6149,6149,6149,7442,7442,7442,7442,7442,7442,7442,7442,7442,7442,7442,7442,7442,43a4d7f8-48ae-4a63-9108-2fa8e3ea9d9c,( 1 1 ) the treatment of advanced renal cell carcinoma ( rcc ),1
6150,6150,6150,6150,6150,6150,6150,7443,7443,7443,7443,7443,7443,7443,7443,7443,7443,7443,7443,7443,43a4d7f8-48ae-4a63-9108-2fa8e3ea9d9c,( 1 2 ) the adjuvant treatment of adult patients at high risk of recurrent rcc following nephrectomy,1
6151,6151,6151,6151,6151,6151,6151,7444,7444,7444,7444,7444,7444,7444,7444,7444,7444,7444,7444,7444,43a4d7f8-48ae-4a63-9108-2fa8e3ea9d9c,( 1 3 ) the treatment of progressive  well differentiated pancreatic neuroendocrine tumors ( pnet ) in patients with unresectable locally advanced or metastatic disease,1
6152,6152,6152,6152,6152,6152,6152,7445,7445,7445,7445,7445,7445,7445,7445,7445,7445,7445,7445,7445,43a4d7f8-48ae-4a63-9108-2fa8e3ea9d9c,( 1 4 ) 1 1 gastrointestinal stromal tumor ( gist ) sutent is indicated for the treatment of gastrointestinal stromal tumor after disease progression on or intolerance to imatinib mesylate,1
6153,6153,6153,6153,6153,6153,6153,7446,7446,7446,7446,7446,7446,7446,7446,7446,7446,7446,7446,7446,43a4d7f8-48ae-4a63-9108-2fa8e3ea9d9c,1 2 advanced renal cell carcinoma ( rcc ) sutent is indicated for the treatment of advanced renal cell carcinoma,1
6154,6154,6154,6154,6154,6154,6154,7447,7447,7447,7447,7447,7447,7447,7447,7447,7447,7447,7447,7447,43a4d7f8-48ae-4a63-9108-2fa8e3ea9d9c,1 3 adjuvant treatment of renal cell carcinoma ( rcc ) sutent is indicated for the adjuvant treatment of adult patients at high risk of recurrent rcc following nephrectomy,1
6155,6155,6155,6155,6155,6155,6155,7448,7448,7448,7448,7448,7448,7448,7448,7448,7448,7448,7448,7448,43a4d7f8-48ae-4a63-9108-2fa8e3ea9d9c,1 4 advanced pancreatic neuroendocrine tumors ( pnet ) sutent is indicated for the treatment of progressive  well differentiated pancreatic neuroendocrine tumors in patients with unresectable locally advanced or metastatic disease,1
6156,6156,6156,6156,6156,6156,6156,7449,7449,7449,7449,7449,7449,7449,7449,7449,7449,7449,7449,7449,faf361cd-46d2-4656-85db-d6a38453a9ad, carefully consider the potential benefits and risks of nabumetone tablets  usp and other treatment options before deciding to use nabumetone tablets  usp,0
6157,6157,6157,6157,6157,6157,6157,7451,7451,7451,7451,7451,7451,7451,7451,7451,7451,7451,7451,7451,faf361cd-46d2-4656-85db-d6a38453a9ad,nabumetone tablets  usp are indicated for relief of the signs and symptoms of rheumatoid arthritis,1
6158,6158,6158,6158,6158,6158,6158,7453,7453,7453,7453,7453,7453,7453,7453,7453,7453,7453,7453,7453,3784c35c-e87f-410c-900b-8fd6313c6010,1  tybost is a cyp3a inhibitor indicated to increase systemic exposure of atazanavir or darunavir ( once daily dosing regimen ) in combination with other antiretroviral agents in the treatment of hiv 1 infection see dosage and administration ( 2 1 ),1
6159,6159,6159,6159,6159,6159,6159,7454,7454,7454,7454,7454,7454,7454,7454,7454,7454,7454,7454,7454,3784c35c-e87f-410c-900b-8fd6313c6010,tybost is a cyp3a inhibitor indicated to increase systemic exposure of atazanavir or darunavir ( once daily dosing regimen ) in combination with other antiretroviral agents in the treatment of hiv 1 infection,1
6160,6160,6160,6160,6160,6160,6160,7455,7455,7455,7455,7455,7455,7455,7455,7455,7455,7455,7455,7455,3784c35c-e87f-410c-900b-8fd6313c6010,( 1 ) limitations of use tybost is not interchangeable with ritonavir to increase systemic exposure of darunavir 600 mg twice daily  fosamprenavir  saquinavir  or tipranavir due to lack of exposure data,0
6161,6161,6161,6161,6161,6161,6161,7456,7456,7456,7456,7456,7456,7456,7456,7456,7456,7456,7456,7456,3784c35c-e87f-410c-900b-8fd6313c6010,the use of tybost is not recommended with darunavir 600 mg twice daily  fosamprenavir  saquinavir  or tipranavir,0
6162,6162,6162,6162,6162,6162,6162,7457,7457,7457,7457,7457,7457,7457,7457,7457,7457,7457,7457,7457,3784c35c-e87f-410c-900b-8fd6313c6010,( 5 4 ) complex or unknown mechanisms of drug interactions preclude extrapolation of ritonavir drug interactions to certain tybost interactions,0
6163,6163,6163,6163,6163,6163,6163,7458,7458,7458,7458,7458,7458,7458,7458,7458,7458,7458,7458,7458,3784c35c-e87f-410c-900b-8fd6313c6010,tybost and ritonavir when administered with either atazanavir or darunavir may result in different drug interactions when used with concomitant medications,0
6164,6164,6164,6164,6164,6164,6164,7459,7459,7459,7459,7459,7459,7459,7459,7459,7459,7459,7459,7459,3784c35c-e87f-410c-900b-8fd6313c6010,( 5 3  7  12 3 ) limitations of use tybost is not interchangeable with ritonavir to increase systemic exposure of darunavir 600 mg twice daily  fosamprenavir  saquinavir  or tipranavir due to lack of exposure data,0
6165,6165,6165,6165,6165,6165,6165,7460,7460,7460,7460,7460,7460,7460,7460,7460,7460,7460,7460,7460,3784c35c-e87f-410c-900b-8fd6313c6010,the use of tybost is not recommended with darunavir 600 mg twice daily  fosamprenavir  saquinavir  or tipranavir see warnings and precautions ( 5 4 ),2
6166,6166,6166,6166,6166,6166,6166,7461,7461,7461,7461,7461,7461,7461,7461,7461,7461,7461,7461,7461,3784c35c-e87f-410c-900b-8fd6313c6010,complex or unknown mechanisms of drug interactions preclude extrapolation of ritonavir drug interactions to certain tybost interactions,0
6167,6167,6167,6167,6167,6167,6167,7462,7462,7462,7462,7462,7462,7462,7462,7462,7462,7462,7462,7462,3784c35c-e87f-410c-900b-8fd6313c6010,tybost and ritonavir when administered with either atazanavir or darunavir may result in different drug interactions when used with concomitant medications see warnings and precautions ( 5 3 )  drug interactions ( 7 )  and clinical pharmacology ( 12 3 ),0
6168,6168,6168,6168,6168,6168,6168,7463,7463,7463,7463,7463,7463,7463,7463,7463,7463,7463,7463,7463,1f3184a9-8136-4ef1-3590-9ad15c231b26, 5 lidocaine hydrochloride and 7 5 dextrose injection  usp is indicated for the production of spinal anesthesia when the accepted procedures for this technique as described in standard textbooks are observed,1
6169,6169,6169,6169,6169,6169,6169,7464,7464,7464,7464,7464,7464,7464,7464,7464,7464,7464,7464,7464,92a6f533-1a3d-4734-b413-d245592454e3,1  heparin sodium is indicated for prophylaxis and treatment of venous thrombosis and pulmonary embolism prophylaxis and treatment of thromboembolic complications associated with atrial fibrillation treatment of acute and chronic consumption coagulopathies ( disseminated intravascular coagulation ) prevention of clotting in arterial and cardiac surgery prophylaxis and treatment of peripheral arterial embolism anticoagulant use in blood transfusions  extracorporeal circulation  and dialysis procedures,1
6170,6170,6170,6170,6170,6170,6170,7465,7465,7465,7465,7465,7465,7465,7465,7465,7465,7465,7465,7465,92a6f533-1a3d-4734-b413-d245592454e3,heparin sodium is indicated for ( 1 ) prophylaxis and treatment of venous thrombosis and pulmonary embolism prophylaxis and treatment of thromboembolic complications associated with atrial fibrillation treatment of acute and chronic consumption coagulopathies ( disseminated intravascular coagulation ) prevention of clotting in arterial and cardiac surgery prophylaxis and treatment of peripheral arterial embolism anticoagulant use in blood transfusions  extracorporeal circulation  and dialysis procedures,1
6171,6171,6171,6171,6171,6171,6171,7466,7466,7466,7466,7466,7466,7466,7466,7466,7466,7466,7466,7466,26f2704c-92ae-41c5-badc-dbebfb2eed35, to reduce the development of drug resistant bacteria and maintain the effectiveness of erythrocin stearate film coated tablets and other antibacterial drugs  erythrocin stearate film coated tablets should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria,4
6172,6172,6172,6172,6172,6172,6172,7469,7469,7469,7469,7469,7469,7469,7469,7469,7469,7469,7469,7469,26f2704c-92ae-41c5-badc-dbebfb2eed35,erythrocin stearate tablets are indicated in the treatment of infections caused by susceptible strains of the designated micro organisms in the diseases listed below upper respiratory tract infections of mild to moderate degree caused by streptococcus pyogenes streptococcus pneumoniae haemophilus influenzae ( when used concomitantly with adequate doses of sulfonamides  since many strains of h influenzaeare not susceptible to the erythromycin concentrations ordinarily achieved ),1
6173,6173,6173,6173,6173,6173,6173,7483,7483,7483,7483,7483,7483,7483,7483,7483,7483,7483,7483,7483,26f2704c-92ae-41c5-badc-dbebfb2eed35,( erythromycin lactobionate for injection  usp ) followed by erythromycin base orally  as an alternative drug in treatment of acute pelvic inflammatory disease caused by n gonorrhoeae,1
6174,6174,6174,6174,6174,6174,6174,7484,7484,7484,7484,7484,7484,7484,7484,7484,7484,7484,7484,7484,1408aabb-6982-48e5-ae9f-504ec43b0003, kinevac ( sincalide for injection ) may be used ( 1 ) to stimulate gallbladder contraction  as may be assessed by various methods of diagnostic imaging  or to obtain by duodenal aspiration a sample of concentrated bile for analysis of cholesterol  bile salts  phospholipids  and crystals ( 2 ) to stimulate pancreatic secretion ( especially in conjunction with secretin ) prior to obtaining a duodenal aspirate for analysis of enzyme activity  composition  and cytology ( 3 ) to accelerate the transit of a barium meal through the small bowel  thereby decreasing the time and extent of radiation associated with fluoroscopy and x ray examination of the intestinal tract,1
6175,6175,6175,6175,6175,6175,6175,7485,7485,7485,7485,7485,7485,7485,7485,7485,7485,7485,7485,7485,c265d69a-3efe-4107-9a9e-e6fd3d531c48, giapreza increases blood pressure in adults with septic or other distributive shock,1
6176,6176,6176,6176,6176,6176,6176,7486,7486,7486,7486,7486,7486,7486,7486,7486,7486,7486,7486,7486,c265d69a-3efe-4107-9a9e-e6fd3d531c48,giapreza is a vasoconstrictor to increase blood pressure in adults with septic or other distributive shock,1
6177,6177,6177,6177,6177,6177,6177,7487,7487,7487,7487,7487,7487,7487,7487,7487,7487,7487,7487,7487,52f01c6e-172a-47a9-98a6-9eab7651a032,1  sodium nitrite injection is indicated for sequential use with sodium thiosulfate for the treatment of acute cyanide poisoning that is judged to be serious or life threatening,1
6178,6178,6178,6178,6178,6178,6178,7488,7488,7488,7488,7488,7488,7488,7488,7488,7488,7488,7488,7488,52f01c6e-172a-47a9-98a6-9eab7651a032,when the diagnosis of cyanide poisoning is uncertain  the potentially life threatening risks associated with sodium nitrite injection should be carefully weighed against the potential benefits  especially if the patient is not in extremis,0
6179,6179,6179,6179,6179,6179,6179,7489,7489,7489,7489,7489,7489,7489,7489,7489,7489,7489,7489,7489,52f01c6e-172a-47a9-98a6-9eab7651a032,sodium nitrite injection is indicated for sequential use with sodium thiosulfate for treatment of acute cyanide poisoning that is judged to be serious or life threatening,1
6180,6180,6180,6180,6180,6180,6180,7491,7491,7491,7491,7491,7491,7491,7491,7491,7491,7491,7491,7491,"Active Ingredient UNII(s)
M0XW1UBI14; ND2M416302    edcd5209-70db-4727-991e-3fdd185d9211
M0XW1UBI14; ND2M416302    edcd5209-70db-4727-991e-3fdd185d9211
Name: SET ID dtype: object",active ingredient unii ( s ) m0xw1ubi14 nd2m416302 active ingredient unii ( s ) m0xw1ubi14 nd2m4163 m0xw1ubi14 nd2m416302 active ingredient unii ( s ) m0xw1ubi14 nd2m4163 name content xml  dtype object,0
6181,6181,6181,6181,6181,6181,6181,7493,7493,7493,7493,7493,7493,7493,7493,7493,7493,7493,7493,7493,dcbd076e-3989-4cae-9466-54a0e9118128, etidronate disodium tablets  usp are indicated for the treatment of symptomatic paget s disease of bone and in the prevention and treatment of heterotopic ossification following total hip replacement or due to spinal cord injury,1
6182,6182,6182,6182,6182,6182,6182,7494,7494,7494,7494,7494,7494,7494,7494,7494,7494,7494,7494,7494,dcbd076e-3989-4cae-9466-54a0e9118128,etidronate disodium tablets are not approved for the treatment of osteoporosis,2
6183,6183,6183,6183,6183,6183,6183,7495,7495,7495,7495,7495,7495,7495,7495,7495,7495,7495,7495,7495,dcbd076e-3989-4cae-9466-54a0e9118128,paget s disease etidronate disodium tablets are indicated for the treatment of symptomatic paget s disease of bone,1
6184,6184,6184,6184,6184,6184,6184,7496,7496,7496,7496,7496,7496,7496,7496,7496,7496,7496,7496,7496,dcbd076e-3989-4cae-9466-54a0e9118128,etidronate disodium therapy usually arrests or significantly impedes the disease process as evidenced by symptomatic relief  including decreased pain and or increased mobility ( experienced by 3 out of 5 patients ),1
6185,6185,6185,6185,6185,6185,6185,7497,7497,7497,7497,7497,7497,7497,7497,7497,7497,7497,7497,7497,dcbd076e-3989-4cae-9466-54a0e9118128,reductions in serum alkaline phosphatase and urinary hydroxyproline levels ( 30 or more in 4 out of 5 patients ),u
6186,6186,6186,6186,6186,6186,6186,7498,7498,7498,7498,7498,7498,7498,7498,7498,7498,7498,7498,7498,dcbd076e-3989-4cae-9466-54a0e9118128,histomorphometry showing reduced numbers of osteoclasts and osteoblasts  and more lamellar bone formation,u
6187,6187,6187,6187,6187,6187,6187,7499,7499,7499,7499,7499,7499,7499,7499,7499,7499,7499,7499,7499,dcbd076e-3989-4cae-9466-54a0e9118128,bone scans showing reduced radionuclide uptake at pagetic lesions,u
6188,6188,6188,6188,6188,6188,6188,7500,7500,7500,7500,7500,7500,7500,7500,7500,7500,7500,7500,7500,dcbd076e-3989-4cae-9466-54a0e9118128,in addition  reductions in pagetically elevated cardiac output and skin temperature have been observed in some patients,u
6189,6189,6189,6189,6189,6189,6189,7501,7501,7501,7501,7501,7501,7501,7501,7501,7501,7501,7501,7501,dcbd076e-3989-4cae-9466-54a0e9118128,in many patients  the disease process will be suppressed for a period of at least one year following cessation of therapy,u
6190,6190,6190,6190,6190,6190,6190,7502,7502,7502,7502,7502,7502,7502,7502,7502,7502,7502,7502,7502,dcbd076e-3989-4cae-9466-54a0e9118128,the upper limit of this period has not been determined,0
6191,6191,6191,6191,6191,6191,6191,7503,7503,7503,7503,7503,7503,7503,7503,7503,7503,7503,7503,7503,dcbd076e-3989-4cae-9466-54a0e9118128,the effects of the etidronate disodium treatment in patients with asymptomatic paget s disease have not been studied,0
6192,6192,6192,6192,6192,6192,6192,7504,7504,7504,7504,7504,7504,7504,7504,7504,7504,7504,7504,7504,dcbd076e-3989-4cae-9466-54a0e9118128,however  etidronate disodium treatment of such patients may be warranted if extensive involvement threatens irreversible neurologic damage  major joints  or major weight bearing bones,u
6193,6193,6193,6193,6193,6193,6193,7505,7505,7505,7505,7505,7505,7505,7505,7505,7505,7505,7505,7505,dcbd076e-3989-4cae-9466-54a0e9118128,heterotopic ossification etidronate disodium tablets are indicated in the prevention and treatment of heterotopic ossification following total hip replacement or due to spinal cord injury,1
6194,6194,6194,6194,6194,6194,6194,7506,7506,7506,7506,7506,7506,7506,7506,7506,7506,7506,7506,7506,dcbd076e-3989-4cae-9466-54a0e9118128,etidronate disodium tablets reduce the incidence of clinically important heterotopic bone by about two thirds,u
6195,6195,6195,6195,6195,6195,6195,7507,7507,7507,7507,7507,7507,7507,7507,7507,7507,7507,7507,7507,dcbd076e-3989-4cae-9466-54a0e9118128,among those patients who form heterotopic bone  etidronate disodium tablets retard the progression of immature lesions and reduces the severity by at least half,1
6196,6196,6196,6196,6196,6196,6196,7508,7508,7508,7508,7508,7508,7508,7508,7508,7508,7508,7508,7508,dcbd076e-3989-4cae-9466-54a0e9118128,follow up data ( at least 9 months post therapy ) suggests these benefits persist,0
6197,6197,6197,6197,6197,6197,6197,7509,7509,7509,7509,7509,7509,7509,7509,7509,7509,7509,7509,7509,dcbd076e-3989-4cae-9466-54a0e9118128,in total hip replacement patients  etidronate disodium tablets do not promote loosening of the prosthesis or impede trochanteric reattachment,u
6198,6198,6198,6198,6198,6198,6198,7510,7510,7510,7510,7510,7510,7510,7510,7510,7510,7510,7510,7510,dcbd076e-3989-4cae-9466-54a0e9118128,in spinal cord injury patients  etidronate disodium tablets do not inhibit fracture healing or st,u
6199,6199,6199,6199,6199,6199,6199,7511,7511,7511,7511,7511,7511,7511,7511,7511,7511,7511,7511,7511,52450d09-b77d-4bae-8d21-6394408e3f88, to reduce the development of drug resistant bacteria and maintain the effectiveness of methenamine hippurate tablets and other antibacterial drugs  methenamine hippurate tablets should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria,4
6200,6200,6200,6200,6200,6200,6200,7514,7514,7514,7514,7514,7514,7514,7514,7514,7514,7514,7514,7514,52450d09-b77d-4bae-8d21-6394408e3f88,methenamine hippurate tablets are indicated for prophylactic or suppressive treatment of frequently recurring urinary tract infections when long term therapy is considered necessary,1
6201,6201,6201,6201,6201,6201,6201,7515,7515,7515,7515,7515,7515,7515,7515,7515,7515,7515,7515,7515,52450d09-b77d-4bae-8d21-6394408e3f88,this drug should only be used after eradication of the infection by other appropriate antimicrobial agents,4
6202,6202,6202,6202,6202,6202,6202,7516,7516,7516,7516,7516,7516,7516,7516,7516,7516,7516,7516,7516,f11c0753-ef0a-4e1b-83dd-8543649df9a5, ethyol ( amifostine ) is indicated to reduce the cumulative renal toxicity associated with repeated administration of cisplatin in patient s with advanced ovarian cancer,1
6203,6203,6203,6203,6203,6203,6203,7517,7517,7517,7517,7517,7517,7517,7517,7517,7517,7517,7517,7517,f11c0753-ef0a-4e1b-83dd-8543649df9a5,ethyol is indicated to reduce the incidence of moderate to severe xerostomia in patients undergoing post operative radiation treatment for head and neck cancer  where the radiation port includes a substantial portion of the parotid glands ( see clinical studies ),1
6204,6204,6204,6204,6204,6204,6204,7518,7518,7518,7518,7518,7518,7518,7518,7518,7518,7518,7518,7518,f11c0753-ef0a-4e1b-83dd-8543649df9a5,for the approved indications  the clinical data do not suggest that the effectiveness of cisplatin based chemotherapy regimens or radiation therapy is altered by ethyol,0
6205,6205,6205,6205,6205,6205,6205,7519,7519,7519,7519,7519,7519,7519,7519,7519,7519,7519,7519,7519,f11c0753-ef0a-4e1b-83dd-8543649df9a5,there are at present only limited data on the effects of amifostine on the efficacy of chemotherapy or radiotherapy in other settings,0
6206,6206,6206,6206,6206,6206,6206,7520,7520,7520,7520,7520,7520,7520,7520,7520,7520,7520,7520,7520,f11c0753-ef0a-4e1b-83dd-8543649df9a5,ethyol should not be administered to patients in other settings where chemotherapy can produce a significant survival benefit or cure  or in patients receiving definitive radiotherapy  except in the context of a clinical study ( see warnings ),2
6207,6207,6207,6207,6207,6207,6207,7521,7521,7521,7521,7521,7521,7521,7521,7521,7521,7521,7521,7521,61f00cb4-ea53-4ba6-a890-78586095d2f6,1  choline c 11 injection is indicated for positron emission tomography ( pet ) imaging of patients with suspected prostate cancer recurrence and non informative bone scintigraphy  computerized tomography ( ct ) or magnetic resonance imaging ( mri ),1
6208,6208,6208,6208,6208,6208,6208,7522,7522,7522,7522,7522,7522,7522,7522,7522,7522,7522,7522,7522,61f00cb4-ea53-4ba6-a890-78586095d2f6,in these patients  11c choline pet imaging may help identify potential sites of prostate cancer recurrence for subsequent histologic confirmation,1
6209,6209,6209,6209,6209,6209,6209,7523,7523,7523,7523,7523,7523,7523,7523,7523,7523,7523,7523,7523,61f00cb4-ea53-4ba6-a890-78586095d2f6,suspected prostate recurrence is based upon elevated blood prostate specific antigen ( psa ) levels following initial therapy,0
6210,6210,6210,6210,6210,6210,6210,7524,7524,7524,7524,7524,7524,7524,7524,7524,7524,7524,7524,7524,61f00cb4-ea53-4ba6-a890-78586095d2f6,in clinical studies  images were produced with pet ct coregistration,0
6211,6211,6211,6211,6211,6211,6211,7525,7525,7525,7525,7525,7525,7525,7525,7525,7525,7525,7525,7525,61f00cb4-ea53-4ba6-a890-78586095d2f6,limitation of use 11c choline pet imaging is not a replacement for histologic verification of recurrent prostate cancer,0
6212,6212,6212,6212,6212,6212,6212,7526,7526,7526,7526,7526,7526,7526,7526,7526,7526,7526,7526,7526,61f00cb4-ea53-4ba6-a890-78586095d2f6,choline c 11 injection is a radioactive diagnostic agent for positron emission tomography ( pet ) imaging of patients with suspected prostate cancer recurrence and non informative bone scintigraphy  computerized tomography ( ct ) or magnetic resonance imaging,1
6213,6213,6213,6213,6213,6213,6213,7530,7530,7530,7530,7530,7530,7530,7530,7530,7530,7530,7530,7530,61f00cb4-ea53-4ba6-a890-78586095d2f6,limitation of use 11c choline pet imaging is not a replacement for histologic verification of recurrent prostate cancer ( 1 ),2
6214,6214,6214,6214,6214,6214,6214,7531,7531,7531,7531,7531,7531,7531,7531,7531,7531,7531,7531,7531,c5ef90b3-6ef0-410c-97d7-66a130b90741, 10 calcium chloride injection is indicated for the treatment of hypocalcemia in those conditions requiring a prompt increase in plasma calcium levels,1
6215,6215,6215,6215,6215,6215,6215,7534,7534,7534,7534,7534,7534,7534,7534,7534,7534,7534,7534,7534,e9f0fe3a-0462-4c24-8f22-3c89afe8fcea,zypitamag is an hmg coa reductase inhibitor indicated for patients with primary hyperlipidemia or mixed dyslipidemia as an adjunctive therapy to diet to reduce elevated total cholesterol ( tc )  low density lipoprotein cholesterol ( ldl c )  apolipoprotein b ( apo b )  triglycerides ( tg )  and to increase high density lipoprotein cholesterol ( hdl c ) ( 1 1 ) limitations of use ( 1 2 ) doses greater than 4 mg once daily were associated with an increased risk for severe myopathy in premarketing clinical studies,1
6216,6216,6216,6216,6216,6216,6216,7535,7535,7535,7535,7535,7535,7535,7535,7535,7535,7535,7535,7535,e9f0fe3a-0462-4c24-8f22-3c89afe8fcea,do not exceed 4 mg once daily dosing,0
6217,6217,6217,6217,6217,6217,6217,7536,7536,7536,7536,7536,7536,7536,7536,7536,7536,7536,7536,7536,e9f0fe3a-0462-4c24-8f22-3c89afe8fcea,the effect of zypitamag on cardiovascular morbidity and mortality has not been determined,0
6218,6218,6218,6218,6218,6218,6218,7537,7537,7537,7537,7537,7537,7537,7537,7537,7537,7537,7537,7537,e9f0fe3a-0462-4c24-8f22-3c89afe8fcea,zypitamag has not been studied in fredrickson type i  iii  and v dyslipidemias,0
6219,6219,6219,6219,6219,6219,6219,7538,7538,7538,7538,7538,7538,7538,7538,7538,7538,7538,7538,7538,e9f0fe3a-0462-4c24-8f22-3c89afe8fcea,1 1 primary hyperlipidemia and mixed dyslipidemia zypitamag is indicated as an adjunctive therapy to diet to reduce elevated total cholesterol ( tc )  low density lipoprotein cholesterol ( ldl c )  apolipoprotein b ( apo b )  triglycerides ( tg )  and to increase hdl c in adult patients with primary hyperlipidemia or mixed dyslipidemia,1
6220,6220,6220,6220,6220,6220,6220,7539,7539,7539,7539,7539,7539,7539,7539,7539,7539,7539,7539,7539,e9f0fe3a-0462-4c24-8f22-3c89afe8fcea,1 2 limitations of use doses of zypitamag greater than 4 mg once daily were associated with an increased risk for severe myopathy in premarketing clinical studies,3
6221,6221,6221,6221,6221,6221,6221,7540,7540,7540,7540,7540,7540,7540,7540,7540,7540,7540,7540,7540,e9f0fe3a-0462-4c24-8f22-3c89afe8fcea,do not exceed 4 mg once daily dosing of zypitamag,4
6222,6222,6222,6222,6222,6222,6222,7543,7543,7543,7543,7543,7543,7543,7543,7543,7543,7543,7543,7543,b61eaf72-4699-4d1a-b153-022418518508, thiamine hydrochloride injection is effective for the treatment of thiamine deficiency or beriberi whether of the dry ( major symptoms related to the nervous system ) or wet ( major symptoms related to the cardiovascular system ) variety,1
6223,6223,6223,6223,6223,6223,6223,7544,7544,7544,7544,7544,7544,7544,7544,7544,7544,7544,7544,7544,b61eaf72-4699-4d1a-b153-022418518508,thiamine hydrochloride injection should be used where rapid restoration of thiamine is necessary  as in wernicke 's encephalopathy  infantile beriberi with acute collapse  cardiovascular disease due to thiamine deficiency  or neuritis of pregnancy if vomiting is severe,u
6224,6224,6224,6224,6224,6224,6224,7545,7545,7545,7545,7545,7545,7545,7545,7545,7545,7545,7545,7545,b61eaf72-4699-4d1a-b153-022418518508,it is also indicated when giving iv dextrose to individuals with marginal thiamine status to avoid precipitation of heart failure,1
6225,6225,6225,6225,6225,6225,6225,7546,7546,7546,7546,7546,7546,7546,7546,7546,7546,7546,7546,7546,b61eaf72-4699-4d1a-b153-022418518508,thiamine hydrochloride injection is also indicated in patients with established thiamine deficiency who cannot take thiamine orally due to coexisting severe anorexia  nausea  vomiting  or malabsorption,1
6226,6226,6226,6226,6226,6226,6226,7547,7547,7547,7547,7547,7547,7547,7547,7547,7547,7547,7547,7547,b61eaf72-4699-4d1a-b153-022418518508,thiamine hydrochloride injection is not usually indicated for conditions of decreased oral intake or decreased gastrointestinal absorption  because multiple vitamins should usually be given,0
6227,6227,6227,6227,6227,6227,6227,7548,7548,7548,7548,7548,7548,7548,7548,7548,7548,7548,7548,7548,70cd982c-151e-48a6-a053-9d5ccd65ba69, ethacrynic acid is indicated for treatment of edema when an agent with greater diuretic potential than those commonly employed is required,1
6228,6228,6228,6228,6228,6228,6228,7549,7549,7549,7549,7549,7549,7549,7549,7549,7549,7549,7549,7549,70cd982c-151e-48a6-a053-9d5ccd65ba69,1 treatment of the edema associated with congestive heart failure  cirrhosis of the liver and renal disease  including the nephrotic syndrome,1
6229,6229,6229,6229,6229,6229,6229,7553,7553,7553,7553,7553,7553,7553,7553,7553,7553,7553,7553,7553,c01906fa-2c73-4c13-9765-2fd06628d263, lincocin sterile solution is indicated in the treatment of serious infections due to susceptible strains of streptococci  pneumococci  and staphylococci,1
6230,6230,6230,6230,6230,6230,6230,7554,7554,7554,7554,7554,7554,7554,7554,7554,7554,7554,7554,7554,c01906fa-2c73-4c13-9765-2fd06628d263,its use should be reserved for penicillin allergic patients or other patients for whom  in the judgment of the physician  a penicillin is inappropriate,0
6231,6231,6231,6231,6231,6231,6231,7555,7555,7555,7555,7555,7555,7555,7555,7555,7555,7555,7555,7555,c01906fa-2c73-4c13-9765-2fd06628d263,because of the risk of antibacterial associated pseudomembranous colitis  as described in the warning box  before selecting lincomycin the physician should consider the nature of the infection and the suitability of less toxic alternatives ( e g  erythromycin ),4
6232,6232,6232,6232,6232,6232,6232,7556,7556,7556,7556,7556,7556,7556,7556,7556,7556,7556,7556,7556,c01906fa-2c73-4c13-9765-2fd06628d263,indicated surgical procedures should be performed in conjunction with antibacterial therapy,u
6233,6233,6233,6233,6233,6233,6233,7557,7557,7557,7557,7557,7557,7557,7557,7557,7557,7557,7557,7557,c01906fa-2c73-4c13-9765-2fd06628d263,the drug may be administered concomitantly with other antimicrobial agents when indicated,4
6234,6234,6234,6234,6234,6234,6234,7558,7558,7558,7558,7558,7558,7558,7558,7558,7558,7558,7558,7558,c01906fa-2c73-4c13-9765-2fd06628d263,lincomycin is not indicated in the treatment of minor bacterial infections or viral infections,0
6235,6235,6235,6235,6235,6235,6235,7559,7559,7559,7559,7559,7559,7559,7559,7559,7559,7559,7559,7559,c01906fa-2c73-4c13-9765-2fd06628d263,to reduce the development of drug resistant bacteria and maintain the effectiveness of lincocin and other antibacterial drugs  lincocin should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria,4
6236,6236,6236,6236,6236,6236,6236,7562,7562,7562,7562,7562,7562,7562,7562,7562,7562,7562,7562,7562,50361fc8-8fba-1c45-e054-00144ff88e88,1  brisdelle is indicated for the treatment of moderate to severe vasomotor symptoms ( vms ) associated with menopause,1
6237,6237,6237,6237,6237,6237,6237,7563,7563,7563,7563,7563,7563,7563,7563,7563,7563,7563,7563,7563,50361fc8-8fba-1c45-e054-00144ff88e88,limitation of use brisdelle is not indicated for the treatment of any psychiatric condition,0
6238,6238,6238,6238,6238,6238,6238,7564,7564,7564,7564,7564,7564,7564,7564,7564,7564,7564,7564,7564,50361fc8-8fba-1c45-e054-00144ff88e88,brisdelle contains a lower dose of paroxetine than that used to treat depression  obsessive compulsive disorder  panic disorder  generalized anxiety disorder  social anxiety disorder  and post traumatic stress disorder,0
6239,6239,6239,6239,6239,6239,6239,7565,7565,7565,7565,7565,7565,7565,7565,7565,7565,7565,7565,7565,50361fc8-8fba-1c45-e054-00144ff88e88,the safety and efficacy of this lower dose of paroxetine in brisdelle have not been established for any psychiatric condition,0
6240,6240,6240,6240,6240,6240,6240,7566,7566,7566,7566,7566,7566,7566,7566,7566,7566,7566,7566,7566,50361fc8-8fba-1c45-e054-00144ff88e88,patients who require paroxetine for treatment of a psychiatric condition should discontinue brisdelle and initiate a paroxetine containing medication that is indicated for such use,0
6241,6241,6241,6241,6241,6241,6241,7567,7567,7567,7567,7567,7567,7567,7567,7567,7567,7567,7567,7567,50361fc8-8fba-1c45-e054-00144ff88e88,brisdelle is a selective serotonin reuptake inhibitor ( ssri ) indicated for the treatment of moderate to severe vasomotor symptoms associated with menopause ( vms ) ( 1 ) limitation of use brisdelle is not indicated for the treatment of any psychiatric condition ( 1 ),1
6242,6242,6242,6242,6242,6242,6242,7568,7568,7568,7568,7568,7568,7568,7568,7568,7568,7568,7568,7568,4e2b687e-47f2-4f3c-80ab-e3224befffca, proleukin ( aldesleukin ) is indicated for the treatment of adults with metastatic renal cell carcinoma ( metastatic rcc ),1
6243,6243,6243,6243,6243,6243,6243,7569,7569,7569,7569,7569,7569,7569,7569,7569,7569,7569,7569,7569,4e2b687e-47f2-4f3c-80ab-e3224befffca,proleukin is indicated for the treatment of adults with metastatic melanoma,1
6244,6244,6244,6244,6244,6244,6244,7570,7570,7570,7570,7570,7570,7570,7570,7570,7570,7570,7570,7570,4e2b687e-47f2-4f3c-80ab-e3224befffca,careful patient selection is mandatory prior to the administration of proleukin,0
6245,6245,6245,6245,6245,6245,6245,7571,7571,7571,7571,7571,7571,7571,7571,7571,7571,7571,7571,7571,4e2b687e-47f2-4f3c-80ab-e3224befffca,see contraindications  warnings and precautions sections regarding patient screening  including recommended cardiac and pulmonary function tests and laboratory tests,0
6246,6246,6246,6246,6246,6246,6246,7572,7572,7572,7572,7572,7572,7572,7572,7572,7572,7572,7572,7572,4e2b687e-47f2-4f3c-80ab-e3224befffca,evaluation of clinical studies to date reveals that patients with more favorable ecog performance status ( ecog ps 0 ) at treatment initiation respond better to proleukin  with a higher response rate and lower toxicity ( see clinical pharmacology section  clinical studies section and adverse reactions section ),0
6247,6247,6247,6247,6247,6247,6247,7573,7573,7573,7573,7573,7573,7573,7573,7573,7573,7573,7573,7573,4e2b687e-47f2-4f3c-80ab-e3224befffca,therefore  selection of patients for treatment should include assessment of performance status,0
6248,6248,6248,6248,6248,6248,6248,7574,7574,7574,7574,7574,7574,7574,7574,7574,7574,7574,7574,7574,4e2b687e-47f2-4f3c-80ab-e3224befffca,experience in patients with ecog ps 1 is extremely limited,0
6249,6249,6249,6249,6249,6249,6249,7575,7575,7575,7575,7575,7575,7575,7575,7575,7575,7575,7575,7575,fa68b35e-9f50-408b-9e70-e84cecf3fd6e, in patients without structural heart disease  flecainide is indicated for the prevention of paroxysmal supraventricular tachycardias ( psvt )  including atrioventricular nodal reentrant tachycardia  atrioventricular reentrant tachycardia and other supraventricular tachycardias of unspecified mechanism associated with disabling symptoms paroxysmal atrial fibrillation flutter ( paf ) associated with disabling symptoms flecainide is also indicated for the prevention of documented ventricular arrhythmias  such as sustained ventricular tachycardia ( sustained vt )  that in the judgment of the physician are life threatening,1
6250,6250,6250,6250,6250,6250,6250,7576,7576,7576,7576,7576,7576,7576,7576,7576,7576,7576,7576,7576,fa68b35e-9f50-408b-9e70-e84cecf3fd6e,use of flecainide for the treatment of sustained vt  like other antiarrhythmics  should be initiated in the hospital,4
6251,6251,6251,6251,6251,6251,6251,7577,7577,7577,7577,7577,7577,7577,7577,7577,7577,7577,7577,7577,fa68b35e-9f50-408b-9e70-e84cecf3fd6e,the use of flecainide is not recommended in patients with less severe ventricular arrhythmias even if the patients are symptomatic,2
6252,6252,6252,6252,6252,6252,6252,7578,7578,7578,7578,7578,7578,7578,7578,7578,7578,7578,7578,7578,fa68b35e-9f50-408b-9e70-e84cecf3fd6e,because of the proarrhythmic effects of flecainide  its use should be reserved for patients in whom  in the opinion of the physician  the benefits of treatment outweigh the risks,4
6253,6253,6253,6253,6253,6253,6253,7579,7579,7579,7579,7579,7579,7579,7579,7579,7579,7579,7579,7579,fa68b35e-9f50-408b-9e70-e84cecf3fd6e,flecainide should not be used in patients with recent myocardial infarction,2
6254,6254,6254,6254,6254,6254,6254,7580,7580,7580,7580,7580,7580,7580,7580,7580,7580,7580,7580,7580,fa68b35e-9f50-408b-9e70-e84cecf3fd6e,use of flecainide in chronic atrial fibrillation has not been adequately studied and is not recommended,2
6255,6255,6255,6255,6255,6255,6255,7581,7581,7581,7581,7581,7581,7581,7581,7581,7581,7581,7581,7581,fa68b35e-9f50-408b-9e70-e84cecf3fd6e,as is the case for other antiarrhythmic agents  there is no evidence from controlled trials that the use of flecainide favorably affects survival or the incidence of sudden death,0
6256,6256,6256,6256,6256,6256,6256,7582,7582,7582,7582,7582,7582,7582,7582,7582,7582,7582,7582,7582,8123cce8-42e3-49e4-a488-3bb836ecccd0, potassium acetate injection  usp  40 meq is indicated as a source of potassium  for the addition to large volume intravenous fluids  to prevent or correct hypokalemia in patients with restricted or no oral intake,1
6257,6257,6257,6257,6257,6257,6257,7584,7584,7584,7584,7584,7584,7584,7584,7584,7584,7584,7584,7584,77785ce3-e8df-4ca1-8f8e-6c418c6a17de,1  chronic lymphocytic leukemia ( cll ) arzerra ( ofatumumab ) is indicated in combination with chlorambucil  for the treatment of previously untreated patients with cll for whom fludarabine based therapy is considered inappropriate see clinical studies ( 14 1 ) in combination with fludarabine and cyclophosphamide for the treatment of patients with relapsed cll see clinical studies ( 14 2 ) for extended treatment of patients who are in complete or partial response after at least two lines of therapy for recurrent or progressive cll see clinical studies ( 14 3 ) for the treatment of patients with cll refractory to fludarabine and alemtuzumab see clinical studies ( 14 4 ) arzerra ( ofatumumab ) is a cd20 directed cytolytic monoclonal antibody indicated for the treatment of chronic lymphocytic leukemia ( cll ) ( 1 ) in combination with chlorambucil  for the treatment of previously untreated patients with cll for whom fludarabine based therapy is considered inappropriate,1
6258,6258,6258,6258,6258,6258,6258,7585,7585,7585,7585,7585,7585,7585,7585,7585,7585,7585,7585,7585,77785ce3-e8df-4ca1-8f8e-6c418c6a17de,in combination with fludarabine and cyclophosphamide for the treatment of patients with relapsed cll,4
6259,6259,6259,6259,6259,6259,6259,7586,7586,7586,7586,7586,7586,7586,7586,7586,7586,7586,7586,7586,77785ce3-e8df-4ca1-8f8e-6c418c6a17de,for extended treatment of patients who are in complete or partial response after at least two lines of therapy for recurrent or progressive cll,1
6260,6260,6260,6260,6260,6260,6260,7587,7587,7587,7587,7587,7587,7587,7587,7587,7587,7587,7587,7587,77785ce3-e8df-4ca1-8f8e-6c418c6a17de,for the treatment of patients with cll refractory to fludarabine and alemtuzumab,1
6261,6261,6261,6261,6261,6261,6261,7588,7588,7588,7588,7588,7588,7588,7588,7588,7588,7588,7588,7588,fac0c875-111e-4af2-d186-ed4d4ee9de59, therapeutic pipracil is indicated for the treatment of serious infections caused by susceptible strains of the designated microorganisms in the conditions listed below intra abdominal infections including hepatobiliary and surgical infections caused by e coli  pseudomonas aeruginosa  enterococci  clostridium spp  anaerobic cocci  or bacteroides spp  including b fragilis,1
6262,6262,6262,6262,6262,6262,6262,7589,7589,7589,7589,7589,7589,7589,7589,7589,7589,7589,7589,7589,fac0c875-111e-4af2-d186-ed4d4ee9de59,urinary tract infections caused by e coli  klebsiella spp  p aeruginosa  proteus spp  including p mirabilis  or enterococci,1
6263,6263,6263,6263,6263,6263,6263,7590,7590,7590,7590,7590,7590,7590,7590,7590,7590,7590,7590,7590,fac0c875-111e-4af2-d186-ed4d4ee9de59,gynecologic infections including endometritis  pelvic inflammatory disease  pelvic cellulitis caused by bacteroides spp  including b fragilis  anaerobic cocci  neisseria gonorrhoeae  or enterococci ( e faecalis ),1
6264,6264,6264,6264,6264,6264,6264,7591,7591,7591,7591,7591,7591,7591,7591,7591,7591,7591,7591,7591,fac0c875-111e-4af2-d186-ed4d4ee9de59,septicemia including bacteremia caused by e coli  klebsiella spp  enterobacter spp  serratia spp  p mirabilis  s pneumoniae  enterococci  p aeruginosa  bacteroides spp  or anaerobic cocci,1
6265,6265,6265,6265,6265,6265,6265,7592,7592,7592,7592,7592,7592,7592,7592,7592,7592,7592,7592,7592,fac0c875-111e-4af2-d186-ed4d4ee9de59,lower respiratorytract infections caused by e coli  klebsiella spp  enterobacter spp  p aeruginosa  serratia spp  h influenzae  bacteroides spp  or anaerobic cocci,1
6266,6266,6266,6266,6266,6266,6266,7593,7593,7593,7593,7593,7593,7593,7593,7593,7593,7593,7593,7593,fac0c875-111e-4af2-d186-ed4d4ee9de59,although improvement has been noted in patients with cystic fibrosis  lasting bacterial eradication may not necessarily be achieved,0
6267,6267,6267,6267,6267,6267,6267,7594,7594,7594,7594,7594,7594,7594,7594,7594,7594,7594,7594,7594,fac0c875-111e-4af2-d186-ed4d4ee9de59,skin and skin structure infections caused by e coli  klebsiella spp  serratia spp  acinetobacter spp  enterobacter spp  p aeruginosa  morganella morganii  providencia rettgeri  proteus vulgaris  p mirabilis  bacteroides spp  including b fragilis  anaerobic cocci  or enterococci,1
6268,6268,6268,6268,6268,6268,6268,7595,7595,7595,7595,7595,7595,7595,7595,7595,7595,7595,7595,7595,6e780825-2a66-41fd-a04c-78fa7c4df05e, for the relief of symptoms of depression,1
6269,6269,6269,6269,6269,6269,6269,7597,7597,7597,7597,7597,7597,7597,7597,7597,7597,7597,7597,7597,6e780825-2a66-41fd-a04c-78fa7c4df05e,one to three weeks of treatment may be needed before optimal therapeutic effects are evident,4
6270,6270,6270,6270,6270,6270,6270,7598,7598,7598,7598,7598,7598,7598,7598,7598,7598,7598,7598,7598,46f30ac5-c96b-429e-976d-8c5ee1c0761b,1  selzentry is indicated in combination with other antiretroviral agents for the treatment of only ccr5 tropic human immunodeficiency virus type 1 ( hiv 1 ) infection in patients 2 years of age and older weighing at least 10 kg,1
6271,6271,6271,6271,6271,6271,6271,7599,7599,7599,7599,7599,7599,7599,7599,7599,7599,7599,7599,7599,46f30ac5-c96b-429e-976d-8c5ee1c0761b,limitations of use selzentry is not recommended in patients with dual mixed or cxcr4 tropic hiv 1 see microbiology ( 12 4 ),2
6272,6272,6272,6272,6272,6272,6272,7600,7600,7600,7600,7600,7600,7600,7600,7600,7600,7600,7600,7600,46f30ac5-c96b-429e-976d-8c5ee1c0761b,selzentry is a ccr5 co receptor antagonist indicated in combination with other antiretroviral agents for the treatment of only ccr5 tropic hiv 1 infection in patients 2 years of age and older weighing at least 10 kg,1
6273,6273,6273,6273,6273,6273,6273,7601,7601,7601,7601,7601,7601,7601,7601,7601,7601,7601,7601,7601,46f30ac5-c96b-429e-976d-8c5ee1c0761b,( 1 ) limitations of use not recommended in patients with dual mixed or cxcr4 tropic hiv 1,2
6274,6274,6274,6274,6274,6274,6274,7602,7602,7602,7602,7602,7602,7602,7602,7602,7602,7602,7602,7602,824f19c9-0546-4a8a-8d8f-c4055c04f7c7,1  stivarga is a kinase inhibitor indicated for the treatment of patients with metastatic colorectal cancer ( crc ) who have been previously treated with fluoropyrimidine  oxaliplatin and irinotecan based chemotherapy  an anti vegf therapy  and  if ras wild type  an anti egfr therapy,1
6275,6275,6275,6275,6275,6275,6275,7603,7603,7603,7603,7603,7603,7603,7603,7603,7603,7603,7603,7603,824f19c9-0546-4a8a-8d8f-c4055c04f7c7,( 1 1 ) locally advanced  unresectable or metastatic gastrointestinal stromal tumor ( gist ) who have been previously treated with imatinib mesylate and sunitinib malate,1
6276,6276,6276,6276,6276,6276,6276,7604,7604,7604,7604,7604,7604,7604,7604,7604,7604,7604,7604,7604,824f19c9-0546-4a8a-8d8f-c4055c04f7c7,( 1 2 ) hepatocellular carcinoma ( hcc ) who have been previously treated with sorafenib ( 1 3 ) 1 1 colorectal cancer stivarga is indicated for the treatment of patients with metastatic colorectal cancer ( crc ) who have been previously treated with fluoropyrimidine  oxaliplatin and irinotecan based chemotherapy  an anti vegf therapy  and  if ras wild type  an anti egfr therapy,1
6277,6277,6277,6277,6277,6277,6277,7605,7605,7605,7605,7605,7605,7605,7605,7605,7605,7605,7605,7605,824f19c9-0546-4a8a-8d8f-c4055c04f7c7,1 2 gastrointestinal stromal tumors stivarga is indicated for the treatment of patients with locally advanced  unresectable or metastatic gastrointestinal stromal tumor ( gist ) who have been previously treated with imatinib mesylate and sunitinib malate,1
6278,6278,6278,6278,6278,6278,6278,7606,7606,7606,7606,7606,7606,7606,7606,7606,7606,7606,7606,7606,824f19c9-0546-4a8a-8d8f-c4055c04f7c7,1 3 hepatocellular carcinoma stivarga is indicated for the treatment of patients with hepatocellular carcinoma ( hcc ) who have been previously treated with sorafenib,1
6279,6279,6279,6279,6279,6279,6279,7607,7607,7607,7607,7607,7607,7607,7607,7607,7607,7607,7607,7607,ce512844-5220-4661-809f-56d088699c9c,1 indications usage montelukast sodium chewable tablet is a leukotriene receptor antagonist indicated for prophylaxis and chronic treatment of asthma in patients 2 years of age and older ( 1 1 ),1
6280,6280,6280,6280,6280,6280,6280,7608,7608,7608,7608,7608,7608,7608,7608,7608,7608,7608,7608,7608,ce512844-5220-4661-809f-56d088699c9c,acute prevention of exercise induced bronchoconstriction ( eib ) in patients 6 years of age and older ( 1 2 ),1
6281,6281,6281,6281,6281,6281,6281,7609,7609,7609,7609,7609,7609,7609,7609,7609,7609,7609,7609,7609,ce512844-5220-4661-809f-56d088699c9c,relief of symptoms of allergic rhinitis ( ar ) seasonal allergic rhinitis ( sar ) in patients 2 years of age and older and perennial allergic rhinitis ( par ) in patients 2 years of age and older ( 1 3 ),1
6282,6282,6282,6282,6282,6282,6282,7610,7610,7610,7610,7610,7610,7610,7610,7610,7610,7610,7610,7610,ce512844-5220-4661-809f-56d088699c9c,1 1 asthma montelukast sodium chewable tablet is indicated for the prophylaxis and chronic treatment of asthma in adults and pediatric patients 2 years of age and older,1
6283,6283,6283,6283,6283,6283,6283,7611,7611,7611,7611,7611,7611,7611,7611,7611,7611,7611,7611,7611,ce512844-5220-4661-809f-56d088699c9c,1 2 exercise induced bronchoconstriction ( eib ) montelukast sodium chewable tablet is indicated for prevention of exercise induced bronchoconstriction ( eib ) in patients 6 years of age and older,1
6284,6284,6284,6284,6284,6284,6284,7612,7612,7612,7612,7612,7612,7612,7612,7612,7612,7612,7612,7612,ce512844-5220-4661-809f-56d088699c9c,1 3 allergic rhinitis montelukast sodium chewable tablet is indicated for the relief of symptoms of seasonal allergic rhinitis in patients 2 years of age and older and perennial allergic rhinitis in patients 2 years of age and older,1
6285,6285,6285,6285,6285,6285,6285,7613,7613,7613,7613,7613,7613,7613,7613,7613,7613,7613,7613,7613,63bad97b-3df6-4e8f-b183-95f1e9801c8f,1  galantamine is a cholinesterase inhibitor indicated for the treatment of mild to moderate dementia of the alzheimer 's type ( 1 ),1
6286,6286,6286,6286,6286,6286,6286,7614,7614,7614,7614,7614,7614,7614,7614,7614,7614,7614,7614,7614,63bad97b-3df6-4e8f-b183-95f1e9801c8f,galantamine tablets  usp are indicated for the treatment of mild to moderate dementia of the alzheimer 's type,1
6287,6287,6287,6287,6287,6287,6287,7615,7615,7615,7615,7615,7615,7615,7615,7615,7615,7615,7615,7615,db23a56f-1e41-4843-9220-1b2e3059db41, 4 citanest plain dental injection is indicated for the production of local anesthesia in dentistry by nerve block or infiltration techniques,1
6288,6288,6288,6288,6288,6288,6288,7617,7617,7617,7617,7617,7617,7617,7617,7617,7617,7617,7617,7617,e6f3e718-bb99-48f1-ab94-b9f0af05fed6,1  steglatro is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus,1
6289,6289,6289,6289,6289,6289,6289,7618,7618,7618,7618,7618,7618,7618,7618,7618,7618,7618,7618,7618,e6f3e718-bb99-48f1-ab94-b9f0af05fed6,steglatro is a sodium glucose co transporter 2 ( sglt2 ) inhibitor indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus,1
6290,6290,6290,6290,6290,6290,6290,7620,7620,7620,7620,7620,7620,7620,7620,7620,7620,7620,7620,7620,e6f3e718-bb99-48f1-ab94-b9f0af05fed6,( 1 ) limitations of use steglatro is not recommended in patients with type 1 diabetes mellitus or for the treatment of diabetic ketoacidosis,2
6291,6291,6291,6291,6291,6291,6291,7621,7621,7621,7621,7621,7621,7621,7621,7621,7621,7621,7621,7621,c2c553d8-5a9d-4366-bf53-8bdb5a876d19,1  steglujan is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both ertugliflozin and sitagliptin is appropriate,1
6292,6292,6292,6292,6292,6292,6292,7622,7622,7622,7622,7622,7622,7622,7622,7622,7622,7622,7622,7622,c2c553d8-5a9d-4366-bf53-8bdb5a876d19,steglujan is a combination of ertugliflozin  a sodium glucose co transporter 2 ( sglt2 ) inhibitor  and sitagliptin  a dipeptidyl peptidase 4 ( dpp 4 ) inhibitor  indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both ertugliflozin and sitagliptin is appropriate,1
6293,6293,6293,6293,6293,6293,6293,7625,7625,7625,7625,7625,7625,7625,7625,7625,7625,7625,7625,7625,c2c553d8-5a9d-4366-bf53-8bdb5a876d19,( 1  5 1 ) limitations of use steglujan is not recommended in patients with type 1 diabetes mellitus or for the treatment of diabetic ketoacidosis,2
6294,6294,6294,6294,6294,6294,6294,7626,7626,7626,7626,7626,7626,7626,7626,7626,7626,7626,7626,7626,c2c553d8-5a9d-4366-bf53-8bdb5a876d19,steglujan has not been studied in patients with a history of pancreatitis,0
6295,6295,6295,6295,6295,6295,6295,7627,7627,7627,7627,7627,7627,7627,7627,7627,7627,7627,7627,7627,c2c553d8-5a9d-4366-bf53-8bdb5a876d19,it is unknown whether patients with a history of pancreatitis are at increased risk for the development of pancreatitis while using steglujan,0
6296,6296,6296,6296,6296,6296,6296,7628,7628,7628,7628,7628,7628,7628,7628,7628,7628,7628,7628,7628,c2c553d8-5a9d-4366-bf53-8bdb5a876d19,see warnings and precautions ( 5 1 ),0
6297,6297,6297,6297,6297,6297,6297,7629,7629,7629,7629,7629,7629,7629,7629,7629,7629,7629,7629,7629,c41eb913-5e47-46c4-9d96-9a67f8380919, clonidine transdermal system is indicated in the treatment of hypertension,1
6298,6298,6298,6298,6298,6298,6298,7630,7630,7630,7630,7630,7630,7630,7630,7630,7630,7630,7630,7630,c41eb913-5e47-46c4-9d96-9a67f8380919,it may be employed alone or concomitantly with other antihypertensive agents,4
6299,6299,6299,6299,6299,6299,6299,7631,7631,7631,7631,7631,7631,7631,7631,7631,7631,7631,7631,7631,c9160db8-cf00-47b5-9a4e-e435b8637f00,indications indication chlorhexidine gluconate oral rinse is indicated for use between dental visits as part of a professional program for the treatment of gingivitis as characterized by redness and swelling of the gingivae  including gingival bleeding upon probing,1
6300,6300,6300,6300,6300,6300,6300,7632,7632,7632,7632,7632,7632,7632,7632,7632,7632,7632,7632,7632,c9160db8-cf00-47b5-9a4e-e435b8637f00,chlorhexidine gluconate oral rinse has not been tested among patients with acute necrotizing ulcerative gingivitis ( anug ),0
6301,6301,6301,6301,6301,6301,6301,7633,7633,7633,7633,7633,7633,7633,7633,7633,7633,7633,7633,7633,c9160db8-cf00-47b5-9a4e-e435b8637f00,for patients having coexisting gingivitis and periodontitis see precautions,1
6302,6302,6302,6302,6302,6302,6302,7634,7634,7634,7634,7634,7634,7634,7634,7634,7634,7634,7634,7634,b2b3be70-17d8-4093-896c-f1c54a2cf242,1  netspot  after radiolabeling with ga 68  is indicated for use with positron emission tomography ( pet ) for localization of somatostatin receptor positive neuroendocrine tumors ( nets ) in adult and pediatric patients,1
6303,6303,6303,6303,6303,6303,6303,7635,7635,7635,7635,7635,7635,7635,7635,7635,7635,7635,7635,7635,b2b3be70-17d8-4093-896c-f1c54a2cf242,netspot  after radiolabeling with ga 68  is a radioactive diagnostic agent indicated for use with positron emission tomography ( pet ) for localization of somatostatin receptor positive neuroendocrine tumors ( nets ) in adult and pediatric patients,1
6304,6304,6304,6304,6304,6304,6304,7636,7636,7636,7636,7636,7636,7636,7636,7636,7636,7636,7636,7636,dac9637f-3326-4f25-b7b9-f9f54b738232, ergomar is indicated as therapy to abort or prevent vascular headache  e g  migraine  migraine variants or a so called histaminic cephalalgia,1
6305,6305,6305,6305,6305,6305,6305,7637,7637,7637,7637,7637,7637,7637,7637,7637,7637,7637,7637,7637,0602c22a-67b7-4708-bdbb-28a69d52d616,1  mometasone furoate monohydrate nasal spray is a corticosteroid indicated for treatment of nasal symptoms of allergic rhinitis in patients 2 years of age ( 1 1 ) treatment of nasal congestion associated with seasonal allergic rhinitis in patients 2 years of age ( 1 2 ) prophylaxis of seasonal allergic rhinitis in patients 12 years of age ( 1 3 ) treatment of nasal polyps in patients 18 years of age ( 1 4 ) 1 1 treatment of allergic rhinitis mometasone furoate monohydrate nasal spray 50 mcg is indicated for the treatment of the nasal symptoms of seasonal allergic and perennial allergic rhinitis  in adults and pediatric patients 2 years of age and older,1
6306,6306,6306,6306,6306,6306,6306,7638,7638,7638,7638,7638,7638,7638,7638,7638,7638,7638,7638,7638,0602c22a-67b7-4708-bdbb-28a69d52d616,1 2 treatment of nasal congestion associated with seasonal allergic rhinitis mometasone furoate monohydrate nasal spray 50 mcg is indicated for the relief of nasal congestion associated with seasonal allergic rhinitis  in adults and pediatric patients 2 years of age and older,1
6307,6307,6307,6307,6307,6307,6307,7639,7639,7639,7639,7639,7639,7639,7639,7639,7639,7639,7639,7639,0602c22a-67b7-4708-bdbb-28a69d52d616,1 3 prophylaxis of seasonal allergic rhinitis mometasone furoate monohydrate nasal spray 50 mcg is indicated for the prophylaxis of the nasal symptoms of seasonal allergic rhinitis in adult and adolescent patients 12 years and older,1
6308,6308,6308,6308,6308,6308,6308,7640,7640,7640,7640,7640,7640,7640,7640,7640,7640,7640,7640,7640,0602c22a-67b7-4708-bdbb-28a69d52d616,1 4 treatment of nasal polyps mometasone furoate monohydrate nasal spray 50 mcg is indicated for the treatment of nasal polyps in patients 18 years of age and older,1
6309,6309,6309,6309,6309,6309,6309,7641,7641,7641,7641,7641,7641,7641,7641,7641,7641,7641,7641,7641,1fbeb566-918d-4bf4-a08a-ef90ce4fd573,1  1 1 hevert arnica is a homeopathic drug indicated for the treatment of muscle pain and stiffness  bruising and swelling due to injuries and overexertion,1
6310,6310,6310,6310,6310,6310,6310,7642,7642,7642,7642,7642,7642,7642,7642,7642,7642,7642,7642,7642,8f549d95-985b-f783-1ebb-ef57bd2ecb05,1  fentora is indicated for the management of breakthrough pain in cancer patients 18 years of age and older who are already receiving and who are tolerant to around the clock opioid therapy for their underlying persistent cancer pain,1
6311,6311,6311,6311,6311,6311,6311,7643,7643,7643,7643,7643,7643,7643,7643,7643,7643,7643,7643,7643,8f549d95-985b-f783-1ebb-ef57bd2ecb05,patients considered opioid tolerant are those who are taking around the clock medicine consisting of at least 60 mg of oral morphine per day  at least 25 mcg per hour of transdermal fentanyl  at least 30 mg of oral oxycodone per day  at least 8 mg of oral hydromorphone per day  at least 25 mg oral oxymorphone per day  at least 60 mg of oral hydrocodone per day  or an equianalgesic dose of another opioid daily for a week or longer,0
6312,6312,6312,6312,6312,6312,6312,7644,7644,7644,7644,7644,7644,7644,7644,7644,7644,7644,7644,7644,8f549d95-985b-f783-1ebb-ef57bd2ecb05,patients must remain on around the clock opioids while taking fentora,0
6313,6313,6313,6313,6313,6313,6313,7645,7645,7645,7645,7645,7645,7645,7645,7645,7645,7645,7645,7645,8f549d95-985b-f783-1ebb-ef57bd2ecb05,limitations of use not for use in opioid non tolerant patients,0
6314,6314,6314,6314,6314,6314,6314,7646,7646,7646,7646,7646,7646,7646,7646,7646,7646,7646,7646,7646,8f549d95-985b-f783-1ebb-ef57bd2ecb05,not for use in the management of acute or postoperative pain  including headache migraine  and dental pain see contraindications ( 4 ),2
6315,6315,6315,6315,6315,6315,6315,7647,7647,7647,7647,7647,7647,7647,7647,7647,7647,7647,7647,7647,8f549d95-985b-f783-1ebb-ef57bd2ecb05,as a part of the tirf rems access program  fentora may be dispensed only to outpatients enrolled in the program see warnings and precautions ( 5 7 ),u
6316,6316,6316,6316,6316,6316,6316,7648,7648,7648,7648,7648,7648,7648,7648,7648,7648,7648,7648,7648,8f549d95-985b-f783-1ebb-ef57bd2ecb05,for inpatient administration of fentora ( e g  hospitals  hospices  and long term care facilities that prescribe for inpatient use )  patient and prescriber enrollment is not required,0
6317,6317,6317,6317,6317,6317,6317,7649,7649,7649,7649,7649,7649,7649,7649,7649,7649,7649,7649,7649,8f549d95-985b-f783-1ebb-ef57bd2ecb05,fentora is an opioid agonist indicated for the management of breakthrough pain in cancer patients 18 years of age and older who are already receiving and who are tolerant to around the clock opioid therapy for their underlying persistent cancer pain,1
6318,6318,6318,6318,6318,6318,6318,7650,7650,7650,7650,7650,7650,7650,7650,7650,7650,7650,7650,7650,8f549d95-985b-f783-1ebb-ef57bd2ecb05,( 1 ) patients considered opioid tolerant are those who are taking  for one week or longer  around the clock medicine consisting of at least 60 mg of oral morphine per day  at least 25 mcg per hour of transdermal fentanyl  at least 30 mg of oral oxycodone per day  at least 8 mg of oral hydromorphone per day  at least 25 mg oral oxymorphone per day  at least 60 mg of oral hydrocodone per day  or an equianalgesic dose of another opioid daily for a week or longer,0
6319,6319,6319,6319,6319,6319,6319,7653,7653,7653,7653,7653,7653,7653,7653,7653,7653,7653,7653,7653,8f549d95-985b-f783-1ebb-ef57bd2ecb05,not for use in the management of acute or postoperative pain  including headache migraine  or dental pain,2
6320,6320,6320,6320,6320,6320,6320,7654,7654,7654,7654,7654,7654,7654,7654,7654,7654,7654,7654,7654,8f549d95-985b-f783-1ebb-ef57bd2ecb05,as a part of the tirf rems access program  fentora may be dispensed only to patients enrolled in the tirf rems access program,0
6321,6321,6321,6321,6321,6321,6321,7656,7656,7656,7656,7656,7656,7656,7656,7656,7656,7656,7656,7656,aaaf3bea-1b21-4edf-9300-b7159ea9ede8,1  myrbetriq is a beta 3 adrenergic agonist indicated for the treatment of overactive bladder ( oab ) with symptoms of urge urinary incontinence  urgency  and urinary frequency,1
6322,6322,6322,6322,6322,6322,6322,7657,7657,7657,7657,7657,7657,7657,7657,7657,7657,7657,7657,7657,aaaf3bea-1b21-4edf-9300-b7159ea9ede8,myrbetriq is a beta 3 adrenergic agonist indicated for the treatment of overactive bladder ( oab ) with symptoms of urge urinary incontinence  urgency  and urinary frequency ( 1 ),1
6323,6323,6323,6323,6323,6323,6323,7658,7658,7658,7658,7658,7658,7658,7658,7658,7658,7658,7658,7658,eee62a16-5d68-4639-8aec-63189f3afe60, naphazoline hydrochloride ophthalmic solution is indicated for use as a topical ocular vasoconstrictor,1
6324,6324,6324,6324,6324,6324,6324,7659,7659,7659,7659,7659,7659,7659,7659,7659,7659,7659,7659,7659,"Active Ingredient UNII(s)
N00W22YO2B    f073b58e-56d6-4c8d-a2ce-b37719402d77
N00W22YO2B    f073b58e-56d6-4c8d-a2ce-b37719402d77
Name: SET ID dtype: object",active ingredient unii ( s ) n00w22yo2b active ingredient unii ( s ) n00w22yo2b active in n00w22yo2b active ingredient unii ( s ) n00w22yo2b active in name content xml  dtype object,0
6325,6325,6325,6325,6325,6325,6325,7661,7661,7661,7661,7661,7661,7661,7661,7661,7661,7661,7661,7661,6f5ede6f-b0b7-4fc8-969e-652f60ead047,1  neoprofen is indicated to close a clinically significant patent ductus arteriosus ( pda ) in premature infants weighing between 500 and 1500 g  who are no more than 32 weeks gestational age when usual medical management ( e g  fluid restriction  diuretics  respiratory support  etc ),1
6326,6326,6326,6326,6326,6326,6326,7662,7662,7662,7662,7662,7662,7662,7662,7662,7662,7662,7662,7662,6f5ede6f-b0b7-4fc8-969e-652f60ead047,the clinical trial was conducted among infants with an asymptomatic pda,0
6327,6327,6327,6327,6327,6327,6327,7663,7663,7663,7663,7663,7663,7663,7663,7663,7663,7663,7663,7663,6f5ede6f-b0b7-4fc8-969e-652f60ead047,however  the consequences beyond 8 weeks after treatment have not been evaluated therefore  treatment should be reserved for infants with clear evidence of a clinically significant pda,0
6328,6328,6328,6328,6328,6328,6328,7664,7664,7664,7664,7664,7664,7664,7664,7664,7664,7664,7664,7664,6f5ede6f-b0b7-4fc8-969e-652f60ead047,neoprofen is a nonsteroidal anti inflammatory drug indicated to close a clinically significant patent ductus arteriosus ( pda ) in premature infants weighing between 500 and 1500 g  who are no more than 32 weeks gestational age when usual medical management is ineffective,1
6329,6329,6329,6329,6329,6329,6329,7667,7667,7667,7667,7667,7667,7667,7667,7667,7667,7667,7667,7667,57165763-29dc-4812-b840-a8a5086416f3, for mydriasis and cycloplegia for diagnostic procedures,1
6330,6330,6330,6330,6330,6330,6330,7668,7668,7668,7668,7668,7668,7668,7668,7668,7668,7668,7668,7668,09beda19-56d6-4a56-afdc-9a77b70b2ef3,1  linzess is indicated in adults for the treatment of irritable bowel syndrome with constipation ( ibs c ) chronic idiopathic constipation ( cic ),1
6331,6331,6331,6331,6331,6331,6331,7669,7669,7669,7669,7669,7669,7669,7669,7669,7669,7669,7669,7669,09beda19-56d6-4a56-afdc-9a77b70b2ef3,linzess is a guanylate cyclase c agonist indicated in adults for treatment of irritable bowel syndrome with constipation,1
6332,6332,6332,6332,6332,6332,6332,7670,7670,7670,7670,7670,7670,7670,7670,7670,7670,7670,7670,7670,09beda19-56d6-4a56-afdc-9a77b70b2ef3,( ibs c ) ( 1 ) chronic idiopathic constipation,1
6333,6333,6333,6333,6333,6333,6333,7671,7671,7671,7671,7671,7671,7671,7671,7671,7671,7671,7671,7671,caa9928e-8cee-408c-ac72-bd6ce1390a70, to reduce the development of drug resistant bacteria and maintain the effectiveness of doxycycline tablets and other antibacterial drugs  doxycycline tablets should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria,1
6334,6334,6334,6334,6334,6334,6334,7674,7674,7674,7674,7674,7674,7674,7674,7674,7674,7674,7674,7674,caa9928e-8cee-408c-ac72-bd6ce1390a70,doxycycline is indicated for the treatment of the following infections rocky mountain spotted fever  typhus fever and the typhus group  q fever  rickettsialpox  and tick fevers caused by rickettsiae,1
6335,6335,6335,6335,6335,6335,6335,7677,7677,7677,7677,7677,7677,7677,7677,7677,7677,7677,7677,7677,caa9928e-8cee-408c-ac72-bd6ce1390a70,psittacosis ( ornithosis ) caused by chlamydia psittaci,1
6336,6336,6336,6336,6336,6336,6336,7678,7678,7678,7678,7678,7678,7678,7678,7678,7678,7678,7678,7678,caa9928e-8cee-408c-ac72-bd6ce1390a70,trachoma caused by chlamydia trachomatis  although the infectious agent is not always eliminated as judged by immunofluorescence,1
6337,6337,6337,6337,6337,6337,6337,7680,7680,7680,7680,7680,7680,7680,7680,7680,7680,7680,7680,7680,caa9928e-8cee-408c-ac72-bd6ce1390a70,uncomplicated urethral  endocervical or rectal infections in adults caused by chlamydia trachomatis,1
6338,6338,6338,6338,6338,6338,6338,7688,7688,7688,7688,7688,7688,7688,7688,7688,7688,7688,7688,7688,"Active Ingredient UNII(s)
N12000U13O; W9WZN9A0GM    ddd9a47e-7d7c-4d0c-aaa6-32702570f696
N12000U13O; W9WZN9A0GM    ddd9a47e-7d7c-4d0c-aaa6-32702570f696
Name: SET ID dtype: object",active ingredient unii ( s ) n12000u13o w9wzn9a0gm active ingredient unii ( s ) n12000u13o w9wzn9a0 n12000u13o w9wzn9a0gm active ingredient unii ( s ) n12000u13o w9wzn9a0 name content xml  dtype object,0
6339,6339,6339,6339,6339,6339,6339,7690,7690,7690,7690,7690,7690,7690,7690,7690,7690,7690,7690,7690,d11fba31-0a6c-11e3-8ffd-0800200c9a66,1  natpara is a parathyroid hormone indicated as an adjunct to calcium and vitamin d to control hypocalcemia in patients with hypoparathyroidism,1
6340,6340,6340,6340,6340,6340,6340,7691,7691,7691,7691,7691,7691,7691,7691,7691,7691,7691,7691,7691,d11fba31-0a6c-11e3-8ffd-0800200c9a66,limitations of use because of the potential risk of osteosarcoma  natpara is recommended only for patients who cannot be well controlled on calcium supplements and active forms of vitamin d alone see warnings and precautions ( 5 1 ),1
6341,6341,6341,6341,6341,6341,6341,7692,7692,7692,7692,7692,7692,7692,7692,7692,7692,7692,7692,7692,d11fba31-0a6c-11e3-8ffd-0800200c9a66,natpara was not studied in patients with hypoparathyroidism caused by calcium sensing receptor mutations,0
6342,6342,6342,6342,6342,6342,6342,7693,7693,7693,7693,7693,7693,7693,7693,7693,7693,7693,7693,7693,d11fba31-0a6c-11e3-8ffd-0800200c9a66,natpara was not studied in patients with acute post surgical hypoparathyroidism,0
6343,6343,6343,6343,6343,6343,6343,7694,7694,7694,7694,7694,7694,7694,7694,7694,7694,7694,7694,7694,d11fba31-0a6c-11e3-8ffd-0800200c9a66,natpara is a parathyroid hormone indicated as an adjunct to calcium and vitamin d to control hypocalcemia in patients with hypoparathyroidism,1
6344,6344,6344,6344,6344,6344,6344,7695,7695,7695,7695,7695,7695,7695,7695,7695,7695,7695,7695,7695,d11fba31-0a6c-11e3-8ffd-0800200c9a66,( 1 ) limitations of use because of the potential risk of osteosarcoma  natpara is recommended only for patients who cannot be well controlled on calcium supplements and active forms of vitamin d alone,u
6345,6345,6345,6345,6345,6345,6345,7696,7696,7696,7696,7696,7696,7696,7696,7696,7696,7696,7696,7696,d11fba31-0a6c-11e3-8ffd-0800200c9a66,( 5 1 ) natpara was not studied in patients with hypoparathyroidism caused by calcium sensing receptor mutations,0
6346,6346,6346,6346,6346,6346,6346,7698,7698,7698,7698,7698,7698,7698,7698,7698,7698,7698,7698,7698,f2c9b713-aafc-49ca-866e-334d9b5c2e2d, endometriosis danazol capsules are indicated for the treatment of endometriosis amenable to hormonal management,1
6347,6347,6347,6347,6347,6347,6347,7699,7699,7699,7699,7699,7699,7699,7699,7699,7699,7699,7699,7699,f2c9b713-aafc-49ca-866e-334d9b5c2e2d,fibrocystic breast disease most cases of symptomatic fibrocystic breast disease may be treated by simple measures ( e g  padded brassieres and analgesics ),u
6348,6348,6348,6348,6348,6348,6348,7700,7700,7700,7700,7700,7700,7700,7700,7700,7700,7700,7700,7700,f2c9b713-aafc-49ca-866e-334d9b5c2e2d,in infrequent patients  symptoms of pain and tenderness may be severe enough to warrant treatment by suppression of ovarian function,0
6349,6349,6349,6349,6349,6349,6349,7701,7701,7701,7701,7701,7701,7701,7701,7701,7701,7701,7701,7701,f2c9b713-aafc-49ca-866e-334d9b5c2e2d,danazol capsules are usually effective in decreasing nodularity  pain  and tenderness,u
6350,6350,6350,6350,6350,6350,6350,7702,7702,7702,7702,7702,7702,7702,7702,7702,7702,7702,7702,7702,f2c9b713-aafc-49ca-866e-334d9b5c2e2d,it should be stressed to the patient that this treatment is not innocuous in that it involves considerable alterations of hormone levels and that recurrence of symptoms is very common after cessation of therapy,0
6351,6351,6351,6351,6351,6351,6351,7703,7703,7703,7703,7703,7703,7703,7703,7703,7703,7703,7703,7703,f2c9b713-aafc-49ca-866e-334d9b5c2e2d,hereditary angioedema danazol capsules are indicated for the prevention of attacks of angioedema of all types ( cutaneous  abdominal  laryngeal ) in males and females,1
6352,6352,6352,6352,6352,6352,6352,7704,7704,7704,7704,7704,7704,7704,7704,7704,7704,7704,7704,7704,6cb6ca5f-b249-49b0-a9eb-8aa583da7c74,1  optiray is indicated for optiray is a radiographic contrast agent indicated for the following intra arterial procedures ( 1 1 ) adults cerebral arteriography ( 300  320 mg iodine ml ) peripheral arteriography ( 300  320  350 mg iodine ml ) visceral and renal arteriography  aortography ( 320 mg iodine ml ) coronary arteriography and left ventriculography ( 320  350 mg iodine ml ) pediatric patients angiocardiography ( 320  350 mg iodine ml ) intravenous procedures ( 1 2 ) adults computed tomography ( ct ) imaging of head and body ( 300  320  350 mg iodine ml ) venography ( 300  320  350 mg iodine ml ) intravenous excretory urography ( 300  320  350 mg iodine ml ) intravenous digital subtraction angiography ( 350 mg iodine ml ) pediatric patients ct imaging of the head and body  and intravenous excretory urography ( 320mg iodine ml ),1
6353,6353,6353,6353,6353,6353,6353,7705,7705,7705,7705,7705,7705,7705,7705,7705,7705,7705,7705,7705,6cb6ca5f-b249-49b0-a9eb-8aa583da7c74,1 1 intra arterial in adults optiray 300 cerebral arteriography  and peripheral arteriography,1
6354,6354,6354,6354,6354,6354,6354,7706,7706,7706,7706,7706,7706,7706,7706,7706,7706,7706,7706,7706,6cb6ca5f-b249-49b0-a9eb-8aa583da7c74,optiray 320 cerebral arteriography  peripheral arteriography  visceral and renal arteriography  aortography  coronary arteriography  and left ventriculography,1
6355,6355,6355,6355,6355,6355,6355,7707,7707,7707,7707,7707,7707,7707,7707,7707,7707,7707,7707,7707,6cb6ca5f-b249-49b0-a9eb-8aa583da7c74,optiray 350 peripheral arteriography  coronary arteriography  and left ventriculography,1
6356,6356,6356,6356,6356,6356,6356,7708,7708,7708,7708,7708,7708,7708,7708,7708,7708,7708,7708,7708,6cb6ca5f-b249-49b0-a9eb-8aa583da7c74,in pediatric patients optiray 320 and optiray 350 angiocardiography,1
6357,6357,6357,6357,6357,6357,6357,7709,7709,7709,7709,7709,7709,7709,7709,7709,7709,7709,7709,7709,6cb6ca5f-b249-49b0-a9eb-8aa583da7c74,1 2 intra venous in adults optiray 300 ct imaging of the head and body  venography  and intravenous excretory u,1
6358,6358,6358,6358,6358,6358,6358,7710,7710,7710,7710,7710,7710,7710,7710,7710,7710,7710,7710,7710,b118a40d-6b56-cee3-10f6-ded821a97018,1  venclexta is indicated for the treatment of patients with chronic lymphocytic leukemia ( cll ) with 17p deletion  as detected by an fda approved test  who have received at least one prior therapy,1
6359,6359,6359,6359,6359,6359,6359,7713,7713,7713,7713,7713,7713,7713,7713,7713,7713,7713,7713,7713,b118a40d-6b56-cee3-10f6-ded821a97018,venclexta is a bcl 2 inhibitor indicated for the treatment of patients with chronic lymphocytic leukemia ( cll ) with 17p deletion  as detected by an fda approved test  who have received at least one prior therapy,1
6360,6360,6360,6360,6360,6360,6360,7714,7714,7714,7714,7714,7714,7714,7714,7714,7714,7714,7714,7714,b118a40d-6b56-cee3-10f6-ded821a97018,this indication is approved under accelerated approval based on overall response rate,1
6361,6361,6361,6361,6361,6361,6361,7716,7716,7716,7716,7716,7716,7716,7716,7716,7716,7716,7716,7716,0b56f6df-a05d-4520-8bf0-d7cefe20f6ad, amikacin sulfate injection is indicated in the short term treatment of serious infections due to susceptible strains of gram negative bacteria  including pseudomonas species  escherichia coli  species of indole positive and indole negative proteus  providencia species  klebsiella enterobacter serratia species  and acinetobacter ( mima herellea ) species,1
6362,6362,6362,6362,6362,6362,6362,7717,7717,7717,7717,7717,7717,7717,7717,7717,7717,7717,7717,7717,0b56f6df-a05d-4520-8bf0-d7cefe20f6ad,clinical studies have shown amikacin sulfate injection to be effective in bacterial septicemia ( including neonatal sepsis ) in serious infections of the respiratory tract  bones and joints  central nervous system ( including meningitis ) and skin and soft tissue intra abdominal infections ( including peritonitis ) and in burns and post operative infections ( including post vascular surgery ),1
6363,6363,6363,6363,6363,6363,6363,7718,7718,7718,7718,7718,7718,7718,7718,7718,7718,7718,7718,7718,0b56f6df-a05d-4520-8bf0-d7cefe20f6ad,clinical studies have shown amikacin also to be effective in serious complicated and recurrent urinary tract infections due to these organisms,1
6364,6364,6364,6364,6364,6364,6364,7719,7719,7719,7719,7719,7719,7719,7719,7719,7719,7719,7719,7719,0b56f6df-a05d-4520-8bf0-d7cefe20f6ad,aminoglycosides  including amikacin sulfate injection are not indicated in uncomplicated initial episodes of urinary tract infections unless the causative organisms are not susceptible to antibiotics having less potential toxicity,u
6365,6365,6365,6365,6365,6365,6365,7720,7720,7720,7720,7720,7720,7720,7720,7720,7720,7720,7720,7720,0b56f6df-a05d-4520-8bf0-d7cefe20f6ad,bacteriologic studies should be performed to identify causative organisms and their susceptibilities to amikacin,0
6366,6366,6366,6366,6366,6366,6366,7721,7721,7721,7721,7721,7721,7721,7721,7721,7721,7721,7721,7721,0b56f6df-a05d-4520-8bf0-d7cefe20f6ad,amikacin may be considered as initial therapy in suspected gram negative infections and therapy may be instituted before obtaining the results of susceptibility testing,0
6367,6367,6367,6367,6367,6367,6367,7722,7722,7722,7722,7722,7722,7722,7722,7722,7722,7722,7722,7722,0b56f6df-a05d-4520-8bf0-d7cefe20f6ad,clinical trials demonstrated that amikacin was effective in infections caused by gentamicin and or tobramycin resistant strains of gram negative organisms  particularly proteus rettgeri  providencia stuartii  serratia marcescens  and pseudomonas aeruginosa,1
6368,6368,6368,6368,6368,6368,6368,7723,7723,7723,7723,7723,7723,7723,7723,7723,7723,7723,7723,7723,0b56f6df-a05d-4520-8bf0-d7cefe20f6ad,the decision to continue therapy with the drug should be based on results of the susceptibility tests  the severity of the infection  the response of the patient and the important additional considerations contained in the warnings box above,0
6369,6369,6369,6369,6369,6369,6369,7724,7724,7724,7724,7724,7724,7724,7724,7724,7724,7724,7724,7724,0b56f6df-a05d-4520-8bf0-d7cefe20f6ad,amikacin has also been shown to be effective in staphylococcal infections and may be considered as initial therapy under certain conditions in the treatment of known or suspected staphylococcal disease such as  severe infections where the causative organism may be either a gram negative bacterium or a staphylococcus  infections due to susceptible strains of staphylococci in patients allergic to other antibiotics  and in mixed staphylococci gram negative infections,1
6370,6370,6370,6370,6370,6370,6370,7725,7725,7725,7725,7725,7725,7725,7725,7725,7725,7725,7725,7725,0b56f6df-a05d-4520-8bf0-d7cefe20f6ad,in certain severe infections such as neonatal sepsis  concomitant therapy with a penicillin type drug may be indicated because of the possibility of infections due to gram positive organisms such as streptococci or pneumococci,u
6371,6371,6371,6371,6371,6371,6371,7726,7726,7726,7726,7726,7726,7726,7726,7726,7726,7726,7726,7726,0b56f6df-a05d-4520-8bf0-d7cefe20f6ad,to reduce the development of drug resistant bacteria and maintain the effectiveness of amikacin and other antibacterial drugs  amikacin should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria,4
6372,6372,6372,6372,6372,6372,6372,7727,7727,7727,7727,7727,7727,7727,7727,7727,7727,7727,7727,7727,0b56f6df-a05d-4520-8bf0-d7cefe20f6ad,when culture and susceptibility information are available  they should be considered,0
6373,6373,6373,6373,6373,6373,6373,7728,7728,7728,7728,7728,7728,7728,7728,7728,7728,7728,7728,7728,5ef52f7c-042e-4f84-8048-5249bd01fade, sestamibi is a diagnostic agent used to assess areas of reversible myocardial ischemia in the presence or absence of infracted myocardium,1
6374,6374,6374,6374,6374,6374,6374,7729,7729,7729,7729,7729,7729,7729,7729,7729,7729,7729,7729,7729,5ef52f7c-042e-4f84-8048-5249bd01fade,evaluation of myocardial ischemia can be accomplished with rest and cardiovascular stress techniques,0
6375,6375,6375,6375,6375,6375,6375,7731,7731,7731,7731,7731,7731,7731,7731,7731,7731,7731,7731,7731,fb77637a-88d9-4aea-958f-e270030ce30d,1  baxdela is a fluoroquinolone antibacterial indicated in adults for the treatment of acute bacterial skin and skin structure infections ( absssi ) caused by designated susceptible bacteria,1
6376,6376,6376,6376,6376,6376,6376,7732,7732,7732,7732,7732,7732,7732,7732,7732,7732,7732,7732,7732,fb77637a-88d9-4aea-958f-e270030ce30d,( 1 1 ) to reduce the development of drug resistant bacteria and maintain the effectiveness of baxdela and other antibacterial drugs  baxdela should be used only to treat infections that are proven or strongly suspected to be caused by bacteria,1
6377,6377,6377,6377,6377,6377,6377,7733,7733,7733,7733,7733,7733,7733,7733,7733,7733,7733,7733,7733,fb77637a-88d9-4aea-958f-e270030ce30d,( 1 2 ) 1 1 acute bacterial skin and skin structure infections baxdela is indicated in adults for the treatment of acute bacterial skin and skin structure infections ( absssi ) caused by susceptible isolates of the following gram positive organisms staphylococcus aureus ( including methicillin resistant mrsa and methicillin susceptible mssa isolates )  staphylococcus haemolyticus  staphylococcus lugdunensis  streptococcus agalactiae  streptococcus anginosus group ( including streptococcus anginosus  streptococcus intermedius  and streptococcus constellatus )  streptococcus pyogenes  and enterococcus faecalis,1
6378,6378,6378,6378,6378,6378,6378,7734,7734,7734,7734,7734,7734,7734,7734,7734,7734,7734,7734,7734,fb77637a-88d9-4aea-958f-e270030ce30d,gram negative organisms escherichia coli  enterobacter cloacae  klebsiella pneumoniae  and pseudomonas aeruginosa,1
6379,6379,6379,6379,6379,6379,6379,7735,7735,7735,7735,7735,7735,7735,7735,7735,7735,7735,7735,7735,fb77637a-88d9-4aea-958f-e270030ce30d,1 2 usage to reduce the development of drug resistant bacteria and maintain the effectiveness of baxdela and other antibacterial drugs  baxdela should be used only to treat infections that are proven or strongly suspected to be caused by susceptible bacteria,1
6380,6380,6380,6380,6380,6380,6380,7738,7738,7738,7738,7738,7738,7738,7738,7738,7738,7738,7738,7738,26610bfe-4c3c-4c20-8b6d-b7c18cd6fe23,1  cilostazol tablets  usp are indicated for the reduction of symptoms of intermittent claudication  as demonstrated by an increased walking distance,1
6381,6381,6381,6381,6381,6381,6381,7739,7739,7739,7739,7739,7739,7739,7739,7739,7739,7739,7739,7739,26610bfe-4c3c-4c20-8b6d-b7c18cd6fe23,cilostazol tablets  usp are a phosphodiesterase iii inhibitor ( pde iii inhibitor ) indicated for the reduction of symptoms of intermittent claudication  as demonstrated by an increased walking distance ( 1 ),1
6382,6382,6382,6382,6382,6382,6382,7740,7740,7740,7740,7740,7740,7740,7740,7740,7740,7740,7740,7740,3cbb485b-6df1-49ce-8747-592b395b1988,1  somavert is indicated for the treatment of acromegaly in patients who have had an inadequate response to surgery or radiation therapy  or for whom these therapies are not appropriate,1
6383,6383,6383,6383,6383,6383,6383,7741,7741,7741,7741,7741,7741,7741,7741,7741,7741,7741,7741,7741,3cbb485b-6df1-49ce-8747-592b395b1988,the goal of treatment is to normalize serum insulin like growth factor i ( igf i ) levels,u
6384,6384,6384,6384,6384,6384,6384,7742,7742,7742,7742,7742,7742,7742,7742,7742,7742,7742,7742,7742,3cbb485b-6df1-49ce-8747-592b395b1988,somavert is a growth hormone receptor antagonist indicated for the treatment of acromegaly in patients who have had an inadequate response to surgery or radiation therapy  or for whom these therapies are not appropriate,1
6385,6385,6385,6385,6385,6385,6385,7744,7744,7744,7744,7744,7744,7744,7744,7744,7744,7744,7744,7744,"Active Ingredient UNII(s)
N91BDP6H0X; Q3JTX2Q7TU    188b8a95-3db7-4a6a-bddf-48b83a0c8e38
N91BDP6H0X; Q3JTX2Q7TU    188b8a95-3db7-4a6a-bddf-48b83a0c8e38
Name: SET ID dtype: object",active ingredient unii ( s ) n91bdp6h0x q3jtx2q7tu active ingredient unii ( s ) n91bdp6h0x q3jtx2q7 n91bdp6h0x q3jtx2q7tu active ingredient unii ( s ) n91bdp6h0x q3jtx2q7 name content xml  dtype object,0
6386,6386,6386,6386,6386,6386,6386,7746,7746,7746,7746,7746,7746,7746,7746,7746,7746,7746,7746,7746,"Active Ingredient UNII(s)
N91BDP6H0X; WY6W63843K    d31076b4-44ac-4f8b-8df6-5200cdbea12b
N91BDP6H0X; WY6W63843K    d31076b4-44ac-4f8b-8df6-5200cdbea12b
N91BDP6H0X; WY6W63843K    d31076b4-44ac-4f8b-8df6-5200cdbea12b
Name: SET ID dtype: object",active ingredient unii ( s ) n91bdp6h0x wy6w63843k active ingredient unii ( s ) n91bdp6h0x wy6w6384 n91bdp6h0x wy6w63843k active ingredient unii ( s ) n91bdp6h0x wy6w6384 n91bdp6h0x wy6w63843k active ingredient unii ( s ) n91bdp6h0x wy6w6384 name content xml  dtype object,0
6387,6387,6387,6387,6387,6387,6387,7749,7749,7749,7749,7749,7749,7749,7749,7749,7749,7749,7749,7749,"Active Ingredient UNII(s)
N91BDP6H0X; YU55MQ3IZY    6224f2c5-8e3c-4bcf-a8c6-a97004d6f432
N91BDP6H0X; YU55MQ3IZY    6224f2c5-8e3c-4bcf-a8c6-a97004d6f432
Name: SET ID dtype: object",active ingredient unii ( s ) n91bdp6h0x yu55mq3izy active ingredient unii ( s ) n91bdp6h0x yu55mq3i n91bdp6h0x yu55mq3izy active ingredient unii ( s ) n91bdp6h0x yu55mq3i name content xml  dtype object,0
6388,6388,6388,6388,6388,6388,6388,7751,7751,7751,7751,7751,7751,7751,7751,7751,7751,7751,7751,7751,1e6bea44-57d6-4bac-9328-46e1ee59f83b,1  nuplazid is indicated for the treatment of hallucinations and delusions associated with parkinson 's disease psychosis see clinical studies ( 14 ),1
6389,6389,6389,6389,6389,6389,6389,7752,7752,7752,7752,7752,7752,7752,7752,7752,7752,7752,7752,7752,1e6bea44-57d6-4bac-9328-46e1ee59f83b,nuplazid is an atypical antipsychotic indicated for the treatment of hallucinations and delusions associated with parkinson 's disease psychosis,1
6390,6390,6390,6390,6390,6390,6390,7753,7753,7753,7753,7753,7753,7753,7753,7753,7753,7753,7753,7753,"Active Ingredient UNII(s)
ND2M416302; P6YC3EG204    579bd1fe-51a1-403f-a422-0fb701aab57d
ND2M416302; P6YC3EG204    579bd1fe-51a1-403f-a422-0fb701aab57d
Name: SET ID dtype: object",active ingredient unii ( s ) nd2m416302 p6yc3eg204 active ingredient unii ( s ) nd2m416302 p6yc3eg2 nd2m416302 p6yc3eg204 active ingredient unii ( s ) nd2m416302 p6yc3eg2 name content xml  dtype object,0
6391,6391,6391,6391,6391,6391,6391,7755,7755,7755,7755,7755,7755,7755,7755,7755,7755,7755,7755,7755,"Active Ingredient UNII(s)
ND2M416302; V13007Z41A    62d2dbfe-9132-4b8e-ab4c-2db1c55920f4
ND2M416302; V13007Z41A    62d2dbfe-9132-4b8e-ab4c-2db1c55920f4
Name: SET ID dtype: object",active ingredient unii ( s ) nd2m416302 v13007z41a active ingredient unii ( s ) nd2m416302 v13007z4 nd2m416302 v13007z41a active ingredient unii ( s ) nd2m416302 v13007z4 name content xml  dtype object,0
6392,6392,6392,6392,6392,6392,6392,7757,7757,7757,7757,7757,7757,7757,7757,7757,7757,7757,7757,7757,66a1e273-ab59-4e7a-a223-a96b86501f51, tnkase ( tenecteplase ) is indicated for use in the reduction of mortality associated with acute myocardial infarction ( ami ),1
6393,6393,6393,6393,6393,6393,6393,7758,7758,7758,7758,7758,7758,7758,7758,7758,7758,7758,7758,7758,66a1e273-ab59-4e7a-a223-a96b86501f51,treatment should be initiated as soon as possible after the onset of ami symptoms ( see clinical studies ),4
6394,6394,6394,6394,6394,6394,6394,7759,7759,7759,7759,7759,7759,7759,7759,7759,7759,7759,7759,7759,d70a39cc-de15-4c12-a1ec-8063b69ea0e1,1  avonex ( interferon beta 1a ) is indicated for the treatment of patients with relapsing forms of multiple sclerosis to slow the accumulation of physical disability and decrease the frequency of clinical exacerbations,1
6395,6395,6395,6395,6395,6395,6395,7760,7760,7760,7760,7760,7760,7760,7760,7760,7760,7760,7760,7760,d70a39cc-de15-4c12-a1ec-8063b69ea0e1,patients with multiple sclerosis in whom efficacy has been demonstrated include patients who have experienced a first clinical episode and have mri features consistent with multiple sclerosis,0
6396,6396,6396,6396,6396,6396,6396,7761,7761,7761,7761,7761,7761,7761,7761,7761,7761,7761,7761,7761,d70a39cc-de15-4c12-a1ec-8063b69ea0e1,avonex is an interferon beta indicated for the treatment of patients with relapsing forms of multiple sclerosis to slow the accumulation of physical disability and decrease the frequency of clinical exacerbations,1
6397,6397,6397,6397,6397,6397,6397,7763,7763,7763,7763,7763,7763,7763,7763,7763,7763,7763,7763,7763,"Active Ingredient UNII(s)
ND2M416302; YI7VU623SF    91ef6b61-cbee-433a-ae69-df88aa1c07f6
ND2M416302; YI7VU623SF    91ef6b61-cbee-433a-ae69-df88aa1c07f6
Name: SET ID dtype: object",active ingredient unii ( s ) nd2m416302 yi7vu623sf active ingredient unii ( s ) nd2m416302 yi7vu623 nd2m416302 yi7vu623sf active ingredient unii ( s ) nd2m416302 yi7vu623 name content xml  dtype object,0
6398,6398,6398,6398,6398,6398,6398,7765,7765,7765,7765,7765,7765,7765,7765,7765,7765,7765,7765,7765,"Active Ingredient UNII(s)
ND2M416302; YKH834O4BH    38a8b524-566a-45b5-82a4-34e5a2ef66a2
ND2M416302; YKH834O4BH    38a8b524-566a-45b5-82a4-34e5a2ef66a2
Name: SET ID dtype: object",active ingredient unii ( s ) nd2m416302 ykh834o4bh active ingredient unii ( s ) nd2m416302 ykh834o4 nd2m416302 ykh834o4bh active ingredient unii ( s ) nd2m416302 ykh834o4 name content xml  dtype object,0
6399,6399,6399,6399,6399,6399,6399,7767,7767,7767,7767,7767,7767,7767,7767,7767,7767,7767,7767,7767,6c63a6af-ad06-453e-9b71-03f46f9599bd,1  desvenlafaxine extended release tablets is a serotonin and norepinephrine reuptake inhibitor ( snri )  is indicated for the treatment of major depressive disorder ( mdd ) see clinical studies ( 14 ) and dosage and administration ( 2 1 ),1
6400,6400,6400,6400,6400,6400,6400,7768,7768,7768,7768,7768,7768,7768,7768,7768,7768,7768,7768,7768,6c63a6af-ad06-453e-9b71-03f46f9599bd,the efficacy of desvenlafaxine has been established in four short term ( 8 week  placebo controlled studies ) in adult outpatients who met dsm iv criteria for major depressive disorder,0
6401,6401,6401,6401,6401,6401,6401,7769,7769,7769,7769,7769,7769,7769,7769,7769,7769,7769,7769,7769,6c63a6af-ad06-453e-9b71-03f46f9599bd,desvenlafaxine extended release tablets is a serotonin and norepinephrine reuptake inhibitor ( snri ) indicated for the treatment of major depressive disorder ( mdd ) ( 1 ),1
6402,6402,6402,6402,6402,6402,6402,7770,7770,7770,7770,7770,7770,7770,7770,7770,7770,7770,7770,7770,2da2ac3d-1a86-4b48-af71-315fd373dde6, perennial and seasonal allergic rhinitis vasomotor rhinitis allergic conjunctivitis due to inhalant allergens and foods mild  uncomplicated allergic skin manifestations of urticaria and angioedema,1
6403,6403,6403,6403,6403,6403,6403,7771,7771,7771,7771,7771,7771,7771,7771,7771,7771,7771,7771,7771,2da2ac3d-1a86-4b48-af71-315fd373dde6,cold urticaria dermatographism as therapy for anaphylactic reactions adjunctive to epinephrine and other standard measures after the acute manifestations have been controlled,1
6404,6404,6404,6404,6404,6404,6404,7772,7772,7772,7772,7772,7772,7772,7772,7772,7772,7772,7772,7772,d375b92a-baa1-4d63-9ad1-1467dcfde7d5, parenteral sedatives,1
6405,6405,6405,6405,6405,6405,6405,7773,7773,7773,7773,7773,7773,7773,7773,7773,7773,7773,7773,7773,d375b92a-baa1-4d63-9ad1-1467dcfde7d5,hypnotics  for the short term treatment of insomnia  since they appear to lose their effectiveness for sleep induction and sleep maintenance after 2 weeks ( see clinical pharmacology section ),1
6406,6406,6406,6406,6406,6406,6406,7774,7774,7774,7774,7774,7774,7774,7774,7774,7774,7774,7774,7774,d375b92a-baa1-4d63-9ad1-1467dcfde7d5,anticonvulsant  in anesthetic doses  in the emergency control of certain acute convulsive episodes  e g  those associated with status epilepticus  cholera  eclampsia  meningitis  tetanus  and toxic reactions to strychnine or local anesthetics,1
6407,6407,6407,6407,6407,6407,6407,7775,7775,7775,7775,7775,7775,7775,7775,7775,7775,7775,7775,7775,f6c717ac-7c37-4b4c-bd94-d81e0f74cb09, prevention of nausea and vomiting associated with highly emetogenic cancer chemotherapy  including cisplatin 50 mg m2,1
6408,6408,6408,6408,6408,6408,6408,7776,7776,7776,7776,7776,7776,7776,7776,7776,7776,7776,7776,7776,f6c717ac-7c37-4b4c-bd94-d81e0f74cb09,prevention of nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy,1
6409,6409,6409,6409,6409,6409,6409,7777,7777,7777,7777,7777,7777,7777,7777,7777,7777,7777,7777,7777,f6c717ac-7c37-4b4c-bd94-d81e0f74cb09,prevention of nausea and vomiting associated with radiotherapy in patients receiving either total body irradiation  single high dose fraction to the abdomen  or daily fractions to the abdomen,1
6410,6410,6410,6410,6410,6410,6410,7778,7778,7778,7778,7778,7778,7778,7778,7778,7778,7778,7778,7778,f6c717ac-7c37-4b4c-bd94-d81e0f74cb09,prevention of postoperative nausea and or vomiting,1
6411,6411,6411,6411,6411,6411,6411,7779,7779,7779,7779,7779,7779,7779,7779,7779,7779,7779,7779,7779,f6c717ac-7c37-4b4c-bd94-d81e0f74cb09,as with other antiemetics  routine prophylaxis is not recommended for patients in whom there is little expectation that nausea and or vomiting will occur postoperatively,0
6412,6412,6412,6412,6412,6412,6412,7780,7780,7780,7780,7780,7780,7780,7780,7780,7780,7780,7780,7780,f6c717ac-7c37-4b4c-bd94-d81e0f74cb09,in patients where nausea and or vomiting must be avoided postoperatively  ondansetron tablets are recommended even where the incidence of postoperative nausea and or vomiting is low,1
6413,6413,6413,6413,6413,6413,6413,7781,7781,7781,7781,7781,7781,7781,7781,7781,7781,7781,7781,7781,bb1bb6dc-0120-46e2-ad1e-d9afc221fa16,1  entecavir is indicated for the treatment of chronic hepatitis b virus infection in adults and pediatric patients 2 years of age and older with evidence of active viral replication and either evidence of persistent elevations in serum aminotransferases ( alt or ast ) or histologically active disease,1
6414,6414,6414,6414,6414,6414,6414,7782,7782,7782,7782,7782,7782,7782,7782,7782,7782,7782,7782,7782,bb1bb6dc-0120-46e2-ad1e-d9afc221fa16,the following points should be considered when initiating therapy with entecavir in adult patients  this indication is based on clinical trial data in nucleoside inhibitor treatment na ve and lamivudine resistant subjects with hbeag positive and hbeag negative hbv infection and compensated liver disease and a more limited number of subjects with decompensated liver disease,u
6415,6415,6415,6415,6415,6415,6415,7783,7783,7783,7783,7783,7783,7783,7783,7783,7783,7783,7783,7783,bb1bb6dc-0120-46e2-ad1e-d9afc221fa16,in pediatric patients 2 years of age and older  this indication is based on clinical trial data in nucleoside inhibitor treatment na ve and in a limited number of lamivudine experienced subjects with hbeag positive chronic hbv infection and compensated liver disease see clinical studies ( 14 2 ),0
6416,6416,6416,6416,6416,6416,6416,7784,7784,7784,7784,7784,7784,7784,7784,7784,7784,7784,7784,7784,bb1bb6dc-0120-46e2-ad1e-d9afc221fa16,entecavir is a hepatitis b virus nucleoside analog reverse transcriptase inhibitor indicated for the treatment of chronic hepatitis b virus infection in adults and children at least 2 years of age with evidence of active viral replication and either evidence of persistent elevations in serum aminotransferases ( alt or ast ) or histologically active disease,1
6417,6417,6417,6417,6417,6417,6417,7785,7785,7785,7785,7785,7785,7785,7785,7785,7785,7785,7785,7785,1b89a045-d552-40b6-a717-09858b5e6239,1  zohydro er ( hydrocodone bitartrate ) is indicated for the management of pain severe enough to require daily  around the clock  long term opioid treatment and for which alternative treatment options are inadequate,1
6418,6418,6418,6418,6418,6418,6418,7786,7786,7786,7786,7786,7786,7786,7786,7786,7786,7786,7786,7786,1b89a045-d552-40b6-a717-09858b5e6239,zohydro er is an opioid agonist indicated for the management of pain severe enough to require daily  around the clock  long term opioid treatment and for which alternative treatment options are inadequate,1
6419,6419,6419,6419,6419,6419,6419,7787,7787,7787,7787,7787,7787,7787,7787,7787,7787,7787,7787,7787,1b89a045-d552-40b6-a717-09858b5e6239,( 1 ) limitations of use because of the risks of addiction  abuse  and misuse with opioids  even at recommended doses  and because of the greater risks of overdose and death with extended release opioid formulations  reserve zohydro er for use in patients for whom alternative treatment options ( e g  non opioid analgesics or immediate release opioids ) are ineffective  not tolerated  or would be otherwise inadequate to provide sufficient management of pain,0
6420,6420,6420,6420,6420,6420,6420,7788,7788,7788,7788,7788,7788,7788,7788,7788,7788,7788,7788,7788,1b89a045-d552-40b6-a717-09858b5e6239,( 1 ) zohydro er is not indicated as an as needed ( prn ) analgesic,2
6421,6421,6421,6421,6421,6421,6421,7789,7789,7789,7789,7789,7789,7789,7789,7789,7789,7789,7789,7789,1b89a045-d552-40b6-a717-09858b5e6239,( 1 ) limitations of use because of the risks of addiction  abuse  and misuse with opioids  even at recommended doses  and because of the greater risks of overdose and death with extended release opioid formulations see warnings and precautions ( 5 1 )  reserve zohydro er for use in patients for whom alternative treatment options ( e g  non opioid analgesics or immediate release opioids ) are ineffective  not tolerated  or would be otherwise inadequate to provide sufficient management of pain,0
6422,6422,6422,6422,6422,6422,6422,7790,7790,7790,7790,7790,7790,7790,7790,7790,7790,7790,7790,7790,1b89a045-d552-40b6-a717-09858b5e6239,zohydro er is not indicated as an as needed ( prn ) analgesic,2
6423,6423,6423,6423,6423,6423,6423,7791,7791,7791,7791,7791,7791,7791,7791,7791,7791,7791,7791,7791,70a7ede0-885a-479a-9c64-dd9f19c2bbb0,1  hydrocodone bitartrate and chlorpheniramine maleate oral solution is a combination of hydrocodone bitartrate  an antitussive  and chlorpheniramine maleate  a histamine 1 ( h 1 ) receptor antagonist  indicated for relief of cough and symptoms associated with upper respiratory allergies or a common cold ( 1 1 ) limitations of use not indicated for pediatric patients under 18 years of age ( 1 1 ) 1 1 cough and upper respiratory allergy symptoms hydrocodone bitartrate and chlorpheniramine maleate oral solution is indicated for relief of cough and symptoms associated with upper respiratory allergies or a common cold in adults 18 years of age and older,1
6424,6424,6424,6424,6424,6424,6424,7792,7792,7792,7792,7792,7792,7792,7792,7792,7792,7792,7792,7792,70a7ede0-885a-479a-9c64-dd9f19c2bbb0,important limitations of use not indicated for pediatric patients under 18 years of age see use in specific populations ( 8 4 ),2
6425,6425,6425,6425,6425,6425,6425,7793,7793,7793,7793,7793,7793,7793,7793,7793,7793,7793,7793,7793,c386c4c5-f2f1-4078-a6fb-f120f56912e4, carefully consider the potential benefits and risks of hydrocodone bitartrate and ibuprofen tablets and other treatment options before deciding to use hydrocodone bitartrate and ibuprofen tablets,4
6426,6426,6426,6426,6426,6426,6426,7795,7795,7795,7795,7795,7795,7795,7795,7795,7795,7795,7795,7795,c386c4c5-f2f1-4078-a6fb-f120f56912e4,hydrocodone bitartrate and ibuprofen tablets are indicated for the short term ( generally less than 10 days ) management of acute pain,1
6427,6427,6427,6427,6427,6427,6427,7796,7796,7796,7796,7796,7796,7796,7796,7796,7796,7796,7796,7796,c386c4c5-f2f1-4078-a6fb-f120f56912e4,hydrocodone bitartrate and ibuprofen tablets are not indicated for the treatment of such conditions as osteoarthritis or rheumatoid arthritis,2
6428,6428,6428,6428,6428,6428,6428,7797,7797,7797,7797,7797,7797,7797,7797,7797,7797,7797,7797,7797,614d0da0-ebcc-4055-a385-645bfe8c26e3,1  mesna injection is indicated as a prophylactic agent in reducing the incidence of ifosfamide induced hemorrhagic cystitis,1
6429,6429,6429,6429,6429,6429,6429,7798,7798,7798,7798,7798,7798,7798,7798,7798,7798,7798,7798,7798,614d0da0-ebcc-4055-a385-645bfe8c26e3,mesna injection is a cytoprotective agent indicated as a prophylactic agent in reducing the incidence of ifosfamide induced hemorrhagic cystitis,1
6430,6430,6430,6430,6430,6430,6430,7799,7799,7799,7799,7799,7799,7799,7799,7799,7799,7799,7799,7799,614d0da0-ebcc-4055-a385-645bfe8c26e3,( 1 ) limitation of use mesna injection is not indicated to reduce the risk of hematuria due to other pathological conditions such as thrombocytopenia,2
6431,6431,6431,6431,6431,6431,6431,7801,7801,7801,7801,7801,7801,7801,7801,7801,7801,7801,7801,7801,463a36fa-3eb2-4326-8bd0-c8c7a11bca3a, buphenyl is indicated as adjunctive therapy in the chronic management of patients with urea cycle disorders involving deficiencies of carbamylphosphate synthetase ( cps )  ornithine transcarbamylase ( otc )  or argininosuccinic acid synthetase ( as ),1
6432,6432,6432,6432,6432,6432,6432,7802,7802,7802,7802,7802,7802,7802,7802,7802,7802,7802,7802,7802,463a36fa-3eb2-4326-8bd0-c8c7a11bca3a,it is indicated in all patients with neonatal onset deficiency ( complete enzymatic deficiency  presenting within the first 28 days of life ),1
6433,6433,6433,6433,6433,6433,6433,7803,7803,7803,7803,7803,7803,7803,7803,7803,7803,7803,7803,7803,463a36fa-3eb2-4326-8bd0-c8c7a11bca3a,it is also indicated in patients with late onset disease ( partial enzymatic deficiency  presenting after the first month of life ) who have a history of hyperammonemic encephalopathy,1
6434,6434,6434,6434,6434,6434,6434,7804,7804,7804,7804,7804,7804,7804,7804,7804,7804,7804,7804,7804,463a36fa-3eb2-4326-8bd0-c8c7a11bca3a,it is important that the diagnosis be made early and treatment initiated immediately to improve survival,2
6435,6435,6435,6435,6435,6435,6435,7805,7805,7805,7805,7805,7805,7805,7805,7805,7805,7805,7805,7805,463a36fa-3eb2-4326-8bd0-c8c7a11bca3a,any episode of acute hyperammonemia should be treated as a life threatening emergency,0
6436,6436,6436,6436,6436,6436,6436,7806,7806,7806,7806,7806,7806,7806,7806,7806,7806,7806,7806,7806,463a36fa-3eb2-4326-8bd0-c8c7a11bca3a,buphenyl must be combined with dietary protein restriction and  in some cases  essential amino acid supplementation,4
6437,6437,6437,6437,6437,6437,6437,7807,7807,7807,7807,7807,7807,7807,7807,7807,7807,7807,7807,7807,463a36fa-3eb2-4326-8bd0-c8c7a11bca3a,( see nutritional supplementation subsection of the dosage and administration section ),0
6438,6438,6438,6438,6438,6438,6438,7808,7808,7808,7808,7808,7808,7808,7808,7808,7808,7808,7808,7808,463a36fa-3eb2-4326-8bd0-c8c7a11bca3a,previously  neonatal onset disease was almost universally fatal within the first year of life  even when treated with peritoneal dialysis and essential amino acids or their nitrogen free analogs,0
6439,6439,6439,6439,6439,6439,6439,7809,7809,7809,7809,7809,7809,7809,7809,7809,7809,7809,7809,7809,463a36fa-3eb2-4326-8bd0-c8c7a11bca3a,however  with hemodialysis  use of alternative waste nitrogen excretion pathways ( sodium phenylbutyrate  sodium benzoate  and sodium phenylacetate )  dietary protein restriction  and  in some cases  essential amino acid supplementation  the survival rate in newborns diagnosed after birth but within the first month of life is almost 80,0
6440,6440,6440,6440,6440,6440,6440,7810,7810,7810,7810,7810,7810,7810,7810,7810,7810,7810,7810,7810,463a36fa-3eb2-4326-8bd0-c8c7a11bca3a,most deaths have occurred during an episode of acute hyperammonemic encephalopathy,0
6441,6441,6441,6441,6441,6441,6441,7811,7811,7811,7811,7811,7811,7811,7811,7811,7811,7811,7811,7811,463a36fa-3eb2-4326-8bd0-c8c7a11bca3a,patients with neonatal onset disease have a high incidence of mental retardation,0
6442,6442,6442,6442,6442,6442,6442,7812,7812,7812,7812,7812,7812,7812,7812,7812,7812,7812,7812,7812,463a36fa-3eb2-4326-8bd0-c8c7a11bca3a,those who had iq tests administered had an incidence of mental retardation as follows ornithine transcarbamylase deficiency  100 ( 14 14 patients tested ) argininosuccinic acid synthetase deficiency  88 ( 15 17 patients tested ) and carbamylphosphate synthetase deficiency  57 ( 4 7 patients tested ),0
6443,6443,6443,6443,6443,6443,6443,7813,7813,7813,7813,7813,7813,7813,7813,7813,7813,7813,7813,7813,463a36fa-3eb2-4326-8bd0-c8c7a11bca3a,retardation was severe in the majority of the retarded patients,0
6444,6444,6444,6444,6444,6444,6444,7814,7814,7814,7814,7814,7814,7814,7814,7814,7814,7814,7814,7814,463a36fa-3eb2-4326-8bd0-c8c7a11bca3a,in patients diagnosed during gestation and treated prior to any episode of hyperammonemic encephalopathy  survival is 100  but even in these patients  most subsequently demonstrate cognitive impairment or other neurologic deficits,0
6445,6445,6445,6445,6445,6445,6445,7815,7815,7815,7815,7815,7815,7815,7815,7815,7815,7815,7815,7815,463a36fa-3eb2-4326-8bd0-c8c7a11bca3a,in late onset deficiency patients  including females heterozygous for ornithine transcarbamylase deficiency  who recover from hyperammonemic encephalopathy and are then treated chronically with sodium phenylbutyrate and dietary protein restriction  the survival rate is 98,0
6446,6446,6446,6446,6446,6446,6446,7816,7816,7816,7816,7816,7816,7816,7816,7816,7816,7816,7816,7816,463a36fa-3eb2-4326-8bd0-c8c7a11bca3a,the two deaths in this group of patients occurred during episodes of hyperammonemic encephalopathy,0
6447,6447,6447,6447,6447,6447,6447,7817,7817,7817,7817,7817,7817,7817,7817,7817,7817,7817,7817,7817,463a36fa-3eb2-4326-8bd0-c8c7a11bca3a,however  compliance with the therapeutic regimen has not been adequately documented to allow evaluation of the potential for buphenyl and dietary protein restriction to prevent mental deterioration and recurrence of hyperammonemic encephalopathy if carefully adhered to,0
6448,6448,6448,6448,6448,6448,6448,7818,7818,7818,7818,7818,7818,7818,7818,7818,7818,7818,7818,7818,463a36fa-3eb2-4326-8bd0-c8c7a11bca3a,the majority of these patients tested ( 30 46 or 65 ) have iq 's in the average to low average borderline mentally retarded range,0
6449,6449,6449,6449,6449,6449,6449,7819,7819,7819,7819,7819,7819,7819,7819,7819,7819,7819,7819,7819,463a36fa-3eb2-4326-8bd0-c8c7a11bca3a,reversal of pre existing neurologic impairment is not likely to occur with treatment and neurologic deterioration may continue in some patients,0
6450,6450,6450,6450,6450,6450,6450,7820,7820,7820,7820,7820,7820,7820,7820,7820,7820,7820,7820,7820,463a36fa-3eb2-4326-8bd0-c8c7a11bca3a,even on therapy  acute hyperammonemic encephalopathy recurred in the majority of patients for whom the drug is indicated,0
6451,6451,6451,6451,6451,6451,6451,7821,7821,7821,7821,7821,7821,7821,7821,7821,7821,7821,7821,7821,463a36fa-3eb2-4326-8bd0-c8c7a11bca3a,buphenyl may be required life long unless orthotopic liver transplantation is elected,4
6452,6452,6452,6452,6452,6452,6452,7822,7822,7822,7822,7822,7822,7822,7822,7822,7822,7822,7822,7822,463a36fa-3eb2-4326-8bd0-c8c7a11bca3a,( see linkhtml href clin pharm lbc7ba1dd 72b1,0
6453,6453,6453,6453,6453,6453,6453,7823,7823,7823,7823,7823,7823,7823,7823,7823,7823,7823,7823,7823,827bc01c-d379-4266-a18c-c7f904b76af3,1  kevzara is indicated for treatment of adult patients with moderately to severely active rheumatoid arthritis ( ra ) who have had an inadequate response or intolerance to one or more disease modifying antirheumatic drugs ( dmards ),1
6454,6454,6454,6454,6454,6454,6454,7824,7824,7824,7824,7824,7824,7824,7824,7824,7824,7824,7824,7824,827bc01c-d379-4266-a18c-c7f904b76af3,kevzara is an interleukin 6 ( il 6 ) receptor antagonist indicated for treatment of adult patients with moderately to severely active rheumatoid arthritis who have had an inadequate response or intolerance to one or more disease modifying antirheumatic drugs ( dmards ),1
6455,6455,6455,6455,6455,6455,6455,7825,7825,7825,7825,7825,7825,7825,7825,7825,7825,7825,7825,7825,abc41ed1-9512-4bea-9295-1a9ca134b6c2, sodium acetate injection  usp ( 2 meq ml ) is indicated as a source of sodium for addition to large volume intravenous fluids to prevent or correct hyponatremia in patients with restricted or no oral intake,1
6456,6456,6456,6456,6456,6456,6456,7827,7827,7827,7827,7827,7827,7827,7827,7827,7827,7827,7827,7827,366e7ca9-4fd3-4688-bd83-1f369885e0fc,1  zn dtpa is indicated for treatment of individuals with known or suspected internal contamination with plutonium  americium  or curium to increase the rates of elimination,1
6457,6457,6457,6457,6457,6457,6457,7828,7828,7828,7828,7828,7828,7828,7828,7828,7828,7828,7828,7828,366e7ca9-4fd3-4688-bd83-1f369885e0fc,pentetate zinc trisodium injection is a radiomitigation chelator indicated for treatment of individuals with known or suspected internal contamination with plutonium  americium  or curium to increase the rates of elimination,1
6458,6458,6458,6458,6458,6458,6458,7829,7829,7829,7829,7829,7829,7829,7829,7829,7829,7829,7829,7829,9f675d38-d02f-455c-bc99-bac5924f5054, ketalar is indicated as the sole anesthetic agent for diagnostic and surgical procedures that do not require skeletal muscle relaxation,1
6459,6459,6459,6459,6459,6459,6459,7830,7830,7830,7830,7830,7830,7830,7830,7830,7830,7830,7830,7830,9f675d38-d02f-455c-bc99-bac5924f5054,ketalar is best suited for short procedures but it can be used  with additional doses  for longer procedures,1
6460,6460,6460,6460,6460,6460,6460,7831,7831,7831,7831,7831,7831,7831,7831,7831,7831,7831,7831,7831,9f675d38-d02f-455c-bc99-bac5924f5054,ketalar is indicated for the induction of anesthesia prior to the administration of other general anesthetic agents,1
6461,6461,6461,6461,6461,6461,6461,7832,7832,7832,7832,7832,7832,7832,7832,7832,7832,7832,7832,7832,9f675d38-d02f-455c-bc99-bac5924f5054,ketalar is indicated to supplement low potency agents  such as nitrous oxide,1
6462,6462,6462,6462,6462,6462,6462,7833,7833,7833,7833,7833,7833,7833,7833,7833,7833,7833,7833,7833,9f675d38-d02f-455c-bc99-bac5924f5054,specific areas of application are described in the clinical pharmacology section,0
6463,6463,6463,6463,6463,6463,6463,7834,7834,7834,7834,7834,7834,7834,7834,7834,7834,7834,7834,7834,cf74ba2f-afc5-4baa-8594-979c889a5831,1  xeljanz xeljanz xr is an inhibitor of janus kinases ( jaks ) indicated for the treatment of adult patients with moderately to severely active rheumatoid arthritis who have had an inadequate response or intolerance to methotrexate,1
6464,6464,6464,6464,6464,6464,6464,7835,7835,7835,7835,7835,7835,7835,7835,7835,7835,7835,7835,7835,cf74ba2f-afc5-4baa-8594-979c889a5831,it may be used as monotherapy or in combination with methotrexate or other nonbiologic disease modifying antirheumatic drugs ( dmards ),4
6465,6465,6465,6465,6465,6465,6465,7836,7836,7836,7836,7836,7836,7836,7836,7836,7836,7836,7836,7836,cf74ba2f-afc5-4baa-8594-979c889a5831,( 1 1 ) xeljanz xeljanz xr is indicated for the treatment of adult patients with active psoriatic arthritis who have had an inadequate response or intolerance to methotrexate or other disease modifying antirheumatic drugs ( dmards ),1
6466,6466,6466,6466,6466,6466,6466,7837,7837,7837,7837,7837,7837,7837,7837,7837,7837,7837,7837,7837,cf74ba2f-afc5-4baa-8594-979c889a5831,( 1 2 ) limitations of use use of xeljanz xeljanz xr in combination with biologic dmards or potent immunosuppressants such as azathioprine and cyclosporine is not recommended,2
6467,6467,6467,6467,6467,6467,6467,7838,7838,7838,7838,7838,7838,7838,7838,7838,7838,7838,7838,7838,cf74ba2f-afc5-4baa-8594-979c889a5831,( 1 1  1 2 ) 1 1 rheumatoid arthritis xeljanz xeljanz xr ( tofacitinib ) is indicated for the treatment of adult patients with moderately to severely active rheumatoid arthritis who have had an inadequate response or intolerance to methotrexate,1
6468,6468,6468,6468,6468,6468,6468,7840,7840,7840,7840,7840,7840,7840,7840,7840,7840,7840,7840,7840,cf74ba2f-afc5-4baa-8594-979c889a5831,limitations of use use of xeljanz xeljanz xr in combination with biologic dmards or with potent immunosuppressants such as azathioprine and cyclosporine is not recommended,2
6469,6469,6469,6469,6469,6469,6469,7841,7841,7841,7841,7841,7841,7841,7841,7841,7841,7841,7841,7841,cf74ba2f-afc5-4baa-8594-979c889a5831,1 2 psoriatic arthritis xeljanz xeljanz xr ( tofacitinib ) is indicated for the treatment of adult patients with active psoriatic arthritis who have had an inadequate response or intolerance to methotrexate or other disease modifying antirheumatic drugs ( dmards ),1
6470,6470,6470,6470,6470,6470,6470,7843,7843,7843,7843,7843,7843,7843,7843,7843,7843,7843,7843,7843,b370e14e-5131-4691-a252-67df6cb6ee96, lorazepam is indicated for the management of anxiety disorders or for the short term relief of the symptoms of anxiety or anxiety associated with depressive symptoms,1
6471,6471,6471,6471,6471,6471,6471,7845,7845,7845,7845,7845,7845,7845,7845,7845,7845,7845,7845,7845,b370e14e-5131-4691-a252-67df6cb6ee96,the effectiveness of lorazepam in long term use  that is  more than 4 months  has not been assessed by systematic clinical studies,0
6472,6472,6472,6472,6472,6472,6472,7847,7847,7847,7847,7847,7847,7847,7847,7847,7847,7847,7847,7847,ab7529ac-fa19-4be8-9906-8889fa3e8398, fluticasone propionate nasal spray  usp is indicated for the management of the nasal symptoms of seasonal and perennial allergic and nonallergic rhinitis in adults and pediatric patients 4 years of age and older,1
6473,6473,6473,6473,6473,6473,6473,7848,7848,7848,7848,7848,7848,7848,7848,7848,7848,7848,7848,7848,ab7529ac-fa19-4be8-9906-8889fa3e8398,safety and effectiveness of fluticasone propionate nasal spray  usp in children below 4 years of age have not been adequately established,0
6474,6474,6474,6474,6474,6474,6474,7849,7849,7849,7849,7849,7849,7849,7849,7849,7849,7849,7849,7849,30046b6b-09ea-46b1-8e60-61c53e1e7282, stannous pyrophosphate is indicated as a blood pool imaging agent which may be used for gated pool imaging and for the detection of sites of gastrointestinal bleeding,1
6475,6475,6475,6475,6475,6475,6475,7850,7850,7850,7850,7850,7850,7850,7850,7850,7850,7850,7850,7850,30046b6b-09ea-46b1-8e60-61c53e1e7282,when administered intravenously  15 30 minutes prior to intravenous administration of sodium pertechnetate tc99m for in vivo red blood cell labeling  approximately 75 percent of the injected activity remains in the blood pool,0
6476,6476,6476,6476,6476,6476,6476,7852,7852,7852,7852,7852,7852,7852,7852,7852,7852,7852,7852,7852,30046b6b-09ea-46b1-8e60-61c53e1e7282,it is also indicated as a skeletal imaging agent used to demonstrate areas of altered osteogenesis  and a cardiac imaging agent used as an adjunct in the diagnosis of acute myocardial infarction,1
6477,6477,6477,6477,6477,6477,6477,7853,7853,7853,7853,7853,7853,7853,7853,7853,7853,7853,7853,7853,4f314d1a-237a-464f-e054-00144ff8d46c,1  norvir is indicated in combination with other antiretroviral agents for the treatment of hiv 1 infection,1
6478,6478,6478,6478,6478,6478,6478,7854,7854,7854,7854,7854,7854,7854,7854,7854,7854,7854,7854,7854,a01a3ccd-d9bc-40b6-b269-cddd6d0e47c5, ultrasal er is indicated for the topical treatment and removal of common warts and plantar warts,1
6479,6479,6479,6479,6479,6479,6479,7855,7855,7855,7855,7855,7855,7855,7855,7855,7855,7855,7855,7855,df12ceb2-5b4b-4ab5-a317-2a36bf2a3cda,1  gazyva ( obinutuzumab ) is a cd20 directed cytolytic antibody and is indicated in combination with chlorambucil  for the treatment of patients with previously untreated chronic lymphocytic leukemia,1
6480,6480,6480,6480,6480,6480,6480,7856,7856,7856,7856,7856,7856,7856,7856,7856,7856,7856,7856,7856,df12ceb2-5b4b-4ab5-a317-2a36bf2a3cda,( 1  14 ) in combination with bendamustine followed by gazyva monotherapy  for the treatment of patients with follicular lymphoma who relapsed after  or are refractory to  a rituximab containing regimen,1
6481,6481,6481,6481,6481,6481,6481,7857,7857,7857,7857,7857,7857,7857,7857,7857,7857,7857,7857,7857,df12ceb2-5b4b-4ab5-a317-2a36bf2a3cda,( 1  14 ) in combination with chemotherapy followed by gazyva monotherapy in patients achieving at least a partial remission  for the treatment of adult patients with previously untreated stage ii bulky  iii or iv follicular lymphoma,u
6482,6482,6482,6482,6482,6482,6482,7858,7858,7858,7858,7858,7858,7858,7858,7858,7858,7858,7858,7858,df12ceb2-5b4b-4ab5-a317-2a36bf2a3cda,( 1  14 ) 1 1 chronic lymphocytic leukemia ( cll ) gazyva  in combination with chlorambucil  is indicated for the treatment of patients with previously untreated chronic lymphocytic leukemia see clinical studies ( 14 1 ),1
6483,6483,6483,6483,6483,6483,6483,7859,7859,7859,7859,7859,7859,7859,7859,7859,7859,7859,7859,7859,df12ceb2-5b4b-4ab5-a317-2a36bf2a3cda,1 2 follicular lymphoma ( fl ) gazyva  in combination with bendamustine followed by gazyva monotherapy  is indicated for the treatment of patients with follicular lymphoma who relapsed after  or are refractory to  a rituximab containing regimen see clinical studies ( 14 2 ),1
6484,6484,6484,6484,6484,6484,6484,7860,7860,7860,7860,7860,7860,7860,7860,7860,7860,7860,7860,7860,df12ceb2-5b4b-4ab5-a317-2a36bf2a3cda,gazyva  in combination with chemotherapy followed by gazyva monotherapy in patients achieving at least a partial remission  is indicated for the treatment of adult patients with previously untreated stage ii bulky  iii or iv follicular lymphoma see clinical studies ( 14 2 ),1
6485,6485,6485,6485,6485,6485,6485,7861,7861,7861,7861,7861,7861,7861,7861,7861,7861,7861,7861,7861,b16c7832-2fd9-49af-b923-1dc0d91fd6e2, proglycem ( oral diazoxide ) is useful in the management of hypoglycemia due to hyperinsulinism associated with the following conditions adults inoperable islet cell adenoma or carcinoma  or extrapancreatic malignancy,1
6486,6486,6486,6486,6486,6486,6486,7862,7862,7862,7862,7862,7862,7862,7862,7862,7862,7862,7862,7862,b16c7832-2fd9-49af-b923-1dc0d91fd6e2,infants and children leucine sensitivity  islet cell hyperplasia  nesidioblastosis  extrapancreatic malignancy  islet cell adenoma  or adenomatosis,1
6487,6487,6487,6487,6487,6487,6487,7863,7863,7863,7863,7863,7863,7863,7863,7863,7863,7863,7863,7863,b16c7832-2fd9-49af-b923-1dc0d91fd6e2,proglycem may be used preoperatively as a temporary measure  and postoperatively  if hypoglycemia persists,4
6488,6488,6488,6488,6488,6488,6488,7864,7864,7864,7864,7864,7864,7864,7864,7864,7864,7864,7864,7864,b16c7832-2fd9-49af-b923-1dc0d91fd6e2,proglycem should be used only after a diagnosis of hypoglycemia due to one of the above conditions has been definitely established,u
6489,6489,6489,6489,6489,6489,6489,7865,7865,7865,7865,7865,7865,7865,7865,7865,7865,7865,7865,7865,b16c7832-2fd9-49af-b923-1dc0d91fd6e2,when other specific medical therapy or surgical management either has been unsuccessful or is not feasible  treatment with proglycem should be considered,0
6490,6490,6490,6490,6490,6490,6490,7866,7866,7866,7866,7866,7866,7866,7866,7866,7866,7866,7866,7866,361338e6-d719-4bea-aca0-7dd591fcfa08,1  pandel ( hydrocortisone probutate ) cream  0 1 is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid responsive dermatoses in patients 18 years of age or older,1
6491,6491,6491,6491,6491,6491,6491,7867,7867,7867,7867,7867,7867,7867,7867,7867,7867,7867,7867,7867,361338e6-d719-4bea-aca0-7dd591fcfa08,pandel ( hydrocortisone probutate ) cream  0 1 is a corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid responsive dermatoses in patients 18 years of age or older,1
6492,6492,6492,6492,6492,6492,6492,7868,7868,7868,7868,7868,7868,7868,7868,7868,7868,7868,7868,7868,75672079-589f-451a-bdbf-eaebcfcc80a9,1  sivextro is an oxazolidinone class antibacterial drug indicated in adults for the treatment of acute bacterial skin and skin structure infections ( absssi ) caused by designated susceptible bacteria,1
6493,6493,6493,6493,6493,6493,6493,7869,7869,7869,7869,7869,7869,7869,7869,7869,7869,7869,7869,7869,75672079-589f-451a-bdbf-eaebcfcc80a9,( 1 1 ) to reduce the development of drug resistant bacteria and maintain the effectiveness of sivextro and other antibacterial drugs  sivextro should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria,4
6494,6494,6494,6494,6494,6494,6494,7870,7870,7870,7870,7870,7870,7870,7870,7870,7870,7870,7870,7870,75672079-589f-451a-bdbf-eaebcfcc80a9,1 1 acute bacterial skin and skin structure infections sivextro is an oxazolidinone class antibacterial indicated for the treatment of acute bacterial skin and skin structure infections ( absssi ) caused by susceptible isolates of the following gram positive microorganisms staphylococcus aureus ( including methicillin resistant mrsa and methicillin susceptible mssa isolates )  streptococcus pyogenes  streptococcus agalactiae  streptococcus anginosus group ( including streptococcus anginosus  streptococcus intermedius  and streptococcus constellatus )  and enterococcus faecalis,1
6495,6495,6495,6495,6495,6495,6495,7871,7871,7871,7871,7871,7871,7871,7871,7871,7871,7871,7871,7871,75672079-589f-451a-bdbf-eaebcfcc80a9,1 2 usage to reduce the development of drug resistant bacteria and maintain the effectiveness of sivextro and other antibacterial drugs  sivextro should be used only to treat absssi that are proven or strongly suspected to be caused by susceptible bacteria,4
6496,6496,6496,6496,6496,6496,6496,7874,7874,7874,7874,7874,7874,7874,7874,7874,7874,7874,7874,7874,b1699f4e-40d5-49d0-ab80-1c8cc68e80a4, vexol 1 ( rimexolone ophthalmic suspension ) is indicated for the treatment of postoperative inflammation following ocular surgery and in the treatment of anterior uveitis,1
6497,6497,6497,6497,6497,6497,6497,7875,7875,7875,7875,7875,7875,7875,7875,7875,7875,7875,7875,7875,1a32c0e8-7d10-447e-a7c4-252c98b629bd, betagan ophthalmic solution has been shown to be effective in lowering intraocular pressure and may be used in patients with chronic open angle glaucoma or ocular hypertension,1
6498,6498,6498,6498,6498,6498,6498,7876,7876,7876,7876,7876,7876,7876,7876,7876,7876,7876,7876,7876,b99a44df-ff38-4602-68ab-9bef1ff3af83, droperidol injection is indicated to reduce the incidence of nausea and vomiting associated with surgical and diagnostic procedures,1
6499,6499,6499,6499,6499,6499,6499,7877,7877,7877,7877,7877,7877,7877,7877,7877,7877,7877,7877,7877,04a413fe-95f4-47a7-42ac-283a9e78297d, trecator is primarily indicated for the treatment of active tuberculosis in patients with m tuberculosis resistant to isoniazid or rifampin  or when there is intolerance on the part of the patient to other drugs,1
6500,6500,6500,6500,6500,6500,6500,7878,7878,7878,7878,7878,7878,7878,7878,7878,7878,7878,7878,7878,04a413fe-95f4-47a7-42ac-283a9e78297d,its use alone in the treatment of tuberculosis results in the rapid development of resistance,0
6501,6501,6501,6501,6501,6501,6501,7879,7879,7879,7879,7879,7879,7879,7879,7879,7879,7879,7879,7879,04a413fe-95f4-47a7-42ac-283a9e78297d,it is essential  therefore  to give a suitable companion drug or drugs  the choice being based on the results of susceptibility tests,4
6502,6502,6502,6502,6502,6502,6502,7880,7880,7880,7880,7880,7880,7880,7880,7880,7880,7880,7880,7880,04a413fe-95f4-47a7-42ac-283a9e78297d,if the susceptibility tests indicate that the patient 's organism is resistant to one of the first line antituberculosis drugs ( i e  isoniazid or rifampin ) yet susceptible to ethionamide  ethionamide should be accompanied by at least one drug to which the m tuberculosis isolate is known to be susceptible 3 if the tuberculosis is resistant to both isoniazid and rifampin  yet susceptible to ethionamide  ethionamide should be accompanied by at least two other drugs to which the m tuberculosis isolate is known to be susceptible 3 to reduce the development of drug resistant bacteria and maintain the effectiveness of trecator and other antibacterial drugs  trecator should be used only to treat infections that are proven or strongly suspected to be caused by susceptible bacteria,4
6503,6503,6503,6503,6503,6503,6503,7883,7883,7883,7883,7883,7883,7883,7883,7883,7883,7883,7883,7883,04a413fe-95f4-47a7-42ac-283a9e78297d,patient nonadherence to prescribed treatment can result in treatment failure and in the development of drug resistant tuberculosis  which can be life threatening and lead to other serious health risks,0
6504,6504,6504,6504,6504,6504,6504,7884,7884,7884,7884,7884,7884,7884,7884,7884,7884,7884,7884,7884,04a413fe-95f4-47a7-42ac-283a9e78297d,it is  therefore  essential that patients adhere to the drug regimen for the full duration of treatment,4
6505,6505,6505,6505,6505,6505,6505,7885,7885,7885,7885,7885,7885,7885,7885,7885,7885,7885,7885,7885,04a413fe-95f4-47a7-42ac-283a9e78297d,directly observed therapy is recommended for all patients receiving treatment for tuberculosis,4
6506,6506,6506,6506,6506,6506,6506,7886,7886,7886,7886,7886,7886,7886,7886,7886,7886,7886,7886,7886,04a413fe-95f4-47a7-42ac-283a9e78297d,patients in whom drug resistant m tuberculosis organisms are isolated should be managed in consultation with an expert in the treatment of drug resistant tuberculosis,4
6507,6507,6507,6507,6507,6507,6507,7887,7887,7887,7887,7887,7887,7887,7887,7887,7887,7887,7887,7887,3fed2817-fc0d-43cd-9f02-948fbc76672c,1  cephalexin is a cephalosporin antibacterial drug indicated for the treatment of the following infections caused by susceptible isolates of designated bacteria respiratory tract infection ( 1 1 ) otitis media ( 1 2 ) skin and skin structure infections ( 1 3 ) bone infections ( 1 4 ) genitourinary tract infections ( 1 5 ) to reduce the development of drug resistant bacteria and maintain the effectiveness of cephalexin capsules  cephalexin for oral suspension  and cephalexin tablets and other antibacterial drugs  cephalexin capsules  cephalexin for oral suspension  and cephalexin tablets should be used only to treat infections that are proven or strongly suspected to be caused by bacteria,1
6508,6508,6508,6508,6508,6508,6508,7888,7888,7888,7888,7888,7888,7888,7888,7888,7888,7888,7888,7888,3fed2817-fc0d-43cd-9f02-948fbc76672c,( 1 6 ) 1 1 respiratory tract infections cephalexin is indicated for the treatment of respiratory tract infections caused by susceptible isolates of streptococcus pneumoniae and streptococcus pyogenes,1
6509,6509,6509,6509,6509,6509,6509,7889,7889,7889,7889,7889,7889,7889,7889,7889,7889,7889,7889,7889,3fed2817-fc0d-43cd-9f02-948fbc76672c,1 2 otitis media cephalexin is indicated for the treatment of otitis media caused by susceptible isolates of streptococcus pneumoniae  haemophilus influenzae  staphylococcus aureus  streptococcus pyogenes  and moraxella catarrhalis,1
6510,6510,6510,6510,6510,6510,6510,7890,7890,7890,7890,7890,7890,7890,7890,7890,7890,7890,7890,7890,3fed2817-fc0d-43cd-9f02-948fbc76672c,1 3 skin and skin structure infections cephalexin is indicated for the treatment of skin and skin structure infections ca,1
6511,6511,6511,6511,6511,6511,6511,7891,7891,7891,7891,7891,7891,7891,7891,7891,7891,7891,7891,7891,0caa2565-12b2-0ad0-1f9a-273e81c3d4cc,1  vimizim ( elosulfase alfa ) is indicated for patients with mucopolysaccharidosis type iva ( mps iva morquio a syndrome ),1
6512,6512,6512,6512,6512,6512,6512,7892,7892,7892,7892,7892,7892,7892,7892,7892,7892,7892,7892,7892,0caa2565-12b2-0ad0-1f9a-273e81c3d4cc,vimizim is a hydrolytic lysosomal glycosaminoglycan ( gag ) specific enzyme indicated for patients with mucopolysaccharidosis type iva ( mps iva morquio a syndrome ) ( 1 ),1
6513,6513,6513,6513,6513,6513,6513,7893,7893,7893,7893,7893,7893,7893,7893,7893,7893,7893,7893,7893,b90f2e5b-10b8-29a7-0360-31bd0dae0ec2,1  risedronate sodium tablets  usp are a bisphosphonate indicated for treatment and prevention of postmenopausal osteoporosis ( 1 1 ) treatment to increase bone mass in men with osteoporosis ( 1 2 ) treatment and prevention of glucocorticoid induced osteoporosis ( 1 3 ) treatment of paget 's disease ( 1 4 ) limitations of use optimal duration of use has not been determined,1
6514,6514,6514,6514,6514,6514,6514,7895,7895,7895,7895,7895,7895,7895,7895,7895,7895,7895,7895,7895,b90f2e5b-10b8-29a7-0360-31bd0dae0ec2,( 1 5 ) 1 1 postmenopausal osteoporosis risedronate sodium tablets  usp are indicated for the treatment and prevention of osteoporosis in postmenopausal women,1
6515,6515,6515,6515,6515,6515,6515,7896,7896,7896,7896,7896,7896,7896,7896,7896,7896,7896,7896,7896,b90f2e5b-10b8-29a7-0360-31bd0dae0ec2,in postmenopausal women with osteoporosis  risedronate sodium tablets  usp reduce the incidence of vertebral fractures and a composite endpoint of nonvertebral osteoporosis related fractures see clinical studies ( 14 1  14 2 ),1
6516,6516,6516,6516,6516,6516,6516,7897,7897,7897,7897,7897,7897,7897,7897,7897,7897,7897,7897,7897,b90f2e5b-10b8-29a7-0360-31bd0dae0ec2,1 2 osteoporosis in men risedronate sodium tablets  usp are indicated for treatment to increase bone mass in men with osteoporosis,1
6517,6517,6517,6517,6517,6517,6517,7898,7898,7898,7898,7898,7898,7898,7898,7898,7898,7898,7898,7898,b90f2e5b-10b8-29a7-0360-31bd0dae0ec2,1 3 glucocorticoid induced osteoporosis risedronate sodium tablets  usp are indicated for the treatment and prevention of glucocorticoid induced osteoporosis in men and women who are either initiating or continuing systemic glucocorticoid treatment ( daily dosage of greater than or equal to 7 5 mg of prednisone or equivalent ) for chronic diseases,1
6518,6518,6518,6518,6518,6518,6518,7899,7899,7899,7899,7899,7899,7899,7899,7899,7899,7899,7899,7899,b90f2e5b-10b8-29a7-0360-31bd0dae0ec2,patients treated with glucocorticoids should receive adequate amounts of calcium and vitamin d,u
6519,6519,6519,6519,6519,6519,6519,7900,7900,7900,7900,7900,7900,7900,7900,7900,7900,7900,7900,7900,c5f32941-3427-4a38-bc3d-38337b41d9d3, estradiol valerate injection is indicated in the 1,0
6520,6520,6520,6520,6520,6520,6520,7906,7906,7906,7906,7906,7906,7906,7906,7906,7906,7906,7906,7906,1dc38234-be65-6be1-e054-00144ff88e88, felodipine tablets are indicated for the treatment of hypertension  to lower blood pressure,1
6521,6521,6521,6521,6521,6521,6521,7908,7908,7908,7908,7908,7908,7908,7908,7908,7908,7908,7908,7908,1dc38234-be65-6be1-e054-00144ff88e88,these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including felodipine,0
6522,6522,6522,6522,6522,6522,6522,7916,7916,7916,7916,7916,7916,7916,7916,7916,7916,7916,7916,7916,1dc38234-be65-6be1-e054-00144ff88e88,some antihypertensive drugs have smaller blood pressure effects ( as monotherapy ) in black patients  and many antihypertensive drugs have additional approved indications and effects ( eg  on angina  heart failure  or diabetic kidney disease ),0
6523,6523,6523,6523,6523,6523,6523,7918,7918,7918,7918,7918,7918,7918,7918,7918,7918,7918,7918,7918,1dc38234-be65-6be1-e054-00144ff88e88,felodipine tablets may be administered with other antihypertensive agents,4
6524,6524,6524,6524,6524,6524,6524,7919,7919,7919,7919,7919,7919,7919,7919,7919,7919,7919,7919,7919,61bf535a-3ed5-4c50-b285-6dcee0624c2d, diltiazem hydrochloride extended release capsules are indicated for the treatment of hypertension,1
6525,6525,6525,6525,6525,6525,6525,7920,7920,7920,7920,7920,7920,7920,7920,7920,7920,7920,7920,7920,61bf535a-3ed5-4c50-b285-6dcee0624c2d,they may be used alone or in combination with other antihypertensive medications,4
6526,6526,6526,6526,6526,6526,6526,7921,7921,7921,7921,7921,7921,7921,7921,7921,7921,7921,7921,7921,61bf535a-3ed5-4c50-b285-6dcee0624c2d,diltiazem hydrochloride extended release capsules are indicated for the management of chronic stable angina and angina due to coronary artery spasm,1
6527,6527,6527,6527,6527,6527,6527,7922,7922,7922,7922,7922,7922,7922,7922,7922,7922,7922,7922,7922,33fd6418-fbdc-42ca-a50d-ce2a476a5418,1  viread is a nucleotide analog hiv 1 reverse transcriptase inhibitor and an hbv reverse transcriptase inhibitor,0
6528,6528,6528,6528,6528,6528,6528,7923,7923,7923,7923,7923,7923,7923,7923,7923,7923,7923,7923,7923,33fd6418-fbdc-42ca-a50d-ce2a476a5418,viread is indicated in combination with other antiretroviral agents for the treatment of hiv 1 infection in adults and pediatric patients 2 years of age and older,1
6529,6529,6529,6529,6529,6529,6529,7924,7924,7924,7924,7924,7924,7924,7924,7924,7924,7924,7924,7924,33fd6418-fbdc-42ca-a50d-ce2a476a5418,( 1 ) viread is indicated for the treatment of chronic hepatitis b in adults and pediatric patients 12 years of age and older,1
6530,6530,6530,6530,6530,6530,6530,7925,7925,7925,7925,7925,7925,7925,7925,7925,7925,7925,7925,7925,33fd6418-fbdc-42ca-a50d-ce2a476a5418,( 1 ) 1 1 hiv 1 infection viread is indicated in combination with other antiretroviral agents for the treatment of hiv 1 infection in adults and pediatric patients 2 years of age and older,1
6531,6531,6531,6531,6531,6531,6531,7926,7926,7926,7926,7926,7926,7926,7926,7926,7926,7926,7926,7926,33fd6418-fbdc-42ca-a50d-ce2a476a5418,the following points should be considered when initiating therapy with viread for the treatment of hiv 1 infection viread should not be used in combination with atripla  complera  descovy  genvoya  odefsey  stribild  truvada  or vemlidy see warnings and precautions ( 5 4 ),u
6532,6532,6532,6532,6532,6532,6532,7927,7927,7927,7927,7927,7927,7927,7927,7927,7927,7927,7927,7927,33fd6418-fbdc-42ca-a50d-ce2a476a5418,1 2 chronic hepatitis b viread is indicated for the treatment of chronic hepatitis b in adults and pediatric patients 12 years of age and older,1
6533,6533,6533,6533,6533,6533,6533,7928,7928,7928,7928,7928,7928,7928,7928,7928,7928,7928,7928,7928,33fd6418-fbdc-42ca-a50d-ce2a476a5418,the following points should be considered when initiating therapy with viread for the treatment of hbv infection the indication in adults is based on safety and efficacy data from treatment of subjects who were nucleoside treatment na ve and subjects who were treatment experienced with documented resistance to lamivudine,0
6534,6534,6534,6534,6534,6534,6534,7929,7929,7929,7929,7929,7929,7929,7929,7929,7929,7929,7929,7929,33fd6418-fbdc-42ca-a50d-ce2a476a5418,subjects were adults with hbeag positive and hbeag negative chronic hepatitis b with compensated liver disease see clinical studies ( 14 2 ),0
6535,6535,6535,6535,6535,6535,6535,7930,7930,7930,7930,7930,7930,7930,7930,7930,7930,7930,7930,7930,33fd6418-fbdc-42ca-a50d-ce2a476a5418,viread was evaluated in a limited number of subjects with chronic hepatitis b and decompensated liver disease see adverse reactions ( 6 1 )  clinical studies ( 14 2 ),0
6536,6536,6536,6536,6536,6536,6536,7931,7931,7931,7931,7931,7931,7931,7931,7931,7931,7931,7931,7931,33fd6418-fbdc-42ca-a50d-ce2a476a5418,the numbers of subjects in clinical trials who had adefovir resistance associated substitutions at baseline were too small to reach conclusions of efficacy see microbiology ( 12 4 )  clinical studies ( 14 2 ),0
6537,6537,6537,6537,6537,6537,6537,7932,7932,7932,7932,7932,7932,7932,7932,7932,7932,7932,7932,7932,1534c9ae-4948-4cf4-9f66-222a99db6d0e,1  sirturo is a diarylquinoline antimycobacterial drug indicated as part of combination therapy in the treatment of adults ( 18 years and older ) with pulmonary multi drug resistant tuberculosis ( mdr tb ),1
6538,6538,6538,6538,6538,6538,6538,7933,7933,7933,7933,7933,7933,7933,7933,7933,7933,7933,7933,7933,1534c9ae-4948-4cf4-9f66-222a99db6d0e,reserve sirturo for use when an effective treatment regimen cannot otherwise be provided,u
6539,6539,6539,6539,6539,6539,6539,7934,7934,7934,7934,7934,7934,7934,7934,7934,7934,7934,7934,7934,1534c9ae-4948-4cf4-9f66-222a99db6d0e,administer sirturo by directly observed therapy ( dot ),4
6540,6540,6540,6540,6540,6540,6540,7935,7935,7935,7935,7935,7935,7935,7935,7935,7935,7935,7935,7935,1534c9ae-4948-4cf4-9f66-222a99db6d0e,this indication is approved under accelerated approval based on time to sputum culture conversion see clinical studies ( 14 ),0
6541,6541,6541,6541,6541,6541,6541,7937,7937,7937,7937,7937,7937,7937,7937,7937,7937,7937,7937,7937,1534c9ae-4948-4cf4-9f66-222a99db6d0e,sirturo is a diarylquinoline antimycobacterial drug indicated as part of combination therapy in adults ( 18 years and older ) with pulmonary multi drug resistant tuberculosis ( mdr tb ),1
6542,6542,6542,6542,6542,6542,6542,7940,7940,7940,7940,7940,7940,7940,7940,7940,7940,7940,7940,7940,1534c9ae-4948-4cf4-9f66-222a99db6d0e,( 1  2 1 ) this indication is approved under accelerated approval based on time to sputum culture conversion,0
6543,6543,6543,6543,6543,6543,6543,7942,7942,7942,7942,7942,7942,7942,7942,7942,7942,7942,7942,7942,1534c9ae-4948-4cf4-9f66-222a99db6d0e,( 1  14 ) limitations of use do not use sirturo for the treatment of latent  extra pulmonary or drug sensitive tuberculosis or for the treatment of infections caused by non tuberculous mycobacteria ( 1 ),2
6544,6544,6544,6544,6544,6544,6544,7943,7943,7943,7943,7943,7943,7943,7943,7943,7943,7943,7943,7943,1534c9ae-4948-4cf4-9f66-222a99db6d0e,safety and efficacy of sirturo in hiv infected patients with mdr tb have not been established  as clinical data are limited ( 14 ),0
6545,6545,6545,6545,6545,6545,6545,7944,7944,7944,7944,7944,7944,7944,7944,7944,7944,7944,7944,7944,1534c9ae-4948-4cf4-9f66-222a99db6d0e,limitations of use do not use sirturo for the treatment of latent infection due to mycobacterium tuberculosis drug sensitive tuberculosis extra pulmonary tuberculosis infections caused by non tuberculous mycobacteria the safety and efficacy of sirturo in the treatment of hiv infected patients with mdr tb have not been established as clinical data are limited see clinical studies ( 14 ),2
6546,6546,6546,6546,6546,6546,6546,7945,7945,7945,7945,7945,7945,7945,7945,7945,7945,7945,7945,7945,492dbdb2-077e-4064-bff3-372d6af0a7a2,1  herceptin is a her2 neu receptor antagonist indicated for the treatment of her2 overexpressing breast cancer,1
6547,6547,6547,6547,6547,6547,6547,7946,7946,7946,7946,7946,7946,7946,7946,7946,7946,7946,7946,7946,492dbdb2-077e-4064-bff3-372d6af0a7a2,( 1 1  1 2 ) the treatment of her2 overexpressing metastatic gastric or gastroesophageal junction adenocarcinoma,1
6548,6548,6548,6548,6548,6548,6548,7947,7947,7947,7947,7947,7947,7947,7947,7947,7947,7947,7947,7947,492dbdb2-077e-4064-bff3-372d6af0a7a2,( 1 3 ) select patients for therapy based on an fda approved companion diagnostic for herceptin ( 1  2 1 ),0
6549,6549,6549,6549,6549,6549,6549,7948,7948,7948,7948,7948,7948,7948,7948,7948,7948,7948,7948,7948,492dbdb2-077e-4064-bff3-372d6af0a7a2,1 1 adjuvant breast cancer herceptin is indicated for adjuvant treatment of her2 overexpressing node positive or node negative ( er pr negative or with one high risk feature see clinical studies ( 14 1 ) ) breast cancer as part of a treatment regimen consisting of doxorubicin  cyclophosphamide  and either paclitaxel or docetaxel as part of a treatment regimen with docetaxel and carboplatin as a single agent following multi modality anthracycline based therapy,1
6550,6550,6550,6550,6550,6550,6550,7949,7949,7949,7949,7949,7949,7949,7949,7949,7949,7949,7949,7949,492dbdb2-077e-4064-bff3-372d6af0a7a2,select patients for therapy based on an fda approved companion diagnostic for herceptin see dosage and administration ( 2 1 ),0
6551,6551,6551,6551,6551,6551,6551,7950,7950,7950,7950,7950,7950,7950,7950,7950,7950,7950,7950,7950,492dbdb2-077e-4064-bff3-372d6af0a7a2,1 2 metastatic breast cancer herceptin is indicated in combination with paclitaxel for first line treatment of her2 overexpressing metastatic breast cancer as a single agent for treatment of her2 overexpressing breast cancer in patients who have received one or more chemotherapy regimens for metastatic disease,1
6552,6552,6552,6552,6552,6552,6552,7952,7952,7952,7952,7952,7952,7952,7952,7952,7952,7952,7952,7952,492dbdb2-077e-4064-bff3-372d6af0a7a2,1 3 metastatic gastric cancer herceptin is indicated  in combination with cisplatin and capecitabine or 5 fluorouracil  for the trea,1
6553,6553,6553,6553,6553,6553,6553,7953,7953,7953,7953,7953,7953,7953,7953,7953,7953,7953,7953,7953,663e39a9-a29e-473f-89ec-4c7c6bc27b8a,1  imiquimod cream is indicated for the topical treatment of clinically typical  nonhyperkeratotic  nonhypertrophic actinic keratoses ( ak ) on the face or scalp in immunocompetent adults ( 1 1 ) external genital and perianal warts condyloma acuminata in patients 12 years old or older ( 1 3 ) limitations of use efficacy was not demonstrated for molluscum contagiosum in children aged 2 to12 ( 1 4  8 4 ) 1 1 actinic keratosis imiquimod cream is indicated for the topical treatment of clinically typical  nonhyperkeratotic  nonhypertrophic actinic keratoses on the face or scalp in immunocompetent adults,1
6554,6554,6554,6554,6554,6554,6554,7954,7954,7954,7954,7954,7954,7954,7954,7954,7954,7954,7954,7954,663e39a9-a29e-473f-89ec-4c7c6bc27b8a,1 3 external genital warts imiquimod cream is indicated for the treatment of external genital and perianal warts condyloma acuminata in patients 12 years old or older,1
6555,6555,6555,6555,6555,6555,6555,7955,7955,7955,7955,7955,7955,7955,7955,7955,7955,7955,7955,7955,663e39a9-a29e-473f-89ec-4c7c6bc27b8a,1 4 limitations of use imiquimod cream has been evaluated in children ages 2 to 12 years with molluscum contagiosum and these studies failed to demonstrate efficacy,u
6556,6556,6556,6556,6556,6556,6556,7957,7957,7957,7957,7957,7957,7957,7957,7957,7957,7957,7957,7957,663e39a9-a29e-473f-89ec-4c7c6bc27b8a,1 5 unevaluated populations the safety and efficacy of imiquimod cream in immunosuppressed patients have not been established,0
6557,6557,6557,6557,6557,6557,6557,7958,7958,7958,7958,7958,7958,7958,7958,7958,7958,7958,7958,7958,663e39a9-a29e-473f-89ec-4c7c6bc27b8a,imiquimod cream should be used with caution in patients with pre existing autoimmune conditions,0
6558,6558,6558,6558,6558,6558,6558,7959,7959,7959,7959,7959,7959,7959,7959,7959,7959,7959,7959,7959,663e39a9-a29e-473f-89ec-4c7c6bc27b8a,the efficacy and safety of imiquimod cream have not been established for patients with basal cell nevus syndrome or xeroderma pigmentosum,0
6559,6559,6559,6559,6559,6559,6559,7960,7960,7960,7960,7960,7960,7960,7960,7960,7960,7960,7960,7960,c89d3ecc-4f4c-4566-8808-79152344194d,1  adreview is a radiopharmaceutical agent for gamma scintigraphy indicated for use in the detection of primary or metastatic pheochromocytoma or neuroblastoma as an adjunct to other diagnostic tests ( 1 1 ) scintigraphic assessment of sympathetic innervation of the myocardium by measurement of the heart to mediastinum ( h m ) ratio of radioactivity uptake in patients with new york heart association ( nyha ) class ii or class iii heart failure and left ventricular ejection fraction ( lvef ) 35,1
6560,6560,6560,6560,6560,6560,6560,7961,7961,7961,7961,7961,7961,7961,7961,7961,7961,7961,7961,7961,c89d3ecc-4f4c-4566-8808-79152344194d,among these patients  adreview may be used to help identify patients with lower one and two year mortality risks  as indicated by an h m ratio 1 6,0
6561,6561,6561,6561,6561,6561,6561,7962,7962,7962,7962,7962,7962,7962,7962,7962,7962,7962,7962,7962,c89d3ecc-4f4c-4566-8808-79152344194d,( 1 2 ) limitations of use in patients with congestive heart failure  adreview utility has not been established for selecting a therapeutic intervention or for monitoring the response to therapy using the h m ratio to identify a patient with a high risk for death,2
6562,6562,6562,6562,6562,6562,6562,7963,7963,7963,7963,7963,7963,7963,7963,7963,7963,7963,7963,7963,c89d3ecc-4f4c-4566-8808-79152344194d,1 1 pheochromocytoma and neuroblastoma adreview is a radiopharmaceutical indicated for use in the detection of primary or metastatic pheochromocytoma or neuroblastoma as an adjunct to other diagnostic tests,1
6563,6563,6563,6563,6563,6563,6563,7964,7964,7964,7964,7964,7964,7964,7964,7964,7964,7964,7964,7964,c89d3ecc-4f4c-4566-8808-79152344194d,1 2 congestive heart failure adreview is indicated for scintigraphic assessment of sympathetic innervation of the myocardium by measurement of the heart to mediastinum ( h m ) ratio of radioactivity uptake in patients with new york heart association ( nyha ) class ii or class iii heart failure and left ventricular ejection fraction ( lvef ) 35,1
6564,6564,6564,6564,6564,6564,6564,7966,7966,7966,7966,7966,7966,7966,7966,7966,7966,7966,7966,7966,c89d3ecc-4f4c-4566-8808-79152344194d,limitations of use in patients with congestive heart failure  adreview utility has not been established for selecting a therapeutic intervention or for monitoring the response to therapy using the h m ratio to identify a patient with a high risk for death,0
6565,6565,6565,6565,6565,6565,6565,7967,7967,7967,7967,7967,7967,7967,7967,7967,7967,7967,7967,7967,7ea3c60a-45c7-44cc-afc2-d87fa53993c0,1  austedo is indicated for the treatment of chorea associated with huntington s disease see clinical studies ( 14 1 ) tardive dyskinesia in adults see clinical studies ( 14 2 ) austedo is a vesicular monoamine transporter 2 ( vmat2 ) inhibitor indicated for the treatment of chorea associated with huntington s disease ( 1 ) tardive dyskinesia in adults ( 1 ),1
6566,6566,6566,6566,6566,6566,6566,7968,7968,7968,7968,7968,7968,7968,7968,7968,7968,7968,7968,7968,"Active Ingredient UNII(s)
P3T5QA5J9N    04212000-ec03-42a3-8b9e-3a28237f415e
P3T5QA5J9N    04212000-ec03-42a3-8b9e-3a28237f415e
P3T5QA5J9N    04212000-ec03-42a3-8b9e-3a28237f415e
P3T5QA5J9N    04212000-ec03-42a3-8b9e-3a28237f415e
P3T5QA5J9N    04212000-ec03-42a3-8b9e-3a28237f415e
Name: SET ID dtype: object",active ingredient unii ( s ) p3t5qa5j9n active ingredient unii ( s ) p3t5qa5j9n active in p3t5qa5j9n active ingredient unii ( s ) p3t5qa5j9n active in p3t5qa5j9n active ingredient unii ( s ) p3t5qa5j9n active in p3t5qa5j9n active ingredient unii ( s ) p3t5qa5j9n active in p3t5qa5j9n active ingredient unii ( s ) p3t5qa5j9n active in name content xml  dtype object,0
6567,6567,6567,6567,6567,6567,6567,7973,7973,7973,7973,7973,7973,7973,7973,7973,7973,7973,7973,7973,1a528236-6375-4630-b4e1-8db250a4cbef, nizatidine capsules usp are indicated for up to 8 weeks for the treatment of active duodenal ulcer,1
6568,6568,6568,6568,6568,6568,6568,7974,7974,7974,7974,7974,7974,7974,7974,7974,7974,7974,7974,7974,1a528236-6375-4630-b4e1-8db250a4cbef,in most patients  the ulcer will heal within 4 weeks,0
6569,6569,6569,6569,6569,6569,6569,7975,7975,7975,7975,7975,7975,7975,7975,7975,7975,7975,7975,7975,1a528236-6375-4630-b4e1-8db250a4cbef,nizatidine capsules usp are indicated for maintenance therapy for duodenal ulcer patients at a reduced dosage of 150 mg h s,1
6570,6570,6570,6570,6570,6570,6570,7976,7976,7976,7976,7976,7976,7976,7976,7976,7976,7976,7976,7976,1a528236-6375-4630-b4e1-8db250a4cbef,after healing of an active duodenal ulcer,0
6571,6571,6571,6571,6571,6571,6571,7977,7977,7977,7977,7977,7977,7977,7977,7977,7977,7977,7977,7977,1a528236-6375-4630-b4e1-8db250a4cbef,the consequences of continuous therapy with nizatidine for longer than 1 year are not known,0
6572,6572,6572,6572,6572,6572,6572,7978,7978,7978,7978,7978,7978,7978,7978,7978,7978,7978,7978,7978,1a528236-6375-4630-b4e1-8db250a4cbef,nizatidine capsules usp are indicated for up to 12 weeks for the treatment of endoscopically diagnosed esophagitis  including erosive and ulcerative esophagitis  and associated heartburn due to gerd,1
6573,6573,6573,6573,6573,6573,6573,7979,7979,7979,7979,7979,7979,7979,7979,7979,7979,7979,7979,7979,1a528236-6375-4630-b4e1-8db250a4cbef,nizatidine capsules usp are indicated for up to 8 weeks for the treatment of active benign gastric ulcer,1
6574,6574,6574,6574,6574,6574,6574,7980,7980,7980,7980,7980,7980,7980,7980,7980,7980,7980,7980,7980,1a528236-6375-4630-b4e1-8db250a4cbef,before initiating therapy  care should be taken to exclude the possibility of malignant gastric ulceration,0
6575,6575,6575,6575,6575,6575,6575,7981,7981,7981,7981,7981,7981,7981,7981,7981,7981,7981,7981,7981,b8eb330a-a75b-46cb-b694-5be9327ed2eb, postanesthesia when the possibility of airway obstruction and or hypoxia have been eliminated  doxapram may be used to stimulate respiration in patients with drug induced postanesthesia respiratory depression or apnea other than that due to muscle relaxant drugs,1
6576,6576,6576,6576,6576,6576,6576,7982,7982,7982,7982,7982,7982,7982,7982,7982,7982,7982,7982,7982,b8eb330a-a75b-46cb-b694-5be9327ed2eb,to pharmacologically stimulate deep breathing in the postoperative patient,1
6577,6577,6577,6577,6577,6577,6577,7983,7983,7983,7983,7983,7983,7983,7983,7983,7983,7983,7983,7983,b8eb330a-a75b-46cb-b694-5be9327ed2eb,( a quantitative method of assessing oxygenation  such as pulse oximetry  is recommended ),0
6578,6578,6578,6578,6578,6578,6578,7984,7984,7984,7984,7984,7984,7984,7984,7984,7984,7984,7984,7984,b8eb330a-a75b-46cb-b694-5be9327ed2eb,drug induced central nervous system depression exercising care to prevent vomiting and aspiration  doxapram may be used to stimulate respiration  hasten arousal  and to encourage the return of laryngopharyngeal reflexes in patients with mild to moderate respiratory and cns depression due to drug overdosage,1
6579,6579,6579,6579,6579,6579,6579,7985,7985,7985,7985,7985,7985,7985,7985,7985,7985,7985,7985,7985,b8eb330a-a75b-46cb-b694-5be9327ed2eb,chronic pulmonary disease associated with acute hypercapnia doxapram is indicated as a temporary measure in hospitalized patients with acute respiratory insufficiency superimposed on chronic obstructive pulmonary disease,1
6580,6580,6580,6580,6580,6580,6580,7986,7986,7986,7986,7986,7986,7986,7986,7986,7986,7986,7986,7986,b8eb330a-a75b-46cb-b694-5be9327ed2eb,its use should be for a short period of time ( see dosage and administration ) as an aid in the prevention of elevation of arterial co2 tension during the administration of oxygen,u
6581,6581,6581,6581,6581,6581,6581,7987,7987,7987,7987,7987,7987,7987,7987,7987,7987,7987,7987,7987,b8eb330a-a75b-46cb-b694-5be9327ed2eb,it should not be used in conjunction with mechanical ventilation,2
6582,6582,6582,6582,6582,6582,6582,7988,7988,7988,7988,7988,7988,7988,7988,7988,7988,7988,7988,7988,eaecd9a1-e13e-49b1-8b3c-8e1ef016cacd, to reduce the development of drug resistant bacteria and maintain the effectiveness of achromycin v ( tetracycline hcl capsules  usp ) and other antibacterial drugs  achromycin v ( tetracycline hcl capsules  usp ) should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria,1
6583,6583,6583,6583,6583,6583,6583,7991,7991,7991,7991,7991,7991,7991,7991,7991,7991,7991,7991,7991,eaecd9a1-e13e-49b1-8b3c-8e1ef016cacd,achromycin v ( tetracycline hcl capsules  usp ) is indicated in the treatment of infections caused by susceptible strains of the designated organisms in the conditions listed below upper respiratory tract infections caused by streptococcus pyogenes  streptococcus pneumoniae and hemophilus influenzae,1
6584,6584,6584,6584,6584,6584,6584,7992,7992,7992,7992,7992,7992,7992,7992,7992,7992,7992,7992,7992,eaecd9a1-e13e-49b1-8b3c-8e1ef016cacd,note achromycin v ( tetracycline hcl capsules  usp ) should not be used for streptococcal disease unless the organism has been demonstrated to be susceptible,0
6585,6585,6585,6585,6585,6585,6585,7993,7993,7993,7993,7993,7993,7993,7993,7993,7993,7993,7993,7993,eaecd9a1-e13e-49b1-8b3c-8e1ef016cacd,lower respiratory tract infections caused by streptococcus pyogenes  streptococcus pneumoniae  mycoplasma pneumoniae ( eaton agent  and klebsiella sp ),1
6586,6586,6586,6586,6586,6586,6586,7994,7994,7994,7994,7994,7994,7994,7994,7994,7994,7994,7994,7994,eaecd9a1-e13e-49b1-8b3c-8e1ef016cacd,skin and soft tissue infections caused by streptococcus pyogenes  staphylococcus aureaus,1
6587,6587,6587,6587,6587,6587,6587,7995,7995,7995,7995,7995,7995,7995,7995,7995,7995,7995,7995,7995,eaecd9a1-e13e-49b1-8b3c-8e1ef016cacd,( tetracyclines are not the drugs of choice in the treatment of any type of staphylococcalinfections ),0
6588,6588,6588,6588,6588,6588,6588,7996,7996,7996,7996,7996,7996,7996,7996,7996,7996,7996,7996,7996,eaecd9a1-e13e-49b1-8b3c-8e1ef016cacd,infections caused by rickettsia including rocky mountain spotted fever  typhus group infections  q fever  rickettsialpox,1
6589,6589,6589,6589,6589,6589,6589,7997,7997,7997,7997,7997,7997,7997,7997,7997,7997,7997,7997,7997,eaecd9a1-e13e-49b1-8b3c-8e1ef016cacd,psittacosis of ornithosis caused by chlamydia psittaci,1
6590,6590,6590,6590,6590,6590,6590,7998,7998,7998,7998,7998,7998,7998,7998,7998,7998,7998,7998,7998,eaecd9a1-e13e-49b1-8b3c-8e1ef016cacd,infections caused by chlamydia trachomatis such as uncomplicated urethral  endocervical or rectal infections  inclusion conjunctivitis  trachoma  and lymphogranuloma venereum,1
6591,6591,6591,6591,6591,6591,6591,7999,7999,7999,7999,7999,7999,7999,7999,7999,7999,7999,7999,7999,eaecd9a1-e13e-49b1-8b3c-8e1ef016cacd,granuloma inquinale caused by calymmatobacterium granulomatis,1
6592,6592,6592,6592,6592,6592,6592,8000,8000,8000,8000,8000,8000,8000,8000,8000,8000,8000,8000,8000,eaecd9a1-e13e-49b1-8b3c-8e1ef016cacd,relapsing fever caused by borrelia sp,1
6593,6593,6593,6593,6593,6593,6593,8001,8001,8001,8001,8001,8001,8001,8001,8001,8001,8001,8001,8001,eaecd9a1-e13e-49b1-8b3c-8e1ef016cacd,bartonellosis caused by bartonella bacilliformis,1
6594,6594,6594,6594,6594,6594,6594,8002,8002,8002,8002,8002,8002,8002,8002,8002,8002,8002,8002,8002,eaecd9a1-e13e-49b1-8b3c-8e1ef016cacd,chancroid caused by hemophilus ducreyi,1
6595,6595,6595,6595,6595,6595,6595,8003,8003,8003,8003,8003,8003,8003,8003,8003,8003,8003,8003,8003,eaecd9a1-e13e-49b1-8b3c-8e1ef016cacd,tularemia caused by francisella tularensis,1
6596,6596,6596,6596,6596,6596,6596,8004,8004,8004,8004,8004,8004,8004,8004,8004,8004,8004,8004,8004,eaecd9a1-e13e-49b1-8b3c-8e1ef016cacd,plaque caused by yersinia pestis,1
6597,6597,6597,6597,6597,6597,6597,8006,8006,8006,8006,8006,8006,8006,8006,8006,8006,8006,8006,8006,eaecd9a1-e13e-49b1-8b3c-8e1ef016cacd,brucellosis caused by brucella species ( tetracycline may be used in conjunction with an aminoglycoside ),1
6598,6598,6598,6598,6598,6598,6598,8007,8007,8007,8007,8007,8007,8007,8007,8007,8007,8007,8007,8007,eaecd9a1-e13e-49b1-8b3c-8e1ef016cacd,infections due to campylobacter fetus,1
6599,6599,6599,6599,6599,6599,6599,8008,8008,8008,8008,8008,8008,8008,8008,8008,8008,8008,8008,8008,eaecd9a1-e13e-49b1-8b3c-8e1ef016cacd,as adjunctive therapy in intestinal amebiasis caused by entamoeba histolytica,1
6600,6600,6600,6600,6600,6600,6600,8009,8009,8009,8009,8009,8009,8009,8009,8009,8009,8009,8009,8009,eaecd9a1-e13e-49b1-8b3c-8e1ef016cacd,urinary tract infections caused by susceptible strains of content st,1
6601,6601,6601,6601,6601,6601,6601,8010,8010,8010,8010,8010,8010,8010,8010,8010,8010,8010,8010,8010,2fb653d6-e2b2-4969-831b-c0dc37b9c0cc, cyanocobalamin is indicated for vitamin b12 deficiencies due to malabsorption which may be associated with the following conditions addisonian ( pernicious ) anemia gastrointestinal pathology  dysfunction  or surgery  including gluten enteropathy or sprue  small bowel bacteria overgrowth  total or partial gastrectomy fish tapeworm infestation malignancy of pancreas or bowel folic acid deficiency it may be possible to treat the underlying disease by surgical correction of anatomic lesions leading to small bowel bacterial overgrowth  expulsion of fish tapeworm  discontinuation of drugs leading to vitamin malabsorption ( see drug interactions )  use of a gluten free diet in nontropical sprue  or administration of antibiotics in tropical sprue,1
6602,6602,6602,6602,6602,6602,6602,8011,8011,8011,8011,8011,8011,8011,8011,8011,8011,8011,8011,8011,2fb653d6-e2b2-4969-831b-c0dc37b9c0cc,such measures remove the need for long term administration of cyanocobalamin,0
6603,6603,6603,6603,6603,6603,6603,8012,8012,8012,8012,8012,8012,8012,8012,8012,8012,8012,8012,8012,2fb653d6-e2b2-4969-831b-c0dc37b9c0cc,requirements of vitamin b12 in excess of normal ( due to pregnancy  thyrotoxicosis  hemolytic anemia  hemorrhage  malignancy  hepatic and renal disease ) can usually be met with oral supplementation,0
6604,6604,6604,6604,6604,6604,6604,8013,8013,8013,8013,8013,8013,8013,8013,8013,8013,8013,8013,8013,2fb653d6-e2b2-4969-831b-c0dc37b9c0cc,cyanocobalamin injection  usp is also suitable for the vitamin b12 absorption test ( schilling test ),1
6605,6605,6605,6605,6605,6605,6605,8014,8014,8014,8014,8014,8014,8014,8014,8014,8014,8014,8014,8014,6a95effd-32a5-46b6-a30e-7f4f9bf8cc77,1  rayaldee is a vitamin d3 analog indicated for the treatment of secondary hyperparathyroidism in adult patients with stage 3 or 4 chronic kidney disease and serum total 25 hydroxyvitamin d levels less than 30 ng ml,1
6606,6606,6606,6606,6606,6606,6606,8015,8015,8015,8015,8015,8015,8015,8015,8015,8015,8015,8015,8015,6a95effd-32a5-46b6-a30e-7f4f9bf8cc77,limitations of use rayaldee is not indicated for the treatment of secondary hyperparathyroidism in patients with stage 5 chronic kidney disease or in patients with end stage renal disease on dialysis,2
6607,6607,6607,6607,6607,6607,6607,8016,8016,8016,8016,8016,8016,8016,8016,8016,8016,8016,8016,8016,6a95effd-32a5-46b6-a30e-7f4f9bf8cc77,rayaldee is a vitamin d3 analog indicated for the treatment of secondary hyperparathyroidism in adults with stage 3 or 4 chronic kidney disease and serum total 25 hydroxyvitamin d levels less than 30 ng ml,1
6608,6608,6608,6608,6608,6608,6608,8017,8017,8017,8017,8017,8017,8017,8017,8017,8017,8017,8017,8017,6a95effd-32a5-46b6-a30e-7f4f9bf8cc77,( 1 ) limitations of use rayaldee is not indicated in patients with stage 5 chronic kidney disease or end stage renal disease on dialysis,2
6609,6609,6609,6609,6609,6609,6609,8018,8018,8018,8018,8018,8018,8018,8018,8018,8018,8018,8018,8018,44c45bfe-461f-4398-8f20-ea771b2403ee,1  natrecor ( nesiritide ) is indicated for the treatment of patients with acutely decompensated heart failure who have dyspnea at rest or with minimal activity,1
6610,6610,6610,6610,6610,6610,6610,8019,8019,8019,8019,8019,8019,8019,8019,8019,8019,8019,8019,8019,44c45bfe-461f-4398-8f20-ea771b2403ee,in this population  the use of natrecor reduced pulmonary capillary wedge pressure and improved short term ( 3 hours ) symptoms of dyspnea,u
6611,6611,6611,6611,6611,6611,6611,8020,8020,8020,8020,8020,8020,8020,8020,8020,8020,8020,8020,8020,44c45bfe-461f-4398-8f20-ea771b2403ee,natrecor is a natriuretic peptide indicated for the treatment of patients with acutely decompensated heart failure who have dyspnea at rest or with minimal activity,1
6612,6612,6612,6612,6612,6612,6612,8021,8021,8021,8021,8021,8021,8021,8021,8021,8021,8021,8021,8021,44c45bfe-461f-4398-8f20-ea771b2403ee,in this population  the use of natrecor reduced pulmonary capillary wedge pressure and improved symptomatic dyspnea when measured at 3 hours of infusion,u
6613,6613,6613,6613,6613,6613,6613,8022,8022,8022,8022,8022,8022,8022,8022,8022,8022,8022,8022,8022,773a19e8-4c3e-4414-99a6-aea98c9790ee, cevimeline hydrochloride capsules are indicated for the treatment of symptoms of dry mouth in patients with sj gren s syndrome,1
6614,6614,6614,6614,6614,6614,6614,8023,8023,8023,8023,8023,8023,8023,8023,8023,8023,8023,8023,8023,a6c24189-293f-42ca-b969-75870bb55af0, paclitaxel injection  usp is indicated as subsequent therapy for the treatment of advanced carcinoma of the ovary,1
6615,6615,6615,6615,6615,6615,6615,8024,8024,8024,8024,8024,8024,8024,8024,8024,8024,8024,8024,8024,a6c24189-293f-42ca-b969-75870bb55af0,as first line therapy  paclitaxel injection  usp is indicated in combination with cisplatin,1
6616,6616,6616,6616,6616,6616,6616,8025,8025,8025,8025,8025,8025,8025,8025,8025,8025,8025,8025,8025,a6c24189-293f-42ca-b969-75870bb55af0,paclitaxel injection  usp is indicated for the adjuvant treatment of node positive breast cancer administered sequentially to standard doxorubicin containing combination chemotherapy,1
6617,6617,6617,6617,6617,6617,6617,8026,8026,8026,8026,8026,8026,8026,8026,8026,8026,8026,8026,8026,a6c24189-293f-42ca-b969-75870bb55af0,in the clinical trial  there was an overall favorable effect on disease free and overall survival in the total population of patients with receptor positive and receptor negative tumors  but the benefit has been specifically demonstrated by available data ( median follow up 30 months ) only in the patients with estrogen and progesterone receptor negative tumors ( see clinical studies  breast carcinoma ),0
6618,6618,6618,6618,6618,6618,6618,8027,8027,8027,8027,8027,8027,8027,8027,8027,8027,8027,8027,8027,a6c24189-293f-42ca-b969-75870bb55af0,paclitaxel injection  usp is indicated for the treatment of breast cancer after failure of combination chemotherapy for metastatic disease or relapse within 6 months of adjuvant chemotherapy,1
6619,6619,6619,6619,6619,6619,6619,8028,8028,8028,8028,8028,8028,8028,8028,8028,8028,8028,8028,8028,a6c24189-293f-42ca-b969-75870bb55af0,prior therapy should have included an anthracycline unless clinically contraindicated,0
6620,6620,6620,6620,6620,6620,6620,8029,8029,8029,8029,8029,8029,8029,8029,8029,8029,8029,8029,8029,a6c24189-293f-42ca-b969-75870bb55af0,paclitaxel injection  usp  in combination with cisplatin  is indicated for the first line treatment of non small cell lung cancer in patients who are not candidates for potentially curative surgery and or radiation therapy,1
6621,6621,6621,6621,6621,6621,6621,8030,8030,8030,8030,8030,8030,8030,8030,8030,8030,8030,8030,8030,a6c24189-293f-42ca-b969-75870bb55af0,paclitaxel injection  usp is indicated for the second line treatment of aids related kaposi 's sarcoma,1
6622,6622,6622,6622,6622,6622,6622,8031,8031,8031,8031,8031,8031,8031,8031,8031,8031,8031,8031,8031,2a569ec5-08d7-44ab-b649-384a496e173c, the use of recombinate antihemophilic factor ( recombinant ) is indicated in hemophilia a ( classical hemophilia ) for the prevention and control of hemorrhagic episodes 2 recombinate is also indicated in the perioperative management of patients with hemophilia a ( classical hemophilia ),1
6623,6623,6623,6623,6623,6623,6623,8032,8032,8032,8032,8032,8032,8032,8032,8032,8032,8032,8032,8032,2a569ec5-08d7-44ab-b649-384a496e173c,recombinate can be of therapeutic value in patients with acquired factor viii inhibitors not exceeding 10 bethesda units per ml 3 in clinical studies with recombinate  patients with inhibitors who were entered into the previously treated patient trial and those previously untreated children who have developed inhibitor activity on study  showed clinical hemostatic response when the titer of inhibitor was less than 10 bethesda units per ml,u
6624,6624,6624,6624,6624,6624,6624,8033,8033,8033,8033,8033,8033,8033,8033,8033,8033,8033,8033,8033,2a569ec5-08d7-44ab-b649-384a496e173c,however  in such uses  the dosage of recombinate should be controlled by frequent laboratory determinations of circulating factor viii levels as well as the clinical status of the patient,0
6625,6625,6625,6625,6625,6625,6625,8034,8034,8034,8034,8034,8034,8034,8034,8034,8034,8034,8034,8034,2a569ec5-08d7-44ab-b649-384a496e173c,recombinate is not indicated in von willebrand s disease,2
6626,6626,6626,6626,6626,6626,6626,8035,8035,8035,8035,8035,8035,8035,8035,8035,8035,8035,8035,8035,85724f95-6fc9-4f0c-b69d-05a23b093e2b, timolol maleate ophthalmic solution is indicated in the treatment of elevated intraocular pressure in patients with ocular hypertension or open angle glaucoma,1
6627,6627,6627,6627,6627,6627,6627,8036,8036,8036,8036,8036,8036,8036,8036,8036,8036,8036,8036,8036,a5c104e7-4d99-49ec-80bf-eccea69b4c79,1  dorzolamide hydrochloride timolol maleate ophthalmic solution is indicated for the reduction of elevated intraocular pressure ( iop ) in patients with open angle glaucoma or ocular hypertension who are insufficiently responsive to betablockers ( failed to achieve target iop determined after multiple measurements over time ),1
6628,6628,6628,6628,6628,6628,6628,8037,8037,8037,8037,8037,8037,8037,8037,8037,8037,8037,8037,8037,a5c104e7-4d99-49ec-80bf-eccea69b4c79,the iop lowering of dorzolamide hydrochloride timolol maleate ophthalmic solution administered twice a day was slightly less than that seen with the concomitant administration of 0 5 timolol administered twice a day and 2 dorzolamide administered three times a day see clinical studies ( 14 ),0
6629,6629,6629,6629,6629,6629,6629,8038,8038,8038,8038,8038,8038,8038,8038,8038,8038,8038,8038,8038,a5c104e7-4d99-49ec-80bf-eccea69b4c79,dorzolamide hydrochloride timolol maleate ophthalmic solution is a carbonic anhydrase inhibitor with a beta adrenergic receptor blocking agent indicated for the reduction of elevated intraocular pressure ( iop ) in patients with open angle glaucoma or ocular hypertension who are insufficiently responsive to beta blockers,1
6630,6630,6630,6630,6630,6630,6630,8039,8039,8039,8039,8039,8039,8039,8039,8039,8039,8039,8039,8039,a5c104e7-4d99-49ec-80bf-eccea69b4c79,the iop lowering of dorzolamide hydrochloride timolol maleate ophthalmic solution twice daily was slightly less than that seen with the concomitant administration of 0 5 timolol twice daily  and 2 dorzolamide three times daily,0
6631,6631,6631,6631,6631,6631,6631,8040,8040,8040,8040,8040,8040,8040,8040,8040,8040,8040,8040,8040,cc7014b1-c775-411d-b374-8113248b4077, besponsa is indicated for the treatment of adults with relapsed or refractory b cell precursor acute lymphoblastic leukemia ( all ),1
6632,6632,6632,6632,6632,6632,6632,8041,8041,8041,8041,8041,8041,8041,8041,8041,8041,8041,8041,8041,cc7014b1-c775-411d-b374-8113248b4077,besponsa is a cd22 directed antibody drug conjugate ( adc ) indicated for the treatment of adults with relapsed or refractory b cell precursor acute lymphoblastic leukemia ( all ),1
6633,6633,6633,6633,6633,6633,6633,8042,8042,8042,8042,8042,8042,8042,8042,8042,8042,8042,8042,8042,26361de8-39b5-4266-90f6-2b307940135d,1  ganciclovir injection is a nucleoside analogue cmv dna polymerase inhibitor indicated for the treatment of cmv retinitis in immunocompromised adult patients  including patients with acquired immunodeficiency syndrome ( aids ),1
6634,6634,6634,6634,6634,6634,6634,8043,8043,8043,8043,8043,8043,8043,8043,8043,8043,8043,8043,8043,26361de8-39b5-4266-90f6-2b307940135d,( 1 1 ) prevention of cmv disease in adult transplant recipients at risk for cmv disease,1
6635,6635,6635,6635,6635,6635,6635,8044,8044,8044,8044,8044,8044,8044,8044,8044,8044,8044,8044,8044,26361de8-39b5-4266-90f6-2b307940135d,( 1 2 ) 1 1 treatment of cmv retinitis ganciclovir injection is indicated for the treatment of cytomegalovirus ( cmv ) retinitis in immunocompromised adult patients  including patients with acquired immunodeficiency syndrome ( aids ) see clinical studies ( 14 ),1
6636,6636,6636,6636,6636,6636,6636,8045,8045,8045,8045,8045,8045,8045,8045,8045,8045,8045,8045,8045,26361de8-39b5-4266-90f6-2b307940135d,1 2 prevention of cmv disease in transplant recipients ganciclovir injection is indicated for the prevention of cmv disease in adult transplant recipients at risk for cmv disease see clinical studies ( 14 ),1
6637,6637,6637,6637,6637,6637,6637,8052,8052,8052,8052,8052,8052,8052,8052,8052,8052,8052,8052,8052,42c49deb-713b-427a-9670-08af08adcffb,1  alecensa is indicated for the treatment of patients with anaplastic lymphoma kinase ( alk ) positive metastatic non small cell lung cancer ( nsclc ) as detected by an fda approved test,1
6638,6638,6638,6638,6638,6638,6638,8053,8053,8053,8053,8053,8053,8053,8053,8053,8053,8053,8053,8053,42c49deb-713b-427a-9670-08af08adcffb,alecensa is a kinase inhibitor indicated for the treatment of patients with anaplastic lymphoma kinase ( alk ) positive metastatic non small cell lung cancer ( nsclc ) as detected by an fda approved test,1
6639,6639,6639,6639,6639,6639,6639,8058,8058,8058,8058,8058,8058,8058,8058,8058,8058,8058,8058,8058,6fa380c4-c885-4743-85bf-88819ae68645,1  almotriptan tablets  usp are 5ht1b 1d receptor agonist ( triptan ) indicated for acute treatment of migraine attacks in adults with a history of migraine with or without aura ( 1 1 ) acute treatment of migraine headache pain in adolescents age 12 to 17 years with a history of migraine with or without aura  and who have migraine attacks usually lasting 4 hours or more ( 1 1 ) important limitations use only after a clear diagnosis of migraine has been established ( 1 2 ) in adolescents age 12 to 17 years  efficacy of almotriptan tablets on migraine associated symptoms was not established ( 1 2 ) not intended for the prophylactic therapy of migraine ( 1 2 ) not indicated for the treatment of cluster headache ( 1 2 ) 1 1 acute treatment of migraine attacks adults almotriptan tablets  usp are indicated for the acute treatment of migraine attacks in patients with a history of migraine with or without aura,1
6640,6640,6640,6640,6640,6640,6640,8059,8059,8059,8059,8059,8059,8059,8059,8059,8059,8059,8059,8059,6fa380c4-c885-4743-85bf-88819ae68645,adolescents age 12 to 17 years almotriptan tablets  usp are indicated for the acute treatment of migraine headache pain in patients with a history of migraine attacks with or without aura usually lasting 4 hours or more ( when untreated ),1
6641,6641,6641,6641,6641,6641,6641,8060,8060,8060,8060,8060,8060,8060,8060,8060,8060,8060,8060,8060,6fa380c4-c885-4743-85bf-88819ae68645,1 2 important limitations almotriptan tablets should only be used where a clear diagnosis of migraine has been established,u
6642,6642,6642,6642,6642,6642,6642,8061,8061,8061,8061,8061,8061,8061,8061,8061,8061,8061,8061,8061,6fa380c4-c885-4743-85bf-88819ae68645,if a patient has no response for the first migraine attack treated with almotriptan tablets  the diagnosis of migraine should be reconsidered before almotriptan tablets are administered to treat any subsequent attacks,0
6643,6643,6643,6643,6643,6643,6643,8062,8062,8062,8062,8062,8062,8062,8062,8062,8062,8062,8062,8062,6fa380c4-c885-4743-85bf-88819ae68645,in adolescents age 12 to 17 years  efficacy of almotriptan tablets on migraine associated symptoms ( nausea  photophobia  and phonophobia ) was not established,0
6644,6644,6644,6644,6644,6644,6644,8063,8063,8063,8063,8063,8063,8063,8063,8063,8063,8063,8063,8063,6fa380c4-c885-4743-85bf-88819ae68645,almotriptan tablets are not intended for the prophylactic therapy of migraine or for use in the management of hemiplegic or basilar migraine see contraindications ( 4 7 ),0
6645,6645,6645,6645,6645,6645,6645,8064,8064,8064,8064,8064,8064,8064,8064,8064,8064,8064,8064,8064,6fa380c4-c885-4743-85bf-88819ae68645,safety and effectiveness of almotriptan tablets have not been established for cluster headache which is present in an older  predominantly male population,0
6646,6646,6646,6646,6646,6646,6646,8065,8065,8065,8065,8065,8065,8065,8065,8065,8065,8065,8065,8065,301f01a7-2b0a-cfba-9c3d-a1dd831785a3,1 indications usage guanfacine extended release tablets are indicated for the treatment of attention deficit hyperactivity disorder ( adhd ) as monotherapy and as adjunctive therapy to stimulant medications,1
6647,6647,6647,6647,6647,6647,6647,8066,8066,8066,8066,8066,8066,8066,8066,8066,8066,8066,8066,8066,301f01a7-2b0a-cfba-9c3d-a1dd831785a3,the efficacy of guanfacine extended release tabletswere studied for the treatment of adhd in three controlled monotherapy clinical trials ( up to 8 weeks in duration ) and one controlled adjunctive trial with psychostimulants ( 8 weeks in duration ) in children and adolescents ages 6 to 17 who met dsm iv criteria for adhd see clinical studies ( 14 ),0
6648,6648,6648,6648,6648,6648,6648,8067,8067,8067,8067,8067,8067,8067,8067,8067,8067,8067,8067,8067,301f01a7-2b0a-cfba-9c3d-a1dd831785a3,the effectiveness of guanfacine extended release tablets for longer term use ( more than 8 weeks ) has not been systematically evaluated in controlled trials,0
6649,6649,6649,6649,6649,6649,6649,8068,8068,8068,8068,8068,8068,8068,8068,8068,8068,8068,8068,8068,301f01a7-2b0a-cfba-9c3d-a1dd831785a3,guanfacine extended release is a central alpha 2a adrenergic receptor agonist indicated for the treatment of attention deficit hyperactivity disorder ( adhd ) as monotherapy and as adjunctive therapy to stimulant medications ( 1 ),1
6650,6650,6650,6650,6650,6650,6650,8069,8069,8069,8069,8069,8069,8069,8069,8069,8069,8069,8069,8069,ae126418-5474-4fbe-b83c-bde8b2b4ae6e, for treatment of the hyperuricemia associated with gout and gouty arthritis,1
6651,6651,6651,6651,6651,6651,6651,8070,8070,8070,8070,8070,8070,8070,8070,8070,8070,8070,8070,8070,ae126418-5474-4fbe-b83c-bde8b2b4ae6e,as an adjuvant to therapy with penicillin or with ampicillin  methicillin  oxacillin  cloxacillin  or nafcillin  for elevation and prolongation of plasma levels by whatever route the antibiotic is given,1
6652,6652,6652,6652,6652,6652,6652,8071,8071,8071,8071,8071,8071,8071,8071,8071,8071,8071,8071,8071,842dd93d-54e6-43b8-8bd5-d135fc5a3400, for the treatment of chronic gouty arthritis when complicated by frequent  recurrent acute attacks of gout,1
6653,6653,6653,6653,6653,6653,6653,8072,8072,8072,8072,8072,8072,8072,8072,8072,8072,8072,8072,8072,446f6b5c-0dd4-44ff-9bc2-c2b41f2806b4,1  praluent is a pcsk9 ( proprotein convertase subtilisin kexin type 9 ) inhibitor antibody indicated as adjunct to diet and maximally tolerated statin therapy for the treatment of adults with heterozygous familial hypercholesterolemia or clinical atherosclerotic cardiovascular disease  who require additional lowering of ldl cholesterol ( ldl c ),1
6654,6654,6654,6654,6654,6654,6654,8073,8073,8073,8073,8073,8073,8073,8073,8073,8073,8073,8073,8073,446f6b5c-0dd4-44ff-9bc2-c2b41f2806b4,( 1 1 ) limitations of use the effect of praluent on cardiovascular morbidity and mortality has not been determined,2
6655,6655,6655,6655,6655,6655,6655,8074,8074,8074,8074,8074,8074,8074,8074,8074,8074,8074,8074,8074,446f6b5c-0dd4-44ff-9bc2-c2b41f2806b4,( 1 2 ) 1 1 primary hyperlipidemia praluent is indicated as an adjunct to diet and maximally tolerated statin therapy for the treatment of adults with heterozygous familial hypercholesterolemia or clinical atherosclerotic cardiovascular disease  who require additional lowering of ldl c 1 2 limitations of use the effect of praluent on cardiovascular morbidity and mortality has not been determined,1
6656,6656,6656,6656,6656,6656,6656,8075,8075,8075,8075,8075,8075,8075,8075,8075,8075,8075,8075,8075,a6c36a36-28ee-4a1b-86fe-98ef94064b68,ascorbic acid is recommended for the prevention and treatment of scurvy,u
6657,6657,6657,6657,6657,6657,6657,8076,8076,8076,8076,8076,8076,8076,8076,8076,8076,8076,8076,8076,a6c36a36-28ee-4a1b-86fe-98ef94064b68,its parenteral administration is desirable for patients with an acute deficiency or for those whose absorption of orally ingested ascorbic acid is uncertain,1
6658,6658,6658,6658,6658,6658,6658,8077,8077,8077,8077,8077,8077,8077,8077,8077,8077,8077,8077,8077,a6c36a36-28ee-4a1b-86fe-98ef94064b68,symptoms of mild deficiency may include faulty bone and tooth development  gingivitis  bleeding gums  and loosened teeth,u
6659,6659,6659,6659,6659,6659,6659,8078,8078,8078,8078,8078,8078,8078,8078,8078,8078,8078,8078,8078,a6c36a36-28ee-4a1b-86fe-98ef94064b68,febrile states  chronic illness  and infection ( pneumonia  whooping cough  tuberculosis  diphtheria  sinusitis  rheumatic fever  etc ),u
6660,6660,6660,6660,6660,6660,6660,8079,8079,8079,8079,8079,8079,8079,8079,8079,8079,8079,8079,8079,a6c36a36-28ee-4a1b-86fe-98ef94064b68,increases the need for ascorbic acid,0
6661,6661,6661,6661,6661,6661,6661,8080,8080,8080,8080,8080,8080,8080,8080,8080,8080,8080,8080,8080,a6c36a36-28ee-4a1b-86fe-98ef94064b68,hemovascular disorders  burns  delayed fracture and wound healing are indications for an increase in the daily intake,1
6662,6662,6662,6662,6662,6662,6662,8081,8081,8081,8081,8081,8081,8081,8081,8081,8081,8081,8081,8081,"Active Ingredient UNII(s)
PQX0D8J21J    8bc6397e-4bd8-4d37-a007-a327e4da34d9
PQX0D8J21J    8bc6397e-4bd8-4d37-a007-a327e4da34d9
PQX0D8J21J    8bc6397e-4bd8-4d37-a007-a327e4da34d9
Name: SET ID dtype: object",active ingredient unii ( s ) pqx0d8j21j active ingredient unii ( s ) pqx0d8j21j active in pqx0d8j21j active ingredient unii ( s ) pqx0d8j21j active in pqx0d8j21j active ingredient unii ( s ) pqx0d8j21j active in name content xml  dtype object,0
6663,6663,6663,6663,6663,6663,6663,8084,8084,8084,8084,8084,8084,8084,8084,8084,8084,8084,8084,8084,ff09a726-9f9b-4e30-b509-396781293220,1  orbactiv is a lipoglycopeptide antibacterial drug indicated for the treatment of adult patients with acute bacterial skin and skin structure infections caused or suspected to be caused by susceptible isolates of designated gram positive microorganisms,1
6664,6664,6664,6664,6664,6664,6664,8085,8085,8085,8085,8085,8085,8085,8085,8085,8085,8085,8085,8085,ff09a726-9f9b-4e30-b509-396781293220,( 1 1 ) to reduce the development of drug resistant bacteria and maintain the effectiveness of orbactiv and other antibacterial drugs  orbactiv should be used only to treat infections that are proven or strongly suspected to be caused by susceptible bacteria,4
6665,6665,6665,6665,6665,6665,6665,8086,8086,8086,8086,8086,8086,8086,8086,8086,8086,8086,8086,8086,ff09a726-9f9b-4e30-b509-396781293220,( 1 2 ) 1 1 acute bacterial skin and skin structure infections orbactiv ( oritavancin ) for injection is indicated for the treatment of adult patients with acute bacterial skin and skin structure infections ( absssi ) caused by susceptible isolates of the following gram positive microorganisms staphylococcus aureus ( including methicillin susceptible and methicillin resistant isolates )  streptococcus pyogenes  streptococcus agalactiae  streptococcus dysgalactiae  streptococcus anginosus group ( includes s anginosus  s intermedius  and s constellatus )  and enterococcus faecalis ( vancomycin susceptible isolates only ),1
6666,6666,6666,6666,6666,6666,6666,8087,8087,8087,8087,8087,8087,8087,8087,8087,8087,8087,8087,8087,ff09a726-9f9b-4e30-b509-396781293220,1 2 usage to reduce the development of drug resistant bacteria and maintain the effectiveness of orbactiv and other antibacterial drugs  orbactiv should be used only to treat infections that are proven or strongly suspected to be caused by susceptible bacteria,4
6667,6667,6667,6667,6667,6667,6667,8090,8090,8090,8090,8090,8090,8090,8090,8090,8090,8090,8090,8090,97cc73cc-b5b7-458a-a933-77b00523e193,1 indicatio ns and usage neupogen is a leukocyte growth factor indicated to decrease the incidence of infection as manifested by febrile neutropenia in patients with nonmyeloid malignancies receiving myelosuppressive anti cancer drugs associated with a significant incidence of severe neutropenia with fever ( 1 1 ) reduce the time to neutrophil recovery and the duration of fever  following induction or consolidation chemotherapy treatment of patients with acute myeloid leukemia ( aml ) ( 1 2 ) reduce the duration of neutropenia and neutropenia related clinical sequelae e g febrile neutropenia  in patients with nonmyeloid malignancies undergoing myeloablative chemotherapy followed by bone marrow transplantation ( bmt ) ( 1 3 ) mobilize autologous hematopoietic progenitor cells into the peripheral blood for collection by leukapheresis ( 1 4 ) reduce the incidence and duration of sequelae of severe neutropenia ( e g fever infections oropharyngeal ulcers ) in symptomatic patients with congenital neutropenia cyclic neutropenia or idiopathic neutropenia ( 1 5 ) increase survival in patients acutely exposed to myelosuppressive doses of radiation ( hematopoietic syndrome of acute radiation syndrome ) ( 1 6 ) 1 1 patients with cancer receiving myelosuppressive chemotherapy neupogen is indicated to decrease the incidence of infection as manifested by febrile neutropenia in patients with nonmyeloid malignancies receiving myelosuppressive anti cancer drugs associated with a significant incidence of severe neutropenia with fever see clinical studies ( 14 1 ),1
6668,6668,6668,6668,6668,6668,6668,8091,8091,8091,8091,8091,8091,8091,8091,8091,8091,8091,8091,8091,97cc73cc-b5b7-458a-a933-77b00523e193,1 2 patients with acute myeloid leukemia receiving induction or consolidation chemotherapy neupogen is indicated for reducing the time to neutrophil recovery and the duration of fever  following induction or consolidation chemotherapy treatment of patients with acute myeloid leukemia ( aml ) see clinical studies (,1
6669,6669,6669,6669,6669,6669,6669,8092,8092,8092,8092,8092,8092,8092,8092,8092,8092,8092,8092,8092,45584fba-8081-4cd1-a21e-3ea8237f62ff,1  mytesi is indicated for symptomatic relief of non infectious diarrhea in adult patients with hiv aids on anti retroviral therapy,1
6670,6670,6670,6670,6670,6670,6670,8093,8093,8093,8093,8093,8093,8093,8093,8093,8093,8093,8093,8093,45584fba-8081-4cd1-a21e-3ea8237f62ff,mytesi is an anti diarrheal indicated for the symptomatic relief of non infectious diarrhea in adult patients with hiv aids on anti retroviral therapy,1
6671,6671,6671,6671,6671,6671,6671,8095,8095,8095,8095,8095,8095,8095,8095,8095,8095,8095,8095,8095,aad8b373-0aec-4efb-8e61-3d8114b31127,drug therapy is indicated as an adjunct to diet when the response to a diet restricted in saturated fat and cholesterol and other non pharmacologic measures alone has been inadequate,u
6672,6672,6672,6672,6672,6672,6672,8096,8096,8096,8096,8096,8096,8096,8096,8096,8096,8096,8096,8096,aad8b373-0aec-4efb-8e61-3d8114b31127,fluvastatin capsules are an hmg coa reductase inhibitor ( statin ) indicated as an adjunctive therapy to diet to reduce elevated tc  ldl c  apo b  and tg  and to increase hdl c in adult patients with primary hypercholesterolemia and mixed dyslipidemia ( 1 1 ) reduce elevated tc  ldl c  and apo b levels in boys and post menarchal girls  10 to 16 years of age  with heterozygous familial hypercholesterolemia after failing an adequate trial of diet therapy ( 1 1 ) reduce the risk of undergoing revascularization procedures in patients with clinically evident chd ( 1 2 ) slow the progression of atherosclerosis in patients with chd ( 1 2 ) limitations of use fluvastatin capsules have not been studied in conditions where the major abnormality is elevation of chylomicrons  vldl  or idl ( i e  hyperlipoproteinemia types i  iii  iv  or v ),1
6673,6673,6673,6673,6673,6673,6673,8097,8097,8097,8097,8097,8097,8097,8097,8097,8097,8097,8097,8097,aad8b373-0aec-4efb-8e61-3d8114b31127,( 1 3 ) 1 1 hypercholesterolemia ( heterozygous familial and nonfamilial ) and mixed dyslipidemia fluvastatin capsules are indicated as an adjunct to diet to reduce elevated total cholesterol ( total c )  low density lipoprotein cholesterol ( ldl c )  triglyceride ( tg ) and apolipoprotein b ( apo b ) levels  and to increase high density lipoprotein cholesterol ( hdl c ) in patients with primary hypercholesterolemia and mixed dyslipidemia ( fredrickson type iia and iib ),1
6674,6674,6674,6674,6674,6674,6674,8098,8098,8098,8098,8098,8098,8098,8098,8098,8098,8098,8098,8098,aad8b373-0aec-4efb-8e61-3d8114b31127,as an adjunct to diet to reduce total c  ldl c  and apo b levels in adolescent boys and adolescent girls who are at least one year post menarche  10 to 16 years of age  with heterozygous familial hypercholesterolemia and the following findings are present ldl c remains 190 mg dl or,1
6675,6675,6675,6675,6675,6675,6675,8099,8099,8099,8099,8099,8099,8099,8099,8099,8099,8099,8099,8099,e60f795b-fce3-4361-aa03-f143451689d1,1  edarbyclor contains an angiotensin ii receptor blocker ( arb ) and a thiazide like diuretic and is indicated for the treatment of hypertension  to lower blood pressure,1
6676,6676,6676,6676,6676,6676,6676,8100,8100,8100,8100,8100,8100,8100,8100,8100,8100,8100,8100,8100,e60f795b-fce3-4361-aa03-f143451689d1,edarbyclor may be used in patients whose blood pressure is not adequately controlled on monotherapy,u
6677,6677,6677,6677,6677,6677,6677,8101,8101,8101,8101,8101,8101,8101,8101,8101,8101,8101,8101,8101,e60f795b-fce3-4361-aa03-f143451689d1,edarbyclor may be used as initial therapy if a patient is likely to need multiple drugs to achieve blood pressure goals,4
6678,6678,6678,6678,6678,6678,6678,8103,8103,8103,8103,8103,8103,8103,8103,8103,8103,8103,8103,8103,e60f795b-fce3-4361-aa03-f143451689d1,these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including thiazide like diuretics such as chlorthalidone and arbs such as azilsartan medoxomil,0
6679,6679,6679,6679,6679,6679,6679,8104,8104,8104,8104,8104,8104,8104,8104,8104,8104,8104,8104,8104,e60f795b-fce3-4361-aa03-f143451689d1,there are no controlled trials demonstrating risk reduction with edarbyclor,0
6680,6680,6680,6680,6680,6680,6680,8107,8107,8107,8107,8107,8107,8107,8107,8107,8107,8107,8107,8107,e60f795b-fce3-4361-aa03-f143451689d1,for specific advice on goals and management of high blood pressure  see published guidelines  such as those of the national high blood pressure education program 's joint national committee on prevention  detection  evaluation  and treatment of high blood pressure ( jnc ),0
6681,6681,6681,6681,6681,6681,6681,8112,8112,8112,8112,8112,8112,8112,8112,8112,8112,8112,8112,8112,e60f795b-fce3-4361-aa03-f143451689d1,some antihypertensive drugs have smaller blood pressure effects ( as monotherapy ) in black patients however  the blood pressure effect of edarbyclor in blacks is similar to that in non blacks,0
6682,6682,6682,6682,6682,6682,6682,8113,8113,8113,8113,8113,8113,8113,8113,8113,8113,8113,8113,8113,e60f795b-fce3-4361-aa03-f143451689d1,many antihypertensive drugs have additional approved indications and effects ( e g  on angina  heart failure  or diabetic kidney disease ),0
6683,6683,6683,6683,6683,6683,6683,8115,8115,8115,8115,8115,8115,8115,8115,8115,8115,8115,8115,8115,e60f795b-fce3-4361-aa03-f143451689d1,the choice of edarbyclor as initial therapy for hypertension should be based on an assessment of potential benefits and risks including whether the patient is likely to tolerate the starting dose of edarbyclor,4
6684,6684,6684,6684,6684,6684,6684,8116,8116,8116,8116,8116,8116,8116,8116,8116,8116,8116,8116,8116,e60f795b-fce3-4361-aa03-f143451689d1,patients with moderate to severe hypertension are at a relatively high risk of cardiovascular events ( e g  stroke  heart attack  and heart failure )  kidney failure  and vision problems  so prompt treatment is clinically re,u
6685,6685,6685,6685,6685,6685,6685,8117,8117,8117,8117,8117,8117,8117,8117,8117,8117,8117,8117,8117,baac91ad-f8ee-4694-89f8-5c47a8eda39a, moexipril hydrochloride tablets are indicated for treatment of patients with hypertension,1
6686,6686,6686,6686,6686,6686,6686,8119,8119,8119,8119,8119,8119,8119,8119,8119,8119,8119,8119,8119,baac91ad-f8ee-4694-89f8-5c47a8eda39a,in using moexipril hydrochloride tablets  consideration should be given to the fact that another ace inhibitor  captopril  has caused agranulocytosis  particularly in patients with renal impairment or collagen vascular disease,0
6687,6687,6687,6687,6687,6687,6687,8120,8120,8120,8120,8120,8120,8120,8120,8120,8120,8120,8120,8120,baac91ad-f8ee-4694-89f8-5c47a8eda39a,available data are insufficient to show that moexipril hydrochloride tablets do not have a similar risk ( see warnings ),0
6688,6688,6688,6688,6688,6688,6688,8121,8121,8121,8121,8121,8121,8121,8121,8121,8121,8121,8121,8121,baac91ad-f8ee-4694-89f8-5c47a8eda39a,in considering use of moexipril hydrochloride tablets  it should be noted that in controlled trials ace inhibitors have an effect on blood pressure that is less in black patients than in non blacks,0
6689,6689,6689,6689,6689,6689,6689,8122,8122,8122,8122,8122,8122,8122,8122,8122,8122,8122,8122,8122,baac91ad-f8ee-4694-89f8-5c47a8eda39a,in addition  ace inhibitors ( for which adequate data are available ) cause a higher rate of angioedema in black than in non black patients ( see warnings  angioedema ),0
6690,6690,6690,6690,6690,6690,6690,8123,8123,8123,8123,8123,8123,8123,8123,8123,8123,8123,8123,8123,609b77de-1ca3-4783-b8f5-01a9c0f1d77d,1  eucrisa is indicated for topical treatment of mild to moderate atopic dermatitis in patients 2 years of age and older,1
6691,6691,6691,6691,6691,6691,6691,8124,8124,8124,8124,8124,8124,8124,8124,8124,8124,8124,8124,8124,609b77de-1ca3-4783-b8f5-01a9c0f1d77d,eucrisa is a phosphodiesterase 4 inhibitor indicated for topical treatment of mild to moderate atopic dermatitis in patients 2 years of age and older,1
6692,6692,6692,6692,6692,6692,6692,8125,8125,8125,8125,8125,8125,8125,8125,8125,8125,8125,8125,8125,0d30fb0a-e343-426d-8203-5816bd4cec2f, cromolyn sodium ophthalmic solution usp  4 is indicated in the treatment of vernal keratoconjunctivitis  vernal conjunctivitis  and vernal keratitis,1
6693,6693,6693,6693,6693,6693,6693,8126,8126,8126,8126,8126,8126,8126,8126,8126,8126,8126,8126,8126,c2768add-5e01-4ff4-afa3-230380d59a1f, diazepam tablets are indicated for the management of anxiety disorders or for the short term relief of the symptoms of anxiety,1
6694,6694,6694,6694,6694,6694,6694,8128,8128,8128,8128,8128,8128,8128,8128,8128,8128,8128,8128,8128,c2768add-5e01-4ff4-afa3-230380d59a1f,in acute alcohol withdrawal  diazepam tablets may be useful in the symptomatic relief of acute agitation  tremor  impending or acute delirium tremens and hallucinosis,1
6695,6695,6695,6695,6695,6695,6695,8129,8129,8129,8129,8129,8129,8129,8129,8129,8129,8129,8129,8129,c2768add-5e01-4ff4-afa3-230380d59a1f,diazepam tablets are a useful adjunct for the relief of skeletal muscle spasm due to reflex spasm to local pathology ( such as inflammation of the muscles or joints  or secondary to trauma )  spasticity caused by upper motor neuron disorders ( such as cerebral palsy and paraplegia )  athetosis  and stiff man syndrome,1
6696,6696,6696,6696,6696,6696,6696,8130,8130,8130,8130,8130,8130,8130,8130,8130,8130,8130,8130,8130,c2768add-5e01-4ff4-afa3-230380d59a1f,oral diazepam tablets may be used adjunctively in convulsive disorders  although it has not proved useful as the sole therapy,1
6697,6697,6697,6697,6697,6697,6697,8131,8131,8131,8131,8131,8131,8131,8131,8131,8131,8131,8131,8131,c2768add-5e01-4ff4-afa3-230380d59a1f,the effectiveness of diazepam tablets in long term use  that is  more than 4 months  has not been assessed by systematic clinical studies,0
6698,6698,6698,6698,6698,6698,6698,8133,8133,8133,8133,8133,8133,8133,8133,8133,8133,8133,8133,8133,fafa4cf1-99c2-43d5-73ad-51f256de3be0,1  symbicort is a combination product containing a corticosteroid and a long acting beta2 adrenergic agonist indicated for treatment of asthma in patients 6 years of age and older,1
6699,6699,6699,6699,6699,6699,6699,8134,8134,8134,8134,8134,8134,8134,8134,8134,8134,8134,8134,8134,fafa4cf1-99c2-43d5-73ad-51f256de3be0,( 1 1 ) maintenance treatment of airflow obstruction and reducing exacerbations in patients with chronic obstructive pulmonary disease ( copd ) including chronic bronchitis and or emphysema,1
6700,6700,6700,6700,6700,6700,6700,8135,8135,8135,8135,8135,8135,8135,8135,8135,8135,8135,8135,8135,fafa4cf1-99c2-43d5-73ad-51f256de3be0,( 1 2 ) important limitations not indicated for the relief of acute bronchospasm,2
6701,6701,6701,6701,6701,6701,6701,8136,8136,8136,8136,8136,8136,8136,8136,8136,8136,8136,8136,8136,fafa4cf1-99c2-43d5-73ad-51f256de3be0,( 1 1  1 2 ) 1 1 treatment of asthma symbicort is indicated for the treatment of asthma in patients 6 years of age and older,1
6702,6702,6702,6702,6702,6702,6702,8137,8137,8137,8137,8137,8137,8137,8137,8137,8137,8137,8137,8137,fafa4cf1-99c2-43d5-73ad-51f256de3be0,symbicort should be used for patients not adequately controlled on a long term asthma control medication such as an inhaled corticosteroid ( ics ) or whose disease warrants initiation of treatment with both an inhaled corticosteroid and long acting beta2 adrenergic agonist ( laba ),u
6703,6703,6703,6703,6703,6703,6703,8138,8138,8138,8138,8138,8138,8138,8138,8138,8138,8138,8138,8138,fafa4cf1-99c2-43d5-73ad-51f256de3be0,important limitations of use symbicort is not indicated for the relief of acute bronchospasm,0
6704,6704,6704,6704,6704,6704,6704,8139,8139,8139,8139,8139,8139,8139,8139,8139,8139,8139,8139,8139,fafa4cf1-99c2-43d5-73ad-51f256de3be0,1 2 maintenance treatment of chronic obstructive pulmonary disease symbicort 160 4 5 is indicated for the maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease ( copd ) including chronic bronchitis and or emphysema,1
6705,6705,6705,6705,6705,6705,6705,8140,8140,8140,8140,8140,8140,8140,8140,8140,8140,8140,8140,8140,fafa4cf1-99c2-43d5-73ad-51f256de3be0,symbicort 160 4 5 is also indicated to reduce exacerbations of copd,1
6706,6706,6706,6706,6706,6706,6706,8141,8141,8141,8141,8141,8141,8141,8141,8141,8141,8141,8141,8141,fafa4cf1-99c2-43d5-73ad-51f256de3be0,symbicort 160 4 5 is the only strength indicated for the treatment of copd,4
6707,6707,6707,6707,6707,6707,6707,8143,8143,8143,8143,8143,8143,8143,8143,8143,8143,8143,8143,8143,ffd1edc1-2f40-4b0a-a53a-9fb53b8d3184, for the treatment of superficial infections of the external auditory canal caused by organisms susceptible to the action of the antimicrobial  complicated by inflammation,1
6708,6708,6708,6708,6708,6708,6708,8144,8144,8144,8144,8144,8144,8144,8144,8144,8144,8144,8144,8144,4368656c-6c2b-474c-6144-4f532d424646,1  cyanokit contains hydroxocobalamin  an antidote indicated for the treatment of known or suspected cyanide poisoning,1
6709,6709,6709,6709,6709,6709,6709,8145,8145,8145,8145,8145,8145,8145,8145,8145,8145,8145,8145,8145,4368656c-6c2b-474c-6144-4f532d424646,( 1 1 ) if clinical suspicion of cyanide poisoning is high  cyanokit should be administered without delay,4
6710,6710,6710,6710,6710,6710,6710,8146,8146,8146,8146,8146,8146,8146,8146,8146,8146,8146,8146,8146,4368656c-6c2b-474c-6144-4f532d424646,( 1 2 ) the expert advice of a regional poison control center may be obtained by calling 1 800 222 1222,0
6711,6711,6711,6711,6711,6711,6711,8147,8147,8147,8147,8147,8147,8147,8147,8147,8147,8147,8147,8147,4368656c-6c2b-474c-6144-4f532d424646,( 1 2 ) 1 1 indication cyanokit is indicated for the treatment of known or suspected cyanide poisoning,1
6712,6712,6712,6712,6712,6712,6712,8148,8148,8148,8148,8148,8148,8148,8148,8148,8148,8148,8148,8148,4368656c-6c2b-474c-6144-4f532d424646,1 2 identifying patients with cyanide poisoning cyanide poisoning may result from inhalation  ingestion  or dermal exposure to various cyanide containing compounds  including smoke from closed space fires,4
6713,6713,6713,6713,6713,6713,6713,8149,8149,8149,8149,8149,8149,8149,8149,8149,8149,8149,8149,8149,4368656c-6c2b-474c-6144-4f532d424646,sources of cyanide poisoning include hydrogen cyanide and its salts  cyanogenic plants  aliphatic nitriles  and prolonged exposure to sodium nitroprusside,0
6714,6714,6714,6714,6714,6714,6714,8150,8150,8150,8150,8150,8150,8150,8150,8150,8150,8150,8150,8150,4368656c-6c2b-474c-6144-4f532d424646,the presence and extent of cyanide poisoning are often initially unknown,0
6715,6715,6715,6715,6715,6715,6715,8151,8151,8151,8151,8151,8151,8151,8151,8151,8151,8151,8151,8151,4368656c-6c2b-474c-6144-4f532d424646,there is no widely available  rapid  confirmatory cyanide blood test,0
6716,6716,6716,6716,6716,6716,6716,8152,8152,8152,8152,8152,8152,8152,8152,8152,8152,8152,8152,8152,4368656c-6c2b-474c-6144-4f532d424646,treatment decisions must be made on the basis of clinical history and signs and symptoms of cyanide intoxication,4
6717,6717,6717,6717,6717,6717,6717,8153,8153,8153,8153,8153,8153,8153,8153,8153,8153,8153,8153,8153,4368656c-6c2b-474c-6144-4f532d424646,if clinical suspicion of cyanide poisoning is high  cyanokit should be administered without delay,4
6718,6718,6718,6718,6718,6718,6718,8154,8154,8154,8154,8154,8154,8154,8154,8154,8154,8154,8154,8154,4368656c-6c2b-474c-6144-4f532d424646,table 1 common signs and symptoms of cyanide poisoning symptoms headache confusion dyspnea chest tightness nausea signs altered mental status ( e g  confusion  disorientation ) seizures or coma mydriasis tachypnea hyperpnea ( early ) bradypnea apnea ( late ) hypertension ( early ) hypotension ( late ) cardiovascular collapse vomiting plasma lactate concentration 8 mmol l,0
6719,6719,6719,6719,6719,6719,6719,8155,8155,8155,8155,8155,8155,8155,8155,8155,8155,8155,8155,8155,ff913271-0090-4832-a0fe-5154fe8f97b9, alkeran tablets are indicated for the palliative treatment of multiple myeloma and for the palliation of non resectable epithelial carcinoma of the ovary,1
6720,6720,6720,6720,6720,6720,6720,8156,8156,8156,8156,8156,8156,8156,8156,8156,8156,8156,8156,8156,de61685e-2b8c-4e22-84bb-869e13600440,1  pegasys is an inducer of the innate immune response indicated for the treatment of chronic hepatitis c ( chc ) ( 1 1 ) adult patients in combination therapy with other hepatitis c virus drugs for adults with compensated liver disease,1
6721,6721,6721,6721,6721,6721,6721,8157,8157,8157,8157,8157,8157,8157,8157,8157,8157,8157,8157,8157,de61685e-2b8c-4e22-84bb-869e13600440,pegasys monotherapy is indicated only if patient has contraindication or significant intolerance to other hcv drugs,1
6722,6722,6722,6722,6722,6722,6722,8158,8158,8158,8158,8158,8158,8158,8158,8158,8158,8158,8158,8158,de61685e-2b8c-4e22-84bb-869e13600440,pediatric patients in combination with ribavirin for pediatric patients 5 years of age and older with compensated liver disease chronic hepatitis b ( chb ) ( 1 2 ) adult patients treatment of adults with hbeag positive and hbeag negative chronic hepatitis b ( chb ) infection who have compensated liver disease and evidence of viral replication and liver inflammation pediatric patients treatment of non cirrhotic pediatric patients 3 years of age and older with hbeag positive chb and evidence of viral replication and elevations in serum alanine aminotransferase ( alt ) 1 1 chronic hepatitis c ( chc ) adult patients pegasys  as part of a combination regimen with other hepatitis c virus ( hcv ) antiviral drugs  is indicated for the treatment of adults with chc and compensated liver disease,1
6723,6723,6723,6723,6723,6723,6723,8159,8159,8159,8159,8159,8159,8159,8159,8159,8159,8159,8159,8159,de61685e-2b8c-4e22-84bb-869e13600440,for information about the safe and effective use of other hcv antiviral drugs to be used in combination with pegasys  refer to their prescribing information,0
6724,6724,6724,6724,6724,6724,6724,8160,8160,8160,8160,8160,8160,8160,8160,8160,8160,8160,8160,8160,de61685e-2b8c-4e22-84bb-869e13600440,pegasys monotherapy is only indicated for the treatment of patients with chc and compensated liver disease if there are contraindications or significant intolerance to other hcv antiviral drugs,1
6725,6725,6725,6725,6725,6725,6725,8161,8161,8161,8161,8161,8161,8161,8161,8161,8161,8161,8161,8161,de61685e-2b8c-4e22-84bb-869e13600440,pediatric patients pegasys in combination with ribavirin is indicated for the treatment of pediatric patients 5 years of age and older with chc and compensated liver disease,1
6726,6726,6726,6726,6726,6726,6726,8162,8162,8162,8162,8162,8162,8162,8162,8162,8162,8162,8162,8162,315c128a-272d-4c57-bfbe-1a8b3402af08, infasurf is indicated for the prevention of respiratory distress syndrome ( rds ) in premature infants at high risk for rds and for the treatment ( rescue ) of premature infants who develop rds,1
6727,6727,6727,6727,6727,6727,6727,8163,8163,8163,8163,8163,8163,8163,8163,8163,8163,8163,8163,8163,315c128a-272d-4c57-bfbe-1a8b3402af08,infasurf decreases the incidence of rds  mortality due to rds  and air leaks associated with rds,0
6728,6728,6728,6728,6728,6728,6728,8164,8164,8164,8164,8164,8164,8164,8164,8164,8164,8164,8164,8164,315c128a-272d-4c57-bfbe-1a8b3402af08,prophylaxis prophylaxis therapy at birth with infasurf is indicated for premature infants less than 29 weeks of gestational age at significant risk for rds,1
6729,6729,6729,6729,6729,6729,6729,8165,8165,8165,8165,8165,8165,8165,8165,8165,8165,8165,8165,8165,315c128a-272d-4c57-bfbe-1a8b3402af08,infasurf prophylaxis should be administered as soon as possible  preferably within 30 minutes after birth,4
6730,6730,6730,6730,6730,6730,6730,8166,8166,8166,8166,8166,8166,8166,8166,8166,8166,8166,8166,8166,315c128a-272d-4c57-bfbe-1a8b3402af08,treatment infasurf therapy is indicated for infants less than or equal to 72 hours of age with rds ( confirmed by clinical and radiologic findings ) and requiring endotracheal intubation,1
6731,6731,6731,6731,6731,6731,6731,8170,8170,8170,8170,8170,8170,8170,8170,8170,8170,8170,8170,8170,2704cdb8-72a4-45cd-b718-d9723a284506,pituitary tsh suppression in the treatment or prevention of various types of euthyroid goiters ( see warnings and precautions )  including thyroid nodules ( see warnings and precautions )  subacute or chronic lymphocytic thyroiditis ( hashimoto 's thyroiditis )  multinodular goiter ( see warnings and precautions ) and  as an adjunct to surgery and radioiodine therapy in the management of thyrotropin dependent well differentiated thyroid cancer,1
6732,6732,6732,6732,6732,6732,6732,8171,8171,8171,8171,8171,8171,8171,8171,8171,8171,8171,8171,8171,7ab61c2b-2d17-4a73-aed7-23e72076d11b, treatment many infections caused by aerobic and anaerobic gram negative bacteria resistant to some cephalosporins respond to cefoxitin,1
6733,6733,6733,6733,6733,6733,6733,8172,8172,8172,8172,8172,8172,8172,8172,8172,8172,8172,8172,8172,7ab61c2b-2d17-4a73-aed7-23e72076d11b,similarly  many infections caused by aerobic and anaerobic bacteria resistant to some penicillin antibiotics ( ampicillin  carbenicillin  penicillin g ) respond to treatment with cefoxitin,u
6734,6734,6734,6734,6734,6734,6734,8173,8173,8173,8173,8173,8173,8173,8173,8173,8173,8173,8173,8173,7ab61c2b-2d17-4a73-aed7-23e72076d11b,many infections caused by mixtures of susceptible aerobic and anaerobic bacteria respond to treatment with cefoxitin,u
6735,6735,6735,6735,6735,6735,6735,8174,8174,8174,8174,8174,8174,8174,8174,8174,8174,8174,8174,8174,7ab61c2b-2d17-4a73-aed7-23e72076d11b,cefoxitin for injection is indicated for the treatment of serious infections caused by susceptible strains of the designated microorganisms in the diseases listed below,1
6736,6736,6736,6736,6736,6736,6736,8175,8175,8175,8175,8175,8175,8175,8175,8175,8175,8175,8175,8175,7ab61c2b-2d17-4a73-aed7-23e72076d11b,( 1 ) lower respiratory tract infections  including pneumonia and lung abscess  caused by streptococcus pneumoniae  other streptococci ( excluding enterococci  e g  enterococcus faecalis formerly streptococcus faecalis )  staphylococcus aureus ( including penicillinase producing strains )  escherichia coli  klebsiella species  haemophilus influenzae  and bacteroides species,1
6737,6737,6737,6737,6737,6737,6737,8176,8176,8176,8176,8176,8176,8176,8176,8176,8176,8176,8176,8176,7ab61c2b-2d17-4a73-aed7-23e72076d11b,( 2 ) urinary tract infections caused by escherichia coli  klebsiella species  proteus mirabilis  morganella morganii  proteus vulgaris and providencia species ( including p rettgeri ),1
6738,6738,6738,6738,6738,6738,6738,8177,8177,8177,8177,8177,8177,8177,8177,8177,8177,8177,8177,8177,7ab61c2b-2d17-4a73-aed7-23e72076d11b,( 3 ) intra abdominal infections  including peritonitis and intra abdominal abscess  caused by escherichia coli  klebsiella species  bacteroides species including bacteroides fragilis  and clostridium species,1
6739,6739,6739,6739,6739,6739,6739,8178,8178,8178,8178,8178,8178,8178,8178,8178,8178,8178,8178,8178,7ab61c2b-2d17-4a73-aed7-23e72076d11b,( 4 ) gynecological infections  including endometritis  pelvic cellulitis  and pelvic inflammatory disease caused by escherichia coli  neisseria gonorrhoeae ( including penicillinase producing strains )  bacteroides species including b fragilis  clostridium species  peptococcus niger  peptostreptococcus species  and streptococcus agalactiae,1
6740,6740,6740,6740,6740,6740,6740,8179,8179,8179,8179,8179,8179,8179,8179,8179,8179,8179,8179,8179,7ab61c2b-2d17-4a73-aed7-23e72076d11b,cefoxitin  like cephalosporins  has no activity against chlamydia trachomatis,0
6741,6741,6741,6741,6741,6741,6741,8180,8180,8180,8180,8180,8180,8180,8180,8180,8180,8180,8180,8180,7ab61c2b-2d17-4a73-aed7-23e72076d11b,therefore  when cefoxitin is used in the treatment of patients with pelvic inflammatory disease and c trachomatis is one of the suspected pathogens  appropriate anti chlamydial coverage should be added,4
6742,6742,6742,6742,6742,6742,6742,8181,8181,8181,8181,8181,8181,8181,8181,8181,8181,8181,8181,8181,7ab61c2b-2d17-4a73-aed7-23e72076d11b,( 5 ) septicemia caused by streptococcus pneumoniae  staphyloc,1
6743,6743,6743,6743,6743,6743,6743,8182,8182,8182,8182,8182,8182,8182,8182,8182,8182,8182,8182,8182,dd3dcc9a-e40c-4677-9ee6-f318e7c7d835,1 indications usage vinorelbine injection  usp is indicated in combination with cisplatin for first line treatment of patients with locally advanced or metastatic non small cell lung cancer ( nsclc ) as a single agent  for the treatment of patients with metastatic nsclc vinorelbine injection  usp is a vinca alkaloid indicated in combination with cisplatin for first line treatment of patients with locally advanced or metastatic non small cell lung cancer ( nsclc ) ( 1 ) as a single agent for first line treatment of patients with metastatic nsclc ( 1 ),1
6744,6744,6744,6744,6744,6744,6744,8183,8183,8183,8183,8183,8183,8183,8183,8183,8183,8183,8183,8183,df60f030-866b-4374-a31f-8ae3f6b45c38, cerezyme ( imiglucerase for injection ) is indicated for long term enzyme replacement therapy for pediatric and adult patients with a confirmed diagnosis of type 1 gaucher disease that results in one or more of the following conditions a anemia b thrombocytopenia c bone disease d hepatomegaly or splenomegaly,1
6745,6745,6745,6745,6745,6745,6745,8184,8184,8184,8184,8184,8184,8184,8184,8184,8184,8184,8184,8184,60ccbdf2-9440-3f1e-e053-2a91aa0ac993, topex fluoride gels are indicated for topical application to teeth to aid in the prevention of dental caries,1
6746,6746,6746,6746,6746,6746,6746,8185,8185,8185,8185,8185,8185,8185,8185,8185,8185,8185,8185,8185,60ccbdf2-9440-3f1e-e053-2a91aa0ac993,the non acidic nature of neutral ph ( naf ) is recommended for patients with ceramic or composite restorations,u
6747,6747,6747,6747,6747,6747,6747,8186,8186,8186,8186,8186,8186,8186,8186,8186,8186,8186,8186,8186,60ccbdf2-9440-3f1e-e053-2a91aa0ac993,treatment frequency should not exceed 4 treatments per year,4
6748,6748,6748,6748,6748,6748,6748,8187,8187,8187,8187,8187,8187,8187,8187,8187,8187,8187,8187,8187,"Active Ingredient UNII(s)
Q830PW7520    eb28c2f5-c222-4f78-97bc-00b8dfb7415f
Q830PW7520    eb28c2f5-c222-4f78-97bc-00b8dfb7415f
Name: SET ID dtype: object",active ingredient unii ( s ) q830pw7520 active ingredient unii ( s ) q830pw7520 active in q830pw7520 active ingredient unii ( s ) q830pw7520 active in name content xml  dtype object,0
6749,6749,6749,6749,6749,6749,6749,8189,8189,8189,8189,8189,8189,8189,8189,8189,8189,8189,8189,8189,8456a8db-a7f6-4bc0-86be-e9c8c374140b, hexalen ( altretamine ) capsules is indicated for use as a single agent in the palliative treatment of patients with persistent or recurrent ovarian cancer following first line therapy with a cisplatin and or alkylating agent based combination,1
6750,6750,6750,6750,6750,6750,6750,8190,8190,8190,8190,8190,8190,8190,8190,8190,8190,8190,8190,8190,d36ba323-f97f-4da8-9b98-ccdf3ac8d0df, gemfibrozil tablets  usp are indicated as adjunctive therapy to diet for 1,1
6751,6751,6751,6751,6751,6751,6751,8191,8191,8191,8191,8191,8191,8191,8191,8191,8191,8191,8191,8191,d36ba323-f97f-4da8-9b98-ccdf3ac8d0df,treatment of adult patients with very high elevations of serum triglyceride levels ( types iv and v hyperlipidemia ) who present a risk of pancreatitis and who do not respond adequately to a determined dietary effort to control them,1
6752,6752,6752,6752,6752,6752,6752,8192,8192,8192,8192,8192,8192,8192,8192,8192,8192,8192,8192,8192,d36ba323-f97f-4da8-9b98-ccdf3ac8d0df,patients who present such risk typically have serum triglycerides over 2  000 mg dl and have elevations of vldl cholesterol as well as fasting chylomicrons ( type v hyperlipidemia ),0
6753,6753,6753,6753,6753,6753,6753,8193,8193,8193,8193,8193,8193,8193,8193,8193,8193,8193,8193,8193,d36ba323-f97f-4da8-9b98-ccdf3ac8d0df,subjects who consistently have total serum or plasma triglycerides below 1  000 mg dl are unlikely to present a risk of pancreatitis,0
6754,6754,6754,6754,6754,6754,6754,8194,8194,8194,8194,8194,8194,8194,8194,8194,8194,8194,8194,8194,d36ba323-f97f-4da8-9b98-ccdf3ac8d0df,gemfibrozil therapy may be considered for those subjects with triglyceride elevations between 1  000 and 2  000 mg dl who have a history of pancreatitis or of recurrent abdominal pain typical of pancreatitis,u
6755,6755,6755,6755,6755,6755,6755,8195,8195,8195,8195,8195,8195,8195,8195,8195,8195,8195,8195,8195,d36ba323-f97f-4da8-9b98-ccdf3ac8d0df,it is recognized that some type iv patients with triglycerides under 1  000 mg dl may  through dietary or alcoholic indiscretion  convert to a type v pattern with massive triglyceride elevations accompanying fasting chylomicronemia  but the influence of gemfibrozil therapy on the risk of pancreatitis in such situations has not been adequately studied,0
6756,6756,6756,6756,6756,6756,6756,8196,8196,8196,8196,8196,8196,8196,8196,8196,8196,8196,8196,8196,d36ba323-f97f-4da8-9b98-ccdf3ac8d0df,drug therapy is not indicated for patients with type i hyperlipoproteinemia  who have elevations of chylomicrons and plasma triglycerides  but who have normal levels of very low density lipoprotein ( vldl ),0
6757,6757,6757,6757,6757,6757,6757,8197,8197,8197,8197,8197,8197,8197,8197,8197,8197,8197,8197,8197,d36ba323-f97f-4da8-9b98-ccdf3ac8d0df,inspection of plasma refrigerated for 14 hours is helpful in distinguishing types i  iv  and v hyperlipoproteinemia,0
6758,6758,6758,6758,6758,6758,6758,8198,8198,8198,8198,8198,8198,8198,8198,8198,8198,8198,8198,8198,d36ba323-f97f-4da8-9b98-ccdf3ac8d0df,reducing the risk of developing coronary heart disease only in type iib patients without history of or symptoms of existing coronary heart disease who have had an inadequate response to weight loss  dietary therapy  exercise  and other pharmacologic agents ( such as bile acid sequestrants and nicotinic acid  known to reduce ldl and raise hdl cholesterol ) and who have the following triad of lipid abnormalities low hdl cholesterol levels in addition to elevated ldl cholesterol and elevated triglycerides ( see warnings  precautions  and clinical pharmacology ),u
6759,6759,6759,6759,6759,6759,6759,8199,8199,8199,8199,8199,8199,8199,8199,8199,8199,8199,8199,8199,d36ba323-f97f-4da8-9b98-ccdf3ac8d0df,the national cholesterol education program has defined a serum hdl cholesterol value that is consistently below 35 mg dl as constituting an independent risk factor for coronary heart disease,0
6760,6760,6760,6760,6760,6760,6760,8200,8200,8200,8200,8200,8200,8200,8200,8200,8200,8200,8200,8200,d36ba323-f97f-4da8-9b98-ccdf3ac8d0df,patients with significantly elevated triglycerides should be closely observed when treated with gemfibrozil,4
6761,6761,6761,6761,6761,6761,6761,8201,8201,8201,8201,8201,8201,8201,8201,8201,8201,8201,8201,8201,d36ba323-f97f-4da8-9b98-ccdf3ac8d0df,in some patients with high triglyceride levels  treatment with gemfibrozil is associated with a significant increase in ldl cholesterol,0
6762,6762,6762,6762,6762,6762,6762,8202,8202,8202,8202,8202,8202,8202,8202,8202,8202,8202,8202,8202,d36ba323-f97f-4da8-9b98-ccdf3ac8d0df,because of potential toxicity such as malignancy  gallbladder disease  abdominal pain leading to appendectomy and other abdominal surgeries  an increased incidence in non coronary mortality  and the 44 relative increase during the trial period in age adjusted all cause mortality seen with the chemically and pharmacologically related drug  clofibrate  the potential benefit of gemfibrozil in treating type iia patients with elevations of ldl cholesterol only is not likely to outweigh the risks,2
6763,6763,6763,6763,6763,6763,6763,8203,8203,8203,8203,8203,8203,8203,8203,8203,8203,8203,8203,8203,d36ba323-f97f-4da8-9b98-ccdf3ac8d0df,gemfibrozil is also not indicated for the treatment of patients with low hdl cholesterol as their only lipid abnormality,2
6764,6764,6764,6764,6764,6764,6764,8204,8204,8204,8204,8204,8204,8204,8204,8204,8204,8204,8204,8204,d36ba323-f97f-4da8-9b98-ccdf3ac8d0df,in a subgroup analysis of patients in the helsinki heart study with above median hdl cholesterol values at baseline ( greater than 46 4 mg dl )  the incidence of serious coronary events was similar for gemfibrozil and placebo subgroups ( see table i,0
6765,6765,6765,6765,6765,6765,6765,8205,8205,8205,8205,8205,8205,8205,8205,8205,8205,8205,8205,8205,aadd18e0-3752-11e4-8510-0800200c9a66,1  auryxia is a phosphate binder indicated for the control of serum phosphorus levels in adult patients with chronic kidney disease on dialysis ( 1 ) auryxia is an iron replacement product indicated for the treatment of iron deficiency anemia in adult patients with chronic kidney disease not on dialysis ( 1 ) 1 1 hyperphosphatemia in chronic kidney disease on dialysis auryxia is indicated for the control of serum phosphorus levels in adult patients with chronic kidney disease on dialysis,1
6766,6766,6766,6766,6766,6766,6766,8206,8206,8206,8206,8206,8206,8206,8206,8206,8206,8206,8206,8206,aadd18e0-3752-11e4-8510-0800200c9a66,1 2 iron deficiency anemia in chronic kidney disease not on dialysis auryxia is indicated for the treatment of iron deficiency anemia in adult patients with chronic kidney disease not on dialysis,1
6767,6767,6767,6767,6767,6767,6767,8207,8207,8207,8207,8207,8207,8207,8207,8207,8207,8207,8207,8207,29b50c42-bff7-4f85-8e70-3aea3c62df25,indications ethambutol hcl is indicated for the treatment of pulmonary tuberculosis,1
6768,6768,6768,6768,6768,6768,6768,8208,8208,8208,8208,8208,8208,8208,8208,8208,8208,8208,8208,8208,29b50c42-bff7-4f85-8e70-3aea3c62df25,it should not be used as the sole antituberculous drug  but should be used in conjunction with at least one other antituberculous drug,4
6769,6769,6769,6769,6769,6769,6769,8209,8209,8209,8209,8209,8209,8209,8209,8209,8209,8209,8209,8209,29b50c42-bff7-4f85-8e70-3aea3c62df25,selection of the companion drug should be based on clinical experience  considerations of comparative safety  and appropriate in vitro susceptibility studies,0
6770,6770,6770,6770,6770,6770,6770,8210,8210,8210,8210,8210,8210,8210,8210,8210,8210,8210,8210,8210,29b50c42-bff7-4f85-8e70-3aea3c62df25,in patients who have not received previous antituberculous therapy  ie  initial treatment  the most frequently used regimens have been the following ethambutol hcl plus isoniazidethambutol hcl plus isoniazid plus streptomycin,0
6771,6771,6771,6771,6771,6771,6771,8211,8211,8211,8211,8211,8211,8211,8211,8211,8211,8211,8211,8211,29b50c42-bff7-4f85-8e70-3aea3c62df25,in patients who have received previous antituberculous therapy  mycobacterial resistance to other drugs used in initial therapy is frequent,0
6772,6772,6772,6772,6772,6772,6772,8212,8212,8212,8212,8212,8212,8212,8212,8212,8212,8212,8212,8212,29b50c42-bff7-4f85-8e70-3aea3c62df25,consequently  in such retreatment patients  ethambutol hcl should be combined with at least one of the second line drugs not previously administered to the patient and to which bacterial susceptibility has been indicated by appropriate in vitro studies,4
6773,6773,6773,6773,6773,6773,6773,8213,8213,8213,8213,8213,8213,8213,8213,8213,8213,8213,8213,8213,29b50c42-bff7-4f85-8e70-3aea3c62df25,antituberculous drugs used with ethambutol hcl have included cycloserine  ethionamide  pyrazinamide  viomycin and other drugs,0
6774,6774,6774,6774,6774,6774,6774,8214,8214,8214,8214,8214,8214,8214,8214,8214,8214,8214,8214,8214,29b50c42-bff7-4f85-8e70-3aea3c62df25,isoniazid  aminosalicylic acid  and streptomycin have also been used in multiple drug regimens,0
6775,6775,6775,6775,6775,6775,6775,8215,8215,8215,8215,8215,8215,8215,8215,8215,8215,8215,8215,8215,29b50c42-bff7-4f85-8e70-3aea3c62df25,alternating drug regimens have also been utilized,0
6776,6776,6776,6776,6776,6776,6776,8216,8216,8216,8216,8216,8216,8216,8216,8216,8216,8216,8216,8216,29d24a6d-f9c1-4300-97c7-fec26bdbc22b, albuterol inhalation aerosol is indicated for the prevention and relief of bronchospasm in patients 4 years of age and older with reversible obstructive airway disease  and for the prevention of exercise induced bronchospasm in patients 4 years of age and older,1
6777,6777,6777,6777,6777,6777,6777,8217,8217,8217,8217,8217,8217,8217,8217,8217,8217,8217,8217,8217,29d24a6d-f9c1-4300-97c7-fec26bdbc22b,albuterol inhalation aerosol can be used with or without concomitant steroid therapy,4
6778,6778,6778,6778,6778,6778,6778,8218,8218,8218,8218,8218,8218,8218,8218,8218,8218,8218,8218,8218,747a5b5b-fe25-4c78-a9cc-662ebffc3183,1  famciclovir  a prodrug of penciclovir  is a nucleoside analog dna polymerase inhibitor indicated for immunocompetent adult patients ( 1 1 ) herpes labialis ( cold sores ) treatment of recurrent episodes genital herpes treatment of recurrent episodes suppressive therapy of recurrent episodes herpes zoster ( shingles ) hiv infected adult patients ( 1 2 ) treatment of recurrent episodes of orolabial or genital herpes limitation of use ( 1 3 ) the efficacy and safety of famciclovir have not been established for patients 18 years of age immunocompromised patients other than for the treatment of recurrent episodes of orolabial or genital herpes in hiv infected patients black and african american patients with recurrent genital herpes 1 1 immunocompetent adult patients herpes labialis ( cold sores ) famciclovir tablets are indicated for the treatment of recurrent herpes labialis,1
6779,6779,6779,6779,6779,6779,6779,8219,8219,8219,8219,8219,8219,8219,8219,8219,8219,8219,8219,8219,747a5b5b-fe25-4c78-a9cc-662ebffc3183,genital herpes recurrent episodes famciclovir tablets are indicated for the treatment of recurrent episodes of genital herpes,1
6780,6780,6780,6780,6780,6780,6780,8220,8220,8220,8220,8220,8220,8220,8220,8220,8220,8220,8220,8220,747a5b5b-fe25-4c78-a9cc-662ebffc3183,the efficacy of famciclovir tablets when initiated more than 6 hours after onset of symptoms or lesions has not been established,4
6781,6781,6781,6781,6781,6781,6781,8221,8221,8221,8221,8221,8221,8221,8221,8221,8221,8221,8221,8221,747a5b5b-fe25-4c78-a9cc-662ebffc3183,suppressive therapy famciclovir tablets are indicated for chronic suppressive therapy of recurrent episodes of genital herpes,1
6782,6782,6782,6782,6782,6782,6782,8222,8222,8222,8222,8222,8222,8222,8222,8222,8222,8222,8222,8222,747a5b5b-fe25-4c78-a9cc-662ebffc3183,the efficacy and safety of famciclovir tablets for the suppression of recurrent genital herpes beyond 1 year have not been established,0
6783,6783,6783,6783,6783,6783,6783,8223,8223,8223,8223,8223,8223,8223,8223,8223,8223,8223,8223,8223,747a5b5b-fe25-4c78-a9cc-662ebffc3183,herpes zoster ( shingles ) famcic,1
6784,6784,6784,6784,6784,6784,6784,8224,8224,8224,8224,8224,8224,8224,8224,8224,8224,8224,8224,8224,34aea106-c7f3-4324-baa9-d6fd3028b108, flunisolide nasal solution is indicated for the treatment of the nasal symptoms of seasonal or perennial rhinitis,1
6785,6785,6785,6785,6785,6785,6785,8225,8225,8225,8225,8225,8225,8225,8225,8225,8225,8225,8225,8225,34aea106-c7f3-4324-baa9-d6fd3028b108,flunisolide nasal solution should not be used in the presence of untreated localized infection involving nasal mucosa,4
6786,6786,6786,6786,6786,6786,6786,8226,8226,8226,8226,8226,8226,8226,8226,8226,8226,8226,8226,8226,78b88748-8318-11dc-8314-0800200c9a66,1  vantas is indicated for the palliative treatment of advanced prostate cancer,1
6787,6787,6787,6787,6787,6787,6787,8227,8227,8227,8227,8227,8227,8227,8227,8227,8227,8227,8227,8227,78b88748-8318-11dc-8314-0800200c9a66,vantas is a gonadotropin releasing hormone ( gnrh ) agonist indicated for the palliative treatment of advanced prostate cancer,1
6788,6788,6788,6788,6788,6788,6788,8228,8228,8228,8228,8228,8228,8228,8228,8228,8228,8228,8228,8228,426f6e64-2c20-4a61-6d65-7320426f6e64,1  kepivance is a mucocutaneous epithelial human growth factor indicated to decrease the incidence and duration of severe oral mucositis in patients with hematologic malignancies receiving myelotoxic therapy in the setting of autologous hematopoietic stem cell support,1
6789,6789,6789,6789,6789,6789,6789,8229,8229,8229,8229,8229,8229,8229,8229,8229,8229,8229,8229,8229,426f6e64-2c20-4a61-6d65-7320426f6e64,kepivance is indicated as supportive care for preparative regimens predicted to result in who grade 3 mucositis in the majority of patients,1
6790,6790,6790,6790,6790,6790,6790,8230,8230,8230,8230,8230,8230,8230,8230,8230,8230,8230,8230,8230,426f6e64-2c20-4a61-6d65-7320426f6e64,( 1 1 ) limitations of use the safety and efficacy of kepivance have not been established in patients with non hematologic malignancies ( 1 2  5 1 ) kepivance was not effective in decreasing the incidence of severe mucositis in patients with hematologic malignancies receiving myelotoxic therapy in the setting of allogeneic hematopoietic stem cell support,0
6791,6791,6791,6791,6791,6791,6791,8231,8231,8231,8231,8231,8231,8231,8231,8231,8231,8231,8231,8231,426f6e64-2c20-4a61-6d65-7320426f6e64,( 1 2  14 3 ) kepivance is not recommended for use with melphalan 200 mg m2 as a conditioning regimen ( 14 2 ),2
6792,6792,6792,6792,6792,6792,6792,8232,8232,8232,8232,8232,8232,8232,8232,8232,8232,8232,8232,8232,426f6e64-2c20-4a61-6d65-7320426f6e64,1 1 indications kepivance is a mucocutaneous epithelial human growth factor indicated to decrease the incidence and duration of severe oral mucositis in patients with hematologic malignancies receiving myelotoxic therapy in the setting of autologous hematopoietic stem cell support,1
6793,6793,6793,6793,6793,6793,6793,8234,8234,8234,8234,8234,8234,8234,8234,8234,8234,8234,8234,8234,426f6e64-2c20-4a61-6d65-7320426f6e64,1 2 limitations of use the safety and efficacy of kepivance have not been established in patients with non hematologic malignancies see warnings and precautions ( 5 1 ),0
6794,6794,6794,6794,6794,6794,6794,8235,8235,8235,8235,8235,8235,8235,8235,8235,8235,8235,8235,8235,426f6e64-2c20-4a61-6d65-7320426f6e64,kepivance was not effective in decreasing the incidence of severe mucositis in patients with hematologic malignancies receiving myelotoxic therapy in the setting of allogeneic hematopoietic stem cell support see clinical studies ( 14 3 ),0
6795,6795,6795,6795,6795,6795,6795,8236,8236,8236,8236,8236,8236,8236,8236,8236,8236,8236,8236,8236,426f6e64-2c20-4a61-6d65-7320426f6e64,kepivance is not recommended for use with melphalan 200 mg m2 as a conditioning regimen see clinical studies ( 14 2 ),2
6796,6796,6796,6796,6796,6796,6796,8237,8237,8237,8237,8237,8237,8237,8237,8237,8237,8237,8237,8237,312042cf-df60-4dc5-90dd-4e77ebd4a781,indications enlon is recommended for the differential diagnosis of myasthenia gravis and as an adjunct in the evaluation of treatment requirements in this disease,1
6797,6797,6797,6797,6797,6797,6797,8238,8238,8238,8238,8238,8238,8238,8238,8238,8238,8238,8238,8238,312042cf-df60-4dc5-90dd-4e77ebd4a781,it may also be used for evaluating emergency treatment in myasthenic crises,4
6798,6798,6798,6798,6798,6798,6798,8239,8239,8239,8239,8239,8239,8239,8239,8239,8239,8239,8239,8239,312042cf-df60-4dc5-90dd-4e77ebd4a781,because of its brief duration of action  it is not recommended for maintenance therapy in myasthenia gravis,4
6799,6799,6799,6799,6799,6799,6799,8240,8240,8240,8240,8240,8240,8240,8240,8240,8240,8240,8240,8240,312042cf-df60-4dc5-90dd-4e77ebd4a781,enlon is also useful whenever a curare antagonist is needed to reverse the neuromuscular block produced by curare  tubocurarine  gallamine triethiodide or dimethyl tubocurarine,u
6800,6800,6800,6800,6800,6800,6800,8241,8241,8241,8241,8241,8241,8241,8241,8241,8241,8241,8241,8241,312042cf-df60-4dc5-90dd-4e77ebd4a781,it is not effective against decamethonium bromide and succinylcholine chloride,0
6801,6801,6801,6801,6801,6801,6801,8242,8242,8242,8242,8242,8242,8242,8242,8242,8242,8242,8242,8242,312042cf-df60-4dc5-90dd-4e77ebd4a781,it may be used adjunctively in the treatment of respiratory depression caused by curare overdosage,1
6802,6802,6802,6802,6802,6802,6802,8243,8243,8243,8243,8243,8243,8243,8243,8243,8243,8243,8243,8243,f495b76d-96c6-48e5-8fa3-30a4336628eb, cystagon is indicated for the management of nephropathic cystinosis in children and adults,1
6803,6803,6803,6803,6803,6803,6803,8244,8244,8244,8244,8244,8244,8244,8244,8244,8244,8244,8244,8244,6e979070-5035-4076-e09c-b52466be3c68, manganese 0 1 mg ml ( manganese chloride injection  usp ) is indicated for use as a supplement to intravenous solutions given for tpn,1
6804,6804,6804,6804,6804,6804,6804,8245,8245,8245,8245,8245,8245,8245,8245,8245,8245,8245,8245,8245,6e979070-5035-4076-e09c-b52466be3c68,administration helps to maintain manganese serum levels and to prevent depletion of endogenous stores and subsequent deficiency symptoms,0
6805,6805,6805,6805,6805,6805,6805,8246,8246,8246,8246,8246,8246,8246,8246,8246,8246,8246,8246,8246,"Active Ingredient UNII(s)
QTG126297Q; UW86K581WY    a5fedb90-0e52-4926-b05d-e4209810c762
QTG126297Q; UW86K581WY    a5fedb90-0e52-4926-b05d-e4209810c762
Name: SET ID dtype: object",active ingredient unii ( s ) qtg126297q uw86k581wy active ingredient unii ( s ) qtg126297q uw86k581 qtg126297q uw86k581wy active ingredient unii ( s ) qtg126297q uw86k581 name content xml  dtype object,0
6806,6806,6806,6806,6806,6806,6806,8248,8248,8248,8248,8248,8248,8248,8248,8248,8248,8248,8248,8248,"Active Ingredient UNII(s)
QTG126297Q; V13007Z41A    07bbc638-58a4-4568-bf51-4156920308be
QTG126297Q; V13007Z41A    07bbc638-58a4-4568-bf51-4156920308be
Name: SET ID dtype: object",active ingredient unii ( s ) qtg126297q v13007z41a active ingredient unii ( s ) qtg126297q v13007z4 qtg126297q v13007z41a active ingredient unii ( s ) qtg126297q v13007z4 name content xml  dtype object,0
6807,6807,6807,6807,6807,6807,6807,8250,8250,8250,8250,8250,8250,8250,8250,8250,8250,8250,8250,8250,32c493f8-c4fa-4564-911b-ca2e1146c754, technetium tc99m disofenin is indicated as a hepatobiliary imaging agent,1
6808,6808,6808,6808,6808,6808,6808,8251,8251,8251,8251,8251,8251,8251,8251,8251,8251,8251,8251,8251,32c493f8-c4fa-4564-911b-ca2e1146c754,hepatolite is indicated in the diagnosis of acute cholecystitis as well as to rule out the occurrence of acute cholecystitis in suspected patients with right upper quadrant pain  fever  jaundice  right upper quadrant tenderness and mass or rebound tenderness  but not limited to these signs and symptoms,1
6809,6809,6809,6809,6809,6809,6809,8252,8252,8252,8252,8252,8252,8252,8252,8252,8252,8252,8252,8252,32c493f8-c4fa-4564-911b-ca2e1146c754,in otherwise healthy individuals  non visualization of the gallbladder 4 hours after administration of hepatolite following a 2 6 hour fast and in the presence of activity in the small intestine is indicative of a diagnosis of acute cholecystitis,0
6810,6810,6810,6810,6810,6810,6810,8253,8253,8253,8253,8253,8253,8253,8253,8253,8253,8253,8253,8253,32c493f8-c4fa-4564-911b-ca2e1146c754,under the same conditions in an otherwise healthy person  visualization of the gallbladder during a 1 hour scintigraphy is effective in excluding a diagnosis of acute cholecystitis,0
6811,6811,6811,6811,6811,6811,6811,8254,8254,8254,8254,8254,8254,8254,8254,8254,8254,8254,8254,8254,32c493f8-c4fa-4564-911b-ca2e1146c754,if the gallbladder is not visualized by 1 hour  scanning must continue for four hours or until the gallbladder is visualized,0
6812,6812,6812,6812,6812,6812,6812,8255,8255,8255,8255,8255,8255,8255,8255,8255,8255,8255,8255,8255,32c493f8-c4fa-4564-911b-ca2e1146c754,when the gall bladder fails to appear within the first 60 minutes of imaging after the administration of hepatolite  a single 0 04mg kg dose of intravenous morphine  diluted in 10ml normal saline may be administered over 3 minutes,0
6813,6813,6813,6813,6813,6813,6813,8256,8256,8256,8256,8256,8256,8256,8256,8256,8256,8256,8256,8256,32c493f8-c4fa-4564-911b-ca2e1146c754,( see clinical pharmacology section ),0
6814,6814,6814,6814,6814,6814,6814,8257,8257,8257,8257,8257,8257,8257,8257,8257,8257,8257,8257,8257,7fdedaec-9e53-4a37-a4e4-a301c8a251b8,1  rapivab is indicated for the treatment of acute uncomplicated influenza in patients 2 years and older who have been symptomatic for no more than 2 days,1
6815,6815,6815,6815,6815,6815,6815,8258,8258,8258,8258,8258,8258,8258,8258,8258,8258,8258,8258,8258,7fdedaec-9e53-4a37-a4e4-a301c8a251b8,limitations of use efficacy of rapivab is based on clinical trials of naturally occurring influenza in which the predominant influenza infections were influenza a virus a limited number of subjects infected with influenza b virus were enrolled,0
6816,6816,6816,6816,6816,6816,6816,8262,8262,8262,8262,8262,8262,8262,8262,8262,8262,8262,8262,8262,7fdedaec-9e53-4a37-a4e4-a301c8a251b8,prescribers should consider available information on influenza drug susceptibility patterns and treatment effects when deciding whether to use rapivab see microbiology ( 12 4 ),4
6817,6817,6817,6817,6817,6817,6817,8263,8263,8263,8263,8263,8263,8263,8263,8263,8263,8263,8263,8263,7fdedaec-9e53-4a37-a4e4-a301c8a251b8,the efficacy of rapivab could not be established in patients with serious influenza requiring hospitalization see clinical studies ( 14 3 ),0
6818,6818,6818,6818,6818,6818,6818,8264,8264,8264,8264,8264,8264,8264,8264,8264,8264,8264,8264,8264,7fdedaec-9e53-4a37-a4e4-a301c8a251b8,rapivab is an influenza virus neuraminidase inhibitor indicated for the treatment of acute uncomplicated influenza in patients 2 years and older who have been symptomatic for no more than two days,1
6819,6819,6819,6819,6819,6819,6819,8265,8265,8265,8265,8265,8265,8265,8265,8265,8265,8265,8265,8265,7fdedaec-9e53-4a37-a4e4-a301c8a251b8,( 1 ) limitations of use efficacy based on clinical trials in which the predominant influenza virus type was influenza a a limited number of subjects infected with influenza b virus were enrolled,0
6820,6820,6820,6820,6820,6820,6820,8266,8266,8266,8266,8266,8266,8266,8266,8266,8266,8266,8266,8266,7fdedaec-9e53-4a37-a4e4-a301c8a251b8,( 1 ) consider available information on influenza drug susceptibility patterns and treatment effects when deciding whether to use,0
6821,6821,6821,6821,6821,6821,6821,8267,8267,8267,8267,8267,8267,8267,8267,8267,8267,8267,8267,8267,7fdedaec-9e53-4a37-a4e4-a301c8a251b8,( 1 ) efficacy could not be established in patients with serious influenza requiring hospitalization,0
6822,6822,6822,6822,6822,6822,6822,8268,8268,8268,8268,8268,8268,8268,8268,8268,8268,8268,8268,8268,1159c24c-d9ce-49a2-b0bd-dc27c710f146, for use as a positive control in evaluation of allergenic ( immediate hypersensitivity or type i ) skin testing,1
6823,6823,6823,6823,6823,6823,6823,8269,8269,8269,8269,8269,8269,8269,8269,8269,8269,8269,8269,8269,91df460c-b896-4600-9d33-e499b49ba1b6,1  dorzolamide hcl ophthalmic solution is indicated in the treatment of elevated intraocular pressure in patients with ocular hypertension or open angle glaucoma,1
6824,6824,6824,6824,6824,6824,6824,8270,8270,8270,8270,8270,8270,8270,8270,8270,8270,8270,8270,8270,91df460c-b896-4600-9d33-e499b49ba1b6,dorzolamide hcl ophthalmic solution is a carbonic anhydrase inhibitor indicated in the treatment of elevated intraocular pressure in patients with ocular hypertension or open angle glaucoma,1
6825,6825,6825,6825,6825,6825,6825,8271,8271,8271,8271,8271,8271,8271,8271,8271,8271,8271,8271,8271,4c2a1403-3862-1efd-0a91-444989222b37,1  durlaza is indicated to reduce the risk of death and myocardial infarction ( mi ) in patients with chronic coronary artery disease  such as patients with a history of mi or unstable angina pectoris or with chronic stable angina reduce the risk of death and recurrent stroke in patients who have had an ischemic stroke or transient ischemic attack limitation of use use immediate release aspirin  not durlaza in situations where a rapid onset of action is required ( such as acute treatment of myocardial infarction or before percutaneous coronary intervention ),1
6826,6826,6826,6826,6826,6826,6826,8272,8272,8272,8272,8272,8272,8272,8272,8272,8272,8272,8272,8272,4c2a1403-3862-1efd-0a91-444989222b37,durlaza is a nonsteroidal anti inflammatory drug indicated to reduce the risk of death and myocardial infarction ( mi ) in patients with chronic coronary artery disease  such as patients with a history of mi or unstable angina pectoris or with chronic stable angina and to reduce the risk of death and recurrent stroke in patients who have had an ischemic stroke or transient ischemic attack ( 1 ) limitation of use use immediate release aspirin  not durlaza in situations where a rapid onset of action is required ( such as acute treatment of myocardial infarction or before percutaneous coronary intervention ),1
6827,6827,6827,6827,6827,6827,6827,8273,8273,8273,8273,8273,8273,8273,8273,8273,8273,8273,8273,8273,b182b7f1-34ea-4c3f-8bf0-df35e83e73e2,1  solosec is a nitroimidazole antimicrobial indicated for the treatment of bacterial vaginosis in adult women,1
6828,6828,6828,6828,6828,6828,6828,8274,8274,8274,8274,8274,8274,8274,8274,8274,8274,8274,8274,8274,b182b7f1-34ea-4c3f-8bf0-df35e83e73e2,( 1 ) to reduce the development of drug resistant bacteria and maintain the effectiveness of solosec and other antibacterial drugs  solosec should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria,4
6829,6829,6829,6829,6829,6829,6829,8275,8275,8275,8275,8275,8275,8275,8275,8275,8275,8275,8275,8275,b182b7f1-34ea-4c3f-8bf0-df35e83e73e2,1 1 bacterial vaginosis solosec is indicated for the treatment of bacterial vaginosis in adult women see use in specific populations ( 8 1 ) and clinical studies ( 14 ),1
6830,6830,6830,6830,6830,6830,6830,8276,8276,8276,8276,8276,8276,8276,8276,8276,8276,8276,8276,8276,b182b7f1-34ea-4c3f-8bf0-df35e83e73e2,1 2 usage to reduce the development of drug resistant bacteria and maintain the effectiveness of solosec and other antibacterial drugs  solosec should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria,4
6831,6831,6831,6831,6831,6831,6831,8279,8279,8279,8279,8279,8279,8279,8279,8279,8279,8279,8279,8279,4790bbe9-d753-1067-02ee-9536011650d9,1  modafinil tablets  usp are indicated to improve wakefulness in adult patients with excessive sleepiness associated with narcolepsy  obstructive sleep apnea ( osa )  or shift work disorder ( swd ),1
6832,6832,6832,6832,6832,6832,6832,8280,8280,8280,8280,8280,8280,8280,8280,8280,8280,8280,8280,8280,4790bbe9-d753-1067-02ee-9536011650d9,limitations of use in osa  modafinil tablets  usp are indicated to treat excessive sleepiness and not as treatment for the underlying obstruction,1
6833,6833,6833,6833,6833,6833,6833,8281,8281,8281,8281,8281,8281,8281,8281,8281,8281,8281,8281,8281,4790bbe9-d753-1067-02ee-9536011650d9,if continuous positive airway pressure ( cpap ) is the treatment of choice for a patient  a maximal effort to treat with cpap for an adequate period of time should be made prior to initiating and during treatment with modafinil tablets  usp for excessive sleepiness,4
6834,6834,6834,6834,6834,6834,6834,8282,8282,8282,8282,8282,8282,8282,8282,8282,8282,8282,8282,8282,4790bbe9-d753-1067-02ee-9536011650d9,modafinil tablets  usp are indicated to improve wakefulness in adult patients with excessive sleepiness associated with narcolepsy  obstructive sleep apnea ( osa )  or shift work disorder ( swd ),1
6835,6835,6835,6835,6835,6835,6835,8283,8283,8283,8283,8283,8283,8283,8283,8283,8283,8283,8283,8283,4790bbe9-d753-1067-02ee-9536011650d9,( 1 ) limitations of use in osa  modafinil tablets  usp are indicated to treat excessive sleepiness and not as treatment for the underlying obstruction,1
6836,6836,6836,6836,6836,6836,6836,8284,8284,8284,8284,8284,8284,8284,8284,8284,8284,8284,8284,8284,59f2f192-b9e3-4425-a754-b8c4f5007427, hylafem is a homeopathic prescription to treat vaginal yeast infection,1
6837,6837,6837,6837,6837,6837,6837,8285,8285,8285,8285,8285,8285,8285,8285,8285,8285,8285,8285,8285,59f2f192-b9e3-4425-a754-b8c4f5007427,rebalance vaginal ph and restore normal vaginal health,1
6838,6838,6838,6838,6838,6838,6838,8286,8286,8286,8286,8286,8286,8286,8286,8286,8286,8286,8286,8286,59f2f192-b9e3-4425-a754-b8c4f5007427,help relieve symptoms of internal and external vaginal burning  itching  and irritation,1
6839,6839,6839,6839,6839,6839,6839,8287,8287,8287,8287,8287,8287,8287,8287,8287,8287,8287,8287,8287,59f2f192-b9e3-4425-a754-b8c4f5007427,help reduce vaginal foul odor due to vaginal infection,u
6840,6840,6840,6840,6840,6840,6840,8288,8288,8288,8288,8288,8288,8288,8288,8288,8288,8288,8288,8288,6e566303-d93a-4130-b764-25749829aa95,1  krystexxa ( pegloticase ) is a pegylated uric acid specific enzyme indicated for the treatment of chronic gout in adult patients refractory to conventional therapy,1
6841,6841,6841,6841,6841,6841,6841,8289,8289,8289,8289,8289,8289,8289,8289,8289,8289,8289,8289,8289,6e566303-d93a-4130-b764-25749829aa95,gout refractory to conventional therapy occurs in patients who have failed to normalize serum uric acid and whose signs and symptoms are inadequately controlled with xanthine oxidase inhibitors at the maximum medically appropriate dose or for whom these drugs are contraindicated,0
6842,6842,6842,6842,6842,6842,6842,8290,8290,8290,8290,8290,8290,8290,8290,8290,8290,8290,8290,8290,6e566303-d93a-4130-b764-25749829aa95,important limitations of use krystexxa is not recommended for the treatment of asymptomatic hyperuricemia,2
6843,6843,6843,6843,6843,6843,6843,8291,8291,8291,8291,8291,8291,8291,8291,8291,8291,8291,8291,8291,6e566303-d93a-4130-b764-25749829aa95,krystexxa ( pegloticase ) is a pegylated uric acid specific enzyme indicated for the treatment of chronic gout in adult patients refractory to conventional therapy,1
6844,6844,6844,6844,6844,6844,6844,8292,8292,8292,8292,8292,8292,8292,8292,8292,8292,8292,8292,8292,6e566303-d93a-4130-b764-25749829aa95,( 1 ) important limitations of use krystexxa is not recommended for the treatment of asymptomatic hyperuricemia,2
6845,6845,6845,6845,6845,6845,6845,8293,8293,8293,8293,8293,8293,8293,8293,8293,8293,8293,8293,8293,b4c13317-88eb-48f2-aba2-50f01c8ff938, labetalol hydrochloride tablets are indicated in the management of hypertension,1
6846,6846,6846,6846,6846,6846,6846,8294,8294,8294,8294,8294,8294,8294,8294,8294,8294,8294,8294,8294,b4c13317-88eb-48f2-aba2-50f01c8ff938,labetalol hydrochloride tablets may be used alone or in combination with other antihypertensive agents  especially thiazide and loop diuretics,4
6847,6847,6847,6847,6847,6847,6847,8295,8295,8295,8295,8295,8295,8295,8295,8295,8295,8295,8295,8295,afb16e94-03bf-4ea2-b2fe-e65f274e55a9, promethazine hcl oral solution is useful for perennial and seasonal allergic rhinitis,1
6848,6848,6848,6848,6848,6848,6848,8296,8296,8296,8296,8296,8296,8296,8296,8296,8296,8296,8296,8296,afb16e94-03bf-4ea2-b2fe-e65f274e55a9,allergic conjunctivitis due to inhalant allergens and foods,1
6849,6849,6849,6849,6849,6849,6849,8297,8297,8297,8297,8297,8297,8297,8297,8297,8297,8297,8297,8297,afb16e94-03bf-4ea2-b2fe-e65f274e55a9,mild  uncomplicated allergic skin manifestations of urticaria and angioedema,1
6850,6850,6850,6850,6850,6850,6850,8298,8298,8298,8298,8298,8298,8298,8298,8298,8298,8298,8298,8298,afb16e94-03bf-4ea2-b2fe-e65f274e55a9,amelioration of allergic reactions to blood or plasma,1
6851,6851,6851,6851,6851,6851,6851,8299,8299,8299,8299,8299,8299,8299,8299,8299,8299,8299,8299,8299,afb16e94-03bf-4ea2-b2fe-e65f274e55a9,anaphylactic reactions  as adjunctive therapy to epinephrine and other standard measures  after the acute manifestations have been controlled,1
6852,6852,6852,6852,6852,6852,6852,8300,8300,8300,8300,8300,8300,8300,8300,8300,8300,8300,8300,8300,afb16e94-03bf-4ea2-b2fe-e65f274e55a9,preoperative  postoperative  or obstetric sedation,1
6853,6853,6853,6853,6853,6853,6853,8301,8301,8301,8301,8301,8301,8301,8301,8301,8301,8301,8301,8301,afb16e94-03bf-4ea2-b2fe-e65f274e55a9,prevention and control of nausea and vomiting associated with certain types of anesthesia and surgery,1
6854,6854,6854,6854,6854,6854,6854,8302,8302,8302,8302,8302,8302,8302,8302,8302,8302,8302,8302,8302,afb16e94-03bf-4ea2-b2fe-e65f274e55a9,therapy adjunctive to meperidine or other analgesics for control of post operative pain,1
6855,6855,6855,6855,6855,6855,6855,8303,8303,8303,8303,8303,8303,8303,8303,8303,8303,8303,8303,8303,afb16e94-03bf-4ea2-b2fe-e65f274e55a9,sedation in both children and adults  as well as relief of apprehension and production of light sleep from which the patient can be easily aroused,1
6856,6856,6856,6856,6856,6856,6856,8304,8304,8304,8304,8304,8304,8304,8304,8304,8304,8304,8304,8304,afb16e94-03bf-4ea2-b2fe-e65f274e55a9,active and prophylactic treatment of motion sickness,1
6857,6857,6857,6857,6857,6857,6857,8305,8305,8305,8305,8305,8305,8305,8305,8305,8305,8305,8305,8305,afb16e94-03bf-4ea2-b2fe-e65f274e55a9,antiemetic therapy in postoperative patients,1
6858,6858,6858,6858,6858,6858,6858,8306,8306,8306,8306,8306,8306,8306,8306,8306,8306,8306,8306,8306,a16297df-3158-48db-85e5-5cd506885556, amoxapine is indicated for the relief of symptoms of depression in patients with neurotic or reactive depressive disorders as well as endogenous and psychotic depressions,1
6859,6859,6859,6859,6859,6859,6859,8307,8307,8307,8307,8307,8307,8307,8307,8307,8307,8307,8307,8307,a16297df-3158-48db-85e5-5cd506885556,it is indicated for depression accompanied by anxiety or agitation,1
6860,6860,6860,6860,6860,6860,6860,8308,8308,8308,8308,8308,8308,8308,8308,8308,8308,8308,8308,8308,4fb02ad7-6e93-4aff-9aca-5162559b99a5, conversion of atrial fibrillation flutter in patients with symptomatic atrial fibrillation flutter whose symptoms are not adequately controlled by measures that reduce the rate of ventricular response  quinidine gluconate is indicated as a means of restoring normal sinus rhythm,1
6861,6861,6861,6861,6861,6861,6861,8309,8309,8309,8309,8309,8309,8309,8309,8309,8309,8309,8309,8309,4fb02ad7-6e93-4aff-9aca-5162559b99a5,if this use of quinidine gluconate does not restore sinus rhythm within a reasonable time ( see dosage and administration )  then quinidine gluconate should be discontinued,4
6862,6862,6862,6862,6862,6862,6862,8310,8310,8310,8310,8310,8310,8310,8310,8310,8310,8310,8310,8310,4fb02ad7-6e93-4aff-9aca-5162559b99a5,reduction of frequency of relapse into atrial fibrillation flutter chronic therapy with quinidine gluconate is indicated for some patients at high risk of symptomatic atrial fibrillation flutter  generally patients who have had previous episodes of atrial fibrillation flutter that were so frequent and poorly tolerated as to outweigh  in the judgment of the physician and the patient  the risks of prophylactic therapy with quinidine gluconate,1
6863,6863,6863,6863,6863,6863,6863,8311,8311,8311,8311,8311,8311,8311,8311,8311,8311,8311,8311,8311,4fb02ad7-6e93-4aff-9aca-5162559b99a5,the increased risk of death should specifically be considered,0
6864,6864,6864,6864,6864,6864,6864,8312,8312,8312,8312,8312,8312,8312,8312,8312,8312,8312,8312,8312,4fb02ad7-6e93-4aff-9aca-5162559b99a5,quinidine gluconate should be used only after alternative measures ( e g  use of other drugs to control the ventricular rate ) have been found to be inadequate,4
6865,6865,6865,6865,6865,6865,6865,8313,8313,8313,8313,8313,8313,8313,8313,8313,8313,8313,8313,8313,4fb02ad7-6e93-4aff-9aca-5162559b99a5,in patients with histories of frequent symptomatic episodes of atrial fibrillation flutter  the goal of therapy should be an increase in the average time between episodes,0
6866,6866,6866,6866,6866,6866,6866,8314,8314,8314,8314,8314,8314,8314,8314,8314,8314,8314,8314,8314,4fb02ad7-6e93-4aff-9aca-5162559b99a5,in most patients  the tachyarrhythmia will recur during therapy  and a single recurrence should not be interpreted as therapeutic failure,4
6867,6867,6867,6867,6867,6867,6867,8315,8315,8315,8315,8315,8315,8315,8315,8315,8315,8315,8315,8315,4fb02ad7-6e93-4aff-9aca-5162559b99a5,suppression of ventricular arrhythmias quinidine gluconate is also indicated for the suppression of recurrent documented ventricular arrhythmias  such as sustained ventricular tachycardia  that in the judgment of the physician are life threatening,1
6868,6868,6868,6868,6868,6868,6868,8316,8316,8316,8316,8316,8316,8316,8316,8316,8316,8316,8316,8316,4fb02ad7-6e93-4aff-9aca-5162559b99a5,because of the proarrhythmic effects of quinidine  its use with ventricular arrhythmias of lesser severity is generally not recommended  and treatment of patients with asymptomatic ventricular premature contractions should be avoided,u
6869,6869,6869,6869,6869,6869,6869,8317,8317,8317,8317,8317,8317,8317,8317,8317,8317,8317,8317,8317,4fb02ad7-6e93-4aff-9aca-5162559b99a5,where possible  therapy should be guided by the results of programmed electrical stimulation and or holter monitoring with,u
6870,6870,6870,6870,6870,6870,6870,8318,8318,8318,8318,8318,8318,8318,8318,8318,8318,8318,8318,8318,e27bedfd-c181-44f9-a920-19c2f8cab644,1  malarone is an antimalarial indicated for prophylaxis of plasmodium falciparum malaria  including in areas where chloroquine resistance has been reported,1
6871,6871,6871,6871,6871,6871,6871,8319,8319,8319,8319,8319,8319,8319,8319,8319,8319,8319,8319,8319,e27bedfd-c181-44f9-a920-19c2f8cab644,( 1 1 ) treatment of acute  uncomplicated p falciparum malaria,1
6872,6872,6872,6872,6872,6872,6872,8320,8320,8320,8320,8320,8320,8320,8320,8320,8320,8320,8320,8320,e27bedfd-c181-44f9-a920-19c2f8cab644,( 1 2 ) 1 1 prevention of malaria malarone is indicated for the prophylaxis of plasmodium falciparum malaria  including in areas where chloroquine resistance has been reported,1
6873,6873,6873,6873,6873,6873,6873,8321,8321,8321,8321,8321,8321,8321,8321,8321,8321,8321,8321,8321,e27bedfd-c181-44f9-a920-19c2f8cab644,1 2 treatment of malaria malarone is indicated for the treatment of acute  uncomplicated p falciparum malaria,1
6874,6874,6874,6874,6874,6874,6874,8322,8322,8322,8322,8322,8322,8322,8322,8322,8322,8322,8322,8322,e27bedfd-c181-44f9-a920-19c2f8cab644,malarone has been shown to be effective in regions where the drugs chloroquine  halofantrine  mefloquine  and amodiaquine may have unacceptable failure rates  presumably due to drug resistance,u
6875,6875,6875,6875,6875,6875,6875,8323,8323,8323,8323,8323,8323,8323,8323,8323,8323,8323,8323,8323,b9322f58-ffcc-4831-5381-93a535b49a09,indications tridione ( trimethadione ) is indicated for the control of petit mal seizures that are refractory to treatment with other drugs,1
6876,6876,6876,6876,6876,6876,6876,8324,8324,8324,8324,8324,8324,8324,8324,8324,8324,8324,8324,8324,8ceb5658-b03c-475d-9ef0-2cd0645191d3,1 indications usage candesartan cilexetil tablets are an angiotensin ii receptor blocker ( arb ) indicated for treatment of hypertension in adults and children 1 to 17 years of age  to lower blood pressure,1
6877,6877,6877,6877,6877,6877,6877,8325,8325,8325,8325,8325,8325,8325,8325,8325,8325,8325,8325,8325,8ceb5658-b03c-475d-9ef0-2cd0645191d3,lowering blood pressure reduces the risk of fatal and non fatal cardiovascular events  primarily strokes and myocardial infarctions ( 1 1 ),0
6878,6878,6878,6878,6878,6878,6878,8326,8326,8326,8326,8326,8326,8326,8326,8326,8326,8326,8326,8326,8ceb5658-b03c-475d-9ef0-2cd0645191d3,treatment of heart failure ( nyha class ii iv ) candesartan reduces cardiovascular death and heart failure hospitalization ( 1 2 ),u
6879,6879,6879,6879,6879,6879,6879,8327,8327,8327,8327,8327,8327,8327,8327,8327,8327,8327,8327,8327,8ceb5658-b03c-475d-9ef0-2cd0645191d3,1 1 hypertension candesartan cilexetil tablets are indicated for the treatment of hypertension in adults and in children 1 to 17 years of age  to lower blood pressure,1
6880,6880,6880,6880,6880,6880,6880,8339,8339,8339,8339,8339,8339,8339,8339,8339,8339,8339,8339,8339,79f5cf6f-a5e2-49a2-9704-fa1bd21338c3, cefuroxime for injection  usp is indicated for the treatment of patients with infections caused by susceptible strains of the designated organisms in the following diseases lower respiratory tract infections  including pneumonia  caused by streptococcus pneumoniae  haemophilus influenzae ( including ampicillin resistant strains )  klebsiella spp  staphylococcus aureus ( penicillinase and non penicillinase producing strains )  streptococcus pyogenes  and escherichia coli,1
6881,6881,6881,6881,6881,6881,6881,8340,8340,8340,8340,8340,8340,8340,8340,8340,8340,8340,8340,8340,79f5cf6f-a5e2-49a2-9704-fa1bd21338c3,urinary tract infections caused by escherichia coli and klebsiella spp,1
6882,6882,6882,6882,6882,6882,6882,8341,8341,8341,8341,8341,8341,8341,8341,8341,8341,8341,8341,8341,79f5cf6f-a5e2-49a2-9704-fa1bd21338c3,skin and skin structure infections caused by staphylococcus aureus ( penicillinase and non penicillinase producing strains )  streptococcus pyogenes  escherichia coli  klebsiella spp  and enterobacter spp,1
6883,6883,6883,6883,6883,6883,6883,8342,8342,8342,8342,8342,8342,8342,8342,8342,8342,8342,8342,8342,79f5cf6f-a5e2-49a2-9704-fa1bd21338c3,septicemia caused by staphylococcus aureus ( penicillinase and non penicillinase producing strains )  streptococcus pneumoniae  escherichia coli  haemophilus influenzae ( including ampicillin resistant strains )  and klebsiella spp,1
6884,6884,6884,6884,6884,6884,6884,8343,8343,8343,8343,8343,8343,8343,8343,8343,8343,8343,8343,8343,79f5cf6f-a5e2-49a2-9704-fa1bd21338c3,meningitis caused by streptococcus pneumoniae  haemophilus influenzae ( including ampicillin resistant strains )  neisseria meningitidis  and staphylococcus aureus ( penicillinase and non penicillinase producing strains ),1
6885,6885,6885,6885,6885,6885,6885,8344,8344,8344,8344,8344,8344,8344,8344,8344,8344,8344,8344,8344,79f5cf6f-a5e2-49a2-9704-fa1bd21338c3,gonorrhea uncomplicated and disseminated gonococcal infections due to neisseria gonorrhoeae ( penicillinase and non penicillinase producing strains ) in both males and females,1
6886,6886,6886,6886,6886,6886,6886,8345,8345,8345,8345,8345,8345,8345,8345,8345,8345,8345,8345,8345,79f5cf6f-a5e2-49a2-9704-fa1bd21338c3,bone and joint infections caused by staphylococcus aureus ( penicillinase and non penicillinase producing strains ),1
6887,6887,6887,6887,6887,6887,6887,8346,8346,8346,8346,8346,8346,8346,8346,8346,8346,8346,8346,8346,79f5cf6f-a5e2-49a2-9704-fa1bd21338c3,clinical microbiological studies in skin and skin structure infections frequently reveal the growth of susceptible strains of both aerobic and anaerobic organisms,0
6888,6888,6888,6888,6888,6888,6888,8347,8347,8347,8347,8347,8347,8347,8347,8347,8347,8347,8347,8347,79f5cf6f-a5e2-49a2-9704-fa1bd21338c3,cefuroxime for injection  usp has been used successfully in these mixed infections in which several organisms have been isolated,u
6889,6889,6889,6889,6889,6889,6889,8348,8348,8348,8348,8348,8348,8348,8348,8348,8348,8348,8348,8348,79f5cf6f-a5e2-49a2-9704-fa1bd21338c3,in certain cases of confirmed or suspected gram positive or gram negative sepsis or in patients with other serious infections in which the causative organism has not been identified  cefuroxime for injection  usp may be used concomitantly with an aminoglycoside ( see precautions ),0
6890,6890,6890,6890,6890,6890,6890,8349,8349,8349,8349,8349,8349,8349,8349,8349,8349,8349,8349,8349,79f5cf6f-a5e2-49a2-9704-fa1bd21338c3,the recommended doses of both antibiotics may be given depending on the severity of the infection and the patient s condition,4
6891,6891,6891,6891,6891,6891,6891,8350,8350,8350,8350,8350,8350,8350,8350,8350,8350,8350,8350,8350,79f5cf6f-a5e2-49a2-9704-fa1bd21338c3,to reduce the development of drug resistant bacteria and maintain the effectiveness of cefuroxime for injection  usp and other antibacterial drugs  cefuroxime for injection  usp should be used only to treat or prevent infections that are proven or strongly suspected to be caused by su,4
6892,6892,6892,6892,6892,6892,6892,8351,8351,8351,8351,8351,8351,8351,8351,8351,8351,8351,8351,8351,c39e65d7-fa44-4e4c-8b12-a654d3ed0eae,1  invega trinza ( paliperidone palmitate )  a 3 month injection  is indicated for the treatment of schizophrenia in patients after they have been adequately treated with invega sustenna ( 1 month paliperidone palmitate extended release injectable suspension ) for at least four months see dosage and administration ( 2 2 ) and clinical studies ( 14 ),1
6893,6893,6893,6893,6893,6893,6893,8352,8352,8352,8352,8352,8352,8352,8352,8352,8352,8352,8352,8352,c39e65d7-fa44-4e4c-8b12-a654d3ed0eae,invega trinza  a 3 month injection  is an atypical antipsychotic indicated for the treatment of schizophrenia in patients after they have been adequately treated with invega sustenna ( 1 month paliperidone palmitate extended release injectable suspension ) for at least four months,1
6894,6894,6894,6894,6894,6894,6894,8353,8353,8353,8353,8353,8353,8353,8353,8353,8353,8353,8353,8353,167ecefd-4553-41b8-8160-81a48dbca076, mentax ( butenafine hcl ) cream  1 is indicated for the topical treatment of the dermatologic infection  tinea ( pityriasis ) versicolor due to m furfur ( formerly p orbiculare ),1
6895,6895,6895,6895,6895,6895,6895,8354,8354,8354,8354,8354,8354,8354,8354,8354,8354,8354,8354,8354,167ecefd-4553-41b8-8160-81a48dbca076,butenafine hcl cream was not studied in immunocompromised patients,0
6896,6896,6896,6896,6896,6896,6896,8356,8356,8356,8356,8356,8356,8356,8356,8356,8356,8356,8356,8356,4764f37b-c9e6-4ede-bcc2-8a03b7c521df,1  sprycel ( dasatinib ) is indicated for the treatment of adult patients with newly diagnosed philadelphia chromosome positive ( ph ) chronic myeloid leukemia ( cml ) in chronic phase,1
6897,6897,6897,6897,6897,6897,6897,8357,8357,8357,8357,8357,8357,8357,8357,8357,8357,8357,8357,8357,4764f37b-c9e6-4ede-bcc2-8a03b7c521df,chronic  accelerated  or myeloid or lymphoid blast phase ph cml with resistance or intolerance to prior therapy including imatinib,u
6898,6898,6898,6898,6898,6898,6898,8358,8358,8358,8358,8358,8358,8358,8358,8358,8358,8358,8358,8358,4764f37b-c9e6-4ede-bcc2-8a03b7c521df,philadelphia chromosome positive acute lymphoblastic leukemia ( ph all ) with resistance or intolerance to prior therapy,1
6899,6899,6899,6899,6899,6899,6899,8359,8359,8359,8359,8359,8359,8359,8359,8359,8359,8359,8359,8359,4764f37b-c9e6-4ede-bcc2-8a03b7c521df,sprycel ( dasatinib ) is indicated for the treatment of pediatric patients with ph cml in chronic phase,1
6900,6900,6900,6900,6900,6900,6900,8360,8360,8360,8360,8360,8360,8360,8360,8360,8360,8360,8360,8360,4764f37b-c9e6-4ede-bcc2-8a03b7c521df,sprycel is a kinase inhibitor indicated for the treatment of newly diagnosed adults with philadelphia chromosome positive ( ph ) chronic myeloid leukemia ( cml ) in chronic phase,1
6901,6901,6901,6901,6901,6901,6901,8361,8361,8361,8361,8361,8361,8361,8361,8361,8361,8361,8361,8361,4764f37b-c9e6-4ede-bcc2-8a03b7c521df,( 1  14 ) adults with chronic  accelerated  or myeloid or lymphoid blast phase ph cml with resistance or intolerance to prior therapy including imatinib,u
6902,6902,6902,6902,6902,6902,6902,8362,8362,8362,8362,8362,8362,8362,8362,8362,8362,8362,8362,8362,4764f37b-c9e6-4ede-bcc2-8a03b7c521df,( 1  14 ) adults with philadelphia chromosome positive acute lymphoblastic leukemia ( ph all ) with resistance or intolerance to prior therapy,1
6903,6903,6903,6903,6903,6903,6903,8363,8363,8363,8363,8363,8363,8363,8363,8363,8363,8363,8363,8363,4764f37b-c9e6-4ede-bcc2-8a03b7c521df,( 1  14 ) pediatric patients with ph cml in chronic phase ( 1  14 ),1
6904,6904,6904,6904,6904,6904,6904,8364,8364,8364,8364,8364,8364,8364,8364,8364,8364,8364,8364,8364,7cbbb12f-760d-487d-b789-ae2d52a3e01f,1  belviq belviq xr is indicated as an adjunct to a reduced calorie diet and increased physical activity for chronic weight management in adult patients with an initial body mass index ( bmi ) of 30 kg m2 or greater ( obese )  or 27 kg m2 or greater ( overweight ) in the presence of at least one weight related comorbid condition ( e g  hypertension  dyslipidemia  type 2 diabetes ) see dosage and administration ( 2 ) limitations of use the safety and efficacy of coadministration of belviq belviq xr with other products intended for weight loss including prescription drugs ( e g  phentermine )  over the counter drugs  and herbal preparations have not been established,1
6905,6905,6905,6905,6905,6905,6905,8365,8365,8365,8365,8365,8365,8365,8365,8365,8365,8365,8365,8365,7cbbb12f-760d-487d-b789-ae2d52a3e01f,the effect of belviq belviq xr on cardiovascular morbidity and mortality has not been established,0
6906,6906,6906,6906,6906,6906,6906,8366,8366,8366,8366,8366,8366,8366,8366,8366,8366,8366,8366,8366,7cbbb12f-760d-487d-b789-ae2d52a3e01f,belviq belviq xr is a serotonin 2c receptor agonist indicated as an adjunct to a reduced calorie diet and increased physical activity for chronic weight management in adults with an initial body mass index ( bmi ) of 30 kg m2 or greater ( obese ) ( 1 ) or 27 kg m2 or greater ( overweight ) in the presence of at least one weight related comorbid condition  ( e g  hypertension  dyslipidemia  type 2 diabetes ) ( 1 ) limitations of use the safety and efficacy of coadministration with other products for weight loss have not been established ( 1 ) the effect of belviq belviq xr on cardiovascular morbidity and mortality has not been established ( 1 ),1
6907,6907,6907,6907,6907,6907,6907,8367,8367,8367,8367,8367,8367,8367,8367,8367,8367,8367,8367,8367,c488fb7c-0a5b-487c-b452-996809d1cb99,1  relistor is an opioid antagonist,u
6908,6908,6908,6908,6908,6908,6908,8368,8368,8368,8368,8368,8368,8368,8368,8368,8368,8368,8368,8368,c488fb7c-0a5b-487c-b452-996809d1cb99,relistor tablets and relistor injection are indicated for the treatment of opioid induced constipation ( oic ) in adults with chronic non cancer pain  including patients with chronic pain related to prior cancer or its treatment who do not require frequent ( e g  weekly ) opioid dosage escalation,1
6909,6909,6909,6909,6909,6909,6909,8369,8369,8369,8369,8369,8369,8369,8369,8369,8369,8369,8369,8369,c488fb7c-0a5b-487c-b452-996809d1cb99,( 1 1 ) relistor injection is indicated for the treatment of oic in adults with advanced illness or pain caused by active cancer who require opioid dosage escalation for palliative care,1
6910,6910,6910,6910,6910,6910,6910,8370,8370,8370,8370,8370,8370,8370,8370,8370,8370,8370,8370,8370,c488fb7c-0a5b-487c-b452-996809d1cb99,( 1 2 ) 1 1 opioid induced constipation in adult patients with chronic non cancer pain relistor tablets and relistor injection are indicated for the treatment of opioid induced constipation ( oic ) in adult patients with chronic non cancer pain  including patients with chronic pain related to prior cancer or its treatment who do not require frequent ( e g  weekly ) opioid dosage escalation,1
6911,6911,6911,6911,6911,6911,6911,8371,8371,8371,8371,8371,8371,8371,8371,8371,8371,8371,8371,8371,c488fb7c-0a5b-487c-b452-996809d1cb99,1 2 opioid induced constipation in adult patients with advanced illness relistor injection is indicated for the treatment of oic in adult patients with advanced illness or pain caused by active cancer who require opioid dosage escalation for palliative care,1
6912,6912,6912,6912,6912,6912,6912,8372,8372,8372,8372,8372,8372,8372,8372,8372,8372,8372,8372,8372,cc7a6a52-0b77-4df7-8403-dd21c1334f6c, lacrisert is indicated in patients with moderate to severe dry eye syndromes  including keratoconjunctivitis sicca,1
6913,6913,6913,6913,6913,6913,6913,8373,8373,8373,8373,8373,8373,8373,8373,8373,8373,8373,8373,8373,cc7a6a52-0b77-4df7-8403-dd21c1334f6c,lacrisert is indicated especially in patients who remain symptomatic after an adequate trial of therapy with artificial tear solutions,1
6914,6914,6914,6914,6914,6914,6914,8374,8374,8374,8374,8374,8374,8374,8374,8374,8374,8374,8374,8374,cc7a6a52-0b77-4df7-8403-dd21c1334f6c,lacrisert is also indicated for patients with exposure keratitis decreased corneal sensitivity recurrent corneal erosions,1
6915,6915,6915,6915,6915,6915,6915,8375,8375,8375,8375,8375,8375,8375,8375,8375,8375,8375,8375,8375,af38711e-8873-4790-a92d-4d583e23fb89, kuvan ( sapropterin dihydrochloride ) is indicated to reduce blood phenylalanine ( phe ) levels in patients with hyperphenylalaninemia ( hpa ) due to tetrahydrobiopterin ( bh4 ) responsive phenylketonuria ( pku ),1
6916,6916,6916,6916,6916,6916,6916,8376,8376,8376,8376,8376,8376,8376,8376,8376,8376,8376,8376,8376,af38711e-8873-4790-a92d-4d583e23fb89,kuvan is to be used in conjunction with a phe restricted diet,4
6917,6917,6917,6917,6917,6917,6917,8377,8377,8377,8377,8377,8377,8377,8377,8377,8377,8377,8377,8377,af38711e-8873-4790-a92d-4d583e23fb89,kuvan is a phenylalanine hydroxylase activator indicated to reduce blood phenylalanine ( phe ) levels in patients with hyperphenylalaninemia ( hpa ) due to tetrahydrobiopterin ( bh4 ) responsive phenylketonuria ( pku ),1
6918,6918,6918,6918,6918,6918,6918,8378,8378,8378,8378,8378,8378,8378,8378,8378,8378,8378,8378,8378,af38711e-8873-4790-a92d-4d583e23fb89,kuvan is to be used in conjunction with a phe restricted diet ( 1 ),4
6919,6919,6919,6919,6919,6919,6919,8379,8379,8379,8379,8379,8379,8379,8379,8379,8379,8379,8379,8379,abef9e9b-a29f-4abe-aeff-88ae42648057,1  magnevist is a gadolinium based contrast agent for intravenous use in diagnostic mri in adults and children ( 2 years of age and older ) to facilitate the visualization of lesions and abnormal vascularity in central nervous system brain  spine and associated tissues ( 1 1 ) extracranial extraspinal tissues head and neck ( 1 2 ) body ( 1 3 ) 1 1 central nervous system magnevist injection is indicated for use with magnetic resonance imaging ( mri ) in adults  and pediatric patients ( 2 years of age and older ) to visualize lesions with abnormal vascularity in the brain ( intracranial lesions )  spine and associated tissues,1
6920,6920,6920,6920,6920,6920,6920,8380,8380,8380,8380,8380,8380,8380,8380,8380,8380,8380,8380,8380,abef9e9b-a29f-4abe-aeff-88ae42648057,magnevist injection has been shown to facilitate visualization of intracranial lesions including but not limited to tumors,u
6921,6921,6921,6921,6921,6921,6921,8381,8381,8381,8381,8381,8381,8381,8381,8381,8381,8381,8381,8381,abef9e9b-a29f-4abe-aeff-88ae42648057,1 2 extracranial extraspinal tissues magnevist injection is indicated for use with mri in adults and pediatric patients ( 2 years of age and older ) to facilitate the visualization of lesions with abnormal vascularity in the head and neck,1
6922,6922,6922,6922,6922,6922,6922,8382,8382,8382,8382,8382,8382,8382,8382,8382,8382,8382,8382,8382,abef9e9b-a29f-4abe-aeff-88ae42648057,1 3 body magnevist injection is indicated for use in mri in adults and pediatric patients ( 2 years of age and older ) to facilitate the visualization of lesions with abnormal vascularity in the body,1
6923,6923,6923,6923,6923,6923,6923,8383,8383,8383,8383,8383,8383,8383,8383,8383,8383,8383,8383,8383,a398400e-bd31-41a9-9696-4f7c06569ede,1  xofigo is indicated for the treatment of patients with castration resistant prostate cancer  symptomatic bone metastases and no known visceral metastatic disease,1
6924,6924,6924,6924,6924,6924,6924,8384,8384,8384,8384,8384,8384,8384,8384,8384,8384,8384,8384,8384,a398400e-bd31-41a9-9696-4f7c06569ede,xofigo is an alpha particle emitting radioactive therapeutic agent indicated for the treatment of patients with castration resistant prostate cancer  symptomatic bone metastases and no known visceral metastatic disease,1
6925,6925,6925,6925,6925,6925,6925,8385,8385,8385,8385,8385,8385,8385,8385,8385,8385,8385,8385,8385,08ed2c17-cd53-4ad9-8b01-185d9c0ab65f, hypertension quinapril hydrochloride is indicated for the treatment of hypertension  to lower blood pressure,1
6926,6926,6926,6926,6926,6926,6926,8388,8388,8388,8388,8388,8388,8388,8388,8388,8388,8388,8388,8388,08ed2c17-cd53-4ad9-8b01-185d9c0ab65f,there are no controlled trials demonstrating risk reduction with quinapril hydrochloride,0
6927,6927,6927,6927,6927,6927,6927,8398,8398,8398,8398,8398,8398,8398,8398,8398,8398,8398,8398,8398,08ed2c17-cd53-4ad9-8b01-185d9c0ab65f,quinapril hydrochloride may be used alone or in combination with thiazide diuretics,4
6928,6928,6928,6928,6928,6928,6928,8399,8399,8399,8399,8399,8399,8399,8399,8399,8399,8399,8399,8399,08ed2c17-cd53-4ad9-8b01-185d9c0ab65f,heart failure quinapril hydrochloride tablets are indicated in the management of heart failure as adjunctive therapy when added to conventional therapy including diuretics and or digitalis,1
6929,6929,6929,6929,6929,6929,6929,8400,8400,8400,8400,8400,8400,8400,8400,8400,8400,8400,8400,8400,0e451c1b-28a7-4f63-9aa5-6a70626d72f1, trifluridine ophthalmic solution  1 ( trifluridine ophthalmic solution ) is indicated for the treatment of primary keratoconjunctivitis and recurrent epithelial keratitis due to herpes simplex virus  types 1 and 2,1
6930,6930,6930,6930,6930,6930,6930,8401,8401,8401,8401,8401,8401,8401,8401,8401,8401,8401,8401,8401,8a023942-01e8-4849-aa3c-1a640ffc7fd3,indications clanza cr is indicated for rheumatoid arthritis  ankylosing spondylitis  osteoarthritis and periarthritis of scapulohumerous  lumbago  ischiadynia  pain caused by nonaticular rheutism,1
6931,6931,6931,6931,6931,6931,6931,8402,8402,8402,8402,8402,8402,8402,8402,8402,8402,8402,8402,8402,b87a89d2-6e45-4eb8-be2c-7f55f34d61e5, oxistat cream and lotion are indicated for the topical treatment of the following dermal infections tinea pedis  tinea cruris  and tinea corporis due to trichophyton rubrum  trichophyton mentagrophytes  or epidermophyton floccosum,1
6932,6932,6932,6932,6932,6932,6932,8403,8403,8403,8403,8403,8403,8403,8403,8403,8403,8403,8403,8403,b87a89d2-6e45-4eb8-be2c-7f55f34d61e5,oxistat cream is indicated for the topical treatment of tinea ( pityriasis ) versicolor due to malassezia furfur ( see dosage and administration and clinical studies ),1
6933,6933,6933,6933,6933,6933,6933,8404,8404,8404,8404,8404,8404,8404,8404,8404,8404,8404,8404,8404,b87a89d2-6e45-4eb8-be2c-7f55f34d61e5,oxistat cream may be used in pediatric patients for tinea corporis  tinea cruris  tinea pedis  and tinea ( pityriasis ) versicolor however  these indications for which oxistat cream has been shown to be effective rarely occur in children below the age of 12,1
6934,6934,6934,6934,6934,6934,6934,8405,8405,8405,8405,8405,8405,8405,8405,8405,8405,8405,8405,8405,5c74bfb0-c80a-4a86-acd1-1e3a1b20255d, adjunctive therapy for the treatment of peptic ulcer,1
6935,6935,6935,6935,6935,6935,6935,8406,8406,8406,8406,8406,8406,8406,8406,8406,8406,8406,8406,8406,5c74bfb0-c80a-4a86-acd1-1e3a1b20255d,methscopolamine bromide has not been shown to be effective in contributing to the healing of peptic ulcer  decreasing the rate of recurrence or preventing complications,0
6936,6936,6936,6936,6936,6936,6936,8407,8407,8407,8407,8407,8407,8407,8407,8407,8407,8407,8407,8407,7b57509a-3d5d-41d4-8fed-1471e26372a3,1  adempas is a soluble guanylate cyclase ( sgc ) stimulator indicated for the treatment of adults with persistent recurrent chronic thromboembolic pulmonary hypertension ( cteph ) ( who group 4 ) after surgical treatment or inoperable cteph to improve exercise capacity and who functional class,1
6937,6937,6937,6937,6937,6937,6937,8408,8408,8408,8408,8408,8408,8408,8408,8408,8408,8408,8408,8408,7b57509a-3d5d-41d4-8fed-1471e26372a3,( 1 1 ) pulmonary arterial hypertension ( pah ) ( who group 1 ) to improve exercise capacity  improve who functional class and to delay clinical worsening,1
6938,6938,6938,6938,6938,6938,6938,8409,8409,8409,8409,8409,8409,8409,8409,8409,8409,8409,8409,8409,7b57509a-3d5d-41d4-8fed-1471e26372a3,( 1 2 ) 1 1 chronic thromboembolic pulmonary hypertension adempas is indicated for the treatment of adults with persistent recurrent chronic thromboembolic pulmonary hypertension ( cteph )  ( who group 4 ) after surgical treatment  or inoperable cteph  to improve exercise capacity and who functional class see clinical studies ( 14 1 ),1
6939,6939,6939,6939,6939,6939,6939,8410,8410,8410,8410,8410,8410,8410,8410,8410,8410,8410,8410,8410,7b57509a-3d5d-41d4-8fed-1471e26372a3,1 2 pulmonary arterial hypertension adempas is indicated for the treatment of adults with pulmonary arterial hypertension ( pah )  ( who group 1 )  to improve exercise capacity  who functional class and to delay clinical worsening,1
6940,6940,6940,6940,6940,6940,6940,8411,8411,8411,8411,8411,8411,8411,8411,8411,8411,8411,8411,8411,7b57509a-3d5d-41d4-8fed-1471e26372a3,efficacy was shown in patients on adempas monotherapy or in combination with endothelin receptor antagonists or prostanoids,u
6941,6941,6941,6941,6941,6941,6941,8412,8412,8412,8412,8412,8412,8412,8412,8412,8412,8412,8412,8412,7b57509a-3d5d-41d4-8fed-1471e26372a3,studies establishing effectiveness included predominately patients with who functional class ii iii and etiologies of idiopathic or heritable pah ( 61 ) or pah associated with connective tissue diseases ( 25 ) see clinical studies ( 14 2 ),0
6942,6942,6942,6942,6942,6942,6942,8413,8413,8413,8413,8413,8413,8413,8413,8413,8413,8413,8413,8413,cbc31ab1-a80f-4b50-a3b1-39910b0fb609,1  tyvaso is indicated for the treatment of pulmonary arterial hypertension ( pah ) ( who group 1 ) to improve exercise ability,1
6943,6943,6943,6943,6943,6943,6943,8414,8414,8414,8414,8414,8414,8414,8414,8414,8414,8414,8414,8414,cbc31ab1-a80f-4b50-a3b1-39910b0fb609,studies establishing effectiveness included predominately patients with nyha functional class iii symptoms and etiologies of idiopathic or heritable pah ( 56 ) or pah associated with connective tissue diseases ( 33 ),4
6944,6944,6944,6944,6944,6944,6944,8415,8415,8415,8415,8415,8415,8415,8415,8415,8415,8415,8415,8415,cbc31ab1-a80f-4b50-a3b1-39910b0fb609,the effects diminish over the minimum recommended dosing interval of 4 hours treatment timing can be adjusted for planned activities,0
6945,6945,6945,6945,6945,6945,6945,8416,8416,8416,8416,8416,8416,8416,8416,8416,8416,8416,8416,8416,cbc31ab1-a80f-4b50-a3b1-39910b0fb609,while there are long term data on use of treprostinil by other routes of administration  nearly all controlled clinical experience with inhaled treprostinil has been on a background of bosentan ( an endothelin receptor antagonist ) or sildenafil ( a phosphodiesterase type 5 inhibitor ),u
6946,6946,6946,6946,6946,6946,6946,8417,8417,8417,8417,8417,8417,8417,8417,8417,8417,8417,8417,8417,cbc31ab1-a80f-4b50-a3b1-39910b0fb609,the controlled clinical experience was limited to 12 weeks in duration see clinical studies ( 14 ),0
6947,6947,6947,6947,6947,6947,6947,8418,8418,8418,8418,8418,8418,8418,8418,8418,8418,8418,8418,8418,cbc31ab1-a80f-4b50-a3b1-39910b0fb609,tyvaso is a prostacyclin vasodilator indicated for the treatment of pulmonary arterial hypertension ( pah who group 1 ) to improve exercise ability,1
6948,6948,6948,6948,6948,6948,6948,8420,8420,8420,8420,8420,8420,8420,8420,8420,8420,8420,8420,8420,988513ab-b06f-4dd0-93f7-d2d4531dcce4,1  fabrazyme ( agalsidase beta ) is indicated for use in patients with fabry disease,1
6949,6949,6949,6949,6949,6949,6949,8421,8421,8421,8421,8421,8421,8421,8421,8421,8421,8421,8421,8421,988513ab-b06f-4dd0-93f7-d2d4531dcce4,fabrazyme reduces globotriaosylceramide ( gl 3 ) deposition in capillary endothelium of the kidney and certain other cell types,u
6950,6950,6950,6950,6950,6950,6950,8422,8422,8422,8422,8422,8422,8422,8422,8422,8422,8422,8422,8422,988513ab-b06f-4dd0-93f7-d2d4531dcce4,fabrazyme is indicated for use in patients with fabry disease,1
6951,6951,6951,6951,6951,6951,6951,8423,8423,8423,8423,8423,8423,8423,8423,8423,8423,8423,8423,8423,988513ab-b06f-4dd0-93f7-d2d4531dcce4,fabrazyme reduces globotriaosylceramide ( gl 3 ) deposition in capillary endothelium of the kidney and certain other cell types ( 1 ),u
6952,6952,6952,6952,6952,6952,6952,8424,8424,8424,8424,8424,8424,8424,8424,8424,8424,8424,8424,8424,ab5a8fa3-2eb2-44fd-bf9b-a1ac114e0c9b,1  qutenza is indicated for the management of neuropathic pain associated with postherpetic neuralgia,1
6953,6953,6953,6953,6953,6953,6953,8425,8425,8425,8425,8425,8425,8425,8425,8425,8425,8425,8425,8425,ab5a8fa3-2eb2-44fd-bf9b-a1ac114e0c9b,qutenza is a trpv1 channel agonist indicated for the management of neuropathic pain associated with postherpetic neuralgia ( phn ),1
6954,6954,6954,6954,6954,6954,6954,8426,8426,8426,8426,8426,8426,8426,8426,8426,8426,8426,8426,8426,a84d61a4-8e7f-4be1-aba6-f633b334aafc, copper 0 4 mg ml ( cupric chloride injection  usp ) is indicated for use as a supplement to intravenous solutions given for total parenteral nutrition ( tpn ),1
6955,6955,6955,6955,6955,6955,6955,8427,8427,8427,8427,8427,8427,8427,8427,8427,8427,8427,8427,8427,a84d61a4-8e7f-4be1-aba6-f633b334aafc,administration helps to maintain copper serum levels and to prevent depletion of endogenous stores and subsequent deficiency symptoms,u
6956,6956,6956,6956,6956,6956,6956,8428,8428,8428,8428,8428,8428,8428,8428,8428,8428,8428,8428,8428,ce850693-bc70-41e8-8af8-426898631f42, oxybutynin chloride syrup is indicated for the relief of symptoms of bladder instability associated with voiding in patients with uninhibited neurogenic or reflex neurogenic bladder ( i e  urgency  frequency  urinary leakage  urge incontinence  dysuria ),1
6957,6957,6957,6957,6957,6957,6957,8429,8429,8429,8429,8429,8429,8429,8429,8429,8429,8429,8429,8429,63e635e0-65d8-4b30-9f2a-ab16deba90bd, alclometasone dipropionate cream usp and alclometasone dipropionate ointment usp are low to medium potency corticosteroids indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid responsive dermatoses,1
6958,6958,6958,6958,6958,6958,6958,8430,8430,8430,8430,8430,8430,8430,8430,8430,8430,8430,8430,8430,63e635e0-65d8-4b30-9f2a-ab16deba90bd,alclometasone dipropionate cream usp and alclometasone dipropionate ointment usp may be used in pediatric patients 1 year of age or older  although the safety and efficacy of drug use for longer than 3 weeks have not been established ( see precautions pediatric use ),4
6959,6959,6959,6959,6959,6959,6959,8431,8431,8431,8431,8431,8431,8431,8431,8431,8431,8431,8431,8431,63e635e0-65d8-4b30-9f2a-ab16deba90bd,since the safety and efficacy of alclometasone dipropionate cream usp and alclometasone dipropionate ointment usp have not been established in pediatric patients below 1 year of age  their use in this age group is not recommended,0
6960,6960,6960,6960,6960,6960,6960,8432,8432,8432,8432,8432,8432,8432,8432,8432,8432,8432,8432,8432,827d60e8-7e07-41b7-c28b-49ef1c4a5a41,1  iressa is indicated for the first line treatment of patients with or metastatic non small cell lung cancer ( nsclc ) whose tumors have epidermal growth factor receptor ( egfr ) exon 19 deletions or exon 21 ( l858r ) substitution mutations as detected by an fda approved test see clinical studies ( 14 ),1
6961,6961,6961,6961,6961,6961,6961,8433,8433,8433,8433,8433,8433,8433,8433,8433,8433,8433,8433,8433,827d60e8-7e07-41b7-c28b-49ef1c4a5a41,limitation of use safety and efficacy of iressa have not been established in patients with metastatic nsclc whose tumors have egfr mutations other than exon 19 deletions or exon 21 ( l858r ) substitution mutations see clinical studies ( 14 ),0
6962,6962,6962,6962,6962,6962,6962,8434,8434,8434,8434,8434,8434,8434,8434,8434,8434,8434,8434,8434,827d60e8-7e07-41b7-c28b-49ef1c4a5a41,iressa is a tyrosine kinase inhibitor indicated for the first line treatment of patients with metastatic non small cell lung cancer ( nsclc ) whose tumors have epidermal growth factor receptor ( egfr ) exon 19 deletions or exon 21 ( l858r ) substitution mutations as detected by an fda approved test,1
6963,6963,6963,6963,6963,6963,6963,8435,8435,8435,8435,8435,8435,8435,8435,8435,8435,8435,8435,8435,827d60e8-7e07-41b7-c28b-49ef1c4a5a41,( 1 ) limitation of use safety and efficacy of iressa have not been established in patients whose tumors have egfr mutations other than exon 19 deletions or exon 21 ( l858r ) substitution mutations,0
6964,6964,6964,6964,6964,6964,6964,8436,8436,8436,8436,8436,8436,8436,8436,8436,8436,8436,8436,8436,53c9942a-e861-493f-95c2-53446bc5f06d, calcipotriene topical solution  0 005 ( scalp solution )  is indicated for the topical treatment of chronic  moderately severe psoriasis of the scalp,1
6965,6965,6965,6965,6965,6965,6965,8438,8438,8438,8438,8438,8438,8438,8438,8438,8438,8438,8438,8438,0ce2c1c4-2a40-485c-b7cb-96a9b85d9d11,1  radicava is indicated for the treatment of amyotrophic lateral sclerosis ( als ),1
6966,6966,6966,6966,6966,6966,6966,8439,8439,8439,8439,8439,8439,8439,8439,8439,8439,8439,8439,8439,0ce2c1c4-2a40-485c-b7cb-96a9b85d9d11,radicava is indicated for the treatment of amyotrophic lateral sclerosis ( als ) ( 1 ),1
6967,6967,6967,6967,6967,6967,6967,8440,8440,8440,8440,8440,8440,8440,8440,8440,8440,8440,8440,8440,dec51fab-3784-deb7-752f-2d4d5692a20f,1  trisenox is an arsenical indicated in combination with tretinoin for treatment of adults with newly diagnosed low risk acute promyelocytic leukemia ( apl ) whose apl is characterized by the presence of the t ( 15 17 ) translocation or pml rar alpha gene expression,1
6968,6968,6968,6968,6968,6968,6968,8441,8441,8441,8441,8441,8441,8441,8441,8441,8441,8441,8441,8441,dec51fab-3784-deb7-752f-2d4d5692a20f,( 1 1 ) for induction of remission and consolidation in patients with apl who are refractory to  or have relapsed from  retinoid and anthracycline chemotherapy  and whose apl is characterized by the presence of the t ( 15 17 ) translocation or pml rar alpha gene expression,1
6969,6969,6969,6969,6969,6969,6969,8442,8442,8442,8442,8442,8442,8442,8442,8442,8442,8442,8442,8442,dec51fab-3784-deb7-752f-2d4d5692a20f,( 1 2 ) 1 1 newly diagnosed low risk apl trisenox is indicated in combination with tretinoin for treatment of adults with newly diagnosed low risk acute promyelocytic leukemia ( apl ) whose apl is characterized by the presence of the t ( 15 17 ) translocation or pml rar alpha gene expression,1
6970,6970,6970,6970,6970,6970,6970,8443,8443,8443,8443,8443,8443,8443,8443,8443,8443,8443,8443,8443,dec51fab-3784-deb7-752f-2d4d5692a20f,1 2 relapsed or refractory apl trisenox is indicated for induction of remission and consolidation in patients with apl who are refractory to  or have relapsed from  retinoid and anthracycline chemotherapy  and whose apl is characterized by the presence of the t ( 15 17 ) translocation or pml rar alpha gene expression,1
6971,6971,6971,6971,6971,6971,6971,8444,8444,8444,8444,8444,8444,8444,8444,8444,8444,8444,8444,8444,7ef9e3a5-fc39-4ae1-0dad-6b47a1684635, survanta is indicated for prevention and treatment ( rescue ) of respiratory distress syndrome ( rds ) ( hyaline membrane disease ) in premature infants,1
6972,6972,6972,6972,6972,6972,6972,8445,8445,8445,8445,8445,8445,8445,8445,8445,8445,8445,8445,8445,7ef9e3a5-fc39-4ae1-0dad-6b47a1684635,survanta significantly reduces the incidence of rds  mortality due to rds and air leak complications,u
6973,6973,6973,6973,6973,6973,6973,8446,8446,8446,8446,8446,8446,8446,8446,8446,8446,8446,8446,8446,7ef9e3a5-fc39-4ae1-0dad-6b47a1684635,prevention in premature infants less than 1250 g birth weight or with evidence of surfactant deficiency  give survanta as soon as possible  preferably within 15 minutes of birth,u
6974,6974,6974,6974,6974,6974,6974,8447,8447,8447,8447,8447,8447,8447,8447,8447,8447,8447,8447,8447,7ef9e3a5-fc39-4ae1-0dad-6b47a1684635,rescue to treat infants with rds confirmed by x ray and requiring mechanical ventilation  give survanta as soon as possible  preferably by 8 hours of age,1
6975,6975,6975,6975,6975,6975,6975,8448,8448,8448,8448,8448,8448,8448,8448,8448,8448,8448,8448,8448,d07b65d5-f8e3-4594-a7fb-108218746cec,1  durezol is a topical corticosteroid that is indicated for the treatment of inflammation and pain associated with ocular surgery ( 1 1 ) the treatment of endogenous anterior uveitis ( 1 2 ) 1 1 ocular surgery durezol ( difluprednate ophthalmic emulsion ) 0 05  a topical corticosteroid  is indicated for the treatment of inflammation and pain associated with ocular surgery,1
6976,6976,6976,6976,6976,6976,6976,8449,8449,8449,8449,8449,8449,8449,8449,8449,8449,8449,8449,8449,d07b65d5-f8e3-4594-a7fb-108218746cec,1 2 endogenous anterior uveitis durezol is also indicated for the treatment of endogenous anterior uveitis,1
6977,6977,6977,6977,6977,6977,6977,8450,8450,8450,8450,8450,8450,8450,8450,8450,8450,8450,8450,8450,0ed08d2b-5051-46b2-aa37-1d6275bf9003,1  mozobil ( plerixafor ) injection is indicated in combination with granulocyte colony stimulating factor ( g csf ) to mobilize hematopoietic stem cells ( hscs ) to the peripheral blood for collection and subsequent autologous transplantation in patients with non hodgkin 's lymphoma ( nhl ) and multiple myeloma ( mm ),1
6978,6978,6978,6978,6978,6978,6978,8451,8451,8451,8451,8451,8451,8451,8451,8451,8451,8451,8451,8451,0ed08d2b-5051-46b2-aa37-1d6275bf9003,mozobil  a hematopoietic stem cell mobilizer  is indicated in combination with granulocyte colony stimulating factor ( g csf ) to mobilize hematopoietic stem cells ( hscs ) to the peripheral blood for collection and subsequent autologous transplantation in patients with non hodgkin 's lymphoma and multiple myeloma,1
6979,6979,6979,6979,6979,6979,6979,8452,8452,8452,8452,8452,8452,8452,8452,8452,8452,8452,8452,8452,52fc28b9-464a-4173-9d0d-000ed0dbf265, sufentanil citrate injection is indicated for intravenous administration in adults and pediatric patients as an analgesic adjunct in the maintenance of balanced general anesthesia in patients who are intubated and ventilated,1
6980,6980,6980,6980,6980,6980,6980,8453,8453,8453,8453,8453,8453,8453,8453,8453,8453,8453,8453,8453,52fc28b9-464a-4173-9d0d-000ed0dbf265,as a primary anesthetic agent for the induction and maintenance of anesthesia with 100 oxygen in patients undergoing major surgical procedures in patients who are intubated and ventilated  such as cardiovascular surgery or neurosurgical procedures in the sitting position to provide favorable myocardial and cerebral oxygen balance or when extended postoperative ventilation is anticipated,1
6981,6981,6981,6981,6981,6981,6981,8454,8454,8454,8454,8454,8454,8454,8454,8454,8454,8454,8454,8454,52fc28b9-464a-4173-9d0d-000ed0dbf265,sufentanil citrate injection is indicated for epidural administration as an analgesic combined with low dose bupivacaine  usually 12 5 mg per administration  during labor and vaginal delivery,1
6982,6982,6982,6982,6982,6982,6982,8455,8455,8455,8455,8455,8455,8455,8455,8455,8455,8455,8455,8455,52fc28b9-464a-4173-9d0d-000ed0dbf265,see dosage and administration section for more complete information on the use of sufentanil,0
6983,6983,6983,6983,6983,6983,6983,8456,8456,8456,8456,8456,8456,8456,8456,8456,8456,8456,8456,8456,23f3c1f4-0fc8-4804-a9e3-04cf25dd302e,1  kadcyla  as a single agent  is indicated for the treatment of patients with her2 positive  metastatic breast cancer who previously received trastuzumab and a taxane  separately or in combination,1
6984,6984,6984,6984,6984,6984,6984,8457,8457,8457,8457,8457,8457,8457,8457,8457,8457,8457,8457,8457,23f3c1f4-0fc8-4804-a9e3-04cf25dd302e,patients should have either received prior therapy for metastatic disease  or developed disease recurrence during or within six months of completing adjuvant therapy,0
6985,6985,6985,6985,6985,6985,6985,8458,8458,8458,8458,8458,8458,8458,8458,8458,8458,8458,8458,8458,23f3c1f4-0fc8-4804-a9e3-04cf25dd302e,kadcyla is a her2 targeted antibody and microtubule inhibitor conjugate indicated  as a single agent  for the treatment of patients with her2 positive  metastatic breast cancer who previously received trastuzumab and a taxane  separately or in combination,1
6986,6986,6986,6986,6986,6986,6986,8460,8460,8460,8460,8460,8460,8460,8460,8460,8460,8460,8460,8460,ca4a9b63-708e-49e9-8f9b-010625443b90, hetlioz is indicated for the treatment of non 24 hour sleep wake disorder ( non 24 ),1
6987,6987,6987,6987,6987,6987,6987,8461,8461,8461,8461,8461,8461,8461,8461,8461,8461,8461,8461,8461,ca4a9b63-708e-49e9-8f9b-010625443b90,hetlioz is a melatonin receptor agonist indicated for the treatment of non 24 hour sleep wake disorder ( non 24 ) ( 1 ),1
6988,6988,6988,6988,6988,6988,6988,8462,8462,8462,8462,8462,8462,8462,8462,8462,8462,8462,8462,8462,4f6ffa29-577b-4377-a068-0846df221771, halog ointment ( halcinonide ointment  usp ) 0 1 is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid responsive dermatoses,1
6989,6989,6989,6989,6989,6989,6989,8463,8463,8463,8463,8463,8463,8463,8463,8463,8463,8463,8463,8463,704e4378-ca83-445c-8b45-3cfa51c1ecad,1  vyvanse is indicated for the treatment of attention deficit hyperactivity disorder ( adhd ) see clinical studies ( 14 1 ) moderate to severe binge eating disorder ( bed ) in adults see clinical studies ( 14 2 ),1
6990,6990,6990,6990,6990,6990,6990,8464,8464,8464,8464,8464,8464,8464,8464,8464,8464,8464,8464,8464,704e4378-ca83-445c-8b45-3cfa51c1ecad,vyvanse is a central nervous system ( cns ) stimulant indicated for the treatment of ( 1 ) attention deficit hyperactivity disorder ( adhd ) moderate to severe binge eating disorder ( bed ) in adults limitation of use vyvanse is not indicated for weight loss,1
6991,6991,6991,6991,6991,6991,6991,8465,8465,8465,8465,8465,8465,8465,8465,8465,8465,8465,8465,8465,704e4378-ca83-445c-8b45-3cfa51c1ecad,use of other sympathomimetic drugs for weight loss has been associated with serious cardiovascular adverse events,0
6992,6992,6992,6992,6992,6992,6992,8466,8466,8466,8466,8466,8466,8466,8466,8466,8466,8466,8466,8466,704e4378-ca83-445c-8b45-3cfa51c1ecad,the safety and effectiveness of vyvanse for the treatment of obesity have not been established,0
6993,6993,6993,6993,6993,6993,6993,8467,8467,8467,8467,8467,8467,8467,8467,8467,8467,8467,8467,8467,704e4378-ca83-445c-8b45-3cfa51c1ecad,limitation of use vyvanse is not indicated or recommended for weight loss,0
6994,6994,6994,6994,6994,6994,6994,8469,8469,8469,8469,8469,8469,8469,8469,8469,8469,8469,8469,8469,704e4378-ca83-445c-8b45-3cfa51c1ecad,the safety and effectiveness of vyvanse for the treatment of obesity have not been established see warnings and precautions ( 5 2 ),0
6995,6995,6995,6995,6995,6995,6995,8470,8470,8470,8470,8470,8470,8470,8470,8470,8470,8470,8470,8470,2f5e24de-3956-4724-a5d7-fe81dcb07f6e,1  colchicine capsules are indicated for prophylaxis of gout flares in adults,1
6996,6996,6996,6996,6996,6996,6996,8471,8471,8471,8471,8471,8471,8471,8471,8471,8471,8471,8471,8471,2f5e24de-3956-4724-a5d7-fe81dcb07f6e,limitations of use the safety and effectiveness of colchicine capsules for acute treatment of gout flares during prophylaxis has not been studied,0
6997,6997,6997,6997,6997,6997,6997,8472,8472,8472,8472,8472,8472,8472,8472,8472,8472,8472,8472,8472,2f5e24de-3956-4724-a5d7-fe81dcb07f6e,colchicine capsules are not an analgesic medication and should not be used to treat pain from other causes,0
6998,6998,6998,6998,6998,6998,6998,8473,8473,8473,8473,8473,8473,8473,8473,8473,8473,8473,8473,8473,2f5e24de-3956-4724-a5d7-fe81dcb07f6e,colchicine capsules are indicated for prophylaxis of gout flares in adults ( 1 ),1
6999,6999,6999,6999,6999,6999,6999,8476,8476,8476,8476,8476,8476,8476,8476,8476,8476,8476,8476,8476,850960a3-9fe2-4999-81eb-b0ae9ba011bc, chlorothiazide sodium for injection  usp is indicated as adjunctive therapy in edema associated with congestive heart failure  hepatic cirrhosis  and corticosteroid and estrogen therapy,1
7000,7000,7000,7000,7000,7000,7000,8477,8477,8477,8477,8477,8477,8477,8477,8477,8477,8477,8477,8477,850960a3-9fe2-4999-81eb-b0ae9ba011bc,chlorothiazide sodium for injection  usp has also been found useful in edema due to various forms of renal dysfunction such as nephrotic syndrome  acute glomerulonephritis  and chronic renal failure,1
7001,7001,7001,7001,7001,7001,7001,8478,8478,8478,8478,8478,8478,8478,8478,8478,8478,8478,8478,8478,850960a3-9fe2-4999-81eb-b0ae9ba011bc,use in pregnancy routine use of diuretics during normal pregnancy is inappropriate and exposes mother and fetus to unnecessary hazard,4
7002,7002,7002,7002,7002,7002,7002,8489,8489,8489,8489,8489,8489,8489,8489,8489,8489,8489,8489,8489,56b1575a-dff4-4c5a-a159-2f858e7a0cb8,1  diarrhea caused by giardia lamblia or cryptosporidium parvum alinia for oral suspension ( patients 1 year of age and older ) and alinia tablets ( patients 12 years and older ) are indicated for the treatment of diarrhea caused by giardia lamblia or cryptosporidium parvum,1
7003,7003,7003,7003,7003,7003,7003,8490,8490,8490,8490,8490,8490,8490,8490,8490,8490,8490,8490,8490,56b1575a-dff4-4c5a-a159-2f858e7a0cb8,limitations of use alinia for oral suspension and alinia tablets have not been shown to be effective for the treatment of diarrhea caused by cryptosporidium parvum in hiv infected or immunodeficient patients see clinical studies ( 14 2 ) alinia is an antiprotozoal indicated for the treatment of diarrhea caused by giardia lamblia or cryptosporidium parvum ( 1 ),1
7004,7004,7004,7004,7004,7004,7004,8491,8491,8491,8491,8491,8491,8491,8491,8491,8491,8491,8491,8491,56b1575a-dff4-4c5a-a159-2f858e7a0cb8,limitations of use alinia has not been shown to be effective for the treatment of diarrhea caused by c parvum in hiv infected or immunodeficient patients ( 1 ),0
7005,7005,7005,7005,7005,7005,7005,8492,8492,8492,8492,8492,8492,8492,8492,8492,8492,8492,8492,8492,11b9fe1d-23cc-4116-8aaf-3bf039ce7264, calcium gluconate injection  usp is used to treat conditions arising from calcium deficiencies such as hypocalcemic tetany  hypocalcemia related to hypoparathyroidism and hypocalcemia due to rapid growth or pregnancy,1
7006,7006,7006,7006,7006,7006,7006,8493,8493,8493,8493,8493,8493,8493,8493,8493,8493,8493,8493,8493,11b9fe1d-23cc-4116-8aaf-3bf039ce7264,it is also used in the treatment of black widow spider bites to relieve muscle cramping and as an adjunct in the treatment of rickets  osteomalacia  lead colic and magnesium sulfate overdosage,1
7007,7007,7007,7007,7007,7007,7007,8494,8494,8494,8494,8494,8494,8494,8494,8494,8494,8494,8494,8494,11b9fe1d-23cc-4116-8aaf-3bf039ce7264,calcium gluconate has also been employed to decrease capillary permeability in allergic conditions  nonthrombocytopenic purpura and exudative dermatoses such as dermatitis herpetiformis and for pruritus of eruptions caused by certain drugs,1
7008,7008,7008,7008,7008,7008,7008,8495,8495,8495,8495,8495,8495,8495,8495,8495,8495,8495,8495,8495,11b9fe1d-23cc-4116-8aaf-3bf039ce7264,in hyperkalemia  calcium gluconate may aid in antagonizing the cardiac toxicity  provided the patient is not receiving digitalis therapy,u
7009,7009,7009,7009,7009,7009,7009,8496,8496,8496,8496,8496,8496,8496,8496,8496,8496,8496,8496,8496,4252d631-03d0-4b37-8a0e-c7dc8fc5438a, estropipate tablets are indicated in the treatment of moderate to severe vasomotor symptoms associated with the menopause,1
7010,7010,7010,7010,7010,7010,7010,8497,8497,8497,8497,8497,8497,8497,8497,8497,8497,8497,8497,8497,4252d631-03d0-4b37-8a0e-c7dc8fc5438a,treatment of moderate to severe symptoms of vulval and vaginal atrophy associated with the menopause,1
7011,7011,7011,7011,7011,7011,7011,8500,8500,8500,8500,8500,8500,8500,8500,8500,8500,8500,8500,8500,4252d631-03d0-4b37-8a0e-c7dc8fc5438a,prevention of postmenopausal osteoporosis,1
7012,7012,7012,7012,7012,7012,7012,8501,8501,8501,8501,8501,8501,8501,8501,8501,8501,8501,8501,8501,4252d631-03d0-4b37-8a0e-c7dc8fc5438a,when prescribing solely for the prevention of postmenopausal osteoporosis  therapy should only be considered for women at significant risk of osteoporosis and for whom non estrogen medications are not considered to be appropriate,0
7013,7013,7013,7013,7013,7013,7013,8505,8505,8505,8505,8505,8505,8505,8505,8505,8505,8505,8505,8505,4252d631-03d0-4b37-8a0e-c7dc8fc5438a,vitamin d supplementation of 400 800 iu day may also be required to ensure adequate daily intake in postmenopausal women,4
7014,7014,7014,7014,7014,7014,7014,8506,8506,8506,8506,8506,8506,8506,8506,8506,8506,8506,8506,8506,ffcaa218-ed6a-4557-9645-b9a91128a214, parenteral sedative,1
7015,7015,7015,7015,7015,7015,7015,8507,8507,8507,8507,8507,8507,8507,8507,8507,8507,8507,8507,8507,ffcaa218-ed6a-4557-9645-b9a91128a214,sedation is obtainable within an hour  and in adequate dosage  the duration of action is more than six hours,0
7016,7016,7016,7016,7016,7016,7016,8508,8508,8508,8508,8508,8508,8508,8508,8508,8508,8508,8508,8508,ffcaa218-ed6a-4557-9645-b9a91128a214,included in the more common conditions in which the sedative action of this class of drugs is desired are anxiety tension states  hyperthyroidism  essential hypertension  nausea and vomiting of functional origin  motion sickness  acute labyrinthitis  pylorospasm in infants  chorea and cardiac failure,1
7017,7017,7017,7017,7017,7017,7017,8509,8509,8509,8509,8509,8509,8509,8509,8509,8509,8509,8509,8509,ffcaa218-ed6a-4557-9645-b9a91128a214,phenobarbital is also a useful adjunct in treatment of hemorrhage from the respiratory or gastrointestinal tract,1
7018,7018,7018,7018,7018,7018,7018,8510,8510,8510,8510,8510,8510,8510,8510,8510,8510,8510,8510,8510,ffcaa218-ed6a-4557-9645-b9a91128a214,phenobarbital controls anxiety  decreases muscular activity and lessens nervous excitability in hyperthyroid patients,u
7019,7019,7019,7019,7019,7019,7019,8511,8511,8511,8511,8511,8511,8511,8511,8511,8511,8511,8511,8511,ffcaa218-ed6a-4557-9645-b9a91128a214,however  thyrotoxic individuals occasionally react poorly to barbiturates,2
7020,7020,7020,7020,7020,7020,7020,8512,8512,8512,8512,8512,8512,8512,8512,8512,8512,8512,8512,8512,ffcaa218-ed6a-4557-9645-b9a91128a214,hypnotic  for the short term treatment of insomnia  since it appears to lose its effectiveness for sleep induction and sleep maintenance after 2 weeks ( see clinical pharmacology ),u
7021,7021,7021,7021,7021,7021,7021,8513,8513,8513,8513,8513,8513,8513,8513,8513,8513,8513,8513,8513,ffcaa218-ed6a-4557-9645-b9a91128a214,long term anticonvulsant  ( phenobarbital  mephobarbital and metharbital ) for the treatment of generalized tonic clonic and cortical focal seizures,1
7022,7022,7022,7022,7022,7022,7022,8514,8514,8514,8514,8514,8514,8514,8514,8514,8514,8514,8514,8514,ffcaa218-ed6a-4557-9645-b9a91128a214,and  in the emergency control of certain acute convulsive episodes  e g  those associated with status epilepticus  cholera  eclampsia  cerebral hemorrhage  meningitis  tetanus  and toxic reactions to strychnine or local anesthetics,1
7023,7023,7023,7023,7023,7023,7023,8515,8515,8515,8515,8515,8515,8515,8515,8515,8515,8515,8515,8515,ffcaa218-ed6a-4557-9645-b9a91128a214,phenobarbital sodium may be administered intramuscularly or intravenously as an anticonvulsant for emergency use,4
7024,7024,7024,7024,7024,7024,7024,8516,8516,8516,8516,8516,8516,8516,8516,8516,8516,8516,8516,8516,ffcaa218-ed6a-4557-9645-b9a91128a214,when administered intravenously  it may require 15 or more minutes before reaching peak concentrations in the brain,4
7025,7025,7025,7025,7025,7025,7025,8517,8517,8517,8517,8517,8517,8517,8517,8517,8517,8517,8517,8517,ffcaa218-ed6a-4557-9645-b9a91128a214,therefore  injecting phenobarbital sodium until the convulsions stop may cause the brain level to exceed that required to control the convulsions and lead to severe barbiturate induced depression,0
7026,7026,7026,7026,7026,7026,7026,8518,8518,8518,8518,8518,8518,8518,8518,8518,8518,8518,8518,8518,ffcaa218-ed6a-4557-9645-b9a91128a214,phenobarbital is indicated in pediatric patients as an anticonvulsant and as a sedative  including its preoperative and postoperative use,1
7027,7027,7027,7027,7027,7027,7027,8519,8519,8519,8519,8519,8519,8519,8519,8519,8519,8519,8519,8519,ab11dd8a-0fd9-4013-89ab-e114557c7e4b,1  firmagon is a gnrh receptor antagonist indicated for treatment of patients with advanced prostate cancer,1
7028,7028,7028,7028,7028,7028,7028,8520,8520,8520,8520,8520,8520,8520,8520,8520,8520,8520,8520,8520,ab11dd8a-0fd9-4013-89ab-e114557c7e4b,firmagon is a gnrh receptor antagonist indicated for treatment of patients with advanced prostate cancer,1
7029,7029,7029,7029,7029,7029,7029,8522,8522,8522,8522,8522,8522,8522,8522,8522,8522,8522,8522,8522,a9241f0b-e1d0-4782-98e6-7f1eaf9ccc85,progestin only oral contraceptives are indicated for the prevention of pregnancy,1
7030,7030,7030,7030,7030,7030,7030,8523,8523,8523,8523,8523,8523,8523,8523,8523,8523,8523,8523,8523,a9241f0b-e1d0-4782-98e6-7f1eaf9ccc85,if used perfectly  the first year failure rate for progestin only oral contraceptives is 0 5,0
7031,7031,7031,7031,7031,7031,7031,8524,8524,8524,8524,8524,8524,8524,8524,8524,8524,8524,8524,8524,a9241f0b-e1d0-4782-98e6-7f1eaf9ccc85,however  the typical failure rate is estimated to be closer to 5  due to late or omitted pills,0
7032,7032,7032,7032,7032,7032,7032,8525,8525,8525,8525,8525,8525,8525,8525,8525,8525,8525,8525,8525,a9241f0b-e1d0-4782-98e6-7f1eaf9ccc85,the following table lists the pregnancy rates for users of all major methods of contraception,0
7033,7033,7033,7033,7033,7033,7033,8526,8526,8526,8526,8526,8526,8526,8526,8526,8526,8526,8526,8526,a9241f0b-e1d0-4782-98e6-7f1eaf9ccc85,table 2 percentage of women experiencing an unintended pregnancy during the first year of typical use and the first year of perfect use of contraception and the percentage continuing use at the end of the first year,0
7034,7034,7034,7034,7034,7034,7034,8527,8527,8527,8527,8527,8527,8527,8527,8527,8527,8527,8527,8527,a9241f0b-e1d0-4782-98e6-7f1eaf9ccc85,of women experiencing an unintended pregnancy within the first year of use of women continuing use at one year 3 method ( 1 ) typical use 1 ( 2 ) perfect use 2 ( 3 ) ( 4 ) chance4 85 85 spermicides5,0
7035,7035,7035,7035,7035,7035,7035,8528,8528,8528,8528,8528,8528,8528,8528,8528,8528,8528,8528,8528,bd79aebb-b221-4844-8e4a-f848b7c52f16, clindamycin is indicated in the treatment of serious infections caused by susceptible anaerobic bacteria,1
7036,7036,7036,7036,7036,7036,7036,8529,8529,8529,8529,8529,8529,8529,8529,8529,8529,8529,8529,8529,bd79aebb-b221-4844-8e4a-f848b7c52f16,clindamycin is also indicated in the treatment of serious infections due to susceptible strains of streptococci  pneumococci  and staphylococci,1
7037,7037,7037,7037,7037,7037,7037,8530,8530,8530,8530,8530,8530,8530,8530,8530,8530,8530,8530,8530,bd79aebb-b221-4844-8e4a-f848b7c52f16,its use should be re served for penicillin allergic patients or other patients for whom  in the judgment of the physician  a penicillin is inappropriate,u
7038,7038,7038,7038,7038,7038,7038,8531,8531,8531,8531,8531,8531,8531,8531,8531,8531,8531,8531,8531,bd79aebb-b221-4844-8e4a-f848b7c52f16,because of the risk of co li tis  as described in the warning box  before selecting clindamycin  the physician should consider the nature of the infection and the suitability of less toxic alternatives ( e g  erythromycin ),4
7039,7039,7039,7039,7039,7039,7039,8532,8532,8532,8532,8532,8532,8532,8532,8532,8532,8532,8532,8532,bd79aebb-b221-4844-8e4a-f848b7c52f16,anaerobes serious respiratory tract infections such as empyema  anaerobic pneumonitis  and lung abscess serious skin and soft tissue infections septicemia intra abdominal infections such as peritonitis and intra abdominal abscess ( typically resulting from anaerobic organisms resident in the normal gastrointestinal tract ) infections of the female pelvis and genital tract such as endometritis  nongonococcal tubo ovarian abscess  pelvic cellulitis  and postsurgical vaginal cuff infection,1
7040,7040,7040,7040,7040,7040,7040,8533,8533,8533,8533,8533,8533,8533,8533,8533,8533,8533,8533,8533,bd79aebb-b221-4844-8e4a-f848b7c52f16,streptococci serious respiratory tract infections serious skin and soft tissue infections,1
7041,7041,7041,7041,7041,7041,7041,8534,8534,8534,8534,8534,8534,8534,8534,8534,8534,8534,8534,8534,bd79aebb-b221-4844-8e4a-f848b7c52f16,staphylococci serious respiratory tract infections serious skin and soft tissue infections,1
7042,7042,7042,7042,7042,7042,7042,8535,8535,8535,8535,8535,8535,8535,8535,8535,8535,8535,8535,8535,bd79aebb-b221-4844-8e4a-f848b7c52f16,pneumococci serious respiratory tract infections,1
7043,7043,7043,7043,7043,7043,7043,8536,8536,8536,8536,8536,8536,8536,8536,8536,8536,8536,8536,8536,bd79aebb-b221-4844-8e4a-f848b7c52f16,bacteriologic studies should be performed to determine the causative organisms and their susceptibility to clindamycin,0
7044,7044,7044,7044,7044,7044,7044,8537,8537,8537,8537,8537,8537,8537,8537,8537,8537,8537,8537,8537,bd79aebb-b221-4844-8e4a-f848b7c52f16,to reduce the development of drug resistant bacteria and maintain the effectiveness of clindamycin hydrochloride and other antibacterial drugs  clindamycin hydrochloride should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria,4
7045,7045,7045,7045,7045,7045,7045,8540,8540,8540,8540,8540,8540,8540,8540,8540,8540,8540,8540,8540,5449ca98-efb8-4c3b-8756-747b2349a472,1  prialt ( ziconotide ) solution  intrathecal infusion is indicated for the management of severe chronic pain in adult patients for whom intrathecal therapy is warranted  and who are intolerant of or refractory to other treatment  such as systemic analgesics  adjunctive therapies  or intrathecal morphine,1
7046,7046,7046,7046,7046,7046,7046,8541,8541,8541,8541,8541,8541,8541,8541,8541,8541,8541,8541,8541,5449ca98-efb8-4c3b-8756-747b2349a472,prialt ( ziconotide ) solution  intrathecal infusion is an n type calcium channel antagonist indicated for the management of severe chronic pain in patients for whom intrathecal therapy is warranted  and who are intolerant of or refractory to other treatment  such as systemic analgesics  adjunctive therapies  or intrathecal morphine,1
7047,7047,7047,7047,7047,7047,7047,8542,8542,8542,8542,8542,8542,8542,8542,8542,8542,8542,8542,8542,ac13647f-2747-493f-a650-ede37d230cd8, acute otitis media of various etiologies prompt relief of pain and reduction of inflammation in the congestive and serous stages,1
7048,7048,7048,7048,7048,7048,7048,8543,8543,8543,8543,8543,8543,8543,8543,8543,8543,8543,8543,8543,ac13647f-2747-493f-a650-ede37d230cd8,adjuvant therapy during systemic antibiotic administration for resolution of the infection,1
7049,7049,7049,7049,7049,7049,7049,8544,8544,8544,8544,8544,8544,8544,8544,8544,8544,8544,8544,8544,ac13647f-2747-493f-a650-ede37d230cd8,because of the close anatomical relationship of the eustachian tube to the nasal cavity  otitis media is a frequent problem  especially in children in whom the tube is shorter  wider  and more horizontal than in adults,0
7050,7050,7050,7050,7050,7050,7050,8545,8545,8545,8545,8545,8545,8545,8545,8545,8545,8545,8545,8545,ac13647f-2747-493f-a650-ede37d230cd8,removal of cerumen facilitates the removal of excessive or impacted cerumen,u
7051,7051,7051,7051,7051,7051,7051,8546,8546,8546,8546,8546,8546,8546,8546,8546,8546,8546,8546,8546,4f6848e5-35ed-4046-b13c-3032b5ba3232,1  provayblue usp is indicated for the treatment of pediatric and adult patients with acquired methemoglobinemia,1
7052,7052,7052,7052,7052,7052,7052,8547,8547,8547,8547,8547,8547,8547,8547,8547,8547,8547,8547,8547,4f6848e5-35ed-4046-b13c-3032b5ba3232,this indication is approved under accelerated approval,0
7053,7053,7053,7053,7053,7053,7053,8548,8548,8548,8548,8548,8548,8548,8548,8548,8548,8548,8548,8548,4f6848e5-35ed-4046-b13c-3032b5ba3232,continued approval for this indication may be contingent upon verification of clinical benefit in subsequent trials see clinical studies ( 14 1 ),0
7054,7054,7054,7054,7054,7054,7054,8549,8549,8549,8549,8549,8549,8549,8549,8549,8549,8549,8549,8549,4f6848e5-35ed-4046-b13c-3032b5ba3232,provayblue ( methylene blue ) is an oxidation reduction agent indicated for the treatment of pediatric and adult patients with acquired methemoglobinemia,1
7055,7055,7055,7055,7055,7055,7055,8551,8551,8551,8551,8551,8551,8551,8551,8551,8551,8551,8551,8551,4f6848e5-35ed-4046-b13c-3032b5ba3232,continued approval for this indication may be contingent upon verification of clinical benefit in subsequent trials,0
7056,7056,7056,7056,7056,7056,7056,8552,8552,8552,8552,8552,8552,8552,8552,8552,8552,8552,8552,8552,2c1cd745-79ab-487d-b759-995794cedb92,1  veregen is a topical ointment indicated for the treatment of external genital and perianal warts ( condylomata acuminata ) in immunocompetent patients 18 years and older ( 1 1 ),1
7057,7057,7057,7057,7057,7057,7057,8553,8553,8553,8553,8553,8553,8553,8553,8553,8553,8553,8553,8553,2c1cd745-79ab-487d-b759-995794cedb92,limitations of use safety and effectiveness of veregen have not been established in immunosuppressed patients  in treatment of external genital and perianal warts beyond 16 weeks  or for multiple treatment courses ( 1 2 ),0
7058,7058,7058,7058,7058,7058,7058,8554,8554,8554,8554,8554,8554,8554,8554,8554,8554,8554,8554,8554,2c1cd745-79ab-487d-b759-995794cedb92,1 1 indication veregen is indicated for the topical treatment of external genital and perianal warts ( condylomata acuminata ) in immunocompetent patients 18 years and older,1
7059,7059,7059,7059,7059,7059,7059,8555,8555,8555,8555,8555,8555,8555,8555,8555,8555,8555,8555,8555,2c1cd745-79ab-487d-b759-995794cedb92,1 2 limitations of use the safety and effectiveness of veregen have not been established for treatment beyond 16 weeks or for multiple treatment courses,0
7060,7060,7060,7060,7060,7060,7060,8556,8556,8556,8556,8556,8556,8556,8556,8556,8556,8556,8556,8556,2c1cd745-79ab-487d-b759-995794cedb92,the safety and effectiveness of veregen in immunosuppressed patients have not been established,0
7061,7061,7061,7061,7061,7061,7061,8557,8557,8557,8557,8557,8557,8557,8557,8557,8557,8557,8557,8557,451f535b-8b6b-4ecf-9f19-d921b72eea39,1  sylvant is indicated for the treatment of patients with multicentric castleman 's disease ( mcd ) who are human immunodeficiency virus ( hiv ) negative and human herpesvirus 8 ( hhv 8 ) negative,1
7062,7062,7062,7062,7062,7062,7062,8558,8558,8558,8558,8558,8558,8558,8558,8558,8558,8558,8558,8558,451f535b-8b6b-4ecf-9f19-d921b72eea39,sylvant is an interleukin 6 ( il 6 ) antagonist indicated for the treatment of patients with multicentric castleman 's disease ( mcd ) who are human immunodeficiency virus ( hiv ) negative and human herpesvirus 8 ( hhv 8 ) negative,1
7063,7063,7063,7063,7063,7063,7063,8559,8559,8559,8559,8559,8559,8559,8559,8559,8559,8559,8559,8559,451f535b-8b6b-4ecf-9f19-d921b72eea39,( 1 ) limitation of use sylvant was not studied in patients with mcd who are hiv positive or hhv 8 positive because sylvant did not bind to virally produced il 6 in a nonclinical study,0
7064,7064,7064,7064,7064,7064,7064,8560,8560,8560,8560,8560,8560,8560,8560,8560,8560,8560,8560,8560,451f535b-8b6b-4ecf-9f19-d921b72eea39,limitation of use sylvant was not studied in patients with mcd who are hiv positive or hhv 8 positive because sylvant did not bind to virally produced il 6 in a nonclinical study,0
7065,7065,7065,7065,7065,7065,7065,8561,8561,8561,8561,8561,8561,8561,8561,8561,8561,8561,8561,8561,49596de6-ab18-49d1-9e5b-30968fc21c36, vincristine sulfate injection is indicated in acute leukemia,1
7066,7066,7066,7066,7066,7066,7066,8562,8562,8562,8562,8562,8562,8562,8562,8562,8562,8562,8562,8562,49596de6-ab18-49d1-9e5b-30968fc21c36,vincristine sulfate injection has also been shown to be useful in combination with other oncolytic agents in hodgkin 's disease  non hodgkin 's malignant lymphomas  rhabdomyosarcoma  neuroblastoma  and wilms' tumor,4
7067,7067,7067,7067,7067,7067,7067,8563,8563,8563,8563,8563,8563,8563,8563,8563,8563,8563,8563,8563,f986fa2a-e667-452f-be4c-bad8588af525, primary skin infections impetigo contagiosa  superficial folliculitis  ecthyma  furunculosis  sycosis barbae  and pyoderma gangrenosum,1
7068,7068,7068,7068,7068,7068,7068,8564,8564,8564,8564,8564,8564,8564,8564,8564,8564,8564,8564,8564,f986fa2a-e667-452f-be4c-bad8588af525,secondary skin infections infectious eczematoid dermatitis  pustular acne  pustular psoriasis  infected seborrheic dermatitis  infected contact dermatitis ( including poison ivy )  infected excoriations  and bacterial super infections of fungal or viral infections,1
7069,7069,7069,7069,7069,7069,7069,8565,8565,8565,8565,8565,8565,8565,8565,8565,8565,8565,8565,8565,f986fa2a-e667-452f-be4c-bad8588af525,please note gentamicin sulfate is a bactericidal agent that is not effective against viruses or fungi in skin infections,0
7070,7070,7070,7070,7070,7070,7070,8566,8566,8566,8566,8566,8566,8566,8566,8566,8566,8566,8566,8566,f986fa2a-e667-452f-be4c-bad8588af525,gentamicin sulfate is useful in the treatment of infected skin cysts and certain other skin abscesses when preceded by incision and drainage to permit adequate contact between the antibiotic and the infecting bacteria,u
7071,7071,7071,7071,7071,7071,7071,8567,8567,8567,8567,8567,8567,8567,8567,8567,8567,8567,8567,8567,f986fa2a-e667-452f-be4c-bad8588af525,good results have been obtained in the treatment of infected stasis and other skin ulcers  infected superficial burns  paronychia  infected insect bites and stings  infected lacerations and abrasions  and wounds from minor surgery,u
7072,7072,7072,7072,7072,7072,7072,8568,8568,8568,8568,8568,8568,8568,8568,8568,8568,8568,8568,8568,f986fa2a-e667-452f-be4c-bad8588af525,patients sensitive to neomycin can be treated with gentamicin sulfate  although regular observation of patients sensitive to topical antibiotics is advisable when such patients are treated with any topical antibiotic,u
7073,7073,7073,7073,7073,7073,7073,8569,8569,8569,8569,8569,8569,8569,8569,8569,8569,8569,8569,8569,f986fa2a-e667-452f-be4c-bad8588af525,gentamicin sulfate ointment helps retain moisture and has been useful in infection on dry eczematous or psoriatic skin,1
7074,7074,7074,7074,7074,7074,7074,8570,8570,8570,8570,8570,8570,8570,8570,8570,8570,8570,8570,8570,f986fa2a-e667-452f-be4c-bad8588af525,gentamicin sulfate ointment may be used in children over one year of age as well as in adults,0
7075,7075,7075,7075,7075,7075,7075,8571,8571,8571,8571,8571,8571,8571,8571,8571,8571,8571,8571,8571,f4d83550-42de-44c7-b8d5-1d0debc6aec2, 1 5 glycine irrigation usp is indicated as an irrigant during transurethral prostatic or bladder surgery,1
7076,7076,7076,7076,7076,7076,7076,8572,8572,8572,8572,8572,8572,8572,8572,8572,8572,8572,8572,8572,21f18cf4-9ed1-4e30-b853-5e2c7ca50542,1  megace es oral suspension is indicated for the treatment of anorexia  cachexia  or an unexplained significant weight loss in patients with a diagnosis of acquired immunodeficiency syndrome ( aids ),1
7077,7077,7077,7077,7077,7077,7077,8573,8573,8573,8573,8573,8573,8573,8573,8573,8573,8573,8573,8573,21f18cf4-9ed1-4e30-b853-5e2c7ca50542,megace es oral suspension is a progestin indicated for the treatment of anorexia  cachexia  or an unexplained significant weight loss in patients with a diagnosis of acquired immunodeficiency syndrome ( aids ) ( 1 ),1
7078,7078,7078,7078,7078,7078,7078,8574,8574,8574,8574,8574,8574,8574,8574,8574,8574,8574,8574,8574,21f18cf4-9ed1-4e30-b853-5e2c7ca50542,1 1 limitations of use other treatable causes therapy with megestrol acetate for weight loss should only be instituted after treatable causes of weight loss are sought and addressed,4
7079,7079,7079,7079,7079,7079,7079,8575,8575,8575,8575,8575,8575,8575,8575,8575,8575,8575,8575,8575,21f18cf4-9ed1-4e30-b853-5e2c7ca50542,these treatable causes include possible malignancies  systemic infections  gastrointestinal disorders affecting absorption  endocrine disease  renal disease or psychiatric diseases,0
7080,7080,7080,7080,7080,7080,7080,8576,8576,8576,8576,8576,8576,8576,8576,8576,8576,8576,8576,8576,21f18cf4-9ed1-4e30-b853-5e2c7ca50542,prophylactic use megestrol acetate is not intended for prophylactic use to avoid weight loss,0
7081,7081,7081,7081,7081,7081,7081,8577,8577,8577,8577,8577,8577,8577,8577,8577,8577,8577,8577,8577,aaeaef94-f3f5-4367-8ea2-b181d7be2da8,1  kisqali is indicated in combination with an aromatase inhibitor as initial endocrine based therapy for the treatment of postmenopausal women with hormone receptor ( hr ) positive  human epidermal growth factor receptor 2 ( her2 ) negative advanced or metastatic breast cancer,1
7082,7082,7082,7082,7082,7082,7082,8578,8578,8578,8578,8578,8578,8578,8578,8578,8578,8578,8578,8578,aaeaef94-f3f5-4367-8ea2-b181d7be2da8,kisqali is a kinase inhibitor indicated in combination with an aromatase inhibitor as initial endocrine based therapy for the treatment of postmenopausal women with hormone receptor ( hr ) positive  human epidermal growth factor receptor 2 ( her2 ) negative advanced or metastatic breast cancer,1
7083,7083,7083,7083,7083,7083,7083,8579,8579,8579,8579,8579,8579,8579,8579,8579,8579,8579,8579,8579,c986f93b-855d-4ef0-b620-5d41a0513e48,1  myalept is a leptin analog indicated as an adjunct to diet as replacement therapy to treat the complications of leptin deficiency in patients with congenital or acquired generalized lipodystrophy,1
7084,7084,7084,7084,7084,7084,7084,8580,8580,8580,8580,8580,8580,8580,8580,8580,8580,8580,8580,8580,c986f93b-855d-4ef0-b620-5d41a0513e48,( 1 ) limitations of use the safety and effectiveness of myalept for the treatment of complications of partial lipodystrophy have not been established,0
7085,7085,7085,7085,7085,7085,7085,8581,8581,8581,8581,8581,8581,8581,8581,8581,8581,8581,8581,8581,c986f93b-855d-4ef0-b620-5d41a0513e48,( 1 ) the safety and effectiveness of myalept for the treatment of liver disease  including nonalcoholic steatohepatitis ( nash )  have not been established,0
7086,7086,7086,7086,7086,7086,7086,8582,8582,8582,8582,8582,8582,8582,8582,8582,8582,8582,8582,8582,c986f93b-855d-4ef0-b620-5d41a0513e48,( 1 ) myalept is not indicated for use in patients with hiv related lipodystrophy,2
7087,7087,7087,7087,7087,7087,7087,8583,8583,8583,8583,8583,8583,8583,8583,8583,8583,8583,8583,8583,c986f93b-855d-4ef0-b620-5d41a0513e48,( 1 ) myalept is not indicated for use in patients with metabolic disease  without concurrent evidence of generalized lipodystrophy,2
7088,7088,7088,7088,7088,7088,7088,8584,8584,8584,8584,8584,8584,8584,8584,8584,8584,8584,8584,8584,c986f93b-855d-4ef0-b620-5d41a0513e48,( 1 ) 1 1 patients with generalized lipodystrophy myalept ( metreleptin ) for injection is indicated as an adjunct to diet as replacement therapy to treat the complications of leptin deficiency in patients with congenital or acquired generalized lipodystrophy,1
7089,7089,7089,7089,7089,7089,7089,8585,8585,8585,8585,8585,8585,8585,8585,8585,8585,8585,8585,8585,c986f93b-855d-4ef0-b620-5d41a0513e48,limitations of use the safety and effectiveness of myalept for the treatment of complications of partial lipodystrophy have not been established,0
7090,7090,7090,7090,7090,7090,7090,8586,8586,8586,8586,8586,8586,8586,8586,8586,8586,8586,8586,8586,c986f93b-855d-4ef0-b620-5d41a0513e48,the safety and effectiveness of myalept for the treatment of liver disease  including nonalcoholic steatohepatitis ( nash )  have not been established,0
7091,7091,7091,7091,7091,7091,7091,8587,8587,8587,8587,8587,8587,8587,8587,8587,8587,8587,8587,8587,c986f93b-855d-4ef0-b620-5d41a0513e48,myalept is not indicated for use in patients with hiv related lipodystrophy,2
7092,7092,7092,7092,7092,7092,7092,8588,8588,8588,8588,8588,8588,8588,8588,8588,8588,8588,8588,8588,c986f93b-855d-4ef0-b620-5d41a0513e48,myalept is not indicated for use in patients with metabolic disease  including diabetes mellitus and hypertriglyceridemia  without concurrent evidence of congenital or acquired generalized lipodystrophy,2
7093,7093,7093,7093,7093,7093,7093,8589,8589,8589,8589,8589,8589,8589,8589,8589,8589,8589,8589,8589,b0915068-cfd4-4d72-b9f8-7e31fe83cd1e,1  neuraceq is indicated for positron emission tomography ( pet ) imaging of the brain to estimate amyloid neuritic plaque density in adult patients with cognitive impairment who are being evaluated for alzheimer s disease ( ad ) and other causes of cognitive decline,1
7094,7094,7094,7094,7094,7094,7094,8590,8590,8590,8590,8590,8590,8590,8590,8590,8590,8590,8590,8590,b0915068-cfd4-4d72-b9f8-7e31fe83cd1e,a negative neuraceq scan indicates sparse to no amyloid neuritic plaques and is inconsistent with a neuropathological diagnosis of ad at the time of image acquisition a negative scan result reduces the likelihood that a patient s cognitive impairment is due to ad,0
7095,7095,7095,7095,7095,7095,7095,8591,8591,8591,8591,8591,8591,8591,8591,8591,8591,8591,8591,8591,b0915068-cfd4-4d72-b9f8-7e31fe83cd1e,a positive neuraceq scan indicates moderate to frequent amyloid neuritic plaques neuropathological examination has shown this amount of amyloid neuritic plaque is present in patients with ad  but may also be present in patients with other types of neurologic conditions as well as older people with normal cognition,0
7096,7096,7096,7096,7096,7096,7096,8592,8592,8592,8592,8592,8592,8592,8592,8592,8592,8592,8592,8592,b0915068-cfd4-4d72-b9f8-7e31fe83cd1e,neuraceq is an adjunct to other diagnostic evaluations,1
7097,7097,7097,7097,7097,7097,7097,8593,8593,8593,8593,8593,8593,8593,8593,8593,8593,8593,8593,8593,b0915068-cfd4-4d72-b9f8-7e31fe83cd1e,limitations of use a positive neuraceq scan does not establish the diagnosis of ad or any other cognitive disorder,0
7098,7098,7098,7098,7098,7098,7098,8594,8594,8594,8594,8594,8594,8594,8594,8594,8594,8594,8594,8594,b0915068-cfd4-4d72-b9f8-7e31fe83cd1e,safety and effectiveness of neuraceq have not been established for predicting development of dementia or other neurologic conditions monitoring responses to therapies,0
7099,7099,7099,7099,7099,7099,7099,8595,8595,8595,8595,8595,8595,8595,8595,8595,8595,8595,8595,8595,b0915068-cfd4-4d72-b9f8-7e31fe83cd1e,neuraceq is a radioactive diagnostic agent indicated for positron emission tomography ( pet ) imaging of the brain to estimate amyloid neuritic plaque density in adult patients with cognitive impairment who are being evaluated for alzheimer s disease ( ad ) and other causes of cognitive decline,1
7100,7100,7100,7100,7100,7100,7100,8596,8596,8596,8596,8596,8596,8596,8596,8596,8596,8596,8596,8596,b0915068-cfd4-4d72-b9f8-7e31fe83cd1e,a negative neuraceq scan indicates sparse to no neuritic plaques and is inconsistent with a neuropathological diagnosis of ad at the time of image acquisition a negative scan result reduces the likelihood that a patient s cognitive impairment is due to ad,0
7101,7101,7101,7101,7101,7101,7101,8601,8601,8601,8601,8601,8601,8601,8601,8601,8601,8601,8601,8601,baa68c79-5f3d-468a-a510-58b9e978cd50,1  radiogardase is indicated for treatment of patients with known or suspected internal contamination with radioactive cesium and or radioactive or non radioactive thallium  in order to increase their rates of elimination,1
7102,7102,7102,7102,7102,7102,7102,8602,8602,8602,8602,8602,8602,8602,8602,8602,8602,8602,8602,8602,baa68c79-5f3d-468a-a510-58b9e978cd50,radiogardase is a decorporation agent  indicated for treatment of patients with known or suspected internal contamination with radioactive cesium and or radioactive or non radioactive thallium to increase their rates of elimination ( 1 ),1
7103,7103,7103,7103,7103,7103,7103,8603,8603,8603,8603,8603,8603,8603,8603,8603,8603,8603,8603,8603,92018a65-38f6-45f7-91d4-a34921b81d0d, corlanor is indicated to reduce the risk of hospitalization for worsening heart failure in patients with stable  symptomatic chronic heart failure with left ventricular ejection fraction 35  who are in sinus rhythm with resting heart rate 70 beats per minute and either are on maximally tolerated doses of beta blockers or have a contraindication to beta blocker use,1
7104,7104,7104,7104,7104,7104,7104,8604,8604,8604,8604,8604,8604,8604,8604,8604,8604,8604,8604,8604,92018a65-38f6-45f7-91d4-a34921b81d0d,corlanor ( ivabradine ) is a hyperpolarization activated cyclic nucleotide gated channel blocker indicated to reduce the risk of hospitalization for worsening heart failure in patients with stable  symptomatic chronic heart failure with left ventricular ejection fraction 35  who are in sinus rhythm with resting heart rate 70 beats per minute and either are on maximally tolerated doses of beta blockers or have a contraindication to beta blocker use,1
7105,7105,7105,7105,7105,7105,7105,8605,8605,8605,8605,8605,8605,8605,8605,8605,8605,8605,8605,8605,d3832a1a-a140-49c1-a7df-134fa81341e3, disulfiram is an aid in the management of selected chronic alcohol patients who want to remain in a state of enforced sobriety so that supportive and psychotherapeutic treatment may be applied to best advantage,u
7106,7106,7106,7106,7106,7106,7106,8606,8606,8606,8606,8606,8606,8606,8606,8606,8606,8606,8606,8606,d3832a1a-a140-49c1-a7df-134fa81341e3,disulfiram is not a cure for alcoholism,0
7107,7107,7107,7107,7107,7107,7107,8607,8607,8607,8607,8607,8607,8607,8607,8607,8607,8607,8607,8607,d3832a1a-a140-49c1-a7df-134fa81341e3,when used alone  without proper motivation and supportive therapy  it is unlikely that it will have any substantive effect on the drinking pattern of the chronic alcoholic,0
7108,7108,7108,7108,7108,7108,7108,8608,8608,8608,8608,8608,8608,8608,8608,8608,8608,8608,8608,8608,f85a48d0-0407-4c50-b0fa-7673a160bf01,1  januvia is a dipeptidyl peptidase 4 ( dpp 4 ) inhibitor indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus,1
7109,7109,7109,7109,7109,7109,7109,8609,8609,8609,8609,8609,8609,8609,8609,8609,8609,8609,8609,8609,f85a48d0-0407-4c50-b0fa-7673a160bf01,( 1 1 ) important limitations of use januvia should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis,0
7110,7110,7110,7110,7110,7110,7110,8610,8610,8610,8610,8610,8610,8610,8610,8610,8610,8610,8610,8610,f85a48d0-0407-4c50-b0fa-7673a160bf01,( 1 2 ) januvia has not been studied in patients with a history of pancreatitis,0
7111,7111,7111,7111,7111,7111,7111,8611,8611,8611,8611,8611,8611,8611,8611,8611,8611,8611,8611,8611,f85a48d0-0407-4c50-b0fa-7673a160bf01,( 1 2  5 1 ) 1 1 monotherapy and combination therapy januvia is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus,1
7112,7112,7112,7112,7112,7112,7112,8612,8612,8612,8612,8612,8612,8612,8612,8612,8612,8612,8612,8612,f85a48d0-0407-4c50-b0fa-7673a160bf01,1 2 important limitations of use januvia should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis  as it would not be effective in these settings,0
7113,7113,7113,7113,7113,7113,7113,8613,8613,8613,8613,8613,8613,8613,8613,8613,8613,8613,8613,8613,f85a48d0-0407-4c50-b0fa-7673a160bf01,januvia has not been studied in patients with a history of pancreatitis,0
7114,7114,7114,7114,7114,7114,7114,8614,8614,8614,8614,8614,8614,8614,8614,8614,8614,8614,8614,8614,f85a48d0-0407-4c50-b0fa-7673a160bf01,it is unknown whether patients with a history of pancreatitis are at increased risk for the development of pancreatitis while using januvia,0
7115,7115,7115,7115,7115,7115,7115,8616,8616,8616,8616,8616,8616,8616,8616,8616,8616,8616,8616,8616,6a5bff43-f922-46ae-a727-d54d9138c46e,1  lartruvo is indicated  in combination with doxorubicin  for the treatment of adult patients with soft tissue sarcoma ( sts ) with a histologic subtype for which an anthracycline containing regimen is appropriate and which is not amenable to curative treatment with radiotherapy or surgery,1
7116,7116,7116,7116,7116,7116,7116,8617,8617,8617,8617,8617,8617,8617,8617,8617,8617,8617,8617,8617,6a5bff43-f922-46ae-a727-d54d9138c46e,this indication is approved under accelerated approval see clinical studies ( 14 ),0
7117,7117,7117,7117,7117,7117,7117,8619,8619,8619,8619,8619,8619,8619,8619,8619,8619,8619,8619,8619,6a5bff43-f922-46ae-a727-d54d9138c46e,lartruvo is a platelet derived growth factor receptor alpha ( pdgfr ) blocking antibody indicated  in combination with doxorubicin  for the treatment of adult patients with soft tissue sarcoma ( sts ) with a histologic subtype for which an anthracycline containing regimen is appropriate and which is not amenable to curative treatment with radiotherapy or surgery,1
7118,7118,7118,7118,7118,7118,7118,8620,8620,8620,8620,8620,8620,8620,8620,8620,8620,8620,8620,8620,6a5bff43-f922-46ae-a727-d54d9138c46e,( 1 ) this indication is approved under accelerated approval,0
7119,7119,7119,7119,7119,7119,7119,8622,8622,8622,8622,8622,8622,8622,8622,8622,8622,8622,8622,8622,4cfdb571-ec4c-478f-bedc-e0669eeea504,1  extavia ( interferon beta 1b ) is indicated for the treatment of relapsing forms of multiple sclerosis to reduce the frequency of clinical exacerbations,1
7120,7120,7120,7120,7120,7120,7120,8624,8624,8624,8624,8624,8624,8624,8624,8624,8624,8624,8624,8624,4cfdb571-ec4c-478f-bedc-e0669eeea504,extavia is an interferon beta indicated for the treatment of relapsing forms of multiple sclerosis to reduce the frequency of clinical exacerbations,1
7121,7121,7121,7121,7121,7121,7121,8626,8626,8626,8626,8626,8626,8626,8626,8626,8626,8626,8626,8626,82428c00-d0da-44e4-4884-a735c150c067, sodium lactate injection  usp 50 meq ( 5 meq ml )  is primarily indicated  after dilution  as a source of bicarbonate for prevention or control of mild to moderate metabolic acidosis in patients with restricted oral intake whose oxidative processes are not seriously impaired,1
7122,7122,7122,7122,7122,7122,7122,8627,8627,8627,8627,8627,8627,8627,8627,8627,8627,8627,8627,8627,82428c00-d0da-44e4-4884-a735c150c067,it is not intended nor effective for correcting severe acidotic states which require immediate restoration of plasma bicarbonate levels,0
7123,7123,7123,7123,7123,7123,7123,8628,8628,8628,8628,8628,8628,8628,8628,8628,8628,8628,8628,8628,82428c00-d0da-44e4-4884-a735c150c067,sodium lactate has no advantage over sodium bicarbonate and may be detrimental in the management of lactic acidosis,0
7124,7124,7124,7124,7124,7124,7124,8629,8629,8629,8629,8629,8629,8629,8629,8629,8629,8629,8629,8629,56429f04-97b6-06a9-e054-00144ff88e88,1 indications usage montelukast sodium tablets are a leukotriene receptor antagonist indicated for prophylaxis and chronic treatment of asthma in patients 15 years of age and older ( 1 1 ),1
7125,7125,7125,7125,7125,7125,7125,8630,8630,8630,8630,8630,8630,8630,8630,8630,8630,8630,8630,8630,56429f04-97b6-06a9-e054-00144ff88e88,acute prevention of exercise induced bronchoconstriction ( eib ) in patients 15 years of age and older ( 1 2 ),1
7126,7126,7126,7126,7126,7126,7126,8631,8631,8631,8631,8631,8631,8631,8631,8631,8631,8631,8631,8631,56429f04-97b6-06a9-e054-00144ff88e88,relief of symptoms of allergic rhinitis ( ar ) seasonal allergic rhinitis ( sar ) in patients 15 years of age and older  and perennial allergic rhinitis ( par ) in patients 15 years of age and older ( 1 3 ),1
7127,7127,7127,7127,7127,7127,7127,8632,8632,8632,8632,8632,8632,8632,8632,8632,8632,8632,8632,8632,56429f04-97b6-06a9-e054-00144ff88e88,1 1 asthma montelukast sodium tablets are indicated for the prophylaxis and chronic treatment of asthma in patients 15 years of age and older,1
7128,7128,7128,7128,7128,7128,7128,8633,8633,8633,8633,8633,8633,8633,8633,8633,8633,8633,8633,8633,56429f04-97b6-06a9-e054-00144ff88e88,1 2 exercise induced bronchoconstriction ( eib ) montelukast sodium tablets are indicated for prevention of exercise induced bronchoconstriction ( eib ) in patients 15 years of age and older,1
7129,7129,7129,7129,7129,7129,7129,8634,8634,8634,8634,8634,8634,8634,8634,8634,8634,8634,8634,8634,56429f04-97b6-06a9-e054-00144ff88e88,1 3 allergic rhinitis montelukast sodium tablets are indicated for the relief of symptoms of seasonal allergic rhinitis in patients 15 years of age and older and perennial allergic rhinitis in patients 15 years of age and older,1
7130,7130,7130,7130,7130,7130,7130,8635,8635,8635,8635,8635,8635,8635,8635,8635,8635,8635,8635,8635,4cb6617c-f787-470f-81d8-0aba46df937f,1  fenofibrate tablet usp is a peroxisome proliferator receptor alpha ( ppar ) activator indicated as an adjunct to diet to reduce elevated ldl c  total c  tg and apo b  and to increase hdl c in adult patients with primary hypercholesterolemia or mixed dyslipidemia ( 1 1 ),1
7131,7131,7131,7131,7131,7131,7131,8636,8636,8636,8636,8636,8636,8636,8636,8636,8636,8636,8636,8636,4cb6617c-f787-470f-81d8-0aba46df937f,for treatment of adult patients with severe hypertriglyceridemia ( 1 2 ),1
7132,7132,7132,7132,7132,7132,7132,8637,8637,8637,8637,8637,8637,8637,8637,8637,8637,8637,8637,8637,4cb6617c-f787-470f-81d8-0aba46df937f,important limitations of use fenofibrate was not shown to reduce coronary heart disease morbidity and mortality in patients with type 2 diabetes mellitus ( 5 1 ),0
7133,7133,7133,7133,7133,7133,7133,8638,8638,8638,8638,8638,8638,8638,8638,8638,8638,8638,8638,8638,4cb6617c-f787-470f-81d8-0aba46df937f,1 1 primary hypercholesterolemia or mixed dyslipidemia fenofibrate tablet usp is indicated as adjunctive therapy to diet to reduce elevated low density lipoprotein cholesterol ( ldl c )  total cholesterol ( total c )  triglycerides and apolipoprotein b ( apo b )  and to increase high density lipoprotein cholesterol ( hdl c ) in adult patients with primary hypercholesterolemia or mixed dyslipidemia,1
7134,7134,7134,7134,7134,7134,7134,8639,8639,8639,8639,8639,8639,8639,8639,8639,8639,8639,8639,8639,4cb6617c-f787-470f-81d8-0aba46df937f,1 2 severe hypertriglyceridemia fenofibrate tablet usp is also indicated as adjunctive therapy to diet for treatment of adult patients with severe hypertriglyceridemia,1
7135,7135,7135,7135,7135,7135,7135,8640,8640,8640,8640,8640,8640,8640,8640,8640,8640,8640,8640,8640,4cb6617c-f787-470f-81d8-0aba46df937f,improving glycemic control in diabetic patients showing fasting chylomicronemia will usually obviate the need for pharmacologic intervention,0
7136,7136,7136,7136,7136,7136,7136,8641,8641,8641,8641,8641,8641,8641,8641,8641,8641,8641,8641,8641,4cb6617c-f787-470f-81d8-0aba46df937f,markedly elevated levels of serum triglycerides ( e g,0
7137,7137,7137,7137,7137,7137,7137,8642,8642,8642,8642,8642,8642,8642,8642,8642,8642,8642,8642,8642,4cb6617c-f787-470f-81d8-0aba46df937f,2  000 mg dl ) may increase the risk of developing pancreatitis,0
7138,7138,7138,7138,7138,7138,7138,8643,8643,8643,8643,8643,8643,8643,8643,8643,8643,8643,8643,8643,4cb6617c-f787-470f-81d8-0aba46df937f,the effect of fenofibrate therapy on reducing this risk has not been adequately studied,0
7139,7139,7139,7139,7139,7139,7139,8644,8644,8644,8644,8644,8644,8644,8644,8644,8644,8644,8644,8644,4cb6617c-f787-470f-81d8-0aba46df937f,1 3 important limitations of use fenofibrate at a dose equivalent to 160 mg of fenofibrate tablet usp was not shown to reduce coronary heart disease morbidity and mortality in a large  randomized controlled trial of patients with type 2 diabetes mellitus see warnings and precautions ( 5 1 ),0
7140,7140,7140,7140,7140,7140,7140,8645,8645,8645,8645,8645,8645,8645,8645,8645,8645,8645,8645,8645,279a43b8-9ff5-4792-ac19-441f3fa49269, caffeine citrate injection usp is indicated for the short term treatment of apnea of prematurity in infants between 28 and 33 weeks gestational age,1
7141,7141,7141,7141,7141,7141,7141,8646,8646,8646,8646,8646,8646,8646,8646,8646,8646,8646,8646,8646,201b0eb8-4a1e-4e22-ab4b-addb642710d6, anzemet tablets are indicated for the prevention of nausea and vomiting associated with moderately emetogenic cancer chemotherapy  including initial and repeat courses in adults and children 2 years and older,1
7142,7142,7142,7142,7142,7142,7142,8647,8647,8647,8647,8647,8647,8647,8647,8647,8647,8647,8647,8647,0feefca3-8c37-4c48-927e-e42fe07c8d30,1  lamotrigine tablets  usp is indicated for epilepsy adjunctive therapy in patients aged 2 years and older partial onset seizures,1
7143,7143,7143,7143,7143,7143,7143,8648,8648,8648,8648,8648,8648,8648,8648,8648,8648,8648,8648,8648,0feefca3-8c37-4c48-927e-e42fe07c8d30,primary generalized tonic clonic seizures,1
7144,7144,7144,7144,7144,7144,7144,8649,8649,8649,8649,8649,8649,8649,8649,8649,8649,8649,8649,8649,0feefca3-8c37-4c48-927e-e42fe07c8d30,generalized seizures of lennox gastaut syndrome,1
7145,7145,7145,7145,7145,7145,7145,8650,8650,8650,8650,8650,8650,8650,8650,8650,8650,8650,8650,8650,0feefca3-8c37-4c48-927e-e42fe07c8d30,( 1 1 ) epilepsy monotherapy in patients aged 16 years and older conversion to monotherapy in patients with partial onset seizures who are receiving treatment with carbamazepine  phenytoin  phenobarbital  primidone  or valproate as the single aed,1
7146,7146,7146,7146,7146,7146,7146,8651,8651,8651,8651,8651,8651,8651,8651,8651,8651,8651,8651,8651,0feefca3-8c37-4c48-927e-e42fe07c8d30,( 1 1 ) bipolar disorder maintenance treatment of bipolar i disorder to delay the time to occurrence of mood episodes in patients treated for acute mood episodes with standard therapy,1
7147,7147,7147,7147,7147,7147,7147,8652,8652,8652,8652,8652,8652,8652,8652,8652,8652,8652,8652,8652,0feefca3-8c37-4c48-927e-e42fe07c8d30,( 1 2 ) limitations of use treatment of acute manic or mixed episodes is not recommended,0
7148,7148,7148,7148,7148,7148,7148,8653,8653,8653,8653,8653,8653,8653,8653,8653,8653,8653,8653,8653,0feefca3-8c37-4c48-927e-e42fe07c8d30,effectiveness of lamotrigine in the acute treatment of mood episodes has not been established,0
7149,7149,7149,7149,7149,7149,7149,8654,8654,8654,8654,8654,8654,8654,8654,8654,8654,8654,8654,8654,0feefca3-8c37-4c48-927e-e42fe07c8d30,1 1 epilepsy adjunctive therapy lamotrigine tablets  usp is indicated as adjunctive therapy for the following seizure types in patients aged 2 years and older monotherapy lamotrigine tablets  usp is indicated for conversion to monotherapy in adults ( aged 16 years and older ) with partial onset seizures who are receiving treatment with carbamazepine  phenytoin  phenobarbital  primidone  or valproate as the single antiepileptic drug ( aed ),1
7150,7150,7150,7150,7150,7150,7150,8655,8655,8655,8655,8655,8655,8655,8655,8655,8655,8655,8655,8655,0feefca3-8c37-4c48-927e-e42fe07c8d30,safety and effectiveness of lamotrigine tablets  usp have not been established ( 1 ) as initial monotherapy ( 2 ) for conversion to monotherapy from aeds other than carbamazepine  phenytoin  phenobarbital  primidone  or valproate or ( 3 ) for simultaneous conversion to monotherapy from 2 or more concomitant aeds,0
7151,7151,7151,7151,7151,7151,7151,8656,8656,8656,8656,8656,8656,8656,8656,8656,8656,8656,8656,8656,0feefca3-8c37-4c48-927e-e42fe07c8d30,1 2 bipolar disorder lamotrigine tablets  usp is indicated for the maintenance treatment of bipolar i disorder to delay the time to occurrence of mood episodes ( depression  mania  hypomania  mixed episodes ) in patients treated for acute mood episodes with standard therapy see clinical studies ( 14 1 ),1
7152,7152,7152,7152,7152,7152,7152,8657,8657,8657,8657,8657,8657,8657,8657,8657,8657,8657,8657,8657,0feefca3-8c37-4c48-927e-e42fe07c8d30,limitations of use treatment of acute manic or mixed episodes is not recommended,0
7153,7153,7153,7153,7153,7153,7153,8658,8658,8658,8658,8658,8658,8658,8658,8658,8658,8658,8658,8658,0feefca3-8c37-4c48-927e-e42fe07c8d30,effectiveness of lamotrigine tablets  u,0
7154,7154,7154,7154,7154,7154,7154,8659,8659,8659,8659,8659,8659,8659,8659,8659,8659,8659,8659,8659,3d282998-ff0c-480a-bd80-155606ef0a65, hemabate sterile solution is indicated for aborting pregnancy between the 13th and 20th weeks of gestation as calculated from the first day of the last normal menstrual period and in the following conditions related to second trimester abortion failure of expulsion of the fetus during the course of treatment by another method premature rupture of membranes in intrauterine methods with loss of drug and insufficient or absent uterine activity requirement of a repeat intrauterine instillation of drug for expulsion of the fetus inadvertent or spontaneous rupture of membranes in the presence of a previable fetus and absence of adequate activity for expulsion,1
7155,7155,7155,7155,7155,7155,7155,8660,8660,8660,8660,8660,8660,8660,8660,8660,8660,8660,8660,8660,3d282998-ff0c-480a-bd80-155606ef0a65,hemabate is indicated for the treatment of postpartum hemorrhage due to uterine atony which has not responded to conventional methods of management,1
7156,7156,7156,7156,7156,7156,7156,8661,8661,8661,8661,8661,8661,8661,8661,8661,8661,8661,8661,8661,3d282998-ff0c-480a-bd80-155606ef0a65,prior treatment should include the use of intravenously administered oxytocin  manipulative techniques such as uterine massage and  unless contraindicated  intramuscular ergot preparations,u
7157,7157,7157,7157,7157,7157,7157,8662,8662,8662,8662,8662,8662,8662,8662,8662,8662,8662,8662,8662,3d282998-ff0c-480a-bd80-155606ef0a65,studies have shown that in such cases  the use of hemabate has resulted in satisfactory control of hemorrhage  although it is unclear whether or not ongoing or delayed effects of previously administered ecbolic agents have contributed to the outcome,u
7158,7158,7158,7158,7158,7158,7158,8663,8663,8663,8663,8663,8663,8663,8663,8663,8663,8663,8663,8663,3d282998-ff0c-480a-bd80-155606ef0a65,in a high proportion of cases  hemabate used in this manner has resulted in the cessation of life threatening bleeding and the avoidance of emergency surgical intervention,u
7159,7159,7159,7159,7159,7159,7159,8664,8664,8664,8664,8664,8664,8664,8664,8664,8664,8664,8664,8664,a9c1d8c5-443e-400e-a42c-16a25fb47231, ethamolin injection is indicated for the treatment of patients with esophageal varices that have recently bled  to prevent rebleeding,1
7160,7160,7160,7160,7160,7160,7160,8665,8665,8665,8665,8665,8665,8665,8665,8665,8665,8665,8665,8665,a9c1d8c5-443e-400e-a42c-16a25fb47231,ethamolin is not indicated for the treatment of patients with esophageal varices that have not bled,0
7161,7161,7161,7161,7161,7161,7161,8666,8666,8666,8666,8666,8666,8666,8666,8666,8666,8666,8666,8666,a9c1d8c5-443e-400e-a42c-16a25fb47231,there is no evidence that treatment of this population decreases the likelihood of bleeding,0
7162,7162,7162,7162,7162,7162,7162,8667,8667,8667,8667,8667,8667,8667,8667,8667,8667,8667,8667,8667,a9c1d8c5-443e-400e-a42c-16a25fb47231,sclerotherapy with ethamolin has no beneficial effect upon portal hypertension  the cause of esophageal varices  so that recanalization and collateralization may occur  necessitating reinjection,0
7163,7163,7163,7163,7163,7163,7163,8668,8668,8668,8668,8668,8668,8668,8668,8668,8668,8668,8668,8668,a6ec8292-9189-4ebd-862a-e1725eb29eef, photochemotherapy ( methoxsalen with long wave uva radiation ) is indicated for the symptomatic control of severe  recalcitrant  disabling psoriasis not adequately responsive to other forms of therapy and when the diagnosis has been supported by biopsy,1
7164,7164,7164,7164,7164,7164,7164,8669,8669,8669,8669,8669,8669,8669,8669,8669,8669,8669,8669,8669,a6ec8292-9189-4ebd-862a-e1725eb29eef,methoxsalen is intended to be administered only in conjunction with a schedule of controlled doses of long wave ultraviolet radiation,4
7165,7165,7165,7165,7165,7165,7165,8670,8670,8670,8670,8670,8670,8670,8670,8670,8670,8670,8670,8670,945f46fa-4b79-49fd-a890-477f251e2164, ovide lotion is indicated for patients infected with pediculus humanus capitis ( head lice and their ova ) of the scalp hair,1
7166,7166,7166,7166,7166,7166,7166,8671,8671,8671,8671,8671,8671,8671,8671,8671,8671,8671,8671,8671,29bddc43-2809-4e1f-ae35-2865e15e9bb6,1 indications usage telmisartan is an angiotensin ii receptor blocker ( arb ) indicated for treatment of hypertension  to lower blood pressure,1
7167,7167,7167,7167,7167,7167,7167,8672,8672,8672,8672,8672,8672,8672,8672,8672,8672,8672,8672,8672,29bddc43-2809-4e1f-ae35-2865e15e9bb6,lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events  primarily strokes and myocardial infractions,0
7168,7168,7168,7168,7168,7168,7168,8673,8673,8673,8673,8673,8673,8673,8673,8673,8673,8673,8673,8673,29bddc43-2809-4e1f-ae35-2865e15e9bb6,( 1 1 ) 1 1 hypertension telmisartan is indicated for the treatment of hypertension  to lower blood pressure,1
7169,7169,7169,7169,7169,7169,7169,8685,8685,8685,8685,8685,8685,8685,8685,8685,8685,8685,8685,8685,29bddc43-2809-4e1f-ae35-2865e15e9bb6,it may be used alone or in combination with other antihypertensive agents see clinical studies ( 14 1 ),4
7170,7170,7170,7170,7170,7170,7170,8686,8686,8686,8686,8686,8686,8686,8686,8686,8686,8686,8686,8686,accf9569-4b57-4e83-a7db-4e890a75d1ba, mitoxantrone is indicated for reducing neurologic disability and or the frequency of clinical relapses in patients with secondary ( chronic ) progressive  progressive relapsing  or worsening relapsing remitting multiple sclerosis ( i e  patients whose neurologic status is significantly abnormal between relapses ),1
7171,7171,7171,7171,7171,7171,7171,8687,8687,8687,8687,8687,8687,8687,8687,8687,8687,8687,8687,8687,accf9569-4b57-4e83-a7db-4e890a75d1ba,mitoxantrone is not indicated in the treatment of patients with primary progressive multiple sclerosis,0
7172,7172,7172,7172,7172,7172,7172,8688,8688,8688,8688,8688,8688,8688,8688,8688,8688,8688,8688,8688,accf9569-4b57-4e83-a7db-4e890a75d1ba,the clinical patterns of multiple sclerosis in the studies were characterized as follows secondary progressive and progressive relapsing disease were characterized by gradual increasing disability with or without superimposed clinical relapses  and worsening relapsing remitting disease was characterized by clinical relapses resulting in a step wise worsening of disability,0
7173,7173,7173,7173,7173,7173,7173,8689,8689,8689,8689,8689,8689,8689,8689,8689,8689,8689,8689,8689,accf9569-4b57-4e83-a7db-4e890a75d1ba,mitoxantrone in combination with corticosteroids is indicated as initial chemotherapy for the treatment of patients with pain related to advanced hormone refractory prostate cancer,1
7174,7174,7174,7174,7174,7174,7174,8690,8690,8690,8690,8690,8690,8690,8690,8690,8690,8690,8690,8690,accf9569-4b57-4e83-a7db-4e890a75d1ba,mitoxantrone in combination with other approved drug ( s ) is indicated in the initial therapy of acute nonlymphocytic leukemia ( anll ) in adults,1
7175,7175,7175,7175,7175,7175,7175,8691,8691,8691,8691,8691,8691,8691,8691,8691,8691,8691,8691,8691,accf9569-4b57-4e83-a7db-4e890a75d1ba,this category includes myelogenous  promyelocytic  monocytic  and erythroid acute leukemias,1
7176,7176,7176,7176,7176,7176,7176,8692,8692,8692,8692,8692,8692,8692,8692,8692,8692,8692,8692,8692,6cbe4864-5174-4365-af07-88b1eb24b1c2,homeopathic indications for temporary relief of allergic reactions to dairy foods including polyarthritis and periarthritis  low back pain  facial burning sensation  gastritis  and in addition insecticide sensitivity,1
7177,7177,7177,7177,7177,7177,7177,8695,8695,8695,8695,8695,8695,8695,8695,8695,8695,8695,8695,8695,3cf2f439-0e97-443e-8e33-25ecef616f6c,1  briviact is indicated for the treatment of partial onset seizures in patients 16 years of age and older with epilepsy,1
7178,7178,7178,7178,7178,7178,7178,8696,8696,8696,8696,8696,8696,8696,8696,8696,8696,8696,8696,8696,3cf2f439-0e97-443e-8e33-25ecef616f6c,briviact is indicated for the treatment of partial onset seizures in patients 16 years of age and older with epilepsy,1
7179,7179,7179,7179,7179,7179,7179,8697,8697,8697,8697,8697,8697,8697,8697,8697,8697,8697,8697,8697,4d624774-3618-423c-89bd-492f4795ad19,indication an aid in the topical treatment of quiescent or chronic psoriasis,1
7180,7180,7180,7180,7180,7180,7180,8698,8698,8698,8698,8698,8698,8698,8698,8698,8698,8698,8698,8698,bfef9e19-d0f5-40fa-954c-b73c812eb242,1  viibryd is indicated for the treatment of major depressive disorder ( mdd ) see clinical studies ( 14 ),1
7181,7181,7181,7181,7181,7181,7181,8699,8699,8699,8699,8699,8699,8699,8699,8699,8699,8699,8699,8699,bfef9e19-d0f5-40fa-954c-b73c812eb242,viibryd is indicated for the treatment of major depressive disorder ( mdd ) ( 1 ),1
7182,7182,7182,7182,7182,7182,7182,8700,8700,8700,8700,8700,8700,8700,8700,8700,8700,8700,8700,8700,d705382b-8aa0-4893-ed9e-bcf7c7d9d0a2, pancuronium bromide is indicated as an adjunct to general anesthesia to facilitate tracheal intubation and to provide skeletal muscle relaxation during surgery or mechanical ventilation,1
7183,7183,7183,7183,7183,7183,7183,8701,8701,8701,8701,8701,8701,8701,8701,8701,8701,8701,8701,8701,425df869-79f5-481b-e054-00144ff88e88,1  triferic is an iron replacement product indicated for the replacement of iron to maintain hemoglobin in adult patients with hemodialysis dependent chronic kidney disease ( hdd ckd ),1
7184,7184,7184,7184,7184,7184,7184,8702,8702,8702,8702,8702,8702,8702,8702,8702,8702,8702,8702,8702,425df869-79f5-481b-e054-00144ff88e88,triferic is an iron replacement product indicated for the replacement of iron to maintain hemoglobin in adult patients with hemodialysis dependent chronic kidney disease ( hdd ckd ),1
7185,7185,7185,7185,7185,7185,7185,8703,8703,8703,8703,8703,8703,8703,8703,8703,8703,8703,8703,8703,425df869-79f5-481b-e054-00144ff88e88,( 1 ) limitation of use triferic is not intended for use in patients receiving peritoneal dialysis,0
7186,7186,7186,7186,7186,7186,7186,8704,8704,8704,8704,8704,8704,8704,8704,8704,8704,8704,8704,8704,425df869-79f5-481b-e054-00144ff88e88,( 1 1 ) triferic has not been studied in patients receiving home hemodialysis,0
7187,7187,7187,7187,7187,7187,7187,8705,8705,8705,8705,8705,8705,8705,8705,8705,8705,8705,8705,8705,425df869-79f5-481b-e054-00144ff88e88,( 1 1 ) 1 1 limitation of use triferic is not intended for use in patients receiving peritoneal dialysis,0
7188,7188,7188,7188,7188,7188,7188,8706,8706,8706,8706,8706,8706,8706,8706,8706,8706,8706,8706,8706,425df869-79f5-481b-e054-00144ff88e88,triferic has not been studied in patients receiving home hemodialysis,0
7189,7189,7189,7189,7189,7189,7189,8707,8707,8707,8707,8707,8707,8707,8707,8707,8707,8707,8707,8707,227784a8-ce68-4dd4-8ac5-a65265969677, daunorubicin hydrochloride in combination with other approved anticancer drugs is indicated for remission induction in acute nonlymphocytic leukemia ( myelogenous  monocytic  erythroid ) of adults and for remission induction in acute lymphocytic leukemia of children and adults,1
7190,7190,7190,7190,7190,7190,7190,8708,8708,8708,8708,8708,8708,8708,8708,8708,8708,8708,8708,8708,ac5785b7-19ec-4715-b05d-cb2c70de4448,1  fentanyl transdermal system is indicated for the management of pain in opioid tolerant patients  severe enough to require daily  around the clock  long term opioid treatment and for which alternative treatment options are inadequate,1
7191,7191,7191,7191,7191,7191,7191,8709,8709,8709,8709,8709,8709,8709,8709,8709,8709,8709,8709,8709,ac5785b7-19ec-4715-b05d-cb2c70de4448,patients considered opioid tolerant are those who are taking  for one week or longer  at least 60 mg of morphine daily  or at least 30 mg of oral oxycodone daily  or at least 8 mg of oral hydromorphone daily  or an equianalgesic dose of another opioid,0
7192,7192,7192,7192,7192,7192,7192,8710,8710,8710,8710,8710,8710,8710,8710,8710,8710,8710,8710,8710,ac5785b7-19ec-4715-b05d-cb2c70de4448,limitations of use because of the risks of addiction  abuse  and misuse with opioids  even at recommended doses  and because of the greater risks of overdose and death with extended release opioid formulations  reserve fentanyl transdermal system for use in patients for whom alternative treatment options ( i e  non opioid analgesics or immediate release opioids ) are ineffective  not tolerated  or would be otherwise inadequate to provide sufficient management of pain,0
7193,7193,7193,7193,7193,7193,7193,8711,8711,8711,8711,8711,8711,8711,8711,8711,8711,8711,8711,8711,ac5785b7-19ec-4715-b05d-cb2c70de4448,fentanyl transdermal system is indicated for the management of pain in opioid tolerant patients  severe enough to require daily  around the clock  long term opioid treatment and for which alternative treatment options are inadequate,1
7194,7194,7194,7194,7194,7194,7194,8712,8712,8712,8712,8712,8712,8712,8712,8712,8712,8712,8712,8712,ac5785b7-19ec-4715-b05d-cb2c70de4448,( ) 1 patients considered opioid tolerant are those who are taking  for one week or longer  at least 60 mg of morphine daily  or at least 30 mg of oral oxycodone daily  or at least 8 mg of oral hydromorphone daily  or an equianalgesic dose of another opioid,0
7195,7195,7195,7195,7195,7195,7195,8713,8713,8713,8713,8713,8713,8713,8713,8713,8713,8713,8713,8713,ac5785b7-19ec-4715-b05d-cb2c70de4448,( ) 1 limitations of use because of the risks of addiction  abuse  and misuse with opioids  even at recommended doses  and because of the greater risks of overdose and death with extended release opioid formulations  reserve fentanyl transdermal system for use in patients for whom alternative treatment options ( i e  non opioid analgesics or immediate release opioids ) are ineffective  not tolerated  or would be otherwise inadequate to provide sufficient management of pain,0
7196,7196,7196,7196,7196,7196,7196,8714,8714,8714,8714,8714,8714,8714,8714,8714,8714,8714,8714,8714,a5b4cdf0-3fa8-4c6c-80f6-8d8a00e3a5b6,1  idhifa is an isocitrate dehydrogenase 2 inhibitor indicated for the treatment of adult patients with relapsed or refractory acute myeloid leukemia ( aml ) with an isocitrate dehydrogenase 2 ( idh2 ) mutation as detected by an fda approved test ( 1 1 ),1
7197,7197,7197,7197,7197,7197,7197,8715,8715,8715,8715,8715,8715,8715,8715,8715,8715,8715,8715,8715,a5b4cdf0-3fa8-4c6c-80f6-8d8a00e3a5b6,1 1 acute myeloid leukemia idhifa is indicated for the treatment of adult patients with relapsed or refractory acute myeloid leukemia ( aml ) with an isocitrate dehydrogenase 2 ( idh2 ) mutation as detected by an fda approved test,1
7198,7198,7198,7198,7198,7198,7198,8716,8716,8716,8716,8716,8716,8716,8716,8716,8716,8716,8716,8716,c00d1607-ac36-457b-a34b-75ad74f9cf0a,1  invirase in combination with ritonavir and other antiretroviral agents is indicated for the treatment of hiv 1 infection in adults ( over the age of 16 years ),1
7199,7199,7199,7199,7199,7199,7199,8717,8717,8717,8717,8717,8717,8717,8717,8717,8717,8717,8717,8717,c00d1607-ac36-457b-a34b-75ad74f9cf0a,the following points should be considered when initiating therapy with invirase ritonavir the twice daily administration of invirase in combination with ritonavir is supported by safety data from the maxcmin 1 trial see adverse reactions ( 6 1 ) and pharmacokinetic data see clinical pharmacology ( 12 3 ),0
7200,7200,7200,7200,7200,7200,7200,8718,8718,8718,8718,8718,8718,8718,8718,8718,8718,8718,8718,8718,c00d1607-ac36-457b-a34b-75ad74f9cf0a,the efficacy of invirase with ritonavir has not been compared against the efficacy of antiretroviral regimens currently considered standard of care,0
7201,7201,7201,7201,7201,7201,7201,8719,8719,8719,8719,8719,8719,8719,8719,8719,8719,8719,8719,8719,c00d1607-ac36-457b-a34b-75ad74f9cf0a,the number of baseline primary protease inhibitor mutations affects the virologic response to invirase ritonavir,0
7202,7202,7202,7202,7202,7202,7202,8720,8720,8720,8720,8720,8720,8720,8720,8720,8720,8720,8720,8720,c00d1607-ac36-457b-a34b-75ad74f9cf0a,invirase is an hiv 1 protease inhibitor indicated for the treatment of hiv 1 infection in combination with ritonavir and other antiretroviral agents in adults ( over the age of 16 years ),1
7203,7203,7203,7203,7203,7203,7203,8721,8721,8721,8721,8721,8721,8721,8721,8721,8721,8721,8721,8721,c90ab05f-8fe5-437e-a1c0-8b11ef63291e,1  ifosfamide injection is indicated for use in combination with certain other approved antineoplastic agentsfor third line chemotherapy of germ cell testicular cancer,1
7204,7204,7204,7204,7204,7204,7204,8722,8722,8722,8722,8722,8722,8722,8722,8722,8722,8722,8722,8722,c90ab05f-8fe5-437e-a1c0-8b11ef63291e,it should be used in combination with mesna for prophylaxis of hemorrhagic cystitis,4
7205,7205,7205,7205,7205,7205,7205,8723,8723,8723,8723,8723,8723,8723,8723,8723,8723,8723,8723,8723,c90ab05f-8fe5-437e-a1c0-8b11ef63291e,ifosfamide injection is an alkylating drug indicated for use in combination with certain other approved antineoplastic agents for third line chemotherapy of germ cell testicular cancer,1
7206,7206,7206,7206,7206,7206,7206,8725,8725,8725,8725,8725,8725,8725,8725,8725,8725,8725,8725,8725,b4c2c9dc-a0bb-4d64-a667-a67ebe88392d,1  cimzia is a tumor necrosis factor ( tnf ) blocker indicated for reducing signs and symptoms of crohn 's disease and maintaining clinical response in adult patients with moderately to severely active disease who have had an inadequate response to conventional therapy ( 1 1 ) treatment of adults with moderately to severely active rheumatoid arthritis ( 1 2 ) treatment of adult patients with active psoriatic arthritis,1
7207,7207,7207,7207,7207,7207,7207,8726,8726,8726,8726,8726,8726,8726,8726,8726,8726,8726,8726,8726,b4c2c9dc-a0bb-4d64-a667-a67ebe88392d,( 1 3 ) treatment of adults with active ankylosing spondylitis ( 1 4 ) 1 1 crohn 's disease cimzia is indicated for reducing signs and symptoms of crohn 's disease and maintaining clinical response in adult patients with moderately to severely active disease who have had an inadequate response to conventional therapy,1
7208,7208,7208,7208,7208,7208,7208,8727,8727,8727,8727,8727,8727,8727,8727,8727,8727,8727,8727,8727,b4c2c9dc-a0bb-4d64-a667-a67ebe88392d,1 2 rheumatoid arthritis cimzia is indicated for the treatment of adults with moderately to severely active rheumatoid arthritis ( ra ),1
7209,7209,7209,7209,7209,7209,7209,8728,8728,8728,8728,8728,8728,8728,8728,8728,8728,8728,8728,8728,b4c2c9dc-a0bb-4d64-a667-a67ebe88392d,1 3 psoriatic arthritis cimzia is indicated for the treatment of adult patients with active psoriatic arthritis ( psa ),1
7210,7210,7210,7210,7210,7210,7210,8729,8729,8729,8729,8729,8729,8729,8729,8729,8729,8729,8729,8729,b4c2c9dc-a0bb-4d64-a667-a67ebe88392d,1 4 ankylosing spondylitis cimzia is indicated for the treatment of adults with active ankylosing spondylitis ( as ),1
7211,7211,7211,7211,7211,7211,7211,8730,8730,8730,8730,8730,8730,8730,8730,8730,8730,8730,8730,8730,3acf6751-827d-11e2-9e96-0800200c9a66,1  otezla  an inhibitor of phosphodiesterase 4 ( pde4 )  is indicated for the treatment of adult patients with active psoriatic arthritis ( 1 1 ) patients with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy ( 1 2 ) 1 1 psoriatic arthritis otezla is indicated for the treatment of adult patients with active psoriatic arthritis,1
7212,7212,7212,7212,7212,7212,7212,8731,8731,8731,8731,8731,8731,8731,8731,8731,8731,8731,8731,8731,3acf6751-827d-11e2-9e96-0800200c9a66,1 2 psoriasis otezla is indicated for the treatment of patients with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy,1
7213,7213,7213,7213,7213,7213,7213,8732,8732,8732,8732,8732,8732,8732,8732,8732,8732,8732,8732,8732,acdd5932-375b-4966-8a06-3806ab74c36d,1  tudorza pressair ( aclidinium bromide inhalation powder ) is indicated for the long term  maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease ( copd )  including chronic bronchitis and emphysema,1
7214,7214,7214,7214,7214,7214,7214,8733,8733,8733,8733,8733,8733,8733,8733,8733,8733,8733,8733,8733,acdd5932-375b-4966-8a06-3806ab74c36d,tudorza pressair is an anticholinergic indicated for the long term maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease ( copd )  including chronic bronchitis and emphysema,1
7215,7215,7215,7215,7215,7215,7215,8734,8734,8734,8734,8734,8734,8734,8734,8734,8734,8734,8734,8734,1b04bb5f-aaa4-12ed-e054-00144ff8d46c,indication vertigo  diarrhea  pain or other indications,1
7216,7216,7216,7216,7216,7216,7216,8735,8735,8735,8735,8735,8735,8735,8735,8735,8735,8735,8735,8735,84a920c8-b637-4741-b9b2-fc607e245ce0, propantheline bromide is effective as adjunctive therapy in the treatment of peptic ulcer,1
7217,7217,7217,7217,7217,7217,7217,8736,8736,8736,8736,8736,8736,8736,8736,8736,8736,8736,8736,8736,9819f033-3bbe-442e-8e92-45fec77b237d,1  dexilant is a proton pump inhibitor ( ppi ) indicated in patients 12 years of age and older for healing of all grades of erosive esophagitis ( ee ),1
7218,7218,7218,7218,7218,7218,7218,8737,8737,8737,8737,8737,8737,8737,8737,8737,8737,8737,8737,8737,9819f033-3bbe-442e-8e92-45fec77b237d,( 1 1 ) maintenance of healed ee and relief of heartburn,1
7219,7219,7219,7219,7219,7219,7219,8738,8738,8738,8738,8738,8738,8738,8738,8738,8738,8738,8738,8738,9819f033-3bbe-442e-8e92-45fec77b237d,( 1 2 ) treatment of symptomatic non erosive gastroesophageal reflux disease ( gerd ),1
7220,7220,7220,7220,7220,7220,7220,8739,8739,8739,8739,8739,8739,8739,8739,8739,8739,8739,8739,8739,9819f033-3bbe-442e-8e92-45fec77b237d,( 1 3 ) 1 1 healing of erosive esophagitis dexilant is indicated in patients 12 years of age and older for healing of all grades of erosive esophagitis ( ee ) for up to eight weeks,1
7221,7221,7221,7221,7221,7221,7221,8740,8740,8740,8740,8740,8740,8740,8740,8740,8740,8740,8740,8740,9819f033-3bbe-442e-8e92-45fec77b237d,1 2 maintenance of healed erosive esophagitis and relief of heartburn dexilant is indicated in patients 12 years of age and older to maintain healing of ee and relief of heartburn for up to six months in adults and 16 weeks in patients 12 to 17 years of age,1
7222,7222,7222,7222,7222,7222,7222,8741,8741,8741,8741,8741,8741,8741,8741,8741,8741,8741,8741,8741,9819f033-3bbe-442e-8e92-45fec77b237d,1 3 treatment of symptomatic non erosive gastroesophageal reflux disease dexilant is indicated in patients 12 years of age and older for the treatment of heartburn associated with symptomatic non erosive gastroesophageal reflux disease ( gerd ) for four weeks,1
7223,7223,7223,7223,7223,7223,7223,8742,8742,8742,8742,8742,8742,8742,8742,8742,8742,8742,8742,8742,584dc66c-063a-4552-a056-74b811e2bc80,1  eszopiclone tablets are indicated for the treatment of insomnia,1
7224,7224,7224,7224,7224,7224,7224,8743,8743,8743,8743,8743,8743,8743,8743,8743,8743,8743,8743,8743,584dc66c-063a-4552-a056-74b811e2bc80,in controlled outpatient and sleep laboratory studies  eszopiclone tablets administered at bedtime decreased sleep latency and improved sleep maintenance,u
7225,7225,7225,7225,7225,7225,7225,8745,8745,8745,8745,8745,8745,8745,8745,8745,8745,8745,8745,8745,584dc66c-063a-4552-a056-74b811e2bc80,the final formal assessments of sleep latency and maintenance were performed at 4 weeks in the 6 week study ( adults only )  at the end of both 2 week studies ( elderly only ) and at the end of the 6 month study ( adults only ),0
7226,7226,7226,7226,7226,7226,7226,8746,8746,8746,8746,8746,8746,8746,8746,8746,8746,8746,8746,8746,584dc66c-063a-4552-a056-74b811e2bc80,eszopiclone tablets are indicated for the treatment of insomnia,1
7227,7227,7227,7227,7227,7227,7227,8747,8747,8747,8747,8747,8747,8747,8747,8747,8747,8747,8747,8747,584dc66c-063a-4552-a056-74b811e2bc80,eszopiclone tablets have been shown to decrease sleep latency and improve sleep maintenance ( 1 ),u
7228,7228,7228,7228,7228,7228,7228,8748,8748,8748,8748,8748,8748,8748,8748,8748,8748,8748,8748,8748,c8d2e135-ec31-4eee-bce2-c85e7858c5e1,1  brevibloc injection is a beta adrenergic blocker indicated for the short term treatment of control of ventricular rate in supraventricular tachycardia including atrial fibrillation and atrial flutter and control of heart rate in noncompensatory sinus tachycardia ( 1 1 ) control of perioperative tachycardia and hypertension ( 1 2 ) 1 1 supraventricular tachycardia or noncompensatory sinus tachycardia brevibloc ( esmolol hydrochloride ) is indicated for the rapid control of ventricular rate in patients with atrial fibrillation or atrial flutter in perioperative  postoperative  or other emergent circumstances where short term control of ventricular rate with a short acting agent is desirable,1
7229,7229,7229,7229,7229,7229,7229,8749,8749,8749,8749,8749,8749,8749,8749,8749,8749,8749,8749,8749,c8d2e135-ec31-4eee-bce2-c85e7858c5e1,brevibloc is also indicated in noncompensatory sinus tachycardia where  in the physician 's judgment  the rapid heart rate requires specific intervention,1
7230,7230,7230,7230,7230,7230,7230,8750,8750,8750,8750,8750,8750,8750,8750,8750,8750,8750,8750,8750,c8d2e135-ec31-4eee-bce2-c85e7858c5e1,brevibloc is intended for short term use,4
7231,7231,7231,7231,7231,7231,7231,8751,8751,8751,8751,8751,8751,8751,8751,8751,8751,8751,8751,8751,c8d2e135-ec31-4eee-bce2-c85e7858c5e1,1 2 intraoperative and postoperative tachycardia and or hypertension brevibloc ( esmolol hydrochloride ) is indicated for the short term treatment of tachycardia and hypertension that occur during induction and tracheal intubation  during surgery  on emergence from anesthesia and in the postoperative period  when in the physician 's judgment such specific intervention is considered indicated,1
7232,7232,7232,7232,7232,7232,7232,8752,8752,8752,8752,8752,8752,8752,8752,8752,8752,8752,8752,8752,c8d2e135-ec31-4eee-bce2-c85e7858c5e1,use of brevibloc to prevent such events is not recommended,0
7233,7233,7233,7233,7233,7233,7233,8753,8753,8753,8753,8753,8753,8753,8753,8753,8753,8753,8753,8753,eac21801-4b9b-41bc-a37d-e30d43639d5e,1  zileuton extended release tablets is indicated for the prophylaxis and chronic treatment of asthma in adults and children 12 years of age and older,1
7234,7234,7234,7234,7234,7234,7234,8754,8754,8754,8754,8754,8754,8754,8754,8754,8754,8754,8754,8754,eac21801-4b9b-41bc-a37d-e30d43639d5e,zileuton extended release tablets is not indicated for use in the reversal of bronchospasm in acute asthma attacks,0
7235,7235,7235,7235,7235,7235,7235,8755,8755,8755,8755,8755,8755,8755,8755,8755,8755,8755,8755,8755,eac21801-4b9b-41bc-a37d-e30d43639d5e,therapy with zileuton extended release tablets can be continued during acute exacerbations of asthma,4
7236,7236,7236,7236,7236,7236,7236,8756,8756,8756,8756,8756,8756,8756,8756,8756,8756,8756,8756,8756,eac21801-4b9b-41bc-a37d-e30d43639d5e,zileuton extended release tablets is a leukotriene synthesis inhibitor indicated for the prophylaxis and chronic treatment of asthma in adults and children 12 years of age and older,1
7237,7237,7237,7237,7237,7237,7237,8757,8757,8757,8757,8757,8757,8757,8757,8757,8757,8757,8757,8757,eac21801-4b9b-41bc-a37d-e30d43639d5e,( 1 ) do not use zileuton extended release tablets to treat an acute asthma attack,2
7238,7238,7238,7238,7238,7238,7238,8758,8758,8758,8758,8758,8758,8758,8758,8758,8758,8758,8758,8758,cb8e8155-5505-44d5-9dee-525e2e45b95d, pentamidine isethionate for injection is indicated for the treatment of pneumonia due to pneumocystis carinii,1
7239,7239,7239,7239,7239,7239,7239,8759,8759,8759,8759,8759,8759,8759,8759,8759,8759,8759,8759,8759,650daa9f-aeec-49ce-95b9-5fa20b988afd, ameluz gel  in combination with photodynamic therapy ( pdt ) using bf rhodoled lamp  a narrowband  red light illumination source  is indicated for lesion directed and field directed treatment of actinic keratoses ( aks ) of mild to moderate severity on the face and scalp,1
7240,7240,7240,7240,7240,7240,7240,8760,8760,8760,8760,8760,8760,8760,8760,8760,8760,8760,8760,8760,650daa9f-aeec-49ce-95b9-5fa20b988afd,ameluz gel  a porphyrin precursor  in combination with photodynamic therapy using bf rhodoled lamp  is indicated for the lesion directed and field directed treatment of actinic keratoses of mild to moderate severity on the face and scalp ( 1 ),1
7241,7241,7241,7241,7241,7241,7241,8761,8761,8761,8761,8761,8761,8761,8761,8761,8761,8761,8761,8761,4ed382df-f2d5-46a4-a68b-aba807777093, fludrocortisone acetate tablets usp  0 1 mg are indicated as partial replacement therapy for primary and secondary adrenocortical insufficiency in addison 's disease and for the treatment of salt losing adrenogenital syndrome,1
7242,7242,7242,7242,7242,7242,7242,8762,8762,8762,8762,8762,8762,8762,8762,8762,8762,8762,8762,8762,02ff6501-cccc-4f7d-9988-856d4e169b0e, hypaque sodium 50 percent is indicated for excretory urography  cerebral and peripheral angiography  aortography  intraosseous venography  direct cholangiography  hysterosalpingography  splenoportography  and contrast enhancement of computed tomographic head imaging,1
7243,7243,7243,7243,7243,7243,7243,8763,8763,8763,8763,8763,8763,8763,8763,8763,8763,8763,8763,8763,02ff6501-cccc-4f7d-9988-856d4e169b0e,urography diatrizoate salts are used in small  medium  and large dose urography ( see dosage and administration excretory urography ),1
7244,7244,7244,7244,7244,7244,7244,8764,8764,8764,8764,8764,8764,8764,8764,8764,8764,8764,8764,8764,02ff6501-cccc-4f7d-9988-856d4e169b0e,visualization of the urinary tract can be achieved by either direct intravenous bolus injection  intravenous drip infusion  or incidentally following intra arterial procedures visualization of the urinary tract is delayed in infants less than 1 month old  and in patients with urinary tract obstruction ( see clinical pharmacology ),1
7245,7245,7245,7245,7245,7245,7245,8765,8765,8765,8765,8765,8765,8765,8765,8765,8765,8765,8765,8765,02ff6501-cccc-4f7d-9988-856d4e169b0e,contrast enhancement of computed tomographic head imaging injectable radiopaque contrast media may be used to refine diagnostic precision in areas of the brain which may not otherwise have been satisfactorily visualized,0
7246,7246,7246,7246,7246,7246,7246,8766,8766,8766,8766,8766,8766,8766,8766,8766,8766,8766,8766,8766,02ff6501-cccc-4f7d-9988-856d4e169b0e,tumors radiopaque diagnostic agents may be useful to investigate the presence and extent of certain malignancies such as gliomas including malignant gliomas  glioblastomas  astrocytomas  oligodendrogliomas and gangliomas  ependymomas  medulloblastomas  meningiomas  neuromas  pinealomas  pituitary adenomas  craniopharyngiomas  germinomas  and metastatic lesions,1
7247,7247,7247,7247,7247,7247,7247,8767,8767,8767,8767,8767,8767,8767,8767,8767,8767,8767,8767,8767,02ff6501-cccc-4f7d-9988-856d4e169b0e,the usefulness of contrast enhancement for the investigation of the retrobulbar space and in cases of low grade or infiltrative glioma has not been demonstrated,0
7248,7248,7248,7248,7248,7248,7248,8768,8768,8768,8768,8768,8768,8768,8768,8768,8768,8768,8768,8768,02ff6501-cccc-4f7d-9988-856d4e169b0e,in calcified lesions  there is less likelihood of enhancement,0
7249,7249,7249,7249,7249,7249,7249,8769,8769,8769,8769,8769,8769,8769,8769,8769,8769,8769,8769,8769,02ff6501-cccc-4f7d-9988-856d4e169b0e,following therapy  tumors may show decreased or no enhancement,0
7250,7250,7250,7250,7250,7250,7250,8770,8770,8770,8770,8770,8770,8770,8770,8770,8770,8770,8770,8770,02ff6501-cccc-4f7d-9988-856d4e169b0e,the opacification of the inferior vermis following contrast media administration has resulted in false positive diagnosis in a number of normal studies,0
7251,7251,7251,7251,7251,7251,7251,8771,8771,8771,8771,8771,8771,8771,8771,8771,8771,8771,8771,8771,02ff6501-cccc-4f7d-9988-856d4e169b0e,nonneoplastic conditions the use of injectable radiopaque diagnostic agents may be beneficial in the image enhancement of nonneoplastic lesions,0
7252,7252,7252,7252,7252,7252,7252,8772,8772,8772,8772,8772,8772,8772,8772,8772,8772,8772,8772,8772,6baec489-724b-4184-9529-7b9ca3573025,indications based on a review of this drug by the national academy of sciences national research and or other information  the fda has classified the indications as follows possibly effective for the relief of symptoms associated with cerebrovascular insufficiency,u
7253,7253,7253,7253,7253,7253,7253,8773,8773,8773,8773,8773,8773,8773,8773,8773,8773,8773,8773,8773,6baec489-724b-4184-9529-7b9ca3573025,in peripheral vascular disease of arteriosclerosis obliterans  thromboangitis obliterans ( buerger 's disease ) and raynaud 's disease,1
7254,7254,7254,7254,7254,7254,7254,8775,8775,8775,8775,8775,8775,8775,8775,8775,8775,8775,8775,8775,4a91a9e2-d035-4cb3-b32d-13a5d72f0468, isoniazid tablets are recommended for all forms of tuberculosis in which organisms are susceptible,1
7255,7255,7255,7255,7255,7255,7255,8776,8776,8776,8776,8776,8776,8776,8776,8776,8776,8776,8776,8776,4a91a9e2-d035-4cb3-b32d-13a5d72f0468,however  active tuberculosis must be treated with multiple concomitant anti tuberculosis medications to prevent the emergence of drug resistance,4
7256,7256,7256,7256,7256,7256,7256,8777,8777,8777,8777,8777,8777,8777,8777,8777,8777,8777,8777,8777,4a91a9e2-d035-4cb3-b32d-13a5d72f0468,single drug treatment of active tuberculosis with isoniazid or any other medication  is inadequate therapy,0
7257,7257,7257,7257,7257,7257,7257,8778,8778,8778,8778,8778,8778,8778,8778,8778,8778,8778,8778,8778,4a91a9e2-d035-4cb3-b32d-13a5d72f0468,isoniazid tablets are recommended as preventive therapy for the following groups  regardless of age,1
7258,7258,7258,7258,7258,7258,7258,8779,8779,8779,8779,8779,8779,8779,8779,8779,8779,8779,8779,8779,4a91a9e2-d035-4cb3-b32d-13a5d72f0468,( note the criterion for a positive reaction to a skin test ( in millimeters of induration ) for each group is given in parenthesis ) persons with human immunodeficiency virus ( hiv ) infection ( greater than or equal to 5 mm ) and persons with risk factors for hiv infection whose hiv infection status is unknown but who are suspected of having hiv infection,u
7259,7259,7259,7259,7259,7259,7259,8780,8780,8780,8780,8780,8780,8780,8780,8780,8780,8780,8780,8780,4a91a9e2-d035-4cb3-b32d-13a5d72f0468,preventive therapy may be considered for hiv infected persons who are tuberculin negative but belong to groups in which the prevalence of tuberculosis infection is high,u
7260,7260,7260,7260,7260,7260,7260,8781,8781,8781,8781,8781,8781,8781,8781,8781,8781,8781,8781,8781,4a91a9e2-d035-4cb3-b32d-13a5d72f0468,candidates for preventive therapy who have hiv infection should have a minimum of 12 months of therapy,0
7261,7261,7261,7261,7261,7261,7261,8782,8782,8782,8782,8782,8782,8782,8782,8782,8782,8782,8782,8782,4a91a9e2-d035-4cb3-b32d-13a5d72f0468,close contacts of persons with newly diagnosed infectious tuberculosis ( greater than or equal to 5 mm ),0
7262,7262,7262,7262,7262,7262,7262,8783,8783,8783,8783,8783,8783,8783,8783,8783,8783,8783,8783,8783,4a91a9e2-d035-4cb3-b32d-13a5d72f0468,in addition  tuberculin negative ( less than 5 mm ) children and adolescents who have been close contacts of infectious persons within the past 3 months are candidates for preventive therapy until a repeat tuberculin skin test is done 12 weeks after contact with the infectious source,0
7263,7263,7263,7263,7263,7263,7263,8784,8784,8784,8784,8784,8784,8784,8784,8784,8784,8784,8784,8784,4a91a9e2-d035-4cb3-b32d-13a5d72f0468,if the repeat skin test is positive ( greater than 5 mm )  therapy should be continued,0
7264,7264,7264,7264,7264,7264,7264,8785,8785,8785,8785,8785,8785,8785,8785,8785,8785,8785,8785,8785,4a91a9e2-d035-4cb3-b32d-13a5d72f0468,recent converters  as indicated by a tuberculin skin test ( greater than or equal to 10 mm increase within a 2 year period for those less than 35 years old greater than or equal to 15 mm increase for those greater than or equal to 35 years of age ),0
7265,7265,7265,7265,7265,7265,7265,8786,8786,8786,8786,8786,8786,8786,8786,8786,8786,8786,8786,8786,4a91a9e2-d035-4cb3-b32d-13a5d72f0468,all infants and children younger than 4 years of age with a greater than 10 mm skin test are included in this category,0
7266,7266,7266,7266,7266,7266,7266,8787,8787,8787,8787,8787,8787,8787,8787,8787,8787,8787,8787,8787,4a91a9e2-d035-4cb3-b32d-13a5d72f0468,persons with abnormal chest radiographs that show fibrotic lesions likely to represent old healed tuberculosis ( greater than or equal to 5 mm ),0
7267,7267,7267,7267,7267,7267,7267,8788,8788,8788,8788,8788,8788,8788,8788,8788,8788,8788,8788,8788,4a91a9e2-d035-4cb3-b32d-13a5d72f0468,candidates for preventive therapy who have fibrotic pulmonary lesions consistent with healed tuberculosis or who have pulmonary silicosis should have 12 months of isoniazid or 4 months of isoniazid and rifampin  concomitantly,u
7268,7268,7268,7268,7268,7268,7268,8789,8789,8789,8789,8789,8789,8789,8789,8789,8789,8789,8789,8789,4a91a9e2-d035-4cb3-b32d-13a5d72f0468,intravenous drug users known to be hiv seronegative ( greater than 10 mm ),u
7269,7269,7269,7269,7269,7269,7269,8790,8790,8790,8790,8790,8790,8790,8790,8790,8790,8790,8790,8790,4a91a9e2-d035-4cb3-b32d-13a5d72f0468,persons with the following medical conditions that have been reported to increase the risk of tuberculosis ( greater than or equal to 10 mm ) silicosis diabetes mellitus prolonged therapy with adrenocorticosteroids immunosuppressive therapy some hematologic and reticuloendothelial diseases  such as leukemia or hodgkin s disease end stage renal disease clinical situations associated with substantial rapid weight loss or chronic undernutrition ( including intestinal bypass surgery for obesity  the postgastrectomy state with or without weight loss  chronic peptic ulcer disease  chronic malabsorption syndromes and carcinomas of the oropharynx and upper gastrointestinal tract that prevent adequate nutritional intake ),u
7270,7270,7270,7270,7270,7270,7270,8792,8792,8792,8792,8792,8792,8792,8792,8792,8792,8792,8792,8792,4a91a9e2-d035-4cb3-b32d-13a5d72f0468,additionally  in the absence of any of the,0
7271,7271,7271,7271,7271,7271,7271,8793,8793,8793,8793,8793,8793,8793,8793,8793,8793,8793,8793,8793,3cc36609-8e2d-4caa-a8e0-c0367e3e52df, in the treatment of tuberculosis  the small number of resistant cells present within large populations of susceptible cells can rapidly become the predominant type,0
7272,7272,7272,7272,7272,7272,7272,8795,8795,8795,8795,8795,8795,8795,8795,8795,8795,8795,8795,8795,3cc36609-8e2d-4caa-a8e0-c0367e3e52df,bacteriologic smears or cultures should be obtained before the start of therapy to confirm the susceptibility of the organism to rifampin and isoniazid  and they should be repeated throughout therapy to monitor response to the treatment,4
7273,7273,7273,7273,7273,7273,7273,8796,8796,8796,8796,8796,8796,8796,8796,8796,8796,8796,8796,8796,3cc36609-8e2d-4caa-a8e0-c0367e3e52df,if test results show resistance to any of the components of rifamate and the patient is not responding to therapy  the drug regimen should be modified,0
7274,7274,7274,7274,7274,7274,7274,8797,8797,8797,8797,8797,8797,8797,8797,8797,8797,8797,8797,8797,3cc36609-8e2d-4caa-a8e0-c0367e3e52df,rifamate is indicated for pulmonary tuberculosis in which organisms are susceptible  and when the patient has been titrated on the individual components and it has therefore been established that this fixed dosage is therapeutically effective,1
7275,7275,7275,7275,7275,7275,7275,8798,8798,8798,8798,8798,8798,8798,8798,8798,8798,8798,8798,8798,3cc36609-8e2d-4caa-a8e0-c0367e3e52df,this fixed dosage combination drug is not recommended for initial therapy of tuberculosis or for preventive therapy,0
7276,7276,7276,7276,7276,7276,7276,8799,8799,8799,8799,8799,8799,8799,8799,8799,8799,8799,8799,8799,3cc36609-8e2d-4caa-a8e0-c0367e3e52df,a three drug regimen consisting of rifampin  isoniazid  and pyrazinamide ( e g  rifater ) is recommended in the initial phase of short course therapy which is usually continued for 2 months,1
7277,7277,7277,7277,7277,7277,7277,8800,8800,8800,8800,8800,8800,8800,8800,8800,8800,8800,8800,8800,3cc36609-8e2d-4caa-a8e0-c0367e3e52df,the advisory council for the elimination of tuberculosis  the american thoracic society  and centers for disease control and prevention recommend that either streptomycin or ethambutol be added as a fourth drug in a regimen containing isoniazid ( inh )  rifampin  and pyrazinamide for initial treatment of tuberculosis unless the likelihood of inh resistance is very low,u
7278,7278,7278,7278,7278,7278,7278,8803,8803,8803,8803,8803,8803,8803,8803,8803,8803,8803,8803,8803,3cc36609-8e2d-4caa-a8e0-c0367e3e52df,following the initial phase  treatment should be continued with rifamate for at least 4 months,4
7279,7279,7279,7279,7279,7279,7279,8804,8804,8804,8804,8804,8804,8804,8804,8804,8804,8804,8804,8804,3cc36609-8e2d-4caa-a8e0-c0367e3e52df,treatment should be continued for longer if the patient is still sputum or culture positive  if resistant organisms are present  or if the patient is hiv positive,0
7280,7280,7280,7280,7280,7280,7280,8805,8805,8805,8805,8805,8805,8805,8805,8805,8805,8805,8805,8805,3cc36609-8e2d-4caa-a8e0-c0367e3e52df,this drug is not indicated for the treatment of meningococcal infections or asymptomatic carriers of n eisseria meningitidis to eliminate meningococci from the nasopharynx,2
7281,7281,7281,7281,7281,7281,7281,8806,8806,8806,8806,8806,8806,8806,8806,8806,8806,8806,8806,8806,db10c116-5cac-4d50-92dd-250729d0ee3c, prednicarbate emollient cream 0 1 is a medium potency corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid responsive dermatoses,1
7282,7282,7282,7282,7282,7282,7282,8807,8807,8807,8807,8807,8807,8807,8807,8807,8807,8807,8807,8807,db10c116-5cac-4d50-92dd-250729d0ee3c,prednicarbate emollient cream 0 1 may be used with caution in pediatric patients 1 year of age or older,4
7283,7283,7283,7283,7283,7283,7283,8808,8808,8808,8808,8808,8808,8808,8808,8808,8808,8808,8808,8808,db10c116-5cac-4d50-92dd-250729d0ee3c,the safety and efficacy of drug use for longer than 3 weeks in this population have not been established,0
7284,7284,7284,7284,7284,7284,7284,8809,8809,8809,8809,8809,8809,8809,8809,8809,8809,8809,8809,8809,db10c116-5cac-4d50-92dd-250729d0ee3c,since safety and efficacy of prednicarbate emollient cream 0 1 have not been established in pediatric patients below 1 year of age  its use in this age group is not recommended,0
7285,7285,7285,7285,7285,7285,7285,8810,8810,8810,8810,8810,8810,8810,8810,8810,8810,8810,8810,8810,3763b7b6-da49-4658-b93d-28f5da24d09e, ropivacaine hydrochloride injection  usp is indicated for the production of local or regional anesthesia for surgery and for acute pain management,1
7286,7286,7286,7286,7286,7286,7286,8811,8811,8811,8811,8811,8811,8811,8811,8811,8811,8811,8811,8811,3763b7b6-da49-4658-b93d-28f5da24d09e,surgical anesthesia epidural block for surgery including cesarean section major nerve block local infiltration acute pain management epidural continuous infusion or intermittent bolus  e g  postoperative or labor local infiltration,1
7287,7287,7287,7287,7287,7287,7287,8812,8812,8812,8812,8812,8812,8812,8812,8812,8812,8812,8812,8812,ae02436e-9528-490e-a844-0c0f6f2843f9,1  bevespi aerosphere is a combination of glycopyrrolate and formoterol fumarate indicated for the long term  maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease ( copd )  including chronic bronchitis and or emphysema,1
7288,7288,7288,7288,7288,7288,7288,8813,8813,8813,8813,8813,8813,8813,8813,8813,8813,8813,8813,8813,ae02436e-9528-490e-a844-0c0f6f2843f9,important limitation of use bevespi aerosphere is not indicated for the relief of acute bronchospasm or for the treatment of asthma see warnings and precautions ( 5 1  5 2 ),2
7289,7289,7289,7289,7289,7289,7289,8814,8814,8814,8814,8814,8814,8814,8814,8814,8814,8814,8814,8814,ae02436e-9528-490e-a844-0c0f6f2843f9,bevespi aerosphere is a combination of glycopyrrolate  an anticholinergic  and formoterol fumarate  a long acting beta2 adrenergic agonist ( laba ) indicated for the long term  maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease ( copd ),1
7290,7290,7290,7290,7290,7290,7290,8815,8815,8815,8815,8815,8815,8815,8815,8815,8815,8815,8815,8815,ae02436e-9528-490e-a844-0c0f6f2843f9,( 1 ) limitation of use not indicated for the relief of acute bronchospasm or for the treatment of asthma,0
7291,7291,7291,7291,7291,7291,7291,8817,8817,8817,8817,8817,8817,8817,8817,8817,8817,8817,8817,8817,77bb4ef4-c10e-4acc-8225-651d003f4561,males androgens are indicated for replacement therapy in conditions associated with a deficiency or absence of endogenous testosterone primary hypogonadism ( congenital or acquired ) testicular failure due to cryptorchidism  bilateral torsion  orchitis  vanishing testis syndrome  or orchidectomy,1
7292,7292,7292,7292,7292,7292,7292,8822,8822,8822,8822,8822,8822,8822,8822,8822,8822,8822,8822,8822,77bb4ef4-c10e-4acc-8225-651d003f4561,safety and efficacy of methyltestosterone in men with age related hypogonadism ( also referred to as late onset hypogonadism have not been established,0
7293,7293,7293,7293,7293,7293,7293,8823,8823,8823,8823,8823,8823,8823,8823,8823,8823,8823,8823,8823,77bb4ef4-c10e-4acc-8225-651d003f4561,androgens may be used to stimulate puberty in carefully selected males with clearly delayed puberty,1
7294,7294,7294,7294,7294,7294,7294,8827,8827,8827,8827,8827,8827,8827,8827,8827,8827,8827,8827,8827,77bb4ef4-c10e-4acc-8225-651d003f4561,an x ray of the hand and wrist to determine bone age should be obtained every 6 months to assess the effect of treatment on the epiphyseal centers ( see warnings ),4
7295,7295,7295,7295,7295,7295,7295,8828,8828,8828,8828,8828,8828,8828,8828,8828,8828,8828,8828,8828,77bb4ef4-c10e-4acc-8225-651d003f4561,females androgens may be used secondarily in women with advancing inoperable metastatic ( skeletal ) mammary cancer who are 1 to 5 years postmenopausal,1
7296,7296,7296,7296,7296,7296,7296,8830,8830,8830,8830,8830,8830,8830,8830,8830,8830,8830,8830,8830,77bb4ef4-c10e-4acc-8225-651d003f4561,other methods of counteracting estrogen activity are adrenalectomy  hypophysectomy  and or antiestrogen therapy,u
7297,7297,7297,7297,7297,7297,7297,8831,8831,8831,8831,8831,8831,8831,8831,8831,8831,8831,8831,8831,77bb4ef4-c10e-4acc-8225-651d003f4561,this treatment has also been used in premenopausal women with breast cancer who have benefitted from oophorectomy and are considered to have a hormone responsive tumor,0
7298,7298,7298,7298,7298,7298,7298,8832,8832,8832,8832,8832,8832,8832,8832,8832,8832,8832,8832,8832,77bb4ef4-c10e-4acc-8225-651d003f4561,judgment concerning androgen therapy should be made by an oncologist with expertise in this field,0
7299,7299,7299,7299,7299,7299,7299,8833,8833,8833,8833,8833,8833,8833,8833,8833,8833,8833,8833,8833,0ac5db3e-4838-499d-940d-2a9706fe9945, carefully consider the potential benefits and risks of salsalate tablets and other treatment options before deciding to use salsalate tablets,0
7300,7300,7300,7300,7300,7300,7300,8835,8835,8835,8835,8835,8835,8835,8835,8835,8835,8835,8835,8835,0ac5db3e-4838-499d-940d-2a9706fe9945,salsalate is indicated for relief of the signs and symptoms of rheumatoid arthritis  osteoarthritis and related rheumatic disorder,1
7301,7301,7301,7301,7301,7301,7301,8836,8836,8836,8836,8836,8836,8836,8836,8836,8836,8836,8836,8836,f9ab6b1c-98d0-4373-0e9b-b10cb4a67543, deferoxamine mesylate for injection  usp is indicated for the treatment of acute iron intoxication and of chronic iron overload due to transfusion dependent anemias,1
7302,7302,7302,7302,7302,7302,7302,8837,8837,8837,8837,8837,8837,8837,8837,8837,8837,8837,8837,8837,f9ab6b1c-98d0-4373-0e9b-b10cb4a67543,acute iron intoxication deferoxamine mesylate is an adjunct to  and not a substitute for  standard measures used in treating acute iron intoxication  which may include the following induction of emesis with syrup of ipecac gastric lavage suction and maintenance of a clear airway control of shock with intravenous fluids  blood  oxygen  and vasopressors and correction of acidosis,1
7303,7303,7303,7303,7303,7303,7303,8838,8838,8838,8838,8838,8838,8838,8838,8838,8838,8838,8838,8838,f9ab6b1c-98d0-4373-0e9b-b10cb4a67543,chronic iron overload deferoxamine mesylate can promote iron excretion in patients with secondary iron overload from multiple transfusions ( as may occur in the treatment of some chronic anemias  including thalassemia ),u
7304,7304,7304,7304,7304,7304,7304,8839,8839,8839,8839,8839,8839,8839,8839,8839,8839,8839,8839,8839,f9ab6b1c-98d0-4373-0e9b-b10cb4a67543,long term therapy with deferoxamine mesylate slows accumulation of hepatic iron and retards or eliminates progression of hepatic fibrosis,u
7305,7305,7305,7305,7305,7305,7305,8840,8840,8840,8840,8840,8840,8840,8840,8840,8840,8840,8840,8840,f9ab6b1c-98d0-4373-0e9b-b10cb4a67543,iron mobilization with deferoxamine mesylate is relatively poor in patients under the age of 3 years with relatively little iron overload,0
7306,7306,7306,7306,7306,7306,7306,8841,8841,8841,8841,8841,8841,8841,8841,8841,8841,8841,8841,8841,f9ab6b1c-98d0-4373-0e9b-b10cb4a67543,the drug should ordinarily not be given to such patients unless significant iron mobilization ( e g  1 mg or more of iron per day ) can be demonstrated,0
7307,7307,7307,7307,7307,7307,7307,8842,8842,8842,8842,8842,8842,8842,8842,8842,8842,8842,8842,8842,f9ab6b1c-98d0-4373-0e9b-b10cb4a67543,deferoxamine mesylate is not indicated for the treatment of primary hemochromatosis  since phlebotomy is the method of choice for removing excess iron in this disorder,2
7308,7308,7308,7308,7308,7308,7308,8843,8843,8843,8843,8843,8843,8843,8843,8843,8843,8843,8843,8843,b56004f0-f23d-47f6-80c7-39884fccbccc, in the treatment of both tuberculosis and the meningococcal carrier state  the small number of resistant cells present within large populations of susceptible cells can rapidly become the predominant type,0
7309,7309,7309,7309,7309,7309,7309,8844,8844,8844,8844,8844,8844,8844,8844,8844,8844,8844,8844,8844,b56004f0-f23d-47f6-80c7-39884fccbccc,bacteriologic cultures should be obtained before the start of therapy to confirm the susceptibility of the organism to rifampin and they should be repeated throughout therapy to monitor the response to treatment,4
7310,7310,7310,7310,7310,7310,7310,8846,8846,8846,8846,8846,8846,8846,8846,8846,8846,8846,8846,8846,b56004f0-f23d-47f6-80c7-39884fccbccc,if test results show resistance to rifampin and the patient is not responding to therapy  the drug regimen should be modified,0
7311,7311,7311,7311,7311,7311,7311,8847,8847,8847,8847,8847,8847,8847,8847,8847,8847,8847,8847,8847,b56004f0-f23d-47f6-80c7-39884fccbccc,tuberculosis rifampin is indicated in the treatment of all forms of tuberculosis,1
7312,7312,7312,7312,7312,7312,7312,8852,8852,8852,8852,8852,8852,8852,8852,8852,8852,8852,8852,8852,b56004f0-f23d-47f6-80c7-39884fccbccc,following the initial phase  treatment should be continued with rifampin and isoniazid ( e g  rifamate ) for at least 4 months,4
7313,7313,7313,7313,7313,7313,7313,8854,8854,8854,8854,8854,8854,8854,8854,8854,8854,8854,8854,8854,b56004f0-f23d-47f6-80c7-39884fccbccc,rifampin iv is indicated for the initial treatment and retreatment of tuberculosis when the drug cannot be taken by mouth,1
7314,7314,7314,7314,7314,7314,7314,8855,8855,8855,8855,8855,8855,8855,8855,8855,8855,8855,8855,8855,b56004f0-f23d-47f6-80c7-39884fccbccc,meningococcal carriers rifampin is indicated for the treatment of asymptomatic carriers of neisseria meningitidis to eliminate meningococci from the nasopharynx,1
7315,7315,7315,7315,7315,7315,7315,8856,8856,8856,8856,8856,8856,8856,8856,8856,8856,8856,8856,8856,b56004f0-f23d-47f6-80c7-39884fccbccc,rifampin is not indicated for the treatment of meningococcal infection because of the possibility of the rapid emergence of resistant organisms ( see warnings ),2
7316,7316,7316,7316,7316,7316,7316,8857,8857,8857,8857,8857,8857,8857,8857,8857,8857,8857,8857,8857,b56004f0-f23d-47f6-80c7-39884fccbccc,rifampin should not be used indiscriminately  and therefore  diagnostic laboratory procedures  including serotyping and susceptibility testing  should be performed for establishment of the carrier state and the correct treatment,4
7317,7317,7317,7317,7317,7317,7317,8858,8858,8858,8858,8858,8858,8858,8858,8858,8858,8858,8858,8858,b56004f0-f23d-47f6-80c7-39884fccbccc,so that the usefulness of rifampin in the treatment of asymptomatic meningococcal carriers is preserved  the drug should be used only when the risk of meningococcal disease is high,0
7318,7318,7318,7318,7318,7318,7318,8859,8859,8859,8859,8859,8859,8859,8859,8859,8859,8859,8859,8859,b56004f0-f23d-47f6-80c7-39884fccbccc,to reduce the development of drug resistant bacteria and maintain the effectiveness of rifampin and other antibacterial,4
7319,7319,7319,7319,7319,7319,7319,8865,8865,8865,8865,8865,8865,8865,8865,8865,8865,8865,8865,8865,7d4f0e3a-5b86-4c43-982a-813b22ae7e22,1  rhopressa ( netarsudil ophthalmic solution ) 0 02 is indicated for the reduction of elevated intraocular pressure ( iop ) in patients with open angle glaucoma or ocular hypertension,1
7320,7320,7320,7320,7320,7320,7320,8866,8866,8866,8866,8866,8866,8866,8866,8866,8866,8866,8866,8866,7d4f0e3a-5b86-4c43-982a-813b22ae7e22,rhopressa ( netarsudil ophthalmic solution ) 0 02 is a rho kinase inhibitor indicated for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension,1
7321,7321,7321,7321,7321,7321,7321,8867,8867,8867,8867,8867,8867,8867,8867,8867,8867,8867,8867,8867,9e58122f-5c75-4905-a774-d3a4dae4ff8c, therapy penicillin g potassium injection  usp is indicated in the treatment of serious infections caused by susceptible strains of the designated microorganisms in the conditions listed below,1
7322,7322,7322,7322,7322,7322,7322,8868,8868,8868,8868,8868,8868,8868,8868,8868,8868,8868,8868,8868,9e58122f-5c75-4905-a774-d3a4dae4ff8c,appropriate culture and susceptibility tests should be done before treatment in order to isolate and identify organisms causing infection and to determine their susceptibility to penicillin g therapy with penicillin g potassium injection  usp may be initiated before results of such tests are known when there is reason to believe the infection may involve any of the organisms listed below however  once these results become available  appropriate therapy should be continued,4
7323,7323,7323,7323,7323,7323,7323,8869,8869,8869,8869,8869,8869,8869,8869,8869,8869,8869,8869,8869,9e58122f-5c75-4905-a774-d3a4dae4ff8c,clinical indication infecting organism septicemia  empyema  pneumonia  pericarditis  endocarditis  meningitis streptococcus pyogenes ( group a hemolytic streptococcus )  other hemolytic streptococci including groups c  h  g  l and m  streptococcus pneumoniae and staphylococcus species ( non penicillinase producing strains ) anthrax bacillus anthracis actinomycosis ( cervico facial disease and thoracic and abdominal disease ) actinomyces israelii botulism ( adjunctive therapy to antitoxin )  gas gangrene  and tetanus ( adjunctive therapy to human tetanus immune globulin ) clostridium species td valign,1
7324,7324,7324,7324,7324,7324,7324,8870,8870,8870,8870,8870,8870,8870,8870,8870,8870,8870,8870,8870,a85e28ea-03be-471f-ad7f-f5c55c67ac97, clindamycin palmitate hydrochloride for oral solution is indicated in the treatment of serious infections caused by susceptible anaerobic bacteria,1
7325,7325,7325,7325,7325,7325,7325,8871,8871,8871,8871,8871,8871,8871,8871,8871,8871,8871,8871,8871,a85e28ea-03be-471f-ad7f-f5c55c67ac97,clindamycin is also indicated in the treatment of serious infections due to susceptible strains of streptococci  pneumococci and staphylococci,1
7326,7326,7326,7326,7326,7326,7326,8873,8873,8873,8873,8873,8873,8873,8873,8873,8873,8873,8873,8873,a85e28ea-03be-471f-ad7f-f5c55c67ac97,because of the risk of colitis  as described in the boxed warning  before selecting clindamycin the physician should consider the nature of the infection and the suitability of less toxic alternatives ( e g  erythromycin ),0
7327,7327,7327,7327,7327,7327,7327,8874,8874,8874,8874,8874,8874,8874,8874,8874,8874,8874,8874,8874,a85e28ea-03be-471f-ad7f-f5c55c67ac97,anaerobes serious respiratory tract infections such as empyema  anaerobic pneumonitis and lung abscess serious skin and soft tissue infections septicemia intra abdominal infections such as peritonitis and intra abdominal abscess ( typically resulting from anaerobic organisms resident in the normal gastrointestinal tract ) infections of the female pelvis and genital tract such as endometritis  nongonococcal tubo ovarian abscess  pelvic cellulitis and postsurgical vaginal cuff infection,1
7328,7328,7328,7328,7328,7328,7328,8879,8879,8879,8879,8879,8879,8879,8879,8879,8879,8879,8879,8879,a85e28ea-03be-471f-ad7f-f5c55c67ac97,to reduce the development of drug resistant bacteria and maintain the effectiveness of clindamycin palmitate hydrochloride for oral solution and other antibacterial drugs  clindamycin palmitate hydrochloride for oral solution should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria,4
7329,7329,7329,7329,7329,7329,7329,8882,8882,8882,8882,8882,8882,8882,8882,8882,8882,8882,8882,8882,875cc32a-219c-4b6b-802a-98a47cbc9a78,1  anagrelide is a platelet reducing agent indicated for the treatment of thrombocythemia  secondary to myeloproliferative neoplasms  to reduce the elevated platelet count and the risk of thrombosis and to ameliorate associated symptoms including thrombo hemorrhagic events,1
7330,7330,7330,7330,7330,7330,7330,8883,8883,8883,8883,8883,8883,8883,8883,8883,8883,8883,8883,8883,875cc32a-219c-4b6b-802a-98a47cbc9a78,( 1 ) anagrelide capsules are indicated for the treatment of patients with thrombocythemia  secondary to myeloproliferative neoplasms  to reduce the elevated platelet count and the risk of thrombosis and to ameliorate associated symptoms including thrombo hemorrhagic events see clinical studies ( 14 )  dosage and administration ( 2 ),1
7331,7331,7331,7331,7331,7331,7331,8884,8884,8884,8884,8884,8884,8884,8884,8884,8884,8884,8884,8884,8bc2ddf8-d695-46b3-bf76-9f85ce6027e3, ganite is indicated for the treatment of clearly symptomatic cancer related hypercalcemia that has not responded to adequate hydration,1
7332,7332,7332,7332,7332,7332,7332,8885,8885,8885,8885,8885,8885,8885,8885,8885,8885,8885,8885,8885,8bc2ddf8-d695-46b3-bf76-9f85ce6027e3,in general  patients with a serum calcium ( corrected for albumin ) 12 mg dl would not be expected to be symptomatic,0
7333,7333,7333,7333,7333,7333,7333,8886,8886,8886,8886,8886,8886,8886,8886,8886,8886,8886,8886,8886,8bc2ddf8-d695-46b3-bf76-9f85ce6027e3,mild or asymptomatic hypercalcemia may be treated with conservative measures ( i e  saline hydration  with or without diuretics ),u
7334,7334,7334,7334,7334,7334,7334,8887,8887,8887,8887,8887,8887,8887,8887,8887,8887,8887,8887,8887,8bc2ddf8-d695-46b3-bf76-9f85ce6027e3,in the treatment of cancer related hypercalcemia  it is important first to establish adequate hydration  preferably with intravenous saline  in order to increase the renal excretion of calcium and correct dehydration caused by hypercalcemia,4
7335,7335,7335,7335,7335,7335,7335,8888,8888,8888,8888,8888,8888,8888,8888,8888,8888,8888,8888,8888,29da357e-e7fc-46af-bf20-806a1e4b5391,1 indications usage caspofungin acetate for injection is an echinocandin antifungal indicated in adults and pediatric patients ( 3 months of age and older ) for empirical therapy for presumed fungal infections in febrile  neutropenic patients,1
7336,7336,7336,7336,7336,7336,7336,8889,8889,8889,8889,8889,8889,8889,8889,8889,8889,8889,8889,8889,29da357e-e7fc-46af-bf20-806a1e4b5391,treatment of candidemia and the following candida infections intra abdominal abscesses  peritonitis and pleural space infections,1
7337,7337,7337,7337,7337,7337,7337,8890,8890,8890,8890,8890,8890,8890,8890,8890,8890,8890,8890,8890,29da357e-e7fc-46af-bf20-806a1e4b5391,treatment of esophageal candidiasis,1
7338,7338,7338,7338,7338,7338,7338,8891,8891,8891,8891,8891,8891,8891,8891,8891,8891,8891,8891,8891,29da357e-e7fc-46af-bf20-806a1e4b5391,treatment of invasive aspergillosis in patients who are refractory to or intolerant of other therapies,1
7339,7339,7339,7339,7339,7339,7339,8892,8892,8892,8892,8892,8892,8892,8892,8892,8892,8892,8892,8892,29da357e-e7fc-46af-bf20-806a1e4b5391,1 1 empirical therapy for presumed fungal infections in febrile  neutropenic patients caspofungin acetate for injection is indicated as empirical therapy for presumed fungal infections in febrile  neutropenic adult and pediatric patients ( 3 months of age and older ) see clinical studies ( 14 1  14 5 ),1
7340,7340,7340,7340,7340,7340,7340,8893,8893,8893,8893,8893,8893,8893,8893,8893,8893,8893,8893,8893,29da357e-e7fc-46af-bf20-806a1e4b5391,1 2 treatment of candidemia and other candida infections caspofungin acetate for injection is indicated for the treatment of candidemia and the following candida infections intra abdominal abscesses  peritonitis  and pleural space infections in adult and pediatric patients ( 3 months of age and older ) see clinical studies ( 14 2 )  ( 14 5 ),1
7341,7341,7341,7341,7341,7341,7341,8894,8894,8894,8894,8894,8894,8894,8894,8894,8894,8894,8894,8894,29da357e-e7fc-46af-bf20-806a1e4b5391,limitation of use caspofungin acetate for injection has not been studied in endocarditis  osteomyelitis  and meningitis due to candida,0
7342,7342,7342,7342,7342,7342,7342,8895,8895,8895,8895,8895,8895,8895,8895,8895,8895,8895,8895,8895,29da357e-e7fc-46af-bf20-806a1e4b5391,1 3 treatment of esophageal candidiasis caspofungin acetate for injection is indicated for the treatment of esophageal candidiasis in adult and pediatric patients ( 3 months of age and older ) see clinical studies ( 14 3  14 5 ) limitation of use caspofungin acetate for injection has not been approved for the treatment of oropharyngeal candidiasis ( opc ),1
7343,7343,7343,7343,7343,7343,7343,8896,8896,8896,8896,8896,8896,8896,8896,8896,8896,8896,8896,8896,29da357e-e7fc-46af-bf20-806a1e4b5391,in the study that evaluated the efficacy of caspofungin in the treatment of esophageal candidiasis  patients with concomitant opc had higher relapse rate of the opc see content stylecod,0
7344,7344,7344,7344,7344,7344,7344,8897,8897,8897,8897,8897,8897,8897,8897,8897,8897,8897,8897,8897,2d4d6a8e-3122-4b91-b46a-5708e60ea5c1,1  keveyis is indicated for the treatment of primary hyperkalemic periodic paralysis  primary hypokalemic periodic paralysis  and related variants,1
7345,7345,7345,7345,7345,7345,7345,8898,8898,8898,8898,8898,8898,8898,8898,8898,8898,8898,8898,8898,2d4d6a8e-3122-4b91-b46a-5708e60ea5c1,keveyis is an oral carbonic anhydrase inhibitor indicated for the treatment of primary hyperkalemic periodic paralysis  primary hypokalemic periodic paralysis  and related variants ( 1 ),1
7346,7346,7346,7346,7346,7346,7346,8899,8899,8899,8899,8899,8899,8899,8899,8899,8899,8899,8899,8899,aa9e250b-f317-42cb-b8d2-e85de56f4ef7, miconazole nitrate vaginal suppositories usp  200 mg are indicated for the local treatment of vulvovaginal candidiasis ( moniliasis ),1
7347,7347,7347,7347,7347,7347,7347,8900,8900,8900,8900,8900,8900,8900,8900,8900,8900,8900,8900,8900,aa9e250b-f317-42cb-b8d2-e85de56f4ef7,effectiveness in pregnancy has not been established,0
7348,7348,7348,7348,7348,7348,7348,8901,8901,8901,8901,8901,8901,8901,8901,8901,8901,8901,8901,8901,aa9e250b-f317-42cb-b8d2-e85de56f4ef7,as miconazole nitrate is effective only for candidal vulvovaginitis  the diagnosis should be confirmed by koh smear and or cultures,4
7349,7349,7349,7349,7349,7349,7349,8902,8902,8902,8902,8902,8902,8902,8902,8902,8902,8902,8902,8902,aa9e250b-f317-42cb-b8d2-e85de56f4ef7,other pathogens commonly associated with vulvovaginitis ( trichomonas and haemophilus vaginalis gardnerella ) should be ruled out by appropriate laboratory methods,0
7350,7350,7350,7350,7350,7350,7350,8903,8903,8903,8903,8903,8903,8903,8903,8903,8903,8903,8903,8903,dad13445-f591-4829-96f9-1598ba03dff8, tobramycin inhalation solution pak ( co packaging of tobramycin inhalation solution and pari lc plus reusable nebulizer ) is indicated for the management of cystic fibrosis in adults and pediatric patients 6 years of age and older with p aeruginosa,1
7351,7351,7351,7351,7351,7351,7351,8904,8904,8904,8904,8904,8904,8904,8904,8904,8904,8904,8904,8904,dad13445-f591-4829-96f9-1598ba03dff8,safety and efficacy have not been demonstrated in patients under the age of 6 years  patients with fev1 25 or 75 predicted  or patients colonized with burkholderia cepacia see clinical studies ( 14 ),u
7352,7352,7352,7352,7352,7352,7352,8905,8905,8905,8905,8905,8905,8905,8905,8905,8905,8905,8905,8905,dad13445-f591-4829-96f9-1598ba03dff8,tobramycin inhalation solution pak contains tobramycin  an aminoglycoside antibacterial drug indicated for the management of cystic fibrosis in adults and pediatric patients 6 years of age and older with pseudomonas aeruginosa ( 1 ),1
7353,7353,7353,7353,7353,7353,7353,8906,8906,8906,8906,8906,8906,8906,8906,8906,8906,8906,8906,8906,3dd9b060-5355-404d-bdf1-09ee8b52a9f5,1  zylet is a topical anti infective and corticosteroid combination for steroid responsive inflammatory ocular conditions for which a corticosteroid is indicated and where superficial bacterial ocular infection or a risk of bacterial ocular infection exists,1
7354,7354,7354,7354,7354,7354,7354,8907,8907,8907,8907,8907,8907,8907,8907,8907,8907,8907,8907,8907,3dd9b060-5355-404d-bdf1-09ee8b52a9f5,ocular steroids are indicated in inflammatory conditions of the palpebral and bulbar conjunctiva  cornea and anterior segment of the globe such as allergic conjunctivitis  acne rosacea  superficial punctate keratitis  herpes zoster keratitis  iritis  cyclitis  and where the inherent risk of steroid use in certain infective conjunctivitides is accepted to obtain a diminution in edema and inflammation,1
7355,7355,7355,7355,7355,7355,7355,8910,8910,8910,8910,8910,8910,8910,8910,8910,8910,8910,8910,8910,3dd9b060-5355-404d-bdf1-09ee8b52a9f5,the particular anti infective drug in this product ( tobramycin ) is active against the following common bacterial eye pathogens staphylococci  including s aureus and s epidermidis ( coagulase positive and coagulase negative )  including penicillin resistant strains,1
7356,7356,7356,7356,7356,7356,7356,8911,8911,8911,8911,8911,8911,8911,8911,8911,8911,8911,8911,8911,3dd9b060-5355-404d-bdf1-09ee8b52a9f5,streptococci  including some of the group a beta hemolytic species  some nonhemolytic species  and some streptococcus pneumoniae  pseudomonas aeruginosa  escherichia coli  klebsiella pneumoniae  enterobacter aerogenes  proteus mirabilis  morganella morganii  most proteus vulgaris strains  haemophilus influenzae  and h aegyptius  moraxella lacunata  acinetobacter calcoaceticus and some neisseria species,1
7357,7357,7357,7357,7357,7357,7357,8912,8912,8912,8912,8912,8912,8912,8912,8912,8912,8912,8912,8912,3dd9b060-5355-404d-bdf1-09ee8b52a9f5,zylet is a topical anti infective and steroid combination for steroid responsive inflammatory ocular conditions for which a corticosteroid is indicated and where superficial bacterial ocular infection or a risk of bacterial ocular infection exists,1
7358,7358,7358,7358,7358,7358,7358,8913,8913,8913,8913,8913,8913,8913,8913,8913,8913,8913,8913,8913,7ecd5eef-46f4-407f-9b63-ba65adb3eced,1  oxcarbazepine tablets are indicated for use as monotherapy or adjunctive therapy in the treatment of partial seizures in adults and as monotherapy in the treatment of partial seizures in pediatric patients aged 4 years and above with epilepsy  and as adjunctive therapy in pediatric patients aged 2 years and above with partial seizures,1
7359,7359,7359,7359,7359,7359,7359,8914,8914,8914,8914,8914,8914,8914,8914,8914,8914,8914,8914,8914,7ecd5eef-46f4-407f-9b63-ba65adb3eced,oxcarbazepine is indicated for adults monotherapy or adjunctive therapy in the treatment of partial seizures pediatrics monotherapy in the treatment of partial seizures in children 4 to 16 years adjunctive therapy in the treatment of partial seizures in children 2 to 16 years,1
7360,7360,7360,7360,7360,7360,7360,8915,8915,8915,8915,8915,8915,8915,8915,8915,8915,8915,8915,8915,ec77bff9-0e76-440c-b896-63caba17c23f, the use of metoclopramide tablets is recommended for adults only,0
7361,7361,7361,7361,7361,7361,7361,8916,8916,8916,8916,8916,8916,8916,8916,8916,8916,8916,8916,8916,ec77bff9-0e76-440c-b896-63caba17c23f,therapy should not exceed 12 weeks in duration,0
7362,7362,7362,7362,7362,7362,7362,8917,8917,8917,8917,8917,8917,8917,8917,8917,8917,8917,8917,8917,ec77bff9-0e76-440c-b896-63caba17c23f,symptomatic gastroesophageal reflux metoclopramide tablets are indicated as short term ( 4 to 12 weeks ) therapy for adults with symptomatic  documented gastroesophageal reflux who fail to respond to conventional therapy,1
7363,7363,7363,7363,7363,7363,7363,8918,8918,8918,8918,8918,8918,8918,8918,8918,8918,8918,8918,8918,ec77bff9-0e76-440c-b896-63caba17c23f,the principal effect of metoclopramide is on symptoms of postprandial and daytime heartburn with less observed effect on nocturnal symptoms,0
7364,7364,7364,7364,7364,7364,7364,8919,8919,8919,8919,8919,8919,8919,8919,8919,8919,8919,8919,8919,ec77bff9-0e76-440c-b896-63caba17c23f,if symptoms are confined to particular situations  such as following the evening meal  use of metoclopramide as single doses prior to the provocative situation should be considered  rather than using the drug throughout the day,0
7365,7365,7365,7365,7365,7365,7365,8920,8920,8920,8920,8920,8920,8920,8920,8920,8920,8920,8920,8920,ec77bff9-0e76-440c-b896-63caba17c23f,healing of esophageal ulcers and erosions has been endoscopically demonstrated at the end of a 12 week trial using doses of 15 mg q i d,0
7366,7366,7366,7366,7366,7366,7366,8921,8921,8921,8921,8921,8921,8921,8921,8921,8921,8921,8921,8921,ec77bff9-0e76-440c-b896-63caba17c23f,as there is no documented correlation between symptoms and healing of esophageal lesions  patients with documented lesions should be monitored endoscopically,0
7367,7367,7367,7367,7367,7367,7367,8922,8922,8922,8922,8922,8922,8922,8922,8922,8922,8922,8922,8922,ec77bff9-0e76-440c-b896-63caba17c23f,diabetic gastroparesis ( diabetic gastric stasis ) metoclopramide tablets are indicated for the relief of symptoms associated with acute and recurrent diabetic gastric stasis,1
7368,7368,7368,7368,7368,7368,7368,8923,8923,8923,8923,8923,8923,8923,8923,8923,8923,8923,8923,8923,ec77bff9-0e76-440c-b896-63caba17c23f,the usual manifestations of delayed gastric emptying ( e g  nausea  vomiting  heartburn  persistent fullness after meals  and anorexia ) appear to respond to metoclopramide within different time intervals,u
7369,7369,7369,7369,7369,7369,7369,8924,8924,8924,8924,8924,8924,8924,8924,8924,8924,8924,8924,8924,ec77bff9-0e76-440c-b896-63caba17c23f,significant relief of nausea occurs early and continues to improve over a three week period,0
7370,7370,7370,7370,7370,7370,7370,8925,8925,8925,8925,8925,8925,8925,8925,8925,8925,8925,8925,8925,ec77bff9-0e76-440c-b896-63caba17c23f,relief of vomiting and anorexia may precede the relief of abdominal fullness by one week or more,0
7371,7371,7371,7371,7371,7371,7371,8926,8926,8926,8926,8926,8926,8926,8926,8926,8926,8926,8926,8926,aaabbaca-ba6f-42d5-980d-71135c7c80ea,indications usage torsemide tablet is indicated for the treatment of edema associated with congestive heart failure  renal disease  or hepatic disease,1
7372,7372,7372,7372,7372,7372,7372,8927,8927,8927,8927,8927,8927,8927,8927,8927,8927,8927,8927,8927,aaabbaca-ba6f-42d5-980d-71135c7c80ea,use of torsemide has been found to be effective for the treatment of edema associated with chronic renal failure,1
7373,7373,7373,7373,7373,7373,7373,8928,8928,8928,8928,8928,8928,8928,8928,8928,8928,8928,8928,8928,aaabbaca-ba6f-42d5-980d-71135c7c80ea,chronic use of any diuretic in hepatic disease has not been studied in adequate and well controlled trials,0
7374,7374,7374,7374,7374,7374,7374,8929,8929,8929,8929,8929,8929,8929,8929,8929,8929,8929,8929,8929,aaabbaca-ba6f-42d5-980d-71135c7c80ea,torsemide tablets are indicated for the treatment of hypertension alone or in combination with other antihypertensive agents,1
7375,7375,7375,7375,7375,7375,7375,8930,8930,8930,8930,8930,8930,8930,8930,8930,8930,8930,8930,8930,fb2fe258-fe2e-47f6-8adf-ca75bf6f90af,1  perforomist inhalation solution is a long acting beta2 adrenergic agonist ( beta2 agonist ) indicated for long term  twice daily ( morning and evening ) administration in the maintenance treatment of bronchoconstriction in patients with chronic obstructive pulmonary disease ( copd )  including chronic bronchitis and emphysema,1
7376,7376,7376,7376,7376,7376,7376,8931,8931,8931,8931,8931,8931,8931,8931,8931,8931,8931,8931,8931,fb2fe258-fe2e-47f6-8adf-ca75bf6f90af,( 1 1 ) important limitations of use perforomist inhalation solution is not indicated to treat acute deteriorations of chronic obstructive pulmonary disease,2
7377,7377,7377,7377,7377,7377,7377,8932,8932,8932,8932,8932,8932,8932,8932,8932,8932,8932,8932,8932,fb2fe258-fe2e-47f6-8adf-ca75bf6f90af,( 1 2  5 2 ) perforomist inhalation solution is not indicated to treat asthma,2
7378,7378,7378,7378,7378,7378,7378,8933,8933,8933,8933,8933,8933,8933,8933,8933,8933,8933,8933,8933,fb2fe258-fe2e-47f6-8adf-ca75bf6f90af,( 1 2 ) 1 1 maintenance treatment of copd perforomist ( formoterol fumarate ) inhalation solution is indicated for the long term  twice daily ( morning and evening ) administration in the maintenance treatment of bronchoconstriction in patients with chronic obstructive pulmonary disease ( copd )  including chronic bronchitis and emphysema,1
7379,7379,7379,7379,7379,7379,7379,8934,8934,8934,8934,8934,8934,8934,8934,8934,8934,8934,8934,8934,fb2fe258-fe2e-47f6-8adf-ca75bf6f90af,1 2 important limitations of use perforomist inhalation solution is not indicated to treat acute deteriorations of chronic obstructive pulmonary disease see warnings and precautions ( 5 2 ),2
7380,7380,7380,7380,7380,7380,7380,8935,8935,8935,8935,8935,8935,8935,8935,8935,8935,8935,8935,8935,fb2fe258-fe2e-47f6-8adf-ca75bf6f90af,perforomist inhalation solution is not indicated to treat asthma,2
7381,7381,7381,7381,7381,7381,7381,8936,8936,8936,8936,8936,8936,8936,8936,8936,8936,8936,8936,8936,fb2fe258-fe2e-47f6-8adf-ca75bf6f90af,the safety and effectiveness of perforomist inhalation solution in asthma have not been established,0
7382,7382,7382,7382,7382,7382,7382,8937,8937,8937,8937,8937,8937,8937,8937,8937,8937,8937,8937,8937,028312dc-d155-4fd5-8abd-6bb9f011d3cc,1  odomzo ( sonidegib ) is indicated for the treatment of adult patients with locally advanced basal cell carcinoma ( bcc ) that has recurred following surgery or radiation therapy  or those who are not candidates for surgery or radiation therapy,1
7383,7383,7383,7383,7383,7383,7383,8938,8938,8938,8938,8938,8938,8938,8938,8938,8938,8938,8938,8938,028312dc-d155-4fd5-8abd-6bb9f011d3cc,odomzo is a hedgehog pathway inhibitor indicated for the treatment of adult patients with locally advanced basal cell carcinoma ( bcc ) that has recurred following surgery or radiation therapy  or those who are not candidates for surgery or radiation therapy,1
7384,7384,7384,7384,7384,7384,7384,8939,8939,8939,8939,8939,8939,8939,8939,8939,8939,8939,8939,8939,c2b6aaa5-3325-403c-9466-977c4f63f36f, silver sulfadiazine cream  usp 1 is a topical antimicrobial drug indicated as an adjunct for the prevention and treatment of wound sepsis in patients with second and third degree burns,1
7385,7385,7385,7385,7385,7385,7385,8940,8940,8940,8940,8940,8940,8940,8940,8940,8940,8940,8940,8940,24837d82-0f3f-4482-9af0-31e5f675c30f, hypertension metoprolol tartrate tablets are indicated for the treatment of hypertension,1
7386,7386,7386,7386,7386,7386,7386,8941,8941,8941,8941,8941,8941,8941,8941,8941,8941,8941,8941,8941,24837d82-0f3f-4482-9af0-31e5f675c30f,they may be used alone or in combination with other antihypertensive agents,4
7387,7387,7387,7387,7387,7387,7387,8942,8942,8942,8942,8942,8942,8942,8942,8942,8942,8942,8942,8942,24837d82-0f3f-4482-9af0-31e5f675c30f,angina pectoris metoprolol tartrate tablets are indicated in the long term treatment of angina pectoris,1
7388,7388,7388,7388,7388,7388,7388,8943,8943,8943,8943,8943,8943,8943,8943,8943,8943,8943,8943,8943,24837d82-0f3f-4482-9af0-31e5f675c30f,myocardial infarction metoprolol tartrate tablets are indicated in the treatment of hemodynamically stable patients with definite or suspected acute myocardial infarction to reduce cardiovascular mortality when used alone or in conjunction with intravenous metoprolol,1
7389,7389,7389,7389,7389,7389,7389,8944,8944,8944,8944,8944,8944,8944,8944,8944,8944,8944,8944,8944,24837d82-0f3f-4482-9af0-31e5f675c30f,oral metoprolol therapy can be initiated after intravenous metoprolol therapy or  alternatively  oral treatment can begin within 3 to 10 days of the acute event ( see dosage and administration  contraindications  and warnings,3
7390,7390,7390,7390,7390,7390,7390,8945,8945,8945,8945,8945,8945,8945,8945,8945,8945,8945,8945,8945,4c9fc6f5-acd4-4fc0-bf4b-c493a08aa3d6, methazolamide is indicated in the treatment of ocular conditions where lowering intraocular pressure is likely to be of therapeutic benefit  such as chronic open angle glaucoma  secondary glaucoma  and preoperatively in acute angle closure glaucoma where lowering the intraocular pressure is desired before surgery,1
7391,7391,7391,7391,7391,7391,7391,8946,8946,8946,8946,8946,8946,8946,8946,8946,8946,8946,8946,8946,1f0edbd9-103e-4a49-b7a8-6552ef172c13,for topical use only not for ophthalmic  oral or intravaginal use,4
7392,7392,7392,7392,7392,7392,7392,8947,8947,8947,8947,8947,8947,8947,8947,8947,8947,8947,8947,8947,aca7768e-28a7-4027-b1d8-e66247665f79, cetrotide ( cetrorelix acetate for injection ) is indicated for the inhibition of premature lh surges in women undergoing controlled ovarian stimulation,1
7393,7393,7393,7393,7393,7393,7393,8948,8948,8948,8948,8948,8948,8948,8948,8948,8948,8948,8948,8948,3ed35d7d-616c-43cd-9776-705821afc1f0, in general  the most common uses of epinephrine are to relieve respiratory distress due to bronchospasm  to provide rapid relief of hypersensitivity reactions to drugs and other allergens  and to prolong the action of infiltration anesthetics,u
7394,7394,7394,7394,7394,7394,7394,8949,8949,8949,8949,8949,8949,8949,8949,8949,8949,8949,8949,8949,3ed35d7d-616c-43cd-9776-705821afc1f0,its cardiac effects may be of use in restoring cardiac rhythm in cardiac arrest due to various causes  but it is not used in cardiac failure or in hemorrhagic  traumatic  or cardiogenic shock,0
7395,7395,7395,7395,7395,7395,7395,8950,8950,8950,8950,8950,8950,8950,8950,8950,8950,8950,8950,8950,3ed35d7d-616c-43cd-9776-705821afc1f0,epinephrine is used as a hemostatic agent,u
7396,7396,7396,7396,7396,7396,7396,8951,8951,8951,8951,8951,8951,8951,8951,8951,8951,8951,8951,8951,3ed35d7d-616c-43cd-9776-705821afc1f0,it is also used in treating mucosal congestion of hay fever  rhinitis and acute sinusitis to relieve bronchial asthmatic paroxysms in syncope due to complete heart block or carotid sinus hypersensitivity for symptomatic relief of serum sickness  urticaria  angioneurotic edema for resuscitation in cardiac arrest following anesthetic accidents in simple ( open angle ) glaucoma for relaxation of uterine musculature and to inhibit uterine contractions,4
7397,7397,7397,7397,7397,7397,7397,8952,8952,8952,8952,8952,8952,8952,8952,8952,8952,8952,8952,8952,3ed35d7d-616c-43cd-9776-705821afc1f0,epinephrine injection can be utilized to prolong the action of local anesthetics ( see contraindications ),4
7398,7398,7398,7398,7398,7398,7398,8953,8953,8953,8953,8953,8953,8953,8953,8953,8953,8953,8953,8953,8d60148f-779c-453a-bd37-51b875ec1656, pytest ( 14c urea breath test ) is indicated for use in the detection of gastric urease as an aid in the diagnosis of h pylori infection in the human stomach,1
7399,7399,7399,7399,7399,7399,7399,8954,8954,8954,8954,8954,8954,8954,8954,8954,8954,8954,8954,8954,8d60148f-779c-453a-bd37-51b875ec1656,the test utilizes a liquid scintillation counter for the measurement of 14co2 in breath samples,0
7400,7400,7400,7400,7400,7400,7400,8955,8955,8955,8955,8955,8955,8955,8955,8955,8955,8955,8955,8955,f3ce78d9-e923-400e-b3cd-3e6124ac7f6d,1  levalbuterol inhalation solution is indicated for the treatment or prevention of bronchospasm in adults  adolescents  and children 6 years of age and older with reversible obstructive airway disease,1
7401,7401,7401,7401,7401,7401,7401,8956,8956,8956,8956,8956,8956,8956,8956,8956,8956,8956,8956,8956,f3ce78d9-e923-400e-b3cd-3e6124ac7f6d,levalbuterol inhalation solution usp is a beta2 adrenergic agonist indicated for treatment or prevention of bronchospasm in adults  adolescents  and children 6 years of age and older with reversible obstructive airway disease,1
7402,7402,7402,7402,7402,7402,7402,8957,8957,8957,8957,8957,8957,8957,8957,8957,8957,8957,8957,8957,43a47783-c605-49eb-a4fa-8524e75e69de, trimethobenzamide hydrochloride capsules are indicated for the treatment of postoperative nausea and vomiting and for nausea associated with gastroenteritis,1
7403,7403,7403,7403,7403,7403,7403,8958,8958,8958,8958,8958,8958,8958,8958,8958,8958,8958,8958,8958,52b27c75-9f5a-4816-bafd-dace9d7d2063,1  edarbi is an angiotensin ii receptor blocker ( arb ) indicated for the treatment of hypertension to lower blood pressure,1
7404,7404,7404,7404,7404,7404,7404,8961,8961,8961,8961,8961,8961,8961,8961,8961,8961,8961,8961,8961,52b27c75-9f5a-4816-bafd-dace9d7d2063,there are no controlled trials demonstrating risk reduction with edarbi,0
7405,7405,7405,7405,7405,7405,7405,8971,8971,8971,8971,8971,8971,8971,8971,8971,8971,8971,8971,8971,52b27c75-9f5a-4816-bafd-dace9d7d2063,edarbi may be used alone or in combination with other antihypertensive agents,4
7406,7406,7406,7406,7406,7406,7406,8972,8972,8972,8972,8972,8972,8972,8972,8972,8972,8972,8972,8972,52b27c75-9f5a-4816-bafd-dace9d7d2063,edarbi is an angiotensin ii receptor blocker indicated for the treatment of hypertension to lower blood pressure,1
7407,7407,7407,7407,7407,7407,7407,8974,8974,8974,8974,8974,8974,8974,8974,8974,8974,8974,8974,8974,52b27c75-9f5a-4816-bafd-dace9d7d2063,edarbi may be used either alone or in combination with other antihypertensive agents,4
7408,7408,7408,7408,7408,7408,7408,8975,8975,8975,8975,8975,8975,8975,8975,8975,8975,8975,8975,8975,f2ec923a-2b88-43c0-ac2a-7ae20c053039, cimetidine hydrochloride oral solution is indicated in ( 1 ) short term treatment of active duodenal ulcer,1
7409,7409,7409,7409,7409,7409,7409,8976,8976,8976,8976,8976,8976,8976,8976,8976,8976,8976,8976,8976,f2ec923a-2b88-43c0-ac2a-7ae20c053039,most patients heal within 4 weeks and there is rarely reason to use cimetidine at full dosage for longer than 6 to 8 weeks ( see dosage and administration duodenal ulcer ),0
7410,7410,7410,7410,7410,7410,7410,8979,8979,8979,8979,8979,8979,8979,8979,8979,8979,8979,8979,8979,f2ec923a-2b88-43c0-ac2a-7ae20c053039,( 2 ) maintenance therapy for duodenal ulcer patients at reduced dosage after healing of active ulcer,1
7411,7411,7411,7411,7411,7411,7411,8980,8980,8980,8980,8980,8980,8980,8980,8980,8980,8980,8980,8980,f2ec923a-2b88-43c0-ac2a-7ae20c053039,patients have been maintained on continued treatment with cimetidine 400 mg h s,0
7412,7412,7412,7412,7412,7412,7412,8981,8981,8981,8981,8981,8981,8981,8981,8981,8981,8981,8981,8981,f2ec923a-2b88-43c0-ac2a-7ae20c053039,( 3 ) short term treatment of active benign gastric ulcer,1
7413,7413,7413,7413,7413,7413,7413,8983,8983,8983,8983,8983,8983,8983,8983,8983,8983,8983,8983,8983,f2ec923a-2b88-43c0-ac2a-7ae20c053039,( 4 ) erosive gastroesophageal reflux disease ( gerd ),1
7414,7414,7414,7414,7414,7414,7414,8986,8986,8986,8986,8986,8986,8986,8986,8986,8986,8986,8986,8986,f2ec923a-2b88-43c0-ac2a-7ae20c053039,the use of cimetidine beyond 12 weeks has not been established ( see dosage and administration gerd ),0
7415,7415,7415,7415,7415,7415,7415,8987,8987,8987,8987,8987,8987,8987,8987,8987,8987,8987,8987,8987,f2ec923a-2b88-43c0-ac2a-7ae20c053039,( 5 ) the treatment of pathological hypersecretory conditions ( i e  zollinger ellison syndrome  systemic mastocytosis  multiple endocrine adenomas ),1
7416,7416,7416,7416,7416,7416,7416,8988,8988,8988,8988,8988,8988,8988,8988,8988,8988,8988,8988,8988,0a3fa925-1abd-458a-bd57-4ae780a1ef2d,1 i ndications and usage banzel is indicated for adjunctive treatment of seizures associated with lennox gastaut syndrome in pediatric patients 1 year of age and older and in adults,1
7417,7417,7417,7417,7417,7417,7417,8989,8989,8989,8989,8989,8989,8989,8989,8989,8989,8989,8989,8989,0a3fa925-1abd-458a-bd57-4ae780a1ef2d,banzel is indicated for adjunctive treatment of seizures associated with lennox gastaut syndrome ( lgs ) in pediatric patients 1 year of age and older  and in adults ( 1 ),1
7418,7418,7418,7418,7418,7418,7418,8990,8990,8990,8990,8990,8990,8990,8990,8990,8990,8990,8990,8990,3b6ac164-0f1e-4f36-94a1-1fdb07d710f5,1  xerese  a combination of acyclovir  a herpes simplex virus nucleoside analog dna polymerase inhibitor  and hydrocortisone  a corticosteroid  is indicated for the early treatment of recurrent herpes labialis ( cold sores ) to reduce the likelihood of ulcerative cold sores and to shorten the lesion healing time in adults and children ( 6 years of age and older ),1
7419,7419,7419,7419,7419,7419,7419,8991,8991,8991,8991,8991,8991,8991,8991,8991,8991,8991,8991,8991,3b6ac164-0f1e-4f36-94a1-1fdb07d710f5,xerese  a combination of acyclovir  a herpes simplex virus nucleoside analog dna polymerase inhibitor  and hydrocortisone  a corticosteroid  is indicated for the early treatment of recurrent herpes labialis ( cold sores ) to reduce the likelihood of ulcerative cold sores and to shorten the lesion healing time in adults and children ( 6 years of age and older ),1
7420,7420,7420,7420,7420,7420,7420,8992,8992,8992,8992,8992,8992,8992,8992,8992,8992,8992,8992,8992,ade50241-2c10-4038-b4e9-72f6bf905f03,1  aliqopa is indicated for the treatment of adult patients with relapsed follicular lymphoma ( fl ) who have received at least two prior systemic therapies,1
7421,7421,7421,7421,7421,7421,7421,8993,8993,8993,8993,8993,8993,8993,8993,8993,8993,8993,8993,8993,ade50241-2c10-4038-b4e9-72f6bf905f03,accelerated approval was granted for this indication based on overall response rate see clinical studies ( 14 1 ),0
7422,7422,7422,7422,7422,7422,7422,8995,8995,8995,8995,8995,8995,8995,8995,8995,8995,8995,8995,8995,ade50241-2c10-4038-b4e9-72f6bf905f03,aliqopa is a kinase inhibitor indicated for the treatment of adult patients with relapsed follicular lymphoma ( fl ) who have received at least two prior systemic therapies ( 1 ),1
7423,7423,7423,7423,7423,7423,7423,8998,8998,8998,8998,8998,8998,8998,8998,8998,8998,8998,8998,8998,5549684b-1724-45ca-b67b-590c62b7c149,1  travatan z ( travoprost ophthalmic solution ) 0 004 is indicated for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension,1
7424,7424,7424,7424,7424,7424,7424,8999,8999,8999,8999,8999,8999,8999,8999,8999,8999,8999,8999,8999,5549684b-1724-45ca-b67b-590c62b7c149,travatan z is a prostaglandin analog indicated for the reduction of elevated intraocular pressure ( iop ) in patients with open angle glaucoma or ocular hypertension ( 1 ),1
7425,7425,7425,7425,7425,7425,7425,9000,9000,9000,9000,9000,9000,9000,9000,9000,9000,9000,9000,9000,80beab2c-396e-4a37-a4dc-40fdb62859cf,1  sovaldi is a hepatitis c virus ( hcv ) nucleotide analog ns5b polymerase inhibitor indicated for the treatment of adult patients with genotype 1  2  3 or 4 chronic hepatitis c virus ( hcv ) infection without cirrhosis or with compensated cirrhosis as a component of a combination antiviral treatment regimen,1
7426,7426,7426,7426,7426,7426,7426,9001,9001,9001,9001,9001,9001,9001,9001,9001,9001,9001,9001,9001,80beab2c-396e-4a37-a4dc-40fdb62859cf,( 1 ) pediatric patients 12 years of age and older or weighing at least 35 kg with genotype 2 or 3 chronic hcv infection without cirrhosis or with compensated cirrhosis in combination with ribavirin,0
7427,7427,7427,7427,7427,7427,7427,9002,9002,9002,9002,9002,9002,9002,9002,9002,9002,9002,9002,9002,80beab2c-396e-4a37-a4dc-40fdb62859cf,( 1 ) adult patients sovaldi is indicated for the treatment of adult patients with chronic hepatitis c virus ( hcv ) infection as a component of a combination antiviral treatment regimen see dosage and administration ( 2 2 )  and clinical studies ( 14 ) genotype 1 or 4 infection without cirrhosis or with compensated cirrhosis for use in combination with pegylated interferon and ribavirin genotype 2 or 3 infection without cirrhosis or with compensated cirrhosis for use in combination with ribavirin,1
7428,7428,7428,7428,7428,7428,7428,9003,9003,9003,9003,9003,9003,9003,9003,9003,9003,9003,9003,9003,80beab2c-396e-4a37-a4dc-40fdb62859cf,pediatric patients sovaldi is indicated for the treatment of chronic hcv genotype 2 or 3 infection in pediatric patients 12 years of age and older or weighing at least 35 kg without cirrhosis or with compensated cirrhosis for use in combination with ribavirin see dosage and administration ( 2 3 ) and clinical studies ( 14 5 ),1
7429,7429,7429,7429,7429,7429,7429,9004,9004,9004,9004,9004,9004,9004,9004,9004,9004,9004,9004,9004,4d9f6f02-ff9d-6aa3-e054-00144ff8d46c, carefully consider the potential benefits and risks of ibuprofentablets and other treatment options before deciding to use ibuprofen use the lowest effective dose for the shortest duration consistent withindividual patient treatment goals ( see warnings ),4
7430,7430,7430,7430,7430,7430,7430,9005,9005,9005,9005,9005,9005,9005,9005,9005,9005,9005,9005,9005,4d9f6f02-ff9d-6aa3-e054-00144ff8d46c,ibu tablets are indicated for relief of the signs and symptoms of rheumatoid arthritis and osteoarthritis,1
7431,7431,7431,7431,7431,7431,7431,9006,9006,9006,9006,9006,9006,9006,9006,9006,9006,9006,9006,9006,4d9f6f02-ff9d-6aa3-e054-00144ff8d46c,ibu tablets are indicated for relief of mild to moderate pain,1
7432,7432,7432,7432,7432,7432,7432,9007,9007,9007,9007,9007,9007,9007,9007,9007,9007,9007,9007,9007,4d9f6f02-ff9d-6aa3-e054-00144ff8d46c,ibu tablets are also indicated for the treatment of primary dysmenorrhea,1
7433,7433,7433,7433,7433,7433,7433,9008,9008,9008,9008,9008,9008,9008,9008,9008,9008,9008,9008,9008,4d9f6f02-ff9d-6aa3-e054-00144ff8d46c,controlled clinical trials to establish the safety and effectiveness of ibu tablets in children have not been conducted,0
7434,7434,7434,7434,7434,7434,7434,9009,9009,9009,9009,9009,9009,9009,9009,9009,9009,9009,9009,9009,51218de3-dabc-4972-9c5b-750c8b1d8083, protopic ointment  both 0 03 and 0 1 for adults  and only 0 03 for children aged 2 to 15 years  is indicated as second line therapy for the short term and non continuous chronic treatment of moderate to severe atopic dermatitis in non immunocompromised adults and children who have failed to respond adequately to other topical prescription treatments for atopic dermatitis  or when those treatments are not advisable,1
7435,7435,7435,7435,7435,7435,7435,9010,9010,9010,9010,9010,9010,9010,9010,9010,9010,9010,9010,9010,51218de3-dabc-4972-9c5b-750c8b1d8083,protopic ointment is not indicated for children younger than 2 years of age ( see boxed warning  warnings and precautions pediatric use ),0
7436,7436,7436,7436,7436,7436,7436,9011,9011,9011,9011,9011,9011,9011,9011,9011,9011,9011,9011,9011,741ff3e3-dc1a-45a6-84e5-2481b27131aa,1  lynparza is a poly ( adp ribose ) polymerase ( parp ) inhibitor indicated ovarian cancer for the maintenance treatment of adult patients with recurrent epithelial ovarian  fallopian tube or primary peritoneal cancer  who are in a complete or partial response to platinum based chemotherapy,1
7437,7437,7437,7437,7437,7437,7437,9012,9012,9012,9012,9012,9012,9012,9012,9012,9012,9012,9012,9012,741ff3e3-dc1a-45a6-84e5-2481b27131aa,( 1 1 ) for the treatment of adult patients with deleterious or suspected deleterious germline brca mutated ( gbrcam ) advanced ovarian cancer who have been treated with three or more prior lines of chemotherapy,1
7438,7438,7438,7438,7438,7438,7438,9013,9013,9013,9013,9013,9013,9013,9013,9013,9013,9013,9013,9013,741ff3e3-dc1a-45a6-84e5-2481b27131aa,select patients for therapy based on an fda approved companion diagnostic for lynparza,0
7439,7439,7439,7439,7439,7439,7439,9014,9014,9014,9014,9014,9014,9014,9014,9014,9014,9014,9014,9014,741ff3e3-dc1a-45a6-84e5-2481b27131aa,( 1 2  2 3 ) breast cancer in patients with deleterious or suspected deleterious gbrcam  human epidermal growth factor receptor 2 ( her2 ) negative metastatic breast cancer who have been treated with chemotherapy in the neoadjuvant  adjuvant or metastatic setting,1
7440,7440,7440,7440,7440,7440,7440,9015,9015,9015,9015,9015,9015,9015,9015,9015,9015,9015,9015,9015,741ff3e3-dc1a-45a6-84e5-2481b27131aa,patients with hormone receptor ( hr ) positive breast cancer should have been treated with a prior endocrine therapy or be considered inappropriate for endocrine therapy,0
7441,7441,7441,7441,7441,7441,7441,9017,9017,9017,9017,9017,9017,9017,9017,9017,9017,9017,9017,9017,741ff3e3-dc1a-45a6-84e5-2481b27131aa,( 1 3  2 4 ) 1 1 maintenance treatment of recurrent ovarian cancer lynparza is indicated for the maintenance treatment of adult patients with recurrent epithelial ovarian  fallopian tube or primary peritoneal cancer  who are in a complete or partial response to platinum based chemotherapy,1
7442,7442,7442,7442,7442,7442,7442,9018,9018,9018,9018,9018,9018,9018,9018,9018,9018,9018,9018,9018,741ff3e3-dc1a-45a6-84e5-2481b27131aa,1 2 advanced gbrca mutated ovarian cancer after 3 or more lines of chemotherapy lynparza is indicated for the treatment of adult patients with deleterious or suspected deleterious germline brca mutated ( gbrcam ) advanced ovarian cancer who have been treated with three or more prior lines of chemotherapy,1
7443,7443,7443,7443,7443,7443,7443,9019,9019,9019,9019,9019,9019,9019,9019,9019,9019,9019,9019,9019,741ff3e3-dc1a-45a6-84e5-2481b27131aa,select patients for therapy based on an fda approved companion diagnostic for lynparza see dosage and administration ( 2 3 ),0
7444,7444,7444,7444,7444,7444,7444,9020,9020,9020,9020,9020,9020,9020,9020,9020,9020,9020,9020,9020,a80ac249-cae4-41f3-88bb-344088b20e60,1  aldurazyme ( laronidase ) is indicated for patients with hurler and hurler scheie forms of mucopolysaccharidosis i ( mps i ) and for patients with the scheie form who have moderate to severe symptoms,1
7445,7445,7445,7445,7445,7445,7445,9021,9021,9021,9021,9021,9021,9021,9021,9021,9021,9021,9021,9021,a80ac249-cae4-41f3-88bb-344088b20e60,the risks and benefits of treating mildly affected patients with the scheie form have not been established,0
7446,7446,7446,7446,7446,7446,7446,9022,9022,9022,9022,9022,9022,9022,9022,9022,9022,9022,9022,9022,a80ac249-cae4-41f3-88bb-344088b20e60,aldurazyme has been shown to improve pulmonary function and walking capacity,1
7447,7447,7447,7447,7447,7447,7447,9023,9023,9023,9023,9023,9023,9023,9023,9023,9023,9023,9023,9023,a80ac249-cae4-41f3-88bb-344088b20e60,aldurazyme has not been evaluated for effects on the central nervous system manifestations of the disorder,0
7448,7448,7448,7448,7448,7448,7448,9024,9024,9024,9024,9024,9024,9024,9024,9024,9024,9024,9024,9024,a80ac249-cae4-41f3-88bb-344088b20e60,aldurazyme is a hydrolytic lysosomal glycosaminoglycan ( gag ) specific enzyme indicated for patients with hurler and hurler scheie forms of mucopolysaccharidosis i ( mps i ) and for patients with the scheie form who have moderate to severe symptoms,1
7449,7449,7449,7449,7449,7449,7449,9027,9027,9027,9027,9027,9027,9027,9027,9027,9027,9027,9027,9027,a80ac249-cae4-41f3-88bb-344088b20e60,aldurazyme has not been evaluated for effects on the central nervous system manifestations of the disorder ( 1 ),0
7450,7450,7450,7450,7450,7450,7450,9028,9028,9028,9028,9028,9028,9028,9028,9028,9028,9028,9028,9028,27bc2cfc-fefb-4b50-a0dc-6268c69b4902,1 indications usage rizatriptan benzoate tablets are indicated for the acute treatment of migraine with or without aura in adults and in pediatric patients 6 to 17 years old,1
7451,7451,7451,7451,7451,7451,7451,9029,9029,9029,9029,9029,9029,9029,9029,9029,9029,9029,9029,9029,27bc2cfc-fefb-4b50-a0dc-6268c69b4902,information related to usage of rizatriptan benzoate in pediatric patients ( 6 to 17 years old ) is approved for merck co  inc s rizatriptan benzoate tablets,u
7452,7452,7452,7452,7452,7452,7452,9030,9030,9030,9030,9030,9030,9030,9030,9030,9030,9030,9030,9030,27bc2cfc-fefb-4b50-a0dc-6268c69b4902,however  due to merck co  inc s marketing exclusivity rights  this drug product is not labeled with that pediatric patient ( 6 to 17 years old ) usage information,0
7453,7453,7453,7453,7453,7453,7453,9031,9031,9031,9031,9031,9031,9031,9031,9031,9031,9031,9031,9031,27bc2cfc-fefb-4b50-a0dc-6268c69b4902,limitations of use rizatriptan benzoate tablets should only be used where a clear diagnosis of migraine has been established,0
7454,7454,7454,7454,7454,7454,7454,9032,9032,9032,9032,9032,9032,9032,9032,9032,9032,9032,9032,9032,27bc2cfc-fefb-4b50-a0dc-6268c69b4902,if a patient has no response for the first migraine attack treated with rizatriptan benzoate tablets  the diagnosis of migraine should be reconsidered before rizatriptan benzoate tablets are administered to treat any subsequent attacks,0
7455,7455,7455,7455,7455,7455,7455,9033,9033,9033,9033,9033,9033,9033,9033,9033,9033,9033,9033,9033,27bc2cfc-fefb-4b50-a0dc-6268c69b4902,rizatriptan benzoate tablets are not indicated for use in the management of hemiplegic or basilar migraine see contraindications ( 4 ),0
7456,7456,7456,7456,7456,7456,7456,9034,9034,9034,9034,9034,9034,9034,9034,9034,9034,9034,9034,9034,27bc2cfc-fefb-4b50-a0dc-6268c69b4902,rizatriptan benzoate tablets are not indicated for the prevention of migraine attacks,0
7457,7457,7457,7457,7457,7457,7457,9035,9035,9035,9035,9035,9035,9035,9035,9035,9035,9035,9035,9035,27bc2cfc-fefb-4b50-a0dc-6268c69b4902,safety and effectiveness of rizatriptan benzoate tablets have not been established for cluster headache,0
7458,7458,7458,7458,7458,7458,7458,9036,9036,9036,9036,9036,9036,9036,9036,9036,9036,9036,9036,9036,27bc2cfc-fefb-4b50-a0dc-6268c69b4902,rizatriptan benzoate is a serotonin ( 5 ht ) 1b 1d receptor agonist ( triptan ) indicated for the acute treatment of migraine with or without aura in adults and in pediatric patients 6 to 17 years of age ( 1 ) limitations of use use only after clear diagnosis of migraine has been established ( 1 ) not indicated for the prophylactic therapy of migraine ( 1 ) not indicated for the treatment of cluster headache ( 1 ),1
7459,7459,7459,7459,7459,7459,7459,9037,9037,9037,9037,9037,9037,9037,9037,9037,9037,9037,9037,9037,ebb177c0-d45d-4443-a85a-e76bd9931a42, dyrenium ( triamterene ) is indicated in the treatment of edema associated with congestive heart failure  cirrhosis of the liver and the nephrotic syndrome steroid induced edema  idiopathic edema and edema due to secondary hyperaldosteronism,1
7460,7460,7460,7460,7460,7460,7460,9038,9038,9038,9038,9038,9038,9038,9038,9038,9038,9038,9038,9038,ebb177c0-d45d-4443-a85a-e76bd9931a42,dyrenium may be used alone or with other diuretics  either for its added diuretic effect or its potassium sparing potential,4
7461,7461,7461,7461,7461,7461,7461,9039,9039,9039,9039,9039,9039,9039,9039,9039,9039,9039,9039,9039,ebb177c0-d45d-4443-a85a-e76bd9931a42,it also promotes increased diuresis when patients prove resistant or only partially responsive to thiazides or other diuretics because of secondary hyperaldosteronism,u
7462,7462,7462,7462,7462,7462,7462,9040,9040,9040,9040,9040,9040,9040,9040,9040,9040,9040,9040,9040,ebb177c0-d45d-4443-a85a-e76bd9931a42,the routine use of diuretics in an otherwise healthy woman is inappropriate and exposes mother and fetus to unnecessary hazard,2
7463,7463,7463,7463,7463,7463,7463,9043,9043,9043,9043,9043,9043,9043,9043,9043,9043,9043,9043,9043,ebb177c0-d45d-4443-a85a-e76bd9931a42,diuretics are indicated in pregnancy ( however  see precautions below ) when edema is due to pathologic causes  just as they are in the absence of pregnancy,1
7464,7464,7464,7464,7464,7464,7464,9049,9049,9049,9049,9049,9049,9049,9049,9049,9049,9049,9049,9049,ae6af35a-b7b4-4520-ac40-8e4a6eb80bb1, chlorpropamide tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus,1
7465,7465,7465,7465,7465,7465,7465,9050,9050,9050,9050,9050,9050,9050,9050,9050,9050,9050,9050,9050,463050bd-2b1c-40f5-b3c3-0a04bb433309,1  trulicity is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus,1
7466,7466,7466,7466,7466,7466,7466,9051,9051,9051,9051,9051,9051,9051,9051,9051,9051,9051,9051,9051,463050bd-2b1c-40f5-b3c3-0a04bb433309,trulicity is a glucagon like peptide 1 ( glp 1 ) receptor agonist indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus,1
7467,7467,7467,7467,7467,7467,7467,9052,9052,9052,9052,9052,9052,9052,9052,9052,9052,9052,9052,9052,463050bd-2b1c-40f5-b3c3-0a04bb433309,limitations of use not recommended as first line therapy for patients inadequately controlled on diet and exercise ( 1 1  5 1 ),0
7468,7468,7468,7468,7468,7468,7468,9056,9056,9056,9056,9056,9056,9056,9056,9056,9056,9056,9056,9056,463050bd-2b1c-40f5-b3c3-0a04bb433309,not for patients with pre existing severe gastrointestinal disease,2
7469,7469,7469,7469,7469,7469,7469,9057,9057,9057,9057,9057,9057,9057,9057,9057,9057,9057,9057,9057,463050bd-2b1c-40f5-b3c3-0a04bb433309,1 1 limitations of use trulicity is not recommended as a first line therapy for patients who have inadequate glycemic control on diet and exercise because of the uncertain relevance of rodent c cell tumor findings to humans,2
7470,7470,7470,7470,7470,7470,7470,9058,9058,9058,9058,9058,9058,9058,9058,9058,9058,9058,9058,9058,463050bd-2b1c-40f5-b3c3-0a04bb433309,prescribe trulicity only to patients for whom the potential benefits outweigh the potential risk see warnings and precautions ( 5 1 ),0
7471,7471,7471,7471,7471,7471,7471,9059,9059,9059,9059,9059,9059,9059,9059,9059,9059,9059,9059,9059,463050bd-2b1c-40f5-b3c3-0a04bb433309,trulicity has not been studied in patients with a history of pancreatitis see warnings and precautions ( 5 2 ),0
7472,7472,7472,7472,7472,7472,7472,9061,9061,9061,9061,9061,9061,9061,9061,9061,9061,9061,9061,9061,463050bd-2b1c-40f5-b3c3-0a04bb433309,trulicity should not be used in patients with type 1 diabetes mellitus or for the treatment of diabetic ketoacidosis,2
7473,7473,7473,7473,7473,7473,7473,9062,9062,9062,9062,9062,9062,9062,9062,9062,9062,9062,9062,9062,463050bd-2b1c-40f5-b3c3-0a04bb433309,trulicity is not a substitute for insulin,2
7474,7474,7474,7474,7474,7474,7474,9063,9063,9063,9063,9063,9063,9063,9063,9063,9063,9063,9063,9063,463050bd-2b1c-40f5-b3c3-0a04bb433309,trulicity has not been studied in patients with severe gastrointestinal disease  including severe gastroparesis,0
7475,7475,7475,7475,7475,7475,7475,9064,9064,9064,9064,9064,9064,9064,9064,9064,9064,9064,9064,9064,463050bd-2b1c-40f5-b3c3-0a04bb433309,the use of trulicity is not recommended in patients with pre existing severe gastrointestinal disease see warnings and precautions ( 5 6 ),2
7476,7476,7476,7476,7476,7476,7476,9065,9065,9065,9065,9065,9065,9065,9065,9065,9065,9065,9065,9065,f305b18b-8506-4414-87a1-10aa3b76a691, for the short term reduction of intraocular pressure,1
7477,7477,7477,7477,7477,7477,7477,9066,9066,9066,9066,9066,9066,9066,9066,9066,9066,9066,9066,9066,f305b18b-8506-4414-87a1-10aa3b76a691,may be used prior to and after intraocular surgery,1
7478,7478,7478,7478,7478,7478,7478,9067,9067,9067,9067,9067,9067,9067,9067,9067,9067,9067,9067,9067,f305b18b-8506-4414-87a1-10aa3b76a691,may be used to interrupt an acute attack of glaucoma,1
7479,7479,7479,7479,7479,7479,7479,9068,9068,9068,9068,9068,9068,9068,9068,9068,9068,9068,9068,9068,"Active Ingredient UNII(s)
WYQ7N0BPYC    c90fca12-12fb-4cf6-bd6f-83bc0d95df81
WYQ7N0BPYC    c90fca12-12fb-4cf6-bd6f-83bc0d95df81
Name: SET ID dtype: object",active ingredient unii ( s ) wyq7n0bpyc active ingredient unii ( s ) wyq7n0bpyc active in wyq7n0bpyc active ingredient unii ( s ) wyq7n0bpyc active in name content xml  dtype object,0
7480,7480,7480,7480,7480,7480,7480,9070,9070,9070,9070,9070,9070,9070,9070,9070,9070,9070,9070,9070,ba44e7d8-0c71-4eb9-a951-3d91038293c5,1  sancuso ( granisetron transdermal system ) is indicated for the prevention of nausea and vomiting in patients receiving moderately and or highly emetogenic chemotherapy regimens of up to 5 consecutive days duration,1
7481,7481,7481,7481,7481,7481,7481,9071,9071,9071,9071,9071,9071,9071,9071,9071,9071,9071,9071,9071,ba44e7d8-0c71-4eb9-a951-3d91038293c5,sancuso is a serotonin 3 ( 5 ht3 ) receptor antagonist indicated for the prevention of nausea and vomiting in patients receiving moderately and or highly emetogenic chemotherapy for up to 5 consecutive days,1
7482,7482,7482,7482,7482,7482,7482,9072,9072,9072,9072,9072,9072,9072,9072,9072,9072,9072,9072,9072,6eeb7bf1-cfd6-4574-94bb-ff69ec91359f,used as a softener for nail grooves,1
7483,7483,7483,7483,7483,7483,7483,9073,9073,9073,9073,9073,9073,9073,9073,9073,9073,9073,9073,9073,6eeb7bf1-cfd6-4574-94bb-ff69ec91359f,also used as a slide medium in potassium hydroxide preparations,1
7484,7484,7484,7484,7484,7484,7484,9074,9074,9074,9074,9074,9074,9074,9074,9074,9074,9074,9074,9074,8852dd44-098c-4d99-88e0-a092a8e08e11,indication and usage dibenzyline is indicated in the treatment of pheochromocytoma  to control episodes of hypertension and sweating,1
7485,7485,7485,7485,7485,7485,7485,9075,9075,9075,9075,9075,9075,9075,9075,9075,9075,9075,9075,9075,8852dd44-098c-4d99-88e0-a092a8e08e11,if tachycardia is excessive  it may be necessary to use a beta blocking agent concomitantly,0
7486,7486,7486,7486,7486,7486,7486,9076,9076,9076,9076,9076,9076,9076,9076,9076,9076,9076,9076,9076,135f85e2-f000-4ef1-98a5-9bf0ab55d2c0,1  morphine sulfate tablets contain morphine  an opioid analgesic  indicated for the relief of moderate to severe acute and chronic pain where use of an opioid analgesic is appropriate,1
7487,7487,7487,7487,7487,7487,7487,9077,9077,9077,9077,9077,9077,9077,9077,9077,9077,9077,9077,9077,135f85e2-f000-4ef1-98a5-9bf0ab55d2c0,morphine sulfate is an opioid analgesic indicated for the relief of moderate to severe acute and chronic pain where an opioid analgesic is appropriate,1
7488,7488,7488,7488,7488,7488,7488,9078,9078,9078,9078,9078,9078,9078,9078,9078,9078,9078,9078,9078,dfe97a3d-247d-4dda-a641-1a95196cd8d8,1 embeda is an extended release oral formulation of morphine sulfate and naltrexone hydrochloride indicated for the management of moderate to severe pain when a continuous  around the clock opioid analgesic is needed for an extended period of time,1
7489,7489,7489,7489,7489,7489,7489,9079,9079,9079,9079,9079,9079,9079,9079,9079,9079,9079,9079,9079,dfe97a3d-247d-4dda-a641-1a95196cd8d8,embeda is not intended for use as a prn analgesic,0
7490,7490,7490,7490,7490,7490,7490,9080,9080,9080,9080,9080,9080,9080,9080,9080,9080,9080,9080,9080,dfe97a3d-247d-4dda-a641-1a95196cd8d8,embeda is not indicated for acute postoperative pain or if the pain is mild or not expected to persist for an extended period of time,2
7491,7491,7491,7491,7491,7491,7491,9081,9081,9081,9081,9081,9081,9081,9081,9081,9081,9081,9081,9081,dfe97a3d-247d-4dda-a641-1a95196cd8d8,embeda is only indicated for postoperative use if the patient is already receiving chronic opioid therapy prior to surgery or if the postoperative pain is expected to be moderate to severe and persist for an extended period of time,1
7492,7492,7492,7492,7492,7492,7492,9082,9082,9082,9082,9082,9082,9082,9082,9082,9082,9082,9082,9082,dfe97a3d-247d-4dda-a641-1a95196cd8d8,physicians should individualize treatment  moving from parenteral to oral analgesics as appropriate,4
7493,7493,7493,7493,7493,7493,7493,9083,9083,9083,9083,9083,9083,9083,9083,9083,9083,9083,9083,9083,5eb971be-8808-4aeb-9898-0d22d5dffe04, xenon xe 133 gas has been shown to be valuable for diagnostic inhalation studies for the evaluation of pulmonary function  for imaging the lungs and may also be applied to assessment of cerebral blood flow,1
7494,7494,7494,7494,7494,7494,7494,9084,9084,9084,9084,9084,9084,9084,9084,9084,9084,9084,9084,9084,c82a64f6-6f69-41b4-aaa9-325098164dbe, herpes zoster infections acyclovir tablets are indicated for the acute treatment of herpes zoster ( shingles ),1
7495,7495,7495,7495,7495,7495,7495,9085,9085,9085,9085,9085,9085,9085,9085,9085,9085,9085,9085,9085,c82a64f6-6f69-41b4-aaa9-325098164dbe,genital herpes acyclovir tablets are indicated for the treatment of initial episodes and the management of recurrent episodes of genital herpes,1
7496,7496,7496,7496,7496,7496,7496,9086,9086,9086,9086,9086,9086,9086,9086,9086,9086,9086,9086,9086,c82a64f6-6f69-41b4-aaa9-325098164dbe,chickenpox acyclovir tablets are indicated for the treatment of chickenpox ( varicella ),1
7497,7497,7497,7497,7497,7497,7497,9087,9087,9087,9087,9087,9087,9087,9087,9087,9087,9087,9087,9087,e4c45bb5-15f4-437e-ab98-a649b3676d14,1  juxtapid is a microsomal triglyceride transfer protein inhibitor indicated as an adjunct to a low fat diet and other lipid lowering treatments  including ldl apheresis where available  to reduce low density lipoprotein cholesterol ( ldl c )  total cholesterol ( tc )  apolipoprotein b ( apo b )  and non high density lipoprotein cholesterol ( non hdl c ) in patients with homozygous familial hypercholesterolemia ( hofh ) ( 1 ),1
7498,7498,7498,7498,7498,7498,7498,9088,9088,9088,9088,9088,9088,9088,9088,9088,9088,9088,9088,9088,e4c45bb5-15f4-437e-ab98-a649b3676d14,limitations of use the safety and effectiveness of juxtapid have not been established in patients with hypercholesterolemia who do not have hofh  including those with heterozygous familial hypercholesterolemia ( hefh ) ( 1 ),0
7499,7499,7499,7499,7499,7499,7499,9089,9089,9089,9089,9089,9089,9089,9089,9089,9089,9089,9089,9089,e4c45bb5-15f4-437e-ab98-a649b3676d14,the effect of juxtapid on cardiovascular morbidity and mortality has not been determined ( 1 ),0
7500,7500,7500,7500,7500,7500,7500,9090,9090,9090,9090,9090,9090,9090,9090,9090,9090,9090,9090,9090,e4c45bb5-15f4-437e-ab98-a649b3676d14,1 1 homozygous familial hypercholesterolemia juxtapid is indicated as an adjunct to a low fat diet and other lipid lowering treatments  including ldl apheresis where available  to reduce low density lipoprotein cholesterol ( ldl c )  total cholesterol ( tc )  apolipoprotein b ( apo b )  and non high density lipoprotein cholesterol ( non hdl c ) in patients with homozygous familial hypercholesterolemia ( hofh ),1
7501,7501,7501,7501,7501,7501,7501,9091,9091,9091,9091,9091,9091,9091,9091,9091,9091,9091,9091,9091,e4c45bb5-15f4-437e-ab98-a649b3676d14,limitations of use the safety and effectiveness of juxtapid have not been established in patients with hypercholesterolemia who do not have hofh  including those with heterozygous familial hypercholesterolemia ( hefh ),0
7502,7502,7502,7502,7502,7502,7502,9092,9092,9092,9092,9092,9092,9092,9092,9092,9092,9092,9092,9092,e4c45bb5-15f4-437e-ab98-a649b3676d14,the effect of juxtapid on cardiovascular morbidity and mortality has not been determined,0
7503,7503,7503,7503,7503,7503,7503,9093,9093,9093,9093,9093,9093,9093,9093,9093,9093,9093,9093,9093,63f60426-e27f-4258-9bfc-b4a15ebdca83, factive is indicated for the treatment of infections caused by susceptible strains of the designated microorganisms in the conditions listed below,1
7504,7504,7504,7504,7504,7504,7504,9094,9094,9094,9094,9094,9094,9094,9094,9094,9094,9094,9094,9094,63f60426-e27f-4258-9bfc-b4a15ebdca83,( see dosage and administration and clinical studies ),0
7505,7505,7505,7505,7505,7505,7505,9095,9095,9095,9095,9095,9095,9095,9095,9095,9095,9095,9095,9095,63f60426-e27f-4258-9bfc-b4a15ebdca83,acute bacterial exacerbation of chronic bronchitis ( abecb ) caused by streptococcus pneumoniae  haemophilus influenzae  haemophilus parainfluenzae  or moraxella catarrhalis,1
7506,7506,7506,7506,7506,7506,7506,9096,9096,9096,9096,9096,9096,9096,9096,9096,9096,9096,9096,9096,63f60426-e27f-4258-9bfc-b4a15ebdca83,because fluoroquinolones  including factive  have been associated with serious adverse reactions ( see warnings ) and for some patients abecb is self limiting  reserve factive for treatment of abecb in patients who have no alternative treatment options,u
7507,7507,7507,7507,7507,7507,7507,9097,9097,9097,9097,9097,9097,9097,9097,9097,9097,9097,9097,9097,63f60426-e27f-4258-9bfc-b4a15ebdca83,community acquired pneumonia ( of mild to moderate severity ) caused by streptococcus pneumoniae ( including multi drug resistant strains mdrsp )  haemophilus influenzae  moraxella catarrhalis  mycoplasma pneumoniae  chlamydia pneumoniae  or klebsiella pneumoniae,1
7508,7508,7508,7508,7508,7508,7508,9098,9098,9098,9098,9098,9098,9098,9098,9098,9098,9098,9098,9098,63f60426-e27f-4258-9bfc-b4a15ebdca83,mdrsp multi drug resistant streptococcus pneumoniae  includes isolates previously known as prsp ( penicillin resistant streptococcus pneumoniae )  and are strains resistant to two or more of the following antibiotics penicillin ( mic 2 g ml )  2nd generation cephalosporins ( e g  cefuroxime )  macrolides  tetracyclines and trimethoprim sulfamethoxazole,1
7509,7509,7509,7509,7509,7509,7509,9099,9099,9099,9099,9099,9099,9099,9099,9099,9099,9099,9099,9099,63f60426-e27f-4258-9bfc-b4a15ebdca83,to reduce the development of drug resistant bacteria and maintain the effectiveness of factive and other antibacterial drugs  factive should be used only to treat infections that are proven or strongly suspected to be caused by susceptible bacteria,4
7510,7510,7510,7510,7510,7510,7510,9102,9102,9102,9102,9102,9102,9102,9102,9102,9102,9102,9102,9102,4c0dd824-b099-47c3-aaf5-f6ddb873b3ee, medrol tablets are indicated in the following conditions 1,0
7511,7511,7511,7511,7511,7511,7511,9105,9105,9105,9105,9105,9105,9105,9105,9105,9105,9105,9105,9105,4c0dd824-b099-47c3-aaf5-f6ddb873b3ee,rheumatic disorders as adjunctive therapy for short term administration ( to tide the patient over an acute episode or exacerbation ) in rheumatoid arthritis  including juvenile rheumatoid arthritis ( selected cases may require low dose maintenance therapy ) ankylosing spondylitis acute and subacute bursitis synovitis of osteoarthritis acute nonspecific tenosynovitis post traumatic osteoarthritis psoriatic arthritis epicondylitis acute gouty arthritis 3,1
7512,7512,7512,7512,7512,7512,7512,9106,9106,9106,9106,9106,9106,9106,9106,9106,9106,9106,9106,9106,4c0dd824-b099-47c3-aaf5-f6ddb873b3ee,collagen diseases during an exacerbation or as maintenance therapy in selected cases of systemic lupus erythematosus systemic dermatomyositis ( polymyositis ) acute rheumatic carditis 4,1
7513,7513,7513,7513,7513,7513,7513,9107,9107,9107,9107,9107,9107,9107,9107,9107,9107,9107,9107,9107,4c0dd824-b099-47c3-aaf5-f6ddb873b3ee,dermatologic diseases bullous dermatitis herpetiformis severe erythema multiforme ( stevens johnson syndrome ) severe seborrheic dermatitis exfoliative dermatitis mycosis fungoides pemphigus severe psoriasis 5,1
7514,7514,7514,7514,7514,7514,7514,9108,9108,9108,9108,9108,9108,9108,9108,9108,9108,9108,9108,9108,4c0dd824-b099-47c3-aaf5-f6ddb873b3ee,allergic states control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment seasonal or perennial allergic rhinitis drug hypersensitivity reactions serum sickness contact dermatitis bronchial asthma atopic dermatitis 6,1
7515,7515,7515,7515,7515,7515,7515,9109,9109,9109,9109,9109,9109,9109,9109,9109,9109,9109,9109,9109,4c0dd824-b099-47c3-aaf5-f6ddb873b3ee,ophthalmic diseases severe acute and chronic allergic and inflammatory processes involving the eye and its adnexa such as allergic corneal marginal ulcers herpes zoster ophthalmicus anterior segment inflammation diffuse posterior uveitis and choroiditis sympathetic ophthalmia keratitis optic neuritis allergic conjunctivitis chorior,1
7516,7516,7516,7516,7516,7516,7516,9110,9110,9110,9110,9110,9110,9110,9110,9110,9110,9110,9110,9110,ae8e299c-4003-4ccf-badc-fb665a997b20, loxapine capsules are indicated for the treatment of schizophrenia,1
7517,7517,7517,7517,7517,7517,7517,9111,9111,9111,9111,9111,9111,9111,9111,9111,9111,9111,9111,9111,ae8e299c-4003-4ccf-badc-fb665a997b20,the efficacy of loxapine in schizophrenia was established in clinical studies which enrolled newly hospitalized and chronically hospitalized acutely ill schizophrenic patients as subjects,0
7518,7518,7518,7518,7518,7518,7518,9112,9112,9112,9112,9112,9112,9112,9112,9112,9112,9112,9112,9112,f103f7e8-1253-43cb-9667-cd0d8f4d5500,1  flector patch is indicated for the topical treatment of acute pain due to minor strains  sprains  and contusions,1
7519,7519,7519,7519,7519,7519,7519,9113,9113,9113,9113,9113,9113,9113,9113,9113,9113,9113,9113,9113,f103f7e8-1253-43cb-9667-cd0d8f4d5500,flector patch contains diclofenac epolamine  a nonsteroidal anti inflammatory drug ( nsaid )  and is indicated for the topical treatment of acute pain due to minor strains  sprains  and contusions,1
7520,7520,7520,7520,7520,7520,7520,9114,9114,9114,9114,9114,9114,9114,9114,9114,9114,9114,9114,9114,9ec59262-35c1-4d8e-8451-a7cfbacb0675,1  babybig  botulism immune globulin intravenous ( human )  is indicated for the treatment of infant botulism caused by toxin type a or b in patients below one year of age,1
7521,7521,7521,7521,7521,7521,7521,9115,9115,9115,9115,9115,9115,9115,9115,9115,9115,9115,9115,9115,9ec59262-35c1-4d8e-8451-a7cfbacb0675,babybig is an immune globulin intravenous ( human ) indicated for treatment of infant botulism caused by toxin types a or b in patients below one year of age ( 1 ),1
7522,7522,7522,7522,7522,7522,7522,9116,9116,9116,9116,9116,9116,9116,9116,9116,9116,9116,9116,9116,dae7d51e-c117-4c8a-b018-45b01ae46100, since no drug is innocuous  strict attention should be paid to the indications and contraindications  particularly when selecting drugs for chronic long term use,0
7523,7523,7523,7523,7523,7523,7523,9117,9117,9117,9117,9117,9117,9117,9117,9117,9117,9117,9117,9117,dae7d51e-c117-4c8a-b018-45b01ae46100,colestipol hydrochloride tablets are indicated as adjunctive therapy to diet for the reduction of elevated serum total and ldl c in patients with primary hypercholesterolemia ( elevated ldl c ) who do not respond adequately to diet,1
7524,7524,7524,7524,7524,7524,7524,9118,9118,9118,9118,9118,9118,9118,9118,9118,9118,9118,9118,9118,dae7d51e-c117-4c8a-b018-45b01ae46100,generally  colestipol hydrochloride tablets have no clinically significant effect on serum triglycerides  but with their use  triglyceride levels may be raised in some patients,0
7525,7525,7525,7525,7525,7525,7525,9119,9119,9119,9119,9119,9119,9119,9119,9119,9119,9119,9119,9119,dae7d51e-c117-4c8a-b018-45b01ae46100,therapy with lipid altering agents should be a component of multiple risk factor intervention in those individuals at significantly increased risk for atherosclerotic vascular disease due to hypercholesterolemia,0
7526,7526,7526,7526,7526,7526,7526,9120,9120,9120,9120,9120,9120,9120,9120,9120,9120,9120,9120,9120,dae7d51e-c117-4c8a-b018-45b01ae46100,treatment should begin and continue with dietary therapy ( see ncep guidelines ),0
7527,7527,7527,7527,7527,7527,7527,9121,9121,9121,9121,9121,9121,9121,9121,9121,9121,9121,9121,9121,dae7d51e-c117-4c8a-b018-45b01ae46100,a minimum of six months of intensive dietary therapy and counseling should be carried out prior to initiation of drug therapy,4
7528,7528,7528,7528,7528,7528,7528,9122,9122,9122,9122,9122,9122,9122,9122,9122,9122,9122,9122,9122,dae7d51e-c117-4c8a-b018-45b01ae46100,shorter periods may be considered in patients with severe elevations of ldl c or with definite chd,0
7529,7529,7529,7529,7529,7529,7529,9123,9123,9123,9123,9123,9123,9123,9123,9123,9123,9123,9123,9123,dae7d51e-c117-4c8a-b018-45b01ae46100,according to the ncep guidelines  the goal of treatment is to lower ldl c  and ldl c is to be used to initiate and assess treatment response,0
7530,7530,7530,7530,7530,7530,7530,9124,9124,9124,9124,9124,9124,9124,9124,9124,9124,9124,9124,9124,dae7d51e-c117-4c8a-b018-45b01ae46100,only if ldl c levels are not available  should the total c be used to monitor therapy,0
7531,7531,7531,7531,7531,7531,7531,9125,9125,9125,9125,9125,9125,9125,9125,9125,9125,9125,9125,9125,dae7d51e-c117-4c8a-b018-45b01ae46100,the ncep treatment guidelines are shown below,0
7532,7532,7532,7532,7532,7532,7532,9126,9126,9126,9126,9126,9126,9126,9126,9126,9126,9126,9126,9126,dae7d51e-c117-4c8a-b018-45b01ae46100,ldl cholesterol mg dl ( mmol l ) definite atherosclerotic diseasecoronary heart disease or peripheral vascular disease ( including symptomatic carotid artery disease ),
7533,7533,7533,7533,7533,7533,7533,9127,9127,9127,9127,9127,9127,9127,9127,9127,9127,9127,9127,9127,dae7d51e-c117-4c8a-b018-45b01ae46100,two or more other risk factorsother risk factors for coronary heart disease ( chd ) include age ( males 45 years female 55 years or premature menopause without estrogen replacement therapy ) family history of premature chd current cigarette smoking hypertension confirmed hdl c 35 mg dl ( 0 91 mmol l ) and diabetes mellitus,u
7534,7534,7534,7534,7534,7534,7534,9128,9128,9128,9128,9128,9128,9128,9128,9128,9128,9128,9128,9128,dae7d51e-c117-4c8a-b018-45b01ae46100,subtract one risk factor if hdl c is 60 mg dl ( 1 6 mmol l ),0
7535,7535,7535,7535,7535,7535,7535,9129,9129,9129,9129,9129,9129,9129,9129,9129,9129,9129,9129,9129,dae7d51e-c117-4c8a-b018-45b01ae46100,initiation level goal no no 190 ( 4 9 ) 160 ( 4 1 ) no yes 160 ( 4 1 ) 130 ( 3 4 ) yes yes or no 130 ( 3 4 ) 100 ( 2 6 ),0
7536,7536,7536,7536,7536,7536,7536,9130,9130,9130,9130,9130,9130,9130,9130,9130,9130,9130,9130,9130,f9a73185-88de-4d7b-b3c0-bbf231483241,1  zyprexa relprevv is available only through a restricted distribution program see warnings and precautions ( 5 2 ),0
7537,7537,7537,7537,7537,7537,7537,9131,9131,9131,9131,9131,9131,9131,9131,9131,9131,9131,9131,9131,f9a73185-88de-4d7b-b3c0-bbf231483241,zyprexa relprevv must not be dispensed directly to a patient,4
7538,7538,7538,7538,7538,7538,7538,9132,9132,9132,9132,9132,9132,9132,9132,9132,9132,9132,9132,9132,f9a73185-88de-4d7b-b3c0-bbf231483241,for a patient to receive treatment  the prescriber  healthcare facility  patient  and pharmacy must all be enrolled in the zyprexa relprevv patient care program,4
7539,7539,7539,7539,7539,7539,7539,9133,9133,9133,9133,9133,9133,9133,9133,9133,9133,9133,9133,9133,f9a73185-88de-4d7b-b3c0-bbf231483241,to enroll  call 1 877 772 9390,0
7540,7540,7540,7540,7540,7540,7540,9134,9134,9134,9134,9134,9134,9134,9134,9134,9134,9134,9134,9134,f9a73185-88de-4d7b-b3c0-bbf231483241,zyprexa relprevv is a long acting atypical antipsychotic for intramuscular injection indicated for the treatment of schizophrenia,1
7541,7541,7541,7541,7541,7541,7541,9135,9135,9135,9135,9135,9135,9135,9135,9135,9135,9135,9135,9135,f9a73185-88de-4d7b-b3c0-bbf231483241,( 1 1 ) efficacy was established in two clinical trials in patients with schizophrenia one 8 week trial in adults and one maintenance trial in adults,0
7542,7542,7542,7542,7542,7542,7542,9136,9136,9136,9136,9136,9136,9136,9136,9136,9136,9136,9136,9136,f9a73185-88de-4d7b-b3c0-bbf231483241,( 14 1 ) 1 1 schizophrenia zyprexa relprevv is indicated for the treatment of schizophrenia,1
7543,7543,7543,7543,7543,7543,7543,9137,9137,9137,9137,9137,9137,9137,9137,9137,9137,9137,9137,9137,f9a73185-88de-4d7b-b3c0-bbf231483241,efficacy was established in two clinical trials in patients with schizophrenia one 8 week trial in adults and one maintenance trial in adults see clinical studies ( 14 1 ),0
7544,7544,7544,7544,7544,7544,7544,9138,9138,9138,9138,9138,9138,9138,9138,9138,9138,9138,9138,9138,572d928c-cb5c-4016-9b0c-6c5ff80f4168, glipizide tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus,1
7545,7545,7545,7545,7545,7545,7545,9139,9139,9139,9139,9139,9139,9139,9139,9139,9139,9139,9139,9139,a5cf75d2-322e-4767-9204-4aaa0889d7db, abciximab is indicated as an adjunct to percutaneous coronary intervention for the prevention of cardiac ischemic complications in patients undergoing percutaneous coronary intervention in patients with unstable angina not responding to conventional medical therapy when percutaneous coronary intervention is planned within 24 hours safety and efficacy of abciximab use in patients not undergoing percutaneous coronary intervention have not been established,1
7546,7546,7546,7546,7546,7546,7546,9140,9140,9140,9140,9140,9140,9140,9140,9140,9140,9140,9140,9140,a5cf75d2-322e-4767-9204-4aaa0889d7db,abciximab is intended for use with aspirin and heparin and has been studied only in that setting  as described in clinical studies,1
7547,7547,7547,7547,7547,7547,7547,9141,9141,9141,9141,9141,9141,9141,9141,9141,9141,9141,9141,9141,703d347c-e240-408a-b69d-9713e958a201, technetium tc 99m medronate injection may be used as a bone imaging agent to delineate areas of altered osteogenesis,1
7548,7548,7548,7548,7548,7548,7548,9142,9142,9142,9142,9142,9142,9142,9142,9142,9142,9142,9142,9142,485ab3c5-0359-4878-872f-2fe1e7df4047,1  brineura is indicated to slow the loss of ambulation in symptomatic pediatric patients 3 years of age and older with late infantile neuronal ceroid lipofuscinosis type 2 ( cln2 )  also known as tripeptidyl peptidase 1 ( tpp1 ) deficiency,1
7549,7549,7549,7549,7549,7549,7549,9143,9143,9143,9143,9143,9143,9143,9143,9143,9143,9143,9143,9143,485ab3c5-0359-4878-872f-2fe1e7df4047,brineura is a hydrolytic lysosomal n terminal tripeptidyl peptidase indicated to slow the loss of ambulation in symptomatic pediatric patients 3 years of age and older with late infantile neuronal ceroid lipofuscinosis type 2 ( cln2 )  also known as tripeptidyl peptidase 1 ( tpp1 ) deficiency,1
7550,7550,7550,7550,7550,7550,7550,9144,9144,9144,9144,9144,9144,9144,9144,9144,9144,9144,9144,9144,81ffe61c-2b0c-4a56-b02b-8463300e218e, for temporary relief of symptoms related to tyramine sensitivity including food cravings  muscle spasm  headache  high blood pressure  excessive sweating  weight loss  fatigue  nervousness  agitation and vasodilation,1
7551,7551,7551,7551,7551,7551,7551,9145,9145,9145,9145,9145,9145,9145,9145,9145,9145,9145,9145,9145,30d4c387-b99c-49f8-a8bd-de23fdafb739, before the initial therapeutic administration of stimate nasal spray  the physician should establish that the patient shows an appropriate change in the coagulation profile following a test dose of intranasal administration of stimate nasal spray,4
7552,7552,7552,7552,7552,7552,7552,9146,9146,9146,9146,9146,9146,9146,9146,9146,9146,9146,9146,9146,30d4c387-b99c-49f8-a8bd-de23fdafb739,desmopressin acetate is also available as a solution for injection ( ddavp injection ) when the intranasal route may be compromised,4
7553,7553,7553,7553,7553,7553,7553,9147,9147,9147,9147,9147,9147,9147,9147,9147,9147,9147,9147,9147,30d4c387-b99c-49f8-a8bd-de23fdafb739,these situations include nasal congestion and blockage  nasal discharge  atrophy of nasal mucosa  and severe atrophic rhinitis,u
7554,7554,7554,7554,7554,7554,7554,9148,9148,9148,9148,9148,9148,9148,9148,9148,9148,9148,9148,9148,30d4c387-b99c-49f8-a8bd-de23fdafb739,intranasal delivery may also be inappropriate where there is an impaired level of consciousness,0
7555,7555,7555,7555,7555,7555,7555,9149,9149,9149,9149,9149,9149,9149,9149,9149,9149,9149,9149,9149,30d4c387-b99c-49f8-a8bd-de23fdafb739,hemophilia a stimate nasal spray is indicated for patients with hemophilia a with factor viii coagulant activity levels greater than 5,1
7556,7556,7556,7556,7556,7556,7556,9150,9150,9150,9150,9150,9150,9150,9150,9150,9150,9150,9150,9150,30d4c387-b99c-49f8-a8bd-de23fdafb739,desmopressin acetate will also stop bleeding in patients with hemophilia a with episodes of spontaneous or trauma induced injuries such as hemarthroses  intramuscular hematomas or mucosal bleeding,1
7557,7557,7557,7557,7557,7557,7557,9151,9151,9151,9151,9151,9151,9151,9151,9151,9151,9151,9151,9151,30d4c387-b99c-49f8-a8bd-de23fdafb739,in the outpatient setting during two clinical trials where patients recorded bleeding episodes  stimate nasal spray provided effective hemostasis 100 of the time in 2 of the 5 patients,0
7558,7558,7558,7558,7558,7558,7558,9152,9152,9152,9152,9152,9152,9152,9152,9152,9152,9152,9152,9152,30d4c387-b99c-49f8-a8bd-de23fdafb739,for those patients not responding in 100 of bleeding occasions  45 ( 14 of 31 ) of bleeding episodes were effectively controlled with stimate nasal spray,0
7559,7559,7559,7559,7559,7559,7559,9153,9153,9153,9153,9153,9153,9153,9153,9153,9153,9153,9153,9153,30d4c387-b99c-49f8-a8bd-de23fdafb739,desmopressin acetate is not indicated for the treatment of hemophilia a with factor viii coagulant activity levels equal to or less than 5  or for the treatment of hemophilia b  or in patients who have factor viii antibodies,2
7560,7560,7560,7560,7560,7560,7560,9154,9154,9154,9154,9154,9154,9154,9154,9154,9154,9154,9154,9154,30d4c387-b99c-49f8-a8bd-de23fdafb739,von willebrand 's disease ( type i ) stimate nasal spray is indicated for patients with mild to moderate classic von willebrand 's disease ( type i ) with factor viii levels greater than 5,1
7561,7561,7561,7561,7561,7561,7561,9155,9155,9155,9155,9155,9155,9155,9155,9155,9155,9155,9155,9155,30d4c387-b99c-49f8-a8bd-de23fdafb739,desmopressin acetate will also stop bleeding in mild to moderate von willebrand 's disease patients with episodes of spontaneous or trauma induced injuries such as hemarthroses  intramuscular hematomas  mucosal bleeding or menorrhagia,1
7562,7562,7562,7562,7562,7562,7562,9156,9156,9156,9156,9156,9156,9156,9156,9156,9156,9156,9156,9156,30d4c387-b99c-49f8-a8bd-de23fdafb739,in the outpatient setting during two clinical trials where patients recorded bleeding episodes  stimate nasal spray provided effective hemostasis 100 of the time in 75 of the patients 106 ( n 16 ),0
7563,7563,7563,7563,7563,7563,7563,9157,9157,9157,9157,9157,9157,9157,9157,9157,9157,9157,9157,9157,30d4c387-b99c-49f8-a8bd-de23fdafb739,for those patients not responding in 100 of bleeding occasions  78 ( 64 of 82 ) of bleeding episodes were effectively controlled with stimate nasal spray,0
7564,7564,7564,7564,7564,7564,7564,9158,9158,9158,9158,9158,9158,9158,9158,9158,9158,9158,9158,9158,30d4c387-b99c-49f8-a8bd-de23fdafb739,patients may respond in a variable fashion depending on the type of molecular defect they have,0
7565,7565,7565,7565,7565,7565,7565,9159,9159,9159,9159,9159,9159,9159,9159,9159,9159,9159,9159,9159,30d4c387-b99c-49f8-a8bd-de23fdafb739,bleeding time and factor viii coagulant activity  ristocetin cofactor activity  and von willebrand factor antigen should be checked after initial administration of stimate nasal spray to ensure that adequate levels have been achieved,4
7566,7566,7566,7566,7566,7566,7566,9160,9160,9160,9160,9160,9160,9160,9160,9160,9160,9160,9160,9160,30d4c387-b99c-49f8-a8bd-de23fdafb739,stimate nasal spray is not indicated for the treatment of severe classic von willebrand 's disease ( type i ) and when there is evidence of an abnormal molecular form of fac,2
7567,7567,7567,7567,7567,7567,7567,9161,9161,9161,9161,9161,9161,9161,9161,9161,9161,9161,9161,9161,d892a312-12ba-4d32-a840-2c0ff3dc1d58, a hypnotic  for the short term treatment of insomnia  since it appears to lose its effectiveness for sleep induction and sleep maintenance after 2 weeks ( see clinical pharmacology ),1
7568,7568,7568,7568,7568,7568,7568,9162,9162,9162,9162,9162,9162,9162,9162,9162,9162,9162,9162,9162,64a9b51b-c982-4d50-ab58-a5b9029a7602, acd solution modified is to be used in the labeling of red blood cells for intravenous administration with cr 51 sodium chromate,1
7569,7569,7569,7569,7569,7569,7569,9163,9163,9163,9163,9163,9163,9163,9163,9163,9163,9163,9163,9163,1aa75a3a-18c9-49e1-91a6-293d0b7da756, matulane is indicated for use in combination with other anticancer drugs for the treatment of stage iii and iv hodgkin 's disease,1
7570,7570,7570,7570,7570,7570,7570,9164,9164,9164,9164,9164,9164,9164,9164,9164,9164,9164,9164,9164,1aa75a3a-18c9-49e1-91a6-293d0b7da756,matulane is used as part of the mopp ( nitrogen mustard  vincristine  procarbazine  prednisone ) regimen,u
7571,7571,7571,7571,7571,7571,7571,9165,9165,9165,9165,9165,9165,9165,9165,9165,9165,9165,9165,9165,e805e60f-741b-4430-afef-659a0a2b8350,1  hepagam b hepatitis b immune globulin intravenous ( human ) is an intravenous immune globulin indicated for the following for intravenous or intramuscular administration only prevention of hepatitis b recurrence following liver transplantation in hbsag positive liver transplant patients ( 1 1 ),1
7572,7572,7572,7572,7572,7572,7572,9166,9166,9166,9166,9166,9166,9166,9166,9166,9166,9166,9166,9166,e805e60f-741b-4430-afef-659a0a2b8350,postexposure prophylaxis ( 1 2 ) in the following settings acute exposure to blood containing hbsag perinatal exposure of infants born to hbsag positive mothers sexual exposure to hbsag positive persons household exposure to persons with acute hbv infection 1 1 prevention of hepatitis b recurrence following liver transplant in hbsag positive liver transplant patients 1 2 post exposure prophylaxis including acute exposure to hbsag positive blood  plasma  or serum ( parenteral exposure  direct mucus membrane contact  oral ingestion  etc )  perinatal exposure of infants born to hbsag positive mothers  sexual exposure to hbsag positive persons  and household exposure to persons with acute hbv infection,1
7573,7573,7573,7573,7573,7573,7573,9167,9167,9167,9167,9167,9167,9167,9167,9167,9167,9167,9167,9167,f768e337-a948-420a-9fbe-9be359c7a170,1  priftin is a rifamycin antimycobacterial drug indicated in patients 12 years of age and older for the treatment of active pulmonary tuberculosis ( tb ) caused by mycobacterium tuberculosis in combination with one or more anti tuberculosis ( anti tb ) drugs to which the isolate is susceptible,1
7574,7574,7574,7574,7574,7574,7574,9168,9168,9168,9168,9168,9168,9168,9168,9168,9168,9168,9168,9168,f768e337-a948-420a-9fbe-9be359c7a170,( 1 1 ) priftin is indicated for the treatment of latent tuberculosis infection ( ltbi ) caused by m tuberculosis in combination with isoniazid in patients 2 years of age and older at high risk of progression to tb disease,1
7575,7575,7575,7575,7575,7575,7575,9169,9169,9169,9169,9169,9169,9169,9169,9169,9169,9169,9169,9169,f768e337-a948-420a-9fbe-9be359c7a170,( 1 1  1 2 ) 1 1 active pulmonary tuberculosis priftin ( rifapentine ) is indicated in adults and children 12 years and older for the treatment of active pulmonary tuberculosis ( tb ) caused by mycobacterium tuberculosis,1
7576,7576,7576,7576,7576,7576,7576,9170,9170,9170,9170,9170,9170,9170,9170,9170,9170,9170,9170,9170,f768e337-a948-420a-9fbe-9be359c7a170,priftin must always be used in combination with one or more antituberculosis ( anti tb ) drugs to which the isolate is susceptible see dosage and administration ( 2 1 ) and clinical studies ( 14 1 ),4
7577,7577,7577,7577,7577,7577,7577,9171,9171,9171,9171,9171,9171,9171,9171,9171,9171,9171,9171,9171,f768e337-a948-420a-9fbe-9be359c7a170,limitations of use do not use priftin monotherapy in either the initial or the continuation phases of active antituberculous treatment,2
7578,7578,7578,7578,7578,7578,7578,9172,9172,9172,9172,9172,9172,9172,9172,9172,9172,9172,9172,9172,f768e337-a948-420a-9fbe-9be359c7a170,priftin should not be used once weekly in the continuation phase regimen in combination with isoniazid ( inh ) in hiv infected patients with active pulmonary tuberculosis because of a higher rate of failure and or relapse with rifampin ( rif ) resistant organisms see warnings and precautions ( 5 3 ) and clinical studies ( 14 1 ),0
7579,7579,7579,7579,7579,7579,7579,9173,9173,9173,9173,9173,9173,9173,9173,9173,9173,9173,9173,9173,f768e337-a948-420a-9fbe-9be359c7a170,priftin has not been studied as part of the initial phase treatment regimen in hiv infected patients with active pulmonary tuberculosis,0
7580,7580,7580,7580,7580,7580,7580,9174,9174,9174,9174,9174,9174,9174,9174,9174,9174,9174,9174,9174,f768e337-a948-420a-9fbe-9be359c7a170,1 2 latent tuberculosis infection priftin is indicated in adults and children 2 years and older for the treatment of latent tuberculosis infection caused,1
7581,7581,7581,7581,7581,7581,7581,9175,9175,9175,9175,9175,9175,9175,9175,9175,9175,9175,9175,9175,8e87bd3b-db25-4e97-bf57-96c875f67ce1,1  spinosad topical suspension is a pediculicide indicated for the topical treatment of head lice infestations in patients six ( 6 ) months of age and older,1
7582,7582,7582,7582,7582,7582,7582,9176,9176,9176,9176,9176,9176,9176,9176,9176,9176,9176,9176,9176,8e87bd3b-db25-4e97-bf57-96c875f67ce1,( 1 1 ) 1 1 indication spinosad topical suspension is indicated for the topical treatment of head lice infestation in patients six ( 6 ) months of age and older,1
7583,7583,7583,7583,7583,7583,7583,9177,9177,9177,9177,9177,9177,9177,9177,9177,9177,9177,9177,9177,8e87bd3b-db25-4e97-bf57-96c875f67ce1,1 2 adjunctive measures spinosad topical suspension should be used in the context of an overall lice management program wash ( in hot water ) or dry clean all recently worn clothing  hats  used bedding and towels,1
7584,7584,7584,7584,7584,7584,7584,9178,9178,9178,9178,9178,9178,9178,9178,9178,9178,9178,9178,9178,8e87bd3b-db25-4e97-bf57-96c875f67ce1,wash personal care items such as combs  brushes and hair clips in hot water a fine tooth comb or special nit comb may be used to remove dead lice and nits,u
7585,7585,7585,7585,7585,7585,7585,9179,9179,9179,9179,9179,9179,9179,9179,9179,9179,9179,9179,9179,c6fcb5d2-8fcd-44fa-a838-b84ee5f44f0f,1  rebif ( interferon beta 1a ) is indicated for the treatment of patients with relapsing forms of multiple sclerosis to decrease the frequency of clinical exacerbations and delay the accumulation of physical disability,1
7586,7586,7586,7586,7586,7586,7586,9180,9180,9180,9180,9180,9180,9180,9180,9180,9180,9180,9180,9180,c6fcb5d2-8fcd-44fa-a838-b84ee5f44f0f,rebif is an interferon beta indicated for the treatment of patients with relapsing forms of multiple sclerosis to decrease the frequency of clinical exacerbations and delay the accumulation of physical disability ( 1 ),1
7587,7587,7587,7587,7587,7587,7587,9181,9181,9181,9181,9181,9181,9181,9181,9181,9181,9181,9181,9181,77dd7fb3-18c4-4acb-af07-f929dff03903, intravascular indications conray 43 is indicated for use in lower extremity venography  intravenous infusion urography  contrast enhancement of computed tomographic brain images and arterial digital subtraction angiography,1
7588,7588,7588,7588,7588,7588,7588,9182,9182,9182,9182,9182,9182,9182,9182,9182,9182,9182,9182,9182,77dd7fb3-18c4-4acb-af07-f929dff03903,conray 43 may also be used for enhancement of computed tomographic scans performed for detection and evaluation of lesions in the liver  pancreas  kidneys  abdominal aorta  mediastinum  abdominal cavity and retroperitoneal space,1
7589,7589,7589,7589,7589,7589,7589,9183,9183,9183,9183,9183,9183,9183,9183,9183,9183,9183,9183,9183,77dd7fb3-18c4-4acb-af07-f929dff03903,continuous or multiple scans separated by intervals of 1 to 3 seconds during the first 30 to 90 seconds post injection of the contrast medium ( dynamic ct scanning ) may provide enhancement of diagnostic significance  and may be of benefit in establishing diagnoses of certain lesions in these sites with greater assurance than is possible with ct alone and in supplying additional features of the lesions,4
7590,7590,7590,7590,7590,7590,7590,9184,9184,9184,9184,9184,9184,9184,9184,9184,9184,9184,9184,9184,77dd7fb3-18c4-4acb-af07-f929dff03903,in other cases  the contrast agent may allow visualization of lesions not seen with ct alone  or may help to define suspicious lesions seen with unenhanced ct ( see clinical pharmacology ),u
7591,7591,7591,7591,7591,7591,7591,9185,9185,9185,9185,9185,9185,9185,9185,9185,9185,9185,9185,9185,77dd7fb3-18c4-4acb-af07-f929dff03903,subsets of patients in whom delayed body ct scans might be helpful have not been identified,0
7592,7592,7592,7592,7592,7592,7592,9186,9186,9186,9186,9186,9186,9186,9186,9186,9186,9186,9186,9186,77dd7fb3-18c4-4acb-af07-f929dff03903,inconsistent results have been reported and abnormal and normal tissues may be isodense during the same time frame used for delayed ct scanning,0
7593,7593,7593,7593,7593,7593,7593,9187,9187,9187,9187,9187,9187,9187,9187,9187,9187,9187,9187,9187,77dd7fb3-18c4-4acb-af07-f929dff03903,the risks of such indiscriminate use of contrast media are well known and such use is not recommended,2
7594,7594,7594,7594,7594,7594,7594,9188,9188,9188,9188,9188,9188,9188,9188,9188,9188,9188,9188,9188,77dd7fb3-18c4-4acb-af07-f929dff03903,at present  consistent results have been documented using dynamic ct techniques only,0
7595,7595,7595,7595,7595,7595,7595,9189,9189,9189,9189,9189,9189,9189,9189,9189,9189,9189,9189,9189,77dd7fb3-18c4-4acb-af07-f929dff03903,retrograde urographic indications conray 43 is indicated for use in retrograde cystography  cystourethrography and retrograde pyelography,1
7596,7596,7596,7596,7596,7596,7596,9190,9190,9190,9190,9190,9190,9190,9190,9190,9190,9190,9190,9190,6d6e13e2-dc33-4b7b-84d0-66146a57c552, coly mycin m parenteral is indicated for the treatment of acute or chronic infections due to sensitive strains of certain gram negative bacilli,1
7597,7597,7597,7597,7597,7597,7597,9193,9193,9193,9193,9193,9193,9193,9193,9193,9193,9193,9193,9193,6d6e13e2-dc33-4b7b-84d0-66146a57c552,coly mycin m parenteral has proven clinically effective in treatment of infections due to the following gram negative organisms enterobacter aerogenes  escherichia coli  klebsiella pneumoniae and pseudomonas aeruginosa,1
7598,7598,7598,7598,7598,7598,7598,9194,9194,9194,9194,9194,9194,9194,9194,9194,9194,9194,9194,9194,6d6e13e2-dc33-4b7b-84d0-66146a57c552,coly mycin m parenteral may be used to initiate therapy in serious infections that are suspected to be due to gram negative organisms and in the treatment of infections due to susceptible gram negative pathogenic bacilli,1
7599,7599,7599,7599,7599,7599,7599,9195,9195,9195,9195,9195,9195,9195,9195,9195,9195,9195,9195,9195,6d6e13e2-dc33-4b7b-84d0-66146a57c552,to reduce the development of drug resistant bacteria and maintain the effectiveness of coly mycin m and other antibacterial drugs  coly mycin m should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria,4
7600,7600,7600,7600,7600,7600,7600,9198,9198,9198,9198,9198,9198,9198,9198,9198,9198,9198,9198,9198,7b656b14-fcaa-2741-f6f0-e0be48971c02,1  spiriva respimat is an anticholinergic indicated for the long term  once daily  maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease ( copd )  and for reducing copd exacerbations ( 1 1 ) the long term  once daily  maintenance treatment of asthma in patients 6 years of age and older ( 1 2 ) limitation of use not indicated for relief of acute bronchospasm ( 1 1  1 2  5 1 ) 1 1 maintenance treatment of chronic obstructive pulmonary disease spiriva respimat ( tiotropium bromide ) is indicated for the long term  once daily  maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease ( copd )  including chronic bronchitis and emphysema,1
7601,7601,7601,7601,7601,7601,7601,9199,9199,9199,9199,9199,9199,9199,9199,9199,9199,9199,9199,9199,7b656b14-fcaa-2741-f6f0-e0be48971c02,spiriva respimat is indicated to reduce exacerbations in copd patients,1
7602,7602,7602,7602,7602,7602,7602,9200,9200,9200,9200,9200,9200,9200,9200,9200,9200,9200,9200,9200,7b656b14-fcaa-2741-f6f0-e0be48971c02,important limitation of use spiriva respimat is not indicated for the relief of acute bronchospasm,2
7603,7603,7603,7603,7603,7603,7603,9201,9201,9201,9201,9201,9201,9201,9201,9201,9201,9201,9201,9201,7b656b14-fcaa-2741-f6f0-e0be48971c02,1 2 maintenance treatment of asthma spiriva respimat is a bronchodilator indicated for the long term  once daily  maintenance treatment of asthma in patients 6 years of age and older,1
7604,7604,7604,7604,7604,7604,7604,9203,9203,9203,9203,9203,9203,9203,9203,9203,9203,9203,9203,9203,44ab9815-39f4-1463-e054-00144ff8d46c, sucralfate tablets  usp are indicated in short term treatment ( up to 8 weeks ) of active duodenal ulcer,1
7605,7605,7605,7605,7605,7605,7605,9204,9204,9204,9204,9204,9204,9204,9204,9204,9204,9204,9204,9204,44ab9815-39f4-1463-e054-00144ff8d46c,while healing with sucralfate may occur during the first week or two  treatment should be continued for 4 to 8 weeks unless healing has been demonstrated by x ray or endoscopic examination,4
7606,7606,7606,7606,7606,7606,7606,9206,9206,9206,9206,9206,9206,9206,9206,9206,9206,9206,9206,9206,129eaf3a-b013-4b29-a58f-1565f9f41d5b,1  indomethacin capsules are a nonsteroidal anti inflammatory drug indicated for moderate to severe rheumatoid arthritis including acute flares of chronic disease moderate to severe ankylosing spondylitis moderate to severe osteoarthritis acute painful shoulder ( bursitis and or tendinitis ) acute gouty arthritis ( 1 ) indomethacin capsules are indicated for moderate to severe rheumatoid arthritis including acute flares of chronic disease moderate to severe ankylosing spondylitis moderate to severe osteoarthritis acute painful shoulder ( bursitis and or tendinitis ) acute gouty arthritis,1
7607,7607,7607,7607,7607,7607,7607,9207,9207,9207,9207,9207,9207,9207,9207,9207,9207,9207,9207,9207,fb546f57-cd2f-4cbf-8c54-fbc23d47fe0f, zafirlukast tablets are indicated for the prophylaxis and chronic treatment of asthma in adults and children 5 years of age and older,1
7608,7608,7608,7608,7608,7608,7608,9208,9208,9208,9208,9208,9208,9208,9208,9208,9208,9208,9208,9208,5c4841b4-fbc0-4163-8ee1-cb28629cbfbf,1  photofrin is a photodynamic therapy drug indicated for esophageal cancer ( 1 1 ) palliation of patients with completely obstructing esophageal cancer  or of patients with partially obstructing esophageal cancer who  in the opinion of their physician  cannot be satisfactorily treated with nd yag laser therapy endobronchial cancer ( 1 2 ) treatment of microinvasive endobronchial non small cell lung cancer ( nsclc ) in patients for whom surgery and radiotherapy are not indicated reduction of obstruction and palliation of symptoms in patients with completely or partially obstructing endobronchial nsclc high grade dysplasia in barrett 's esophagus ( 1 3 ) ablation of high grade dysplasia ( hgd ) in barrett 's esophagus ( be ) patients who do not undergo esophagectomy 1 1 esophageal cancer photofrin is indicated for the palliation of patients with completely obstructing esophageal cancer  or of patients with partially obstructing esophageal cancer who  in the opinion of their physician  cannot be satisfactorily treated with nd yag laser therapy,1
7609,7609,7609,7609,7609,7609,7609,9209,9209,9209,9209,9209,9209,9209,9209,9209,9209,9209,9209,9209,5c4841b4-fbc0-4163-8ee1-cb28629cbfbf,1 2 endobronchial cancer photofrin is indicated for the treatment of microinvasive endobronchial non small cell lung cancer ( nsclc ) in patients for whom surgery and radiotherapy are not indicated,1
7610,7610,7610,7610,7610,7610,7610,9210,9210,9210,9210,9210,9210,9210,9210,9210,9210,9210,9210,9210,5c4841b4-fbc0-4163-8ee1-cb28629cbfbf,photofrin is indicated for the reduction of obstruction and palliation of symptoms in patients with completely or partially obstructing endobronchial nsclc,1
7611,7611,7611,7611,7611,7611,7611,9211,9211,9211,9211,9211,9211,9211,9211,9211,9211,9211,9211,9211,5c4841b4-fbc0-4163-8ee1-cb28629cbfbf,1 3 high grade dysplasia in barrett 's esophagus photofrin is indicated for the ablation of high grade dysplasia in barrett 's esophagus patients who do not undergo esophagectomy,1
7612,7612,7612,7612,7612,7612,7612,9212,9212,9212,9212,9212,9212,9212,9212,9212,9212,9212,9212,9212,f15b043d-fcfa-4ade-a3da-76700c0c5c2a, prograf is indicated for the prophylaxis of organ rejection in patients receiving allogeneic liver  kidney  or heart transplants,1
7613,7613,7613,7613,7613,7613,7613,9213,9213,9213,9213,9213,9213,9213,9213,9213,9213,9213,9213,9213,f15b043d-fcfa-4ade-a3da-76700c0c5c2a,it is recommended that prograf be used concomitantly with adrenal corticosteroids,4
7614,7614,7614,7614,7614,7614,7614,9214,9214,9214,9214,9214,9214,9214,9214,9214,9214,9214,9214,9214,f15b043d-fcfa-4ade-a3da-76700c0c5c2a,because of the risk of anaphylaxis  prograf injection should be reserved for patients unable to take prograf capsules orally,4
7615,7615,7615,7615,7615,7615,7615,9215,9215,9215,9215,9215,9215,9215,9215,9215,9215,9215,9215,9215,f15b043d-fcfa-4ade-a3da-76700c0c5c2a,in heart and kidney transplant recipients  it is recommended that prograf be used in conjunction with azathioprine or mycophenolate mofetil ( mmf ),4
7616,7616,7616,7616,7616,7616,7616,9216,9216,9216,9216,9216,9216,9216,9216,9216,9216,9216,9216,9216,f15b043d-fcfa-4ade-a3da-76700c0c5c2a,the safety and efficacy of the use of prograf with sirolimus has not been established ( see clinical studies ),0
7617,7617,7617,7617,7617,7617,7617,9217,9217,9217,9217,9217,9217,9217,9217,9217,9217,9217,9217,9217,6d0f94b4-82ca-37c7-edb0-4f0702cf6c8d,1  north american coral snake antivenin ( equine ) is indicated only for the treatment of envenomation caused by bites of north american coral snakes micrurus ( including the eastern and texas varieties ),1
7618,7618,7618,7618,7618,7618,7618,9218,9218,9218,9218,9218,9218,9218,9218,9218,9218,9218,9218,9218,6d0f94b4-82ca-37c7-edb0-4f0702cf6c8d,north american coral snake antivenin ( equine ) is a horse derived antivenin indicated for the treatment of envenomation caused by north american coral snakes micrurus,1
7619,7619,7619,7619,7619,7619,7619,9219,9219,9219,9219,9219,9219,9219,9219,9219,9219,9219,9219,9219,ed6c506c-5535-4b7c-ae1a-d63f09d796c9, phentolamine mesylate for injection is indicated for the prevention or control of hypertensive episodes that may occur in a patient with pheochromocytoma as a result of stress or manipulation during preoperative preparation and surgical excision,1
7620,7620,7620,7620,7620,7620,7620,9220,9220,9220,9220,9220,9220,9220,9220,9220,9220,9220,9220,9220,ed6c506c-5535-4b7c-ae1a-d63f09d796c9,phentolamine mesylate for injection is indicated for the prevention or treatment of dermal necrosis and sloughing following intravenous administration or extravasation of norepinephrine,1
7621,7621,7621,7621,7621,7621,7621,9221,9221,9221,9221,9221,9221,9221,9221,9221,9221,9221,9221,9221,ed6c506c-5535-4b7c-ae1a-d63f09d796c9,phentolamine mesylate for injection is also indicated for the diagnosis of pheochromocytoma by the phentolamine blocking test,1
7622,7622,7622,7622,7622,7622,7622,9222,9222,9222,9222,9222,9222,9222,9222,9222,9222,9222,9222,9222,9dd522a3-587e-44ab-9de3-a0fd079f2ffb, olsalazine is indicated for the maintenance of remission of ulcerative colitis in patients who are intolerant of sulfasalazine,1
7623,7623,7623,7623,7623,7623,7623,9223,9223,9223,9223,9223,9223,9223,9223,9223,9223,9223,9223,9223,bb5a9e59-0f51-11df-8a39-0800200c9a66, exparel is indicated for administration into the surgical site to produce postsurgical analgesia,1
7624,7624,7624,7624,7624,7624,7624,9224,9224,9224,9224,9224,9224,9224,9224,9224,9224,9224,9224,9224,bb5a9e59-0f51-11df-8a39-0800200c9a66,exparel has not been studied for use in patients younger than 18 years of age,0
7625,7625,7625,7625,7625,7625,7625,9225,9225,9225,9225,9225,9225,9225,9225,9225,9225,9225,9225,9225,bb5a9e59-0f51-11df-8a39-0800200c9a66,exparel is a liposome injection of bupivacaine  an amide local anesthetic  indicated for single dose infiltration into the surgical site to produce postsurgical analgesia ( 1 ),1
7626,7626,7626,7626,7626,7626,7626,9226,9226,9226,9226,9226,9226,9226,9226,9226,9226,9226,9226,9226,79b7bbb6-b021-46ab-99a5-cef95472532b, calcium acetate tablets  usp are indicated for the control of hyperphosphatemia in end stage renal failure and does not promote aluminum absorption,1
7627,7627,7627,7627,7627,7627,7627,9227,9227,9227,9227,9227,9227,9227,9227,9227,9227,9227,9227,9227,c05ee6a5-c98b-45f4-83fd-40781639d653,1  digifab is indicated for the treatment of patients with life threatening or potentially life threatening digoxin toxicity or overdose  including known suicidal or accidental consumption of fatal doses of digoxin 10 mg or more of digoxin in healthy adults  or 4 mg ( or more than 0 1 mg kg ) in healthy children  or ingestion of an amount that can cause steady state serum concentrations of 10 ng ml chronic ingestions causing steady state serum digoxin concentrations 6 ng ml in adults or 4 ng ml in children manifestations of life threatening toxicity of digoxin overdose such as severe ventricular arrhythmias  progressive bradycardia  and second or third degree heart block not responsive to atropine  serum potassium levels exceeding 5 5 meq l in adults or 6 meq l in children with rapidly progressive signs and symptoms of digoxin toxicity,1
7628,7628,7628,7628,7628,7628,7628,9228,9228,9228,9228,9228,9228,9228,9228,9228,9228,9228,9228,9228,c05ee6a5-c98b-45f4-83fd-40781639d653,digifab is a digoxin immune fab ( ovine ) and is indicated for treatment of life threatening or potentially life threatening digoxin toxicity or overdose,1
7629,7629,7629,7629,7629,7629,7629,9229,9229,9229,9229,9229,9229,9229,9229,9229,9229,9229,9229,9229,8983d6a0-f63f-4f8e-bba4-38223f39e29b,1  benznidazole tablets are indicated in pediatric patients 2 to 12 years of age for the treatment of chagas disease ( american trypanosomiasis ) caused by trypanosoma cruzi,1
7630,7630,7630,7630,7630,7630,7630,9230,9230,9230,9230,9230,9230,9230,9230,9230,9230,9230,9230,9230,8983d6a0-f63f-4f8e-bba4-38223f39e29b,this indication is approved under accelerated approval based on the number of treated patients who became immunoglobulin g ( igg ) antibody negative against the recombinant antigens of t cruzi see clinical studies ( 14 ),0
7631,7631,7631,7631,7631,7631,7631,9232,9232,9232,9232,9232,9232,9232,9232,9232,9232,9232,9232,9232,8983d6a0-f63f-4f8e-bba4-38223f39e29b,benznidazole tablets  a nitroimidazole antimicrobial  is indicated in pediatric patients 2 to 12 years of age for the treatment of chagas disease ( american trypanosomiasis )  caused by trypanosoma cruzi ( 1 ),1
7632,7632,7632,7632,7632,7632,7632,9233,9233,9233,9233,9233,9233,9233,9233,9233,9233,9233,9233,9233,8983d6a0-f63f-4f8e-bba4-38223f39e29b,this indication is approved under accelerated approval based on the number of treated patients who became immunoglobulin g ( igg ) antibody negative against the recombinant antigens of t cruzi,0
7633,7633,7633,7633,7633,7633,7633,9234,9234,9234,9234,9234,9234,9234,9234,9234,9234,9234,9234,9234,8983d6a0-f63f-4f8e-bba4-38223f39e29b,continued approval for this indication may be contingent upon verification and description of clinical benefit in confirmatory trials ( 1  14 ),0
7634,7634,7634,7634,7634,7634,7634,9235,9235,9235,9235,9235,9235,9235,9235,9235,9235,9235,9235,9235,efbdafa9-d18c-4e85-b4a2-1e620fc74e50,1  zydelig is a kinase inhibitor indicated for the treatment of patients with relapsed chronic lymphocytic leukemia ( cll )  in combination with rituximab  in patients for whom rituximab alone would be considered appropriate therapy due to other co morbidities,1
7635,7635,7635,7635,7635,7635,7635,9236,9236,9236,9236,9236,9236,9236,9236,9236,9236,9236,9236,9236,efbdafa9-d18c-4e85-b4a2-1e620fc74e50,( 1 1 ) relapsed follicular b cell non hodgkin lymphoma ( fl ) in patients who have received at least two prior systemic therapies,1
7636,7636,7636,7636,7636,7636,7636,9237,9237,9237,9237,9237,9237,9237,9237,9237,9237,9237,9237,9237,efbdafa9-d18c-4e85-b4a2-1e620fc74e50,( 1 2 ) relapsed small lymphocytic lymphoma ( sll ) in patients who have received at least two prior systemic therapies,1
7637,7637,7637,7637,7637,7637,7637,9238,9238,9238,9238,9238,9238,9238,9238,9238,9238,9238,9238,9238,efbdafa9-d18c-4e85-b4a2-1e620fc74e50,( 1 3 ) limitation of use zydelig is not indicated and is not recommended for first line treatment of any patient,2
7638,7638,7638,7638,7638,7638,7638,9239,9239,9239,9239,9239,9239,9239,9239,9239,9239,9239,9239,9239,efbdafa9-d18c-4e85-b4a2-1e620fc74e50,( 1 1  1 2  1 3 ) zydelig is not indicated and is not recommended in combination with bendamustine and or rituximab for the treatment of fl,2
7639,7639,7639,7639,7639,7639,7639,9240,9240,9240,9240,9240,9240,9240,9240,9240,9240,9240,9240,9240,efbdafa9-d18c-4e85-b4a2-1e620fc74e50,( 1 2 ) accelerated approval was granted for fl and sll based on overall response rate,0
7640,7640,7640,7640,7640,7640,7640,9241,9241,9241,9241,9241,9241,9241,9241,9241,9241,9241,9241,9241,efbdafa9-d18c-4e85-b4a2-1e620fc74e50,improvement in patient survival or disease related symptoms has not been established,0
7641,7641,7641,7641,7641,7641,7641,9242,9242,9242,9242,9242,9242,9242,9242,9242,9242,9242,9242,9242,efbdafa9-d18c-4e85-b4a2-1e620fc74e50,continued approval for these indications may be contingent upon verification of clinical benefit in confirmatory trials,0
7642,7642,7642,7642,7642,7642,7642,9243,9243,9243,9243,9243,9243,9243,9243,9243,9243,9243,9243,9243,efbdafa9-d18c-4e85-b4a2-1e620fc74e50,1 1 relapsed chronic lymphocytic leukemia zydelig is indicated  in combination with rituximab  for the treatment of patients with relapsed chronic lymphocytic leukemia ( cll ) for whom rituximab alone would be considered appropriate therapy due to other co morbidities,1
7643,7643,7643,7643,7643,7643,7643,9244,9244,9244,9244,9244,9244,9244,9244,9244,9244,9244,9244,9244,efbdafa9-d18c-4e85-b4a2-1e620fc74e50,limitation of use zydelig is not indicated and is not recommended for first line treatment of patients with cll,2
7644,7644,7644,7644,7644,7644,7644,9245,9245,9245,9245,9245,9245,9245,9245,9245,9245,9245,9245,9245,efbdafa9-d18c-4e85-b4a2-1e620fc74e50,1 2 relapsed follicular b cell non hodgkin lymphoma zydelig is indicated for the treatment of patients with relapsed follicular b cell non hodgkin lymphoma ( fl ) who have received at least two prior systemic therapies,1
7645,7645,7645,7645,7645,7645,7645,9246,9246,9246,9246,9246,9246,9246,9246,9246,9246,9246,9246,9246,efbdafa9-d18c-4e85-b4a2-1e620fc74e50,accelerated approval was granted for this indication based on overall response rate see clinical studies ( 14 2 ),0
7646,7646,7646,7646,7646,7646,7646,9247,9247,9247,9247,9247,9247,9247,9247,9247,9247,9247,9247,9247,efbdafa9-d18c-4e85-b4a2-1e620fc74e50,an improvement in patient survival or disease related symptoms has not,0
7647,7647,7647,7647,7647,7647,7647,9248,9248,9248,9248,9248,9248,9248,9248,9248,9248,9248,9248,9248,b23b67eb-78b7-48eb-84ff-c95d3ce8683c, prochlorperazine 25 mg suppositories are indicated in the control of severe nausea and vomiting in adults,1
7648,7648,7648,7648,7648,7648,7648,9249,9249,9249,9249,9249,9249,9249,9249,9249,9249,9249,9249,9249,7603f1ba-cfbd-4ec5-881a-13f4832c9893, diprivan injectable emulsion is an iv sedative hypnotic agent that can be used as described in the table below,u
7649,7649,7649,7649,7649,7649,7649,9250,9250,9250,9250,9250,9250,9250,9250,9250,9250,9250,9250,9250,7603f1ba-cfbd-4ec5-881a-13f4832c9893,indications for diprivan injectable emulsion indication approved patient population initiation and maintenance of monitored anesthesia care ( mac ) sedation adults only combined sedation and reginoal anesthesia adults only ( see precautions ) induction of general anesthesia patients more than or equal to 3 years of age maintenance of general anesthesia patients more than or equal to 2 years of age intensive care unit ( icu ) sedation of intubated  mechanically ventilated patients adults only safety  effectiveness and dosing guidelines for diprivan injectable emulsion have not been established for mac sedation in the pediatric population therefore  it is not recommended for this use ( see precautions  pediatric use ),1
7650,7650,7650,7650,7650,7650,7650,9251,9251,9251,9251,9251,9251,9251,9251,9251,9251,9251,9251,9251,7603f1ba-cfbd-4ec5-881a-13f4832c9893,diprivan injectable emulsion is not recommended for induction of anesthesia below the age of 3 years or for maintenance of anesthesia below the age of 2 months because its safety and effectiveness have not been established in those populations,2
7651,7651,7651,7651,7651,7651,7651,9252,9252,9252,9252,9252,9252,9252,9252,9252,9252,9252,9252,9252,7603f1ba-cfbd-4ec5-881a-13f4832c9893,in the intensive care unit ( icu )  diprivan injectable emulsion can be administered to intubated  mechanically ventilated adult patients to provide continuous sedation and control of stress responses only by persons skilled in the medical management of critically ill patients and trained in cardiovascular resuscitation and airway management,1
7652,7652,7652,7652,7652,7652,7652,9253,9253,9253,9253,9253,9253,9253,9253,9253,9253,9253,9253,9253,7603f1ba-cfbd-4ec5-881a-13f4832c9893,diprivan injectable emulsion is not indicated for use in pediatric icu sedation since the safety of this regimen has not been established ( see precautions  pediatric use ),2
7653,7653,7653,7653,7653,7653,7653,9254,9254,9254,9254,9254,9254,9254,9254,9254,9254,9254,9254,9254,7603f1ba-cfbd-4ec5-881a-13f4832c9893,diprivan injectable emulsion is not recommended for obstetrics  including cesarean section deliveries,2
7654,7654,7654,7654,7654,7654,7654,9255,9255,9255,9255,9255,9255,9255,9255,9255,9255,9255,9255,9255,7603f1ba-cfbd-4ec5-881a-13f4832c9893,diprivan injectable emulsion crosses the placenta  and as with other general anesthetic agents  the administration of diprivan injectable emulsion may be associated with neonatal depression ( see precautions ),3
7655,7655,7655,7655,7655,7655,7655,9256,9256,9256,9256,9256,9256,9256,9256,9256,9256,9256,9256,9256,7603f1ba-cfbd-4ec5-881a-13f4832c9893,diprivan injectable emulsion is not recommended for use in nursing mothers because diprivan injectable emulsion has been reported to be excreted in human milk  and the effects of oral absorption of small amounts of propofol are not known ( see precautions ),2
7656,7656,7656,7656,7656,7656,7656,9257,9257,9257,9257,9257,9257,9257,9257,9257,9257,9257,9257,9257,aec9984e-34c5-481b-b6bf-9bb5caf1daf8,1  xatmep is a folate analog metabolic inhibitor indicated for the treatment of pediatric patients with acute lymphoblastic leukemia ( all ) as a component of a combination chemotherapy maintenance regimen ( 1 1 ) management of pediatric patients with active polyarticular juvenile idiopathic arthritis ( pjia ) who are intolerant of or had an inadequate response to first line therapy ( 1 2 ) 1 1 acute lymphoblastic leukemia xatmep is indicated for the treatment of pediatric patients with acute lymphoblastic leukemia ( all ) as part of a multi phase  combination chemotherapy maintenance regimen,1
7657,7657,7657,7657,7657,7657,7657,9258,9258,9258,9258,9258,9258,9258,9258,9258,9258,9258,9258,9258,aec9984e-34c5-481b-b6bf-9bb5caf1daf8,1 2 polyarticular juvenile idiopathic arthritis xatmep is indicated in the management of pediatric patients with active polyarticular juvenile idiopathic arthritis ( pjia ) who have had an insufficient therapeutic response to  or are intolerant of  an adequate trial of first line therapy including full dose non steroidal anti inflammatory agents ( nsaids ),1
7658,7658,7658,7658,7658,7658,7658,9259,9259,9259,9259,9259,9259,9259,9259,9259,9259,9259,9259,9259,ac51d3e3-ed76-e033-e1d6-1ffbd14d94c2, hypertension isradipine is indicated in the management of hypertension,1
7659,7659,7659,7659,7659,7659,7659,9260,9260,9260,9260,9260,9260,9260,9260,9260,9260,9260,9260,9260,ac51d3e3-ed76-e033-e1d6-1ffbd14d94c2,it may be used alone or concurrently with thiazide type diuretics,4
7660,7660,7660,7660,7660,7660,7660,9261,9261,9261,9261,9261,9261,9261,9261,9261,9261,9261,9261,9261,e5721cb8-4185-47b9-bbb3-1c587e558a03, caprelsa is indicated for the treatment of symptomatic or progressive medullary thyroid cancer in patients with unresectable locally advanced or metastatic disease,1
7661,7661,7661,7661,7661,7661,7661,9262,9262,9262,9262,9262,9262,9262,9262,9262,9262,9262,9262,9262,e5721cb8-4185-47b9-bbb3-1c587e558a03,use caprelsa in patients with indolent  asymptomatic or slowly progressing disease only after careful consideration of the treatment related risks of caprelsa,u
7662,7662,7662,7662,7662,7662,7662,9263,9263,9263,9263,9263,9263,9263,9263,9263,9263,9263,9263,9263,e5721cb8-4185-47b9-bbb3-1c587e558a03,caprelsa is a kinase inhibitor indicated for the treatment of symptomatic or progressive medullary thyroid cancer in patients with unresectable locally advanced or metastatic disease,1
7663,7663,7663,7663,7663,7663,7663,9264,9264,9264,9264,9264,9264,9264,9264,9264,9264,9264,9264,9264,e5721cb8-4185-47b9-bbb3-1c587e558a03,( 1 ) use caprelsa in patients with indolent  asymptomatic or slowly progressing disease only after careful consideration of the treatment related risks of caprelsa,u
7664,7664,7664,7664,7664,7664,7664,9265,9265,9265,9265,9265,9265,9265,9265,9265,9265,9265,9265,9265,58b25d79-78f2-4953-b0c6-61658dc4ef0d, rimso 50 ( dimethyl sulfoxide ) is indicated for the symptomatic relief of patients with interstitial cystitis,1
7665,7665,7665,7665,7665,7665,7665,9266,9266,9266,9266,9266,9266,9266,9266,9266,9266,9266,9266,9266,58b25d79-78f2-4953-b0c6-61658dc4ef0d,rimso 50 has not been approved as being safe and effective for any other indication,0
7666,7666,7666,7666,7666,7666,7666,9267,9267,9267,9267,9267,9267,9267,9267,9267,9267,9267,9267,9267,58b25d79-78f2-4953-b0c6-61658dc4ef0d,there is no clinical evidence of effectiveness of dimethyl sulfoxide in the treatment of bacterial infections of the urinary tract,0
7667,7667,7667,7667,7667,7667,7667,9269,9269,9269,9269,9269,9269,9269,9269,9269,9269,9269,9269,9269,f8c9773e-a780-4cb1-ace9-b8feb2d8e057,drug therapy is recommended as an adjunct to diet when the response to a diet restricted in saturated fat and cholesterol and other nonpharmacologic measures alone has been inadequate,1
7668,7668,7668,7668,7668,7668,7668,9270,9270,9270,9270,9270,9270,9270,9270,9270,9270,9270,9270,9270,f8c9773e-a780-4cb1-ace9-b8feb2d8e057,in patients with chd or multiple risk factors for chd  atorvastatin calcium tablets can be started simultaneously with diet,4
7669,7669,7669,7669,7669,7669,7669,9271,9271,9271,9271,9271,9271,9271,9271,9271,9271,9271,9271,9271,f8c9773e-a780-4cb1-ace9-b8feb2d8e057,atorvastatin calcium tablets are an inhibitor of hmg coa reductase ( statin ) indicated as an adjunct therapy to diet to reduce the risk of mi  stroke  revascularization procedures  and angina in patients without chd  but with multiple risk factors ( 1 1 ),1
7670,7670,7670,7670,7670,7670,7670,9272,9272,9272,9272,9272,9272,9272,9272,9272,9272,9272,9272,9272,f8c9773e-a780-4cb1-ace9-b8feb2d8e057,reduce the risk of mi and stroke in patients with type 2 diabetes without chd  but with multiple risk factors ( 1 1 ),1
7671,7671,7671,7671,7671,7671,7671,9273,9273,9273,9273,9273,9273,9273,9273,9273,9273,9273,9273,9273,f8c9773e-a780-4cb1-ace9-b8feb2d8e057,reduce the risk of non fatal mi  fatal and non fatal stroke  revascularization procedures  hospitalization for chf  and angina in patients with chd ( 1 1 ),1
7672,7672,7672,7672,7672,7672,7672,9274,9274,9274,9274,9274,9274,9274,9274,9274,9274,9274,9274,9274,f8c9773e-a780-4cb1-ace9-b8feb2d8e057,reduce elevated total c  ldl c  apo b  and tg levels and increase hdl c in adult patients with primary hyperlipidemia ( heterozygous familial and nonfamilial ) and mixed dyslipidemia ( 1 2 ),1
7673,7673,7673,7673,7673,7673,7673,9275,9275,9275,9275,9275,9275,9275,9275,9275,9275,9275,9275,9275,f8c9773e-a780-4cb1-ace9-b8feb2d8e057,reduce elevated tg in patients with hypertriglyceridemia and primary dysbetalipoproteinemia ( 1 2 ),1
7674,7674,7674,7674,7674,7674,7674,9276,9276,9276,9276,9276,9276,9276,9276,9276,9276,9276,9276,9276,f8c9773e-a780-4cb1-ace9-b8feb2d8e057,reduce total c and ldl c in patients with homozygous familial hypercholesterolemia ( hofh ) ( 1 2 ),1
7675,7675,7675,7675,7675,7675,7675,9277,9277,9277,9277,9277,9277,9277,9277,9277,9277,9277,9277,9277,f8c9773e-a780-4cb1-ace9-b8feb2d8e057,reduce elevated total c  ldl c  and apo b levels in boys and postmenarchal girls  10 to 17 years of age  with heterozygous familial hypercholesterolemia after failing an adequate trial of diet therapy ( 1 2 ),1
7676,7676,7676,7676,7676,7676,7676,9278,9278,9278,9278,9278,9278,9278,9278,9278,9278,9278,9278,9278,f8c9773e-a780-4cb1-ace9-b8feb2d8e057,limitations of use atorvastatin calcium tablets have not been studied in fredrickson types i and v dyslipidemias,0
7677,7677,7677,7677,7677,7677,7677,9279,9279,9279,9279,9279,9279,9279,9279,9279,9279,9279,9279,9279,f8c9773e-a780-4cb1-ace9-b8feb2d8e057,1 1 prevention of cardiovascular disease in adult patients without clinically evident coronary heart disease  but with multiple risk factors for coronary heart disease such as age  smoking  hypertension  low hdl c  or a family history of early coronary hea,1
7678,7678,7678,7678,7678,7678,7678,9280,9280,9280,9280,9280,9280,9280,9280,9280,9280,9280,9280,9280,23b6d4a3-b273-4e10-9da9-1376933fdbdf, therapy penicillin g sodium for injection  usp is indicated in the treatment of serious infections caused by susceptible strains of the designated microorganisms in the conditions listed below,1
7679,7679,7679,7679,7679,7679,7679,9281,9281,9281,9281,9281,9281,9281,9281,9281,9281,9281,9281,9281,23b6d4a3-b273-4e10-9da9-1376933fdbdf,appropriate culture and susceptibility tests should be done before treatment in order to isolate and identify organisms causing infection and to determine their susceptibility to penicillin g therapy with penicillin g sodium for injection  usp may be initiated before results of such tests are known when there is reason to believe the infection may involve any of the organisms listed below  however  once these results become available  appropriate therapy should be continued,4
7680,7680,7680,7680,7680,7680,7680,9282,9282,9282,9282,9282,9282,9282,9282,9282,9282,9282,9282,9282,23b6d4a3-b273-4e10-9da9-1376933fdbdf,clinical indication infecting organism septicemia  empyema  pneumonia  pericarditis  endocarditis  meningitis streptococcus pyogenes ( group a hemolytic streptococcus )  other hemolytic streptococci including groups c  h  g  l and m  streptococcus pneumoniae and staphylococcus species ( non penicillinase producing strains ) anthrax bacillus anthracis actinomycosis ( cervico facial disease and thoracic and abdominal disease ) actinomyces israelil,1
7681,7681,7681,7681,7681,7681,7681,9283,9283,9283,9283,9283,9283,9283,9283,9283,9283,9283,9283,9283,c4d65f28-983f-42b4-bb23-023ae0fe81b2,1  xadago is indicated as adjunctive treatment to levodopa carbidopa in patients with parkinson 's disease ( pd ) experiencing off episodes,1
7682,7682,7682,7682,7682,7682,7682,9284,9284,9284,9284,9284,9284,9284,9284,9284,9284,9284,9284,9284,c4d65f28-983f-42b4-bb23-023ae0fe81b2,xadago is a monoamine oxidase type b ( mao b ) inhibitor indicated as adjunctive treatment to levodopa carbidopa in patients with parkinson 's disease ( pd ) experiencing off episodes ( 1 ) limitations of use xadago has not been shown to be effective as monotherapy for the treatment of pd,1
7683,7683,7683,7683,7683,7683,7683,9285,9285,9285,9285,9285,9285,9285,9285,9285,9285,9285,9285,9285,c4d65f28-983f-42b4-bb23-023ae0fe81b2,limitations of use xadago has not been shown to be effective as monotherapy for the treatment of pd,0
7684,7684,7684,7684,7684,7684,7684,9286,9286,9286,9286,9286,9286,9286,9286,9286,9286,9286,9286,9286,bc9dff5c-db3b-4cdf-b0bc-7ef94fd38486, anxiety disorders alprazolam tablets are indicated for the management of anxiety disorder ( a condition corresponding most closely to the apa diagnostic and statistical manual dsm iii r diagnosis of generalized anxiety disorder ) or the short term relief of symptoms of anxiety,1
7685,7685,7685,7685,7685,7685,7685,9288,9288,9288,9288,9288,9288,9288,9288,9288,9288,9288,9288,9288,bc9dff5c-db3b-4cdf-b0bc-7ef94fd38486,generalized anxiety disorder is characterized by unrealistic or excessive anxiety and worry ( apprehensive expectation ) about two or more life circumstances  for a period of 6 months or longer  during which the person has been bothered more days than not by these concerns,0
7686,7686,7686,7686,7686,7686,7686,9289,9289,9289,9289,9289,9289,9289,9289,9289,9289,9289,9289,9289,bc9dff5c-db3b-4cdf-b0bc-7ef94fd38486,at least 6 of the following 18 symptoms are often present in these patients motor tension ( trembling  twitching  or feeling shaky muscle tension  aches  or soreness restlessness easy fatigability ) autonomic hyperactivity ( shortness of breath or smothering sensations palpitations or accelerated heart rate sweating  or cold clammy hands dry mouth dizziness or light headedness nausea  diarrhea  or other abdominal distress flushes or chills frequent urination trouble swallowing or 'lump in throat' ) vigilance and scanning ( feeling keyed up or on edge exaggerated startle response difficulty concentrating or 'mind going blank' because of anxiety trouble falling or staying asleep irritability ),0
7687,7687,7687,7687,7687,7687,7687,9290,9290,9290,9290,9290,9290,9290,9290,9290,9290,9290,9290,9290,bc9dff5c-db3b-4cdf-b0bc-7ef94fd38486,these symptoms must not be secondary to another psychiatric disorder or caused by some organic factor,0
7688,7688,7688,7688,7688,7688,7688,9291,9291,9291,9291,9291,9291,9291,9291,9291,9291,9291,9291,9291,bc9dff5c-db3b-4cdf-b0bc-7ef94fd38486,anxiety associated with depression is responsive to alprazolam tablets,u
7689,7689,7689,7689,7689,7689,7689,9292,9292,9292,9292,9292,9292,9292,9292,9292,9292,9292,9292,9292,bc9dff5c-db3b-4cdf-b0bc-7ef94fd38486,panic disorder alprazolam tablets are also indicated for the treatment of panic disorder  with or without agoraphobia,1
7690,7690,7690,7690,7690,7690,7690,9293,9293,9293,9293,9293,9293,9293,9293,9293,9293,9293,9293,9293,bc9dff5c-db3b-4cdf-b0bc-7ef94fd38486,studies supporting this claim were conducted in patients whose diagnoses corresponded closely to the dsm iii r iv criteria for panic disorder ( see clinical studies ),0
7691,7691,7691,7691,7691,7691,7691,9294,9294,9294,9294,9294,9294,9294,9294,9294,9294,9294,9294,9294,bc9dff5c-db3b-4cdf-b0bc-7ef94fd38486,panic disorder ( dsm iv ) is characterized by recurrent unexpected panic attacks  i e  a discrete period of intense fear or discomfort in which four ( or more ) of the following symptoms develop abruptly and reach a peak within 10 minutes ( 1 ) palpitations  pounding heart  or accelerated heart rate ( 2 ) sweating ( 3 ) trembling or shaking ( 4 ) sensations of shortness of breath or smothering ( 5 ) feeling of choking ( 6 ) chest pain or discomfort ( 7 ) nausea or abdominal distress ( 8 ) feeling dizzy  unsteady  lightheaded  or faint ( 9 ) derealization ( feelings of unreality ) or depersonalization ( being detached from oneself ) ( 10 ) fear of losing control ( 11 ) fear of dying ( 12 ) paresthesias ( numbness or tingling sensations ) ( 13 ) chills or hot flushes,0
7692,7692,7692,7692,7692,7692,7692,9295,9295,9295,9295,9295,9295,9295,9295,9295,9295,9295,9295,9295,bc9dff5c-db3b-4cdf-b0bc-7ef94fd38486,demonstrations of the effectiveness of alprazolam tablets by systematic clinical study are limited to 4 months duration for anxiety disorder and 4 to 10 weeks duration for panic disorder however  patients with panic disorder have been treated on an open basis for up to 8 months without apparent loss of benefit,0
7693,7693,7693,7693,7693,7693,7693,9297,9297,9297,9297,9297,9297,9297,9297,9297,9297,9297,9297,9297,5368616d-6520-6f6e-2053-686b72656c69, treatment of toxoplasmosis daraprim is indicated for the treatment of toxoplasmosis when used conjointly with a sulfonamide  since synergism exists with this combination,1
7694,7694,7694,7694,7694,7694,7694,9298,9298,9298,9298,9298,9298,9298,9298,9298,9298,9298,9298,9298,dd966338-c820-4270-b704-09ef75fa3ceb,1  to reduce the development of drug resistant bacteria and maintain the effectiveness of dificid and other antibacterial drugs  dificid should be used only to treat infections that are proven or strongly suspected to be caused by clostridium difficile,4
7695,7695,7695,7695,7695,7695,7695,9299,9299,9299,9299,9299,9299,9299,9299,9299,9299,9299,9299,9299,dd966338-c820-4270-b704-09ef75fa3ceb,dificid is a macrolide antibacterial drug indicated in adults ( 18 years of age ) for treatment of clostridium difficile associated diarrhea,1
7696,7696,7696,7696,7696,7696,7696,9300,9300,9300,9300,9300,9300,9300,9300,9300,9300,9300,9300,9300,dd966338-c820-4270-b704-09ef75fa3ceb,( 1 1 ) 1 1 clostridium difficile associated diarrhea dificid is a macrolide antibacterial drug indicated in adults ( 18 years of age ) for treatment of clostridium difficile associated diarrhea ( cdad ),1
7697,7697,7697,7697,7697,7697,7697,9301,9301,9301,9301,9301,9301,9301,9301,9301,9301,9301,9301,9301,3387574f-5eaa-4501-a71d-4cbfbd563031,1  strensiq is indicated for the treatment of patients with perinatal infantile and juvenile onset hypophosphatasia ( hpp ),1
7698,7698,7698,7698,7698,7698,7698,9302,9302,9302,9302,9302,9302,9302,9302,9302,9302,9302,9302,9302,3387574f-5eaa-4501-a71d-4cbfbd563031,strensiq is a tissue nonspecific alkaline phosphatase indicated for the treatment of patients with perinatal infantile and juvenile onset hypophosphatasia ( hpp ),1
7699,7699,7699,7699,7699,7699,7699,9303,9303,9303,9303,9303,9303,9303,9303,9303,9303,9303,9303,9303,485ff360-32c8-11df-928b-0002a5d5c51b,1  contrave is indicated as an adjunct to a reduced calorie diet and increased physical activity for chronic weight management in adults with an initial body mass index ( bmi ) of 30 kg m2 or greater ( obese ) or 27 kg m2 or greater ( overweight ) in the presence of at least one weight related comorbid condition ( e g  hypertension  type 2 diabetes mellitus  or dyslipidemia ),1
7700,7700,7700,7700,7700,7700,7700,9304,9304,9304,9304,9304,9304,9304,9304,9304,9304,9304,9304,9304,485ff360-32c8-11df-928b-0002a5d5c51b,limitations of use the effect of contrave on cardiovascular morbidity and mortality has not been established,0
7701,7701,7701,7701,7701,7701,7701,9305,9305,9305,9305,9305,9305,9305,9305,9305,9305,9305,9305,9305,485ff360-32c8-11df-928b-0002a5d5c51b,the safety and effectiveness of contrave in combination with other products intended for weight loss  including prescription drugs  over the counter drugs  and herbal preparations  have not been established,0
7702,7702,7702,7702,7702,7702,7702,9306,9306,9306,9306,9306,9306,9306,9306,9306,9306,9306,9306,9306,485ff360-32c8-11df-928b-0002a5d5c51b,contrave is a combination of naltrexone  an opioid antagonist  and bupropion  an aminoketone antidepressant  indicated as an adjunct to a reduced calorie diet and increased physical activity for chronic weight management in adults with an initial body mass index ( bmi ) of 30 kg m2 or greater ( obese ) or 27 kg m2 or greater ( overweight ) in the presence of at least one weight related comorbidity ( e g  hypertension  type 2 diabetes mellitus  or dyslipidemia ),1
7703,7703,7703,7703,7703,7703,7703,9307,9307,9307,9307,9307,9307,9307,9307,9307,9307,9307,9307,9307,485ff360-32c8-11df-928b-0002a5d5c51b,( 1 ) limitations of use the effect of contrave on cardiovascular morbidity and mortality has not been established,0
7704,7704,7704,7704,7704,7704,7704,9308,9308,9308,9308,9308,9308,9308,9308,9308,9308,9308,9308,9308,485ff360-32c8-11df-928b-0002a5d5c51b,( 1 ) the safety and effectiveness of contrave in combination with other products intended for weight loss  including prescription and over the counter drugs  and herbal preparations  have not been established,0
7705,7705,7705,7705,7705,7705,7705,9309,9309,9309,9309,9309,9309,9309,9309,9309,9309,9309,9309,9309,d6e65fd4-dcbd-461e-b7b5-d9a7eb799489, for treatment of tinea versicolor  seborrheic dermatitis of scalp and treatment of dandruff,1
7706,7706,7706,7706,7706,7706,7706,9310,9310,9310,9310,9310,9310,9310,9310,9310,9310,9310,9310,9310,"Active Ingredient UNII(s)
Z8J84YIX6L    e4f2a84f-5117-4738-b769-aba8debbddb0
Z8J84YIX6L    e4f2a84f-5117-4738-b769-aba8debbddb0
Name: SET ID dtype: object",active ingredient unii ( s ) z8j84yix6l active ingredient unii ( s ) z8j84yix6l active in z8j84yix6l active ingredient unii ( s ) z8j84yix6l active in name content xml  dtype object,0
7707,7707,7707,7707,7707,7707,7707,9312,9312,9312,9312,9312,9312,9312,9312,9312,9312,9312,9312,9312,1e484a50-55db-4b85-8c57-6cd1b0353abd,1  opsumit is an endothelin receptor antagonist ( era ) indicated for the treatment of pulmonary arterial hypertension ( pah  who group i ) to delay disease progression,1
7708,7708,7708,7708,7708,7708,7708,9313,9313,9313,9313,9313,9313,9313,9313,9313,9313,9313,9313,9313,1e484a50-55db-4b85-8c57-6cd1b0353abd,disease progression included death  initiation of intravenous ( iv ) or subcutaneous prostanoids  or clinical worsening of pah ( decreased 6 minute walk distance  worsened pah symptoms and need for additional pah treatment ),u
7709,7709,7709,7709,7709,7709,7709,9314,9314,9314,9314,9314,9314,9314,9314,9314,9314,9314,9314,9314,1e484a50-55db-4b85-8c57-6cd1b0353abd,opsumit also reduced hospitalization for pah ( 1 1 ),u
7710,7710,7710,7710,7710,7710,7710,9315,9315,9315,9315,9315,9315,9315,9315,9315,9315,9315,9315,9315,1e484a50-55db-4b85-8c57-6cd1b0353abd,1 1 pulmonary arterial hypertension opsumit is an endothelin receptor antagonist ( era ) indicated for the treatment of pulmonary arterial hypertension ( pah  who group i ) to delay disease progression,1
7711,7711,7711,7711,7711,7711,7711,9317,9317,9317,9317,9317,9317,9317,9317,9317,9317,9317,9317,9317,1e484a50-55db-4b85-8c57-6cd1b0353abd,opsumit also reduced hospitalization for pah,u
7712,7712,7712,7712,7712,7712,7712,9318,9318,9318,9318,9318,9318,9318,9318,9318,9318,9318,9318,9318,1e484a50-55db-4b85-8c57-6cd1b0353abd,effectiveness was established in a long term study in pah patients with predominantly who functional class ii iii symptoms treated for an average of 2 years,0
7713,7713,7713,7713,7713,7713,7713,9319,9319,9319,9319,9319,9319,9319,9319,9319,9319,9319,9319,9319,1e484a50-55db-4b85-8c57-6cd1b0353abd,patients were treated with opsumit monotherapy or in combination with phosphodiesterase 5 inhibitors or inhaled prostanoids,0
7714,7714,7714,7714,7714,7714,7714,9320,9320,9320,9320,9320,9320,9320,9320,9320,9320,9320,9320,9320,1e484a50-55db-4b85-8c57-6cd1b0353abd,patients had idiopathic and heritable pah ( 57 )  pah caused by connective tissue disorders ( 31 )  and pah caused by congenital heart disease with repaired shunts ( 8 ) see clinical studies ( 14 1 ),0
7715,7715,7715,7715,7715,7715,7715,9321,9321,9321,9321,9321,9321,9321,9321,9321,9321,9321,9321,9321,ef5f9dd4-945f-ec27-518d-90996a7bd4b6,1  tetrabenazine tablets are indicated for the treatment of chorea associated with huntington s disease,1
7716,7716,7716,7716,7716,7716,7716,9322,9322,9322,9322,9322,9322,9322,9322,9322,9322,9322,9322,9322,ef5f9dd4-945f-ec27-518d-90996a7bd4b6,tetrabenazine is a vesicular monoamine transporter 2 ( vmat ) inhibitor indicated for the treatment of chorea associated with huntington s disease,1
7717,7717,7717,7717,7717,7717,7717,9323,9323,9323,9323,9323,9323,9323,9323,9323,9323,9323,9323,9323,47ceb7e1-b2f7-47f8-8b6a-85eea36606b8, bupropion hydrochloride extended release tablets  usp ( xl ) is an aminoketone antidepressant  indicated for the treatment of major depressive disorder ( mdd ) and prevention of seasonal affective disorder ( sad ),1
7718,7718,7718,7718,7718,7718,7718,9325,9325,9325,9325,9325,9325,9325,9325,9325,9325,9325,9325,9325,47ceb7e1-b2f7-47f8-8b6a-85eea36606b8,( 1 ) 1 1 major depressive disorder bupropion hydrochloride extended release tablets  usp ( xl ) are indicated for the treatment of major depressive disorder ( mdd )  as defined by the diagnostic and statistical manual ( dsm ),1
7719,7719,7719,7719,7719,7719,7719,9328,9328,9328,9328,9328,9328,9328,9328,9328,9328,9328,9328,9328,47ceb7e1-b2f7-47f8-8b6a-85eea36606b8,1 2 seasonal affective disorder bupropion hydrochloride extended release tablets  usp ( xl ) are indicated for the prevention of seasonal major depressive episodes in patients with a diagnosis of seasonal affective disorder ( sad ),1
7720,7720,7720,7720,7720,7720,7720,9330,9330,9330,9330,9330,9330,9330,9330,9330,9330,9330,9330,9330,900e7dc0-9afe-4f50-80de-90567bb78519,1  ravicti is indicated for use as a nitrogen binding agent for chronic management of patients 2 months of age and older with urea cycle disorders ( ucds ) who cannot be managed by dietary protein restriction and or amino acid supplementation alone,1
7721,7721,7721,7721,7721,7721,7721,9331,9331,9331,9331,9331,9331,9331,9331,9331,9331,9331,9331,9331,900e7dc0-9afe-4f50-80de-90567bb78519,ravicti must be used with dietary protein restriction and  in some cases  dietary supplements ( e g  essential amino acids  arginine  citrulline  protein free calorie supplements ),4
7722,7722,7722,7722,7722,7722,7722,9332,9332,9332,9332,9332,9332,9332,9332,9332,9332,9332,9332,9332,900e7dc0-9afe-4f50-80de-90567bb78519,limitations of use ravicti is not indicated for the treatment of acute hyperammonemia in patients with ucds because more rapidly acting interventions are essential to reduce plasma ammonia levels,2
7723,7723,7723,7723,7723,7723,7723,9333,9333,9333,9333,9333,9333,9333,9333,9333,9333,9333,9333,9333,900e7dc0-9afe-4f50-80de-90567bb78519,the safety and efficacy of ravicti for the treatment of n acetylglutamate synthase ( nags ) deficiency has not been established,0
7724,7724,7724,7724,7724,7724,7724,9334,9334,9334,9334,9334,9334,9334,9334,9334,9334,9334,9334,9334,900e7dc0-9afe-4f50-80de-90567bb78519,ravicti is a nitrogen binding agent indicated for chronic management of patients 2 months of age and older with urea cycle disorders ( ucds ) who cannot be managed by dietary protein restriction and or amino acid supplementation alone,1
7725,7725,7725,7725,7725,7725,7725,9335,9335,9335,9335,9335,9335,9335,9335,9335,9335,9335,9335,9335,900e7dc0-9afe-4f50-80de-90567bb78519,ravicti must be used with dietary protein restriction and  in some cases  dietary supplements,4
7726,7726,7726,7726,7726,7726,7726,9336,9336,9336,9336,9336,9336,9336,9336,9336,9336,9336,9336,9336,900e7dc0-9afe-4f50-80de-90567bb78519,( 1 ) limitations of use ravicti is not indicated for treatment of acute hyperammonemia in patients with ucds,0
7727,7727,7727,7727,7727,7727,7727,9337,9337,9337,9337,9337,9337,9337,9337,9337,9337,9337,9337,9337,900e7dc0-9afe-4f50-80de-90567bb78519,( 1 ) safety and efficacy for treatment of n acetylglutamate synthase ( nags ) deficiency has not been established,0
7728,7728,7728,7728,7728,7728,7728,9338,9338,9338,9338,9338,9338,9338,9338,9338,9338,9338,9338,9338,de4e66cc-ca05-4dc9-8262-e00e9b41c36d,1  lucentis is indicated for the treatment of patients with lucentis  a vascular endothelial growth factor ( vegf ) inhibitor  is indicated for the treatment of patients with neovascular ( wet ) age related macular degeneration ( amd ) ( 1 1 ) macular edema following retinal vein occlusion ( rvo ) ( 1 2 ) diabetic macular edema ( dme ) ( 1 3 ) diabetic retinopathy ( dr ) ( 1 4 ) myopic choroidal neovascularization ( mcnv ) ( 1 5 ) 1 1 neovascular ( wet ) age related macular degeneration ( amd ) 1 2 macular edema following retinal vein occlusion ( rvo ) 1 3 diabetic macular edema ( dme ) 1 4 diabetic retinopathy ( dr ) 1 5 myopic choroidal neovascularization ( mcnv ),1
7729,7729,7729,7729,7729,7729,7729,9339,9339,9339,9339,9339,9339,9339,9339,9339,9339,9339,9339,9339,3a27d0ef-83a7-4e1c-9430-46a3326ee8d8, metopirone is a diagnostic drug for testing hypothalamic pituitary acth function,1
7730,7730,7730,7730,7730,7730,7730,9340,9340,9340,9340,9340,9340,9340,9340,9340,9340,9340,9340,9340,4595bfbe-c3b5-4053-b6f5-2e2b9ff85c82, l cysteine hydrochloride injection  usp is intended for use only after dilution as an additive to crystalline amino acid injections to meet the intravenous amino acid nutritional requirements of infants receiving total parenteral nutrition,1
7731,7731,7731,7731,7731,7731,7731,9341,9341,9341,9341,9341,9341,9341,9341,9341,9341,9341,9341,9341,6025e8d4-5083-4c3a-58a0-050e7b0b6150, nalbuphine hydrochloride injection is indicated for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate,1
7732,7732,7732,7732,7732,7732,7732,9342,9342,9342,9342,9342,9342,9342,9342,9342,9342,9342,9342,9342,6025e8d4-5083-4c3a-58a0-050e7b0b6150,nalbuphine hydrochloride injection can also be used as a supplement to balanced anesthesia  for preoperative and postoperative analgesia  and for obstetrical analgesia during labor and delivery,1
7733,7733,7733,7733,7733,7733,7733,9343,9343,9343,9343,9343,9343,9343,9343,9343,9343,9343,9343,9343,6025e8d4-5083-4c3a-58a0-050e7b0b6150,limitations of use because of the risks of addiction  abuse  and misuse  with opioids  even at recommended doses see warnings  reserve nalbuphine hydrochloride injection for use in patients for whom alternative treatment options e g  non opioid analgesics have not been tolerated  or are not expected to be tolerated have not provided adequate analgesia  or are not expected to provide adequate analgesia,4
7734,7734,7734,7734,7734,7734,7734,9344,9344,9344,9344,9344,9344,9344,9344,9344,9344,9344,9344,9344,08982e49-d2eb-4b25-b01a-1be52fd669ef,1  aptivus  co administered with ritonavir  is indicated for combination antiretroviral treatment of hiv 1 infected patients who are treatment experienced and infected with hiv 1 strains resistant to more than one protease inhibitor ( pi ),1
7735,7735,7735,7735,7735,7735,7735,9345,9345,9345,9345,9345,9345,9345,9345,9345,9345,9345,9345,9345,08982e49-d2eb-4b25-b01a-1be52fd669ef,this indication is based on analyses of plasma hiv 1 rna levels in two controlled studies of aptivus ritonavir of 48 weeks duration in treatment experienced adults and one open label 48 week study in pediatric patients age 2 to 18 years,0
7736,7736,7736,7736,7736,7736,7736,9346,9346,9346,9346,9346,9346,9346,9346,9346,9346,9346,9346,9346,08982e49-d2eb-4b25-b01a-1be52fd669ef,the adult studies were conducted in clinically advanced  3 class antiretroviral ( nrti  nnrti  pi ) treatment experienced adults with evidence of hiv 1 replication despite ongoing antiretroviral therapy,0
7737,7737,7737,7737,7737,7737,7737,9347,9347,9347,9347,9347,9347,9347,9347,9347,9347,9347,9347,9347,08982e49-d2eb-4b25-b01a-1be52fd669ef,the following points should be considered when initiating therapy with aptivus ritonavir the use of aptivus ritonavir in treatment na ve patients is not recommended see warnings and precautions ( 5 1 ),0
7738,7738,7738,7738,7738,7738,7738,9348,9348,9348,9348,9348,9348,9348,9348,9348,9348,9348,9348,9348,08982e49-d2eb-4b25-b01a-1be52fd669ef,the use of other active agents with aptivus ritonavir is associated with a greater likelihood of treatment response see clinical pharmacology ( 12 4 ) and clinical studies ( 14 ),0
7739,7739,7739,7739,7739,7739,7739,9349,9349,9349,9349,9349,9349,9349,9349,9349,9349,9349,9349,9349,08982e49-d2eb-4b25-b01a-1be52fd669ef,genotypic or phenotypic testing and or treatment history should guide the use of aptivus ritonavir see clinical pharmacology ( 12 4 ),0
7740,7740,7740,7740,7740,7740,7740,9350,9350,9350,9350,9350,9350,9350,9350,9350,9350,9350,9350,9350,08982e49-d2eb-4b25-b01a-1be52fd669ef,the number of baseline primary protease inhibitor mutations affects the virologic response to aptivus ritonavir see clinical pharmacology ( 12 4 ),0
7741,7741,7741,7741,7741,7741,7741,9351,9351,9351,9351,9351,9351,9351,9351,9351,9351,9351,9351,9351,08982e49-d2eb-4b25-b01a-1be52fd669ef,use caution when prescribing aptivus ritonavir to patients with elevated transaminases  hepatitis b or c co infection or patients with mild hepatic impairment see warnings and precautions ( 5 1 ),2
7742,7742,7742,7742,7742,7742,7742,9352,9352,9352,9352,9352,9352,9352,9352,9352,9352,9352,9352,9352,08982e49-d2eb-4b25-b01a-1be52fd669ef,liver function tests should be performed at initiation of therapy with aptivus ritonavir and monitored frequently throughout the duration of treatment see warnings and precautions ( 5 1 ),4
7743,7743,7743,7743,7743,7743,7743,9353,9353,9353,9353,9353,9353,9353,9353,9353,9353,9353,9353,9353,08982e49-d2eb-4b25-b01a-1be52fd669ef,the drug drug interaction potential of aptivus ritonavir when co administered with other drugs must be considered prior to and during aptivus ritonavir use see contraindications ( 4 2 ) and drug interactions ( 7 ),2
7744,7744,7744,7744,7744,7744,7744,9354,9354,9354,9354,9354,9354,9354,9354,9354,9354,9354,9354,9354,08982e49-d2eb-4b25-b01a-1be52fd669ef,use caution when prescribing aptivus ritonavir in patients who may be at risk for increased bleeding or who are receiving medications known to increase the risk of bleeding see warnings and precautions linkhtml href section 5 4,3
